{
    "papers": [
        {
            "paper_name": "(2)5-Methylcytosine DNA demethylation_ more than losing a methyl group.pdf",
            "cleaned_text": "GE46CH19PetersenMahrt ARI August Methylcytosine DNA Demethylation Losing Methyl Group DonMarc FranchiniKerstinMaike Schmitz dna edit Immunity Epigenetics IFOMFondazione Istituto Oncologia email Annual Genetics online genetannualsorg article annurevgenet Copyright right reserve author contribute equally epigenetic dna repair dna reprogramming cytosine deamination cytosine hydroxylation demethylation methylcytosine dna integral nance intact epigenome balance presence absence methylcytosine determine many physiological aspect cell metabolism turnover measure Biochemically addition methyl group share live kingdom well characterize moval reversion mark seem diverse much less stand present summary dna demethylation initiate directly utilize translocation TET family protein activationinduced deaminase AID dna mod ifye enzyme indirectly transcription rna metabolism dna repair intermediate pathway substrate DNA repair machinery demethylation pathway link possibly balanced avoid mutation post online Changes still occur final publication online print change still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI introduction mammalian cpg methylation methyl modication cytosine double strand dimer provide mean local heritable control gene expression reversible notion foster search mechanism lead dna demethylation Biochemically DNA methyla tion serve multitude purpose figure alter Waals radius cytosine addition bulky methyl group help foster formation non dna alter base stack potential cytosine possibly inuence com pactness winding nucleosome inhibit bind dna bind protein enhance bind methylcpg bind protein dna structure dna bend nucleosome transcription location compaction Proliferation Differentiation Development Imprinting Cellular pluripotency oncogenesis rna metabolism dna replication silence dna bind protein bind consequence NH2 Cytosine methyl cytosine NH2 CH3 Figure overview methylation cytosine inuence biological process methyl group cytosine exert biochemical change dna direct dna structure dna bend nucleosome indirect enablingdisable association protein bind biochemical modication serve molecular signal chromosome function various mean combination molecular signal determine development physiology pathology organism MBPs nucleus DNA methylation serve figure change compaction chromatin change subnuclear localization gene locus change activation potential gene repress transposon selsh dna alter dna replication efcacy inuence rate rna process diverse functionality profound effect cellular proliferation differentiation pluripotency development imprinting oncogenesis figure Demethylation subject temporal cellular regulation raise likelihood several type effector involve give time mammal numerous example active dna demethylation scribe extent active demethylation Changes still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI variable range global genome wide local genespecic demethylation possibly even single cytosine active tissue dna demethylation carry early step development character ize genomewide loss methylcytosine 5mCFirstinthezygotethepaternalgenome undergo massive wave loss right fertilization Second global demethylation observe cellular migration primordial germ cell PGCs genital ridge aside global dna reprogramming event evidence active dna demethyla tion somatic cell report mature neuron lymphocyte breast cancer cell line local dna demethylation lead specic gene activation detect follow cellular stimulation wealth datum global methylation status local cpg demethylation derive study physiological development cancer tissue differentiation stem cell survival explain simple single static pathway dna demethylation cpg methylation provide mark numerous molecular function presence absence detect broad dynamic scale range uctuation perfect stability generation demethylation cyclic directly follow remethylation burst promoter activation also persist developmental path conclude time gene cell return quiescent state persistent demethylation require terminally differentiate cell highlight pathway cur rently know lead dna demethylation focus mostly mammal importance epigenetic reprogramming health dis ease increasingly appreciate also hope provide nonexpert enough overview allow independent exploration exciting DNA Demethylation Loss Methylcytosine recognition progress science dependent avail able technology tech nique commonly use identify dna methylation include restriction analysis methylationsensitive enzyme stain antibody recognize chemical treatment follow sequence approach strength limitation particularly sensitive modication modie alter pattern striction digest antibody recognition prevent loss methyl group also modication methyl group modied different chem ical property treatment chemical difference affect tection vitro also important molecular recognition vivo reversibility methylation therefore understand term function well chemistry chemical biological function describe mod ulate modication removal methyl group also shield hiding hide potentially important source regulation discuss systematically test experimentally hiding principle achieve chemically tautomerization pyrimidine usually amino tautomer form recognize methylcpg bind domain MBPs local acidic change stimulate example loss basic protamine buffer DNA phosphodiester backbone induce transition imino form possibly prevent ing recognition Return neutral enable recognition local change commonly use precise mean inuence biological activity DNA Demethylation change still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI August see subtle shift promote catalysis histidinecontaine enzyme inhibit recognition cpg dna nucleotide methyltrans ferase DNMT thereby lead demethylated phenotype recognize chromatin positioning respect face core nucleosome inuence MBD bind linker DNAassociated 5mcs even accessible suggest hide nucleosome depend position nucleosome methylate region methyl moiety mean prevent recognition induce change epigenetic tus locus see discussion translocation TET family protein reversible allow transient namic loss methylation response devel opmental environmental stimulus Base removal stable mechanism dna demethylation bring high price mutability nonetheless discovery several dna repair pathway involve dna demethylation see follow section detail seem indicate risk evolutionary acceptable absentee DNA covalent modication protein phosphorylation alter structure protein interaction protein bond energy protein phosphorylation allow rapid addition removal biological advantage fully exploit see large number kinase phosphatase participate aspect biology however chemistry cytosine methylation seem forbid comparable transience Methylation position cytosine stable carbon carbon bond require substantial energy break share aromatic cytosine ring input energy sufcient break position dissipate duce bond breakage carbon bond preclude direct demethylation position explain activity directly demethylate dna identie instead cytosine dna demethylation appear require cascade enzyme lead production cytosine term DNA demethylase suggest single activity use discuss avoid possible confusion however dna demethylase describe act directly remove cleave carbon bond AlkB dioxygenase find prokaryote eukaryote carry oxidative demethy lation remove alkylation DNA DNA repair enzyme use oxygen oxoglutarate cofactor release methyl group methyl adenine methyl cytosine formaldehyde demethylation pathway acting NEAR METHYLCYTOSINE recent explosion num ber factor implicate dna demethyla tion lead con fusing misleading picture attempt simplify figure separate pathway group specic factor act thymine dna glycosylase TDG MBD4 TET AID DNMT1 link identie likely indirect gadd45 hormone direct interact protein divide directly mutagenic tar get lesioninduced demethylation indirectly nonmutagenic target modicationinduced demethylation see sidebar Triggering Active DNA Demethylation demethylation path way involve signicant overlap dna repair protein pathway use Changes still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI August passive dna demethylation dna methylation symmetrical carbon methylate basepaired dinucleotide dna strand replicative dna polymerase incorporate hemimethylated DNA termediate form DNA replication prokaryote repression methyltrans ferase activity replication lead dilution methylate basis daugh ter DNA molecule lack methylation dnmt essential establishment maintenance methylation prole vertebrate dna replica tion number protein associate replicative dna polymerase include pro cessivity factor nucleosome remodeler dna repair protein DNA polymerase clamp loader PCNA interact maintenance methyltransferase Reducing expression inhibit interaction PCNA lead genomewide loss cpg methylation genome instability possess autoinhibitory mechanism ensure target hemimethylated prevent act dna follow demethylation dna strand furthermore inhibition recruitment also lead passive dna demethylation presence UHFR1 bind hemimethylated DNA domain tether locus accordingly depletion lead loss genomewide methylation mark dnmt include DNMT2 DNMT3A also act hemimethylate however usually consider novo methylate enzyme role dna demethylation indirect see extent dynamic genome mammal suggest passive dna demethylation alone account change prokaryote replicate genome minute even multi copy available growth mammalian TRIGGERING active dna demethylation protein induce active demethylation divide type proceed mutagenic intermediate targeted LesionInduced Demethylation TLD rst group include protein able induce dna demethylation introduce lesion include product site well DNA deaminase produce mismatch importantly pathway require direct efcient activation DNA repair machinery Targeted ModicationInduced Demethylation TMD second category involve protein able modify lead change dsdna base pair modication serve hide recognition become target importantly protein directly link dna repair allow demethylation proceed different kinetic methylation dynamic cover occur rence even dna replication DNA Glycosylases Base Excision Repair Mammalian genome experience event efciently repair numerous dna repair pathway dna glycosylase play pivotal role repair remove damage dna basis genome gly cosylases implicate base excision repair uracil dna glycosylase mitochondrial UNG1 nuclear TDG singlestrand selective monofunctional uracil dna glycosylase MBD4 oxidize basespecic glycosylase NTH1 NEIL1 dna glycosylase report act BER pathway thus implicate active dna demethylation dna glycosylase remove wwwannualsorg 5mC DNA Demethylation change still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI aid aid DNMT1 inhibitor TET TDG MBD4 BER BER BER BER MMR MMR Direct TLD TMD Indirect TET dna damage DNA topology rna transcription elongation PARP1 TDG BER BER BER MMR NER NER Intermediate figure active dna demethylation machinery protein green pathway orange act protein classie target lesioninduced demethylation target modicationinduced demethylation see sidebar Triggering Active DNA Demethylation currently protein include include TET protein family protein pathway act unknown possibly share intermediate Arrows indicate link pathway generate abasic site site become substrate endonuclease APE turn cleave strand dna backbone remove deoxyribosephosphate result single nucleotide gap lle dna polymerase incorporate opposite backbone ligate thus scenario result replacement figure glycosylasedependent dna demethyla tion pathway already describe plant employ DNA glycosy lase ROS1 bifunc tional enzyme initiate demethylation rst remove base cleav ing result site plant discuss detail reader encourage look recent Changes still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI August modification Oxidation Base removal Backbone cleavage dna lesion dna mismatch dna pol dna ligase mismatch recognition dna pol Processivity factor dna ligase dna pol dna resynthesis dna ligase 2nd lesion recognition dna resection dna resynthesis Processivity factor RNF4 ape MBD4 AID tet BER UNG PARP BER BER MSH2 PCNA PCNA MMR TDGMBD4 DNA pol beta dna pol dna pol dna pol deltaepsilon TET MSH2 PCNA 5mC UNG PARP Figure Mechanisms active dna demethylation current model active dna demethylation involve dna repair pathway orange include short patch long patch base excision repair mismatch repair target modicationinduced demethylation pathway show top leave Activationinduced deaminase AIDinduced target lesioninduced demethylation pathway show top right glycosylasesinduce show top center key protein show schematic Intermediates pathway resolve pathway dna lesion target enter repair pathway various stage lead demethylation BER lead single base demethylation activity processive dna polymerase enable single lesion initiate extensive demethylation protein indicate green act pair analogous plant enzyme however enzyme kinetic vivo genetic seem preclude direct function analo gous rst step ROS1 plant dna dna demethylation rst propose activity describe chicken embryo extract function coordination explain early observation replace cytosine rather change cyto sine preferred substrate thymine uracil mispaire guanine mismatch cpg context enhance enzymatic activity report show directly excise guanine pair activity reduce factor relative thymine guanine pair subsequently laboratory wwwannualsorg DNA Demethylation change still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI unable reproduce nde importance epigenetic reprogramming aptly show demonstrate tdgdecient mice exhibit reduce global methylation embryonic lethality author speculate observed phenotype due global impairment dna methylation possibly also due broad regulatory function interact transcription factor histone ferase see second knockout conrme function dna demethylation author speculate trimeric complex GADD45 propose BER drive global demethylation DNA glycosylase remove thymine uracil mismatch initiate demethylation con junction BER machinery similar TDG MBD4 activity enhance mismatch cpg context activity pair reduce fold however knockout mouse cient viable show increase transition mutation rate enhanced tumorigenesis tive demethylation paternal pronucleus zygote unaffected suggest essential global dna demethylation event functional domain terminal MBD highly conserve terminal glycosylase domain belong family MBD protein bind symmetrically methylate cytosine exclusively context doublestranded DNA play substantial role novo silencing maintenance silent state target gene MBD MBD4 bind preferentially mismatch primary product deamination single cpg context Base Modications circumvent absence direct deglyco sylation mammal mean initiate dna demethylation idation deamination radical adenosyl methionine sambase demethylation result modication lead loss dna methylation recognition loss methyl group figure TET Pathway Hydroxymethylcytosine5hmCinDNAwas discover riophage express glucosyl transferase convert bulk nomic cytosine modication protect bacteriophage dna striction host serve mark selfrecognition identication 5hmC mammalian genome recent detection neu ronal cell embryonic stem cell provide resurgence interest modied base mammal hydroxymethylation reaction catalyze member TET protein family oxoglutarate dependent dioxygenase able convert figure TET protein express tissue active dna demethylation take place tet1 expression mainly con embryonic stem cell TET2 TET3 expres sion ubiquitous mouse embryonic stem cell TET2 necessary cellular commitment identity zygote TET3 responsible conversion paternal pronucleus TET1 bind preferentially transcription start site promoter region high density plain presence CXXC zinc nger domain recognize unmethylate cpg interestingly 5hmC show broad Changes still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI distribution gene find gene accumulation promoter region preferentially detect gene bivalent chromatin contain ing activating repressive mark actively transcribe gene 5hmC distribute gene body particularly exon similar distribution report mouse cerebellum human brain methylation cytosine forma tion 5hmC cause alteration molecular recognition MBDcontaining MECP2 protein exhibit fold reduced recognition 5hmC compare loss recognition also observe turn promote passive demethylation recognize hemimethylated thereby pro vide bridge passive active dna demethylation recent study report TET pro tein oxidize formylcytosine 5fC carboxylcytosine 5caC raise possibility TET protein carry active DNA lation successive oxidation TET enzyme efciency decrease succe sive oxidation interesting know important enzy matic mechanism control due lack yetidentie cofactor analogous sumoylation bind substrate allow turnover kinetic proceed date enzyme identie promote loss formyl carboxyl group lead complete demethylation enzymatic step TET pathway lead forma tion course analogous describe work focus ing oxidation removal methyl group thymine Thymine hydroxylase oxidize methyl group free thymine successive step toform5hydroxymethyluracilformyluracil carboncarbon bond cleave separate carboxylase mention neces sary remove moiety obtain biological function oxidation pre clude binding protein usually recognize yet identie prevent version TET reaction 5hmC 5mC 5hmC sufcient hide Inter estingly presence high concentration absence relate elevated transcription rate however complete oxidation 5hmC 5fC 5caC provide substrate level 5caC elevate genome decient cell least vitro system act 5caC pair Base Excision Repair aid rst characterize function diversication immunoglobulin aid target cytosine singlestranded DNA ssdna locus induce ination create mismatch due hijack DNA repair misfunction lead mutation recombination process diversication highly mutagenic mutator activity order magnitude low locus transcription gene drive estrogen expression limit immune cell interestingly nonimmune tissue oocyte germ cell stem cell dna demethylation highly active correlate aid expression address possi bility deamination mechanistic pathway DNA demethyla tion test ability use substrate show deaminate generate mismatch genetic evidence involvement dna demethylation come zebrash overexpression induce global dna demethylation wwwannualsorg DNA Demethylation change still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI furthermore nondivide heterokaryon reprogramming broblast nucleus duce aid expression change methy lation status pluripotency gene oct4 Importantly AID decient mouse content increase suggest involve genomewide demethylation PGCs Mechanistically figure function demethylation combine deamination activity various dna repair pathway already show immune diversication damage elicit response BER protein mismatch repair translesion synthesis endjoining pathway similar pathway utilize site deam ination lead DNA demethylation Deam ination 5mC generate context result mismatch pre ferred substrate describe repair mismatch lead cytosine incorpora tion use factor BER pathway number model propose form com plex promote demethylation sociation suggest zebrash biochemical analysis need conrm well plain member DNA deaminase family lack catalytic activity induce lation zebrash recently also propose form complex TDG context demethylation pathway Unfor tunately proper biochemical evidence miss ing unlikely function 5fC 5caC recent work lab other indicate bind pocket accommo date side chain large methyl group suggest dna deaminases TET protein utilize different initiation pathway dna demethylation sion resolution proceed common intermediate immune diversication cytosine deamination lead mutation neighbor known phase somatic hypermutation key enzyme pathway responsible effect include MSH2 MSH6 error prone dna pol link MMR factor dna demethyla tion provide number unique insight figure mis matcheswouldberecognizedbymmrprotein MSH2 classical lead recruitment resection basis ssdna gap resynthesized DNA pol incorporate cytosine newly form strand therefore single lesion lead removal stretch dna type processive dna polymerasedependent dna demethylation efcient less mutagenic target single BER pathway future work need deter key factor distinguish errorfree MMR classical mutagenic MMR observe diversication pathway control demethylation aid possibility extend demethylation single site especially intriguing know travel stalledrestarted elon gate RNA pol Willmann Milosevic Rangam Skehel unpublishe observation deaminate limited sequence context hence induce local dna demethylation always achieve static mechanism target AID individual currently clear determine dna repair pathway choice induction lesion aid importantly relevant repair pathway interlink substrate Changes still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI intermediate specic protein PCNA likely efciency demethyla tion depend number mis match versus mismatch activity activation Targeting important caveat model postulate role dna demethylation essential target achieve DNA lation Deamination also gener ate mismatch activity mismatch initiate DNA demethy lation adjacent position extension DNA repair pathway utilize proce sive dna polymerasenot also nucleotide excision repair long patch BER see induce dna demethylation specically target therefore target dna damage induce dna demethylation target lesion arise aside TETcoupled BER yet determine butcouldincludetargetingmechanismsoftran scription dna replication chromatin remod eling transposon silence figure see DNA damageinduced dna demethyla tion propose prior discovery tet function chro matin association modify zymes rather random environmental damage physical chemical agent make understanding current pathway even pertinent dna damage recently propose dnmt participate active dna demethylation base observation perform lation concentration methyl donor SAM formation certain threshold instead initiate deamination already form experiment show requirement function genetic requirement DNMTs cyclic DNA demethylation promoter vivo datum seem suggest necessary fold drop SAM concentration induce deamination methyltransferase unlikely global event also clear choose condition allow act product rather substrate however possibility DNMT enzyme induce deamination cytosine lead dna demethylation plausible activity link dna repair interaction demonstrate various lab furthermore demethylation quite efcient pro pathway involve aside mammal contain least active DNA deaminase human large primate contain ditional dna deaminase member family evolve deaminate rna also ability target dna APOBEC3 subfamily antiviral activity APOBEC3 member function deaminating retrovirus rst strand cDNA synthesis APOBEC1 know act know member likely future work determine mostly cytoplasmic protein involve demethylation pathway predict dna demethylation also initiate event target physiologi cal dna damaging protein also duce demethylation end port show druginduced inhibi tion DNA topoisomerase lead change dna methylation effect drug likely indirect camptothecin inhibitor dna topo induce methylation etoposide wwwannualsorg DNA Demethylation change still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI inhibitor dna topo indicate dna structural change always lead global demethylation dependence dna repair achieve dna demethylation also carry price tation random demethylation target dna damage induce demethylation preclude random dna damage also duce change epigenome light oxidative damage number environ mental dna damage agent induce local bad case global dna demethyla tion possibly single lesion lesion repair leave genetic mark mutation leave epi genetic mark also lead patholo gy include cancer circumvent much change environment backup system form epigenetic mark tone modication polycomb complex binding coordinate methylome indirect dna aid tet TDG MBD4 DNMTs act yet number protein apparent dna modication activity identie least genetically induce dna demethylation figure transcription somewhat paradoxical transcription induce active dna demethylation cause high oxidative potential process transcription induce dna lesion damage basis repair involve processive polymerase replace past think glycosylase also transcrip tion factor inducible retinoic acid interact retinoic acid receptor light involvement dna demethylation need determine function transcription factor mean target promoter mean recruit transcription factor inactive promoter mean induce dna demethylation chromatin remodeling mention part elongate RNA pol complex possi induce dna demethylation tran scription direct association SPT5 well polymerase associate factor Rangam Skehel unpublished observation demonstrate transcription mutational activity find limited region start maximum downstream TSS Analogously TET protein usually sociate promoter product also detect code region upstream still needs deter mine association occur pre post transcription possible difference TET pattern distribution gene especially respect point differential usage dna demethylation pathway also exhibit difference temporal association rna pol seem asso ciate transcription initiation factor seem associate elongationrestart factor RNA pol elongator complex also show play role partial genome wide demethylation paternal genome zygote knockdown ELP3 part holoelongator complex well partially impair paternal dna demethylation domain map ping ELP3 indicate radical SAM domain critical demethylation lead direct attack dnmt recruitment factor also play signicant role ELP3 dependent dna demethylation transcription initiate dna demethylation promoter still govern transcription machinery Franchini Schmitz PetersenMahrt Changes still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI case cycling pS2TFF1 promoter show coordinate BER pathway protein induce strandspecic demethylation estrogeninduced transcriptional cycling possible link promoter activa tion dna demethylation show knockdown constitutive tor ERCC1 lead pro moter methylation experiment demonstrate correlation histone modication gene activation pro tein well loss demethylation promoter DNA play important part dna demethylation hypothesize datum present mammal divide subpathway global genome repair GGR transcriptioncouple repair figure region lesion recognition unknown signal open dna dna resynthesis dna excision dna ligation gadd45 xpa ercc1xpf dna pol PCNA tfiih NER figure schematic nucleotide excision repair lead dna demethylation lesion recognize yet identied signal initiate possibly recruit TAF12 factor growth arrest dna damageinducible alpha turn bring endonuclease lesion bind serve landing platform tfiih endonuclease ERCC1XPF bind complex dene region approximately subsequently unwound excise cleavage target strand provide entry pol complex dna resynthesis ligation excise replace unmodied cytosine result processive polymerasedependent short stretch dna demethylation wwwannualsorg DNA Demethylation change still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI anke damage dna incised nucleotide oligomer excise Subsequently DNA polymerase similar gap dna ligase seal end chromatinassociated step recognition initial damage detection damage verication tfiih XPB XPD enzymatic action excision machinery XPG XPFERCC1 damage dna substrate resynthesis PCNA DNA pol ligase IIIXRCC1 base recognition rate limit lesion identication paramount dna demethylation induce dna demethylation show growth arrest dna damage inducible alpha isolate screen potential protein furthermore interact involvement dna demethylation demonstrate protein involvement dna demethylation also demonstrate rdna locus TAF12 play key role keep gene free methylation factor part RNA pol pol specic TBPTAF complex bind promoter recruit induce NERdependent demethylation thereby pro vide rst molecular connection dna demethylation GGR classical independent therefore boundary pathway blur participate dna demethylation system specic lesion stimulate demethylation yet identie recent work demonstrate necessity lesion unknown origin induce global dna demethylation stain mouse zygote dna break phos phorylation possible monitor dynamic DNA strand repair event correlate active dna demethylation distinct developmental stage site dna damage indicate utilization well pathway respond dna nick critical seem play differentiate role short patch BER BER longpatch BER BER induce BER stretch DNA remove dna glycosylase activity facilitate FEN1 ap FEN1induced nucleotide away initial lesion dna pol conjunction PCNA perform dna resynthesis strand displacement BER gap religate DNA MMR BER allow dna demethylation target PARP1 rst implicate active dna demethylation study PGCs embryonic stage mrna encoding factor associate BER less extent detect activity base chemical inhibi tion correlate appearance dna demethylation author study suggest involve contrast other identie role development technical difference account dif ferent result interestingly effect inhibition dna demethylation observe globally locally APE key protein BER inhibition seem inu ence global DNA methylation status sug geste different protein pathway share unequal responsibility dna demethylation furthermore thor also see correlation DNA lation increase TET protein mrna detailed analysis delineate dna demethylation pathway active time locus extent provide proper insight Demethylation discussion chromatin change epi genetic state proceed include histone modication rather explore possible histone mark lead Changes still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI repressive active chromatin focus modication show direct link dna demethylation interplay dna methylation histone modication extensively demonstrate show evolutionary loss certain specie regulatory function dna methylation demethylation substitute possibly nondna dependent pathway observation also relevant understanding dna demethylation mammal histone cation substitute dna methylation reveal complete molecular mecha nism biogenesis epigenetic environment require dna demethylation dna reprogramming fertilize zygote paternal genome target dna demethylation maternal genome seems protect active process suggest protection maternal genome asymmetric chromatin mark distinguish genome also play role absence PGC7Stella result aberrantly target dna demethylation maternal paternal pronucleus zygote PGC7Stella null female activation BER component detectable parental pronucleus fertiliza tion paternal genome undergo histone variant incorporation protamine exchange moreover mono trimethylation trimethylation barely detect paternal genome identie maternal pronucleus indicate even global scale histone modication dna demethylation interdependent similarly migration genital ridge PGCs associate dynamic change histone modication interestingly time seem quire dna demethylation chromatin undergo change similar observe male pronucleus lose repressive mark H3K9me2 h3k9me3 H3K27me3 H3K64me3 linker histone gain permissive modication h3k9ac h3k4me change precede occur concomitant dna demethylation prerequisite clear create permissive chromatin provide accessibility DNA demethylation path way accordingly tet1 occupancy positively correlate H3K4me3 depletion TET1 result increase cpg island methylation occupancy present inverse correlation presence H3K27me3 TET1 also bind gene present bivalent chromatin H3K4me3 H3K27me3 cell bivalent gene represent gene high content promoter usually developmentally regulate gene surprisingly knockdown TET1 downregulate gene expression also cause gene upregulation suggest broad role gene transcription regulation context find colocalize polycomb repressor complex PRC2 associate corepressor complex Sin3A therefore activate repress transcription activity regulate histone modication presence polycomb complex dnmt directly involve dna demethylation histone mod ication also inuence dna demethyla tion plant homeodomainlike main recognize histone tail modication occur depend methylation status induce activity furthermore guide partner clude chromatin presence specic histone mark H3K4me3 hence DNA become available novo methylation full epigenetic land scape genome change recently show interact member RNA pol elongation wwwannualsorg DNA Demethylation change still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI complex chromatin remodeling factor Rangam Skehel unpublished observation importantly part target due presence histone trimethylation show interact SPT5 need induce phosphorylation ser5 restart rna pol pause serve platform complex Rangam Skehel unpublished observation turn promote histone monoubiquitination ubiqutination allow dependent trimethylation H3K36 time fact facilitate chromatin transcription complex facilitates efcient rna pol elongation fact SSRP1SUPT16H cooperate chromatin remodeling histone ability destabilize histone nucleosome enhance cotranscriptional chromatin mark FACT complex also play key role chromatin tion pathway recruit dna demethylation transcription furthermore recent datum indicate evolutionarily conserve fact complex play direct role DEMETERinduced dna demethylation identify orthologous pathway plant mammal link chromatin modify fact complex show interact histone acetyltransferase hat CBPp300 possible duality function suggest knockout exhibit phenotype combine alter dna demethylation histone modication pecially regard expression bivalent modied gene status important target TMD TLD factor initiate demethylation also deter mine efciency possibly choice downstream processing machinery recently show nucleosome tion remodeling alter activity BER dna pol hibite presence nucleosome unaffecte tantly remodeler reacti vate BER pathway dispensable variant use clearly even example inter intraplay pathway lead dna methylation nucleosome modication dna demethylation provide rich source regulatory interaction well potential drug target disease Mutation effect loss dna methylation extensively document reader kindly ask consult comprehen sive detail like highlight follow important aspect spontaneous dna damage include deamination cytosine major source mutation cancer 5mC fold high spontaneous deamination rate cytosine yet small difference explain observe number onco genic mutation occur estimate point tation therefore likely active direct indirect dna demethylation physiological pathological contribute development mutation furthermore pharmacological agent induce dna demethylation lead reacti vation tumor suppressor gene receive lot attention move clin ical trial phase become important cancertherapy drug currently approach center inactivation remethylation azacytidine evolve stand protein enzyme enhance dna demethylation provide direct proliferationindependent drug target Changes still occur final publication online print",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "epigenetic": 7,
                    "demethylation": 135,
                    "methylation": 32,
                    "5mC": 5,
                    "H3K27me3": 3
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "methyltrans": 2,
                    "daugh": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "methyltrans": 182,
                    "daugh": 182
                },
                "Ethnographic Terms": {
                    "epigenetic": 3,
                    "demethylation": 3,
                    "methylation": 3,
                    "5mC": 3,
                    "H3K27me3": 3
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "(2)A common mutation in the 5_ 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status.pdf",
            "cleaned_text": "common mutation methylenetetra hydrofolate reductase gene affect genomic dna methylation interaction folate status Choi Metabolism Laboratory Mass Spectrometry Laboratory Department Agriculture Human Nutrition Research Aging Policlinico Rossi University communicate Camptom receive DNA methylation essential epigenetic feature dna modulate gene expression genomic integrity catalyze methyltransferase use universal methyl donor adeno sylmethionine catalyze synthesis methyltetrahydrofolate methyl methyl donor synthesis methionine homo cysteine precursor adenosylmethionine present study seek determine effect folate status genomic dna methylation emphasis interaction common C677 mutation MTHFR gene liquid chromatography method analysis nucleotide basis use assess genomic dna methylation peripheral blood mononuclear cell DNA subject homozygous mutation homozygous wildtype MTHFR genotype result show genomic dna methylation directly correlate folate status inversely plasma homocys teine tHcy level genotype diminish level dna methylation compare wildtype methylcytosine DNA analyze accord folate status however subject low level folate account diminished dna methylation moreover subject dna methyl ation status correlate methylated proportion red blood cell folate inversely relate formylate proportion red blood cell folate know solely represent individual result indicate MTHFR C677 polymorphism inuence DNA methylation interaction folate status methylation important epigenetic feature dna play critical mechanistic role gene regulation cellular differentiation eukaryote cell dna methylation primarily comprise methyl group position cytosine feature especially prevalent sequence know cpg island reside gene promoter region aberrant genomic dna methylation widely recognize associate different disease implicate genesis cancer neurodevelopmental disorder DNA methylation pattern cell establish maintain dna methyltransferase many cellular methylation reaction use adenosyl methionine SAM donor methyl group major source methyl group use methylation reaction folatedependent novo synthesis onecarbon unit specific enzyme involve methyl group synthesis process B12dependent methionine synthase use methylTHF methylation homocysteine methionine methylenetetrahydrofolate reductase mthfr methylTHF acceptor oxidoreductase MTHFR consider key enzyme onecarbon metabolism responsible irreversible con version methylenetetrahydrofolate methylTHF serve methyl donor methionine precursor SAM pathway important methyl group synthesis lack methyl group production result intracellular accumulation adenosylhomocysteine well increase plasma total homocysteine level soon isolation cdna gene map human MTHFR common missense mutation iden tifie MTHFR gene substitution position encode thermolabile variant reduce enzymatic function determination strong genenutrient interaction demonstrate phenotypic expression genetic mutation MTHFR enzyme condition low folate plasma level mutant allele show associate high level relationship MTHFR polymorphism plasma folate value implicate likely link C677 polymorphism cardiovascular disease neural tube defect consistent concept homozygosity reduce vivo availability recent observation distribution different coenzymatic form folate alter homozygote red blood cell rbc homozygous mutant diminish proportion methylate tetrahydrofolate well variable amount formylate folate contrast cell wildtype individ ual contain exclusively methylate folate derivative ever different availability methylate form folate affect biological methylation reaction dna methylation demonstrate recently observe preliminary fashion individual MTHFR C677 mutation possess low degree dna methylation however small number subject indirect method use assess genomic dna methylation limit conclusion draw design present study evaluate large cohort subject effect folate status genomic dna meth ylation directly measure genomic dna methylation develop quantitative highly specific assay use liquid abbreviation liquid chromatography MTHFR methylenetetrahydrofolate reductase methylTHF methyltetrahydrofolate plasma total homocysteine red blood cell mCyt methylcytosine Cyt cytosine reprint request address mail jselhubhnrctuftsedu publication cost article defray part page charge payment article therefore hereby mark advertisement accordance solely indicate fact PNAS April vol chromatography technique method allow direct measurement methylcytosine mCyt DNA digest differ indirect enzymatic method semiquantitative know suffer considerable inter assay variability seek emphasize effect folate status dna methylation determine direct measurement impact interaction MTHFR C677 mutation folate status dna methylation relationship different coenzymatic form folate homozygous mutant dna methylation Materials Methods Study Population study total unrelated age sexmatched subject recruit single geographical area northern characteristic study population includ ing MTHFR genotype distribution describe detail else subject angiographically document coronary atherosclerosis normal coronary artery document angiography clinical laboratory evidence atherosclerosis examine reason coronary artery disease case valvular heart disease ref informed consent obtain subject full explanation study approve study Biochemical Analysis sample venous blood draw subject fast DNA extract whole blood use phenol chloroform isoamyl alcohol protocol laboratory method biochemical analysis form describe level measure high performance liquid chromatography HPLC fluorescent tection accord folate vitamin b12 concentration measure automate nescence method level measure HPLC method accord folate form distribution detect affinity follow reversephase chromatography electro chemical detection describe MTHFR genotype analysis mthfr C677 mutation perform pcr follow hinf digestion accord measure genomic dna meth ylation develop method use instrument Ion equip electrospray ionization source microgram dna enzymatically hydrolyze sequential digestion unit nuclease unit venom phosphodie terase unit alkaline phosphatase describe microliter hydrolyzeddna solution inject analytical column protect Suplex pKb precolumn Supelco Bellefonte isocratic mobile phase consist ammonium acetate methanol volvol water deliver flow rate min min allow separation dna basis well identification methylcytosine mass spectrometry operating condition relate electrospray source follow capillary nebulizer psi dry gas min dry temperature ion trap scan use internal standard mixture methyldeoxycytidine deoxycytidine use external standard Identification cyto sine Cyt obtain combined detection analysis chromatographic peak elute min min respectively ion peak correspond ion peak correspond confirm describe other ion peak correspond stable isotope use internal standard Quantification Cyt do comparison internal standard quantification obtain comparison external standard know concentration stable isotope standard commercially available linear working range method limit detection Cyt dna methylation status define amount DNA Coefficients variance day Statistical Analysis computation perform use software version Windows SPSS distribution continuous variable group express mean Analysis perform log transform datum skewed variable include dna meth ylation Therefore geometric mean antilogarithms transform mean present confidence interval ci calculate use transform value display antilogarithms transform data statistical signif icance difference continuous variable test student unpaired test categorical variable analyze use test linear regression analysis appropriate adjustment confound variable age sex smoking creatinine vitamin status appropriate perform general linear model analysis specifically analysis covari ance statistical significance refer twotailed analysis result Fig show typical chromatogram hydrolyze dna peripheral blood mononuclear cell first peak elute min correspond Cyt second peak elute min correspond linear regression analysis pool genotype demon strate highly significant direct relationship plasma folate dna methylation however relationship drive entirely datum individual significant individual see indirect relationship observe dna methylation find significant correlation dna methylation vitamin B12 status characteristic population accord MTHFR genotype describe Table show difference find age sex vitamin vitamin b12 level MTHFR C677 wild type homozygous mutant group folate folate tion low compare group total plasma homocysteine high group difference MTHFR genotype also extend dna methylation mean level mCyt DNA group approximately find group Table difference genotype evident folate status take account plasma folate status median value nmolliter genomic dna methylation similar mthfr genotype table however plasma folate status median level dna methylation consider ably low subject homozygous C677 mutation wildtype genotype moreover level genomic dna methylation low group April vol compare individual level folate equal median group low range plasma folate table illustration difference show population sample divide tertiles plasma folate accord genotype grade effect folate determine level dna methylation detect individual level dna methylation individual low tertile folate compare high approximately low statistically significant genotype however dna methylation different tertile result analysis folate use measure folate status precisely parallel observation make plasma folate Table individual divide group accord median folate value nmolfolate group folate median diminish dna methylation difference find group Table folate level median dna methylation influence MTHFR genotype assessment folate vitamer distribution demon strate folate contain rbc individual carry genotype comprise entirely methyl THFs folate individual mozygous mutant genotype consists formylate polyglutamate confirm describe furthermore profile folate coenzyme cell individual bear close relationship peripheral blood mononuclear cell dna methylation show regression analysis group reveal inverse relationship proportion DNA Fig typical chromatogram hydrolyze peripheral blood mononuclear cell dna rst peak elute min correspond Cyt second peak elute min correspond mCyt Table Characteristics population accord mthfr genotype value Age Sex male Plasma folate nmolliter folate nmol vitamin B12 vitamin nmolliter tHcy molliter Genomic DNA methylation status mCyt DNA value express age folate folate vitamin b12 vitamin DNA methylation status present geometric mean antilogarithms transform mean condence interval report parenthesis twotailed value statistical difference evaluate student test differently indicate statistically signicant statistical difference evaluate test wwwpnasorgcgipnas Friso methylation well positive association DNA methylation methylTHF proportion discussion control epigenetic pattern dna methylation fundamental regulation gene expression position cytosine major epigenetic mechanism control dna gene expression silence consider crucial maintenance genomic structural integrity essential normal devel opment dna methylation become misdirect lead carcinogenesis abnormal condition therefore considerable interest identify endogen ous exogenous factor determine pattern methylation present study show level methylcytosine genomic dna peripheral blood mononuclear cell relate folate status relationship modify interaction nutrient common mutation onecarbon metabolism pathway regulate availability methyl group methylation reaction homozygous mutant C677 polymorphism MTHFR gene exhibit significantly low level DNA con dition low folate status high level folate amount DNA homozygous mutant differ C677 wildtype individual interac tion folate status MTHFR genotype also describe relation plasma level Studies other show plasma level significantly high homozygote mutation wildtype genotype mutant level plasma folate low high folate status plasma level unaffected MTHFR genotype presence genenutrient interaction mutant MTHFR enzyme folate status consistent recent study author evaluate biochemical structure mutant MTHFR explain propensity lose essential flavin cofactor use thermolabile variant MTHFR model express coli show C677 mutation result exposure bind site flavin adenine dinucleotide cofactor otherwise embed barrellike structure exposure result weaken complex hence loss activity presence methylthf substrate associate conformational change strengthen complex thereby protect mthfr loss flavin cofactor find low level peripheral blood mononuclear cell dna high observe subject low folate status strongly imply limited capacity mutant mthfr synthesize sufficient methylTHF meet demand novo methionine methyl group supply consistent previous report rbc homozygous mutant individual C677 mutation formylate tetrahydrofolate polyglutamate addition sole form folate rbc MTHFR wildtype individual present study observe inverse relationship dna methylation Homocysteine product intracellular hydrolysis condense methylTHF form Fig Correlation dna methylation level plasma folate divide tertile accord MTHFR genotype left Right table genomic dna methylation status DNA accord MTHFR genotype plasma folate level stratication folate value median folate nmolliter Plasma folate nmolliter value value dna methylation status present geometric mean antilogarithm transform mean condence interval report thesis twotailed value statistical difference evaluate dent test statistically signicant April vol MEDICAL SCIENCES methionine transsulfurate dependent reaction form cysthathionine therefore surprising inversely correlate DNA elevation reflection folate depletion elevation total plasma homocysteine level indication elevate cellular increase concentration act end product inhibitor adenosylmethionine dependent methylation reaction finding consistent recent report identify plasma SAH strong predictor genomic methylation nucleate blood cell show current study modulation MTHFR variant folate hold true plasma folate level concentration folate plasma generally accept indicator shortterm change nutrient folate consider good index body folate store present finding however suggest plasma level folate population reliable folate indicator longterm folate status key vitamin involve onecarbon meet abolic pathway influence dna methylation also present study however association find vitamin b12 vitamin level feature present study strengthen confidence observation pertain development method directly measure genomic dna methylation exist method assess genomic dna methylation suffer semiquantitative rather quantita tive assess dna methylation indirectly iii pos sesse large intra well interassay variation method afford much great reproducibility precision base direct quantitative measurement methylate cytosine basis dna digest use specificity technique study mthfr C677 variant suggest folate important role modulate epigenetic feature dna control gene expression however remain determined dna hypomethylation see peripheral blood mononuclear cell DNA also occur tissue particularly rapid rate proliferation thereby susceptible adverse effect low folate status colon bone marrow other hypo hypergenespecific methylation scribe relation impaired folate status previously show animal study folate deficiency induce critical region p53 gene dietary folatemethyl depletion dna methyltransferase activity rat describe regulate lead hypermethylation specific loci future study dna methylation express logscale level different coenzymatic form subject inverse relationship detect dna methylation formylate tetrahydrofolate polyglutamate leave positive correlation detect dna methylation methyltetrahydrofolate polyglutamate methylTHF Right Table rbcs folate form distribution dna methylation status accord MTHFR C677 genotype stratication low high rbcs folate value Low folate value High RBC folate value total folate nmol RBC methylTHF total genomic dna methylation status mCyt DNA low high rbcs folate status intend level total rbcs median value nmol hemoglobin respectively value express mean rbcs folate level dna methylation present geometric mean antilogarithm transformed mean condence interval report parenthesis twotailed value statistical difference evaluate student test statistically signicant wwwpnasorgcgipnas crucial identify dna methylation anomaly specific loci human material base work support agreement work also support part grant Italia Ministero dellUniversita della Proc Natl Acad Sci USA Razin Riggs Science Bird Wolffe Cell Holliday Pugh Science Bird Nature London Bird Cell Antequera Bird Proc Natl Acad Sci USA Laird Weinhold Chem Okano Bell Haber cell Selhub Annu Rev Nutr Matthews van den Faccini Pignatti Mazzucco Corrocher Blood Welch Loscalzo Refsum Beresford Vollset Clin Nutr van der Put SteegersTheunissen Frosst Trijbels den Epidemiol Bagley Selhub Proc Natl Acad Sci USA SternLathrop cancer epidemiol biomarker prev Kim Christman Fleet Hatch Selhub Ther Ferraresi Araki Sako Chromatogr Kimura Kanehira Yokoi Chromatogr Bagley Selhub Clin Chem Crain Methods Enzymol Zambonin Palmisano Rapid Comm Fenn Anal Chem Lorincz Groudine Veenstra Kass London Wolffe Matzke Science cancer Res Schneede Refsum Vollset Trends Pharmacol Hennekens Rozen circulation Nutr Rev Biol James Biol Chem Smith Kane Roman Rollinson Cartwright Morgan Proc Natl Acad Toyota OheToyota Sci USA Choi Wiemels Smith Eden Alexander Greaves Proc Natl Acad Sci USA Wall Teitell Proc Natl Acad Sci USA Christman Sheikhnejad Wainfan Carcinogenesis April MEDICAL SCIENCES",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 63,
                    "epigenetic": 5
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "methylenetetra": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "methylenetetra": 68
                },
                "Ethnographic Terms": {
                    "methylation": 1,
                    "epigenetic": 1
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "(2)Demethylation of _Cytosine-5-C-methyl_ DNA and regulation of transcription in the epigenetic pathways of cancer development.pdf",
            "cleaned_text": "NONTHEMATIC DNA regulation transcription epigenetic pathway cancer development Patra publish online February Springer cancer cell tissue exhibit genome wide hypomethylation regional hypermethylation cpg methylation DNA MeCpGDNA define formation covalent bond cytosine CH3 group adenosylmethionine Removal sole CH3 group methylate cytosine DNA one many way dna demethylation contribute activation transcrip tion mechanism demethylation candidate enzyme exhibit direct demethylase activity associate cofactor firmly establish wide hypomethylation obtain several way inactivation dnmt enzyme activity include covalent trapping DNMT cytosine base analogue removal methyl layer also occur excision methyl cytosine base dna glycosylase impor tance truly chemically define direct demethylation intact dna regulation gene expression development cell differentiation transformation discuss contribution Cancerepigenetics cpg island CytosinemethylDNAdemethylation cancer biology become increasingly evident epigenetic control gene expression play important role determine phenotype cancer cell possibly suggest novel approach strategy epigenetically restore normal phenotype cancer cell modification dna methylationdemethylation event central epige netic regulations development mechanism control event dynamic change important implication developmental cell biology well carcinogenesis tumor progression little mammalian genome contain carbon methyl cytosine paternal genome undergo preferential demethylation fertilization maternal genome remain largely unaffected mouse rat pig bovine human zygote later maternal genome passively demethylated replication dependent mechanism twocell embryo stage main key understand development unravel mechanism control expression pattern gene regulate cell proliferation differentiation embryo cancer Metastasis Rev s10555 West mail skpatra99yahoocom KB21 Sector III Salt Lake City Parma Parma Italy Biosistemi inbb Italy Scheme VII Kolkata West Bengal influence many epigeneticenvironmental factor factor contribute signal cell tissue trigger completion development whole body final biological response deregulated signal cause tumour development hence development require constant negotiation environment Studies field advance much probably difficulty monitor individual cell cellcell cellextracellular matrix interaction organ vivo many decade ago suggest idea epigenesis development discover carbon methylate cytosine DNA name epicytosine enzyme dna methyltransferase dnmt receive convincing confirmation responsible methylate DNA cytosine carbon position create additional layer epigenetic information post replicatively mechanism action dnmt characterize addition methyl group cytosine CpGdinucleotide DNMT also implicate regulate transcription maintain genome stability imprinting chromosome inactivation mammalian cell DNAmethylation catalyze important class dnmt reside replication fork methylate newly synthesize strand essential maintain DNAmethylation pattern proliferate cell member second class methyltransferase DNMT3b require novo methylation embryonic development cooperate family establish maternal imprint mouse however mechanism direct removal methyl group keep DNA strand intact obscure candidate protein possibly responsible activity controversial obviously possible modality achieve active demethylation require DNA strand break nucleoside excision repair dna overexpression dnmt hypermethylation cpg island regulatory region certain gene global hypomethylation well selective demethylation well know participate regulation transcription close association crucial biological event include cancer development cpg site present specific region promoter highly express gene rarely methylate perhaps quickly late normal cell important exception inactivate chromosome imprint gene recent datum show methylation dna deacetylation histone lead inactivationrepression selective acetylation histone methylation dna demethylation associate activation nucleosome gene transcription repression transcription occur different mechanism include recruitment protein repressor prevent transcription factor bind dna regulatory element methylate dna bind protein MeCP2 MBD1 MBD2 MBD3 selectively bind methylate cpg sequence contrib uting remodeling nucleosome chromatin structure condition chromatin inactivate consequence histone deacetylation cause recruitment histone deacetylase hdac event precede inhibit bind transcription factor include rna polymerase dna demethylation cause reduction repression potential gene MBD protein long remain bind respective demethylated activation energy require nucleosome promote transition state complex formation lower bind activator transcription factor event allow rna polymerase enter bind promoter initiation transcription show cause dna demethylation different mechanism suggest probably together know protein cofactor responsible removal CH3 group methylate cytosine originally isolate mismatch glyco particularly active MeCdeamination dinucleotide enzyme believe remove whole base methylate create abasic site seal help mismatchbase nucleotide excision repair enzyme secondary ligase ref clear abnormal methylation genome wide hypomethylation siteselected hypermethylation cpg island restrict cultured cell also occur ageing tumor development specific mechanism involve dna bind protein enzyme repressor activator participate recruitment active transcriptional complex interaction specific response element present promoter partially understand early work epigenetic control mechanism gene main hypothesis concern methylationdemethylation DNA biological significance first hypothesis cytosine CH3 covalent bond formation unusual event even irreversible alter native hypothesis suggest dynamic nature event tissue specific gene expression clear indeed enzyme directly methylate demethylate dna demethylase require study purification reconstitution Cancer Metastasis Rev recent datum active demethylation role development cancer progression raise considerable growth interest field understanding process replicationcouple loss local demethylation trigger transcription factor rna mediate catalysis dna repair base mechanism progress begin science epigenetic dna methylation assume methylation biochemical strategy positively select evolution safe guard microbial dna endonuclease digestion many useful information concern chromatin remodeling chemical modification dna histone greatly improve understand preferential gene expression importance biological process differentiation totipotent cell presence high level regional CpGisland methylation fact increase rate mutation due global genomic hypomethylation correlate tumor progression make clear precise genetic alteration time major drive force neoplastic onset progression virtually cancer type fortunately mutation specific gene inefficient process unceasing maintenance genomic integrity complex array enzyme continuously monitor repair dna thus genome maintenance team make many protein component work active complex strive ensure dna sequence information remain unchanged reach critical mass information helpful well understand chemical mechanism complexity direct demethylation intact dna devoted address current status discuss possibility future advancement specific issue direct dna demethylation active demethylation break DNA strand role development cancer dna methylation chromatin structure basic building block small functional unit chromatin core comprise dna wrap time histone octamer make copy histone type H2B lefthande super helix connect linker DNA naked association histone protect additional dna nuclease digestion core particle boundary core histone contain functional domain histonefold motif histonehistone histoneDNA contact nucleosome domain contain site posttranslational modification acetylation methylation phosphorylation ubiquitination NH2 COOHterminals relate core histone linker histone also contain globular domain flank NH2 terminal tail subdomain domain linker histone essential bind nucleosome tail domain probably important high order chromatin fold structural change primarily impose DNA level methylation DNA sequence GGCGCC show cause extend eccentric double helix structure call dna dna DNA long helical rise base perpendicular helix axis endo sugar conformation origin charac teristic deep major groove shallow minor groove dna also allow crystallize long period time respect yield dna methylate sequence originate standard DNA suggest ing dna kinetically trap intermediate transition dna thus structure present report chart emphasize graphic pathway DNA DNA DNA intermediate single sequence DNA surface highly accessible solvent water mole cule interact expose surface stack nucleotide major groove suggest geometry interaction promote neous deamination transition mutation base pair require deaminase activity analysis hydration pattern methylate cpg site crystal structure dna decamer high resolution reveal methyl group cytosine residue well hydrated comparative study native structure structurally distinct form fully methylate site show specific structural sequence context methylate cytosine base hydrated unmodified one water molecule seem stabilize methyl group formation type interaction addition structure provide first observation magnesium cation bind major groove dna reveal distinct mode metal bind methylated native duplex finding suggest methylated cytosine basis ecognize protein dna polar residue tightly bind water molecule cancer Metastasis Rev structure level nucleosome dna methylation inhibit gene expression animal cell probably affect chromatin structure presence methyl group dna affect interaction protein enzyme local nucleosome Methylation DNA bring general deacety lation histone prevent methylation induce methylation histone methylation associate transcriptionally active nucleosome chromatin trimethylated Methylation histone regard stable modification define epigenetic program cell regulate chromatin structure transcription however recent discovery histone demethylase challenge stable nature histone methylation demonstrate protein RBP2 PLU1 histone demethylase specific trimethylated histone show LSD1 repress transcription demethylation use patchmethylated stable episome methylate dna patch promoter luciferase reporter gene colleague recently demonstrate dna methylation affect chromatin structure gene expression observe acetylate histone associate unmethylated DNA nearly absent methylate dna region dna methylation immediately downstream transcription start site dramatic impact transcription show important effect transcription elongation initiation col league also show dimethylate histone H3K4Me2 deplete region DNA methyla tion effect link transcriptional activity region local effect extend methylate dna region deplete primarily methylate dna region presence trimethylate histone affected transcriptional activity datum suggest dna methylation junction transcription initiation elongation critical transcription suppression effect mechanistically mediate chromatin structure important implication suggest study impact methylate dna segment transcription difficult interpret size location methylate dna region differently affect transcription methylated code region little impact transcription initiation downstream promoter observe conceivable methylated sequence much large impact transcription initiation immediately downstream promoter observe tight correlation depletion H3K4Me2 region dna methylation regardless reporter gene activity conversely level H3K4Me2 remain high unmethylated dna region regardless presence Furthermore dna methylation approximately downstream affect presence H3K4Me2 unmethylated promoter pmeluc distinct boundary effect strongly support view dna methylation affect presence H3K4Me2 directly propose dna methylation dictate close chromatin structure devoid H3K4Me2 inhibit transcrip tion presence H3K4me2 marks open chromatin structure permit transcription condition active transcription fulfil early development genomic methylation erase somatic methylation pattern establish time tation experimen tal information study dna contain short mecpgsequence compare unmod ifie therefore effect methyl layer individual nucleosome overall nuclear chromatin structure infer observation initiation nuclear process highly dependent chromatin structure imply nucleosome position bias DNA sequence facilitate access initiation factor activation special ize domain removal loosely associate mobile protein hmg conjunction insulator action regulate expression independent gene well know special boundary present regulation chromatin domain Boundary elementsinsulators act subdivide eukaryotic chromo some autonomous regulatory domain bind arie represent structuralfunctional barrier prevent processive spread active silence chromatin domain addition partitioning consequence underlie structural subdivision chromosome high order loop domain view boundary think delimit structural domain interact nuclear structure insulator dna sequence exert action bind form complex specific protein partner demethylase demethylation reaction biochemical term DNA cytosinecarbon methylation postreplicative addition methyl group Cancer Metastasis Rev cytosine CpGdinucleotide sequence dna dnmt adenosylmethionine sam donor methyl group Fig Figure show DNA methyltransferase DNMT catalytically remove CH3 group square block methionine put carbon cytosine cpg sequence SAM change teine detail see figure show detailed mechanism mammalian mediate catalysis propose dna demethylation Fig removal methyl group DNA Removal methyl group demethylation essential transcription many gene obtain follow possible path direct active processdemethylation Indirect active processmismatchexcision repair passive loss methyl group due failure maintenance methylation replication mechanical incorporate DNA cultured cell demethylate dna vivo system represse activate transcription gene bind cpg sequence Indirect removal CH3 occur removal whole cytosine base block DNMT enzyme activity DNA cytosinecarbon methylation reaction NH2 CH2 H3C CH2 COO CH2 COO H3N Adenosine Adenosyl homocysteine sah DNMTase NH2 Cytosine Methylated dna dna substrate NH3 Fig DNA methyltrans ferase DNMT catalytically remove CH3 group square block methionine put arrow point cpg sequence SAM change Adenosyl homocysteine SAH enzyme remain intact reaction see also detail detailed mechanism pro pose Reither mammalian mediate catalysis see detail Cancer Metastasis Rev DNA methyl cytosine demethylation reaction link cofactor receptor Direct active process demethylation Indirect active process mismatch excision repair passive loss methyl group failure maintenance methylation status replication deoxycytidine incorporate DNA Cofactor Methylated DNA DNA h2n NH2 CH3 deoxyribose Phosphate H2N dna pol Glyco Remodeling factor join factor site dna MeCglycosylase endonuclease dna break dna pol join dna pol dna ligase DNA demethyla Cofactor III Remodeling exist nucleosome dna transcriptionally competent form DNA transcriptionally competent form Fig dna demethylase protein complexe biomolecule cofactor yet discover demethylate dna vivo system represse activate transcription gene bind cpg sequence Indirect removal CH3 occur removal whole cytosine base block DNMT enzyme activity artificially create thylation status type true demethylation reaction enzymatic removal CH3 group carbon cytosine context cpg island contain promoter necessary transcriptional activation many gene fate expel CH3 group form likely trap scavenger take cofactor see possible level action removal methyl group Methyl excision demethylase methylcytosine base excision excision mecpgdinucleotide excision Inset show structure deoxyribose sugar phosphate group DNA glycosylase break glycosidic bond create site endonuclease recognize site nick damage dna side upstream site create free dna polymerase extend dna free use exonuclease activity replace nucleotide damage base well downstream follow seal new DNA strand dna ligase activity see step representation dna glycosylase mediate removal methyl layer gene need activate left panel atypical BERNER pathway demethylation dna direct excision methyl group right panel signal transmit nuclear chromatin specific nucleosome respective gene become activate step attack glycosylase specific example propose break glycosidic bond create site step endonuclease recognize site nick damage dna side upstream site create free step first step MeCpGdinucleotide excision repair base mechanism specifically hemimethylate DNA propose suggest involvement enzyme small RNA Step III dna polymerase extend dna free use exonuclease activity replace nucleotide damage base well downstream follow seal new DNA strand dna ligase step finally chromatin remodeling factor fold DNA normal nucleosome fold stabilize stabilize factor suggest mechanism involve mononucleotide MeCpGdinucleotide excision Tat gene follow common step NERBER pathwaystep III step direct demethylation intact DNA Right panel Cancer Metastasis Rev artificially create hypomethylation status type demethylation reaction completely chemically define enzymatic removal CH3 group carbon cytosine context cpg island contain promoter necessary transcriptional activation many gene fate expel CH3 group form likely trap scavenger take cofactor see hypothesize mecha nism demethylation protein require cofactor know date propose mechanism form cytosine adduct prevail view adduct chemistry type complexe SN2 mechanism occur general water add double bond hydroxyl group attack carbon follow elimination ammonia yield thymidine yet think term SN2 mechanism involvement cofactor leave group activate cytosine ring complex enzyme nucleophile methanol alternative assumption cofactor p450 monooxygenase mediate attack molecular oxygen presence nadph convert methyl group hydroxymethyl group formyl group expel formic acid intermediate formyl cytosine experi mental evidence type reactionbase hypothesis lack possible way look similar type dna demethylation removal methyl group methyl cytosine keep DNA strand intact work dna methylation epigenetic search dna demethylase associate factor include investigation dnmt MBD protein preliminary datum convince purify unable demethylate MeCDNA MeCpolyCpG MeI polyipgduplexe crude tumor cellular extractsfraction contain together elution fraction contain show demethylase activity vitro fully substrate possibility lation machinery huge protein complex function chaperoncomponent apparent work other demethylase inertness fraction rich demethylation reaction argue different set inhibitor cell Indirect active mechanism account loss methyl groupslayer DNA excision repair base excision repair cellular mechanism repair damage dna dna replication repair dna sequence error necessary mutation conserve replication single basis dna chemically mutate example deamination alkylation result incorrect basepairing mutation DNA repair system versatile term damage recognition pathway exist partly distinct substrate specificity global genome survey entire genome distort injury transcriptioncoupled repair focus damage block elongate RNA poly merase detailed see BER involve flip mutated base DNA helix repair base alone main enzyme involve BER pathway dna glycosylase apurinicapyrimidinic endonuclease dna gly cosylase use break glycosidic bond create site endonuclease recognize site nick damage dna side upstream site create free compare DNA polymerase extend dna free use exonuclease activity replace nucleotide damage base well downstream basis follow seal new DNA strand dna ligase leave panel dna glycosylase typically low molecular weight monomeric enzyme responsible recognize base lesion genome initiate DNA BER pathway propose active mechanism DNA demeth ylation excision CH3 group alone actually damage DNA cell pay price recruit costly dna repair team hence removal CH3 group total total MeCnucleotide dinucleotide obviously active conceive really chemically define also term cellular economy BERNER reaction account genome wide loss methyl group certainly observe cellular system Cells use repair process buffer additional localize demethylation pathway gene transcription moreover cellular physiology chemistry normally permit removal pathway genome heavily methylate rationale suggest factor certainly responsible reversible regulation dna methylation possible level action removal methyl group show Methyl excision demethylase methylcytosine base excision mononucleotide excision MeCpGdinucleotide excision Single MeC base excision excision genome follow BER first DNA BER repair Cancer Metastasis Rev process call role dna glycosylase cleave bond base deoxyribose moiety DNA fig step abasic site repair resident BER repair activity result replacement cytosine accord second mechanism MeCmononucleotide remove nucleotide excision directly enter Step Fig replace cytosine Fig possibility possibly mimic pathway use extract tissue culture cell observe loss methyl group excision MeCpGdinucleotide Fig several experimental observation support suggestion reaction mediate participation rna molecule propose active role rna nucleotide excision repair reaction later evaluate mismatchrepair glycosylase mismatch repair enzyme methylated bind protein show possess DNA glycosylase activity Chicken embryo nuclear extract promote active loss methyl group associate cytosine base use purify enzyme enzyme dna glycosylase act preferentially hemimethylate initiate removal methylbase break glycosidic bond thus leave abasic site process endonuclease dna repair enzyme finally follow BER pathway Fig cloning characterization enzyme prove correspond gene encode mismatch repair dna glycosylase human homolog chicken enzyme also dna glycosylase activity author also report evi dence rna rna helicase p68 component enzyme complex involve demethylation activity overexpression human human embryonic kidney cell lead demethylation promoter hormoneregulate reporter gene specific demethylation transgene promoter genomewide demethylation attribute physical association retinoid receptor bind site transgene promoter major concern function mismatch repair dna glycosylase demethylase activity enzyme methylcytosine dna substrate weak compare activity mismatch dna substrate thus possible enzyme strong dna glycosylase activity possibly require cofactor support dna glycosylase mechanism active loss methyl group independently also find HeLa nuclear extract cause loss methyl group dna dna glycosylase mechanism partially purify enzyme activity however identity protein identify date recently add example BERNER mediate mechanism local target dna demethylation living cell discover enhancer specific demethylation event endogenous gene trigger transcriptional activator development analyze demethylation occur ticoidresponsive unit locate upstream transcription start site tyrosine aminotransferase Tat gene activation glucocorticoid receptor event take place liver birth involve memorization first stimulation gene glucocorticoid demonstrate demethylation cytosine gene physiological condition result active mechanism involve creation nick DNA nucleotide event indicate involvement mechanism produce dna strand break suggest methylated base process base lesion repair pathway excision repair compatible cleavage observe evidence mechanism demeth ylate nuclease activity report excise dinucleotide key experimental datum use technique suggest mono functional dna glycosylase compatible cleavage product overall datum produce convincing suggest mechanism involve mononucleotide dinucleotide excision Tat gene follow common step NERBER pathway compare passive loss methyl groupslayer genome dinucleotide display symmetrical configuration allow conservation methylation pattern follow replication replication machinery incorporate unme thylated cytosine newly synthesize strand result hemimethylated site convert back fully methylate site maintenance methyltransferase act preferentially hemimethylate act soon replication enzyme target replication focus interaction DNA polymerase clamp PCNA observe nonmethylatedcpg genome wide hypomethylation simply result absence maintenance methylation replication know passive cancer Metastasis Rev demethylation discuss passive mechanism involve demethylate enzyme passive loss take place several dna replication cycle ensure significant part daughter molecule effectively demethylated round replication deme thylate statistic consistent kinetic demethylation maternal genome observe early mouse development observe local glucocorticoidregulated demethylation Tat enhancer genome wide passive loss methyl group available past recent article many facet methylcpgbinding proteinmbd2 discovery gene envisage important landmark science epigenetic development cancer sequence contain gene suppressor also bind unmethylated promoter CpGsequences act activator investigate regulation transcriptional repression methylate cyclic campresponsive element find mbd2a promote activation unmethylated campresponsive gene vivo bind assay reveal MBD2a selectively interact rna helicase component CREB transcriptional coactivator complex MBD2a cooperatively enhance CREBdependent gene expression immunoprecipitation assay demonstrate MBD2a bind associate HDAC1 result indicate novel role gene regulation cloning mutational conditional knock covalent trapping show various regulatory mechanism act enzyme fundamental embryonic development induction cell transformation presence demethylation activity elegantly show however active protein cofactor unknown recently show associate demethylase activity discuss many laboratory study demethylase activity research group show transfection construct gene urokinase type plasminogen activator hexokinase type activate demethylation hypermethylate promoter lead overexpression protein product recently confirm predominant association endogenous methylate promoter trans fection chromatin immunoprecipitation analyse cell lysate suggest selective role methylationmediate inhibition ribosomal rna gene expression result implicate mediate gene specific binding repression activate transcription dna deme thylation reaction associate specific demethylase machinery animal model knockout show lack protein prevent growth tumour know associate hypermethylation important gene gene test p16 Integrin tissue inhibitor metalloproteinase find almost com pletely methylate knock animal possible demethylation mechanism gene dependent protein association fact mbd2deficient mouse viable fertile mean associate demethylase function suggest protein exist component demethylase machinery study knock mouse extend recently colon cancer mouse lack human colon cancer cell line suggest modulation gut development establish regionspecific gene expression pattern essential establish correct segmental character demonstrate sexspecific time window concomitant upregulation DNMT1 DNMT3A associate prenatal methylation human male female germ line provide important clue molecular mechanism parentspecific epigenetic mod ification human male female germ cell fertilization sperm egg genome remodel first embryonic mitosis nonetheless highly compact sperm chromatin require extensive nuclear remodeling protaminehistone exchange require nucleosomal maternal chromatin discovery demethylation murine paternal fertilization dna replication observe demonstrate existence active demethylation process mammalian cell sheep rabbit use interspecie intra cytoplasmic sperm injection beaujean demonstrate sheep sperm dna demethylate mouse oocyte amazingly mouse sperm also demethylate limited extent sheep oocyte finding provide evidence embryonic murine demethylation process mainly paternally drive nature activity unknown noteworthy Cancer Metastasis Rev mutant mouse lack functional methylcpg bind domain show demethylation profile paternal pronucleus wildtype control testis specific truncate transcript identify report oocytespecific form date posses demethylase activity suggest protein demethylase activity interest finding bovine somatic cell nuclear transfer embryo donor nucleus show efficient satellite demethylation presence oocyte nucleus enucleated oocyte suggest much demeth ylating activity associate maternal nucleus enucleated sheep oocyte also able demethylate serumstarved fibroblast nucleus sheep ooplasm considerable residual demethylate activity sheep fibroblast DNA particularly prone demethylation therein elucidate mechanistic role MBD proteins methylationdependent restrict expression tumorassociate mage antigen include possi bility protein play role silence result display transcriptional repression domain inhibit effect promoter activity furthermore cotransfection deficient mouse fibroblast cell show strong methylationdependent repression mage promoter downregulate MBD protein MBD1 MeCP2 interestingly however observe MBD1 splice variant able repress basal activity unmethylate mage promoter transcription factor abrogate sup pression contrast repressive effect mediate MBD1 MBD2a find regulate basal activity promoter recent report show protein control methylation enzyme arginine methyltransferase identify catalyze methylation residue inhibit repressive function reduce DNA MBD2HDAC repression complexe formation report provide molecular description potential regulatory mechanism MBD protein family member work first demonstration arginine methyltransferase participate epigenetic dna methylation system control chromatin function clarify issue study inactivation dnmt need yet result simply show correlation methylation gene repression suggest virtual existence protein demethylase activity fundamental bio chemical approach solve problem identify cognate component purification follow reconstitu tion active cofactorenzymesubstrate complex switching activation transcription recently define small region interleukin gene get demethylated lymphocyte follow activation remain demethylated thereafter demethylation process start stimulation prevent phase cell cycle inhibitor block dna replication finding imply demethylation process dependent enzymatic mechanism dna methylation emerge central switch allow inter conversion permissive repressive chromatin domain principle heart transcriptional regulation also likely govern process involve chromatin substrate indicate elsewhere domainwide sitespecific histone acetylation necessary transcription sufficient establish full chromatin accessibility lysine methylation robust epigenetic mark essential regulation multiple cellular process methylation perhaps large impact nucleosome activation transcription however switch permissive chromatin structure require subsequent synergistic action nucleosome remodelling complex contain ATPase family therein enzyme increase acces sibility nucleosomal dna weakening interaction lead signal cascade dependent demethyla tion activation promoter transcription specific promoterdriven gene follow Azadeoxycytidine induce transcription mechanistic dilemma catalytic mechanism dnmt involve formation covalent bond cysteine residue active site enzyme carbon cytosine DNA event increase electronic flow carbon subsequent attack methyl group SAM ion proton follow elimination allow reformation double bond release enzyme substrate DNA methylate cytosine mechanism describe recent article long suggest clinical use trial assessment safetytoxicity efficacy treatment various tumour do still ongoing molecular analysis Cancer Metastasis Rev AzdC treatment confirm expression gene repression condition association high cpgisland methylation possible mechanism suggest AzdC inhibit dna methylation incorporate DNA formation covalent bond enzyme AzdC dnmtazdc adduct consider stable thus assume trapping DNMTs generate hypomethylation cause activation transcription dnmtazdc complex tethered distinct regulatory site modify dna sequence drive interaction nucleosome hence section dna incorporate properly package chromatin even histone deacetylase hyper active repair enzyme operate assumption require dnmt avidly bind unusual structure form AzdC damage gene pack heterochromatin model transition state analog form unusual structure prevent enzyme complete catalytic cycle thus trap dnmt target appro priate repair recombination condensation complexe site ref transcriptional activation permissive domain frequently correlate additional target demethyla tion dna promoter nucleosome notable exception exist intriguing question transcription machinery bind roll AzdC entrap dnmt maybe follow path base excision repair tether dnmt define site explain local hypomethylation less obvious demethylation large domain achieve potential mechanism include recruitment histone acetyltransferase distinct entry site spread domain possibly attachment tracking protein associate rna polymerase transcription complex alternatively residence particular chromosomal domain demethylation competent nuclear compartment ensure relative uniform modification transcription activation complex generate highaffinity bind site demethylase scheme explain propagation envisage interpreting demethylation signal cell important issue study epigenetically mediate expression gene silence cancer CpGisland hypermethylation understanding demethyla tion participate gain gene transcription experimental system seem methylation promoter lead silence transcription chromatin protein recruit specific region mediate gene silence similarly CpGislands enhancer region methylate inhibit structural change function enhanceosome alternatively demethylation enhancerpromoter require signal remove protein bind chromatin activation gene expression precisely specifically methylcpgbinde protein remove set acetylation lysine terminal position methylation seem initiate process result regain transcription however cellular setting include abnormal geneexpression typical cancer unclear demethylation initial event expression target region early chromatin remodeling event system action inhibitor require initiate gene expression promoter region become densely methylate sequence event give promoter seem promoter demethylation histone hyper acetylation integral gain gene function drug block dna methylation AzdC procanamide drug block histone deacetylation acid salt partially reactivate silence gene cancer cell restore function induce expression broad spectrum gene prostate cancer cell procanamide induce expression P16 transcript gstp1 cell grow nude mouse EGCG induce clusterin SGP2ApoJ gene prostate cancer cell Clusterin gene know regulate promoter hypermethylation chromatin crucial aberrant gene silencingexpression cancer primarily secondarily process involve vertebrate genome normally package transcriptionally repressive chromatin kind find region type chromatin heavily methylate identity chromatin associated protein complex link DNAmethylation transcriptional silenc ing discover transcriptionally silent region dna package compact nucleo some contain deacetylated histone deacetylate particular histone extensively deacetylate action hdac maintain nucleosome compact transcriptionally silent state tran scriptional repression status also stabilize participation key protein CBX5 human homologue Drosophila Chromodomain protein pp1 Cancer Metastasis Rev also know suppressor varigation DNA methylation also seem involve crucially transcriptionally silent state heterochromatin MethylCpGdomain bind protein MBPs associate methylate cytosine also various chromatin remodeling complex also show act transcriptional repressor importantly mbp also find complex contain HDACs sin3 corepressor harbour MeCP2 MBD1 contrast small fraction genome transcriptionally competent state chromatin region dynamic meet change transcrip tional requirement cell balance euchromatin heterochromatin ensure gene expression pattern give cell type stably maintain daughter cell heritable state term dna methylation type gene promoter type account gene mammalian genome contain unmethy lated CpGislands promoter type composition rest genome gene promoter know many modulatory role transcription however example methylation individual promoter determine transcriptional status gene block access certain transcription factor sensitive methylation cpg site alternatively methylation site region also silence gene help recruit chromatin protein complex repress transcription cpg island generally assume unmethy late germ line imprint locus however several research team attempt predict cytosine methylation pattern different cell base DNA sequence attempt discriminate cpg island prone methylation human lymphocyte remain unmethylated find cpg island remain unmethylated particularly GpC conversely island prone methylation lymphocyte enrich segmental duplication tandem repeat sequence multiple selfalignment attempt identify general sequence predictor dna methylation brain tissue Das colleague expect find unmethylated sequence enrich island deplete alu element investigator also identify short sequence motif help discriminate methylate unmethylated DNA fraction brain tissue functional signification remain unclear see also mammalian genome depend patterns meth ylate cytosine normal function relationship genomic methylation pattern underlie sequence unclear characterize methylation landscape human genome global analysis pattern cpg depletion direct sequencing unmethylat",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "epigenetic": 11,
                    "methylation": 57,
                    "demethylation": 56
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "methyltrans": 1,
                    "MeCpGdinucleotide": 2,
                    "Tat": 4,
                    "SN2": 2,
                    "Clusterin": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "methyltrans": 124,
                    "MeCpGdinucleotide": 124,
                    "Tat": 124,
                    "SN2": 124,
                    "Clusterin": 124
                },
                "Ethnographic Terms": {
                    "epigenetic": 10,
                    "methylation": 10,
                    "demethylation": 10
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "(2)DNA methylation and its basic function.pdf",
            "cleaned_text": "DNA Basic function Lisa Moore1 Thuc le1 Neuroscience Human Genetics David California Los Angeles mammalian genome dna methylation epigenetic mechanism involve transfer methyl group position cytosine form methylcytosine dna methylation regulate gene expression recruiting protein involve gene repression inhibit bind transcription factor dna development pattern dna methylation genome change result dynamic process involve novo DNA methylation demethylation consequence differentiate cell develop stable unique dna methylation pattern regulate tissuespecific gene transcription chapter process dna methylation demethylation nervous system describe DNA methylation machinery association epigenetic mechanism histone modification noncoding rna intriguingly postmitotic neuron still express dna methyltransferase component involve dna demethylation neuronal activity modulate pattern dna methylation response physiological environmental stimulus precise regulation dna methylation essential normal cognitive function indeed dna methylation altered result developmental mutation environmental risk factor drug exposure neural injury mental impairment common side effect investigation DNA methylation continues show rich complex picture epigenetic gene regulation central nervous system provide possible therapeutic target treatment neuropsychiatric disorder Neuropsychopharmacology advance online publication npp epigenetic gene regulation neuron synaptic plasticity demethylation introduction Genetics study heritable change gene activity function due direct alteration dna sequence alteration include point mutation deletion inser tion translocation contrast epigenetic study heritable change gene activity function associate change dna sequence virtually cell organism contain genetic information gene express simultaneously cell type broad sense epigenetic mechanism mediate diversify gene expres sion profile variety cell tissue multicellular organism chapter introduce major epigenetic mechanism involve direct chemical modification DNA call dna methylation historically DNA methyla tion discover mammal early DNA identify genetic material first discover modify cytosine preparation calf thymus use paper chromatography Hotchkiss hypothesize fraction methylcytosine separate cytosine manner similar way thymine also know separate uracil suggest modify cytosine exist naturally DNA many research er propose dna methylation regulate gene expression several study demonstrate dna methylation involve gene regulation cell differentiation recognize dna methylation concert regulator major epigenetic factor influence gene activity dna methylation catalyze family dna methyltransferase dnmt transfer methyl group adenyl methionine SAM fifth carbon cytosine residue form figure dnmt3b establish new methylation pattern unmodified dna thus know novo Dnmt Figure hand function DNA replication copy dna methylation pattern Received revise accept May Correspondence Human Genetics David Los Angeles Charles Young Drive South Los Angeles USA Tel fax mail right reserve 133X parental DNA strand newly synthesize daughter strand figure Dnmts extensively involve development embryo time cell reach terminal differentiation Dnmt expression much reduce seem suggest DNA methyla tion pattern postmitotic cell stable however postmitotic neuron mature mammalian brain still express substantial level Dnmts raise possibility Dnmts dna methylation play novel role brain react environment pattern depolarization relay information encode response become increasingly apparent follow depolarization alteration gene expression accompany modification epigenetic landscape include alteration pattern dna methylation order DNA methylation pattern alter active dna methylation demethylation neuronal genome however enzyme know cleave methyl group directly discuss recent identification hydroxymethylcytosine postmitotic neuron suggest 5hmC serve intermediate DNA demethylation pathway discuss basic function dna methylation epigenetic gene regulation highlight role neural develop ment neurological disease location dna brain contain high level dna methylation tissue body account nucleic acid human genome majority dna methylation occur cytosine precede guanine nucleotide cpg site overall mammalian genome deplete cpg site result mutagenic potential 5mC deaminate thymine remain cpg site spread genome heavily methylate exception cpg island Bird interestingly evidence noncpg methylation mouse human embryonic stem cell however methylation lose mature tissue Ramsahoye Lister thorough analysis murine frontal cortex recently reveal majority methylation occur site significant percentage methylate noncpg site recent discovery role noncpg methylation still unclear dna methylation essential silence retroviral element regulate tissuespecific gene expression geno mic imprinting chromosome inactivation tantly dna methylation different genomic region exert different influence gene activity base underlie genetic sequence follow section elaborate role dna methylation different genomic region Intergenic Regions approximately mammalian genome consist transposable viral element silence bulk methylation vast majority element inactivate dna methylation mutation acquire time result deamina tion Walsh express element potentially harmful replication insertion lead gene disruption dna mutation Ukai intracisternal particle aggressive retrovirus mouse genome heavily methylate life gametogenesis development adulthood even embryo rest genome relatively hypomethylated Dnmt1 maintain repression element Dnmt1 deplete genetic mutation lead extensive hypomethylation element express dnmt3b ch3 CH3 CH3 Dnmt1 figure DNA methylation pathway family dna methyltrans ferases Dnmts catalyze transfer methyl group adenyl methionine SAM fifth carbon cytosine residue form methylcytosine dnmt3b novo Dnmts transfer methyl group red naked DNA maintenance Dnmt maintain dna methylation pattern replication DNA undergo semiconservative replication parental dna stand retain original dna methylation pattern gray Dnmt1 associate replication focus precisely replicate original dna methylation pattern add methyl group red newly form daughter strand blue dna methylation basic function demonstrate intergenic region main role dna methylation repress expression potentially harmful genetic element cpg island stretch dna roughly base pair long high cpg density rest genome often methylate bird majority gene promoter roughly reside island Saxonov particular promoter housekeeping gene often imbed cpg island island espe cially associate promoter highly conserve mouse human location preservation cpg island evolution imply region possess functional importance appear cpg island evolutionarily conserve promote gene expression regulate chromatin structure transcription factor bind dna regularly wrap histone protein form small package section call nucleosome tightly associate histone protein DNA less permissive gene expression common feature cpg island contain less nucleo some stretch DNA nucleosome cpg island associate often contain histone modification involve enhance gene expression island contain known transcription start site cpg island often devoid common promoter element box many transcription factor bind site rich cpg island likely enhance bind transcriptional start site lack common promoter element cpg island enhance accessibility dna promote transcription factor bind methylation cpg island result stable silence gene expression gametogenesis early embryonic development cpg island undergo differential methylation ability methylation regulate gene expression cpg island particularly important establish imprint imprinted gene express inherit parental chromosome expres sion determine parent inheritance imprint gene dna methylation cpg island regulate gene expression development differentiation cpg island associate control gene expression expect island display tissuespecific pattern dna methylation cpg island intragenic gene body region tissuespecific pattern methylation cpg island associate transcription start site rarely show tissuespecific methyla tion pattern Illingworth Maunakea instead region call CpG island shore locate far island highly conserve pattern tissuespecific methylation Irizarry cpg island methylation cpg shore highly correlate reduce gene expression role island regulate gene expression still uncover Methylation cpg island impair transcription factor bind recruit repressive methylbinding protein stably silence gene expres sion however island especially associate gene promoter rarely methylate study need determine degree dna methylation cpg island regulate gene expression majority site mammalian genome methylate gene also contain methylation gene body consider region gene first exon methylation first exon promoter methylation lead gene silence Brenet evidence suggest dna methyla tion gene body associate high level gene expression divide cell however slowly divide nondivide cell brain gene body methylation associate increase gene expres sion furthermore murine frontal cortex methylation noncpg site gene body negatively correlate gene expression dna methylation gene body contribute gene regulation still unclear basic mechanism DNA enzyme establish recognize remove dna methylation break class writer eraser reader Writers enzyme catalyze addition methyl group cytosine residue eraser modify remove methyl group reader recognize bind methyl group ultimately influence gene expression thank research devote understand epigenetic landscape erase reshape embryonic development many protein mechanism involve dna methylation already identify write DNA methylation Dnmts member Dnmt family directly catalyze addition methyl group DNA dna methylation basic function dnmt3b enzyme share similar structure large terminal regulatory domain terminal catalytic domain unique function expres sion pattern probably well study Dnmt especially nervous system highly express mammalian tissue include brain Dnmts preferentially methylate hemimethylate DNA Pradhan Ramsahoye DNA replication Dnmt1 localize replication fork newly synthesize hemimethylated DNA form Dnmt1 bind newly syn thesize dna methylate precisely mimic original methylation pattern present dna replication Additionally Dnmt1 also ability repair dna methylation Mortusewicz reason Dnmt1 call main tenance Dnmt maintain original pattern dna methylation cell lineage Knockout Dnmt1 mice result embryonic lethality time knockout embryo exhibit twothird loss dna methylation addition numerous apoptotic cell variety develop tissue include brain interestingly mouse embryonic stem cell lack Dnmt1 remain viable however differentiation result massive cell death recapitulate phenotype observe knockout embryo JacksonGrusby finding firmly establish Dnmt1 play critical role cellular differentiation well divide cell dnmt3b extremely similar structure function Dnmt1 Dnmt3a dnmt3b overexpresse capable methylate native synthetic dna hemimethylate DNA Okano reason dnmt3b refer novo Dnmt introduce methylation naked DNA figure primarily distinguish dnmt3b gene expression pattern express relatively ubiquitously dnmt3b poorly express majority differentiate tissue exception thyroid testis bone marrow similar knockout dnmt3b mouse embryonic lethal Okano hand knockout mouse runte survive birth result appear dnmt3b require early development require normal cellular differentiation final member Dnmt family Dnmt3L protein lack catalytic domain present Dnmt enzyme mainly express early development restrict germ cell thymus adulthood catalytic function associate dnmt3b stimulate methyltransferase activity consistent presence early development germ cell mouse Dnmt3L require establish maternal paternal genomic imprinting methylate compaction chromosome Zamudio express develop brain regulate neuronal differentiation observe brain postnatally write DNA methylation targeting Novo DNA methylation novo Dnmts target specific genetic region still unclear however several mechanism propose dnmt3b bind dna conserved domain however unclear dnmt3b target specific DNA sequence hypothesis suggest rna interference RNAi mechan ism target Dnmts silence specific sequence DNA RNAi clearly involve dna methylation plant cell exist evidence still weak role RNAi dna methylation mammalian cell theory transcription factor regulate novo dna methylation transcription factor regulate dna methylation bind specific dna sequence recruit Dnmts methylation protect dna methylation case Dnmts bind transcription factor component repressor complex target methylation DNA case regardless gene express transcription factor bind help protect site novo methylation cpg island appear primarily protect methylation transcription factor bind transcription factor bind site mutate cpg island unable retain unmethylated state similarly differentiation induce downregula tion transcription factor bind specific gene promoter nowexpose site target dna methylation study describe mechanism likely function together establish novo dna methylation dnmt3b recruit promoter specific transcrip tion factor novo Dnmt simply methylate cpg site genome protect bind transcription factor erase dna methylation dna demethylation characterize passive active passive dna demethylation occur divide cell actively maintain dna methylation cell dna methylation basic function replication inhibition dysfunction allow newly incorporate cytosine remain unmethylated conse quently reduce overall methylation level follow cell division active dna demethylation occur divide nondivide cell process require enzymatic reaction process order revert back naked cytosine yet know mechanism mammalian cell cleave strong covalent carboncarbon bond connect cytosine methyl group instead demethylation occur series chemical reaction modify deamination oxidation reaction product recognize base excision repair BER pathway replace modify base naked cytosine generally agree BER pathway final step dna demethylation specific enzyme chemical intermediate form dna demethylation still debate several mechanism active dna demethylation propose Figure chemically modify site amine group methyl group Deamination amine carbonyl group aid activationinduced enzyme complex effectively convert thymine thus create mismatch induce BER pathway correct base Overexpression promote DNA lation zebrafish knockdown knockout inhibit dna demethylation various gene necessary cellular reprogramming development various Dnmt knockout mouse aid mouse viable fertile global DNA demethyla tion critical dna methylation early development knockout aid mice study raise possibility multiple mechanism active dna demethylation exist compensate line multiple mechanism hypothesis active dna demethylation mechanism find mediate translocation Tet enzyme Tet3 Tet enzyme add hydroxyl group methyl group form develop brain contain significant level multiple region range approximately tenfold low average abundance Kriaucionis 5hmC form separate mechanism convert 5hmC back cytosine mammal first iterative oxidation Tet enzyme continue oxidize first formylcytosine carboxycytosine Ito second 5hmC deaminate form hydro consistent role Tet convert vivo tet1 knockout mouse embryonic stem cell reduce level 5hmC accompany subtle increase global level function intermediate dna demethylation still unclear methylation 5hmC regulate gene expression support theory conversion 5mC impair bind repressive methylbinding protein clear time 5hmC find vivo mammalian tissue play important role regulate dna demethylation gene expression mention mechanism active dna demethylation pathway use thymine dna glycosylase cleave modify residuef thymine replace naked cytosine Cortellino essential dna demethylation require normal develop ment knockout inactivation lead embryonic lethality mouse moreover mutant embryo exhibit hypermethylation particularly imprint gene H19 suggest active demethylation protect imprint gene spontaneous novo methylation monofunctional uracildna glycosylase BER enzyme uracil dna glycosylase family also find involve dna demethylation summary active dna demethylation arise multiple pathway involve multiple enzyme complexity likely contribute much current scientific debate Reading DNA Methylation Whereas dna methylation reduce gene expres sion impair bind transcriptional activator second class protein high affinity inhibit transcription factor bind dna methylation recognize separate family protein MBD protein protein zincfinger protein family MBD first identify MBD protein contain conserve methylcpgbinde domain MBD confer high affinity single methylate cpg site family include first identify methylbinding protein MBD1 MBD3 Bird MBDs highly express brain tissue many important normal neuronal develop ment function family MBD3 unusual example MBD3 incapable directly bind dna due mutation domain MBD4 bind DNA normally preferentially recognize guanine mismatch thymine uracil fluorouracil associate protein involve dna mismatch repair dna methylation basic function remain member family ability directly bind methylate dna contain transcriptional repression domain allow MBD protein bind variety repressor complex addition role transcriptional repressor appear unique role maintenance dna methylation MeCP2 bind Dnmt1 recruit Dnmt1 hemimethylated DNA perform main tenance methylation good study class methylbinding protein ubiquitinlike contain ring finger domain protein include multidomain protein flip bind methylated cytosine SET domain methyl bind protein primary function protein bind dna repress transcription protein family first bind Dnmt1 target hemimethylated dna order maintain dna methyla tion especially dna replication appear interact closely Dnmt1 deletion deletion Dnmt1 lead embryonic lethality Muto last family methylbinding protein bind methylate dna zincfinger domain compose ZBTB4 ZBTB4 zbtb38 distinct tissue expression pattern highly press brain bind single methylate cpg domain protein unusual ability recognize methylcytosine ZBTB4 preferential binding sequence motif lack methylcytosine NH2 Tet Tet TDG TDG NH2 AIDAPOBEC AIDAPOBEC 5hmC NH2 5fC Tet NH2 5caC NH2 Cyt 5hmU Thy TDGSMUG1 TDG Figure active dna demethylation pathway chemically modify site amine group methyl group amine group deaminate green convert thymine thy methyl group modify addition hydroxyl group mediate Tet enzyme generate hydroxymethylcytosine 5hmC also chemically modify site amine group hydroxymethyl group deaminate green 5hmC produce chemical pathway 5hmC Tet oxidize yellow 5hmC form formylcytosine carboxycytosine 5caC eventually product pathwayFThy 5hmU 5fC recognize cleave replace naked cytosine mediate component base excision repair pathway red dna methylation basic function methylbinding protein prefer bind consecutively methylate cpg site difference zincfinger domain protein similar family repress transcription dna methylationdependent manner DNA Methylation Epigenetic Mechanisms dna methylation work histone modification regulate transcription figure eukaryote dna associate histone protein help package long strand DNA small nuclear compartment modification include methylation acetylation ubiquitination phosphoryla tion add specific amino acid terminal histone tail modification influence dna strand package also transcriptional activity modification loosen DNA association histone generally provide permis sive environment transcription histone mod ification tightly package dna histone repress gene expression Dnmts directly interact enzyme regulate histone modification typically involve gene repression figure Dnmt1 Dnmt3a know bind histone methyltransferase restrict gene expression methylation H3K9 Fuks furthermore Dnmt1 dnmt3b bind histone deacetylase remove acetylation histone make dna pack tightly restrict access transcription general Dnmts cooperate histonemodifying enzyme involve add strip histone marker order impose repressive state gene region modification also influence dna methylation pattern figure Dnmt3L bind histone tail recruit dnmt3b methylate DNA Ooi direct binding Dnmt3a histone tail sometimes facilitate H3K36 trimethylation repressive histone mark also stimulate methyltrans ferase activity however presence active histone modification trimethylation H3K4me3 impair bind dnmt3b histone tail prevent methylation cpg island contain particularly high level H3K4me3 component methyltransferase complex target unmethylate cpg site often find murine cpg island play role maintain hypomethylation know regard DNA demethylation machinery interact histone modification yet still evidence suggest cooperate instance elevated histone acetylation trigger dna demethylation Cervoni contain dnabinding motif similar suggest protein target similar site case cpg island maintain dna demethyla tion direct connection yet show indeed localize cpg island depletion result increase methylation island mouse embryonic stem cell study Zhang Future study need probe interaction Tet histone modification Methylbinding protein serve strong link dna methylation histone modification protein interact methylate dna histone enhance gene repression figure recruit histone deacetylase remove active histone modification repressed transcription Dnmt3L MBD HMT MBD HDAC Dnmt SUV39H1 Dnmt HDAC H3K9 Histone methylation histone acetylation methylate cpg active transcription H3K4 H3K4 H3K4 Tet Tet H3K4 H3K4 Unmethylated cpg Hydroxymethylated cpg figure epigenetic crosstalk Transcription ultimately regulate interaction multiple epigenetic mechanism cooperate activate silence gene expression regulate protein Dnmt Tet purple involve active addition chemical modification red DNA methylation suppress gene expression Dnmts target site actively methylate dna Dnmts catalytic activity enhance association histone tail Dnmt3L dna methylation recognize methylbinding protein yellow Dnmts recruit enzyme modify histone tail orange include histone deacetylase hdac remove acetylation red histone methyltransferase hmt methylate histone green conjunction dna methylation serve repress gene expression region dna activate transcription Tet remove dna methylation histone tail region often contain H3K4me3 inhibit Dnmt bind unmethylate cpg site maintain permissive environment transcription dna methylation basic function repress gene transcription Jones furthermore enhance repressive chromatin state recruiting histone methyl transferase add repressive methylation Fuks overall dna methylation histone modification work closely together regulate gene expression recently mirna emerge important epigenetic mechanism influence gene expression Precursor form doublestranded RNA connect hairpin loop transport cytoplasm precursor miRNA process Dicer generate nucleotide duplex Mature mirnas eat miRNAinduced silence complex miRISC bind target mrna repress gene expression inhibit translation induce rna degradation sequence genome dna methylation regulate expression mirnas Han Lujambio loss dnmt1 dnmt3b colon cancer cell line reveal detect mirnas regulate DNA methyla tion Han Dnmts inhibit cancer cell reactivate mirnas initially silence hypermethylation cpg island Understood together study demonstrate dna methylation regulate mirna expression conversely mirnas also regulate histone tion Dnmt expression regulate dna methylation Benetti Sinkkonen Knockout Dicer mouse embryonic stem cell result depletion mirnas indirectly regulate dnmt3b expression lead loss dna methylation increase repressive histone methylation study provide evidence bidirectional influence mirna dna methylation dna BRAIN DNA Methylation develop CNS precise temporal regulation novo methylation demethylation particularly important differentia tion maturation mammalian central nervous system CNS Multipotent neural progenitor cell npc sequentially undergo neurogenesis Stiles particular differentiation switch npc neurogenesis astrogliogenesis coincide dna methylation demethylation event glial fibrillary acidic protein gene promoter region early neurogenesis e11 dna methylation promoter repress expression continual expression npc find important maintenance methylation pattern promoter subsequent cell division Fan interestingly neurogenesis E11 E14 time neural development dnmt3b strongly express decline nearly undetectable level CNS Fan E14 promoter undergo dna demethylation coincide differentiation astrocytic lineage development progress decline dnmt3b peak expression dnmt3a postnatally coincide remethylation reduce transcription promoter coordinated expression Dnmts ability regulate methylation pattern promoter organize regulate neuronal development importance coordinate event highlight conditional knockout model Dnmts neural development conditional knockout E13 time period coincide neurogenesis lead hypomethylation differentiate neuron demethyla tion promoter neural precursor cell thus accelerate astrogliosis lated neuron characterize multiple maturation defect include dendritic arborization impaired neuro nal excitability Fan result consistent conclusion Dnmt1 critical role neuronal differentiation maintain methylation promoter furthermore result suggest dna methylation essential neuronal maturation knock instead neural precursor cell majority cortical neuron develop normally case promoter normally remethylated postnatal astrocyte remain hypomethylated B50 cortical tissue likely correspond glial population consistent idea require differentiation maturation majority cortical neuron together knockout datum confirm precise regulation dna methylation essential differentiation maturation CNS Dnmts methylbinding protein express embryonic stem cell neural precursor Dnmts expression little effect neuronal glial differentiation protein MeCP2 well study CNS mutation result Syndrome common form mental retardation female development first express brainstem thalamus ancient region brain follow rostral progression expression methylbinding protein associate variety transcriptional repressor include Dnmt1 influence gene expression Neural activity lead phosphorylation MeCP2 alter ability bind gene promoter silence gene expression dna methylation basic function require normal neuronal maturation loss loss ability phosphorylate result aberrant dendritic arborization synaptic function plasticity conclusion neural development brain primarily consist postmitotic neuron glial cell little proliferation potential expression Dnmts normally decline terminally differentiate cell brain appear exception Dnmt1 express postmitotic neuron dnmt3b expression low virtually undetectable surprising discovery lead researcher investigate role active dna methylation postmitotic neuron adult brain DNA Methylation Adult Brain date majority DNA methylation mechanism characterize embryonic stem cell model predict function dna methylation divide cell embryonic stem cell inadequate model study dna methylation postmitotic cell fact Dnmts require normal neuronal differentiation maturation hinder study dna methylation solely postmitotic neuron limitation model emerge study dna methylation postmitotic neuron first model utilize pharmacological inhibitor azadeoxycytadine inject brain impair Dnmt activity pharmalogical inhibition Dnmts advantage inhibit dna methylation designate time point mechanism action Dnmt inhibitor postmitotic neuron still debate Nucleoside inhibitor azadeoxycytadine first incorpo rate dna order inhibit incorporate dna nucleoside inhibitor trap Dnmts chromosome lead substantial cellular toxicity ttermann possible BER pathway source nucleoside incorporation still unclear nucleoside inhibitor incorporate DNA nondivide cell postmitotic neuron concern surround use nucleoside inhibitor newgeneration Dnmt inhibitor include develop discovery structure catalytic domain identify silico screen small molecule inhibit Dnmt1 incorporate DNA Brueckner Stresemann RG108 emerge promise Dnmt1 inhibitor less cytotoxicity cellfree assay RG108 capable impair Dnmts catalytic domain similar dnmt3b share highly conserve catalytic domain Dnmt1 still unclear inhibit methyltransferase alleviate concern offtarget effect incomplete Dnmt inhibition second experimental model emerge model Dnmts conditionally knock use creloxP system express brainspecific promoter pharmacological inhibition second method allow investigator study role specific Dnmt subpopulation neuron Dnmts require normal neuronal differentiation therefore study role Dnmts adult brain express postmitotic brainspecific promoter CamKIIa Fan Golshani Nguyen Hutnick Feng postmitotic neuron Dnmt1 Dnmt3a appear overlap role Dnmt1 forebrain postmitotic neuron lead observable change dna methylation gene expression synaptic plasticity behavior however double knockout reduce dna methylation lead deficit synaptic plasticity addition learning memory research yet tease apart role Dnmt1 postmitotic neuron DNA methyla tion repeatedly show play role learning memory adult brain neuronal activity inhibit fear con ditioning memory formation prevent change dna methylation early study demonstrate vitro neuronal activity regulate expression activitydependent manner depolarization demethylate promoter release repressor complex promoter increase expression persistent activity neuron occur electroconvulsive stimulation exercise lead active dna methylation demethyla tion several gene brain however alteration dna methylation always correlate alteration gene expression observe heightened activity hence dna methylation demethylation alter neuronal activity dna methylation function regulatory protein epigenetic mechanism determine gene expression class protein work DNA methyla tion regulate gene expression CNS class methylbinding protein Methylbinding protein tinually express adult CNS often act repressor recognize bind methylated cytosine hence methylation remove result neuronal activity surprising often release promoter however role methylbinding protein simple dna methylation basic function MBDs undergo posttranslational modification alter ability bind dna induce neuronal activity result alter gene expression phosphorylation inhibit synapse formation synaptic plasticity learning memory behavior affect phosphorylation normally shortterm modification activitydependent phosphorylation porarily release promoter make gene sequence accessible demethylation hand dna methylation demethylation responsible longterm change gene expression regulate synaptic plasticity well learning memory DNA Methylation Etiology Neurological Psychiatric Disorders pattern dna methylation establish development modulate neural activity order encode learning memory mechanism establish recognize DNA methylation pattern dysfunctional problem learning memory fre quently result common form mental retardation Syndrome frequently cause mutation methylbinding protein MeCP2 Amir onset symptom month age coincide time early development sensory experience drive dendritic pruning shape connection brain express majority cell particularly important normal neuronal function mice loss mecp2 neuron sufficient recapitulate majority symptom phenotype mecp2 mutant mouse reverse restoration gene postmitotic neuron previously mention regulate neuronal activity turn regulate expression bdnf enhance expression follow depolar ization overexpression bdnf postmitotic neuron mutant mice ameliorate phenotype suggest critical regulate expression gene bdnf regulate neuronal activity essential normal cognitive function role Syndrome discuss later chapter extremely rare neurodegenerative disease illustrate importance proper dnmt activity adult brain patient hereditary sensory autonomic neuropathy type develop dementia hear loss adulthood result autosomaldominant muta tion terminal regulatory domain mutation result misfolde impaired nuclear localization early degradation however mutation affect target replication focus cellular replication association heterochromatin phase disrupt association affect maintenance dna methylation region modest reduction global dna methylation level neurodegeneration result involvement pathogenic mechanism support necessity adult brain improper methylation single gene single allele drastic consequence brain fragile Syndrome cause abnormal methylation trinucleotide repeat expansion FMR1 gene chromosome common form mental retardation tion repeat expansion FMR1 result transcrip tional silence FMR1 gene regulate neuronal activity protein product FMRP involve protein synthesis synapsis follow depolarization see similarly improper methylation single imprint allele find disorder cause significant mental impairment see buite incorrect expression loss function single gene dramatic effect brain important understand mechanism dna methylation affect gene expression dna methylation also alter repeat modulation microenvironment brain case recurrent seizure microenvironment repeatedly subject unusual synchronize neuronal activity way mimic unusual neural activity electric convulsive stimulation find result genomewide change DNA methylation pattern similarly repeat drug usage modulate neuronal function case cocaine cocaine usage modulate dnmt3a expres sion nucleus accumben enhance spine formation also repeat cocaine usage increase mecp2 turn increase expression sometimes drug exposure neural activity add posttranslational modification component methylation machinery dna methylation clearly alter disorder stem mutation inappropriate lation repeat modulation microenvironment role dna methylation psychiatric disorder less clear mount evidence alter pattern dna methylation associate many psychiatric disorder example earlylife stress form maternal neglect sufficient alter dna methylation brain rodent model Maternal neglect increase methylation promoter glucocorticoid receptor thus reduce expression surprisingly alteration DNA methylation pattern retain adulthood lead heightened stress response similarly human dna methylation basic function childhood abuse result increase methylation promoter glucocorticoid receptor decrease expression recapitulate rodent model furthermore alter pattern dna methylation observe psychiatric patient diagnose schizophrenia bipolar disorder Mill FUTURE direction CLINICAL implication dna methylation vary tissue also brain region gray matter white matter possibly even cell current technology limit ability distinguish cellspecific methylation pattern advent nextgeneration dna sequencing provide powerful tool examine genomewide DNA methyla tion pattern singlenucleotide resolution technology improve cost perform sequence analysis decline thus make technology accessible recent technical development allow genomewide dna methylation analysis perform even sample amount low aberrant dna methylation pattern observe wide variety psychiatric neurological illness decline cost ability perform genomewide methylation analysis limited tissue quantity soon possible map genomewide dna methylation pattern distinct brain region patient neurological psychia tric disorder analysis neural tissue psychiatric patient lead new insight etiology psychiatric illness open new avenue drug discovery target therapy current protocol enable scientist precisely quantify dna methylation singlenucleotide resolution use progressively small tissue quantity many commonly use method profiling quantifica tion dna methylation bisulfite sequencing methylationsensitive enzymebase assay unable distinguish protocol capable distinguish 5hmC genome cpg end labeling follow chromatography highperformance liquid chromatography HPLC detection Liutkeviciute tandem mass spectrometry DNA enrich use antibody bind specifically biotinylation modify 5hmC precipitate sequence identify use microarray chip dna sequence szwagierczak Pastor method quantify identify dna sequence associate single resolution attain order clarify genomic distribution epigenetic role brain locusspecific method identify 5hmC need develop highthroughput technique include rna chromatin immunoprecipitation chip sequencing come accessible researcher grow need integrate highthroughput datum currently dna methylation histone modification study relative isolation order fully understand gene expression regulate nervous system future research consider epigenome whole dissect biological mechanism mediate",
            "term_counts": {
                "Mental Health Terms": {
                    "bipolar": 1
                },
                "Epigenetic Terms": {
                    "methylation": 166,
                    "epigenetic": 16,
                    "demethylation": 32,
                    "5mC": 2
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Hotchkiss": 1,
                    "methyltrans": 2,
                    "zincfinger": 2,
                    "MBD1": 1,
                    "MBD3": 1,
                    "ZBTB4": 2,
                    "Dnmts": 1,
                    "Methylbinding": 2,
                    "Tet": 2,
                    "Han": 2
                }
            },
            "co_occurrence_matrix": {
                "Mental Health Terms": {
                    "methylation": 1,
                    "epigenetic": 1,
                    "demethylation": 1,
                    "5mC": 1,
                    "Hotchkiss": 1,
                    "methyltrans": 1,
                    "zincfinger": 1,
                    "MBD1": 1,
                    "MBD3": 1,
                    "ZBTB4": 1,
                    "Dnmts": 1,
                    "Methylbinding": 1,
                    "Tet": 1,
                    "Han": 1
                },
                "Epigenetic Terms": {
                    "bipolar": 216,
                    "Hotchkiss": 216,
                    "methyltrans": 216,
                    "zincfinger": 216,
                    "MBD1": 216,
                    "MBD3": 216,
                    "ZBTB4": 216,
                    "Dnmts": 216,
                    "Methylbinding": 216,
                    "Tet": 216,
                    "Han": 216
                },
                "Ethnographic Terms": {
                    "bipolar": 16,
                    "methylation": 16,
                    "epigenetic": 16,
                    "demethylation": 16,
                    "5mC": 16
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "(2)Folate and DNA methylation_ a review of molecular mechanisms and the evidence for folate_s role.pdf",
            "cleaned_text": "folate DNA methylation Molecular Mechanisms Role1 Bailey5 3national Center Birth Defects Developmental Disabilities Division Birth Defects Developmental Disabilities Atlanta Biochemistry Molecular Biology Center Epigenetics Division Pediatric Genetics University 5Foods dna methylation epigenetic modication critical normal genome regulation development vitamin folate key source carbon group use methylate dna normal mammalian development dependent dna methylation enormous interest assess potential change folate intake modulate dna methylation biomarker folate status mechanistic link developmental disorder chronic disease include cancer highlight role dna methylation normal genome function alter evidence role acid process Introduction Folate essential watersoluble vitamin occur natu rally select food well synthetic form folic acid use supplement food fortication pro gram many critical cellular pathway pendent folate carbon source include DNA rna protein methylation dna synthesis maintenance limit factor reaction study heritable change phenotype gene expression result change primary dna sequence recognize mechanism epigenetic regulation mammal include DNA methyla tion posttranslational modication histone chromatin remodeling micrornas long noncoding rna epigenetic regulatory mechanism modulate chroma tin structure contribute regulation major lecular process nucleus include transcription replication repair rna process dna methylation covalent modication genomic DNA modie gene expression provide mechanism transmit perpetuate epigenetic information DNA rep lication cell division role dna methylation cellular regulation also provide potential new paradigm disease intervention treatment development various inhibitor dna methylation alter methylation pattern intact mammalian cell lead clinical use inhibitor exper therapy human disease hematological malignancy myelodysplastic disorder dna methylation pattern stable retain puried genomic DNA therefore study dna methyl ation amenable wide variety cellfree assay technology include dna methylation analysis single nucleotide resolution nextgeneration sequencing genomewide methylation prole Table Cur rently new dna sequencing technology begin provide novel insight genomewide pattern dna methylation highresolution truly genomewide study limit small sample size recent study describe DNA methylation level individual site loci gene man genomic dna sample even tremendous datum set cover tiny portion genome ite number sample recent advance basic understand normal variation genomic Author disclosure author report conflict interest perform work employee government finding conclusion report author necessarily represent official position available Online Supporting Material link online post article link online table content correspondence address mail kcridercdcgov SASKATCHEWAN advancesnutritionorg pattern dna methylation human tissue age population disease environmental condition includ ing dietary intake well describe method need undertake type study infrastructure analysis rapidly emerge write provide nutritional scien tist synopsis mechanistic aspect dna meth ylation background understand potential nutrient folate affect molecular process highlight follow cover role mechanism dna methylation demethylation mechanism gene silence dna methylation function DNA methlyation reprogramme dna methylation pattern development differ entiation importance change dna methyla tion hyper hypomethylation follow potential role folate dna methylation process assessment folate status biomarker link disease outcome cover folate role carbon relate DNA methylation low folate status dna methylation background dna methylation cancer folate study cancer patient folate status global dna methylation study healthy adult folate status change dna methylation response environment importance develop mental timing exposure study folate fetus fant cord blood high folate folic acid intake dna methylation conclude focus search issue include methodological consideration key planning interpret research investigation relate assess difference dna methylation sponse change folate status clearly many challenging research issue need address fill gap knowledge relate potential late modulate dna methylation potentially impact development health maintenance current status knowledge part overview dna methylation introduction dna methylation Methylation cyto sine common human genome lend commonly occur cytosine cpg dinucleotide methyl group adenosylmethionine enzymatically transfer position cytosine generate methylcytosine genomic dna dna methylation pattern product frequency cytosine dna methylation specific site strand dna recent genomewide highresolution dna methylation analysis primary man fibroblast cell line demonstrate total tosine genomic DNA methylate methylate dna methylation occur cpg dinucleotide similar analysis human embryonic stem cell line show cytosine methyl ate cpg dinucleotide methylate cytosine methylation occur site early study also report high level noncpg methylation mouse embryonic stem cell contrast methylation pattern mouse somatic cell importance cpg methylation establish role noncpg methylation new active area research interestingly frequency cpg dinucleotide low expect mammalian nome believe due spontaneous deamination yield thymine cytosine thymidine transition dna however certain region genome approximately fold high figure Folic acid metabolism schematic show process acid use dna methylation MTHFR 677C variant reduce enzyme activity help divert available methyl group DNA methylation pathway DNA synthesis pathway pathway complex highly regulated feedback loop interaction show schematic name enzyme italic cofactor parenthesis dihydrofolate dhfr dihydrofolate reductase dnmt dna methyltransferase dtmp thymidylate deoxyuridine monophosphate methionine synthase mthfr methylenetetrahydrofolate reductase sah adenosylhomocysteine SAM adenosylmethionine serine tetrahydrofolate thymidylate synthase Abbreviations use BER base excision repair bpa bisphenol differentially methylate region dnmt dna methyltransferase hydroxymethylcytosine intracisternal particle methylcytosine methylTHF methyltetrahydrofolate line long interspersed element mthfr methylenetetrahydrofolate reductase neural tube defect red blood cell SAH adenosylhomocysteine SAM adenosylmethionine short interspersed element tetrahydrofolate Crider UNIV SASKATCHEWAN advancesnutritionorg list commonly use methodology analyze dna methylation1 description Pros Cons Global Liquid chromatog raphy tandem mass spectrometry genomic dna nucleoside fractionation highly sensitive quantitative accurate reproducible require costly instrumentation quire amount dna Shellnut HPLC genomic dna nucleotide fractionation hplc highly quantitative accurate reproducible require costly instrumentation quire amount DNA Methyl acceptance Global methylation determine level tion genomic DNA SssI methylase technical simplicity lack sensitivity imprecise weak reproducibility specific Methylsensitive striction enzyme digestion assess methylation specic restriction site use Southern blot Standard molecular biology technique analysis individual striction site strictly quantitative polymerase chain reaction amplie methylate genomic dna sequence sodium bisulte treatment genomic DNA sensitivity technical simplicity quantitative limited sequence coverage determine level methylation specic cpg site highly quantitative singlenucleotide resolution technically straightforward require costly instrumentation stricted sequence coverage Gut Microarray large number individual site specic gene assay use standard microarray equipment treatment K site sample Quantitative specic technically straightforward large number costly instrumentation quire DNA bisulfite genomic sequencing determine methylation status cytosine region interest single dna molecule Singlenucleotide resolution reveal dna meth ylation pattern individual dna molecule intensive timeconsuming stricted sequence coverage profile determine methylation status cytosine nome chemical conversion unmethylated cyto sine uracil genomic DNA Singlenucleotide resolution full genome cover age comprehensive method nomewide prole dna methylation requires sequence full genome w15fold coverage cost antimethylated cytosine antibody methylate dna bind protein enrich methylate dna successfully use wide variety publish study technically accessible low resolution full genome cov erage efciency dependent density sizeselecte portion genome isolate striction enzyme digestion sequence sodium bisulte treatment Singlenucleotide resolution bias analyze cpg island lack full genome coverage CHARM Uses restriction enzyme specically cleave methylate DNA Quantitative Lacks full genome coverage Irizarry help compare relative representation MspI fragment individual locus Assays cpg island site quantitative lack full genome coverage Khulan MSCC Assesses methylation status recognition site methylationsensitive restriction enzyme high resolution restrict cpg island strictly quantitative indirect sessment methylation tecte unmethylate cpg site lack full genome coverage ball sodium bisulfite conversion use polymerase chain reaction pyrosequence sodium bisulfite genomic sequence full genome sequence cytosine methylate cytosine genomic DNA chemically convert uracil sodium bisulfite methylate cytosine resistant conversion detect various method table comprehensive list method use assay dna methylation CHARM com prehensive highthroughput array relative methylation help HpaII tiny fragment enrichment ligationmediated polymerase chain reaction HPLC highperformance liquid chromatography liquid chromatographymass spec trometry meDIP methylate dna immunoprecipitation medna methylate dna MIRA methylate island recovery assay MSCC methylationsensitive cut count reduce representation bisulfite sequence folate dna methylation SASKATCHEWAN advancesnutritionorg frequency dinucleotide rest nome region refer cpg island often correlate location gene particularly promoter region regulatory region island compose genome typically unmethylated fig mapping cpg island use tool gene discovery mammalian gene associate cpg island land originally define genomic region pair size content serve cpg defini tion somewhat arbitrary refine recently correlate closely promoter region regulatory region Fig functionally important region dna methylation cpg island shore region island contain low density cpg site show recent work location tissue specific differential methylation normal tissue Methylation cpg island shore correlate gene expression certain shore show alter methylation pattern colon cancer dna methylation demethylation role mechanism dinucleotide provide mechanism transmit dna methylation pattern ter dna replication perpetuate pattern epigenetic regulation subsequent cell generation Methylation figure dna methylation pattern different type genetic locus pattern change cancer response maternal diet cartoon hypothetical single section doublestranded DNA bar represent cpg site Methylated cpg indicate bar ball end green arrow indicate transcription start active transcription red equal gene silence numbered blue rectangle exon dna methylation pattern conducive transcription pattern set development genome target methylation dna methyltransferase dnmt3a DNMT3b cpg island region concentration often always associate promoter region gene cpg island generally think actively protect dna methylation allow appropriate regulation transcription dysregulation dna methylation see cancer posttransformation cancer cell aberrant dna methylation pattern overall dna methylation level reduce subset genetic site hypermethylate include tumor suppressor gene specific loci hypermethylate vary type tumor maternal diet change methylation level metastable epiallele change transcription neighboring region Metastable epiallele region genome variable methylation pattern semiheritable generation illustrate mouse model mouse maternal diet include additional methyl donor lead increase methylation metastable epiallele intracisternal particle retrotransposon change expression genetic locus permanent change phenotype distribution offspring sequence retrotransposon candidate methylation early embryo however extent become methylated varie genetically identical individual base maternal diet methyl donor well dietary factor recent study find candidate locus human genome show differential methylation dependent birth Crider SASKATCHEWAN advancesnutritionorg dinucleotide result symmetrically methylate cpg site methylation sequence strand DNA see however dna replication result daughter dna molecule become hemimethylated parental template strand main taine methylation newly synthesize strand lack methylation continue dna replication hemimethylated daughter molecule eventually result loss dna methylation pattern subsequent gen erations propose scheme dna methylation pattern cpg dinucleotide restore newly synthesize dna dna replication postulate hemime thylate cpg site generate dna replication specifically recognize maintenance DNA methyltrans ferase methylate cpg site newly synthe sized DNA strand immediately dna replication regenerate pattern symmetrically methylate cpg dinucleotide daughter cell maintain epige netic state pattern gene regulation exist parental cell dna methyltransferase dnmt refer identify demon strate predict hemimethylated DNA thus general mechanism widely cepte mechanism maintain dna methylation pattern dna replication cell division recent evidence suggest maintenance methyla tion alone sufficient fully perpetuate dna methylation pattern genomewide nonetheless maintenance dna methylation hemimethylated sub strate provide clear example mechanism allow transmission retention epigenetic information multiple cell generation postulate availability folate source methyl group affect ability maintain dna methylation pattern replicate cell Mammals type DNMT DNMT1 DNMT3a DNMT3b DNMT1 abundant dnmt cell previously describe believe act primary maintenance methyltransferase methylate hemi methylate dna dna replication preserve parental dna methylation pattern daughter cell contrast dnmt3b function novo methyltransfer ase methylate fully unmethylate cpg site function primarily mammalian development establish dna methylation pattern epigenetic remodeling ram proceed differentiation methylate different subset dna sequence genome evidence different phenotype mouse carry knockout methyltransferase methyltransferase also appear play role maintenance methylation fully preserve parental dna methylation pattern daughter cell dna methylation usually regard relatively stable epigenetic mark clear example dna demethylation mammalian cell occur absence dna replication cell division suggest existence mechanism active dna demethylation however study dna demethylation mechanism demethylation mammal still well understand mechanism passive dna demethylation involve inhibition loss mainte nance methylation cpg site multiple round dna replication cell division eventually result loss dna methylation site subsequent cell gen eration several mechanism active dna demethylation also postulate report none conclusively demonstrate potential mechanism tive demethylation involve direct removal methyl group cleavage highly stable bond however port demonstrate mechanism quently reproduce potential mechanism active demethylation involve base excision pair BER DNA event removal dna glycosylase activity enzymatic deamination thymidine formation mismatch case excise base replace unme thylated cytosine BER Nucleotide excision repair also report play role active dna demethylation study seem contradict mechanism recently appreciation notable level hydroxymethylcytosine present mam malian genomic DNA conversion DNA catalyze mammalian TET translocation protein generate interest possible role mechanism dna demethylation potential mechanism demethylation involve recognition removal replacement unmethy lated cytosine BER thus regard highly stable terminal epigenetic state dna methyla tion becoming increasingly view dynamic process genomewide methylation study port evidence increase decrease dna methylation differentiation finding variation dna methylation sex change methylation aging suggest interindividual variation variation dna methylation pattern previously expect mechanism gene silence dna methylation Methylation cpg island especially island colocal ize promoter regulatory region generally associate gene repression mechanism dna methylation silence transcription fully stand several mechanism propose First methylation specic regulatory dna sequence attendant insertion methyl group jor groove DNA prevent stable bind regula tory protein transcription factor sequence thereby directly prevent gene activation transcrip tion factor bind study identie transcription factor folate dna methylation SASKATCHEWAN advancesnutritionorg interaction cognate dna recognition sequence negatively affect methylation cpg dinucleotide bind sequence however many transcrip tion factor sensitive dna methylation dna sequence bind transcription factor contain dinucleotide therefore indirect mechanism also involve repre sing transcription dna methylation indirect mechanism DNAbinding protein contain methyl ate dnabinding domain methylate dna bind protein methyl cpgbinde protein methylate dnabinding domain recognize bind methylate cpg dinucleotide pro tein turn interact recruit transcriptional silence complex contain chromatin remodeling complex histone modification enzyme histone deacety lase act form transcriptionally repressive con dense chromatin structure associated gene dnmt also find component multisubu nit chromatin modify remodeling complex volve transcriptional repression suggest DNA methylation machinery also recruit spe cific gene mechanism similar cruit histone modification remodeling activity chromatin modificationremodeling DNA methyl ation act cooperatively silence transcription contrast intragenic dna methylation active gene often high promoter region suggest methylation body gene positive regulator gene expression recent study suggest occur suppress repressive effect polycomb complex sociate chromatin remodeling function dna methylation methylation hypothesize ancient component mune system design recognize inactivate parasitic viral dna sequence inltrate genome genome contain large proportion repetitive dna sequence nearly human genomic dna include retroviral sequence transposon transposon long interspersed element lines short terspersed element SINEs extended block tandemly repeat dna sequence satellite dna DNA methylation present mammalian genome sociate repetitive dna sequence serve suppress potential activity deleterious effect petitive DNA include suppress mobility propagation repetitive element capable transposi tion suppress illegitimate recombination lated repetitive element function serve prevent widespread genome instability rearrangement mediate repetitive dna sequence hypothesize time function dna methylation evolve play additional role clude transcriptional regulation chromosome tion imprinting tissuespecic gene expression Hypermethylation cpg island highly correlate transcriptional silence associated gene particularly cpg island associate gene promoter region clear example aber rant stable transcriptional silence certain tumor sup pressor gene cancer cell hypermethylation promoter cpg island however methylation cpg island necessarily lead gene silence example gene telomerase show activate methylation dna methylation also cur body gene gene func tion methylation cpg site region still poorly understand also clear methylation critical site island trigger hyperme thylation island gene silence level hypermethylation island govern silence mechanism contribute recently contrast cpg island methylation report indicate methylation body gene role positive regulator transcription also role transcription elongation alternative promoter use nucleosome positioning generally dna methylation thought maintain gene silence sus initiate gene silence gene silence initially mechanism silence stabi lize methylation associate regulatory region island promoter region chromosome inactivation process female mammal compensate unequal dose link gene male female cell Females randomly inactivate chromo some present somatic cell process occur early female embryogenesis result monoallelic expression gene subject chromosome inactivation female cell early embryogenesis run domly choose chromosome inactivate maternally paternally inherit chromosome totic progeny cell maintain inactivation chromosome remainder development adult tissue hallmark inactive chromosome hypermethylation promoter land length inactive contribute stable maintenance transcriptional silence associate gene inactive chromosome cpg island typically unmethylate active chromosome imprint mammalian epigenetic system monoallelic gene expression allele particular gene cell differentially regulate case parentorigin fashion thus imprint gene paternally inher ite allele express maternally inherit lele stably silence conversely imprint gene paternally inherit allele stably silence maternally inherit allele transcriptionally active differential monoallelic expression maternal pater nal allele usually associate differential dna methyl ation regulatory region gene Crider UNIV SASKATCHEWAN advancesnutritionorg call differentially methylate region generally always hypermethylate tran scriptionally silence allele hypomethylate press allele imprinting control region regulate imprint entire domain imprint gene typically differential parentorigin dna methylation pattern imprint gene estab lishe gametogenesis dna male male gamete acquire maternal paternalspecic methylation pattern fertilization parentorigin methylation pattern also continue develop postzygotically Supplemental Fig differential gametic methylation imprint maintain propagate subsequent somatic velopment facilitate parentorigin pattern monoallelic transcription associate imprint gene imprint gene think comprise small proportion mammalian genome currently confirm human mouse human limit number know imprint locus subset share mouse however recent study imprint embryonic adult mouse brain find parentorigin bias expression gene transcript isoform confirm suggest imprint parentorigin effect wide spread complex originally believe Reprogramming dna methylation pattern development differentiation dna methylation pat tern undergo remodeling course mammalian differentiation development eventually generate cell typespecific methylation pattern find adult matic cell dynamic change methylation particularly pronounce gametogenesis early embryogenesis Supplemental Fig course gametogenesis dna methylation pattern erase demethylated develop germ cell primordial germ cell remethylate reset genomic dna meth ylation pattern specific sperm egg metogenesis proceed process particularly important establish gametespecific methylation pattern imprint gene sperm egg fertili zation current datum suggest nonimprinte locus also subject least partial erasure reset dna methylation pattern gametogenesis early embryogenesis dna methylation pattern also undergo genomewide process erasure mouse embryogenesis begin shortly fertilization continue blastocyst stage wave demeth ylation erase methylation pattern gamete follow DNA remethylation remain course embryogenesis establish genomewide celltype specific dna methylation pattern find fully differentiate adult somatic cell small study human embryo show wave demethylation cell stage follow remethylation beginning early late morula important exception dynamic reprogramming dna methyl ation pattern embryogenesis occur imprint gene escape process erasure resetting thereby maintain embryogenesis differ ential dna methylation paternally maternally herited allele somatic cell characteristic imprinted locus period dynamic reprogramming dna meth ylation pattern gametogenesis embryogenesis also present window opportunity environmental inuence diet nutrition develop bryo alter normal process establish dna meth ylation epigenetic pattern change dna methylation pattern affect normal pattern gene expression alter genome stability thereby lead increase risk disease later life even change methylation occur subset cell give tissue also possible alter dna methylation level pattern intact mammalian cell treatment various chemical inhibitor commonly ana log ribonucleotide analog azacytidine functions deme thylate agent result hypomethylation nome treat cell cytidine analog drug recently introduce potential therapeutic agent treatment human disease particularly myelodysplastic syndrome change dna methylation reect Hypermethylation hypomethylation cpg site single dna molecule methylate unmethylate level methylation site ther however single diploid cell methylation level give cpg site strand dna symmetrically unmethylate chro mosomes symmetrically methylate chromo unmethylate chromosome often see imprint gene symmet rically methylate chromosome DNA methyla tion assay usually perform population cell therefore level methylation give cpg site assay reect collective methylation site multiple cell multiple dna molecule var iation methylation see individual site thus nde particular site methylate population cell mean site methyl ate cell allele methylate allele unmethylate site unmethylate cell population fully methylate cell combination methylation level cell population yield composite meth ylation level different functional consequence different scenario important consider implication change centage methylation specic site dietary condition important consider folate dna methylation SASKATCHEWAN advancesnutritionorg change dna methylation level site distribute entire population cell appreciably affect transcription reect change subpopulation cell represent gene silence tivation cell something potential scenario different implication impact change methylation level case cpg island gene silencing generally sociate multiple methylate cpg site strand DNA however sitespecific methylation sult gene silence methylate cpg block bind ing dna methylationsensitive transcription factor genetic locus unknown cpg site many strand DNA methylate lence give gene evaluate impact change dna methylation important consider exact cation assay potential methylation site region change gene expression biological pro cesse interest part folate dna methylation Folate role carbon metabolism relate dna methylation normal dietary condition absorb folate metabolize methyltetrahydrofolate meth ylTHF monoglutamyl form intestine liver MethylTHF primary folate constituent take nonhepatic tissue polyglutamate cellular retention carbon cycle coenzyme function effective substrate polyglutamate synthetase therefore methylTHF convert methionine synthase reaction folic acid consume fortify food supplement metabolize primarily methylTHF intestinal absorption first pass liver ter behave identically natural dietary folate Folic acid normally first reduce dihydrofolate dihydrofo late reductase subsequently enter folate pool Fig case capacity dihydrofolate ductase exceed folic acid appear tion oxidize form coenzyme form folic acid dietary folate first con verte methyleneTHF vitamin dependent enzyme subsequently irreversibly reduce reaction key main taine flux methyl group remethylation homocysteine methionine vitamin dependent methionine synthase reaction methionine substrate cofactor methyl group donor merous methylation reaction include methylation DNA rna neurotransmitter small molecule phospholipid protein include histone num ber samdependent reaction regulatory role affect genome stability gene transcription calization protein small molecule degradation addition folate number dietary nutrient require maintain carbon ux ensure normal homocysteine remethylation SAM formation dna methylation nutrient include vitamin activity riboavin MTHFR sta bility vitamin methionine synthase function choline betaine precursor hepatic methyl source taine homocysteine methyltransferase carbon pathway thus DNA methylation func tion tight regulatory control SAM major folatedependent homocysteine remethylation potent inhibitor MTHFR con dition high inhibit reduce synthesis methylTHF hence methylation homocysteine conversely con low remethylation homocysteine favor MTHFR activity thus methylthf formation also modie common genetic variant reduce enzyme activity also rec ognize adenosylhomocysteine function potent product inhibitor methyltransfer ase reason continual hydrolysis SAH homocysteine essential maintain normal dna methyl ation moderate elevation plasma homocysteine concentration report associate creased concentration SAM increase concentration associate global DNA pomethylation low folate status dna methylation low folate status dene various measure include blood folate con centration folate intake folic acid intake associate increase risk cardiovascular disease multiple cancer neural tube defect mechanism low folate status contribute disorder remain unclear dna replication folate depletion destabilizing consequence inadequate folate availability cell division result com promise production thymidine uracil substitute DNA sequence mutagenic event trigger attempt repair defect increase frequency chromosomal break tissue cul ture show low folic acid result mation micronucleus indicative chromosome breakage MTHFR genotype lead increase micro nucleus formation low folate condition dna methylation cancer folate Global hypomethy lation targeted hypermethylation consider den ing characteristic human tumor Fig dna methylation pattern widely dysregulate human cancer Fig early study dna meth ylation genomewide hypomethylation find tumor tissue compare match healthy tissue tionally gene find hypermethylate nonrandom pattern specific type tumor determine change dna meth ylation tumor result silence tumor suppressor gene chromosome instability SASKATCHEWAN advancesnutritionorg Hypomethylation repetitive element predictive increase risk cancer increased mortality cancer recent largescale dna methylation study multiple type primary tumor thousands loci tumor dna methylation change tumor associate concomitant change gene expression tumor characteristic dna methylation change cancer appear random mor specific cell lineage show similar dna methylation change distinct tumor type normal tissue tumor increase severity progressive number locus show increase dna methylation primarily cpg island decrease dna methylation noncpg island site magnitude dna methylation change serve cancer tissue substantially great dif ference dna methylation type normal tissue Folic acid intake report prevent loss het erozygosity tumor suppressor gene small supple mentation trial human folate depletion human tissue culture cell result expect global hypomethylation also target hyper methylation cadherin locus unclear increase dietary folate folic acid result change healthy tissue predispose carcino genesis many study effect folic acid supplemen tation focus prevent promote cancer especially colon cancer Supplemental Table Studies cancer patient folate status global dna methylation great interest rever ing epigenetic change see early tumorigenesis global hypomethylation rapidly divide tissue tumor susceptible low folate availability result global hypomethylation clinical trial examine impact folic acid supplementation global dna methylation colon cancer patient plemental table study show dna methylation biomarker colorectal cancer methylation dna colon leukocyte increase supplementation folic acid human patient observational study cohort casecontrol association folate status measure acid intake blood folate con centration cancer study examine global DNA methylation level Supplemental Table study association find cancer global dna hypomethylation circulate blood tumor tissue however consistent association tween global DNA methylation folate status intake blood folate study lack defini tive association low folate status global DNA pomethylation due limited sample size imprecision assay study outline supple mental Table global hypomethylation find tumor even normal colon cell blood cancer patient association global hypomethylation folate status intake blood folate concentration consistent study cancer patient Supplemental Table unexpected give variety study design different global dna methylation assay type tissue examine many technique available assess global dna methylation level include look repetitive element methylation level line Alu examine various restriction site genome however correlation measure actually quite low neces sarily due accuracy measure due fact think global tually measure different type subset dna quence disparate region genome regulate differently indeed recent work suggest different change dna methylation type tumor type repetitive dna element often use proxy global methylation additionally early trial global dna methylation colon cancer patient use methyl acceptance assay assay provide estimate global dna methylation use enzyme methylate purify genomic dna radiolabeled tritium Methyl acceptance limited precision necessitate intact dna use damage dna occur result outcome interest preparation handling result inaccurate result careful consideration say methodology critical study design ensure appro priate interpretation reproducibility datum Studies cancer patient folate status site specic dna methylation patient previous adenoma colon date trial examine fect folic acid supplementation site specic dna methylation limited loci tumor methylation tumor suppressor land generally fully methylate silence methylate unmethylated methylate depend exact location site change dna methylation observe association variation red blood cell folate concentration human much small present tumor evaluate dna methylation level cpg islandcontaine gene colon tissue person previous adenoma placebocontrolle folic acid supplementation trial find trend great methylation genetic locus quintile folate increase low folate quintile high folate quin tile methylated trend SFRP1 methylate methylated trend statistically significant functional impact small change dna methylation gene transcription long term health outcome unclear time association dna methylation locus folate dna methylation SASKATCHEWAN advancesnutritionorg treatment folic acid plasma folate concentration dietary folate intake age pro tein intake race strongly associate dna methylation locus study statis tically significant association methylation locus hyperplasic polyp adenoma treatment additional observational study cancer examine DNA methylation folate status examine dna methylation genetic locus find high plasma folate concentration case associate creased methylation p73 p16in4a hMLH1 Christensen recently examine cohort woman breast cancer DNA methylation level site gene find dietary folate take associate DNA methylation class member ship primary breast tumor type study examine thousands locus simultaneously likely pro duce well understand interaction dna methylation folate substantial analytic challenge exist important note low folate status lead hypo hypermethylation result misregula tion complex system change observe cer appear random cpg island susceptible hypermethylation change appear precede transformation initiation cancer other consequence transformation time unclear sub set genetic locus susceptible dna methylation change response folatefolic acid intake cancer tient study highlight Supplemental Table show number locus warrant examination future study largescale genomewide analysis provide additional candidate study healthy adult folate status healthy adult divide tissue blood gut mucosa likely susceptible low folate diet human study examine effect control folate depletion repletion global dna methylation leu kocyte Supplemental Table Folate depletion result reduction global dna methylation old woman control feeding study find observe young male adult Shelnutt observe considerable increase methylation folate intake repletion period study increase limit MTHFR genotype see location folic acid cycle Axume find dna methyla tion change response depletion repletion however study restrict MTHFR gen otype result control feeding trial healthy adult somewhat inconsistent study limit small sample size individual group difference age group different initial folate vary length intervention additional observational study examine global dna methylation folate status patient cer Supplemental Table Friso find MTHFR genotypedependent association tween low global dna methylation low plasma late concentration Pufulete observe trend low dna methylation low serum folate concentration take together finding suggest differential global dna methylation sponse folate depletion repletion dependent age genotype duration magnitude exposure none study healthy adult examine sitespecific dna methylation change however study man hyperhomocystinemia global hypomethylation reverse monoallelic expression imprint gene store patient give folic acid therapy supple mental Table Changes dna methylation response environment diet importance developmental timing exposure increase evidence variation variation dna methylation pat tern life span previously expect change modulate environmental posure dna methylation vary sex change age addition increase number environmental exposure human air pollution benzene exposure late pollution link change dna methylation repetitive element hypomethylation adult furthermore find estrogen replacement result lower plasma homocysteine concentration increase global methylation small postmenopausal woman doubleblind placebocontrolle doublecrossover study change methylation find erb p16 gene thus certain environmental exposure associate change dna methylation change carbon metabolite increase interest utero effect environmental exposure toxin nutrition longterm health outcome hypothesize disease risk part determine maternal paternal diet Studies cancer find change dna methylation blood reect cancer risk tissue interest divide tissue suscep tible insult change result predisposition cancer happen embryonic riod reecte many tissue Supplemental Fig mouse clear maternal dietary change carbon availability affect DNA methylation pattern phenotype offspring beststudied example mouse mouse strain insertion intracisternal particle sequence upstream SASKATCHEWAN advancesnutritionorg region gene encode paracrine signal molecule gene strain regulate promoter activity increase availabil ity methyl donor mother diet pregnancy result increase dna methylation notypic change associate altered regulation gene offspring recently find locus human genome also act metastable epiallele similar locus mouse show differential methylation sponse season birth small human study study identity causative agent change dna methylation unclear pool methyl donor supply mouse model multiple dietary factor alter small human study effect dietary compone",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 215,
                    "epigenetic": 12,
                    "demethylation": 14
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Shellnut": 1,
                    "Methylsensitive": 1,
                    "Southern": 1,
                    "methyltrans": 1,
                    "SINEs": 1,
                    "statis": 1,
                    "Pufulete": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "Shellnut": 241,
                    "Methylsensitive": 241,
                    "Southern": 241,
                    "methyltrans": 241,
                    "SINEs": 241,
                    "statis": 241,
                    "Pufulete": 241
                },
                "Ethnographic Terms": {
                    "methylation": 7,
                    "epigenetic": 7,
                    "demethylation": 7
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "(2)Intrathecal 5-azacytidine inhibits global DNA methylation and methyl-CpG-binding protein 2 expression and alleviates neuropathic pain in rats following chronic__.pdf",
            "cleaned_text": "Research Report Intrathecal azacytidine inhibit global dna methylation methyl cpgbinde protein expression alleviates neuropathic pain rat follow chronic constriction injury Department Anesthesiology Article history accept Available online pathogenesis neuropathic pain remain largely unknown mechanism play major role regulate expression pro antinociceptive gene dna meth ylation major epigenetic mechanism vertebrate methyl CpGbinding protein mecp2 directly involve methylationmediate gene silencing determine change global dna methylation expression occur follow chronic constric tion injury repression dna methylation affect change attenu ate neuropathic pain use intrathecal azacytidine dna methyltransferase inhibitor rat rat receive saline azacytidine mol spinal jection daily surgery Global dna methylation expression increase spinal cord rat day surgery chanical allodynia thermal hyperalgesia induce attenuate intrathecal azacytidine surgery increase global DNA methyla tion expression spinal cord rat also significantly inhibit intrathecal azacytidine result demonstrate increase global DNA methyla tion expression spinal cord nerve damage play important role neuropathic pain azacytidine show potential treat neuropathic pain Elsevier right reserve neuropathic pain chronic constriction injury DNA methylation azacytidine methylcpgbinde protein Introduction Chronic neuropathic pain cause primary secondary damage dysfunction nervous system neuropathic pain characterize hyperalgesia allodynia spontane ous pain pathogenesis neuropathic pain complex many factor remain unknown recent evidence suggest expression level painassociated gene sensory neuron immune cell glial cell highly involve generation maintenance neuropathic pain genetic mechanism induce heritable change gene pression change dna sequence regulate transcription expression pro antinociceptive gene doehre dna methylation char acterize epigenetic mechanism vertebrate major contributor stability gene expression first Corresponding author Fax mail address qulianguo0731com Guo available online see front matter right reserve bind protein clone bind methyl inhibit transcription dna methylation dependent gene express predominantly neuron nearly absent glial cell mature mammalian central nervous system CNS Akbarian adult spinal cord MeCP2 express dorsal horn neuron link mecp2 gene mutation rearrangement main cause syndrome recent study tient mutation suffer syndrome reveal abnormal response sensitivity pain also suggest play important role regulate gene expression flammatory pain therefore hypothesize dna methylation involved development maintenance neuro pathic pain study examine global dna methyl ation expression spinal cord rat follow chronic constriction injury surgery fur ther examine effect intrathecal administration demethylation reagent azacytidine extensively study dna methyltransferase DNMT inhibi tor Oki global DNA methylation mecp2 expression neuropathic pain rat result change behavior neuropathic pain measurement rat suffer neuropathic pain show various sign protect posture movement disorder foot toe closing dorsiflexion eversion mark limp rat show sign ipsilateral mechanical withdrawal threshold thermal latency show similar change rat catheterization surgery significant difference MWT TWL rat surgery MWT rat decrease obviously low fore operation indicate mechanical thermal hyperalgesia become apparent rat MWT reduce vehicletreated rat surgery Mechanical allo dynia thermal hyperalgesia consistently attenuate rat surgery change level global dna methylation level global dna methylation lumbar spinal cord rat day follow surgery significantly differ ent group dna methylation level increase vehicletreated rat compare shamoperate rat rat show low global dna methylation level compare vehicle treat rat thus upregulation global dna methylation inhibit DNMT blocker Fig mean data ipsilateral mechanical withdrawal threshold thermal withdrawal latency rat change mechanical allodynia rat time follow change thermal hyperalgesia rat time follow comparison MWT rat different treatment operation vehicletreated rat Fig global dna methylation profile mean global dna methylation level lumbar spinal cord rat day follow Comparison global DNA methylation level rat different treatment shamoperate rat vehicletreated rat change mecp2 expression reverse transcription pcr pcr analysis pcr analysis show clear expression actin mrna lumbar spinal cord rat day follow result significantly different group rat show low mecp2 mrna expression level significant crease see vehicletreated rat sham control rat show moderate increase mecp2 mrna expression low vehicletreated rat indicate reduce mediate western blot analysis Western blot result consistent PCR observe clear expression nuclear mecp2 protein actin lumbar spinal cord rat day follow significant difference observe group expres sion significantly increase vehicletreated rat sham control rat show moderate increase low vehicle treat rat result also consistent finding PCR western blot abundant mecp2 labeling see dorsal horn lumbar spinal cord rat day follow surgery rat mecp2positive cell Fig treat rat intermediate level sham operate rat least mecp2 label Fig Discussion Transcription expression painassociated gene dna methylation exert major effect highly relevant genesis development neuropathic pain elucidate role dna methylation neuropathic pain facilitate development new therapy urgently need conventional painkiller opi oid nonsteroidal antiinflammatory drug poor ficacy neuropathic pain Dworkin study strongly express lumbar spinal cord rat agreement report increase global dna methylation mecp2 mrna level nuclear mecp2 protein localization clearly detect lumbar spinal cord surgery companie mechanical allodynia thermal hyperalgesia rat increase global dna methylation expression rat indicate important role neuropathic pain increase global dna meth ylation expression involved ing expression DNA methylationdependent antinociceptive gene lumbar spinal cord rat dna methylation catalyze dnmt transfer methyl group adenosylmethionine cytosine basis DNA Guz AZA intensively study dnmt inhibitor show potential reduce dna methylation reactivate silence gene cell syn thesize DNA store expression tropomyosinrelate kinase TrkA TrKB liver cell line spinal cord make class cell neuron glial cell long time consider mature neuron Fig pcr western blot analysis expression mrnas lumbar spinal cord rat day follow actin fragment use internal control mean integral optical density IOD MeCP2actin rat expression nuclear mecp2 kda lumbar spinal cord rat day follow actin kda use internal control mean IOD MeCP2actin rat comparison IOD MeCP2actin rat different treatment shamoperate rat vehicletreated rat shamoperate rat vehicletreated rat AZAtreated CCI rat potential synthesize dna neurogenesis non existent adult mammalian CNS recent study show dna synthesis neurogenesis occur adult mammalian CNS pathological condition injury even normal physiological condition Schultze Shechter Cell proliferation dna synthesis examine glia cell adult mammalian CNS injury DNA synthesis occur neuron glia cell spinal dorsal horn nerve damage rat current study mechanical allodynia thermal hyperalgesia induce markedly attenuate intrathecal treat ment rat Intrathecal treat ment alleviate neuropathic pain upregulate expression DNA methylationdependent antinocicep tive gene lumbar spinal cord rat similarly report significantly enhance rate recovery herpes simplex virus latent herpes sim plex virus type infect dorsal root ganglia spinal cord reduce global dna methylation expression result treatment contribute effect determine exact mechanism lead decrease mecp2 expression scope current experiment hypothesis less mecp2 need bind methylcpg follow crease methylcpg nucleus therefore indirectly inhibit nuclear mecp2 expression induce hypomethylation rat thus dna methylation significant mech anism neuropathic pain approve chemotherapy myelodysplastic syndrome malignant disease also tential drug treat neuropathic pain however study limit focused change post complete expand observation neuropathic pain dna methylation long term model model summary result suggest dna methylation play important role neuropathic pain bition dnmt drug new ther approach neuropathic pain provide hint study involvement DNA methyla tion neuropathic pain Experimental procedure animal study perform accordance approve procedure male rat weigh provide animal experiment center deep anesthesia induce intraperitoneal injection chloral hydrate chronic lumbar intra thecal catheter implant subarachnoid space rat describe recovery rat randomly divide shamoperate group group vehicletreate group deep anesthesia modify sciatic nerve perform left side sham operation nerve expose ligate pharmacological treatment different dose mol intrathecal use pilot study accord previous report find intrathecal effective dose pro duce significant side effect rat motor function operate rat receive vehicle saline rat receive vehicle saline USA surgery Neuropathic pain measurement mechanical allodynia thermal hyperalgesia rat monitor electronic vonfrey Anesthesi ometer Ugo Basile Italy respectively MWT rat measure day Fig Representative image show immunoreactivity lumbar spinal cord rat day follow Representative mecp2positive cell dorsal horn point arrow lumbar spinal cord shamoperate rat basal expression lumbar spinal cord vehicletreated rat highly increase mecp2 expression lumbar spinal cord rat moderately increase mecp2 expression surgery behavioral testing do observer unaware animal treatment Sample preparation day rat group choose run domly observe global dna methylation ELISA mecp2 mrna expression pcr nuclear mecp2 protein calization western blot analysis rat kill deep anesthesia lumbar spinal cord mediately dissect remain rat group use immunostaine expression deep anesthesia normal saline follow paraformaldehyde perfuse rat cende aorta rat kill lumbar spi nal cord dissect global DNA methylation measurement measure global dna methylation genomic DNA extract TissueGen dna kit dna methylation measure use ELISA meth MethylampGlobal DNA Methylation Quantifica tion kit pcr analysis pcr analysis primer sequence forward CGCGAAAGCTTAAACAGAGGA reverse TGCAAT CAATTCTACTTTAGAGCGA actin primer sequence tgagctgcgtgtggcccctgag reverse Total RNA extract use cdna template synthesize reverse transcription store pcr condition amplification cycle pre denaturation min cycle denaturation anneal extension cycle extension min termination positive band analyze Quantity soft ware measure optical density MeCP2 expres sion level normalize actin level Western blot analysis western blot analysis nuclear protein extract tissue Keygen Nucleoprotein cytoplasmic protein extraction kit nuclear protein sample separate polyacrylamide gel electrotransferre nitrocellulose membrane transblot electrophoresis transfer Cell BioRad USA Membranes block skim milk powder membrane incubate antirabbit MeCP2 molecular weight kda antimouse actin molecular weight kda room temperature shaker follow incubation goat anti rabbit IgG conjugate horseradish peroxidase goat antimouse IgG conjugate horseradish room temperature shaker visualize chemiluminescence use kit Positive band analyze Quantity software expres sion level normalize actin level analysis immunocytochemistry tissue fix parafor dehydrated embed paraffin section thickness store dewaxe section treat citrate buffer min retrieval section treat H2O2 min block goat serum min incubat rabbit polyclonal antimecp2 section incubate biotinylated antirabbit IgG min horseradish peroxidaseconjugated streptavidin min finally section incubate diaminobenzidine H2O2 min velopment color incubation section wash phosphatebuffere saline time min Negative control lack primary antibody cell brownyellow granule consider positive statistical analysis datum reflect mean ANOVA use compare value obtain MWT TWL global dna methylation expression use test LSD test use compare group value consid ere significant role funding source study support Postgraduate cx2010b089 excellent Doctors acknowledgment study support Postgraduate cx2010b089 excellent Doctors cholinergic differentiation azacytidine neuronal cell Akbarian Jaenisch Jones expression pattern syndrome gene primate prefrontal cortex syndrome cause mutation link encoding methylcpgbinde protein cell cycleapoptosis connection revisit adult brain Cell Biol peripheral rat produce disorder pain sensation see man pain Cruccu Haanpaa EFNS guideline neuropathic pain assessment Lotsch Epigenetics pain analgesia imminent research field Eur Pain Downs Geranton Bebbington Ravine pain sensitivity example syndrome 152A Bennett Weinstein Advances neuropathic pain diagnosis mechanism treatment recommendation role transcriptional repressor methylcpgbinde protein plasticityrelated gene serum glucocorticoidinducible kinase induction inflammatory pain state Neurosci descend serotonergic control regulate inflammationinduced induce mechanical sensitivity methylcpgbinde protein phosphorylation rat superficial dorsal horn DNA methyltransferase target cancer therapy Drugs Today Mechanism DNA methylation role control gene expression Postepy Biochem Effects chronic haloperidol clozapine treatment neurogenesis adult rat hippocampus Neuropsychopharmacology Holliday dna methylation epigenetic inheritance Methods Jaenisch Bird epigenetic regulation gene expression genome integrate intrinsic environmental signal Kim Son DNA methylationdependent regulation TrkA TrkB trkc gene human hepatocellular carcinoma progressively express postmigratory neuron involve neuronal maturation rather cell fate decision unschedule various type cell mousebrain vivo Exp Brain Res Kuan Schloemer Burns induce dna synthesis cell proliferation die neuron adult rodent brain Purification sequence cellularlocalization novel chromosomal protein bind methylate DNA Cell abnormal dna methylation cell patient subacute cutaneous lupus erythematosus Dermatol inflammatory mechanism neuropathic pain Brain Res Rev Transmural compressioninduced proliferation dna synthesis activation tyrosine kinase pathway rat astrocytoma RCR cell Brain Res Oki Issa recent clinical trial epigenetic therapy Rev recent Clin Trials neuropathic pain triad neuron immune cell glia DNA methylation inhibitor azacytidine modulate thioguanine toxicity mammalian cell Toxicol Lett syndrome mecp2 level display tissue cellspecific difference correlate neuronal maturation induce downregulation primary cortical culture Epigenetics New GABAergic support myelinspecific cell form intact adult spinal cord Stem Cells Enhanced reactivation herpessimplex virus type latently infect guineapig neural tissues azacytidine Gen Virol prevent cisplatin induce nephrotoxicity potentiate anticancer activity cisplatin involve inhibition metallothionein pakt expression chemical induce cancer rat Toxicol Adult neurogenesis primate rodent spinal cord compare cervical dorsal rhizotomy dorsal column transection Eur Neurosci inhibitor suppress expression p2x receptor attenuate hyperalgesia follow chronic constriction injury rat Neurosci improve method protect fix lumbar catheter place spinal subarachnoid space rat Neurosci Methods orchestrate braincell renewal role immune cell adult neurogenesis health disease Trends",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 36,
                    "epigenetic": 5,
                    "demethylation": 1
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Western": 2,
                    "MethylampGlobal": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "Western": 42,
                    "MethylampGlobal": 42
                },
                "Ethnographic Terms": {
                    "methylation": 3,
                    "epigenetic": 3,
                    "demethylation": 3
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "(2)Nutrition and epigenetics_ an interplay of dietary methyl donors_ one-carbon metabolism and DNA methylation.pdf",
            "cleaned_text": "current epigenetic interplay dietary methyl donor onecarbon metabolism dna methylation Anderson1 Karilyn sant1 Dana Dolinoy Ann USA receive receive revise form accept DNA methylation extensively study mechanism epigenetic gene regulation increase evidence indicate dna methylation labile response nutritional environmental influence Alterations dna methylation profile lead change gene expression result diverse phenotype potential increase disease risk primary methyl donor dna methylation adenosylmethionine SAM specie generate cyclical cellular process call onecarbon metabolism Onecarbon metabolism catalyze several enzyme presence dietary micronutrient include folate choline betaine vitamin reason nutrition status particularly micronutrient intake focal point investigate epigenetic mechanism animal evidence link nutrition dna methylation fairly extensive epidemiological evidence less comprehensive serve integrate study animal vivo human epidemiological datum pertain nutritional regulation dna methylation identify area current knowledge limit right reserve metabolism dietary methyl donor dna methylation examine dna methylation context diet Epigenetics study mitotically heritable yet potentially reversible molecular modication dna chromatin alteration underlie dna sequence increasingly recognize epigenetic mark provide mechanistic link environment nutrition disease dna sequence fairly permanent epigenetic modication dynamic life course heavily inuence external factor thus external effect epigenome alter gene expression give rise phenotypic disparity include disease formation modication include chromatin remodeling histone tail modication dna methylation recently expand include noncoding RNA microRNA gene regulation dna methylation widely study form epigenetic modication occur onecarbon metabolism pathway dependent several enzyme presence dietary micronutrient cofactor include availability folate choline betaine diet Fig ATPdriven reaction methionine convert adenosylmethionine sam universal cellular methyl donor dna methyltransferase dnmt covalently attach methyl group carbon position cytosine basis generate methylcytosine thus methylate dna mammal dna methylation primarily stable repressive mark find cytosine cpg dinucleotide however regulation dynamic previously believe regulatory event occur genespecic global manner passive demethyl ation dna tissue widely accept evidence active demethylation mostly limit various stage develop ment passive demethylation typically occur DNMT activity reduce inhibit time dna replication occur simply addition methyl group newly synthesize strand DNA cell division active demethylation enzymatic conversion methylcytosine cytosine fairly controversial mechanism occur still remain elucidate Enzymatic conversion methylcytosine produce additional basis carboxylcytosine potential role epigenetic regulation yet characterize addition Lister provide evidence methylation noncpg cytosine human embryonic available online wwwsciencedirectcom Journal Nutritional Biochemistry Funding work support grant P30 Core Center P30 ES017885 P20 grant ES018171 Support KES provide Grant T32 es007062 Conict interest author conict interest declare compete nancial interest corresponding author mail address author contribute equally article consider rst author see front matter right reserve cell suggest methylation noncpg site important developmental homeostasis distribution cpg sequence mammalian genome nonrandom greatly underrepresented mammalian genome due evolutionary spontaneous deamination methylcytosine majority unmethylate cpg site occur island dene discreet region contain preponderance content normally cpg island locate gene promoter exon housekeeping gene contrast promoter regulatory region repetitive dna sequence transposable element methylate consequently inhibit parasitic transposable repetitive element replicate dna methylation pattern prone change life course especially reprogramme event associate mal development aging example epigenome particularly dynamic embryogenesis extensive dna synthesis elaborate dna methylation patterning require normal tissue development establish early development individual age gradual dna hypomethylation occur genomewide level concurrent promoter hyper methylation normally unmethylate cpg island lead example genome instability genespecic suppression respec tively additionally cancer often associate lated DNA notable hypermethylation tumor suppressor gene compare normal tissue reprogramme event life course result tissuespecic dna methylation pattern difference epigenetic pattern important cellular differentiation tissue homeostasis context nutritional biochemistry signicant onecarbon metabolism pathway cyclical regenerate dietary micronutrient Nutriepigenomics emerge discipline examine role dietary inuence gene expression mately dna methylation event dietary practice particularly micronutrient intake inuence disease phenotype study nutriepigenomic particularly timely context deve lopmental origin health disease dohad hypothesis posit increase susceptibility disease follow early life experience shape epigenetic modication dna methylation modication take interspecie approach synthesize exist nutriepigenomic literature order identify sensitive period life course diet substantially alter dna methylation vestigate vary level nutrient exposure vulnerable time point researcher grasp magnitude degree impact nutrient onecarbon metabolism subsequently dna methylation careful attention give area research need understand link dietary micronutrient dna methylation life course health disease Nutriepigenomics study utilize combination global candidate gene less extent genomewide approach examine inuence methyl donor dna methylation recently attempt elucidate effect nutritional status epigenome candidate gene drive base epigenetic technique limited genome restrict doseresponse assessment con animal model emerge advance epigenomic highthroughput quantitative epigenetic technology allow identication constellation genomic loci altered epigenetic status follow dosedependent exposure epigenetic epidemiology proache facilitate identication epigenetically gion genome human cell thus identify epigenetic biomarker enable clinician identify risk individual prior disease onset furthermore genetic mutation epigenetic mark potentially reversible therefore epigenetic approach prevention treatment nutritional supplementation pharmaceutical therapy develop counteract negative epigenomic prole study combine methyl donor supplementation novel experiment investigate maternal methyl donor supple mentation utero clearly demonstrate impact early nutrition shape epigenome axin fuse axinfu viable yellow Avy murine model contain metastable epiallele locus variably express isogenic individual due establishment stochastic epigenetic modication early development variable dna methylation intracisternal particle dietary micronutrient onecarbon metabolism substrate obtain diet highlight yellow Vitamin cofactor conversion tetrahydrofolate methylene precursor cofactor methylenetetrahydrofolate reductase mthfr conversion methylene methyl B12 precursor methionine synthase involve production methionine homocysteine betaine avin adenine dinucleotide DMG dimethyl glycine MTHFR methylenetetrahydrofolate reductase adenosylhomo cysteine tetrahydrofolate retroelement intron gene result distinct kinky tail phenotype kinky hypomethylated tail kink hypermethylate genetically identical mouse Waterland demonstrate maternal diet supplement methyl donor include folic acid vitamin B12 betaine choline result offspring display less kinky tail phenotype accordingly hypermethylation axinfu metastable epial lele similarly coat color isogenic Avy mouse correlate sto chastic methylation upstream gene promoter result phenotype range yellow hypomethylated brown hypermethylate fur methyl donorsupplemente maternal diet shift distribution coat color phenotype brown comparison unsupplemented mother shift brown phenotype concomitant hypermethylation Avy furthermore use Avy model demonstrate maternal diet supplement methyl donor negate shift hypomethylation due bisphenol exposure restore normal stochastic methylation offspring AxinFu Avy model serve informative visual epigenetic biosensor maternal nutritional status particularly methyl donor need maintenance onecarbon metabolism dna methylation additional vivo rodent study rely wild type strain rodent investigate effect maternal methyl donor supplementation alter phenotype especially exacerbation disease example modulation allergic airway disease risk explore use C57BL mouse Hypermethylation gene crucial lymphocyte regulation Runx3 arise offspring expose methyl donor utero result increase allergic airway disease development conjunction amplied symptom severity furthermore C57BL mouse expose methyl donor sup plementation utero exhibit enhanced colitis susceptibility also associate aberrant dna methylation gene associate immunologic process crucial carbon metabolism catalyze conversion homocysteine methionine generate methyltetrahydrofolate relationship role MTHFR genotype dna methylation investigate extensive study look MTHFR variant conduct healthy woman week participant randomly assign study diet consist establish concentration folate betaine choline phosphatidylcholine sphin various choline source cell cytosine extension assay use determine global percent methylation diet MTHFR covariate show signicant effect leukocyte dna methylation study reduce dietary choline folate intake woman associate decrease global methylation leukocyte dna moreover dietary resupplementation folate result DNA remethylation global scale strength association robust individual MTHFR mutation suggest folate supple mentation crucial methylation maintenance individual MTHFR polymorphism Studies individual methyl donor folate dietary folate extensively study micronutrient animal epidemiological dna methylation research Table Folate reduce dihydrofolate subsequently tetrahydrofolate serve single carbon donor form methyl consequently methyl feed onecarbon metabolism cycle donate methyl group homocysteine convert methionine cofactor vitamin provide enzymatic support necessary transformation make possible dietary folate feed onecarbon metabolism cycle replenish cellular reason folate supplementation generally associate increase dna methylation vice versa folate restriction underscore however conicte evidence emerge suggest mechanism associate micro nutrient inuence dna methylation complex previously understand notable animal study evaluate global methyl ation effect maternal folate status First murine offspring expose lowfolate diet gestation lactation exhibit crease global methylation small intestinal tissue adult measure cytosine extension technique quantify unmethy lated cytosine island contrast measurement global methylation methyl acceptance incorporation methyl follow utero folate supplementation associate cpg hypomethylation mammary tissue rat offspring age finally postweane folate sup plementation equivalent recommend intake level woman childbeare age result decrease global methylation level murine colorectal tissue measure liquid chromatog raphymass spectrometry thus vivo animal datum support role global dna hypomethylation folate restric tion folate supplementation number human epidemiological study also measure global dna methylation indirectly incorporation methyl SAM look correlation folate dna methylation colorectal cancer postmenopausal woman First study conduct patient admit colonoscopy patient test negative colonic mucosa lymphocyte dna methylation find weakly associate serum folate concentration dietary folate measure use food frequency questionnaire patient diagnose folate supplementation diagnosis correlate increase global dna methylation Table Studies provide folate impact dna methylation author study populationtissue methylation measure human pregnant woman maternal blood cord blood Primary breast tumor pregnant woman cord blood leukocyte Genespecic cancer case control leukocyte Genespecic Stidley smoker sputum cultured glioblastomas Donk Colon tumor MTHFR variant Healthy adult colonic mucosa leukocyte colonic mucosa woman leukocyte Global van Engeland Colon tumor Genespecic Rampersaud Postmenopausal woman leukocyte various adult tissue Adult small intestine various adult tissue Genespecic Rat Adult mammary tissue small intestine colonic mucosa liver adipose tissue Adult liver blood Global genespecic postmenopausal woman dietary folate restriction correspond decrease serum folate concentration associate decrease dna methylation leukocyte dosedependent manner moreover folate supplementation cell cultured human glioblastomas methylate dna globally hypomethylated glioblastoma therefore human evidence suggest folate intake global dna methylation positively correlate numerous study utilize candidate genespecic approach investigate effect folate dna methylation locus select often associate disease outcome interest cancer diabetes prospect future preventative therapeutic strategy diet target epigenome example acetyltransferase gene human homologue NAT1 associate cancer development include breast carcinogenesis overexpresse display increase methylation adult rat expose highfolate diet additionally effect folate deciency methylation p53 important tumor suppressor gene evaluate rat feed lowfolate diet exhibit hepatic hypomethylation exon region p53 suggest methylation status play role molecular underpinning carcinogenesis Folic acid supplementation rat juvenilepubertal period increase methylation promoter region insulin receptor PPAR glucocorticoid receptor gene involve metabolic homeostasis compare offspring expose utero environment exception folateadequate diet puberty rat exhibit distinct alteration dna methylation measure several locus involve weaning adult exposure folate depletion gestation lactation importantly result experiment indicate folate exposure alter dna methylation gene tissuespecic manner different life stage additionally difference methylation dependent sex genotype aforementioned vivo candidate study explore folate role methylation target tissue type use blood surrogate biomarker methylation target tissue permit thorough human epigenetic research develop ment noninvasive methylation measurement epigenetic epi demiology study mouse deprive folate utero show hypomethylation differentially methylate region imprint locus insulinlike growth factor slc389a4cgl1 blood liver kidney tissue conversely show signicant methylation difference blood kidney liver provide evidence methylation gene tissue specic grow investigation folate role methylation status select gene know alter disease susceptibility human evidence obtain food frequency questionnaire suggest folate intake signicant effect genespecic methylation white blood cell likewise low folate intake combine high alcohol consumption demonstrate nonsignicant change gene promoter methylation blood patient study examine serum folate tion smoker detect methylation gene previously hypermethylate lung cancer interestingly increase serum folate associate decrease methylation smoker gene examine alternatively positive correlation serum folate concentration promoter methylation identie RASSF1A gene increase expression implicate multiple disease breast lung cancer gene expression examine study increase promoter methylation repress RASSF1A expression subsequently decrease cancer risk together datum suggest folate associate protection cancer human study also investigate role maternal folate status offspring methylation crosssectional study pregnant woman time parturition look imprint gene IGF2 imprint gene express due allelic repression epigenetic modication dna methylation imprinted gene functionally prone deregulate event investigate methylationbased study blood maternal blood collect time delivery serum folate concentration determine specimen determine maternal cord blood folate concentration associate methylation outcome promoter IGF2 additionally hypomethylation IGF2 promoter umbilical cord blood leukocyte inversely associate maternal report folate supplementation pregnancy study look correlation diet methyl ation epigenomewide scale Illumina GoldenGate bead array use conduct epigenomewide study examine connection human folate intake breast cancer dietary folate determine food frequency questionnaire strongly associate genomewide scale hypermethylation cpg site cancerrelate gene promoter epigenomewide scale study necessary discover candidate locus variable methylation potential increase individual popu lation susceptibility disease betaine Choline indirect methyl group donor onecarbon metabolism pathway dietary choline oxidize betaine contribute methionine homeostasis donation methyl group homocysteine result homo cysteine conversion methionine Fig thus number animal vivo less extent human study investigate role dietary choline betaine impact global candidate gene dna methylation Table Choline deciency associate altered neurogenesis low decline memory function choline crucial maintenance onecarbon metabolism several study investigate choline deciency inuence global didate gene methylation fetal brain well tissue global methylation analysis Embryonic Day mouse fetal brain display signicant shift hypomethylation candidate gene also analyze dna methylation status include Cdkn3 Cdkn2b Calb2 candidate gene show hypomethylation promoter region offspring expose maternal cholinedecient diet additionally choline deciency Gestational Days decrease methylation cpg site locate promoter fetal hippocampus examination early choline exposure fetal brain gene methylation perform candidate locus display hypomethylation expose maternal choline decient diet correlate increase expression encode protein VEGF angiopoietin respectively global methylation rat brain liver tissue analyze follow exposure cholinedecient diet ed interestingly global hypomethylation occur brain global hypermethylation observe liver tissue furthermore hypermethylation liver correlate hypomethylation cpg site Dnmt1 gene encode dna methyltransferase thus datum suggest early choline deciency ability deprive DNA methylation machinery proper substrate onecarbon olism lead increase expression methyltransferase subsequently increase methylation specic locus case imprinted gene complex concept explore understand wholly mechanism involve genespecic methylation supplementation also explore role carcinogenesis adult rat expose vary level betaine diet Hypermethylation tumor suppressor gene p16 display liver tissue rat expose dose compare control group concomitantly correlate decrease mrna expression p16 chicken betaine supplementation associate modest positional effect lipoprotein lipase gene promoter measure adipocyte promoter highly hypomethylated several site find hypermethylate betaine supplementation gene expression signicantly decrease betaine supplementation inuence dna methylation change unknown Vitamins B12 watersoluble vitamin B12 important catalytic role folate onecarbon metabolism serve coenzyme key enzyme folate cycle convert methylene vitamin precursor dinucleotide cofactor mthfr enzyme responsible reduction methylene methyl b12 coenzyme methionine synthase cata lyze reaction homocysteine product SAM methionine thus dietary consumption watersoluble vitamin potential affect efciency onecarbon metabolism pathway animal human study evaluate role vitamin b12 dna methylation prole table vivo rat model show deprivation vitamin B12 addition diet supplement folate enhance placental global hypomethyla tion compare diet exclusively supplement folate sug geste interaction micronutrient alter methylation pattern profoundly excess deprivation micronutrient human epidemiological study examine role vitamin b12 regulation dna methyla tion use crosssectional study design assess vitamin b12 folate status pregnant woman time parturition blood igf2 methylation promoter inversely correlate maternal blood serum b12 additionally maternal blood methylation promoter inversely correlate maternal serum B12 second study examine relationship plasma vitamin b12 concentration dna methylation smoking status former smoker increase serum vitamin b12 concentration associate decrease methylation several multidiseaserelated gene promoter similar decrease methylation associate increase serum vitamin concentration disease link gene essential amino acid continuously regenerate homocysteine onecarbon metabolism serve precursor SAM Fig thus uctuation methionine diet potential effect dna methylation methionine immense role methyl donor limited evidence evaluate methionine dna methylation table rat feed methioninesupplemented diet change p53 promoter region methylation additionally plasma methionine concen tration inversely correlate dna methylation pro moter several multidiseaserelated gene former current smoker discussion role nutrition onecarbon metabolism DNA methyla tion extensively study animal model human however reveal epidemiologic datum become increasingly robust Herein highlight datum alter consumption folate choline betaine vitamin methionine act modify methylation globally promoter diseaserelate gene animal human thus nutriepigenetic approach provide molecular foundation understand role diet life course prospective role disease prevention therapy limited number human study micronutrient intake methylation nonetheless multiple laboratory establish solid foundation use animal vivo model future study discipline body literature indicate importance exposure timing genotype tissue gene specic dna methylation interpretation result methylation cell type dependent comprehensive epigenetic analysis remain optimal approach future study continue focus tissue specicity dna methylation investigation likely signicantly inuence vary disease state addition examine surround methyl donor exposure window susceptibility life course embryogenesis fertilization neonatal puberty aging thoroughly investigate vulnerable epigenetic state combine tissuespecic outcome shape knowledge disease etiology possibly preventive thera peutic approach disease vast array methodology use detect dna methylation nutriepigenetic study even epigenetic technology evolve traditional method use restriction enzyme focus candidate gene modern technology allow unbiased epigenomewide investigation tissue specie main goal nutriepigenetic well understand role diet disease epigenomewide investigation involve deep sequenc ing tile array technology valuable future study Table Studies provide choline betaine vitamin methionine impact dna methylation author study populationtissue methylation measure Choline betaine adipocyte fetal brain fetal brain Genespecic Rat adult liver fetal liver brain Global genespecic fetal brain Global genespecic vitamin pregnant woman maternal blood cord blood Genespecic Kulkarni Rat placenta global Vineis Lung cancer case control leukocyte Genespecic Methionine adult kidney cancer case control leukocyte Nutritional Biochemistry apply integrative approach identify key regulatory pathway interaction diet epigenetic mechanism histone modication chromatin remodeling complex also consider additionally investigate interaction micronutrient require onecarbon metabolism indirectly affect supply maintain cycle efciency implicit integrate genomewide application nutriepigenetics continue emerge enable clinical public health practice apply epigenetically drive therapeutic preventative strategy evaluate population individual certain disease state example register dietitian make nutritional recommendation base individual epigenetic prole epigenome particularly sensitive various time point life course target nutriepigenomic population intervention efcient cost effective continue animal nutriepigenomic model translate human research strengthen understanding biological pathway associate diet human health modification epigenetic reprogramming mammalian development reprogramming mammalian develop ment science pathway nucleus Selhub Homocysteine metabolism Maunakea conserve role intragenic dna methylation regulate alternative promoter Nature Zhang Active DNA demethylation many road lead Nat Rev Mol Cell Biol Ito Tet protein convert methylcytosine formylcytosine carboxylcytosine Science lister hotspot aberrant epigenomic reprogramming human induce pluripotent stem cell Nature methylation fate cpg dinucleotide vertebrate genome dna methylation mutation Mol Mech Mutagen cpg island regulation transcription Genes Dev difference arise lifetime monozygotic twin reprogramming mouse primordial germ cell Mech Dev drift age identical twin time everything environmentally induce change epigenome animal epigenetic Mugatroyd Janus face dna methylation age aging phenotypic plasticity epigenetic human disease Nature developmental origin adult disease Attig programming epigenetic epiallele mammal Trends Genet Vasicek dominant mutation mouse fuse gene result transposon insertion Waterland maternal methyl supplement increase offspre dna methylation fuse mutation obese yellow mouse Waterland element target early nutritional effect epigenetic gene regulation Mol Cell Biol Jirtle Maternal nutrient supplementation counteract bisphenol induce dna hypomethylation early development Hollingsworth utero supplementation methyl donor enhance allergic airway disease mouse Clin Invest Schaible Maternal methyldonor supplementation induce prolong murine offspring colitis susceptibility association mucosal epigenetic microbiomic change methylenetetrahydrofolate reductase enzyme metabolic significance risk impact folate requirement status reliable indicator moderate change dietary choline consumption premenopausal woman Shelnutt reductase 677C polymorphism affect dna methylation response control folate intake young woman depletion pregnancy lactation reduce genomic DNA methylation murine adult offspring effect maternal postweaning folic acid supplementation mammary tumor risk offspring cancer res sie KKY effect maternal postweaning folic acid supplementation colorectal cancer risk offspring Gut Pufulete Effect folic acid supplementation genomic DNA methyla tion patient colorectal adenoma Gut Pufulete Influence folate status genomic DNA methylation colonic mucosa subject colorectal adenoma cancer cancer rampersaud genomicdna methylation decrease response moderate folate depletion elderly woman supplementation limit aggressiveness glioma remethylation dna repeat element gene govern apoptosis proliferation Wakefield Boukouvala Sim Characterisation cpg methylation upstream control region mouse Nat2 evidence geneenvironment inter action polymorphic gene implicate folate metabolism deficiency rat induce dna strand break hypo methylation p53 tumor suppressor gene Burdge Folic acid supplementation juvenilepubertal period rat modify phenotype epigenotype induce prenatal nutrition Nutr Effect maternal post wean folate supply genespecific dna methylation small intestine weaning adult wild type mouse Front Genet McKay blood surrogate marker tissuespecific dna methylation change due folate depletion postpartum female mouse Mol Nutr Food Res folate intake combination MTHFR C677 genotype promoter methylation tumor suppressor dna repair gene sporadic colorectal adenomas cancer epidemiol biomarker Prev Effects dietary folate alcohol intake promoter methylation sporadic colorectal cancer folate green vegetable protect gene promoter methylation aerodigestive tract smoker Cancer res dna methylation change associate cancer risk factor blood level vitamin metabolite prospective study folate vitamin b12 methylation insulinlike growth factor maternal cord blood Eur Clin Nutr dolinoy disease variation IGF2 differentially methylate region maternal folic acid use pregnancy epigenetic Christensen Breast cancer dna methylation profile associate tumor size alcohol folate intake e1001043 choline metabolism gene variant development uterine cervical carcinoma dietary choline reverse effect folate deficiency neurogenesis apoptosis fetal mouse brain maternal dietary choline deficiency alter fetal mouse hippocampus dietary choline deficiency alter global genespecific DNA methylation develop hippocampus mouse fetal brain deficiency alter global histone methylation epigenetic mark Re1 site calbindin gene gestational choline deficiency cause global gene dna hypermethylation regulation expression assessment effect betaine p16 myc dna methylation mrna expression chemical induce rat liver cancer model Cancer Biochemistry Effect dietary betaine supplementation lipogenesis gene expression cpg methylation lipoprotein lipase gene broiler Mol Biol Rep Perry Effect vitamin availability serine cell Biophys Low dietary choline low dietary riboflavin pregnancy influence reproductive outcome heart development mouse Kulkarni Effects alter maternal folic acid vitamin B12 docosahexaenoic acid placental global DNA methylation pattern rat e17706 effect dietary supplementation methionine genomic stability p53 gene promoter methylation rat Environ Mutagen dolinoy variable histone modification Avy metastable epiallele epigenetic",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "epigenetic": 35,
                    "methylation": 127,
                    "demethylation": 4
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "angiopoietin": 1,
                    "Re1": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "angiopoietin": 166,
                    "Re1": 166
                },
                "Ethnographic Terms": {
                    "epigenetic": 2,
                    "methylation": 2,
                    "demethylation": 2
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "(2)Profound Methyl Effects in Drug Discovery and a Call for New C_ H Methylation Reactions.pdf",
            "cleaned_text": "issue WileyVCH KGaA Weinheim Organic chemistry chin Profound Methyl Effects Drug Discovery call New Methylation reaction ref SCHOENHERR CERNAK Angew Chem Int Dep Med Chem Merck Res Lab Rahway USA",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {}
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "4-_5-Methyl-3-phenylisoxazol-4-yl_-benzenesulfonamide_ valdecoxib_ a potent and selective inhibitor of COX-2.pdf",
            "cleaned_text": "derivative isoxazole derivative Potent Selective Inhibitor COX Compound IIIa active metabolite IIIb find inhibitor human whole blood recombinant human enzyme Res Dev Monsanto",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "isoxazole": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "5-Methylcytosine DNA demethylation_ more than losing a methyl group.pdf",
            "cleaned_text": "GE46CH19PetersenMahrt ARI August Methylcytosine DNA Demethylation Losing Methyl Group DonMarc FranchiniKerstinMaike Schmitz dna edit Immunity Epigenetics IFOMFondazione Istituto Oncologia email Annual Genetics online genetannualsorg article annurevgenet Copyright right reserve author contribute equally epigenetic dna repair dna reprogramming cytosine deamination cytosine hydroxylation demethylation methylcytosine dna integral nance intact epigenome balance presence absence methylcytosine determine many physiological aspect cell metabolism turnover measure Biochemically addition methyl group share live kingdom well characterize moval reversion mark seem diverse much less stand present summary dna demethylation initiate directly utilize translocation TET family protein activationinduced deaminase AID dna mod ifye enzyme indirectly transcription rna metabolism dna repair intermediate pathway substrate DNA repair machinery demethylation pathway link possibly balanced avoid mutation post online Changes still occur final publication online print change still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI introduction mammalian cpg methylation methyl modication cytosine double strand dimer provide mean local heritable control gene expression reversible notion foster search mechanism lead dna demethylation Biochemically DNA methyla tion serve multitude purpose figure alter Waals radius cytosine addition bulky methyl group help foster formation non dna alter base stack potential cytosine possibly inuence com pactness winding nucleosome inhibit bind dna bind protein enhance bind methylcpg bind protein dna structure dna bend nucleosome transcription location compaction Proliferation Differentiation Development Imprinting Cellular pluripotency oncogenesis rna metabolism dna replication silence dna bind protein bind consequence NH2 Cytosine methyl cytosine NH2 CH3 Figure overview methylation cytosine inuence biological process methyl group cytosine exert biochemical change dna direct dna structure dna bend nucleosome indirect enablingdisable association protein bind biochemical modication serve molecular signal chromosome function various mean combination molecular signal determine development physiology pathology organism MBPs nucleus DNA methylation serve figure change compaction chromatin change subnuclear localization gene locus change activation potential gene repress transposon selsh dna alter dna replication efcacy inuence rate rna process diverse functionality profound effect cellular proliferation differentiation pluripotency development imprinting oncogenesis figure Demethylation subject temporal cellular regulation raise likelihood several type effector involve give time mammal numerous example active dna demethylation scribe extent active demethylation Changes still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI variable range global genome wide local genespecic demethylation possibly even single cytosine active tissue dna demethylation carry early step development character ize genomewide loss methylcytosine 5mCFirstinthezygotethepaternalgenome undergo massive wave loss right fertilization Second global demethylation observe cellular migration primordial germ cell PGCs genital ridge aside global dna reprogramming event evidence active dna demethyla tion somatic cell report mature neuron lymphocyte breast cancer cell line local dna demethylation lead specic gene activation detect follow cellular stimulation wealth datum global methylation status local cpg demethylation derive study physiological development cancer tissue differentiation stem cell survival explain simple single static pathway dna demethylation cpg methylation provide mark numerous molecular function presence absence detect broad dynamic scale range uctuation perfect stability generation demethylation cyclic directly follow remethylation burst promoter activation also persist developmental path conclude time gene cell return quiescent state persistent demethylation require terminally differentiate cell highlight pathway cur rently know lead dna demethylation focus mostly mammal importance epigenetic reprogramming health dis ease increasingly appreciate also hope provide nonexpert enough overview allow independent exploration exciting DNA Demethylation Loss Methylcytosine recognition progress science dependent avail able technology tech nique commonly use identify dna methylation include restriction analysis methylationsensitive enzyme stain antibody recognize chemical treatment follow sequence approach strength limitation particularly sensitive modication modie alter pattern striction digest antibody recognition prevent loss methyl group also modication methyl group modied different chem ical property treatment chemical difference affect tection vitro also important molecular recognition vivo reversibility methylation therefore understand term function well chemistry chemical biological function describe mod ulate modication removal methyl group also shield hiding hide potentially important source regulation discuss systematically test experimentally hiding principle achieve chemically tautomerization pyrimidine usually amino tautomer form recognize methylcpg bind domain MBPs local acidic change stimulate example loss basic protamine buffer DNA phosphodiester backbone induce transition imino form possibly prevent ing recognition Return neutral enable recognition local change commonly use precise mean inuence biological activity DNA Demethylation change still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI August see subtle shift promote catalysis histidinecontaine enzyme inhibit recognition cpg dna nucleotide methyltrans ferase DNMT thereby lead demethylated phenotype recognize chromatin positioning respect face core nucleosome inuence MBD bind linker DNAassociated 5mcs even accessible suggest hide nucleosome depend position nucleosome methylate region methyl moiety mean prevent recognition induce change epigenetic tus locus see discussion translocation TET family protein reversible allow transient namic loss methylation response devel opmental environmental stimulus Base removal stable mechanism dna demethylation bring high price mutability nonetheless discovery several dna repair pathway involve dna demethylation see follow section detail seem indicate risk evolutionary acceptable absentee DNA covalent modication protein phosphorylation alter structure protein interaction protein bond energy protein phosphorylation allow rapid addition removal biological advantage fully exploit see large number kinase phosphatase participate aspect biology however chemistry cytosine methylation seem forbid comparable transience Methylation position cytosine stable carbon carbon bond require substantial energy break share aromatic cytosine ring input energy sufcient break position dissipate duce bond breakage carbon bond preclude direct demethylation position explain activity directly demethylate dna identie instead cytosine dna demethylation appear require cascade enzyme lead production cytosine term DNA demethylase suggest single activity use discuss avoid possible confusion however dna demethylase describe act directly remove cleave carbon bond AlkB dioxygenase find prokaryote eukaryote carry oxidative demethy lation remove alkylation DNA DNA repair enzyme use oxygen oxoglutarate cofactor release methyl group methyl adenine methyl cytosine formaldehyde demethylation pathway acting NEAR METHYLCYTOSINE recent explosion num ber factor implicate dna demethyla tion lead con fusing misleading picture attempt simplify figure separate pathway group specic factor act thymine dna glycosylase TDG MBD4 TET AID DNMT1 link identie likely indirect gadd45 hormone direct interact protein divide directly mutagenic tar get lesioninduced demethylation indirectly nonmutagenic target modicationinduced demethylation see sidebar Triggering Active DNA Demethylation demethylation path way involve signicant overlap dna repair protein pathway use Changes still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI August passive dna demethylation dna methylation symmetrical carbon methylate basepaired dinucleotide dna strand replicative dna polymerase incorporate hemimethylated DNA termediate form DNA replication prokaryote repression methyltrans ferase activity replication lead dilution methylate basis daugh ter DNA molecule lack methylation dnmt essential establishment maintenance methylation prole vertebrate dna replica tion number protein associate replicative dna polymerase include pro cessivity factor nucleosome remodeler dna repair protein DNA polymerase clamp loader PCNA interact maintenance methyltransferase Reducing expression inhibit interaction PCNA lead genomewide loss cpg methylation genome instability possess autoinhibitory mechanism ensure target hemimethylated prevent act dna follow demethylation dna strand furthermore inhibition recruitment also lead passive dna demethylation presence UHFR1 bind hemimethylated DNA domain tether locus accordingly depletion lead loss genomewide methylation mark dnmt include DNMT2 DNMT3A also act hemimethylate however usually consider novo methylate enzyme role dna demethylation indirect see extent dynamic genome mammal suggest passive dna demethylation alone account change prokaryote replicate genome minute even multi copy available growth mammalian TRIGGERING active dna demethylation protein induce active demethylation divide type proceed mutagenic intermediate targeted LesionInduced Demethylation TLD rst group include protein able induce dna demethylation introduce lesion include product site well DNA deaminase produce mismatch importantly pathway require direct efcient activation DNA repair machinery Targeted ModicationInduced Demethylation TMD second category involve protein able modify lead change dsdna base pair modication serve hide recognition become target importantly protein directly link dna repair allow demethylation proceed different kinetic methylation dynamic cover occur rence even dna replication DNA Glycosylases Base Excision Repair Mammalian genome experience event efciently repair numerous dna repair pathway dna glycosylase play pivotal role repair remove damage dna basis genome gly cosylases implicate base excision repair uracil dna glycosylase mitochondrial UNG1 nuclear TDG singlestrand selective monofunctional uracil dna glycosylase MBD4 oxidize basespecic glycosylase NTH1 NEIL1 dna glycosylase report act BER pathway thus implicate active dna demethylation dna glycosylase remove wwwannualsorg 5mC DNA Demethylation change still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI aid aid DNMT1 inhibitor TET TDG MBD4 BER BER BER BER MMR MMR Direct TLD TMD Indirect TET dna damage DNA topology rna transcription elongation PARP1 TDG BER BER BER MMR NER NER Intermediate figure active dna demethylation machinery protein green pathway orange act protein classie target lesioninduced demethylation target modicationinduced demethylation see sidebar Triggering Active DNA Demethylation currently protein include include TET protein family protein pathway act unknown possibly share intermediate Arrows indicate link pathway generate abasic site site become substrate endonuclease APE turn cleave strand dna backbone remove deoxyribosephosphate result single nucleotide gap lle dna polymerase incorporate opposite backbone ligate thus scenario result replacement figure glycosylasedependent dna demethyla tion pathway already describe plant employ DNA glycosy lase ROS1 bifunc tional enzyme initiate demethylation rst remove base cleav ing result site plant discuss detail reader encourage look recent Changes still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI August modification Oxidation Base removal Backbone cleavage dna lesion dna mismatch dna pol dna ligase mismatch recognition dna pol Processivity factor dna ligase dna pol dna resynthesis dna ligase 2nd lesion recognition dna resection dna resynthesis Processivity factor RNF4 ape MBD4 AID tet BER UNG PARP BER BER MSH2 PCNA PCNA MMR TDGMBD4 DNA pol beta dna pol dna pol dna pol deltaepsilon TET MSH2 PCNA 5mC UNG PARP Figure Mechanisms active dna demethylation current model active dna demethylation involve dna repair pathway orange include short patch long patch base excision repair mismatch repair target modicationinduced demethylation pathway show top leave Activationinduced deaminase AIDinduced target lesioninduced demethylation pathway show top right glycosylasesinduce show top center key protein show schematic Intermediates pathway resolve pathway dna lesion target enter repair pathway various stage lead demethylation BER lead single base demethylation activity processive dna polymerase enable single lesion initiate extensive demethylation protein indicate green act pair analogous plant enzyme however enzyme kinetic vivo genetic seem preclude direct function analo gous rst step ROS1 plant dna dna demethylation rst propose activity describe chicken embryo extract function coordination explain early observation replace cytosine rather change cyto sine preferred substrate thymine uracil mispaire guanine mismatch cpg context enhance enzymatic activity report show directly excise guanine pair activity reduce factor relative thymine guanine pair subsequently laboratory wwwannualsorg DNA Demethylation change still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI unable reproduce nde importance epigenetic reprogramming aptly show demonstrate tdgdecient mice exhibit reduce global methylation embryonic lethality author speculate observed phenotype due global impairment dna methylation possibly also due broad regulatory function interact transcription factor histone ferase see second knockout conrme function dna demethylation author speculate trimeric complex GADD45 propose BER drive global demethylation DNA glycosylase remove thymine uracil mismatch initiate demethylation con junction BER machinery similar TDG MBD4 activity enhance mismatch cpg context activity pair reduce fold however knockout mouse cient viable show increase transition mutation rate enhanced tumorigenesis tive demethylation paternal pronucleus zygote unaffected suggest essential global dna demethylation event functional domain terminal MBD highly conserve terminal glycosylase domain belong family MBD protein bind symmetrically methylate cytosine exclusively context doublestranded DNA play substantial role novo silencing maintenance silent state target gene MBD MBD4 bind preferentially mismatch primary product deamination single cpg context Base Modications circumvent absence direct deglyco sylation mammal mean initiate dna demethylation idation deamination radical adenosyl methionine sambase demethylation result modication lead loss dna methylation recognition loss methyl group figure TET Pathway Hydroxymethylcytosine5hmCinDNAwas discover riophage express glucosyl transferase convert bulk nomic cytosine modication protect bacteriophage dna striction host serve mark selfrecognition identication 5hmC mammalian genome recent detection neu ronal cell embryonic stem cell provide resurgence interest modied base mammal hydroxymethylation reaction catalyze member TET protein family oxoglutarate dependent dioxygenase able convert figure TET protein express tissue active dna demethylation take place tet1 expression mainly con embryonic stem cell TET2 TET3 expres sion ubiquitous mouse embryonic stem cell TET2 necessary cellular commitment identity zygote TET3 responsible conversion paternal pronucleus TET1 bind preferentially transcription start site promoter region high density plain presence CXXC zinc nger domain recognize unmethylate cpg interestingly 5hmC show broad Changes still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI distribution gene find gene accumulation promoter region preferentially detect gene bivalent chromatin contain ing activating repressive mark actively transcribe gene 5hmC distribute gene body particularly exon similar distribution report mouse cerebellum human brain methylation cytosine forma tion 5hmC cause alteration molecular recognition MBDcontaining MECP2 protein exhibit fold reduced recognition 5hmC compare loss recognition also observe turn promote passive demethylation recognize hemimethylated thereby pro vide bridge passive active dna demethylation recent study report TET pro tein oxidize formylcytosine 5fC carboxylcytosine 5caC raise possibility TET protein carry active DNA lation successive oxidation TET enzyme efciency decrease succe sive oxidation interesting know important enzy matic mechanism control due lack yetidentie cofactor analogous sumoylation bind substrate allow turnover kinetic proceed date enzyme identie promote loss formyl carboxyl group lead complete demethylation enzymatic step TET pathway lead forma tion course analogous describe work focus ing oxidation removal methyl group thymine Thymine hydroxylase oxidize methyl group free thymine successive step toform5hydroxymethyluracilformyluracil carboncarbon bond cleave separate carboxylase mention neces sary remove moiety obtain biological function oxidation pre clude binding protein usually recognize yet identie prevent version TET reaction 5hmC 5mC 5hmC sufcient hide Inter estingly presence high concentration absence relate elevated transcription rate however complete oxidation 5hmC 5fC 5caC provide substrate level 5caC elevate genome decient cell least vitro system act 5caC pair Base Excision Repair aid rst characterize function diversication immunoglobulin aid target cytosine singlestranded DNA ssdna locus induce ination create mismatch due hijack DNA repair misfunction lead mutation recombination process diversication highly mutagenic mutator activity order magnitude low locus transcription gene drive estrogen expression limit immune cell interestingly nonimmune tissue oocyte germ cell stem cell dna demethylation highly active correlate aid expression address possi bility deamination mechanistic pathway DNA demethyla tion test ability use substrate show deaminate generate mismatch genetic evidence involvement dna demethylation come zebrash overexpression induce global dna demethylation wwwannualsorg DNA Demethylation change still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI furthermore nondivide heterokaryon reprogramming broblast nucleus duce aid expression change methy lation status pluripotency gene oct4 Importantly AID decient mouse content increase suggest involve genomewide demethylation PGCs Mechanistically figure function demethylation combine deamination activity various dna repair pathway already show immune diversication damage elicit response BER protein mismatch repair translesion synthesis endjoining pathway similar pathway utilize site deam ination lead DNA demethylation Deam ination 5mC generate context result mismatch pre ferred substrate describe repair mismatch lead cytosine incorpora tion use factor BER pathway number model propose form com plex promote demethylation sociation suggest zebrash biochemical analysis need conrm well plain member DNA deaminase family lack catalytic activity induce lation zebrash recently also propose form complex TDG context demethylation pathway Unfor tunately proper biochemical evidence miss ing unlikely function 5fC 5caC recent work lab other indicate bind pocket accommo date side chain large methyl group suggest dna deaminases TET protein utilize different initiation pathway dna demethylation sion resolution proceed common intermediate immune diversication cytosine deamination lead mutation neighbor known phase somatic hypermutation key enzyme pathway responsible effect include MSH2 MSH6 error prone dna pol link MMR factor dna demethyla tion provide number unique insight figure mis matcheswouldberecognizedbymmrprotein MSH2 classical lead recruitment resection basis ssdna gap resynthesized DNA pol incorporate cytosine newly form strand therefore single lesion lead removal stretch dna type processive dna polymerasedependent dna demethylation efcient less mutagenic target single BER pathway future work need deter key factor distinguish errorfree MMR classical mutagenic MMR observe diversication pathway control demethylation aid possibility extend demethylation single site especially intriguing know travel stalledrestarted elon gate RNA pol Willmann Milosevic Rangam Skehel unpublishe observation deaminate limited sequence context hence induce local dna demethylation always achieve static mechanism target AID individual currently clear determine dna repair pathway choice induction lesion aid importantly relevant repair pathway interlink substrate Changes still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI intermediate specic protein PCNA likely efciency demethyla tion depend number mis match versus mismatch activity activation Targeting important caveat model postulate role dna demethylation essential target achieve DNA lation Deamination also gener ate mismatch activity mismatch initiate DNA demethy lation adjacent position extension DNA repair pathway utilize proce sive dna polymerasenot also nucleotide excision repair long patch BER see induce dna demethylation specically target therefore target dna damage induce dna demethylation target lesion arise aside TETcoupled BER yet determine butcouldincludetargetingmechanismsoftran scription dna replication chromatin remod eling transposon silence figure see DNA damageinduced dna demethyla tion propose prior discovery tet function chro matin association modify zymes rather random environmental damage physical chemical agent make understanding current pathway even pertinent dna damage recently propose dnmt participate active dna demethylation base observation perform lation concentration methyl donor SAM formation certain threshold instead initiate deamination already form experiment show requirement function genetic requirement DNMTs cyclic DNA demethylation promoter vivo datum seem suggest necessary fold drop SAM concentration induce deamination methyltransferase unlikely global event also clear choose condition allow act product rather substrate however possibility DNMT enzyme induce deamination cytosine lead dna demethylation plausible activity link dna repair interaction demonstrate various lab furthermore demethylation quite efcient pro pathway involve aside mammal contain least active DNA deaminase human large primate contain ditional dna deaminase member family evolve deaminate rna also ability target dna APOBEC3 subfamily antiviral activity APOBEC3 member function deaminating retrovirus rst strand cDNA synthesis APOBEC1 know act know member likely future work determine mostly cytoplasmic protein involve demethylation pathway predict dna demethylation also initiate event target physiologi cal dna damaging protein also duce demethylation end port show druginduced inhibi tion DNA topoisomerase lead change dna methylation effect drug likely indirect camptothecin inhibitor dna topo induce methylation etoposide wwwannualsorg DNA Demethylation change still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI inhibitor dna topo indicate dna structural change always lead global demethylation dependence dna repair achieve dna demethylation also carry price tation random demethylation target dna damage induce demethylation preclude random dna damage also duce change epigenome light oxidative damage number environ mental dna damage agent induce local bad case global dna demethyla tion possibly single lesion lesion repair leave genetic mark mutation leave epi genetic mark also lead patholo gy include cancer circumvent much change environment backup system form epigenetic mark tone modication polycomb complex binding coordinate methylome indirect dna aid tet TDG MBD4 DNMTs act yet number protein apparent dna modication activity identie least genetically induce dna demethylation figure transcription somewhat paradoxical transcription induce active dna demethylation cause high oxidative potential process transcription induce dna lesion damage basis repair involve processive polymerase replace past think glycosylase also transcrip tion factor inducible retinoic acid interact retinoic acid receptor light involvement dna demethylation need determine function transcription factor mean target promoter mean recruit transcription factor inactive promoter mean induce dna demethylation chromatin remodeling mention part elongate RNA pol complex possi induce dna demethylation tran scription direct association SPT5 well polymerase associate factor Rangam Skehel unpublished observation demonstrate transcription mutational activity find limited region start maximum downstream TSS Analogously TET protein usually sociate promoter product also detect code region upstream still needs deter mine association occur pre post transcription possible difference TET pattern distribution gene especially respect point differential usage dna demethylation pathway also exhibit difference temporal association rna pol seem asso ciate transcription initiation factor seem associate elongationrestart factor RNA pol elongator complex also show play role partial genome wide demethylation paternal genome zygote knockdown ELP3 part holoelongator complex well partially impair paternal dna demethylation domain map ping ELP3 indicate radical SAM domain critical demethylation lead direct attack dnmt recruitment factor also play signicant role ELP3 dependent dna demethylation transcription initiate dna demethylation promoter still govern transcription machinery Franchini Schmitz PetersenMahrt Changes still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI case cycling pS2TFF1 promoter show coordinate BER pathway protein induce strandspecic demethylation estrogeninduced transcriptional cycling possible link promoter activa tion dna demethylation show knockdown constitutive tor ERCC1 lead pro moter methylation experiment demonstrate correlation histone modication gene activation pro tein well loss demethylation promoter DNA play important part dna demethylation hypothesize datum present mammal divide subpathway global genome repair GGR transcriptioncouple repair figure region lesion recognition unknown signal open dna dna resynthesis dna excision dna ligation gadd45 xpa ercc1xpf dna pol PCNA tfiih NER figure schematic nucleotide excision repair lead dna demethylation lesion recognize yet identied signal initiate possibly recruit TAF12 factor growth arrest dna damageinducible alpha turn bring endonuclease lesion bind serve landing platform tfiih endonuclease ERCC1XPF bind complex dene region approximately subsequently unwound excise cleavage target strand provide entry pol complex dna resynthesis ligation excise replace unmodied cytosine result processive polymerasedependent short stretch dna demethylation wwwannualsorg DNA Demethylation change still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI anke damage dna incised nucleotide oligomer excise Subsequently DNA polymerase similar gap dna ligase seal end chromatinassociated step recognition initial damage detection damage verication tfiih XPB XPD enzymatic action excision machinery XPG XPFERCC1 damage dna substrate resynthesis PCNA DNA pol ligase IIIXRCC1 base recognition rate limit lesion identication paramount dna demethylation induce dna demethylation show growth arrest dna damage inducible alpha isolate screen potential protein furthermore interact involvement dna demethylation demonstrate protein involvement dna demethylation also demonstrate rdna locus TAF12 play key role keep gene free methylation factor part RNA pol pol specic TBPTAF complex bind promoter recruit induce NERdependent demethylation thereby pro vide rst molecular connection dna demethylation GGR classical independent therefore boundary pathway blur participate dna demethylation system specic lesion stimulate demethylation yet identie recent work demonstrate necessity lesion unknown origin induce global dna demethylation stain mouse zygote dna break phos phorylation possible monitor dynamic DNA strand repair event correlate active dna demethylation distinct developmental stage site dna damage indicate utilization well pathway respond dna nick critical seem play differentiate role short patch BER BER longpatch BER BER induce BER stretch DNA remove dna glycosylase activity facilitate FEN1 ap FEN1induced nucleotide away initial lesion dna pol conjunction PCNA perform dna resynthesis strand displacement BER gap religate DNA MMR BER allow dna demethylation target PARP1 rst implicate active dna demethylation study PGCs embryonic stage mrna encoding factor associate BER less extent detect activity base chemical inhibi tion correlate appearance dna demethylation author study suggest involve contrast other identie role development technical difference account dif ferent result interestingly effect inhibition dna demethylation observe globally locally APE key protein BER inhibition seem inu ence global DNA methylation status sug geste different protein pathway share unequal responsibility dna demethylation furthermore thor also see correlation DNA lation increase TET protein mrna detailed analysis delineate dna demethylation pathway active time locus extent provide proper insight Demethylation discussion chromatin change epi genetic state proceed include histone modication rather explore possible histone mark lead Changes still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI repressive active chromatin focus modication show direct link dna demethylation interplay dna methylation histone modication extensively demonstrate show evolutionary loss certain specie regulatory function dna methylation demethylation substitute possibly nondna dependent pathway observation also relevant understanding dna demethylation mammal histone cation substitute dna methylation reveal complete molecular mecha nism biogenesis epigenetic environment require dna demethylation dna reprogramming fertilize zygote paternal genome target dna demethylation maternal genome seems protect active process suggest protection maternal genome asymmetric chromatin mark distinguish genome also play role absence PGC7Stella result aberrantly target dna demethylation maternal paternal pronucleus zygote PGC7Stella null female activation BER component detectable parental pronucleus fertiliza tion paternal genome undergo histone variant incorporation protamine exchange moreover mono trimethylation trimethylation barely detect paternal genome identie maternal pronucleus indicate even global scale histone modication dna demethylation interdependent similarly migration genital ridge PGCs associate dynamic change histone modication interestingly time seem quire dna demethylation chromatin undergo change similar observe male pronucleus lose repressive mark H3K9me2 h3k9me3 H3K27me3 H3K64me3 linker histone gain permissive modication h3k9ac h3k4me change precede occur concomitant dna demethylation prerequisite clear create permissive chromatin provide accessibility DNA demethylation path way accordingly tet1 occupancy positively correlate H3K4me3 depletion TET1 result increase cpg island methylation occupancy present inverse correlation presence H3K27me3 TET1 also bind gene present bivalent chromatin H3K4me3 H3K27me3 cell bivalent gene represent gene high content promoter usually developmentally regulate gene surprisingly knockdown TET1 downregulate gene expression also cause gene upregulation suggest broad role gene transcription regulation context find colocalize polycomb repressor complex PRC2 associate corepressor complex Sin3A therefore activate repress transcription activity regulate histone modication presence polycomb complex dnmt directly involve dna demethylation histone mod ication also inuence dna demethyla tion plant homeodomainlike main recognize histone tail modication occur depend methylation status induce activity furthermore guide partner clude chromatin presence specic histone mark H3K4me3 hence DNA become available novo methylation full epigenetic land scape genome change recently show interact member RNA pol elongation wwwannualsorg DNA Demethylation change still occur final publication online print IUPUI personal use GE46CH19PetersenMahrt ARI complex chromatin remodeling factor Rangam Skehel unpublished observation importantly part target due presence histone trimethylation show interact SPT5 need induce phosphorylation ser5 restart rna pol pause serve platform complex Rangam Skehel unpublished observation turn promote histone monoubiquitination ubiqutination allow dependent trimethylation H3K36 time fact facilitate chromatin transcription complex facilitates efcient rna pol elongation fact SSRP1SUPT16H cooperate chromatin remodeling histone ability destabilize histone nucleosome enhance cotranscriptional chromatin mark FACT complex also play key role chromatin tion pathway recruit dna demethylation transcription furthermore recent datum indicate evolutionarily conserve fact complex play direct role DEMETERinduced dna demethylation identify orthologous pathway plant mammal link chromatin modify fact complex show interact histone acetyltransferase hat CBPp300 possible duality function suggest knockout exhibit phenotype combine alter dna demethylation histone modication pecially regard expression bivalent modied gene status important target TMD TLD factor initiate demethylation also deter mine efciency possibly choice downstream processing machinery recently show nucleosome tion remodeling alter activity BER dna pol hibite presence nucleosome unaffecte tantly remodeler reacti vate BER pathway dispensable variant use clearly even example inter intraplay pathway lead dna methylation nucleosome modication dna demethylation provide rich source regulatory interaction well potential drug target disease Mutation effect loss dna methylation extensively document reader kindly ask consult comprehen sive detail like highlight follow important aspect spontaneous dna damage include deamination cytosine major source mutation cancer 5mC fold high spontaneous deamination rate cytosine yet small difference explain observe number onco genic mutation occur estimate point tation therefore likely active direct indirect dna demethylation physiological pathological contribute development mutation furthermore pharmacological agent induce dna demethylation lead reacti vation tumor suppressor gene receive lot attention move clin ical trial phase become important cancertherapy drug currently approach center inactivation remethylation azacytidine evolve stand protein enzyme enhance dna demethylation provide direct proliferationindependent drug target Changes still occur final publication online print",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "epigenetic": 7,
                    "demethylation": 135,
                    "methylation": 32,
                    "5mC": 5,
                    "H3K27me3": 3
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "methyltrans": 2,
                    "daugh": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "methyltrans": 182,
                    "daugh": 182
                },
                "Ethnographic Terms": {
                    "epigenetic": 3,
                    "demethylation": 3,
                    "methylation": 3,
                    "5mC": 3,
                    "H3K27me3": 3
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "A common mutation in the 5_ 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status.pdf",
            "cleaned_text": "common mutation methylenetetra hydrofolate reductase gene affect genomic dna methylation interaction folate status Choi Metabolism Laboratory Mass Spectrometry Laboratory Department Agriculture Human Nutrition Research Aging Policlinico Rossi University communicate Camptom receive DNA methylation essential epigenetic feature dna modulate gene expression genomic integrity catalyze methyltransferase use universal methyl donor adeno sylmethionine catalyze synthesis methyltetrahydrofolate methyl methyl donor synthesis methionine homo cysteine precursor adenosylmethionine present study seek determine effect folate status genomic dna methylation emphasis interaction common C677 mutation MTHFR gene liquid chromatography method analysis nucleotide basis use assess genomic dna methylation peripheral blood mononuclear cell DNA subject homozygous mutation homozygous wildtype MTHFR genotype result show genomic dna methylation directly correlate folate status inversely plasma homocys teine tHcy level genotype diminish level dna methylation compare wildtype methylcytosine DNA analyze accord folate status however subject low level folate account diminished dna methylation moreover subject dna methyl ation status correlate methylated proportion red blood cell folate inversely relate formylate proportion red blood cell folate know solely represent individual result indicate MTHFR C677 polymorphism inuence DNA methylation interaction folate status methylation important epigenetic feature dna play critical mechanistic role gene regulation cellular differentiation eukaryote cell dna methylation primarily comprise methyl group position cytosine feature especially prevalent sequence know cpg island reside gene promoter region aberrant genomic dna methylation widely recognize associate different disease implicate genesis cancer neurodevelopmental disorder DNA methylation pattern cell establish maintain dna methyltransferase many cellular methylation reaction use adenosyl methionine SAM donor methyl group major source methyl group use methylation reaction folatedependent novo synthesis onecarbon unit specific enzyme involve methyl group synthesis process B12dependent methionine synthase use methylTHF methylation homocysteine methionine methylenetetrahydrofolate reductase mthfr methylTHF acceptor oxidoreductase MTHFR consider key enzyme onecarbon metabolism responsible irreversible con version methylenetetrahydrofolate methylTHF serve methyl donor methionine precursor SAM pathway important methyl group synthesis lack methyl group production result intracellular accumulation adenosylhomocysteine well increase plasma total homocysteine level soon isolation cdna gene map human MTHFR common missense mutation iden tifie MTHFR gene substitution position encode thermolabile variant reduce enzymatic function determination strong genenutrient interaction demonstrate phenotypic expression genetic mutation MTHFR enzyme condition low folate plasma level mutant allele show associate high level relationship MTHFR polymorphism plasma folate value implicate likely link C677 polymorphism cardiovascular disease neural tube defect consistent concept homozygosity reduce vivo availability recent observation distribution different coenzymatic form folate alter homozygote red blood cell rbc homozygous mutant diminish proportion methylate tetrahydrofolate well variable amount formylate folate contrast cell wildtype individ ual contain exclusively methylate folate derivative ever different availability methylate form folate affect biological methylation reaction dna methylation demonstrate recently observe preliminary fashion individual MTHFR C677 mutation possess low degree dna methylation however small number subject indirect method use assess genomic dna methylation limit conclusion draw design present study evaluate large cohort subject effect folate status genomic dna meth ylation directly measure genomic dna methylation develop quantitative highly specific assay use liquid abbreviation liquid chromatography MTHFR methylenetetrahydrofolate reductase methylTHF methyltetrahydrofolate plasma total homocysteine red blood cell mCyt methylcytosine Cyt cytosine reprint request address mail jselhubhnrctuftsedu publication cost article defray part page charge payment article therefore hereby mark advertisement accordance solely indicate fact PNAS April vol chromatography technique method allow direct measurement methylcytosine mCyt DNA digest differ indirect enzymatic method semiquantitative know suffer considerable inter assay variability seek emphasize effect folate status dna methylation determine direct measurement impact interaction MTHFR C677 mutation folate status dna methylation relationship different coenzymatic form folate homozygous mutant dna methylation Materials Methods Study Population study total unrelated age sexmatched subject recruit single geographical area northern characteristic study population includ ing MTHFR genotype distribution describe detail else subject angiographically document coronary atherosclerosis normal coronary artery document angiography clinical laboratory evidence atherosclerosis examine reason coronary artery disease case valvular heart disease ref informed consent obtain subject full explanation study approve study Biochemical Analysis sample venous blood draw subject fast DNA extract whole blood use phenol chloroform isoamyl alcohol protocol laboratory method biochemical analysis form describe level measure high performance liquid chromatography HPLC fluorescent tection accord folate vitamin b12 concentration measure automate nescence method level measure HPLC method accord folate form distribution detect affinity follow reversephase chromatography electro chemical detection describe MTHFR genotype analysis mthfr C677 mutation perform pcr follow hinf digestion accord measure genomic dna meth ylation develop method use instrument Ion equip electrospray ionization source microgram dna enzymatically hydrolyze sequential digestion unit nuclease unit venom phosphodie terase unit alkaline phosphatase describe microliter hydrolyzeddna solution inject analytical column protect Suplex pKb precolumn Supelco Bellefonte isocratic mobile phase consist ammonium acetate methanol volvol water deliver flow rate min min allow separation dna basis well identification methylcytosine mass spectrometry operating condition relate electrospray source follow capillary nebulizer psi dry gas min dry temperature ion trap scan use internal standard mixture methyldeoxycytidine deoxycytidine use external standard Identification cyto sine Cyt obtain combined detection analysis chromatographic peak elute min min respectively ion peak correspond ion peak correspond confirm describe other ion peak correspond stable isotope use internal standard Quantification Cyt do comparison internal standard quantification obtain comparison external standard know concentration stable isotope standard commercially available linear working range method limit detection Cyt dna methylation status define amount DNA Coefficients variance day Statistical Analysis computation perform use software version Windows SPSS distribution continuous variable group express mean Analysis perform log transform datum skewed variable include dna meth ylation Therefore geometric mean antilogarithms transform mean present confidence interval ci calculate use transform value display antilogarithms transform data statistical signif icance difference continuous variable test student unpaired test categorical variable analyze use test linear regression analysis appropriate adjustment confound variable age sex smoking creatinine vitamin status appropriate perform general linear model analysis specifically analysis covari ance statistical significance refer twotailed analysis result Fig show typical chromatogram hydrolyze dna peripheral blood mononuclear cell first peak elute min correspond Cyt second peak elute min correspond linear regression analysis pool genotype demon strate highly significant direct relationship plasma folate dna methylation however relationship drive entirely datum individual significant individual see indirect relationship observe dna methylation find significant correlation dna methylation vitamin B12 status characteristic population accord MTHFR genotype describe Table show difference find age sex vitamin vitamin b12 level MTHFR C677 wild type homozygous mutant group folate folate tion low compare group total plasma homocysteine high group difference MTHFR genotype also extend dna methylation mean level mCyt DNA group approximately find group Table difference genotype evident folate status take account plasma folate status median value nmolliter genomic dna methylation similar mthfr genotype table however plasma folate status median level dna methylation consider ably low subject homozygous C677 mutation wildtype genotype moreover level genomic dna methylation low group April vol compare individual level folate equal median group low range plasma folate table illustration difference show population sample divide tertiles plasma folate accord genotype grade effect folate determine level dna methylation detect individual level dna methylation individual low tertile folate compare high approximately low statistically significant genotype however dna methylation different tertile result analysis folate use measure folate status precisely parallel observation make plasma folate Table individual divide group accord median folate value nmolfolate group folate median diminish dna methylation difference find group Table folate level median dna methylation influence MTHFR genotype assessment folate vitamer distribution demon strate folate contain rbc individual carry genotype comprise entirely methyl THFs folate individual mozygous mutant genotype consists formylate polyglutamate confirm describe furthermore profile folate coenzyme cell individual bear close relationship peripheral blood mononuclear cell dna methylation show regression analysis group reveal inverse relationship proportion DNA Fig typical chromatogram hydrolyze peripheral blood mononuclear cell dna rst peak elute min correspond Cyt second peak elute min correspond mCyt Table Characteristics population accord mthfr genotype value Age Sex male Plasma folate nmolliter folate nmol vitamin B12 vitamin nmolliter tHcy molliter Genomic DNA methylation status mCyt DNA value express age folate folate vitamin b12 vitamin DNA methylation status present geometric mean antilogarithms transform mean condence interval report parenthesis twotailed value statistical difference evaluate student test differently indicate statistically signicant statistical difference evaluate test wwwpnasorgcgipnas Friso methylation well positive association DNA methylation methylTHF proportion discussion control epigenetic pattern dna methylation fundamental regulation gene expression position cytosine major epigenetic mechanism control dna gene expression silence consider crucial maintenance genomic structural integrity essential normal devel opment dna methylation become misdirect lead carcinogenesis abnormal condition therefore considerable interest identify endogen ous exogenous factor determine pattern methylation present study show level methylcytosine genomic dna peripheral blood mononuclear cell relate folate status relationship modify interaction nutrient common mutation onecarbon metabolism pathway regulate availability methyl group methylation reaction homozygous mutant C677 polymorphism MTHFR gene exhibit significantly low level DNA con dition low folate status high level folate amount DNA homozygous mutant differ C677 wildtype individual interac tion folate status MTHFR genotype also describe relation plasma level Studies other show plasma level significantly high homozygote mutation wildtype genotype mutant level plasma folate low high folate status plasma level unaffected MTHFR genotype presence genenutrient interaction mutant MTHFR enzyme folate status consistent recent study author evaluate biochemical structure mutant MTHFR explain propensity lose essential flavin cofactor use thermolabile variant MTHFR model express coli show C677 mutation result exposure bind site flavin adenine dinucleotide cofactor otherwise embed barrellike structure exposure result weaken complex hence loss activity presence methylthf substrate associate conformational change strengthen complex thereby protect mthfr loss flavin cofactor find low level peripheral blood mononuclear cell dna high observe subject low folate status strongly imply limited capacity mutant mthfr synthesize sufficient methylTHF meet demand novo methionine methyl group supply consistent previous report rbc homozygous mutant individual C677 mutation formylate tetrahydrofolate polyglutamate addition sole form folate rbc MTHFR wildtype individual present study observe inverse relationship dna methylation Homocysteine product intracellular hydrolysis condense methylTHF form Fig Correlation dna methylation level plasma folate divide tertile accord MTHFR genotype left Right table genomic dna methylation status DNA accord MTHFR genotype plasma folate level stratication folate value median folate nmolliter Plasma folate nmolliter value value dna methylation status present geometric mean antilogarithm transform mean condence interval report thesis twotailed value statistical difference evaluate dent test statistically signicant April vol MEDICAL SCIENCES methionine transsulfurate dependent reaction form cysthathionine therefore surprising inversely correlate DNA elevation reflection folate depletion elevation total plasma homocysteine level indication elevate cellular increase concentration act end product inhibitor adenosylmethionine dependent methylation reaction finding consistent recent report identify plasma SAH strong predictor genomic methylation nucleate blood cell show current study modulation MTHFR variant folate hold true plasma folate level concentration folate plasma generally accept indicator shortterm change nutrient folate consider good index body folate store present finding however suggest plasma level folate population reliable folate indicator longterm folate status key vitamin involve onecarbon meet abolic pathway influence dna methylation also present study however association find vitamin b12 vitamin level feature present study strengthen confidence observation pertain development method directly measure genomic dna methylation exist method assess genomic dna methylation suffer semiquantitative rather quantita tive assess dna methylation indirectly iii pos sesse large intra well interassay variation method afford much great reproducibility precision base direct quantitative measurement methylate cytosine basis dna digest use specificity technique study mthfr C677 variant suggest folate important role modulate epigenetic feature dna control gene expression however remain determined dna hypomethylation see peripheral blood mononuclear cell DNA also occur tissue particularly rapid rate proliferation thereby susceptible adverse effect low folate status colon bone marrow other hypo hypergenespecific methylation scribe relation impaired folate status previously show animal study folate deficiency induce critical region p53 gene dietary folatemethyl depletion dna methyltransferase activity rat describe regulate lead hypermethylation specific loci future study dna methylation express logscale level different coenzymatic form subject inverse relationship detect dna methylation formylate tetrahydrofolate polyglutamate leave positive correlation detect dna methylation methyltetrahydrofolate polyglutamate methylTHF Right Table rbcs folate form distribution dna methylation status accord MTHFR C677 genotype stratication low high rbcs folate value Low folate value High RBC folate value total folate nmol RBC methylTHF total genomic dna methylation status mCyt DNA low high rbcs folate status intend level total rbcs median value nmol hemoglobin respectively value express mean rbcs folate level dna methylation present geometric mean antilogarithm transformed mean condence interval report parenthesis twotailed value statistical difference evaluate student test statistically signicant wwwpnasorgcgipnas crucial identify dna methylation anomaly specific loci human material base work support agreement work also support part grant Italia Ministero dellUniversita della Proc Natl Acad Sci USA Razin Riggs Science Bird Wolffe Cell Holliday Pugh Science Bird Nature London Bird Cell Antequera Bird Proc Natl Acad Sci USA Laird Weinhold Chem Okano Bell Haber cell Selhub Annu Rev Nutr Matthews van den Faccini Pignatti Mazzucco Corrocher Blood Welch Loscalzo Refsum Beresford Vollset Clin Nutr van der Put SteegersTheunissen Frosst Trijbels den Epidemiol Bagley Selhub Proc Natl Acad Sci USA SternLathrop cancer epidemiol biomarker prev Kim Christman Fleet Hatch Selhub Ther Ferraresi Araki Sako Chromatogr Kimura Kanehira Yokoi Chromatogr Bagley Selhub Clin Chem Crain Methods Enzymol Zambonin Palmisano Rapid Comm Fenn Anal Chem Lorincz Groudine Veenstra Kass London Wolffe Matzke Science cancer Res Schneede Refsum Vollset Trends Pharmacol Hennekens Rozen circulation Nutr Rev Biol James Biol Chem Smith Kane Roman Rollinson Cartwright Morgan Proc Natl Acad Toyota OheToyota Sci USA Choi Wiemels Smith Eden Alexander Greaves Proc Natl Acad Sci USA Wall Teitell Proc Natl Acad Sci USA Christman Sheikhnejad Wainfan Carcinogenesis April MEDICAL SCIENCES",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 63,
                    "epigenetic": 5
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "methylenetetra": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "methylenetetra": 68
                },
                "Ethnographic Terms": {
                    "methylation": 1,
                    "epigenetic": 1
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "A comprehensive view of the epigenetic landscape part I_ DNA methylation_ passive and active DNA demethylation pathways and histone variants.pdf",
            "cleaned_text": "comprehensive View epigenetic Landscape part DNA Methylation passive active DNA Demethylation Pathways Histone Variants Anna SadakierskaChudy receive Revised Accepted Author article publish open access multicellular organism cell genetically identical turn gene right time promote differentiation specic cell type regulation chromatin structure essential genomewide reprogramming tissuespecic pattern gene expression complexity genome regulate epigenetic mechanism act level dna histone nucleosome machinery involve many biological process include genomic imprint chromosome tion heterochromatin formation transcriptional regu lation dna damage repair summarize recent understand dna methylation cytosine derivative active passive demethylation pathway well histone variant dna methylation wellcharacterize epigenetic signal tool methylation promoter region usually repress transcription methylation gene body positive correlation gene expression attachment methyl group cytosine residue DNA sequence catalyze enzyme DNA methyltransferase family recent study show translocation family enzyme involve stepwise oxidation methylcytosine create new cytosine derivative include formyl cytosine carboxylcytosine additionally histone variant nucleosome create strategy regu late structure function chromatin replace ment canonical histone specialized histone variant regulate accessibility dna thus affect multiple biological process replication transcription dna repair play role various dis order cancer variant dna methylation dna methyltransferase variant passive active demethylation TET family enzyme introduction epigenetic become important topic genetic research classical denition epi genetic refer heri table change gene activity involve alteration dna sequence denition emphasize heritability cellular phenotype therefore include change germ line pass generation generation change divide cell transfer daughter cell currently know epigenetic change induce environmental factor different time life potentially reversible propose broad term epigenetic refer study regulation gene activity dependent gene sequence include heritable nonheritable mail annascpankrakow Quillen College Medicine East Tennessee State University Toxicology Faculty Pharmacy Jagiellonian University Medical College Medyczna Krako s12640 alteration gene activity transcriptional potential cell newsevents100908epigenetics20meeting20report epigenetic control operate major level DNA histone nucleosome relationship various epigenetic element currently extensively investigate datum literature analyze discuss signicance dna methylation demethylation cytosine derivative well histone variant epigenetic regulation genome dna Level dna Methylation dna methylation biochemical process crucial normal development high organism thoroughly study epigenetic mark entail covalent attachment methyl CH3 group position cytosine residue form methylcytosine organism modication frequent denote nucleotide methyl group transfer adenosylmethionine SAM cyto sine DNA methyltransferase DNMT family enzyme DNMT3B preferentially meth ylate hemimethylate cytosine cpg dinucleotide sequence maintain methylation pattern replication contrast DNMT1 DNMT3A prefer unmethylate cpg dinucleotide perform novo methylation early development Thus act primarily maintenance methyltransferase DNA synthesis DNMT3B act novo enzyme development grow body evidence suggest also necessary novo methylation genomic dna DNMT3B also responsible maintenance methylation cell replication worth note DNMT2 display weak dna methyltransferase activity actually function rna methyltransfer ase methylate cytosine anticodon loop aspartic acid transfer rna protect trnas cleavage stress condition recent nding suggest involved mammalian paramutation pathway protect small rna molecule endonucleolytic cleavage thus induce heritable epigenetic phenotype share homology catalytic activity instead increase ability bind methyl group thus facilitate methylation vivo moreover recognize nucleosome unmethylated histone lysine recruit DNMT3B target functional domain mam malian DNMTs show Fig level affect gene expression deregu lation cytosine methylation play role devel opment cellular differentiation disease dna methylation level affect transcriptional activity hypermethylation surplus methyl group promoter region generally associate transcriptional silencing decit methyl group cause increase level gene expression Crider Approximately cytosine mammalian genome methylate mostly cpg sequence human genome cpg dinucleotide dis tribute asymmetrically rich poor dna region cpg site methylate pattern dna methylation vary different cell type tissue specic example differentiate mammalian cell cytosine residue rich region typically contain usually methylate dna region contain high frequency cpg site call represent important feature mammalian genome locate promoter preferentially transcription start site tss human gene cgi methylation low promoter high gene body inter genic region promoter largely free dna methylation abundance rich transcription factorbinde site Bird Methylation DNA cytosine residue promoter region usually correlate high order chromatin state repression mrna transcription however reveal protein facilitate transcriptional activation methyl ate promoter interestingly recent nding suggest undifferentiated stem cell cytosine site methylate well process particularly important proper regulation gene expression embryonic stem cell esc Lister viously mention gene body highly methylate role methylation remain largely unresolved study begin decipher molecular implication gene body methylation example methylation gene body contribute suppression transcriptional noise stimulate transcription elongation recent study suggest exon methylate high level intron possibly play role regulation mrna splice detail genomic location dna methylation consequence find excellent recent dna methylation consider stable persis tent heritable mark therefore methyl group add remove recent datum indicate tran scription factor related protein protect sequence methylation also initiate active dna demethylation passive demeth ylation replication active demethylation take place eukaryotic cell example dna methylation pattern undergo reprogramming establishment primordial germ cell well fertiliza tion surprisingly establishment dna methylation pattern occur development differentiation central vous system implicate synaptic plasticity learning memory human brain dna methylation change strongly correlate age turn pathological activation dnmt aberrant formation cause neurode gradation apoptotic neuronal death DNA methylation inuence gene expression impede bind specic transcription factor also recruit chromatinmodifying protein dna methylation also determine histone modication pat tern dnmt methylcpgbinde domain MBD protein help recruit repressor complex contain histone deacetylase hdac conversely interaction structure mammalian DNMT family member rst describe methyltransferase preferentially methyl ate hemimethylate DNA lack terminal domain terminal domain contain full set sequence motif show transmethylase activity Bestor DNMT3A DNMT3B similar domain arrangement equal hemimethylated unmethylated DNA closely relate catalytic domain lack canonical dna cytosinemethyltransferase motif Bestor regulatory domain exhibit little similarity catalytic domain dnmt conserve terminal domain possess pbdproliferating cell nuclear antigen PCNA bind domain localization signal trftargeting replication focus CXXCcysteine rich zinc nger dnabinding motif polybromo homology domain PWWPtetrapeptide domain contain ing prolinetryptophantryptophanproline motif terminal terminal domain link dinucleotide repeat glycinelysine repeat terminal domain consist conserved amino acid motif motif form bind site motif bind cytosine active site map interaction site dnmts HDACs histone deacetylase indicate diagram border domain mark accord Song methyltransferase replication complex lead histone lysine repressive epigenetic mark bind heterochromatin protein interact directly result cytosine methylation small wood interaction methyltransferase SUV39H1 ESET DNMT3B also cause dna methylation notably chromatin orga nization differ promoter rich DNA preferentially bind CXXC domain protein recruit chromatin modier include CXXC nger protein Cfp1 subunit H3K3me3 methyltransferase complex H3K36me2 demethylase Vavouri addition participate histone modication dna methyla tion inuence incorporation histone variant H2A nucleosome grow body evidence suggest exclude methylate dna global anticorrelation dna methylation h2a observe take together dna methylation affect interaction histone dna result activation repression transcription well know disruption methylation pattern cause many disease include cancer autoimmune disease well chro mosomal instability mental retardation syndrome human muta tion gene include dnmt methylcpg bind protein MBPs profound impact specic dna methylation pattern lead epigenetic disease study signie life style environmental factor nutrient supply drug pollutant patho gen sex hormone radiation heavy metal early stress modulate dna methylation Song interestingly certain dietary constituent folate bioactive component alter genomic genespecic dna methylation level embryonic development adult life Mathers concern reversible nature dna methyla tion seem attractive epigenetic modulation long know cytosine exist functional state unmethylate methylate moreover mechanism dna methylation good understand epigenetic phenomenon recently several cyto sine variant include hydroxymethylcytosine 5hmC formylcytosine 5fC carboxylcytosine 5caC methylcytosine identie Hydroxymethylcytosine 5hmC Hydroxymethylcytosine discover bacteriophage find base mammalian cell early nding rep licate later study independent group show 5hmC exist mouse Purkinje neuron ESCs currently 5hmC regard sixth base genome high organism nzel level genome relatively low account cytosine compare Branco 5hmC consti tut approximately modied cytosine mouse brain amount increase maturation hippocampus cerebellum Szulwach recently conrme 5hmC generate TenEleven Translocation TET enzyme oxoglutaratedependent dioxygenase TET subfamily include TET2 TET3 catalyze conversion vivo engage oxidation TET protein contain iron oxyglutarate domain well cysteinerich region likely involve dna bind Iyer Moreover TET3 contain CXXC zinc nger domain allow bind unmethylated methylate hydroxymethylated dna CXXCcontaining protein example almost solely bind unmethylated dna therefore poor recognition 5hmC lead passive demethylation valinluck sower level adult tissue high level central nervous system Globisch biological role 5hmC still unclear postulate 5hmC intermediate active dna demethylation play important role gene regulation observe 5hmC enrich body active gene TSSs transcrip tionally inactive gene Song vitro analysis reveal gene body prevent bind MBD protein act tran scriptional repressor level gene body modify accessibility chromatin transcriptional machinery Nestor demonstrate pattern tissue specic global content 5hmC vary markedly tissue correlate global level demonstrate aging increase global content mouse hippocampus possible 5hmC initiate pathway passive active dna demethylation exclude MBD protein methylate cytosine recruit unknown effector protein recent vitro study reveal TET protein contribute removal methylate cytosine enzyme family capacity oxidize 5hmC also carboxylcytosine researcher show thymineDNA glycosylase belong uracildna glycosylase superfamily rec ognize excise 5fC 5caC thus base excision repair BER system trigger Bestor Matarese crystal structure human reveal bind pocket accommodate 5caC facilitate cleavage furthermore remove hmU mismatch generate enzy matic deamination thymine addition alternative glycosylase include methyl CpGbinding domain protein singlestrand selective monofunctional uracildna glycosylase involve active dna demethylation pathway recent study report hydroxylation mediate protein promote active dna demethylation adult brain deaminating cytosine residue uracil activation induce deaminase mrnaedite enzyme complex family deaminate cytosine residue excise dna glycosylase repair BER pathway potential mechanism responsible passive active demethyl ation present passive active dna demethylation pathway passive dna demethylation cause reduction activity absence dnmt yellow arrow active demethylation oxidation path way green arrow tet enzyme hydroxylate methylcytosine form hydroxymethylcytosine oxidation produce formylcytosine 5fC carboxylcytosine 5caC 5fC 5caC actively remove DNA glycosylase addition putative deformylase convert 5fC decarboxylase convert 5caC active demethylation pathway red arrow family member deaminate 5hmC form thymidine cil 5hmU intermediate replace cytosine base excision repair mediate uracildna glycosylase family TDG SMUG1 recognize thymine 5hmU aid activationinduced deaminase apolipoprotein mrnaedite enzyme complex BER base excision repair dnmt1dna methyltransferase mbd4methylbinding domain protein SMUG1singlestrand specic monofunctional uracildna glycosylase TET1ten methylcytosine dioxygenase family TDGthymineDNA glycosylase color gure online DNA base variant pro duce oxidation TET family enzyme layer chromatography tandem liquid chromatographymass spectrometry reveal mouse esc brain cortex Raiber level estimate genomic dna cell fold low level 5hmC Ito Pfaffeneder level seem reasonable TET2 highly express likely play role dna methylation reprogramming cell differentia tion indeed differentiation level decrease suggest participation develop ment germ cell programming Pfaffeneder recent study report cgi promoter enrich level level correlate active gene expression moreover show actively involve removal exon promoter region Raiber therefore excision help establish rect methylation pattern develop mental program surprisingly promoter region overlap H3K4me3 suggest crosstalk mark transcriptionally active gene intermediate active dna demethylation produce enzymatic oxidation protein likely responsible conversion date 5caC find esc mouse pre implantation embryo worker show 5caC detectable somatic cell amphibian ovary primarily localize generich euchromatic region similar study also demonstrate glycosylase initiate BER pathway cleave 5caC vitro vivo enzyme exhibit activity 5caC Interestingly 5caC level increase deplete mouse cell thus likely enzyme capable pro cesse 5caC know able recognize excise 5caC duplex dna additional enzyme engage conversion 5caC mammalian cell dna adduct create spontaneous exposure endogenous environmental alkylate agent lead cytotoxicity carcinogenesis mutagenic lesion directly repair partic ipation ABH2 DNA dioxygenase BER pathway human dealkylated AlkB bacteria experiment indicate ALKBH2 prefer doublestranded dna dsDNA substrate prefer singlestranded dna ssdna substrate generate activating signal cointegrator complex ASCC Dango Dango demonstrate loss ALKBH3 ASCC3 signicantly reduce cell proliferation vitro vivo xenograft model concurrently accumulation endogenous 3meC genomic DNA observe ALKBH2 show play efcient role pediatric brain tumor chemotherapy treatment combination ALKBH2 knockdown cis platin chemotherapy seem improve efcacy treatment Cetica take together nding indicate important role alkylation repair remove environmentally induce dna lesion well maintain genome integrity stability Histone Variants Histones small basic highly conserve protein serve structural scaffold DNA packaging DNA molecule length wrap octamer histone dimer H2AH2B heterotetramer constitute nucleosome fundamental repeat unit eukaryotic chromatin bind linker DNA nucleosome form macromolec ular structure help compaction genomic dna protein tri partite structure consist central globular domain anke terminal part Fig unstruc tured tail locate terminal portion protrude away nucleosome therefore prone variety posttranslational modications PTMs kouzaride highly conserve globular domain term helixturnhelix contain helix separate loop region involve histonehistone histone dna interaction Luger terminal domain histone histone h2a relatively short tail many positively charge amino acid especially lysine facilitate bind negatively charge dna molecule tranucleosomal interaction terminal histone tail study extensively little know function terminal part show terminal tail play pivotal role regulate chromatin structure dynamic experiment reveal terminus require efcient nucleosome translocation chromatin remodeler act novel recognition module linker histone appear terminal tail dual function hand provide stabilization nucleosomal core particle hand par ticipate interaction protein control chro matin dynamic conformation highly similar form histone term tone variant estimate approximately different variant linker core histone exist various specie human histone variant encode Fig Schematic structure histone protein ter minal part exible positively charge protrude nucleosome short helix length amino acid residue central helix comprise amino acid residue Luger h2adocke domain span amino acid implicate structural functional property nucleosome stabilize wrapping helical turn dna histone octamer bind dimer tetramer nisch Hake addition terminus also find crucial bind linker histone nucleosome helix strand histone fold extension show open box arrow respectively Table Variants histone human express replicationdependent manner express manner Variants Name genes Genomic location Ensembl Protein length Swiss Prot Function H1F0 Nucleosome spacing chromatin compaction HIST1H1A 6p22 Linker histone inhibit slide histone octamer postulate inhibit chromatin remodeling hist1h1c however recent study suggest deplete active promoter gene regulatory element enriched region carry repressive histone mark bind sensitive initiation transcription transcriptional elongation Linker histone operate conjunction network chromatinbinde protein dene permissive euchromatin repressive heterochromatin dna domain H1xb 3q21 H1oo H1FOO 3q22 H1 HIST1H1 Testis specic H1FNT Spermatid specic HILS1 gene majority present cluster cluster chromosome cluster chromosome cluster chromosome cluster chromosome incor poration specic histone variant nucleosome signicant impact gene expression heterochromatiza tion formation specialized region chromatin histone variant recently emerge important factor regulate chromatin state also DNA repair response genotoxic treatment moreover likely histone variant potential driver cancer initiation progression thus utilize prognostic indicator cancer protein consist amino acid resi due depend variant Approximately dif ferent member family report diverse specie thus far Eleven variant histone describe human code single gene exhibit expression Table variant testisspe HIST1H1 H1FNT HILS1 oocytespecic H1foo other somatic vari ant Linker histone involve chromatin compac tion play role formation chromatin structure Table Variants histone H2A human variant name gene genomic location Ensembl Protein length SwissProt function h2a type histone core octamer HIST1H2AL H2A1 type type1 HIST1H2AE HIST1H2AB h2a type type type type h2a type HIST2H2AA4 1q21 h2a type HIST2H2AB h2a type h2a type unknown function type H2AFB1 Xq28 transcription activation type transcription activation h2a H2AFJ unknown function H2AFX integrity dna repair regulation H2A maintenance heterochromatin transcription repression activation H2A macroH2A H2AFY silencing enrich inactivated chromosome h2afy2 silence enrich inactive chromosome chromatin senescenceassociate heterochromatin specic role histone variant still far clear genomic distribution challenge due lack antibody H2A protein compose amino acid residue atypical differ size Approximately different member histone H2A identie variety specie human variant histone encode gene report Table Histone H2B variant variant histone con tain amino acid residue histone family contain different member describe diverse specie H2B form dimer histone nucleosome core H2B variant encode gene human majority assemble cluster table relatively ptm identie amino acid residue histone compare core histone consist amino acid residue centromere protein long variant histone family contain different member various specie histome humans gene encode variant tone cluster chromosome extensively posttrans histone contain amino acid residue form heterotetramer histone histone family consist member report different organism interestingly human single histone protein encode by14gene cluster chromosome Table Table variant histone H2B human Variants Name gene genomic location Ensembl Protein length SwissProt Function H2B type HIST1H2BA 6p22 Specic role variant poorly understand probable specialize chromatin compaction transcription repression particularly gametogenesis H2B type HIST1H2BB H2B type HIST1H2BG 6p22 HIST1H2BF HIST1H2BE hist1h2bi H2B type H2B type HIST1H2BH H2B type H2B type HIST1H2BK H2B type HIST1H2BK H2B type HIST1H2BM 6p22 type HIST1H2BN H2B type HIST1H2BN H2B type type HIST2H2BF type type H2B type H2B type H2BFWT putative H2B type putative type Res Table Variants histone human Variants name gene genomic location Ensembl Protein length SwissProt DNA repair Szenker HIST1HAD HIST1H3C hist1h3b reorganization spermatogenesis replication DNA repair Szenker hist2h3a h3f3a transcription activation also name transcription activation H3X protein detect vivo H3Y probable regulation cellular response stress transcription activation centromeric protein cenpa proper chromosome segregation express replicationdependent manner express replicationindependent manner human Histone Name gene genomic location Ensembl Protein length SwissProt Function HIST4H4 variant recognize HIST1H4C HIST1H4H make contact histone octamer HIST1H4I 6p22 HIST1H4J k 6p22 HIST1H4L 6p22 1q21 hist2h4b dna methylation consider relatively stable epigenetic modication recent genomewide analyse DNA methylation mammalian cell suggest enzyme capable erase modify exist methylation pattern DNA cytosine methylation wellcharacterize little know role cytosine derivative gene expression regulation future highresolution sequencing technology enable creation quantitative map 5fC 5caC different cell type understand dynamic modication help explain role phy iological pathological condition interestingly due subtle sequence divergence incorporation histone variant inuence stability nucleosome change potential specic histone modication variant composition key player shape chromatin structure also consider epigenetic regulation element well know epigenetic disturbance lead different phenotype monogenic complex disease well oncogenic transformation strongly believe rapidly grow understand epigenetic phenomenon bring breakthrough diagnosis treatment many dis order moreover well knowledge epigenetic etiology disease provide opportunity develop innovative new epigenetic drug acknowledgment work support NZ3 statutory fund interest author declare conict interest Open Access article distribute term permit use dis tribution reproduction medium provide original author source credit paramutation paradigm e1003537 environment complex relationship Appl Physiol Wheldon Abakir carboxylcytosine localize euchromatic region nucleus follicular cell axolotl ovary Nucleus variantsthe structure function brief Funct Genom Proteom Bestor dna methyltransferase mammal bird dna methylation pattern epigenetic memory variant nucleosome chromatin less stable uncover role hydroxymethylcytosine epigenome Giunti brain tumor mutation dioxygenase habh2 directly repair alkyl ation damage Neurooncol effect age hydroxymethylcytosine mouse hippocampus Restor Neurol Neurosci Chestnut Lesuisse Epigenetic regulation motor neuron cell death dna methylation Neurosci Choi Friso Epigenetics new bridge nutrition health clausell subtype differentially modulate chromatin condensation prevent remodeling NURF plo e0007243 Henikoff change occupancy dna methylation cell lymphomagenesis Cooper cell molecular approach 2nd edn organization cellular genome Crider dna methylation molecular mechanism evidence folate role Adv Nutr Dango Mosammaparast Sowa Xiong Park DNA unwind helicase couple alkbh3dependent dna alkylation repair cancer proliferation Mol Cell cpg island regulation transcription Genes Dev analysis dna methylation eds molecular diagnostic clinical 2nd edn human disease prospect epigenetic therapy Nature Cortez Liang Identication DNMT1 DNA methyltransferase hypomorph somatic knockout suggest essential role cell survival Estecio MRH dissecting dna hypermethylation cancer FEBS Lett Fan Rangasamy alter nucleosome surface promote HP1alphamediated chro matin bre folding Mol Cell DNA protein kinetochore assembly vertebrate cell dna methyltransferase associate histone methyltransferase Globisch nzel ller Koch Bruckl Biel Carell tissue distribution hydroxymethylcytosine search active demethylation intermediate e15367 Maggert Yoder Asp DNA methyltransferase homolog dnmt2 science role dna dioxygenase epigenetic reprogramming oocyte nature histone globally localize promoter inactive yeast gene regulate nucleosome positioning e384 Song Hydroxylation methylcytosine promote active dna demethylation adult brain cell dna methylation dynamic mammalian life cycle dynamic chromatin ber solution determinant mechanism function struct Sun Tet mediate formation carboxylcytosine excision mammalian DNA Science use dna methylation understand biological consequence genetic variability Dis Longo Singleton Distinct dna methylation change highly correlate chronological age human brain Huh Zeng Park DNA methylation transcriptional noise Epigenet Chromatin replicationdependent dilution 5fC 5caC mouse preimplantation development Cell res Hong Role Tet protein conversion cell selfrenewal inner cell mass specica tion nature Tet protein convert methylcytosine carboxylcytosine Science Aravind Prediction novel family enzyme involve oxidative complex modication basis nucleic acid cell cycle Noureen Kind genomic landscape somatic linker histone subtype human cell Cell Rep Javierre Hernando Ballestar Environmental trigger epigenetic deregulation autoimmune disease Discov Med specicity dna methylation prole technique methylcytosine hydroxymethylcytosine DNA Methylation superior subordinate epigenetic hierarchy Genes cancer Jones Functions DNA methylation island start site gene body variant deviant Genes Dev Tuorto Ghanbarian epigenetic heredity require cytosine methyltransferase e1003498 Rao Nardone Laiho Mostoslavsky Lahesmaa Daley Rao tet1 regulate hydroxymethylcytosine production cell lineage specication mouse embryonic stem cell Cell Stem Cell TET enzyme dynamic dna demethylation Nature Koivisto Robins Lindahl DNA bacterial human DNA dioxygenase modication function cell nuclear dna base present brain enrich neuron science Low change human methylome differentiation modication epigenetic reprogramming mammalian development lifestyle factor dna methylation Methods Mol Biol lister Stewart Human DNA methylomes base resolution show widespread epigenomic difference Nature Luger Nucleosomes structure function pedia life sciences New York Malik nucleosome Nat struct Biol Santa Pau Stunnenberg hydroxymethylcytosine new kid epigenetic block McKay Mathers Diet induce epigenetic change implication health Acta Physiol Islam ABMMK IzquierdoBouldstridge Mayor Terme Jordan Mapping somatic linker histone variant human breast cancer cell uncovers specic feature prole histone replacement pattern Fan DNA methylation basic function neuropsychopharmacology nzel sixth DNA base hydroxymethylcytosine brain Engl Dunican Katz type major hydroxymethylcytosine content human gene Rastogi Boss Blanck Activation methylate promoter mediate colorful history active dna demethylation cell presence hydroxymethylcytosine animal acid Pfaffeneder nzel ller Deiml discovery formylcyto sine embryonic stem cell Probst epigenetic inheritance cell cycle functional diversication core histone variant FEBS Raiber Beraldi distribution formylcytosine embryonic stem cell associate transcription depend thymine dna glycosylase R69 Hartley variant end active inactive gene euchromatin cell Riggs Xiong Methylation epigenetic delity DNA methylation methyltransferase cancer Epigenetic reprogram ming mouse preimplantation development primordial germ cell Development Jordan Depletion human variant uncovers specic role gene expression cell growth e1000227 MMG implication abnormal epigenetic pattern human disease Pollex Hanna Tuorto Lyko rna methylation dnmt2 protect transfer rna stressinduce cleavage Genes Dev Zilbauer hominidspecic histone variant specically express seminiferous tubule human testis function oxidative reversal DNA rna methylation Annu Rev Biochem Dimitrov docking domain histone H2A require bind nucleosome remodeling Smallwood Este Pradhan Carey functional cooperation mediate gene silence Genes Dev Song Szulwach selective chemical labeling reveal genomewide distribution hydroxymethylcytosine song Rechkoblit Bestor Patel Structure DNMT1DNA complex reveal role autoinhibition maintenance DNA methylation science Burger Wirbelauer Tiwari Schubeler DNAbinding factor shape mouse methylome distal regulatory region Nature Stroud Feng Kinney associate enhancer gene body human embryonic stem cell R5433 Szenker RayGallet Almouzni double face histone variant H33 cell Res Szulwach Song Upadhyay Gearing Levey hmcmediate epigenetic dynamic postnatal neurodevelopment age Pastor Agarwal Iyer Conversion methylcytosine hydroxymethylcytosine mammalian DNA partner TET1 Science variant associate active transcription mrna process human cell endogenous cytosine damage product alter site selectivity human dna maintenance methyltransferase DNMT1 Cancer Res Rogstad damage methylcpg sequence inhibit bind methylcpg bind domain MBD methyl cpg bind protein mecp2 Nucleic Acids Res variant emerge player cancer biology dna methylation epigenetic evolution vertebrate fact challenge human gene cpg island promoter distinct transcriptionassociated chromatin organization Chassignet FernandezCapetillo ngst terminus regulate chromatin dynamic remodeling histone bind e1001234 variant dynamic punctuation transcription Genes Dev nisch Merkl Kremmer characteriza tion novel primatespecic histone variant h3x H3Y cell Biol expression novel human histone gene dna demethylation many road lead Nat Rev Mol Cell Biol Zhao Sun Zhang genomewide analysis hydroxymethylcytosine distribution reveal dual function transcriptional regulation mouse embryonic stem cell Genes Dev Downregulation ALKBH2 increase cisplatin sensitivity h1299 Acta Pharmacol sin new pyrimidine base bacterio phage nucleic acid nature Res Yang Lay Targeting dna methylation epigenetic therapy Trends Pharmacol Sci Dinner interrogation direct dna repair protein search base damage Nat Struct Mol Biol Thymine DNA glycosylase specically recognize Zhu active dna demethylation mediate dna glycosylase Annu Rev Genet",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "epigenetic": 36,
                    "methylation": 62,
                    "demethylation": 21
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "CXXCcysteine": 1,
                    "Vavouri": 1,
                    "Szulwach": 2,
                    "TSSs": 1,
                    "HIST1H1D": 1,
                    "H1foo": 1,
                    "posttrans": 1,
                    "Szenker": 1,
                    "HIST1H4C": 1,
                    "Islam": 1,
                    "Dunican": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "CXXCcysteine": 119,
                    "Vavouri": 119,
                    "Szulwach": 119,
                    "TSSs": 119,
                    "HIST1H1D": 119,
                    "H1foo": 119,
                    "posttrans": 119,
                    "Szenker": 119,
                    "HIST1H4C": 119,
                    "Islam": 119,
                    "Dunican": 119
                },
                "Ethnographic Terms": {
                    "epigenetic": 12,
                    "methylation": 12,
                    "demethylation": 12
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "A kinetic model for methyl decanoate combustion.pdf",
            "cleaned_text": "kinetic model methyl decanoate combustion Article history receive receive revise form accept January available online methyl decanoate Biodiesel kinetic model Diffusion ame Transportweighted enthalpy detailed kinetic model oxidation biodiesel surrogate methyl decanoate devel ope test broad range experimental datum methyl decanoate model consist low high temperature oxidation chemistry construct strictly extension chemical kinetic thermochemical parameter use describe oxidation betterunder stand small methyl ester methyl butanoate construct model test priori manner computation appropriate experimental datum available methyl decanoate oxidation result show generally improve performance present model relative literature model generally construct base similarity alkane oxidation reaction kinetics path analyse available methyl decanoate model analyze result reveal fuel oxidation pathway exhibit completely different chemical mechanism depend modeling prescription kinetic thermochemical parameter particular wide degree variability fate prescribe methyl ester functionality addition experimental analysis diffusion ame extinction methyl butanoate methyl decanoate reveal high temperature reactivity methyl butanoate similar methyl decanoate introduce con cept transportweighted enthalpy consequently present modeling work experimental analy sis suggest study small methyl ester system methyl butanoate require order improve model delity large biodiesel methyl ester publish behalf recent climate change energy security concern drive signicant interest biofuel biodiesel alcohol provide mean replace petroleum use reduce net co2 emission associate transportation rive transesterication triglyceride lipid ethanol compose mixture long alkyl chain methyl ethyl ester specic molecular component distribution depend lipid source limit small set alkyl alkenyl ester carbon atom unsaturation understand combustion property molecular structure interaction blend petroleum derive diesel fuel considerable interest however biodiesel compound dif cult study gas phase fundamental fuel vaporoxidizer experiment shock tube reactor jet stir reactor ame conguration large molecular weight hence low vapor pressure thus investigation kinetic small molecular specie behave combustion kinet ically similar actual biodiesel constituent prevalent model fuel refer surrogate surrogate fuel single molecule simple mixture several molecule mimic chemical physical proper tie fuel interest result oxidation kinetic number different ester study C5H10O2 rst pro pose emulate biodiesel reaction kinetics con structed rst detailed kinetic model assume similarity oxidation kinetic alkane model later test experimental measurement jetstirred reactor JSR variable pressure reactor diffusion ame speciation prole recently recognize uniqueness reactivity methyl ester moiety develop model structure model test com prehensively previous experimental datum ignition delay Diluent mixture shock tube rapid compression machine RCM temperature range RCM experiment high pressure atm conrme JSR reactor measurement show methyl butanoate exhibit low temperature oxidation behavior thus consider appropriate biodiesel surrogate low temperature consequently recent study recommend large methyl ester biodiesel surrogate emulate negative see front matter Published behalf combustame Corresponding author mail address pdievartprincetonedu Divart Combustion Flame content list available journal homepage wwwelseviercomlocatecombustame temperature coefcient behavior actual biodiesel study experimentally ignition methyl ter RCM study detail behavior methyl hexanoate C7H14O2 Dayma also study particular ester JSR atm presence behavior base kinetic model develop kinetic model methyl hexanoate test experimental datum recently experimental model study extend large methyl ter methyl heptanoate C8H16O2 methyl octanoate methyl decanoate C11H22O2 kinetic model large methyl ester develop base assume similarity oxidation kinetic alkane exist large reaction kinetic datum base thus methyl ester kinetic model development date quite limited focus specic role methyl ester functional group result model occasion ally overpredict reactivity methyl ester oxidation example exhibit short ignition delay high extinction limit diffusion ame previous model devel ope base analogy alkane chemistry various modi cation rate constant relate reaction methyl ester functionality approach result signicant ambiguity description role methyl ester moiety cent experimental study small methyl ester show clearly fuel oxidation co2 formation methyl ester depend strongly particular molecular structure fore accurate kinetic model biodiesel surrogate quire specic knowledge kinetic methyl ester moiety describe display true low temperature reactivity comprehensive kinetic model develop test result rel atively good agreement broad range experimental datum logical expect methyl ester specic kinetic process accentuate small ester structure denite funda mental knowledge gap certainly exist implication gen eral reproduction detail experimental observation model important methyl ester specic kinetic process adequately describe objective study develop kinetic model construct employ similarity rule ester moiety small methyl butanoate system large system evaluate extent chemical kinetic similarity high temperature fundamental philosophy model construction aim utilize rate constant thermo chemical parameter assembly derive small methyl ester comprehensively test kinetic model similarity rule apply estimation rate constant thermochemical parameter exactly pre scribe similar chemistry adjust ment methodology kinetic model use rationalize appropriateness similarity rule hypothesis alkyl chain length great little inuence thermochemistry kinetic ester moiety order evaluate extent similarity high temperature oxidation prior experimental analysis extend finally present study evaluate clare fundamental knowledge gap methyl ester thermo chemistry reaction kinetic result recommend detailed study small methyl ester essential order construct reliable kinetic model biodiesel type fuel Model construction Methyl decanoate oxidation scheme kinetic model propose design origi nal oxidation framework methyl decanoate propose net scheme encompass low high temperature kinetic fuel methyl ester oxida tion scheme small methyl ester produce degradation parent fuel chemical scheme use template rate constant parameter thermochem ical data substitute consistently approach adopt study describe necessarily oxidation kinetic small specie C0AC5 update accord recent work datum recent study deal estimation thermo chemical property methyl ethyl ester specie determine initio computation complete basis set method CBSQB3 Osmont pro pose new computational approach estimate formation large set hydrocarbon include large methyl ter group derive BDEs methyl ethyl ester moi ety computational result Sumathi work oxygenated fuel alcohol ester ether carboxylic acid propose new estimate methyl ester group derive initio computation complete basis set method propose group pre sente table reasonable consistency kcal mol observe study important uncertainty signicant difference equivalent alkane parameter apparent especially CAH BDE methyl ester group fall range kcal mol lower kcal mol primary bond alkane bond carbonyl position value kcal mol intermediate secondary CAH bond kcal mol secondary allylic mol great consensus thermochemical delay methyl decanoateoxygenargon mixtures aerosol shock tube equivalence ratio fuel mole fraction ppm pressure atm computation model propose study detail reduce specie reduce specie model Flame propertie methyl ester fuel oxygenate specie volve kinetic model thus require input strongly affect kinetic parameter thermochemical datum specie involve methyl decanoate reaction set methyl pentanoate methyl decanoate consistent small methyl ester methyl butanoate sub model estimate group additivity method propose implement software contribution ester group choose consistently employ take mostly Green Figure show result estimate ble show comparison bde employ previous kinetic model BDEs compute present model consistent small discrepancy kcal mol attribute uncer taintie associate estimation enthalpy forma tion large alkyl radical group additivity method BDEs calculate present model methyl decanoate consistent determine difference value also consistent compute rst version methyl decanoate model however model work er prescribe generally low model also note second version methyl decan oate model Herbinet model suggest extremely low value bond carbon atom low value imply rate constant compute unimolecular fuel decomposi tion UFD reaction associate bond high crease oxidation rate fuel substantially parameter different oxidation model propose literature model test different experimental datum set different prescription BDEs methyl ter specie also use different kinetic parameter set key reaction methyl ester oxidation especially hydrogen ion rate constant position carbonyl methyl ester specic widely inconsistent branching ratio dene ratio rate constant hydrogen ion reaction radical position interest sum individual rate constant hydrogen ion fuel radical branching ratio ion reaction methyl ester specic position function temperature show plot show large variability model propensity hydrogen atom ion methyl ester carbon also adopt assume position similar primary carbon atom consider weakening relative analogous posi tion propane evaluate work Sumathi account particu larity propose rate constant enhance branching ratio position value nominate Hakka intermediate value aforementione model similar also present scission reaction reaction involve ester moiety large disparity observe different model formation formaldehyde radical attempt account uniqueness process work er propose high decomposition rate constant fish Hakka previous study show formation formaldehyde oxidation methyl ester play signicant role regulate diffusion ame extinction indicate accurate description process target model improvement Accounting previous observation consider experimental validation range work adopt base model study thus subset add set reaction describe kinetic parameter propose methyl butanoate oxidation prescribe reaction reaction sis analogous reaction oxidation scheme methyl decanoate small methyl ester specie reaction class modie hydrogen ion reaction fuel stable intermediate Table Isomerization reaction methyl ester alkyl radical scission reaction methyl ester alkyl radical fuel decomposition reaction reaction class rate constant parameter prescribe reverse reaction follow approach forward rate constant com put microscopic reversibility thus also test sign thermochemistry moreover fully consistent approach reaction treat quantum theory master equation analysis result rate constant expression tte formalism use model pressure dependence correction strongly impact rate con stant rate constant highpressure limit relative Table Methyl Decanoate Bond Dissociation Energies comparison study computational value available literature kinetic model unit kcal mol Bond Nahas Osmont Sumathi Present model present model Herbinet Version version rco2ch2ah RCO2ACH3 raco2ch3 RACH2CO2CH3 Fig Bond Dissociation Energies bde black bond gray bond calculate methyl decanoate unit QRRK estimate rate constant atmospheric pressure crease approximately factor factor however rate constant parameter associate low temperature oxidation chemistry alkane methyl butano eat recognize uncertain new rate constant esti mate propose consistent goal study low temperature kinetic parameter retain initial model however note preliminary test date kinetic parameter generic low temperature scheme show enhancement fuel reactivity end region Transport datum parameter methyl ester specie estimate accord dipole moment choose equal polarizability cal culate accord Sales different set transport coefcient available previous modeling work present Table coefcient propose ratio methyl butanoate atom radical rate constant c3h7co2ch2 radical scission reaction unimolecular methyl butanoate decomposition reaction CH3O c3h7co radical model Fisher Table ion rate constant parameter exp unit cm3 mol mol main radical adopt present kinetic model model Herbinet Present model Herbinet Present model HO2 Herbinet Present model Herbinet Present model CH3 Herbinet Present model Divart Combustion Flame reasonable agreement propose previous study main difference observe welldepth potential difference value suggest however collision diameter main parameter govern binary diffusion coefcient show computed binary dif fusion coefcient consistent different trans port dataset therefore deviation dimensional conguration model related difference thermochemistry kinetic employ reduction detailed model involve specie reaction large use ame simulation multigeneration Pathway Flux Analysis PFA method implement software use reduce size model reduce model generate large specie reaction validate successfully detailed model use compute laminar ame speed small reduce model specie reac tion use compute series diffusion ame result determination extinction strain rate reduce model good agreement experiment premixed ame condition high temperature ignition delay stir reactor speciation comparison detailed model reduce model available Supplemen tary material modeling method model describe test shock tube ignition delay JSR speciation diffusion ame speciation laminar ame velocity extinction limit diffusion ame SENKIN module package respectively use model experiment JSR shock tube exercise constant volume vari able volume assumption ame simulation perform code CHEMKIN III package utilize mixture average transport flame velocity compute Premix utilize multicomponent transport description solution code extremely similar model prediction available experimental datum low intermediate temperature oxidation ignition delay Wang recently measure igni tion delay air mixture different equivalence shock tube atm investigate broad range initial temperature observe behavior ignition delay figure show modeling com putation present model model model experimental datum stoichiometric mixture model estimate ignition delay region predict ignition delay high temperature point Oehlschlaeger model Herbinet relatively good agreement experimental datum present model also Table Comparison transport parameter adopt methyl decanoate study kinetic model available literature Study Comment Present study parameter estimate molecular weight correlation method take equal specie similar size structure Tee Gotoh method estimate extrapolation critical property small ester Wang Tee Gotoh method estimate Joback group additivity method methyl decanoate function temperature compute use parameter propose study delay stoichiometric air mixture atm symbol experimental datum green line present model black line model blue line model run variable volume history solid line report constant volume dash line interpretation color gure legend reader refer web version article Divart Combustion Flame show quite good agreement high temperature mate ignition delay low temperature regime deciency present model low temperature regime attribute follow reason Firstly low temperature oxidation scheme present model directly adopt ther mochemical datum low temperature relate specie estimate present model additivity group use high temperature relate specie also adopt order maintain consistency model low temperature ignition strongly control chemis try peroxy alkyl RO2 specie formation specie subsequent reaction isomerization second addition govern chemical equilibrium thus highly depen dent thermochemical datum therefore modication thermochemical property result change chemical equi librium spite keep forward rate constant sug gested Herbinet consequently present model exhibit somewhat different performance low temperature compare model Secondly present kinetic write strictly propagate methyl butanoate kinetic model molecule previous experimental study show exhibit low temperature reactivity clearly show ignition delay thus regard low temperature chemistry implement present model quire detailed study order improve model del ity moreover recent study aim compute rene kinetic parameter associate low tempera ture oxidation alkane indicate important uncertainty still exist submodel present model show reasonable agreement relatively limit range low temperature oxidation measurement improve quan titative fundamental understanding low temperature reac tion kinetic alkane methyl ester require Jetstirred reactor study oxidation methyl decanoate mixture JSR atmospheric pressure study provide speciation datum lowtempera ture oxidation methyl decanoate reactant product main intermediate however author detect formaldehyde main intermediate specie specic methyl ester oxidation chemistry figure pre sent comparison present detailed model model model model experimental datum present detailed model overall good agreement experimental datum main difference model observe methyl acrylate formaldehyde Fig difference important ethylene formaldehyde identie control intermediate many combustion netic phenomenon methyl acrylate formaldehyde inter mediate specie result oxidation pathway directly attributable methyl ester functionality model compute low methyl acrylate concentration close experimental prole model forecast large amount unsaturated ester however model also compute signicantly high mole fraction formaldehyde high model forma tion ethylene relate decomposition alkyl chain methyl ester molecule large alkyl chain ethylene production inuence little process specic ester moiety discrepancy serve ethylene fraction compute model ascribe different C0AC3 subset therefore Fig oxidation stoichiometric methyl decanoateoxygenhelium mixture ppm jet stir reactor atm residence time datum symbol model computation line present detailed model co2 CH4 C2H4 C3H6 methyl acrylate Divart Combustion Flame consumption reaction adopt however large deviation observe computation methyl acrylate formaldehyde prole govern kinetic methyl ester group modication thermochemical datum low tempera ture relate specie find strongly affect low tempera ture prole fuel small unsaturated specie C2H4 C3H6 methyl acrylate example model compute fuel convert study residence time temperature present detailed model compute close agreement conversion yield experimentally measure observation consistent result show model find show fast rate oxidation present model find show slow rate oxidation slow term ignition delay high temperature oxidation ignition delay measure ignition delay methyl decanoate mixture aerosol shock tube fuel lean mixture equivalence ratio investigate inter mediate temperature pressure atm model computation model study previously publish model experimental datum present Fig different reduce model derive detailed model present study show consistent computed ignition delay model evolve work strongly overestimate oxidation rate compute igni tion delay low experimentally mea sure model well agreement still underpredict ignition delay present model also underpredict ignition delay modestly average deviation thus show considerably close agreement aforementioned model Laminar burn velocity determine laminar burn velocity methyl decanoateair mixture atmospheric pressure ini tial temperature burner Figure pre sent experimental data computation different model reduce model pro pose study reduce model reduced model reduce model pro pose study good quantitative agreement max compute experimentally compute maximum ame speed peak slightly shift high equivalence ratio result model overestimate experimental datum tion laminar burn velocity fuellean condi tion underestimate Diffusion ame extinction Limits report diffusion ame extinction limit function fuel mole fraction methyl butanoate heptane methyl decanoate diffusion ames counterow facility atmospheric pressure fuel stream temperature xe hydrocarbon oxidizer stream hold figure present experimental datum com puted mixtureaverage transport extinction limit pres ent reduce model specie reduce model generate approach detailed model computation model derive rst version model derive second version model also show tailed model model involve hundreds specie thousands reac tion large compute necessary series dimen sional simulation result extinction limit therefore computation model present diffusion ame condition Fig model overestimate extinction strain rate model much well agreement present reduce model compute extinction limit close agreement model experiment methyl butanoate model computation exhibit similar behavior computation model extinction strain rate model capture reasonably well experimental datum low fuel mole fraction extinction limit fuel mole fraction increase model perform well computation heptane Fig Formaldehyde mole fraction compute different model JSR atm ppm methyl decanoateoxygenhelium mixture speed methyl decanoateair mixture atmospheric pressure datum reduce model species reduce model specie Flame extinction limit discrepancy observe large fuel fraction high temperature kinetic applicable alkyl functionality implement present model thus reli able therefore discrepancy observe high tempera ture oxidation likely attribute uncertainty associate thermochemical kinetic property pre scribe methyl ester moiety suggest previous work Moreover also suggest discrepancy serve computation extinction propagate sim ilar computation present modeling methodology apply consequence improve mechanistic quantita tive kinetic comprehension kinetic small methyl ester main intermediate primary target move large methyl ester Diffusion ame speciation publish speciation datum methyl decanoate diffusion ame identie quantied reactant product major intermediate specie unsat urated methyl ester comparison present duce model specie model experimental datum present Fig model exhibit negligible difference computation temperature prole concentration prole reac tant oxidation product co2 however computed prole small intermediate specie especially oxy genates formaldehyde ketene find different tween test model model fail reproduce rate consumption methyl decanoate systematic discrepancy experimental computed prole fuel pose diffusion ame due signicant part nonideal velocity prole exit nozzle describe physical simulation model however model perform well capture spatial evolution inter mediate specie present model compute low maxi mum formaldehyde mole fraction still predict experimental datum factor model show extreme deviation factor high experi ment different behavior observe ketene prole present model compute high mole fraction factor high compute model large discrepancy kinetic model formaldehyde experimental datum previ ously point suggest issue explain observation formaldehyde polymerize sampling probe result low tion sample gas nonetheless lack reliable quantita tive datum intermediate specie limit accuracy methyl ester combustion model Path analysis previous section present overall performance propose model experimental datum previous mod computation section reaction pathway analysis strain rate methyl model computation study study study temperature prole methyl decanoate oxidation atmospheric pressure diffusion ame symbol experimental datum solid line computation solve gas energy equation present reduce model specie model model model Seshadri Divart Combustion Flame perform select combustion condition identify point difference initial oxidation path fore cast different model oxidation intermediate temperature fuel lean mixture rst conguration investigate constant volume con stant internal energy autoignition simulation overall pathway analysis model perform thermo dynamic condition study experimentally regardless model parent fuel react mainly atom ion reaction radical atom main or fuel fraction decompose reaction find strongly dependent various bde prescribe model model low BDEs compute larg proportion predominance reaction produce octyl CH3OCOCH2 radical contrast present model predict total fuel consumption reaction class detailed path analysis atm fuel conversion different detailed model present tailed model model model present initial distribution radical compute differently model Firstly model compute small amount radical specic methyl ester functionality MD2J CH3CH27CHCO2CH3 versely parent fuel convert radical model present model strong relative model ude however model compute different consump tion path methyl ester specic radical model emphasize isomerization reaction scission reaction present model radical exclusively decompose scission reaction thus different overall reactivity compute model analysis demon strate branching ratio scission isomeriza tion reaction specic methyl ester radical need investigation order reproduce global oxidation parame ter speciation datum oxidation counterow second conguration investigate opposed diffusion ame fuel mixture fuel side air oxidizer side ure present overview fuel consumption pathway present reduced model model Fig model show react mainly ion reaction main ing rad ical model atom follow radical note worthy proportion react increase strain rate suggest previously however yield ufd widely different present model model derive though note model show reaction class become less prominent ame close extinction fundamental analysis rationaliz ing behavior present previously model fuel break unimolecularly model present study compute maximum yield reaction class tailed path ux analysis show reaction produce ch2coch3 ME2J octyl radical fuel prominent fuel consumption rate constant reaction previously report overestimate model Herbinet due low prescribe large deviation reaction yield present model model surprising model compute similar extinction limit Fig initial distribution radical compute different present model model lump methyl decanoate md9j MD5J MD2J MD10J Fig Path analysis shock tube ppm atm conversion value green black blue refer present detailed model model model respectively interpretation color gure legend reader refer web version article Divart Combustion Flame radical model preclude similar delineation detailed oxidation pathway reduced model consider radical CH2CH28CO2CH3 MDMJ c9h19co2ch2 thus assume atom ion position unlikely Accord ing present model nearly fuel convert radical react scission reaction gen erate formaldehyde however model consider radical MD2J CH3CH27CHCO2CH3 main radical generate parent fuel model agree consider scission reac tion radical main consumption pathway minor contribution isomerization reaction finally noteworthy fate radical ME2J CH3OCOCH2 quite different model production rate rad ical rstly different directly produce fuel model interesting consumption path present model forecast radical break apart produce ketene methoxy radical model ch3co2ch2 decompose formaldehyde acetyl radical sensitivity analysis show sensitivity analyse kinetic parameter perform computation ignition delay laminar ame speed extinction limit result show global parameter mainly sensitive chemistry small intermediate specie specie show weak dependence fuel specic chemistry therefore result discuss paper highly detailed analysis perform previously extract meaningful information rene methyl decanoate oxidation kinetic Conclusions kinetic modeling model develop propagate kinetic thermochemistry employ appro priate analogy model test large set available experimental datum ignition delay speciation prole JSR diffusion ame laminar ame speed extinction limit diffusion ame compare computation previous kinetic model aim develop model assess hypothesis propagate well perform kinetic tion result well model prediction present anal yse show model perform reasonably well large range condition show signicant difference performance previous model different kinetic subset prescribe result com pletely different oxidation pathway therefore formation different pool control intermediate spe cie future experimental study methyl ester reaction kinet ics thus focus speciation measurement small methyl ester model molecule gain sight methyl ester oxidation framework constrain kinetic model similarity oxidation methyl ester show previously exhibit strong resistance molar basis extinction smal ester however discuss different ame property make draw fair conclusion chemical kinetic contribution difcult recently study extinction limit large set fuel component include alkanes iso kanes Motivated question suggest new parameter transportweighted enthalpy metric order fairly compare chemical kinetic mass diffusive potential energy contribution different fuel occurrence ame phenomena account difference Fig consumption pathway methyl decanoate diffusion ame differ ence present model MDiJ MD10J scission scission path analysis air counterow diffusion value green black refer present reduced model model respectively refer translation molecular formula chemical structure interpretation color gure legend reader refer web version article Divart Combustion Flame energy content addition property separate experiment rate mass diffusion inherent molecule size however show difference theoretically normalize square root molecular weight fuel use enthalpy combustion fuel decouple kinetic contribution diffusion ame extinction thermal transport sue different molecular weight differ ent enthalpy combustion fuel mole fraction diffuse fast reaction zone due small mol mol respec tively heat combustion higher thus result ing high peak ame temperature mol kcal mol Transport weight dene fuel dhcomb mwdiluent MWfuel figure show extinction strain rate func tion experiment numerical computation extinction limit heptane choose representative alkane also present normalization exhibit extinction behavior well similar measure comparison suggest chemical kinetic reactivity fuel high temperature extremely similar rationalize tion computation perform duce model cal equate mole fraction respectively initial fuel temperature noteworthy computation Fig Extinction strain rate methyl butanoate blue methyl decanoate green heptane black diffusion ame transportweighted enthalpy symbol experimental datum line model computation interpretation color gure legend reader refer web version article Fig Temperature specie prole main intermediate radical atmospheric methyl decanoate solid line methyl butanoate symbol diffusion ame transportweighted present model also reproduce experimental observa tion follow present computed concentration prole main radical HO2 maximum ame temperature heat release rate function strain rate expect radical temperature prole find nearly identical biofuel alkane prole main intermediate C2H4 widely different understand reason difference analysis formation formaldehyde cal diffusion ame present similar analysis methyl butanoate ame concentration formaldehyde compute fuel ame differ almost factor compute alkane fuel ame methyl ester fuel ame formaldehyde produce core reaction zone directly decomposition methyl ester fuel frag ment MDMJ MP2DMJ CH3O MBMJ core reaction zone heat release major formaldehyde produce investigate fuel reaction involv ing small radical Formaldehyde react mainly abstrac tion reaction atom radical generate formyl radical formyl radical decompose atom radical chain brancher HO2 radical radical chain propagator react unimolecularly ular oxygen analysis suggest global parameter diffusion extinction high temperature ignition delay methyl ester exhibit similar reactivity simple alkane account necessary fuel characteristic actually extinction limit diffusion ame strongly dictate high temperature chemistry propensity populate radical pool mostly govern kinetic C0AC2 chemistry link fuel consumption pathway nevertheless similar reactivity alkane methyl ester global parameter diffusion ame extinction essarily imply similarity detailed structure ame nature concentration intermediate specie thus detailed study methyl ester kinetic specicitie need perform order improve current kinetic mod methyl ester conclude remark detailed kinetic model biodiesel surrogate methyl decanoate develop model use chemical consumption pathway formaldehyde atmospheric diffusion ame fuel methyl butanoate CH3O CH2O CH3 CH2O CH2 CH2O CH2O C2H3 CH2O HCO MP2DMJ CH2O MBMJ CH2O nC3H7CO CH2O HCO CH2O CH3 HCO CH4 methyl decanoate ch3o CH2O CH3 CH2O CH2 CH2O CH2O C2H3 CH2O HCO MP2DMJ CH2O MDMJ CH2O nC9H19CO CH2O HCO CH2O HCO CH2O CH3 HCO CH4 heptane CH2O CH2OH CH3 CH2O CH2 CH2O CH2O C2H3 CH2O HCO CH2OH CH2O HO2 CH2O HCO CH2O HCO CH2O HCO Divart Combustion Flame reaction scheme construct prescribe kinetic thermochemical parameter develop describe methyl butanoate oxidation reaction rate constant thermochemical parameter propagate modication model subset mod test manner perform generally well experimental datum shock tube JSR laminar burn ing velocity diffusion ame speciation prole extinction limit overall well performance model demonstrate methodology adopt similarity rule methyl ester moiety rather alkane kinetics lead improve computational predictability however discrepan cie model computation experiment also apparent computational comparison present model previous publish model highlight inuence input parameter thermochemical datum rate constant cially estimation thermochemical parameter signicantly affect consumption pathway thus model pre dictability Likewise rate constant parameter reaction specic methyl ester moiety observe strongly impact oxi dation pathway parent fuel consequently pool intermediate specie CH2O methyl acrylate CH2CO thus also impact model predictability Foundational study thermo chemical property kinetic parameter specic methyl ester moiety presently lack highlight require ment development reliable combustion model methyl ester apparent expendability methyl butanoate model parameter model oxidation place particu larly emphasis study small methyl ester inu ence specic methyl ester moiety easily discernible system extinction limit compare transportweighted enthalpy abling decouple kinetic effect issue diffusion enthalpy combustion fuel observe similar kinetic behavior extinction limit compare new metric however main intermediate centration CH2O C2H4 compute different class fuel highlight methyl ester kinetics specicities spite similar kinetic potential high temperature condi tions alkanes methyl ester exhibit unique reaction path therefore result different population intermediate specie acknowledgment author sity provide shock tube datum publication work support part fund ofce Award Number SC0001198 Appendix Supplementary material Supplementary datum associate article find online version combustame Energy Combust Sci Dooley Chaos Heyne Dryer Kumar Litzinger Combust Flame Dagaut Bakali Yan edding Combust Sci Technol Egolfopoulos Farrell Friend Pitsch SAE Paper Westbrook Proc Combust Inst Gail Thomson Marchese Dryer Proc Combust Inst Simmie Combust flame Dooley Uddi Dryer Combust Flame press combustame Hakka Sirjean BattinLeclerc Int Chem Kinet HadjAli Crochet Combust Inst Dayma Energy Fuel Dayma Togb Dagaut Energy Fuel Seshadri Herbinet Sarathy Thomson Pitz Proc Combust Inst Glaude Herbinet BattinLeclerc Hanson Wang Oehlschlaeger Combust Flame Herbinet Pitz Westbrook Combust Flame Herbinet Pitz Westbrook Energy Fuel Violi Proc Combust Inst Healy Energy Fuel Osmont Energy Fuel Osmont Catoire Dagaut Phys Chem Sumathi Green Phys Chem Chem Phys Benson New York Chem Dean Proc 7th National Meeting Paper Chem Hayes Burgess Proc Combust Inst Asatryan Bozzelli Phys Chem McClellan Tables Experimental Dipole Moments Freeman San Francisco Bosque Sales Chem inform Comput Sci Sun enginepri",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "analy": 1,
                    "Hakka": 3,
                    "chemis": 1,
                    "involv": 1,
                    "Sirjean": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "AMP-activated protein kinase is activated in Parkinson_s disease models mediated by 1-methyl-4-phenyl-1_ 2_ 3_ 6-tetrahydropyridine.pdf",
            "cleaned_text": "ampactivated protein kinase activate Parkinson disease model mediate methylphenyltetrahydropyridine JaeSun Park JooWon Jeong Department Anatomy Korea Article history receive available online AMPK MPP MPTP Parkinson disease selective loss dopaminergic neuron substantia nigra pars compacta feature son disease Methylphenyltetrahydropyridine mptpinduced neurotoxicity common experimental model use investigate pathogenesis Administration MPTP mice produce neuropathological defect observe induce cell death neuronal cell culture use protein kinase AMPK key regulator energy homeostasis present study demonstrate AMPK activate MPTP mouse MPP SY5Y cell inhibition AMPK compound result increase cell death show overexpression AMPK increase cell viability exposure MPP SY5Y cell base result suggest activation AMPK pre vent neuronal cell death play role survival factor right reserve Introduction neurodegenerative disease characterize progressive selective loss dopaminergic neuron substantia nigra pars compacta striatum mitochondrial complex defect find patient trigger decrease ATP synthesis excess production reactive oxygen specie MPTP duce neurotoxicity use produce animal model convert MPP monoamine oxidase glial cell MPP accumulation dopaminergic neuron cause mitochondrial respiratory defect MPP also trigger apoptotic cell death dna damage mechanism regulate neuronal cell death extensively investigate AMPK key regulator cellular energy metabolism heterotrimeric enzyme consist catalytic subunit regulatory subunit AMPK activate phosphoryla tion subunit mediate several nase include LKB1 calmodulindependent protein kinase activation regulate cellular AMPATP ratio Ca2 concentration ROS Activated AMPK phosphory late acetylCoA carboxylase nitric oxide synthase oxisome proliferatoractivate receptor gamma coactivator report AMPK activation prevent apop totic cell death ceramide accumulation astrocyte ing brain development rat AMPK highly express induce neuronal survival glucose deprivation con trast activation AMPK follow ischemia promote damage hippocampal cortical neuron present study investigate relationship AMPK examine AMPK activate mod vivo moreover seek identify function AMPK neuronal cell death progression material method Materials MPP purchase compound recognize phosphospecic form AMPKa ACCSer79 obtain ogy Beverly Antibodies poly adpribose polymerase actin Myc ampka tyrosine hydroxylase antibody purchase respectively mammalian expres sion vector myctagged wildtype AMPKa subunit dominant negative AMPKa subunit kindly provide culture transfection human neuroblastoma cell maintain Dulbecco modie medium supplement fetal bovine serum antibiotic air co2 cell expose MPP culture medium contain serum Transient transfection SY5Y cell conduct use lenimine method see front matter right reserve bbrc Corresponding author Fax mail address list available journal homepage wwwelseviercomlocateybbrc Animals MPTP mouse model Male mouse purchase administrate injection MPTP interval total dosage sacriced nal injection indicated previously adhere edit bromide assay treatment add well incubate medium remove well dimethyl sulfoxide add optical density measure ELISA plate reader dissolve value average least well indepen dent experiment Western blot analysis whole cell lysate harvest lysis buffer EDTA NaCl protease inhibitor Western blot analysis use cell lysate perform previously describe immunohistochemistry statistical analysis animal perfuse transcardially paraformaldehyde brain remove frozen cut slice freeze microtome Microsystems Bensheim Germany Sections stain previously describe stain intensity phosphoampka measure use image analysis program software result express mean student test ducte Differences consider signicant value treatment MPP cell grow glass coverslip xe paraformaldehyde solution min room tempera ture wash time permeabilize triton min room temperature block antibody form block solution overnight Cy3conju gate secondary antibody use immunodetection cell incubate min room temperature result exposure MPP induce activation AMPK SY5Y cell MPP add cell cell viability gradually decrease MPP exposure dosedependent man period previously report conrm effect MPP cell death cleavage exam ine show Fig cleaved form increase exposure MPP identify effect MPP AMPK activity phosphorylation AMPK monitor MPP increase phosphorylation level thr172 active site AMPKa Ser79 well characterize ampk sub strate result indicate AMPK acti vate progression cell death mediate MPP Activation AMPK midbrain MPTPintoxicated mouse investigate activation AMPK use MPTP jected mouse model induce specic degeneration dopaminergic neurons substantia nigra pars compacta show mouse produce signicant loss positive neuron substantia nigra immunohistochemical study perform use coronal midbrain section control MPTP mice phosphorylation AMPKThr172 increase fold degenerate midbrain MPTPintoxication Fig condition AMPK level remain unchanged mouse datum show moreover phosphorylation ACCSer79 increase fold MPTP jected mouse indicate AMPK activation stimulate substantia nigra MPTPintoxicated mouse cell AMPK inhibit cell death SY5Y cell ascertain activation AMPK play role MPP duce cell death use compound potent AMPK inhibitor widely use study AMPK signal ing show pretreatment cell Fig MPP induce cell death activation AMPK SY5Y cell SY5Y cell expose MPP indicated concentration viability examine assay datum express mean determination independent experiment whole cell lysate subject Western blot analysis use antiphosphoAMPKa antiampka antiphosphoACC antibody respectively serve loading control compound prevent AMPK activation MPP stimulate cell death conrm function AMPK wildtype AMPK transiently transfecte cell AMPK overexpresse cell death signicantly inhibit suggest activation AMPK function survival factor cell death verify effect AMPK mppinduced cell death use dominant negative AMPK expression vector function endogenous AMPK inhibit dominant negative form cell death stimulate effect com pound Fig finally tried examine AMPK activate die cell mediate MPP show distinctnuclear condensation observe cell phosphory lated form AMPK specically detect cell show nucle condensation Fig indicate AMPK activate die cell collectively result indicate activation AMPK function survival signal MPP treatment cell discussion many study conduct cause dopaminergic cell death substantia nigra pars compacta patient still clearly identie administration experimental model commonly use examine pathogenesis many different mole show involve neuronal cell death model make identication underlie stimulus com plex molecule include nitric oxide ROS ceramide sev eral protein transcription regulator Bcl caspase protein kinase Rescue protection study involve interfere cell death process well promot ing growth function remain dopaminergic neuron leave nigrostriatum AMPK master cellular energy gauge activate accumulation specic condition hypoxia oxi dative stress glucose deprivation accelerate con sumption occur rapid contraction skeletal muscle mitochondrial dysfunction implicate part patho genesis patient dysfunction increase free radical production oxidative stress decrease ATP production show MPP activate AMPK SY5Y cell duce cell death Fig Exposure MPTP result parkinsonism symptom indistinguishable induce specic loss dopaminergic neuron substantia nigra pars compacta activate MPTPinduced mouse model stain coronal midbrain section saline mouse phosphoAMPK stain statistical analysis perform quantitative value normalize control mouse Data mean representative experiment mouse group Con salineinjecte mouse MPTP MPTPinjected mouse positive neuron decrease MPTP midbrain region phosphoampkthr172 phosphoACCSer79 increase indicate AMPK activate Fig AMPK play role cell survival ceramideinduce apopto sis glucose deprivationmediated cell death develop rat brain hand active AMPK pro mote damage hippocampal cortical neuron ische mic condition thus role active AMPK cell survival remain controversial show cell death increase inhibition ampk decrease ampk overexpression moreover also show acti vation AMPK occur die cell mediate treatment MPP Fig datum strongly indicate activation AMPK exert protective effect neurotoxic effect MPP base result seem rational view AMPK survival factor dopaminergic neuron consequently study mechanism underlie exact role help make AMPK valuable molecular target therapy acknowledgment thank pro vide AMPK expression vector work support Fig Effects AMPK mppinduced cell death SY5Y cell cell treat compound expose MPP indicate viability measure assay datum express mean determination independent experiment condition total cell extract subject Western blot analysis indicate bottom Com compound Cells transfecte myctagged wildtype AMPK dominant negative AMPK expression vector MPP add assay datum representative indicate base independent experiment triplicate transfection expression AMPK assess Western blot analysis use antiAMPK antibodie bottom serve loading control mock empty vector transfecte AMPK pcdnaampkamyc transfecte AMPK pcdnadominant negative AMPKamyc transfecte analysis perform Cy3conjugated secondary antibody use visualize protein uorescence microscopy mpptreated SY5Y cell immunostaine cell also stain arrow indicate chromosomal dna fragmentation Forno Neuropathology Parkinson disease Tretter Sipos AdamVizi Initiation neuronal damage complex deciency oxidative stress Parkinson disease oxidative stress Parkinson disease S26S36 discussion S36S38 DNA degradation induce methylphenylpyridinium neuron Smeyne JacksonLewis model Parkinson disease Brain Res Mol Brain Res Borsello signal possible target prevent neurodegeneration activation p38 mitogenactivated protein kinase dopaminergic neurons substantia nigra lead nuclear translocation p53 methylphenyltetrahydropyridinetreated mouse Neurosci function protein kinase Acta Physiol Davies characterization protein kinase kinase rat liver identication threonine major site phosphorylate protein kinase protein kinase Edelman protein kinase kinasebeta alternative upstream kinase protein kinase Cell Metab Kang reactive oxygen specie stabilize hypoxiainducible factor alpha protein stimulate transcriptional activity protein kinase human prostate cancer cell Carcinogenesis Park Hwang Kim Park differential modulation ampk signal pathway low high level exogenous reactive oxygen specie colon cancer cell Sci Weekes Hawley Corton rat liver ampactivated protein kinase kinase kinase puried reconstituted system Effects analogue Eur Biochem Effects chronic AICAR treatment ber composition enzyme activity rat muscle Appl Physiol Fryer Hajduch Rencurel Salt Carling Activation glucose transport protein kinase stimulation nitric oxide synthase diabetes AMPK signal contract human skeletal muscle acetylCoA carboxylase synthase phosphorylation Physiol Endocrinol Metab protein kinase prevent ceramide synthesis novo apoptosis astrocyte feb protein kinase highly express neuron develop rat brain promote neuronal survival follow glucose deprivation McFadden Ronnett Pharmacological inhibition ampactivated protein kinase provide neuroprotection stroke acid promote angiogenesis activation hypoxiainducible factor Cancer Lett Ehrhanrdt Schmolke polyethylenimine costeffective transfection reagent Signal Transduct JacksonLewis Przedborski Protocol mouse model Parkinson disease TuckerBurden Olson Mackman Brat epidermal growth factor receptor modulate tissue factor expression glioblastoma JunDactivator protein transcriptional activity Cancer Res Stull Antioxidant compound protect dopamine neuron death due oxidative stress",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Western": 5,
                    "MPTPinduced": 1,
                    "antiAMPK": 1,
                    "AMPKamyc": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Analysis of carbohydrates as 1-phenyl-3-methyl-5-pyrazolone derivatives by capillary_microchip electrophoresis and capillary electrochromatography.pdf",
            "cleaned_text": "analysis carbohydrate phenylmethylpyrazolone derivative capillarymicrochip electrophoresis capillary electrochromatography Susumu Atsushi receive receive revise form accept Dedicated Professor occasion retirement birthday phenylmethylpyrazolone PMP method many advantage hitherto report method base reductive amination hydrazone formation short summarize various aspect PMP method include principle derivatization simplicity derivatization procedure high sensitivity monitor diversity separation mode capillary electrophoresis present number application datum carbohydrate analysis biological sample method also describe successful automation carbohydrate analysis capillary derivatization PMP miniaturization microchip electrophoresis whole channel detection allow rapid min analysis small amount PMP derivative carbohydrate furthermore discuss possibility capillary electrochromatography carbohydrate analysis PMP derivative propose capillary modification strategy improve column efficiency elution time reproducibility Elsevier Science right reserve carbohydrate analysis capillary electrophoresis microchip electrophoresis Capillary electrochromatography Phenyl methylpyrazolone derivative PMP method protein component monosaccharide milk oligosaccharide Rafnosefamily oligosaccharide glycan proteoglycanderived oligosaccharide glycan capillary derivatization Multi mode analysis Electrospray ionization mass spectrometry Introduction major interest carbohydrate function energy storage starch plant seed root structure support living body cellulose plant bark chitosan sea animal shell cell wall material bacteria recent progress life corresponding author fax mail address Biomedical Analysis wwwelseviercomlocatejpba see front matter Elsevier Science right reserve PII science however reveal importance type oligo polysaccharide animal body give rise much interest biological function special type glycan glycan exist free state also conjugate state glycoprotein proteo glycan glycolipid well glycan glycoprotein consider function specifically recognize certain kind protein function believe relate important event animal chapter glycoconjugate biosynthesize cell glycosylation polypeptide core form Golgi body thussynthesized glycopro tein regard important group compound postgenome proteome era recent glycoproteinaceous drug produce biotechnology pose problem different glycosylation pattern native glycoprotein cause change specificity recognition receptor chapter hand advance immunology pathology related field necessitate insight fine structure various kind polysaccharide bacteria plant trend glycobiology glycotechnology mand development intelligent method carbohydrate become strong meanwhile carbohydrate analysis special feature capable separation sample almost always accompany number structurally resem bling substance isomer homologue addition structural diversity due variation sequence linkage type attach position monosaccharide residue take account therefore history carbohydrate analysis effectively adapt separation method individual time thus carbohydrate analysis owe pro gress paper chromatography gas chromatography paper membrane electrophoresis highperformance liquid chromatography gel electrophoresis currently capillary electrophoresis microchip electro phoresis capillary electrochromatogra phy also devote progress carbohydrate analysis author group engage method development carbohydrate analysis history publish book gas chromatography highperformance liquid chromatogra phy HPLC carbohy drate analysis many excellent book appear subject different view coherent strategy appropriate adaptation separation method consider separation detection side late technique doubt high capability separation detec tion however problem carbohydrate electric charge fetal problem normally separate ion recent method micellar electro kinetic chromatography make possible analyze also neutral compound carbohydrate sample moderately hydrophobic though unfortunately carbohydrate strongly hydrophilic problem inherent lack sensitively detectable functional group carbohydrate molecule method overcome difficulty analyze strongly alkaline solution carbo hydrate dissociate give negatively charge specie condition separate zone electrophoresis detect electrolysis copper electrode repeat monitor pulse amperometric method use gold electrode integration allow much sensitive detection pmol level however method permit analysis limited specie carbohydrate single separation mode zone electrophoresis allow addition skilful operation require detection promising solution problem chemical derivatization solve difficulty come lack chargehydrophobicity detectable functional group numerous method develop precapillary derivatization carbohydrate summarize Table classify category involve reductive amination various kind amine conversion glycamine follow couple amino groupreactive compound hydrazone formation condensation active methylene group method involve reductive amination base base formation amino group amine reagent reduce end reduce carbohydrate follow reduction glycamine derivative Schiff base formation require acid catalyst normally elevate temperature cause partial degradation acidlabile group well sulfate group sialic acid residue carbohydrate sample derivative characteristic feature regard electric charge hydrophobicity absorption fluorescence generation depend ing kind amine reagent use second type modification reductive amination method perform step first step reduce carbohydrate transform reductive amination ammonium salt multistep procedure involve hydrogenation benzylate glycamine derivative thus taine reactive compound type derivatization tedious involve least step FITC CBQCA method also need acid catalyst formation also suffer problem necessity acid catalyst addition theoretical problem syn anti isomerism product reason type reaction become popular already describe detail method omit argument individual method condensation active methylene group quite different type reaction require acid catalyst condensation phenylmeth pyrazolone PMP typical example type reaction first develop author group reduce carbohydrate utility also report number paper basal part method already include abovementioned pub lishe great development make thereafter applicability tend use type reaction proceed quantitative yield mild condition free disadvantage type reaction product strong absorption region readily oxidizable glassy carbon electrode detect sensitively also notable derivative separate multiple mode reason PMP method become robust convenient mean carbohydrate analysis summarize various aspect PMP method place emphasis recent advancement principle derivatization PMP description reaction aldehyde group active methylene group pyrazolone ring document early book study type table various method derivatization carbohydrate reductive amination acid ethyl ester ABEE aminobenzoic acid hexyl ester trifuloroacetamiodoaniline aminobenzonitrile aminocyanoethylpyridine biotinylate pyridine aminoquinoline amino benzoic acid 2aba aminobenzoic acid 4ABA aminobenzamide ant aminonaphthalenedisulfonate aminopyrenetrisulfonate acetyaminoaminoacridone AAMC amino methylcoumarin Amine coupling glycamine Phenylisothiocyanate PITC carboxytetramethylrhoda mine succinyl ester TRSE CBQCA formation fluorenylmethoxycar bonylhydrazone FMOChydrazine Condensation active methylene group PMPMP reaction find literature example condensation glucose PMP report author group time author group undertake method development study quantitative glycan release mucous glycoprotein glycan know release alkali product rapidly decompose release drastic condition suitable reagent explore block redu cing end release glycan prevent decomposition time introduce chromophore release glycan PMP candidate test purpose efficacy purpose demonstrate unpublished result find condensation glycan PMP proceed alkaline medium also almost neutral medium attempt make use reagent derivatization reduce carbohydrate first paper derivatization reduce thus publish detailed optimization study aim use HPLC author use name publication many chemical compa ny Wako use name list name methylphenylpyrazolinone also use chemical company document term pyrazol proton nmr spectrum product glucose indicate presence PMP group glucose unit molecule derivative negative spectrum also support composition give intense ion peak base assignment major signal structure PMP glucose determine show Fig use insufficient amount PMP result derivative reaction monoPMP derivative additional amount PMP give bisPMP experimental evidence indicate PMP group introduce reduce end reduce carbohy drate reaction conduct add aqueous methanol solution PMP aqueous solution carbohydrate sample PMP kind acid sense keto group pyrazolone ring convert weakly acidic enol group tautomerism sodium salt reactive reagent solu tion neutralize sodium hydroxide prior mix sample solution optimize condition derivatization complete min beneficial carbohydrate analysis reaction proceed aqueous methanol solution almost carbohy drate sample readily dissolve sol vent PMP method widely applicable reduce carbohydrate less reactive PMP result incomplete derivatization unpublished result free amino sugar oligosaccharide sulfate group position example oligosaccharide heparin resist condensation PMP acetylation desulfation follow acetylation allow quantitative derivatiza tion PMP unpublished result sialic acid residue conjugation release oligosaccharide derivatize PMP method due presence electronwithdrawe carboxyl group neigh boring position unpublished result analogue PMP phenyl group substitute methoxy group PMPMP report react reduce approximately reactivity PMP various property PMP derivative physical property detection analytical point view characteristic feature PMP derivative strong absorption region absorp tion maximum molar absorptivity ethanol excellent property detection attractive property high reactivity PMP derivative readily oxidizable glassy carbon electrode electric current generate allow detection concentration order magnitude low detection electrochemical detection easy present stage commercial detector available require special technique homemade device use useful property highly sensitive detection property allow parent sugar recovery glycamine derivative form reductive amination generally stable acidic alka line solution property useful carbohy drate analysis derivative store long time PMP derivative different feature glycamine derivative weakly alkaline solution PMP glucose bisPMP derivative heat PMP group remove give mono PMP derivative monoPMP derivative identical intermediate mono PMP derivative form course derivatiza tion conversion parent sugar glucose removal PMP group easy require much drastic condi tion possible chemical proper tie bis monoPMP derivative common carbohydrate generalize unpublished result series reaction useful recover original reduce carbohydrate PMP derivative use structure elucidation enzyme inhibition assay chemical property der weakly alkaline condition high tempera ture PMP derivative store long time store refrigerator recommend however store PMP derivative PMPfree state solvent extraction analysis do long duration aqueous solution dryness storage dry product refrigerator also recommendable property versatile separation mode introduction PMP group carbohydrate molecule endow derivative phy sicochemical property base introduction tag PMP group high bicity due presence pyrazolone ring basal structure presence phenyl methyl group pyrazolone reduce carbohydrate PMP decomposition PMP derivative weakly alkaline solution ring enhance hydrophobicity property useful micellar electrokinetic chromatography describe later hand keto group pyrazolone ring tautomerize enol group give negative charge ionization tautomerism affect change give influence negativity derivative accordingly chargebase separation mode base charge difference also describe later Mass spectrometry Mass spectrometry generally provide versatile information structure amount carbohydrate sample quality struc tural information dependent mode ionization Electron impact general mode give number fragment ion total ion monitoring base ioniza tion mode allow sensitive detection sample component separate various separation method include however method suitable obtain information molecular mass basically important structural analysis carbohydrate Fast atom bombardment generally convenient mode obtain intense peak relate molecular mass unfortunately however intact carbohydrate quite accelerated atom give degradation product therefore sensitivity intact carbohydrate normally low spray ionization also useful mode analysis molecular ion certain kind compound protein relate sub stance favorable intact carbohy drate give poor ionization circumstance compare sensitivity various derivative include acid ethyl ester ABEE ami noethanethiol AET aminobenzenethiol ABZ PMP methoxyPMP PMPMP derivative maltopentaitol reduce form use various sample matrix PMP derivative give low detection limit triethanolamine matrix negative mode give high sensitivity matrix positive negative ion format contrast interface positive ion format give low detection limit derivative give exclusively intense peak assignable PMPMP methoxy derivative PMP also give intense peak interface well compatible use high electric field high sensitivity PMP PMPMP greatly benefit coupling PMP derivative promise technique carbohydrate analysis thus result also indicate priority PMP method mass spectrometry Standard procedure derivatization Optimization study indicate derivatiza tion complete min PMP solution aqueous methanol use neutralize sodium hydroxide addition sample reaction condition easily optimize removal excess reagent key step establish efficient procedure fortunately excess amount PMP easily remove reaction solution extraction ethyl acetate method precapillary derivatization solvent extraction efficient due low hydrophobicity reagent analysis mono saccharide ethyl acetate replace chloroform order minimize loss derivative due slightly low hydrophobicity solvent include benzene carbon tetra chloride hexane useful purpose give poor extraction efficiency method cleanup column employ procedure drawback tedious operation low reproducibility addition error due loss derivative occur especially different batch col umn use established standard procedure tization follow add reagent solution aqueous sample solution reduce carbohydrate mixture reduce carbohydrate nmol contain tube Cover tube stopper keep tube min open cover add hydrochloric acid dry mixture centrifugal concentrator dissolve residue water extract solution ethyl acetate time aqueous layer place tube vacuum desiccator contain pellet sodium hydroxide dissolve final residue appropriate volume water analyze aliquot solution reagent solution prepare dissol ve PMP methanol concentration add sodium hydroxide volume concentration sodium hydroxide hydrochloric acid exactly normalize indicate volume solution exactly take whole pip ettes need know amount internal standard preferably reduce carbohy drate different sample component example rhamnose case analyte add sample solution ordinary analysis procedure ensure accurate determination reduce carbohydrate sometimes accompany salt sodium chloride high concentration due neutraliza tion reaction solution interfere separation sample component micro scale electrodialysis use Acylizer Showa Denko ShibaDaimon quite effective case stability acidlabile group point section problem exist method base reductive amina tion hydrazone formation drastic reaction condition use acid catalyst high temperature treatment glycan condition cause partial release well sulfate group sialic acid residue contrast PMP method free problem show reaction mixture ddi DDi mixture isomeric disaccharide compose unsaturated uronic acid residue acetygalactosamine residue sulfate group position respectively obtainable sulfate respectively subject derivatization PMP unpublished result desulfation occur PMP derivative ddi form reality peak PMP DDi indicate case similarly mixture sialyllactose subject derivatization PMP standard procedure desialylation occur appear small peak observe position con sidered impurity sample unpublished result result show demonstrate sulfation desialylation occur derivatization sulfate group proteoglycan sialic acid residue glycoprotein consider important role biological function jugates exist method allow derivatization allpartial release functional group PMP method highly evaluate reliable method glycan analysis diversity separation mode PMP derivative PMP derivative carbohydrate sepa rate various mode base excellent physicochemical property mention Section Zone electrophoresis mode PMP derivative carbohydrate sepa rate basal mode base difference charge mass ratio negative charge result enolization keto group pyrazolone Pharm Biomed Anal ring follow dissociation resultant enol group reduce carbohydrate consider charge hence carbohydrate specie mass aldopen tose aldohexose set expect separate mode surprisingly however good separation occur epimer set example show postulate cular ring formation hydrogen bonding keto group hydroxyl group aldose order explain phenomenon Fig aldose favorable steric dis position easily form ring hydrogen bonding easy bonding leave small proportion keto group intact enolizable turn dissociable enolate ion result negative charge decrease accordingly velocity slow run buffer around fill capillary mixture PMP derivative aldopentoses introduce anodic end EOF cathode PMP derivative weakly negative charge hold anode Separation occur difference negativity difference magnitude ring formation set retardation ribose great arabinose show weak retardation good separation achieve migration time order arabinose xylose lyxose ribose Com parison configuration hydroxyl group indicate importance hydroxyl group assumption intramolecular ring formation verify thermodynamic analysis aldohexose set migration time order altrose glucose mannose allose con formation hydroxyl group series galactose idose hydroxyl group series range permit separation aldose narrow careful control necessary notice basal monosaccharide Fig stability sulfate group derivatization PMP mixture Ddi4S derivatize PMP standard procedure analytical condition capillary fused silica run buffer borate buffer apply voltage detection absorption Stability sialic acid residue derivatization PMP commercial sample mixture derivatize PMP standard procedure analytical condition capillary fused silica run buffer phosphate buffer contain SDS apply voltage detection absorption PMP derivative aldopentoses zone electrophoresis slightly alkaline phosphate buffer Capillary fuse silica run buffer phosphate buffer sample introduction anodic end apply voltage detection absorption intramolecular ring formation hydrogen bonding explain vary mobility due vary negative charge easily separate control phenomenon inherent PMP derivative observe derivative separation oligosaccharide show differ ent feature example show isomaltooligosaccharide different degree polymerization dp give peak order increase dps fairly well separate zone electrophoresis unpublished result configuration hydroxyl group glucose residue reduce end common oligosac charide negative charge extent therefore separation consider due difference molecular mass zone electrophoresis borate complex complexation hydroxyl group borate ion give anionic complex well know phenomenon long utilize carbohydrate separation anion exchange mode HPLC first example carbohydrate separation also base mode though PMP derivative derivative hydroxyl group different configuration react borate ion different magnitude total charge varied carbohydrate specie result mutual separation even difference molecular size Complexation enhanced borate concentration increase also enhance increase borate ion concentration increase borate concentration naturally occur monosaccharide completely sepa rate figure show excess amount reagent interfere separation migrate fast well isolated peak monosaccharide derivative PMP derivative monosacchar ide also well separate mode show typical example separation PMP derivative aldopentoses aldohexoses mode strike set aldopentoses completely separate run buffer simple compo sition borate buffer efficient separation monosaccharide hitherto report kind separation method zone electrophoresis metal complex hydroxyl group carbohydrate also react metal ion form cationic complex type complexation also useful separation carbohydrate various kind metal ion investigate alkaline earth metal ion prove well suited purpose show example separation PMP derivative aldopentoses base mode PMP derivative aldopentoses easily separate simply intro duce mixture aqueous solution acetate salt alkaline earth metal tion rapid problem gradual reversal EOF metal ion adsorb surface capillary inner wall adsorb metal ion remove capillary inner wall removal rate slow notice PMP portion negatively charge positive charge complex large result total charge derivative still negative therefore derivative introduce cathodic end migrate anode EOF movement anode weakly accelerate net negative charge Separation occur difference total nega tivity aldose difference migration time kind metal ion due different charge derivative electrokinetic chromatography mode base different magnitude solubilization hydrophobic solute SDS micelle promising mode PMP derivative carbohydrate member PMP derivative homologous series commonly PMP group carbohy drate structure different degree Pharm Biomed Anal polymerization therefore relative hydro phobicitie different difference cause variation magnitude solubilization result separation homo logue Fig show excellent separation PMP derivative isomaltooligosaccharide publish result separation mode directly base configurational difference group aforementioned direct zone electrophoresis mode zone electrophoresis ionic complex mode separate even isomer provide slight difference relative hydrophobicity derivative paration PMP derivative mono oligosaccharide coworker explain mechanism result separation glycan glycoprotein fetuin show later section also example electrokinetic chromatography ionic polymer anionic cationic add running buffer solute counter charge introduce solute inter act additive ionic association magnitude association dependent electric charge therefore separation occur difference magnitude association sample introduction Fig Separation PMP derivative aldopentoses zone electrophoresis borate complex Capillary fused silica run buffer borate buffer sample introduction anodic end apply voltage detection absorption Fig Separation PMP derivative aldopentoses zone electrophoresis alkaline earth metal complex Capil lary fuse silica run buffer alkaline earth metal acetate sample introduction cathodic end apply voltage detection absorption do proper end depend direction EOF order investigate detail ionic association mode adopt hexadimethrine bromide positively charge ditive negatively charge sample select additive carbohydrate almost neutral even PMP derivative weak negativity therefore adopt situ form borate complex PMP compare separation PMP derivative aldopentoses borate buffer buffer contain migration direction tive reverse due reversal EOF migration order regard presence absence however resolution greatly order magnitude specie increase addition brene presumably owe concerted effect borate complexation borate complex ionic interaction analysis PMP derivative aldohexose much surprising phenomenon observe migra tion order greatly change absence presence follow glucose mannose galactose absence altrose glucose idose allose galactose man presence thus binary system make coupling zone electrophoresis presence cationic polymer zone electrophoresis borate com plexe cause change separation profile PMP derivative alter migration order resolution size exclusion electrophoresis gel electrophoresis capillary give excellent separation derivative oligosacchar ide owe size exclusion mechanism however PMP derivative give good result due difficulty sample introduc tion unpublished result sample introduc tion rely electromigration method hamper introduction PMP derivative weakly negative charge accompany ing chloride ion much strong negativity predominantly introduce still improve introduction PMP derivative Use entangle polymer neutral polysac charides practical separation PMP derivative unpublished result separa tion PMP derivative isomaltooligosacchar Fig Separation PMP derivative isomaltooligosaccharide various electrokinetic chromatography mode SDS micelle Capillary fused silica run buffer phosphate buffer contain SDS apply voltage sample introduction anodic end detection absorption ide improve add owe molecular sieving effect great improvement obtain increase electrophoresis specific interaction carbohydrate type compound especially protein utilize separation PMP derivative carbohydrate Fig show typical example separation affinity electrophoresis mode PMP derivative disaccharide maltose cellobiose gentiobiose melibiose lactose well separate zone electro phoresis neutral phosphate buffer give group separation glucobiose maltose cello biose gentiobiose lactose peak galactosylglucose peak especially lactose peak retard addition agglutinin RCA60 galactoserecog nize lectin retardation become prominent RCA60 concentration increase concentration peak oligosaccharide almost completely resolve inter este addition different kind lectin run buffer give combine effect lectin thus addition glucose recognize lectin concentration enough complete separation oligosaccharide realize complete separation bond formation electrophoresis recently number chiral selector develop separation drug enantiomer HPLC selector know separation carbohydrate enantio mer find optically active effective selector purpose example glucose separate phosphate buffer Fig completely separate order separation factor resolution respectively add concentration aldose include nose xylose galactose also resolve completely lauroylvaline give chiral separation participation carba group obvious NMR spectrum reaction mixture indi cat shift sugar proton signal possible mechanism chiral separation difference magnitude stable ring formation hydrogen bonding Fig stabilization ring involve hydroxyl group asymmetric carbon sugar ring easy separation enantiomer important analysis component monosaccharide plant polysaccharide contain enantiomer Fig Separation PMP derivative disaccharide afnity Capillary linear polyacrylamidecoated fused silica run buffer phosphate buffer phosphate buffer contain sample introduction cathodic end apply voltage detection absorption owe extraordinarily high absorptivity PMP derivative detection absorption allow quanti fication level use ordinary detector instal commercial apparatus correspond fmol level inject amount inject volume assume average volume use tube reduce inject amount order magnitude use bubble tube take account fact need much large volume sample solution small sample volume handle reasonable reliability therefore small sample amount analysis pmol time large inject amount approximately level HPLC calibration curve sample component taine use internal standard linear wide range allow reproducible nation component relative standard deviation less middle linear range determinable range vary slightly depend separation mode analytical condition interesting slope calibration curve vary carbohydrate specie derivative com monly PMP group yield derivative almost quantitative regard carbohydrate specie varia tion slope consider come variation ketoenol equilibrium due intramolecular ring formation hydrogen bonding internal standard carbohydrate specie similar structure compo nent desirable recommend analysis carbohydrate biological source typical example application carbohydrate analysis quantitative derivatization mild con dition strong absorption high sensitivity Fig separation PMP derivative glucose absence presence dodecoxycarbonylvaline DCV Capillary fuse silica run buffer phosphate buffer phosphate buffer contain sample introduction anodic end apply voltage detection absorption intermolecular hydrogen bonding involve hydroxyl group sugar ring mass spectrometry product diverse separation mode permit reliable analysis mono oligosaccharide PMP derivative number report application PMP method follow representative example accumulate datum component monosaccharide glycoconjugate analysis component monosaccharides glycoconjugate primarily important figure structural outline glycan part glycoconjugate especially monosaccharide composition analysis glycoprotein give basic information glycan kind analysis long perform HPLC glycamine derivative also permit rapid analysis use PMP derivative mention show example perform zone electrophoresis mode borate complex unpub lishe result analytical procedure include hydro lysis step simple hydrolysis glycoprotein sample trifluoroacetic acid evaporation hydrolyzate derivati zation residue mention duction derivatize mixture anodic end capillary fill borate buffer application voltage do release monosaccharide accurately reproducibly determined use calibration curve use rhamnose internal standard naturally occur oligosaccharide kind oligosaccharide present plant also animal body oligosaccharide animal origin milk oligosac charide especially interesting nutri tional aspect infancy female mammal excrete high concentration lactose nutrient feed baby interesting colostrum excrete immediately parturition contain relatively high concentration various kind oligosaccharide gradually decrease disappear unique oligo saccharide consider good carbon source enterobacteria newborn baby recognize factor enterobacteria produce various immunogen Fig Analysis component monosaccharide commonly find glycoprotein PMP derivative Capillary fuse silica run buffer borate buffer sample introduction anodic end apply voltage detection absorption Fig Analysis oligosaccharide ordinary cow milk cow colostrum PMP derivative Capillary fuse silica run buffer phosphate buffer sample introduction anodic end apply voltage detection absorption peak lactose NeuAcLac asterisked peak digestive organ indispensable anti body production excretion consider important pediatric also biosynthesis oligosaccharide indifferent production glycopro tein glycolipid closely relate immunological phenomenon show example analysis oligosaccharide cow milk obtain zone electrophoresis borate complex unpublishe result difference oligosaccharide profile ordinary milk colostrum remarkable relative peak intensity varied individual sample note volume ordinary milk give upper chart approximately time large volume give low chart unpublished result mean concentration oligosaccharide colostrum lactose much high ordinary milk Glycans glycoprotein well know protein glycosy late glycoconjugate glycoprotein heterogeneity respect glycan structure type glycan bind asparagine residue preformed polypeptide core glycan link serine threonine residue glycan type glycan structural feature different relatively well study specie characterize classify category highmannose type complex type hybrid type highmannose type glycan first biosynthesize complextype gly can derive process hydrolase processing complete leave part mannose chain intact resultant glycan classify hybrid type systematic analysis glycan study use HPLC number researcher especially group devote dimensional mapping derivative system quire direct comparison authentic specimen due high reproducibility much high reproducibility ensure provide relative mobility take migration index author group attempt twodimensional map ping desialylated glycan vative coworker also report similar attempt attempt group successful engage multimode analysis glycan PMP derivative program still way foresee successful multidiman sional mapping permit reliable identifica tion glycan direct comparison authentic specimen show example analysis glycan SDS micellar electrokinetic chromatography glycan release perform enzy matic digestion use recombinant coli indicate various specie complex type glycan efficiently sepa rate unsaturated oligosaccharide derive proteoglycan Proteoglycans group glycosylated protein longchain acidic Fig Analysis sialoglycans bovine fetuin PMP derivative sialoglycans release bovine fetuin digestion derivatize PMP standard procedure Capillary fused silica run buffer phosphate buffer contain SDS sample introduction anodic end apply voltage detection absorption ide attach important constituent connective tissue also many physiological function include blood anticoagulation lipemea clearing effect cell pro liferation inhibition current interest structural diversity glycosylation site diversity consider relate many important biological phenomenon polysaccharide glycosaminoglycan por tion proteoglycan basic structure compose alternately link uronic acid residue hydroxyl group variously modify sulfate group amino group acetylate sulfate hand proteoglycan noglycan therein large molecule differentiate ordinary method however oligosaccharide rive proteoglycan object analysis therefore simultaneous analysis oligosaccharide important strategy obtain useful information fine structure proteoglycan indirect method use series eliminase facilitate release oligosaccharide yield oligosaccharide con taine uronic acid residue double bond show analysis unsaturated disaccharide form various proteoglycan digestion oligosaccharide detect weak absorption due double bond derivatization PMP enhance sensitivity zone electrophoresis borate complex allow simultaneous analysis possible unsaturated disaccharide form popular enzyme detection PMP derivative give maximum absorption simply apparatus use equip discontinuous wave length type detector zinc lamp correspond interference filter Heparin degraded various unsaturated oligosaccharide heparinase heparitinase oligo saccharide fragment quantitatively derivatize PMP due presence electronwithdrawe sulfate group adjacent reduce end Oligosaccharides glycolipid Sphingoglycolipids exist generally cell face play role recognize cell molecule matrix tendency make micelle aqueous solution hamper normal separation certain kind endoglycoseramidase release oligosaccharide sphingosine moiety release oligosaccharide analyze PMP derivative show example analysis PMP derivative release bovine brain ganglioside endoglycoceramidase separation do SDS micellar electrokinetic chroma tography mode Fig 18a zone electrophoresis borate complex Fig oligosaccharide Plant oligo polysaccharide side scope journal like Fig Analysis unsaturated disaccharide derive proteoglycan digestion chondroitinase PMP derivative Capillary fuse silica run buffer borate buffer sample introduction anodic end apply voltage detection absorption describe analysis briefly widely abundantly distribute food therefore important human health plant oligosaccharide sucrose outstanding sweetener unique one characteristic structure hemiacetal ketal group monosaccharide residue glucose fructose respectively link application PMP method therefore quire prior conversion component mono saccharide reduce end easily achieve use intestinal invertase resultant glucose quantitatively derivatize PMP Galactosyla tion glucose residue sucrose give raffinose galactosylation result stachyose series oligosaccharide include sucrose raffinose stachyose widely dis tribute plant root recognize potent factor also hydrolyze invertase melibiose manninotriose respectively latter reduce end derivatize PMP author group demon strate usefulness series procedure base invertase digestion analysis PMP derivative quality evaluation study radix popular crude drug fermentation product starch wine beer sake contain various kind glucooligosaccharide content contri bute taste alcoholic beverage analysis also achieve PMP derivative unpublished result automate analysis capillary derivatization perform free solution separation method single phase Fig Analysis oligosaccharide release bovine brain ganglioside PMP derivative oligosaccharide release digestion endoceramidase derivatize PMP Capillary fuse silica run buffer phosphate buffer contain SDS sodium tetraborate sample introduction anodic end apply voltage detection absorption property bring forth number advantage inherent method author group make systematic study utilize advantage development capillary derivatization technique systematic study classify technique type include inlet zonepassing throughoutcapillary format point merit demerit format initially use combination amino acid mixture phthalaldehyde model system complete almost instant",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Capil": 1,
                    "Glycans": 1,
                    "Proteoglycans": 1,
                    "sialoglycans": 1,
                    "Sphingoglycolipids": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Anticancer activity_ structure_ and theoretical calculation of N-_1-phenyl-3-methyl-4-propyl-pyrazolone-5_-salicylidene hydrazone and its copper _II_ complex.pdf",
            "cleaned_text": "anticancer activity structure theoretical calculation phenylmethylpropylpyrazolonesalicylidene hydrazone copper complex Zhang Wang Urumqi State Key Laboratory Oncology Southern China Cancer Center Sun YatSen University Article history receive receive revise form accept Available online copper complex Pyrazolone Crystal structure DFT biological activity pyrazolone derivative phenylmethylpropylpyrazolonesalicylidene hydrazone H2L copper complex cu2l2ch3oh2ch3oh synthesize characterize ele mental analysis spectroscopy ray crystallography theoretical calculation pharmacological testing find complex possess powerful anticancer effectivity ligand order make anticancer principium clearly investigate structure ligand several coordination spot atom close biological environment crystallographic structural analysis complex reveal center display dif ferent coordination pattern ligand take part coordination atom result formation doublenuclear complex pharmacological testing result show coordination effect improve antitumor activity ligand calculated function deprotonated form predict probable reactive site electro philic attack oxygen atom result agreement experimental data crystal structure analysis publish Elsevier Introduction recently important branch pharmaceutical chemistry synthesis research base metal complex attract many attention Pyrazolone prominent structural motif find numerous active compound easy preparation rich biological activity antibacterial action antitumor antisepsis pyrazolone complex receive considerable attention coordination chemistry medicinal chemistry pyrazolone derivative contain hold many coordinate atom also exhibit div ersiform coordination mode phenoxy derivative capable chelate bridge property gand metal complex also possess strong biological activity recently group actively engage study synthesis structural characterization property pyrazolone derivative complex work acyl pyrazolone derivative exhibit various coordination pattern property however knowledge little appear biological activity derive salicylidene hydrazone Herein report synthesis structural characterization biological activity binuclear copper complex pharmacological testing prove coordination effect improve antitumor activ ity copper complex much great ligand theoretical calculation perform ligand pre coordination ability result consist crystal structural analyse complex measurement material spectra record EQUINOX spectropho use sample prepare pellet KBr crystal structure perform use Rigaku axis Spider diffractometer calculation perform use Gaussian program anticancer activity test Oncology Sun YatSen University reagent purchase commercial source directly use see front matter publish elsevier ica corresponding author fax mail address Chimica Acta Contents list available journal homepage pyrazolone prepare accord literature Preparation H2L copper complex ligand prepared follow literature method yield Anal Calc find complex cu2l2ch3oh2ch3oh prepare follow methanol solution ligand mmol add methanol solution OAcH2O mmol mixture stir reuxe result solution cool room temperature ltere dark green powder obtain single crystal suitable ray diffraction analysis obtain slow evaporation ltrate crystal protect mother liquor result airslake yield Anal Calc C43H48Cu2N8O7 Found ray crystallography crystallographic datum collect imaging plate system axis spider graphite monochromatize radiation crystal mount grease top glass ber quench liquid nitrogen stream cell constant orientation matrix datum col lection obtain leastsquare renement range Crystal structure solve direct method rene fullmatrix least square method program non atom rene anisotropically atom oxygen atom locate Fourier map atom place geometrically idealized position crystal datum structure renement detail give table select bond length bond angle list Table result discussion structural description title complex crystallize triclinic space group crystal structure Cu2L2CH3OH2CH3OH numbering scheme illustrate Fig crystallo graphic structural analysis copper complex reveal whole structure exhibit axisymmetric way central metal atom adopt different coordination pattern distance Cu1 Cu2 cu1 locate squarepyramidal geometry atom o1a dene basal plane square pyramid leastsquare mean plane deviation Cu1 ion stray bottom plane deviation apical position occupy atom methanol molecule Fur thermore bond angle N3A o1a slightly deviate theoretical value observation indicate coordination geometry cu1 ion little distorted square pyramid however Cu2 ion exist squareplanar geometry oxygen atom O2A nitrogen atom N4A ligand coordinate atom O2A N4A deviate badly leastsquare mean plane respectively bond angle respectively geometry Cu2 ion seriously distort square plane addition methanol molecule structure complex see intermolec ular hydrogen bond O4A exist methanol mole intermolecular hydrogen bond o3b O4A O2A methanol complex mole dimer form owe interaction lecular hydrogen bond spectra study bonding mode ligand coordinate copper ion elucidate comparison spectra h2l complex molecular structure ligand show crystal structure see ligand exist keto form broad peak free ligand corre spond strong band assign pyrazolone ring bear ligand exist keto form solid state consist crystal structure band attribute stretching vibration salicyl lateral chain Table crystallographic datum complex empirical formula C43H48N8O7Cu2 Formula weight Crystal system triclinic group Unit cell dimension volume Crystal size density calculate cm3 absorption coefcient limiting index absorption correction empirical Renement method fullmatrix leastsquare GOF Final index indice datum large difference peak hole Table selected bond length bond angle complex Zhang Inorganica Chimica Acta Fig Crystal structure complex cu2l2ch3oh2ch3oh noncarbon atomic numbering atom omit clarity Fig hydrogen bond centrosymmetric dimer complex Fig Crystal structure ligand spectrum complex obviously observe stretch vibration disappear new band attribute appear respectively change absorption peak slightly shift low wave number indicate coordination phenolic oxygen atom azomethine nitrogen central metal atom addi tion new band assign stretch vibration result indicate ligand undergo isomerization keto form enol form coordination lose proton atom double negative charge tetradentate ligand Scheme enol furthermore lateral chain gand occur torsion nearly go lose proton perhaps result coordination effect copper ion theoretical calculation h2l geometric parameter ligand take way neutral form ray single crystal diffraction datum ionic form copper complex structure optimize DFTB3LYP level use g basis set optimize geometry show torsion lateral chain ionic form compare neutral form condense function value represent rel ative reactivity different site ligand frequently use point atom suitable electrophilic attack value neutral deprotonated form calcu late population analysis Natural Popula tion analysis NPA select value neutral deprotonated H2L give Table calculate condense function predict probable reactive site electrophilic attack oxygen atom sug geste metal atom initially approach oxygen atom metal atom coordinate adjacent reac tive site addition much positive value find strong coordinated site ory Furthermore atom demonstrate coordinate ion previously report compound actually atom Scheme Tautomerism enol form keto form optimize geometry form complex Zhang participate coordination title compound owe stereohindrance effect propyl group position pyrazole ring result ion rstly coordinate atom atom least site negative value consistent structure ligand calculation show deprotonated form much positive value corresponding neutral form hence reactive activity enhance accord sult complex structure analysis spectral analysis Pharmacology biological activity ligand complex detect assay pharmacological testing result H2L copper complex present Table crystal structure know several dination spot atom ligand close bio logical environment pharmacological testing also prove ligand complex show excellent efcacy ovarian cancer cell OVCAR3 liver cancer cell Hep result effect resistant Hep reveal copper complex active compound lethal concen tration IC50 value IC50 find good complex conclude coordination improve anticancer activity compound meanwhile anticancer activitie test compound Hep well OVCAR3 title complex research anticancer mechanism undergo fur ther thorough pharmacological investigation look forward synthesize novel analogous compound try good discover structureactivity relationship conclusion summary novel copper complex coordinate demonstrate pharmacological testing result sug g novel copper complex ligand potent anticancer agent efcacy resist cancer cell copper complex powerful ligand show coordination improve antitumor activ ity compound condense function calcu late predict metal atom initially approach result approve structure analyse copper complex nding supply way synthesis sign new anticancer medicine Supplementary material contain supplementary crystallographic datum paper datum obtain free charge ment work support National Natural Science Foun dation project western light Chinese Academy Science Higher Education Institution Shi Cancer Ali Inorg Biochem TuranZitouni Eur Med Chem Polyhedron Ohyama Suzuki Costa Marques Reis Radical Biol Med struct Chem Liu Polyhedron scand Preparation Organic Intermediate Chem Sheldrick Program ray Crystal Structure Solution University Inorg Chim Acta Zhou Zhao Polyhedron Butcher Polyhedron Rao Bhadbhade Chem Yang mortier Chem Soc Kostova Trendalova Trendalova Biochem Table Condensed Fukui function select atom neutral ion form ligand Atoma neutral form ion form NPA Atom numbering give Fig Table Lethal concentration ligand complex OVCAR3 Hep Sample IC50 OVCAR3 Hep h2l cu22ch3oh2ch3oh Zhang",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Rigaku": 1,
                    "Gaussian": 1,
                    "Zhang": 2,
                    "azomethine": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Antifungal activity of 4-methyl-6-alkyl-2H-pyran-2-ones.pdf",
            "cleaned_text": "Antifungal Activity Methylalkylpyranones tarun CHATTAPADHYAY PREM DUREJA Division Agricultural Chemicals Indian Agricultural Research Institute number methylalkylpyrone synthesize characterize basis nmr mass spectroscopy compound test pathogenic fungus namely bataticola aphanidermatum homologue less effective compound methylbutylpyrone methylheptylpyrone find effective test fungi inhibit mycelial growth approximately ED50 Methylhexylpyrone find effective test rolfsii greenhouse concentration aqueous emulsion methyl hexylpyrone suppress disease development tomato compare untreated infest soil greenhouse treatment Methylalkylpyrones antifungal activity Pythium aphanidermatum Pythium debaryanum Rhizoctonia solani green house test introduction yield major food cash crop reduce nearly pathogenic fungus sclerotium rolfsii devastating soil bear fungus wide host range infect seed seedling mature plant field cause collar rot wilt damp dry root rot large number chemical crop protectant use control organism detrimental environment human health need replace safe biodegradable product Lactones considerable significance fragrance food industry due potent fragrant organoleptic characteristic convey desirable objection able quality report alkylpyrones show smooth progressive change flavor increase molecular weight low homologue coumarincoconut high homologue waxy green floral alkylpyrones evaluate consider pleasant flavor organoleptic property antifungal activity natural product PAP fungal metabolite isolate various Trichoderma spp wellknown vitro activity range phytopathogen report natural product innately biodegradable combine establish use food additive assume low toxicity PAP find attractive candidate development agricultural fungicide identification natural product chemical synthesis PAP structural analogue receive attention however synthesis PAP find costly therefore cost apparent obstacle development early structureactivity relationship determine antifungal activity range synthetic analogue indicate structural requirement antifungal activity appear stringent Shortening alkyl substituent result marked loss activity saturation bond pyrone ring pent enylsubstituted analogue show similar antifungal activity find methylpentylpyranone substi tut analogue PAP show comparable activity prepare relative ease economy relative PAP study structureactivity relationship several methylalkylpyrone prepare paper report vivo fungicidal activity methyl alkylpyranone number soil bear patho gen material METHODS chemical acids thionyl chloride alumi chloride dimethyl acrylic acid procure locally Thionyl chloride distil use organic solvent use synthesis analytical grade distil dry use pathogenic fungus rolfsii aphanidermatum collect New Delhi pathogenic fungus maintain potato dextrose agar PDA subcultured PDA Petri dish prior use inoculum correspondence address mail jf052792s publish Web Chromatography Spectroscopy thinlayer chromatography TLC perform silica gel plate preactivate plate develop chloroform visualize iodine vapor spray alcoholic solution dinitrophenyl hydrazine gas liquid chromatographic analysis perform model gas liquid chromatograph fit capillary column film thickness equip flame ionization detector HewlettPackard 3390A integrator operating condition follow column temperature program injector temperature use carrier gas flow rate min Infrared spectra record spectrophotometer neat NMR spectra record spectrometer use tetramethylsilane internal Mass spectra record HRGCMEGA series gas chromatograph couple ion trap mass spectrometer connect P1150 multimode printer ionization potential gas chromatograph fit capillary column film thickness Helium use carrier gas flow rate min General Procedure Synthesis Methylalkylpyran one prepare methyl methylbutenoate turn prepare dimethyl acrylic acid esterification use methanol sulfuric acid purify distillation yield nmr cdcl3 Methyl methylbutenoate convert acylation use aluminum chloride dichloromethane solvent presence different acyl chloride crude keto ester thus obtain purify fractional distillation reduce pressure keto ester convert use mixture glacial acetic acid sulfuric acid methyl alkylpyrone thus obtain purify crude product fractional vacuum distillation reduce pressure identity product confirm comparison nmr gas chromatographymass spectrometry report literature Antifungal Assay antifungal activity test debaryanum vivo tomato seedling infest rolfsii Vitro Antifungal activity abovesynthesized compound test ability inhibit soil bear pathogenic fungus standard fungicide hexaconazole concentration latter recommend manufacturer fungicidal activity synthesize compound evaluate various tion poison food technique use PDA medium ready make PDA medium suspend distilled water heat boiling completely dissolve medium Petri dish autoclaved min compound test concentration stock solution prepare dilute acetone give require concentration use control solution add medium contain conical flask obtain desire concentration test compound medium medium pour set Petri dish diameter aseptic condition laminar flow hood plate keep light laminar flow chamber solidification medium solidification mycelial plug cut actively grow front old colony desire pathogenic fungus place inoculum side center treatment plate aseptically treat Petri dish incubate fungal growth almost complete control plate experiment quadruplet treatment fungus Recording Observations mycelial growth fungus treat control Petri dish measure diametrically mean standard error calculate replicate treatment percentage inhibition growth calculate use follow formula Table Antifungal Activity Methylalkylpyrones ED50 pathogenic fungib compd CH3 CH2CH3 CH22CH3 CH22CH3 CH23CH3 CH23CH3 CH24CH3 CH25CH3 CH26CH3 CH27CH3 CH28CH3 CH29CH3 C2H5CH23CH3 CH3dCH2 CHdCHCH3 clch2 CHdCCH3 hexaconazole standard Average replicate deberianum Dureja Calculation ED50 value calculation ED50 value effective dose require inhibition growth percent inhibition convert correct percent inhibition use formula correction factor obtain equation diameter Petri dish diameter growth fungus control plate concentration ppm correspond correct percentage inhibition datum compound ED50 ppm value calculate statistically probit analysis help Probit package MSTATC software use personal computer ED50 value calculate effective dose inhibition inhibition growth use Basic LD50 program version Vivo Antifungal Activity active compound series test vivo antifungal activity rolfsii pot choose extensive host range least specie family susceptible primarily attack host stem infect part plant favorable environmental condition include root fruit petiole leave flower first sign infection usually undetectable darkbrown lesion stem soil level first visible symptom progressive yellowing wilt leave follow fungus produce abundant white fluffy mycelia infect tissue soil seedling susceptible die quickly become infected old plant form woody tissue gradually girdle lesion eventually die invaded tissue pale brown soft watery Inoculum Preparation Mycelial mat rolfsii grow potato dextrose broth conical flask incubate horizontally medium decant sterile deionized water add bottle incubate vertically harvest rinse culture time deionized water homogenize small blender min mycelial suspension ground glass tissue grinder break mycelia suspension filter layer cheesecloth sonicate water bath period disrupt remain viable mycelia examination verify cytoplasm remain mycelial fragment Inoculum flask thoroughly incorporate compost soil previously sift sieve sterilize autoclave psi min infested soil incubate laboratory room temperature approximately sterilize autoclaved uninfested soil use control experiment treatment experimental treatment disease control experiment greenhouse uninfected soil moisten water check infest soil water add infested moisten soil treat formulate compound concentration infested moisten soil treat commercial fungicide metalaxyl cm3 soil incubation period infested soil treat incorporate aqueous emulsion formulate compound soil rate aqueous emulsion cm3 soil treat soil place double polyethylene bag close tightly incubate incorporate similarly cm3 soil incubation period soil treatment place diameter standard plastic pot tomato seedling transplant soil pot place randomly greenhouse bench Disease characteristic wilting mortality assess transplant thereafter number symptomless plant record treatment assay date express term proportion symptomless plant trial experiment tion repeat Disease severity rate inoculation base scale follow visible disease symptom slightly wilted leave brownish lesion beginning appear stem entire plant disease entire plant disease entire plant diseased dead plant mean plant treatment experiment greenhouse transform arcsine square root proportion symptomless plant stand analyze repeat measure design analysis variance determine use MSTATC software cal package significance level determine analysis base observe variation plant growth trial due external greenhouse variable result discussion number methylalkylpyranone pre pare use suitable concentrated acid conveniently mixture glacial acetic acid concentrated sulfuric acid purify crude product fractional vacuum distil lation yield boiling point similar report literature purity compound confirm spectra methylalkylpyranone show absorption characteristic pyrone nmr spectra methylsubstitutedpyran one show ring proton singlet correct inhibition correct inhibition correction factor figure effect different concentration hexylmethylyran one mycelial growth test fungus Key control proton also indicate normal aliphatic chain vinyl proton typical spin system mass spectra methylalkylpyranone show molecular ion peak various fragment ion peak mass spectra show major ion arise cleavage alkyl group loss methyl group respectively methylalkylpyran one test fungicidal activity abovereporte soil bear pathogenic fungus poison food technique smooth progressive increase fungicidal activity observe increase molecular weight table low homologue methyl ethyl propylsubstituted compound result marked loss activity table compound namely find effective test fungi Table Compounds octyl nonyl decanoyl side chain show marked decrease activity Table hexylmethylpyranone show maxi mum activity roflsii ED50 debaryanum ED50 ED50 Table Figure show inhibition mycelial growth different concentration compare control hexylmethylpyranone test vitro complete inhibition mycelial growth different pathogenic fungus observe concen tration figure compare control full growth similar length condition compound branch unsaturation heteroatom prepare examine additional effect position pyrone ring find enhance activity activity isopropylmethylpyranone compound ED50 Table considerably high ethylmethylpyranone compound ED50 corresponding length similarly compound ED50 significantly high activity propylmethyl pyranone compound ED50 rolfsii unsaturated alkyl substituent compound result loss fungicidal activity chloromethyl methylpyrone compound find active methyl ethyl analogue correspond chain length antifungal activity alkylmethylpyran follow order methyl ethyl propyl butyl pentyl hexyl heptyl octyl nonyl straight chain compound Table Figure Disease Control greenhouse compound test antifungal activity vitro hexylmethylpyrone compound Table Figure find effective test pathogenic fungus therefore think worthwhile study antifungal activity hexylmethylpyrone rolfsii greenhouse control tomato Mill different concentration aqueous emulsion cm3 soil commercial fungicide use comparison occurrence symptom different treatment record assay date express term proportion symptomless healthy plant stand result show figure untreated control result disease incidence healthy plant stand transplant treatment soil aqueous emulsion compound result healthy plant stand transplant healthy plant stand observe transplant Soil treat metalaxyl cm3 soil result healthy plant stand figure comparison antifungal activity different analogue methylalkylpyrone deberianum figure percent healthy tomato plant treatment rolfsii infest soil hexylmethylpyron metalaxyl point represent mean repeat trial experiment replication plant pot trial Soil treat aqueous emulsion formulate compound metalaxyl cm3 soil respectively Control uninfeste soil transplant however experimental variation healthy plant stand significant treatment soil aqueous emulsion compound show survival healthy plant stand transplant however healthy plant stand significantly different soil treat medium dose metalaxyl cm3 healthy plant stand figure treatment soil aqueous emulsion compound result significantly great healthy plant stand obtain metalaxyl transplant figure thus significant difference exist concentration time disease control experiment greenhouse aqueous emulsion compound prevent tomato damp significantly allow plant stand comparable uninfested control metalaxyl cm3 soil conclusion methylalkylpyrone butyl pentyl hexyl heptlsubstitute methyl pyrone show antifungal activity aphanidermatum solani Nees vitro methylhexylpyrone find effective series reduce disease development tomato cause condition optimize survival rolfsii soil disease development greenhouse favorable condition pathogen aqueous formulation methylhexylpyrone reduce pathogen population result high healthy plant stand compare control pathogen thank Agricultural Chemicals IARI provide facility LITERATURE CITED Nobuhara Synthesis unsaturated lactone part flavorous nature aliphatic lactone Collins Halim Characterization major aroma constituent fungus Trichoderma viride Pers Agric Food Chem Hanson Avent Antifungal alkyl pyrones active natural product fungus template tomorrow Pesticides Bioregulators Chemistry Uses Ory Rittig Eds pyrone harzianum plant growth inhibi tory antimicrobial property Parker Cutler Jacyno Hill Biological activity pentylpyranone analogue vitro activity pentylpyrone metabolite Trichoderma harzianum inhibition Fusarium oxysporum Roger characterization pentenylpyrone istry comprise methylpentylpyranone Patent Vogel Text Book Practical Organic Chemistry 5th Furniss Tatchell Eds flavour property alkyl substitute pyrones derivative receive revise manuscript receive Accepted thank financial support",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Thionyl": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Antifungal activity of lawsone methyl ether in comparison with chlorhexidine.pdf",
            "cleaned_text": "Antifungal activity lawsone methyl ether comparison chlorhexidine Nattapon Sritrairat1 Narin Sansuk1 Piamsawad1 Chanowanna4 Janpim Hintao5 Rawee Teanpaisan3 Chaethong3 Yongstar6 Pruphetkaew7 Virasakdi Chongsuvivatwong7 1faculty Dentistry Hat Yai 2department Hat Yai 3department Stomatology Faculty Dentistry Prince Songkla University Hat Yai 4Dental 5department Hat 6rural Oral Hat Unit Hat Yai objective aim study determine antifungal activity lawsone methyl ether mouthwash comparison chlorhexidine mouthwash CHX vivo MATERIALS METHODS study mouthwash preparation add inoculum Candida turbidity record incubation culture perform number colony Candida albican record vivo study crossover clinical trial conduct subject denture wearer clinical examination perform oral rinse technique carry immediately use mouthwash Allergy subjective assessment mouthwash record statistical analysis perform use oneway ANOVA mixed effect modeling result vitro antifungal activity signicantly great comparable CHX vivo antifungal activity hour mouthwash evidence group subject signi cantly low CHX allergic reaction report mouthwash grade less bitter taste CHX subject satisfaction taste smell mouthwash signicantly great CHX conclusion methyl ether mouthwash possess potent antifungal activity vitro vivo however concentration mouthwash need adjust addition clinical trial longterm use antifungal activity Candida chlorhexidine HIV law sone methyl ether mouthwash introduction oral candidiasis cause Candida specie frequently observe subject denture wearer colonization growth prosthesis Candida specie clinical importance wide variety agent include topical systemic antifungal drug available treatment however opportunistic oral disease increase prevalence therapeutic progress relative ease treat contrast high rate recurrence observe many patient HIV infection suer recurrent episode relapse rate high mouth follow successful treatment HIV infect individual persistent repeat course antifungal therapy obtain clinical reduc tion disease real resolution thus control symptom rather cure goal treatment patient group develop country antiretroviral therapy available small percentage population still major problem HIV infect individual likely develop course disease prevention well frequent use antifungal lead development drug resistance gluconate concentration long show use mouthwash treatment chronic atrophic acute pseudomembranous candi diasis recent study Prof Faculty Medicine Prince Songkla University Hat Tel fax mail publication Oral Pathol Med right reserve wileyonlinelibrarycomjournaljop report useful mouthwash maintenance free period HIV infect subject however bitter taste tooth stain CHX cause poor compliance methyl ether methoxynapthoqui none isolate Swertia calycina find group active constituent exhibit potent antifungal antibacterial activity value minimal inhibitory concentration minimal fungicidal concentration study report minimal amount require inhibit growth Candida albican previous study cell culture reveal exhibit anti allergic antioxidative activity toxicity cell antifungal activity report agent use intervention successful treatment prolong time relapse reduce antifungal drug use thus purpose study determine antifungal activity mouthwash vivo compare method Preparation LME mouthwash methyl ether potassium salt perform method previously describe mouthwash prepare follow LME potassium salt dissolve puried water glycerol add mixed well dissolve menthol peppermint oil absolute ethanol add solution potassium salt sucient water add make total volume determination antifungal activity mouthwash vitro Candida albican priori isolate HIV infect subject inoculum cell prepare isolate colony albican stock rpmi use adjust inoculum place test tube mouthwash volume add test tube control test tube incubate turbidity tube compare control record antifungal activity mouth wash perform subculturing aliquot tube Sabouraud dextrose agar SDA plate plate incubate number colony count number colony growth use assessment antifungal activity addition aliquot control tube pour SDA plate keep incubator period time conrm medium sterility viability test organism determination antifungal activity mouthwash CHX mouthwash vivo subject crossover clinical trial perform group adult rst group consist subject previously diagnose seropositive anti body HIV use particle agglutination test antibody HIV enzymelinked immunosorbent assay antihiv1 Beh ring come regular treatment Internal Medicine Clinic second group comprise denture wearer come routine dental care southern inclusion criterion common group current use history antifungal therapy history allergy mouthwash iii able use mouthwash properly willing provide inform consent CHX LME Baseline HIV group percent reduction CHX LME Baseline Time Time Denture wearer group percent reduction figure Antifungal activity lawsone methyl ether mouthwash chlorhexidine mouthwash determine geometric mean percent reduction colony form unit isolate subject denture wearer use mouthwash Lawsone methyl ether mouthwash Sritrairat Oral Pathol med exclusion criterion history local radia tion therapy head neck region pregnant woman severely ill subject cooperate study procedure use mouthwash sample size calculation crossover study hypothesis test subject meaningful intrasubject dierence onethird standard deviation formula calculation sample size sample size require ratio standard deviation dierence level change consider importance assume important change small onethird standard deviation require sample size subject practice recruit subject denture wearer history take study procedure history take oral examination perform subject clinical diagnosis oral lesion make accord criterion classie follow datum record age gender marital status education income smoking habit alcohol consumption systemic disease current drug use presence oral symptom presence oral lesion oral hygiene type denture number tooth use mouthwash oral rinse technique perform subject determine Candida baseline datum subject randomize receive advise rinse mouth mouthwash min spit use mouthwash oral rinse technique obtain specimen culture perform immediately respectively questionnaire assess sub ject satisfaction use mouthwash give immediate assessment subject appoint come procedure switch ing mouthwash Allergy subjective assessment comparison ask observe record allergy mouthwash dierent time point min use mouthwash feel burn sensation feel bitter taste assess use visual analog scale VSA subject satisfaction use mouthwash grade term taste smell Ethics study protocol approve research committee information patient identity anonymous subject give verbal write information nature study write consent obtain allow leave study time procedure entry statistical analysis computerize SPSS SPSS clean code analyze use program study distribution colony recover break mouthwash type table test carry examine population mean overall dierence signif icant ANOVA test comparison possible pair preparation make value adjustment multiple comparison use method vivo study geometric mean reduction group subject mouthwash ration plot time specimen collection baseline mouth wash test repeat subject time preparation mix eect regre sion use main interest reduction baseline loge baseline insert model oset term word predict reduction baseline absolute value random eect part denote varia tion subject study group main interest study therefore display xed part model consist variable eect xe subject variable group time specimen collection baseline referent group treatment eect mouthwash change time vary group subject interaction term time treat group treat add Package lme4 use interaction term test compare model term indicate well mouthwash preparation inconsistent level superiority time Signi cance grouptreat mean superi ority mouthwash consistent group subject signicant level set result Antifungal activity comparison CHX vitro tube mouthwash clear compare control positive culture Candida find plate plate plate respectively mean number Candida culture mouthwash range range range respectively Antifungal activ ity find signicantly dierent concentration CHX however methyl ether mouthwash Sritrairat Oral Pathol Med signicant dierence observe antifungal activity CHX activity comparison CHX vivo subject mean thirtytwo subject denture age range mean enrol demographic datum group show Table Figure show reduction overtime mouthwashe subject denture wearer immediate eect mouthwash show distinct depression line follow slow gain application mouthwash interest show potent antifungal activity HIV infect subject denture wearer low CHX result mixed eect regression xed part summarize Table nal model term highly statis tically signicant signicant indicate order use vise versa person eect test result word carryover eect mouthwash second main eect interaction term time signif icant suggest group subsequent low initial interaction term time HIV positive suggest less inhibitory eect especially HIV group Allergy subject satisfaction comparison CHX subject report allergic reaction due mouthwash VSA burn sensation feel bitter taste use mouthwash show signicant dierence mouth wash degree bitter taste compare subject score signicantly less bitter CHX Satisfaction subject taste smell show signicantly well CHX discussion vitro study demonstrate mouth wash exhibit potent antifungal activity albican activity signicantly great comparable CHX result vivo study consistent nding Antifungal activity mouthwash distinct HIV infect subject denture wearer signi cantly low CHX knowledge rst study attempt determine antifungal activity active constituent extract balsamina oral Candida vitro vivo Table Number mean colony Candida grow mouthwash culture type mouthwash number candidal isolate test range number colony mean colony 85a methyl ether mouthwash CHX chlorhexidine mouthwash test value aRows superscript denote signicant dierence value adjustment multiple comparison use method Table demographic datum characteristic subject enrol Variables subject subject denture wearer Age Age range year mean Gender Male Female marital status Single Married Divorce Widow Education none primary level secondary level polytechnic level bachelor degree Income Baht month smoking habit Smoker Nonsmoker Alcohol consumption Drinker Nondrinker Presence systemic disease current drug take oral hygiene Good Fair Poor Presence oral symptom Pain Dryness burn sensation pain dryness pain burn sensation number tooth Mean Range lawsone methyl ether mouthwash Sritrairat Oral previous study reveal methoxy nap thoquinone compound responsible antifun gal activity report detect major quinone find leave bilawsone minor addition mixture chloroform methanol suitable solvent naphthoquinone extraction study report preparation oral base antifungal activity similar clotrimazole cream study toxicity perform rat skin rash observe application even apply Chlorhexidine gluconate concentration widely prescribe dentistry antiseptic mouth wash due broad spectrum antimicrobial activity include albican little know mechanism action study expose CHX show coagulation nucleoprotein inhibition bud ding cell wall change lead death cell cell previously protrude bud survive reveal fungicidal fungistatic eect mouthwash propose fungicidal activity CHX due penetration region glycerol moiety subsequent breakdown permeability barrier leak cytoplasmatic content previous study demon strate exposure oral mucosa CHX devastate normal ultrastructure epithelial cell receptor microbe ecacy CHX depend pharmacodynamic associate bind oral mucosa show rinse CHX min approximately drug retain mouth mode action clearly understand ultrastructural study expose compound perform determine compound aect organism study antifungal activity CHX find less potent CHX nding consistent previous study study report mouthwash contain triclosan sodium uoride find decrease count placebo ever good substantivity CHX mouthwash still consider eective chemical antimicrobial agent study suggest mouthwash represent appropriate conventional antifungal drug management unfortunately brown stain tooth oral mucosa usually occur follow application mouthwash addition many patient nd initial taste unpleasant repeat use often produce taste disturbance last Desqua mative lesion soreness oral mucosa also report thus developed alternative mouthwash prophylaxis avoid unwanted eect however fact useful signicantly inferior indicate need concentration adjustment alternative mouthwash study assess antifungal activity comparison antifungal drug nystatin uconazole previous study reveal eective prevent vivo contrast uconazole bistriazole antifungal agent show eective prevent clinical episode compare placebo treatment however concern prolong use uconazole increase risk develop azoleresis tant albican thus use uconaz ole reduce risk patient advanced HIV recommend primary prophylaxis potential resistant Candida organism develop well cost prophylaxis frequently observe subject denture wearer cost prophylaxis seem particular concern major impact choice treatment resource poorsetting costeectiveness prophylaxis oppor tunistic infection vary widely general azole expensive compound ketoconazole cheap sideeect trial report cost gentian violet nystatin ketoconazole Africa Gentian violet much cheap ketoconazole tablet nystatin oral suspension bottle unit necessary treatment course bottle study cost mouthwash comparable mouthwash thus resourcepoor set urgent need less expensive antifungal drug use prophylaxis also strong need research perform treatment prevention child report frequent fungal infection child adolescent HIV positive clearly research eectiveness less expensive Table Final model predict loge various treatment group patient time base mixed model regression Variables Estimate value 1st visit1 LME CHX baseline baseline baseline treat HIV denture treat treat treat Group HIV methyl ether mouthwash CHX chlorhexidine mouthwash Baseline level referent group Lawsone methyl ether mouthwash Sritrairat Oral Pathol Med intervention need carry develop country Development drug resistance remain understudied work carry area conclusion study demonstrate possess potent antifungal activity oral ideal antimycotic treat yet available appropriate alter native mouthwash prophylaxis individual denture wearer immunocompromise patient risk develop proper concentration mouthwash however require research Feigal Katz prevalence oral lesion HIV infect homosexual bisexual man epidemiological cohort AIDS Oral AIDS Collaborative Group Oral manifestation HIV infection Oral Surg oral med oral Pathol oral manifestation associate disease marker immune suppression AIDS Oral Surg oral med oral Pathol oral lesion group Thai people AIDS Oral Dis Suppl S41 PereiraCenci Crielaard Ten Candidaassociated denture stoma titis new insight chlorhexidine nystatin rinse prevention oral complication leukemia bone marrow Oral Surg oral med oral Pathol oral lesion HIV infection mycobacterial infection patient infect human immunode ciency virus Baily Perry Denning Fluconazole resistant candidosis HIV cohort AIDS lie treatment oral candidiasis seriously disease child Acta Paediatr scand randomize clinical trial chlorhexidine nance oral candidiasisfree period HIV infection oral Dis ically active compound isolate plant report literature Triphathi principle leave inermis tia compound leave Smith Bernards Isolation antimicrobial com pound use bioassayguided fractionation antifun gal action naturally occur methoxynaphtho quinone antifungal naphthoquinone xanthones secoirids nant antioxidative activ itie compound Thai medicinal plant Panichayupakaranant Reanmongkol Evaluation chemical stability skin irritation lawsone methyl ether oral base clearinghouse Oral Problems related HIV Infection Collaborating Centre Oral Man ifestation Immunodeciency Virus Classication diagnostic criterion oral lesion HIV infection Oral Pathol Med Samaranayake MacFarlane comparison oral rinse imprint sampling technique detection yeast coliform aureus carriage oral cavity oral Pathol Multiple signicance test Bonferrorni method lme4 Linear MixedEects model use Classes Fit Linear Generalized Linear MixedEects Models available access Sakunphueak Panichayupakaranant Quantitative HPLC determination naphthoquinone leave Antimicrobial property aliphatic amine chlorhexidine saliva chlorhexidine bud Candida albican scanning transmission electron microscope study Elferink Booij Interaction chlorhexidine yeast cell ultrastructure intact situ chlorhexidinetreate human buccal cell method scan electron microscopy Acta Odontol Scand interaction Inuence tooth plaque denture retention chlorhexidine human oral cavity control dental carie periodontal disease eds Pharmacology dental therapeutic Press activity chlorhexidine contain study matol fungal eect mouth rinse oral Candida count salivary treatmentna patient AIDS Patient care stds eect single morning rinse chlorhexidine development tooth staining plaque accumulation blind crossover trial methyl ether mouthwash Sritrairat Oral Pathol Med randomize trial continuous intermittent therapy uconazole oropharyngeal candidiasis HIV infect patient clinical outcome development uconazole resistance med systematic eectiveness antifungal drug prevention treatment oropharyngeal candidiasis HIV positive patient oral Radiol Endod Cost eectiveness prophy laxis opportunistic infection AIDS overview methodological discussion pharmacoeconomic Lumbila Gentian violet ketoconazole nystatin oropharyngeal esophageal candidiasis Zairian AIDS patient ment study support grant grant author wish thank subject include study kind cooperation generosity provide product gift set compliment subject methyl ether mouthwash Sritrairat Oral Pathol Med",
            "term_counts": {
                "Mental Health Terms": {
                    "depression": 1
                },
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Sritrairat": 6,
                    "intrasubject": 1,
                    "statis": 1,
                    "gentian": 1,
                    "Africa Gentian": 1,
                    "Thai": 2,
                    "secoirids": 1,
                    "Gentian": 1,
                    "Zairian": 1
                }
            },
            "co_occurrence_matrix": {
                "Mental Health Terms": {
                    "Sritrairat": 1,
                    "intrasubject": 1,
                    "statis": 1,
                    "gentian": 1,
                    "Africa Gentian": 1,
                    "Thai": 1,
                    "secoirids": 1,
                    "Gentian": 1,
                    "Zairian": 1
                },
                "Ethnographic Terms": {
                    "depression": 15
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Assessment of genotoxicity of methyl-tert-butyl ether_ benzene_ toluene_ ethylbenzene_ and xylene to human lymphocytes using comet assay.pdf",
            "cleaned_text": "available online wwwsciencedirectcom genotoxicity methyltertbutyl ether benzene toluene ethylbenzene xylene human lymphocyte use comet assay Hseu Department Biotechnology National Kaohsiung Normal University Kaohsiung Taiwan Department receive receive revise form accept available online Methyltertbutyl ether gasoline oxygenate antiknock additive substituting lead currently use worldwide toluene ethylbenzene xylene BTEX volatile monoaromatic hydrocarbon commonly find together crude petroleum petroleum product gasoline aim study evaluate genotoxic effect test chemical human lymphocyte use alkaline comet assay show test chemical induce dna damage isolate human lymphocyte effect follow induction dna strand break neutral version test reveal benzene xylene induce DNA doublestrand break apart spin trap dimethylpyrrolineoxide tertbutylphenylnitrone PBN decrease level dna damage BTEX indicate dna damage result participation free radical dnadamage effect support fact posttreatment glycosylase enzyme recognize oxidize dna purine give rise signicant increase extent dna damage cell treat benzene xylene result obtain suggest induce variety type dna damage singlestrand break doublestrand break dsb oxidative base modication publish elsevier spin trap Lymphocyte dna strand break Introduction Motor fuel complex organic mixture comprise specic compound indicator compound usually dene compound consider toxic mobile soil groundwater reason many cleanup standard guideline focus toluene ethylbenzene xylene commonly know chemical volatile monoaromatic hydrocarbon commonly find together crude petroleum petroleum product gasoline compound represent hazardous component gasoline also produce scale mega ton year bulk chemical industrial use solvent start material manufacture pesticide plastic synthetic ber correspond author Fax mail address osycchnakstsseednet author contribute equally organic compound major pollution problem groundwater presence water create hazard public health environment practice add methyltertbutyl ether gasoline start increase dramatically effort increase combustion efciency reduce air pollution gasoline component release envi ronment production distribution storage use fuel follow accidental release gasoline typically rst compound detect groundwater high solubility low sorption potential common source contamination soil groundwater spill involve release petroleum product oxygenated gasoline leak oil tank rel atively high water solubility low value compound tend dissolve water phase evaporate air space soil relative hydrophilic nature attenuate much soil particle constituent see front matter publish transport rather long distance right condi tion site find several kilometres downstream source reason enter soil groundwater system consider serious problem acute longterm toxic effect likely dominate lead edge gasolineimpacte groundwater plume expected coexist monoaromatic component gasoline contaminant source lag edge taminant plume major aromatic constituent gasoline collectively know BTEX compound high water solu bility relative aliphatic constituent gasoline however give time sufcient distance point source dis solve plume expect migrate BTEX plume rodent human metabolize oxida tive demethylation know weak carcinogen tertbutanol TBA formaldehyde induce renal tubular tumor male female rat hepatic neoplasms mouse adduct DNA mouse lung liver kidney latter induce relationship find mutagenic carcinogenic various animal experiment epidemiological study especially associate bone marrow toxicity leukemia suggest DNA damage lymphocyte glue sniffer cause toluene however experiment toluene still need investigate component glue also play role genotoxicity isomer xylene human lymphocyte determine comet assay report report induce non genotoxic mode action responsible lung liver tumor observe mouse follow inhalation exposure present work investigate potential BTEX human lymphocyte use comet assay employ comet assay version alkaline version reveal singlestrand break version reveal furthermore order assess oxidative dna damage contribute lesion use formamidopyrimidine dna glycosylase convert oxidized purine strand break detect comet assay addition involvement free radical genotoxic ity MTBE evaluate pretreate cell dimethylpyrrolineoxide DMPO scavenger free radical material method purchase phosphate buffer saline PBS Ca2 mg2 free rpmi medium fetal bovine serum purchase Carlsbad low meltingpoint agarose normal agarose buffer ethidium bromide trypsin antibiotic solution phytohemagglutin trypan blue obtain tertbutylphenylnitrone chemical analytical reagent grade test chemical freshly prepared dissolve dmso keep dark nal concentration dmso less reaction mixture culture human peripheral blood lymphocyte treat test chemical lymphocyte culture perform accord pro ceduresoffengetalbloodwithdrawnfromafemaledonor health nonsmoker age collect Hypague sample centrifuge min form lymphocyte form layer directly FicollHypague isolated lymphocyte cultured rpmi medium include heatinactivated fetal calf serum phytohemagglutin penicillin streptomycin glutamine co2 atmosphere cell dilute concentration cell prior use lymphocyte incubate different concentration test chemical dissolve dmso nal concentration dark incubator subsequently cell centrifuge min mix low melting point agar comet assay describe spin trapping experiment incubation cell precede incubation spin trap DMPO PBN nal concentration accord procedure Cell viability analysis procedure conduct follow procedure volume cell suspension treat test chemical dose range mix trypan blue solution viability determine min reaction cell analyze microscopic observation determine percentage viable cell Comet assay comet assay perform alkaline condition follow method previous study Conventional microscope slide dip solution normal melting point agarose low melt ing point agarose allow dry surface room temperature microliter cell suspension cell gently mix micro liter suspension rapidly layer slide precoate mixture cover cover glass slide maintain min cover glass remove cell immerse freshly make lysis solution NaCl Tris slide place double row wide horizontal electrophoresis tank contain min thereafter electrophoresis conduct min electrophoresis slide soak cold neutralize buffer Tris buffer min slide dry methanol min store low humidity environment stain neutral comet assay perform alka line comet assay cell lyse neutral lysis buffer TrisHCl sodium laurylsarcosine Triton DMSO electrophorese freshly neutral buffer sodium acetate TrisHCl min Quantication comet assay hundreds comet slide score visually accord relative intensity tail intensity score class undamaged class severely damage assign cell thus total score comet range cell observe individually comet assay extent dna damage analyze score experienced person observation bar blind way observer knowledge identity slide dna repair enzyme treatment examine level oxidize purine lymphocyte slide cell lysis wash time min enzyme buffer contain MKCl mMEDTAand0 mlbovineserumalbumin slide drain buffer apply agarose slide incubate min control receive buffer check ability enzyme recognize oxidize purine experimental condition lymphocyte incubate H2O2 posttreate enzyme statistical analysis image random cell triplicate slide analyze experiment experiment cell use experiment unit follow sta tistical method homogeneity variance treatment group ascertain prior statistical analysis Comet assay datum mean Comet datum dna damage score analyze use oneway anal ysis variance anova dna damage dependant variable concentration test compound inde pendent variable signicant value obtain multiple comparison test conduct consider signicant spin trapping dna repair experiment dif ference control group test group analyze use pair test consider sig nicant result dna damage viability lymphocyte cell treat evaluate observe cell viability treatment compound least use trypan blue dye assay datum show furthermore dose solubility test chemical dissolve dmso solvent limit thus BTEX dose use separately determination genotoxicity use comet assay Table summarize result dna damage human lymphocyte treat vary concentration test chemical measure alkaline comet assay result indicate positive group cell pre treat H2O2 show maximum level dna damage score negative control DMSO sol vent test chemical reveal low dna damage score concentration test chemical exhibit signicant dna damage com pare negative control group test chemical reveal genotoxicity lymphocyte neu tral comet assay Table toluene compound dose show genotoxic ity human lymphocyte compare control group dmso result indicate dna damage chemical induce dna doublestrand break lymphocyte effect spin trap pretreatment dna damage check ability spin trap scavenge free radical experimental condition incubation lymphocyte H2O2 concentration presence absence PBN perform follow procedure signicant decrease dna damage cell incubate H2O2 DMPO PBN comparison cell treat trap observe decrease PBN Table result also show presence spin trap evoke decrease level dna damage lymphocyte treat test compound Hazardous Materials Table dna damage human lymphocyte expose different dose BTEX benzene ethylbenzene toluene xylene use alkaline comet assay Chemicals Dose DNA damage mean arbitrary unit MTBE H2O2 Benzene 21b Ethylbenzene H2O2 Xylene H2O2 Xylene 22c H2O2 Xylene 15c h2o2 toluene 25b h2o2 score dna damage calculate respective values least treatment cellsslide duplicate slidestreatment represent respectively detection dna damage dna repair enzyme table show DNA damage score lymphocyte expose posttreatment compare cell treat ment enzyme toluene ethylbenzene compound show increase dna damage score lymphocyte compare cell treatment enzyme elicit variety type DNA dam age include base modication DNA adduction singlestrand Table DNA damage human lymphocyte expose use neutral comet assay Chemicalsa Dose dna damage mean arbitrary unit chemical dissolve dmso dmso use control group bDNA damage score calculate respective values least treatment cellsslide duplicate slidestreatment represent respectively break break intra interstrand crosslink DSBs regard severe type damage comet assay sensitive reliable rapid method detection dna double singlestrand break alkalinelabile site delay repairsite detection eukaryotic individual cell alkaline neutral comet assay apply detect genotoxicity study furthermore information geno toxicity cell treat parent chemical short time still unclear thus aim study focus determination genotoxicity human lymphocyte expose use alkaline comet assay Table find BTEX cause increase dna damage score suggest ing compound genotoxin research show compound elicit double dna strand break toluene ethylbenzene table result indicate test chemical cause severe dna damage elucidate induce reactive oxygen specie preincubate lympho cyte spin trap PBN Spin trap form adduct free radical way reduce extent dna damage choose PBN form complex lot reactive free radical pres ence PBN signicant decrease dna damage cause observe Table result indicate induce free radical dna damage human lymphocyte incubate BTEX presence PBN compare control group PBN treatment DNA damage score mean arbitrary unit DMPO DMPO PBN PBN MTBE Benzene 10b Ethylbenzene Toluene Xylene Control DMSO H2O2 dna damage score calculate respective values least treatment cellsslide duplicate slidestreatment represent lymphocyte base result table sug geste single double dna strand break induce result free radical action experimental condition find signicant increaseinDNAdamageafterposttreatmentofDNAexposedto benzene xylene xylene xylene DNA repair enzyme compare control group treatment Table report excise variety modie basis DNA enhance DNA damaging effect alkylate agent main substrate seem oxoguanine oxog probably abundant baseoxidation product find DNA also commonly use biomarker oxidative dna damage thus suggest chemical generate oxidative damage human lymphocyte table summary type dna damage cause worth note report non genotoxic use genotoxic test include Salmonella microsuspension assay bone marrow micronucleus test appear positive animal carcinogenicity testis variety specie target organ fur Table dna damage human lymphocyte incubate posttreate compare untreated cell Chemical dna strand break arbitrary unit MTBE Benzene Ethylbenzene Toluene Xylene Xylene Xylene Control DMSO H2O2 dna damage score calculate respective values least treatment cellsslide duplicate slidestreatment Represent Represent ther point still evoke positive reaction mouse lymphomas assay genotoxicity study necessary evaluate toxicological mechanism knowledge rst report type DNA dam age cause DNA strand break lymphocyte worker print company act mutagen indirect mecha nism lead oxidative dna damage formation hydroxyl radical hydrogen peroxide biomarker oxidative dna damage prove detect lymphocyte human expose benzene furthermore metabolite benzene bind dna benzenederived quinine metabolite generate reactive oxygen specie ROS redox cycling lead oxidative DNA dam age result support fact metabolite benzene genotoxin addition benzene high dose low dose report cause dna damage human lymphocyte treatment chemical use comet assay detect genotoxicity benzene even low dose study detection free radicalinduced genotoxicity benzene study decrease dna damage pretreate increase dna damage cell posttreate suggest benzene cause oxidative dna damage human lymphocyte Table summary result table SSBa DSBb PBN Benzene Xylene Xylene Xylene SSB represent singlestrand break represent break result signicant compare correspond group result insignicant compare correspond group presence PBN DNA damage cell treat toluene decrease suggest radical dna damage treat cell however fact enhance dna damage effect compound indicate chemical mediate oxidation pyrimidine rather purine hand enhancement dna damage cell cause presence effect decrease DNA dam age cell pretreate suggest participation free radical dnadamage potential important recently report also recognize alkylation dna damage addition oxidative dna damage conclusion study able detect type dna damage single doublestrand break dna oxidative DNA basis modication benzene xylene xylene xylene treat lymphocyte apart produce oxidative dna damage human lymphocyte overall variety type dna damage observe human lymphocyte treat BTEX MacDonald Evaluating natural attenuation groundwater cleanup aromatic hydrocarbon aquifer microorganism denitrifying condition AlvarezCohen Substrate interaction mixture isolate gasoline additivecause testicular lymphohaematopoietic cancer rat Health Ether Vapor Inhalation Oncogenicity Study Fisher rat BRRC Report Union BurleighFlayer Ether Vapor Inhalation oncogenicity study Mice BRRC Report Union adduct mouse measure accelerator mass spectrometry Environ Toxicol Yin Hayes Linet expand cohort study cancer benzeneexposed worker epidemiologic evidence benzene lymphatic hematopoietic cancer Ind med Assessment DNA damage glue sniffer use alkaline comet assay vivo micronucleus test mouse phenylethanol Arch Toxicol vitro genotoxicity lead acetate induction single double dna strand break crosslink Mutat Res Feng Kong assess genotoxicity imidacloprid human peripheral blood lymphocyte comet assay cytogenetic test Safety Assessment genotoxicity benzidine structural analogue human lymphocyte use comet assay Toxicol Sci Wojewodzka Buraczewska Kruszewski modie neutral comet assay elimination lysis high temperature validation assay antisinglestranded dna antibody Musarrat Parmar dna damage mutagenicity induce endosulfan metabolite comparative study use comet assay focus formation detection methyl nitronitrosoguanidineinduce dna damage Toxicol Vitro Rojas Lopez Valverde single cell gel electrophoresis assay methodology application protein alkylation damage comet assay role dna damage extendedterm culture human lym phocyte mouse lymphoma cell hOGG1 recognize oxida tive damage use comet assay great specicity Boiteux specicity Escherichia coli protein excision purine lesion dna produce ionize radiation pho tosensitization Biochemistry oxidative damage dna reliable biomarker structural characterization family dna glycosylase DNA Repair Kado toxicity test methyl tertiarybutyl ether MTBE Salmonella microsuspension assay mouse bone marrow micronucleus test Single strand dna break lymphocyte granulocyte worker expose benzene Toxicol Lett DNA damage human lymphocyte alkaline single cell gel electrophoresis exposure benzene benzene metabolite Hertel Loft Urban benzene expo sure oxidative dna damage inuence genetic polymorphism metabolic gene Subrahmanyam Hydroxylation phenol hydroquinone catalyze human myeloperoxidasesuperoxide com plex possible implication benzeneinduced myelotoxicity Free Radic res investigation DNA damage ability benzene metabolite human lymphocyte hOGG1 recognize oxida tive damage use comet assay great specicity",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "demethylation": 1
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "dimethylpyrrolineoxide": 1,
                    "Mutat": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "dimethylpyrrolineoxide": 1,
                    "Mutat": 1
                },
                "Ethnographic Terms": {
                    "demethylation": 2
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Bardoxolone methyl and kidney function in CKD with type 2 diabetes.pdf",
            "cleaned_text": "volume wwwnaturecomnrneph NEWS view diabete improve kidney function type diabetes recent clinical study bardoxolone methyl demonstrate improvement glomerular filtration rate diabetic patient chronic kidney disease CKD mechanism action uncertain persist effect bardoxolone methyl challenge group patient source optimism management CKD publish online nrneph management advance chronic kidney disease CKD patient type diabetes mellitus easy cur rently reward substantial progress make stand pathogenesis diabetic kidney disease conventional therapy achieve well modest slow relentless decline kidney function treat ment many patient still prog ress endstage kidney disease make type diabetes mellitus lead cause endstage kidney disease Western world need new approach manage exponentially increase number patient type diabetes mellitus CKD urgent approach augment natural cytoprotective response body use small molecule activator bardox olone methyl phase doubleblind randomize placebocontrolle trial recently publish bardoxolone methyl increase estimate glomerular filtration rate min patient type diabetes mellitus impaired renal function methyl oral modulator nuclear factor erythroid relate factor negative regula tor protein trigger cytoprotective response affect gene code detoxification antioxidant anti inflammatory molecule Nrf2KEAP1 consider central player cellular defense modifier chronic disease expression activity often increase response oxida tive stress oxidantinduced injury example expression increase diabetic kidney parallel raise level reactive oxygen specie activation nuclear factor mouse deficient nrf2 increase sensitivity variety stressor include hyperglycemia dyslipidemia Nrf2knockout mouse develop accelerate renal damage follow induction diabetes mellitus associate increase oxidative nitrosative stress mouse also high level vas cular reactive oxygen specie endothelial dysfunction feed high fat diet wildtype mouse range putative activator show renoprotective effect experimental diabetes mellitus Box example sulforaphane nrf2 activator find Brassica specie broccoli able attenuate vascular damage associate hyperglycemia Diallyl sulfide garlic onion chive curcumin caffeic acid phenethyl ester find many plant bee hive also weak activator Interest pathway lead development range selective activator first agent undergo formal clinical investigation bardoxolone methyl originally explore potential anticancer property however improvement kidney function also note phase study prompt range trial large trial long duration publish phase study colleague randomly assign adult CKD receive placebo bardoxolone methyl dose addition standard therapy include blockade system patient receiv e bardoxolone methyl mean eGFR increase significantly baseline group great increase min observe take dose importantly improvement dose sustain active treatment suggest ing increase renal function adverse effect fail kidney withdraw renal function return baseline level egfr still significantly high baseline level stop drug increase min observe patient receive bardoxolone methyl datum indicate action bardoxolone methyl egfr likely reversible modulation impair glomerular func tion indeed report action eGFR nondiabetic patient cancer support hypothesis nrf2 activator increase GFR entirely consistent role detoxification pathway interac tion antioxidant response element regulatory domain target gene Advanced CKD include functional structural component contrib ute impairment renal function structural component include glomerulo tubular atrophy dropout effectively irrever ible especially window however renal function also activator methyl Caffeic acid ester curcumin Diallyl sulfide fumarate acid Tocopherol Oltipraz Resveratrol Sulforaphane Tertiary butylhydroquinone patient receive bardoxolone methyl mean eGFR increase significantly right reserve NATURE volume news view functionally downregulate oxidative stress hypoxia partly activation tubuloglomerular feedback Heme oxyge nase inhibit tubuloglomerular feedback directly indirectly reduce superoxide methyl act increase expression heme oxy genase renal tubule reduce super oxide also predict inhibit tubuloglomerular feedback lead reduce afferent arteriolar vasoconstriction subsequently increase GFR egfr improve patient include study bardoxolone methyl truly improve kidney function remains establish egfr rely serum creatinine level calculation bar doxolone methyl also affect muscle muscle spasm major side effect possible agent also affect creatinine metabolism hypoth esis serum urea level also reduce urinary creatinine clearance improve response bardoxolone methyl study nonetheless sur prise study noncreatininebase marker GFR cystatin iso topic GFR testing publish allay concern study worker focus induction rever ible change bardoxolone methyl direct renoprotective action also possible certainly proportion patient experience decline egfr low patient receive differ ent dose respectively receive placebo experimental study also suggest activation able inhibit promoter activ ity transform growth factor key growth factor implicate development progression renal fibrosis trial test bardoxolone methyl much large cohort patient type diabetes mellitus result available nrf2 activator also active investigation similar improvement kidney function reproduce represent major advance conventional therapy muchlauded renoprotective effect losartan renaal trial slow decline renal function year Angiotensinconvertingenzyme inhibition standard therapy come close improvement renal function achieve bardoxolone methyl much remain establish effect reproducible sustained mean delay dialysis least IDI Heart Diabetes Institute Box Kilda Road Central interest declare association follow company article online full detail relationship Renal Data System usrd Annual Data Report Atlas EndStage Renal Disease online effect bardoxolone methyl kidney function patient T2D Stage CKD Nephrol Jiang protective role streptozotocininduce diabetic nephropathy Diabetes induce oxidative nitrosative stress increase renal functional impairment Nrf2deficient mouse Genes cell adaptive induction relate factordriven antioxidant gene endothelial cell response hyperglycemia Physiol Heart Circ Physiol H1133H1140 Xue Activation relate factor reverse biochemical dysfunction endothelial cell induce hyperglycemia link vascular disease diabetes novel oral anti inflammatory agent shown improve renal function a129 oxygenase metabolite inhibit tubuloglomerular feedback vivo Physiol Heart Circ Physiol H1320H1326 National Library Medicine ClinicalTrials gov online showNCT01351675termnct01351675 cardiovascular outcome patient type diabetes nephropathy TRANSPLANTATION mTOR inhibition kidney transplant recipient study confirm previous finding conversion calcineurin inhibitors mammalian target rapamycin mTOR inhibitor seem improve glomerular filtration rate renal transplant recipient seem beneficial patient well renal function baseline question remain regard role mTOR inhibitor kidney transplantation publish online nrneph standard immunosuppression regimen renal transplant recipient evolve include combination calcineurin inhibitor CNI antiproliferative agent steroid use regimen reduce risk graft rejec tion improve shortterm allograft survival however cni carry burden renal toxic effect toxic effect include reversible hemodynamic decrease renal blood flow glomerular filtration rate GFR associa tion interstitial fibrosis Mammalian target rapamycin mTOR inhibitor exhibit hemodynamic effect kidney associate inter stitial fibrosis agent therefore pursue mean decrease potential nephrotoxicity CNIs numerous welldesigned study investigate minimization elimination cni immunosuppressive regimen use mTOR inhibitor sirolimus everolimus replace CNI part study show rather mixed result clear answer question use mTOR inhibitor fit routine clinical practice general study mTOR inhibi tion split class use mTOR inhibitor CNI novo mTOR inhibition CNI con version CNI mTOR inhibitor study type investigate right reserve",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Western": 1,
                    "Heme": 1,
                    "Mammalian": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Benzoyl 2-methyl indoles as selective PPAR\u03b3 modulators.pdf",
            "cleaned_text": "Indole derivative modifica tion methylindoles identify selective submicromolar hPPAR agonist routine screening lead series potent substituted benzoyl methylindole enantiomer derivative display robust antidia betic activity acton black JONES moller colwell DOEBBER WOOD Lett Dep Med Chem Merck Res Lab Rahway USA",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Indole": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Biodegradation of ethyl t-butyl ether _ETBE__ methyl t-butyl ether _MTBE_ and t-amyl methyl ether _TAME_ by Gordonia terrae.pdf",
            "cleaned_text": "gcc GCC C51",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {}
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Comparative study of methyl-CpG-binding domain proteins.pdf",
            "cleaned_text": "page number citation purpose study methylcpgbinde domain protein Address Ihnestrasse 2freie Takustrasse Email roloftmolgenmpg ropersmolgenmpg nubermolgenmpg corresponding author background methylation cpg dinucleotide genomic dna fundamental epigenetic mechanism gene expression control vertebrate protein methylcpgbinde domain MBD bind single methylate involve transcription control far vertebrate MBD protein describe family member result perform database search new protein contain MBD identify amino acid sequence different previously describe one present comparison MBD sequence additional protein motif expression encoding gene calculate unrooted dendrogram indicate existence least different group protein polypeptide present predict amino acid sequence base partial human cdna investigate expression northern blot analysis find transcript respectively normal tissue study conclusion Eleven polypeptide identify mouse man analysis protein domain suggest role transcriptional regulation knowledge additional exist MBD protein expression pattern important context syndrome Background Methylation cpg dinucleotide genomic dna fundamental epigenetic mechanism gene expression control vertebrate strong evidence exist correlation dna hypermethylation poacetylation histone tightly pack chromatin transcriptional repression effect dna methylation mediate protein bind symmetrically methylate protein contain specific main methylcpgbinde domain MBD consist residue sandwich fold build twisted sheet helix character istic hairpin loop opposite layer recently transcriptional repressor protein lack also show bind methylate CpG bind mediate zinc finger tifs Members MBD protein family find different animal specie far vertebrate MBD protein identify member MBD protein family MBD1 MBD3 MBD4 see associate histone deacetylase HDAC tran scriptional repression mechanism mediate show Published January receive accept article available licensee Open Access article verbatim copying redistribution article permit medium purpose provide notice preserve article original url page number citation purpose protein MECP2 implicate human neurological disorder call syndrome symptom syndrome mental retarda tion loss speech purposeful hand use autism atax stereotypic hand movement similar phenotype conditional mecp2 knockout mouse vit study functional consequence muta tion indicate disorder due loss function nervous system remain know patient present neurological phenotype ubiquitously express propose complement MBD protein nonneural tissue hypothesis test cross knockout mouse knockout mouse however evidence functional redundancy gene find way report new polypeptide sequence well MBD protein man mouse mention MBD protein family member date analysis amino acid sequence reveal additional domain associate chromatin point function transcription control result Discussion human MBD protein use bioinformatics approach man query sequence search new mem ber MBD protein family initial standard blast search Celera database sulte protein MECP2 MBD1 MBD3 previously describe study intensively however search protein domain family database Prosite reveal similarity additional protein BAZ2ATIP5 CLLD8 cdnas database use Hidden Markov Models HMM detect motifs amino acid sequence MBD describe CLLD8 SETDB1 TIP5 far mbdcontaining protein sequence also detect screen sequence similar ity DataBase SSDB cdnas find underlie SSDB result summa rize Tab MBD amino acid sequence previously publish newly describe human polypeptide align Fig sequence logo rive alignment sequence show analysis implicate small number high conserved apparently essential amino acid domain position identical amino acid present position conservative substitution find phylogenetic tree MBD amino acid sequence polypeptide show Fig major subset indicate origi nally describe protein MBD1 MBD3 MBD4 find group second BAZ2ATIP5 third subset CLLL8 join short branch appear fourth branch original protein similar novel one explain Figure alignment human methylcpgbinding protein accord ClustalX alignment human MBDs Columns colored conservation property residue conservation column indicate com pletely conserve favor substitution weakly favor substitution quality graph depict alignment page number citation purpose analysis MBD query fail identify second third fourth class domain analysis analysis amino acid sequence reveal MBD domain share sequence Figure Sequence logo human MBD sequence height letter correspond frequency amino acid position size stack stand information present position measure bit Top let ter represent consensus sequence bar indicate gap align sequence table summary human MBD polypeptides Accession Name Search method database domain position P51608 Q9UIS9 MBD1 CXXC q9ubb5 O95983 MBD3 q9z2d7 MBD4 HhHGPD Q9UIF9 BAZ2ATIP5 DDT PHD bromodomain Q9UIF8 DDT PHD bromodomain Q96T68 CLLD8 SET q15047 SETDB1 SET q9p267 q96q00 number accord SwissProt database BLASTP TBLASTN TBLASTX psiblast Pfam Ncbi SSDB Celera database TBLASTN Celera database Celera database domain nomenclature accord database sequence contain addition position amino acid sequence page number citation purpose MBD MECP2 MBD1 TIP5 mediate bind dna case preferentially methylate special role act dna repair reverse spontaneous cpg base change thereby maintain methylate cpg motif bind preferably m5cpggpt mismatch case human MBD3 SETDB1 show mediate proteinprotein interaction Xenopus MBD3 exceptional bind methylate cpg explain difference ami acid residue MBD Lys30 important dna bind remain determined BAZ2B CLLD8 mediate dna bind proteinprotein interaction ditional domain find polypep tide indicate associate chromatin function epigenetic mechanism gene regulation protein already know involve transcriptional repression domain strongly suggest comparable function recruit Sin3A repressor complex repressor complex con tain MBD3 complex contain HDACs also associate HDAC activity identi deacetylase remain unknown terminal part histidine prolinerich gion present conserve certain neuralspecif transcription factor BAZ2ATIP5 part nucleolar remodeling complex repress rdna transcription recruit ing histone methyltransferase hdac dna methyl transferase domain structure similar BAZ2ATIP5 contain DDT dna bind homeobox differ ent transcription factor tandem main domain zincfingerlike motif bromodomain consist amino acid find many chromatinassociated protein interact specifically acetylate lysine PHD bromodomain find several transcription repressor DDT domain exclusively asso ciate nuclear domain protein find different transcription chromatin remode ling factor motif allow bind ing minor groove rich dna region find BAZ2ATIP5 baz2b SETDB1 histone methyltransferase mouse homologue ESET furthermore show interact mSin3A repressor complex SET domain signature motif lysinespecific tone methyltransferase domain also present CLLD8 function yet assign predict protein sequence harbor motif name conserved amino acids ProTrpTrpPro first describe WHSC1 tein encode gene syn drome critical region domain dnmt3b dna methyltransferase recently show bind dna common feature contain protein presence additional domain know ate chromatin furthermore show interact protein yeasttwohybrid experiment hugeppi interaction partner study detail far contain stretch helixturnhelix motif PS00622 LuxR family accord turnhelix motif find many transcription reg ulation protein predict protein sequence prolinerich extension protein motif find existence domain involve chro matin modification present many identify polypeptide also point connection latter mechanism methylate dna interestingly recent study show methyltransferase activity indicate link dna methylation histone methylation MBD protein specie mouse homologue find human MBD protein Sequence identity score range indicate conserved function specie Human mouse MBD1 MBD3 MBD4 curate orthologue Homology search ENSEMBL database reveal follow murine homologue CLLD8 KIAA1461 protein protein mouse homologue ENSEMBL protein ensmusp00000028367 gene show amino acid sequence identity pre dicte mouse gene coding ENSEMBL protein ENSMUSP00000022552 amino acid sequence identity human CLLD8 furthermore find predict gene ensmusg00000036792 coding pro tein ENSMUSP00000036847 mouse homologue human protein amino acid page number citation purpose quence identity protein mouse gene sequence ENSEMBL pro tein sequence identity present database latter database entry however consist amino acid existence translate protein remain determined mouse gene dna methylation mechanism gene expression reg ulation exist also plant database search detect plant MBD protein database contain polypeptide thaliana cum aestivum blast analysis reveal additional protein vulgare MBD contain protein plant elegan mouse human present Pfam Expression pattern MBD gene expression analysis carry previously gene mousehuman MBD family abundance est different tissue report result publish Northern blot experiment summarize expression level low detect northern blot result pcr study tissue show however presence sequence merous tissue point ubiquitous expression perform Northern blot analysis strong signal detect skeletal muscle heart pancrea kidney placenta faint band detect brain lung liver strong band present heart kidney liver skeletal muscle placenta pancreas weak signal see brain lung tissue Fig take together MBD1 MBD3 well SETDB1 CLLL8 show broad tissue distribution expression restrict accord northern blot result note CLLL8 show low expression brain Conclusions study present additional protein cdnas methylcpgbinde domain mouse man Transcripts SETDB1 baz2a CLLL8 find adult tissue study protein describe new member MBD protein family CLLL8 show low expression brain find preferentially mature neuron brain cell type express CLLD8 TIP5 SETDB1 well predict brain know syndrome cause mutation even ubiquitously express phenotype syndrome restrict brain plain great need long live nondivide neu ronal cell special chromatin state involve tightly suppress transcription undesired gene explanation loss func tion MECP2 nonneural tissue compensate protein similar property study respect evidence genetic inter action gene find combine mecp2null mouse base gene expression stud ies knockout mouse biochemical evidence table mouse homologue human MBD protein human protein Mouse protein identity human protein Mouse protein identity MBD3 Mbd3 Baz2a ENSMUSP00000028367 CLLD8 ENSMUSP00000022552 SETDB1 ESET KIAA1461 ensmusp00000036847 KIAA1887 ensmusp00000026476 Comparison human MBD protein mouse homologue identity score calculate program number amino acid residue indicate number align amino acid exceed residue number sequence due gap insert algorithm page number citation purpose suggest essential function brain transcriptional view aspect proteinprotein interaction property methylcpgbinde domain human MBD3 functional compensation necessarily require dna bind property almost present polypeptide know predict involve mechanism gene expression regula tion order understand interplay MBD protein associated complex major task identify interact protein well regulate target component help solve que tion polypeptide functionally complement tissue brain Methods blastbased database search high throughput genomic quence express sequence tag est database search use TBLASTN web tool apply fault condition human chain use query input carry apply web tool use human MECP2 query release release version database screen protein domain result polypeptide sort accord specie origin addi tional identify domain sequence SSDB search MBD query motif BLASTN search carry Celera data base standard setting Homologues KIAA1461 CLLL8 identify phylogenetic tree compute use ClustalW program nome standard setting clustalx pro gram version graphical representation sequence logo construct mean plogo script html File format convert pack age version necessary sequence comparison mouse man car rie use algorithm EMBNET default setting cell line rna genomic DNA isolation cdna synthesis ccrfcem lymphoblastoid cell grow accord ing manufacturer instruction DSMZ harvest confluency genomic DNA isolate QIAGEN Blood MaxiKIT QIAGEN Total RNA table expression pattern mousehuman MBD gene Tissue MECP2a MBD3b MBD4b CLLD8c BAZ2Ad baz2bd SETDB1e g Brain Heart Kidney Liver Lung skeletal muscle cell Placenta Pancreas table show expression MBD gene major tissue detect northern blot empty space denote lack information tissue indicate low doubtful expression expression gene comprehensive expression datum available mouse expression additional tissue report expression additional tissue report originally call blot result study northern blot result study page number citation purpose isolate use reagent reverse transcriptase reaction perform presence oligo reverse transcriptase Germany result cdna purify qiaquick PCR purification kit QIAGEN cDNA use subsequent pcr amplification Standard pcr condition respective anneal use northern blotting cdna fragment pcramplifie exon specific primer KIAA1461for CTAGACCAT gggaaaaatgt KIAA1461rev ACTTGGAGACT GCTCCTCTA human genomic dna template use standard condition cDNA frag ment pcramplifie exon specific primer KIAA1887for CAGACCCCCTACTGTATTTC KIAA1887rev CAAAAGGTTAAAGCTTCCAT lymphoblastoid cell line template use standard condition cdna fragment actin ampli fie primer TGAACCCTAAG GCCAACCGTG actinrev GCTCATAGCTCTTCTCCAGGG use loading control probe radioactively label dctp random prime reaction hybridize solution CLONTECH human multiple tissue northern blot CLONTECH Washing perform SSC SDS min Signals detect MBD methylcpgbinde domain HDAC histone deacetylase Authors contribution TCR carry database search comparative anal yse molecular genetic experiment revise manuscript participate study coordination devise study supervise coordinate draft manuscript author read approve manuscript ment thank excellent technical assist ance critical reading suggestion work support grant schaft Teilprojekt figure Unrooted dendrogram depict methylcpgbind ing domain human protein family Tree repre sentation similarity human MBD protein left branch cluster original MBD protein Branch length proportional amount infer evolution ary change figure northern blot Human mul tiple tissue Northern blot show expression gene calculate size transcript actin probe hybridize loading control show bottom page number citation purpose Bird essential dna methylation cell Singal Ginder dna methylation blood Wolffe DNA methylation histone deacetylation control gene expression basic bio chemistry human development disease structure methylcpgbinde domain methyl ationdependent transcriptional repressor MBD1 EMBO Wakefield Smith Nan Free Soteriou Uhrin Bird solution structure domain bind methylate dna Mol Biol Ballestar Wolffe methylcpgbinding protein tar get specific gene repression Eur Biochem Bird Dissection methylcpg bind domain chromosomal protein Res interact novel domain zinc finger transcription factor Mol Cell Biol Prokhortchouk p120 catenin partner repressor Wade Methyl CpGbinding protein transcriptional repression Bird Transcriptional repression methylcpg bind protein mecp2 involve histone deacetylase complex Nature Bird MBD2 transcrip tional repressor belong MeCP1 histone deacetyla complex Jeppesen Bird active repression methylate gene chromosomal protein MBD1 Mol Cell Biol syndrome cause mutation link ing methylcpgbinde protein syndrome clinical correlate newly dis cover gene consequence syndrome mutation human MeCP2 Nucleic Acids Res Segawa Fujita analyse mecp2 mutation associate syndrome use transient expression system Brain Dev Suppl S165S173 Bird biological function methylcpg bind protein mecp2 implication syndrome Brain Dev Suppl S32S37 Bird mouse Mecp2null mutation cause neurological symptom mimic syndrome Deficiency thylcpg bind protein CNS neuron result phenotype mouse YuvaPaylor Noebels truncate mecp2 recapitulate many syndrome feature dis play hyperacetylation histone characterization CLLD8 novel candidate gene leukemogenesis chromosome region commonly delete cell chronic lymphocytic leukemia cancer res novel KAPassociated histone lysine spe cific methyltransferase contribute lence euchromatic gene protein Genes Dev novel member mammalian ISWIcontaining chromatin remodeling machine data basis MaurerFogy Bird Purification sequence cellular localization novel chromosomal protein bind methylate dna cell Hendrich Bird Identification characterization family mammalian methylcpg bind protein Mol cell Biol bird dna methylation pattern epigenetic memory Jiricny Bird thymine glycosylase bind product deamination methylate cpg site Nature tion substrate spectrum human mismatchspe cific DNA glycosylase fundamental role catalytic domain Cell Physiol mcpgbinde domain human MBD3 bind mcpg interact NuRDMi2 component HDAC1 MTA2 Biol Chem Pini Mutation analysis gene British Italian syndrome female Grummt nucleolar remodeling complex mediate heterochromatin formation silence ribosomal gene transcription histone deacetylase complex finger protein bromodomain KAP form cooperative unit recruit novel isoform subunit Dev DDT novel domain differ ent transcription chromosome remodeling factor Trends Biochem Sci ZielinskaKwiatkowska etsrelated geneassociated histone methyltransferase teract histone deacetylase msin3 transcrip tion corepressor mSin3A Borchers functional characterization histone lysine specific methyltransferase Fukushima Shinkai Set domain contain protein G9a novel lysinepreferre mamma lian histone methyltransferase hyperactivity specif selectivity lysine histone den Dunnen WHSC1 SET domaincontaine gene express early develop ment homologous Drosophila dysmorphy gene map syndrome critical region fuse multiple myeloma domain mammalian DNA methyltransferase dnmt3b define new family dnabinding fold Nat struct Biol Kouzarides thylcpgbinde protein mecp2 link dna methylation histone methylation Abbott structure chromosomal mapping murine human Mbd1 Mbd3 gene publish scientist read work free charge significant development disseminate result biomedical research lifetime Sir Cancer Research research paper available free charge entire biomedical community peer publish immediately acceptance cite archive keep copyright submit manuscript page number citation purpose Tate Cross Bird physical mapping gene encode methyl bind protein mouse chromosome Brown isolation physical mapping northern analysis link human gene encode methyl bind protein Mamm genome code quence unidentified human gene XXI complete quence new cdna clone brain code large protein DNA res Jones novel family bro modomain gene genomic syndrome mecp2 level display tissue cell specific difference correlate neuronal maturation Quantitative calization heterogeneous methylcpgbinde protein mecp2 expression phenotype normal syn drome brain laser scan cytometry pro filing mouse model syndrome reveal subtle transcriptional change brain window interface flexible strategy multiple sequence alignment aid quality analysis tool complex pattern evolutionary conservation alternative polya denylation long untranslated region methylcpgbinde protein gene MeCP2 suggest reg ulatory role gene expression Nomura Nagase Prediction cod ing sequence unidentified human gene code quence new gene deduce analysis cdna clone human cell line supplement DNA res",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 11,
                    "epigenetic": 4
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "CpG": 1,
                    "MBD1": 7,
                    "SwissProt": 1,
                    "MBD3": 1,
                    "S32S37": 1,
                    "NuRDMi2": 1,
                    "British": 1,
                    "Italian": 1,
                    "Mbd1": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "CpG": 15,
                    "MBD1": 15,
                    "SwissProt": 15,
                    "MBD3": 15,
                    "S32S37": 15,
                    "NuRDMi2": 15,
                    "British": 15,
                    "Italian": 15,
                    "Mbd1": 15
                },
                "Ethnographic Terms": {
                    "methylation": 15,
                    "epigenetic": 15
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Critically evaluated rate coefficients in radical polymerization_7. Secondary-radical propagation rate coefficients for methyl acrylate in the bulk.pdf",
            "cleaned_text": "critically evaluate rate coecient radical polymerization propagation rate coecient methyl acrylate bulk Beuermann Igor Lac Gregory rate coecient datum radical polymerization methyl acrylate bulk critically evaluate benchmark dataset put forward taskgroup IUPAC Subcommittee Modeling Polymerization Kinetics Processes dataset comprise previously publish result laboratory well new datum fourth laboratory value fulll recommend consistency check reliability also excellent agreement obtain employ technique pulsedlaser polymerization couple molarmass determination sizeexclusion chromatography carry pulserepetition rate enable reliable obtain good therefore recommend parameter activation energy mol preexponential frequency factor mol hold secondaryradical propagation use calculate eective propagation rate coecient situation signicant population midchain radical result backbiting case technically relevant temperature benchmark dataset reveal value obtain use conjunction MALDIToF mass spectrometry accurate also conrm comparison previously obtain benchmark value butyl acrylate methyl methacrylate butyl methacrylate seem identical family type behavior alkyl acrylate alkyl methacrylate specically butyl member family high corresponding methyl member eect appear entropic origin furthermore family characterize approximately constant value mol low acrylate mail bInstitut KIT HermannvonHelmholtz Platz EggensteinLeopoldshafen Clausthal University Technology ClausthalZellerfeld dTechnical ottingen Tammannstrae ottingen eUniversity Western Sydney Australian Centre Research Separation Science ACROSS School Science Health Parramatta Campus lock Bag Penrith fUniversit C2P2 Equipe LCPP Bat 308F Novembre Villeurbanne France gARC Centre Excellence hDepartment Queen University K7L iPolymer mail Dubravska Christchurch New Zealand Pesek Road mEindhoven University Technology Polymer Reaction Engineering Box Eindhoven supplementary information available see c3py00774j Cite receive 13th June accept 8th July c3py00774j wwwrscorgpolymer journal article license View Article Online View Journal View issue introduction precise knowledge rate coecient individual reaction radical polymerization crucial modeling polymerization process understanding development new polymerization methodology fundamental reaction govern radical polymerization process initiation propagation termination propagation reaction take prominent role nes rate monomer consumption thus directly aect overall rate polymerization consequence propaga tion rate coecient utmost importance rate coecient termination transfer measure relative IUPAC Subcommittee Modeling Polymerization Kinetics Processes recommend call pulsedlaser raphy PLPSEC technique1 method choice reliably determine series benchmark paper report accurate datum broad range monomer become available correlation time consecutive laser pulse chain length generate polymeric material correlation base almost instantaneous initiating terminate action laser pulse give rise speci molarmass distribution exhibit pattern peak accord darktime multiple thereof ecte circumstance grow radical survive laser pulse continue growth extended time period directly access eqn DPi refer characteristic degree polymerization outline manifest point ection know monomer concentration accuracy method limited prob lem associate molarmass determination addition side reaction chain transfer rapid radical termination pose problem family monomer prove dicult access acrylate MMDs occur monomer well dependence obtain apparent propagation rate coecient pulserepetition rate thus clear correlation obscure importance transferpolymer reaction acrylate polymerization foresee gle however important nde Chiefari absence characteristic structure understand result primarily formation tertiary midchain radical mcr mcr exhibit considerably high stability thus low propagation activity secondary chainend radical see Scheme thereby broaden radical thus invalidate eqn Transferpolymer occur inter intramolec ular reaction transfer matter term kinetic polymerization high polymer concentration occur typical experiment transfer hand occur random transfer step frequently membered cyclic transition state important process even low degree monomer conversion latter reaction refer backbite impact intramolecular chain transfer consequence address benchmark paper butyl acrylate reliable value secondary radical determine low temperature laser pulsing apply repetition rate suciently high minimize occurrence formation parameter report propagation rate coecient extrapolate technically relevant temperature however important note extrapolation yield data secondary chainend macroradical actual polymer ize system high temperature contain mixture secondary much slowly propagate tertiary radical propagation rate secondary radical thus confuse eective rate propagation apply acrylate polymerization low temperature refer joint action propagate secondary tertiary radical Signicant advance make understand acrylate transfer kinetic benchmark report online discrimination quantication MCRs secondary propagate radical become available electron paramagnetic resonance spectroscopy rate coecient backbiting report rate monomer addition MCRs study detail advent pulse laser repetition rate high successful experiment carry result value excellent agreement one extrapolate previously report benchmark datum determine low polymerization tempera ture underpin quality dataset result however also indicate limitation namely scission mcr temperature deviation behavior evaluate rate coecient observe explain transferpolymer step attribute scission mcr scission reaction associate relatively high activation energy yield signicant amount unsaturated macro monomer specie temperature especially polymerization low radical concentration scission step precede transferpolymer step scission step pose additional problem experi ment radical form small Scheme Formation midchain radical intramolecular transferpolymer reaction secondary chainend radical acrylate polymerization favored backbiting process sixmembered ring transition structure journal article license View Article Online precede however moderate temperature impact scission neglect demonstrate deduce extrapolation conclusion understand acrylate kinetic advance signicantly uncertainty still exist propagation rate coecient secondary chainend radical accurately measure present report focus provide benchmark datum bulk polymerization methyl acrylate monomer applicationoriente academic interest inherent dicultie determination reliable acrylate propagation rate coecient limited number dataset exist early datum method exhibit large scatter consider present evaluation follow group provide critically evaluate datum bulk collate table worker laboratory group report dataset measure classical pulse repetition rate temperature polymerization investigate DMPA photoinitiator mol analysis molar mass distribution MarkHouwinkKuhn MHKS value provide employ recent study group molar masse poly analyze matrixassisted laserdesorption MALDIToF technique latter method avoid band broaden problem use repeti tion rate advantage determination result accuracy datum address Buback worker laboratories investigate highpressure condi tion dmpa photo initiator consistent datum adhere criterion reliable determination obtain pressure dependence associate activation volume cm3 mol cm3 mol extrapolation datum ambient pressure yield mol mol MHKS parameter provide use analysis Junkers Castignolles worker Karlsruhe laboratory Junkers provide datum range successfully carry measurement high temperature fast pulse laser apply order largely eliminate uence backbite result molar mass distribu tion excellent repeatability mmd include ection point observe temperature order stay safe side Junkers use restricted temperature range derive ter levelingoof see attribute uence scission polymer eect lead underestimation due increase polymer background sample stem scission fragment MHKS parameter broad temperature range use poly sample determine Additionally sample assess respect error margin associate sizeexclusion chromatography local dispersity pro result multiple detection analysis branch polymer relatively branching distribution observe conrme indeed use high accuracy determination MMDs poly also find however nding necessarily hold true acrylate ethylhexyl acrylate34 tertbutyl acrylate Bratislava laboratorie framework current collation new dataset bulk polymerization compile also use high pulse repetition rate temperature cover see experimental detail mol DMPA photoinitiator MHKS parameter study Junkers use analysis also study observe temperature point ection eqn see even addition produce polymer single sequence laser pulse apply high repetition rate second type experiment polymer sample make apply several sequence laser pulse reduce number pulse sequence second approach reaction mixture equilibrate thermostat temperature experiment mean enhancement temperature consequence rapid pulsing hence rapid polymerization become visible comparison value obtain pulse strategy gratify note signicant dierence find apply pulse procedure see table comparison derive benchmark value dataset Table estimate use slightly dierent monomer density calculation bulk monomer concentration addition dierent MHKS param eter apply analysis depend type temperature eluent associate error small compare limit accuracy sizeexclusion chro matographic analysis thus previous benchmark report recalculation datum perform journal article license datum table refer dierent temperature laser repetition rate average laser pulse energy initiator concentration datum obtain use Table critically evaluate value propagation rate coecient bulk methyl acrylate polymerization ambient pressure measure function temperature laser pulse repetition rate average laserpulse energy initiator concentration value use deduce parameter give mmol mol Ref work work work work work work workb work work work work work work work work workb Table Contd mmol mol Ref 31a work work work work work work work work work work workb work work work work work work work work work work work Characteristic MMDs determine rather PLP experiment perform interrupted sequence laser pulse see text journal article license View Article Online photoinitiator dmpa prove excellent choice acrylate experiment fulllment reliability criterion close match datum obtain dierent laser pulse energy observe consistent value thus derive variation initial radical concentration combine dataset display good agreement exhibit satisfactory behavior depict Fig scatter datum provide dierent group rela tively small well general error margin cent associate measurement unweighted datum give mol absolute temperature give activation energy mol frequency preexponential factor mol error margin parameter represent condence interval Fig estimate make assumption constant relative error individual value result uncertainty amount mol mol mol mol error margin close one benchmark dataset error limitation obtain joint condence interval mostly depend scatter datum try dierent relative error yield similar contour plot datum Willemse play special role value determine analysis mmd thus problem imperfect calibration band broaden hand feature measure number distribution always unambiguously identi additional uncer taintie exist regard question ect true distribution mass spectrometry inherently prone mass discrimination eect especially high molar masse broad distribution occur experiment gratify note irre spective limitation PLPMALDIToF pleasing agreement datum method molar mass analysis see plot datum together PLPMALDIToF datum yield excellent agreement value deduce method parameter less identical remark make point band broaden systematically underestimate value take low molecular weight ection point point shi low value due band broaden MALDIToF datum systematically slightly high datum observe statement however prove general applicability PLPMALDIToF method nevertheless close agreement hint good applicability MALDI Fig Arrhenius plot value propagation rate coecient bulk methyl acrylate good line point also show interval parameter bulk estimate tte datum see text Comparison literature datum bulk obtain datum Fig full circle datum open square dash line represent equation give combine dataset method journal article license View Article Online approach order follow suggestion use reliable determina tion value provide include joint show Discussion Benchmark datum empirical use example serve nitively elucidate mechanistic trend also establish utility predictive calculation methodology quantumchemical calculation increase computational power ongoing nement model seem worthwhile compare experimental benchmark datum result quantumchemical calculation perform bulk worker use methodology calcula tion gasphase rate account solvation eect apply model activation energy mol frequency factor mol obtain addition dimer radical mono bulk monomer solution absolute calcu late parameter underestimate value benchmark dataset eqn factor agreement quantumchemically estimate parameter well order magnitude experimental benchmark value indicate improvement make computational method recent time nevertheless approximation require calculation yet allow initio calculation benchmark value benchmark datum monomer value series methacrylate monomer well previously publish largely base extensive result methacrylate monomer familytype behavior propose family monomer show minor systematic increase size alkyl ester group due largely perhaps entirely variation observed trend help predict value family member less thoroughly study comparison benchmark value bulk bulk corresponding value butyl methacrylate methyl methacrylate MMA illustrate undoubtedly represent signicant achievement experimental science way neatly establish family behavior time dierence family methyl butyl member family close dierence family distinct activation energie mma dier mol frequency factor pose problem safely establish parameter dierent hand clearly establish bulk associated value mma number mol mma mol BMA ratio value MMABMA benchmark datum enable similar comparison acrylate exhibit low activation energy correspond methacrylate marginally mol limit experimental accuracy frequency factor bulk also close butyl member exhibit high methyl member family find systematic eect ester chain length bulk methacrylic ester genuine kinetic explain detail elsewhere also point ref fact increase size ester group see bulk radical polymerization alkyl acrylate alkyl methacrylate occur solution even invert toluene solution see datum provide accuracy establish latter case due available use study polymerization indicate intramolecular hydrogen bonding play great role low polarity environment compare bulk monomer provide explanation diere behavior Future activity focus quantitative analysis eect substituent molecular environment eect basically relate extent internal rotational freedom tran sition state propagation rst point Heuts Signicant hindrance internal rotational motion associate low preexponential factor thus low eect also explain large dierence acrylate methacrylate also due dierence compare acrylate methacrylate severe hindrance rotational mobility methyl group present polymer backbone give abovementioned kinetic argument purely entropic one datum tte Fig assume identical viz mol arithmetic mean parameter benchmark propagation rate coecient bulk methyl acrylate butyl acrylate methyl methacrylate MMA butyl methacrylate journal article license view Article Online value ref mol present value mol yield frequency factor mol mol dierence certainly naked eye seem tte approach perfectly adequate therefore value mol cautiously recommend secondaryradical propagation alkyl acrylate vary indicate line family member increase alkyl ester chain length illustrate number table acrylate methacrylate high degree rotational freedom transitionstate structure butyl ester understand conse quence ecient shielding dipolar interaction large side chain perhaps associate well internal solubilize eect butyl compare methyl moiety variation solvent environment explain kind argument propagation rate coecient mention typical condition acrylate radical polymerization secondary chainend tertiary mid chain radical occur overemphasize benchmark value report present study entirely refer propagation secondary radical addition radical take place much low rate coecient ktert major radical overall propagation rate thus result loss secondary radical due transformation midchain radical account presence type radical eective propagation rate show give by6 keff kbb ktert propagation rate coecient secondary radical value report refer rate coecient backbiting see Scheme monomer tion reliable value ktert kbb yet available datum exist Based tion condition almost identical amount mcr observe polymerization temperature assume kbb similar monomer close basis exist datum well homopropagation rate dimer trimer serve model propagation ktert estimate approximation ktert kbb precisely determine forthcoming study however even accurately know parameter current approximate knowledge allow adequate estimate eective propagation rate coecient bulk polymerization result value mol third benchmark value accord secondary propagating radical temperature datum collect analyze chaingrowth kinetic bulk secondary propagate radi cal temperature availability commercial pulse laser pulse repetition rate high allow study temperature high show unfavorable eect backbiting largely eliminate allow sucient time pulse occur signicant extent however high temperature impact scission reaction plpstructure poly carefully consider value PLPMALDIToF good agreement suggest latter technique also suitable reliable determination preexponential factor activation energy secondary propagate radical obtain tte benchmark dataset mol mol respectively number close associated one butyl acrylate bulk propagate fast bulk dierence close one see MMA Thus family type behavior alkyl methacrylate conrme overall propagation acrylate estimate eective propagation rate coecient addition plot compare benchmark datum methyl acry late present work butyl acrylate dataset tte use mol see text table parameter value bulk methyl butyl ester acrylic methacrylic acid Monomer mol mol mol Ref Methyl methacrylate Butyl methacrylate Methyl acrylate work journal article license View Article Online require accurate knowledge far latter rate coecient determine subsequent activity focus measurement rate coecient acrylate include development standard protocol determination coecient solvent eect methacrylate propagation information hand complete picture propagation kinetic acrylate family available ment financial support project gratefully Olaj Bitai Buback Gilbert Hutchinson Phys Beuermann buback Davis Olaj Phys Phys Beuermann Buback Davis Hutchinson Asua Phys Hesse Kuchta Lac Appl Chem Schultz Commun Scott Scott Junkers theory Simul Vandenbergh Junkers Macromolecules Plessis Arzamendi Leiza Schoonbrood Charmot Macromolecules Junkers Junkers unzler Macromolecules Hirano Junkers Manders PhD thesis dechema Phys Junkers SchneiderBaumann Commun Macromol symp Couvreur Coutin Charleux symp Beuermann journal article license view article Online Macromolecules Phys Junkers PhD thesis ottingen ottingen journal article license View Article Online",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {}
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.pdf",
            "cleaned_text": "Fig generation mecp2decient mouse locus Lines top bottom genomic orga nization mouse Mecp2 locus structure conditional targeting construct 3lox construct conditional 2lox mutant analysis different mecp2 allele digestion ecori probe kpnispei inter nal fragment indicate note dna isolate male cell thus copy give allele present wildtype control 3lox respectively activitie transgene recombi nation frequency determine analysis dna isolate brain E14 Mecp22lox embryo tissue P16 Mecp22lox mouse carry transgene forebrain hindbrain cere bral cortex cerebellum hip pocampus brainstem testis liver kidney heart lung Germline activity transgene allow transmis sion germlinerecombine mecp2null allele offspring show Southernblot analysis tail dna pup produce crossing wildtype male female carry Mecp22lox transgene transgene activate oogenesis result offspring germlinedeleted allele isk presence westernblot analysis protein sample prepare whole brain wildtype mecp2null mouse use antimecp2 antibody ref carboxyterminal peptide peptide immunohistochemical analysis brain section hippocampus cerebellum adult wildtype mecp2null mut mouse use peptide antimecp2 antibody show intense staining neu ronal nucleus wildtype brain section loss immunoreactivity mutant stratum radiatum stratum stratum cell layer granule cell layer boundary hippocampal CA1CA2 region scale bar letter nature genetic volume march Deciency methylcpg bind protein CNS neuron result phenotype mouse Akbarian1 Jaenisch1 Psychiatry Massachusetts USA Correspondence address mail link gene encode nuclear protein bind specically methylate dna ref function general transcriptional repressor associate express high level postna indicate methylationdependent regulation gene expression crucial role mammalian central nervous system consistent notion recent demon stration mutation cause RTT MIM childhood neurological disorder represent common cause mental retardation show mouse exhibit phenotype resemble symptom RTT patient mecp2null mouse normal age begin develop disease lead death mutant brain show substantial reduction weight neuronal cell size obvious structural defect sign neurodegenera tion result phenotype identical null mutation indicate phenotype cause deciency CNS rather peripheral tissue Deletion mecp2 postnatal CNS neuron lead similar neuronal phenotype later age result indicate role restrict immature brain become critical mature neuron deciency neuron sufcient cause neuronal dysfunction symptomatic manifestation similar syndrome previous mouse chimeric study indicate essential role consistent early lethality com plete deciency predominance severe symptom identied boy carry generate conditional Mecp2 allele use CreloxP recombination system mecp2 target construct delete exon encode amino acid include methylcpgbinde domain mouse carry Nature Publishing Group Nature Publishing Group Mecp22lox allele derive independent mouse embryonic stem cell deletion use transgenic mouse carry transgene cause recombination brain begin E12 gestation20 male Mecp22lox female Mecp22lox pup carry transgene mal birth also obtain mouse carry germline recombine mutant allele Mecp21lox allele find hemizygous mutant male normal dene effect exon deletion expression compare rna protein mutant control brain analysis detect slightly small transcript reduce level mutant brain datum show westernblot analysis use antimecp2 antibody detect protein reveal peptide small size mutant control brain fig immunohistochemical analysis detect immunoreactivity mutant brain mouse carry exon deletion compare complete identical phenotype time death reduction brain weight neuronal cell size observe conclude deletion exon result Mecp2null mutation disruption lead embryonic lethality mecp2null conditional mutant seem healthy fertile develop abnormal behavior nervousness body tremble pila erection occasional hard respiration signicant portion mutant mouse Table become overweight exhibit sign physical deterioration stage disease mutant hypoactive tremble handle often begin lose weight mutant die obvious correlation physical deterioration time death heterozygous mutant female seem normal begin show symptom weight gain reduce activity ataxic gait later age fail reveal obvious alteration reduce brain size weight null conditional mutant small brain size also report RTT patients23 comparison mutant control brain section reveal obvious abnormality brain architecture exception cell body nucleus Fig mutant neuron section hippocampus cerebral cortex mecp2deficiency lead stagnation brain growth reduction neuronal cell size Deceleration brain growth Mecp2deficient mouse fill circle brain mutant mouse mecp2null conditional mutant roughly equal number open circle brain wildtype littermate insert box show brain image mutant wildtype littermate brain weight small neuron neuronal nucleus Mecp2deficient brain demonstrate section show neuron region layer cerebral cortex folium cerebellum neuronal nucleus region wildtype mecp2null mut brain molecular layer Purkinje cell layer gran ule cell layer boundary hippocampal CA1CA2 region Scale bar letter nature genetic volume march Table obesity mecp2decient mouse genotype number mouse Overweightedb valuec Germline deletion age day number mediate deletion number littersa CamKCre93 mediate deletion age number littersa aOnly male litter least mutant control mouse include bThose body weight least standard deviation 3SDs mean value control littermate find case represent least body weight cFrom test cerebellum small size densely pack consistent nding patients25 quantify dif ference measure neuronal cell size trace cell contour brain section Neurons region mutant brain small compare control table investigate deletion postmitotic neuron lead neuronal dysfunction introduce transgene21 camkcre93 cre transgene control Cam kinase promoter Mecp22lox mouse lacZ reporter show became widely activate postnatal forebrain hippocampus brainstem marginally cerebellum glia21 datum show analysis show recombination start perinatal stage reach maximum postnatal forebrain barely detectable cerebellum Fig time course deletion agreement Cre activa tion postmitotic neurons21 recombination frequency consistent expression neuron glia camkcre93 conditional mutant healthy begin show symptom include gain body weight Table ataxic gait reduce nocturnal activity Fig similar see null conditional mutant autopsy brain weight CamK Cre93 mutant reduce Fig histological analysis reveal small neuronal cell body cortex hip pocampus Fig Table cerebellum deletion occur conclude deletion postnatal neuron result phenotype seem similar delay less severe see animal carry germline mediate deletion gene ate deletion postnatal neuron phenotype condi tional mutant CamK Cre activity determine lacZ reporter trans gene show brain tion stain gal represent cerebral cortex hip pocampus P21 brain respec tively brain layer layer Scale bar cre93mediated mecp2 deletion determine sis percentage lane indicate frequency ate recombination fore brain hindbrain cerebral cortex cere image brain conditional mutant wildtype litter mate control age total measure brain condi tional mutant mouse wildtype littermate least mutant find case mutant brain reduce size weight compare control average reduction brain weight pair student test small neuron camkcre93 conditional mutant brain note neuron hippocampal CA2 region layer cerebral cortex different wild type mutant cerebellar region similar stratum pyramidale molecular layer Purkinje cell layer granule cell layer boundary hippocampal CA1CA2 region scale bar reduce nocturnal activity measure infrared beam activate movement detector camkcre93 conditional mutant mouse measure time average use comparison pair student test letter nature genetic volume march Table Reduction neuronal size brain body weight Brain weight CA2 neuronal size deletion age mediate deletion age deletion age comparison group littermate brain ple table xe simultaneously formalin subsequently process measurement con neuron cut level nucleolus pyramidal layer region see Methods also compare brain xe PBSbuffered paraformaldehyde mutant control mouse perfuse transcardially formalin mutant control case also observe consistent dif ference mutant littermate control absolute value vary different xation procedure number neuron mea sure Asterisk unpaired student test Nature Publishing Group Nature Publishing Group letter nature genetic volume march human classic form restrict female male carry mutation think die pre therefore deciency mouse cause less severe phenotype human hemizygous mutant male mouse develop symptom die young adult heterozygous female remain healthy well adult hood mutant mouse frequently display tremor heavy breathing cold extremity indicate autonomic abnormality also characteristic human patients11 change see mutant mouse consistent human condition small brain size general reduction neuronal cell size thus similarity brain mutant mouse RTT patient indicate deciency lead compa rable brain neuronal change specie major unresolved issue pathogenesis disease cause dysfunction postnatal neuron time symptom become apparent prenatal devel opmental disorder postnatal phenotypic manifestation CNS phenotype see conditional mutant mouse relevant etiology several aspect NestinCremediated deletion mecp2 brain indicate primary cause phenotype due brain malfunction rather mecp2 deciency peripheral tissue camkcre93mediated deletion occur mostly postmitotic neuron addi tional conclusion draw phenotype cause deciency neuron rather glia deciency Mecp2 postmitotic neuron cell autonomous sufcient cause disease last result potential clinical signicance indicate cause defect neuronal physiology due abnormal brain development rather absence continuous function mature neuron ongoing critical role mature CNS neuron prolong deciency lead neu ronal dysfunction characteristic disease correct therapeutic strategy aim prevent postnatal defect neuron develop rather correct neuronal exist birth phenotype deciency unex pecte consider gene express ubiquitously think act general repressor transcription remain major challenge understand mechanism Mecp2medi ate change chromatin conformation gene expression change relate brainspecic phenotype RTT patient expression prole brain peripheral tis sue mutant mice microarray analysis likely facil itate dene molecular change cause locus isolate genomic fragment contain exon part exon genomic library use construct conditional mecp2 target vector Fig loxp site cmvhygtk doubleselection cassette flank loxp site sequentially insert intron respectively Fig target vector pMecp23lox linearize NotI transfecte cell line screen clone analysis genomic dna digest EcoRI use KpnISpeI internal fragment probe presence lox site loxP confirm pcr use primer flank nsii site cell line pMecp23lox construct demonstrate high target frequency high approximately target clone contain lox site cmvhygtk cassette homologously target clone remove transient transfection recombinase expression vector give rise conditional allele exon flank loxP site Mecp22lox allele cell derive original cell line inject BALB host blastocyst generate chimera quently cross BALB mouse derive mice bear germline transmit Mecp22lox allele Generation mecp2null brainspecic conditional mutant mouse mouse use mix genetic background C57BL BALB cross male mouse carry ref ref line transgene female het erozygous homozygous Mecp22lox produce male mecp22loxcre female conditional mutant find active male female germ line Mecp22lox male carry transgene fertile develop disease die young adult cross Mecp22loxNestinCre female wild type male produce rst generation mouse carry germline recombine mecp2null allele Mecp21lox allele subsequently use Mecp21lox female healthy transmit te Mecp21lox rna protein sample prepare tissue mutant control mouse northern westernblot analysis carry histology immunohistochemistry neuronal size measurement brain immersionxed formalin paraformaldehyde phosphate buffer cryoprotecte sucrose frozen dry ice histological analysis series sagittal section slidemounte stain Thionine Sigma immuno histochemistry section incubate rabbit antiserum terminus mouse Mecp2 Upstate virtualize biotinylated goat antirabbit secondary antibody immunoperoxidase stain Vector measure neuronal cell size neuron project tion computer screen somal area neuron deter mine trace outline neuronal cell body cut level nucleolus use software activity measurement measure total spontaneous nocturnal activity use infrared beam activate movementmonitoring chamber OptoVarimaxMini Columbus Instruments measurement mouse place least starting time tory mouse cage fresh bedding Recording start time light normally turn stop light normally come back acknowledgment thank Fan critical read manuscript Dausman technical support Bird provide mouse carry independently generate conditional allele nancial support receive accept sequence cellular localization novel chromosomal protein bind methylate DNA repression methylcpgbinde protein mecp2 involve histone deacetylase complex Nature Jones Methylated DNA recruit histone deacetylase repress transcription Nature Genet Coy Sedlacek Bachner Delius Poustka complex pattern evolutionary conservation alternative polyadenylation long untranslated region methylcpgbinde protein gene mecp2 suggest regulatory role gene expression syndrome cause mutation link encoding methylcpgbinde protein Nature syndrome recurrent spontaneous familial mutation hotspot methylcpgbinde protein mutation syndrome Curr Opin Genet Dev syndrome surprising result mutation Kindersalter Med Wochenschr Hagberg progressive syndrome autism dementia ataxia loss purposeful hand use girl syndrome report case syndrome Tate Skarnes Bird methylcpg bind protein mecp2 essential embryonic development mouse Nature Genet Nature Publishing Group Nature Publishing Group letter nature genetic volume march syndrome clinical update recent genetic advance Health Neonatal encephalopathy boy family recurrent syndrome Child Neurol severely affect male bear syndrome kindred support link inheritance allow extension exclusion map Fontes affected boy syndrome family clinical molecular nding Neurology mutation rett syndrome gene cause link mental retardation progressive spasticity male Black Somatic mutation nonfatal neurodevelopmental disorder male mutation male patient link mental retardation FEBS Bishop mediate gene inactivation demonstrate FGF8 require cell survival pattern rst branchial arch Genes Dev Fan DNA hypomethylation perturb function survival CNS neuron postnatal animal mouse Mecp2null mutation cause neurological symptom mimic syndrome Nature syndrome Hagberg Head growth syndrome Acta Paediatr Bauman Kemper observation brain syndrome abnormality brain case syndrome Neurology Minichiello essential role TrkB receptor hippocampusmediate learn Neuron generalize lacz expression rosa26 cre reporter strain CaMKIICre transgene expression recombination pattern mouse brain",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "CreloxP": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Demethylation of _Cytosine-5-C-methyl_ DNA and regulation of transcription in the epigenetic pathways of cancer development.pdf",
            "cleaned_text": "NONTHEMATIC DNA regulation transcription epigenetic pathway cancer development Patra publish online February Springer cancer cell tissue exhibit genome wide hypomethylation regional hypermethylation cpg methylation DNA MeCpGDNA define formation covalent bond cytosine CH3 group adenosylmethionine Removal sole CH3 group methylate cytosine DNA one many way dna demethylation contribute activation transcrip tion mechanism demethylation candidate enzyme exhibit direct demethylase activity associate cofactor firmly establish wide hypomethylation obtain several way inactivation dnmt enzyme activity include covalent trapping DNMT cytosine base analogue removal methyl layer also occur excision methyl cytosine base dna glycosylase impor tance truly chemically define direct demethylation intact dna regulation gene expression development cell differentiation transformation discuss contribution Cancerepigenetics cpg island CytosinemethylDNAdemethylation cancer biology become increasingly evident epigenetic control gene expression play important role determine phenotype cancer cell possibly suggest novel approach strategy epigenetically restore normal phenotype cancer cell modification dna methylationdemethylation event central epige netic regulations development mechanism control event dynamic change important implication developmental cell biology well carcinogenesis tumor progression little mammalian genome contain carbon methyl cytosine paternal genome undergo preferential demethylation fertilization maternal genome remain largely unaffected mouse rat pig bovine human zygote later maternal genome passively demethylated replication dependent mechanism twocell embryo stage main key understand development unravel mechanism control expression pattern gene regulate cell proliferation differentiation embryo cancer Metastasis Rev s10555 West mail skpatra99yahoocom KB21 Sector III Salt Lake City Parma Parma Italy Biosistemi inbb Italy Scheme VII Kolkata West Bengal influence many epigeneticenvironmental factor factor contribute signal cell tissue trigger completion development whole body final biological response deregulated signal cause tumour development hence development require constant negotiation environment Studies field advance much probably difficulty monitor individual cell cellcell cellextracellular matrix interaction organ vivo many decade ago suggest idea epigenesis development discover carbon methylate cytosine DNA name epicytosine enzyme dna methyltransferase dnmt receive convincing confirmation responsible methylate DNA cytosine carbon position create additional layer epigenetic information post replicatively mechanism action dnmt characterize addition methyl group cytosine CpGdinucleotide DNMT also implicate regulate transcription maintain genome stability imprinting chromosome inactivation mammalian cell DNAmethylation catalyze important class dnmt reside replication fork methylate newly synthesize strand essential maintain DNAmethylation pattern proliferate cell member second class methyltransferase DNMT3b require novo methylation embryonic development cooperate family establish maternal imprint mouse however mechanism direct removal methyl group keep DNA strand intact obscure candidate protein possibly responsible activity controversial obviously possible modality achieve active demethylation require DNA strand break nucleoside excision repair dna overexpression dnmt hypermethylation cpg island regulatory region certain gene global hypomethylation well selective demethylation well know participate regulation transcription close association crucial biological event include cancer development cpg site present specific region promoter highly express gene rarely methylate perhaps quickly late normal cell important exception inactivate chromosome imprint gene recent datum show methylation dna deacetylation histone lead inactivationrepression selective acetylation histone methylation dna demethylation associate activation nucleosome gene transcription repression transcription occur different mechanism include recruitment protein repressor prevent transcription factor bind dna regulatory element methylate dna bind protein MeCP2 MBD1 MBD2 MBD3 selectively bind methylate cpg sequence contrib uting remodeling nucleosome chromatin structure condition chromatin inactivate consequence histone deacetylation cause recruitment histone deacetylase hdac event precede inhibit bind transcription factor include rna polymerase dna demethylation cause reduction repression potential gene MBD protein long remain bind respective demethylated activation energy require nucleosome promote transition state complex formation lower bind activator transcription factor event allow rna polymerase enter bind promoter initiation transcription show cause dna demethylation different mechanism suggest probably together know protein cofactor responsible removal CH3 group methylate cytosine originally isolate mismatch glyco particularly active MeCdeamination dinucleotide enzyme believe remove whole base methylate create abasic site seal help mismatchbase nucleotide excision repair enzyme secondary ligase ref clear abnormal methylation genome wide hypomethylation siteselected hypermethylation cpg island restrict cultured cell also occur ageing tumor development specific mechanism involve dna bind protein enzyme repressor activator participate recruitment active transcriptional complex interaction specific response element present promoter partially understand early work epigenetic control mechanism gene main hypothesis concern methylationdemethylation DNA biological significance first hypothesis cytosine CH3 covalent bond formation unusual event even irreversible alter native hypothesis suggest dynamic nature event tissue specific gene expression clear indeed enzyme directly methylate demethylate dna demethylase require study purification reconstitution Cancer Metastasis Rev recent datum active demethylation role development cancer progression raise considerable growth interest field understanding process replicationcouple loss local demethylation trigger transcription factor rna mediate catalysis dna repair base mechanism progress begin science epigenetic dna methylation assume methylation biochemical strategy positively select evolution safe guard microbial dna endonuclease digestion many useful information concern chromatin remodeling chemical modification dna histone greatly improve understand preferential gene expression importance biological process differentiation totipotent cell presence high level regional CpGisland methylation fact increase rate mutation due global genomic hypomethylation correlate tumor progression make clear precise genetic alteration time major drive force neoplastic onset progression virtually cancer type fortunately mutation specific gene inefficient process unceasing maintenance genomic integrity complex array enzyme continuously monitor repair dna thus genome maintenance team make many protein component work active complex strive ensure dna sequence information remain unchanged reach critical mass information helpful well understand chemical mechanism complexity direct demethylation intact dna devoted address current status discuss possibility future advancement specific issue direct dna demethylation active demethylation break DNA strand role development cancer dna methylation chromatin structure basic building block small functional unit chromatin core comprise dna wrap time histone octamer make copy histone type H2B lefthande super helix connect linker DNA naked association histone protect additional dna nuclease digestion core particle boundary core histone contain functional domain histonefold motif histonehistone histoneDNA contact nucleosome domain contain site posttranslational modification acetylation methylation phosphorylation ubiquitination NH2 COOHterminals relate core histone linker histone also contain globular domain flank NH2 terminal tail subdomain domain linker histone essential bind nucleosome tail domain probably important high order chromatin fold structural change primarily impose DNA level methylation DNA sequence GGCGCC show cause extend eccentric double helix structure call dna dna DNA long helical rise base perpendicular helix axis endo sugar conformation origin charac teristic deep major groove shallow minor groove dna also allow crystallize long period time respect yield dna methylate sequence originate standard DNA suggest ing dna kinetically trap intermediate transition dna thus structure present report chart emphasize graphic pathway DNA DNA DNA intermediate single sequence DNA surface highly accessible solvent water mole cule interact expose surface stack nucleotide major groove suggest geometry interaction promote neous deamination transition mutation base pair require deaminase activity analysis hydration pattern methylate cpg site crystal structure dna decamer high resolution reveal methyl group cytosine residue well hydrated comparative study native structure structurally distinct form fully methylate site show specific structural sequence context methylate cytosine base hydrated unmodified one water molecule seem stabilize methyl group formation type interaction addition structure provide first observation magnesium cation bind major groove dna reveal distinct mode metal bind methylated native duplex finding suggest methylated cytosine basis ecognize protein dna polar residue tightly bind water molecule cancer Metastasis Rev structure level nucleosome dna methylation inhibit gene expression animal cell probably affect chromatin structure presence methyl group dna affect interaction protein enzyme local nucleosome Methylation DNA bring general deacety lation histone prevent methylation induce methylation histone methylation associate transcriptionally active nucleosome chromatin trimethylated Methylation histone regard stable modification define epigenetic program cell regulate chromatin structure transcription however recent discovery histone demethylase challenge stable nature histone methylation demonstrate protein RBP2 PLU1 histone demethylase specific trimethylated histone show LSD1 repress transcription demethylation use patchmethylated stable episome methylate dna patch promoter luciferase reporter gene colleague recently demonstrate dna methylation affect chromatin structure gene expression observe acetylate histone associate unmethylated DNA nearly absent methylate dna region dna methylation immediately downstream transcription start site dramatic impact transcription show important effect transcription elongation initiation col league also show dimethylate histone H3K4Me2 deplete region DNA methyla tion effect link transcriptional activity region local effect extend methylate dna region deplete primarily methylate dna region presence trimethylate histone affected transcriptional activity datum suggest dna methylation junction transcription initiation elongation critical transcription suppression effect mechanistically mediate chromatin structure important implication suggest study impact methylate dna segment transcription difficult interpret size location methylate dna region differently affect transcription methylated code region little impact transcription initiation downstream promoter observe conceivable methylated sequence much large impact transcription initiation immediately downstream promoter observe tight correlation depletion H3K4Me2 region dna methylation regardless reporter gene activity conversely level H3K4Me2 remain high unmethylated dna region regardless presence Furthermore dna methylation approximately downstream affect presence H3K4Me2 unmethylated promoter pmeluc distinct boundary effect strongly support view dna methylation affect presence H3K4Me2 directly propose dna methylation dictate close chromatin structure devoid H3K4Me2 inhibit transcrip tion presence H3K4me2 marks open chromatin structure permit transcription condition active transcription fulfil early development genomic methylation erase somatic methylation pattern establish time tation experimen tal information study dna contain short mecpgsequence compare unmod ifie therefore effect methyl layer individual nucleosome overall nuclear chromatin structure infer observation initiation nuclear process highly dependent chromatin structure imply nucleosome position bias DNA sequence facilitate access initiation factor activation special ize domain removal loosely associate mobile protein hmg conjunction insulator action regulate expression independent gene well know special boundary present regulation chromatin domain Boundary elementsinsulators act subdivide eukaryotic chromo some autonomous regulatory domain bind arie represent structuralfunctional barrier prevent processive spread active silence chromatin domain addition partitioning consequence underlie structural subdivision chromosome high order loop domain view boundary think delimit structural domain interact nuclear structure insulator dna sequence exert action bind form complex specific protein partner demethylase demethylation reaction biochemical term DNA cytosinecarbon methylation postreplicative addition methyl group Cancer Metastasis Rev cytosine CpGdinucleotide sequence dna dnmt adenosylmethionine sam donor methyl group Fig Figure show DNA methyltransferase DNMT catalytically remove CH3 group square block methionine put carbon cytosine cpg sequence SAM change teine detail see figure show detailed mechanism mammalian mediate catalysis propose dna demethylation Fig removal methyl group DNA Removal methyl group demethylation essential transcription many gene obtain follow possible path direct active processdemethylation Indirect active processmismatchexcision repair passive loss methyl group due failure maintenance methylation replication mechanical incorporate DNA cultured cell demethylate dna vivo system represse activate transcription gene bind cpg sequence Indirect removal CH3 occur removal whole cytosine base block DNMT enzyme activity DNA cytosinecarbon methylation reaction NH2 CH2 H3C CH2 COO CH2 COO H3N Adenosine Adenosyl homocysteine sah DNMTase NH2 Cytosine Methylated dna dna substrate NH3 Fig DNA methyltrans ferase DNMT catalytically remove CH3 group square block methionine put arrow point cpg sequence SAM change Adenosyl homocysteine SAH enzyme remain intact reaction see also detail detailed mechanism pro pose Reither mammalian mediate catalysis see detail Cancer Metastasis Rev DNA methyl cytosine demethylation reaction link cofactor receptor Direct active process demethylation Indirect active process mismatch excision repair passive loss methyl group failure maintenance methylation status replication deoxycytidine incorporate DNA Cofactor Methylated DNA DNA h2n NH2 CH3 deoxyribose Phosphate H2N dna pol Glyco Remodeling factor join factor site dna MeCglycosylase endonuclease dna break dna pol join dna pol dna ligase DNA demethyla Cofactor III Remodeling exist nucleosome dna transcriptionally competent form DNA transcriptionally competent form Fig dna demethylase protein complexe biomolecule cofactor yet discover demethylate dna vivo system represse activate transcription gene bind cpg sequence Indirect removal CH3 occur removal whole cytosine base block DNMT enzyme activity artificially create thylation status type true demethylation reaction enzymatic removal CH3 group carbon cytosine context cpg island contain promoter necessary transcriptional activation many gene fate expel CH3 group form likely trap scavenger take cofactor see possible level action removal methyl group Methyl excision demethylase methylcytosine base excision excision mecpgdinucleotide excision Inset show structure deoxyribose sugar phosphate group DNA glycosylase break glycosidic bond create site endonuclease recognize site nick damage dna side upstream site create free dna polymerase extend dna free use exonuclease activity replace nucleotide damage base well downstream follow seal new DNA strand dna ligase activity see step representation dna glycosylase mediate removal methyl layer gene need activate left panel atypical BERNER pathway demethylation dna direct excision methyl group right panel signal transmit nuclear chromatin specific nucleosome respective gene become activate step attack glycosylase specific example propose break glycosidic bond create site step endonuclease recognize site nick damage dna side upstream site create free step first step MeCpGdinucleotide excision repair base mechanism specifically hemimethylate DNA propose suggest involvement enzyme small RNA Step III dna polymerase extend dna free use exonuclease activity replace nucleotide damage base well downstream follow seal new DNA strand dna ligase step finally chromatin remodeling factor fold DNA normal nucleosome fold stabilize stabilize factor suggest mechanism involve mononucleotide MeCpGdinucleotide excision Tat gene follow common step NERBER pathwaystep III step direct demethylation intact DNA Right panel Cancer Metastasis Rev artificially create hypomethylation status type demethylation reaction completely chemically define enzymatic removal CH3 group carbon cytosine context cpg island contain promoter necessary transcriptional activation many gene fate expel CH3 group form likely trap scavenger take cofactor see hypothesize mecha nism demethylation protein require cofactor know date propose mechanism form cytosine adduct prevail view adduct chemistry type complexe SN2 mechanism occur general water add double bond hydroxyl group attack carbon follow elimination ammonia yield thymidine yet think term SN2 mechanism involvement cofactor leave group activate cytosine ring complex enzyme nucleophile methanol alternative assumption cofactor p450 monooxygenase mediate attack molecular oxygen presence nadph convert methyl group hydroxymethyl group formyl group expel formic acid intermediate formyl cytosine experi mental evidence type reactionbase hypothesis lack possible way look similar type dna demethylation removal methyl group methyl cytosine keep DNA strand intact work dna methylation epigenetic search dna demethylase associate factor include investigation dnmt MBD protein preliminary datum convince purify unable demethylate MeCDNA MeCpolyCpG MeI polyipgduplexe crude tumor cellular extractsfraction contain together elution fraction contain show demethylase activity vitro fully substrate possibility lation machinery huge protein complex function chaperoncomponent apparent work other demethylase inertness fraction rich demethylation reaction argue different set inhibitor cell Indirect active mechanism account loss methyl groupslayer DNA excision repair base excision repair cellular mechanism repair damage dna dna replication repair dna sequence error necessary mutation conserve replication single basis dna chemically mutate example deamination alkylation result incorrect basepairing mutation DNA repair system versatile term damage recognition pathway exist partly distinct substrate specificity global genome survey entire genome distort injury transcriptioncoupled repair focus damage block elongate RNA poly merase detailed see BER involve flip mutated base DNA helix repair base alone main enzyme involve BER pathway dna glycosylase apurinicapyrimidinic endonuclease dna gly cosylase use break glycosidic bond create site endonuclease recognize site nick damage dna side upstream site create free compare DNA polymerase extend dna free use exonuclease activity replace nucleotide damage base well downstream basis follow seal new DNA strand dna ligase leave panel dna glycosylase typically low molecular weight monomeric enzyme responsible recognize base lesion genome initiate DNA BER pathway propose active mechanism DNA demeth ylation excision CH3 group alone actually damage DNA cell pay price recruit costly dna repair team hence removal CH3 group total total MeCnucleotide dinucleotide obviously active conceive really chemically define also term cellular economy BERNER reaction account genome wide loss methyl group certainly observe cellular system Cells use repair process buffer additional localize demethylation pathway gene transcription moreover cellular physiology chemistry normally permit removal pathway genome heavily methylate rationale suggest factor certainly responsible reversible regulation dna methylation possible level action removal methyl group show Methyl excision demethylase methylcytosine base excision mononucleotide excision MeCpGdinucleotide excision Single MeC base excision excision genome follow BER first DNA BER repair Cancer Metastasis Rev process call role dna glycosylase cleave bond base deoxyribose moiety DNA fig step abasic site repair resident BER repair activity result replacement cytosine accord second mechanism MeCmononucleotide remove nucleotide excision directly enter Step Fig replace cytosine Fig possibility possibly mimic pathway use extract tissue culture cell observe loss methyl group excision MeCpGdinucleotide Fig several experimental observation support suggestion reaction mediate participation rna molecule propose active role rna nucleotide excision repair reaction later evaluate mismatchrepair glycosylase mismatch repair enzyme methylated bind protein show possess DNA glycosylase activity Chicken embryo nuclear extract promote active loss methyl group associate cytosine base use purify enzyme enzyme dna glycosylase act preferentially hemimethylate initiate removal methylbase break glycosidic bond thus leave abasic site process endonuclease dna repair enzyme finally follow BER pathway Fig cloning characterization enzyme prove correspond gene encode mismatch repair dna glycosylase human homolog chicken enzyme also dna glycosylase activity author also report evi dence rna rna helicase p68 component enzyme complex involve demethylation activity overexpression human human embryonic kidney cell lead demethylation promoter hormoneregulate reporter gene specific demethylation transgene promoter genomewide demethylation attribute physical association retinoid receptor bind site transgene promoter major concern function mismatch repair dna glycosylase demethylase activity enzyme methylcytosine dna substrate weak compare activity mismatch dna substrate thus possible enzyme strong dna glycosylase activity possibly require cofactor support dna glycosylase mechanism active loss methyl group independently also find HeLa nuclear extract cause loss methyl group dna dna glycosylase mechanism partially purify enzyme activity however identity protein identify date recently add example BERNER mediate mechanism local target dna demethylation living cell discover enhancer specific demethylation event endogenous gene trigger transcriptional activator development analyze demethylation occur ticoidresponsive unit locate upstream transcription start site tyrosine aminotransferase Tat gene activation glucocorticoid receptor event take place liver birth involve memorization first stimulation gene glucocorticoid demonstrate demethylation cytosine gene physiological condition result active mechanism involve creation nick DNA nucleotide event indicate involvement mechanism produce dna strand break suggest methylated base process base lesion repair pathway excision repair compatible cleavage observe evidence mechanism demeth ylate nuclease activity report excise dinucleotide key experimental datum use technique suggest mono functional dna glycosylase compatible cleavage product overall datum produce convincing suggest mechanism involve mononucleotide dinucleotide excision Tat gene follow common step NERBER pathway compare passive loss methyl groupslayer genome dinucleotide display symmetrical configuration allow conservation methylation pattern follow replication replication machinery incorporate unme thylated cytosine newly synthesize strand result hemimethylated site convert back fully methylate site maintenance methyltransferase act preferentially hemimethylate act soon replication enzyme target replication focus interaction DNA polymerase clamp PCNA observe nonmethylatedcpg genome wide hypomethylation simply result absence maintenance methylation replication know passive cancer Metastasis Rev demethylation discuss passive mechanism involve demethylate enzyme passive loss take place several dna replication cycle ensure significant part daughter molecule effectively demethylated round replication deme thylate statistic consistent kinetic demethylation maternal genome observe early mouse development observe local glucocorticoidregulated demethylation Tat enhancer genome wide passive loss methyl group available past recent article many facet methylcpgbinding proteinmbd2 discovery gene envisage important landmark science epigenetic development cancer sequence contain gene suppressor also bind unmethylated promoter CpGsequences act activator investigate regulation transcriptional repression methylate cyclic campresponsive element find mbd2a promote activation unmethylated campresponsive gene vivo bind assay reveal MBD2a selectively interact rna helicase component CREB transcriptional coactivator complex MBD2a cooperatively enhance CREBdependent gene expression immunoprecipitation assay demonstrate MBD2a bind associate HDAC1 result indicate novel role gene regulation cloning mutational conditional knock covalent trapping show various regulatory mechanism act enzyme fundamental embryonic development induction cell transformation presence demethylation activity elegantly show however active protein cofactor unknown recently show associate demethylase activity discuss many laboratory study demethylase activity research group show transfection construct gene urokinase type plasminogen activator hexokinase type activate demethylation hypermethylate promoter lead overexpression protein product recently confirm predominant association endogenous methylate promoter trans fection chromatin immunoprecipitation analyse cell lysate suggest selective role methylationmediate inhibition ribosomal rna gene expression result implicate mediate gene specific binding repression activate transcription dna deme thylation reaction associate specific demethylase machinery animal model knockout show lack protein prevent growth tumour know associate hypermethylation important gene gene test p16 Integrin tissue inhibitor metalloproteinase find almost com pletely methylate knock animal possible demethylation mechanism gene dependent protein association fact mbd2deficient mouse viable fertile mean associate demethylase function suggest protein exist component demethylase machinery study knock mouse extend recently colon cancer mouse lack human colon cancer cell line suggest modulation gut development establish regionspecific gene expression pattern essential establish correct segmental character demonstrate sexspecific time window concomitant upregulation DNMT1 DNMT3A associate prenatal methylation human male female germ line provide important clue molecular mechanism parentspecific epigenetic mod ification human male female germ cell fertilization sperm egg genome remodel first embryonic mitosis nonetheless highly compact sperm chromatin require extensive nuclear remodeling protaminehistone exchange require nucleosomal maternal chromatin discovery demethylation murine paternal fertilization dna replication observe demonstrate existence active demethylation process mammalian cell sheep rabbit use interspecie intra cytoplasmic sperm injection beaujean demonstrate sheep sperm dna demethylate mouse oocyte amazingly mouse sperm also demethylate limited extent sheep oocyte finding provide evidence embryonic murine demethylation process mainly paternally drive nature activity unknown noteworthy Cancer Metastasis Rev mutant mouse lack functional methylcpg bind domain show demethylation profile paternal pronucleus wildtype control testis specific truncate transcript identify report oocytespecific form date posses demethylase activity suggest protein demethylase activity interest finding bovine somatic cell nuclear transfer embryo donor nucleus show efficient satellite demethylation presence oocyte nucleus enucleated oocyte suggest much demeth ylating activity associate maternal nucleus enucleated sheep oocyte also able demethylate serumstarved fibroblast nucleus sheep ooplasm considerable residual demethylate activity sheep fibroblast DNA particularly prone demethylation therein elucidate mechanistic role MBD proteins methylationdependent restrict expression tumorassociate mage antigen include possi bility protein play role silence result display transcriptional repression domain inhibit effect promoter activity furthermore cotransfection deficient mouse fibroblast cell show strong methylationdependent repression mage promoter downregulate MBD protein MBD1 MeCP2 interestingly however observe MBD1 splice variant able repress basal activity unmethylate mage promoter transcription factor abrogate sup pression contrast repressive effect mediate MBD1 MBD2a find regulate basal activity promoter recent report show protein control methylation enzyme arginine methyltransferase identify catalyze methylation residue inhibit repressive function reduce DNA MBD2HDAC repression complexe formation report provide molecular description potential regulatory mechanism MBD protein family member work first demonstration arginine methyltransferase participate epigenetic dna methylation system control chromatin function clarify issue study inactivation dnmt need yet result simply show correlation methylation gene repression suggest virtual existence protein demethylase activity fundamental bio chemical approach solve problem identify cognate component purification follow reconstitu tion active cofactorenzymesubstrate complex switching activation transcription recently define small region interleukin gene get demethylated lymphocyte follow activation remain demethylated thereafter demethylation process start stimulation prevent phase cell cycle inhibitor block dna replication finding imply demethylation process dependent enzymatic mechanism dna methylation emerge central switch allow inter conversion permissive repressive chromatin domain principle heart transcriptional regulation also likely govern process involve chromatin substrate indicate elsewhere domainwide sitespecific histone acetylation necessary transcription sufficient establish full chromatin accessibility lysine methylation robust epigenetic mark essential regulation multiple cellular process methylation perhaps large impact nucleosome activation transcription however switch permissive chromatin structure require subsequent synergistic action nucleosome remodelling complex contain ATPase family therein enzyme increase acces sibility nucleosomal dna weakening interaction lead signal cascade dependent demethyla tion activation promoter transcription specific promoterdriven gene follow Azadeoxycytidine induce transcription mechanistic dilemma catalytic mechanism dnmt involve formation covalent bond cysteine residue active site enzyme carbon cytosine DNA event increase electronic flow carbon subsequent attack methyl group SAM ion proton follow elimination allow reformation double bond release enzyme substrate DNA methylate cytosine mechanism describe recent article long suggest clinical use trial assessment safetytoxicity efficacy treatment various tumour do still ongoing molecular analysis Cancer Metastasis Rev AzdC treatment confirm expression gene repression condition association high cpgisland methylation possible mechanism suggest AzdC inhibit dna methylation incorporate DNA formation covalent bond enzyme AzdC dnmtazdc adduct consider stable thus assume trapping DNMTs generate hypomethylation cause activation transcription dnmtazdc complex tethered distinct regulatory site modify dna sequence drive interaction nucleosome hence section dna incorporate properly package chromatin even histone deacetylase hyper active repair enzyme operate assumption require dnmt avidly bind unusual structure form AzdC damage gene pack heterochromatin model transition state analog form unusual structure prevent enzyme complete catalytic cycle thus trap dnmt target appro priate repair recombination condensation complexe site ref transcriptional activation permissive domain frequently correlate additional target demethyla tion dna promoter nucleosome notable exception exist intriguing question transcription machinery bind roll AzdC entrap dnmt maybe follow path base excision repair tether dnmt define site explain local hypomethylation less obvious demethylation large domain achieve potential mechanism include recruitment histone acetyltransferase distinct entry site spread domain possibly attachment tracking protein associate rna polymerase transcription complex alternatively residence particular chromosomal domain demethylation competent nuclear compartment ensure relative uniform modification transcription activation complex generate highaffinity bind site demethylase scheme explain propagation envisage interpreting demethylation signal cell important issue study epigenetically mediate expression gene silence cancer CpGisland hypermethylation understanding demethyla tion participate gain gene transcription experimental system seem methylation promoter lead silence transcription chromatin protein recruit specific region mediate gene silence similarly CpGislands enhancer region methylate inhibit structural change function enhanceosome alternatively demethylation enhancerpromoter require signal remove protein bind chromatin activation gene expression precisely specifically methylcpgbinde protein remove set acetylation lysine terminal position methylation seem initiate process result regain transcription however cellular setting include abnormal geneexpression typical cancer unclear demethylation initial event expression target region early chromatin remodeling event system action inhibitor require initiate gene expression promoter region become densely methylate sequence event give promoter seem promoter demethylation histone hyper acetylation integral gain gene function drug block dna methylation AzdC procanamide drug block histone deacetylation acid salt partially reactivate silence gene cancer cell restore function induce expression broad spectrum gene prostate cancer cell procanamide induce expression P16 transcript gstp1 cell grow nude mouse EGCG induce clusterin SGP2ApoJ gene prostate cancer cell Clusterin gene know regulate promoter hypermethylation chromatin crucial aberrant gene silencingexpression cancer primarily secondarily process involve vertebrate genome normally package transcriptionally repressive chromatin kind find region type chromatin heavily methylate identity chromatin associated protein complex link DNAmethylation transcriptional silenc ing discover transcriptionally silent region dna package compact nucleo some contain deacetylated histone deacetylate particular histone extensively deacetylate action hdac maintain nucleosome compact transcriptionally silent state tran scriptional repression status also stabilize participation key protein CBX5 human homologue Drosophila Chromodomain protein pp1 Cancer Metastasis Rev also know suppressor varigation DNA methylation also seem involve crucially transcriptionally silent state heterochromatin MethylCpGdomain bind protein MBPs associate methylate cytosine also various chromatin remodeling complex also show act transcriptional repressor importantly mbp also find complex contain HDACs sin3 corepressor harbour MeCP2 MBD1 contrast small fraction genome transcriptionally competent state chromatin region dynamic meet change transcrip tional requirement cell balance euchromatin heterochromatin ensure gene expression pattern give cell type stably maintain daughter cell heritable state term dna methylation type gene promoter type account gene mammalian genome contain unmethy lated CpGislands promoter type composition rest genome gene promoter know many modulatory role transcription however example methylation individual promoter determine transcriptional status gene block access certain transcription factor sensitive methylation cpg site alternatively methylation site region also silence gene help recruit chromatin protein complex repress transcription cpg island generally assume unmethy late germ line imprint locus however several research team attempt predict cytosine methylation pattern different cell base DNA sequence attempt discriminate cpg island prone methylation human lymphocyte remain unmethylated find cpg island remain unmethylated particularly GpC conversely island prone methylation lymphocyte enrich segmental duplication tandem repeat sequence multiple selfalignment attempt identify general sequence predictor dna methylation brain tissue Das colleague expect find unmethylated sequence enrich island deplete alu element investigator also identify short sequence motif help discriminate methylate unmethylated DNA fraction brain tissue functional signification remain unclear see also mammalian genome depend patterns meth ylate cytosine normal function relationship genomic methylation pattern underlie sequence unclear characterize methylation landscape human genome global analysis pattern cpg depletion direct sequencing unmethylat",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "epigenetic": 11,
                    "methylation": 57,
                    "demethylation": 56
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "methyltrans": 1,
                    "MeCpGdinucleotide": 2,
                    "Tat": 4,
                    "SN2": 2,
                    "Clusterin": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "methyltrans": 124,
                    "MeCpGdinucleotide": 124,
                    "Tat": 124,
                    "SN2": 124,
                    "Clusterin": 124
                },
                "Ethnographic Terms": {
                    "epigenetic": 10,
                    "methylation": 10,
                    "demethylation": 10
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Dimethyl ether carbonylation to methyl acetate over nanosized mordenites.pdf",
            "cleaned_text": "Xiumin Huang Evert Ditzel Ensheng State Key Laboratory Catalysis Dalian Institute Chemical Physics Chinese Academy Sciences Dalian China Hull Research Technology Centre Chemicals Limited Hull HU12 Nanosized mordenites find show signicantly enhance reaction eciency dimethyl ether DME carbonylation methyl acetate greatly facilitate diusion process copper incorporation channel nanosized mordenites promote reaction rate selectivity stability moreover addition small amount feed gas deactivation suppress DME carbonylation catalyst stability rate formation increase introduction carbonylation dimethyl ether DME methyl acetate solid zeolite new route transform compound chemical coupling mordenite serve active catalyst reaction far kinetic study identie DME carbonylation initiate dissociative adsorption DME Brnsted acid site zeolite form CH3 specie follow insertion CH3 specie produce acetyl group CH3CO crucial intermediate react molecule form methyl acetate regenerate surface methoxy species Experimental theoretical analysis reveal size eightmemberedre channel unique orientation methoxy group channel responsible stabilize intermediate thus factor account superior activity DME carbonylation however catalyst similarly zeolites suer severe deactivation due deposition carbonaceous specie course reaction example surface methoxy group memberedre channel react rapidly DME form trimethyl oxonium cation TMO aggregate hydrocarbon aromatic therefore suppress coke formation channel enhance catalyst stability still remain challenge zeolite find greatly facilitate diusion thereby dramatically suppress coke deposition reduce crystalline size typical micrometer scale nanometer level shorten diusion pathway improve eciency molecule trans portation example decrease size HZSM find markedly enhance catalytic stability hexane crack acetone olen methanol gasoline methanol DME Nanosized Beta zeolite also exhibit activity stability superior conventional zeolite large particle size acylation anisole toluene work examine nanosized DME carbonylation respect catalytic activity stability compare conventional nanosize mordenite provide substantially enhance reaction rate longterm stability doping promote overall reaction eciency base crucial role copper activating eliminate coke accumulation moreover addition small amount feed gas suppress accumulation carbonaceous specie consequently prolong high catalytic performance experimental section synthesis hmor Catalysts microsize mordenite HMOR prepare commercial sample follow typical ionexchange procedure report previously nanosized hmor prepare hydrothermal process case NO33H2O Et6diquat hexaethylpentanediammonium cation dissolve aqueous solution silica sol SiO2 mean particle size add mixture stir room temperature transfer autoclave crystallize stir solid product ltrate wash water dry nally calcine air obtain convert sequential ion exchange NH4NO3 aqueous solution sample dry calcine air yield hmor catalyst prepare incipient impregnation case suspend NO3 aqueous solution room temperature allow dry result solid calcined air remove external copper specie sample wash receive revise Accepted publish Article pubsacsorgIECR orgie400909u hno3 aqueous solution result solid dry calcine air give catalyst copper loading measure analysis characterization ray diraction xrd pattern sample record ray diractometer Rigaku use radiation adsorption isotherm obtain use Quantachrome Autosorb gas sorption analyzer measurement sample degas scan electron microscopy FESEM image record use microscope operate sample place conductive carbon tape adhere aluminum sample holder electron microscopy image record use FEI Tecnai Spirit microscope operate specimen prepare ultrasonically disperse sample ethanol depositing droplet suspension carbonenhanced copper grid dry air Fourier transform infrared spectra record instrument resolution measurement sample evacuate Solidstate magicanglespinne nuclear magnetic resonance nmr experiment carry spectrometer NMR spectra collect mhz recycle delay scan spinning rate khz Chemical shift admantane deconvolution perform use Dmt software base line shape desorption ammonia NH3 TPD experiment conduct shape quartz tube reactor experiment sample heat rate min maintain temperature min sample purge vol NH3 mixture min min physically adsorb ammonia remove purge sample vol h2o mixture min allow cool room temperature sample heat rate min min amount NH3 desorb monitor mass spectrometry QMS200 Temperatureprogrammed oxidation TPO mea urement used sample conduct instrument experiment sample pretreate min allow cool room temperature sample heat rate min owe vol mixture min euent monitor mass spectrometer DME Carbonylation DME carbonylation test continuousow xedbed microreactor inner diameter experiment sample mesh load reactor heat rate min vol mixture min keep temperature gas feed composition shift mixture ratio reactor pressurize mpa euent reactor analyze online gas chromatograph Agilent 6890N equip thermal conductivity detector ame ionization detector result discussion textural Chemical Properties Catalysts Figure show pattern sample typical diraction line mordenitetype zeolite pdf number clearly observe sample compare nanosized hmor catalyst slightly decrease relative crystallinity increase surface area pore volume see table indicate acidic treatment copper removal leach extraframe work alumina specie channel figure show image sample sample cubic morphology size range diere signicantly traditional blocklike morphology typical size copper loading alter morphology size catalyst analysis reveal presence copper particle surface imply copper specie exchange proton locate channel figure show spectra sample band usually assign stretching vibration band acidic bridging stretching vibration actually combination band type acid site channel channel obvious band sample decrease signicantly comparison sample indicate acidic bridge group exchange ion Figure show nmr spectra sample peak ppm attribute isolated crystallite surface defect site peak ppm assign group brnste acidic site adsorb water respectively ratio sample sample intensity peak ppm decrease figure xrd pattern sample Table textural Chemical Properties Catalysts sample SBET HMOR HMOR NH3 desorption amount mmol total HMOR HMOR Industrial Engineering Chemistry Research Article orgie400909u considerably probably substitution acidic site copper cation nmr measurement estimate acidic site remove addition copper Figure show NH3 TPD prole sample distinct ammonia desorption appear sample correspond weak strong acidic site respectively weakly adsorb ammonia eectively remove water vapor facilitate quantitative determination strong Brnsted acidic site kinetic diameter pyridine molecule much large channel close pore size channel preadsorption pyridine selectively poison acidic site channel accordingly amount Brnsted acid site channel estimate sample total amount Brnsted acidic site mmol comprise mmol channel mmol channel sample additional desorption peak observe result decomposition copper ammonia complex form ammonia adsorption together NMR result figure total amount acidic site catalyst estimate mmol mmol channel mmol channel result demonstrate copper cation almost equally exchange proton channel DME Carbonylation Figure compare conversion product selectivity DME carbonylation HMOR hmor catalyst microsize catalyst conversion initial stage decrease sharply gradually decrease show rapid deactivation pattern nanosized catalyst conversion initially approach almost aromatic mostly light olen ethylene propylene butene produce major product selectivity olen rapidly decrease beginning selectivity aromatic decrease selectivity gradually increase reaction pattern conrm formation aromatic olen induction period dominant reaction mainly occur channel accumu lation aromatic channel DME carbonylation channel become major reaction induction period subsequent reaction period apparent deactivation observe conversion decrease selectivity aromatic decrease selectivity increase product distribution indicate formation channel link production aromatic channel thereafter reaction experience relatively slow deactivation process conversion decrease gradually selectivity aromatic decline selectivity gradually increase catalyst however reaction pattern alter considerably induction period shorten catalyst stability promote signicantly begin reaction substantial amount aromatic readily produce selectivity selectivity aromatic decrease sharply figure FESEM image sample figure nmr spectra sample figure prole water treatment pyridine adsorption pyridine adsorption Article orgie400909u selectivity increase rapidly result indicate copper channel activate expedite carbonylation eectively agreement previous observation presence copper HMOR activate also adsorb preferentially thereafter selectivity aromatic decrease selectivity gradually increase figure compare deactivation rate constant DME carbonylation catalyst distinct deactivation region fast deactivation occur induction period result heavy deposition coke mostly acidic site slow deactivation last long period gradual buildup carbonaceous specie catalyst surface kd1 refer rate constant rapid slow deactivation respectively derive production rate use powerlaw equation deactivation rate relative activity catalyst time order deactivation catalyst fast deactivation rate constant kd1 whereas catalyst notably deactivation rate correlate well number acidic site locate channel sample however apparent dierence slow deactivation rate constant sample case figure compare TPO prole coke catalyst dierent interval coke catalyst desorption carbon oxide occur presence least type coke specie desorption peak likely combustion soft coke surfacebound methyl acetyl specie associate formation desorption peak ascribe combustion hard coke quantitative analysis indicate substantial amount soft hard coke immediately form begin reaction approach thereafter amount coke increase slightly include soft coke hard coke coke behavior indicate heavy coke deposition occur mainly induction period contrast coke behavior catalyst quite dierent low temperature desorption peak initial stage reaction represent soft coke amount soft coke min increase thereafter new desorption peak carbon oxide appear indicate formation type coke gradually increase time total amount coke increase slightly contain soft coke hard coke compare catalyst amount soft coke catalyst relatively high probably result copper activation catalyst CO2 desorption peak appear catalyst conrm copper specie almost completely suppress formation hard coke distinguish chemical nature coke TPO figure DME conversion product selectivity deactivation pattern HMOR hmor catalyst DME carbonylation reaction condition mpa dme figure TPO prole coke catalyst dierent interval DME carbonylation HMOR hmor sample reaction Article orgie400909u measurement coke sample end run investigate compare COx h2o evolution show figure simultaneous formation COx water indicate high ratio soft coke presumably assign surfacebound methyl acetyl specie hightemperature desorp tion peak catalyst catalyst much low mole ratio indicate combustion hard coke Promotion Eect Addition small amount feed stream demonstrate eective suppress coke formation zeolite high temper atures compare reaction result show figure hydrogen addition reaction gas find markedly promote activity stability catalyst illustrate Figure catalyst hydrogen concentration feed gas increase induction period obviously extend selectivity aromatic increase selectivity decrease slightly take conversion account formation rate increase mmol concentration increase vol conrme promote eect hydrogen DME carbonylation phenomenon signicant catalyst formation rate increase mmol mmol vol therefore activity stability promote considerably hydrogen addition catalyst Table summarize amount coke deposit deactivation rate constant kd1 kd2 addition feed gas kd1 kd2 decrease obviously amount increase imply deactivation suppress addition moreover hydrogen concentration feed gas increase vol amount hard coke form induction period catalyst eectively suppress evidence positive role hydrogen coke elimination reaction condition investigate conclusion show signicantly enhance activity stability DME carbonylation reaction compare conventional incorporation channel promote overall reaction eciency lower deactivation rate base fact copper activate reaction condition simultaneously eliminate accumulation hard coke furthermore addition hydrogen feed gas also eective suppress coke formation promotion eect signicant catalyst consequence production rate methyl acetate approach mmol author information corresponding author mail author declare compete nancial interest acknowledgment nancial support research Chemicals Limited Iglesia Selective Carbonylation Dimethyl Ether Methyl Acetate catalyze acidic Zeolites Angew Chem Int Blasco Boronat Concepcio Corma Law VidalMoya Carbonylation Methanol MetalAcid Zeolites evidence Mechanism Involving Multisite Active Center Angew Chem Int Cheung Bhan Sunley Law Iglesia Site Requirements Elementary Steps Dimethyl Ether Carbonylation catalyze acidic Zeolites Catal Iglesia Specificity Sites EightMembered Ring zeolite channel Carbonylation Methyls Acetyls Chem Soc Boronat MartinezSanchez Law Specificity zeolite Unique Site Position Mordenite figure formation rate catalyst addition vol feed gas reaction condition DME vol vol MPa Table Deactivation rate Constants Coke Amounts deactivation rate constant coke form dierent interval kd2 min min HMOR HMOR aInduction period catalyst respectively Article orgie400909u Armitage Sunley Selective Dealumination MOR Type Zeolites European Patent EP2174713 Ditzel Law Sunley Carbonylation Process use bound Silver Stability Enhancement Mordenite Dimethyl Ether Carbonylation Methyl Acetate Preadsorption Pyridine Dimethyl Ether Carbonylation Methyl Acetate HZSM Methanol Dimethyl Ether Carbonylation side pocket Mochizuki Tatsumi Facile Control Crystallite Size ZSM Catalyst crack Hexane Microporous Mesoporous Mater Rownaghi Selective Formation light olefin hexane crack HZSM influence Crystal Size Acid Sites Nano MicrometerSized Crystals Chem Eng Tago Masuda Selective Synthesis Light Olefins ZSM Zeolites Catal Tago Konno SizeControlled Synthesis application Light olefin synthesis Catal Surv Asia stable Zeolite MFI Active LongLived Catalysts Nature Size effect catalysis MethanolOlefin reaction Appl Catal Rownaghi Hedlund Selective Dehydration Methanol Dimethyl Ether ZSM Nanocrystals Appl Catal Wang Dou Wang Acetic Anhydride NanoSized Beta Zeolites Catal Lett Xue Hong Synthesis Zeolite ZSM Catalytic Evaluation Butene skeletal Isomerization Durand Bujoli Gan Hoatson Modelling One TwoDimensional SolidState NMR Spectra Hall Multitechnique Characterization Zholobenko Inhomogeneity Bronsted Acid Sites Mordenite Phys Chem Maache Benazzi Infrared Study Bronsted Acidity Mordenites Heterogeneity Zeolites Accessibility Protonic Cationic Sites partially Exchanged Lett Freude hunger Chem Phys NMR Studies MolecularSieve Catalysts Chem Rev hunger MagicAngle Spinning Nuclear Magnetic Resonance Studies Water Molecules Adsorbed Brnsted lewisacid Sites Zeolites Amorphous Silica Aluminas Chem Soc Faraday HZSM Hayashi Kojima Acid Properties type Studied SolidState NMR Microporous Mesoporous selectivity NH3 TPD measurement Catal Katada Niwa Analysis Acidic Properties Zeolitic solid acid catalyst use temperaturepro grammed NOx Reduction NH3 Dry Humid Conditions Appl Catal Putluru Riisager Fehrmann Alkali resistant zeolite denox Catalysts Flue Gas Cleaning Biomass Fired Applications Appl Catal Deactivation reactor performance modelpilotplant life Test Applications Energy Fuels Levenspi Experimental Search simple rate equation describe Deactivating porous Catalyst Particles Catal Levenspiel ComingAge ChemicalReaction Engineering Chem Eng Sci Yao Sun Shen Combined Methane co2 reforming Dehydroaromatization enhance Catalyst Stability Ind Eng Chem Res Guisnet Magnoux Organic Chemistry Coke Formation Appl catal Bordiga Conversion Methanol Hydrocarbons Spectroscopic Characterization carbonaceous Species form ZSM Phys Chem enhance catalytic performance CopperExchanged SAPO Molecular Sieve MethanolOlefin reaction technol Descorme Provendier oxidative Steam reforming ethanol ceo2 catalyst structure sensitivity analysis Effects co2 reactant Methane reaction catalyze ZSM Catal Ichikawa highly stable performance Catalytic Methane Dehydrocondensation HZSM Periodic Switching Treatment CO2",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "kd1": 3
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Discovery of 5-Chloro-N2-__1S_-1-_5-fluoropyrimidin-2-yl_ethyl_-N4-_5-methyl-1H-pyrazol-3-yl_pyrimidine-2_4-diamine _AZD1480_ as a Novel Inhibitor of the Jak__.pdf",
            "cleaned_text": "pubsacsorgjmc jm1011319 JakStat Pathway Lynsie Isabelle Green Pollard Marat Minwei Department Department Drug Metabolism Discovery Enabling Capabilities AstraZeneca Alderley SK10 author contribute equally preparation manuscript receive myeloproliferative neoplasms polycythemia vera essential thrombocythemia idiopathic myelofibrosis heterogeneous related group hematological malignancy characterize clonal expansion myeloid lineage discovery jak2 gain function mutation highlight Jak2 potential therapeutic target MPNs Herein disclose discovery series identification azd1480 potent Jak2 inhibitor inhibit signal proliferation jak2 cell line demonstrate vivo efficacy TELJak2 model excellent physical property preclinical pharmacokinetic currently evaluate phase clinical trial Introduction Jak Janusassociated kinase family consist nonreceptor tyrosine kinase Tyk2a Jak2 play critical role cytokine growth factor medi ate signal transduction cytosolic receptorassociated Jaks activate cytokine growth factor engagement result downstream activation associate signal pathway chief family transcrip tion factor comprise Stat1 Stat2 Stat3 Stat4 stat6 Pharmacological inhibition jak2 become anintensefocusfor small moleculedrug discovery effort discovery single activating somatic mutation pseudokinase Janus Homology JH2 domain Jak2 myeloproliferative neoplasms MPNs MPNs pri marily comprise essential thrombocythemia poly cythemia vera myelofibrosis hetero geneous related group hematological malignancy characterize clonal expansion myeloid lineage represent great unmet medical need starting point clinical trial jak2 inhibitor typical clinical feature include mark symptomatic splenomegaly progressive anemia constitutional symptom include weight loss fever night sweat morbidity mortality commonly occur result infection thrombohemorrhagic event portal hyper tension organ failure leukemic transformation TG101348 CYT387 CEP inhibitor evaluate man figure collectively show dramatic reversal splenomegaly alleviation constitutional symptom evidence significant impact natural course disease lack Herein describe discovery series pyrazol pyrimidinamines Jak2 inhibitor structureactivity relationship series figure detailed biological pharmacokinetic evaluation lead compound also describe work culminate discovery evaluation potent selective ATPcompetitive Jak2 inhibitor currently phase clinical trial synthetic route preparation diamino substitute pyrimidines illustrated Scheme Aminopyr azole attach regioselectively position pyrimidine ring treatment alcoholic solution dichloropyrimidine base ambient tempera ture desire chloropyrazolpyrimidin amine intermediate isolate almost quantitative yield simple extraction reaction mixture pre paration intermediate require heat ethanolic solution reflux presumably reduce electrophilicity dichloromethylpyrimi dine correspondence address fax mail stephanosioannidisastrazenecacom Abbreviations kinase diisopro pylazodicarboxylate diisopropylethyl amine D5W dextrose water essential thrombocythemia hydro xypropylmethylcellulose Jak2 Janus kinase Janus kinase jak3 Janus kinase idiopathic myelofibrosismpk MPNs myeloproliferative neoplasms PEG polyethylene glycol poly cythemia vera Stat signal transducer activator transcription phosphorylated signal transducer activator transcrip tion tStat total signal transducersand activator transcription Tyk2 tyrosine kinase Medicinal Chemistry Vol finally reaction fluoropyrimidinethanamine hydrochloride11 force condition presence afford desire disubstituted pyrimidine synthesis heteroaromatic alcohol illustrated Scheme palladiumcatalyze cyanation commer ciallyavailable2chlorofluoropyrimidineproceededsmoothly afford corresponding fluoropyrimidinecarbonitrile synthetic route complete addition methylmagnesium bromide nitrile follow reduction intermediate ketone yield desire alcohol almost quantitative yield heating solution pyrazolpyrimidinamine presence yield desire oxygensubstituted pyrimi dine mixtureof enantiomer readily separable chiral purification Scheme see figure chiral purification information case trisubstitute pyrimidine desire analogue generate first expose opyrimidines ethanolic solution pyrazol amine presence base follow nucleophilic aromatic substitution position pyrimidine core regioselectivity latter aromatic substitution influence substituent ofthepyrimidine absence substituent usually lead exclusive formation desire regioisomer presence chloro substituent typically give mix ture ratio favor desire dichloro fluoropyrimidinethylpyrazol pyrimidinediamine intermediate Exposure hydrogen chlorosubstitute chloro intermediate 15a morpholine furnish target molecule 16a Scheme however substituent fluorine reaction favor regioisomer correspond regioisomer readily sepa rate flash column chromatography overall yield desire regioisomer poor alternative route Scheme therefore pursue reaction 14e morpholine proceed smoothly afford inter mediate 17a respectively microwave irradiation presence chiral amine hydrochloride give 16b good yield scheme reaction morpholine result mixture substitute intermediate use morpholine conserve precious chiral amine Trichloropyrimidines 13a commercially available prepare accord previously report procedure depict Scheme methoxy readily synthesize commercially available aminohydroxypyrazole reaction synthesis dimethylaminosubstitute carry start methyl mate thiocarbamate accessible treatment carbon disulfide dimethylamine aqueous basic condition Reaction lithium anion acetonitrileprepared exposureofthelatter tonbuli follow quench intermediate thiol MeI furnished dimethylaminomethylthioacrylonitrile mixture geometric isomer subsequent formation pyrazole ring accomplish moderate yield treatment diastereomeric mixture hydrazine Results hope modify size substituent influence modulate inhibitory activity jak2 proximity relatively large aliphatic side chain methionine gatekeeper residue order test hypothesis several substituent examine Table Comparing enzymatic inhibition closely relate analogue inconclusive failed discriminate methoxy cyclopropyl methyl analogue cyclopropyl methyl give IC50 value detection limit assay methoxysubstituted analogue estimate slightly less active dimethylamine substituent less well tolerate however compound still singledigit nanomolar inhibitor likewise enzymatic datum close analogue well prevent establish preferred substituent thus well differentiate activity analogue jak2 test high tion ATP utilize presume use concentration high end concen tration cell oppose allow accurately discriminate potent closely relate also expect Jak2 high datum Figure Jak inhibitor clinic figure Pyrazol pyrimidinamines Jak2 inhibitor Vol Ioannidis effectively predict potential cellular activity cells13 correlate well corresponding enzyme datum high ATP Table see indeed particular series potent activity high translate cellular potency addition consider Jak2 high ATP teljak2 datum able determine methyl group prefer interaction Jak2 gatekeeper residue strategy development Jak2 inhibitor build selectivity order avoid immunosuppression associate deficiency hence high enzyme assay introduce order well evaluate selectivity series compar ison Jak2 high assay indicate Table significant level selectivity observe series attribute fluoro substituent pyrimidine ring unfavorable interaction bind site vide infra interestingly methoxy dimethylamine sub stituted compound show improved selectivity possibly expense Jak2 activity methyl group seem achieve optimum balance activity selectivity bio chemical cellular level exploration structureactivity relationship involve variation substituent central pyrimidine ring ring depict Table biochemical datum substituent position tolerate instance high ATP Jak2 datum able distinguish molecule due high potency prioritization accom plished use datum TELJak2 cellular assay Compounds demonstrate combination favorable enzymatic cellular activity together selectivity however substituent respect selectivity former prog resse cascade bromo analogue profile increase datum show fluoro chloro methyl analogue noteworthy switch nitrogen linker ring ring result potent jak2 inhibitor biochemical level enzymatic activity secure desire level activity TELJak2 cellular assay addition base example become apparent stereochemistry benzylic center crucial activity introduction Substituents Position Pyrimi dine ring orient Solvent Channel Cognizant potential improvement Jak2 activity modulation overall property substitution position pyrimidine ring due potential access solvent channel elect explore 16a Incorporation morpholine moiety result improvement cellular potency show Table seek reevaluate effect group position analogue morpholine occupy solvent channel wanted explore combination morpholine methoxy pyrazolamine potentially provide compound prove cellular potency compare desmorpholino Scheme Preparation Diamino Substituted Pyrimidinesa Reagents condition BuOH DIPEA BuOH microwave Fluoropyrimidin ethanol reagent condition Pd2dba dppf MeMgBr THF NaBH4 MeOH Scheme Preparation Alkoxy Pyrimidinaminesa Reagents condition naotbu chiral purification Article Journal Medicinal Chemistry Vol analogue hypothesis less fruitful cellular activity much low activity correspond methyl analogue seem particular case methoxy substituent bulky enough lead steric clash sidechain methionine gatekeeper Jak2 kinase result less optimum potency comparison methyl match pair jak3 potency cmpd jak2 IC50 high ATP IC50 Jak3 High ATP IC50 teljak2 Cyclo NDe Cyclo 058f 36f OMe measure ATP experimental detail see ref value average least independent doseresponse curve experimental detail see ref experimental detail see ref denote test datum generate accord procedure report ref test assay report ref jak2 IC50 Jak3 IC50 Scheme Preparation Trisubstituted Pyrimidinesa reagent condition hydrochloride EtOH DIPEA BuOH microwave Scheme Synthetically Preferred Route FluoroTrisubstituted Pyrimidinesa Reagents condition hydrochloride Vol Ioannidis seem control ring substituent indicate Table greatly influence nature substituent absence substituent tends shift activity nanomolar range indicate achievement decent selectivity require substitution identify lead show excellent inhibitory activity carry evaluation pharmacokinetic property compound rat prior vivo profile metabolic stability lead rat liver microsome determine see Table datum predict compound exhibit reason able metabolic stability vivo indeed analogue 16a show low clearance dose intravenously rat surprisingly chloro analogue find highly clear exhibit high volume distribu tion close analogue 16a basis difference unclear involvement alternative metabolic clearance pathway possibility Compound also exhibit long halflife administer rat 16b display reasonably good halflive analogue display short halflife compound demonstrate good solubility physiological low lipophilicity assess logd7 measurement excellent profile rat together good cellular activity enzymatic selectivity decide progress vivo study gratify observe excellent profile mouse dog Table long halflife observe dog excellent oral bioavailability specie sug geste possible full absorption minimal firstpass olism follow oral administration preclinical cie tiomer ensure stereochemistry result improved biological activity synthesis enantiomer initiate Scheme Commencing previously report alcohol formation desire racemic benzyliclike azide proceed conversion alcohol correspond methanesulfonate subsequent displacement sodium azide azide convert target amine rac hydrogenation standard condition racemic material readily prepared heating pyrazolpyrimidinamine antipode readily separable chiral purification support information figure screen biochemical cellular assay dicate stereochemistry effect activity discuss examine property rat show difference enantiomer overall profile particularly increase clearance short halflife Table Crystal Structure Kinase domain JAK2 interaction adenine bind site confirm ray structure jak2 construct contain domain necessary carry isolation purification crystallization construct presence staurosporine Subsequent dis placement staurosporine potent afford suitable crystal ray analysis indicate figure pyrazole interact hinge donoracceptor donor hydrogenbonding motif protein backbone 6da reagent condition MeOH DIAD PPh3 DCM CH3CN BuLi Cf25 MeI H2NNH2 EtOH Table Biochemical dinethylmorpholinopyrazolpyrimidinedia mine Analogues 16a cmpd Jak2 IC50 high ATP IC50 Jak3 High ATP IC50 TELJak2 GI50 16a OMe 16e OMe OMe value average least independent doseresponse curve Table Rat Microsomal Stabilitya CLobs min Vdss 16a experimental detail see rat male specie route CLobs min hour Vdss AUC mouse dog mouse female Beagle dog male TEGD5W auc0f12 Article Journal Medicinal Chemistry vol atom leucine l932 glutamate methyl group pyrazole terminal carbon methionine explain observed methyl rather large substituent position placement methyl chiral center aliphatic side chain valine glycine loop glycinerich loop show contribute enantiomer fluoro pyrimidine ring occupy hydrophobic pocket show Figure fluoro substituent wellaccommodate presence glycine residue G993 Jak2 prior activation loop motif interestingly difference amino acid back bone alanine posi tion factor selectivity observe series Figure likely steric clash fluoro substituent methyl side chain result tilt ring away optimal interaction site hence observed selectivity Kinase selectivity Evaluation Millipore kinase panel different kinase previously report demonstrate kinase activity inhibition IC50 Table cell induction mitotic block assess phenotypic end point Aurora inhibition change phase population cell cycle observe follow treatment SW620 colorectal adeno carcinoma cell support Information Figure thus demonstrate significant cellular selectivity jak2 antiproliferative activ ity Aurora inhibition likewise autophosphoryla tion cell line21 evaluate treatment show fold selectivity jak2 TrkA cellular context previously describe potently inhibit growth TELJak2 cell line tetrazolium colorimetric assay antiproliferative activity show tightly correlate inhibition Stat5 phosphorylation pStat5 teljak2 cell IC50 also show exhibit significant selectivity small extent test cell transfecte kinase domain family member tyk2 fuse domain demonstrate growth inhibition datum table establish potential effect clinically relevant set effect human hema topoietic cell line identify carry Jak2 mutation examine thus test cellline human megakaryoblastic cell line derive patient hetero zygous V617F homozygous homozygous amplify copy reveal significant growth inhibition line show datum give Table study SET cell line show Stat5 Stat3 phosphorylation inhibit IC50 respectively treatment indicate SET correlate closely inhibition figure similar manner effect Stat5 phosphoryla tion cell examine IC50 find close correlation observe figure contrast human erythroleukemia cell line inhibit stat5 phosphorylation IC50 stat3 phosphorylation IC50 figure discordance IC50 value value result least part amplification Jak2 locus cell line well secondary change associate leukemic transformation furthermore duration exposure experiment cell demonstrate onset inhibition Stat5 Scheme Preparation rac condition Et3N NaN3 DMF DIPEA BuOH microwave Table Biological Pharmacokinetic Evaluationa Jak2 ATP TELJak2 Mb min hour Vdss Han Wistar rat male independent doseresponse curve Vol Ioannidis phosphorylation min treatment maximal inhibition phosphorylation min drug treatment Recovery phosphorylation also rapid complete min drug removal Stats Figure demonstrate clear Pharmacodynamic Effect Mouse Allograft Model biomarker Jak2 inhibition vivo measure pStat5 level splenic tissue mouse implant murine teljak2 cell support Information Figure single dose give oral gavage individual mouse sacrifice different time point postdose almost complete inhibition Stat5 phosphorylation observe least follow single dose determine quantification pStat5 level spleen lysate western blot dose pstat5 inhibit least largely recover dose level inhibition pStat5 observe postdose approximately inhibition maintain figure thus dosedependent duration pStat5 inhibition observe vivo model show tumor Growth inhibition Mouse TELJak2 Allograft Efficacy Model teljak2 cell genetically modify express firefly luciferase gene luc tumor cell growth readily monitor quantify vivo bioluminescent imaging BLI use IVIS imaging system nude mouse implant teljak2luc cell randomize treatment group base give orally twice start tumor cell implantation vehicletreated mouse intensity bioluminescent signal increase exponentially agreement rapid proliferation tumor cell vivo datum show contrast observe significant dosedependent inhibition tumor cell growth treat animal indicate relative reduction light emission compare vehicletreated mouse Figure fold reduction bioluminescent signal intensity figure contribution residue observe selectivity jak2 jak3 Protein backbone atom white wheat overlay represent cartoon bond compound protein show yellow select residue structure represent stick label residue name number figure Crystal structure compound bind Jak2 kinase carbon atom show green protein backbone cartoon represent white selected atom hinge region left gatekeeper l932 well G993 top represent stick refined electron density contour inhibitor represent wire mesh glycinerich loop remove clarity Table Kinase profiling 9ea target enzyme fold selectivity jak2 Aurora Flt FGFR1 JAK3 ALK4 LKB1 jak2 inhibitory activity measure inhibitory activity measure number give enzyme fold selectivity correspond minimum possible selectivity Table inhibition Janus Kinase Family Members Driven Cellular Proliferation Engineered Cell Lines Cell line carry clinically relevant V617F Mutation fold selectivity TELJak2 TELJak3 TELTyk2 SET figure inhibition pStat5 phosphorylate total protein tStat5 human megakaryoblastic cell Cells treat decrease concentration harvested run SDSPAGE phosphorylate total Stat protein assay quantitate use Licor Odyssey imager figure inhibition pStat5 phosphorylate stat5 total protein tStat5 homozygous human hematopoietic cell Cells treat decrease concentration harvested run SDSPAGE phosphorylate total Stat protein assay quantitate use Licor Odyssey imager figure inhibition pStat5 phosphorylate stat5 pstat3 total protein tStat5 human erythroleukemia cell cell treat decrease concentration harvested run SDSPAGE phosphorylate total Stat protein assay Western blot quantitate use imager figure kinetic response pstat3 pStat5 addition reduction pStat5 level apparent min complete inhibition observe min addition pstat3 expression partially inhibit min incubation Jak2 signal change addition pStat5 pstat3 signal recover min washout Jak2 denote phosphorylate jak2 denote untreated Vol Ioannidis dose group approximately fold reduction dose group compare control animal figure conclusion describe discovery series pyrazol potent inhibitor path way screen biochemical cellular assay allow select azd1480 extensive preclinical evaluation compound show good selectivity jak2 family many test kinase suppress activation Jak2Stat pathway low nano molar concentration hematopoietic lineage carry mutation excellent pharmacokinetic property compound prompt explore pharmacodynamic effect TELJak2 model dosedependent manner significant weight loss adverse effect observe dosing single dose sufficient prevent phosphorylation Stat5 study teljak2 luciferase cell demonstrate figure modulation pStat5 level splenic tissue single dose TELJak2 mouse model bar represent mean percentage inhibition phosphorylation Stat5 dose time point calculate use vehicle veh control inhibitor establish maximum minimum value western blot quantitation describe engineer cell perform previously describe Figure Effect treatment teljak2luc cell growth vivo group animal treat vehicle twice daily twice start posttumor cell implantation image represent luciferaseemitte light intensity superimpose photograph tumorbeare mouse treatment group image acquire posttumor cell implantation color scheme luminescence intensity show color bar total bioluminescent signal intensity mouse body determine day average time point treatment group Means plot use prism software dosedependent tumor growth inhibition welltolerate dose attractive preclinical profile result pro gression clinical evaluation myelofibrosis NMR spectra record nmr spectrometer use deuterated dmso dmso otherwise state temperature give degree Celsius operation carry room ambient temperature range shift express part ppm unit constant give unit hertz splitting pattern describe apparent multiplicity designate singlet doublet doubletdoublet triplet quartet multiplet broad singlet Mass spectro copy analysis perform Agilent equip water column Atlantis Atlantis dc18 elute gradient mixture h2oacetonitrile formic acid ammonium acetate purity determination report compound perform Agilent equip water column Atlantis Atlantis dc18 elute min gradient mixture h2oacetonitrile formic trifluoroacetic acid wavelength compound analyze g95 pure chromatography perform system use reversephase HPLC column dimension TFA mobile phase Elemental analysis perform Route East Salem Industrial Park Bldg Whitehouse reaction describe monitor silica gel plate visualize light Flash column chromatography perform MPLC system otherwise mention use silica gel cartridge SFC super critical fluid chromatography refer Diode Array Detector preparative SFC aps AutoPrep preparative SFC obtain use accord manufacturer instruction solution add triphenyl phosphine result mixture cool azodicarboxylate add dropwise period min maintain internal temperature give slurry reaction mixture stir beige precipitate form min MeOH add dropwise period min slurry thin considerably give light yellow slurry reaction mixture stir warm slowly ambient temperature period reaction mixture stir ambient temperature filter remove precipitate filtrate dry MgSO4 concen trate reduce pressure give yelloworange oil fication flash column chromatography MeOH CH2Cl2 afford title compound waxy solid yield nmr mhz hydrochloride salt obtain dissolve meth MeOH dropwise treatment result mixture solution HCl dioxane mixture allow stir room temperature evaporation volatile reduce pressure afford hydrochloride salt white solid yield quantitative mixture dimethylaminomethylthioacrylonitrile hydrazine hydrate ethanol heat overnight volatile remove reduce pressure residue leave purify flash column chromatography gradient methanol afford title compound yield thick oil nmr mhz solution of5methoxypyrazolamine absolute add triethylamine trichloropyrimidine ambient temperature result solution aged room temperature partition h2o organic layer wash brine dry MgSO4 solvent remove reduce pressure give title compound oil crystallize stand yield follow similar procedure follow compound synthesize Dichlorocyclopropylpyrazolpyrimidin amine cyclopropylpyrazolamine trichloropyrimidine yield amine methylpyrazolylamine dichlorofluoropyrimidine yield cyclopropylpyrazolamine dichlorofluoropyrimidine yield Dichloromethylpyrazolpyrimidinamine methylpyrazolylamine tri chloropyrimidine yield amine bromodichloropyrimidine yield amine methylpyrazolamine bro dichloropyrimidine yield NMR CDCl3 Chlorofluoropyrimidindimethyl pyrazolediamine dichlorofluoropyrimidine NMR mhz diamine mine amine solution dichloromethylpyrimidine EtOH add ylamine room tempera ture mixture heat overnight mixture allow cool room temperature whereupon pre cipitate observe title compound collect filtration vacuum white solid yield nmr fluoropyrimidinethanamine rac round bottom flask contain fluoropyrimidinethanol charge triethylamine anhydrous CH2Cl2 ambient temperature solution cool add dropwise result mixture allow stir room temperature point volatile component remove reduce pressure resi due dissolve treat sodium azide result mixture stir room partition brine organic layer collect dry Na2SO4 evaporate reduce pressure dryness crude Vol Ioannidis material purify flash column chromatography hexanes gradient afford fluoropyrimidine colorless oil yield yield step NMR CDCl3 roundbottom flask contain pyrimidine charge evacuate backfille filled balloon MeOH add mixture stir room mixture filter plug diatomaceous earth subsequently wash well MeOH filtrate concentrate reduce pressure give title compound pale yellow oil yield NMR CDCl3 Chlorofluoropyrimidinethylmeth oxypyrazolpyrimidinediamine mixture dichloromethoxypyrazolpyrimidinamine heat overnight solvent evaporate reduce pressure remain material separate water combine organic extract wash brine dry MgSO4 Evaporation solvent reduce pressure give brown oil purification reversephase chromatography tfa min afford trifluor oacetate salt title compound white solid yield NMR fluoropyrimidinethylpyrimidinediamine mixture fluoropyrimidinethanamine hydrochloride amine heat seal microwave vessel microwave reactor solvent remove reduce pressure residue purify reversephase chromatography tfa min give trifluoroa cetate salt title compound yield NMR mixture fluoropyrimidinethanamine hydrochloride chlorofluoromethylpyrazolpyri midinamine heat seal microwave vessel microwave reactor solvent remove reduce pressure andthe residuewaspurifiedbyreversephasechromato graphy tfa min give trifluoroacetate salt title compound yield NMR fluoropyrimidinethylpyrimidinediamine mixture fluoropyrimidinethanamine hydrochloride heat seal microwave vessel microwave reactor solvent remove reduce pressure residue purify reversephase chroma tography tfa min give trifluoroacetate salt title compound yield NMR mixture fluoropyrimidinethanaminehydrochloride 08 dichloromethylpyrazolpyrimidinamine heat seal microwave vessel microwave reactor solvent remove reduce pressure residue purify reversephase chromatography tfa min give trifluoroacetate salt title compound yield NMR anal c14h14clfn83 find find find mixture fluoropyrimidinethanamine anhydrous heat seal microwave vessel microwave reactor solvent remove reduce pressure residue purify reversephase chromatography tfa min give trifluoro thetitle compound yield NMR pyrimidinamine Sodium butoxide add solution rimidinamine fluoropyrimidinethanol intBuOH result mixturewas heat partition organic layer wash saturated NH4Cl solution brine Purification flash column chroma tography etoachexane afford title compound mixtureof enantiomer NMR mixture separate use chiral SFC Column solvent condition column Chiralcel Modifier isopropanol dimethylethylamine flow rate min oven outlet bar Postpurification purity check Chiral SFC use ultraviolet diode array column Chiralcel Conditions isopropanol dimethylethylamine flow rate min min Oven Outlet bar elute first yield column retention time min detect use ultraviolet diode array detector elute second yield column retention time min detect use ultraviolet diode array detector excess estimate use area percentage elemental analysis c14h13clfn7o find find find mixture amine add mixture fluoropyrimidinethanamine hydrochloride anhydrous heat seal microwave vessel microwave reactor reaction mixture concentrate reduce pressure result residue purify flash column chromatography elute gradient MeOH DCM afford title compound yield NMR compound prepare follow similar proce dure describe Vol afford desire product yield NMR chlorodimethylaminopyrazol fluoropyrimidinethylpyrimidinediamine diamine fluoropyrimidinethanamine hydrochloride afford title compound white solid yield NMR CD3OD hydrochloride afford title compound white solid yield NMR CD3OD Fluoropyrimidinecarbonitrile microwave vial charge cyanide zinc dust flask evacuate backfille anhydrous DMA vial mount sonal microwave reactor heat reaction mixture dilute wash brine time organic layer obtain evaporate dryness reduce pressure dry residue purify flash column chromatography elute gradient hexane afford title compound creamy solid yield nmr CDCl3 Fluoropyrimidinethanone solution add dropwise solution MeMgBr et2o result solution stir perature min allow warm ambient temperature overnight mixture quench solu tion saturate NH4Cl extract organic extract dry mgso4 evaporation reduce pressure give colored residue Purification flash column chromatography elute afford title compound yield NMR cdcl3 Fluoropyrimidinethanol nabh4 Et2O add slowly solution fluoropyrimidin ethanone MeOH result solution allow stir room temperature min solvent evaporate reduce pressure residue obtain partition organic layer wash saturated NH4Cl solu tion brine organic extract dry mgso4 evaporation volatile reduce pressure give title compound yield NMR cdcl3 compound 14a prepare follow similar proce dure describe trichloropyrimidine amine trichlorofluoropyrimidine methylpyrazolamine Trichloromethylpyrazolpyrimidinamine 14c Dichloromethoxypyrazolpyrimidinamine 14d trichloropyrimidine NMR Dichlorofluoromethoxypyrazolpyrimidin amine 14e trichlorofluoropyrimidine yield Trichloromethoxypyrazolpyrimidinamine yield follow compound synthesize follow procedure describe methylpyrazolpyrimidinamine 14a fluoropyrimidinethanamine hydrochloride methylpyrazolpyrimidinediamine 15b chlorofluoromethylpyrazolpyrimidinamine fluoropyrimidinethanamine hydrochloride trichloromethylpyrazolpyrimidinamine fluoropyrimidinethanamine hydrochloride 15d dichloro methoxylpyrazolpyrimidinamine 14d fluoropyrimidinethanamine hydrochloride NMR methoxypyrazolpyrimidinediamine dichlorofluoromethoxypyrazolpyrimidinamine 14e fluoropyrimidinethanamine hydrochloride 15f methoxypyrazolpyrimidinamine fluoropyrimidinethanamine hydrochloride NMR ylpyrimidinamine 17a mixture morpholine dichlorofluoromethylpyrazolpyrimidin amine absolute ethanol heat solvent remove reduce pressure residue purify reverse phase chromatography tfa min give trifluoroacetate salt title compound yield NMR linylpyrimidinamine 17b prepare similar procedure describe 17a use dichlorofluoro methoxypyrazolpyrimidinamine 14e start material yield NMR Fluoropyrimidinethylmethyl pyrazolmorpholinylpyrimidinediamine 16a mixture chlorofluoropyrimidinethyl methylpyrazolpyrimidinediamine 15a morpholine heat solvent remove reduce pressure residue purify reversephase chromatography tfa min give trifluoroacetate salt title compound yield NMR Vol pyrazolmorpholinylpyrimidinediamine 16b mixture fluoropyrimidinethanamine hydrochlo ride chlorofluoromethylpyrazol morpholinylpyrimidinamine 17a innBuOH5mL washeatedinasealedvesselinamicro wave reactor solvent remove reduce pressure residue purify matography tfa min give trifluoroacetate salt title compound yield NMR chlorofluoropyrimidinethylmethyl pyrazolmorpholinopyrimidinediamine mixture dichlorofluoropyrimidinethyl methylpyrazolpyrimidinediamine 15c morpholine heat solvent remove reduce pressure residue purify reversephase chromatography tfa min give trifluoroacetate salt title compound yield NMR meod fluoropyrimidinethylmethoxy pyrazolmorpholinylpyrimidinediamine 16d mixture chlorofluoropyrimidinethyl methoxypyrazolpyrimidinediamine morpholine heat overnight solvent remove reduce pressure residue purify reverse phase chromatography tfa min give trifluoroacetate salt title compound yield NMR pyrazolmorpholinylpyrimidinediamine mixture fluoropyrimidinethanamine hydrochloride chlorofluoromethoxypyrazol morpholinylpyrimidinamine andDIPEA heat sealed vessel solvent remove reduce pressure residue purify reversephase chromatography tfa min give trifluoroacetate salt title compound yield NMR pyrazolmorpholinylpyrimidinediamine 16f mixture dichlorofluoropyrimidin ethylmethoxypyrazolpyrimidinediamine 15f morpholine heat sealed vessel solvent remove reduce pressure residue purifiedby reversephase chromatography tfa min give trifluoroacetate salt title compound yield NMR Methyl Dimethyldithiocarbamate Dimethylamine THF cool carbon disulfide add portionwise follow aqueous solution reaction mixture stir min subsequently room temperature reaction mixture recoole methyl iodide add slowly result reaction mixture stir room temperature overnight mixture dilute diethyl ether extract aqueous layer organic extract combine dry MgSO4 Removal volatile reduce pressure afford title compound yield quantitative white solid nmr CDCl3 cool BuLi hexane add dropwise addition funnel reaction allow stir min methyl dimethyldithio carbamate add portion result mixture stir min subsequently room temperature reaction mixture cool methyl iodide add reaction mixture allow warm room temperature stir room temperature overnight mixture dilute ethyl acetate organic layer wash water organic phase concentrate reduce pressure give residue purify flash column chromatography gradient ethyl acetate hexane afford title compound yield mixture isomer NMR major isomer CDCl3 mixture fluoropyrimidinethanamine hydrochloride heat seal microwave vessel microwave reactor solvent remove reduce pressure purified reversephase chromatography tfa min give trifluoroacetate salt chloro fluoropyrimidinethylmethylpyrazolpyri midinediamine yield racemic mixture resolve use chiral SFC Column solvent condition column Chiralpak Modifier isopropanol dimethylethylamine flow rate min oven outlet bar Postpurification purity check Chiral SFC use ultraviolet diode array column Chiralcel Conditions isopropanol methylethylamine flow rate min min Oven Outlet bar elute first retention time min detect ultraviolet diode array detector elute second retention time min detect ultraviolet diode array detector excess retention time min retention time min estimate use peak area percentage analytical datum nmr mhz Rat Microsome stability Assay primary test carry assess propensity compound metabolize rat liver microsomal enzyme time dependent disappearance compound initial concen tration incubate microsome measure use result report intrinsic clearance com pound clint min protein octanolwater partition coefficient log measure use shake flask method Aliquots test compound stock solution add mixture phosphate buffer octanol test compound allow distribute phase shake sample rpm concentration test compound phase analyze use HPLC confirmation primary test assess equilibrium solubility compound phosphate buffer solid compound prepare evapora tion DMSO solution dry compound incubate agitation buffer compound remove filtration concentration test compound filtrate measure hplc confirmation calculate onepoint standard low high limit quantification assay respectively Aurora Assay vitro test use measure change dna content flow cytometry compound treatment Cells plate day establish seeding density control add day require time point cell harvest fix icecold ethanol fix cell resuspend permeabilization buffer Tri",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Pyrazol pyrimidinamines Jak2": 1,
                    "hetero": 1,
                    "Han": 1,
                    "Dichlorocyclopropylpyrazolpyrimidin": 1,
                    "trichloropyrimidine": 1,
                    "Dichlorofluoromethoxypyrazolpyrimidin": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Discovery of N-_2-Chloro-6-methyl- phenyl_-2-_6-_4-_2-hydroxyethyl_- piperazin-1-yl_-2-methylpyrimidin-4- ylamino_thiazole-5-carboxamide _BMS-354825__ a Dual Src__.pdf",
            "cleaned_text": "Discovery Chloromethyl phenylhydroxyethyl piperazinmethylpyrimidin ylaminothiazolecarboxamide Kamelia Behnia Marathe Squibb Pharmaceutical Research Institute Box receive series substitute aminopyridyl identify tent kinase inhibitor excellent antiproliferative activity hematological solid tumor cell line Compound orally active K562 xenograft model chronic myelogenous leukemia demonstrate complete tumor regression low toxicity multiple dose level basis robust vivo activity favorable pharma cokinetic profile select additional characteriza tion oncology indication targeted therapy represent preclinical clinical oncology research use imatinib treatment chronic myelog enous leukemia serve validation concept therapeutic agent target cancer specific pathway offer significant improvement traditional chemotherapeutic agent myeloproliferative disorder characterize hyperproliferation stem cell follow sub sequent differentiation peripheral white blood cell presence chromosome arise translocation Abl kinase domain chromosome specific breakpoint cluster region bcr chromosome characteristic gene product translocation constitutively activate tyrosine kinase know drive proliferation stem cell bone marrow cause result pathology disease target tyrosine kinase activity tinib normalize peripheral white blood cell count substantially reduce chromosome positive clone stem cell bone marrow effectively offer hematological cytogenetic response clinic protooncogene play major role development growth progression metastasis wide variety human cancer Src activation form elevated kinase activity protein expres sion level demonstrate several major cancer type include colon breast pancreatic lung brain carcinoma Src kinase modulate signal transduction multiple oncogenic pathway include EGFR Her2neu PDGFR thus anticipate block signal inhibition kinase activity effective mean modulate aberrant pathway drive oncologic transformation cell Herein describe synthesis anticancer activity thiazolebase dual kinase inhibitor Lck kinase activity relate previously describe provement Lck inhibitory activity series compound afford replace acyl functionality variety heterocycle lead identification compound kinase selectivity panel compound show potent inhibitor multiple Srcfamily member include basis kinase activity chemical series select evaluation potential anticancer agent compound potent biochemical inhibitor kinase IC50 antiproliferative activity human prostate tumor human blastphase CML tumor cell Table spectrum vitro activity hematological solid tumor cell line confirm potential chemotype cology indication motivated characterize additional analogue expand panel cellular assay include K562 PC3 MDA human breast tumor WiDr human colon tumor cell line compound describe fall subclass differ heterocycle append amino group thiazole pyridinebased pyrimidine base analogue demonstrate nanomolar subnano molar inhibitory activity Src effectively differentiate biochemical assay thus focused activity tumor cell proliferation assay mouse oral exposure screen select compound vivo evaluation human tumor xenograft efficacy model imidazolylpropylaminosubstituted pyridine potent compound test cellular assay demonstrate low nanomolar activity tumor type however screen dose oral exposure assay compound produce low circulate plasma level poor oral absorption property combination high correspondence address telephone fax mail jm049486a publish web level plasma protein bind preclude advancement vivo assay similar potent broad spectrum cellular activity observe thylaminopropylamino hydroxyethylamino substitute pyridine encouraging profile offset low oral exposure compound apparent high clearance determine large difference peak plasma drug level compound Improvement pharmacokinetic profile observe incorporation morpholinopropylamine side chain compound afford high peak plasma concentration sustain blood level excess duration assay Incorporation variety morpholinotethere side chain pyrimidinesubstitute aminothiazoles meet limited success general compound maintain excellent potency cell line less effective pyridinesubstituted derivative solid tumor line Compounds bear morpholine directly pyrimidine ring demonstrate encourage spectrum cell activity suffer low oral exposure mouse screen assay Consistent favor able pharmacokinetic profile pyridine com pound generate high sustained blood level follow oral dosing Conservative substitution methyl group pyrimidine ring hydrogen compound afford slight improvement cellular activity profile negative impact compound oral bioavailability follow favorable cellular profile reduce plasma protein bind pyridine primary alcoholsubstituted pyrimidine evaluate Consistent previous result hydroxyethylamino analogue excellent activity cell line unfortunately compound substantially less effective remainder panel piperidinyl methanol piperazinyl ethanol identify compound good balance broad spectrum antiproliferative activity oral exposure mouse screen assay compound demonstrate low midnanomolar potency cell line favorable circulate plasma level fol low oral dosing basis modest plasma protein bind sustained blood level duration exposure study compound select characterization additional kinetic vivo efficacy study prepare overall yield chlorothiazole follow optimize synthetic sequence detail Scheme Condensation lithium anion chloromethylphenyl isocyanate7 proceed smoothly afford correspond carboxamide protect methoxybenzyl derivative Displacement Table Antiproliferative Activities activity determine base tetrazolium dye conversion follow drug exposure IC50 value report mean least individual determination individual IC50 value case less measurement variability mean value otherwise indicate value parenthesis Compounds evaluate formulate solution propylene glycol water protein bind human serum compound concentration chloro substituent thiazole sodium salt aminochloromethylpyrimidine8 reflux fol low deprotection group give chloropyrimidine finally reac tion hydroxyethylpiperazine9 dioxane reflux give subsequently convert corresponding hydrochloride salt methanolic HCl ether sequence prove amenable scale step execute large scale comparable chemical yield threedimensional structure Abl kinase com determine ray crystallography Figure Key feature enzymeinhibitor com plex identify placement activation loop Abl depict magenta active conformation hydrogen bond compound protein pair hydrogen bond form hinge region site amino hydrogen carbonyl oxygen met318 nitrogen thiazole ring amide nitrogen Met318 hydrogen bond also form hydroxyl oxygen Thr315 amide nitrogen Abl loop depict orange partially disorder suggest interaction part protein less critical bind hypothesize specific interaction Abl responsible compound favorable activity mutant kinase forms10 datum show Abl cocrystal structure support share many feature propose bind mode Src kinase figure Src kinase ATP bind site take entry Compound manually dock site complex energyminimize hydrogen bond observe tween Abl kinase also observe kinase model additionally potential hydrogen bond amide carbonyl identify chloromethylbenzamide occupy deep hydrophobic pocket protein substi tut pyrimidine occupy hydrophobic cleft create bury hydrophobic surface area protein ligand region pyrimidine account increase bind affinity observe series relative early pendant hydroxyethylpiperidine group direct solventexpose protein observe engage specific interaction well understand enzyme inhibitory proper tie compound evaluate house kinase selectivity panel value determine confirm highly potent competitive inhibitor measure value respectively selectivity summarize Table Consis tent biochemical profile compound find potently inhibit Srcfamily member compound also demonstrate significant activity kit pdgfr Greater fold selectivity observe kinase target panel rat pharmacokinetic study characterize high volume distribution systemic clearance approximately hepatic blood flow oral dose administer solution propylene glycol water rapidly absorb demonstrate favorable halflife Scheme Synthesis Compound BuLi chloromethylphenyl isocyanate NaH methoxybenzyl chloride aminochloromethylpyrimidine reflux tfa hydroxyethylpiperazine dioxane reflux HCl Et2O MeOH step figure ribbon diagram Abl kinase complex compound Figure Compound model Src kinase atp bind site kinase enzyme IC50 kinase enzyme IC50 BcrAbl MEK src VEGFR lck CDK2 yes kit AKT pdgfr FAK p38 IGF her1 MK2 FGFR PKC Journal Medicinal Chemistry Vol Letters mean residence time measure oral bioavailability study conjunc tion mouse oral exposure datum conclude pharmacokinetic profile propriate continued advancement vivo ficacy study summary parameter rat study contain Table vivo activity evaluate K562 xenograft assay nude mouse figure tumor cell implant subcutaneously stage proximately prior cycle oral drug administration day day schedule follow dose compound show partial tumor regression treatment cycle complete disappearance tumor mass end drug treatment toxicity animal death lack weight gain observe cohort animal thus determined possess potent vivo activity high safety margin animal model vivo activity imatinib refractory model solid tumor xenograft report separate communication conclusion novel series aminopyridyl aminopyrimidinylthiazolecarboxamide potent kinase inhibitory activity identify Analogues demonstrate broad spectrum antiproliferative activity hematological solid tumor cell line originate breast prostate colon tissue Compound picomolar inhibitor kinase orally active K562 xenograft model chronic myelogenous leukemia demonstrate tumor regression multiple dose level basis favorable vivo efficacy pharmacokinetic profile advance clinical trial acknowledgment thank Laurence synthetic chemistry support compound characterization effort support Information available characterization datum compound full experimental proce dure characterization datum compound detailed description pharmacokinetic assay material avail able free charge Internet Dwyer STI571 target therapy Frame Src cancer deregulation consequence cell behaviour Wityak Das Pitt initial aminocarboxamidothiazole inhibitor Srcfamily kinase p56lck Leith Pitt Zhang Shuster Behnia Schieven Barrish Identification BMS novel potent orally active Srcfamily kinase p56lck inhibitor Lett press activity determine base tetrazolium dye conversion follow drug exposure detail assay culture condition tumor cell line contain follow Kim Long BMS novel mode action similar paclitaxel possess superior efficacy Clin Cancer Res Begtrup Hansen new method introduction substituent thiazole scand Minami Commercially available Nagar Bornmann Pellicena Schindler Veach structure kinase domain Abl complex small molecule inhibitor pd173955 imatinib STI Cancer Res Sawyers novel pyridopyrimidine inhibitor Abl kinase picomolar inhibitor cell effective sti571resistant mutant Norris sawyer override resistance novel Abl kinase inhibitor Science structure reveal feature autoinhibitory mecha JM049486A Table Pharmacokinetic Properties Compound SpragueDawley Rats parameter unit dosea oral dosea dose AUCtot MRT min Vss Fpo Data report average animal associated standard deviation parenthesis figure vivo antitumor activity compound K562 xenograft nude mouse drug formulate solution citric acid buffer",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Conservative": 1,
                    "isocyanate7": 1,
                    "hydroxyethylpiperazine9": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Discovery of __2R_5R__5____5_Fluoropyridin_2_yl_oxy_methyl__2_methylpiperidin_1_yl__5_methyl_2__pyrimidin_2_yl_phenyl_methanone _MK_6096__ A Dual Orexin__.pdf",
            "cleaned_text": "Discovery Fluoropyridinoxymethyl methylpiperidinmethylpyrimidin phenylmethanone Potent SleepPromoting Properties Thomayant Prueksaritanont Winrow define difficulty initiate sleep maintain sleep find sleep nonrestorative common disorder affect general population high incidence elderly also disease include depression cardiovascular dis ease chronic pain total direct indirect cost sociate insomnia project great lion year current regimen treat insom nia involve use central nervous system CNS depre sant modulate GABA receptor function associate risk dependence nextday residual effect amnesia rebound insomnia myorelaxation give limitation current treatment novel approach dress sleep onset maintenance provide excel lend tolerability need neuropeptide discover inde pendent research group find bind previously identify orphan proteincoupled receptor gpcrs orexin receptor orexin receptor ox2r Orexin secrete neuron localize hypothalamus orexin proteolytically derive common preproorexin peptide neuropeptide receptor dis Insomnia common disorder comorbid physical psychological illness traditional manage ment insomnia rely general central nervous system CNS suppression use gaba modulator many agent fail meet patient need respect sleep onset maintenance nextday residual effect issue late tolerance memory disturbance balance neuropeptide central regulator wakefulness orexin antagonism identify novel mechanism treat insomnia clinical proof concept Herein describe discovery series methylpiperidine car boxamide dual orexin orexin receptor OX1ROX2R tagonist dora design molecule inspire early work laboratory understand prefer conformational property potent orexin receptor bind Minimization allylic strain interaction use design principle synthesize disubstitute piperidine car boxamide axially orient substituent include exceptional vivo activity pre clinical sleep model advance phase clinical trial treatment insomnia Laboratories Box Sumneytown mail Sumneytown USA Sumneytown USA Fox Laboratories Box Sumneytown USA Cabalu Cui Prueksaritanont Drug Metabolism Laboratories Box Sumneytown Lincoln Highway Rahway USA Stellabott Basic Pharmaceutical Sciences Merck Research Laboratories Box Sumneytown information article available KGaA tinct partially overlap distribution CNS project region brain regulate arousal sleepwake cycle bind similar affinity orexin bind avidly strong genetic linkage orexin hypofunction regulation wakefulness inbred dog inheritable lossfunction mutation narcoleptic pheno type Human narcolepsy associate loss orexin produce neuron hypothalamus low absent level orexin cerebrospinal fluid CSF significant gulation sleepwake cycle observe genetically modify mouse loss orexinergic neuron deletion preproorexin gene Secretion orexin CNS occur circadian frequency orexinergic neuron become active period wakefulness become quiescent sleep administer centrally orexin peptide sufficient induce wakefulness locomotor activity specie include mouse rat dog monkey validation role orexin smallmolecule orexin antagonist promote sleep rat dog mouse human laboratory recently describe discovery suvorex ant dual orexin receptor antagonist cur rently phase clinical study treatment insomnia figure suvorexant high affinity OX1 OX2 receptor promote sleep multiple specie include human indeed clinical proof concept study establish increase sleep efficiency tient primary insomnia suvorexant member diazepanebase structural class chemotype previously describe structurally distinct almorexant also enter clinical study Figure report decrease wakefulness rat dog first achieve clinical proof concept treat symptom insomnia clinical development subsequently halt identify potent enter clinical trial show efficacious rodent primate sleep model place clinical hold late fol low phase study due emergence report pre clinical toxicity Herein describe discovery dinphenylmethanone potent reversible dual orexin receptor antagonist currently clinical develop ment treatment primary insomnia result Discussion effort describe herein begin know piperidine car boxamide newly synthesize compound evaluate radioligand displacement assay measure bind affinity express value subsequently imaging plate reader format provide functional readout receptor antagonism CHO cell overexpress human receptor datum report IC50 value antagonist possess good potency respect receptor bind excellent potency high plasma clearance preclinical specie poor physicochemical property initial investigation probe transposition substituent posi tion position maintain threecarbonatom linkage piperidine nitrogen atom oxygen aryl ether give compound figure transposi tion result fold loss potency orexin ceptor subtype early work laboratory indicate cyclic constraint find piperidine essential good receptor potency fact unconstrained amidopro poxy aryl ether fourfold less potent respect bind Acyclic also exhibit high clearance preclinical specie poor physicochemical property initial effort focus understanding substitute piperidine carboxamide prefer high potency rela tive substitute analogue give result unconstrained linear carboxamide figure enter clinical study figure constrained unconstrained amidopropoxy ether wwwchemmedchemorg WileyVCH KGaA allylic strain govern preferred con formation substitute piperidines nitrogen atom sp2 hybridize case compound substituent predict adopt minimize eclipse interaction amide carbonyl alkyl substitution contrast sub stituted piperidine carboxamide predict alkyl substitution orient pseudoequatorially ground state Pre viously report analysis potent diaze panebased use single crystal ray molecular model ing nmr solution suggest diazepane prefer adopt shaped conformation lution solid state conformational property cyclic carboxamide complex multiple ring conformer present restrict rotation bond amide additional study highly con strained molecule suggest shape partly stabilize interaction represent bioactive conformation orexin receptor bind ing inspection reveal substitute piperidine carboxamide potentiate similar interaction serve provide access bioac tive conformation figure explore strategy induce axial orientation alkyl substituent instal methyl group sition adjacent sp2hybridized nitrogen atom peridine case allylic strain provide bias axial orientation methyl substituent provide ch2or substituent orient trans methyl substituent piperidine ring expect substituent piperidine disposed transdiaxial orientation installation methyl group position piperidine perform scaffold phenylthiazole carboxamide tria improve bind affinity compound enhancement potency realize replace fluorophenyl ether phenyl ether provide insertion methyl group provide cis isomer trans isomer racemic trans isomer exceptionally potent gaining fold bind affinity respectively unsub stitute contrast cis isomer less potent anticipate methylation increase bind affinity direct substituent axial orientation magnitude effect receptor potency remarkable disubstituted piperidine derivative synthesize show scheme hydrogenation methyl nicotinate use platinum oxide acetic acid moderate pressure afford mixture cistrans piperidines ratio carboxylate ester separable independently advance subsequent synthetic quence reduction ester follow formation aryl ether reaction provide aryl ether Hydrogenolysis benzyl carbamate follow amide formation triazolmethylbenzoic acid provide orexin antagonist Additional SAR development carry piperidine objective improve physicochemical property maintain good receptor potency compound series high lipophilicity correlate high intrinsic clear ance human animal liver microsome poor pharmacokinetic replacement methylfluorophenyl ether investigate table place phenyl ether azaheterocycles naphthyridine pyrimidine pyrazine ate replace phenyl ether pyridine Scheme Methylation piperidine carboxamide figure predict lowenergy conformation compound KGaA wwwchemmedchemorg attenuate receptor potency bind affinity gain reinstallation substituent dine importantly incorporation pyridine signifi cantly improve physicochemical property decrease measure logp point optimization piperidine series focus alternate strategy duce transdiaxial substitu tion pattern piperidine carboxamide also stall methyl group alter nate position methyl alkylpiperidine derivative prepare commercially available substi tut piperidine Scheme show Table transdisubstituted peridine also gain significant potency nonmethylate piperidine extent gain potency less observe methyl substitution com pound observation consistent structural hypothesis methylation favor transdiaxially substitute piperidine axial orien tation CH2OAr group specific advantage disubstitution exploration center compound compound exceptional potency suffer poor aqueous solubility mgmL low oral bioavailability rat optimization focus aryl moiety carboxamide key molecule list table synthetic sequence optimize provide improve access trans disubstitute piperidine Scheme Hydrogenation pyridine provide ratio racemic mixture equilibrate treatment sodium meth oxide methanol 508C equilibration ratio cistrans invert favor thermodynamically stable trans isomer ratio unpurified product isomerization reduce crude amino cohol protect carbamate adduct reaction purified HPLC chiral stationary sup port provide pure cbz high enantiomeric excess Replacement triazoyl moiety present phenyl group compound improve receptor bind tency compromise physicochemical property aqueous solubility mgmL compound high lipo Scheme Synthesis disubstitute piperidine condition PtO2 AcOH CBz Et3N cis trans lialh4 methylfluorophenol Ph3P methyltria acid HOBT Et3N Table SAR exploration aryl ether clogP OX1R measure value mean experiment Scheme Preparation disubstituted piperidine carboxamide condition lialh4 methyltriazolbenzoyl chloride step fluoropyridin DIAD chiral HPLC Table effect methylation piperidine potency OX1R wwwchemmedchemorg WileyVCH KGaA philicity tend highly shift IC50 value assay Table triazolyl substituent replace pyrazole pyridine pyrimidine case pyrazole significant activity lose improve physicochemical property modest decrease potency pyrimidinyl substituent afford good balance OX1ROX2R potency provide unexpected improvement aqueous solubility pyrimidine substitution also drive increase plasmafree fraction antagonist high free frac tion generally achieve high CSF concentration great sleeppromoting efficacy comparably low plasma level tolylmethyl substituent critical potency deletion methyl group replacement fluorine compound compromise potency emerge interesting molecule study Lowtemperature NMR study indi cat equilibrating mixture isomer ratio abundant isomer piperidine chair conformation transdiaxial substitution differ slow rotation amide bond major isomer depict Figure strong no serve proton ies preferred conformation confirm solid state singlecrystal ray Howev solid state preferred conformation isomer diarylamide substituent rotate configuration pyrimidine ring adjacent ropyridine group ray structure show trans axial arrangement disubstitute piperidine receptor conserve specie com pound highly potent human rat dog mouse rabbit rhesus orexin bind ing assay Compound favorable pharmacokinetic pro file preclinical specie pharmacokinetic evaluate rat beagle Table administration exhibit high plasma clearance rat low moderate plasma clearance dog Table terminal halflife short specie range bioavailability rat dog respectively peak plasma concentration specie achieve rapidly oral dosing protein bind ing high mea sured value rat dog human respectively major route clearance preclinical specie oxidative olism significant oxidation scheme optimize synthesis transdisubstitute piperidine reagent con dition PtO2 AcOH NaOMe MeOH lialh4 CBz overall Figure NMR no observe compound ray crystal structure Table Optimization biaryl carboxamide IC50 value mean experiment bind determined FLIPR assay human plasma protein bind solubility measure highthroughput solubility assay KGaA wwwchemmedchemorg benzylic carbon observe rate liver microsomal metabolism human close dog low rat microsomal intrinsic clearance protein dog human rat pound potent reversible inhibitor IC50 value respectively also potent timedependent inhibitor spective kinact value min dosedependently promote sleep rat dog follow oral administration decrease locomotor activity rat relative vehicle treatment sevenday cross study dose active phase rat mgkg elicit dosedependent crease active wake concomitant crease rem nonREM sleep dog EEGtelemetry study promote sleep oral dose dose active phase dose significant change sleep measure record pharmacokinetic assess cohort satellite animal effective dose oral admin istration associate value respectively corresponding auc0 value mmh attenuation response drug serve cumulative dosing rat dog preclinical datum suggest high potential brain penetration human compound substrate human rat glycoprotein mediate efflux express cell line high passive permea bility control cell Papp cms base preclinical datum project good brain penetration favorable human profile predict rapid absorption follow oral administration consistent desire profile sedativehypnotic Compound favorable physicochemical property neutral crystalline form polar surface area good solubility simulate intesti nal fluid fast state mgmL also high selectivity orexin receptor bind ing Evaluation counterscreen panel receptor enzyme target reveal ancillary activity IC50 value compound potent inhibitor herg channel IC50 treatmentrelated cardiovascular change observe preclinical evalua tion compound anesthetize vagotomize dog model plasma concentration Compound achieve high receptor occupancy humanize ox2roverexpresse transgenic rat brain assay low infusion anesthetize rat achieve cupancy plasma exposure Binding ox2r fully reversible demonstrate vitro kinetic dis placement assay base favorable preclinical datum select move clinical study designate recently advance phase clinical study treatment insomnia conclusion summary identify dual orexin receptor antago nist excellent potency brain penetra tion physicochemical property selectivity activity multiple preclinical specie previously describe discovery characterization suvorexant currently latestage clinical study respect preclinical efficacy potent suvorexant rat dog eeg study furthermore measure receptor occupancy suvorexant transgenic rat overexpresse human Occ90 value respectively suggest great potency design drive part understand formational property anticipate favorable high orexin receptor activity early conformational study provide strong rationale design molecule central template permit intramolecu lar arylaryl interaction particular piperidine methylation adjacent amide nitrogen atom provide analogue transdiaxial substitution enable critical interac tion represent novel therapy treat insomnia disorder relate sleepwake dysregulation Table Pharmacokinetics compound rat dog Species Dose mgkg mlmin1 kg Vdss Lkg Dose mgkg AUC mmh tmax rat dog aqueous tocopheryl polyethylene glycol succinate value mean experiment table sleep change male beagle dog com pound Dose mgkg Active wake sleep rem slow wave slow wave Quantitation sleep stage duration express mean percent change relative treatment vehicle alone follow treatment population test wwwchemmedchemorg WileyVCH KGaA animal study perform accord NIH Guide experimental proto col radioligand bind receptor occupan assay well polysomnographic analysis rat dog previously disclose solvent use commercially available anhydrous grade reagent use purification otherwise note reaction carry oven heat gundried glassware atmosphere Magnetic stirring use agitate reaction monitor completion TLC silica gel Smith Creator microwave use micro wave heating CombiFlash system use use silica gel chromatography frac tion collection HPLC purification carry HPLC XBridge Prep C18 column use gradient TFA H2OCH3CN sample collection trigger photodiode array detection report yield isolated compound purity wise note extensively optimize purity analysis carry hplc Waters Separations Module equip column interface water spectrometer use gradient TFA H2OCH3CN detection nmr spectra record Varian INOVA mhz spectrometer chemical shift internal standard tetramethylsilane CDCl3 solvent peak respectively high resolve power accurate mass measure ment electrospray atmospheric pressure chemical ioniza tion APCI mass spectral datum acquire use transform ion cyclotron resonance mass spec trometer rotation determine 238C spectrometer solvent specify substituted piperidine orexin receptor antagonist describe manuscript exhibit complex conformation solution exist multiple conformation result hinder rotation slow nmr timescale proton spectra com pound consist broad overlap multiplet preclude tailed couple constant analysis feel pictorial repro duction NMR spectra informative comparative purpose thus NMR resonance final compound list numerical format instead include reproduction nmr spectra 258C final compound support information compound shift assign analysis COSY HSQC spectra acquire sample dissolve CDCl3 258C methanone solution methylphenylthiazole carboxylic acid mmol piperidinylmethanol mmol EDC mmol HOBT mmol seal heat microwave actor min mixture dilute wash saturated aqueous nahco3 brine organic layer dry Na2SO4 filter concentrate crude mate rial purify gradient elution silica gel EtOH NH4OHH2O etoac yield product colorless film see figure end reproduction mhz mhz NMR spectra CDCl3 258C LRMS cool solution droxymethylpiperidinmethylphenylthiazol thanone mmol fluorophenol mmol treat dropwise diethyl azodicarboxylate mmol stir room temperature mixture concentrate residue absorb silica gel purified gradient elution silica gel hexane yield paleyellow solid see figure end support formation reproduction mhz mhz NMR spectra CDCl3 258C kbr HRMS calcd C23H23FN2O2S find synthesis benzyl dinedicarboxylate cis trans solution methyl methylpyridinecarboxylate treat platinum oxide mmol acetic acid bottle evacuate backfille time stir atmos phere atm room temperature overnight mixture filter filter cake wash MeOH filtrate treat TEA mmol CBz mmol mixture stir room tempera ture min concentrate residue partition tween h2o organic phase dry Na2SO4 filter concentrate crude material purify gel hexane yield cis colorless oil trans colorless oil yield see figure end reproduction mhz mhz NMR spectra CDCl3 LRMS Benzylfluoromethylphenoxymethylmethylpi peridinecarboxylate cis solution cis mmol cool treat slowly lialh4 mmol solution warm stir min treat dropwise successively Na2SO4 add mixture stir room tempera ture mixture filter pad fil trate concentrate yield alcohol product cis take crude next step solution crude alcohol mmol methylfluorophenol mmol bind treat DIAD mmol mixture stir filter filtrate concentrate crude material purify gradient elution silica gel hexanes yield cis yellow oil yield step see figure end reproduction mhz mhz NMR spectra CDCl3 LRMS cisFluoromethylphenoxymethylmethylpiperi dinmethyltriazolphenylmethanone KGaA wwwchemmedchemorg solution cis treat carbon mmol flask evacuate backfille time stir atmosphere atm room temperature min mix ture filter syringe filter filtrate concentrat yield amine product take crude next step solution crude amine mmol DMF treat methyltriazolben zoic acid mmol EDC mmol HOBT mmol TEA mmol stir ring room temperature overnight mixture dilute wash brine organic phase dry Na2SO4 filter concentrate mate rial purify gradient elution HPLC CH3CN tfa give pure fraction concentrate dilute wash saturated aqueous NaHCO3 organic phase dry Na2SO4 filter concentrat yield white solid yield step see figure end production mhz mhz NMR spectra CDCl3 258C kbr HRMS calcd C24H27FN4O2 find peridinecarboxylate trans solution trans mmol cool treat slowly lialh4 mmol solution warm stir min treat dropwise successively Na2SO4 add mixture stir room tempera ture mixture filter pad fil trate concentrate yield alcohol product take crude next step solution crude alcohol mmol methylfluorophenol mmol resinbound treat DIAD mmol mixture stir filter filtrate concentrate crude material purify gradi ent elution silica gel hexanes yield step see fig ure end reproduction mhz mhz NMR spectra CDCl3 LRMS solution trans treat mmol flask evacuate backfille time stir atmosphere atm room temperature min mix ture filter syringe filter filtrate concentrat yield amine product take crude next step solution crude amine mmol DMF treat acid mmol EDC mmol HOBT mmol TEA mmol stir ring room temperature overnight mixture dilute wash brine organic phase dry Na2SO4 filter concentrate mate rial purify gradient elution HPLC CH3CN tfa give pure fraction concentrate dilute wash saturated aqueous NaHCO3 organic phase dry Na2SO4 filter concentrat yield white solid step see figure end reproduc tion MHz mhz NMR spectra CDCl3 258C kbr HRMS calcd C24H27FN4O2 find Hydroxymethylmethylpiperidinmethyl triazolphenylmethanone acid hydrochloride mmol dissolve cool stirring lution add lialh4 mmol dropwise solution allow stir room temperature reaction mixture cool cooled solution add successively dropwise solu tion h2o result biphasic mixture stir Na2SO4 add stir additional min mixture filter cake wash concentrated yield crude amino alcohol offwhite solid use next step crude amino alcohol mmol dissolve add stir separate flask chloride mmol dissolve solution cool 08c min solution contain amino alcohol add small portion complete addition ice bath remove reaction allow stir reaction mixture dilute wash saturated nahco3 solution brine dry Na2SO4 concentrated residue purify silica gel chromatography elute etoachexane pure fraction desire product concentrate yield white solid see figure end reproduction mhz mhz NMR spectra CDCl3 LRMS Compound mmol dissolve add solution stir min DIAD mmol add dropwise solution stir reaction mixture dilute wash saturated nahco3 brine dry concentrate residue purify silica gel elute yield residue resolve chiral SFC column elute EtOH CO2 DEA flow rate compound elute first min see figure end port information reproduction mhz mhz nmr spectra CDCl3 CHCl3 KBr HRMS calcd C22H24FN5O2 find hydroxymethylmethylpiperidinecarbox ylate CBz solution methyl methylpyridine carboxylate hydrochloride treat mol PtO2 mmol AcOH mmol Parr bottle evacuate backfille time stir atmosphere charge time room temperature mixture wwwchemmedchemorg WileyVCH KGaA filter filter cake wash MeOH filtrate concentrated yield product cis trans ratio material dilute MeOH treat NaOMe mmol heat 508C stir temperature mixture cool room neutralize concentrated HCl filter filtrate concentrate residue suspend MeOH filter result filtrate concentrate yield crude amine hydrochloride transcis suspension amine hydrochloride transcis mmol THF overhead stirring cool treat dropwise LiAlH4 mmol addi tion funnel stir min maintain mix ture treat dropwise addition funnel H2O successively Na2SO4 add mixture stir room tempera ture mixture filter filtrate concentrate yield crude amino alcohol solution crude amino alcohol mmol CH2Cl2 treat TEA mmol CBz mmol mixture stir room temperature overnight concentrate residue partition h2o organic phase dry Na2SO4 filter concentrate crude material purify gradient elution silica gel hexane yield racemic material transcis trans material separate away cis diastereomer enantiomer resolve Chiracel column isocratic elution hexanesiPrOH yield CBz tan oil first elute peak step include chiral separation see figure end reproduction mhz mhz NMR spectra CDCl3 258C CHCL3 fluoropyridinoxymethylmethylpi peridinecarboxylate solution mmol fluorohydroxypyridine mmol resinbound treat DIAD mmol mixture stir filter filtrate con centrate crude material purify gradient elution HPLC CH3CN tfa give pure fraction concentrate dilute wash turate aqueous NaHCO3 organic phase dry Na2SO4 filter concentrated yield colorless film see figure end support formation reproduction mhz mhz NMR spectra CDCl3 258C CHCL3 LRMS solution treat mol mmol flask evacuate backfille time stir atmos phere atm room temperature min mixture fil tere syringe filter filtrate concentrate yield desire amine take purification solution crude amine mmol DMF treat iodomethylbenzoic acid mmol EDC mmol HOBT mmol TEA mmol stir room temperature overnight mixture dilute wash organic phase dry Na2SO4 filter concentrate crude material purify gel hexane yield colorless oil step see figure end reproduction mhz mhz nmr spectra CDCl3 258C CHCl3 LRMS solution treat mmol CuI mmol ph3p4pd mmol mixture heat stir mixture cool room temperature dilut wash organic phase con centrate purify gradient elution HPLC CH3CN tfa give pure fraction con centrated dilute wash saturated aqueous NaHCO3 organic phase dry Na2SO4 filter concentrated yield white solid exist mixture rotameric component chemical exchange CDCl3 room temperature chemical shift populated rotamer assign anal ysis COSY HSQC spectra acquire sample dis solve CDCl3 total nmr MHz CDCl3 ppm nmr mhz CDCl3 total nmr MHz CDCl3 ppm nmr mhz dmso ppm See Supporting Information reproduction nmr spectra KBr HRMS calcd c24h25fn4o2 find also include experimental detail synthesis compound ment author thank Professor helpful synthetic chemistry discussion also thank analysis synthetic support model stud ies compound insomnia medicinal chemistry neurotransmitter orexin receptor KGaA wwwchemmedchemorg palomer Prinep Guglietta Ann Lecea Daniel son Frankel Proc Natl Acad Sci USA Kozlowski Wilson Arch Buckingham Haynes Carr Mignot Cell Thannickal Moore Neuron Sinton elmquist Yanagisawa Cell Grady Nishino Czeisler Hepner Deadwyler Neurosci Ripley Mignot Nishino Sleep genet Toxicol ChemMedChem Coleman Renger Expert Whitman Prueksaritanont Cui Herring snavely Liu Lines Sleep Supplement itanont ChemMedChem BrisbareRoch Hoever Aissaoui Flores Mueller Weller Fischli Clozel Donati Stasi Branch Braggio Chiarparin Porter Stemp Cox Roecker Curr Top Med Chem Sugg Griffin Portoghese Org Chem Paulsen Todt Angew Chem Angew Chem Int Engl Johnson Chem Rev axial conformer calculate kcalmol stable conformer equatorial substituent generate use combination communication subsequent conformation minimize use MacroModel Schrdinger force field use distancedependent dielectric Ball nont Lett Coleman Cox Garson Prueksaritanont Winrow Renger Lett replace phenylthiazoyl carboxamide triazol methylbenzamide improve physicochemical property orexin bind affinity preparation triazolmethylbenzoic acid see ref relate occupancy experiment rat high unbound plasma con centration correlate high level drug Compound c24h25fn4o2 monoclinic P21 gcm monochromatize radiation Data collect Bruker CCD diffractometer limit yield reflection unique reflection observe level structure solve direct method Crystallogr Sect find refine use fullmatrix leastsquare compound crystallize independent molecule asym metric unit lattice final model refine use param eter datum nonhydrogen atom refine thermal displacement final agreement statistic base reflection max maximum peak height final difference Fourier map peak chemical significance contain supplementary crystallographic datum paper datum obtain free charge Winrow Gotter Cox Harrell test effect herg channel heterologous express cell use standard wholecell voltageclamp techniques Compound inhibit herg current IC50 value Compound administer intravenously period vehicle ypropylcyclodextrin water determine effect cardiovascu lar function anesthetize vagotomize dog effect compare vehicle previously test separate set dog heart rate mean arterial pressure electrocardiographic rameter QTc interval monitor predose min infusion period treatmentrelated effect observe Peak compound plasma concentration mean measure min infusion respectively description occupancy assay see ref Jackson Hutzelmann snavely Herring Sleep Biol rhythm receive publish online wwwchemmedchemorg WileyVCH KGaA",
            "term_counts": {
                "Mental Health Terms": {
                    "depression": 1
                },
                "Epigenetic Terms": {
                    "methylation": 4
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "cistrans": 2,
                    "concentrat": 4,
                    "Chiracel": 1
                }
            },
            "co_occurrence_matrix": {
                "Mental Health Terms": {
                    "methylation": 1,
                    "cistrans": 1,
                    "concentrat": 1,
                    "Chiracel": 1
                },
                "Epigenetic Terms": {
                    "depression": 4,
                    "cistrans": 4,
                    "concentrat": 4,
                    "Chiracel": 4
                },
                "Ethnographic Terms": {
                    "depression": 7,
                    "methylation": 7
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "DNA methylation and body-mass index_ a genome-wide analysis.pdf",
            "cleaned_text": "article wwwthelancetcom publish online DNA methylation index genomewide analysis Loukia Tsaprouni Cambien Ouwehand Trgout Panos Deloukas Summary Background obesity major health problem determine interaction lifestyle environmental genetic factor association several genetic variant index BMI identi little know epigenetic change relate BMI undertake genomewide analysis methylation cpg site relation BMI Methods individual European origin recruit form discovery cohort type wholeblood dna nium humanmethylation450 array quality control methylation level test association site show association BMI false discovery rate value less take forward replication cohort unrelated white patient northern European origin cohort Sites remain signi not primary replication cohort test second replication cohort white patient European origin cohort examine methylation level identi site also show association BMI DNA adipose tissue skin obtain white female individual participate study finally examine association methylation site genetic variant gene expression finding individual discovery cohort exclude analysis check leave participant adjustment covariate identi association value methylation probe di erent gene bmi association probescg22891070 cg16672562 intron primary second replication cohort increase methylation value cg22891070 BMI high discovery cohort high primary replication cohort high second replication cohort cohort methylation cg22891070 associate BMI adipose tissue skin observe signi not inverse correlation methylation cg22891070 expression geneexpression probe adipose tissue single nucleotide polymorphismsrs8102595 rs3826795had independent association methylation cg22891070 cohort however single nucleotide polymorphism signi cantly associate BMI Interpretation increase BMI adult European origin associate increase methylation locus blood cell adipose tissue nding suggest perturbation hypoxia inducible transcription factor pathway important role response increase weight people Introduction Obesity associated comorbiditie constitute major grow health problem worldwide therefore understand mechanism ect bodymass index BMIthe widely use measure downstream ect important health priority BMI complex phenotype determine lifestyle physical activity environmental factor food availability intake genetic factor major ort identify genetic determinant BMI genomewide association study show single nucleotide polymorphism snp associate BMI together explain interindividual variation BMI dna methylation reversible heritable attachment methyl group nucleotide common form dna methylation occur carbon cytosine cpg dinucleotide create methylcytosine cpg dinucleotide often locate cpg island cluster site promoter region rst exon gene upstream gene island shore dna region island shelf shore DNA publish online see OnlineComment S0140 Department Cardiovascular Sciences phd Prof Prof Prof Glen Prof Prof Human Genetics Wellcome Trust Sandling phd Meduri phd Prof Ouwehand Prof phd University Bedforshire Uppsala Sweden Sandling Sorbonne Universits Univ Assi MSc Prof phd INSERM Assi Prof Nutrition Paris Assi Prof MSc Grallert Waldenberger phd Prof Epidemiology Waldenberger Prof Articles wwwthelancetcom publish online Gieger phd Helmholtz Zentrum MnchenGerman Health inserm France Prof Morange Division Epidemiology Gagnon phd German Centre Cardiovascular Research Munich Heart Alliance Prof Prof fr Integrative und Prof German Centre Cardiovascular Research HamburgKielLbeck Prof Herzzentrum Mnchen Technische Prof Prof Department Prof Ouwehand Prof Ouwehand Genetic Epidemiology King College Spector Barts Prof Hereditary Disorders King Abdulaziz University Jeddah Saudi Arabia Prof Correspondence Prof Department eld Hospital methylation play part transcriptional regulation gene mirnas control alternative promoter usage alternative splicing genetic environmental factor ect extent dna methylation view range potential downstream functional outcome epigenetic change ect dna methylation integrate impact genetic environmental factor phenotype alternatively epigenetic change cause phenotype mediate downstream ect change gene expression genomewide association study genetic variant progress systematic analysis dna methylation hitherto hamper absence analogous platform study epigenetic phenomenon however newly develop nium human methylation450 array assay methylation site span gene database average cpg site gene region array validate consistently detect cpg methylation change use array largescale analysis methylation pattern wholeblood dna relation BMI Methods Participants white individual recruit form discovery cohort history myocardial infarction recruit centre healthy blood donor recruit genotype previously obtain participant Human Quad Custom array genomewide gene expression datum obtain monocyte derive macrophage HumanRef Beadchip array primary replication cohort use datum unrelated white patient French origin venous thrombosis recruit cohort patient genotype Human 660WQuad array analyse methylation site show signi not association primary replication cohort second replication cohort white participant recruit survey genotyping do ymetrix GeneChip array Santa Clara USA investigate association methylation hif3a site BMI observe blood dna also see tissue analyse datum white female individual obtain part study HumanMethylation450 array do subcutaneous adipose tissue biopsy skin biopsy adipose tissue sample come twin pair monozygotic dizygotic twin singleton skin sample come twin pair monozygotic dizygotic singleton collection process biopsy sample study describe previously addition methylation array genomewide genotype datum obtain combination HumanHap610 array genomewide expression adipose tissue obtain illuminaht array available participant individual provide write informed consent participate primary study allow dna analysis sample procedure detail methylation assay do discovery cohort quality check undertake give appendix Methylation describe value continuous variable range methylation full methylation sample probe detection value measure individual probe performance assign miss status probe miss sample exclude sample exclude probe basis avoid spurious association also exclude probe contain genomic site variation already know accord humanmethlyation450 annotation niumHD Methylation SNP list minor allele frequency leave probe analysis methylation value correct background value normalise SWAN18 Package min use array annotation provide version assign probe corresponding gene use array replication cohort sample follow similar experimental procedure postarray process similar way study normalise methylation value analysis SWAN18 blood replication cohort quantile normalisation19 study sample statistical analysis BMI normally distribute discovery cohort therefore transform log scale regression analysis logtransformed BMI methylation level probe adjust age sex smoking status methylation array batch centre adjustment centre also adjust patient niumHD Methylation SNP list see Package min see min html see Online appendix article wwwthelancetcom publish online myocardial infarction Chip assignment associate BMI therefore include model model dependent variable BMI case log transform regression analysis interpret change dependent variable coe cient increase unit independent variable therefore present coe cient percentage change correction genomic control apply appendix estimate value false discovery association false discovery rate value less take forward replication sequential replication cohort linear regression analysis log transform BMI adjust age sex smoking status array batch assess signi cance correction cohort account family structure tte linear mixed ect model lme4 package adjust model age array batch smoking status xed ect family identi cation number zygosity random ect use likelihood ratio test statistic assess signi cance calculate value distribution degree freedom assess association methylation level site show correlation BMI genotype adjacent snp discovery cohort assume additive allele ect use mixed ect model age sex smoking status centre BMI methylation batch array ect methylation chip random ect apply correction multiple testing result analyse signi not independent association similar manner replication cohort sample addition family identi cation number zygosity random ect exclusion sex also use model analyse association methylation level BMI individual blood cell count discovery cohort power calculation version role funding source sponsor study role study design datum collection datum analysis data interpretation write report full access datum discovery cohort datum cohort cohort cohort nal responsibility decision submit publication result individual discovery cohort myocardial infarction healthy blood donor exclude analysis check methylation array datum appendix leave participant table report others21 genomic level methylation cpg dinucleotide discovery cohort bimodal distribution frequent level methylation occur value second slightly low peak lme4 package see packageslme4lme4pdf Discovery cohort Cardiogenics Primary replication cohort replication cohort MuTHER cohort Individuals myocardial infarction healthy blood donor Adipose tissue sample skin sample age year Men index ever smoker Height weight systolic blood pressure diastolic blood pressure Diabetic Methylation cg22891070 methylation cg27146050 Methylation cg16672562 Data mean mean range available subset participant also provide adipose tissue sample value table characteristic participant study cohort article wwwthelancetcom publish online appendix previous study Illumina Bead Chip precursor humanmethylation450 Bead Chip use robust association current smoking methylation cg03636183 locus F2RL3 show replicate form overall validation discovery analysis examine association current ever smoke methylation site dataset record similarly highly signi not association methylation cg03636183 smoke reduce methylation smoker appendix distribution value discovery cohort regression methylation level site BMI show gure quantilequantile plot expect observe value show appendix probe achieve false discovery rate value less include individual probe cluh chromosome chromosome appendix probe hif3a chromosome table exclude possibility probe show crossreactivity several site take probe forward analysis primary replication cohort methylation level probe CLUH KLF13 associate BMI cohort appendix hif3a probe signi not correction multiple testing table test association probe second replication cohort probe signi cantly associate BMI association weak cohort table identi hif3a probe cg22891070 cg27146050 cg16672562 neighbouring probe intron gene gure Methylation level cg22891070 cg27146050 cg16672562 highly correlate discovery cohort probe anke other nominally signi not association BMI discovery cohort cg05286653 cg12068280 meet false discovery rate value threshold lower overall probe site array result probe show appendix Methylation cpg site member plot show distribution value association methylation probe index discovery cohort red dot indicate probe fall chromosome CLUH chromosome hif3a chromosome log10 value Chromosome Position Discovery cohort Cardiogenics Primary replication cohort replication cohort value percentage change bmi value percentage change bmi value percentage change BMI cg22891070 cg27146050 cg16672562 signi cance threshold correction multiple testing primary replication cohort second replication cohort index correct association analysis convert percentage change BMI unit increase methylation value table association methylation site chromosome wholeblood DNA bmi discovery replication cohort article wwwthelancetcom publish online hypoxia inducible transcription factor family HIF1A probe EPAS1 probe arnt probe associate BMI datum show DNA use methylation analysis derive mixture erent white blood cell type methylation probe vary erent white cell population correlation BMI simply result vary proportion cell type individual di erent BMIs therefore use cg22891070 exemplar examine association methylation level probe number cell type discovery cohort use mixed ect model additionally test association number cell type BMI record weak positive correlation methylation cg22891070 lymphocyte count survive correction multiple testing record association cell type appendix furthermore adjustment lymphocyte monocyte neutrophil count substantially attenuate association methylation cg22891070 BMI also examine association dna methylation hif3a individual component BMI height weight discovery cohort signi cantly associate weight height exploratory analyse populationbase cohort association methylation characteristic associate BMI physical activity type diabetes mellitus signi not site overall methylation value discovery cohort range cg22891070 cg16672562 appendix value similar replication cohort table correlation methylation level cg22891070 blood dna BMI discovery cohort change methylation level cg22891070 quintile BMI vice versa show appendix increase methylation value cg22891070 associate high BMI discovery cohort table person discovery cohort mean BMI increase equate high BMI average increase BMI great participant myocardial infarction blood donor percentage change bmi replication cohort increase methylation small discovery cohort table equivalent high BMI average cohort methylation level hif3a site strongly associate BMI adipose tissue skin table range methylation value narrow tissue blood dna table however narrow adipose tissue skin mean reduced range reason association observe skin direction association methylation hif3a adipose tissue BMI blood percentage change great analyse methylation locus correlate hif3a gene expression adipose dataset genomewide expression available record weak value signi not inverse correlation methylation cg22891070 ILMN1663015 hif3a geneexpression probe array appendix genomewide expression datum monocyte macrophage discovery cohort expression detectable level cell directly examine variation methylation level cg22891070 associate expression gene blood cell dna sequence variation associate methylation level look association snp cg22891070 methylation probe use genomewide datum available discovery cohort appendix snp rs8102595 rs3826795 independent association methylation cg22891070 table rs8102595 strong association rs3826795 table figure location methylation probe associate index snp ecte methylation level probe locus vertical black line represent exon arrow indicate direction transcription methylation site intron showing association index show red snp show association methylation level probe show blue green block represent position island locus nucleotide polymorphism cg22891070 cg27146050 rs3826795 rs8102595 cg16672562 hif3a adipose tissue skin value percentage change bmi value percentage change BMI cg22891070 cg27146050 cg16672562 Data parenthesis ci index association analysis convert percentage change BMI unit increase methylation value table association BMI methylation site adipose tissue skin dna cohort article publish online rs8102595 locate rs3826795 2 kb upstream cg22891070 gure Associations snp methylation cg22891070 also highly signi not replication cohort table furthermore association record adipose tissue skin cohort table variation rs8102595 account variation methylation cg22891070 blood dna discovery cohort cohort cohort genetic variation also account variation methylation cg22891070 adipose tissue skin study view association snp methylation cg22891070 next test association BMI discovery cohort observe consistently signi not association appendix however power analysis low appendix therefore also test association snp index body mass publicly available consortium dataset find signi not association BMI rs8102595 rs3826795 appendix discussion identi replicate speci association BMI methylation hif3a whole blood dna record association dna adipose tissue high relevance bodyweight obesity imply biologically relevant preliminary report available wholeblood methylation relation index body composition obesity rst undertake largescale analysis replication principal nde panel component hypoxia inducible transcription factor regulate wide variety cellular physiological response reduce oxygen concentration control expression many target gene heterodimer compose subunit arnt subunit HIF1A EPAS1 hif3a bind subunit arnt target erent set downstream gene cellspeci manner case layer complexity add fact locus subject much alternate splicing lead least variant di ere target induction target gene hif3a bind arnt generally weak evoke HIF1A EPAS1 bind arnt furthermore especially situation amount ARNT limit least isoform hif3a seem hinder response hypoxia sequestering ARNT restrict bind HIF1A EPAS1 main focus role cellular vascular response change oxygen tension normal development pathological process cardiovascular disease cancer30 compelling increase experimental datum suggest system also play key part metabolism energy expenditure obesity Speci cally target disruption HIF1A arnt adipocyte transgenic mouse associate reduce fat formation protection obesity insulin resistance induce highfat diet similarly systemic use antisense oligonucleotide HIF1A mouse dietinduced obesity substantially suppress HIF1A expression liver adipose tissue associate increase energy expenditure weight loss hypothalamus signal primarily EPAS1 role glucose sensing regulation energy balance weight ecte expression investigate thoroughly subunit context show role cellular response glucose insulin function accelerator adipocyte furthermore sirna inhibition hif3a Hep3B cell signi cantly downregulate mrna expression role acquire obesity crosssectional nature analysis mean assign cause ect association directly association observe hif3a methylation BMI previous studies41 show DNA rs8102595 rs3826795 Frequency ect allele value Frequency ect allele value Discovery Cardiogenics Primary replication cohort replication cohort MuTHER cohort adipose tissue cohort skin value additive model unit change methylation copy ect allele table association methylation level cg22891070 single nucleotide polymorphism locus dataset see broadinstituteorg publish online sequence variation ect level methylation individual site methylation quantitative trait locus investigate directionality association hif3a methylation BMI search genetic variant associate hif3a methylation establish variant also associate BMI turn identi signi not independent association genotype SNPsrs8102595 rs3826795 upstream methylation identi probe cg22891070 however identi association variant bmi cohort large genomewide association metaanalysis BMI include individual analysis datum power detect association snp exist appendix nding suggest association increase methylation high BMI causal furthermore nding methylation hif3a skin associate BMI strong methylation quantitative trait locus tissue also indicate absence causal directionality therefore nding suggest increase methylation locus result increase BMI alternative possibility association methylation hif3a BMI due confounding factor ect variable however observe association hif3a methylation bmi skin furthermore observe association characteristic associate BMI physical activity diabetes mechanism increase BMI lead rise hif3a methylation unknown obesity predispose individual obstructive sleep apnoea associate intermittent hypoxia turn hypoxia activate signal therefore chronic upregulation HIFs response obstructive sleep apnoea result secondary change methylation gene however association methylation level locus show linear correlation range BMI level increase methylation con ned obese individual appendix furthermore association BMI variation methylation speci note HIF1A EPAS1 identi signi not inverse association hif3a methylation hif3a expression adipose tissue association record hif3a expression probe genomewide expression array appendix suggest ect methylation transcriptspeci context note site locus associate BMI situate region open chromatin identi formaldehydeassiste isolation regulatory element cell K562 cell suggest site lie regulatory region however expression probe analyse report tag transcript appendix reason discrepant nding probe unclear therefore work need do con ect methylation expression transcript speci city however nding support possibility even association increase methylation hif3a BMI secondary alteration signal result obesityinduced hif3a methylation still important role deleterious downstream ect disorder recorded signi not association increase hif3a methylation blood dna increase BMI di erent cohort strength association vary substantially di erent cohort gradient relation methylation hif3a fourtime steep discovery cohort second populationbase replication cohort similar distribution methylation value represent element winner ect variation characteristic cohort include presence disease unclear even discovery cohort note level association individual myocardial infarction healthy blood donor strength association blood donor similar cohort comprise patient deep vein thrombosis suggest variation entirely relate disease status therefore search medline Dec term BMI dna methylation obesity dna methylation BMI epigenetic obesity epigenetic identi hundreds report many potential relevance epigenetic obesity original research report focus methylation speci gene already know associate index BMI obesity POMC small genomewide study association methylation BMI index obesity explore de nitive nding study overweight obese adolescents28 identi region show erential methylation level individual high low response multidisciplinary weightloss intervention study show signi not change genomewide methylation pattern human adipose tissue exercise intervention validation necessary study show dna methylation dynamic also ect weight change response lifestyle dietary measure rst largescale genomewide analysis association adult BMI dna methylation show BMI associate methylation hif3a blood adipose tissue nding provide strong foundation exploration part play epigenome regulation BMI downstream detrimental ect increase bodyweight understand role identify novel therapeutic target tackle obesity article wwwthelancetcom publish online study need identify factor ect hif3a methylation modulate association BMI hif3a methylation wholeblood dna work also necessary deduce timing variation methylation locus relation BMI dynamic blood readily accessible dna analysis contrast genetic analysis challenge epigenetic analysis circulate source DNA bloodare compose several di erent cell subtype show celltype speci variation DNA methylation pattern extent show variation assess statistical adjustment do perhaps fundamental issue epigenetic community analysis blood dna methylation worthwhile ect change relevant tissue phenotype regard nde association BMI speci methylation site blood adipose tissue dna support use wholeblood dna methylation pro le identi cation relevant epigenetic change provide rationale study type use strict sequential replication design avoid penalty multiple testing con rmation association probe identi discovery cohort also start fairly small discovery cohort therefore recognise probably miss association methylation gene BMI Metaanalyses dataset use study together dataset yield additional insight epigenetic change associate BMI summary report novel association increase BMI adult European origin increase methylation locus blood cell adipose tissue nding extend report link obesity experimental model provide direct evidence people perturbation signal important role mediation downstream adverse response increase BMI Contributors CPN conceive study responsible recruitment phenotype discovery cohort generate methylation array datum discovery cohort analyse datum discovery cohort supervise provide datum primary replication cohort analysis provide datum second replication cohort analyse JKS TDS provide datum cohort analyse CPN write report author report provide comment Declaration interest declare compete interest acknowledgment work do part fund project support grant Hospitalier Recherche Clinique methylation array type fund grant grant T6484 Statistical analyse dataset do computing centre fund pour Recherche Mdicale study initiate nance Helmholtz Zentrum MnchenGerman fund study fund programme grant receive support base fund work come portfolio translational research support unit support PhD grant Rgion Ile France hold collaborate 12CVD02 Senior Investigator holder award support core grant fund dna methylation analysis hold chair fund Senior Investigator thank genotype facility Wellcome Trust Sanger Institute sample preparation quality control type cohort global obesity pandemic shape global driver local environment Speakman Rahilly Fat evolve issue Speliotes analyse individual reveal new locus associate body mass index Jones Functions DNA methylation island start site gene body DNA methylationassociated silence tumorsuppressor micrornas cancer change human methylome Conserved role intragenic dna methylation regulate alternative promoter Nature cation genetic element autonomously determine dna methylation state environment emerge pattern implication network sensor driver common human disease nature Heyn Validation DNA methylation microarray site human genome epigenetic Garnier haplotype analysis cis expression quantitative trati loci monocyte transact locus regulate antiviral expression network type diabetes risk nature susceptibility allele unlikely contribute strongly ABO loci VTE risk result GWAS approach Blood Wichmann Gieger Illig KORAgenresource population genetic control broad spectrum disease phenotype suppl architecture gene regulatory variation multiple human tissue study e1002003 article publish online Grundberg Small Mapping cis transregulatory ect multiple tissue twin subsetquantile array normalization nium humanmethylation450 BeadChips Genome Biol R44 comparison normalization method high density oligonucleotide array datum base variance bias false discovery rate practical powerful approach multiple testing statist soc Evaluation nium Methylation k technology epigenomic di erential dna methylation k discovery replication crossreactive probe polymorphic nium humanmethylation450 microarray epigenetic DNA methylation pattern cord blood dna body size childhood e31821 Obesity relate methylation change dna peripheral blood leukocyte wide analysis reveal association FTO gene variant epigenetic change epigenomic signature stable time covary body mass index Moleres Campin Milagro erential dna methylation pattern high low responder weight loss intervention overweight obese adolescent study exercise intervention uence genomewide dna methylation pattern human adipose tissue e1003572 Wang Ohh update biology hypoxiainducible factor role human hypoxiainducible factor variant hypoxia response Cell Mol Life Sci Svensson Inhibitory PAS domain protein negative regulator hypoxiainducible gene expression Nature Makino Tanaka Poellinger Inhibitory PAS domain protein hypoxiainducible splicing variant hypoxiainducible locus hypoxiainducible factor adipocyte improve insulin sensitivity decrease adiposity highfat dietfed mouse diabetes consequence highfat diet attenuate suppression e46562 Park factor direct gene mediate hypothalamic glucose sensing energy balance regulation e1001112 Park vivo delivery cellpermeable antisense hypoxiainducible factor oligonucleotide adipose tissue reduce adiposity obese mice Control release induction deoxyglucose insulin Biophys Res Commun Hypoxiainducible factor function accelerator 3T3 adipose angiopoietinlike protein level expression adipose tissue inversely correlate obesity monozygotic twin Lipid Res DNA methylation pattern associate genetic gene expression variation HapMap cell line R10 abundant quantitative trait locus exist dna methylation gene expression human brain e1000952 Adipose tissue obesity obstructive sleep apnoea Eur Respir function active chromatin hypersensitive site FEBS otherwise genetic epidemiology Epidemiology",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 139,
                    "epigenetic": 14
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "European": 5,
                    "French": 1,
                    "coe": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "European": 153,
                    "French": 153,
                    "coe": 153
                },
                "Ethnographic Terms": {
                    "methylation": 7,
                    "epigenetic": 7
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "DNA methylation and cancer.pdf",
            "cleaned_text": "ed DNA Histone Methylation Cancer Targets Cancer Drug Discovery Development DNA Methylation Changes Cancer cancer genetic disease broad change epigenomic pro file key observation many distinct cancer type diagnostic reflect alter directly contribute disease state short focus dna modification change contribute understand cancer progression hypothesis cancer cell epigenome reflect altered dependency compare tissue origin dna methylation reprogramme hydroxymethylcytosine land scape cancer diagnostic Tet enzyme introduction concept epigenetic originate resolve potential paradox cellular differentiation embryological cell genetic material differentiate multiple distinct cell type importantly epigenetic mechanism incorporate idea inheritance alter gene expression state subsequent division com mitte cell even signal initiate epigenetic change long cease concept run parallel idea signal pathway gene regulatory network organise development organism fer tilize egg embryogenesis adulthood fundamentally genetic basis development disease illustrative epigenetic landscape bed action gene influence epigenetic state adopt differentiate cell landscape cell progress valley genetic information become modify lose restrict developmental potential subsequent molecular analysis identify chromatin centred mechanism promote selective gene silence activation Human Edinburgh Crewe Road Edinburgh EH4 mail richardmeehanigmm profile characteristic cell type however ability transdif ferentiate cell core transcription factor offer strong evidence gene regu latory network GRN dominant mode development specification context epigenetic mechanism operate question arise embryo development cancer transformation occur active epi genetic pathway understand potential role epigenetic process cer predicate comprehend role development alter cellular transformation functional consequence alteration become increasingly clear disruption epigenome result alteration epigenetic regulator fundamental mechanism cancer implication molecular diagnostic small molecule cancer therapie DNA core feature epigenetic developmental potential link change gene activity independently genetic alteration concept drive identification dna chromatin modify activity participate regu lating gene expression profile development disease state however target many activity depend classical transcriptional mech anism DNAbinding protein recruit chromatinDNAmodifying activity concert transcriptional machinery mammal dna methylation good study epigenetic mark develop ment disease context especially cancer study partly due relatively simple model correlate change chromatin function alter dna methylation profile efficient datum generation sophisticated bioinformat ics analysis well establish CpG Island cgi methylation provide strong heritable repression transcription ectopic novo methylation CGI associate tumour suppressor gene potentially con tribute establish cancer state however still strong debate observe promoter methylation alteration consequence gene inactivation cancer much analysis rely correlative evidence maintenance methyltransferase Dnmt1 cofactor cally consider responsible perpetuation dna methylation cell division novo dna methylation initially establish development combination Dnmt3B act concert cofactor Dnmt3L Dnmt3L essential germ cell development ensure endogenous retrotransposon inactivate Somatic pattern dna methylation participate multiple level locus specific genome stability indi rectly epigenetic mechanism include chromosome inactivation ensure genomic imprinting retrotransposon silence gene repression methyl cytosine 5mC enzymatically generate mammalian DNA Meehan addition methyl group carbon position pyrimidine ring cytosine mostly context dinucleotide dna strand symmetrically methylate replication hemimethylated DNA potent substrate maintenance DNA methyltransferase dnmt1 perpetuate parental pattern profiling demonstrate methylate cpg pervasive mammalian genome exception discrete nonmethylate cgi feature regulatory landmark mostly associate gene promoter change dna methylation pro file content indicative alter cellular state first exemplify early cancer study replicate many time culminate nucleotide resolution modification map cancer cell line tumour exam ple colon cancer exhibit characteristic alteration dna methylation datum many cancer genome consortium continuously incorporate comprehensive resource somatic mutation human cancer improve defini tion disease type presentation remission reoccurrence dna meth ylation profiling also use extensively reprogramming disease study chart change cell state also link physiological process ageing metabolism attraction dna methylation epigenetic mark observation symmetrically methylate dna relatively stable originate cell pattern propagate cell division DNA methylation machinery integrate dna replication pathway general occurrence dna methylation regulatory region enhancer active cgi promoter associate induced transcriptional repression mediate direct inhibition bind attract chromatin silence activity differentially methylate promot er associate gene inactivation different tissue type identify correspond remarkably small number gene normally express germline silent nonmethylated CGI gene asso ciated histone repressive modification profile dependent responsible add ubiquityl moiety histone lys119 addition methyl group histone lead H3K27me1 H3K27me2 H3K27me3 PRC2 respectively H3K27me3 mark reso lutely associate gene repression dna methylation undergo extensive reprogramming early embryo development primordial germ cell progression link signal induce pathway shift dna methylation profile mouse cell similar developmental change observe somatic cell context recently unclear ular mechanism underpin dna demethylation pathway disruption account alter pattern hyper hypoDNA methyla tion observe many cancer DNA Methylation Changes cancer dna methylation basic mechanism lead dna demethylation consider passive mechanism methylation hemimethylated substrate DNA replication prevent thus lead progressive loss concert cellular proliferation active process remove modification modify basis DNA convert back unmod ifie state methylcytosine dioxygenase enzyme know TenEleven Translocases TETs generate intermediate potential dna demethylation pathway hydroxymethylcytosine 5hmC formylcytosine 5fC carboxylcytosine 5caC Fig 5hmC gather much interest stable relative abundance predict biological function addition role dna demethylation intermediate presence oxidation derivative also lead passive demethylation Fig Overview dna methylation cycle dna modification occur largely cytosinephosphodiesterguanine dinucleotide mammalian genome bulk modify methylation cpg recent report reveal methylate cytosine convert hydroxymethylcytosine 5hmCpG action TET enzyme relatively stable convert formylcytosine carboxylcytosine rapidly remove base excision repair result unmodified cpg dinucleotide relative amount modification suggest font size text presence genome dampen activity dna methyltransferase dnmt lead passive hypomethylation dna replication properly recognize methylation maintenance machinery example active hemihydroxymethylate DNA possibility 5hmC 5caC 5fC trigger erasure dna glycosylase thymine dna glycosylase follow base excision repair however oocytespecific Tdg conditional knockout give rise normal offspring exhibit alter level zygotic result indicate existence yetunknown demethylation mechanism downstream oxidation TET enzyme conversion methyl modify cytosine basis hydroxymethyl mark basis oxidation occur iron ketoglutarate dependent manner Changes TET activity link alter pattern many cancer less abundant absolute term cytosine level hydroxymarked cytosine far great downstream dna demethylation modification 5fC 5caC abundant 5hmC also functional role genome pattern modification vary greatly tissue cell type extent profiling use exquisite identifier cell state tissue type Fig consensus view 5hmC modify Fig DNA modification pattern act identifier cell state pattern unique give cell type strongly alter cancer understand epigenetic change relate transcriptional outcome give cell important understand significance cancer DNA Methylation change cancer CpGs generally deplete majority promoter element enrich body transcriptionally active gene enhancer element well small number transcriptional start site associate silence gene contrast profile present genome wide enriched satellite repeat dna sequence proximal enrichment 5hmC enhanc ers upstream annotate transcriptional start site suggest role region regulation gene expression modification profile gene strongly overlap peak normal tissue example active enhancer mark associate region flank transcription start site fact profile relate transcriptional landscape mean far dynamic modifi cation typically think stable lock inactive chroma tin state DNA modification perturbation cancer disruption epigenetic landscape include pattern hall mark cancer underlie mechanism cancer specific methylation change still largely unclear apparent occur early cancer initiation progression focal hypermethylation specific region genome first report inactivation RB1 gene retinoblastoma cell novo methylation cgi report subsequently causation mechanism scope potential experimental artefact address multiple study investigate relation ship alteration genomic methylation pattern carcinogenesis accumulative evidence suggest dna methylation pattern often drastically different cancer compare find normal healthy tissue create alter epigenetic dependency major epigenetic alteration frequently observe global dna hypomethylation cancer large domain affect repetitive dna sequence global hypo hydroxymethylation majority genome include promoter gene body discrete genespecific hypermethylation CGIs CGI shore enhancer element affect hundreds locus give dynamic interplay exhibit observe change modi fication cancer dynamically link Discrete HyperMethylation Events cancer recent evidence suggest disruption normal DNA carcinogenesis mechanism responsible aberrant cgi hypermethylation event TET1 gene associate hematopoietic malignancy loss gain promoter tet1 cell result regulation expression derailment differentiation process interest observation oncogenic inhibit TET1 expression pathway restoration TET1 expression pathway inhi bition ectopic TET1 reintroduction cell reactivate select number target gene indicate dichotomy signal induced regulation methylation discrete number cgi target gene generalised tissue determine cgi methylator profile variable tumour type latter case novo methylation occur predominantly already silence gene passenger gene therefore affect expression status former silence dna methylation select target gene dependent active signal pathway therefore strictly epi genetic character Oncogenic RAS braf require tion pathway maintenance repression activation pathway cpg cpg cpg tet1 mediate dna demethylation active passive keep hypomethylated enhancer promoter Reduced Tet expressionprotein activity promote hypermethylation carcinogenesis loss dna demethylation pathway TET dnmt Reduced Tet activity protein dnmt enhancer regulatory region Normal 5hmC Cancer 5hmC Normal cancer Cancer Loss 5hmC promoter enhancer protection result hypermethylation Global loss accompany hypomethylation 5hmC 5hmC Direct loss 5hmC due globally reduce level DNMT dysregulation reduction total TET levelsactivity TET gene expression reduce Cancer TET mutation Cancer TET gene TET gene TET gene TET protein TET protein reduce TET protein level Cancer reduce TET activity metaboliteshypoxia Cancer TET protein Cancer tet protein pattern genome normal cancer cell coloured plot show typical 5hmC pattern genome Typically 5hmC find enrich enhancer promoter proximal genic region find enhancer genic repetitive element show cancer 5hmC lose promoter enhancer region contribute aberrant hypermethylation event contrast genic loss accompa nies loss dash box indicate possible mechanism observation DNA Methylation Changes cancer intermediate direct methylation select target cgi gene consideration lead question tumour suppressor gene become methylated dna methylation tumour suppressor gene inherit multiple generation idea dna methylation tsg epigenetically inherit maintain instructive transcrip tional mechanism potentially repress multiple gene contrast recently show aberrant cgi hypermethylation several mouse model liver cancer occur site mark unique chromatin state healthy liver promoter proximal site destine become hypermethylate liver cancer find rich 5hmC associate mark histone tail modification H3K27me3 H3K4me3 typically associate transcriptionally poise active expression state observe loss 5hmC occur site prior accumulation relate reduction level enzyme previously show bind preferentially CGIs Loss reduce bind ultimately result loss active protective dna demethylation acquisition 5mC Fig activity tet enzyme also reduce tumour hypoxia human mouse cell occur independently hypoxiaassociate alteration TET expression depend directly oxygen shortage result increase hypermethylation gene promoter patient exhibit markedly methylated select promoter hypoxic tumour tissue independently proliferation stromal cell infiltration tumour characteristic increase hypoxia mouse breast tumour also increase hyper methylation restoration tumour oxygenation abrogate effect often invoke mechanism transcriptional inactivation tumour suppressor gene directly drive carcinogenic pro cess however many gene associate hyperethylate CGIs cancer already silent host tissue begin recent datum suggest change profile enhancer element instead relate phenotypic transcriptomic change observe cancer pro gression Enhancers consistently differentially methylate region progression normal tissue primary tumour subsequently metastasis compare genomic feature change level locus link cancer type overall patient outcome anticancer effect dna methyltransferase inhibitor link upregulation immune signal cancer viral defence path way independently profile exam ple upregulation intergenic hypomethylated endogenous retrovirus ERV gene accompany drive response antiviral response underlie antitumour activity drug Azacytidine transfection dsRNA derive cell control cell induce antiviral response recipient cell pathway gene also upregulate correlate increase expression endoge nous retroviral transcript rather repression interferon pathway transcrip tion factor 5hmC Landscape Cancer Studies use immunohistochemistry blot mass spectroscopy con report strong global loss cancer cell line tumour Fig concert reduce global level 5hmC genomewide pattern also markedly alter tumour sample normal surround tissue melanoma loss gain genic large number gene body change far subtle gene tend associate melanoma relate pathway Wnt signal component surprisingly gen eral cancer progression lung liver cancer specific relationship set chromatin mark present normal tissue largely absent tumour drive reflect altered regulation gene expression mouse liver cancer human cancer cell line 5hmC lose series promoter region result aberrant hypermethylation event site reinforce reciprocity regulation DNA modi fication landscape well genic promoter region 5hmC typically strongly enriched promoterproximal enhancer element mouse cell loss TET enzyme result hypermethylation enhancer ele ment delay gene induction differentiation similar result also observe acute myeloid leukemia loss TET2 enzyme link hypermethylation active enhancer element result indicate TET enzyme fundamentally require maintain normal epigenetic transcriptomic landscape give cell least part protection key regulatory loci enhancer promoter ele ment dysregulation turn provide cell growth advantage increase stem proliferation silence tumour suppressor gene compare change tumour type sub type essential shed light molecular event associate cancer progression identification biomarker clinical use molecular mechanism combine Azacytidine vitamin treat ment generate antitumour response loss multiple endogenous retrovirus ERV gene occur inhibition stimulation active dna demethylation elevated TET enzyme activity follow vitamin treatment result induction double strand rna dsrnas recognise cell stimulate interferon response enhance immune signal result reduce cell proliferation ultimately apoptosis tumour cell DNA Methylation Changes cancer role TET enzyme Cancer TET methyl cystosine dioxygenase enzyme sev eral cofactor often mutate transcriptionally downregulate reduce protein level substantial amount overlap deposition member Tet null mouse viable loss 5hmC absolute null mouse liver short hairpin rna shrna reduction TET enzyme human embryonic carcinoma cell show loss result great elevation pro moter element well widespread reduction depletion TET2 TET3 reduce subset target suggest functional dependence TET mediate 5hmC prevent hypermethylation genome particularly CGI shore loss TETs relate hypermethylation event Loss 5hmC enhancer mouse cell result hypermethylation impact gene expression early stage cell differentiation analysis large number human cancer study record Catalogue Somatic Mutations Cancer COSMIC database reveal fere number mutation TET enzyme TET2 fre quently mutate however mutation less exclusively find haematopoietic lymphoid cancer COSMIC dataset TET1 TET3 comparison find mutate rare number case typically human cancer TET3 mutate skin cancer colorectal cancer specific mutation gene directly associate cancer progression reduce transcriptional protein level report colon gastric lung liver cancer TET2 transcriptionprotein level typically reduce leukaemia melanoma TET1 downregulation also show promote malignancy breast cancer act tumour suppressor inhibit colon cancer growth repress inhibitor path way addition reduce level also show result ele vate rate metastasis gastric cancer missregulation downstream pathway require tumour migration interestingly TET1 find methylate transcriptionally repress series cell line primary tumour multiple carcinoma lymphoma meth ylation causative reflective TET transcriptional inactivation still fully elucidate activity tet enzyme inhibit stimulate several cofactor metabolite posttranslational modification evident cancer harbour gainfunction mutation gene cycle enzyme isocitrate dehydrogenase result aberrant conversion hydroxyglutarate potent inhibitor TET activ ity Mutations cycle protein hydratase succinate dehydrogenase SDH relatively common subset human Meehan cancer include gastrointestinal stromal tumour SDH case renal cell carcinoma SDH case case Mutations lead accumulation fumarate succinate inhibit multiple dioxygen as include TET family enzyme Loss TET activity tumour hypoxia find result loss gain gene promoter enhancer element reinforce protective role enzyme play loci normal cell contrast show increase level ascorbic acid vitamin stimulate TET protein enzymatic activity cultured cell well mouse tissue addition vitamin low dose result synergistic inhibition cancercell proliferation increase apoptosis effect associate enhanced immune signal include increase expres sion bidirectionally transcribe erv increase cytosolic dsrna activation cellular response many patient hematological neo markedly vitamin deficient treatment patient hematological cancer vitamin improve response epigenetic therapy dna methyltransferase inhibitor treatment dna methylation inhibi tor activate growthinhibite immune response also effective thera peutic approach colon cancer take together result highlight complex relationship disruption cancer progression reliant directly transcriptional state TET enzyme also overall environment cancer cell Indirect Impact DNA Methylation Reprogramming Cancer Epigenomes major difference observe normal mammalian DNA methyla tion landscape find cancer cell line tumour discuss many become aberrantly hypermethylate cancerous cell hypodna methylation occur genomic region Genes subject cgi promoter hypermethylation frequently mark PRC2 deposit H3K27me3 early development persistence H3K27me3 region normal cell development dependent global content induced hypomethylation result loss H3K27me3 previously unmethylate CGIs somatic cell context lead gene activation importantly dna hypomethylation result accumulation PRC2 complex component H3K27me3 genomic loca tion previously DNA methylate suggest dense dna methyla tion prevent PRC2 bind chromatin addition require significant proportion target mouse cell connect putative demethylation pathway recruitment context formally DNA Methylation Changes cancer possible delocalisation complex tandem loss demethylation activity make cgi gene formerly mark H3K27me3 susceptible novo methylation epigenomic reprogramming phase carcinogenesis bring relationship dna methylation system forefront cancer epigenomic also implication genome regula tion important inference reprogramme dna methylation pat tern cancer trigger misregulation transcriptional program subsequent redistribution repressive activity PRCs addition also feed back ectopic target novo methylation previously mark H3K27me3 target include large number gene key func tion cell lineage decision regulation cell cycle major impact development progression cancer Mutations result ing histone variant cancer resistant modification impact diverse aspect chromatin biology include dna methylation gene expres sion functional interplay dna methylation pathway also likely important biological system especially age cancer mechanism promote transcriptome facilitate cancer formation plasticity progression analysis multiple cancer DNA lome imply alter binding occur contribute altered enhancer tie impact transform process carcinogenesis checkpoint enable correct preservation transcriptional circuit metabolic program often absent tumorigenic lesion thus impart cancer cell ability generate novel transcriptional metabolic etic dependency Future Perspectives Future study concentrate dissect causeconsequence relation ship involve cancer transformation role epigenetic plasticity drive tumour progression identity epigenetic cellular heterogeneity explore potential point combinatorial therapeutic intervention involve patienttumour stratification genetic metabolic epigenetic profiling provide new marker early diagnosis Fig ability identify dna base marker liquid biopsy circulate tumour cell effective identify origin tumour especially metastasis Regulation inhibitory immune receptor program cell death govern cisDNA element tfs epigenetic tion note report promoter methylation indepen dent prognostic biomarker biochemical recurrencefree survival prostate cancer patient link immune surveillance finally availability new geneedite tool enable exquisite manipulation cancer epigenetic profile include Tet gene function promote cell death rather cell proliferation ment like thank helpful comment insight Part work support prize support MRCMCPC U127574433 Work lab support Waddington strategy gene discussion aspect theoretical biology Book epigenotype Int Epidemiol dna methylation tumour suppressor gene epigenetic elife e02475 eLife Commentary epigenotype Epidemiol ijedyr186 origin epigenetic Exp Biol core misconcept Implications developmental gene regulatory network developmental biology ctdb Lander Initial impact sequence human genome Nature origin evolution fashionable topic ydbio Fig Utility DNA modification base assay clinical application analysis genome wide dna modification landscape hold potential development novel early stage diagnostic screen stratification tumour subclass efficient personalised med icine regime development new realtime screening tool epigenetic base liquid biopsy screen DNA Methylation Changes Cancer Epigenetic programming reprogramming develop ment nsmb pluripotent stem cell mouse adult fibroblast culture define factor cell cell cancer dysregulate epigenome allow cellular growth advantage expense host Cancer nrc3486 silence endogenous gene hitandrun target epigenetic editing cell e214 cell Razvi Oosta Epigenetics market landscape qualitative quantitative picture advance profile DNA tion cytosine methylation function DNA lome gene regulation bj20121585 Farlik Sheffield dna methylome sequencing bioinformatic inference epigenomic cell state dynamic Cell Rep Hon Hawkins Caballero Lister Pelizzola Simpson Ren Global DNA hypomethylation couple repressive chromatin domain formation gene silence breast cancer van Dijk Tollenaar Van Den Berg Laird Regions focal dna hypermethylation longrange hypomethylation colorectal cancer coincide nuclear laminaassociated domain Plass Mutations regulator epigenome connection global chromatin pattern cancer Bestor Unanswered question role promoter methylation carcino genesis alter methylation pattern cancer cell genome cause consequence cancer cell Epigenetics cancer carcinogenesis cooperate family novo DNA methyltransferase establish maternal imprint mice development Bestor Jaenisch Targeted mutation DNA methyltransferase gene result embryonic lethality cell Okano Bell Haber dna methyltransferase dnmt3b essential novo methylation mammalian development Cell Regulation DNA methyltransferase interac tion modification Nucleus nucl Meiotic catastrophe retrotransposon reactivation male germ cell lack Dnmt3L Nature genome enemy mechanism retrotransposon suppression mouse germline Cell Mol Life Sci Promoter dna methylation couple genome defence mechanism epigenetic reprogramming mouse germline development dev New insight establishment maintenance dna methyla tion imprint mammal rstb target dynamic promoter dna methylation early mouse development control mammalian DNA methyltransferase new regulatory paradigm Hawkins Hon Stewart Human DNA methylomes base resolution show widespread epigenomic difference Nature Nusbaum Jaffe Gnirke Jaenisch DNA meth ylation map pluripotent differentiated cell Nature nature07107 Bird Taggart Frommer Miller Macleod fraction mouse genome derive island nonmethylate DNA cell Bird CpGrich island function dna methylation Nature Illingworth GruenewaldSchneider Webb Kerr cpg island identify numerous conserved promoter mammalian genome e1001134 journal reduced genomic methylcytosine content human colonic neoplasia Cancer Res distinguish gene human cer normal counterpart Nature Trewyn Oxenhandler methylcytosine content dna human tumor Nucleic Acids Res Hypomethylation DNA benign malignant human colon neoplasms science comprehensive molecular characterization human colon rectal cancer Nature Boutselakis Cole Ward Teague explore world knowledge somatic mutation human cancer issue Trapnell Akopian Integrative analyse human reprogramming reveal dynamic nature induce pluripotency cell cell Tuyn Edwards cell harbour feature cancer epigenome trumble Kaplan Allayee Ritz Chen QuintanaMurci Fagny Kobor epigenetic clock analysis raceethnicity sex coronary heart disease s13059 DNA Methylation Changes Cancer Puri Lee Park Lee Hussein Bleazard epigenomic roadmap induce pluripotency reveal dna methylation reprogramming modulator reprogramming epigenetic transcriptional profile mammalian culture system s13059 Jones transcriptional epigenomic founda tion ground state pluripotency cell cell Boulanger Stunnenberg stable methylation promoter distinguish epiblast stem cell embryonic stem cell vivo epiblast Stem Cells Dev scd Nishiyama Nakanishi Shimamura Arita ubiq uitylation couple maintenance dna methylation replication Nature Rose Klose Targeting polycomb system regulate gene expression modification complex story nrm4067 Occupying chromatin polycomb mechanism get genomic target stop transcriptional traffic staying put cell fate epigenetic memory erasure memory HarganCalvopina DNA demethylation dynamic human prenatal germline cell Smith Mekhoubad dna methylation dynamic human preimplantation embryo Nature Smith unique regulatory phase dna methylation early mammalian embryo Nature Nestor Lentini Hagg Nilsson Mattson Wang Rundquist hydroxymethylcytosine remodeling precede lineage specification differen tiation human CD4 cell Cell Rep Butler dna methylation change complex intermediate state accompany lineage specificity adult hematopoietic com partment Mol Cell Bestor note role dynamic dna methylation mammalian development Ooi Bestor colorful history active dna demethylation cell TET protein aberrant dna modification cancer trends Genet TET protein aberrant DNA tion cancer Trends Genet S0168 Meehan Inoue tion 5fC 5caC mouse preimplantation development Cell Res cr2011189 pii loss hydroxymethylcytosine mouse preimplantation embryo Science science sci ence pii Amouroux Nashun Hill Kudo Sasaki Hajkova novo dna methylation drive accumulation mouse zygote Nat Cell Biol ncb3296 epub DNA glycosylase essential active dna demethylation link repair cell S0092 pii cell Genomewide analysis reveal TET TDGdependent methylcytosine oxidation dynam ics Cell cell S0092 pii Pastor Agarwal Iyer Conversion methylcytosine hydroxymethylcytosine mammalian DNA partner TET1 Science pii science nuclear dna base hydroxymethylcytosine present neuron brain Science pii science diving map lowabundance modi fication DNA demethylation pathway pii Bachman UribeLewis Balasubramanian hydroxymethylcytosine predominantly stable dna modification nchem hydroxymethylcytosine profiling indicator cellular state Epigenomics Santa Pau Stunnenberg hydroxymethylcytosine new kid epigenetic block cytosine damage product alter site human DNA maintenance methyltransferase DNMT1 Cancer Res Sun formation carboxylcytosine excision mammalian DNA Science Tet mediate dna demethylation essential mesenchymalepithelial transition somatic cell reprogram ming Cell Stem Cell Watt Liu Multifaceted role thymine dna glycosylase embryonic development human carcinogenesis Acta Biochim Biophys sin passive demethylation male female pronuclear DNA mammalian zygote Cell Stem Cell oxidative dna demethylation mediate Tet enzyme nwv029 DNA Methylation Changes Cancer Loss hydroxymethylcytosine cancer cause consequence Genomics S0888 pii ygeno Krepelova tumour suppressor inhibit colon cancer growth derepress ing inhibitor pathway onc onc2014356 Katsushima Suzuki TET1 methylation closely associate phenotype colorectal cancer cancer Prev res Phila tet1dependent dna demethylation essential celrep Zhao Anna Kuchnio Ploumakis Ghesquiere Boeckx Carmeliet hypoxia cause dna hypermethylation reduce TET activity Nature nature19081 Moggs tet1associated concomitant aberrant pro moter hypermethylation liver cancer cancer Res pii Nestor Ottaviano Dunican Katz type major modifier hydroxymethylcytosine content human gene pii Thomson Lempiainen Hackett Nestor Muller Terranova carcinogen exposure induce define change hydroxymethylome Genome Biol r93 pii r93 Song Mapping recently identify nucleotide variant genome transcriptome nbt pii nbt Dunican Terranova Comparative analysis affinitybase enrichment technique e206 Smits Ford Veenstra Lister active dna demethylation enhancer vertebrate phylotypic period whole genome analysis lome hydroxymethylome normal malignant lung liver Genome res biorxiv epigenetic modulator modifier mediator cancer aetiology progression nrg nrg cancer next generation cell cell Sproul Kitchen Nestor Meehan Tissue origin determine cancerassociate cpg island promoter hypermethylation pattern R84 r84 pii r84 Thomson insight cancerassociate aberrant cpg island hypermethylation brief Funct Genomics bfgpels063 els063 pii epigenetic progenitor origin human nrg1748 pii nrg1748 Lips Nelkin dna methylation pattern calcitonin gene human lung cancer lymphoma cancer Res Hopping epigenetic change contribute formation spontaneous regression retinoblastoma decade explore cancer epigenome biological translational implication Cancer Irizarry LaddAcosta Onyango Potash human colon cer methylome show similar hypo hypermethylation conserve tissuespecific cpg island shore pii Bell Golan Sheinboim Malcov Gelfman Enhancer methylation dynamic contribute cancer plasticity patient mortality Genome res pii Wang analyse dna methylation reveal tumor sup pressive role EOMES human hepatocellular carcinoma Genome Biol s13059 Ward Sun Godley Thompson Leukemic IDH1 IDH2 mutation result hyper methylation phenotype disrupt TET2 function impair hematopoietic differentiation Cancer Cell S1535 pii ccr Rampal Ward tosello Paietta DNA profiling reveal WT1 mutation result loss TET2 func tion acute myeloid leukemia Cell Rep celrep NdiayeLobry TET1 tumor suppressor pii Fang Hutchinson Green BRAF oncoprotein function transcriptional repressor MAFG mediate island methylator phenotype Jiang Cicero mapping variable dna methylation multiple cell type define dynamic regulatory landscape human genome Green KRASdirected transcrip tional silencing pathway mediate island methylator phenotype elife e02313 eLife DNA Methylation change cancer Transcriptionally repress gene become aberrantly methyl ate distinguish tumor different lineage breast cancer Staaf Bendahl integrate genomic analysis epigenetic subtype human breast tumor link dna methylation pattern chromatin state normal mammary cell Breast cancer res Teschendorff Widschwendter multi omic landscape transcription factor inactivation cancer Slamon Wolchok Pardoll inhibit dna methyl ation cause interferon response cancer dsRNA include endogenous retrovirus cell cell Han agent target cancer cell induce viral mimicry endogenous transcript cell cell Decrease hydroxymethylcytosine associate progression hepa tocellular carcinoma downregulation TET1 PLoS e62828 Decrease gastric cancer associate TET1 silence dna methylation bivalent histone mark TET1 cpg island shore pii Zhou Liu Yuan Loss hydroxymethylcytosine link gene body hyper methylation kidney cancer cell Res pii Kroeze Carell Boezeman Wevers acute myeloid leukemia base level global hydroxymethylation blood blood blood pii Larson Thompson Kakavand Houvras Zon Schatton hydroxymethylcytosine epigenetic hallmark melanoma Cell S0092 pii cell Zhu Wang dna methylation profiling hepatocellular carcinoma Int Oncol ijo overlap control methylcytosine hydroxymethylcytosine TET protein human cancer cell Genome Biol R81",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 67,
                    "epigenetic": 37,
                    "5mC": 2,
                    "H3K27me3": 9,
                    "demethylation": 22
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "chromatinDNAmodifying": 1,
                    "Somatic": 1,
                    "promoterproximal": 1,
                    "Azacytidine": 1,
                    "Meiotic": 1,
                    "Dunican": 1,
                    "Han": 1,
                    "Boezeman": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "chromatinDNAmodifying": 137,
                    "Somatic": 137,
                    "promoterproximal": 137,
                    "Azacytidine": 137,
                    "Meiotic": 137,
                    "Dunican": 137,
                    "Han": 137,
                    "Boezeman": 137
                },
                "Ethnographic Terms": {
                    "methylation": 8,
                    "epigenetic": 8,
                    "5mC": 8,
                    "H3K27me3": 8,
                    "demethylation": 8
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "DNA methylation and its basic function.pdf",
            "cleaned_text": "DNA Basic function Lisa Moore1 Thuc le1 Neuroscience Human Genetics David California Los Angeles mammalian genome dna methylation epigenetic mechanism involve transfer methyl group position cytosine form methylcytosine dna methylation regulate gene expression recruiting protein involve gene repression inhibit bind transcription factor dna development pattern dna methylation genome change result dynamic process involve novo DNA methylation demethylation consequence differentiate cell develop stable unique dna methylation pattern regulate tissuespecific gene transcription chapter process dna methylation demethylation nervous system describe DNA methylation machinery association epigenetic mechanism histone modification noncoding rna intriguingly postmitotic neuron still express dna methyltransferase component involve dna demethylation neuronal activity modulate pattern dna methylation response physiological environmental stimulus precise regulation dna methylation essential normal cognitive function indeed dna methylation altered result developmental mutation environmental risk factor drug exposure neural injury mental impairment common side effect investigation DNA methylation continues show rich complex picture epigenetic gene regulation central nervous system provide possible therapeutic target treatment neuropsychiatric disorder Neuropsychopharmacology advance online publication npp epigenetic gene regulation neuron synaptic plasticity demethylation introduction Genetics study heritable change gene activity function due direct alteration dna sequence alteration include point mutation deletion inser tion translocation contrast epigenetic study heritable change gene activity function associate change dna sequence virtually cell organism contain genetic information gene express simultaneously cell type broad sense epigenetic mechanism mediate diversify gene expres sion profile variety cell tissue multicellular organism chapter introduce major epigenetic mechanism involve direct chemical modification DNA call dna methylation historically DNA methyla tion discover mammal early DNA identify genetic material first discover modify cytosine preparation calf thymus use paper chromatography Hotchkiss hypothesize fraction methylcytosine separate cytosine manner similar way thymine also know separate uracil suggest modify cytosine exist naturally DNA many research er propose dna methylation regulate gene expression several study demonstrate dna methylation involve gene regulation cell differentiation recognize dna methylation concert regulator major epigenetic factor influence gene activity dna methylation catalyze family dna methyltransferase dnmt transfer methyl group adenyl methionine SAM fifth carbon cytosine residue form figure dnmt3b establish new methylation pattern unmodified dna thus know novo Dnmt Figure hand function DNA replication copy dna methylation pattern Received revise accept May Correspondence Human Genetics David Los Angeles Charles Young Drive South Los Angeles USA Tel fax mail right reserve 133X parental DNA strand newly synthesize daughter strand figure Dnmts extensively involve development embryo time cell reach terminal differentiation Dnmt expression much reduce seem suggest DNA methyla tion pattern postmitotic cell stable however postmitotic neuron mature mammalian brain still express substantial level Dnmts raise possibility Dnmts dna methylation play novel role brain react environment pattern depolarization relay information encode response become increasingly apparent follow depolarization alteration gene expression accompany modification epigenetic landscape include alteration pattern dna methylation order DNA methylation pattern alter active dna methylation demethylation neuronal genome however enzyme know cleave methyl group directly discuss recent identification hydroxymethylcytosine postmitotic neuron suggest 5hmC serve intermediate DNA demethylation pathway discuss basic function dna methylation epigenetic gene regulation highlight role neural develop ment neurological disease location dna brain contain high level dna methylation tissue body account nucleic acid human genome majority dna methylation occur cytosine precede guanine nucleotide cpg site overall mammalian genome deplete cpg site result mutagenic potential 5mC deaminate thymine remain cpg site spread genome heavily methylate exception cpg island Bird interestingly evidence noncpg methylation mouse human embryonic stem cell however methylation lose mature tissue Ramsahoye Lister thorough analysis murine frontal cortex recently reveal majority methylation occur site significant percentage methylate noncpg site recent discovery role noncpg methylation still unclear dna methylation essential silence retroviral element regulate tissuespecific gene expression geno mic imprinting chromosome inactivation tantly dna methylation different genomic region exert different influence gene activity base underlie genetic sequence follow section elaborate role dna methylation different genomic region Intergenic Regions approximately mammalian genome consist transposable viral element silence bulk methylation vast majority element inactivate dna methylation mutation acquire time result deamina tion Walsh express element potentially harmful replication insertion lead gene disruption dna mutation Ukai intracisternal particle aggressive retrovirus mouse genome heavily methylate life gametogenesis development adulthood even embryo rest genome relatively hypomethylated Dnmt1 maintain repression element Dnmt1 deplete genetic mutation lead extensive hypomethylation element express dnmt3b ch3 CH3 CH3 Dnmt1 figure DNA methylation pathway family dna methyltrans ferases Dnmts catalyze transfer methyl group adenyl methionine SAM fifth carbon cytosine residue form methylcytosine dnmt3b novo Dnmts transfer methyl group red naked DNA maintenance Dnmt maintain dna methylation pattern replication DNA undergo semiconservative replication parental dna stand retain original dna methylation pattern gray Dnmt1 associate replication focus precisely replicate original dna methylation pattern add methyl group red newly form daughter strand blue dna methylation basic function demonstrate intergenic region main role dna methylation repress expression potentially harmful genetic element cpg island stretch dna roughly base pair long high cpg density rest genome often methylate bird majority gene promoter roughly reside island Saxonov particular promoter housekeeping gene often imbed cpg island island espe cially associate promoter highly conserve mouse human location preservation cpg island evolution imply region possess functional importance appear cpg island evolutionarily conserve promote gene expression regulate chromatin structure transcription factor bind dna regularly wrap histone protein form small package section call nucleosome tightly associate histone protein DNA less permissive gene expression common feature cpg island contain less nucleo some stretch DNA nucleosome cpg island associate often contain histone modification involve enhance gene expression island contain known transcription start site cpg island often devoid common promoter element box many transcription factor bind site rich cpg island likely enhance bind transcriptional start site lack common promoter element cpg island enhance accessibility dna promote transcription factor bind methylation cpg island result stable silence gene expression gametogenesis early embryonic development cpg island undergo differential methylation ability methylation regulate gene expression cpg island particularly important establish imprint imprinted gene express inherit parental chromosome expres sion determine parent inheritance imprint gene dna methylation cpg island regulate gene expression development differentiation cpg island associate control gene expression expect island display tissuespecific pattern dna methylation cpg island intragenic gene body region tissuespecific pattern methylation cpg island associate transcription start site rarely show tissuespecific methyla tion pattern Illingworth Maunakea instead region call CpG island shore locate far island highly conserve pattern tissuespecific methylation Irizarry cpg island methylation cpg shore highly correlate reduce gene expression role island regulate gene expression still uncover Methylation cpg island impair transcription factor bind recruit repressive methylbinding protein stably silence gene expres sion however island especially associate gene promoter rarely methylate study need determine degree dna methylation cpg island regulate gene expression majority site mammalian genome methylate gene also contain methylation gene body consider region gene first exon methylation first exon promoter methylation lead gene silence Brenet evidence suggest dna methyla tion gene body associate high level gene expression divide cell however slowly divide nondivide cell brain gene body methylation associate increase gene expres sion furthermore murine frontal cortex methylation noncpg site gene body negatively correlate gene expression dna methylation gene body contribute gene regulation still unclear basic mechanism DNA enzyme establish recognize remove dna methylation break class writer eraser reader Writers enzyme catalyze addition methyl group cytosine residue eraser modify remove methyl group reader recognize bind methyl group ultimately influence gene expression thank research devote understand epigenetic landscape erase reshape embryonic development many protein mechanism involve dna methylation already identify write DNA methylation Dnmts member Dnmt family directly catalyze addition methyl group DNA dna methylation basic function dnmt3b enzyme share similar structure large terminal regulatory domain terminal catalytic domain unique function expres sion pattern probably well study Dnmt especially nervous system highly express mammalian tissue include brain Dnmts preferentially methylate hemimethylate DNA Pradhan Ramsahoye DNA replication Dnmt1 localize replication fork newly synthesize hemimethylated DNA form Dnmt1 bind newly syn thesize dna methylate precisely mimic original methylation pattern present dna replication Additionally Dnmt1 also ability repair dna methylation Mortusewicz reason Dnmt1 call main tenance Dnmt maintain original pattern dna methylation cell lineage Knockout Dnmt1 mice result embryonic lethality time knockout embryo exhibit twothird loss dna methylation addition numerous apoptotic cell variety develop tissue include brain interestingly mouse embryonic stem cell lack Dnmt1 remain viable however differentiation result massive cell death recapitulate phenotype observe knockout embryo JacksonGrusby finding firmly establish Dnmt1 play critical role cellular differentiation well divide cell dnmt3b extremely similar structure function Dnmt1 Dnmt3a dnmt3b overexpresse capable methylate native synthetic dna hemimethylate DNA Okano reason dnmt3b refer novo Dnmt introduce methylation naked DNA figure primarily distinguish dnmt3b gene expression pattern express relatively ubiquitously dnmt3b poorly express majority differentiate tissue exception thyroid testis bone marrow similar knockout dnmt3b mouse embryonic lethal Okano hand knockout mouse runte survive birth result appear dnmt3b require early development require normal cellular differentiation final member Dnmt family Dnmt3L protein lack catalytic domain present Dnmt enzyme mainly express early development restrict germ cell thymus adulthood catalytic function associate dnmt3b stimulate methyltransferase activity consistent presence early development germ cell mouse Dnmt3L require establish maternal paternal genomic imprinting methylate compaction chromosome Zamudio express develop brain regulate neuronal differentiation observe brain postnatally write DNA methylation targeting Novo DNA methylation novo Dnmts target specific genetic region still unclear however several mechanism propose dnmt3b bind dna conserved domain however unclear dnmt3b target specific DNA sequence hypothesis suggest rna interference RNAi mechan ism target Dnmts silence specific sequence DNA RNAi clearly involve dna methylation plant cell exist evidence still weak role RNAi dna methylation mammalian cell theory transcription factor regulate novo dna methylation transcription factor regulate dna methylation bind specific dna sequence recruit Dnmts methylation protect dna methylation case Dnmts bind transcription factor component repressor complex target methylation DNA case regardless gene express transcription factor bind help protect site novo methylation cpg island appear primarily protect methylation transcription factor bind transcription factor bind site mutate cpg island unable retain unmethylated state similarly differentiation induce downregula tion transcription factor bind specific gene promoter nowexpose site target dna methylation study describe mechanism likely function together establish novo dna methylation dnmt3b recruit promoter specific transcrip tion factor novo Dnmt simply methylate cpg site genome protect bind transcription factor erase dna methylation dna demethylation characterize passive active passive dna demethylation occur divide cell actively maintain dna methylation cell dna methylation basic function replication inhibition dysfunction allow newly incorporate cytosine remain unmethylated conse quently reduce overall methylation level follow cell division active dna demethylation occur divide nondivide cell process require enzymatic reaction process order revert back naked cytosine yet know mechanism mammalian cell cleave strong covalent carboncarbon bond connect cytosine methyl group instead demethylation occur series chemical reaction modify deamination oxidation reaction product recognize base excision repair BER pathway replace modify base naked cytosine generally agree BER pathway final step dna demethylation specific enzyme chemical intermediate form dna demethylation still debate several mechanism active dna demethylation propose Figure chemically modify site amine group methyl group Deamination amine carbonyl group aid activationinduced enzyme complex effectively convert thymine thus create mismatch induce BER pathway correct base Overexpression promote DNA lation zebrafish knockdown knockout inhibit dna demethylation various gene necessary cellular reprogramming development various Dnmt knockout mouse aid mouse viable fertile global DNA demethyla tion critical dna methylation early development knockout aid mice study raise possibility multiple mechanism active dna demethylation exist compensate line multiple mechanism hypothesis active dna demethylation mechanism find mediate translocation Tet enzyme Tet3 Tet enzyme add hydroxyl group methyl group form develop brain contain significant level multiple region range approximately tenfold low average abundance Kriaucionis 5hmC form separate mechanism convert 5hmC back cytosine mammal first iterative oxidation Tet enzyme continue oxidize first formylcytosine carboxycytosine Ito second 5hmC deaminate form hydro consistent role Tet convert vivo tet1 knockout mouse embryonic stem cell reduce level 5hmC accompany subtle increase global level function intermediate dna demethylation still unclear methylation 5hmC regulate gene expression support theory conversion 5mC impair bind repressive methylbinding protein clear time 5hmC find vivo mammalian tissue play important role regulate dna demethylation gene expression mention mechanism active dna demethylation pathway use thymine dna glycosylase cleave modify residuef thymine replace naked cytosine Cortellino essential dna demethylation require normal develop ment knockout inactivation lead embryonic lethality mouse moreover mutant embryo exhibit hypermethylation particularly imprint gene H19 suggest active demethylation protect imprint gene spontaneous novo methylation monofunctional uracildna glycosylase BER enzyme uracil dna glycosylase family also find involve dna demethylation summary active dna demethylation arise multiple pathway involve multiple enzyme complexity likely contribute much current scientific debate Reading DNA Methylation Whereas dna methylation reduce gene expres sion impair bind transcriptional activator second class protein high affinity inhibit transcription factor bind dna methylation recognize separate family protein MBD protein protein zincfinger protein family MBD first identify MBD protein contain conserve methylcpgbinde domain MBD confer high affinity single methylate cpg site family include first identify methylbinding protein MBD1 MBD3 Bird MBDs highly express brain tissue many important normal neuronal develop ment function family MBD3 unusual example MBD3 incapable directly bind dna due mutation domain MBD4 bind DNA normally preferentially recognize guanine mismatch thymine uracil fluorouracil associate protein involve dna mismatch repair dna methylation basic function remain member family ability directly bind methylate dna contain transcriptional repression domain allow MBD protein bind variety repressor complex addition role transcriptional repressor appear unique role maintenance dna methylation MeCP2 bind Dnmt1 recruit Dnmt1 hemimethylated DNA perform main tenance methylation good study class methylbinding protein ubiquitinlike contain ring finger domain protein include multidomain protein flip bind methylated cytosine SET domain methyl bind protein primary function protein bind dna repress transcription protein family first bind Dnmt1 target hemimethylated dna order maintain dna methyla tion especially dna replication appear interact closely Dnmt1 deletion deletion Dnmt1 lead embryonic lethality Muto last family methylbinding protein bind methylate dna zincfinger domain compose ZBTB4 ZBTB4 zbtb38 distinct tissue expression pattern highly press brain bind single methylate cpg domain protein unusual ability recognize methylcytosine ZBTB4 preferential binding sequence motif lack methylcytosine NH2 Tet Tet TDG TDG NH2 AIDAPOBEC AIDAPOBEC 5hmC NH2 5fC Tet NH2 5caC NH2 Cyt 5hmU Thy TDGSMUG1 TDG Figure active dna demethylation pathway chemically modify site amine group methyl group amine group deaminate green convert thymine thy methyl group modify addition hydroxyl group mediate Tet enzyme generate hydroxymethylcytosine 5hmC also chemically modify site amine group hydroxymethyl group deaminate green 5hmC produce chemical pathway 5hmC Tet oxidize yellow 5hmC form formylcytosine carboxycytosine 5caC eventually product pathwayFThy 5hmU 5fC recognize cleave replace naked cytosine mediate component base excision repair pathway red dna methylation basic function methylbinding protein prefer bind consecutively methylate cpg site difference zincfinger domain protein similar family repress transcription dna methylationdependent manner DNA Methylation Epigenetic Mechanisms dna methylation work histone modification regulate transcription figure eukaryote dna associate histone protein help package long strand DNA small nuclear compartment modification include methylation acetylation ubiquitination phosphoryla tion add specific amino acid terminal histone tail modification influence dna strand package also transcriptional activity modification loosen DNA association histone generally provide permis sive environment transcription histone mod ification tightly package dna histone repress gene expression Dnmts directly interact enzyme regulate histone modification typically involve gene repression figure Dnmt1 Dnmt3a know bind histone methyltransferase restrict gene expression methylation H3K9 Fuks furthermore Dnmt1 dnmt3b bind histone deacetylase remove acetylation histone make dna pack tightly restrict access transcription general Dnmts cooperate histonemodifying enzyme involve add strip histone marker order impose repressive state gene region modification also influence dna methylation pattern figure Dnmt3L bind histone tail recruit dnmt3b methylate DNA Ooi direct binding Dnmt3a histone tail sometimes facilitate H3K36 trimethylation repressive histone mark also stimulate methyltrans ferase activity however presence active histone modification trimethylation H3K4me3 impair bind dnmt3b histone tail prevent methylation cpg island contain particularly high level H3K4me3 component methyltransferase complex target unmethylate cpg site often find murine cpg island play role maintain hypomethylation know regard DNA demethylation machinery interact histone modification yet still evidence suggest cooperate instance elevated histone acetylation trigger dna demethylation Cervoni contain dnabinding motif similar suggest protein target similar site case cpg island maintain dna demethyla tion direct connection yet show indeed localize cpg island depletion result increase methylation island mouse embryonic stem cell study Zhang Future study need probe interaction Tet histone modification Methylbinding protein serve strong link dna methylation histone modification protein interact methylate dna histone enhance gene repression figure recruit histone deacetylase remove active histone modification repressed transcription Dnmt3L MBD HMT MBD HDAC Dnmt SUV39H1 Dnmt HDAC H3K9 Histone methylation histone acetylation methylate cpg active transcription H3K4 H3K4 H3K4 Tet Tet H3K4 H3K4 Unmethylated cpg Hydroxymethylated cpg figure epigenetic crosstalk Transcription ultimately regulate interaction multiple epigenetic mechanism cooperate activate silence gene expression regulate protein Dnmt Tet purple involve active addition chemical modification red DNA methylation suppress gene expression Dnmts target site actively methylate dna Dnmts catalytic activity enhance association histone tail Dnmt3L dna methylation recognize methylbinding protein yellow Dnmts recruit enzyme modify histone tail orange include histone deacetylase hdac remove acetylation red histone methyltransferase hmt methylate histone green conjunction dna methylation serve repress gene expression region dna activate transcription Tet remove dna methylation histone tail region often contain H3K4me3 inhibit Dnmt bind unmethylate cpg site maintain permissive environment transcription dna methylation basic function repress gene transcription Jones furthermore enhance repressive chromatin state recruiting histone methyl transferase add repressive methylation Fuks overall dna methylation histone modification work closely together regulate gene expression recently mirna emerge important epigenetic mechanism influence gene expression Precursor form doublestranded RNA connect hairpin loop transport cytoplasm precursor miRNA process Dicer generate nucleotide duplex Mature mirnas eat miRNAinduced silence complex miRISC bind target mrna repress gene expression inhibit translation induce rna degradation sequence genome dna methylation regulate expression mirnas Han Lujambio loss dnmt1 dnmt3b colon cancer cell line reveal detect mirnas regulate DNA methyla tion Han Dnmts inhibit cancer cell reactivate mirnas initially silence hypermethylation cpg island Understood together study demonstrate dna methylation regulate mirna expression conversely mirnas also regulate histone tion Dnmt expression regulate dna methylation Benetti Sinkkonen Knockout Dicer mouse embryonic stem cell result depletion mirnas indirectly regulate dnmt3b expression lead loss dna methylation increase repressive histone methylation study provide evidence bidirectional influence mirna dna methylation dna BRAIN DNA Methylation develop CNS precise temporal regulation novo methylation demethylation particularly important differentia tion maturation mammalian central nervous system CNS Multipotent neural progenitor cell npc sequentially undergo neurogenesis Stiles particular differentiation switch npc neurogenesis astrogliogenesis coincide dna methylation demethylation event glial fibrillary acidic protein gene promoter region early neurogenesis e11 dna methylation promoter repress expression continual expression npc find important maintenance methylation pattern promoter subsequent cell division Fan interestingly neurogenesis E11 E14 time neural development dnmt3b strongly express decline nearly undetectable level CNS Fan E14 promoter undergo dna demethylation coincide differentiation astrocytic lineage development progress decline dnmt3b peak expression dnmt3a postnatally coincide remethylation reduce transcription promoter coordinated expression Dnmts ability regulate methylation pattern promoter organize regulate neuronal development importance coordinate event highlight conditional knockout model Dnmts neural development conditional knockout E13 time period coincide neurogenesis lead hypomethylation differentiate neuron demethyla tion promoter neural precursor cell thus accelerate astrogliosis lated neuron characterize multiple maturation defect include dendritic arborization impaired neuro nal excitability Fan result consistent conclusion Dnmt1 critical role neuronal differentiation maintain methylation promoter furthermore result suggest dna methylation essential neuronal maturation knock instead neural precursor cell majority cortical neuron develop normally case promoter normally remethylated postnatal astrocyte remain hypomethylated B50 cortical tissue likely correspond glial population consistent idea require differentiation maturation majority cortical neuron together knockout datum confirm precise regulation dna methylation essential differentiation maturation CNS Dnmts methylbinding protein express embryonic stem cell neural precursor Dnmts expression little effect neuronal glial differentiation protein MeCP2 well study CNS mutation result Syndrome common form mental retardation female development first express brainstem thalamus ancient region brain follow rostral progression expression methylbinding protein associate variety transcriptional repressor include Dnmt1 influence gene expression Neural activity lead phosphorylation MeCP2 alter ability bind gene promoter silence gene expression dna methylation basic function require normal neuronal maturation loss loss ability phosphorylate result aberrant dendritic arborization synaptic function plasticity conclusion neural development brain primarily consist postmitotic neuron glial cell little proliferation potential expression Dnmts normally decline terminally differentiate cell brain appear exception Dnmt1 express postmitotic neuron dnmt3b expression low virtually undetectable surprising discovery lead researcher investigate role active dna methylation postmitotic neuron adult brain DNA Methylation Adult Brain date majority DNA methylation mechanism characterize embryonic stem cell model predict function dna methylation divide cell embryonic stem cell inadequate model study dna methylation postmitotic cell fact Dnmts require normal neuronal differentiation maturation hinder study dna methylation solely postmitotic neuron limitation model emerge study dna methylation postmitotic neuron first model utilize pharmacological inhibitor azadeoxycytadine inject brain impair Dnmt activity pharmalogical inhibition Dnmts advantage inhibit dna methylation designate time point mechanism action Dnmt inhibitor postmitotic neuron still debate Nucleoside inhibitor azadeoxycytadine first incorpo rate dna order inhibit incorporate dna nucleoside inhibitor trap Dnmts chromosome lead substantial cellular toxicity ttermann possible BER pathway source nucleoside incorporation still unclear nucleoside inhibitor incorporate DNA nondivide cell postmitotic neuron concern surround use nucleoside inhibitor newgeneration Dnmt inhibitor include develop discovery structure catalytic domain identify silico screen small molecule inhibit Dnmt1 incorporate DNA Brueckner Stresemann RG108 emerge promise Dnmt1 inhibitor less cytotoxicity cellfree assay RG108 capable impair Dnmts catalytic domain similar dnmt3b share highly conserve catalytic domain Dnmt1 still unclear inhibit methyltransferase alleviate concern offtarget effect incomplete Dnmt inhibition second experimental model emerge model Dnmts conditionally knock use creloxP system express brainspecific promoter pharmacological inhibition second method allow investigator study role specific Dnmt subpopulation neuron Dnmts require normal neuronal differentiation therefore study role Dnmts adult brain express postmitotic brainspecific promoter CamKIIa Fan Golshani Nguyen Hutnick Feng postmitotic neuron Dnmt1 Dnmt3a appear overlap role Dnmt1 forebrain postmitotic neuron lead observable change dna methylation gene expression synaptic plasticity behavior however double knockout reduce dna methylation lead deficit synaptic plasticity addition learning memory research yet tease apart role Dnmt1 postmitotic neuron DNA methyla tion repeatedly show play role learning memory adult brain neuronal activity inhibit fear con ditioning memory formation prevent change dna methylation early study demonstrate vitro neuronal activity regulate expression activitydependent manner depolarization demethylate promoter release repressor complex promoter increase expression persistent activity neuron occur electroconvulsive stimulation exercise lead active dna methylation demethyla tion several gene brain however alteration dna methylation always correlate alteration gene expression observe heightened activity hence dna methylation demethylation alter neuronal activity dna methylation function regulatory protein epigenetic mechanism determine gene expression class protein work DNA methyla tion regulate gene expression CNS class methylbinding protein Methylbinding protein tinually express adult CNS often act repressor recognize bind methylated cytosine hence methylation remove result neuronal activity surprising often release promoter however role methylbinding protein simple dna methylation basic function MBDs undergo posttranslational modification alter ability bind dna induce neuronal activity result alter gene expression phosphorylation inhibit synapse formation synaptic plasticity learning memory behavior affect phosphorylation normally shortterm modification activitydependent phosphorylation porarily release promoter make gene sequence accessible demethylation hand dna methylation demethylation responsible longterm change gene expression regulate synaptic plasticity well learning memory DNA Methylation Etiology Neurological Psychiatric Disorders pattern dna methylation establish development modulate neural activity order encode learning memory mechanism establish recognize DNA methylation pattern dysfunctional problem learning memory fre quently result common form mental retardation Syndrome frequently cause mutation methylbinding protein MeCP2 Amir onset symptom month age coincide time early development sensory experience drive dendritic pruning shape connection brain express majority cell particularly important normal neuronal function mice loss mecp2 neuron sufficient recapitulate majority symptom phenotype mecp2 mutant mouse reverse restoration gene postmitotic neuron previously mention regulate neuronal activity turn regulate expression bdnf enhance expression follow depolar ization overexpression bdnf postmitotic neuron mutant mice ameliorate phenotype suggest critical regulate expression gene bdnf regulate neuronal activity essential normal cognitive function role Syndrome discuss later chapter extremely rare neurodegenerative disease illustrate importance proper dnmt activity adult brain patient hereditary sensory autonomic neuropathy type develop dementia hear loss adulthood result autosomaldominant muta tion terminal regulatory domain mutation result misfolde impaired nuclear localization early degradation however mutation affect target replication focus cellular replication association heterochromatin phase disrupt association affect maintenance dna methylation region modest reduction global dna methylation level neurodegeneration result involvement pathogenic mechanism support necessity adult brain improper methylation single gene single allele drastic consequence brain fragile Syndrome cause abnormal methylation trinucleotide repeat expansion FMR1 gene chromosome common form mental retardation tion repeat expansion FMR1 result transcrip tional silence FMR1 gene regulate neuronal activity protein product FMRP involve protein synthesis synapsis follow depolarization see similarly improper methylation single imprint allele find disorder cause significant mental impairment see buite incorrect expression loss function single gene dramatic effect brain important understand mechanism dna methylation affect gene expression dna methylation also alter repeat modulation microenvironment brain case recurrent seizure microenvironment repeatedly subject unusual synchronize neuronal activity way mimic unusual neural activity electric convulsive stimulation find result genomewide change DNA methylation pattern similarly repeat drug usage modulate neuronal function case cocaine cocaine usage modulate dnmt3a expres sion nucleus accumben enhance spine formation also repeat cocaine usage increase mecp2 turn increase expression sometimes drug exposure neural activity add posttranslational modification component methylation machinery dna methylation clearly alter disorder stem mutation inappropriate lation repeat modulation microenvironment role dna methylation psychiatric disorder less clear mount evidence alter pattern dna methylation associate many psychiatric disorder example earlylife stress form maternal neglect sufficient alter dna methylation brain rodent model Maternal neglect increase methylation promoter glucocorticoid receptor thus reduce expression surprisingly alteration DNA methylation pattern retain adulthood lead heightened stress response similarly human dna methylation basic function childhood abuse result increase methylation promoter glucocorticoid receptor decrease expression recapitulate rodent model furthermore alter pattern dna methylation observe psychiatric patient diagnose schizophrenia bipolar disorder Mill FUTURE direction CLINICAL implication dna methylation vary tissue also brain region gray matter white matter possibly even cell current technology limit ability distinguish cellspecific methylation pattern advent nextgeneration dna sequencing provide powerful tool examine genomewide DNA methyla tion pattern singlenucleotide resolution technology improve cost perform sequence analysis decline thus make technology accessible recent technical development allow genomewide dna methylation analysis perform even sample amount low aberrant dna methylation pattern observe wide variety psychiatric neurological illness decline cost ability perform genomewide methylation analysis limited tissue quantity soon possible map genomewide dna methylation pattern distinct brain region patient neurological psychia tric disorder analysis neural tissue psychiatric patient lead new insight etiology psychiatric illness open new avenue drug discovery target therapy current protocol enable scientist precisely quantify dna methylation singlenucleotide resolution use progressively small tissue quantity many commonly use method profiling quantifica tion dna methylation bisulfite sequencing methylationsensitive enzymebase assay unable distinguish protocol capable distinguish 5hmC genome cpg end labeling follow chromatography highperformance liquid chromatography HPLC detection Liutkeviciute tandem mass spectrometry DNA enrich use antibody bind specifically biotinylation modify 5hmC precipitate sequence identify use microarray chip dna sequence szwagierczak Pastor method quantify identify dna sequence associate single resolution attain order clarify genomic distribution epigenetic role brain locusspecific method identify 5hmC need develop highthroughput technique include rna chromatin immunoprecipitation chip sequencing come accessible researcher grow need integrate highthroughput datum currently dna methylation histone modification study relative isolation order fully understand gene expression regulate nervous system future research consider epigenome whole dissect biological mechanism mediate",
            "term_counts": {
                "Mental Health Terms": {
                    "bipolar": 1
                },
                "Epigenetic Terms": {
                    "methylation": 166,
                    "epigenetic": 16,
                    "demethylation": 32,
                    "5mC": 2
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Hotchkiss": 1,
                    "methyltrans": 2,
                    "zincfinger": 2,
                    "MBD1": 1,
                    "MBD3": 1,
                    "ZBTB4": 2,
                    "Dnmts": 1,
                    "Methylbinding": 2,
                    "Tet": 2,
                    "Han": 2
                }
            },
            "co_occurrence_matrix": {
                "Mental Health Terms": {
                    "methylation": 1,
                    "epigenetic": 1,
                    "demethylation": 1,
                    "5mC": 1,
                    "Hotchkiss": 1,
                    "methyltrans": 1,
                    "zincfinger": 1,
                    "MBD1": 1,
                    "MBD3": 1,
                    "ZBTB4": 1,
                    "Dnmts": 1,
                    "Methylbinding": 1,
                    "Tet": 1,
                    "Han": 1
                },
                "Epigenetic Terms": {
                    "bipolar": 216,
                    "Hotchkiss": 216,
                    "methyltrans": 216,
                    "zincfinger": 216,
                    "MBD1": 216,
                    "MBD3": 216,
                    "ZBTB4": 216,
                    "Dnmts": 216,
                    "Methylbinding": 216,
                    "Tet": 216,
                    "Han": 216
                },
                "Ethnographic Terms": {
                    "bipolar": 16,
                    "methylation": 16,
                    "epigenetic": 16,
                    "demethylation": 16,
                    "5mC": 16
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "DNA methylation and the expanding epigenetics of T cell lineage commitment.pdf",
            "cleaned_text": "seminar Immunology dna methylation expand epigenetic cell lineage commitment David Fitzpatrick Departments Immunology 1st Ave development progenitor lymphocyte make series cell fate decision decision reect require change overall program gene expression maintain cellular identity program gene expression iterate mitosis heritable manner epigenetic process include dna methylation methylcpg bind protein histone modication transcription factor high order chromatin structure current evidence consistent notion dna methylation act concert epigenetic process limit probability aberrant gene expression stabilize rather initiate cell fate decision particular dna methylation appear nonredundant repressor CD8 expression TCR cell th2 cytokine expression th1 CD8 cell require enforce clonally restrict gene expression cell however knowledge derive study importance dna methylation memory cell lineage delity vivo remain show convincingly right reserve epigenetic dna methylation cell introduction development bone marrow progenitor lymphocyte make series sequential largely binary irrevocable cell fate choice cell cell eage cell cell receptor TCR TCR CD4 CD8 CD4 cell th1 Th2lineages exception TCR rearrangement reect change primary netic information sequence basis cell cell fate choice initiate maintain change dna sequenceencoded information rather lineage choice require cell transcribe enable activationinduced transcription specic set gene repress silence other change gene expression encode permanent change primary genetic information cell change corresponding author fax correspond author fax mail address tzpatdamgencom epigenetically encode information determine gene express control part assembly rele vant complex transcription factor regulatory region gene thus abundance posttranslational modication localization high order interaction tran scription factor activator repressor set mechanism transcription regulate ond level control provide epigenetic process affect accessibility transcription factor regula tory region target gene highly order chro matin structure thus modulate ease probability transcription factor engage regulatory region gene recruit rna polymerase contain complex epigenetic factor silence dampen facil itate efcient transcription necessary dictate proper function specic cell type maintain solely continue expression transcription factor use initially establish specic program alternatively heritability main taine initiate transcription factor induce stable see front matter right reserve Immunology Fig feature genetic code compare epigenetic code epigenetic imprint memory gene expression program transmit phase parental cell progeny absence factor require ini tiate change mammal epigenetic information encode variation methylation dna cytosine difference composition histone protein post translational modication histone associate DNA chromatin high order chromatin structure epigenetic regulation gene expression active area biology publication moreover importance epigenetic event development proper function immune receive increase attention dna methylation well dene epigenetic mechanism ble propagation epigenetic information emphasize recent development regard role dna methylation immunology important advance area histone modication affect affect difference dna methylation process integrate achieve proper balance stability plastic ity gene expression need maintain delity cell fate function respond environmental cue second focus discuss epigenetic regulation context key differentiation process immunology include lymphocyte lineage development issue address important epigenetic inuence cell development antibody response apologize advance author primary research per space limitation cite directly mechanism gene silence dna methylation mammal methylation dna cytosine residue occur almost solely context symmetrical cpg dinu cleotide maintenance methyltransferase dna methyl transferase Dnmt1 upregulate phase cruite dna replication fork proliferate cell clear antigen PCNA preferentially active hemi methylate cpg substrate generate dur ing replication symmetrically methylate cpg site methylate cpg site new daughter strands Dnmt1 maintain methylation pattern complementary parental strand Dnmt1 Fig DNA methyltransferase dnmt1 maintain dna methylation pattern phase copy pattern cpg methylation parental strand progeny strand copy high imperfect delity pattern cyto sine methylation DNA parental cell DNA progeny manner conducive heritable gation information need assure consistency cell fate function enzymatically tive dna methyltransferase prefer hemimethylate cpg substrate cat alyze novo methylation unmodie site pathway inuence Dnmt1 also affect dnmt3b distinction main tenance novo methylation absolute evidence role dnmt3b nance methylation high density cpg sequence con versely Dnmt1 cooperate novo methylation setting example cooperation maintenance novo methylation methylation spread focus methylate cpg site extend yield long sequence contigu ously methylate dna Dnmts undergo alternative splicing create distinct isoform appear vary function pattern tissue expression add additional complexity control dna methylation counterpoint maintenance methylation novo methylation methylation spread demethylation methylate cpg site occur pas sively DNA replication dnmt1 level cient lose delity Dnmt1 exclude replication fork copy parental DNA methy lation site generate hemimethylate cpg site progeny dna strand become fully demethylated ditional dna replication passive demethylation protec tion displacement maintenance novo methyltransferase machinery describe cpg rich island example sp1 transcription factor bind consensus site even methylate sterically clude methyltransferase induce constitutive transcrip tion numerous report active lation sometimes stimulation cell division area intense investi gation example include demethylation dna male pronucleus fertilize egg brain derive neurotrophic factor bdnf promoter primary neuronal cell response depolarization vitro promoter activate primary cell however yet clearly dene entity responsible enzymatic demethylation sym metrically methylate cpg site nondivide mammalian cell dna methylation repress gene expression direct mechanism block bind transcription factor cpg site recognition motifs Indirect mechanism broad regulatory potential include interact methylcpgbinde protein recruit histone deacetylase histone methyl transferase nucleate process involve formation compact chromatin render less accessible stably inaccessible transcription apparatus see methylcpgbinde protein multiple protein afnity sequence contain methylated cytosine describe important regulation mammalian gene appear MBD1 bind sin gle symmetrically methylate cpg site MBD1 possess homologous methylcpgbinding domain exhibit similar bind property also associate nonmethylated DNA require multiple methylate cpg site bind effectively interaction partner function protein manifold incompletely understand scope however follow working model cient topic cover methylcpg bind protein bind methylate DNA directly com pete displace DNAbinding protein press transcription methylate promoter repression also occur indirectly recruitment protein complex methylate dna MeCP2 MBD1 recruit histone deacetylase histone methyltransferase complex thereby localize modication chromatin structure association Dnmt1 dna methyltransferase histone modify complex reinforce recruitment local ization methylcpgbinding protein thus triangulate key set epigenetic machinery DNA histone modication contrast rela tively promiscuous bind protein methylate cpg naked dna bind fraction methylate cpg situ relate limita tion abundance methylcpgbinde protein rel ative methylate cpg distribution appear random methylcpgbinde protein tar get away specic gene sequence poorly include interaction methyl CpGbinding protein partner convey sequence specicity posttranslational modication notably depolarization neuron cause rapid reduc tion dna methylation bdnf promoter note dissociation associated repressor com plex protein promoter sequence transcription bdnf gene phosphorylation causally link dna demethyla tion vice versa present unclear nonetheless nding recent nding cytokine gene regulation discuss indicate classical signal ing pathway lead rapid epigenetic modication nondividing cells Evidence relevance cell type signal pathway gene eagerly await Immunology Posttranslational histone modication histone variant Nucleosomes comprise dna wrap core histone consist copy h2b animate view see neighboring nucleosome connect short segment dna compact linker histone tail histone protein protrude nucleosome site posttranslational modication multiple modication possible histone molecule multiple histone stretch nucleosomal dna combinatorial potential epigenetic modication high term histone code many context interpretation code yet cipher however follow feature pear consistent several gene mammalian cell type acetylation histone lysine residue H3K18 histone lysine residue associate open accessible chromatin active gene expression Lysine residue also modie addition methyl group histone lysine residue also ate active expression acetylation persist long transcription cease provide mark transcriptional competence conversely methylation histone lysine residue associate closed condense chromatin repress silence gene expression stable repression gene find heterochromatin associate gene trimethylated lysine imprint interact example methylation preclude acetylation residue phosphorylation appear facilitate transcriptionally favorable modicationsacetylation methylation addition many histone tion include acetylation methylation phosphory lation site ubiquitination function less well characterize generalize Histone acetylation dynamic process histone acetyl transferase deacetylase hdac rapidly add remove acetyl group respectively trast histone methylation appear stable modi cation consistent role K3K27 methylation gene silence absence date demethylase catalyze removal methyl group lysine residue however recent evidence late residue remove pep tidyl arginine deiminase indicate least form histone methylation reversible moreover histone methylation commonly associate stable repression gene heterochromatin also find euchromatin play dynamic role gene regulation example rapid induction IFN response virus infection associate transcription terminate termination IFN transcription due part sequen tial deacetylation follow methylation histone methyltransferase G9a addition posttranslational histone modication number variant histone use place canonical histone note turn affect transcrip tional competence chromatin structure example variant h2a incorporate nucleosome site doublestranded dna break play critical role immunoglobulin class switch recombination variant incorporate phase replicationdependent manner incorporate phase exchange replicationindependent manner compare enrich transcriptionally favorable histone modication K9Ac least ies thus mechanism nucleo some contain repressive modication replace one favorable modication phase dna replicate replication independent exchange time latter mechanism recently show participate dependent replacement methylate lysine lack modication site heavy chain locus undergo recombination assembly chromatin structure chromatin remodeling note histone octamer assemble parental daughter strand DNA phase accomplish assembly nucleosome contain exclusively original histone octamer parentalstrandandnewlyincorporatedhistonesonthedaugh ter strand half new half original histone strand unclear assemble dna nucleosome provide barrier transcriptional machinery association DNA histone octamer alter facilitate bind transcription factor transit RNA polymerase com plex consequence specic site gene actively transcribe poise transcription response environmental signal identi ed accessibility endonuclease cleavage call hypersensitivity site restriction enzyme often always site correlate regulatory sequence involve activate gene expression include promoter enhancer locus control region map site recently port cell line however genetic modication likely high level cell stimulusspecicity necessitate tailed mapping puried primary cell specic stage differentiation see nucleosomeDNA interaction mediate macromolecular chromatin remodeling complex slide roll reposition case remove reassemble histone octamer appear substantial diversity composition spe cic functions octamer cell type include lymphocyte matin remodeling complex contain SNF2family Pases require proper regulation dna methyla tion methylation example cell mouse lack lymphocytespecic helicase Lsh show global dna demethylation selective enrichment tri methylate h3k4 change methylate pericentromeric heterochromatin DNA wrap nucleosome compact beadsstre conformation approximately size thence zigzag array nucleosome form structure know chromatin ber Chro matin ber turn compact high order structure position nucleus open area euchromatin closed area con dense heterochromatin much learn structure courtesy advance molecular biophysical imaging technique purpose worth highlight aspect nucleosome condensa tionintonmsizedstructuresishighlydependentonthelinker histone histone afnity methylate cpg site heterochromatin formation dependent heterochromatin protein bind histone methyltransferase product latter enzyme intranuclear localization gene heterochromatin associate repression silence expression tivation gene expression associate relocalization euchromatin Interaction integration target dna methylation epigenetic modication specic region gene gene cell type dna methylation histone modication high order chromatin structure likely operate independently shortterm induction repression gene expression change histone modi cation likely provide level control subservient dominant change dna methylation methylcpgbinde protein localization epigenetic element see case shortterm subservience dominance real case reect shortcoming snapshot populationbase analytical method use longterm regulation gene expression clear modied histone usually act concert change DNA methy lation chromatinassociated factor yield epige netically stable program gene expression process link extent faithful heritance specic pattern modie histone assure assembly histone octamer phase cur semiconservative mechanism tone parental strand divide share parental daughter dna strand provide plat form heritable propagation histone composition modication phase mechanism read copy pattern exist analogous mechanism Dnmt1 copy pattern cpg methylation histone assembly occur semiconservative mechanism unclear recently mechanism copy ing suggest dna methylation methylcpgbinde protein direct methyla tion human cell show associate methyltransferase SETB1 complex recruit replication fork PCNA Dnmt1 result link copy methylate cpg pattern bind MBD1 methylate cpg methylation p53 bind protein gene extent nde general ize yet uncertain allude deter mine methylcpgbinde protein associate methyl cpg specic site area active interest conversely associate associate MBD3 Dnmt1 replication fork late phase associate hdac provide mechanism gion genome target dna methylation histone deacetylation methylation case locus cell major unanswered question novo dna methylation repressive histone tion target specic site induce transcriptional silence report use promyelocytic leukemia cell scribe retinoic acid receptorpml fusion protein sociate Dnmt1 target dna hyper methylation aberrant silence retinoic acid response gene exciting recent information relate series publication indicate role noncoding rna silence antisense rna transcript volved target dna methylation inherit silence human alphaglobin gene Dnmt recruitment examine case also recently show Dicer generate small interfere rnas sirnas require formation stable chickenmouse cell hybrid suggest sirnas require direct dna histone methylation region destine become constitutive heterochromatin evaluate study recent report show articial sirnas target cpg contain pro moter human cell induce recruitment Dnmt1 Dnmt3b novo DNA methylation methylation transcriptional silence remain termined endogenous micrornas sirnas involve target silence specic gene ological manner similarly dna demethylation passive active direct specic region yet unknown tantalizing datum regard demethylation cell discuss probability heritability plasticity description machinery epigenetic reg ulation potentially misinterpretable linear series switch static set positive negative build ing block arithmetically sum kinetic pro gression qualitative inuence allnone decision complex reality epigenetic mechanism appear actmoreastunablethresholdsorrheostatsthatfacilitateoran tagonize action transcriptional activator repre sor probability associate dna methylation histone modication chromatin remodeling reaction vary allele gene different gene individual cell accord phase cell cycle individual cell pende current stimulus previous experience different cell type make interpretation cell population datum challenge nevertheless quan titative feature epigenetic regulation emerge worth monitoring future development estimate delity Dnmt1 maintenance methyla tion make use new technology good agree ment predict observe datum site delity appear extraordinarily high especially give know proofread machinery DNA methylation methylationbase epi genetic delity dependent pattern rather individual cpg site datum probably sufcient explain faith ful inheritance hundreds cell division thus lifespan cell body however mate yet make condition rapid cell division Dnmt1 limit control abundance transcription factor epigenetic factor affect ability transcriptional tor bind target site chromatin accessibility purpose simplicity transcription factor activate transcription show transcriptional repressor many different histone histone modication encode information affect transcription subset modication show cell respond antigen vivo also lack estimate dnmt3b processivity steadystate limit ing condition novo methylation consequently yet know methylation underlie repressed state inherit delity demethylation underlie prime state vice versa threshold methylationmediate effect low average density methylate cpg site vertebrate genome mcpg sufcient repress weak endogenous promoter Experimentally methylation level low mCpG sig nicantly incompletely repress episomal reporter gene cell line number mecp2 molecule cell suggest key factor limit molecule nucleus calculate mouse brain kidney tissue dna coverage estimate mecp2 molecule nucleosome abun dance methylcpgbinde protein also limit contrast histone abundant probably sufcient cover expose internucleosomal methylate cpg site currently quantitative estimate level histone even acetylated histone several histone acetylase deacetylase enzyme well charac terize attempt make quantify level HP1 rate gene heterochromatinization recent study suggest unexpected dynamism plasticity level much exchange nuclei living cell include lymphocyte estimate cumulatively suggest equilibrium multilayered epigenetic machinery cell prob ably sufcient maintain repressed expression entire genome inheritance delity poten tial capable cover division lifespan average cell perhaps accordingly transcriptional noise random gene expression estimate aberrant transcript cell test gene betaglobin erythroid cell line extrapolation aberrant transcript mammalian genome time repression completely remove overall dynamic range average inducible gene estimate fold appear match recent tion endogenous gene lymphocyte dif ferentiation function see example immune system cell development thymus Dnmt1 require proper maturation thymic genitor show knockout mouse conditional deletion Dnmt1 early doublenegative thymocyte follow DNA replication dna demethylation response selection DN3 stage result mark DNA demethylation doublepositive later stage associate profound reduction cell singlepositive mature cell stage result apoptosis cell level dna methylation fall critical threshold occur mammalian cell lineage study date exception undifferentiated cell rare tumor cell line addition attrition TCR lineage cell number TCR cell increase mouse appear reect part ite intrathymic replication consequence less pro find dna demethylation similar less severe trition TCR lineage cell see thymocyte lack lymphocytespecic helicase markedly reduce aberrant dna methylation TCR TCR DNA TCR locus methylate doublenegative thymocyte Activation gene proceed pathway involve signal emergence DNa sei hypersensitivity site demethylation cpg site event open locus recombi nation machinery allow expression chain part complex signal trig ger ATPdependent BAF chromatin remodeling complex affect expression multiple survival differentiation gene well exclude expression TCR allele exclude allele characterize dna permethylation compact chromatin repressed termediate precede silence state yet dissect noteworthy target histone methyltransferase articial TCR minilocus induce feature render TCR gene inaccessible plausible mechanism yet examine context endogenous TCR locus shown affect allelic exclusion similar process occur recombination less well study TCR locus comparison allelic exclusion TCR loci weak hap potent enhancer regulate demethylation failure TCR rearrangement knockout mouse associate persistent dna methylation enhancer suggest dna demethylation essary rearrangement occur consequence process essential however dnmt1decient thymocyte exhibit normal recombination allelic exclusion exclude possibility demethylation necessary recombination occur suggest dna demethylation limit factor recombination proper level DNA require enforce allelic exclusion recombi nation immunoglobulin heavy chain locus also impair absence irreversible silence terminal transferase expres sion mature thymocyte also relevant cell devel opment describe great detail accompany paper worker elegant timecourse study recently show silencing occur removal maturation stimulus associate nucleosome remodeling loss gain terminal transferase gene promoter methylation setting initiate promoter spread gene remarkable rate nucleosome normal thymocyte portantly rapid spreading occur abnormal cell line terminal transferase gene repressed irreversibly silence mal silence scenario heterochromatin relocalization terminal transferase gene relatively early event mocyte cpg dna methylation relatively late event continued increase mature cell emi gration thymus spleen CD4 CD8 thecd4geneisatargetofreversiblerepressionindouble negative thymocyte permanent silence double positive cell differentiate singlepositive CD8 state silence epigenetically regulate event dna methylation appear necessary instead specic repressive pathway CD8 cell diate runx3 interact cis dene CD4 lencer sequence silence machinery trigger Runx3 involve silencerbinde factor stone deacetylation BAF chromatin remodeling com plexe heterochromatin HP1 Signicantly inheritance epigenetic modication cient delity maintain even removal stigate silencer process remain prototypic permanent silence event endogenous gene normal cell differentiation equivalent silence process shut CD8 gene expression CD4 cell describe CD8 CD8 gene occur ing thymocyte maturation doublenegative CD4CD8 stage retention demethylated CD8 gene singlepositive cd4 cell provide early evidence notion cell derive previously CD8 precursor later prove lineage trac ing study role dna methylation regulation CD8 expression also see conditional aberrant CD8 CD8 expression curre large fraction lineage cell novo remethylation CD8 gene associate death misselected thymic emigrant however mechanism able silence CD8 gene ter commitment CD4 lineage doublepositive cd4cd8 cell find periphery condi tional dnmt1mice repression transcription factor candidate mechanism study suggest role relative CD8 gene activation rather silence alternative candi date GATA3 overexpression transcription tor inhibit CD8 singlepositive thymocyte development expression repressor GATA3 ROG increase level CD8CD4neg thymocyte direct mechanistic link epigenetic regulation CD8 expression yet dene interaction GATA3 methylcpgbinde protein play important role control expression cell discuss section cell function role dna methylation regulation cell function suggest early study expres sion show enhance agent inhibit dna methylation subsequent study show gene quiescent promoter DNA late locus contain inactive chromatin rest ing cell early activa tion allele become activate depend strength stimulus expression cur absence cell division cell division increase probability frequency event CD4 CD8 cell conditional dnmt1mice expression increase vefold follow activation vitro relatively modest increase reect fact gene normally undergo rapid dna demethylation wildtype cell response acti vation remarkably demethylation promoter pear commence cell stimulation vitro min cell stimulation vivo well fore entry cell phase suggest occurrence active catalytic dna demethylation target specic subset transcription ini tiation site study also show methylation cytosine repress transcription support functional importance demethylation expression support notion active dna demethyla tion target specic region response cell activation come recent study th2 cytokine locus describe nding active demethylation gene response cell activation reproduce mechanism eluci date represent major advance yet know enzyme catalyze dna demethylation IFN IFN rst cytokine shown regulate epigenetically role dna methylation regulation IFN cell support several line evidence augment expression treatment DNA methy lation inhibitor level dna methylation promoter correlate inversely difference pression IFN neonatal adult memory cell th1 th2 cell heritability demethylate state CD8 cell clone correlate directly expression novo methylation cell population correlate reduce expression rst feature faith fully reproduce dnmt1 cell expression IFN increase fold follow activation vitro increased IFN expression appear primarilyifnotsolelyduetodnademethylationintheifn gene due increase expression transcription torsknowntofacilitateIFNexpressionbetoreome sodermin indirect transmediate effect IFN promoter Consistent nding cell cell lack methylcpg bind protein produce increase amount IFN response activation enter cell cycle absence cell division likely result bind methylate regulatory region IFN gene recruitment repressive chromatin modify complex evaluate report dna demethylation IFN promoter relate expression construct transgene con taine IFN promoter drive signicant expres sion intronic distal element accessible require full expression wal dene site intron mouse IFN gene exhibit increase accessibility dur ing th1 differentiation general regulatory role accessibility reinforce situ study reposition IFN gene heterochromatin euchromatin nucleus polarize th1 th2 cell recent study augment understanding area characterize epigenetic modication conserve nucleotide sequence element IFN gene modication include dna methylation histone acetylation histone lation sequence element involve extend conservation mouse human rat dog genome distance upstream downstream IFN exon signicant conserve nucleotide sequence element designate CNS 6ifn IFNgCNS1 upstream start codon element exhibit dna demethylation th1 cell line association modied histone target key transcription factor Stat5 bet conjugate IFN reporter construct also signicantly enhance IFN expres sion recently dene conserved nucleotide sequence designate IFNgCNS2 stream IFN ATG start codon element exhibit activity place downstream IFN reporter construct hypersensitivity primary mouse th1 CD8 cell association modied histone sign modie chromatin transcrip tion detect region specically th1 cell interestingly bet knockout CD8 cell signicant stone modication IFNgCNS2 still find suggest potential betindependent chromatin remodeling site yet know reect activ ity box family member distinct pathway operative CD8 CD4 cell th2 cytokine regulation perhaps well understand IFN cellspecic enhancer associate hypersensitivity site second intron dene soon discovery important interleukin DNase hypersensitivity site mouse gene subsequently map characterize chromatin remodeling behavior Th1Th2 differentiation time evidence epigenetic regulation emerge demonstration monoallelic expression CD4 cell nding crease signicance expression characteristic find extend coordinated manner gene cluster th2 cytokine show coordinately regulate nucleotide sequence element conserve several specie CNS hereafter refer IL4CNS1 upstream start codon gene correspond DNase hypersensi tivity site identie worker CNS hereafter il4cns2 downstream start codon gene correspond hypersensitivity site dene Rao worker IL4CNS1 engineer mouse signicant impact expression cell deletion il4cns2 affect expression cell mast cell recent study colleague indicate regulatory region tend include additional hypersensitive site putative locus control region locate downstream gene portion adjacent ubiquitously express RAD50 gene moreover show chromatin loop form region promoter gene approximate create core conguration cell type modie inclusion locus control region cell cell type however term epigenetic characterization IL4CNS1 IL4CNS2 proximal element gene receive study multiple component epigenetic machinery target regulatory sequence element locus dna methylation identie important level control gene expression IFN mapping cpg site methylation change gene cell differentiation analysis effect inhibit use sequencing show pro moter intronic enhancer methylate CD4 CD8 cell degree methylation maintain active recruitment region cell activate nonpolarizing th1 condition region fully methylate proximal promoter locus remain poise euchromatin lack histone methylation mark associate stable gene silence feature residual expression small amount portant allow CD4 cell express low level shortly activation early th2 differentiation mapping study suggest dna demethylation initiate promoter occur IL4CNS1 IL4CNS2 extend promoter downstream exon IL4 gene later th2 polarization however DNA lation region observe prior cell replication decline slowly association exclu sion Dnmt1 region failure copy pattern dna methylation parental daughter dna strand cellular replication passive demethyla tion substantial demethylation lag crease expression increase tone acetylation locus suggest reduction dna methylation th2 condition help stabilize rather initiate highlevel th2 cytokine expression contrast group recently report specic th2 locus control region lie portion RAD50 gene undergo complete demethylation activation th2 condition manner suggest active rather passive dna demethylation result suggest focus dna demethylation control region play role rapid increase expression th2 condition passive lation locus progressively contribute sustained highlevel th2 cytokine expression consistent latter possibility longterm murine th2 clone different level demethylation IL4CNS1 second intron asso ciate quantitatively different level expression human th2 cell population polarize adult CD45RA cell change dna methylation IL4CNS1 promoter intron pronounce focus demethylation promoter rst exon map study implicate dna methylation regula tion th2 cytokine cd4 cell CD8 cell mechanism play even profound role wildtype CD4 cell express low detectable amount mrna activation nonpolarizing condition CD8 cell express cytokine cell autonomous man cultured condition sharp contrast cell conditional dnmt1mice induction cytokine markedly high con trol cell distinctive lineage bias fold peripheral cd4 cell fold peripheral CD8 cell result expression th2 cytokine Dnmt1CD8 CD4 cell comparable great expression control CD4 cell analysis cpg methylation histone modication transcription factor expression suggest increase expression result dna demethylation secondary increase transcriptionally favorable histone modication locus Loss dna methylation override factor regulate th2 cytokine expression rather appear act concert CD8 cell expose th2tc2 polarizing condition crease tc2 cell produce least much th2 cell th1tc1 condition expression decline remain substantially great control cell cul ture nonpolarizing th1tc1 condition cell mbd2decient mouse Dnmt1 cell exhibit enhance expression th2 even th1 condi tion together nding conditional Dnmt1and MBD2 cell support model DNA methy lation methylate dna bind protein posttranslational histone modication abundance th2 transcription factor collaborate control appropriate pattern th2 cytokine expression function dna methylation appear repress expression gene encoding perforin human cell base study cell treat azacytidine Treatment associate DNA demethylation region core promoter demethylate con stitutively cell contrast little increase expression perforin granzyme Dnmt1CD4 CD8 cell directly vivo activation discordance due difference human murine cell technical aspect study unclear cell CD8 cell express activate inhibitory receptor mouse human family clonally restrict often monoallelic manner Expression corre late dna demethylation cpg transcription start site treatment cell azacytidine induce demethylation ectopic expression unexpresse recep tor cell effector function lineage commitment CD4 CD8 lymphocyte emigrate thymus secondary lymphoid organ distinct differ ence effector function potential CD4 cell differentiate th1 th2 cell control master regulator transcription factor bet respectively contrast CD8 cell emerge thy mus precommitted differentiate cell produce Fig cumulative effect dna methylation methylation expression model base datum IFN lytic effector perforin granzyme induce differentiate tc2 cell produce exposure exogenous also bet essential expression IFN th1 fate cd4 cell true CD8 cell also express bet paralog eomesodermin nding describe previous section raise follow question epigenetic control cell effector function begin effector lineage begin independent relevant master regulator fate ever lineage commitment indelible lineagespecic master regulator long require sustaincommitmentandwhatistheroleofdnamethylation initiation maintenance commitment study area incomplete clue emerge explore origin bias th2 cytokine expression CD8 cell track bias thymocyte stage activate CD4 CD8 thymocyte express mrna CD8 mocyte express fold less difference parallel low level paucity transcriptionally vorable histone modication modestly high level dna methylation locus CD8 cyte dna methylation increase expression decline cell mature thymocyte cell concert recruitment Dnmt1 locus CD4 CD8 thymocyte dnmt3b IL4CNS1 CD4 thymocyte difference dna methylation CD4 CD8 thymocyte long evident CD4 CD8 cell account fact CD4 CD8 cell able produce small amount response activation rather residual expression associate continue expression CD4 CD8 cell great expression repressor GATA3 ROG protein CD8 CD4 cell competitively displace regulatory region gene direct indirect fect unknown pioneer factor open locus epigenetic remodeling machinery however GATAregulating factor friendgata FOG also involve pathway yet stud CD8 cell key inter genic transcription human locus also exhibit precocious expression thymus interesting see signal trans factor control intergenic transcription cis factor locus serve initiation point epigenetic machinery affect active lowlevel transcrip tion fourth additional possibility presence specic repressor silencer element lineagespecic activity element exist downstream stop codon untranslated region hypersensi tivity site activity CD4 CD8 cell yet examine difference dna methylation locus appear account difference expres sion CD4 CD8 cell study Dnmt1 cell indicate dna methylation necessary repress expression lineage absence lineage express high amount nding consistent cell mbd2cd4 cell stud suggest dna methylation perhaps work recruitment histone chro matin modify complex likely essential stable th1 CD8 effector lineage commitment remains show moreover also unknown process alone sufcient maintain com mitment absence master regulator bet IFN gene yet study tail thymocyte study find high IFN expression potential CD8 compare CD4 thymocyte level IFN promoter higher rest activate single positive CD8 thymocyte nevertheless epigenetic modeling IFN gene clearly continue periph ery Th1Th2 Tc1Tc2 polarization response environmental inuence cell differentiate standard th1 condition vitro anti unstable th1 pheno type cell differentiate induce produce th2 cytokine switch th1 th2 condition consistent model progressive commitment th1 phenotype time stable commitment IFN expression require collaboration bet transcription factor induce bet committed state correlate maximal expression IFN chromatin remodel IFN promoter intron occur",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 90,
                    "epigenetic": 35,
                    "demethylation": 35
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "MBD1": 3,
                    "H3K18": 1,
                    "MBD3": 1,
                    "methy": 2,
                    "Tc1Tc2": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "MBD1": 160,
                    "H3K18": 160,
                    "MBD3": 160,
                    "methy": 160,
                    "Tc1Tc2": 160
                },
                "Ethnographic Terms": {
                    "methylation": 8,
                    "epigenetic": 8,
                    "demethylation": 8
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "DNA methylation_ past_ present and future directions.pdf",
            "cleaned_text": "carcinogenesis vol dna methylation past present future direction model tumor formation mechanism remain unclear prevent novo methylation cpg islandassociated promoter region normal cell recent study potential role DNA methylation dna repair genomic correspondence address ity cloning characterization new enzymatic email jonespfroggyhscuscedu activity add remove methylcytosine dna methylation covalent addition methyl DNA make extremely interesting period group cytosine context dinucleot DNA methylation discuss ide profound effect mammalian genome major advance methylation past effect include transcriptional repression inhibition end discussion current transcription factor bind recruitment methyl exciting direction likely take next bind protein associate chromatin remodeling factor chromosome inactivation imprinting suppression parasitic dna sequence dna methylation Azacytidine dna methylation gene expression also essential proper embryonic development study carry rst reveal connection ever presence add additional burden dna methylation gene expression early genome normal methylation pattern frequently dis study methylation inhibitor azacytidine use rupted tumor cell global hypomethylation accom treat undifferentiated mouse embryo cell line panye regionspecic hypermethylation striking result formation several differentiate hypermethylation event occur promoter cell phenotype muscle fat cell tumor suppressor gene silence gene change phenotype stably inherit dna isolate provide cell growth advantage manner akin variant capable induce differentiation deletion mutation recent work indicate transfecte back undifferentiated parental line dna methylation important player DNA repair genome stability discovery later show azacytidine deoxy version new family dna methyltransferase make azadeoxycytidine trap dna methyltransferase exciting period methylation dnmt enzyme covalent complex DNA highlight major nding methylation result progressive loss dna methylation summarize important round cell division compound relatively interesting future direction likely take poor chemotherapeutic agent extremely valu able study role dna methylation gene expres sion Treatment variety cell line reveal large number gene reactivate however appear introduction specicity effect later realize cell line contain alter pattern methylcytosine Mammalian cell possess capacity epigenetically modify genome covalent addition methyl group distribution relative primary cell presumably adaptation tissue culture condition mostly abnormal position cytosine ring context cpg dinucleotide approximately residue cultureassociate methylation preferentially remove associated gene reactivate azacytidine mammalian genome methylate however distribution cpg nonrandom majority treatment detail study effect dna methylation genome certain region genome often cluster end gene possess promoter activity reveal dna methylation potent suppressor gene activity mechanism expect cpg frequency term cpg island island protect methylation normal propose repression rst involve direct inhibition bind sequencespecic transcription factor cell mechanism remain unclear dna methylation show essential normal development bind site contain site MycMyn E2F ATFCREBlike protein bind cAMP chromosome inactivation imprinting suppression parasitic DNA sequence however responsive element mechanism require cpg dinucleotide present bind site criterion presence mammalian cell also add additional burden dna methylation cause increase mutation rate clearly fullle transcription factor second mechanism repression mediate methylcpg bind heritably silence gene promoter associate cpg island control cellular proliferation protein example MeCP1 also know family specic occur promoter region gene act step twohit methylate dna protein compete tran mutate lose support role DNA table example cpg island promoter tumor suppressor gene hypermethylation primary inactivate event become hypermethylate silence human tumor contribute tumorigenesis tumor suppressor gene tumor type endogenou mutagen Retinoblastoma cpg site show act hotspot mutation renal carcinoma estimate contribute point p16INK4a Melanoma many other hematologic malignancy mutation germline addition site hMLH1 colorectal carcinoma code region tumor suppressor gene strong hotspot Colorectal carcinoma acquire somatic mutation lead cancer BRCA1 Breast cancer example site p53 code region methylate human tissue study contribute many inactivate mutation colon cancer scription factor bind site methylate dna cancer general reorganize dna tightly pack chromatin structure increase mutability methylcytosine cytosine incompatible transcription discuss later think inuence factor differential repair Studies utilize variety different system show efciency rate spontaneous deamination rate cell repression transcription promoter appear division Deamination cytosine form uracil readily rely former mechanism other recognize repair highly abundant efcient indicate prominent role latter mechanism uracil dna glycosylase however deamination exact mode transcriptional repression vivo methylcytosine form thymine naturally occur DNA likely result combination mechanism base signicantly difcult detect repair also dependent density regulatory thymine dna glycosylase end result element composition specic promoter increase transition rate methylate cpg site aberration repair pathway seem dna methylation cancer common human tumor second factor rate recognize methylation pattern spontaneous deamination appear relatively constant tumor cell alter relative normal cell sufcient account mutation global hypomethylation genome accompany observe doublestranded dna third factor regionspecic hypermethylation region inuence enhance mutability methylcytosine appear frequent target hypermethylation event cytosine rate cell division model bacterial island island GpC region system methylcytosine stable cytosine usually associate gene cpg cell divide fact note island methylation rare normal cell play role cpg mutation common human cancer chromosome inactivation imprint increase cell division stimulate hormone damage tissue age cell culture numerous undergo repair example cpg island promoter hypermethylation tumor methylation machinery contribute suppressor gene accompany silence presumably increase mutability methylcytosine Mutations pro growth advantage cell describe DNA methylase leave dna bind function summarize table intact destroy catalytic function result methylase debate direct role dna unable bind methyl donor adenosylmethionine methylation carcinogenesis selection cell contain SAM result mutator enzyme increase methyl hypermethylate allele tumor suppressor gene cytosine deamination mutant dna methylase list Table likely represent generalized also actively block repair deaminate methylcytosine defect maintenance methylationfree island presumably due steric hindrance mechanism similar figure several line evidence point direct naturally occur catalytic site mutation human causal role dna methylation tumorigenesis rst DNMT1 detect human cancer human reduce dna methylation suppress formation tumor appear level SAM sufcient catalysis intestinal polyp ApcMin mouse Secondly promoter remain unclear mechanism contribute region methylation retinoblastoma prb gene signicantly enhance mutability methylcytosine gene document vivo familial case unilateral retinoblastoma renal cancer respectively Thirdly study sporadic case interaction dna methylation carcinogen carcinoma exhibit microsatallite instability demonstrate high frequency promoter region hyperme mention previous section cpg site frequently act mutational hotspot p53 gene p53 mutation thylation mismatch repair gene hMLH1 treat ment colon cell line contain hypermethylate hMLH1 spectrum give tumor type vary however transition mutation result spontaneous deamination gene azadeoxycytidine result expression restoration ability indicate cpg site frequent colon carcinoma internal cancer transversion mutation predominate hypermethylation island primary inactivating event lastly several example lung cancer transition mutation dipyrimidine sequence predominate skin cancer reecte specicity copy tumor suppressor gene wildtype silence hypermethylation second copy causative exogenous carcinogen elegant study dna methylation past present future direction diagram show interaction various DNMTs case cellular protein target methylation proper region show interaction hypothetical protein protect cpg island novo methylation show hypothetical protein block access DNMT dna aberrant methylation pattern tumor result mistargete DNMT improper expression cell cycle leave combination loss mutation overexpression DNMTs right Mechanisms cpg methylation contribute tumorigenesis presence methylate cpg code region gene predispose region mutation due deamination failure repair result point mutation leave alternatively alteration normal cellular methylation pattern mechanism remain unknown result gene silence alter chromatin structure right novo methylation occur promoter region tumor suppressor gene gene involve maintain genome stability cell gain growth advantage black lollipop methylate open lollipop unmethylated represent point mutation promoter silence fill box exon bent arrow promoter several group show occurrence latter method show PDE activate form react preferentially fold type p53 mutation also enhance methylate cytosine guanines anked methylcytosine site PDE guanines adjacent methylcytosine transversion mutation p53 gene occur high frequency smokingrelated lung cancer also observe bulky chemical carcinogen majority mutation observe skin cancer think result bulky adductproducing compound polycyclic aromatic hydrocarbon example benzo transition mutation dipyrimidine sequence result lightinduced cyclobutane pyrimidine dimer pyrene present tobacco smoke Denissenko use highly sensitive ligationmediated pcr formation Methylation cytosine show enhance Jones pyrimidine dimer formation result exposure cell turn know transcriptional enhancer repressor protein respectively inactive region DNA sunlight fold due high energy absorption max methylcytosine cytosine DNA demonstrate heavily methylate also find enriched hypoacetylated histone major thus presence methylcytosine mammalian DNA add mutational burden several different mechanism advancement understand link dna methyl ation histone hypoacetylation gene silence come recent study laboratory group demon dna methylation repair strate methylbinding protein know several recent line evidence point role dna involve transcriptional repression methylate dna methylation dna repair particularly system recruit histone deacetylase HDAC1 bridging rst study demonstrate target protein sin3 provide rst direct connection newly replicate dna replicationassociated protein transcriptional silence pathway nding proliferate cell nuclear antigen PCNA PCNA also also implication cancer altered methylation know polymerase processivity factor slide clamp pattern hypo hypermethylation event result require dna replication dna repair inappropriate gene expression silence alter target nucleotide excision repair cell ing histone deacetylase also indicate inhibitor cycle regulatory protein p21WAF1CIP1 also interact PCNA histone deacetylase alone combination DNA mediate ability p53 arrest cell division hypomethylate agent useful reactivate silence response dna damage study tumor suppressor gene cancer cell show bind p21WAF1CIP1 DNMT1 PCNA mutually exclusive level inversely methylation machinery relate normal transformed cell p53 function commonly lose cancer concomitant recently DNMT clone loss p21WAF1CIP1 result disruption human mouse cell large enzyme balance p21waf1cip1dnmt1 interaction kda compose terminal catalytic domain PCNA result mistargete methylation homology bacterial cytosine methylase large especially damage DNA good substrate terminal regulatory domain several function include target replication focus Disruption Dnmt1 mouse clear link dna methylation result abnormal imprint embryonic lethality greatly establish demonstration reduce level dna methylation promoter frequently hypermethylate silence endogenous retrovirus know IAPs Dnmt1 sporadic colorectal tumor additional connection embryonic stem cell however viable still possess dna methylation come paper ability novo methylate viral dna suggest describe interesting phenom existence independently encode novo DNMT enon retroviral infection cell line Targeting DNMT1 replication focus terminal lead novo methylation transcriptional silence domain believe allow copy methylation pattern proviral dna infection MMRprocient cell line parental newly synthesize daughter dna lead novo methylation proviral dna strand several form detect line competent express retrovirally encode differ translation start site reporter gene lead proposal hemimethylated unmethylated substrate force distinct pathway lead genomic instability overexpression cleavage terminal observe many tumor term regulatory domain terminal catalytic domain methylation prociency MMRMET shown result increase novo methylation activity study lend support idea show difference cellular transformation furthermore inhibi methylation pattern several cellular gene tion activity use antisense knockout mmrprocient cell line still unclear pharmacologic means combination latter exactly relationship DNA inhibit tumor cell growth induce differentiation methylation role PCNADNMT1 interaction novo methylation activity remain repair nature gene involve cause knockout cell exact role phenotype result point major role tumorspecic methylation abnormality remain unclear dna methylation DNA repair process search additional dnmt carry several group second potential dnmt dnmt2 isolate dna methylation chromatin structure group show possess methylation ability recently group dnmt strong correlation DNA hypermethylation tran scriptional silence tightly compact chromatin isolate database search enzyme show express increase level undifferentiate establish many different system work lead remarkable increase knowledge cell downregulate differentiate cell adult murine tissue furthermore Dnmt3a mechanism chromatin structure modulation reveal chromatin dynamic structure play methylate hemimethylated unmethylated DNA equal efciencie make potential candidate long large role transcriptional regulation least major portion chromatin remodeling appear accomplish seek novo methyltransferase Overexpression family report acetylation deacetylation histone octamer tail many acetylation deacetylation enzyme human tumor contribute global methylation dna methylation past present future direction abnormality see cancer cell increase expres role dna methylation genome stability Figure begin explore also likely sion DNMTs likely partially responsible observed methylation abnormality tumor major focus future research recent study use murine embryonic stem cell decient Dnmt1 indicate overexpress enzyme figure enzymatic removal methylcytosine DNA reduce dna methylation lead increase genomic instability demonstrate loss hprt locus point also describe far less extensively study mechanism identie involve methylcytosine dna role dna methylation suppression mitotic recombination nding Lengauer glycosylase activity recent mechanism report appear involve specic removal inversely relate methylation prociency interest context genome stability methyl group methylcytosine form methanol single polypeptide also contain methylcpg MMR MET cell line know stable diploid chromosome composition MMR MET bind motif likely interplay methyltransferase novo maintenance line unstable genome exhibit aneuploidy chromo somal loss duplication translocation path demethylase new methylation pattern establish embryogenesis dysregulation way gene responsible phenotype unknown future work area likely greatly enhance pathway likely responsible global hypomethylation cpg island hypermethylation observe tumor cell knowledge role DNA methylation tumori genesis important area likely dominate future include characterization demethyl Future direction ation machinery study relationship dna methylation chromatin structure study likely great task researcher DNA methyl ation use new yield major contribution understand role dna methylation cancer methylation change knowledge methylation machinery describe determine dysregulation system reversible also lead development novel thera peutic strategy reverse transformed phenotype contribute cancer use specically target tumor cell destruction other report use know novel demethylate agent correct aberrant methylation pattern restore growth control recently discover family methyltransferase overexpresse tumor relative tumor cell adjacent normal tissue clearly story frequency degree overexpression ment tumor remain controversial issue new work support grant enzyme hand essential characterize catalytic support postdoctoral fellowship activity new DNMTs compare wellcharacterize well determine preferred substrate dnmt example particular DNMT splice variant preferentially bind essential dna methylation Cell Cooper methylation fate sequence cpg island thus responsible cpg dinucleotide vertebrate genome initiate aberrant island hypermethylation Targeted mutation DNA sequence cancer furthermore DNMT target methyltransferase gene result embryonic lethality cell different region nucleus regulate differently RNA epigenetic regulation chromosome inactivation cell cell cycle DNMT crucial Role dna methylation determine respective prole protein genomic imprint Nature interaction partner subcellular localization dnmt targeting vary cell cycle endogenous retrovirus constrain cytosine methylation Nature Genet target alter transform cell figure second major area research likely dominate endogenous mutagen human ldl receptor DNA methylation future determine role p53 gene science dna repair genome stability Figure discuss dna methylation error cancer Cancer Res evidence hypermethylation MMR gene contribute directly phenotype DNA methylation fundamental aspect neoplasia Adv status cell inversely relate ability novo Cancer Res methylate foreign dna sequence recent report suggest methylation involve target MMR Human DNAcytosine methyltransferasePCNA complex target p21waf1 Science novel protein term also call DNA methylation identie associate bind preferentially genetic instability colorectal cancer cell methylate dna methyl bind domain terminus possess endonuclease activity terminus investigation require determine DNA hypomethylation lead elevated mutation rate Nature function novel protein simply preferentially cloning characterization target repair deaminate methylcytosine family novel mammalian DNA cytosine methyltransferase Nature represent human homolog bacterial gene allow strand discrimination target Gaulis dna puried chick embryo methylcytosine repair apparatus newly synthesize DNA strand DNA glycosylase require protein RNA Nucleic Acids Res Shen Rideout Jones High frequency mutagenesis dna methyltransferase cell mammalian protein specic demethylase activity mcpg DNA mutant methyltransferase function mutator enzyme new phenotype induce Jones cell treat azacytidine Cell Mechanisms involvement dna methylation colon alter gene expression azacytidine cell carcinogenesis Cancer Res Pfeifer Tang hotspot Juttermann toxicity aza dna methylation deoxycytidine mammalian cell mediate primarily covalent press trap dna methyltransferase rather dna demethylation formation benzopyrene adduct lung cancer mutational hotspot Bird High level novo p53 science methylation alter chromatin structure cpg island cell line induce Cell pyrimidine dimer preferentially methylcytosine basis Cancer Res Jones epigenetic come age Kong Bird Effects dna methylation dna Crystal structure eukaryotic dna polymerase processivity factor bind protein gene expression PCNA Cell Boyes Bird Repression gene dna methylation depend density promoter strength evidence involvement protein mismatch repair step precede dna resynthesis Cell Robertson Ambinder mapping promoter region PCNA nucleotide hypersensitive methylationmediate inhibition transcription excision repair protein methylation cassette assay EpsteinBarr virus p21 inhibitor major latency promoter cyclindependent kinases control dna replication interaction chromatin PCNA Nature spread focus methylation Mol Cell Biol Vogelstein p53 function dysfunction Cell DNA benign malignant human colon foldback codon human island veterbrate ras gene trinucleotide repeat gene fragile genome DNA methylation colorectal mucosa cancer Cancer Res Baylin cpg island methylation microsatellite instability colorectal cancer Cancer Res Laird JacksonGrusby Suppression intestinal neoplasia dna methylation dna hypomethylation cell repress transcription trend chromatin disruption DNA transcriptional regulator acetylate histone cell methylation span promoter retinoblastoma tumor inactive chromosome female res mammal distinguish lack histone acetylation cytogenetic Lerman Samid marker gene expression Cell transcriptional tumorsuppressor gene dna methylation renal carcinoma repressor abundant bind site genomic chromatin Vermaak DNA recruit histone deacetylase repress transcription Nature Incidence functional consequence promoter hypermethylation colorectal cancer repression methylcpgbinde protein mecp2 involve histone deacetylase selectively silence individual p16INK4a allele neoplasia cancer complex nature Res dinucleotide human sequence direct dna methyltransferase site dna replication genetic disease mammalian nucleus Cell Greenblatt Bennett Hollstein Harris Juttermann Mutations p53 tumor suppressor gene clue cancer etiology novo DNA cytosine methyltransferase activity mouse molecular pathogenesis cancer res embryonic stem cell ubiquitous tenacious methylation Pradhan Hornstra Yaenisch site codon p53 gene explain frequent expression appearance mutational hot spot human cancer Mol Cell Biol characterization fulllength murine dna methyltransferase Mismatch repair cancer Cancer Surveys Genetic Vol methylation island sequence human broblast overexpresse Fishel DNA cytosinemethyltransferase Mol Cell Biol Human thyminedna glycosylase map chromosome 12q22q24 Bestor Activation mammalian DNA methyltransferase region high loss heterozygosity gastric cancer cancer Res cleavage bind regulatory domain rate hydrolytic expression exogenous eukaryotic dna methyltransferase deamination methylcytosine doublestranded DNA Nucleic Acids gene induce transformation cell mutagen hot spot nondivide antisense dna dna methylation past present future direction methyltransferase mrna induce dna demethylation inhibit regulation dna methyltransferase human colon cancer reecte increase cell proliferation tumorigenesis Bestor candidate mammalian DNA methyltransferase relate pmt1 ssion yeast novel human methylcpgbinde endonuclease interact DNA require novo maintenance methylation viral dna embryonic stem cell nucleic mismatch repair protein p16ink4acdkn2a tumor suppressor Acids Res relative Acta F115F177 increase activity colon cancer progression associate inactivation indicate tumor suppressor role p15INK4B Cancer Res Alhonen Paakkonen APC human DNA methyltransferase dnmt coordinate mrna expression normal tissue adenomatous polyposis coli gene promoter region human colorectal carcinoma Int cancer overexpression tumor Nucleic Acids Res aspect genome BRCA1 gene sporadic breast cancer Cancer Res wide demethylation preimplantation embryo Received accept",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 97,
                    "epigenetic": 2,
                    "demethylation": 3
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Mammalian": 1,
                    "Hornstra": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "Mammalian": 102,
                    "Hornstra": 102
                },
                "Ethnographic Terms": {
                    "methylation": 2,
                    "epigenetic": 2,
                    "demethylation": 2
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "DNA methyltransferases and methyl-binding proteins of mammals.pdf",
            "cleaned_text": "dna methyltransferase methylbinding protein mammal Song Key Laboratory Animal Reproductive Physiology Embryo Technology Institution biotechnology College Veterinary Medicine Northwest University Yangling Correspondence address Fax mail zhangyong19561013yahoo mammal dna methylation characterize transfer methyl group mainly refer cytosine act major epigenetic modification parallel DNA sequence arrangement modification methylation dna sequence farreache influence biological func tion activity involve control gene tran scription regulate chromatin structure sustain genome stability integrity maintain parental imprinting chromosome inactivation suppress homologous recombination well limit element dna methyltransferase dnmt methylbinding protein play important role give rise dysregulation gene expression cell maltransformation hence necessary gain good understanding important kind protein help well investigate epigenetic mechanism manipulate modification accord base briefly current understanding dnmt methylbinding protein mammal dna methylation dna methyltransferase methylbinding protein receive accept introduction occurrence incident invariably attribute internal external cause biological event typical gen etic act former epigenetic serve latter property noninterference dna sequence response environmental signal com pletion human genome project investigation become rather fascinating intensive dna methylation major epigenetic modification pay attention currently commonly dna methylation involve control ling gene transcription maintain genome stability integrity parental imprinting chromosome inactivation limit transposable element mammal dna methylation preferentially occur pos ition cytosine context form minor basis methylcytosine account approximately mammalian genome mostly find cpg island call cpg island feature least length content well frequency observedexpected enzyme responsible dna methylation refer dna methyltransferase dnmt catalyze reaction transfer methyl group adenosylmethionine cytosine Murine DNMT1 first report mammalian DNMT several enzyme harbor methyltransferase activity identify dna methylation pattern estab lishe DNMTs emerge question decipher information encode methylate sequence methylcpgbinde protein regard interpreter DNA methylation signal ability bind methylate dna family include MeCP2 MBD1 MBD3 MBD4 charac terize methylbinding motif identify mammal seemingly indispensable methyl CpGbinding protein harbor methylbinding motif nevertheless challenge discovery new protein name methylbinde motif brief overview methyltransferase mammalian present follow description methylbinding protein mammalian DNA mainly focus conserve motif carboxyl terminal region motif create Adometbinding site fold together motif encom pass prolylcysteinyl dipeptide serve active Biophys sin author publish ABBS Editorial Office association behalf abbsgmq015 Biochim Biophys Sin volume Issue Page University Manchester site motif function protonate position target cytosine glutamyl residue motif VIII target recognition domain genomic localization involve mammal show Table isoform date isoform identify namely DNMT1b DNMT1DE3 interestingly untranslated tran script also discover also know DNMT1 DNMT1a consist terminal regulatory domain terminal catalytic domain connect glycinelysine repeat indispensable normal activity base correct folding mation maintenance MTase function heritance preexisting methylation pattern parent strand newly synthesize daughter strand fact maintenance dna methylation perform bona fide error frequency approximately cpg site cell division establish quantitative study endogenou cpg site overall methylation state however stay stable DNMT1s work couple replication fork early phase cell cycle somatic cell dnmt1s translate transport nucleus virtue nuclear localization signal NLS target replication focus guide target replication focus attach hemimethylated dna strand embed euchromatin complex PCNA domain zincbinding domain catalytic domain enter late phase replication focus appear heterochromatin complex becomes HDAC2 attach process polybromo homology domain interplay HDAC facilitate maintenance repression state chromatin alternative pathway replication independent occur phase regard auxiliary way distribution find embryo pre implantation stage global genomic demethyla tion begin fertilization mouse low concentration confine cytoplasm pronuclear distribute wholly cell twocell stage report proper localization dnmt different specie mammal Species DNMT1 DNMT2 DNMT3a DNMT3b Homo sapiens Mus musculus 9A3 10C1 norvegicus taurus figure Schematic draw architecture human DNMT1 DNMT2 splicing isoform exception bovine PBD PCNAbinding domain NLS nuclear localization signal target replication focus atrx homology also know namely zincbinde motif PHD polybromo homology domain repeat glycinelysine repeat remain conserve motif catalytic center locate motif interaction domain HDAC1 hdac2 indicate DNMT2 consist terminal catalytic domain amino acid premature stop codon dna methyltransferase mammal Biophys Sin volume Issue Page University Manchester concentration essential maintenance methylation pattern imprint gene early embryo development absence overex pression lethal embryo adult tissue DNMT1s show high expression predominant form dysregulate normal somatic cell get susceptible malignancy establish DNMT1s overexpression serve hallmark cancer prostate cancer endometrioid carcinoma however evidence show genomic dna methylation hardly impair absence give cancer cell explain point different cancer cell different dependency DNMT1s expression maintenance dna methylation survival present preimplantation embryo mouse believe fail function play real role instead oocyte specific isoform short due loss foremost region terminal locate cytoplasm oocyte preimplantation embryo porcine mouse exception eightcell stage traffic nucleus behavior traffic significance abnormity give rise gene ectopic expression unexpectedly fail identify oocytespecific sheep bovine however surprisingly novel isoform con taine additional amino acid encode unspliced exon exon observe sheep oocyte preimplantation embryo early fetal lineage adult tissue absence lead embryo nic developmental arrest late morula stage splice variant DNMT1 DNMT1b contain additional amino acid compare first identify human tissue retain almost biological property DNMT1s dis play robust activity low expression level seem act assistant require inve tigation bovine DNMT1b lack dmap1binde region express low DNMT1a conform tissuespecific mode regulation later work show novel variant DNMT1DE3 deletion part interaction domain PCNAbinding domain correspond exon MT1KO DKO cell line lose ability bind PCNA still functional MTase maintain genomic methylation respect splice transcript regard exclusive untranslatable pachytene spermatocyte identical transcript however detect skeletal muscle prisingly translate product also detect find strongly challenge traditional perspective untranslated transcript question also exist tissue role respectively play spermatogenesis myogenesis need answer DNMT2 isoform severely truncate protein contain consensus motif low expression level tissue examine detectable activity vitro experiment show still ability attach dna late evidence show weak activity vivo vitro suggest terminal domain seem unnecessary activity intriguingly demonstrate specificity methylation noncpg dinu cleotide similar mechanism extend mammal remains confirm recently new discovery make human DNMT2 catalyze rna methylation give DNA RNA act substrate affinity former DNMT2 low latter assume evolutionary product transit DNA rna target additionally testis preimplantation embryo novel isoform identify seemingly nonfunctional protein cause premature stop codon isoform member include DNMT3b knowledge own isoform DNMT3a1 DNMT3a4 DNMT3b isoform dnmt3b1 dnmt3b8 compare DNMT3b also respectively know DNMT3a1 DNMT3b1 short length unique structure tetrapep tide prolinetryptophantryptophanproline loss analysis show role direct chromatin particularly major satellite region pericentric heterochromatin notably pwwp motif NDMT3b ability combine dna definition DNMT3b novo responsible establishment methyl ation pattern unmethylated dna strand devel opment experimentally demonstrate indispensable embryogenesis mouse fails develop term mouse loss sustain life short period birth explain mouse early DNA methyltransferase mammal Biophys Sin volume Issue Page University Manchester embryo development DNMT3b appear mation blastocyst disappear switch DNMT3b occur suggest assign distinct commitment different stage cell line single combi national mutation analysis DNMT3b confirm require compensate extent human exhibit abun dant expression level low level DNMT3b tissue testis thyroid bone marrow Overexpression DNMT3b however associate tumorigenesis carcinogenesis depend cancer type reflect ing certain extent DNMT3b unique function characteristic show fulfill dna methylation distri butive manner DNMT3b mode process incline methylate major satellite pericentromeric region DNMT3b tend methylate minor satellite meric region furthermore vivo study reveal sequence RCGY ycgr preferentially methylate DNMT3b respectively recently vitro study reveal mouse tend methylate linker dna nucleosome absence protein DNMT3b show activity methylate dna embed nucleosome core region additionally mutation DNMT3b correlation immunodeficiency meric instability facial anomaly syndrome demonstrate dnmt3b responsible methylation imprinted gene presence DNMT1 variant isoform dnmt3b due alternative splicing also play role different stage animal development form vary specie DNMT3a2 transcribe nic promoter feature loss amino acid residue terminal however retain ability interact achieve regional methylation preferen tially establish human cell characterize absence catalytic motif activity western blot analysis confirm scarce cell cycle upregulate cell cycle testicular cell fibroblast DNMT3a4 isolate bovine testis also lack activity loss amino acid central code region lack part amino acid region coincident exon however novo MTase activity hardly impaired compare DNMT3b1 furthermore detect predominantly mouse male gonocyte switch DNMT3b1 DNMT3b2 occur substitution DNMT3a2 gamete embryo major isoform respectively raise question conform similar regulat ory mechanism defect also afford loss key region correspond exon become unable methylate DNA however show vitro system human almost ability fulfill novo methylation DNMT3b1 notably presumably act regulator dna methylation together exert function alone less efficiently cooperation DNMTs efficiently remain isoform appear catalytically inactive disruption region coincident exon DNMT3b4 dnmt3b5 transcript also deficiency exon moreover former exon latter exon DNMT3b4 DNMT3b5 low expression analyze cell line normal human tissue testis figure Schematic draw architecture mouse isoform exception dnmt3a3 DNMT3a4 belong human bovine respectively conserved region contain core tetrapeptide homology region conserved motif indicate color respectively interaction region DNMT3b give delete region isoform DNMT3b correspond exon transcript dna methyltransferase mammal Biophys Sin volume Issue Page University Manchester translate truncate motif due distinctive premature stop codon report DNMT3b4 potential contri butor hepatocarcinogenesis upregulation cause hypomethylation pericentromeric satellite region possibly compete target region play opposite role however opposite result show DNMT3b4 correlate hypermethylation promoter region RASSF1A gene human lung cancer cell study need elucidate exact role transcript first isolate cell retain exon compare transcript recent study report correlation polymorphism gene dna methylation suggest associate gene transcription mouse cell transcript dnmt3b7 DNMT3b8 discover keep exon integrate exon respectively human dnmt3b7 establish aberrant transcript involve dna methylation profile cancer cell translate product require study bovine isoform DNMT3b obtain correspond human DNMT3b1 DNMT3b3 DNMT3b4 dnmt3b5 last member produce gametogenesis possess atrx homology region terminal lose key catalytic domain terminal exhibit dnabinding ability activity serve regulator DNMT3b isoform bind together induce dna methylation improve activity approximately fold moreover indispensable establishment maternally imprint gene deletion lead biallelic expression normally maternally imprint gene disruption global methylation level addition attach HDAC induce novo methylation interaction zinc finger atrx domain histone tail unmethylate lastly strictly speak functionally divide overlap func tion early first report possess novo methylation activity absence region suggest connection structural foundation possess novo MTase activity give also structure Cysrich region consider dual controller con fine novo MTase activity regulable range also confer activity give circumstance exper iment show play role main tenance novo methylation furthermore study confirm cooperation DNMT3a dnmt3b maintenance dna methylation take together name fail live func tion noteworthy cooperation DNMTs also exist carcinogenesis expression differ various cancer extent involve cancer remain investigate DNA Methylbinding Proteins huge amount inheritable information store dna methylation sequence act interpreter read big chal lenge researcher interpreter ident ifie include MBD3 MBD4 together protein MBD3 common property bind methylate dna addition genomic localization mammal show Table general description protein MeCP1 protein complex include chro matin remodeling complex NuRDMi2 contain HDAC1 rbap46 protein responsible preferentially target methylated nucleosomal dna traditionally regard belong MeCP1 complex however Figure map methylbinding protein NuRDMi2 complex MBD methylbinding domain transcriptional repression domain CxxC cysteinerich domain repeat glycine arginine repeat repeat glutamate repeat MBD3 ability bind methylate dna pozbtb pox virus zinc fingerbricbrac tramtrack broad complex pozbtb motif Gray indicate inability MBD3 bind methylate dna recognize methylate dna zinc finger instead MBD DNA methyltransferase mammal Biophys Sin volume Issue Page University Manchester point view seem hold water hence study demand resolve controversy MeCP2 regard found member family protein hold important domain methyl bind domain exist motif directly interact DNA transcriptionalrepression domain show unique methylated DNAbinding region methylcpg flank basis require target rule suitable bind additionally involve dna maintenance methylation complex comparison MeCP1 show hand mecp2 bind methylate dna strongly mecp1 lead stability gene silence hand densely methylate cpg site single one need target MeCP1 respectively noteworthy mutation associate syndrome regard common cause mental retardation female characterize progressive neurological impairment possible reason overexpression neural developmentrelate gene due disruption accord recent study MBD1 dissect key domain MBD Cysrich domain CxxC include CxxC3 terminal TRD MBD CxxC3 ability bind methylate unmethylated dna respectively actively function distance interact DNA gene inhibition dynamic molecular mechanism interaction MBD1 DNA advance far emerge least isoform MBD1v3 MBD1v4 closely resemble MBD3 own additional amino acidlong terminus com pare MBD3 assemble NuRDMi2like complex form MeCP1 protein demonstrate involve repression tumor suppressor gene tumor development growth however recently find methylbinding protein responsible high expression human telomerase reverse transcriptase htertpositive cancer line also report demethylate methylated gene promoter result activation suggest employed potential target cancer therapy MBD3 special lose capability bind methylate dna due insertion amino acid His30 Phe34 domain however component NuRDMi2 complex MBD3 ability combine domain unable directly contact DNA NuRD Mi2MBD3 complex still ability participate gene suppression important indirect mediator possible way complex recruit DNA specific DNAbinding protein additionally find MBD3 indispensable proper differentiation pluripotent stem cell similar surprising study show overexpression MBD3 also play role global demethylation suggest MBD3 act bipartite participator methylation demethylation also designate identify use yeast twohybrid system homologous bacterial dna repair responsible correct mutation methylate cpg site endonuclease activity maintain genomic stability deficient cpg mutability accumulate accompany tumorigenesis hence consider potential candidate tumor suppressor gene last novel methylbinding protein name ability bind least symmetrically methylate cpg site preferably context furthermore bind non methylate dna sequence affinity fold lower methylate region evidence show global repressor methyl ate gene necessary early embryo development detail remain elucidated collectively term genomic structure chromo location infer MBD3 share relatively recent ancestor find invert ebrate diverge relatively distant period DNA MBD presumably regard localization methylbinding protein different specie mammal Species mecp2 MBD1 MBD3 Homo sapiens Mus musculus XA7 norvegicus Xq37 place Bos taurus place place dna methyltransferase mammal Biophys Sin volume Issue Page University Manchester protein base common ability bind dna existence numerous animal genome methylbinding protein build bridge con necte DNA methylation gene repression tumor well DNA repair directly indirectly perspective much information store epigenetically modify dna earth date substantial body information reveal convinced understand dna methylation tip iceberg DNA methylbinde protein isoform identify future mam malian specie continuously produce possibly rna selective splicing normal abnormal con dition furthermore diverse function remain investigate instance recent study show play role bind methylate dna also regulate rna splicing hence delicate net work regulate dna methylation deserve exploration whole genome give site functional interact methylbinding protein other indicate street sign traveler still other nothing exact recognition mech anism involve methylbinding protein work still focus future research meanwhile study need investigate relationship DNMTs methylbinding protein tumorcancer development provide valuable insight epigenetic mechan ism tumorigenesiscarcinogenesis embryogen esisontogenesis however thing certain still long way analysis diverse function dna methylation regulator relate complicated mech anism fortunately rapidly develop dna methylationrelate technology make possible uncover mystery future Funding work fund key scientific technological special program culture diseaseresistance trans genic cattle specie Government Bird Epigenetic regulation gene expression genome integrate intrinsic environmental signal Jones role DNA methylation mammalian genetic science Yoder Bestor candidate mammalian DNA methyltransfer ase relate pmt1p fission yeast Bird cpg island rough guide 34th Prague Czech Republic Elsevier science Bestor DNA methyltransferase mammal Razin Substrate sequence specificity eukaryotic dna methylase Nature Prokhortchouk Hendrich MethylCpG bind protein cancer important MBDs p120ctnbinde partner modal dnabinding protein recognize sequencespecific consensus methylate dinu cleotide DNA methylation chromatinunravele tangled web interaction replication machinery require maintenance dna methylation human cell Cell Biol change dna methylation status Dnmt1 locus mouse early development mammalian DNA methyltransferase family bird dna methylation pattern epigenetic memory dynamic epigenetic fidelity chromosome structure Found Symp activity murine DNA methyltransferase Dnmt1 control interaction catalytic domain terminal part enzyme lead allosteric activation enzyme bind methylate DNA Mol Biol bind hdac2 new repressor form complex replication focus HughesDavies Kouzarides DNA methyltransferase associates histone deacetylase activity Easwaran chromatin loading phase EMBO Rep Chaillet Preimplantation expression somatic form Dnmt1 suggest role inheritance genomic imprint Uchijima genomic methylation pattern preimplantation development require somatic form dna methyl transferase Dev Biol parental identity Dnmt1 maintain imprint epigenetic reprogramming early embryogen esis Genes Dev human DNA methyltransferase dnmt coordinate mrna expression normal tissue overexpre sion tumor Nucleic Acids Res Ushijima Nakagawa increase DNA methyltransferase DNMT1 protein expression correlate significantly poor tumor differentiation DNA methyltransferase mammal Biophys Sin volume Issue Page University Manchester frequent dna hypermethylation multiple island gastric cancer deacetylase dna methyl transferase human prostate cancer Jiang Opposite alteration dna methyltransferase gene expression endometrioid serous endometrial cancer cpg methylation maintain human cancer cell lack DNMT1 Nature requirement dna methyltransferase maintain human cancer cell gene pro moter hypermethylation cancer res Gay inactivation lead mitotic catastrophe human cancer cell Clarke Bestor Chaillet Dynamics dnmt1 methyltransferase expression intracellular localization oogenesis preimplantation develop ment absence oocytederived Dnmt1o protein lead anatomical molecular abnormality placenta 41st Meeting societyforthestudyreproduction Kona Soc Study Reproduction Taylor Moore Young cloning expression sheep dna methyltransferase developmentspecific isoform Alternative splicing expression analysis bovine dna methyltransferase major form dna cytosine methyltransferase human somatic tissue human dna methyltransferase splice variant dnmt1b alternative Dnmt1 isoform muscle differentiation cell growth differ cloning expression chromosome location human gene family Cheng Structure human DNMT2 enigmatic dna methyltransferase homolog display denaturantresistant bind DNA Nucleic Acids Res human residual dnacytosine methyltransferase activity Endogenous assay dna methyltransferase evidence differential activity mammalian cell vivo Mol Cell Biol dnmt21ike protein mediate dna methylation methylate molecule use DNA methyltransferaselike catalytic mechanism rna substrate well dual specificity methyltransferase Trends Biochem Sci Golding Analysis dna cytosine methyltransferase mrna sequence expression bovine preimplanta tion embryo fetal adult tissue pattern den Dunnen domain potential proteinprotein interaction domain nuclear pro tein influence differentiation FEBS Lett target novo DNA methyltransferase domain domain dnmt3b require direct dna methylation major satellite repeat pericentric heterochromatin Mol Cell Biol cloning characterization family novel mammalian DNA cytosine methyltransferase Okano analyse dna methyltransferase gene mouse model system DNA methyltransferase dnmt3b essential novo methylation mamma lian development Cell cellspecific expression dnmt3b embryogenesis Mech Dev Wang Establishment maintenance genomic methylation pattern mouse embryonic stem cell Mol Cell Biol Motamed Socha mediate promoter hypermethylation Sparc ovarian cancer Cancer Res Annu Meeting Gowher enzymology catalytic domain dnmt3b dna methyltransferase site preferen tially methylate Dnmt3a vivo Takeshima Suetake preferentially methylate linker dna inhibited histone Roles Dnmt3b mammalian development mouse model ICF syndrome development bind suggest model novo DNA methyl ation nature biology mammalian DNA methyltransferase Cell Mol Life Sci Suetake Morimoto Stimulation effect Dnmt3L DNA methylation activity Dnmt3a2 Biochem DNMT3A tran script nucleolar localization protein human testicu lar fibroblast cell suggest role novo dna methylation nucleolar inactivation Cell Biochem dna methyltransferase mammal Biophys Sin volume Issue Page University Manchester expression dnmt3b isoform male germ cell development mouse expression novo dna methyltransferase Dnmt3a2 gonocytes mouse embryo pattern DNA methyltransferase contrib ute oncogenic transformation induce SV40 antigen acti vate Ras Oncogene Jones Role dna methyltransferase variant dna methylation Mol Cancer Res novel isoform produce alternative promoter localize expression correlate active novo methylation Overexpression splice variant dna methyltransferase DNMT3b4 associate DNA hypomethylation pericentromeric satellite region human hepatocarcinogenesis Proc Assoc Cancer Res Annu Meeting DNMT3B variant regulate dna methylation promoter specific manner Cancer res island methylation dna damage response gene advance ovarian cancer cancer res Ostler ExpositoCespedes Beau cancer cell express aberrant dnmt3b transcript encode truncate protein DNA cytosine methyltransfer ase expression Clin Immunol suetake Shinozaki Miyagawa Takeshima Tajima DNMT3L stimulate DNA methylation activity dnmt3b direct interaction establishment maternal genomic imprint science Ooi SKT DNMT3L connect unmethylated lysine histone novo methylation DNA Nature Bestor Activation mammalian dna methyltransferase cleavage bind regulatory domain Suzuki cpg island methylation human cancer cell Cancer res operation communication human maintenance novo DNA cytosine methyltransferase Park Jair cooperate silence gene human cancer cell Nature Foltz DNA methyltransferasemediated transcriptional silence malignant glioma combine wholegenome microarray promoter array analysis Klose Bird Genomic DNA methylation mark mediator Trends Biochem Sci mcpgbinde domain human MBD3 bind mcpg interact NuRDMi2 component HDAC1 MTA2 Biol Chem Bird Role MBD2 gene regulation esis cross Bird component tran scriptional repressor MeCP1 share motif dna methyltransferase HRX protein transcriptional repressor belong e MeCP1 histone deacetylase complex Wade MBD protein familyreade genetic mark Bird dna bind selectivity mecp2 due requirement sequence adjacent methylCpG Mol Cell protein mecp2 target molecule maintenance dna methyltransferase Dnmt1 Biol Chem Francke syndrome cause mutation link encoding methylcpgbinde protein differentiation ID1 ID29 gene neuronal target mecp2 elevate syndrome recruit methylate nonmethylate distinct dna bind domain Mol Cell Biol structure methylcpg bind domain human MBD1 complex methylate DNA cell Fujita Regulation transcription chromatin methylcpg bind protein MBD1 Brain DevJpn MBD2NuRD MBD3 NuRD distinct complex different biochemical functional property Mol Cell Biol Perriaud Lachuer methylcpg bind domain protein specific interpret methylated loci cancer cell cancer Perriaud Lachuer Specific association methylcpgbinde domain protein hypermethylated region human telomerase reverse tran scriptase promoter cancer cell carcinogenesis activation demethylation Biol Chem Villa component complex facilitate chromatin alteration deposition epigenetic mark Mol cell Biol component repressor complex require development pluripotent cell Development Szyf DNA demethylation induce methylcpgbinde domain protein MBD3 Gene novel human methylcpgbinde dna methyltransferase mammal Biophys Sin volume Issue Page University Manchester endonuclease interact dna mismatch repair protein Selfridge enhance cpg mutability tumorigenesis mbd4deficient mouse science role complex cancer cancer ruzov Dunican Prokhortchouk Pennings genomewide repressor transcription essential amphibian development Development domain evolve role dna methylation animal Trends Genet Young Hong Castle rna splice methylation dependent transcriptional repressor methylcpg bind protein dna methyltransferase mammal Biophys Sin volume Issue Page University Manchester",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 61,
                    "epigenetic": 9,
                    "demethylation": 4
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "MBD1": 3,
                    "DNMT1s": 2,
                    "contri": 1,
                    "DNAbinding": 1,
                    "MBD3": 2,
                    "Czech": 1,
                    "NuRDMi2": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "MBD1": 74,
                    "DNMT1s": 74,
                    "contri": 74,
                    "DNAbinding": 74,
                    "MBD3": 74,
                    "Czech": 74,
                    "NuRDMi2": 74
                },
                "Ethnographic Terms": {
                    "methylation": 11,
                    "epigenetic": 11,
                    "demethylation": 11
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Dynamic reprogramming of DNA methylation in the early mouse embryo.pdf",
            "cleaned_text": "dynamic Reprogramming DNA Methylation Early Mouse Embryo tima Santos Imprinting Developmental Genetics Programme Cambridge CB2 4AT University Edinburgh Edinburgh EH8 9YL epigenetic modication genome occur early development mouse active demethylation paternal genome occur zygote follow passive demethylation cleavage stage novo methylation think happen implantation investigate process use indirect immunouoresence antibody methyl cytosine contrast previous work show demethylation male pronucleus complete fertilisation activity intricately link separable pronucleus formation condition permissive polyspermy male pronucleus undergo demethylation oocyte paternal demethylation fertilise oocyte decient candidate demethylase occur normally passive loss methylation occur stepwise fashion morulae stage evidence compartmentalisation novo methylation observe specically inner cell mass trophectoderm blastocyst hence important role early lineage specication rst complete detailed analysis epigenetic reprogramming cycle preimplantation development phase methylation reprogramming role imprint control gene expression establishment nuclear totipotency Elsevier Science Key Words demethylation active passive paternal maternal resistance epigenetic mouse introduction dna methylation cpg dinucleotide play impor tant role regulation gene expression essential normal mammalian development general dna methylation function regu lation specic gene transcriptional repression mechanism thought mediate part methylcpg bind protein MBDs Bird dna methylation important sexspecic germline mark parental allele contribute appropriate expression many imprinted gene specic function dna methylation include silence ret rotransposons part genomewide defence system silence expression provide chromosome stability structural integrity loss dna methylation observe ing early mouse development reach low point blastocyst stage early phase demeth ylation con paternal pronucleus prior dna replication describe active demethylation completion rst cell cycle dna methylation con tinue decline due absence maintenance methylase refer passive phase demethylation time methylation decline housekeeping gene repeat sequence genome remarkably print gene largely exempt process maintain methylation long implantation dna methylation restore maintain thereafter somatic lineage restoration methylation carry Dnmt methylase Okano precise time point lineage specicity novo methylation know correspondence address Fax mail dbio available online right reserve pronuclear stage result procedure order describe kinetic pattern demethylation fertilise oocyte sample interval permit prole pronuclear maturation stage function time construct stage describe term methylation status Fig result establish sampling window descriptive mechanistic evaluation antibody accessibility evaluate twocell embryo xe prepare label brdu pseudodic optical image embryo standard xation procedure twocell embryo stain distribution use secondary antibody note polar body positive methylation signal counterstaine identify nuclear compartment detection nucleus accessibility note polar body negative micrograph consistent absence replication Scale bar Methylation Changes Mouse Embryo Elsevier science right reserve FIG distribution cpg methylation stage mouse fertilise oocyte indirect immunouoresence dynamic methylation change portray red polar body resolve use YOYO green mouse identity pronucleus easily assign female small reside often close proximity polar body contrast male pronucleus large immediately sperm entry completion meiosis trigger respective haploid pronucleus begin form sperm righthand side elimination second polar body proceed quickly stage haploid genome highly condense advanced sample collect fertilisation pronuclei appear similar size difference intensity methylation already evident post fertilisation male pronucleus undergo considerable demethylation female appear resistant activity pronucleus reach maximum size right reserve perhaps intriguing feature methylation repro gramme asymmetric loss methylation male pronucleus fertilisation enzyme responsible active demethylation newly fertilise oocyte isolate recently candidate identie attempt understand process gain mechanistic insight interested characterise precise timing active demethylation mouse investigate involvement vivo present evidence active process extremely rapid measure fertilise embryo examination metaphase chromosome respective male female suggest sequence male pronucleus resist active methylation also interested establish outcome passive phase demethylation respect spatial distribution interphase nucleus nd passive demethylation signal compartmentalised previously report rather random twocell stage previous expectation nd novo methylation complete cycle methylation programming preimplantation development clearly occur inner cell mass trophectoderm blastocyst stage result repre send rst complete description temporal spatial alteration methylation preimplantation development mouse MATERIALS METHODS Collection Mouse Oocytes embryo collect superovulated female cleavagestage embryo accord standard procedure use study derive cross C57BL female hereafter refer B6CBAF1 mate B6CBAF1 male mating term day also obtain natural mating female male female male mouse use experiment derive C57BL hybrid line precise timing progression pronuclei stage make possible fertilise vitro unfertilised oocyte use IVF collect b6cba mouse approximately post human chorionic gonadotropin hcg injection gen eration fertilise oocyte procedure follow describe exception sperm capacitation carry modied bigger contain glucose initially absence presence embryo test Two eightcelled embryo morulae blasto cyst collect follow IVF fertilisation culture standard condition datum represent herein comprise collective result indepen dent IVF experiment order generate polyspermic fertilisation oocyte IVF oocyte collect post hcg zonae remove oocyte incubate min accord sperm concentration standard IVF drop Oocytes wash extensively cultured approximately exposure sperm way condition establish permit highly control degree polyspermy range normal single sperm penetration extra sperm Fertilised oocyte collect B6CBAF1 mouse day place culture post hcg order sample embryo syngamy BrdU Labelling Fertilised oocyte early preimplantation mouse embryo pulselabelle order evaluate antibody accessibility zygote incu bate KSOM medium supplement BrdU Sigma co2 air incubation zygote rinse xed min paraformaldehyde permeabilize min room temperature stain Fertilised oocyte early preimplantation embryo wash xed min paraformaldehyde permeabilize min room temperature zygote block overnight incubate room temperature monoclonal antibody histone rabbit polyclonal antiH4Ac5 secondary antibody couple detection brdu male appear completely demethylate pronucleus move close together oppose immediately prior syngamy syngamy methylation status male negative female positive appear clear Scale bar Methylation distribution function maturation Fertilised oocyte generate IVF score accord stage assess size morphology pronucleus follow stain antibody fertilise oocyte score positive signal pronuclei double positive total number oocyte score produce prole PN0 PN1 remodelling immediately follow fertilisation maturation Fertilised oocyte collect regular interval evaluate extent chromatin remodelling accord stage immediately follow fertilisation sperm complexe protamine acquire histone maternal cytoplasm histone already acetylate newly acquire decondense sperm nucleus nuclear compartment positive methylation early stage subsequent stage pan histone acetylated histone remain constant pronucleus contrast diminish methylation signal male pronucleus Methylation Changes Mouse Embryo Elsevier Science right reserve label DNA methylcytosine zygote treat HCl room temperature min subsequently neutralise min TrisHCl buffer permeabilisation extensive washing zygote block overnight antimec antibody antibrdu antibody detect secondary antibody couple Cy3 Red respectively Double antibody stain BrdU accomplish sequential incubation rst second round primary secondary antibody DNA stain intercalate dye diamidino phenylindole zygote mount glycerol perform BX40 epiuore record digitally high resolution CCD camera View use analySIS image analysis software Greyscale image pseudo colour capture use separate lter set FITC YOYO CY3Texas Red merge software optical section fertilise oocyte early preimplantation embryo record confocal laser scanning microscope wave length series slice scan export bit image later project use 19z pseudocoloure use Adobe Photoshop RESULTS Timing Active Demethylation order provide precisely dene time point fertilisation monitor rate active demethylation mouse oocyte fertilise genomic methyl ation visualise use indirect immunouoresence antibody methyl cytosine reliability technique rmly establish number independent study antibody well character ise use success several laboratory progression decondensation fertilise sperm clearly follow overall pattern change assign stage term use nomenclature extend terminology include recently fertilise oocyte refer PN0 vitro fertilise oocyte score group take post fertilisation assign group PN0PN5 Fig previous report employ similar approach fail establish negative result attribute inaccessibility antibody methyl moiety antibody work condition compatible methyl detec tion compatibility procedure detection nuclear antigen addition methyl cytosine embryo therefore important requirement study useful compatible antigen identie brdu sit major groove methyl group however fertilise zygote enter phase demethylation take place twocell embryo elect ideal stage demonstrate antibody access nucleus Fig Accessibility nucleus cell embryo demonstrate signal provide indirect immunouoresence antibody methyl cytosine BrdU Fig nucleus identie basis staining DAPI Fig note polar body act reliable positive control stain methyl brdu incorporation useful feature xation procedure spatial relationship embryo compartment retain absence dna methylation male pronucleus establish specic locus use sequence possibility remain aspect genome wide loss also explain consequence specic mask methylation moiety male fertilise sperm take approxi mately min mouse thus initial stage loss protamine reacquisition nucleosomal histone methylation signal weak owe inaccessibility antibody transition immediately phase male female pronuclei stain methyl cytosine Fig male pronucleus already less intensely stain female suggest loss paternal methylation begin quickly removal protamine early initiate IVF substantial proportion oocyte display PN3 Fig pattern indicate process active demethylation take place rapidly result almost complete loss methylation male pro nucleus Fig process take min measure suggest vivo process likely take place less min maturation continue fertilise embryo enter syngamy apparent remain methylation attribute female pronucleus small pronucleus polar body use classication characterise time point stage demethylation male pronucleus occur thus dene window active demethylation collect xed time point assign stage correspond change size shape position pronuclei evaluate methylation status antibody Elsevier Science right reserve methyl cytosine Fig histogram show centage embryo show stain pronuclei function stage pronucleus Fig identie stage demethylation initiate embryo evaluate positive pronuclei staining methyl antibody PN1 suggest demethylation initiate immedi ately stage fertilisation sperm chromatin remodelle protamines replace histone previous study investigate process acquisition histone acetylate histone follow loss protamine period pronuclear maturation ideally interested describe simultaneous loss protamine incorporation histone methylation status paternal genome embryo unfortunately technical requirement stain basic protein DNA compatible pro cesse thus group embryo select specic times fertilisation xe evaluation histone cytosine methylation independently soon removal protamine take place decondense sperm becomes associate histone cpg methylation latter portion rst cell cycle enter mitosis early metaphase condensation respective genome reveal separation maternal positively stain paternal component chromosome approach form metaphase plate position maintain respect chromosome mix maternal paternal staining pattern reecte difference pattern uorescent staining DNA completion mitosis positive methylation signal telophase nucleus twocell embryo appear less intense compare early stage attribute absence maintenance methylase activity cleavage stage scale bar spatial distribution residual methyl cytosine signal maternal paternal compartment condensation respective genome residual positive signal reveal though weak compare maternal attributable paternal component zygote note intensity staining antibody correspond area diminish intensity YOYO staining see maternal haploid genome chromosome approach position maintain metaphase plate see example note high degree cytoplasmic staining due tendency YOYO stain DNA mitochondria Scale bar Methylation Changes Mouse Embryo Elsevier Science right reserve moreover bias acquisition acetylate histone male pronucleus Fig result close agreement report thus presence histone nucleosomal organisation demethylation take place preferentially male pronucleus female pronucleus remain highly methylate unaffected enter mitosis align properly equator maternal paternal component discernible methylation signal anaphase genome mix equal contribution mater nal paternal chromosome move opposite pole Fig twocell embryo product cell cycle typical pattern telophase nucleus depict careful observation population zygote move syngamy latter phase cell cycle stepwise feature separate parental genome newly emergent zygotic genome become apparent Fig separate diploid genome condense begin reform chromosome maternal lower highly methylate pater nal upper however paternal genome low signicant positive signal Fig extend arm chromosome respective genome approach metaphase plate distinc tive methylation pattern evident maternal left conrm methylation pattern respective genome prior division spatial separation maternal paternal genome early preimplantation stage mouse suggest however observation use different method data show show separation genome clarify discrepancy evaluate cell morula blastocyststage embryo stain methyl antibody order strictly compare evaluate methylation status individual embryo phase important stage treat stain together slide result show pattern methylation stain nucleus random eightcell stage apparent separation spatially uneven distribution Fig morulae stage little methylation detect nucleus polar body remain strongly stain however blastocyst stage intense signal clearly visible trophectoderm mostly negative demonstrate novo methylation begin preimplantation embryo interesting ask residual positive cell FIG spatial distribution methyl cytosine pas sive phase demethylation collect eightcell morula blastocyst stage xed immediately prepare immunouorescence evaluation stain DNA DAPI cy3 secondary antibody image capture use Olympus Epiuorescence microscope image merge use Adobe Photoshop Scale bar Elsevier Science right reserve trophectoderm represent specic population cell identied basis nuclear complement diploid giant cell Functional Evaluation Demethylating Activity titration demethylation activity polyspermic cyte oocyte rich resource protein zymes rna support maturation growth pronucleus follow fertilisation achieve incorporation lamin cytoplasm mature pronucleus suggest oocyte capacity support decondensation sperm interested possibility capacity demethylation titrate addition supernumerary sperm order investigate hypothesis oocyte subject IVF condition select polyspermy min exposure capacitate sperm zone free oocyte xe prepare stain evaluate methylation status respective observe supernumerary male Representative embryo experimental group show oocyte contain single male pronucleus able mature PN5 stage closely resemble pn2pn3 stage pronucleus variable extent maturation condition however irrespective extent nuclear swelling hence maturation demethylation male pronucleus occur result suggest condition demethylation activity limit fertilise oocyte activity intimately associate sperm fact maternal pronucleus become sensitive demethylate activity notable active demethylation fertilise oocyte lack begin investigate mechanistic basis active demethylation observe fertilise oocyte make use mice decient candidate demethylase enzyme protein isolate independently identied methyl CpGbinding protein Bird Reciprocal cross null mice result pattern staining identical wildtype embryo result show active demethylase responsible removal methylation paternal pronucleus fertilised oocyte discussion study provide rst complete descrip tion cycle methylation reprogramme mouse preimplantation embryo cycle initiate shortly sperm decondensation fully characterise phase selective demethylation paternal genome use IVF create precisely time prole pronuclear maturation chromatin remodelle mouse use sensitive immunouorescence assay wellcharacterised antibody methyl cytosine identie early stage activity become apparent paternal genome selectively demethylate immediately follow fertilisation dezonate mouse oocyte evaluate demethylation paternal allele titratable oocyte expose capacitated sperm removal zonae incubate prior xation procedure produce fertilise oocyte contain multiple extra male pronucleus result show polyspermic fertilise embryo male male oocyte evaluate use laser scan confocal micro scope twodimensional projection optical section produce Scale bar Methylation Changes Mouse Embryo Elsevier Science right reserve sperm decondensation maternal paternal genome unequally methylate ylation complete min sperm deconden sation result contradict previous report suggest paternal maternal chromosome stain equally intensely fertilisation discrepancy arise part use oocyte derive naturally time mating rather IVF parallel evaluation naturally fertilise however unequal methylation pronounce early post fertilisation majority show complete demethylation paternal pronucleus datum show syngamy small signicant residual methylation signal paternally derive chromosome candidate sequence sidual methylation include repeat exact nature epigenetic status interest share common feature imprint gene remain methylate plantation use sequencing indeed identie specic family resist active demethylation unpublished observation oocyte possess limited capacity decondense remodel sperm functional maturation pronu clei coincident event attempt titrate activity polyspermic fertilisation unsuccessful male pronucleus demethylate yet methylation status unaffected protamine removal histone deposition tightly couple least study report occurrence naked sperm dna protamine removal histone acquisition male female pronucleus experience brief period susceptibility demethylate activity however con tinued presence naked DNA clearly require completion demethylation reasonable specu late demethylation activity target male pronucleus histoneprotamine exchange thus chromatin remodelling require trigger demethylation reaction absence chromatin model female pronucleus explain persis tence methylation phase nature vivo demethylate activity unknown previous work show microinjected methylate dna fragment undergo active demethyl ation early mouse embryo various assay demonstrate demethylate activity FIG distribution cpg methylation stage null mouse fertilise oocyte oocyte collect reciprocal crosse mouse null inherit maternally paternally oocyte stain DNA YOYO Cy3 secondary antibody image capture use Olympus Epiuorescence microscope image pseudocoloure merge use Adobe Photoshop Scale bar Elsevier Science right reserve nuclear extract cultured cell embryo report activity isolate remove methyl group vitro produce methanol reaction activity iden tie short form methylbinding domain protein propose candidate demethylase activity early embryo study fail reproduce vitro result important assess vivo require demethylation zygote evaluation fertilise oocyte homozygous knockout allele give result wildtype control therefore require active demethylation observe mouse zygote methylation asymmetry maternal paternal lead speculation functional importance spatial organi sation nucleus onecell stage recent report suggest transient gation parental genome fourcell stage support result methyl ation distribution cleavage stage difference due preparative technique employ harsh xation protocol result signicant embryo loss unpublished observation morula stage little genomic methylation remain contrast early report use dna extract blastocyst show novo methylation occur blastocyst stage restrict trophectoderm virtually devoid methylation thus lineagebased methylation difference establish time differentiation embryonic lineage observation cell substan tially methylate therefore consis tent origin early novo methylation essential early embryo decient novo methylase show abnormality embryonic lineage effect extraembryonic tissue functional importance temporal quantita tive feature loss methylation prior implanta tion present unclear demethylation widely observe mammalian embryo unpublished observation observe zebrash imprint germline reprogramming ensure totipotency suggest indeed critical requirement oocyte form maintain methylation imprint locus raise interesting question outcome place somatic nucleus environ ment oocyte cytoplasm cloning somatic nucleus highly methylate donor cell come transcriptionally reeducate time meth ylation reprogramming event normally take place consistently low efciency somatic nuclear cloning relate inability somatic nucleus undergo normal change methylation attractive question pose interested evaluate possibility well iden tify somatic nuclear donor improve reprogramming efciency lead improve rate clone resolve question make cloning powerful technique investigate fundamental question early mammalian embryogenesis development especially genomic imprinting acknowledgment thank kind gift methyl cytosine antibody gift antibody acetylate histone also like thank expert assistance confocal microscopy provid ing intercross embryo generously offer valuable advice prepara tion manuscript discussion early phase work work support grant BBSRC GHT Adenot Mercier Renard Thompson differential acetylation paternal maternal chromatin precede dna replication differential transcrip tional activity pronuclei cell mouse embryos develop ment Bird repressionbelt brace chromatin Cell mammalian protein specic demethylase activity mcpg DNA Nature Carlson Page property dna methyltransferase preimplantation mouse embryo implication genomic imprinting Genes Dev Hendrich Bird Identication characteriza tion family mammalian methylcpg bind protein Mol Cell Biol Hendrich closely relate protein MBD3 play distinc tive interact role mouse development Genes Dev Hogan Manual 2nd Cold Spring Harbor Laboratory Press Cold Spring Harbor Howell Bestor imprinting disrupt maternal effect mutation Dnmt1 gene Cell Methylation change Mouse Embryo Elsevier science right reserve level maternal paternal genome preimplantation development velopment dna demethylation chicken embryo property methylcytosinedna glycosylase Kafri Shemer Urven pattern genespecic dna methylation mouse embryo germ line Genes Dev aspect genomewide demethylation preimplantation mouse bryo induction regulation genomic print mouse U2afbp gene preimplantation development Biggers Culture preimplantation embryo Methods Enzymol Mayer demethylation zygotic paternal genome Nature Haaf spatial separation parental genome preimplantation mouse Cell Biol McLay ability organize sperm dna functional chromatin acquire mei otic maturation murine oocyte Bird absence genome wide change dna methylation development zebrash Sibella abnormal methylation pattern constitutive inactive chromosome heterochromatin patient Decrease dna methylase activity preimplantation development mouse Development temporal regional change dna methylation embryonic traembryonic germ cell lineage mouse embryo development Development transcriptional repressor belong MeCP1 histone deacetylase complex Pain Polymerase chain reaction product contain methylcytidine microplate immunoquantication method DNA methyltransferase dnmt3b essential novo methylation mammalian development Cell preimplantation ontogeny H19 methylation imprint demethyl ation paternal genome mouse zygote nuclear deconden sation mammal role spermassociated proteinase vivo remodeling mammalian zygote Mutat Res Reik Dean reprogram ming mammalian development imprinting parental inuence genome Evolution imprint mecha nisms battle sex begin zygote monitor urinary excretion modied nucleoside cancer patient use set monoclonal antibody Cancer Lett Rideout III Eggan cloning epigenetic reprogramming genome DNA methylation health disease ViegasPequignot Chromosome methylation pattern mammalian preimplantation devel opment Genes Dev Stein redistribution acetylate tone nucleus early preimplantation mouse embryo Reprod Dev Biggers Fertilization vitro mouse inbred outbred strain complete preimplantation embryo development glucosesupplemente Reprod Bird Methyl ation genome gene invertebratevertebrate bind ary Mol Cell Biol Wade Gregonne Jones complex couple dna methylation chromatin remodelling histone deacetylation methylation mouse H19 gene embryonic cell decient Dnmt gene DNA demethylation involvement rna cell Yoder Walsh methylation ecology intragenomic parasite Trends Genet receive publication Revised online Santos Elsevier Science right reserve",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "epigenetic": 5,
                    "demethylation": 43,
                    "methylation": 76
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Mutat": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "Mutat": 124
                },
                "Ethnographic Terms": {
                    "epigenetic": 1,
                    "demethylation": 1,
                    "methylation": 1
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Effect of soil conditions on the degradation of cloransulam_methyl.pdf",
            "cleaned_text": "effect soil Conditions Degradation CloransulamMethyl efficacy environmental fate often control soil condition aerobic soil laboratory study undertake determine degradation herbicide cloransulammethyl carbomethoxychlorophenylethoxyfluorotriazolo pyrimidinesulfonamide range soil factor treat ment include soil temperature moisture water fill pore space soil type soil study clay loam finesilty mix super active mesic silt loam fine smectitic mesic Variability molecular degradation investigate use radiolabeled form parent compound soil solution sorb phase formation radiolabele metabolite mineral ization total microbial respiration bound residue formation measure Dissipation parent formation bind residue Drummer soil increase great temperature influence temperature mineralization however dependent position radiolabel suggest distinct group microorganism degrade different part molecule high temperature mineralization influence moisture response depend soil type increase moisture result mineralization soil attribute increase microbial access pesticide great moisture content soil reduce availability suggest great sorption Drummer soil explain persistence parent soil bind residue extensive exhibit great dependence biological activity soil owe enhance dissipation parent compound soil LORANSULAMMETHYL phenylethoxyfluorotriazolo Illinois Urbana USDAARS Science New receive Corresponding author Published Environ Qual recently develop control broadleaf weed soybean Glycine max Merr triazolopyri midine sulfonamide herbicide Fig function inhibition plant enzyme acetolactate synthase ALS notable characteristic compound include low application rate label rate preplant preemergent respectively low pKa short halflife solubility water LT1 apparent range little publish datum limited degradation study exist behavior cloransulammethyl make research important understand environmental fate new xenobiotic compound study herbicide degradation fate vital maintain environmental quality optimize agricultural practice Herbicidal activity environ mental behavior affect influence environmental condition soil process Herbicide fate process sorption desorption volatiliza tion chemical hydrolysis biodegradation bound residue formation exhibit variability depen dent factor soil temperature moisture redox potential general importance datum relat ing effect moisture temperature condition fate xenobiotic soil temperature response environmental fate pro cesse variable range observe sorption phenomenon sett hyperbolic exponential function optima often associate system chemical process generally hibit exponential increase temperature exam ple Arrhenius plot mesophilic bacterial growth pure culture exhibit response maximum proximately reduce rate higher publish CUPPLES DEGRADATION cloransulammethyl low temperature thus pesticide degradation control biological factor expect display temperature optima relative importance chemical biological degradative process investigate examine activation energy value degradation study range temperature activation energy taine regress natural logarithm rate constant accord equa tion degradation rate constant empir ical constant temperature universal gas constant activation energy reaction temperature responsiveness various degradation mechanism characterize use system ergy value great mol frequently report chemical physical reaction xenobi otic soil biological reaction typically result value less mol sug geste catalytic nature biological reaction result low energy requirement hence minished response temperature objective study determine temperature dependence soil moisture content affect biological abi otic environmental fate process general trend reduce degradation rate low moisture content observe many pesticide picloram imazaquin Mervosh chlorsulfuron limited diffusion substrate xenobiotic increase toxicity high solution concentration great sorption low moisture content result less dissipation low enough water content physiological constraint result reduce microbial activity lead retarded degradation reduce availability oxygen occur high moisture content therefore aerobic microbial activity often maximal water content sub strate diffusion oxygen supply optimize process sorption trans port volatilization also dependent diffusion kinetic thus also expect respond water content study investigate importance soil moisture cloransulammethyl fate process include dissipation parent sorb solution pool bind residue formation mineralization ing range moisture content optimal soil micro bial activity sorption hydrophobic organic compound usu ally great soil organic carbon often result bioavailability limitation pesticide deg radation hydrophobic sorption intrinsically equilibrium extent sorption result bioavailability constraint strongly influence temperature librium condition present unsaturated soil owe sorption nonequilibrium solution phase typically deplete preferentially sorb phase unsaturated soil however movement substrate inacces sible pore space important sorption limit bioavailability many soil relative importance physical inaccessibility xenobiotic biodegradation appear function water content role bio availability soil degradation cloransulammethyl investigate function temperature moisture degradative characteristic cloransulam methyl extensively determine relation temperature soil moisture goal search demonstrate important dissipation mechanism xenobiotic cloransulammethyl soil pool influence soil temperature moisture process pathway study employ range moisture condition bioavailability constraint important physiological stress temperature condition span range expect soil surface pesticide apply MATERIALS METHODS chemical form utilize Phe radiochemical rity radiochemical purity labeling pattern depict Fig primary impurity label sample cloransulam form hydrolysis methyl ester group important transformation product soil water compound QUAL VOL MAYJUNE analytical grade cloransulammethyl metabolite purity gift solvent water Soils include top silty clay loam collect Champaign silt collect Soil sieve screen mix store soil property describe Table Experimental Design Temperature Moisture Degradation cloransulammethyl Phenyl14C measure soil function temperature moisture condition Herbicide apply rate soil equivalent field application rate describe soil subject range temperature study soil subject range moisture content water fill pore space WFPS addition H20 soil H20 soil experimental treatment field moist soil equivalent airdry material add tripli cate produce bulk density approxi mately Soils spike herbicide methanol gently mix approximately min jar fit glass vial contain trap CO2 Soils temperature study extract DAT day treatment soil moisture study extract DAT describe analytical section also co2 trap study sample analysis include determination parent radiolabeled degradation product soil solution sorb phase mineralization formation bind residue unextractable total microbial respiration Radiolabel Position Drummer soil sample equivalent airdry material spike separately form label methanol soil sample ceive Phenyl application soil soil Pyrimi dine Herbicide apply temperature triplicate co2 trap sample analysis a4C mineralization describe Sterile Controls sterile condition achieve subject soil radiation source total exposure dose apply verify end incubation dilution plate counting agar contain nutrient broth sterile nonsterile soil spike cloran sulammethyl rate soil Herbicide apply temperature triplicate DAT soil prepare bound residue analysis organic solvent extraction trap sample mineralization bound residue formation investigate study Sorption Isotherm equilibrium batch sorption isotherm study ducte soil Soils airdried sieve pass ram screen soil solution ratio use soil solution solution phase consist cloransulam methyl concentration soil solution mix horizontal reciprocate shaker preliminary study show sufficient mixing time reach equilibrium cloransulammethyl degrade time verify high pressure liquid chromatography HPLC describe sample centrifuge min aliquot analyze liquid scintillation spectrometry total radioactivity sampling time triplicate soil sample range place separate Teflon centrifuge tube solution contain HgCI2 inhibitor add obtain ratio soil solution soil sample size increase improve cloransulammethyl detection later sample date tube place shaker centrifuge remove solid base preliminary study reproducible endpoint obtain repeat extrac tion process additional time extract subsequently refer solution pool organic extraction ace Table Properties silt silty clay nutrient base saturation moisture release curve particle size fraction CEC Pressure moisture Size fraction oct sand Silt SMP Clay cmol cmol Analyses perform describe Klute organic carbon SMP buffer cation exchange capacity CUPPLES DEGRADATION CLORANSULAMMETHYL tone water acetic acid tempera ture study acetone water acetic acid study carry manner organic extract solution pool subsequently refer sorb pool extract filter ixm ptfe filter Deerfield Water extract undergo solid phase extraction ExtractClean C18 column follow resuspension water acetonitrile sample well organic extract evaporate make specified volume ixL latter acetonitrile solution radiolabele degradation prod ucts determine reverse phase radiochromatic HPLC equip 500TR Series Packard Instrument Company Meriden Conditions injection volume mobile phase flow rate min detector use reverse phase column cocktail Meriden multiplestep mobile phase gradient acetonitrile water use facilitate separation parent com pound degradation product gradient water acetonitrile follow gradient change linear unspecified time interval rain total radioactivity present determine add search ixL concentrated extract use liquid scintillation analyzer Meriden Bound Residue Analysis Total soil determine combust subsample dry extract soil organic solvent traction biometer Harvey biological oxidizer trap cocktail ment cocktail sample analyze use co2 trap analyze mineralization radio label herbicide degradation product rection chemiluminescence Microbial respiration soil determine titration sample trap follow carbonate precipitate bac12 unreacted titrate H2SO4 use phenolphthalein indicator Statistical Analysis statistical analysis conduct use tute data analysis tool Excel result discussion average mass balance study duration incubation apply soil apply soil rapidly tribute solution phase soil pool solution pool preferentially deplete sorb pool formation degradation prod uct bind residue result report figure express fraction recover material simplify presentation treatment partial depletion sorb pool observe end incubation period preferential depletion solution phase report previously hydroxybenzoic acid zone summary overall fate cloransulammethyl WFPS soil present soil less parent compound maining solution DAT apply parent compare soil Fig similarly less parent sorb phase compare expect increase dissipation parent soil accompany great occurrence radiolabele degradation prod ucts apply radioactivity DAT contrast addition lOO Time Fig Summary herbicide fate phenyl label radiolabele car bon dioxide bind residue radiolabele degrada tion product radio parent sorb sorbed solution solution soil water fill pore space WFPS ENVIRON qual VOL MAYJUNE Time Fig Summary herbicide fate phenyl label soil radiolabele carbon dioxide bind residue radiolabele degradation product radio parent sorb sorbed solution solution temperature datum report treatment DAT due excessive experimental error DAT mineralization bound residue formation significant respectively compare soil respectively sorption isotherm wellrepresente equation log 1In log log concentration cloransulam methyl remain solution sorb soil respectively correction factor equilibrium sorption coefficient soil use equation value calculate soil respec tively greater sorption soil uted high organic matter content sorption process dominate hydrophobic partitioning great persistence parent compound soil solution soil compare soil incubation attribute inaccessibility pesticide present extensive fine pore space expect fine textured soil similar persistent solution pool note hydroxybenzoate attribute physical inaccessibility residue formation Fig inset great compare Drummer soil great parent com pound degradation soil perhaps lead degradation product capable bind concentration cloransulammethyl sorb phase use calculate non equilibrium apparent sorption coefficient cord equation gda CsaCwa Csa sorb phase solution phase important recog nize estimate rather CUPPLES respiration function temperature function moist ure waterfilled pore space WFPS soil bar indicate standard deviation indicator sorption nonequilibrium system useful predict bioavailability constraint soil approach incubation increase soil equilibrate slowly significantly less final Kda slightly great slow response sorption soil attribute diffusion constraint fine textured soil Temperature Effect temperature cloransulammethyl mass balance Drummer soil depict Fig Parent compound soil solution decline temperature crease apply parent DAT parent metabolite remain solution observe slow degradation similar pattern observe sorb parent example sampling time phase persistent result timeaveraged determine value increase tempera ture trend explain great response temperature process deplete solution phase replenish solution desorption fraction parent remain soil temperature condition use determine degradation rate constant determine first order kinetics Arrhenius dia gram datum present note introduction value range less etal think represent biological mechanism value great frequently report chemical reaction xenobiotic soil Burnside etal activation energy obtain dissipation parent solution suggest chemical physical mechanism important overall fate cloransulammethyl Drummer soil phenyllabele function temperature Drummer soil Bars indicate standard deviation qual ofphenyl label cloransulammethyl asa func tion soil moisture water fill pore space WFPS soil bar indicate standard deviation bound residue formation increase temperature reach Fig increase bound residue formation temperature report xenobiotic high temperature also result great respiration soil microbial community Fig Growth particular specie microorganism think restrict range span approximately thus increase respiration probably due shift specie dominance tempera ture increase mesophilic range contrast mineralization rate optimum decline high low temperature Fig incubation phenyllabeled material regardless soil type similar result report herbicide clomazone lack temperature response also attribute volatilization loss high temperature study vapor pressure cloransulammethyl however negligible contrast datum pyrimidinelabeled compound illustrate different trend fig mineralization increase range employ result suggest distinct group microorganism grade different part molecule high temper atures appear organism responsible degrade phenyl ring unresponsive soil pesticide label pattern temperature treatment produce maximum mineralization rate exhibit accelerate kinetic indicative growth Apparent growth response xenobiotic report concentration low soil well rate ploye herein note increase degrader population occur study due factor addition cloransulam methyl adjustment soil moisture tion carrier solvent moisture soil moisture influence concentration parent solution datum show moisture range apparently large enough effect parent disappearance process also report effect soil moisture clo mazone solution apparent incubation period Biodegradation rate herbicide however influence soil moisture condi tion several mechanism include reduce oxygen availability high moisture content duce diffusion substrate low moisture con tent analogous parent disappearance formation bind residue affect soil moisture large moisture range produce effect influence mois ture condition bind residue formation already note pesticide contrast soil moisture influence respiration mineralization Fig response mineralization change moisture condition differ soil high moisture con tent microorganism think physiological disadvantage therefore dif ference mineralization attribute largely bioavailability limitation mer soil mineralization kinetic slow considerably change moisture content mineralization virtually eliminate suggest reduction microbial access cloransulammethyl result differential labeling study suggest involvement group organism biodegradation cloransulammethyl mineralization depen dent microscale transport herbicide microbial colony Pesticide transport drum mer soil restrict high clay organic carbon content thus explain response mineralization moisture content result low water content also explain reduce physiological wellbeing degrading microorganism conversely effect decrease moisture observe soil content WFPS achieve result support previous observation parent signifi cantly deplete solution soil CUPPLES DEGRADATION CLORANSULAMMETHYL much remain soil periment Importance Biological Processes effect soil sterilization examine bound residue formation mineralization expect significantly less mineralization occur sterile condition influence abiotic condi tion bind residue formation however differ soil Introduction sterile condition reduce formation pool soil little influ ence soil datum suggest biological process important soil abiotic pro cesse main mechanism formation pool soil hypothesis support extensive accumulation degradation product soil detailed process contribute bind residue formation present Calderbank substance bind soil stable chemical linkage matter diffusion IOMD occur describe diffusive mass transfer sorbate interior organic matter suggest physical occlu sion responsible detainment com pound soil due entrapment soil micropore prevalent soil use summary bind cloransulammethyl residue result combination process chemical biological dominance single process depend factor soil type environmental variable conclusion disappearance function temperature soil type insensitive soil moisture range condition use study Soil environmental variable influence mineralization bound residue formation vary degree effect temperature mineralization differ tween radiolabele form herbicide contrast temperature response label sug gest group organism involve degradation furthermore illustrate impor tance label position environmental fate study increase soil moisture result great tion soil however soil difference mineralization high mois ture content effect soil attribute increase moisture improve microbial access pesticide temperature soil type affect bind residue formation great formation pool occur high temperature soil accumulate soil possibly due great accumu lation degradation product inclusion sterile con trols reveal biological abiotic process contribute bound residue formation Relative con tribution biological process depend soil type finally note formation bind residue mineralization respond differently temperature lustrate variability response dissipation process change environmental condition summary study depict significance chemical structure soil type soil temperature moisture cloransulammethyl dissipation mechanism acknowledgment thank provide cloran sulammethyl also thank assistance laboratory Names necessary report factually available datum however guarantee warrant standard product use name imply proval product exclusion other also suitable qual VOL MAYJUNE",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Herbicidal": 1,
                    "HgCI2": 1,
                    "influ": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Effect of the free radical scavenger_ 3-methyl-1-phenyl-2-pyrazolin-5-one _MCI-186__ on hypoxia-ischemia-induced brain injury in neonatal rats.pdf",
            "cleaned_text": "effect free radical scavenger methylphenylpyrazolin hypoxiaischemiainduced brain injury neonatal rat Xia Masatoki Obstetrics Gynecology Miyazaki Medical College receive receive revise form accept free radical scavenger methylphenylpyrazolinone approve use patient cerebral infarction use treat ischemichypoxic brain damage neonatal rat rat pup subject modied procedure give vehicle dosage level extent brain damage evaluate day later administration signicantly attenuate damage dosedependent manner result indicate promise candidate treatment neonatal hypoxicischemic encephalopathy Elsevier Science Ireland Ltd right reserve neonatal rat hypoxiaischemia oxidative stress free radical scavenger Methylphenylpyrazolinone grow body literature concern generation free radical perinatal hypoxicischemic brain damage standard regimen medication establish role oxidative stress seem important pathogenesis asphyxia induce brain damage neonatal brain adult brain newborn infant experience great increase oxygenation birth relative experience intrauterine environment contribute produc tion reactive oxygen specie system protect oxidative stress less effective neonate adult example concentration serum trans ferrin ceruloplasmin glutathione peroxidase superox ide dismutase low correspond adult value newborn infant relative deciency brain superoxide dismutase glutathione peroxidase newly synthesize free radical scavenger methyl phenylpyrazolinone inhibit hydroxyl radical also ironinduce peroxidative inju rie protective effect confer transient permanent cerebral ischemia report adult rat clinical trial endorse become commer cially available treatment acute cerebral infarction due thrombosis embolism reasonable expect great benecial effect neonatal brain damage adult damage purpose study evaluate effect rat model neonatal hypoxic ischemic encephalopathy study approve Pregnant Wistar rat purchase Charles River postnatal day littermate assign group MCI MCI MCI vehicle normal saline pup subject modied procedure produce hypoxicischemic injury pup anesthetize ether left carotid artery section double ligature surgical silk pup allow recover expose hypoxia plastic container perfuse mixture humidie oxygen balanced nitrogen temperature container maintain 338C usual temperature rat see front matter right reserve PII s0304 wwwelseviercomlocateneulet corresponding author fax mail address pup expose huddle mother immediately removal hypoxic chamber pup treat intraperitoneal injection vehicle dissolve normal saline injection repeat min rst one experiment number vehicletreated control animal animal prepare histological result vary littermate affected experimental condi tion modied procedure Brain damage evaluate application hypoxicischemic insult Brain damage recovery consider necrosisderived observe recovery attribute combination necrosis apoptosis pathogenesis Animals vehicletreated set different dosage group anesthetize kill ischemichypoxic insult brain remove brain cut coronal slice thick ness use rat brain slicer determine infarction area section stain triphenyltetrazolium chloride TTC solution Wako Infarcted area stain size infarcte area measure section front use computerizedimage analysis system analyze section take front datum insufcient infarcted area dene area unstaine divide hemispheric area brain side contralateral ligated carotid artery express percentage hypoxicischemic insult animal vehicletreated set different dosage group anesthetize kill brain remove xed ethanolacetic acid coronal brain slice cut anterior interaural line embed thick light microscopy cut stain hematoxylin eosin Hypoxicischemic damage induce parietal frontal cortex CA1 CA3 dentate gyrus hippocampus striatum thalamus evaluate microscopically code section different investigator accord arbitrary scale severity describe previously none damage mild damage less surface area single section moderate damage less severe damage area Nonparametric statistic use statistical analysis datum normally distribute compare vehicle group test use follow analysis variance value consider statistically signicant animal die vehicle treat group respectively surgery hypoxic stress recovery phase infarction area evaluate staining show difference infarction area vehicle treat group infarction area treat group small vehicletreated group slice respectively respectively slice treat group infarction area small vehicletreated group slice level respectively respectively respectively Table show number animal corre sponding grade damage Neuroscience Letters Fig effect MCI infarcte area hypoxic ischemic insult dayold rat result give mean SEM size infarcte area measure section front brain infarcted area dene area unstaine divide hemispheric area brain side contralateral ligated carotid artery express percentage number animal bar vehicletreated control group insult histologically great majority vehicletreated animal demonstrate massive infarction involve cerebral cortex injure hemisphere complete necrosis tissue breakdown cavitation usual outcome cortex incidence various grade damage part cerebrum differ vehicle treat group treat group part hippocampus less severe histological damage vehicletreated group however damage level part cerebrum differ group incidence damage signicantly reduce treat group part brain evaluate result study clearly show confer protection hypoxiaischemiainduced brain damage neonatal rat dosedependent manner antioxidant report tective neuronal rescue effect animal model neonatal hypoxicischemic brain damage Allopurinol xanthine oxidase inhibitor reduce histological damage neonatal rat apply hypoxicischemic insult benecial effect still evident inhibitor apply insult iron chelator also demonstrate neuroprotective rescue effect antioxidative effect vitamin well known associate histo logical improvement brain damage cause hypoxiaischemia animal experiment clinical human trial carry anti oxidant treat group signicant improvement neuronal damage observe hypoxic ischemic insult however insult hippocampus show improvement explanation nding second injection min recovery exert enough tive effect extend insult impor tant evaluate effect repeat injection current standard clinical practice treat ment adult cerebral infarction effec tive neonatal patient good theoretical reason use drug choice treat neonatal hypoxicischemic encephalopathy First signicant adverse effect report inception clinical trial acute cerebral infarction Second describe early neonate thought susceptible oxidative stress expose physiological hyperoxygenation relative intrauterine environment relatively decient antioxidative system Third adult cerebral infarction neonatal infarction involve organ heart kidney lung brain oxidative stress play important role pathogenesis organ fact take together suggest prove effective potent protective agent perinatal hypoxicischemic encephalopathy Ikeda Neuroscience Letters Table Number animal histological grading damage follow ischemichypoxic insultsa none mild moderate Severe none Mild Moderate Severe Vehicle MCI Cortex Hippocampus CA1 Hippocampus CA3 Hippocampus dentate Vehicle MCI Cortex Hippocampus CA1 Hippocampus CA3 Hippocampus dentate CA3 Hippocampus dentate none damage mild less surface area single section moderate less severe incidence damage decrease treat group represent asterisk attenuation ischemic postischemic brain edema rat novel free radical scavenger Stroke radical brain damage newborn Biol asphyxial brain damage possible pharmacologic intervention fetus Obstet Gynecol Evans iron plasma premature fullterm neonate FEBS Lett peroxidation neonatal mouse brain subject different type hypoxia Brain Dev Houkin Nakayama effect free radical scavenger patient cerebral infarction clin ical evaluation use magnetic resonance imaging spectroscopy Stroke Hurn reduce early metabolic failure associate severe cerebral ischemic acidosis dog Stroke stress brain white matter damage fetal lamb Int Dev Neurosci Inder Lipid peroxidation measure oxygen free radical damage low birth weight infant Fetal Neonatal F107F111 Evaluation triphenyltetrazolium chloride stain delineate rat brain infarct Stroke Levine Anoxicischemic encephalopathy rat Effects hypoxia ambient temperature gaseous metabolism newborn rat Physiol R267R272 brain edema rat Stroke Oishi Itoh ischemiainduce change monoamine metabolism rat brain Stroke Ota Ikeda Ikenoue neuronal response assess immunohistochemistry newborn rat brain hypoxiaischemia Obstet Tohgi Terashi Gotoh efcacy free radical scavenger acute cerebral infarc tion Ther Res Palmer Roberts post treatment reduce ischemic brain injury neonatal rat Stroke purinol administer induce hypoxiaischemia reduce brain injury dayold rat Pediatr Res Saugstad Blizzard Update oxygen radical disease neonatology Obstet Gynecol MitsubishiTokyo Opin Investig Drugs Watanabe cerebral arachidonate cascade Pharmacol Exp Ther Watanabe Morita Nishi tive effect vascular endothelial cell injury prostaglandin leukot Essent Fatty Acids effect cerebral ischemia possible involve ment free radical scavenging antioxidant action Ikeda Neuroscience Letters",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "ischemichypoxic": 3
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Effects of mixtures of polychlorinated biphenyls_ methylmercury_ and organochlorine pesticides on hepatic DNA methylation in prepubertal female Sprague-Dawley__.pdf",
            "cleaned_text": "online version article find Toxicology YongLai hepatic DNA Methylation Prepubertal Female SpragueDawley rat effect mixture polychlorinate Biphenyls Methylmercury publish behalf find service information Email alert subscription reprint permission Jul Version Record UMKC University Libraries ijtsagepubcom Libraries May ijtsagepubcom Female SpragueDawley rat YongLai DNA methylation epigenetic mechanism regulate gene expression chromosome structure stability objective determine DNA methylation system target follow ing utero postnatal exposure human blood contaminant pregnant rat dose dose level organochlorine pesticide OCP day methylmercury chloride day polychlorinate biphenyls pcb day mixture include group chemical liver female offspring litter collect post natal day hepatic analysis reveal mrna abundance dna methyltransferase dnmt significantly reduce high dose PCB high dose also reduce mrna level DNMT significant effect compare control high dose pcb Mix reduce abundance universal methyl donor adenosylmethionine Mix also reduce global genome dna methylation methyldeoxycytidinemethyldeoxycytidine deox ycytidine latter consistent pyrosequence methylation analysis reveal highdose group OCP generally decrease methylation cpg site position promoter tumor suppressor gene p16INK4a Overall hepatic result suggest DNA methylation system affect exposure high dose blood OCP least potent chemical group investigate mixture dna methylation rat mixture methyl mercury polychlorinate biphenyls organochlorine pesticide methylation normal epigenetic mechanism involve control dna structure chromosome stability mobility parasitic element transposon retrotranspo son viral element gene imprinting gene expression abnormal dna methylation associate number cancer infertility develop mental neurological immunological age relate disorder grow evidence suggest early exposure environmental agent lead longterm transgenerational effect epigenetic mechanism involve dna methylation global genome methylation site specific dinucleotide methylation different element DNA methylation system show affect drug radiation environmental estrogen contaminant metal arsenic chromium nickel cadmium dna methylation observe number dis ease cancer originate dietary insufficiency choline methionine vitamin folic acid disorder carbon metabolism pathway lead reduce availability JulyAugust author host Libraries May ijtsagepubcom universal methyl donor adenosylmethionine sam DNA methylation machinery include numerous methylbinding protein DNA family DNA methyltransferase DNMT multiple variant DNMTs catalyze transfer methyl group mostly cytosine locate next guanine cpg mitosis methylation pattern original DNA strand copy mostly constitutively express dna methyltransferase replicate dna novo methyltransferase catalyze transfer methyl group previously unmethylate dna gameto embryogenesis however dnmt often work cooperatively normally low expression somatic cell increase cancer cooperate silence tumor suppressor gene understand ing effect environmental contaminant DNA methylation machinery biological consequence open avenue well differ entiate transient effect adaptive persis tent effect development diagnostic tool screening method polychlorinate biphenyls pcb organochlorine pesticide OCPs legacy chemi cal ban level environment decline exposure chemical still concern health agen cie give still present human tis sue human diet particularly circumpolar population consume traditional food breast milk cord blood level pcb dichlorodiphenyldichloroethene DDE organochlorine high Inuit many Canadian noncanadian population recent paper possible association exposure chemical cancer infertility developmental anomaly endocrine disrup tion immunological function neurologi cal impairment contaminant concern give substantially high Canadian Arctic marine biota compare circumpolar coun try fish contaminate component Inuit diet accu fetus utero contrast organochlorine level breast milk low fetus sensitive adult demonstrate fact high level exposure result severe neurological impairment baby bear asymptomatic mother low level exposure subtle cognitive language delay observe old child little information effect human health chronic exposure mixture contaminant fetal postnatal period pre postnatal phase critical develop mental stage tissue differentiation organ growth detoxification system blood barrier yet matured abnormal event period lead longterm adverse health effect show postnatal exposure high dose reconstitute mixture aryl hydrocarbon receptor AhR agonist polychlorinateddibenzodioxin dibenzofuran prepare base proportion find breast milk decrease mrna expression liver brain female pup postnatal day PND develop mixture pcb OCPs base chemical profile Cana dian Arctic Inuit maternal blood demon strate exposure rat mixture gestation lactation produce blood chemical profile comparable human rodent dam pup pcbocpmehg mixture test dose produce serum level rat pup fold high human level report decrease growth rate rat pup clinical biochemical histopathological effect subsequent work mixture currently study adverse effect attribute PCB OCP com ponent investigate developmental systemic neurotoxic genomic effect latter publish stage part ini tiative current manuscript report effect Ontario Canada Exposure Biomonitoring Division Health Canada Healthy Environments Consumer Safety Branch Environmental Health Science address correspondence phd 0803D Tunney Pasture k1a 0K9 mail Mixtures hepatic DNA Methylation Desaulniers UMKC University Libraries May ijtsagepubcom mixture chemical family component PCB OCP element DNA methy lation system liver include abundance SAM dnmt mrnas global genome genespecific change dna methylation specific methylation change address bisulfite pyrosequencing analysis cpg site promoter gene cyclindependent kinase inhibitor Cdkn2a express tumor sup pressor protein p16INK4a gene know DNMT methylation target expression report regulate dna methylation dur ing carcinogenesis follow exposure various environmental agent finally sensi tivity end point indicator exposure xenobiotic compare change abundance cytochrome p450 cyp1a1 mrna phase metabolism enzyme cyp1a1 sensitive indicator exposure AhR agonist expression regulate classical dioxin response element pathway Methods Animal Treatment Animal treatment housing condition approve conform Guidelines Canadian Council Animal Care Housing breeding condition origin test chemi cal analytical grade pure method preparation validation mixture previously describe Female rat mate male purchase constant Quebec detection vaginal plug denote gestation day preg nant dam dose PND provide ham cookie lace measure dose adjust body weight day mixture dissolve corn oil mixture describe table pregnant dam expose corn oil control CTRL low dose high dose OCP day methylmercury chloride day PCB day complete mixture include chemical mix day dam monitor parturi tion beginning litter cull male female PND4 female pup litter sacrifice decapitation PND29 provide follow number investigate pup treatment group CTRL OCP OCP PCB PCB mix PND99 liver sample also collect old sibling treat high dose CTRL OCP PCB Mix male pup investigate give pcb AhRagonists classical hepatocarcinogen mostly female Highdose Contaminant Mixturea Contaminants Dose mixture Organochlorine pesticide Aldrin Hexachlorocyclohexane Dieldrin epoxide Mirex Toxaphene cisNonachlor DDE DDT total ortho PCBsb TetraCB total Monoortho pcb TriCB Total Methyl mercury chloride Total Mix polychlorinated biphenyl treatment include ortho substitute chemical total combined dose polychlorinate biphenyl numbering system accord Libraries May ijtsagepubcom measurement SAM Adenosyl methionine universal methyl donor involve various methylation reaction include dna methylation concentration SAM quantify liver sample use commercially available fluorescence assay kit homogenize volume clarify centrifugation min supernatant dilute cold absolute ethanol final tion maintain ice bath prior clarify centrifugation min supernatant philize resuspend cold buffer prior final clarification centri fugation min Adenosyl methionine concentration measure supernatant dilution level use fluorescence microplate reader excitation emission point standard curve describe manufacturer protocol sample measure single assay intraassay coeffi cient variation calculate range standard DNA Methylation Methyldeoxycytidine 5mdC measure indicator level dna methylation gen ome express percentage ratio 5mdC measurement also provide correction amount dna sample total DNA prepare liver sample use kit concentration purify DNA measure sample use spectro photometer sample DNA usually first denature water bath chill immediately ice water add volume ammo nium acetate buffer contain unit nuclease mixture incubate autoshaker volume ammonium bicarbonate buffer include unit snake venom phos phodiesterase add incubate unit shrimp alkaline phosphatase unit gly solution add mixture incubate finally mixture incubate inacti vate shrimp alkaline phosphatase ple spin supernatant store analysis liquid chromatographyultraviolet electrospray ionizationmass spectrometry control dna hydrolysis analytical variability aliquot pool rat genomic DNA prepare include batch sample nucleotide cytosine deoxycytidine methylcytosine methyldeoxycytidine 5mdC uracil adenine deoxyguanosine thymine quantify use dc18 column chromatography separation perform flow rate min use solution formic acid linear gradient methanol increase rate min ute Methanol increase min ute maintain injection volume conduct use nitrogen nebulizer psi min dry gas capillary voltage main taine sampling orifice set positive mode operate scan mode spectra acquire range diode array detector wavelength set Quantification accomplish analyze reading con firm scan use single ion monitoring pair ion mdc respectively Realtime Reverse Transcriptase Polymerase Chain reaction Total RNA isolate use RNeasy minikit set Qiagen Mixtures hepatic DNA Methylation Desaulniers UMKC University Libraries May ijtsagepubcom Omniscript Reverse Transcriptase kit use reverse transcription negative control ple test residual dna contamination enzyme omit result cdna ampli fie quantitative realtime polymerase chain reac tion pcr analysis use QuantiTect SYBR Green PCR Master Mix BioRad product primer forward reverse temperature cycle minute pcr primer forward reverse design use BioRad CAA TGA GCT GCG TGT GGC TCT TTT CAC GGT TGG actin NM031144 aac GGA ACA CTC CTC dnmt AF116344 ATA GAA GAA GTG TGA GGT ATT GAT dnmt XM220319 AGG aga TGG AGA dnmt BN000397 CGC TAA Cyp1A1 CCC ACA GAG AGG GTG GTG GGG p16ink4a NM031550 result normalize abundance actin mrna cpg methylation analyse Cdkn2a Pyrosequencing total dna extract liver sample use kit sample ship independent laboratory blind analysis process Worcester nucleotide sequence accession number rat gene cyclindependent kinase inhibitor Cdkn2a investigate sequence include cpg dinucleotide locate upstream start codon position pyrogram disrupt position likely point mutation prevent quantification percentage methylation dinucleotide close start codon position therefore methylation analysis focus cpg dinucleotide locate position Sodium bisulfite conversion perform use DNA kit bisulfitetreated DNA approxi mately amplify pcr reaction min buffer include MgCl2 forward reverse primer HotStar Taq Polymerase pcr product strand end biotin label capture streptavidincoate bead Baie Urfe Que bec biotinylated strand DNA separate purify alkali treatment subject pyrosequencing use sequence primer GGGTTTTATTGGTTATATTA pyrosequencing analysis perform use Pyr omarkmd system degree methylation analyze artificial use mode percentage methylate calculate peak height peak height peak height quality con trol completeness sodium bisulfite reaction confirm analysis conversion site part dinucleo tide absence pcr bias disproportional amplification allele capabil ity absolute quantification methylation verify test linearity stepwise increment methylation sample prepare mix unmethylated artificially methylate dna methylated dna derive normal dna extract rat blood methylate dna artificially fully methylate use SssI enzyme system accord manufacturer proto col Ipswich USA dna control mixed increase propor tion methylate dna bisulfite modification pyrosequencing analysis reveal strong linear correlation expect measure methyla tion level Statistical Analysis normality datum verify goodness fit test Data fail normality log transform normality reach datum analyze analysis variance ANOVA follow Vol Libraries May ijtsagepubcom control treatment mean comparison use HSD test comparison pair fail normality test datum analyze use nonparametric test group compare rank sum test difference group test assay perform measure mrna abundance cyp1a1 PND29 Figure analysis control rat repeat assay explain presence control bar Figure Assay include sample control PCB group Assay include control highdose group OCP include control lowdose group levels p16 mrna analyze assay low dose second assay highdose group level CYP1A1 mrna PND99 analyze single assay text comparison con trol group refer control respective assay datum p16INK4a normally distribute comparison treatment group exclude control analyze use way anova testing effect treatment OCP PCB Mix dose low high interaction step possible give datum express percentage relative mean respective control group var iance control group obtain different assay significantly different test mean comparison end point perform describe previous paragraph datum set regression 5mdC use simultaneous linear regression mod els SAS version Level XPPRO Platform SAS Institute Inc analysis perform use software version consider statistically significant level result hepatic concentration universal methyl donor SAM significantly reduce high dose pcb Mix group compare control Table assess possible effect reduce availability SAM global genome DNA methyla tion method develop quantify nucleoside calculate percentage ratio 5mdC 5mdC5mdC global genome dna methylation method separate quantify nucleoside figure confirm identity use distinct molecular ion limit detection less table show deoxycytidine methylate DNA control group percentage methylation low group treat low dose PCB control high dose mixture induce tendency reduce global genome dna methylation highdose Mix group statistically significant linear relationship obtain availability sam global genome DNA methy lation expect give large number deoxycytidine genome differ ence global genome dna methylation table small treatment group therefore min mdc min mdc figure Chromatogram DNA nucleoside separate show different elution time cytosine deoxyribocytosine methylcytosine deoxyriboadenosine guano sine deoxyribo thymidine Electrospray ionisationmass spectrometry electropherogram use confirm peak identity use pair specific molecular ion Mixtures hepatic DNA Methylation Desaulniers UMKC University Libraries May ijtsagepubcom relationship 5mdC investigate simultaneous linear regression analysis Figure Briefly simultaneous linear regression model fit 5mdC full datum set treatment dose combination overall test significant indicate slope least treatment dose combination dif ferent Mix group remove datum simultaneous regression model run statistical difference slope remain treatment dose combination group therefore group Mix statistically significantly different slope compare group figure sup port abnormal dna methylation group datum Mix group locate upper right area graph genomic DNA analyze sample group quantity total nucleotide 5mdC measure rat right graph range average sample mean amount genomic dna impact slope figure summarize treatment effect dnmt cyp1a1 p16INK4a mrna abundance highdose treatment sig nificantly reduce mrna abundance control level statistically significant com control group indicate aster isk additional analysis reveal mrna abundance significantly less Mix OCP group significant difference lowdose highdose PCB treat ment highdose PCB treatment signifi cantly reduce mrna abundance control level addition mrna significantly less abundant Mix group treatment group effect indicate capital letter abundance DNMT3b mrna significantly reduce highdose treatment compare lowdose treatment bracket highdose pcb high Table Abundance hepatic SAM mean follow OCP pcb mix Chemicals Control Dosea OCP PCB Mix Low High Abbreviations methylmercury chloride mix chemical OCP organochlorine pesticide pcb polychlorinate biphenyls SAM adenosylmethionine significantly different control rat highdose group remove datum set outli standard deviation away mean way analysis variance exclude control group indicate effect treatment dose comparison reveal less abundant PCB Mix group group OCP pcb day day mix day addition chemical Table Treatment Effects Global DNA Methylation indicate difference percentage ratio measure Liquid ChromatographyUltraviolet Electrospray IonizationMass Spectrometry mean Control Dosea OCP PCB Mix Low high abbreviation methylmercury chloride mix chemical OCP organochlorine pesticide pcb polychlorinate biphenyls OCP pcb day day mix day addition chemical significantly different control lowdose effect robust give support observation Tendency difference control Libraries May ijtsagepubcom dose treatment reduce mrna abundance control level asterisk DNMT datum highdose treatment change mrna abundance relative control asterisk PCB affect DNMTs decrease hepatic mrna abundance control val ues respectively reduce DNMT3B mrna level control value respectively level mrna OCP mix group significantly dif ferent control lowdose OCP treatment group cyp1a1 mrna significantly abundant treatment group compare control Figure see asterisk highdose group mrna significantly abundant lowdose group group abun dance lowdose significantly different synergic effect apparent Mix highdose group fold increase control OCP PCB Mix group respectively note log scale lowdose group fold increase control OCP PCB Mix group respectively cyclindependent kinase inhibitor p16INK4a know methylation target DNMT3b 5mdC group high dose mixture figure regression line amount methyl deoxycytidine 5mdC deoxycytidine measure liver dna sample simultaneous linear regression model fit 5mdC full datum set indicate slope least treatment dose combination different Mix group remove datum simultaneous regression model run statistical difference slope remain treatmentdose combination group demonstrate highdose mixture group statistically significantly different slope compare group CYP1A1 percent percent Percent DNMT1 Percent Control assay Low Dose High Dose p16 INK4a Percent Control OCP PCB Figure change abundance DNMT CYP1A1 p16INK4a mrnas follow utero lactational exposure complex mixture mix component include organochlorine pesticide OCP polychlorinate biphenyls PCB methylmercury chloride dose level mean significantly different control describe specific comparison associate value normally distribute datum identify letter Capital letter describe treatment effect wayanovas small letter identify mean difference reveal pair comparison test letter associate large value means share letter significantly different example different different note log scale cyp1a1 Mixtures Hepatic DNA Methylation Desaulniers UMKC University Libraries May ijtsagepubcom mrna abundance significantly reduce control level highdose Mix group control asterisk OCP group mrna significantly abundant group capital letter Abundance mrna sig nificantly reduce high dose compare low dose MeHg Mixtreated group mrna expression gene also measure liver sample sible female control highdose group significant effect detect cyp1a1 mrna abundant PCB mix group compare group trol OCP PCB mix reduction mrna expression p16ink4a decrease availability reduc tion global genome dna methylation highdose Mix group lead investigate PND methylation level dinucleotide close initiation site promoter region gene p16INK4a Figure demonstrate consistent pattern methylation significantly different level methylation cpg site capital letter significant treatment effect asterisk OCP treatment signifi not effect dinucleotide treatment alter methylation site position generally methylation level decrease PCB Mix treatment cpg dinucleotide locate position appear different other increase treatment OCP case Mix appear produce great change methylation level OCP treat ment never induce significant effect accurate measurement methylation level cpg dinucleotide close start codon location obtain due disruption pyrogram suggest singlenucleotide poly morphism attributable point mutation location occur frequency follow mendelian inheritance pattern rat discussion study epigenetic effect environmental taminant include mechanism dna methyla tion relatively new area investigation toxicology investigate rat liver project demonstrate lactational exposure mixture persistent organochlorine pollutant decrease availability SAM dnmt mrna abundance DNA methylation sup port small decrease global genome dna methylation cpg methylation segment promoter p16INK4a gene change occur concomitantly hepatic inflammation vacuolation hypertrophy hyperplasia necrosis change liver weight report rat treat mixture cur rent investigation suggest OCP component mixture least potent chemical group affect DNA methylation system obvious effect dnmt mrna abundance SAM concentration dna methylation interestingly consistent current reduction DNA methy lation rat negative correlation recently observe serum level persistent organic pollutant global genome dna methylation Greenlandic Inuit similar association also report human population expose chemical location dinucleotide relative start codon OCP PCB Mix figure Pyrosequencing methylation analysis reveal effect highdose treatment percentage methylate cpg dinucleotide locate nucleotide upstream start codon position rat gene cyclindependent kinase inhibitor Cdkn2a p16ink4a accession number study sequence mean significantly different control group location different capital letter indicate cpg site significantly different percentage methylation high low percentage methylation Vol Libraries May ijtsagepubcom change abundance different DNMT induce chemical group sug g chemical mixturespecific effect Com pare control PCB treatment reduce mrna expression dnmt treat ment reduce expression dnmt OCP treatment affect observation DNMT mrna level Mix group statistically similar control suggest antagon ism chemical component effect evident DNMT1 Explaining origin chemicalspecific imbalance dnmt mrna expression require investigation end point know relevant DNMT promoter include occupation dioxin response element methylation cpg dinucleotide role regulatory site well micrornas know interfere DNMT expres sion general pattern reduction dnmt mrna expression consistent reduction dna methylation observe technique sodium bisulfite pyrosequen cing stage specific relationship establish mrna expression dna methylation literature report instance dnmt work independently other work cooperatively expression many gene often regulate mrna level translational posttranslational mechanism other find correlation dnmt mrna expression dna methylation cancerous noncancerous tissue contrast dnmt mrna abundance mrna level cyp1a1 appear exhibit synergistic increase however use rat treat mixture ethoxyresorufindeethylase classical enzyme reaction assess cyp1a1 activity measurement reveal synergistic increase Mix treatment induce enzyme activity similar approxi mately fold control level increase enzyme activity close fold increase cyp1a1 mrna abundance report change cyp1a1 mrna abundance activity suggest significant complex detoxification response likely associate increase amount protein know seque ter contaminant include CYP protein metal glutathione involve oxidative stress modulation indicator exposure effect change expression dnmt sensitive change CYP1A1 mrna expression however increase cyp1a1 expression normal detoxifi cation response biological consequence treatmentspecific reduction dnmt mrna require investigation high dose mix pcb reduce availability sam universal methyl donor involve methylation reaction well know change availability SAM associate dna hypomethylation provide robust quantita tive methylation analysis sequential series cpg dinucleotide result figure appear follow additive pattern chemical treatment lead consistent reduction methylation Mix group line reduction availability global genome methylation table global genome hypomethylation sitespecific hypermethylation usually landmark progression carcino genic event Hypomethylation involve activation prometastatic gene tumor promote gene precede genomic damage cancer perhaps exposure decrease global genome methylation induce predisposition hepatocarcinogenesis hypothesis line observation pcb agonist classical hepatocarcino gen mostly female highdose mix treatment decrease abundance p16INK4a mrna observation support predisposition hepatocarcinogenesis protein originate INK4bARFINK4a locus elevated expression cause phase arrest dependent functional retinoblastoma protein p16INK4a important role oncogeneinduced senescence tumorigenesis barrier slow inhibit progression preneoplastic lesion neoplasia decrease p16ink4a expression common var ious cancer suggest increase mitotic activity less time dna repair reduction p16INK4a mrna expression due mechanism late dna methylation polycomb repressor protein mrna stability often associate DNA methylation promoter investigation demonstrate link mrna expression dna methylation other able associate hypermethylation p16INK4a promoter region Mixtures hepatic DNA Methylation Desaulniers UMKC University Libraries May ijtsagepubcom reduce mrna expression chromium arsenic radiation acetylaminofluorene rat comparison cur rent investigation hazardous give differ ence chemical treatment various technique use assess methylation level sex difference chemical sensitivity effect dna methylation importantly DNA segment investigate result consis tent pyrosequence analysis pro moter region show low methylation level site upstream transcriptional start site well bisulfite genomic sequencing result demonstrate little methylation site promoter region normal lung tissue preneoplasiacontaine tissue rat fact show increase methylation cpg site occur downstream tran scriptional start site lung tumor DNA segment investigate perhaps small increase methylation position position close transcriptional start site Figure part progressive process give silence p16INK4a precede dna methylation change suggest maintain rather initiate gene silence investigate human liver hepatocarcinomas use pyrosequence report average methylation level multiple cpg site p16INK4a promoter obtain normal tissue mean dna methylation level close observation rat figure percentage rise early carcinogenesis reach cancer comparison human tissue suggest change observe reach carcinogenic process involve hyper methylation p16INK4a promoter finally current pyrosequencing analysis sup port existence p16INK4a gene location follow mendelian inheritance pattern Singlenucleotide polymorph ism frequent outbred strain rat inbred strain com plicate interpretation methylation analysis however biological impact protein activity give part exon summary project assess impact component DNA methylation system utero lactational exposure mixture envi ronmental contaminant base chemical measure Inuit blood generate highdose rat pup serum level organochlorines time human level decrease abun dance mrna induce treatment group decrease avail ability dna methylation observe independent technique pyrosequence site promoter gene p16INK4a global genome dna hypomethylation Mix group support DNA methylation system affect follow expo sure environmental contaminant compare component complex mix ture OCP group least potent affect current series end point Methylation DNA fundamental importance cellular molecu lar biology identification specific dna locus change biological impact slowly emerge give biological importance change dna methylation plausible exposure contaminant induce sitespecific change methylation predictive adverse health effect investigation acknowledgment work support Northern Contami nant diand author grateful Nanqin preparation analysis dosing solution statistical advice Martin technical assistance Worcester pyrosequen cing analysis carefully ing manuscript Reinberg Caparros Epigenetics Cold Spring Harbor Szyf dynamic epigenome implication toxicology Toxicol Sci Epigenetic change nontar geted radiation effect link Vol Libraries May ijtsagepubcom epigenetic transgenerational phenotype reprod toxicol dna methyltransferase inhibitor cancer therapy cancer genetic change rat liver induce pyrazinamide treatment Tryndyak Kovalchuk reprogramme liver cell tamoxifeninduced rat hepatocarcinogenesis Mol Carcinog induce dna damage modulate epigenetic effec tor distant bystander tissue vivo phenobarbital produce alter pattern methylation rich region DNA b6c3f1 mouse hepatocyte similar result choline deficiency Toxicol Sci Alworth Uterine responsiveness estradiol dna methylation alter fetal exposure diethylstilbestrol meth oxychlor mouse effect low high dose dolinoy disease DNA methyla tion analysis use microarray impaired expose cell DNA hypomethylation induce drinking water disinfection product mouse rat kidney Toxicol Sci Chanda Dasgupta Guhamazumder dna hypermethylation promoter gene p53 p16 arsenicexpose people malignancy dna methylation gene expression liver newborn mouse transplacentally expose hepatocarcinogenic dose inorganic arsenic toxicology germ cell epimutation spacer promoter 45s ribosomal RNA gene iii exposure Toxicol Appl Pharmacol reduce expression aberrant methylation p16INK4a chromate worker lung cancer Lung cancer Salnikow Zhitkovich Genetic Cocarcino genesis icol Yan ion increase histone lysine dimethylation induce transgene silence Webber suppressor gene inactivation cadmiuminduced malignant trans formation human prostate cell correlate overex pression novo DNA methyltransferase Perspect Poirier effect diet genetic chemical toxicity aberrant dna methylation introduction Suppl:2336S2339S adenosylhomocysteine dna hypomethylation potential epigenetic mechanism homocysteinerelated pathology prevention hepatocarcinogenesis adenosyl methionine alcohol cytosine demethylation trigger nuclear receptor involve dna strand break DNMT3B variant regulate dna methylation promoter specific manner cancer res Park DNMT1 cooperate silence gene human cancer cell Nature level maternal umbilical cord blood plasma Bruneau Inuit exposure organochlorine aquatic food chain Perspect Carcinogenicity nondioxinlike polychlorinate biphenyls Crit Rev toxicol Humblet environmental pollutant breast cancer epidemiologic study Cancer Suppl Reproductive toxicol ogy environmental toxicant emerge issue con cern Des evidence effect envi ronmental chemical endocrine system chil dren chemical impact thyroid target consequence thyroid Schoeters Den Hond Leijs Endocrine disruptor abnormality Mixtures hepatic DNA Methylation Desaulniers UMKC University Libraries May ijtsagepubcom pubertal development toxicol HertzPicciotto Park Dostal Prenatal exposure persistent nonpersistent organic com pound effect immune system development toxicol Prenatal exposure poly chlorinate biphenyls attention school age Pediatr biphenyls orga nochlorine pesticide neurodevelopment Persistent organic pollutant mercury marine biota Canadian Arctic overview spatial temporal trend Albanus Methylmercury exposure lactation milk concentration tissue uptake mercury neonatal rat Bull Environ Con tam Toxicol decline risk methylmercury exposure infant lactation Environ Res disease methylmercury poisoning cause environmental pollution Crit Rev toxicol cognitive deficit child prenatal exposure methyl mercury Neurotoxicol Teratol SaintAmour visual evoke potential preschool Inuit child expose methylmercury polychlorinate biphenyls marine diet Neurotoxicology son brain uterus liver mrna expression cyto chrome P450s Dnmt catecholmethyltransferase prepubertal female rat expose aryl hydrocarbon receptor agonist Toxicol Sci Disentangling developmental neurobehavioural effect peri natal exposure chemical mixture find blood Arctic population differential toxicity mixture com ponent effect utero lactational exposure rat mixture environmental contaminant detect Canadian Arctic human population expression profile rat cerebellum follow utero tional exposure mixture methylmercury poly chlorinate biphenyls organochlorine pesticide Toxicol Lett Cui Wakai trioxide inhibit dna methyltransferase restore methylation silence gene human liver cancer cell change muscle liver tissue male female mouse expose acute chronic lowdose diation receptor bind cognate response element require dioxinmediated toxicity Toxicol Sci Persky Health effect occupational exposure pcb ed pcb recent Lexington DNA hypomethylation associate high serum persis tent organic pollutant Perspect Bollati Changes dna methylation pattern subject expose lowdose benzene Cancer Res Rapid DNA Methylation Changes exposure traffic particle Respir Crit care Med Akiyama Yuasa Transcriptional regulation human dna methyl transferase gene sp3 Sp1 zinc finger protein effect tetrachlorodibenzodioxin temporal modulation sp1 dna bind develop cere bral cortex cerebellum Exp Toxicol Pathol family revert aberrant methylation lung cancer tar get dna methyltransferase Benetti mammalian micro RNA cluster control dna methylation telomere recombination rbl2dependent regulation dna methyltransferase suetake Shinozaki Miyagawa Takeshima Tajima DNMT3L stimulate DNA methylation activity dnmt3b direct interac tion park Shim DNA methyltransferase expres sion dna hypermethylation human carcinoma Cancer Lett Suzuki Alterations DNA methylation histone modification contribute gene silence hepatocellular carcinoma Hepatol res Vol Libraries May ijtsagepubcom Perinatal Exposure Northern Contaminant mixture Effects Compo nent Interactions Hepatic Microsomal Enzyme Induction Thyroid Hormones Hematological Para meter Day Pups 15th North American Regional Meeting ter Yoshida Satoh transfer mercury metallothioneinnull pregnant mouse exposure mercury vapor toxicology Induction metallothionein liver female rat treat toxic metal molecular cry Environ Health Perspect Suppl folate methyl deficient diet alter expression dna methyltrans ferase methyl cpg bind protein involve epigenetic gene silence liver F344 rat Nutr quantitative promoter methylation analysis use pyrosequencing combine bisulfite restriction analysis inhibition expression oncogene divergence growth control invasion breast cer cell carcinogenesis gene play critical role phenobarbital induce liver tumorigenesis due alter dna methylation Toxicol Sci Shukeir Pakneshan Chen Szyf Rabban",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 95,
                    "epigenetic": 8,
                    "demethylation": 1
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Inuit": 5,
                    "Canadian": 2,
                    "Cana dian": 1,
                    "AhRagonists": 1,
                    "cisNonachlor": 1,
                    "inacti": 1,
                    "Omniscript": 1,
                    "Pyr": 1,
                    "methy": 1,
                    "Greenlandic Inuit": 1,
                    "Cocarcino": 1,
                    "Perspect": 3,
                    "Neurotoxicol": 1,
                    "methyltrans": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "Inuit": 104,
                    "Canadian": 104,
                    "Cana dian": 104,
                    "AhRagonists": 104,
                    "cisNonachlor": 104,
                    "inacti": 104,
                    "Omniscript": 104,
                    "Pyr": 104,
                    "methy": 104,
                    "Greenlandic Inuit": 104,
                    "Cocarcino": 104,
                    "Perspect": 104,
                    "Neurotoxicol": 104,
                    "methyltrans": 104
                },
                "Ethnographic Terms": {
                    "methylation": 21,
                    "epigenetic": 21,
                    "demethylation": 21
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Effects of vitamin B12 and folate deficiencies on DNA methylation and carcinogenesis in rat liver.pdf",
            "cleaned_text": "Berlin Laurent Brunaud1 JeanMarc Alberto1 Fars Namour1 Laurent Antunes1 JeanPierre Bronowicki1 Laurent Bresler3 Guant1 inserm EMI l General Endocrine Surgery CHU NancyBrabois l Radiology CHU NancyCentral Deficiencies major dietary source methyl group methionine choline lead formation liver cancer rodent widely investi gate hypothesis dietary methyl insuffi ciency result abnormal dna methylation vitamin b12 folate also play important role DNA methy lation coenzyme require synthesis methionine adenosyl methionine common methyl donor require nance methylation pattern dna aim study effect methyldeficient et dna methylation liver carcinogenesis rat evaluate role vitamin b12 status define carcinogenicity methyldeficient diet several study show methyldeficient diet influence global dna methylation evidence vivo study clearly establish link vitamin B12 DNA methylation port vitamin b12 low methionine synthase activity determinant dna hypo methylation cholinemethioninedeficient diet show cause hepatocellular noma animal contrast effect vitamin B12 withdrawal addi tion choline methionine folate induce hepa tocellular carcinoma less rat key word Cancer MTHFR methylenetetrahydrofo late reductase methionine syn introduction dietary choline lipotrope deficiency study pathological process induce nutritional modification experimental animal longterm administration diet defi cient choline know liver cancer rat even diet later find contaminate aflatoxin role methyldefi cient diet liver carcinogenesis evaluate well establish defi ciencie major dietary source methyl donor methionine choline lead formation liver cancer rodent several plausible mechanism propose explain enhance effect methyl deprivation carcinogenesis widely investigate hypothesis dietary methyl insufficiency result abnormal dna methylation subsequent development cellular methyl sufficiency different study use diet defi cient choline methionine vitamin b12 use deficient diet total gastrectomy folate deficient diet presence absence gens drug impair methylenete trahydrofolate metabolism carbon metabolism figure use carcinogen specific drug consider controversial sub stance responsible liver tumour emer gence direct effect abnormal dna methylation thus study role methionine metabolism dna methylation effect global DNA methylation carcinogene sis lastly focus rat model sesse effect use carcinogen liver carcinogenesis role diet deficient choline methionine vitamin b12folate liver carcinogenesis effect total gastrec tomy vitamin b12 level Methionine Metabolism DNA Methylation vitamin b12 folate play important role dna methylation coenzyme require synthesis methionine adenosyl thionine common methyl donor require maintenance methylation pattern DNA Methylation carbon cytosine residue catalyze dna methyltransferase enzyme use methyl group derive methionine mail corresponding author lbrunaudplanetenet Effects Vitamin b12 folate Deficiencies DNA Methylation Carcinogenesis Rat Liver Brunaud effect B12 folate liver carcinogenesis synthesize methylation homocysteine thionine synthase presence coenzyme methyltetrahydrofolate methylcobalamin ure normal situation cpg sequence genome methylate methylated cpg dinucleotide mainly cluster sequence term cpg island highly represent gene promoter region initial exon gene dna methylation fundamental mech anism epigenetic control gene expression maintenance genomic integrity figure therefore evaluation genomic dna methylation status important study cell growth regula tion tissuespecific differentiation carcinogenesis several study suggest nutritional status influ ence global dna hypomethylation however fluence nutrition genespecific dna methylation less clearly understand dietary factor involve onecarbon metabolism likely impact dna methylation process mainly include vitamin b12 folate methionine choline concentration vitamin b12 thionine low adenosyl methionine synthesis duce methylation dna theoretically duce however evidence culture vivo study clearly establish link vitamin b12 deficiency increase genomic instability dna methylation report adenosylmethionine normal subject nega tively correlate folate vitamin level vitamin b12 level assess study healthy man age micronucleus index chromosome early damage bio marker significantly correlate folate lev el significant negative relation serum vitamin b12 however level unmethylate cpg significantly relate vitamin b12 status recently report total activity holo apoenzyme lower vitamin b12 level pmol F344 rat vita min B12 single independent determinant low activity logistic regression analysis Fur thermore find low activity low min B12 lower quartile determinant dna hypomethylation conclusive experi ment confirm issue yet perform major source methyl group food come methionine onecarbon metabolism methylfolate choline well estab lishe metabolic pathway methionine choline folate interdependent example exogenous methionine choline limit diet folate need remethylation homocysteine form methionine Choline methio folate metabolism interact point homocysteine convert methionine tight interrelationship dietary source methyl group make important figure Diagram show methionine synthesize transmethylation homocysteine methionine synthase presence late methylcobalamin AdoHcy adenosylhomocysteine Adomet adenosylmethionine ATP adenosine triphosphate flavine adenine dinucleotide phosphate pyro phosphate tetrahydrofolate Figure Relationship dna methylation control gene expression maintenance genomic integrity effect B12 folate liver carcinogenesis assess study diet DNA deficiency induce dietary folatefree diet result diminish hepatic total choline decrease adenosylmethionine show animal feed diet deficient choline methionine lated DNA seem organ change global dna methylation elicit nutritional status however study sesse dna methylation liver gut brain kidney leucocyte elsewhere moreover result study rodent suggest severe folate deficiency cause dna hypomethylation also DNA strand break increase uracil apurinic site dna similar datum report mans folic acid depletion study post menopausal woman metabolic unit show crease dna hypomethylation lymphocyte cervical gastriccolonicrectal epithelium dna methylation also significantly correlate serum tissue folate concentration respectively DNA Methylation Carcinogenesis several recent human study link deficiency vitamin B12 folic acid methionine creased risk cancer various organ include colon breast cervix lung stomach pancrea multiple myeloma question thus arise cie exert activity diminished subsequent abnormal dna methylation fundamental property quire generate characteristic malignant attrib ute associate cancer cell ability repli cate limitation indifference positive growth signal disregard growth inhibitory factor eva sion program cell death sustain ability invade metastasize trait influence gene set gene fail express gene correctly produce func tional regulatory protein lead uncontrolled pat tern cell behaviour observe typical neoplasm much focus molecular biological research concentrate investigate role genetic change direct alteration dna base sequence alternative mechanism gene modulation dna methylation come scrutiny disrupt actual sequence gene affect expression remain preserved cell division likely mechanism global dna hypomethylation induce neoplastic mation include activation oncogene inactivation tumoursuppressor gene induction genomic insta bility increase mutability result abnormal chromosomal structure thus change methylation status consider pre establish state facilitate tumour initiation progression dna methylation heritable epigenetic event mediate transfer methyl group frequently observe cancerassociate increase regional hypermethylation near universality global dna hypomethylation many type human cancer suggest hypomethylation play sig nificant fundamental role tumourigenesis pattern alter methylation serve wide area global hypomethylation genome localize area hypermethylation certain specific site island gene promoter region thus theory decrease methylation hence relief transcriptional allow expression previously quiescent become active induce cell proliferation event alternatively increase methyla tion previously unmethylated site pro moter region tumour suppressor gene result silence inhibition transcription inability suppress cell proliferation observation several group show total methylcytosine content DNA decrease hepatocarcinogenesis colonic carcinogenesis hypomethylation DNA also coincide change mrna level several gene myc fos ras ras p53 way methyltetrahydrofolate reductase gene relate genomic hypomethyla tion carcinogenesis example carrier methylenetetrahydrofolate reductase mthfr C677 variant consider increase risk develop colorectal neo Moreover methylation dna reduce hibition adenosylmethionine reductase minimise result irreversible conversion methylenetetrahydrofo late methyltetrahydrofolate thus favour crease dump pool uracil incorporation DNA dump accumulate result uracil incorporate DNA instead thymine good evidence mechanism lead point mutation also result gen eration single doublestranded DNA break chromosome breakage micronucleus formation thus abnormal methylation pattern also directly affect gene activity disruption transcriptiontranslation process increase probability mutational event take place duce overall chromosomal stability result manufacture dysfunctional protein product several study show uracil level DNA fold high individual serum folate relative individual serum folate study evidence dna damage measure increase amount dna strand break spleen cell rat feed methylfolate deficient diet lastly dna methylation also consider effect cytosine deamination rate purify dna methylation cytosine know increase effect B12 folate liver carcinogenesis rate deamination factor therefore seem likely one cause mutational hot spot simply increase generation mis match target cytosine methylate Rat Model Hepatocarcinoma use diet carcinogen absence carcinogen chronic feed amino aciddefined diet lack methionine choline lead formation alter hepatic focus continuously increase volume number observation consistent hypothesis methyl deprivation continuously initiate stress rather highly effective promoter cer occurrence preexisting initiate hepatocyte investigation consequently ducte interaction hepatocarcinogen liver tumour promoter labile methyl group category chemical agent provide evidence chemical carcinogenesis occur part abnormal methylation process classical carcino gen tumour promoter antimetabo lite methylation reaction first include acetylaminofluore diethylnitrosamine phenobarbital deficiency methapyrilene agent ter adenosylmethionine dna methylation level tumourigenic activity acetyl aminofluore diethylnitrosamine phenobarbital dichlorodiphenyltrichloroethane show enhance dietary methyl group deficiency hibite supplemental methyl donor hepatocarcinogenic stressor activity hibite methyl donor also show decrease hepatic content adenosylmethionine er chronically feed rat antimetabolite methylation ethionine azacytidine provide addi tional evidence causative role abnormal lation carcinogenesis finally consider dietary methyldeficiency lower apparent threshold chemical carcino genesis liver severe deficiency induce marked fatty liver cirrhosis enhance ment carcinogenesis require moderate defi ciency induce cirrhosis genesis even reduce severe deficiency Methyldeficiency accelerate magnify appearance preneoplastic molecular morpho logical change target cell ultimately celerate development tumour however use carcinogen consider contro versial study liver carcinogenesis possible differentiate respective effect substance restrictive diet liver tumouri genesis vivo diet carcinogen effect diet deficient choline methionine carcinogen male rat feed diet deficient choline low thionine develop hepatocellular carcinoma sence carcinogen diet frequently use longterm study methyldeficient rat model diet low methionine choline deficient adequate amount tamin B12 folate peanut meal soy pro tein isolate casein feed rat diet show hepatocellular carcinoma animal table strong indication methionine cholinedeficient diet serve effective promote agent multistage hepatocarcinogenesis con troversial diet also cause tiation individual hepatocyte diet use methyldeficient cancer model amino acid define diet pure amino acid choline low methionine adequate amount vitamin b12 folate rationale Table Studies report liver carcinogenic effect methyldeficient diet use carcinogen rat Authors Year Diet composition Hepatocellular Delay carcinoma month choline Methionine folate B12 Amino acid define Low define cholinedeficient amino acid define diet define low methionine effect B12 folate liver carcinogenesis modification unavoidable unpredictable con tamination target nutrient protein source semipurifie diet comparison diet show rat feed amino acid define diet develop patocellular carcinoma interpretation different effect carcinogenesis diet diet provide whole protein require gestion peptide form digestion stimulate amino acid absorption thus increase methion ine intake tumourigenic activity amino aciddefined methionine cholinedeficient diet find rat proportional corre sponding decrease hepatic adenosylmethion ratio produce diet deficient diet also generate pres ence new form dna methyltransferase Dnmt activity liver tumour rat feed methionine choline deficient diet pos sibly explain part alteration dna methylation produce diet alteration dna methylation genetic susceptibility hormonal status also important factor liver tumourigene sis rodent interestingly hepatocarcinogenic activity diet solely deficient choline diet adequate methionine folate content also report deficiency alone sufficient trigger carcino genesis need exposure know car suggest addition hypomethylation dna accumulation acylglycerol subsequent activation protein nase liver choline deficiency critical abnormality eventually contribute develop ment liver cancer effect diet deficient choline methionine folate carcinogen Folate deficiency alone little effect hepatic lipid carcinogenesis cholinemethionine defi ciency alone able generate relative folate meta bolic deficiency theoretically combined folate choline methioninedeficient diet strong carcinogenic effect compare diet deficient choline methionine however study support view develop folatemethyldeficient diet also lead typical symptom choline deficient diet fatty liver decrease hepatic adenosyl methionine concentration increase hepatic adenosylhomocysteine level diet base casein gelatine soy oil contain methionine vitamin b12 diet add choline folate diet rat develop hepatocellular carcinoma month period Table conclude diet severely methyldeficient compare folate addition cholinemethioninedeficient diet markedly increase hepatic lipid content Feeding folatecholine deficient methioninelow diet also result similar decrease adenosylmethionine ratio liver compare diet deficient choline methionine effect diet deficient choline methionine folate vitamin b12 carcinogen show dietary deficiency vita min B12 alone result fatty liver sheep effect vitamin b12 withdrawal addition choline methionine folate deficient diet also sparsely evaluate liver rat feed severely deficient choline methionine folate vitamin b12 decrease overall level dna methylation accompany simultaneous alteration gene expression yield pattern closely resemble report occur liver animal expose cancerpromote chemical hepatoma however worker show rat feed diet carcinogen hepatocarcinoma incidence also confirm low occurrence find liver tumour occurrence group rat feed methyldeficient diet median period month rat undergo liver magnetic resonance image negative result liver harvest death free tumour pathology examination however histological activity index assess rat liver ing modify semiquantitative score derive Gastroenterology score compare con trol methyl adequate diet methyldeficient diet rat significant difference liver dysplasia score result suggest severe methyldeficient diet deficient choline methionine folate vitamin b12 probably sufficient promote tumour occurrence Table result contrast effect diet deficient choline methionine folate carcinogen last diet able trigger liver tumour rat table however discrep ancy effect severe methyldeficient diet deficient choline methionine folate vitamin b12 lipotropedeficient diet already notice author consider diet induce frequent carcinoma male rat role completely methyldeficient diet deficient choline methionine folate vitamin b12 liver carcinogenesis uncertain thus hypothesize vitamin b12 status cru cial parameter define carcinogenicity methyl deficient diet rat surgical model total gastrectomy develop surgical model rat assess role severe vitamin b12 deficiency combine methyldeficient diet dna methylation liver carcinogenesis confirm vitamin b12 plasma effect B12 folate liver carcinogenesis level low gastrectomize rat methyl vitamin B12deficient diet animal fact experience vitamin B12deficient diet efficient reach vitamin b12 deficiency dramatic decrease plasma B12 level Disappear ance gastric intrinsic factor total gastrectomy think lead vitamin b12 deficiency rat diminution absence vitamin b12 absorption find vitamin b12 plasma level similar rat undergo total gastrectomy concomitant ileal resection total gastrectomy ileal resection alone effi cient enough provide low plasma level vitamin b12 indicate intrinsic factor likely produce gastric wall duodenum junum propose author also dicate intrinsic factorvitamin B12 receptor pression likely restrict ileum rat advantage use surgical model reach vitamin b12 deficiency obtain dra matic decrease b12 plasma level avoid sub stance nitrous oxide drug produce b12 deficiency possible exclude interference liver tumour car cinogenesis direct effect main disadvantage use total gastrectomy operation major procedure rat diate postoperative mortality evaluate furthermore body weight loss occur survivor rat survival long gastrectomy sin rat consider gastrectomy effective way get long term B12deficient survivor rat thus gastrectomize rat survive long enough permit evaluation liver tumourigenic ity Table Deficiencies choline methionine less degree major dietary nutrient govern ing severity methyldeficiency liver carcino genesis hepatocellular carcinoma rat model ever composition methyldeficient diet quite variable different study respect type amount protein major source methionine level methionine choline diet presence amount important component include vitamin B12 folic acid consequently difference magnitude effect carcinogenesis methyldeficient diet observe difficult compare intensity methyldeficiencie liver carcinogenicity different study dietary vit amin B12 crucial carcinogenicity methyldefi cient diet indeed carcinogenicity methyldefi cient diet much higher presence vitamin b12 compare methyldeficient diet B12 deficiency lipotrope defi ciency development liver disease include liver cancer new perspective occurrence neoplasms liver lung tissue rat result pro long choline deficiency Pathol effect diet genetic chemical toxicity aberrant dna methylation introduction 2336S deficiency Metab Rev Physiological methyla tion carcinogenesis Prog Clin Biol Res role folate choline methionine carcinogenesis induce methyldefi cient diet Delongchamp Sinha Blood termination adenosylmethionine homocysteine correlation diet cancer epidemiol biomarker Prev Hoover genesis rat feed methyldeficient amino aciddefined et carcinogenesis Profound postinitiation enhancement shortterm severe methionine choline vitamine b12 folate deficiency hepatocarcinogenesis F344 rat give single lowdose diethylnitrosamine jection NatI Cancer Inst Sells Reddy promote action diet rat Cancer Res LynCook Poirier set oncogene hypomethylation liver rat feed methyldeficient amino aciddefined diet extremely low activity methionine synthase vitamin b12deficient rat relate effect deficient total b12 deficiency median survival Liver mean liver Liver tumour gastrectomy quartile mri dysplasia score pathology choline methionine folate severe tumour deficiency severe tumour Choline methionine folate Mild normal tumour deficiency deficiency normal tumour MRI magnetic resonance image Table Liver pathology dysplasia score rat diet choline methionine folate B12 deficiency total gastrectomy B12deficient diet personal datum effect B12 folate liver carcinogenesis coenzyme stabilisation rather change coen group carcinogenesis fect dna methylation gene expression Cancer Res sible involvement DNA methylation azacytidine duce neuronal cell apoptosis AlonsoAperte pair methionine synthesis hypomethylation rat expose valproate gestation neurology role folic acid vitamin b12 genomic stability human cell epigenetic aspect dna methylation genome expression evolution muta tion carcinogenesis carcinogenesis thionine synthase interaction dna methylation Nutr 2382S Piyathilake Johanning Cellular vitamin DNA methy lation cancer risk 2340S Proceedings transHHS work shop diet dna methylation process health vitamin B12 homo cysteine status dna damage young Australian adult carcinogenesis tune vitamin b12 strong determinant low methionine synthase activity dna hypomethylation gastrectomize rat digestion press Diet methyl donor dna methylation interaction dietary folate choline important nutrient brain develop ment liver function carcinogenesis pearance hypomethylated dna liver rat feed diet Cancer res deficiency rat induce dna strand break hypomethylation p53 tumour genomic DNA p53 gene associate hypomethylation liver folate methyldeficient rat Cancer res Moderate folate depletion increase plasma homocysteine decrease lymphocyte dna methyla tion postmenopausal woman induction liver cancer etary deficiency choline methionine add carcinogen carcinogenesis Rogers Methyl donor diet response chemical carcinogen dna methylation alternative pathway cancer role dna methylation epigenetic Annu Rev Genet distinguish gene human cancer normal counter part Nature Bestor Gene silence meet acetylation nature DNA methylation gas trointestinal carcinogenesis Gastroenterol Hepatol Martin reduce mrna abundance main enzyme involve methionine metabolism human liver cirrho sis hepatocellular carcinoma prospective study methylenete trahydrofolate reductase methionine synthase gene polymorphism risk colorectal adenoma genesis stampfer Christensen polymorphism methionine syn thase gene association plasma folate vitamin b12 homocysteine colorectal cancer risk cancer Epi demiol biomarker Prev relevance folate metabolism pathogenesis colorectal cancer Alterations nucleotide pool rat feed diet deficient choline methionine folic acid carcinogenesis DNA damage folate deficiency Principal cause hot spot cytosine thymine mutation site cytosine grow cell effect choline methionine deficiency number volume percentage alter hepatic focus presence absence diethylnitrosamine initiation rat liver car cinogenesis carcinogenesis lipotropedeficient rat cancer res cell proliferation inci dence hepatocellular carcinoma rat tively cholinesupplemented diet carcinogenesis Nakae Yoshiji Mizumoto High incidence hepatocellular mas induce choline deficient amino acid define diet rat cancer res Nakae endogenous liver carcinogenesis rat role methionine carcinogenesis vivo Adv Exp Med Biol Lopatina elevated pression altered pattern activity dna methyl transferase liver tumor rat feed carcinogenesis DNA damage alter cleotide metabolism lymphocyte deficient rat carcinogenesis Swendseid Hepatic content adenosylmethionine adenosylhomocysteine glutathione rat receive treatment modulate methyl donor availability Young Blanchflower Histopathologic ultra structural alteration white liver disease sheep exper imentally deplete cobalt effect B12 folate liver carcinogenesis METAVIR Cooperative Study group algorithm grading activity chronic hepatitis Hepatology working party nodular hepatocellular lesion ogy sley WGE regulatory role liver kidney cobal amin metabolism rat Ballanti osteopenia rat role vitamin b12 deficiency type reconstruc tion digestive tract retention cobal amin intrinsic factor receptor present ileum gastrectomize rat Scand Gastroenterol intrinsic factor secretion rat teral vitamin b12 supplement reverse postgastrectomy B12 deficiency Ann Surg Alpers RusellJones intrinsic factor haptocorrin receptor Barnerjee editor biochemistry B12 Effects dietary nitrous oxide induce vitamin b12 deficiency uptake trahydrofolate isolated rat hepatocyte Nutr Destri Trombatore Total gastrectomy nutritional status different reconstruction technique experimental study Surg Oncol Schwille Gastrectomy rat use modification esophagojejunal anastomosis Gen eral status local histological change relationship bone density Eur Surg partly responsible reduce food take body weight loss total gastrectomy rat Surg Tredici due cobalamin defi ciency rat Neurol Sci scalabrino Buccellato Tredici enhance level biochemical mark er cobalamin deficiency totally gastrectomized rat uncouple enhancement severity spongy vacuolation spinal cord receive revise accept Corresponding author Cell Molecular Pathology Nutrition INSERM EMI l cedex Phone fax mail",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 51,
                    "epigenetic": 4
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "influ": 1,
                    "dra": 1,
                    "Australian": 1,
                    "Barnerjee": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "influ": 55,
                    "dra": 55,
                    "Australian": 55,
                    "Barnerjee": 55
                },
                "Ethnographic Terms": {
                    "methylation": 4,
                    "epigenetic": 4
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.pdf",
            "cleaned_text": "epigenetic regulation methylguaninedna methyltransferase gene expression histone acetylation methylcpg bind protein Jude Children Research Hospital Tennessee Transcriptional silence DNA repair gene methyl guanineDNA methyltransferase proportion transform cell line associate methylate cpg hotspot goal study evaluate mechanism methylation promoter region influence silence gene Analysis histone acetylation status region promoter use assay show high level histone acetylation associate expression express cell line HeLa CCL2 HT29 com pare mgmtsilenced cell line HeLa TK6 determine modulation cpg methylation histone acetylation influence pression expose cell Aza inhibitor dna methylation strongly regulate expression mgmtsilenced cell line inhibitor histone deacetylase weakly induce however combined treatment Aza significantly regulate rna expression great extent cell treat agent alone suggest histone deacetylation play role cpg methylation dominant effect Consistent enhanced expression Aza increase association acetylate histone bind promoter immuno precipitation analysis methylcpg bind domain contain protein detect great amount MeCP2 MBD1 bind promoter cell finding implicate specific MBD protein methylationmediate transcriptional silence MGMT Mol Cancer Ther introduction dna repair protein methylguaninedna methyl transferase remove alkyl adduct position guanine dna protect cell mutagenic carcinogenic cytotoxic effect alkyl ate agent express human cell tissue tumor expression vary widely furthermore silence significant proportion f20 malignant transform cell line fraction primary tumor silence cell hypersensitive cancer therapeutic carcinogenic alkylate agent gene promoter contain cpg island box puta tive recognition site glucocorticoid receptor bind element activator protein putative bind sequence silence cell lack detectable level MGMT rna protein however gross rearrangement deletion gene report suggest sence rna due regulation transcriptional level previous report lab other show suppression strongly link cpg methylation flanking region gene also report cell line xenograft hotspot region region gene cpg methylation almost always associate silence methylation clearly involve silence precise mechanism methylationmediate transcriptional inactivation gene understand dna methylation repress gene transcription interfere sequencespecific binding function transcription factor due cytosine meth ylation recognition site recruit methyl bind domain MBD contain family protein MBD protein mediate transcriptional repression alter chromatin structure block access transcription machinery base study demonstrate connection dna methylation histone deacetylation model propose methylationmediate tran scriptional silence accord model MBD protein bind methylate recruit histone deacetylase HDAC directly corepressor complex HDAC remove acetyl group Received revise accept support grant grant cost publication article defray part payment page charge article therefore hereby mark advertisement accordance section solely indicate fact request reprint Jude Children Research Hospital North Lauderdale Memphis Phone fax mail lysine histone tail restore positive charge lysine residue promote stabilization interaction result chromatin condensation inaccessibility transcription factor transcriptional inactivation conversely tone acetylation reverse process lead open chromatin accessibility transcription factor transcriptional activation methylcpg bind protein MeCP2 MBD1 MBD2 MBD3 identify date mammalian system protein MeCP2 bind methylate cpg conserved protein motif call MBD MeCP2 MBD1 show recruit HDAC function transcriptional repressor MBD3 non dna bind component corepressor complex uracil dna glycosylase activity implicate dna repair pro tein bind methylate dna zinc finger motif behave transcriptional repressor present study design first assess histone acetylation associate cpg methylation promoter region evaluate relative contribution histone acetylation expression Second goal identify MBD protein associate promoter express silence cell line thereby understand role MBD protein mediate transcriptional repression human cervical tumor cell line HeLa CCL2 grow minimum essential medium supplement human colon adenocar cinoma cell line grow medium supplement human lymphoblast cell line TK6 cultured rpmi contain cell grow humidified air co2 cell obtain seed treatment cell give follow treatment Aza deoxycytidine Sigma treatment medium contain Aza Sigma treatment cell treat drug present culture day addition nmol harvest cell Immunoblotting Cell lysate prepare mammalian protein extraction reagent contain protease inhibitor Equal amount protein size fractionated SDSPAGE transfer polyvinylidene difluoride membrane membrane probe anti body MeCP2 Biotechnology MGMT Temecula tubulin Sigma protein detect enhanced chemilumiscence western blotting detection system cultured describe culture nmol cell vest wash icecold isolate dounce homogenization cell lysis buf fer mmol TrisHCl mmol sodium bisulfite sucrose Triton mmol MgCl2 centrifuge rpm minute wash twice lysis buffer later TrisEDTA solution mmol TrisHCl isolate nuclear fraction acid extraction describe Histones separate SDSPAGE minigels transfer nitro cellulose membrane BioRad Hercules probe different antibody follow antibody use antiacetylate histone antihistone anti acetylate histone antihistone nology protein detect enhance chemiluminescence Western blotting detection system use chromatin immunoprecipitation ChIP assay kit follow manufacturer protocol modification protein crosslinke DNA addition formaldehyde culture medium final tion incubate crosslinke reaction quench add mmol glycine room temperature medium remove cell suspend icecold contain protease inhibitor Cells pellete resuspend SDS lysis buffer cell incubate ice minute Sonicated lysate centrifuge rpm 4jC minute dilute fold ChIP dilution buffer provide kit aliquot chromatin preparation set aside designate input fraction reduce nonspecific background chromatin solution pre clear salmon sperm DNAProtein agarose slurry slurry rock 4jC clear chromatin immunoprecipitate antiacetylate histone antiacetylate histone antimecp2 p150 antibody incubate overnight rotation later salmon sperm DNAProtein agarose slurry add sample rock immune complex collect centrifugation wash recommend Histone Deacetylation MBD Proteins MGMT Mol Cancer Ther buffer complex elute twice elution buffer room temperature microliters mol NaCl add combine eluate sample incubate mmol EDTA mmol TrisHCl proteinase add sample incubate dna immunoprecipitation sample input recover phenol extraction ethanol precipitation analyze pcr PCR amplification region promoter designate hotspot region region Fig region actin promoter analyze pcr primer pair use hotspot region promoter chip analysis forward GAGCCGAGGACCTGAGAAAAGCAA GAGAG reverse primer amplify hotspot minimal promoter region locate upstream transcription start site second set primer use amplify region promoter forward reverse region include bind site primer pair use actin promoter ChIP analysis forward AGATCGCAACCGCCTGGAAC reverse ref optimal pcr condition determine buffer pcr pair anneal temperature hotspot region region actin respectively pcr product resolve agarose gel stain ethidiumbromide quantitate use ager documentation analysis software ReverseTranscriptionPCR total RNA isolate use kit Ambion Austin RNA reverse transcribe use avian myeblastosis virus reverse transcriptase deox ynucleotide triphosphates oligo primer Invitro gen Carlsbad amplification cdna do use primer specific actin primer specific cdna amplification cgacttgg TACTTGGAAAAATG forward CGCATCCGATG reverse primer pair specific actin cdna GTGGGGCGCCCCAGGCACCA forward CTCCTTAATGTCACGCACGATTTC reverse plification actin cDNA serve internal control pcr amplification actin mrna do anneal temperature yield product respectively pcr product resolve agarose gel stain ethidium bromide quantitate describe result difference Histone Acetylation Status MGMT Expressing Silenced Cell line determine histone acetylation associate expression compare level acetylate histone ach4 bind flank promoter immuno precipitate chromatin MGMTexpressing cell line HeLa CCL2 HT29 silence cell line HeLa TK6 use ChIP assay different region promoter amplify designate hotspot region yield pcr product respectively Fig pcr fragment hotspot extend nucleotide relative transcription start site also include minimal promoter show almost always methylate cell PCR fragment region extend nucleotide include site quence choose comparison contain methylation upstream associate silence figure show amount acetylate histone associate hotspot region promoter low TK6 cell compare express CCL2 cell similarly amount acetylate histone associate region promoter also reduce cell compare express cell methylation region previously show associate silence reduction amount acetylate histone region likely mediate closed chromatin figure Schematic representa tion Hot Spot AP1 region promoter use ChIP analysis region almost always methylate cell SP1 site promoter region consequently result suggest enrichment acetylate histone hotspot promoter region associate open chromatin transcrip tional activation express cell line determine difference histone acetylation status specific examine level acetylation histone actin promoter constitutively express actively proliferate cell Fig consistent difference observe abundance acetylate histone bind actin promoter compare MGMTexpressing cell line normal rabbit serum immunoprecipitation do neg ative control pcr product detect actin nonspecific product observe promoter analysis sample nevertheless signal subtract experimental sample interpretation result remain Cellular Level Histones Next ask inhibition histone deacetylase result global increase cellular histone ace tylation determine level histone acetylation TK6 cell treatment western blot analysis show untreated TK6 cell level acetylate histone low Fig Treatment nmol TSA result accumulation remain unchanged period slight increase level ach3 observe cell increase ach4 observe follow treatment datum show test demethylation dna reverse silence Aza inhibitor dna methyltransferase use demethylate agent Treatment MGMTsilenced cell line alone regulated mrna expression determine reverse TK6 cell seem respond fast cell line significant increase expression measure compare cell examine potential role histone hyperacetylation control expression cell also treat inhibitor histone deace tylase cell treat nmol TSA alone slight regulation observe cell line suggest alone activate expression TSAsensitive HDAC activity critical methylation mediate silence however add cell Aza exposure expression enhance level induce Aza alone silence cell line datum HeLa seem statistically significant clearly trend enhance expres sion generate Aza alone significant regulation observe cell follow exposure Aza TSA Figure Comparison histone acetylation status express cell line AP1 region promoter chip assay cell line chip antiacetyl antibody NRS ChIP normal rabbit serum input dna isolate lysate immunoprecipitation DNA immunoprecipitate antiacetyl antibody dna immunoprecipitate antiacetyl antibody amplification actin promoter serve positive control Figure Time course treatment TK6 cell western blot analysis nuclear histone acetylated histone total histone acetylate histone total histone MGMT Mol Cancer Ther add cell day Aza exposure expression induce fold level induce alone datum show apparent synergistic effect regulate expression TK6 cell first treat dna methyltransferase inhibitor follow HDAC inhibitor Treatment cell result cell death therefore expression measure additional time point exposure however show effect global histone acetylation maximal hour show expo probably result enhanced effect expression Effect Aza Association Acetylated Histones MGMT Promoter investigate effect Aza acetyla tion status histone promoter use assay cell show Fig proportion acetylate histone bind hotspot region enhance fold respectively treatment cell Aza contrast association acetylate histone region increase fold fol low bind protein interpreter DNA methylation signal protein MeCP2 MBD1 show function transcriptional repressor interaction HDAC complexe assembly factor multiprotein complex compose subunit p150 p60 p48 initiate nucleosome assembly recruit acetylate histone newly replicate dna key player determina tion inheritance chromatin state assess MBD protein involve lence examine expression different MBD pro tein cell association promoter use ChIP assay Figure depict total figure MGMT rna expression follow exposure Aza different cell line measure reverse TK6 cell treatment combination agent Representative multiplex reverse gel together histogram depict mean band intensity normalize actin signal least independent experiment Expression actin serve internal control intensity pcr band quantitate AlphaImager system open column alonetreate sample shade column treat sample solid column sample Molecular Cancer Therapeutics Mol Cancer Ther amount MeCP2 MBD1 CAF protein panel express silence cell line determine Western blot analysis MBD1 express cell line approximately equal level however expression low cell respectively vivo Binding MBD Proteins MGMT Promoter ChIP assay show relative amount associate hotspot region promoter fold high HeLa cell line express ing HeLa CCL2 cell line show interact COOH terminus also investigate bind promoter abundance hotspot region almost fold great CCL2 cell line region proportion bind fold high cell compare CCL2 cell difference bind MBD1 cell line result show difference bind MBD protein hotspot region compare region promoter suggest involve methylation mediate silence control evaluate MeCP2 MBD1 bind actin promoter constitutively express gene expect detect bind protein actin promoter demonstrate specificity MBD protein bind promoter discussion previous study lab other show silence strongly correlate promoter hyper methylation study test hypothesis silence promoter mediate dna methylation histone deacetylation examine association histone acetylation expression first determine difference tween histone acetylation status MGMTexpressing cell line use ChIP assay Fig express cell line high level acetylate histone associate promoter compare cell line support model gene expression associate histone acetylation similar tion report show reduce level acetylate histone bind methylated promoter dna compare unmethy lated promoter several line evidence suggest histone acetyla tion play role transcriptional regulation probably alter chromatin structure hdac histone acetyltransferase act together modulate chromatin structure transcriptional activity change pat tern acetylation status histone known dynamic linkage dna methylation histone deacetylation examine ing methylation histone acetylation affect expression exposure cell DNA methyl transferase inhibitor Aza reduce dna methyla tion regulated MGMT rna expression observe accumulation total cellular acetylate histone increase cell culture TSA Fig weak expression MGMT RNA detect Fig activation alone support dominant role tion play silence illustrate observation inhibition methylation Aza follow inhibition histone deacetyla tion synergistically enhance transcription cell line furthermore observe increase bind acetylated histone region promoter follow treatment laboratory also report robust expression p16 INK4a estrogen receptor gene combine dna methyltransferase HDAC inhibition mechanism synergistic effect think formation condense chromatin induce extensive methylation concomitant bind ing MBD protein associate corepressor complexe Reactivation MGMT gene require least partial demethylation unfold chromatin consequent loss repressor complex inhibition figure western blot analysis MBD protein different cell line use loading control Figure ChIP assay HeLa cell Effect Aza bind acetylated histone Hot Spot AP1 region promoter open column untreated sample solid column treat sample Columns mean independent experiment bar Histone Deacetylation MBD Proteins MGMT Mol Cancer Ther January HDACs become advantageous event enable accessibility transcription rna polymerase transcription start site lead activation gene identify protein responsible interpretation methylation signal gene sequence choose evaluate MeCP2 MBD1 bind promoter mecp2 MBD1 act methylationdependent transcriptional repressor bind ing methylate mediate repression association HDACs CAF involve nucleosome assembly chromatin show colocalize heavily methylate mouse cell general expression protein cell extract com parable panel cell line examine Fig ChIP assay datum show difference bind MeCP2 MBD1 hotspot region MGMTexpressing CCL2 cell Fig hotspot region comprise bind protein fold high cell compare express cell bind promoter corroborate report partner COOH terminus p150 subunit however lack dif ference proportion bind region due low density moreover association methylation status region silence unknown datum suggest hotspot region high density methylate cell high occupancy mecp2 MBD1 associate corepressor complex result compact chromatin reason low detectable level MBD1 bind hotspot region express cell lack cpg methylation clear possible datum reflect presence subset cell express population result consistent recent report histone methylate bind preferentially cpg island negative cell line report evaluate bind methylated acetylate Lys area promoter also span hotspot region observe histone methylation directly correlate histone acetylation inversely correlate promoter methylation report mediate methylation recruiting histone vivo also interact heterochromatin protein ref normally associate heterochromatin recognize bind methyl ate site heterochromatinization probably result exclusion transcription factor bind region SP1 site upstream other upstream transcription start site MGMT Fig however lack expression cell probably reflect alteration nucleosomal structure modulate methylation exclud ing SP1 bind promoter summary methylationmediate silencing seem associate reduction acetylate histone bind promoter region MeCP2 bind methylate dna recruit hdac histone methyltransferase lead change pattern histone modification alteration chromatin structure Similarly MBD1 bind methylate dna associate turn link anchor histone h3k9me site therefore MGMTsilenced cell hypothesize multiprotein complex contain together histone methyltransferase form hotspot region promoter sulting condense close chromatin transcrip tional inactivation first report implicate complex methylation mediate transcriptional silence gene figure comparison bind MBD protein Hot Spot AP1 region promoter express CCL2 open column silence solid column cell line ChIP assay use antiMeCP2 actin promoter serve negative control highly express actin MeCP2 MBD1 associate chip antibody dna isolate lysate immuno precipitation mecp2 dna immunopre cipitate antimecp2 antibody MBD1 DNA immunoprecipitate antibody CAF1 DNA immu noprecipitate antiCAF antibody Columns mean independent experiment bar Molecular Cancer Therapeutics Mol Cancer Ther January Reactivation achieve demethylation inhibition histone deacetylation future study use coimmunoprecipitation ChIP assay rna interference elucidate precise role individual component promoter transcription repressive complex pursue tumor hypermethylated promoter express sensitive alkylate drug express therefore hypermethylation potentially use clinical predictive marker therapeutic response tumor however tumor silence accumu late point mutation ras p53 tumor result genomic instability colon tumor hypermethylation confer resistance methylate agent induce cell death Pharmacologic intervention dnmt HDAC control expression tumor suppressor gene propose novel anticancer therapeutic modality well understand effect drug specific gene drug resistance affect warrant acknowledgment thank support excellent guidance retire research oligonucleotide synthesize AlkylguanineDNA alkyl transferase activity correlate therapeutic response human rhabdomyosarcoma xenografts chloroethyltran methylcyclohexylnitrosourea Harris acterization promoter region human methylguanineDNA methyltransferase gene Danam Qian Howell select methyltransferase promoter region marker gene silence specific methyla tion pattern promoter region associate reduce expression primary colorectal cancer Esteller Hamilton Burger Inactiva tion DNA repair gene methylguanineDNA methyltransferase promoter hypermethylation common event primary human neoplasia Cancer Res Futscher methylation discrete region methylguanine DNA methyl transferase cpg island associate heterochromatinization transcription start site silence gene Mol Cell Biol hot spot flank region denote silence methylguanineDNA methyltransferase gene cpg methylation inhibit gene expression bind transcription factor DNA cpg methylation inhibit binding protein HIV long terminal repeat cognate dna motif New Biol Bird Wolffe Methylationinduced repression belt brace chromatin cell Hendrich Bird Identification characterization mammalian methylcpg bind protein Mol cell Biol transcriptional repression methylcpgbinde protein mecp2 involve histone deacetylase complex Nature Jones Veenstra Wade Methylated DNA recruit histone deacetylase repress transcription bind protein cancer important MBDs thymine glycosylase bind product deamination methylate cpg site Nature Prokhortchouk Hendrich Jorgensen p120 catenin partner repressor Richon deacetylase inhibitor selectively induce p21waf1 expression geneassociated histone acetylation Localization methylation site human methylguanineDNA methyltransferase promoter correlation gene suppression carcinogenesis Wade Methyl cpg bind protein couple chromatin architec ture gene regulation p150 p60 subunit chromatin assembly factor molecular link newly synthesize histone dna replication cell inheritance chromatin state crossroad dna replication repair cpg methylationdependent repression human methylguanineDNA methyltransferase gene link chro matin structure alteration carcinogenesis acetylation chromatin structure tran scription Nature deacetylase cancer cause therapie cancer acetyltransferase Annu Rev Biochem Myohanen Synergy demeth ylation histone deacetylase inhibition expression gene silence cancer Synergistic activation functional estrogen receptor dna methyltransferase histone deacetylase inhibition human negative breast cancer cell Cancer res genomic screen gene upregulate demethylation histone deacetylase inhibition human colorectal cancer methylcpg bind domain chromosomal protein mecp2 Nucleic Acids Res solution structure domain bind methylate dna Mol Biol tran scriptional regulation methylcpg bind protein MBDI Mol Cell Biol Baylin Rountree methylcpg bind protein MBD1 interact p150 subunit chromatin assembly factor Mol Cell Biol Silencing effect cpg histone Deacetylation MBD Proteins MGMT Mol Cancer Ther island hypermethylation histone modification methylguanine dna methyltransferase gene expression human cancer role histone methylation tumor suppressor gene silence colorectal cancer Mol Cell Biol Nan Bird Kouzarides methyl CpGbinding protein mecp2 link dna methylation histone methylation dynamic mouse cell interaction chromatin assembly factor HP1 protein Mol Cell Jenuwein Methylation histone lysine create bind site HP1 protein nature chromatin structure associate exclusion transcription suppress expression methylguanine dna methyltransferase gene human glioma cell line Mol Cell Biol Patel Graunke Pieper aberrant silence islandcontaine human methylguanine dna methyltransferase gene associate loss nucleosomelike positioning Mol Cell Biol gene clinical response glioma alkylate agent Generating mutation provide chemo sensitivity role methylguanine dna methyltransferase human cancer molecular Cancer Therapeutics Mol Cancer Ther",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "epigenetic": 1,
                    "methylation": 36,
                    "demethylation": 4
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "MBD1": 8,
                    "Western": 2,
                    "deox": 1,
                    "CTCCTTAATGTCACGCACGATTTC": 1,
                    "SP1": 2,
                    "MGMTsilenced": 2,
                    "TSAsensitive": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "MBD1": 41,
                    "Western": 41,
                    "deox": 41,
                    "CTCCTTAATGTCACGCACGATTTC": 41,
                    "SP1": 41,
                    "MGMTsilenced": 41,
                    "TSAsensitive": 41
                },
                "Ethnographic Terms": {
                    "epigenetic": 17,
                    "methylation": 17,
                    "demethylation": 17
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Folate and DNA methylation_ a review of molecular mechanisms and the evidence for folate_s role.pdf",
            "cleaned_text": "folate DNA methylation Molecular Mechanisms Role1 Bailey5 3national Center Birth Defects Developmental Disabilities Division Birth Defects Developmental Disabilities Atlanta Biochemistry Molecular Biology Center Epigenetics Division Pediatric Genetics University 5Foods dna methylation epigenetic modication critical normal genome regulation development vitamin folate key source carbon group use methylate dna normal mammalian development dependent dna methylation enormous interest assess potential change folate intake modulate dna methylation biomarker folate status mechanistic link developmental disorder chronic disease include cancer highlight role dna methylation normal genome function alter evidence role acid process Introduction Folate essential watersoluble vitamin occur natu rally select food well synthetic form folic acid use supplement food fortication pro gram many critical cellular pathway pendent folate carbon source include DNA rna protein methylation dna synthesis maintenance limit factor reaction study heritable change phenotype gene expression result change primary dna sequence recognize mechanism epigenetic regulation mammal include DNA methyla tion posttranslational modication histone chromatin remodeling micrornas long noncoding rna epigenetic regulatory mechanism modulate chroma tin structure contribute regulation major lecular process nucleus include transcription replication repair rna process dna methylation covalent modication genomic DNA modie gene expression provide mechanism transmit perpetuate epigenetic information DNA rep lication cell division role dna methylation cellular regulation also provide potential new paradigm disease intervention treatment development various inhibitor dna methylation alter methylation pattern intact mammalian cell lead clinical use inhibitor exper therapy human disease hematological malignancy myelodysplastic disorder dna methylation pattern stable retain puried genomic DNA therefore study dna methyl ation amenable wide variety cellfree assay technology include dna methylation analysis single nucleotide resolution nextgeneration sequencing genomewide methylation prole Table Cur rently new dna sequencing technology begin provide novel insight genomewide pattern dna methylation highresolution truly genomewide study limit small sample size recent study describe DNA methylation level individual site loci gene man genomic dna sample even tremendous datum set cover tiny portion genome ite number sample recent advance basic understand normal variation genomic Author disclosure author report conflict interest perform work employee government finding conclusion report author necessarily represent official position available Online Supporting Material link online post article link online table content correspondence address mail kcridercdcgov SASKATCHEWAN advancesnutritionorg pattern dna methylation human tissue age population disease environmental condition includ ing dietary intake well describe method need undertake type study infrastructure analysis rapidly emerge write provide nutritional scien tist synopsis mechanistic aspect dna meth ylation background understand potential nutrient folate affect molecular process highlight follow cover role mechanism dna methylation demethylation mechanism gene silence dna methylation function DNA methlyation reprogramme dna methylation pattern development differ entiation importance change dna methyla tion hyper hypomethylation follow potential role folate dna methylation process assessment folate status biomarker link disease outcome cover folate role carbon relate DNA methylation low folate status dna methylation background dna methylation cancer folate study cancer patient folate status global dna methylation study healthy adult folate status change dna methylation response environment importance develop mental timing exposure study folate fetus fant cord blood high folate folic acid intake dna methylation conclude focus search issue include methodological consideration key planning interpret research investigation relate assess difference dna methylation sponse change folate status clearly many challenging research issue need address fill gap knowledge relate potential late modulate dna methylation potentially impact development health maintenance current status knowledge part overview dna methylation introduction dna methylation Methylation cyto sine common human genome lend commonly occur cytosine cpg dinucleotide methyl group adenosylmethionine enzymatically transfer position cytosine generate methylcytosine genomic dna dna methylation pattern product frequency cytosine dna methylation specific site strand dna recent genomewide highresolution dna methylation analysis primary man fibroblast cell line demonstrate total tosine genomic DNA methylate methylate dna methylation occur cpg dinucleotide similar analysis human embryonic stem cell line show cytosine methyl ate cpg dinucleotide methylate cytosine methylation occur site early study also report high level noncpg methylation mouse embryonic stem cell contrast methylation pattern mouse somatic cell importance cpg methylation establish role noncpg methylation new active area research interestingly frequency cpg dinucleotide low expect mammalian nome believe due spontaneous deamination yield thymine cytosine thymidine transition dna however certain region genome approximately fold high figure Folic acid metabolism schematic show process acid use dna methylation MTHFR 677C variant reduce enzyme activity help divert available methyl group DNA methylation pathway DNA synthesis pathway pathway complex highly regulated feedback loop interaction show schematic name enzyme italic cofactor parenthesis dihydrofolate dhfr dihydrofolate reductase dnmt dna methyltransferase dtmp thymidylate deoxyuridine monophosphate methionine synthase mthfr methylenetetrahydrofolate reductase sah adenosylhomocysteine SAM adenosylmethionine serine tetrahydrofolate thymidylate synthase Abbreviations use BER base excision repair bpa bisphenol differentially methylate region dnmt dna methyltransferase hydroxymethylcytosine intracisternal particle methylcytosine methylTHF methyltetrahydrofolate line long interspersed element mthfr methylenetetrahydrofolate reductase neural tube defect red blood cell SAH adenosylhomocysteine SAM adenosylmethionine short interspersed element tetrahydrofolate Crider UNIV SASKATCHEWAN advancesnutritionorg list commonly use methodology analyze dna methylation1 description Pros Cons Global Liquid chromatog raphy tandem mass spectrometry genomic dna nucleoside fractionation highly sensitive quantitative accurate reproducible require costly instrumentation quire amount dna Shellnut HPLC genomic dna nucleotide fractionation hplc highly quantitative accurate reproducible require costly instrumentation quire amount DNA Methyl acceptance Global methylation determine level tion genomic DNA SssI methylase technical simplicity lack sensitivity imprecise weak reproducibility specific Methylsensitive striction enzyme digestion assess methylation specic restriction site use Southern blot Standard molecular biology technique analysis individual striction site strictly quantitative polymerase chain reaction amplie methylate genomic dna sequence sodium bisulte treatment genomic DNA sensitivity technical simplicity quantitative limited sequence coverage determine level methylation specic cpg site highly quantitative singlenucleotide resolution technically straightforward require costly instrumentation stricted sequence coverage Gut Microarray large number individual site specic gene assay use standard microarray equipment treatment K site sample Quantitative specic technically straightforward large number costly instrumentation quire DNA bisulfite genomic sequencing determine methylation status cytosine region interest single dna molecule Singlenucleotide resolution reveal dna meth ylation pattern individual dna molecule intensive timeconsuming stricted sequence coverage profile determine methylation status cytosine nome chemical conversion unmethylated cyto sine uracil genomic DNA Singlenucleotide resolution full genome cover age comprehensive method nomewide prole dna methylation requires sequence full genome w15fold coverage cost antimethylated cytosine antibody methylate dna bind protein enrich methylate dna successfully use wide variety publish study technically accessible low resolution full genome cov erage efciency dependent density sizeselecte portion genome isolate striction enzyme digestion sequence sodium bisulte treatment Singlenucleotide resolution bias analyze cpg island lack full genome coverage CHARM Uses restriction enzyme specically cleave methylate DNA Quantitative Lacks full genome coverage Irizarry help compare relative representation MspI fragment individual locus Assays cpg island site quantitative lack full genome coverage Khulan MSCC Assesses methylation status recognition site methylationsensitive restriction enzyme high resolution restrict cpg island strictly quantitative indirect sessment methylation tecte unmethylate cpg site lack full genome coverage ball sodium bisulfite conversion use polymerase chain reaction pyrosequence sodium bisulfite genomic sequence full genome sequence cytosine methylate cytosine genomic DNA chemically convert uracil sodium bisulfite methylate cytosine resistant conversion detect various method table comprehensive list method use assay dna methylation CHARM com prehensive highthroughput array relative methylation help HpaII tiny fragment enrichment ligationmediated polymerase chain reaction HPLC highperformance liquid chromatography liquid chromatographymass spec trometry meDIP methylate dna immunoprecipitation medna methylate dna MIRA methylate island recovery assay MSCC methylationsensitive cut count reduce representation bisulfite sequence folate dna methylation SASKATCHEWAN advancesnutritionorg frequency dinucleotide rest nome region refer cpg island often correlate location gene particularly promoter region regulatory region island compose genome typically unmethylated fig mapping cpg island use tool gene discovery mammalian gene associate cpg island land originally define genomic region pair size content serve cpg defini tion somewhat arbitrary refine recently correlate closely promoter region regulatory region Fig functionally important region dna methylation cpg island shore region island contain low density cpg site show recent work location tissue specific differential methylation normal tissue Methylation cpg island shore correlate gene expression certain shore show alter methylation pattern colon cancer dna methylation demethylation role mechanism dinucleotide provide mechanism transmit dna methylation pattern ter dna replication perpetuate pattern epigenetic regulation subsequent cell generation Methylation figure dna methylation pattern different type genetic locus pattern change cancer response maternal diet cartoon hypothetical single section doublestranded DNA bar represent cpg site Methylated cpg indicate bar ball end green arrow indicate transcription start active transcription red equal gene silence numbered blue rectangle exon dna methylation pattern conducive transcription pattern set development genome target methylation dna methyltransferase dnmt3a DNMT3b cpg island region concentration often always associate promoter region gene cpg island generally think actively protect dna methylation allow appropriate regulation transcription dysregulation dna methylation see cancer posttransformation cancer cell aberrant dna methylation pattern overall dna methylation level reduce subset genetic site hypermethylate include tumor suppressor gene specific loci hypermethylate vary type tumor maternal diet change methylation level metastable epiallele change transcription neighboring region Metastable epiallele region genome variable methylation pattern semiheritable generation illustrate mouse model mouse maternal diet include additional methyl donor lead increase methylation metastable epiallele intracisternal particle retrotransposon change expression genetic locus permanent change phenotype distribution offspring sequence retrotransposon candidate methylation early embryo however extent become methylated varie genetically identical individual base maternal diet methyl donor well dietary factor recent study find candidate locus human genome show differential methylation dependent birth Crider SASKATCHEWAN advancesnutritionorg dinucleotide result symmetrically methylate cpg site methylation sequence strand DNA see however dna replication result daughter dna molecule become hemimethylated parental template strand main taine methylation newly synthesize strand lack methylation continue dna replication hemimethylated daughter molecule eventually result loss dna methylation pattern subsequent gen erations propose scheme dna methylation pattern cpg dinucleotide restore newly synthesize dna dna replication postulate hemime thylate cpg site generate dna replication specifically recognize maintenance DNA methyltrans ferase methylate cpg site newly synthe sized DNA strand immediately dna replication regenerate pattern symmetrically methylate cpg dinucleotide daughter cell maintain epige netic state pattern gene regulation exist parental cell dna methyltransferase dnmt refer identify demon strate predict hemimethylated DNA thus general mechanism widely cepte mechanism maintain dna methylation pattern dna replication cell division recent evidence suggest maintenance methyla tion alone sufficient fully perpetuate dna methylation pattern genomewide nonetheless maintenance dna methylation hemimethylated sub strate provide clear example mechanism allow transmission retention epigenetic information multiple cell generation postulate availability folate source methyl group affect ability maintain dna methylation pattern replicate cell Mammals type DNMT DNMT1 DNMT3a DNMT3b DNMT1 abundant dnmt cell previously describe believe act primary maintenance methyltransferase methylate hemi methylate dna dna replication preserve parental dna methylation pattern daughter cell contrast dnmt3b function novo methyltransfer ase methylate fully unmethylate cpg site function primarily mammalian development establish dna methylation pattern epigenetic remodeling ram proceed differentiation methylate different subset dna sequence genome evidence different phenotype mouse carry knockout methyltransferase methyltransferase also appear play role maintenance methylation fully preserve parental dna methylation pattern daughter cell dna methylation usually regard relatively stable epigenetic mark clear example dna demethylation mammalian cell occur absence dna replication cell division suggest existence mechanism active dna demethylation however study dna demethylation mechanism demethylation mammal still well understand mechanism passive dna demethylation involve inhibition loss mainte nance methylation cpg site multiple round dna replication cell division eventually result loss dna methylation site subsequent cell gen eration several mechanism active dna demethylation also postulate report none conclusively demonstrate potential mechanism tive demethylation involve direct removal methyl group cleavage highly stable bond however port demonstrate mechanism quently reproduce potential mechanism active demethylation involve base excision pair BER DNA event removal dna glycosylase activity enzymatic deamination thymidine formation mismatch case excise base replace unme thylated cytosine BER Nucleotide excision repair also report play role active dna demethylation study seem contradict mechanism recently appreciation notable level hydroxymethylcytosine present mam malian genomic DNA conversion DNA catalyze mammalian TET translocation protein generate interest possible role mechanism dna demethylation potential mechanism demethylation involve recognition removal replacement unmethy lated cytosine BER thus regard highly stable terminal epigenetic state dna methyla tion becoming increasingly view dynamic process genomewide methylation study port evidence increase decrease dna methylation differentiation finding variation dna methylation sex change methylation aging suggest interindividual variation variation dna methylation pattern previously expect mechanism gene silence dna methylation Methylation cpg island especially island colocal ize promoter regulatory region generally associate gene repression mechanism dna methylation silence transcription fully stand several mechanism propose First methylation specic regulatory dna sequence attendant insertion methyl group jor groove DNA prevent stable bind regula tory protein transcription factor sequence thereby directly prevent gene activation transcrip tion factor bind study identie transcription factor folate dna methylation SASKATCHEWAN advancesnutritionorg interaction cognate dna recognition sequence negatively affect methylation cpg dinucleotide bind sequence however many transcrip tion factor sensitive dna methylation dna sequence bind transcription factor contain dinucleotide therefore indirect mechanism also involve repre sing transcription dna methylation indirect mechanism DNAbinding protein contain methyl ate dnabinding domain methylate dna bind protein methyl cpgbinde protein methylate dnabinding domain recognize bind methylate cpg dinucleotide pro tein turn interact recruit transcriptional silence complex contain chromatin remodeling complex histone modification enzyme histone deacety lase act form transcriptionally repressive con dense chromatin structure associated gene dnmt also find component multisubu nit chromatin modify remodeling complex volve transcriptional repression suggest DNA methylation machinery also recruit spe cific gene mechanism similar cruit histone modification remodeling activity chromatin modificationremodeling DNA methyl ation act cooperatively silence transcription contrast intragenic dna methylation active gene often high promoter region suggest methylation body gene positive regulator gene expression recent study suggest occur suppress repressive effect polycomb complex sociate chromatin remodeling function dna methylation methylation hypothesize ancient component mune system design recognize inactivate parasitic viral dna sequence inltrate genome genome contain large proportion repetitive dna sequence nearly human genomic dna include retroviral sequence transposon transposon long interspersed element lines short terspersed element SINEs extended block tandemly repeat dna sequence satellite dna DNA methylation present mammalian genome sociate repetitive dna sequence serve suppress potential activity deleterious effect petitive DNA include suppress mobility propagation repetitive element capable transposi tion suppress illegitimate recombination lated repetitive element function serve prevent widespread genome instability rearrangement mediate repetitive dna sequence hypothesize time function dna methylation evolve play additional role clude transcriptional regulation chromosome tion imprinting tissuespecic gene expression Hypermethylation cpg island highly correlate transcriptional silence associated gene particularly cpg island associate gene promoter region clear example aber rant stable transcriptional silence certain tumor sup pressor gene cancer cell hypermethylation promoter cpg island however methylation cpg island necessarily lead gene silence example gene telomerase show activate methylation dna methylation also cur body gene gene func tion methylation cpg site region still poorly understand also clear methylation critical site island trigger hyperme thylation island gene silence level hypermethylation island govern silence mechanism contribute recently contrast cpg island methylation report indicate methylation body gene role positive regulator transcription also role transcription elongation alternative promoter use nucleosome positioning generally dna methylation thought maintain gene silence sus initiate gene silence gene silence initially mechanism silence stabi lize methylation associate regulatory region island promoter region chromosome inactivation process female mammal compensate unequal dose link gene male female cell Females randomly inactivate chromo some present somatic cell process occur early female embryogenesis result monoallelic expression gene subject chromosome inactivation female cell early embryogenesis run domly choose chromosome inactivate maternally paternally inherit chromosome totic progeny cell maintain inactivation chromosome remainder development adult tissue hallmark inactive chromosome hypermethylation promoter land length inactive contribute stable maintenance transcriptional silence associate gene inactive chromosome cpg island typically unmethylate active chromosome imprint mammalian epigenetic system monoallelic gene expression allele particular gene cell differentially regulate case parentorigin fashion thus imprint gene paternally inher ite allele express maternally inherit lele stably silence conversely imprint gene paternally inherit allele stably silence maternally inherit allele transcriptionally active differential monoallelic expression maternal pater nal allele usually associate differential dna methyl ation regulatory region gene Crider UNIV SASKATCHEWAN advancesnutritionorg call differentially methylate region generally always hypermethylate tran scriptionally silence allele hypomethylate press allele imprinting control region regulate imprint entire domain imprint gene typically differential parentorigin dna methylation pattern imprint gene estab lishe gametogenesis dna male male gamete acquire maternal paternalspecic methylation pattern fertilization parentorigin methylation pattern also continue develop postzygotically Supplemental Fig differential gametic methylation imprint maintain propagate subsequent somatic velopment facilitate parentorigin pattern monoallelic transcription associate imprint gene imprint gene think comprise small proportion mammalian genome currently confirm human mouse human limit number know imprint locus subset share mouse however recent study imprint embryonic adult mouse brain find parentorigin bias expression gene transcript isoform confirm suggest imprint parentorigin effect wide spread complex originally believe Reprogramming dna methylation pattern development differentiation dna methylation pat tern undergo remodeling course mammalian differentiation development eventually generate cell typespecific methylation pattern find adult matic cell dynamic change methylation particularly pronounce gametogenesis early embryogenesis Supplemental Fig course gametogenesis dna methylation pattern erase demethylated develop germ cell primordial germ cell remethylate reset genomic dna meth ylation pattern specific sperm egg metogenesis proceed process particularly important establish gametespecific methylation pattern imprint gene sperm egg fertili zation current datum suggest nonimprinte locus also subject least partial erasure reset dna methylation pattern gametogenesis early embryogenesis dna methylation pattern also undergo genomewide process erasure mouse embryogenesis begin shortly fertilization continue blastocyst stage wave demeth ylation erase methylation pattern gamete follow DNA remethylation remain course embryogenesis establish genomewide celltype specific dna methylation pattern find fully differentiate adult somatic cell small study human embryo show wave demethylation cell stage follow remethylation beginning early late morula important exception dynamic reprogramming dna methyl ation pattern embryogenesis occur imprint gene escape process erasure resetting thereby maintain embryogenesis differ ential dna methylation paternally maternally herited allele somatic cell characteristic imprinted locus period dynamic reprogramming dna meth ylation pattern gametogenesis embryogenesis also present window opportunity environmental inuence diet nutrition develop bryo alter normal process establish dna meth ylation epigenetic pattern change dna methylation pattern affect normal pattern gene expression alter genome stability thereby lead increase risk disease later life even change methylation occur subset cell give tissue also possible alter dna methylation level pattern intact mammalian cell treatment various chemical inhibitor commonly ana log ribonucleotide analog azacytidine functions deme thylate agent result hypomethylation nome treat cell cytidine analog drug recently introduce potential therapeutic agent treatment human disease particularly myelodysplastic syndrome change dna methylation reect Hypermethylation hypomethylation cpg site single dna molecule methylate unmethylate level methylation site ther however single diploid cell methylation level give cpg site strand dna symmetrically unmethylate chro mosomes symmetrically methylate chromo unmethylate chromosome often see imprint gene symmet rically methylate chromosome DNA methyla tion assay usually perform population cell therefore level methylation give cpg site assay reect collective methylation site multiple cell multiple dna molecule var iation methylation see individual site thus nde particular site methylate population cell mean site methyl ate cell allele methylate allele unmethylate site unmethylate cell population fully methylate cell combination methylation level cell population yield composite meth ylation level different functional consequence different scenario important consider implication change centage methylation specic site dietary condition important consider folate dna methylation SASKATCHEWAN advancesnutritionorg change dna methylation level site distribute entire population cell appreciably affect transcription reect change subpopulation cell represent gene silence tivation cell something potential scenario different implication impact change methylation level case cpg island gene silencing generally sociate multiple methylate cpg site strand DNA however sitespecific methylation sult gene silence methylate cpg block bind ing dna methylationsensitive transcription factor genetic locus unknown cpg site many strand DNA methylate lence give gene evaluate impact change dna methylation important consider exact cation assay potential methylation site region change gene expression biological pro cesse interest part folate dna methylation Folate role carbon metabolism relate dna methylation normal dietary condition absorb folate metabolize methyltetrahydrofolate meth ylTHF monoglutamyl form intestine liver MethylTHF primary folate constituent take nonhepatic tissue polyglutamate cellular retention carbon cycle coenzyme function effective substrate polyglutamate synthetase therefore methylTHF convert methionine synthase reaction folic acid consume fortify food supplement metabolize primarily methylTHF intestinal absorption first pass liver ter behave identically natural dietary folate Folic acid normally first reduce dihydrofolate dihydrofo late reductase subsequently enter folate pool Fig case capacity dihydrofolate ductase exceed folic acid appear tion oxidize form coenzyme form folic acid dietary folate first con verte methyleneTHF vitamin dependent enzyme subsequently irreversibly reduce reaction key main taine flux methyl group remethylation homocysteine methionine vitamin dependent methionine synthase reaction methionine substrate cofactor methyl group donor merous methylation reaction include methylation DNA rna neurotransmitter small molecule phospholipid protein include histone num ber samdependent reaction regulatory role affect genome stability gene transcription calization protein small molecule degradation addition folate number dietary nutrient require maintain carbon ux ensure normal homocysteine remethylation SAM formation dna methylation nutrient include vitamin activity riboavin MTHFR sta bility vitamin methionine synthase function choline betaine precursor hepatic methyl source taine homocysteine methyltransferase carbon pathway thus DNA methylation func tion tight regulatory control SAM major folatedependent homocysteine remethylation potent inhibitor MTHFR con dition high inhibit reduce synthesis methylTHF hence methylation homocysteine conversely con low remethylation homocysteine favor MTHFR activity thus methylthf formation also modie common genetic variant reduce enzyme activity also rec ognize adenosylhomocysteine function potent product inhibitor methyltransfer ase reason continual hydrolysis SAH homocysteine essential maintain normal dna methyl ation moderate elevation plasma homocysteine concentration report associate creased concentration SAM increase concentration associate global DNA pomethylation low folate status dna methylation low folate status dene various measure include blood folate con centration folate intake folic acid intake associate increase risk cardiovascular disease multiple cancer neural tube defect mechanism low folate status contribute disorder remain unclear dna replication folate depletion destabilizing consequence inadequate folate availability cell division result com promise production thymidine uracil substitute DNA sequence mutagenic event trigger attempt repair defect increase frequency chromosomal break tissue cul ture show low folic acid result mation micronucleus indicative chromosome breakage MTHFR genotype lead increase micro nucleus formation low folate condition dna methylation cancer folate Global hypomethy lation targeted hypermethylation consider den ing characteristic human tumor Fig dna methylation pattern widely dysregulate human cancer Fig early study dna meth ylation genomewide hypomethylation find tumor tissue compare match healthy tissue tionally gene find hypermethylate nonrandom pattern specific type tumor determine change dna meth ylation tumor result silence tumor suppressor gene chromosome instability SASKATCHEWAN advancesnutritionorg Hypomethylation repetitive element predictive increase risk cancer increased mortality cancer recent largescale dna methylation study multiple type primary tumor thousands loci tumor dna methylation change tumor associate concomitant change gene expression tumor characteristic dna methylation change cancer appear random mor specific cell lineage show similar dna methylation change distinct tumor type normal tissue tumor increase severity progressive number locus show increase dna methylation primarily cpg island decrease dna methylation noncpg island site magnitude dna methylation change serve cancer tissue substantially great dif ference dna methylation type normal tissue Folic acid intake report prevent loss het erozygosity tumor suppressor gene small supple mentation trial human folate depletion human tissue culture cell result expect global hypomethylation also target hyper methylation cadherin locus unclear increase dietary folate folic acid result change healthy tissue predispose carcino genesis many study effect folic acid supplemen tation focus prevent promote cancer especially colon cancer Supplemental Table Studies cancer patient folate status global dna methylation great interest rever ing epigenetic change see early tumorigenesis global hypomethylation rapidly divide tissue tumor susceptible low folate availability result global hypomethylation clinical trial examine impact folic acid supplementation global dna methylation colon cancer patient plemental table study show dna methylation biomarker colorectal cancer methylation dna colon leukocyte increase supplementation folic acid human patient observational study cohort casecontrol association folate status measure acid intake blood folate con centration cancer study examine global DNA methylation level Supplemental Table study association find cancer global dna hypomethylation circulate blood tumor tissue however consistent association tween global DNA methylation folate status intake blood folate study lack defini tive association low folate status global DNA pomethylation due limited sample size imprecision assay study outline supple mental Table global hypomethylation find tumor even normal colon cell blood cancer patient association global hypomethylation folate status intake blood folate concentration consistent study cancer patient Supplemental Table unexpected give variety study design different global dna methylation assay type tissue examine many technique available assess global dna methylation level include look repetitive element methylation level line Alu examine various restriction site genome however correlation measure actually quite low neces sarily due accuracy measure due fact think global tually measure different type subset dna quence disparate region genome regulate differently indeed recent work suggest different change dna methylation type tumor type repetitive dna element often use proxy global methylation additionally early trial global dna methylation colon cancer patient use methyl acceptance assay assay provide estimate global dna methylation use enzyme methylate purify genomic dna radiolabeled tritium Methyl acceptance limited precision necessitate intact dna use damage dna occur result outcome interest preparation handling result inaccurate result careful consideration say methodology critical study design ensure appro priate interpretation reproducibility datum Studies cancer patient folate status site specic dna methylation patient previous adenoma colon date trial examine fect folic acid supplementation site specic dna methylation limited loci tumor methylation tumor suppressor land generally fully methylate silence methylate unmethylated methylate depend exact location site change dna methylation observe association variation red blood cell folate concentration human much small present tumor evaluate dna methylation level cpg islandcontaine gene colon tissue person previous adenoma placebocontrolle folic acid supplementation trial find trend great methylation genetic locus quintile folate increase low folate quintile high folate quin tile methylated trend SFRP1 methylate methylated trend statistically significant functional impact small change dna methylation gene transcription long term health outcome unclear time association dna methylation locus folate dna methylation SASKATCHEWAN advancesnutritionorg treatment folic acid plasma folate concentration dietary folate intake age pro tein intake race strongly associate dna methylation locus study statis tically significant association methylation locus hyperplasic polyp adenoma treatment additional observational study cancer examine DNA methylation folate status examine dna methylation genetic locus find high plasma folate concentration case associate creased methylation p73 p16in4a hMLH1 Christensen recently examine cohort woman breast cancer DNA methylation level site gene find dietary folate take associate DNA methylation class member ship primary breast tumor type study examine thousands locus simultaneously likely pro duce well understand interaction dna methylation folate substantial analytic challenge exist important note low folate status lead hypo hypermethylation result misregula tion complex system change observe cer appear random cpg island susceptible hypermethylation change appear precede transformation initiation cancer other consequence transformation time unclear sub set genetic locus susceptible dna methylation change response folatefolic acid intake cancer tient study highlight Supplemental Table show number locus warrant examination future study largescale genomewide analysis provide additional candidate study healthy adult folate status healthy adult divide tissue blood gut mucosa likely susceptible low folate diet human study examine effect control folate depletion repletion global dna methylation leu kocyte Supplemental Table Folate depletion result reduction global dna methylation old woman control feeding study find observe young male adult Shelnutt observe considerable increase methylation folate intake repletion period study increase limit MTHFR genotype see location folic acid cycle Axume find dna methyla tion change response depletion repletion however study restrict MTHFR gen otype result control feeding trial healthy adult somewhat inconsistent study limit small sample size individual group difference age group different initial folate vary length intervention additional observational study examine global dna methylation folate status patient cer Supplemental Table Friso find MTHFR genotypedependent association tween low global dna methylation low plasma late concentration Pufulete observe trend low dna methylation low serum folate concentration take together finding suggest differential global dna methylation sponse folate depletion repletion dependent age genotype duration magnitude exposure none study healthy adult examine sitespecific dna methylation change however study man hyperhomocystinemia global hypomethylation reverse monoallelic expression imprint gene store patient give folic acid therapy supple mental Table Changes dna methylation response environment diet importance developmental timing exposure increase evidence variation variation dna methylation pat tern life span previously expect change modulate environmental posure dna methylation vary sex change age addition increase number environmental exposure human air pollution benzene exposure late pollution link change dna methylation repetitive element hypomethylation adult furthermore find estrogen replacement result lower plasma homocysteine concentration increase global methylation small postmenopausal woman doubleblind placebocontrolle doublecrossover study change methylation find erb p16 gene thus certain environmental exposure associate change dna methylation change carbon metabolite increase interest utero effect environmental exposure toxin nutrition longterm health outcome hypothesize disease risk part determine maternal paternal diet Studies cancer find change dna methylation blood reect cancer risk tissue interest divide tissue suscep tible insult change result predisposition cancer happen embryonic riod reecte many tissue Supplemental Fig mouse clear maternal dietary change carbon availability affect DNA methylation pattern phenotype offspring beststudied example mouse mouse strain insertion intracisternal particle sequence upstream SASKATCHEWAN advancesnutritionorg region gene encode paracrine signal molecule gene strain regulate promoter activity increase availabil ity methyl donor mother diet pregnancy result increase dna methylation notypic change associate altered regulation gene offspring recently find locus human genome also act metastable epiallele similar locus mouse show differential methylation sponse season birth small human study study identity causative agent change dna methylation unclear pool methyl donor supply mouse model multiple dietary factor alter small human study effect dietary compone",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 215,
                    "epigenetic": 12,
                    "demethylation": 14
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Shellnut": 1,
                    "Methylsensitive": 1,
                    "Southern": 1,
                    "methyltrans": 1,
                    "SINEs": 1,
                    "statis": 1,
                    "Pufulete": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "Shellnut": 241,
                    "Methylsensitive": 241,
                    "Southern": 241,
                    "methyltrans": 241,
                    "SINEs": 241,
                    "statis": 241,
                    "Pufulete": 241
                },
                "Ethnographic Terms": {
                    "methylation": 7,
                    "epigenetic": 7,
                    "demethylation": 7
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Global methylation profiles in DNA from different blood cell types.pdf",
            "cleaned_text": "article publisher Wales Registered Number registered office W1 Epigenetics Publication detail include instruction author subscription information global methylation profile dna different blood cell type DelgadoCruzatab Maya Kappilb Regina Epidemiology Mailman School Public Health Columbia University New York USA Department Environmental Health Sciences Mailman School Public Health Columbia University New York USA Columbia University publish online Jan cite article Maya Yuyan Terry Global methylation profile dna different blood cell type epigenetic epi link article PLEASE SCROLL ARTICLE make effort ensure accuracy information contain publication platform however agent licensor make representation warranty whatsoever accuracy completeness suitability purpose opinion view express publication opinion view author view endorse accuracy rely independently verify primary source information liable loss action claim proceeding demand cost expense damage liability howsoever cause arise directly indirectly connection relation arise use article use research teaching private study purpose substantial systematic reproduction redistribution resell loan sublicense systematic supply distribution form anyone expressly forbid Terms Conditions access use find wwwtandfonlinecompagetermsandcondition epigenetic January Landes Bioscience RESEARCH PAPER Epigenetics Volume issue correspondence Email mt146columbiaedu submit Accepted previously publish online epi introduction DNA methylation epigenetic modification mark genomic DNA create addition methyl group carbon position cytosine predominantly cpg sequence context change dna methylation pattern include global demethylation localize hypermethylation promoter cpg island region gene common molecular alteration tumor Global demethyl ation see human cancer tissue include breast gastric colon6 prostate Lower level genomic tion WBC DNA also observe head bladder9 cancer case relative control animal model aberrant global methylation lead increase mutation rates10 chromosomal instability instability also correlate global dna demethylation human colorectal cancer tissue dna methylation measure white blood cell dna increasingly use study cancer susceptibility however little known correlation different assay measure global methylation source dna matter examine methylation profile different blood cell type use information woman woman dna available granulocyte total white blood cell respectively woman DNA available different source mononuclear lymphoblastoid cell line compare dna methylation repetitive element methyl acceptance assay assay dna methylation level measure correlate methylation WBC exception sat2 dna methylation correlate methylation methyl acceptance Alu assay Methylation correlate methylation methyl acceptance LUMA assay compare assay source dna observe statistically significant correlation range cell type exception Alu woman stratify dna source correlation assay high repetitive element range result LUMA assay modestly correlate result suggest assay source dna critical component interpretation global dna methylation pattern methylation profile dna different blood cell type Maya Yuyan Santella2 Terry1 1department Mailman School Public Health Columbia University 3Herbert word methyl acceptance assay Alu dna demethylation epigenetic Breast Cancer Family Registry DPM disintegration minute Gran granulocyte HPLC high performance liquid chromatography lymphoblastoid cell line long intersperse nucleotide element assay m5c methylcytosine mononuclear SAM adenosylmethionine sat2 satellite short interspersed nucleotide element white blood cell repetitive element consist interspersed repeat tandem repeat comprise human genome contain much cpg methylation find normal human postnatal somatic tissue Short interspersed nucleotide ele ment SINEs long intersperse nucleotide element lines together account least human genome repeat plentiful SINEs human dna comprise human genome endogenous mobile genetic element accumulate human genome constitute least total human genome DNA sequence locate tandem repeat several chromosome compose variant tandem repeat follow copy loss dna meth ylation sequence think largely account global demethylation characterize large percentage human cancer wwwlandesbiosciencecom Epigenetics RESEARCH paper research paper respectively global methyl ation DNA also correlate correlation coefficient similarly use observe statistically significant correlation dna spearman correlation coefficient table report withinindividual Spearman correlation coefficient source dna subject methyla tion level DNA correlate DNA spearman correlation coefficient respectively Alu methylation level also correlate DNA sat2 methylation Gran statistically significantly correlate DNA correlation dna methylation assay blood cell table report withinperson correlation marker global dna methylation methyl acceptance assay source dna level methyl acceptance assay correlate methyla tion level DNA inversely correlate dna level methyl acceptance assay correlate percentage methylation assay loci methylation correlate sat2 methylation dna source spearman correlation ficient Gran LCL respectively methylation also correlate Alu methylation Gran LCL DNA spearman correlation ficient respectively Alu global DNA methyla tion level also correlate spearman correlation coefficient Gran LCL respectively Alu level correlate cell assess correlation subject level overall inference materially change exclusion datum show table report rank correlation marker global dna methylation separately dna source individual source dna available total WBC Consistent individual result report table correlation dna methylation measure methyl acceptance assay repetitive element sat2 methyl acceptance assay level positively correlate LUMA level Gran level LUMA correlate Spearman correla tion coefficient respectively sat2 methylation correlate WBC Global DNA methylation level measure repetitive ele ment positively correlate DNAs also estimate spearman correlation comparison table adjust age breast cancer status smoking status partial correlation coefficient repeat measure use realtime pcr assay significantly associate global dna methylation measure HPLC quantitation methyl cytosine m5C combine measurement Alu sat2 methylation also correlate global dna methylation measurement contract assay measure meth ylation particular repetitive element surrogate marker estimate global methylation level global dna methylation also measure directly commonly use method determine genomic methylation level methyl acceptance refer methyl acceptance methyl acceptance assay base ability bacterial methyltransferase sssi transfer radiolabele methyl group methyl adenosylmethionine specifically unmeth ylate cpg site DNA LUMA base digestion genomic dna methylation sensitive insensitive restric tion enzyme follow quantification result num ber cut site use pyrosequence measure genomic methylation blood cell DNA use phenotypic marker genomic instability potential cancer risk however information global methylation profile different blood cell type addi tion various method measure global dna methylation include hplc methyl acceptance assay LUMA assay study directly com pare method use biospecimen site BCFR measure methylation level use methyl acceptance assay MethyLight assay Alu evaluate correlation assay dna source vidual individual source dna use peripheral blood dna set lym phoblastoid cell line DNA result Methylation level different blood cell type figure report overall distribution mean median interquartile range cell type assay subject DNA multiple source level methyl acceptance DNA statistically significantly high individual cell type Fig contrast LUMA assay Fig global dna methylation measure low cell type methyla tion high aver age global dna methylation overall distribution Alu methylation significantly different cell type dna respectively Table report withinperson correlation global methylation measure use methyl acceptance assay LUMA source DNA global methylation DNA statistically significantly associate Spearman correlation coefficient Epigenetics Volume Issue sat2 correlate global dna methylation level measure methyl acceptance LUMA assay datum show spearman correlation coefficient combine methylation Alu sat2 respectively materially different adjustment overall inference datum shown also perform supplemental analysis examine combine measure methylation alu sat2 highly correlate global dna methylation single measure combined measure Alu figure Box plot withinperson DNA methylation level use methyl acceptance LUMA assay source DNA wwwlandesbiosciencecom epigenetic methylation profile however subset gene region differentially methylate source large difference methylation profile localize area low density consistent finding compare cell type low methylation level measure see measure correlate cell type observe low methylation level repetitive element contain much methylation Alu element measure correlate result suggest interested level Alu repeat methylation DNA serve valid rogate tissue contrast level methylation Gran statistically significantly correlate DNA sequence small tandem repeat locate juxtacentromeric region chromosome therefore represent different set cpg site Alu element explain different result find different element fact difference level global dna methylation different cell type unexpected study show main type Gran neutrophil gene expression profile find signifi cantly different monocyte alter gene expression discussion Withinindividual variability blood dna methylation level cell type Overall observe strong withinperson correlation assay measure global dna methylation methyl acceptance compare assay global dna methylation level measure uncorrelated measurement exception sat2 global dna level correlate method measure direct global dna methylation level methyl acceptance LUMA assay meth ylation level statistically significantly correlate individual divide category granulocyte mononuclear cell include lym phocyte monocyte result suggest global dna methylation level well representation level find Gran LCL lymphoblastoid cell line obtain viral EBV transformation lymphocyte cell concern utility resource methylation study likely transformation process extend replication capacity cell global dna meth ylation level decrease study compare dna methyla tion profile individual find majority gene similar correlation coefficient global dna methylation measure use methyl acceptance assay LUMA source DNA methyl acceptance Gran LCL LCL WBC Table Withinperson correlation global methylation measure assay source dna assay Gran LCL Gran LCL Gran LCL LCL Epigenetics volume issue explain lack correlation methyla tion individual global dna methylation assay observe substantial heterogeneity global DNA methylation level assay type assay methyl acceptance assay high value indicate global dna meth ylation methyl acceptance assay SssI methylase presence specifically catalyze transfer methyl group SAM cytosine residue cpg sequence ability dna incorporate methyl group vitro inversely relate endogenous dna methylation compare dna methylation level measure liquid chromatographytandem mass spectrometry methyl acceptance assay conclude assay good dna methylation status specific sequence also find correlate neutrophil count suggest dif ferent cell type alternative way regulate expression genome evidence support presence differential methylation pattern different blood cell subset readily explain result dna methylation correlate closely methylation expect represent large propor tion cell blood correlate DNA methylation profile however study use phils highlight effect infection inflammation expression profile cell therefore possible epigenetic mechanism involve response neu trophil infection cellular stress help spearman correlation coefficient marker global methylation measure methyl acceptance assay source DNA Source Marker Methyl acceptance Sat2 Sat2 Alu LCL luma LINE1 Sat2 Sat2 Alu Sat2 measure methylation cpg sequence genome measure methylation sequence account genomic site thus study need establish appropriate indicator global methylation level methylation level LINE1 Alu strongly correlate Correlations consistently find overall study population withinindividual sample correlation methylation Alu element report previously however percentage methylation repetitive element mea sure MethyLight assay correlate methyl acceptance assay lack correlation MethyLight methyl acceptance datum unexpected different technique provide information dna methylation differ ent level span genomewide methylation content methylation set specific site specific region repetitive element however methylation correlate large sample set consistent datum Limitations relate assay also explain variability overall correlation assay make bulk estimate methyla tion repetitive elements21 bisulfitetreated DNA use directly template standard pcr reaction major limitation bisulfite treatment prone reaction artifact affect reliability extent reaction easily measure incomplete con version cytosine uracil common incomplete denaturation dna template partial renaturation ing bisulfite treatment dna degradation due partial long incubation result extensive damage template sequence subsequently agreement simplicity methyl acceptance assay prone number technical problem batch variation considerable primarily due instability variation SssI methyltrans ferase activity account variability use batch fresh sam enzyme set run DNA different source set use batch fresh sam enzyme measure second large set sample however find different result set sample large sample size show less consis tent result probably result batch variability problem highlight need assay easy perform reliable study dna methylation large population study addition methyl acceptance assay also highly sensitive dna amount difficulty dissolve genomic dna lead inaccurate dna concentration measurement quantify dna reaction use double strand dna quantification reagent LUMA global measure methylation use distinctive enzymatic restriction cleavage isoschizomer Hpall MspI Cleavage sequence enzyme dependent methylation internal cytosine Therefore LUMA reflect overall contribution specific set m5c include cpg island region addition require good quality DNA even partially degraded sample bias measurement dependence enzymatic activity variation also possible difficulty assay however find sample completely digest validation experiment LUMA m5c publish date methyl acceptance assay LUMA measure global dna meth ylation level entire genome lack association assay methyl acceptance assay Table spearman correlation coefficient marker global methylation measure methyl acceptance assay source DNA Source Methyl acceptance LUMA LINE1 Sat2 Sat2 Alu total Sat2 Epigenetics volume issue measure content directly result suggest cell type matter methylation study effect method collection time blood draw processing freezing storage condition affect integrity m5c dif ferent source DNA use method extract dna different cell type addition protocol blood collection processing storage dna extraction apply specimen study comparison individual associa tion explain factor fix individual cancer status smoking age diet example even dietary pattern influence methyla tion withinindividual comparison diet smoking tus cancer status age explain correlation cell type large study single source dna possible cancer status age diet smoking affect dna methylation level sample collect fast study suggest shortterm folate restriction sufficient modify methylation content leukocyte dna however able adjust individuallevel factor large study adjustment affect inference correlation assay type summary study highlight importance use source blood dna measure global methylation also find difference assay global dna meth ylation level suggest use different technique sure change m5c affect interpretation datum molecular epidemiologic study result methyl acceptance assay correlate endpoint phenotype multiple method need study association environmental expo sure global dna methylation profile Materials Methods study participant study population select family participate site BCFR site BCFR recruit high risk breast ovarian cancer family cancer clinic area eligible participate family least follow female relative breast ovarian cancer diagnose female relative breast ovarian cancer regardless age diagnosis relative breast ovarian cancer diagnose male breast cancer diagnose age family member known BRCA mutation con sente family member ask complete epidemiologic questionnaire collect information demographic ethnicity smoke alcohol consumption reproductive tory hormone use weight height physical activity dietary intake also complete extensive family history pedigree family collect blood participant time recruitment permit isolation plasma white blood cell fraction specifically collect blood sample difficult amplify account limitation bisulfite treat DNA different cell type set use incubation time withinperson comparison set however track bisulfite batch determine influence correlation person large study limitation site primer probe bind region methylate detection limitation partially explain modest correlation assay use study unclear methyla tion level locus different percentage methylation level cent recently measure methylation several commercial sample methylate dna find around methylated well know population polymorphic presence element human genome contain truncate ele ment datum methylation repetitive element DNA assay limit however datum consistent study use dna tumor mal tissue limitation method several important advantage include quantitative format highthroughput nature assay minimal dna requirement dna methylation measurement epidemiologic study repertoire methylation screen methodology expand widely different approach use estimate genomic methylation single technique fulfill criterion generate unambiguous datum methylation present study find good correlation methylation locus consistent fact dna meth ylation typically occur cpg dinucleotide cpg dinucleotide occur repetitive sequence know m5c lie retrotransposon sequence include satellite repeat line also find correlate sat2 methylation LINE1 methylation Gran suggest ing particular repetitive element serve surrogate marker estimate global dna methylation level measurement biomarker blood specimen become integral component many epidemiologic study widespread interest explore association genomic m5c content clinical outcome well environmental lifestyle dietary exposure study suggest global dna methylation level decrease time thus role endogenous exogenous factor change global dna methylation level support various method study DNA meth ylation genomewide scale epidemiologic study conduct large population focus methyl acceptance luma42 assay whole blood blood fraction comprise major portion biospeciman collection epidemiologic study present study find methylation level Gran DNA correlate DNA methylation level correlate assay wwwlandesbiosciencecom Epigenetics MethyLight reaction perform duplicate value represent mean methyl acceptance assay methyl accep tance assay carry describe DNA incubate adenosylmethionine presence SssI prokary otic methylase enzyme indiscriminately methylate unmethylate cpg sequence therefore ability dna incorporate methyl group vitro inversely relate endogenous dna methylation briefly DNA incubate SssI methylase mol Ci label adenosylmethionine EDTA trishcl mixture incubate reaction terminate ice reaction mixture apply Whatman DE81 filter paper filter wash vacuum filtration apparatus time mol sodium phosphate buffer follow ethanol dry filter place vial scintillation fluid analyze scintillation counter dna sample process cate processing run include sample background reaction mixture component SssI enzyme universal methylated unmethylated dna positive negative control respectively methyl acceptance assay quality DNA sample reproducibility dna concentration measure major factor determine inter intraassay variability pool sample dna control use quality control batch test sample Intra interassay respectively quantify amount doublestrand DNA reaction aliquot dna use determine dna concentration use PicoGreen blestrand DNA quantification reagent Molecular Probes disintegration minute value express DNA quantify laboratory investigator perform assay blind epidemiologic data LUMA assay carry describe previously DNA cleave HpaII EcoRI mspi ecori separate reaction contain Trisacetate acetate acetate unit restriction enzyme reaction set well mat incubate anneal buffer Trisacetate acetate add cleavage reaction sample place system follow dispensation order calculation peak height dispensation use cut peak height Dispensations use assess quality digest DNA cut value use peak height correspond dispensation value high indicative sample low quality dna use assay percentage dna methylation express HpaII EcoRI mspi EcoRI interassay granulocyte mononuclear cell fraction collect centrifugation study approve write informed con send obtain subject strict quality control safeguard use protect confidentiality beginning study store dna multiple source specifically use sample subject breast cancer case unaffected sister different source white blood cell WBC granulocyte Gran mono nuclear lymphoblastoid cell line DNA available investigate withinperson correlation methyla tion marker addition also use sample woman Gran case unaffected sister total case unaffected sister single source dna investigate correlation global DNA methylation marker dna extraction bisulfite treatment extract genomic dna cell salt procedure cell lyse SDS nucleus lysis buffer treat final final unit remove RNA Proteins coprecipitate saturate NaCl add solution centrifugation Genomic DNA recover supernatant precipita tion ethanol wash ethanol dissolve TrisEDTA buffer assay aliquot DNA bisul fitetreate DNA methylation kit convert unmethylated cytosine uracil leave methylated cytosine unmodifie DNA resus pended distil water store use assay sodium bisulfite conversion carry use follow forward reverse primer probe refer manuscript respectively describe PCR perform reaction volume forward reverse pcr primer probe MgCl2 use follow PCR program min cycle follow min Standard curve Alu repeat control reaction generate serial dilution bisulfiteconverte universal methylate unmethylated dna pool sample dna control use quality control analyze batch test sample Assays run ABI Prism Sequence Detection System Perkin Elmer Foster City Intra interassay coefficient vari ation cv respectively Methylation calculation methylate dna serve methylate control reaction Alu use control reaction measure level input dna normalize signal methylation reaction data specific methylated repetitive element express percent methylate value target gene sample control gene sample methylate target sample control gene sample Epigenetics volume Issue also explore combine measure correlate global dna methylation level measure methyl acceptance assay analysis perform software ment work support award grant CA69398 P30 CA13696 P30 ES009089 work also support cooperative agreement member CFR content manuscript necessarily reflect view policy collaborating center mention trade name commercial product organization imply endorsement Government CFR statistical method use correlation coefficient estimate withinindividual correlation source dna assay table cell type Gran LCL estimate pair wise Coefficients respond confidence limit analysis do separately global dna methylation assay compare assay use correlation coefficient separately stratify cell type analysis individualspe cific information cancer type smoking history age individual adjust factor large study single source dna compare assay sepa rately Gran analysis examine overall correlation coefficient well par tial spearman correlation coefficient adjust age cancer status smoking history supplemental analysis repression science DNA methylation cancer pattern dna methylation chromatin formation gene expression cancer DNA methylation pattern hereditary human cancer mimic sporadic tumorigenesis Suzuki DNA demethylation gastrointestinal cancer age dependent precede genomic damage cancer cell Hypomethylation DNA benign malignant human colon neoplasms science Seifert hypermethylation specific gene prostate carcinoma precede line hypomethylation cancer Eddy Furniss McClean Global DNA methylation level whole blood biomarker head neck squamous cell carcinoma cancer epidemiol biomarker Prev Moore Kogevinas silverman genomic dna hypomethylation biomarker bladder cancer susceptibility casecontrol study dna hypomethylation lead elevated mutation rate Nature Eden Gaudet Waghmare Jaenisch Chromosomal instability tumor promote dna hypomethylation science instability corre late genomewide dna demethylation human primary colorectal cancer cancer res initial sequencing analysis human genome Nature substantial fraction human regulatory sequence transposable element Trends Genet Batzer element mammalian genome evolution lines art bite hand feed Kazazian Mobile element driver genome evolution science Jeanpierre Human satellite DNA methylation cancer much also little dna methylation analysis tech nique Biogerontology Long Kim Woods Fiala Analysis repetitive element res David Methyl group accep tance assay determination global dna meth ylation Levels Methods Mol Biol Dan high throughput method analysis genomic dna methylation Knight infrastructure cooperative multinational inter disciplinary translational study genetic epidemiology breast cancer Breast Cancer Res Balaghi Wagner DNA Methylation Folate deficiency use cpg Methylase Biochem Biophys Res Commun methylation peripheral blood leukocyte dna influence arsenic folate adult Intraindividual change dna methylation time familial cluster sadli comparative analysis dna methylation profile peripheral blood leukocyte lymphoblastoid cell line Epigenetics Subrahmanyam yvbk rna expression pattern change dramatically human neutrophil expose bacteria blood Sharma Sahni Tibshirani Berghagen early detection breast cancer base geneexpression pattern peripheral blood cell Breast cancer res Gene expression mature phil early response inflammatory stimulus Biol DNA methylation determination liquid chromatographytandem mass spectrometry use novel biosynthetic ycytidine internal standard Nucl Acids res Oakeley dna methylation analysis current methodology Pharmacol Ther Brandenburg Jeddeloh Comprehensive highthroughput array relative methylation CHARM cancer res Yoo Moon cpg island locus hypomethylation line Alu repeat prostate adenocarcinoma relationship clinicopatho logical feature Pathol increase dna methylation patient myelodysplastic syndrome Leukemia bisulfite method mapping minimize template degradation Anal Biochem MRH simple method estimate global dna methylation use bisulfite pcr repetitive dna element Nucl acids res Paz Ropero Epigenetic difference arise lifetime monozygotic twin Genomic DNA methylation woman multiethnic birth cohort cancer epidemiol biomarker Prev DNA methyla tion analysis Metab Care Dan high throughput method analysis genomic dna methylation wwwlandesbiosciencecom Epigenetics vivo methylation capacity impair healthy man shortterm dietary folate methyl group restriction Axume Smith MTHFR 677TT genotype folate intake interact low global leukocyte dna methylation young Mexican american woman dna methylation diet cancer Moderate folate depletion increase plasma homocysteine decrease lymphocyte DNA postmenopausal woman Pogribny Moriarty leukocyte dna methylation similar African American Caucasian woman condi tions control folate intake Epigenetics",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 139,
                    "epigenetic": 6,
                    "demethylation": 6
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "SINEs": 2,
                    "methyltrans": 1,
                    "HpaII EcoRI": 2,
                    "Mexican": 1,
                    "African American": 1,
                    "Caucasian": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "SINEs": 151,
                    "methyltrans": 151,
                    "HpaII EcoRI": 151,
                    "Mexican": 151,
                    "African American": 151,
                    "Caucasian": 151
                },
                "Ethnographic Terms": {
                    "methylation": 8,
                    "epigenetic": 8,
                    "demethylation": 8
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Guar gum methyl ethers. Part I. Synthesis and macromolecular characterization.pdf",
            "cleaned_text": "guar gum methyl ether Part Synthesis macromolecular characterization Crescenzi Department Chemistry University Rome Sapienza receive receive revise form accept available online gum partially methyletherie heterogeneous reaction condition result product methyl ether guar different degree substitution characterize mean viscosity nmr ftir measurement introduction methoxyl group polysaccharidic chain reduce hydrogen bonding site guar backbone reduce primarely extent hydrogen bonding guar macromolecule hence aggregation tendency comparative analysis parameter characteristic ratio sample aqueous solution carry use Fixman method exible semiexible chain chain exhibit exibility native guar gum traceable disruption bond right reserve Guar gum Methyl ether guar Solution property Introduction Guar gum watersoluble polysaccharide extract seed leguminous shrub gonaloba act food water reservoir belong galactomannan family structure show Fig consist link mannopyranose backbone random branchpoint galactose unit link galactopyranose residue gum possess high level galactose substitution backbone approximately average mannose residue galactose residue nonsubstituted region widely use many industrial sector oil recovery food personal care owe ability produce highly viscous pseudoplastic aqueous solution even low concentration due high molecular weight typical polysaccharide mda presence extensive chain hyperentanglement promote hydrogen bonding however native sample dissolution water give rise much insoluble residue depend gum purity residue likelyhood compose heavily intertwine polysaccharide chain protein ashe together tendency form aggregate solution undesirable characteristic commercial application synthesis derivative well know carboxymethyl obviate say problem quite naturally allow obtain new productsmaterial application orient bulk solution property laboratory partial methyl etherication process optimize mind future scale industrial production non ionic derivative likely marketing interest derivate study scientic standpoint term potential industrial application reaction carry heterogeneous phase obtain methyl guar sample different degree substitution aqueous solution latter Scheme sample characterize comparative fashion use appropriate model parameter characteristic ratio derivative evaluate dependence intrinsic viscosity temperature polymer wwwelseviercomlocatepolymer see front matter right reserve polymer corresponding author C39 fax C39 mail address determine sample solution study particularly aim shed light effect primary structure polysaccharide chain exibility result report herein gum supply Italy Dimethylsulfate DMS obtain use receive chemical commercially available product use purication Methylation etherication procedure adopt follow guar gum slowly disperse form solution hydroalcoholic mixture isopropyl terbutyl alcohol z30 clean round bottom ask maintain constant stirring rpm overhead mechanical stirrer result heterogeneous mixture heat purge nitrogen calculated amount aqueous solution sodium hydroxide add slurry mixture stir min temperature reaction decrease require amount alkylate agent add dropwise constant stirring reaction continue reaction mixture cool gradually disperse acetone excess alkali neutralize glacial acetic acid bring product nally wash successive portion acetone ltered dry vacuum use aforementioned general technique concen tration alkylate agent change obtain derivative different degree substitution Scheme Fig structure guar gum guar gum linear backbone link mannose unit link galactose unit attach h2o alcohol top bottom native guar gum methylguar degree substitution Risica Polymer Purication sample commercial guar gum use methylguar sample synthesize puried dissolution deionise water centrifugation extensive dialysis deionised water lyophilisation crude protein content guar sample estimate purication method polymer solution prepare add proper amount polymer deionize water vigorous stirring overnight determination degree substitution Fourier transform infrared spectroscopy ftir ftir spectra guar gum record use Shimadzu FTIR spectrometer twentyeight scan average resolution cmK1 triangle apodization Prior use spectrometer purge dry spectra baseline correct area normalize sample solution cast IRTRAN crystal obtain thin lm dry dryness lm control band associate deformation vibration bond water molecule nmr experiment degree substitution sample control mean nmr measurement completely degraded polymer sample latter prepare dissolve modied D2O stir solution pass cotton lter directly NMR tube crystal TSP trimethylsilylpropionic acid sodium salt place inner record mhz spectrometer sample measure time NMR spectra Fig possible observe case native guar ratio non anomeric proton signal ppmza6 anomeric proton signal expect case ratio non anomeric AD6 anomeric proton give great value elaboration ratio AD6 3ZDS allow estimate degree substitution methylate sample acid degradation dilute solution solution guar methylguar sample DSZ0 respectively prepare acid hydrolysis initiate adjust solution use concentrated HCl solution continuously Fig nmr spectra bold number refer integral anomeric non anomeric proton stir maintain water bath sample periodically remove immediately neutralize halt degradation analysis conduct obtain weightaverage molecular weight polydispersity index sample viscosity measurement viscosity dilute aqueous solution determine use apparatus Ubbelohde capillary FZ0 temperature thermostat control Gel permeation chromatography GPC measurement system equip pump Shimadzu RID10A refractive index detector column TSKGEL series protection guard column use column column maintain minimize peak broaden mobile phase Na2SO4 NaN3 ow rate min standard guar sample use calibration degrade guar MGs sample dilute ltered lter prior analysis injection volume result discussion polymer sample mannan galactose ratio puried sample find nmr measurement use totally degraded polymer sample absence protein material prove elemental analysis infrared spectroscopy experiment Methylation derivatization protocol employ design provide derivative lead principle substitution hydroxyl group sugar ring scheme process conduct twophase reaction system solid guar gum derive directly endosperm split suspend hydroalcoholic mixture isopropyl terbutyl alcohol water alcohol ratio mixture solution important variable lower possible quantity water present reaction medium prevent swell solubilization polysaccharide complicate product recovery purication diminish oxidative degradation polysaccharidic chain reaction system oxygen deplete combination inert gas purging partial vacuum etherication reaction guar gum alkyl reactant conduct presence stoichiometric quantity preferably slight excess sodium hydroxide perform reactant catalyst Table hydroxide polygalactomannan gum interact form alkoxide derivative react alkylate agent mechanism introduce methoxyl substituent polysaccharidic chain alkylate agent use dimethylsulfate good methylate agent etherication carry latter condition small yield obtain result attribute nonhomogeneity reaction mixture due low solubility aqueous mixture high density process yield function also type alcohol use reaction mixture fact alkylate agent consume etherication polysaccharide also side reaction alcohol solvent mixture tertiary alcohol less reactive secondary give low amount product yield high degree polysaccharide methylation table choose reaction temperature fact different temperature range test result suggest good compromise Table Formulation synthesis purity dZ1 component weight gram number mole molar ratio component saccaridic unit table Theoretical DST experimental degree substitution reaction yield OCH3 subtituent induce respectively miscible solvent DST DSE yield DMS DMS Isopropanol Terbutanol Risica Polymer reaction rate chain depolymerization heterogeneous phase obtain alkylate agent guar gum ratio usually great use homogeneous reaction galactomannan molecule isolate pack aggregate aggregate difcult penetrate reagent methylation guar galactomannan heterogeneous phase produce pattern substitution depend relative reactivity hydroxyl group govern state aggregation polysaccharide quite naturally increase amount alkylate agent increase degree substitution however maximize nal necessary increase sodium hydroxyde concentration lead extensive chain cleavage hence reduction molecular weight temperature important variable optimization process relatively high temperature reaction fast formation product increase etherication process therefore carry normal pressure high temperature also allow safe handle hazardous reagent boiling temperature lower necessary work low reaction temperature order diminish loss alkylate agent reaction period term degree substitution mean number mole ether group sugar unit employ method explain obtain derivative degree substitution range aqueous solution exhibit excellent heat stability great clarity stability extreme condition presence polyvalent metal ion solution Fourier transform infrared spectroscopy FTIR Fig infrared lm spectra native methylated guar gum degree substitution show native guar spectrum band shift low frequency asymmetric narrow sample suggest formation strong hydrogen bond attribute methyl substitution polysaccharide chain lead signicant change intra inter molecular hydrogen bonding array prevail pure spectrum moreover absorption band cmK1 characteristic stretching bend mode group methyl ether moietie Analysis ftir datum show particular polysaccharide specic band maximum region band previously spectra lm sample frequency cmK1 complete range frequency cmK1 show insert assign vibration bond glycosidic bridge fact band evident spectra Complex vibration involve stretch bond link galactose residue main chain participation bond vibration result appearance band cmK1 native guar spectrum band slightly shift high frequency cmK1 DSZ0 guar structure large proportion primary alcoholic group portion group methyl etherie substitution cause reduction band intensity cmK1 show spectrum band cmK1 relative stretch alcoholic group substantial reduction band spectrum thus conrm formation ether bond consistent band cmK1 typical asymmetric ether bond stretch intrinsic viscosity effect methyl substitution Fig show plot native guar MGs calculate intrinsic viscosity value list Table plot also draw similar result calculate intrinsic viscosity report gure obtain coefcient independent long chain value roughly good solvent bad solvent coefcient measure polymerpolymer interaction solution thus intermolecular association exist coefcient increase natural guar intrinsic viscosity coefcient higher sample water fairly good solvent guar however coefcient water indicate importance polymerpolymer hydrogen bonding interaction aggregation intrinsic property native guar report guar highly prone form hydrogenbonded complex inter culary unsubstituted region backbone methyl group add guar substitution occur hydroxyl group chain backbone galactose side group heterogeneous substitution methyl group sterically block hydrogen bonding site guar backbone reduce inter intramolecular hydrogen bond respectively polymer molecule single chain adjacent residue Table report coefcient function methyl substitution temperature rst drop DSZ0 become independent trend suggest regime behaviour rst sharp decrease intermolecular interaction average molecular weight guar determinate analysis list table molecular weight sample decrease proportionally substi tution combine intrinsic viscosity result equation effective molecular volume polymer coil report different substitution degree assume value equal gK1 Table Guar exhibit high value molecular volume already mention methyl substitution reduce inter intra molecular attraction decrease effective molecular volume local chain rigidity relationship DSZ0 DSZ0 guar degrade use acid hydrolysis procedure describe sp Fig reduce specic viscosity aqueous solution different table intrinsic viscosity Huggins coefcient molecular volume derivative molecular volume molecule DSZ0 DSZ0 DSZ1 Risica Polymer Experimental part number average molecular weight weight average molecular weight polydispersity index IZMw degrade polymer determine GPC degradation process produce sample rather uniform molecular weight distribution polydispersity change signicantly different degraded sample average value intrinsic viscosity relate viscosity average polymer MarkHouwinkSakurada MHS relationship ZKMa constant relate stiffness chain exible polymer coil vary solvent good solvent increase increase chain stiffness rigid rod relationship determine use degraded sample various random distribution thus assume approxi mation determination base universal calibration curve relationship report literature analysis degraded sample guar gum select also set degraded MGs DSZ0 thus intrinsic viscosity measure datum degraded sample analyze use rst iteration parameter natural guar report double log plot intrinsic viscosity Fig datum give respectively follow parameter az0 az0 DSZ0 az0 DSZ0 molecular weight recalculate use experimental value obtain mean MGs plot iterative process calculate molecular weight determine parameter resolve molecular weight repeat identical result experimental error obtain Table iteration procedure permit obtain relationship sample analyse report table guar gum value good agreement provide literature regard sample exponent range slight increase value symptom less thermodynamically favourable polymerwater interaction respect BurchardStockmayerFixman method characteristic ratio chain persistence length BurchardStockmayerFixman BSF equation mitsthrough extrapolation estimate unperturbed coil dimension perturb one condition intrinsic viscosity polymer scrutiny know wide range molecular weight table intrinsic viscosity Huggins coefcient weight average molecular weight number average molecular weight polydispersity index degrade sample different time hydrolysis Sample hydrolysis mol mol DSZ0 DSZ0 log mol log guar MGd MGd Fig relationship intrinsic viscosity molecular weight DSZ0 respectively show plot Table MHS constant characteristic ratio persistence length DSZ0 sample CNG1 lpg1 DSZ0 DSZ0 Risica Polymer BurchardStockmayerFixman equation dene zkqc0:51fbm1 slope measure longrange interaction intercept plot correspond polymeric chain state exclude volume proportional character istic ratio accord represent length monomeric unit universal constant characteristic ratio measure degree directional correlation neighbouring residue hence stiffness real chain Fig Fixman plot guar MGs DSZ0 show intercept plot give characteristic ratio value sample report table assume guar DSZ0 DSZ0 wormlike chain approximation characteristic ratio simply equal obtain value persistence length sample table value agree quite well early tabulate value guar cellulose derivative xyloglucan overall difference value obtain sample experimental error value obtain native guar good agreement previous result determine light scattering viscosity measurement report literature sample value low obtain native guar accord expectation base experimental solution datum collect present previous section effect temperature intrinsic viscosity guar derivative effect temperature intrinsic viscosity guar sample DSZ0 aqueous solution study result report Table Fig plot inverse absolute temperature KK1 derivative slope dln obtain regression analysis list insert value decrease increase degree substitution show chain exibility methylate sample great guar gum intrinsic viscosity decrease increase solution temperature DSZ0 decrease linearly result complex temperature dependent rheological behaviour traceable gradual collapse hydrogen bond chain ensemble conclusion improve process etherication guar gum carry heterogeneous phase lead new non ionic hydrocolloid interesting property mw1 mw1 Fig plot DSZ0 respectively determine characteristic ratio intercept represent local conformational constraint polymer slope measure long range interaction table intrinsic viscosity degree substitution different temperature DSZ0 DSZ0 sample dln Fig plot natural logarithmic intrinsic viscosity inverse absolute temperature KK1 DSZ0 respectively aqueous solution slope dln linear behavior report insert respect native biopolymer show distinctly high solubility aqueous medium high chain exibility difference guar gum traceable primarily partial suppression inter intra molecular hydrogen bond cause methoxyl substitution dependence viscosity temperature show degree substitution sufcient markedly reduce interaction guar chain comparative analysis parameter characteristic ratio estimate plot suggest sample consider behave linear exiblesemiexible coiled carbohydrate polymer show sample exhibit high exibility native guar conclusion scrutinize come paper deal light scattering diluite ment financial support work gratefully McCleary Ser editor thickening gelling agent food Blackie Academic Professional Whistler BeMiller Industrial gum polysaccharide derivative Academic Press editor pharmaceutical application polymer Gidley Carbohydr Tetrahedron Lett Hakamori Biochem Hough Theobald Methods Carbohydr Chem Tetrahedron Lett chemical analysis food infrared spectra complex molecule Young Lovell Introduction polymes 2nd Asoc Polym Sci Bochek Wilson Viscosity polymer solution Elsevier Morris Polym Flory Principles polymer chemistry Morris Int Biol Macromol lecule RossMurphy editor chemistry application Yilong Picout Ellis RossMurphy Biomacromolecules Jinping Polym Sci Part Polym Phys Chem Tsaih Int Biol Macromol editor functional property food macromolecule Elsevier Applied science Noguchi editor Water activity inuence food quality Academic Press Risica Polymer",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 2
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {}
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Human methyl purine DNA glycosylase and DNA polymerase \u03b2 expression collectively predict sensitivity to temozolomide.pdf",
            "cleaned_text": "Human Methyl Purine dna Ram Trivedi Pharmacology Hillman Cancer Center receive accept Overexpression methylpurine dna glycosylase MPG suggest possible gene therapy approach sen sitize tumor cell cellkilling effect temozolomide imidazotetrazineclass chemotherapeutic alkylate agent present study show elevate mpg expression short hairpin loss dna polymerase Pol expression human breast cancer cell increase lular sensitivity temozolomide Resistance temozolomide restore complementation wildtype human human inactivate mutation specific polymerase active site yet functional deoxyribose phosphate drp lyase activity genetic cellular study uniquely demonstrate overexpression mpg cause imbalance base excision repair lead accumulation cytotoxic lesion drp lyase activity Pol require restore resistance temo result imply dependent drp lyase activity ratelimite step BER cell suggest BER tightly balanced pathway repair alkylate basis methylguanine methyl adenine furthermore find drpmediate cell death independent caspase activation induce formation autophagosome measure green fluore cent localization experiment pre sente herein suggest important investigate active BER pathway partially responsible temozolomidemediated resistance see mor balance BER protein expression overall BER capacity help predict sensitivity temozolomide Base excision repair BER predominant pathway repair base damage mediate endogenous ogenous stressor repair dna basis damage alkylation initiate mammalian cell methylpurine dna glycosylase MPG also know alkyladenine DNA glyco sylase Wood majority repair initiate MPG occur shortpatch BER mechanism whereby nucleotide replace modify base remove MPG result abasic site hydro lyze endonuclease cata lyze incision damage strand leave deoxyribosephosphate moiety mar gin repair site dna polymerase quently hydrolyze drp moiety fill single nucleotide gap prepare strand ligation DNA ligase complex DNA ligase III XRCC1 many dna repair process BER function series repair complex assemble site DNA lesion repair dna damage alkylation mpg APE1 Pol XRCC1 essential little evidence effective complementary repair capacity suggest inhibition research support research scholar grant grant grant Health p20ca103730 1p50 CA09719001A1 UPMC Health System Com petitive project also fund part grant Health Article publication date citation information find mol ABBREVIATIONS BER base excision repair MPG methylpurine DNA glycosylase endonuclease Pol polymerase drp deoxyribosephosphate small hairpin rna rnai rna interference green fluorescent proteinlight chain mAb monoclonal antibody PCNA proliferate cell nuclear antigen FLAGPol d256a polymerase defective mutant human benzyloxycarbonylvalalaaspomefluoromethylketone wild type feline immunodeficiency virus knockdown etoposide methyladenine immunoprecipitation immunoblot page polyacrylamide gel electrophoresis dimethyl thiazoldiphenyltetrazolium bromide ORF open reading frame untranslated region Vol Copyright Printed ASPET Journals April molpharmaspetjournalsorg deficiency essential BER protein lead DNA repairintermediate induced cell death alkylate basis abasic site drpcontaine lesion dna singlestrand break cell case mouse deficient Mpg Xrcc1 Pol hyper sensitive alkylate agent Elder addition decrease expression also lead increase sensitivity alkylate agent extend character ization role repair alkylation damage mouse cell demonstrate provide cellular resistance clinical alkylate agent temozolomide imidazotetrazineclass chemotherapeutic repair lesion ultimately trigger acti vation DNA damage response checkpoint interestingly MPG knockdown increase expression mpg find sensitize cell avoid alkylation damageinduced mutation accumulate absence mpg expression force expression MPG suggest strategic viable gene therapy approach sensitize tumor cell directly evaluate role MPG human tumor cell regard cellular response alkylation damage develop human Pol specific shRNAexpress ing lentiviruse completely deplete human tumor cell Pol vector ectopic expression mpg rnairesistant human transgene define enzymatic activity Pol dRP lyase DNA polymerase activity confer resistance show elevate mpg expression loss Pol expression increase cellular sensitivity human breast cancer cell case resistance store complementation wildtype human human inactivate mutation specific polymerase active site yet functional drp lyase activity genetic cellular study uniquely demonstrate overexpression mpg cause imbalance BER saturate Pol dependent removal cytotoxic drp lesion failure remove cytotoxic lesion induce caspase activation induce formation autophagosome measure localization study support possibility lyase activity Pol ratelimite step BER human cell suggest BER tightly balanced pathway repair alkylate basis methylguanine methyladenine Materials Methods Chemicals reagent RPMI medium vate fetal bovine serum IUPAC name prepare stock dimethyl sulfoxide use follow primary antibody antipol mAb clone Waltham antihuman mpg mAb clone kindly provide Oak Ridge antiAPE1 mAb SigmaAldrich Louis electrophoresis reagent protein purchase gentamicin sulfate flag peptide respectively obtain VADFMK table cell line develop use study Cell Line name Clone TMZ IC50 Cell line description growth medium MDA Human Caucasian breast adenocarcinoma epithelial cell rpmi medium heatinactivate fetal bovine serum gentamicin MDAPol Human breast cancer cell express lentiviral shrna Growth medium supplement puromycin MDAMPG mpg overexpression human breast cancer cell Growth medium supplement MDAPol mpg mpg overexpression regulated human breast cancer cell Growth medium supplement puromycin MDAPol FLAGPol FLAGPol reconstitute downregulate human breast cancer cell Growth medium supplement puromycin MDAPol FLAGPol D25A d256a mutant FLAGPol reconstitute regulated human breast cancer cell Growth medium supplement puromycin FLAGPol reconstitute human breast cancer cell Growth medium supplement puromycin Trivedi Journals April molpharmaspetjournalsorg caspase colorimetric activ ity assay kit pegfp LC3 plasmid kindly provide Japan Plasmid Expression vector RNAi Development use follow mammalian expression vector human MPG human piresneoflag pIRESNeoFLAG Pol D256A Sobol Human Pol target fivbased lentiviral shrna expression vector pfivpurohpol pfiv pfivpurohpol pFIV34N pvsv construct pSuperRetro shRNA pSuperRetro shRNA pSuper Retro shrna expression vector Viral transduction Conditions human mpg overexpression knockdown FLAGPol FLAGPol d256a overexpresse cell line pre pare transfection use FuGene transfection reagent accord manufacturer struction stable cell line Table select human mpg expression plasmid pires NeoFLAGPol pIRESNeoFLAGPol D256A puromycin pIRESPuroFLAGPol individual clone stably express human mpg Pol amplify nuclear extract analyze immuno blotting expression human mpg human Pol protein also probe expression PCNA Lentiviral particle generate transfection pla mid expression plasmid pfivpurohpolb pfiv34n pvsv cell Poeschla use FuGene Culture medium transfecte cell collect transfection isolate viral particle pass filter use immediately store single use lentiviral transduction complete follow brief cell seed sixwell plate incubate co2 Cells transduce shrnaexpression lentiviral stock cultured stable cell line isolate transduction describe follow selection puromycin individual clone stable knockdown human Pol protein amplify nuclear extract analyze immuno blotting expression endogenous human Pol protein also probe expression MPG APE1 PCNA descriptive list cell line develop use study detail Table Culture Conditions Cell Cytotoxicity Assays MDA breast cancer cell obtain mpg overexpression human Pol knockdown human Pol overexpresse MDA cell line cultured humidify incubator CO2 RPMI medium supplement heatinac tivate fetal bovine serum gentamicin TMZ ETO induce cytotoxicity determine modified assay describe previously result calculate average separate experiment report percentage treat cell relative cell control well control extract prepared protein concentration determine describe previously protein separate electrophoresis SDSpolyacrylamide gel electrotransferre nitrocellulose membrane detect use standard protocol primary antibody antipol antihmpg antiAPE horseradish peroxidaseconjugated secondary antibody goat mouse horseradish peroxidase dilute milk immunoprecipitation cell lysate abovemen tione cell line prepare radioimmunoprecipitation assay buffer incubate antibody follow incubation protein immunoprecipitated material wash assay buffer elute flag peptide separate PCNA MPG Pol MDA mdampg mdampg mdampg TMZ Fig overexpression human MPG MDA cell shift ratelimite step BER pathway induce temozolomide hypersensitive phenotype MPG overexpression determine analysis nuclear protein isolate MDA mpg overexpresse MDA cell protein isolate separate clone show compare protein isolate control cell MDA lane expression determine immunoblot PCNA expression show loading control bottom MDA cell mpg overexpression MDA cell mdampg MDA MPG MDAMPG cultured well plate exposure viable cell determine use modified assay plot show percentage viable cell compare untreated control cell Means calculate qua druplicate value experiment result indicate mean independent experiment MPG DNA April molpharmaspetjournalsorg SDSPAGE transfer nitrocellulose filter probe antipol antibody Induction Apoptosis Caspase Activation Assay Twentyfour seed duplicate plate cell line cellswell plate plate pretreate medium alone medium supplement vadfmk final concentration vadfmk treatment cell treat various dose incubate cell cytotoxicity deter mine modify assay describe Caspase activation measure use caspase colorimetric activity assay kit manufacturer instruction brief assay base spectrophotometric identification nitroaniline cleavage label DEVD nitroaniline substrate caspase activation assay cell seed dish seed ing cell MDA MDAPol MDA MPG MDAPol mpg treat correspond IC50 value cell line table medium Cells treat separately medium induction apoptosis cell pellet contain approximately cell resuspend cell lysis buffer supernatant cytosolic extract use measure caspase activation sample mixed assay mixture well plate incubate absorbance mea sure fold increase caspase activation calculate compare optical density sample optical density untreated control sample seed duplicate plate cell line cellswell plate plate pretreate medium alone medium supplement final concentration min treatment cell treat various range incubate cell cytotoxicity determine modified assay scribe identification Autophagosome Formation GFP LC3 MDA derive cell line seed cell well slide cultured CO2 cell transfecte pEGFPLC3 use FuGene describe Cells pretreate medium alone medium supplement min treat IC50 dose Table Cells wash twice phosphatebuffere saline fix form aldehyde min room temperature counterstaine diamidinophenylindole min result overexpression human mpg shift induce TMZ Hyper sensitive Phenotype line hypothesis BER pathway repair tmzinduced lesion therefore variation BER protein expression affect cell death analyze involve PCNA Flag Flag Pol Pol antipol control human FLAGPol MDA cell restore resistance temozolomide DNA Pol expression determine immunoblot analysis nuclear protein isolate MDA mpg overexpresse MDA cell transfecte FLAGPol Proteins isolate separate FLAGPol express clone show MPGFLAGPol lane compare protein isolate control cell MDA lane mpg overexpresse MDA cell MDAMPG lane transfecte MPGoverexpressingMDA cell MDA MPGPuro lane flag MPG expression deter mine immunoblot PCNA expression show loading control bottom cell lysate abovementioned cell line incubate antibody follow incu bation protein elute FLAG peptide separate SDSPAGE transfer nitro cellulose filter probe antipol antibody cell MPGoverexpressing MDA cell transfecte cell MDAMPGPuro circle square MPG cell express FLAGPol MDA MPGFLAGPol half square fill half square invert half square cultured well plate exposure viable cell determine use modify assay describe ASPET Journals April molpharmaspetjournalsorg ment MPG responsiveness human tumor cell table increase mpg expression enhance BER initiation mpg expression system allow signifi cantly overexpress MPG MDA human breast cancer cell Fig much fold determine immuno blot analysis quantification image version analysis note almost undetectable expression mpg parental cell compare pSuperRetro shRNA TTGCTACAGTCTGTGGCAG pSuperRetro shrna TGAGTACACCATCCGTCCC pFIVPuro shrna CTGGCAGACACAACCCAAT pFIVPuro shrna atcccagcttcacttcaga Pol specific shrna target UTR UTR DNA Pol mrna ORF PCNA PCNA PCNA Control MDAPol MDAPol MDAPol MDA TMZ Fig Downregulation endogenous human Pol protein expression human breast cancer cell diagram depict target sequence separate shrnaexpresse vector plasmid lentiviralbase specific different region Pol mrna Four predict sequence shrna target ORF sequence specific region ORF sequence target different Pol specific shrna vector downregulation endogenous human Pol protein expression human breast cancer cell MDA transduction different lentiviral vector DNA Pol expression determine immunoblot analysis nuclear protein isolate separate shrnaexpresse clone show PCNA expression show loading control bottom DNA Pol expression determine immunoblot analysis nuclear protein isolate MDA MDA cell transduce human Pol shrna lentiviral vector protein isolate separate shrnaexpresse clone show MDAPol MDAPol mdapol lane compare protein isolate control cell MDA lane expression determine immunoblot PCNA expression show loading control bottom MDA cell MDA cell express specific shrna MDAPol MDAPol MDAPol cultured well plate exposure viable cell determine use modify assay describe Fig Resistance Mediated MPG DNA April molpharmaspetjournalsorg overexpression cell line Fig compare lane lane overexpression mpg alter expression BER protein Pol APE1 Fig hypothesis mpg overexpression shift rate limit step BER pathway significantly enhance BER initiation result accumulation BER interme diate drp support hypothesis crease sensitivity observe MPG overex press cell Fig line mpg perform first step BER path way essential manifest null phenotype observe mouse cell reason MPG overexpression saturate endogenous yield apparent Pol deficiency glycosylase overexpression cause overall BER imbalance Coquerelle determine endogenous level Pol rate limit MPG overexpresse MPG overexpresse MDA human breast cancer cell modify also overexpress Pol increase expression severalfold compare endogenous level MPG overexpression cell complement human epitopetagge Pol Fig change expression endogenous Pol protein expression BER protein cell exhibit robust expression transgenic FLAGPol Fig immunoblot analysis estimate cell express time great transgenic Pol endogenous level Pol cell however overexpression wildtype Pol mpg overexpression cell completely restore resistance cell vector control sensitive original cell demonstrate hypersensitivity cell overexpress MPG due unrepaired Pol substrate cytotoxic lesion accumulate exposure Pol step ratelimite Human DNA Pol Protein require Resis tance Cytotoxicity Alkylating Agent facilitate analysis BER pathway particular human tumor cell design shrna press vector specific different region Pol mrna show Fig shrna expression plasmid specific human develop base sequence nm002690 sequence specific human Pol open reading frame ORF sequence specific region ORF noteworthy UTRtargeted shRNA prove effective sequence shrna target show Fig vector plasmid lentivirus use develop singlecell clone analyze effectiveness Pol knockdown probe expression immunoblot analysis nuclear protein pSuper Retro shrna expression vector effective Pol knockdown datum show noteworthy ORF specific shrna lentiviral vector partially min imally effective pfivpurohpol lead decrease expression clone identify lose expression many present partial expression much expression compare parental cell line empty vector control datum show however cell clone express lead complete loss Pol protein expression Fig note expression human Pol specific shRNA affect expression BER protein Fig PCNA expression show loading control Fig loss Pol expression observe cell culture long month analyze long period culture next test cell sensitivity evaluate impact loss tumor cell lose Pol APE1 PCNA Control MDA MDA Pol mpg MDA Pol mpg TMZ Fig overexpression human mpg Pol downregulate MDA cell result increase sensitivity temozolomide MPG overexpression determine immunoblot analysis nuclear protein isolate MDA mpg overexpresse MDA cell transduce Pol shrna lentiviral vector protein isolate separate clone show MDA Pol MPG MDAPol mpg lane compare protein isolate control cell MDA lane Pol knockdown cell MDAPol lane expression determine immunoblot PCNA expression show loading control bottom MDA cell MDA cell express specific shrna MDA Pol mpg overexpression downregulate MDA cell MDAPol MPG MDA Pol MPG cultured well plate exposure viable cell determine use modify assay describe ASPET Journals April molpharmaspetjournalsorg expression significantly sensitive parental cell next evaluate role breast cancer cell elevated expression mpg analysis combine mpg overexpression Pol knockdown demonstrate deficient hypersensitivity mediate repair initiation Immuno blot show demonstrate human tumor cell harbor mpg overexpression loss Pol expression find overexpression mpg combine Pol knockdown drastically increase sensitivity human tumor cell decrease IC50 value almost fold compare parental cell therefore play important role protect tmzinduced cell death support pothesis active BER pathway partially sponsible resistance see mor significantly result emphasize intimate balance repair protein expression maintain prevent accumulation cytotoxic geno toxic lesion repair intermediate drp hypersensitivity Human unrepaired drp lesion show loss Pol expression mediate shRNA expres sion saturation Pol step pathway mpg overexpression lead hypersensitivity TMZ dem onstrate observed hypersensitivity specific Pol aberrant nonspecific effect complement Pol knockdown cell rnairesistant human epitopetagge Pol feasible take advantage shRNA system compliment Pol knockdown human tumor cell use expression vector lack shrna target show expression endog enous Pol robust expression transgenic flag Pol Fig addition note change expression APE1 Fig confirm observe expression expression endog enous Pol characterize expression transgene use antiflag antibody immunoblot analysis precipitate material Pol monoclonal antibody confirm presence flag epitopetagge Pol transfecte cell line fig lane noteworthy expression wildtype FLAGPol human tumor Pol knockdown cell completely restore resistance cell vector control sensitive original knockdown cell however show previously mouse cell Pol substrate BER intermediate drp highly toxic suggest observe persensitivity human knockdown cell due loss drp lyase activity Pol end complement Pol knockdown cell human PCNA Flag Pol antipol MDAPol MDAPol vector control MDAPol MDAPol MDAPol TMZ Fig reconstitution human FLAGPol Pol downregulate MDA cell restore resistance temozolomide DNA Pol expression determine immunoblot analysis nuclear protein isolate MDA cell MDAPol cell transfecte FLAGPol Proteins isolate separate FLAGPol express clone show MDAPol FLAGPol MDAPol FLAGPol MDAPol FLAGPol lane compare protein isolate control cell MDA lane MDA Pol cell MDAPol lane pires MDAPol cell MDAPol Neo lane flag expression determine immunoblot PCNA expression show loading control bottom cell lysate abovementioned cell line incubate anti flag antibody follow incubation protein elute flag peptide separate SDS PAGE transfer nitrocellulose filter probe antipol antibody MDA cell MDA cell express specific shrna MDAPol pIRESNeotrans fecte Pol MDA cell MDAPol MDA cell express FLAGPol MDA Pol FLAGPol square diagonal line MDA MDAPol FLAGPol dotted square cultured well plate exposure viable cell determine use modify assay describe Fig Resistance Mediated MPG DNA April molpharmaspetjournalsorg epitopetagge encode d256a mutation poly merase active site retain complete drp lyase activity yet devoid polymerase activity Fig cell complement expression endogenous robust expression transgenic FLAGPol d256a mutant Fig addition change expression note expression transgene confirm combine Fig lane importantly expression polymerasedefectivedRP lyaseactive D256A mutant human tumor Pol knockdown cell com pletely restore resistance cell vector control sensitive orig inal Pol knockdown cell indicate hypersensi tivity cell lose Pol expression due Pol specific shrna due unrepaired cytotoxic lesion Minimal Contribution Apoptosis Auto phagy dRP LesionInduced cell Death MDA Cells Temozolomide Treatment inve tigate involvement apoptosis due loss Pol mpg overexpression MDA cell treat ment measure caspase activation addition also determine tmzinduced cell death cell prevent pretreatment VADFMK pancaspase inhibitor widely use DNA damage agent induce apoptosis use pos itive control study Bockbrader dose response essentially cell line use herein pretreatment VAD prevent apoptosis cell Fig indicate functional apoptotic pathway notewor thy pretreatment vadfmk fail prevent tmzinduced cell death suggest drpinduced cell death apoptosis sup port result caspase activation assay observe fold increase caspase acti vation fold increase exposure cell line test suggest minor level caspase activation independent drp lesion accumulation expect observe fold crease caspase activation expo sure recently report induce apoptosis melanoma cell similar result MDA cell line present herein result present study support view TMZinduced drp lesioninduced cell death MDA cell independent caspase activation onset apoptosis next evaluate impact specific inhibitor autophagy dRP lesionmediated cell death BER defective cell due loss Pol mpg overexpression treatment treatment alone similar effect MDA cell use herein pretreatment show fail APE1 antipol MDAPol MDAPol vector control MDAPol D256A MDAPol D256A MDAPol D256A TMZ Fig reconstitution polymeraseinactive mutant human FLAGPol D256A downregulate MDA cell restore resistance temozolomide DNA Pol expression determine immunoblot analysis nuclear protein isolate MDA Pol MDA cell transfecte polymeraseinactive mutant FLAGPol D256A protein isolate separate FLAGPol d256aexpressing clone show MDAPol flag Pol D256A MDAPol FLAGPol d256a mdapol FLAGPol d256a lane compare protein isolate control cell MDA lane MDA Pol cell MDAPol lane piresneo transfecte MDAPol cell MDAPol Neo lane flag expression determine immunoblot PCNA expression show loading control bottom cell lysate abovementioned cell line incubate anti flag antibody follow incubation protein elute flag peptide separate SDS PAGE transfer nitrocellulose filter probe antipol antibody MDA cell MDA cell express specific shrna MDAPol piresneotransfecte MDAPol cell MDAPol neo MDAPol cell express FLAGPol d256a MDA Pol FLAGPol D256A MDAPol FLAGPol d256a MDAPol FLAGPol d256a cultured well plate exposure viable cell determine use modify assay describe ASPET Journals April molpharmaspetjournalsorg prevent tmzinduced cell death consistent sult find drpmediate cell death induce formation autophagosome measure localization greater cell regardless BER status exposure present diffuse pattern GFP LC3 stain Fig Less cell serve punctate expression pattern dicative spontaneous formation autophagosome however pattern alter exposure BER protein expression status datum show sugge tive low background level autophagosome formation cell line use herein discussion overexpression methylspecific dna glycosylase report vary effect mammalian cell range effect elicit increase decrease sensitivity alkylate agent Habraken increase caspase activation untreated control MDA MDAPol mdampg MDAPol mpg MDAPol VAD mdampgvad MDAPol MDAPol mdampg MDAPol mpg ETO hour TMZ treat hour TMZ treat hour TMZ treat hour TMZ treat hour ETO treat ETO treat ETOVAD treat ETO Fig analyze contribution apoptosis dRP lesioninduced cell death MDA cell temozolomide treatment dose response determine culturing cell label figure plate exposure viable cell determine use modify assay describe Fig Cells MDA cell group MDA cell express specific shrna MDAPol group MDA cell MDAMPG group mpg overexpression downregulate MDA cell MDAPol mpg group cultured well plate exposure medium vadfmk vadfmk pretreatment cell treat viable cell determine use modify assay describe Fig cell label figure cultured well plate exposure medium vadfmk vadfmk pretreatment cell treat viable cell determine use modify assay describe Fig caspase activation determine follow MDA cell group MDA cell express specific shrna MDAPol group MDA cell MDAMPG group mpg overexpression downregulate MDA cell MDAPol mpg group treat correspond IC50 value cell line table medium cell also treat medium drug treatment cell pellet resuspend cell lysis buffer cytosolic extract use assay caspase activation MPG DNA April molpharmaspetjournalsorg other find mpg overexpression induce dna damage sensitivity phenotype mouse fibroblast human breast ovarian tumor cell study demonstrate mpg overexpression knockdown similarly affect sensitivity human breast cancer MDA cell alkylation damage however collective expression dna repair protein define sensitivity phenotype herein demonstrate Pol substrate dRP BER intermediate cytotoxic lesion mpgoverexpresse human tumor cell tmzinduced cell death due drp lesion accumulation likely caspasemediate apoptosis observe caspase activation exposure autophagy report play role tmzinduced cell death glioma cell line observe exposure Kanzawa study suggest drpmediate cytotoxicity induce formation autophagosome measure localization sug geste possible role necrotic mechanism cell death due fail repair cytotoxic BER intermediate also seem p53 involve genotoxin induce cell death observe MDA cell press mutant form p53 elevated level Hui line early observation mouse cell MPG berinitiating enzyme DNA Pol generally consider ratelimite enzyme BER study test hypothesis MPG overexpression induce BER imbalance rate Pol drp lyase activity BER pathway lead drpmediate cell death cell leave unrepaired drp moiety give rise increase genomic instability eventually lead cell death first enzyme BER process mpg expression require initiation BER repairalkylate basis wealth information regard ing enzymology structural biology MPG Wyatt however little known mech anism MPGinitiated BER vivo report MPG expression level vary considerably addition also report multiple posttranslational modification form proteinprotein interaction many dna repair protein include XRCC1 hR23A other role posttranslational modifi cation proteinprotein interaction unknown cause many bind partner mpg possible overexpression mpg lead cellular sensi tivity negatively affect function bind protein study describe suggest mpg expression increase repair initiation alkylate basis vivo increase cellular sensitivity observe cell expose TMZinduced cell sensitiv ity alter expression level Pol increase repair initiation lead imbalance BER case saturate Pol step repair pathway DNA long consider dna repair poly merase amino acid bifunctional enzyme facilitate dna synthesis step BER MDA MDAPol mdampg MDAPol mpg MDA MDAPol mdampg MDAPol mpg rtn rtn MDA MDAPol mdampg MDAPol mpg Fig measure contribution autophagy drp lesioninduced cell death MDA cell temozolomide treatment induce dose response determine culturing cell label figure plate exposure viable cell determine use modify assay describe cytotox icity pretreatment evaluate culturing cell label figure plate exposure medium min pretreatment cell treat viable cell determine use modify assay describe Representative image show diffuse pattern pEGFPLC3 expression observe cell punctate pattern pegfplc3 expression see arrow localization observe less cell population expression pattern independent status treatment treatment April molpharmaspetjournalsorg gaptailore step remove drp group form hydrolysis abasic site Extensive enzymology protein biochemistry structural biology provide intimate detail structure protein Beard mechanism dna synthesis drp lyase activity conduct use purified recombinant enzyme extract mouse human cell facilitate repair formation protein complexe lesion site several BER protein include DNA ligase XRCC1 PCNA polyadpribose polymer ase other genetic complementation Pol null mouse fibroblast determine increase sensitivity Pol null mouse cell alkylation damage result failure repair drp BER intermediate however little known significance drp lyase activity Pol human cell impact Pol expression function human cellular response dna damage clearly these study demonstrate vari ation Pol expression affect cellular sensitivity manner due failure repair drp repair intermediate Expression Pol highly variable human cell Pol regulate adenocarcinoma ovarian tumor glioma cells find overexpresse human tumor furthermore function alter posttranslational modification include methylation acet ylation ubiquitylation suggest requirement regulate Pol function addition many Pol variant altered function isolate human tumor DNA Pol seem major polymerase MDA human breast cancer cell rnaimediated pression loss affect cell viability cell hypersensitive cytotoxic effect clinical alkylate agent enhance MPG express increase increase cellular sensi tivity consistent early study use mouse knockout fibroblast use knockdownknockin strategy show hypersensitive phenotype direct result loss Pol expression eliminate concern knockdown phenotype result offtarget effect RNA interferencemediate gene silence study address problem cellular resistance alkylation damage induce chemotherapeutic agent yet consider model many type base lesion repair BER focus study biochemical molecular mechanism mediate repair alkylationinduced dna damage human tumor cell overall show MPG Pol base excision repair contribute significantly repair alkylation induce dna damage human cell therefore modulate BER pathway mpg overexpression expression enhance chemotherapeutic index agent damage dna initiate BER cellular condition affect Pol expression BER balance predispose give human cell population drpmediate genome instability cytotoxicity ever overall BER capacity consider evaluate cellular response similar age agent experiment present herein suggest important investigate active BER pathway partially responsible resistance see tumor overall help predict sensitivity furthermore important evaluate BER imbalance predispose human primary cell cellular induce increase genome instability cellular senescence case postmitotic cell neu ron neurodegeneration result fail drp lesion repair also interesting speculate increase genome instability due BER imbalance combine chronic inflammation ulcerative colitis bring deficiency repair BER intermediate finally finding clinical applicability design specific BER modulator adjuvant treatment reverse phenotype suggest alkylate agent combine BER modulator plored possible therapeutic treatment breast cancer acknowledgment thank provide helpful discussion unified view base excision repair lesion dependent protein complex regulate posttranslational modification DNA Repair Beard mechanism dna polymerase beta Chem Rev Minto enhanced expression activity dna polymerase human ovarian tumor cell impact sensitivity agent small molecule Smacmimic compound induce apoptosis sensitize etoposideinduced apoptosis breast cancer cell alter expression DNA repair protein glycosylase mpg breast cancer FEBS Lett glycosylase Chinese hamster ovary cell render sensitive production chromosomal aberration methylate agent case repair Elder Jansen Weeks Bailey knockout mouse show increase susceptibility induction mutation methyl methanesulfonate Mol Cell Biol methyladenine DNA glycosylase homozygous mutant mouse cell increase sensitivity alkylationinduced chromosome damage cell kill Fishel Smith Manipulation base excision repair sensitize ovarian cancer cell alkylate agent temozolomide Sakai Elevated expression DNA polymerase beta gene glioma cell line acquire resis tance sourea Increased resistance Chinese hamster mutant irs1 cell monofunctional alkylate agent transfection coli mammalian methyladenineDNAglycosylase gene Zhou Mechanic adaptive imbalance base excisionrepair enzyme generate microsatellite instability chronic inflammation polyadp ribose polymerase activity prevent signal pathway cell cycle arrest fol low DNA methylate agent exposure MPG DNA April molpharmaspetjournalsorg DNA polymerase beta cellular protection cytotoxic dna singlestrand break Cell res Hui p53 MDA breast cancer cell stabilize elevated phospholipase activity contribute survival signal generate phospholipase Ibeanu Hartenstein Dunn Overexpression human dna repair protein rineDNA glycosylase result increase removal DNA concomitant increase resistance alkylate agent Chinese hamster ovary cell carcinogenesis Role autophagy temozolomideinduced cytotoxicity malignant glioma cell cell death differ Joo Choi Lee Expression DNA repair enzyme glycosylase mpg astrocytic tumor Anticancer res sion coli methyladenine dna glycosylase gene mammalian cell reduce toxic mutagenic effect methylate agent Dimaio E295 K DNA polymerase beta gastric cancerassociate variant interfere base excision repair induce cellular transformation Mol Cell Biol control dna repair science induce senescence apoptosis human melanoma cell cancer stable expression rat glioma cell sense antisense nucleic acid human multifunctional DNA repair enzyme APEX nuclease human carcinoma cell alkylate agent small interfere rna suppression glycosylase cancer Res Poeschla WongStaal viding human cell feline immunodeficiency virus lentiviral vector Prasad Batra insight DNA polymerase beta deoxyribose phosphate lyase mechanism DNA Repair adenoviral methylpurine dna glycosylase overexpression impart chemotherapeutic sensitivity human breast cancer cell Mol Cancer Ther DNA polymerase null mouse embryonic fibroblast harbor homozygous null mutation dna polymerase iota DNA Repair Sobol chip away base excision repair Mol Cell Sobol 2008b Temozolomide Encyclopedia Cancer 2nd Schwab Springer Singhal mammalian DNA polymerase baseexcision repair Nature Sobol Kartalou Almeida Joyce Engelward Horton Prasad Samson excision repair intermediate induce p53independent cytotoxic genotoxic response Sobol Prasad lyase activity DNA repair protein polymerase protect cytotoxicity nature DNA polymerase expression difference select human tumor cell line carcinogenesis link DNA polymerase beta cancer cell cycle frequent mutation relate overexpression DNA polymerase beta pri precancerous lesion human stomach Cancer Lett role base excision repair sensitivity resistance temozolomide mediate cell death cancer res role human DNA repair enzyme HAP1 cellular protection dna damaging agent hypoxic stress Wood Mitchell Sgouros DNA repair gene science agent dna repair response methylated basis source strand break address correspondence Research Pavilion Suite Centre Ave Pittsburgh mail April molpharmaspetjournalsorg",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 1
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "FLAGPol": 25,
                    "Pol": 3,
                    "Caucasian": 1,
                    "LC3": 1,
                    "NeoFLAGPol": 1,
                    "MPGoverexpressing": 1,
                    "Alkylating": 1,
                    "pIRESNeotrans": 1,
                    "VADFMK": 1,
                    "Hui": 2,
                    "Chinese": 3,
                    "Ibeanu": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "FLAGPol": 1,
                    "Pol": 1,
                    "Caucasian": 1,
                    "LC3": 1,
                    "NeoFLAGPol": 1,
                    "MPGoverexpressing": 1,
                    "Alkylating": 1,
                    "pIRESNeotrans": 1,
                    "VADFMK": 1,
                    "Hui": 1,
                    "Chinese": 1,
                    "Ibeanu": 1
                },
                "Ethnographic Terms": {
                    "methylation": 41
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Human thymine DNA glycosylase _TDG_ and methyl_CpG_binding protein 4 _MBD4_ excise thymine glycol _Tg_ from a Tg_ G mispair.pdf",
            "cleaned_text": "human thymine dna glycosylase methylcpgbinde protein MBD4 excise thymine glycol JungHoon iwai1 Biology Beckman Research Institute City Hope Duarte receive revise Accepted repair enzyme thymine dna glycosylase methylcpgbinde protein MBD4 remove thymine mismatch result amination methylcytosine Thymine glycol common dna lesion produce oxidative stress arise oxidation thymine oxida tive deamination methylcytosine present opposite adenine opposite guanine respectively use oligonucleotide thymine glycol incorporate different sequence context pair adenine gua show remove mine glycol present opposite guanine pair adenine ciency enzyme removal thymine glycol removal thymine sequence context protein evolve act specically dna mismatch produce amination oxidationcoupled deamination methylcytosine repair pathway contribute mutation avoidance methylate cpg dinucleotide introduction dna basis susceptible damage reactive agent derive endogenous exogenous origin prominent form endogenous damage arise hydrolytic deamination basis cytosine methylcytosine carry exocyclic amino group deamination exocyclic amino group cytosine methylcytosine generate uracil thymine respectively reaction give rise guanine uracil mispair guanine thymine respectively doublestranded DNA unrepaire prior dna replication mispair induce transition mutation replicate DNA mechanism involve methylcytosine appear particularly common methylate cpg dinucleotide mutational hotspot human gene example cancerrelevant p53 gene organism evolve repair enzyme remove deaminate basis several dna glycosylase repair mispair identi accurate cient repair mediate uracil dna glycosylase deamination cytosine produce deamination methylcytosine produce repair thymine dna glycosylase speci activity rst discover HeLa cell extract activity show substrate addition recent study show human protein ciently process mutagenic exocyclic adduct cytosine ethenocytosine arise dna consequence reaction lipid peroxidation product exposure chemical carcinogen vinyl chloride several protein bind methylate cpg site identi mecp2 group protein contain conserve methylcpgbinde domain MBD domain methylcpgbinde protein dna glycosylase activity methylcpgbinde domain recognize remove thymine uracil mispair unmethylate cpg sequence well furthermore also remove uracil analog uorouracil context weak glycosylase activity ethenocytosine interesting function quite similar complete lack sequence homology Thymine glycol form product exposure ionize radiation oxidative stress H2O2 major replicationinterfere lesion generate reactive oxygen specie vivo recognize excise DNA endonuclease III endo III endonuclease VIII endo VIII encode nth nei gene coli respectively Mammalian homolog gene characterize recently study use Nth1knockout mouse suggest several back glycosylase repair Mammalian Neilike gene encode protein sequence similarity bacterial family protein identi recombinant NEIL1 correspondence address fax email Vol right reserve show cient removal doublestranded substrate produce dna oxidation thymine however also arise oxidative deamination methyl cytosine present study puri recombinant human protein analyze activity enzyme repair mispair MATERIALS METHODS reagent oligonucleotide Oligonucleotides pcr primer purchase contain residue synthesize accord publish procedure restriction enzyme BamHI SacI purchase Beverly DNA ligase polynucleotide kinase purchase Promega Madison chemical reagent purchase protein laboratory stock previously describe construction plasmid contain human MBD4 gene pcr fragment fulllength human prepare Pfu turbo DNA polymerase primer human forward primer AGGGATCCATGGAAGCGGA GAACGCG BamHI cut site underline reverse primer SacI site underline human forward primer AGGGATCCATGGGCACGACTGGGCTG BamHI site underline reverse primer TCCTCGAGAGATA GACTTAATTTTTC XhoI site underline pcr product subclone plasmid pET28b cut restriction enzyme BamHI SacI human BamHI human respectively ligation restrict pcr product dna ligase ligate plasmid transform bacterial competent BL21 DE3 cell Stratagene human BL21 cell Stratagene human plasmid isolate sequence con cdna sequence expression vector generate His6tagged open reading frame tag locate terminal region protein recombinant human MBD4 protein single colony inoculate medium contain kanamycin culture add medium kanamycin grow vigorous shaking protein expression induce add isopropyl thiogalactopyranoside nal concentration grow culture additional room temperature cell pellet resuspend lysis buffer sodium phosphate Triton imidazole DNase solution solution add incubate room temperature min mix cell lysate centrifuge min mix slurry room temperature lysate mixture load column column wash washing buffer sodium phosphate Triton imidazole NaCl bind protein elute elution buffer sodium phosphate imidazole respectively procedure human purication human lysis buffer sodium phosphate Triton imidazole NaCl column wash washing buffer sodium phosphate Triton imidazole elute buffer contain sodium phosphate imidazole respectively exchange chromatography use additional purication remove contaminant human chromatography column use imidazole fraction human dialyze loading buffer mercaptoethanol glycerol load dialyze fraction contain protein column washing loading buffer bind protein elute linear gradient NaCl dialysis buffer Human MBD4 elute fraction NaCl puri human dialyze storage buffer KCl EDTA mercaptoethanol glycerol store imidazole fraction human dialyze dialysis buffer mercaptoethanol glycerol separate low molecular weight contaminant elute human protein ACA gel ltration buffer TrisHCl KCl EDTA mercaptoethanol glycerol column use additional purication human procedure washing elution human describe judge pure analysis sdspage dna glycosylase activity assay dna glycosylase activity puri human protein test mean cleavage assay oligonucleotide contain 30mer oligonucleotide ATCATACAGTCAGTG normal thymine indicate thymine glycol endlabele polynucleotide kinase endlabeled oligonucleotide anneal bottom strand anneal buffer NaCl KCl bottom strand contain methylcytosine guanine sequence substrate use standard cleavage assay carry volume reaction buffer HEPES KCl human human protein enhance cleavage activity human his6tagged apurinic endonuclease add reaction mixture mixture incubate follow phenolchloroform extraction ethanol precipitation mixture incubate piperidine min solution lyophilized DNA pellet dissolve formamide loading dye cleavage oligomer analyze denature polyacrylamide gel electrophoresis band detect quantitate phosphorimage Figure cleavage thymine glycolcontaining oligonucleotide coli dna glycosylase left panel show oligonucleotide thymine glycol opposite adenine right panel show oligonucleotide thymine glycol opposite guanine oligonucleotide incubate coli Nth Fpg Nfo protein cleavage elimination accomplish heat DNA piperidine min gel loading figure cleavage thymine glycolcontaine oligonucleotide human dna glycosylase left panel show cleavage double strand oligonucleotide thymine glycol opposite guanine right panel sequence thymine glycol opposite adenine sequence context methylcytosine guanine oligonucleotide incubate human recombinant protein cleavage elimination accomplish heat DNA piperidine min gel loading human recombinant include glycosylase reaction indicate result residue synthesize use substrate dna glycosylase major pyrimidine lesion produce oxidative damage DNA cisisomer produce dna equal amount irradiation chemical oxidation thymine produce predominantly isomer cis isomer equilibrium trans isomer solution initially test contain substrate use coli dna glycosylase Nth protein protein Nfo protein Fig contain doublestranded oligo nucleotide ciently cleave bacterial protein conrme suitability DNA substrate study mammalian protein Cleavage occur figure Enzyme substrate plot MBD4 thymine glycol oligonucleotide aliquot incubate min different amount substrate mismatch sequence context lane label contain pmol oligonucleotide additional protein add min oligonucleotide methylate cpg sequence context Quantication reaction protein different substrate Quantication reaction protein different substrate different amount MBD4 incubate min pmol different oligonucleotide substrate different amount incubate min pmol different oligonucleotide substrate reaction contain hAPE1 protein Diamonds mismatch sequence context square mismatch sequence context triangle mismatch ATgC sequence context either pair adenine opposite guanine Cleavage oligonucleotide slightly cient Fig recombinant human puri terminal Histagged protein use column column gel ltration column next test contain substrate recombinant human protein dna glycosylase cleave thymine mismatch surprisingly able cleave substrate base pair however react substrate contain opposite possess lyase activity cleave result abasic site removal base Cleavage achieve treatment glycosylase reaction product alkali piperidine produce elimination result elimination appearance short fragment alternatively sugarphosphate backbone break incubation endonuclease several dna glycosylase include prone substrate inhibition bind abasic site inclusion expect increase turnover rate enzyme see increase cleavage observe less extent presence human APE1 Fig order determine relative activity substrate contain mismatch base pair carry enzyme reaction use different substrate sequence present place guanine sequence context reaction cleavage reaction reaction substrate strongly depend base pair present sequence context methylate cpg slightly cient mcpg sequence literature mismatch cleavage indicate enzyme turn due inhibitory bind abasic site Experiments addition enzyme protein initial incubation min result additional cleavage Fig suggest turn substrate suggest back dna glycosylase repair become apparent nth1cient background addition mammalian NeiFpg homolog function back repair also act mismatch yet specically test result indicate remove thymine mismatch also repair Tgs form oxidationdeamination process operate methylcytosine analogy thymidine oxida tion dihydroxydihydromethyldeoxycytidine expect major oxidation product methyl deoxycytidine saturation double bond cytosine methylcytosine promote deamination reaction fact find oxidative attack methylcytosine result almost exclusively formation show replicationblocking lesion assay use replicative dna polymerase nonetheless correctly bypass dna damagetolerant polymerase dna polymerase arise oxidation thymine outcome mutation avoidance however arise oxidation deamination methylcytosine outcome transition mutation thus mutagenic pathway lead methylcytosine follow errorfree bypass incorporation adenine lesion likely biologically relevant mutation involve methylcytosine cpg dinucleotide particularly common possible least fraction produce oxidative damage pathway datum apparent specicity enzyme limit repair deaminate methylcytosine basis ethenocytosine case also extend damage produce oxidative deamination methylcytosine ment author like thank isolation cdnas work support grant Instability decay primary structure DNA Nature Cooper dinucleotide human genetic disease epigenetic effect dna methylation hotspot dna methylation fundamental role epigenetic event cancer nature Rev dna occurrence consequence repair Figure Schematic model generation mutation induce oxidation deamination methylcytosine hydrolytic deamination methylcytosine produce duplex dna deamination methylcytosine occur oxidative process thymine glycol form opposite guanine repair induce transition mutation polymerase bypass contrast production thymine glycol oxidation thymine mostly nonmutagenic event assume dna damagetolerant DNA polymerase bypass lesion correctly replication Jiricny Cloning expression human glycosylase Jiricny vitro correction mispair pair nuclear extract human cell Nature Hardeland versatile thymine DNAglycosylase comparative characterization human ssion yeast orthologs separate substrate recognition base hydrolysis human thymine dna glycosylase mutational analysis action thymine dna glycosylase Singer kda protein isolate human cell show dna glycosylase activity ethenocytosine mismatch ethenocytosine highly mutagenic adduct primary substrate coli double strand uracildna glycosylase human mismatchspeci thymine DNA glycosylase main role human thyminedna glycosylase removal thymine produce deamination methylcytosine removal ethenocytosine characterization family mammalian methylcpg bind protein Mol Cell Biol Hendrich Hardeland Jiricny Bird thymine glycosylase bind product deamination methylate cpg site Nature Stoerker kinetic human DNA repair protein dna glycosylase substrate spectrum human mismatchspeci dna glycosylase fundamental role catalytic domain Cell Physiol Beckman decay dna Biol Chem repair thymine glycol detect ultrasensitive assay dna damage Boiteux Substrate specicity coli endonuclease III excision thymine cytosine derive lesion DNA produce radiationgenerate free radical Biochemistry characterization human NTH1 homolog coli endonuclease III Direct identication active nucleophilic residue Teebor Cloning expression cdna encoding human homologue DNA repair enzyme Escherichia coli endonuclease III Biol Chem Aspinwall Rothwell Anselmino characterization functional human homolog coli endonuclease back glycosylase knock mouse functional Nei endonuclease VIII homologue Biol Chem Altamirano target deletion reveal novel dna repair enzyme activity Shiromoto Hasegawa Novel nuclear mitochondrial glycosylase reveal disruption mouse gene encoding endonuclease III homolog repair thymine glycol EMBO Rosenquist Zaika novel dna glycosylase NEIL1 protect mammalian cell radiationmediate cell death DNA Repair novel human dna glycosylase remove oxidative dna damage homologous Escherichia coli endonuclease VIII DNA Repair Hazra Kow Hatahet characterization novel human dna glycosylase repair cytosinederived lesion Biol Chem Hazra Izumi Boldogh Imhoff Kow Jaruga characterization human dna glycosylase repair modi basis oxidatively damage DNA Human DNA glycosylase bacterial fpgmutm superfamily alternative pathway repair oxoguanine oxidation product DNA Nucleic Acids Res Zuo Boorstein damage methylcytosine DNA Nucleic Acids Res Iwai Synthesis thymine glycol contain oligonucleotide build block oxidize base use dna glycosylase detect dna damage York terminal deoxyribose phosphate damage DNA catalyze protein Biol Chem Shaw Cadet Quantitative measurement diastereoisomer cis thymidine glycol gammairradiated DNA duplex dna contain thymine glycol residue solution Teebor Synthesis diastereomer thymidine glycol determination concentration rate interconversion cistrans epimer equilibrium demonstration differential alkali lability DNA thymine DNA glycosylase bind apurinic site DNA displace human apurinic endonuclease kinetic study deamination cis diastereomer dihydroxydihydro methyldeoxycytidine kinetic analysis deamination reaction cyclobutane dimer thymidylyl deoxycytidine deoxycytidylylthymidine Biochemistry methylcytosine cyclobutane pyrimidine dimer important component uvb mutagenesis synthesis human dna polymerase eta thymine glycol lesion Biochemistry DNA polymerase zeta zeta essential errorfree replication thymine glycol Genes Dev Hatahet Human DNA polymerase kappa bypass extend thymine glycol translesion synthesis preferentially incorporate correct nucleotide",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "epigenetic": 2,
                    "methylation": 2
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Mammalian": 1,
                    "cistrans": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "Mammalian": 4,
                    "cistrans": 4
                },
                "Ethnographic Terms": {
                    "epigenetic": 2,
                    "methylation": 2
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Hydroxyl radical scavenging by edaravone derivatives_ Efficient scavenging by 3-methyl-1-_pyridin-2-yl_-5-pyrazolone with an intramolecular base.pdf",
            "cleaned_text": "Hydroxyl radical scavenge edaravone derivative ecient scavenge methylpyridinpyrazolone intramolecular base receive revise accept Available online synthesize various derivative evaluate oxidation potential hydroxyl radical scavenge activity find methylpyridinpyrazolone much high ability scavenge radical ecient radical scavenge activity assume due increase anion form active form hydrogenbonde intramolecular base right reserve reactive oxygen specie involve many patholog ical condition injury cellular aging progression arteriosclerosis recently new compound methylphenylpyrazolinone also know develop medical drug brain ischemia report eec tive myocardial ischemia know ecient antioxidant consider basis protective eect ischemia enolate form interact hydroxyl radical follow formation stable oxidation product oxo phenylhydrazonobutanoic acid radical intermediate8 Fig encourage study structureactivity rela tionship SAR mean characterize structural feature edaravone optimize structure regard radical scavenging activity aqueous solution purpose synthesize edaravone derivative various substituent electron withdraw group electrondonate group conjugate group posi tion pyrazolone ring see support informa tion oxidation potential synthesize pyrazolone derivative measure cyclic voltam metry aqueous solution hydroxyl radical scavenge activity evaluate use elec spin resonance ESR spintrapping method 894X see front matter right reserve bmcl pyrazolone derivative form amount corresponding author mail address Figure reaction mechanism edaravone free radical oxophenylhydrazonobutanoic acid Letters Oneelectron oxidation potential synthe sized derivative measure NaCl solu tion Table oxidation current observe test compound irreversible probably oneelectron oxidation product convert degraded compound report poor solubility several derivative neutral aqueous solution solution slightly basie use aqueous solubilize compound derivative strong ewg compound benzoyl group relatively high oxidation poten tial expect derivative show wide variety oxidation potential regardless electron property substituent Table possible oxidation potential aecte electron density pyrazolone ring also stability result radical specie con jugated orbital substituent comparison position substituent substitution position positively aect reduction oxidation potential position seem eective Fig radical scavenge activity evaluate spintrappe method dimethylpyrro lineoxide spin trap radical generate irradiation cm2 hydrogen peroxide solution contain ravone derivative inhibitory eect deriv atives formation hydroxyl radical adduct use measure radical scavenging activity IC50 value determine derivative diverse oxidation potential relationship IC50 value oxidation potential sim ply proportional show shape correlation oxidation poten tial show low IC50 value derivative test edaravone anion report active form scavenge free radical oneelectrontransferre mechanism actually case dation edaravone azobisdimethylvalero nitrile radical initiator oxidation rate increase dependent manner methanol buer solution therefore amount anionic form synthesize derivative important scav enge activity hand electron density pyrazolone moiety also important oneelec tron oxidation reactivity relatively electronrich sub stituent pyrazolone ring lower oxidation potential concomitantly decrease amount anionic form protonation due increase partial negative charge contrast substituent increase amount anionic form enlarge oxidation potential show Table figure edaravone almost good oxidation potential hydroxyl radical scavenging experimental con dition activity oxidation potential amount anion form well balance Table Oxidation potential derivative Compound Epa edaravone CH3 edaravone CH3 CH3OPh CH3 ClPh CH3 cyclohexyl ch3 pyridinyl ch3 CF3 NO2Ph CH3OPh CH3OCONH PhOCONH CH3 Isobutyl ch3 CH3 Cyclopropyl CH3 PhCO NO2Ph CH3 Conditions measurement sample electrode electrode AgCl counter electrode speed scan range oxidation potential express report derivative lipophilic sub stituent phenyl group position pyraz olone ring show high inhibitory activity lipid peroxidation likely increas ing concentration derivative lipid phase aqueous solution result suggest increase anionic form derivative appear important requirement ecient radical scavenging pKa value derivative aqueous solution hardly evaluate due poor solubil ity derivative neutral acidic solution refer database use datum comparison relative stability deproto nate form novel compound pKa value esti mate calculate free energy change deprotonation density functional theory B3LYP see support information calculated pKa value find roughly high derivative low oxidation potential imply amount anionic form related radical ing activity derivative low oxidation poten tial edaravone light property clarie increase anionic form concomitant positive shift oxidation potential eective ecient electron radical reduction tion derivative apparently occur anion form deprotonation derivative potential oneelectron oxidation oxidation current next focus compound pyridin moiety intramolecular base position pyrazolone ring basic function facili tate partial deprotonation pyrazolone ring moiety expect IC50 value time small almost oxidation figure structure edaravone derivative synthesize study figure relationship oxidation potential IC50 value datum point represent specic derivative number side imply pyri din function partially deprotonate pyraz olone ring form intramolecular hydrogenbond marked decrease electron density pyrazolone ring support idea conrme nmr analysis enol form CDCl3 solution singlet methyne proton broaden enol proton observe instead methylene proton pyrazolone ring see support information conclusion determine oxidation potential hydroxyl radical scavenging activity various ravonerelated derivative aqueous solution analyze characteristic free radical scavenger aqueous condition finally find tive ecient radical scavenge aqueous solution stabilize active anionic form intramolecular base acknowledgment work support part grant Ministry Health Labor datum associate article find online version bmcl note Enzymol Chapple Clin Periodontol Kirkwood Exp Gerontol DarleyUsmar Halliwell Pharm Res Suga Saito Pharmacol Exp Ther Watanabe Yuki Egawa Nishi Pharmacol Exp Ther Zeng Fung Life Sci Yamamoto Redox Rep Ono Okazaki Sakurai Inoue Phys Chem Yuki Nishi Redox Rep Shimazu Biophys Takai Shimazu Biophys Jpn Pharmacol Ther Yamamoto Jpn Oil Chem Soc Table Hydroxyl radical scavenging activity IC50 edaravone derivative Compound IC50 edaravone CH3 Pyridinyl ch3 CF3 PhOCONH ch3 CH3 Cyclopropyl CH3 PhCO NO2Ph CH3 Conditions measurement mixture H2O2 DMPO compound irradiate ESR spectrometer parameter microwave power modulation width time constant sweep width sweep time min gain",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "AgCl": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Hydroxyl terminated poly _ether ether ketone_ with pendent methyl group toughened epoxy resin_ miscibility_ morphology and mechanical properties.pdf",
            "cleaned_text": "terminate polyether ether ketone pendent methyl group toughen epoxy resin miscibility morphology mechanical property Special Chemicals Division Propellants Special Chemicals Group Propellants Chemicals Materials Entity Vikram Sarabhai Space Centre Thiruvananthapuram Kerala University receive receive revise form accept available online synthesis process thermal mechanical property fracture toughness epoxy resin formulate hydroxyl terminate polyether ether ketone pendent methyl group report terminate polyether ether ketone oligomer base methyl hydroquinone peekmoh synthesise peekmoh oligomer different molecular weight synthesise characterise Blends diglycidyl ether bisphenol epoxy resin peekmoh prepare melt mix uncured blend homogeneous composition behaviour predict use equation reaction induce phase separation occur blend cure diaminodiphenyl sulfone Scanning electron microscopy study reveal twophase morphology blend domain size blend increase increase PEEKMOH8 blend phase separation blend occur nucleation growth mechanism spectroscopic study reveal epoxy group open hydroxyl group peekmoh tensile exural property blend comparable neat epoxy resin property dependent composition blend molecular weight peekmoh use Dynamic mechanical analysis reveal glass transition temperature correspond epoxy rich thermoplastic rich phase crosslink density epoxy resin decrease addition peekmoh epoxy resin blend exhibit superior fracture toughness compare unmodied epoxy resin increase fracture toughness due local plastic deformation matrix crack path deection crack pin thermal stability amine cured epoxy resin affect incorporation PEEKMOH epoxy resin right reserve epoxy resin peekmoh Morphology introduction thermosette resin widely use composite industry high modulus easy processability various thermosette resin epoxy resin extensively use matrix high performance composite aerospace automotive industry due high modulus corrosion resistance low shrinkage cure excellent property arise highly crosslinke structure cured epoxy resin practical disadvantage highly crosslinke material poor resistance crack propagation material brittle use damage tolerant application large amount literature regard improvement toughness epoxy resin common method increase fracture toughness incorporate rubber epoxy resin various reactive functionalise butadiene acrylonitrile rubber carboxy terminate butadiene acrylonitrile amine terminate butadiene acrylonitrile epoxy terminate butadiene acrylo nitrile widely use modier epoxy resin especially diglycidyl ether bisphenol DGEBA resin advantage reactive functionalise elastomer blend homogeneous uncured state undergo phase separation cure give rise uniform distribution rubber particle epoxy matrix low rubber concentration disperse rubber particle initiate different toughening mechanism important Polymer wwwelseviercomlocatepolymer see front matter right reserve polymer corresponding author C91 fax C91 Tel C91 fax C91 mail address sabutsancharnet Thomas raovlrediffmail com mechanism rubber particle cavitation matrix shear yield even rubber toughen effective DGEBA resin ineffective highly crosslinked epoxy resin tgddm inability rubber toughen multifunctional epoxy system due high crossslink density epoxy shear deformation matrix prevent apart rubbertoughened system low modulus decrease thermal stability order get improve toughness loose thermal mechanical property engineering thermoplastic often use toughen epoxy resin advantage use thermoplastic mechanical thermal property epoxy resin retain even blend frequently use thermoplastic polyether sulfone polyether imide polyaryl ether ketone polyphenylene oxide polyamide report good toughening agent epoxy resin thermoplastic toughen epoxy form homogeneous blend uncured state undergo phase separation cure curing phase separation process well study blend case rubber modie epoxy resin functional group polymer enhance initial miscibility interfacial adhesion phase cured state example toughen epoxy resin use functionalise polyester report several researcher Polyether ether ketone PEEK engineering thermoplastic excellent property commercially available immiscible epoxy resin even high temperature hence alternative introduce bulky pendent group reactive functional group backbone investigate improve processability amorphous peek phenolphthalein polyether ether ketone synthesise use modify epoxy resin miscible epoxy resin ultimate morphology blend dependent cure agent curing condition use investigate fracture toughness mechanical property blend DGEBA epoxy resin amine terminate tert butyl hydroquinone methyl hydroquinone bisphenol base oligomer blend exhibit enhanced fracture toughness morphology range disperse thermoplastic continuous thermoplastic depend composition morphology blend dependent cure agent curing condition employ prepare blend observe similar result methyl hexahydrophthalic anhydride cure bisphenol epoxy resin modie polyaryl ether ketone prepare chloride diphenyl ether early report kinetic cure blend DGEBA epoxy resin pendent tertbutyl group cure present study devote synthesis peekmoh oligomer modication epoxy resin use PEEKMOH prime objective investi gation nd effect molecular weight peekmoh morphology mechanical property fracture toughness DDS cure DGEBA epoxy resin thermal stability select blend system also investigate finally attempt make correlate morphology fracture toughness blend use High purity methylhydroquinone DFBP Spectrochem potassium car bonate Qualigens methylpyrrolidone NMP toluene Qualigens use synthesis vacuum dry respectively potassium carbonate dry mufe furnace use distil reduce pressure store molecular sieve distil sodium store sodium wire Diglycidyl ether bisphenol DGEBA epoxy resin epoxide equivalent weight use hardener use diaminodiphenylsulfone material use receive specied chemical structure epoxy resin give Fig CH2 CH2 CH2 CH2 CH2 ch2 ch3 ch3 ch3 CH3 Diglycidyl ether bisphenol NH2 h2n diaminodiphenyl sulfone structure epoxy resin oligomer terminate PEEK oligomer pendent methyl group different molecular weight synthesise nucleophilic substitution reaction DFBP MeHQ Scheme molecular weight control take specied amount monomer calculate use equation hydroxyl functional group maintain take calculated excess dihydroxy monomer typical procedure synthesis hydroxyl terminate oligomer number average molecular weight Mn follow synthesis conduct clean dry fournecked ask equip mechanical stirrer thermowell nitrogen inlet trap outtte condenser ask purge dry nitrogen start reaction ask charge mol MeHQ mol potassium carbonate compound carefully wash ask use toluene add solution azeotrope agent reaction mixture heat constant stirring Water form reaction form azeotrope toluene effectively remove trap reaction temperature bring mol DFBP add ask reaction mixture heat cool room temperature polymer form precipitate add distilled water room temperature Complete precipitation ensure heat solution constant stirring precipitate oligomer ltered puried dry vacuum number average molecular weight synthesise designate PEEKMOH3 PEEKMOH6 PEEKMOH8 respectively blend preparation blend prepare melt mix oligomer dissolve epoxy resin constant stirring phr triphenylphosphine add catalyst blend complete dissolution stoichiometric amount add dissolve completely ternary solution evacuate vacuum oven evacuation mixture transfer open mould keep blend cure air convection oven post cure post cure blend allow cool slowly room temperature blend phr PEEKMOH prepared characterisation molecular weight molecular weight distribution PEEKMOH determine use gel permeation chromatog raphy separation module conjunction differential refractive index detector use machine calibrate use polystyrene standard analysis do use chloroform solvent rate min inherent viscosity oligomer determine polymer solution concentrate sulphuric acid room temperature use suspend level viscometer nmr spectrum oligomer record use spectrometer CDCl3 use solvent tetramethyl silane internal standard ftir spectrum polymer KBr pellet record use GXA FTIR spectrometer DSC analysis glass transition temperature pristine epoxy resin peekmoh oligomer binary blend determine use instrument model Scheme General reaction scheme synthesis hydroxyl terminate pendent methyl group differential scan calorimeter order determine oligomer heat heating rate min nitrogen atmosphere determine pristine epoxy binary epoxyPEEKMOH8 blend sample heat K50 heating rate min nitrogen atmosphere ftir analysis Infra red study conduct investigate completion cure reaction fully cure sample powdered spectra sample kbr pellet record use GXA ftir spectrometer tensile exural property tensile exural property determine ASTM d638 ASTM d790 respectively measure ment do use universal testing machine model TNE crosshead speed min rectangular specimen mm3 use determine exural strength Flexural strength calculate use equation Flexural strength load break span length breadth thickness specimen respectively flexural modulus determine slope initial portion exural stressstrain curve Fracture toughness fracture toughness blend determine accord ASTM STP410 Rectangular specimen use fracture toughness measurement notch make edge specimen natural crack make press fresh razor blade notch analysis do tension mode fracture toughness express stress intensity factor calculate use stress intensity factor KIc load initiation crack crack length breadth specimen thickness specimen geometry constant calculate use C18 c53 scan electron microscopy fracture surface cryogenically fractured specimen fail specimen fracture toughness measurement analyse use scan electron microscope cryogenically fractured surface etch chloroform remove thermoplastic phase specimen dry vacuum overnight remove solvent specimen sputter coat gold take micrograph Dynamic mechanical thermal analysis viscoelastic property unmodied resin blend measure use dynamic mechanical thermal analyser rectangular specimen mm3 use analysis analysis do dual cantilever mode frequency sample heat room temperature heating rate min Thermogravimetric analysis thermal stability blend analyse thermogravimetric study model thermal analyser use thermogravimetric analysis sample heat room temperature heating rate min nitrogen atmosphere result ftir spectrum peekmoh show Fig peak due carbonyl stretching vibration observe symmetrical stretch vibration bond methyl group observe cmK1 stretch vibration observe broad peak cmK1 symmetrical stretch vibration bond stretch bend vibration bond observe respectively stretch vibration benzene ring observe cmK1 ring hydrogen Fig ftir spectrum rock vibration observe cmK1 plane bend vibration bond benzene ring observe nmr spectrum PEEKMOH8 peak assignment show Fig spectrum reveal peak correspond distinguishable carbon atom oligomer chemical shift assignment various carbon atom base additivity constant substituted benzene peak due carbonyl carbon observe ppm methyl carbon peak observe ppm peak spectrum due aromatic ring carbon polymer number average molecular weight inherent viscosity oligomer give Table inherent viscosity glass transition temperature find increase increase molecular weight oligomer blend melt mixed blend transparent visual heterogeneity observe different blend system blend choose differ ential scan calorimetric study single glass transition temperature observe binary DGEBA PEEKMOH8 blend glass transition temperature increase increase peekmoh content blend lie pure DGEBA PEEKMOH8 presence single conrme fact blend homogeneous cure ftir study maximum property epoxy resin attain fully crosslinke system ftir study conduct investigate completion cure reaction spectrum blend give Fig epoxy peak vanish cure indicate curing reaction reach completion Fracture toughness fracture toughness cure epoxy resin well blend peekmoh give Table fracture toughness increase addition peekmoh epoxy resin blend exhibit vary degree enhance fracture toughness general fracture toughness dependent molecular weight oligomer table use modify epoxy resin maximum increase toughness attain addition phr PEEKMOH8 Fig nmr spectrum PEEKMOH8 Table Properties PEEK oligomer pendent methyl group oligomer mol inherent cosity PEEKMOH3 PEEKMOH6 PEEKMOH8 Neat epoxy resin 10phr Fig ftir spectrum fully cure blend blend give improvement fracture toughness compare unmodied resin morphological analysis scanning electron microscopy excellent tool study morphology polymer blend preferential extraction minor component helpful get clear picture morphology blend scan electron micrograph cryogenically fractured surface DGEBAPEEKMOH6 blend show respectively blend show twophase morphology peekmoh rich domain disperse continuous epoxy matrix cavity micrograph represent space occupy peekmoh domain extraction domain uniformly distribute blend phase inversion observe composition study domain size determine use image analysis technique number average weight average domain diameter polydispersity index calculate use following equation number average diameter nidi weight average diameter nidi index pdi number domain diameter number average weight average domain diameter polydispersity index calculate use equation blend summarise Table observe domain size polydispersity index increase increase PEEKMOH8 content blend Dynamic mechanical thermal analysis dynamic mechanical analysis blend give insight viscoelastic property well morphology blend tan temperature plot DGEBAPEEK MOH8 blend give reveal peak peak correspond PEEKMOH8 rich phase peak high temperature correspond epoxy rich phase storage modulus blend room temperature neat epoxy phr show high value Fig inection see plot storage modulus thermoplastic second epoxy storage modulus low epoxy resin glass transition continue plateau region loss modulus blend neat resin respect temperature give Fig loss modulus high blend neat resin high value loss Table Fracture toughness dgebapeekmoh blend peekmoh content phr KIc mK3 PEEKMOH3 PEEKMOH6 06g0 PEEKMOH8 Fig Scanning electron micrograph DGEBAPEEKMOH6 blend etch chloroform Fig Scanning electron micrograph blend etch chloroform modulus blend show blend well interaction phase tensile exural property result tensile exural property measurement summarise Table small increase tensile strength observe blend tensile modulus calculate initial slope tensile stress strain curve show slight decrease blend system study exural strength blend low neat resin decrease exural strength dependent molecular weight PEEKMOH use modify epoxy resin low molecular weight peekmoh modied epoxy resin show nearly reduction exural strength exural modulus show small decrease neat resin analysis thermal stability blend analyse use blend show initial decomposition temperature temperature rate decomposition maximum remain unmodied epoxy resin Activation energy decomposition calculate use nonisothermal integral equation viz equation main advantage nonisothermal technique obtain kinetic value single measure ment whole temperature range coatsredfern equation give use compute activation energy ga 1k2rt ga 1kn fraction decompose temperature heating rate gas constant factor good correlation coefcient ro0 obtain activation energy determine plot kln1ka reciprocal absolute temperature Activation energy calculate slope kinetic plot calculated value correlation coefcient parameter thermogravimetric analysis give Table parameter comparable neat epoxy resin Table Number average weight average domain diameter DGEBAPEEK MOH8 blend PEEKMOH8 content phr pdi 10phr tan Temperature Fig tan temperature plot blend 10phr mpa Temperature Fig storage modulus blend 10phr mpa Temperature Fig loss modulus blend Francis Polymer Discussion improve fracture toughness epoxy resin reduction thermomechanical property aim blend thermoplastic epoxy resin order achieve good toughness improvement homogeneous blend phase separate cure require uniform dispersion domain good interfacial adhesion essential achieve tough epoxy resin system reaction induce phase separation homogeneous blend curing yield uniform dispersion domain thermoplastic epoxyther moplastic blend low thermoplastic content use modi immense potential good physicomechanical property general bility epoxy resin overcome use low molecular weight oligomer reactive functional group PEEK bulky pendent group ultimate proper tie blend dependent inherent property oligomer use well property matrix present work use hydroxyl terminate PEEK oligomer pendent methyl group modify DGEBA epoxy resin cure oligomer different molecular weight synthesise use solvent presence anhydrous potassium carbonate hydroxyl functionality maintain react calculated excess DFBP glass transition temperature inherent viscosity dependent molecular weight oligomer possible prepare blend epoxy resin melt mix heterogeneity observe dgebapeekmoh blend visual inspection change visual transparency blend DSC study binary blend give single increase increase peekmoh content blend conrme homogeneity blend glass transition temperature homogeneous blend system calculate theoretically use equation equation give respectively w1Tg1 Ckw2Tg2 v1Tg1 Ckv2Tg2 Tg1 tg2 glass transition temperature blend tg1 glass transition temperature weight fraction volume fraction component respectively adjustable parameter plot experimental theoretically calculate value show Fig composition behaviour phr blend show inset see gure equation deviate experimental determine use DSC always great experimental value equation give good correlation experimental value worker suggest value equation indicate interaction blend component epoxy PEEKMOH blend value show good agreement experimental low value indicate weak interaction uncrosslinked epoxy resin PEEK hence initial miscibility mainly associate entropic contribution arise low molecular weight uncrosslinked epoxy resin blend composition phr tensile strength mpa young modulus gpa flexural strength mpa flexural modulus GPa PEEKMOH3 62g2 65g3 64g0 PEEKMOH8 6G0 weight temperature 10phr Fig blend Table IDT Tmax activation energy decomposition correlation coefcient blend mol correlation coefcient extent crosslinke play crucial role determine ultimate property cured resin also property dependent amount cure agent use sufcient cure agent crosslink epoxy group ultimate property reduce stoichiometric amount cure agent give maximum cure dgeba resin epoxythermoplastic blend presence thermoplastic report hinder curing reaction example cure blend cure anhydride absorption due unreacted epoxy group present spectrum cured blend present system spectra blend show characteristic absorption epoxy group observation reveal free epoxy group present cure blend indicate fully crosslinke system blend exhibit high fracture toughness compare unmodied resin extent improve ment fracture toughness dependent molecular weight oligomer composition blend morphology important criterion enhancement fracture toughness exception heterogeneous blend give high fracture toughness compare homogeneous blend scan electron micrograph clear DGEBAPEEKMOH blend heterogeneous frequency domain increase peekmoh content blend disperse peekmoh blend initiate various energy absorb mechanism result increase fracture toughness scan electron micrograph failure surface give information fracture mechanism blend reveal fail fracture surface cure epoxy resin blend PEEKMOH8 fracture surface neat epoxy resin show typical characteristic brittle fracture surface smooth crack propagate uninterrupted fracture surface blend rough ridge pattern river mark see fracture surface roughness fracture surface due reason First indication crack path deection crack deviate original plane increase area crack hence energy require propagation PEEKMOH8 content phr Experimental Fox GordonTaylor Temperature equation Fig Comparison experimental theoretical value glass transition temperature blend electron micrograph fail surface neat epoxy resin phr phr phr DGEBAPEEKMOH8 blend crack increase Second roughness indicate ductile nature crack describe phase morphology desirable increase fracture toughness time good interaction disperse phase epoxy matrix also essential enhance fracture toughness often achieve incorporate reactive group modi disperse peekmoh domain good adhesion epoxy matrix due presence hydroxyl group add catalyse reaction epoxy hydroxyl group micrograph see vacant space fracture surface due removal domain fracture surface ductile tear domain indicate exist strong interfacial adhesion matrix domain due opening epoxy ring hydroxyl group due bonding interaction ftir analysis binary epoxypeekmoh8 blend reveal epoxy group open hydroxyl group hence PEEK chain incorporate crosslinke network structure catalyse polyetherication epoxy resin reaction hydroxyl epoxy group decrease intensity due hence ftir spectra epoxy resin heat take quantitative analysis demonstrate decrease intensity epoxy peak decrease intensity less case blend therefore conclude catalyse reaction hydroxyl epoxy group polyetherication epoxy resin hence clear exist good adhesion phase also scan electron micrographs white ring see domain mean exist diffuse layer thermoplastic epoxy present external load apply disperse domain act stress concentrator lead plastic deformation local area surround domain river mark fracture surface also indicate plastic deformation ductile nature crack close observation micrograph tail mark see domain indicate crack pin mechanism crack pinning report epoxyPPO blend improve fracture toughness blend factor contribute increase fracture toughness blend fracture surface PEEKMOH6 PEEKMOH3 blend show fracture surface PEEKMOH6 blend show similar feature modied epoxy resin fracture surface PEEKMOH3 modied system appear smooth little feature see due well miscibility PEEKMOH3 epoxy resin find ftir investigation interaction hydroxyl epoxy group molecular weight decrease number terminal hydroxyl group increase proportionally result extent miscibility high case PEEKMOH3 modie epoxy resin Table find improvement fracture toughness dependent molecular weight concentration peekmoh blend addition phr PEEKMOH8 high molecular weight give maximum improvement fracture toughness case PEEKMOH6 PEEKMOH3 toughened system phr addition give increase fracture toughness say blend fracture toughness increase composition 15phr give maximum toughness blend phr addition give less fracture toughness phr blend several factor inuence fracture toughness blend interparticle distance interfacial area unit volume domain size domain size distribution inuence extent improvement fracture toughness various blend system interparticle distance interfacial area unit volume calculate use respectively summarise Table distance Fig scan electron micrograph fail surface DGEBAPEEKMOH3 blend Table Interfacial area unit volume interparticle distance DGEBAPEEK MOH8 blend PEEKMOH8 content phr distance Interfacial areaunit volume area unit volume diameter domain radius domain volume fraction thermoplastic interparticle distance decrease interfacial area unit volume increase increase PEEKMOH8 content blend phr domain diameter increase increase oligomer content blend factor favour improvement fracture toughness increase concentration peekmoh blend fracture toughness phr blend low phr blend explain basis domain size distribution blend domain size distribution blend give Fig narrow size distribution show phr blend phr show broad distribution 10phr blend domain diameter also see graph small large domain present almost equal amount phr blend small large domain less effective improve fracture toughness factor lead low fracture toughness phr blend compare phr blend scanning electron micrograph blend exhibit phase morphology initially homogeneous blend phase separate cure due increase molecular weight epoxy resin result crosslinke phase separation mechanism epoxy resinthermoplastic blend study extensively phase separation mechanism find dependent composition blend nature cure agent cure temperature secondary phase separation observe case composition blend critical composition phase separation occur spinodal decomposition critical composition phase separation occur nucleation growth mechanism thermoplastic average molar mass mol critical concentration thermoplastic liquid epoxy diamine monomer calculate FloryHuggins model present study PEEKMOH low molecular weight use modify epoxy resin hence critical concentration high mention range therefore phase separation expect occur nucleation growth mechanism mechanical thermal analysis blend also support twophase morphology blend peak correspond epoxy rich thermoplastic rich phase appear tan temperature blend Fig epoxy rich phase decrease addition PEEKMOH8 due presence small amount PEEKMOH8 remain epoxy matrix decrease also due decrease crosslink density blend result incorporation PEEKMOH8 epoxy ftir study reveal exist reaction epoxy hydroxyl group peekmoh peak height peak area peak width half height value effective crosslink density blend tabulate Table peak height peak width peak area DGEBA PEEKMOH8 blend high neat resin PEEKMOH6 PEEKMOH3 modie epoxy resin show low value calculate use follow equation glass transition temperature crosslinked epoxy resin tg0 glass transition temperature uncrosslinked polymer chemical composition crosslinked polymer value tg0 take dgebadds system effective crosslink density domain domain size 10phr Fig Domain size distribution blend Table Peak height peak width half height peak area effective crosslink density blend dynamic mechanical thermal analysis peekmoh content phr Peak height width half height Peak area cm2 mol chain PEEKMOH8 PEEKMOH6 PEEKMOH3 calculate use follow equation effective crosslink density rNA density number find crosslink density decrease addition peekmoh epoxy resin decrease crosslink density due incorporation peekmoh chain epoxy network result reaction hydroxyl epoxy group storage modulus blend decrease increase temperature blend show inection Fig rst inection PEEKMOH8 second epoxy storage modulus blend low blend neat epoxy rst inection point indication low crosslink density blend loss modulus blend also give peak dynamic mechanical spectrum correspond epoxy rich thermoplastic rich phase loss modulus blend always high unmodied resin tensile exural property blend dependent molecular weight oligomer use composition blend tensile strength blend high neat resin cure modulus marginally decrease addition DGEBAPEEKMOH3 blend exhibit low value plot tensile stressstrain curve blend phr blend different molecular weight peekmoh show respectively yield observe tensile stress strain curve cure epoxy resin blend show cure epoxy blend peekmoh basically brittle material tensile strain PEEKMOH8 blend increase increase concen tration PEEKMOH8 blend strain decrease decrease molecular weight peekmoh exural strength decrease decrease acceptable limit exural modulus blend 10phr Fig tensile stressstrain curve blend DGEBAPEEKMOH3 Fig tensile stressstrain curve DGEBA phr peekmoh different molecular weight Flexural strain flexural stress mpa 10phr Fig flexural stressstrain curve blend flexural stress Flexural strain DGEBAPEEKMOH3 Fig Flexural stressstrain curve DGEBA phr peekmoh different molecular weight comparable neat epoxy resin exural stress strain curve blend show Fig exural strain blend comparable neat epoxy resin exural strain phr PEEKMOH blend show fig low molecular weight peekmoh toughen epoxy resin show low strain decrease tensile strain exural strain maximum DGEBAPEEKMOH3 blend inherently low property PEEKMOH3 low molecular weight thermogravimetric analysis find decrease blend PEEKMOH6 PEEKMOH3 blend show similar beha viour activation energy decomposition remain slightly high neat resin conrme thermal stability affect presence peekmoh blend Conclusions melt processable epoxypeekmoh system investi gate miscibility fracture toughness tensile exural property thermal property terminate pendent methyl group synthesise nucleo philic substitution reaction blend uncured state homogeneous glass transition temperature homogeneous system theoretically calculate ftir study binary epoxypeekmoh blend reveal hydroxyl group react epoxy group presence induce phase separation occur blend cure blend exhibit twophase morphology uniform dispersion peekmoh domain epoxy matrix see DGEBAPEEKMOH blend domain size size distribution dependent molecular weight concentration peekmoh blend substantial improvement fracture toughness achieve incorporation peekmoh epoxy resin extent improvement fracture toughness dependent domain size distribution molecular weight oligomer composition blend various toughening mechan ism crack pin crack path deection ductile nature crack plastic deformation matrix responsible increase fracture toughness blend mechanical property blend comparable unmodied resin glass transition temperature epoxy rich thermoplastic rich phase see dynamic mechanical spectrum blend loss modulus blend high neat resin indicate well interaction phase deterioration thermal stability epoxy resin observe blend peekmoh ment author thank authority give permission publish article author thankful provide also due Spectroscopy Division VSSC analytical support technology epoxy resin Blackie Academic Professional Lee Neville Handbook epoxy resin Pearson Park Lim Appl Polym Sci Nigam Setua Mathur Appl RJJ polymer Ramos Costa Soares RSV Polym Test Miller Miller Butta Levita Marchetti Lazzeri Nigam Mimura Ito Fujioka Polymer Acierno Polymer Bueno Polym Int Polymer Int Choe Appl Polym Sci Blanco Cicala Faro Recca Appl Polym Sci Giannotti Solsona Galante Oyanguren Appl Macromol Symp Recca Appl Part Polym Phys Mondragon Eur Polym Legras Polymer Cao Shao Sun Lin Appl tomoi Appl Polym Sci Zhang Liaohai Appl Polym Sci Posada Groeninckx Coats Redfern Nature Phys Soc belorgeygprudhommerejpolymscipartb polymphys1982 Polymer Meyer Sanz Polymer Ragosta Scarinzi Polym Phys Carlier Polymer Bellenger Verdu Morel Polym Sci B25",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "DGEBAPEEKMOH6": 2,
                    "PEEKMOH6": 1,
                    "TgKTg0": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "In vitro and in vivo Leishmanicidal activity of 2_hydroxy_3__3_methyl_2_butenyl__1_4_naphthoquinone _lapachol_.pdf",
            "cleaned_text": "vivo Activity naphthoquinone Teixeira1 Joseval Viana1 Filha1 Castelo Coelho1 vietla rao2 Pompeu1 Prof Faculdade Medicina Universidade Federal Fortaleza Brazil Fisiologia Federal Fortaleza study aim evaluate vivo leishmanicidal activity naphthoquinone find seed heartwood certain tropical plant compare efcacy drug sodium stibogluconate Pentostam1 compound evaluate intracellular amastigote braziliensis LVb test animal model hamster try reproduce leishmanicidal activity vitro lapachol exhibit antiamas tigote effect vivo prevent development LVbinduced lesion oral dose day Pentostam1 demonstrate signicant antiamastigote effect LVb apparent clinical cure vivo day however completely eradicate parasite tissue infect animal observation exert leishmanicidal activity vitro offer signicant protection lesion hamster suggest possibly inhibit microbicidal function macrophage alternatively trans form inactive metabolite neutralize lose leishmanicidal activity also possible optimal sustained plasma level drug achieve dose use study treatment introduction cutaneous leishmaniasis endemic disease prevalent many part world characterize chronic skin ulcer site sandy bite meglumine antimoniate sodium stibogluconate pentamidine drug choice treatment leishmaniasis drug administer parenteral route unpleasant serious side effect renal neural cardiac toxicity shock pancreatitis risk diabetes Pearson addition clinical failure antimonyresistant para site report therefore drug effective less toxic easy use strongly need increase search new antiparasitic drug develop medicinal plant hydroxymethylbutenyl naphthoquinone Fig antimicrobial antitumour agent naphthoquinone group isolate specie derivative show antiparasitic action Schistosoma mansoni Trypanosoma cruzi report biological activity lapachol lead investigate leishmanicidal potential substance antileishmanial activity evaluate Figure Chemical structure lapachol PHYTOTHERAPY research Phytother res copyright Correspondence Teixeira Fortaleza mail contractgrant sponsor contractgrant sponsor ESP receive Revised test Viannia braziliensis LVb amastigote vivo cutaneous LVbinfected lesion hamster compare efcacy Pentostam1 material METHODS drug test pure lapachol supply Pernambuco lafepe yellow coloured crystal vial sodium stibogluconate Pentostam1 MEHECO provide Brazil Parasites braziliensis stock MHOM use originally isolate skin lesion patient type use enzyme electrophor esis monoclonal antibody parasite maintain drosophila medium antibiotic penicillin potassium streptomycin sulphate bottle parasite serially passage hamster serve need freshly isolate medium supplement antibiotic glutamine sterile fetal bovine serum sterile normal human urine stationary phase promastigote use infection use promastigote harvest culture wash sterile saline resuspend get desire concentration vitro assay Macrophage culture Swiss mouse peritoneal macro phage stimulate injection starch day collect rpmi medium contain heparin macrophage centrifuge rpm wash sterile saline resuspend rpmi medium obtain concentration cell Aliquots deposit well culture plate cell allow adhere CO2 Nonadherent cell remove washing warm culture medium supernatant replace fresh rpmi fbs antibiotic follow additional incubation evaluation drug cytotoxicity macrophage Cytotoxicity eval uated expose nonparasitized peritoneal macro phage different concentration lapachol Pentostam1 incubate co2 percentage viable cell determine staining trypan blue dye exclusion procedure viable cell count tion drug produce less cell death consider toxic activity Swiss mice peritoneal macro phage plate well plate cell well rpmi medium supplement antibiotic infect stationary phase LVb promastigote parasite well co2 extracellular parasite remove washing warm culture medium compound test add different concentration drug dilute dimethyl sulphoxide dmso rpmi medium nal concentration culture follow additional incubation super natant replace medium suppleman ted antibiotic sterile human urine plate incubate order allow survive LVb amastigote transform promastigote well thymidine add cell incubate harvest thymidine incorporation measure counter perform replicate inhibition growth express percent decrease radioactive incorporation treat cell compare untreated control formula calculation antileishmanial activity parasitize macrophage cpm treat cell parasitize macrophage drug cpm control cell parasitize macrophage consider good antileishmanial activity value equal great obtain vivo study experimental animal female male golden hamster auratus obtain Prof AlencaUFC Animals house group water food libitum study experimental procedure approve Federal Ceara Brazil infection treatment Twentytwo hamster infect right hind footpad contain stationaryphase LVb promastigote treatment initiate inoculation infection well establish lesion obvious animal randomly divide group drug administer group drug dissolve distil water contain ethanol administer oral route intragastric intubation Pentostam1 group antimonial administer day route Pentostam1 group administer day oral route Pentostam1 administer day route group untreated group receive orally drugless vehicle tween ethanol lesion growth lesion size measure dial gauge caliper sensitivity LEISHMANICIDAL ACTIVITY LAPACHOL copyright Phytother Res express difference thickness infect footpad contralateral uninfected footpad measurement initiate inoculation promastigote continue effect treatment animal kill cessation treatment assess parasitological load drain lymph node use limit dilution assay modie drain lymph node aseptically excise weigh homogenize tissue glass grinder medium removal debris sedimentation min homogenate serially dilute medium supplement antibiotic sterile human urine plate contain blood agar slant replicate dilution well incubate well contain motile parasite identie use invert microscope statistical analysis number parasite present lymph node determine minimum analysis apply distribution Taswell statistical signicance datum analyse student test result discussion Lapachol display mark antiamastigote activity LVb concentration toxicity macrophage concentration contrast antimo nial Pentostam1 show inhibitory activity LVb amastigote concentration find toxic macrophage concentra tion thus lapachol exhibit powerful antiamastigote effect low cytotoxicity macrophage Pentostam1 table show important vitro antiamastigote activity protect hamster LVb lesion development vivo model hamster treat lapachol day present signicantly small footpad lesion compare untreated control represent reduction lesion size Fig Table result vivo model also show untreated control present progressive lesion Pentostam1 treatment effectively bring footpad size normal treatment efcacy lapachol Pentostam1 treatment similar Pentostam1 alone well evaluate drug effectively reduce parasite burden treatment viable parasite quantitate drain lymph node treat untreated hamster use limit dilution assay previously describe Table activity lapachol Pentostam1 Swiss mice peritoneal macrophage culture Drug cytotoxicity macrophage mean SEM Antiamastigote activity mean SEM Lapachol Pentostam1 figure effect treatment lapachol day Pentostam1 day combina tion time course lesion development hamster point represent mean SEM animal untreated control untreate Lapachol Pentostam1 Lapachol Pentostam1 Table Treatment effect lapachol day Pentostam1 day combination lvbinfecte hamster Group Lesion size mean SEM mean parasite load lymph node untreate Lapachol Pentostam1 12a Lapachol Pentostam1 08a 103a figure parenthesis indicate percentage reduction lesion size compare untreated group animal number animal group untreated control untreated control TEIXEIRA Copyright Phytother res Lymph node hamster treat lapachol Pentostam1 hamster treat Pentostam1 alone signicantly low parasite load respectively compare untreated control nevertheless signicant difference observe untreated lapachol treat group indicate inefciency lapachol suppress parasite growth vivo model Table report naphthoquinones extract several member plant family possess activity vitro vivo various strain active member group work demonstrate exhibit mark leishmanicidal activity mechanism lapachol induce lysis intracellular amasti gote vitro clear however characteristic naphthoquinone especially lapachol interfere oxygen metabolism tumour cell block cell respiration generate free oxygen radical free oxygen radical evidence nitric oxide production follow induction nitric oxide synthetase IFN play important role death intracellular amastigote murine macrophage consider important metabolite involve kill mouse recently suggest quinone compound lapachol possibly inhibit dependent physiological pathophysiological action vivo show leishmanicidal activity vitro therapeutic effect vivo experimental leishmaniasis suggest act directly parasite necessarily activation macro phage lapachol transform nonactive metabolite neutralize lose leishmanicidal activity regard naphthoquinone derivative demonstrate drug inactivate reduction interact serum protein structureactivity relationship various analogne find removal hydroxyl group group reduce antitumour activity removal aromatic ring give inactive product replacement methyl group side chain hydrogen abolish activity reduction oxidation isomerization side chain also abolish activity addition water double bond replacement hydroxyl amino methylamino group finally also possible optimal sustained plasma level drug achieve dose day use study knowledge rst report show direct inhibition braziliensis rewarding continue evaluate derivative differently substitute quinone represent new chemotype less toxicity efcacy estimate people live develop country depend traditional medicine primary health care therefore new therapy derive medicinal herb offer promise practical avenue development new drug need Leishmaniaendemic country ment thank Professor Matos Professor collaboration wish thank technical advice also grateful ESP nancial support nitric oxide superoxide activate macrophage kill major Eur Immunol VelascoCastrejon cacy pentamidine combine allopurinol immunotherapy treatment patient diffuse cutaneous leishmaniasis Binutu Antibacterial antifungal compound pinnata Planta Med action lapachol search novel anticancer agent differentiationbase assay analysis folklore product Anticancer Res Driscoll Hazard Wood activity relationship none derivative Cancer Chemother Rep Part Cave Effect natural naphthoquinone BALB mouse infect Leishmania amazonensis venezue lensis Parasitol SeigleMurandi Comparison antifungal activity lapachol lapa chone Iwu Jackson Schuster Medicinal plant leishmaniasis Parasitol Today plant control parasite plant control protozoal disease particular malaria Kumagai Nakajima Midorikawa HommaTakeda Shimojo inhibition nitric oxide formation neuronal nitric oxide synthase quinone nitric oxide synthase quinone reductase Tumor necrosis factoralpha synergize kill major induction nitric oxide immunol high incidence treatment failure due emergence antimonyresistant strain Infect Dis vitro vivo evaluation toxicity naphthoquinone LEISHMANICIDAL ACTIVITY LAPACHOL copyright Phytother Res naphthoquinone derivative Ann Trop Med Parasitol Immunology murine leishmaniasis PetrilloPeixoto effect glucantime patient isolate use growth parameter promastigote assess antimony susceptibility progress new drug change pattern leishmaniasis Parasitol Today specie visceral kalaazar cutaneous mucosal leishmaniasis Principles Practice Infections Diseases Warhurst Phytochemistry plant use traditional medicine treatment protozoal disease soc Eur evaluation lapachol antitumor agent cancer Res bisnaphthoquinone novel inhibitor type dna topoisomerase change low dose shortterm therapy cutaneous leishmaniasis pentavalent antimonial meglumine Effect vivo depletion cd4 cell experimental infection susceptible BALB mouse Leishmania amazonensis Acta Trop taswell limit dilution assay determina tion immunocompetent cell frequency validity test singlehit Poisson model Immunol Meth Louis Therapeutic effect monoclonal antibody cutaneous leishmaniasis genetically susceptible BALB mouse Immunol TEIXEIRA Copyright Phytother Res",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Swiss": 3,
                    "Twentytwo": 1,
                    "Leishmaniaendemic": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "iN6-Methyl _5-step__ Identifying RNA N6-methyladenosine sites using deep learning mode via Chou_s 5-step rules and Chou_s general PseKNC.pdf",
            "cleaned_text": "Accepted Manuscript iN6Methyl step identify rna methyladenosine site use deep learning mode step rule general PseKNC S0169 article number CHEMOM appear Received Date February Revised date May accepted date July cite article iN6Methyl step identify rna methyladenosine site use deep learning mode step rule general PseKNC pdf file unedited manuscript accept publication service customer provide early version manuscript manuscript undergo copyediting typesetting result proof publish final form note production process error discover affect content legal disclaimer apply journal pertain MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT iN6Methyl step identify rna methyladenosine site use deep learning mode step rule general PseKNC Electronics Information Engineering Chonbuk National University Jeonju South Korea bDepartment Computer Science University cAdvanced Electronics Information Research Center Chonbuk National University Jeonju South Korea methyladenosine m6A rna methylation modication volved various biological progress translation alternative splicing degradation stability therefore highly recommended develop computational model detect methyldenosine site RNA experi mental technology MeRIPSeq expensive time consume previous work start feature design step require domain knowledge follow classier cascade classier m6A site identication paper hand utilize automatic fea ture learn approach base widely use natural language technique learn feature extract automatically human genome explicit denition learn feature feed simple convolution neural network model classication propose model denote iN6Methyl step evaluate publicly available benchmark dataset outperform current state theart method anticipate propose model helpful academia drug discovery finally userfriendly webserver establish make freely available corresponding author submit MANUSCRIPT ACCEPTED ACCEPTED manuscript Methylhtm methyladenosine site deep learn convolution neural network rna methylation introduction methyladenosine frequent rna modication ist various specie play important role various biological pro cesse alternative splicing regulation circadian clock cell reprogramme primary microRNA processing rna structural dynamic m6A find mrna small nuclear rna long noncoding RNA also exist archaea virus bacteria eukaryote yeast plant mammal therefore identify m6A important understand functional mechanism recently highthroughput experiment m6A seq MeRIPSeq provide genomewide prole various specie Homo sapiens Mus musculus Saccharomyces cerevisiae base experimental nding reveal m6A site likely occur long internal exon stop codon addition nonrandom existence m6A site genome conserve yeast human therefore essential important specie hand MeRIPSeq periment expensive accurate enough therefore important develop reliable computational tool identify m6A site several type post transcription modication study recently machine learn base approach use develop computational tool m6A site identication iRNAMethyl develop m6A site identication method informa tion use pseudo dinucleotide composition physicochemical manuscript ACCEPTED ACCEPTED MANUSCRIPT property use feature extraction follow support vector chine physicochemical property add scal able transformation algorithm well feature extraction suggest use dierent type feature descriptor improve performance m6A site identication model prove performance incorporate type feature descriptor dinucleotide composition prole score hand merge mer frequency binary encoding scheme improve performance recently powerful tool sramp propose work various feature extraction technique utilize near neighbor encode secondary structure pattern positional nary encoding nucleotide sequence binary representation nucleotide sequence random forest model train base extract fea ture performance outperform method propose predictor base positionspecic compositional information m6A site mouse human previously mention predictor speciesspecic however propose multiple specie predictor m6A site use cal positionspecic dinucleotide frequency dinucleotide binary encoding feature extraction enhance use sequential forward search score algorithm XGBoost algorithm use construct predictive model generally several m6a predictor propose m6Apred irnapsecoll irna3typea deepm6aseq sramp RNAMethPre BERMP general propose predictor require domain knowledge man design feature feature design way sequencepattern information preserve instance amino acid composition PseAAC good example feature extraction tech nique popularity concept lead develop open source soft ware propy pseaacgeneral MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT extend PseKNC pseudo tuple Nucleotide Compo sition obtain numerical feature sequence PseKNC construct webserver PseOne pseone2 hand deep learn base predictor enable design power ful tool raw sequence handcraft feature DeepCpG iDeepS branch point selection alternative splicing site prediction site prediction process learn base predictor m6A deepm6aseq extract feature raw m6A site use however learn new represen tation m6A site use algorithm utilize new representation m6A identication learn feature comprehensive base whole mrna rather small set sample paper propose novel multiplespecie sequencebase predictor namely in6methyl step identify m6A site rna sequence consist step rst step feature representation stage sequence divide word mer natural language processing model call apply order map word corresponding feature representation second step deep learn computational model predict m6A site base generate feature rst step achieve result perform method evaluation metric addition userfriendly webserver prediction establish make available work follow step rule similar previous study step rule benchmark dataset construction mathematical mulation sample dataset prediction engine design perform crossvalidation test evaluate performance predictor engine nally webserver construction MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT material METHODS Benchmark Datasets order predict site multiple specie use benchmark dataset dierent specie namely Saccharomyces cerevisiae musculus M41 dataset M41 contain sample respectively length sample dataset dataset sample dataset center m6A site positive sequence negative sequence prepare adenine center biologically m6A peak quality control utilize fold crossvalidation training process case randomly split dataset fold fold use training early stopping remain fold use test Methodology present novel method order nde predict site dierent specie call iN6Methyl step model propose method consist major step rst step feature representation stage sequence divide word mer natural language processing model call apply order map word corresponding feature representation second step deep learn com putational model predict m6A site base generate feature rst step process illustrate Figure describe detail follow section Distributed feature Representation exist approach m6A site identication require domainknowledge handcraft input feature classication model work aim build computational model learn feature representation tomatically base genomic datum technique help obtain MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT optimal feature reduce noise datum consequently improve performance nal computational model datum consider language represent DNA rna sequence information pass cell base continue chain nucleotide addition technique use successfully various biological problem alternative splicing site prediction thus utilize model get interpretable representation m6A site figure rst step corpus construction step split continuous genomic sequence word represented overlap mer break continuity model empirically set selection perform well use value selection conrm previous nding set good choice addition mer widely use dnarna sequence formulation thus construct corpus dierent nucleotide consequently form unique word instance biological sequence ACAGAATG result follow word ACA AGA GAA generate corpus sequence use train word2vec model generally use human mrna available soeucscedu genome assembly divide chromosome chromosome divide sentence length 100nt finally sentence cut overlap eat word continuous bagword CBOW method use train model CBOW method predict current word base surround context word predened window detailed parameter use train model give Table parame ter widely use genomic datum result use word2vec word mer represent dimensional vector sequence length represent array shape show mammalian m6A drach consensus motif manuscript ACCEPTED ACCEPTED MANUSCRIPT denote overlap mer AGA GGA UGAUAA GAC ACA mer show space Figure2 learn representation ing Figure2 obtain use distribute stochastic neighbor embed learning model extracted feature representation sequence rst step use train propose deep learning model simple ecient convolution neural network show figure grid search algorithm utilize search good hyperparameter input shape propose model length input sequence consist dilate convolution layer number lter size lter dilation rate set rst second convolution layer respectively dilate convolution produce exponentially large receptive less number layer comparison conventional convolution layer layer follow rectie unit ReLU activation function ReLU max Alpha dropout use order retain variance mean input original value apply dropout dropout probability set generate feature dilated convolution layer average use average pooling operator window size equal pass fully connect layer rst layer node follow ReLU activation function alpha dropout probabilty hand second fully connect layer node sigmoid activation function prediction result discussion section introduce evaluation metric obtain result comparison statetheart method MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT evaluation metric wrok use accuracy sensitivity specicity correlation coecient base symbol troduce derive metric widely use recent publication total portion m6A investigate portion m6A incorrectly predict non sequence total portion non m6a investigate portion non m6A sequence incorrectly predict one addition area receiver operate characteristic rocauc curve graphical form visualize performance propose model use large AUC well model performance result comparison describe Section propose model evaluate dataset order study eect use dierent value mer test mer mer show Table result show use mer produce good performance dataset compare value mer result conrm nde previous study mer well performing selection MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT figure show confusion matrix result S51 H41 see in6methyl step model perform well case H41 dataset S51 dataset figure show acheive AUC S51 H41 observe H41 AUC receptively AUC S51 addition compare result propose model state theartmodel prnam M6AMRFS use fold crossvalidation test Figure show performance propose model comparison classier term see in6methyl step outperform method show figure Table specically accuracy in6methyl step improve dataset respectively sensitivity improve S51 H41 dataset respectively specicity improve also improve dataset respectively thus achieve big improvement case dataset result indicate use extract feature raw genomic sequence enhance performance m6a prediction model learn feature use extract whole mrna comprehensive compare handcraft feature use pre vious model prnam M6AMRFS web server highly recommend construct webserver make devel ope tool accessible research community therefore develop userfriendly easyuse webserver make available webserver build Python library MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT conclusion study propose novel deep learn base model call iN6Methyl step identication m6A site multiple specie consist step namely feature extraction classication adopt order automatically extract feature form raw gen moics sequence simple ecient deep learning model base dilate convolution neural network use classify m6A site obtain result outperform model evaluation meet ric accuracy sensitivity specicity correlation coecient finally user friendly webservr make available m6A site identication multiple specie Conict Interest Statement author declare conict interest Funding research support fund Korean government MSIT NRF2017M3C7A1044815 Data Availability Statement dataset generate study freely available Wang rna methylation regulate MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT microrna promote reprogramming pluripotency cell stem cell numerous modied nucleotide eukaryotic ribosomal rna progress nucleic acid research molecular biology vol structural switch regulate interaction Nature Hida dependent rna processing control speed circadian clock Cell Dominissini Hershkovitz Peer m6a methylation facilitate resolution pluripotency dierentiation Science Alarc Lee Goodarzi Halberg primary microrna process Nature Roost Lynch thermodynamic methyladenosine rna spring loaded base modication American Chemical Society Rna methyladenosine methylation post transcriptional gene expression regulation Genes development Reddy Localization modie spliceosomal small nuclear rna MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT modied nucleotide cluster functionally important region Vendeix trna wobble decode genome molecular biology rous sar coma virus genome molecular biology Timpte Bokar Induction sporulation saccharomyce cerevisiae lead formation methyladenosine mrna potential mechanism activity ime4 gene Nucleic acid research Identication methylate rna Proceedings terminal structure poly cytoplasmic rna poly poly heterogeneous nuclear rna cell dipteran drosophila melanogaster molecular biology capstructure maize poly contain rna Acta BBANucleic Acids Protein Synthesis Dominissini MoshitchMoshkovitz SalmonDivon mapping methyladenosine base immunocapturing massively parallel sequencing ture protocol Mason Jarey comprehensive analysis mrna methylation reveal enrichment near stop codon Cell MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT Dominissini Schwartz SalmonDivon Ungar JacobHirsch human mouse rna methylomes reveal seq Nature Mumbach Tabach Ruvkun Highresolution mapping reveal conserve widespread dynamic methylation program yeast meiosis Cell use ensemble identify human gpcrs link glycosylation site base general form Selection Wang Prediction protein nitrosylation site base adapt normal distribution prole pseudo amino acid composition identica tion protein methylation site pseudo amino acid composition approach research international pre dicte hydroxyproline hydroxylysine protein incorporate dipeptide positionspecic propensity pseudo amino acid tion International journal molecular science prediction nitrotyrosine site protein general pseudo amino acid composition plo e105018 predict cysteine nitrosylation site incorporate various sequencederive feature general MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT form journal molecular science prediction sine ubiquitination site protein extract sequence evolution formation gray system model identify rna pseudouridine site Molecular TherapyNucleic acids e332 identify lysine succinylation site protein incorporate sequencecoupling eect pseudo component optimize imbalanced training dataset biochemistry Xiao predict lysine suc cinylation site protein ensemble random forest theoretical biology identify carbonyla tion site protein monte sampling incorporate sequence couple eect general pseaac predict sumoylation site protein covariance discriminant algorithm incorporate sequencecoupled eect general pseaac predict lysine phosphoglycerylation fuzzy svm incorporate spaced amino acid pair theoretical biology identify hydroxyproline hydroxylysine protein incorporate MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT sequencecouple eect general pseaac iden tifying multiple lysine ptm site dierent type Bioinformatics identify phos phorylation site protein fuse dierent pseudo component ensemble classier recent progress predict posttranslational mod ication site protein current topic medicinal chemistry Yang irnapsecoll identify occurrence site dierent rna modication incor porate collective eects nucleotide Prediction lysine crotonylation site incorporate composition spaced amino acid pair identify lysine erylation site protein incorporate dierent tier amino acid pairwise couple information Sun identify rna methylation site incorporate sequence couple eect general pseknc ensemble classy identify rna methylcytosine site incorporate physicalchemical MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT property pseudo dinucleotide composition identi fye human phosphorylate protein incorporate evolutionary infor mation general theory identify terminal cysteine prenylation site protein incorporate tier sequence coupling Identication methyladenosine site extend idea saac formulate theoretical biology prediction phosphoglycerylated lysine residue use structural property amino acid Scientic report Identication protein sulfenylation site fuse forest theoretical biology identify methyladenosine site use pseudo nucleotide composition analytical biochemistry identify combination spot pseudo dinucleotide composition nucleic acid research e68e68 weight linear loss multiple birth support vector machine base information granulation multiclass classication Pattern Recognition MANUSCRIPT ACCEPTED ACCEPTED improve multiple birth support vector machine pattern classication prnam pre dicte methyladenosine site rna sequence physicalchemical property analytical biochemistry Rnamethylpred highaccuracy pre dictor identify analytical biochemistry web server prediction query m6a site journalpone URL pre diction mammalian methyladenosine m6a site base sequencederive feature url M6amrfs robust prediction methyladenosine site sequencebased feature multiple specie Frontiers Genetics fgene URL M6apred sequencebased predictor identify methyladenosine site use ensemble learn Molecular TherapyNucleic acid new tool predict site arabidopsis thaliana Plant molecular biology MANUSCRIPT ACCEPTED ACCEPTED manuscript Zhou identify methyladenosine site use pseudo dinucleotide tion Analytical biochemistry identify type modication rna adenosine site Molecular TherapyNucleic acid Deepm6aseq prediction characterization m6acontaine sequence use deep learn bioinformatic crossspecies classier predict m6a site integrate deep learning algorithm random forest approach journal biological sciences Prediction protein cellular attribute use pseudoamino acid composition Chou Using amphiphilic amino acid composition predict enzyme subfamily class Bioinformatics Pseaacbuilder stand alone program generate various special acid composition analytical biochemistry tool generate various fast build various mode general form acid composition largescale pro tein dataset MANUSCRIPT ACCEPTED ACCEPTED manuscript exible web server generate pseudo tuple nucleotide composition analytical biochemistry nucleotide composition pseknc eective formulation analyze genomic sequence Molecular BioSystems Liu Yang predictor identify promoter type multiwindowbase Fang web server generate various mode pseudo component dna rna protein sequence Nucleic acid research W65W71 Liu Chou Pseone improve package web server generate various mode pseudo component dna rna protein sequence Natural Science accurate pre diction state use deep learn biology Yan Shen Prediction structure binding use deep convolutional recurrent neural network genomic Nazari Tayara Chong Branch point selection rna splicing use deep learn IEEE access access Oubounyt Louadi learning model base distribute feature representation alternative splicing pre diction IEEE access ACCESS MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT irnapseknc2methyl identify rna methylation site convolution neural network URL s0022519318306349 idna6ma step rule Identication dna methyladenine site rice genome intelligent computa tional model chou step rule ipseucnn identify rna pseudouri dine site use convolutional neural network Molecular TherapyNucleic acid isscnn identify splicing site ing convolution neural network Oubounyt robust promoter predictor use deep learn genetic remark protein attribute prediction pseudo amino acid composition theoretical biology identify dna methyladenosine site incorporate cleotide physicochemical property pseknc Genomics Song Takemoto Haari integrative approach infer catalytic residue MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT use sequence structural network feature machinelearning framework theoretical biology predict subcellular localiza tion multilabel eukaryotic protein extract key information general pseaac Purcell Lithgow Daly Song Quokka compre hensive tool rapid accurate prediction kinase phosphorylation site human proteome Song comprehensive package accurately map predict proteasespecic substrate cleavage site bioinformatic MarquezLago Akutsu Bastion3 twolayer ensemble predictor type iii secrete eector Bioinformatics predictor identify promoter strength hybrid feature pseudo tuple nucleotide composition Akutsu computational analysis predic tion lysine malonylation site exploit informative feature integrative machinelearning framework Bioinformatics prediction disulde bonding site integration MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT statistical moment theoretical biology Xiao identify proteinprotein interaction incorporate chaos game representation theoretical biology Chou Song Jia Multiply novel multilayer predictor discover general specic type promoter Bioinformatics inucstnc sequencebased predictor tion nucleosome positioning genome extend concept saac base predictor tion enhancer type apply general form method program biomedicine inucextpsetnc model identication nucleosome positioning extend concept composition Genomics twolayer computational model discrimination enhancer type use hybrid feature pace tuple nucleotide composition learn base identication protein protein interaction use derive feature physiochemical property evolutionary prole Articial intelligence medicine MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT identication transmembrane helix segment use ensemble feature space incorporate fuzzy support vector machine Molecular web server language nature semiotic metaphor biology String variable grammar logic grammar formalism biological language dna Journal Logic Programming Yandell Majoros Genomics natural language process url Asgari Mofrad Continuous distribute representation biolog ical sequence deep proteomic genomic plo e0141287 sequencebase tool predict bacterial transcrip tional terminator Bioinformatics origin replication saccharomyce cerevisiae use twostep feature selection technique datum use research Nov Koltun Multiscale context aggregation dilate convolution preprint MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT Nair linear unit improve restrict boltzmann machine proceeding international conference machine learn ICML Klambauer neural network abs url use subsite coupling predict signal peptide Protein Engineering incor porate amino acid coupling predict cysteine nitrosylation site protein PeerJ e171 pseaac sequencebased model develop chou step rule general pseaac identify prenylation site protein theoretical biology sequencebase predictor identify sigma promoter prokaryote pseudo tuple nucleotide composition Nucleic acids research identify human origin replication incorporate dinucleotide physico chemical property pseudo nucleotide composition sequencebased tool identify anticancer peptide twolayer ensemble classier identify piwiinteracting rna function Molecular Therapy Nucleic Acids MANUSCRIPT ACCEPTED ACCEPTED manuscript identify recombination spot ensemble learning approach Bioinformatics identi fye adenosine inosine editing site rna sequence novel model mathematical biology classication signal peptide report recent advance develop webserver predict protein attribute Natural Science identify lysine crotonylation site histone protein pseudo component ensemble classier Genomics predict subcellular localiza tion gramnegative bacterial protein deep gene ontology learn general pseaac Genomics pre dict subcellular localization grampositive bacterial protein quasi balance training dataset Genomics incorporate key gene ontology information general pseaac predict localization grampositive bacterial protein Natural science multilabel clas sier predict class anatomical therapeutic chemical MANUSCRIPT ACCEPTED ACCEPTED manuscript identify recombination spot trinucleotide composition pseudo amino acid component journal molecular science predict subcellular localization animal protein balance training dataset Bioinformatics predict subcellular calization gramnegative bacterial protein quasibalance training dataset general pseaac theoretical biology predict subcellular localization plant protein general balance training dataset current pharmaceutical design Tables table word2vec training parameter Parameters Word2vec model Training Method CBOW Vector Size Corpus Human Genome context Words mer Window Size Minimum Count negative sampling Epochs MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT table performance propose model use dierent value mer MCC mer H41 mer H41 mer H41 mer H41 Table performance in6methyl step algorithm prnam M6AMRFS iN6Methyl step MethyRNA H41 M6AMRFS iN6Methyl step MethyRNA M41 M6AMRFS iN6Methyl step MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT Figure Convolution neural network CNN Convolution layer activation Dropout flatten Dropout Dense average Pooling actgggcggcta GATCTTACATTCA ACT CTG GCT cta create word consist mer set figure illustration iN6Methyl step model representation Word2vec model Convolution neural network classication task MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT figure visualization feature use tsne highlighted word show important m6A site prediction author Preparation Papers IEEE TRANSACTIONS figuresmodel3copypdf figure Diagram m6acw model convolution neural network classication task Feature representation Word2vec model predict label true label predict label true label predict label true label figure confusion matrix result test dataset confusion matrix dataset S51 Confusion matrix dataset H41 Confusion matrix dataset table confusion matrix table prediction actual AUCROC essential mesurment tool classication task AUCROC AUCROC curve mainly use assess model Figure show AUCROC m6acw model accord ing dataset comparison STATETHEART MODELS section compare propose model m6acw figure confusion matrix propose model iN6Methyl step benchmark S51 H41 ACCEPTED MANUSCRIPT false positive rate true positive rate AUC S51 AUC H41 AUC M41 figure AUC curve propose model iN6Methyl step benchmark S51 H41 M41 author Preparation Papers IEEE TRANSACTIONS figuress51rocpdf figuresh41rocpdf figuresm41rocpdf figure confusion matrix result test dataset confusion matrix dataset S51 Confusion matrix dataset H41 Confusion matrix dataset M41 M6AMRFS FIGURE bar graph comparison propose model dataset comparison base dataset comparison base H41 dataset base dataset prnam M6AMRFS performance mea surement show Table m6acw model exhibit signicant progressive formability dataset compare M6AMRFS MethyRNA Last least M6AMRFS model dataset implicate absolute improvement model result comparison method show table anf gure table text performance measurement MCC Model Dataset S51 m6amrfs RNA iN6Methyl step step step figure performance in6methyl step model classier benchmark S51 H41 ACCEPTED MANUSCRIPT Highlights computational predictor develop prediction RNA Methyladenosine Sites Features learn use natural language processing technique achieve promise outcome exist method",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 10
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "PseKNC": 1,
                    "Korean": 1,
                    "Nazari": 1,
                    "Identication": 1,
                    "Articial": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "PseKNC": 10,
                    "Korean": 10,
                    "Nazari": 10,
                    "Identication": 10,
                    "Articial": 10
                },
                "Ethnographic Terms": {
                    "methylation": 5
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Insight into Methyl tert-Butyl Ether _MTBE_ Stable Isotope Fractionation from Abiotic Reference Experiments.pdf",
            "cleaned_text": "insight Methyl tertbutyl ether MTBE Stable Isotope Fractionation Toronto Russell Street Ontario M5S Methyl group oxidation hydrolysis hydrolysis suggest natural transformation mechanism study report first time isotopic fractionation acid hydrolysis oxidation permanganate acid hydrolysis isotopic enrichment factor carbon hydrogen Position specific value reactive position reactive position give kinetic isotope effect KIEC consistent hydrolysis involve tert butyl group characteristic slope bulk bulk suggest identify SN1 type hydrolysis also setting pathway well constrain oxidation permanganate find involve specifically methyl group similar aerobic biodegradation large hydrogen enrichment factor reactive position indicate large primary large secondary hydrogen isotope effect significantly small valuesreportedpreviouslyforaerobicbiodegradationsugg intrinsic fractionation often mask additional non fractionating step conservative estimate biodegradation field site large value report therefore use introduction gasoline additive methyl tertbutyl ether organic chemical high production volume worldwide frequently detect groundwater contaminant owe low sorption organic material log transport almost retardation aquifer absence biotransformation form large contaminant plume use concentration measurement alone unequivocal determinationofMTBEbiodegradationwasnotpossibleeven site wellknown hydrogeology dense network sampling well observation information however much warrant hand natural attenuation potentially provide attractive sink compound environment hand illustrate Scheme know transfor mation pathway directly lead mineralization intermittently form problematic product tertbutyl alcohol TBA degrade oxic condition anoxic condition report therefore receive much attention new alternative method detect even quantify situ biodegradation approach rely measure compound stable isotope ratio gas chromatograph isotope ratio mass spectrometry Pronounced kinetic isotope effect observe chemical biochemical degradation reaction molecule heavy isotope reactive position react slowly molecule contain light isotope specifically isotopic enrichment remain contaminant strong molecule contain heavy isotope directly react bond primary kinetic isotope effect adjacent bond secondary kinetic isotope effect molecule heavy isotope distant position discriminate change stable isotope ratiosseither time laboratory degradation study distance field sitesshave potential deconvolve concentration change due transformation concentration change due process mass loss relative large isotope fractionation identify abiotic biotic degradation many organic contaminant study date investigate isotope fractionation process volatilization dissolution diffusion sorption show small significant fractionation analytical uncertainty typical carbon hydrogen Whilethereispotentialforfractionationtobemoresignificant 2H case element 2H large fractionation effect typically see low fraction remain instance sorption occur vaporization recent study document carbon isotope fractionation due diffusion zone diffusive isotope effect expect pronounced compare saturate zone effect observable measure spill measurement do fine spatial scale note fractionation due nondegradative process relevant case remediation air sparge large isotopic shift likely insignificant natural system comparably extensive mass loss due volatilization sorption unusual similarly publish evidence diffusive fractionation CH4 isotope signature laboratory study short spatial temporal scale effect turn significant phenomenon field scale contrast isotope fractionation pronounce aerobic anaerobic degradation observable enrichment heavy isotope remain contaminant molecule successfully model accord equation give case carbon isotope correspond author mail Neuherberg Germany vol ENVIRONMENTAL science TECHNOLOGY Published web case hydrogen isotope average isotope ratio moleculesatagiventimeandatthebeginningofthereaction respectively fraction contaminant remain time rvpdb bulk isotope ratio express notation relative international carbon standard value 2H RVSMOW express respect hydrogen standard VSMOW ratio compare begin reaction mental datum evaluate accord give corresponding bulk fractionation factor enrichment factor measure strongly heavy isotope become enrich average molecule reaction proceed case fractionation small negative strong change bulk isotope ratio certain degree conversion sensitive use assess contaminant transformation con taminate site change isotope ratio example use quantitatively estimate extent biotic abiotic degradation field short biodegradation accord expression contaminant isotope ratio source change ratio distance away approach clearly great importance value robust reproducible otherwise estimate associate considerable uncertainty aerobic biodegradation measure relatively constrain bulk isotopic enrichment factor carbon determine value hydrogen contrast different result obtain case anaerobic biodegradation MTBE Somsamak determine much great carbon enrichment factor measure significantly small hydrogen enrichment factor important understand systematic variation hand value need constrain use basis quantification field hand isotope pattern reveal important information biotransformation reaction mechanism natural abundance isotope present molecular position however molecule heavy isotope reactive position fractionate see kinetic isotope effect dilute observable average bulk isotope fractionation measurable adequate analysis provide correct dilution nonfractionate molecule evaluate observablebulkisotopefractionationwithrespecttoposition specific kinetic isotope effect lightk rate constant molecule contain light heavy isotope react position comparison literature value show strong hydrogen weak carbon isotope fractionation aerobic biodegradation match well mechanistic model initial methyl H3C group oxidation contrast strong carbon relatively weak hydrogen isotope fractionation anaerobic degradation suggest initial hydrolysis step SN2 mechanism H3C group addition oxidation SN2 reaction acidcatalyze SN1 hydrolysis propose third possible degradation mechanism small primary carbon secondary hydrogen isotope effect predict reaction pathway however mechanism involve large tertbutyl group H3C rather small methyl H3C group relevant atom therefore locate proximity react bond positionspecific strongly represent observable bulk fractionation therefore postulate relative pattern carbon hydrogen fractionation similar aerobic degradation oxidation even actual KIE value small bond even break reaction datum test hypothesis provide isotopic enrichment factor serve value fractionation associate drolysis lack date additional knowledge gap exist fractionation aerobic degradation selective oxidation methyl H3CgroupAlthoughthepositionspecifickineticisotope effect hydrogen calculate datum consistent primary isotope effect expect reaction relatively small compare number generally report bond cleavage additional ratelimite step strongly fractionate bond cleavage mask intrinsic kinetic isotope effect small apparent kinetic isotope effect term akiehandsmallervaluesofhareobservedforasystematic investigation model reaction mimic specific oxidation methyl H3C group precede slow step helpful interestinginthisrespectasitisreportedtoperformselective oxidation bond ether group reagent know oxidize bond nonselective fashion research communication address isotope fractionation abiotic reaction transformation first time carbon hydrogen isotope fractionation measure acid hydrolysis result compare report datum aerobic anaerobic biodegradation addition study test permanganateoxidizesMTBEselectivelyatthemethylH3C reaction order constrain maximum isotope fractionation expect aerobic biodegradation expect pronounced change hydrogen emphasize element rather carbon inve 2H science technology vol tigation observable bulk fractionation interpret context mechanistic understanding use position specific kinetic isotope effect Materials Methods detailed description transformation experiment analytical method give support Information Briefly acid hydrolysis conduct presence HCl Oxidation permanganate investigate solution contain ppm MTBE 2MKMnO4and280ppmditertbutyletherin02MKMnO4 respectively headspace sample take tion isotope analysis compound concentration measure gas chromatograph flame ionization detector isotope analysis conduct FinniganMATDelta interface micropyrolysis furnace carbon isotope analyze Varian MAT equip combustion interface isotope analysis reaction aliquot acid hydrolysis quench total uncertainty incorporate accuracy reproducibility respect carbon isotope analysis respect SMOW hydrogen isotope analysis regression analysis isotopic enrichment factor calculate linear regression logarithmic form rate constant determine plot oflnversustimeandslopesof obtain regression original experimental datum different measure uncertainty compare standard deviation associate slope respective linear regression total error slope calculate propagation known total error concentration measurement carbon hydrogen isotope analysis confidence interval slope regression obtain use function Data Analysis theAddAnalysisTool PackStandarddeviations half large calculate total error value still small confidence interval exemplary case discuss study therefore consistently report confidence interval large calculate error result Discussion Acid hydrolysis presence HCl hydrolyze halflife day kobs correspond constant see figure good agreement value report tert butanol product detect pronounced isotope fractionation observe carbon hydrogen isotope ratio correspond shift bulk isotope ratio conversion evaluation experimental datum accord equation result bulk enrichment factor figure case carbon half pronounce anaerobic degradation twice much report aerobic methyl group oxidation hydrogen value comparable number report aerobic degradation remarkable consider bond break SN1 reaction therefore primary hydrogen isotope effect expect see Scheme result understand however interplay primary secondary isotope effect consider context reactive position Interpretation Isotope Fractionation Terms Kinetic Isotope Effects correct molecule carry heavy isotope nonreacting position dis criminate reaction change bulk isotope ratio need convert positionspecific change show Scheme carbon atom central position tertbutyl group react shift bulk isotope ratio need multiply factor figure show appropriate regression yield positionspecific enrichment factor reactive position scheme Different Reaction Mechanisms MTBE Degradation Rreactive position reactive position reactive position reactive position vol ENVIRONMENTAL SCIENCE TECHNOLOGY correspond kinetic isotope effect calculate method number lie upper range value expect SN1 reaction possibly secondary effect carbon atom tertbutyl group also contribute overall fractionation case hydrogen primary isotope effect expect secondary isotope effect anticipate fortheninehydrogenpositionsofthetertbutylgrouphence shift bulk isotope ratio multiply factor appropriate regression show figure yield positionspecific value reactive position stabilization carbenium ion affect hydrogen atom way intramolecular kinetic isotope effect calculate method agreement value report reaction overall measure carbon hydrogen isotope frac tionation acid hydrolysis therefore con sistent propose mechanistic model also demonstratedbytheratioofthepositionspecificenrichment factor reactive positionreactive position consistent range predict follow equation derivation approximate equivalence rprp andrrp Plots Ele ment interpretation datum sample degradation mechanism unknown great interest determine relative change isotope ratio element sufficiently distinct distinguish hydrolysis aerobic degradation methyl group oxidation anaerobic biodegradation hydrolysis figure show datum present study together datum previous study measure isotopic fractionation anaerobic aerobic biodegradation correspond slope drolysis methyl group oxidation hydrolysis give error confidence interval obtain slope linear figure Rayleigh plot isotope fractionation acid hydrolysis bulk hydrogen isotope fractionation bulk carbon isotope fractionation positionspecific hydrogen isotope fractionation hydrogen atom tertbutyl group accord positionspecific carbon isotope fractionation central atom tertbutyl group accord KIEC reactive position position reactive position 2Hbulk reactive position reactive position reactive position reactive position reactive position position position KIEC environmental science technology VOL regressionforthecaseofacidhydrolysistheresultillustrate that2hbulk13cbulkbulkbulkandreactive positionreactive position approximately related accord slope twodimensional isotope plot principle predict mention introductionwhilethisapproachcouldindeedunequivocally establish characteristic trend aerobic methyl group oxidation anaerobic hydrolysis possible however predict theory significantly different trend expect actual experimental datum acid hydrolysis demonstrate significant difference exist reaction suggest trend havethepotentialtodiscernamongdegradationmechanism natural system well figure indicate least conversionisnecessaryhowevertodistinguishbetween methyl oxidation hydrolysis SN2 mechanism discerned already early stage degradation MTBE presence permanganate rapid halflife of076dayskobs03dcorrespondingtoasecond order rate constant see figure value good agreement report value correspond selectivity oxidation test investigate reactivity tertbutyl presence permanganate day significant conversion observe time see figure demonstrate bond tertbutyl group wereinertduringoxidationbypermanganateItcantherefore conclude tertbutyl group reactive condition transforma tion occur entirely oxidation methyl group Scheme show reaction analogy mechanism propose permanganate oxidation toluene water Hydrogen Isotope Fractionation Pronounced hydrogen isotope fractionation observe oxidation permanganate isotope ratio 2H change value value enrich 2H conversion carbon isotope fractionation analyze experiment show figure evaluation hydrogen bulk isotope datum accord result remarkably large bulk enrichment factor specific enrichment factor calculate consider total hydrogen atom locate react methyl group give reactive position corresponding regression show figure indicate high value regression well case bulk datum figure phenomenon predict atom methyl group expect accumulate preferentially remain substrate compare molecule tertbutyl group reaction proceed enrichment strongly fractionate molecule result nonlinear regression bulk fractionation become large datum late timepointsareincludedcorrectionfornonreactingposition FIGURE Changes carbon hydrogen isotope ratio degradationofmtbebydifferentmechanismsthetwodimensional plot include datum study acid hydrolysis SN1 mechanism datum SN2 mechanism datum aerobic biodegradation methyl group oxidation dash linesindicate95confidenceintervalsoftherespectiveregression bulk bulk reactive position reactive position FIGURE plot hydrogen isotope fractionation oxidation permanganate bulk isotope fractionation positionspecific isotope fractionation hydrogen atom methyl group accord position reactive position 2Hbulk reactive position reactive position vol ENVIRONMENTAL science TECHNOLOGY accord serve eliminate artifact datum study illustrate inadequate result indeed obtain value reactive position calculate accord follow approximate equation give current example number instead value calculate Interpretation Terms Kinetic Isotope Effects significance difference become evident value reactive position use calculate positionspecific kinetic isotope effect accord equation take account natural isotopic abundance atom present methyl group onethird case therefore react bond cause primary isotope effect twothird react bond cause secondary isotope effect secondary effect often neglect give approximately approximation evident reactive position negative number expect methyl group otherwise calculate number become negative reactive position study slightly exceed limit rationalize addition also secondary effect take account accord possible combination result reactive position example KIEHprimary KIEHsecondary KIEHprimary KIEHsecondary see contrast value reactive position obtain difficult explain follow proximate equation lead meaningful result case large hydrogen isotope fractionation note however effect discuss mainly relevant case strong fractionation hydrogen good approximation neglect element generally give good result mask aerobic Biodegradation result present study demonstrate positionspecific enrichment factor reactive position expect methyl group oxidation actual reaction mech anism propose monooxygenase see Scheme kinetic isotope effect calculate accord well comparable large value typically determine enzyme indicate number around serve tentative benchmark also biotransformation provide enzymatic bond cleavage aerobic biotransformation rate determine evaluation original datum however result much smallervaluesofhreactive positionbetweenand suggest additional ratelimite reaction step biochemical transformation follow equation derive describe relationship apparent AKIE intrinsic KIE isotope effect experiment label substrate term call commitment catalysis describe fast actual bond cleavage compare step lead back free substrate large bond break quickly reverse reaction precede step slow molecule get back original substrate poolsirrespective isotopic compositionsthe intrinsic discrimination serve AKIE value much small intrinsic kienumbersinparts4ofthesupportinginformationvalue ofcbetween1and23areestimatedbasedontheassumption intrinsic positionspecific enrichment factor aerobic biodegradation abiotic oxidation Eveninthecaseofrelativelypronouncedhydrogen fractionation observe precede step biochemical transformation therefore already equally slow even factor slow actual bond cleavage masking affect carbon isotope fraction ation way effect clearly need consider enrichment factor choose quantify natural biodegradation accord limited number hydrogen enrichment factor available literature result study show associate aerobic biodegradation potential large large value measure date conservative estimate effect biodegradationtheuseoflargestreportedvaluesistherefore recommend environmental significance fundamentally different mechanism pro pose degradation hydrolysis aerobic degradation methyl group oxidation anaerobic biodegradation hydrolysis study mechanism distinct relationship carbon hydrogen fractionation high light potential distinguish different mechanism contaminate field site plot isotope datum twodimensional diagram figure contaminate site procedure assist selection appropriate bulk enrichment factor bulk quantification extent natural biodegradation use take however rather overestimate natural attenuation order obtain conservative estimate study illustrate report bulk enrichment factor reflect scheme Methyl Group Oxidation Permanganate reactive position bulk reactive position reactive position deuteriumcontaining bond reactive position reactive position bulk AKIElabeled substrate science technology VOL intrinsic fractionation biochemical transformation also affect presence additional rate limit step overall biodegradation similar effect report biotransformation chlorinate ethene toluene discuss quantification biodegradation accord therefore recommended use large value bulk report range acknowledgment work support German Research Founda tion DFG Research Fellowship NSERC Strategic Grants Program thank anonymous er helpful comment improve quality manuscript Supporting Information Available MethodsandMaterialsExemplaryregressionanalysis derivation approximate equivalence rprp possible combination primary secondary result reactive position tentative calculation commitment catalysis value report biotransfor mation figure regression tiontime datum acid hydrolysis oxidation permanganate figure reactivity tertbutyl ether time presence permanganate material available free charge Internet pubsacsorg Literature cite Harremoes Eds MTBE Petrol Substitute Lead Office Squillace MTBE gasoline hydrocarbon ground water Ground Water Schmidt Haderlein Analysis fuel oxygenate environment Analyst Squillace environmental behavior fate methyl tertbutyl ether schirmerbarkerastudyoflongtermmtbeattenuation borden aquifer degradation methyl tertbutyl ether tertbutyl alcohol subsurface Contam Hydrol Wilson Kaiser Adair monitor Natural attenuation MTBE Risk Management Option Leaking UndergroundStorageTankSitesEPA new concept link observable stable isotope fractionation transformation pathway organic pollutant Drever Colberg Kelly Carbon isotope systematic monoaromatic hydrocarbon vaporization adsorption experiment Org Geochem Ward Slater Hydrogen isotope fractionation methanogenic degradation toluene potential direct verification bioremediation Elsner scheme twodimensional isotope analysis decipher biodegradation process application groundwater con tamination contaminant groundwater new methodology use compoundspecificisotopicanalysisenvironscitechnol Ahad Headspace analysis new application isotopic character ization dissolve organic contaminant Contam Hydrol Effect source variability transport process carbon isotope ratio sandy aquifer Contam Hydrol Bouchard use stable isotope analysis assess volatile organic compound unsaturated zone Thesis University Neuchatel Neuchatel AllenKing Sleep carbon isotope effect result equilibrium sorption dissolve vocs Meckenstock Morasch isotope fractionation aromatic hydrocarbon microbial deg radation Schuth Taubald Bolano Maciejczyk Carbon hydrogen isotope effect sorption organic carbonaceous material Contam carbon isotopefractionationoforganiccontaminantsduetoretardation humic substance implication natural attenuation study aquifer Hydrogen isotopic fractionation petro leum hydrocarbon vaporization implication assess artificial natural remediation petroleum contamination org Geochem Isotopically light methane natural gas bacterial imprint diffusive fractionation Scow Sherwood Lollar Carbon hydrogenisotopicfractionationduringbiodegradationofmethyl tertbutyl ether Monitoring biodegradation methyl tertbutyl ether use com poundspecific carbon isotope analysis Slater Sleep Witt Klecka stable carbon isotope evidence intrinsic bioremediation tetrachloroethene trichloroet hene Richnow stable isotope fractionation analysis tool monitor biodegradation contaminate acquifer Contam Hydrol Kolhatkar Kuder use compoundspecific stable carbon isotope analyse demon strate anaerobic biodegradation groundwater gasoline release site Kolhatkar Wilson Allen Application stable carbon hydrogen isotopic technique monitor biodegradation MTBE field NGWA api Petroleum Hydrocarbons Organic Chemicals Ground Water American Petroleum Institute Kuder Wilson Kaiser stable carbon hydrogen isotope anaerobic biodegradation field evidence SomsamakRichnowHaggblomCarbonisotopic fractionationduringanaerobicbiotransformationofmethyltert butyl ether tertamyl methyl ether somsamakrichnowhaggblomcarbonisotope fractionation anaerobic degradation methyl tertbutyl ether sulfatereduce methanogenic condition Microbiol new evaluation scheme dimensional isotope analysis decipher biodegradation pro cesse application groundwater contamination MTBE Environ Sci Technol tertbutyl methyl ether dilute aqueous acid science TECHNOLOGY oxidation ether benzyl triethylammoniumpermanganate AngewChemIntEngl Zhao Chemical oxidative degradation methyl tertbutyl ether aqueous solution Fenton reagent Chemosphere oxidation methyl tertbutyl ether potassium permanganate understand bond oxida tion transfer oxidation toluene permanganate Lipscomb large kinetic isotope effect methane oxidation catalyze methane monooxygenase evidence bond cleavage reaction cycle intermediate biochemistry Northrop SteadyState Analysis kinetic Isotope effect enzymatic reaction Biochemistry PCE abiotic reaction cyanocobalamin Microbiol ManciniHirschornElsnerLacrampeCouloume Sleep Edwards Sherwood Lollar Effects Trace Element Concentration Enzyme control stable isotopefractionationduringaerobicbiodegradationoftoluene receive revise manuscript ceive accept",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "deconvolve": 1,
                    "SN2": 4,
                    "German": 1,
                    "Contam": 3
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Intrathecal 5-azacytidine inhibits global DNA methylation and methyl-CpG-binding protein 2 expression and alleviates neuropathic pain in rats following chronic__.pdf",
            "cleaned_text": "Research Report Intrathecal azacytidine inhibit global dna methylation methyl cpgbinde protein expression alleviates neuropathic pain rat follow chronic constriction injury Department Anesthesiology Article history accept Available online pathogenesis neuropathic pain remain largely unknown mechanism play major role regulate expression pro antinociceptive gene dna meth ylation major epigenetic mechanism vertebrate methyl CpGbinding protein mecp2 directly involve methylationmediate gene silencing determine change global dna methylation expression occur follow chronic constric tion injury repression dna methylation affect change attenu ate neuropathic pain use intrathecal azacytidine dna methyltransferase inhibitor rat rat receive saline azacytidine mol spinal jection daily surgery Global dna methylation expression increase spinal cord rat day surgery chanical allodynia thermal hyperalgesia induce attenuate intrathecal azacytidine surgery increase global DNA methyla tion expression spinal cord rat also significantly inhibit intrathecal azacytidine result demonstrate increase global DNA methyla tion expression spinal cord nerve damage play important role neuropathic pain azacytidine show potential treat neuropathic pain Elsevier right reserve neuropathic pain chronic constriction injury DNA methylation azacytidine methylcpgbinde protein Introduction Chronic neuropathic pain cause primary secondary damage dysfunction nervous system neuropathic pain characterize hyperalgesia allodynia spontane ous pain pathogenesis neuropathic pain complex many factor remain unknown recent evidence suggest expression level painassociated gene sensory neuron immune cell glial cell highly involve generation maintenance neuropathic pain genetic mechanism induce heritable change gene pression change dna sequence regulate transcription expression pro antinociceptive gene doehre dna methylation char acterize epigenetic mechanism vertebrate major contributor stability gene expression first Corresponding author Fax mail address qulianguo0731com Guo available online see front matter right reserve bind protein clone bind methyl inhibit transcription dna methylation dependent gene express predominantly neuron nearly absent glial cell mature mammalian central nervous system CNS Akbarian adult spinal cord MeCP2 express dorsal horn neuron link mecp2 gene mutation rearrangement main cause syndrome recent study tient mutation suffer syndrome reveal abnormal response sensitivity pain also suggest play important role regulate gene expression flammatory pain therefore hypothesize dna methylation involved development maintenance neuro pathic pain study examine global dna methyl ation expression spinal cord rat follow chronic constriction injury surgery fur ther examine effect intrathecal administration demethylation reagent azacytidine extensively study dna methyltransferase DNMT inhibi tor Oki global DNA methylation mecp2 expression neuropathic pain rat result change behavior neuropathic pain measurement rat suffer neuropathic pain show various sign protect posture movement disorder foot toe closing dorsiflexion eversion mark limp rat show sign ipsilateral mechanical withdrawal threshold thermal latency show similar change rat catheterization surgery significant difference MWT TWL rat surgery MWT rat decrease obviously low fore operation indicate mechanical thermal hyperalgesia become apparent rat MWT reduce vehicletreated rat surgery Mechanical allo dynia thermal hyperalgesia consistently attenuate rat surgery change level global dna methylation level global dna methylation lumbar spinal cord rat day follow surgery significantly differ ent group dna methylation level increase vehicletreated rat compare shamoperate rat rat show low global dna methylation level compare vehicle treat rat thus upregulation global dna methylation inhibit DNMT blocker Fig mean data ipsilateral mechanical withdrawal threshold thermal withdrawal latency rat change mechanical allodynia rat time follow change thermal hyperalgesia rat time follow comparison MWT rat different treatment operation vehicletreated rat Fig global dna methylation profile mean global dna methylation level lumbar spinal cord rat day follow Comparison global DNA methylation level rat different treatment shamoperate rat vehicletreated rat change mecp2 expression reverse transcription pcr pcr analysis pcr analysis show clear expression actin mrna lumbar spinal cord rat day follow result significantly different group rat show low mecp2 mrna expression level significant crease see vehicletreated rat sham control rat show moderate increase mecp2 mrna expression low vehicletreated rat indicate reduce mediate western blot analysis Western blot result consistent PCR observe clear expression nuclear mecp2 protein actin lumbar spinal cord rat day follow significant difference observe group expres sion significantly increase vehicletreated rat sham control rat show moderate increase low vehicle treat rat result also consistent finding PCR western blot abundant mecp2 labeling see dorsal horn lumbar spinal cord rat day follow surgery rat mecp2positive cell Fig treat rat intermediate level sham operate rat least mecp2 label Fig Discussion Transcription expression painassociated gene dna methylation exert major effect highly relevant genesis development neuropathic pain elucidate role dna methylation neuropathic pain facilitate development new therapy urgently need conventional painkiller opi oid nonsteroidal antiinflammatory drug poor ficacy neuropathic pain Dworkin study strongly express lumbar spinal cord rat agreement report increase global dna methylation mecp2 mrna level nuclear mecp2 protein localization clearly detect lumbar spinal cord surgery companie mechanical allodynia thermal hyperalgesia rat increase global dna methylation expression rat indicate important role neuropathic pain increase global dna meth ylation expression involved ing expression DNA methylationdependent antinociceptive gene lumbar spinal cord rat dna methylation catalyze dnmt transfer methyl group adenosylmethionine cytosine basis DNA Guz AZA intensively study dnmt inhibitor show potential reduce dna methylation reactivate silence gene cell syn thesize DNA store expression tropomyosinrelate kinase TrkA TrKB liver cell line spinal cord make class cell neuron glial cell long time consider mature neuron Fig pcr western blot analysis expression mrnas lumbar spinal cord rat day follow actin fragment use internal control mean integral optical density IOD MeCP2actin rat expression nuclear mecp2 kda lumbar spinal cord rat day follow actin kda use internal control mean IOD MeCP2actin rat comparison IOD MeCP2actin rat different treatment shamoperate rat vehicletreated rat shamoperate rat vehicletreated rat AZAtreated CCI rat potential synthesize dna neurogenesis non existent adult mammalian CNS recent study show dna synthesis neurogenesis occur adult mammalian CNS pathological condition injury even normal physiological condition Schultze Shechter Cell proliferation dna synthesis examine glia cell adult mammalian CNS injury DNA synthesis occur neuron glia cell spinal dorsal horn nerve damage rat current study mechanical allodynia thermal hyperalgesia induce markedly attenuate intrathecal treat ment rat Intrathecal treat ment alleviate neuropathic pain upregulate expression DNA methylationdependent antinocicep tive gene lumbar spinal cord rat similarly report significantly enhance rate recovery herpes simplex virus latent herpes sim plex virus type infect dorsal root ganglia spinal cord reduce global dna methylation expression result treatment contribute effect determine exact mechanism lead decrease mecp2 expression scope current experiment hypothesis less mecp2 need bind methylcpg follow crease methylcpg nucleus therefore indirectly inhibit nuclear mecp2 expression induce hypomethylation rat thus dna methylation significant mech anism neuropathic pain approve chemotherapy myelodysplastic syndrome malignant disease also tential drug treat neuropathic pain however study limit focused change post complete expand observation neuropathic pain dna methylation long term model model summary result suggest dna methylation play important role neuropathic pain bition dnmt drug new ther approach neuropathic pain provide hint study involvement DNA methyla tion neuropathic pain Experimental procedure animal study perform accordance approve procedure male rat weigh provide animal experiment center deep anesthesia induce intraperitoneal injection chloral hydrate chronic lumbar intra thecal catheter implant subarachnoid space rat describe recovery rat randomly divide shamoperate group group vehicletreate group deep anesthesia modify sciatic nerve perform left side sham operation nerve expose ligate pharmacological treatment different dose mol intrathecal use pilot study accord previous report find intrathecal effective dose pro duce significant side effect rat motor function operate rat receive vehicle saline rat receive vehicle saline USA surgery Neuropathic pain measurement mechanical allodynia thermal hyperalgesia rat monitor electronic vonfrey Anesthesi ometer Ugo Basile Italy respectively MWT rat measure day Fig Representative image show immunoreactivity lumbar spinal cord rat day follow Representative mecp2positive cell dorsal horn point arrow lumbar spinal cord shamoperate rat basal expression lumbar spinal cord vehicletreated rat highly increase mecp2 expression lumbar spinal cord rat moderately increase mecp2 expression surgery behavioral testing do observer unaware animal treatment Sample preparation day rat group choose run domly observe global dna methylation ELISA mecp2 mrna expression pcr nuclear mecp2 protein calization western blot analysis rat kill deep anesthesia lumbar spinal cord mediately dissect remain rat group use immunostaine expression deep anesthesia normal saline follow paraformaldehyde perfuse rat cende aorta rat kill lumbar spi nal cord dissect global DNA methylation measurement measure global dna methylation genomic DNA extract TissueGen dna kit dna methylation measure use ELISA meth MethylampGlobal DNA Methylation Quantifica tion kit pcr analysis pcr analysis primer sequence forward CGCGAAAGCTTAAACAGAGGA reverse TGCAAT CAATTCTACTTTAGAGCGA actin primer sequence tgagctgcgtgtggcccctgag reverse Total RNA extract use cdna template synthesize reverse transcription store pcr condition amplification cycle pre denaturation min cycle denaturation anneal extension cycle extension min termination positive band analyze Quantity soft ware measure optical density MeCP2 expres sion level normalize actin level Western blot analysis western blot analysis nuclear protein extract tissue Keygen Nucleoprotein cytoplasmic protein extraction kit nuclear protein sample separate polyacrylamide gel electrotransferre nitrocellulose membrane transblot electrophoresis transfer Cell BioRad USA Membranes block skim milk powder membrane incubate antirabbit MeCP2 molecular weight kda antimouse actin molecular weight kda room temperature shaker follow incubation goat anti rabbit IgG conjugate horseradish peroxidase goat antimouse IgG conjugate horseradish room temperature shaker visualize chemiluminescence use kit Positive band analyze Quantity software expres sion level normalize actin level analysis immunocytochemistry tissue fix parafor dehydrated embed paraffin section thickness store dewaxe section treat citrate buffer min retrieval section treat H2O2 min block goat serum min incubat rabbit polyclonal antimecp2 section incubate biotinylated antirabbit IgG min horseradish peroxidaseconjugated streptavidin min finally section incubate diaminobenzidine H2O2 min velopment color incubation section wash phosphatebuffere saline time min Negative control lack primary antibody cell brownyellow granule consider positive statistical analysis datum reflect mean ANOVA use compare value obtain MWT TWL global dna methylation expression use test LSD test use compare group value consid ere significant role funding source study support Postgraduate cx2010b089 excellent Doctors acknowledgment study support Postgraduate cx2010b089 excellent Doctors cholinergic differentiation azacytidine neuronal cell Akbarian Jaenisch Jones expression pattern syndrome gene primate prefrontal cortex syndrome cause mutation link encoding methylcpgbinde protein cell cycleapoptosis connection revisit adult brain Cell Biol peripheral rat produce disorder pain sensation see man pain Cruccu Haanpaa EFNS guideline neuropathic pain assessment Lotsch Epigenetics pain analgesia imminent research field Eur Pain Downs Geranton Bebbington Ravine pain sensitivity example syndrome 152A Bennett Weinstein Advances neuropathic pain diagnosis mechanism treatment recommendation role transcriptional repressor methylcpgbinde protein plasticityrelated gene serum glucocorticoidinducible kinase induction inflammatory pain state Neurosci descend serotonergic control regulate inflammationinduced induce mechanical sensitivity methylcpgbinde protein phosphorylation rat superficial dorsal horn DNA methyltransferase target cancer therapy Drugs Today Mechanism DNA methylation role control gene expression Postepy Biochem Effects chronic haloperidol clozapine treatment neurogenesis adult rat hippocampus Neuropsychopharmacology Holliday dna methylation epigenetic inheritance Methods Jaenisch Bird epigenetic regulation gene expression genome integrate intrinsic environmental signal Kim Son DNA methylationdependent regulation TrkA TrkB trkc gene human hepatocellular carcinoma progressively express postmigratory neuron involve neuronal maturation rather cell fate decision unschedule various type cell mousebrain vivo Exp Brain Res Kuan Schloemer Burns induce dna synthesis cell proliferation die neuron adult rodent brain Purification sequence cellularlocalization novel chromosomal protein bind methylate DNA Cell abnormal dna methylation cell patient subacute cutaneous lupus erythematosus Dermatol inflammatory mechanism neuropathic pain Brain Res Rev Transmural compressioninduced proliferation dna synthesis activation tyrosine kinase pathway rat astrocytoma RCR cell Brain Res Oki Issa recent clinical trial epigenetic therapy Rev recent Clin Trials neuropathic pain triad neuron immune cell glia DNA methylation inhibitor azacytidine modulate thioguanine toxicity mammalian cell Toxicol Lett syndrome mecp2 level display tissue cellspecific difference correlate neuronal maturation induce downregulation primary cortical culture Epigenetics New GABAergic support myelinspecific cell form intact adult spinal cord Stem Cells Enhanced reactivation herpessimplex virus type latently infect guineapig neural tissues azacytidine Gen Virol prevent cisplatin induce nephrotoxicity potentiate anticancer activity cisplatin involve inhibition metallothionein pakt expression chemical induce cancer rat Toxicol Adult neurogenesis primate rodent spinal cord compare cervical dorsal rhizotomy dorsal column transection Eur Neurosci inhibitor suppress expression p2x receptor attenuate hyperalgesia follow chronic constriction injury rat Neurosci improve method protect fix lumbar catheter place spinal subarachnoid space rat Neurosci Methods orchestrate braincell renewal role immune cell adult neurogenesis health disease Trends",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 36,
                    "epigenetic": 5,
                    "demethylation": 1
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Western": 2,
                    "MethylampGlobal": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "Western": 42,
                    "MethylampGlobal": 42
                },
                "Ethnographic Terms": {
                    "methylation": 3,
                    "epigenetic": 3,
                    "demethylation": 3
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Mechanisms of disease_ methyl-binding domain proteins as potential therapeutic targets in cancer.pdf",
            "cleaned_text": "methylbinding domain protein potential therapeutic target cancer introduction DNA methylate covalent addition methyl group fifth carbon position cytosine form methyl cyto sine mammal bulk methylation occur sequence DNA cytosine directly follow guanine residue form symmetrical cpg dinucleotide methylated form action family dna methyltransferase dnmt enzyme use methyl donor dna methylation ate diverse function normal cell include transcriptional repression genomic imprint chromosome inactivation genomic stability role DNA lation tumor cell however extensively study contrast change pattern associate neoplasia global hypomethylation genome regional hypermethylation cpg island importance hypomethylation genesis still somewhat unclear associate genomic instability role hypermethylation cpg island clear cpg island think account genome frequently find promoter region first exon region gene cpg island present promoter estimate RNA polymerase transcribe gene generally unmethylate neoplastic process however numerous impor tant tumor suppressor gene include p16INK4a also call CDKN2A RB1 BRCA1 show hypermethylate tran scriptionally repress Hypermethylation gene silence important mechanism process drug resistance clear example silence mismatchrepair gene follow cisplatin treatment ovarian cell line notably sensitivity cisplatin line subsequently restore use inhibitor dna methylation methylcpgbinde domain MBD protein read interpret methylation moiety dna thus critical mediator many epigenetic process currently family comprise member MBD1 MBD3 MBD4 classical protein also mediate transcriptional repression use zinc finger domain bind target dna hypermethylation wellrecognize mechanism underlie gene silence event tumorigenesis drug resistance likely MBD protein important modulator tumorigenesis recent work address possibility discuss several MBD protein potentially excellent novel therapeutic target methylbinding domain Leader Garscube Estate Glasgow Maddison Postdoctoral Fellow Head Research 3us clarkear Received accept wwwnaturecomclinicalpractice ncponc0812 CRITERIA information compile use medline database search article publish Electronic earlyrelease publication also include article publish English consider search term use include DNA methylation association follow term epigenetic bind domain dna bind methylate cpg DNMT intestinal adenoma methylation status possible primary source quote full article obtain check additional material appropriate choose basis good clinical laboratory evidence especially work corroborate publish work center summary vol nature CLINICAL practice ONCOLOGY nature CLINICAL practice ONCOLOGY SANSOM VOL wwwnaturecomclinicalpracticeonc essence potential reversibility dna hypermethylation dna mutation provoke significant excitement tion dna methylation reactivation gene therapeutic importance proof principle datum mouse show inhibition dna methylation slow tumor formation growth use drug azacytidine genetic modulation maintenance methylase gene thus mouse bear allele model human colorectal syndrome familial adenomatous polyposis multiple intestinal metaplasia show strongly suppress adenoma development background hypomorphic recent study begin unravel role dna methyl transferase process tumorigenesis use conditional inactivation DNMT3B ApcMin background show loss DNMT3B affect early stage intestinal tumor formation tion microadenoma formation seem inhibit formation large macro adenomas complexity role DNMT3B illustrate fact number macroscopic adenoma reduce absence DNMT3B many large tumor observe study show region DNMT3B inactivation suggest finding narrow window action DNMT3B transitional stage initiation tumor outgrowth phase suggest DNMT3B require growth tumor give robust preclinical datum availability dna methylation inhibitor azacytidine deoxycytidine decitabine perhaps surprising take long drug reach clinic number reason include problem drug specificity toxic effect associate drug selection patient cohort perhaps significantly agent prove cytotoxic high dose recent datum indicate lower level decitabine induce dna hypo methylation tumor well preclinical result difficulty report emerge improve patient outcome long median time progression death follow decitabine treatment particular concern target potent inhibition protein toxic normal cell mouse complete inacti vation die shortly gastru lation loss fibroblast lead p53 dependent apoptosis also considerable concern potential protumorigenic effect tissue thus mouse stem cell deficient show enhanced level microsatellite instability hypomorphic mouse express normal level gene show runte birth age develop aggressive cell lymphoma display high frequency chromosome trisomy finally reduction macroscopic intestinal tumor mouse hypomorphic background report show increase microadenoma formation multifocal liver tumor significant attention focus possibility protein interpret dna methylation pattern rather directly modify represent alternate even improve therapeutic target methyl bind domain MBD protein example protein evidence beginning accumulate inactivation member family effectively suppress tumorigenesis drawback genomic instability cytotoxicity METHYLBINDING DOMAIN protein originally methylbinding activity identify eukaryotic cell identi fie complex term methylcpg bind protein MeCP1 subsequently reveal complex multisubunit protein corepressor complex MeCP2 single protein protein common identify subsequently use identify family protein include MBD1 MBD3 MBD4 MeCP2 protein also show repress transcription methylationdependent sequencespecific manner struc turally unrelated protein also show bind methylated CGCG sequence C2H2 zinc finger motif MBD protein repress transcription methylate promoter vitro vivo association transcription repression vol SANSOM nature CLINICAL practice wwwnaturecomclinicalpracticeonc domain corepressor complex contrast primarily character ize thymine dna glycosylase little role transcriptional repression however datum suggest protein also mediate transcriptional repression protein MBD MBD3 specifically bind methylate dna require recruit methylate dna precise inter dependency MBD protein still unclear identify number target use chromatin immunoprecipitation chip cpg island microarray ChIP chip approach research strategy reveal combination example apoe promoter find associate promoter find associate MeCP2 chip chip approach provide high throughput method identi fye cpg island also use identify novel gene epi genetically inactivate hyper lation cancer cell recent study reiterate importance MBD occupancy cpg island normal rather neoplastic cell lineage simplify structure protein discuss show figure relevant TRDs indicate potential role protein modulate tumorigenesis discuss METHYLBINDING DOMAIN PROTEIN MBD1 occur isoform differ entially splice cysteinerich CXXC terminal domain find isoform repress transcription methyl ate promoter MBD1v1 contain CXXC domain also repress transcription unmethylated promoter relevance different splice isoform vivo remain unclear date rela tively little direct evidence link mutation MBD1 neoplasia MBD1 recently implicate acute promyelocytic leukemia observe cooperation PMLRARalpha transcriptional repre sion furthermore show cooperate DNA damage protein glycosylase also know glycosylase tran scriptional repression DNA repair impli cating direct role MBD1 sense base damage chromatin nevertheless frequent MBD1 mutation yet detect human colon lung tumor furthermore constitutive knockout seem generate overt tumor phenotype mouse increase genomic instability report cell hence basis current datum literature clear substantial role modify tumorigenesis methylbinding DOMAIN protein demonstrate recognize single methylate cpg pair sequence possible prefer moredensely lated DNA early result suggest require ment least consecutive cpg sequence methylbinding component MeCP1 complex also contain histone deacetylase HDAC protein HDAC1 HDAC2 rbap46 RbAp48 protein also know allow target remodeling activity methylate template also mecp2 MBD CXXC CXXC CXXC TRD repeat MBD TRD repeat MBD BTBPOZ domain Zn2 finger motif MBD DNA glycosylase domain MBD TRD Name Structure MBD1 MBD3 MBD4 Kaiso figure Schematic structure major family member general structure protein shownsome alternative isoform terminus left termini right abbreviation broad complex tramtrack bric bracpox virus zinc finger refer alternate glycine arginine repeat MBD methylbinding domain MeCP2 methylcpgbinde protein trd transcription repression domain obtain nature CLINICAL practice ONCOLOGY SANSOM VOL wwwnaturecomclinicalpracticeonc associate MBD3 part Mi2 corepressor complex figure MBD3 form complex hemimethylated DNA replication focus help retain repressive transcription state replication also act synergistically protein example recently identify zinc finger protein MIZF interact act hdacdependent transcriptional repressor deficient mouse null mouse viable fertile normal imprinting pattern methylation level however knockout mouse entirely benign show impaired nurture behavior deficiency strongly suppress intestinal tumorigenesis cross background mouse live long control median day show greatly reduce tumor burden significantly gene dosage also affect tumorigenesis heterozygote show significant reduction adenoma burden increase survival compare wildtype mouse precise mechanism suppression remain unclear interesting note many important negative regula tor pathway transcriptionally repress colorectal cancer implicate negative regulator potential target mediate transcriptional repression strong candidate mechanistic target include p16ink4a p14ARF tumor suppressor gene promoter region identify mbd2binde target addition show reduce intestinal tumor predisposition mouse bear hypomorphic mutation also characterize increase lymphomagenesis occur spontaneously mutation mismatchrepair pathway importantly recapitulate pheno type alteration predisposition lymphomagenesis alone context null p53 mutation datum indicate strategy aim inhibit raise concern antidnmt1 strate gy respect possible increase genomic instability tumori genesis critical issue relate therapeutic window antimbd2 strategy useful mouse knockout study derive animal bear constitutive mutation therefore study differentiate effect tumor tion tumor growth hence study highlight potential prophylactic use antimbd2 strategy estab lish rationale therapeutic use fore extremely encouraging observe sequencespecific antisense inhibitor inhibit anchorageindependent growth human lung A549 colorectal HCT116 cancer cell line vitro tumorigenic growth human cancer cell xenografts vivo indeed synergy observe antisense strategy exposure agent bleomycin METHYLBINDING DOMAIN protein MBD3 share significant dna protein sequence homology compo nent chromatinremodele complex bind property MBD3 vary specie mammalian MBD3 bind methylate dna Xenopus MBD3 bind strongly methylate dna MBD3 similar sequence suggest number redundant function vivo contrast MBD3 essential normal embryo genesis highlight fact normal Mbd3 embryo identify implantation stage observation show MBD3 functionally redundant vivo MBD3 require function simply transcription repression confer MeCP1 complex term potential therapeutic target currently little direct evidence literature associate MBD3 neoplasia indeed MBD3 report major target genetic epigenetic alteration lung colon cancer clearly implicate process however associa tion Furthermore MBD3 recently associate mechanism HDAC inhibitor specifi cally inhibit growth survival cancer cell thus lung tumor cell treatment HDAC inhibitor lead mbd3dependent overexpression also know CDKN1A silence gene MBD3 release p21 promoter recruit gene embryonic lethality MBD3 knockout occur early development make somewhat less attractive MAY vol SANSOM nature CLINICAL practice wwwnaturecomclinicalpracticeonc potential target therapy tion toxic normal cell however potential antidnmt1 agent inhibitor effective therefore reduction MBD3 activity represent viable therapeutic approach novel gene identify human chromosome iden tical human MBD3 lack capable bind lated dna gene name mbd3l1 mbd3l2 find overexpressed germcell tumor human ovarian teratocarcinoma cell line PA1 mouse embryonal carcinoma cell line P19 mbd3l2 protein show interact MBD3 vivo suggest transcriptional modulator interchange mbd3interacte component NuRD complex thus mbd3l2 potential recruit MeCP1 complex away lated DNA reactivate transcription datum suggest mbd3l2 role modulate genesis remain establish expression localization alter tumorigenesis expression elevate intes tinal adenomas arise mouse human colon tumor regulation complex tumor suppression clearly link ability suppress transcription methylationdependent manner belong broad complex tramtrack bric bracpox virus zinc finger family protein methyl CpGbinding domain protein contain classical MBD instead bind methylate cpg dinucleo tide zinc finger motif locate terminus recognize bind sequence contain least methyl cpg dinucleotide capable repress transcription methylated template methylation dependent manner critically ectopic expression fibro blast show capable restore repression methylate construct indicate potential role modify neoplasia first identify bind partner kda catenin protein p120ctn protein contain several armadillo repeat structural similarity beta catenin component cadherincatenin cell adhe sion complex distinct juxtamembrane site implicate regulation cell adhesion motility observation raise provide link cellsurface signaling methylation dependent gene regulation ate nucleus think negatively regulate transcriptional repression show alter intracellular localiza tion cancer cell compare wild type cell manipulation localization provide ready mechanism deregulation activity addition mediate methylation dependent transcriptional repression show sequencespecific tran scriptional repressor recognize minimal core nucleotide sequence CTGCNA nucleotide addition methylcpg dinucleotide indeed high affinity consensus nucleotide bind site methyl cpg site mouse promoter show regulate show repress canonical non canonical signal datum raise distinct possibility first act methylationdependent tran scriptional repressor similar manner promote tumorigenesis second act negative regulator signal suppress tumorigenesis determine vivo role mamma lian null mouse generate contrast phenotype resemble null mouse mouse viable fertile seem healthy gross phenotypic abnormality result establish primary role different specie mammal degree functional redundancy examine role mouse cross background Deficiency Kaiso expres sion strongly suppress tumorigenesis model indicate net effect gene loss antagonize tumorigenesis tissue precise mechanism underlie effect remain unclear however datum identify promising potential therapeutic target protein contain Kaisolike zinc finger ZBTB4 recently nature CLINICAL practice ONCOLOGY SANSOM VOL wwwnaturecomclinicalpracticeonc HDAC NCoR1 DNMT NCoR1 HDAC3 MBD1 MBD1 cpg methylate cpg mecp2 MTA1 HDAC1 HDAC2 MBD3 HDAC1 HDAC2 HDAC1 HDAC2 RbAp4 RbA MBD2 bind mismatch BER DOC DOC MBD3 MBD3NuRD complex Sin3A SAP18 SAP30 Figure simplify diagram show mode action MBD3 Kaiso MBD4 MeCP2 MBD1 bind methylate mediate repression interaction NCoR1 HDAC3 DNMT protein responsible methylation cytosine guanine residue create pattern methylation mammalian genome component complex bind methylate mediate transcriptional repression MBD3 directly bind methylate component recruit complex recent work show MBD3 coexist complex rather inhabit mutually exclusive complex putative tumor suppressor also find core subunit complex MBD3 bind methylate dna still unclear MBD3NuRD complex target methylate dna contain homologous MBD bind methylate zinc finger motif mediate sequencespecific transcriptional repression methylationdependent suppression primary function repair mismatch arise follow spontaneous deamination event recent evidence suggest also function transcriptional repressor seem bind Sin3A repressor complex act remodel chromatin state refractory transcription recruitment HDACs Abbreviations BER baseexcision repair dnmt dna methyltransferase delete oral cancer HDAC histone deacetylase MDB methylbinding domain metastasis associate nuclear receptor corepressor nucleosome remodeling deacetylase RbAp retinoblastomabinde protein MAY vol SANSOM nature CLINICAL practice wwwnaturecomclinicalpracticeonc characterize protein find bind methylate dna vivo repress methylate template dna capable bind single methylate zbtb38 highly express mouse brain tissue distinct expression pattern seem suggest nonredundancy perhaps methyl bind motif discover add complexity methylation signal methylcpgbinde protein present little evidence link cancer mutation cause human disorder syndrome complex neurodevelopmental syndrome affect estimate live birth syndrome mainly affect female rare male case report boy syndrome tend bear severe encephalopathy die age syndrome cause premature death association low level tumorigenesis closely investigate contain amino acid MBD similar structure find MBD protein amino acid TRD nuclear localization signal terminal portion mediate bind nucleosome core mecp2 localize rich heterochromatic pericentromic region mouse chromosome Studies use rat tissue show repress transcription lated promoter nonmethylate promoter also find seem bind Sin3A repressor complex act remodel chromatin state refractory transcription recruitment hdac datum fact bind single symmetri cally methylate cpg pair widespread genome imply MeCP2 global transcriptional repressor vivo instability msi cell lymphoma Liver tumor ApcMin background transcriptional repression mediator apoptosis mediator baseexcision repair interact protein Represses canonical noncanonical Wnt pathway MBD1 Intestinal tumorigenesis background Human mutation cause syndrome figure MBD protein neoplasia red arrow indicate give protein tumor augment effect blue arrow indicate give protein protective effect tumor formation null mouse exhibit embryonic lethality midgestation hypomorphic allele use explore consequence lower methylation level reduce methylation lead chromosomal instability induction tumor reduce intestinal tumorigenesis ApcMin intestinal tumor model background also increase liver tumor formation model show involve transcription repression tumor suppressor gene p16ink4a p14ARF deficiency also show greatly reduce incidence tumor model intestinal tumorigenesis also show augment tumorigenesis deficiency repress tumor formation background multifunctional protein role genome surveillance apoptosis tumorigenesis link mismatch repair machinery primary consequence loss function seem tumor promotion due loss dna repair activity clearly establish tumorigenesis role MeCP2 MBD1 however role interpretation methylation pattern genome indicate role tumorigenesis seem likely abbreviation dnmt dna methyltransferase enzyme MBD methylbinding domain MeCP2 methylcpgbinde protein mismatch repair MSI microsatellite instability nature CLINICAL practice ONCOLOGY SANSOM VOL wwwnaturecomclinicalpracticeonc yet transcriptional change report absence vivo identify associate relief sequencespecific repression indeed recent datum suggest rather pronounced sequence specificity recently number study postulate link cancer coauthor show androgen free growth human prostate cancer cell MeCP2dependent phenomenon seem rely retain MYC expression similarly level also find correlate estrogenreceptor status breast cancer specimen addition report mediate tran scriptional silence DNA repair enzyme methylguaninedna methyltransferase report raise possibility level therapeutic relevance present time insufficient experimental datum conclude viable therapeutic target METHYLBINDING DOMAIN protein MBD protein little evidence ability repress tran scription important function instead primarily act methylationspecific DNA repair protein interact mismatch repair family dna repair protein also find mutate nearly colorectal cancer much debate significance mutation act tumor suppressor functional domain direct bind hemi methylate fully methylate dna terminal domain act thymine dna glycosylase remove thymine uracil mismatched cpg site cpg dinucleotide hyper mutable mismatch form hydrolytic deamination methylcytosine produce thymine deamination cytosine produce uracil deamination event frequent occur ring rate cellday leave unrepaired form transition muta tion next round dna replica tion prevent mutation act caretaker genomic hyper mutable cpg site mutation know contribute tumorigenesis nearly somatic P53 mutation colorectal cancer arise hotspot cytosine deaminate form transition mutation mbd4deficient mouse generate show viable overt pheno type predict frequency mutation methylcytosine reporter transgene significantly increase mouse mouse show increase spontaneous tumorigenesis defici ency accel erate intestinal tumorigenesis background significantly tumor form mouse show increase number mutation site allele datum indicate func tion tumor suppressor DNA repair activity also shown directly interact mismatch repair protein originally lead proposal act homolog coli homolog function MMR lack establish endonuclease activity fact mouse show increase mutation frequency methylate however indicate significant role canonical possible mediate function particular signal response dna damage originally role protein consider restrict agent mimic mismatch show important response numerous different dna damage stimulus include cis platin fluorouracil ionize radia tion null show similar damage dependency significantly reduce apoptotic response range dnadamage agent fluorouracil temozo lamide irradiation cisplatin observation indicate inter action MBD4 impor tant DNA damage signal response support hypothesis mouse deficient show synergistic decrease apoptosis expose fluorouracil temozolamide imply involve pathway dependent apoptosis mediate route modulate apop totic response also show functional interaction death domain protein fadd MAY vol SANSOM nature CLINICAL practice even protein function damage responsive pathway explain frequently mutate colorectal cancer lack functional seem likely mutation find cancer simply reflect status consequent increase micro satellite instability indeed show gene contain simple repeti tive sequence potentially generate instability separate study report MBD4 mutation approximately human colorectal gastric carcinoma virtually mutation poly tract central portion gene result frame shift produce truncate protein terminal domain catalytic ability test addi tional loss accelerate tumorigenesis MMR background also intercrosse MBD4 mouse mouse mutant MSH2 background additional MBD4 defi ciency alter tumorigenesis mutation frequency endogenous locus also know DLEU1 likely interpreta tion datum mutation see MMRdeficient tumor simply reflect poly tract repeat human remain possible mutation confer dominant gain function phenotype clear role suppress deami nation event vivo mediate DNA damage response vivo however still debate regard significance mutation cancer find mutate cancer character ize deficiency true significance tumor suppressor remain unclear conclusion discover relatively recently family protein significant role control gene expression vivo also link multiple diverse function tumorigenesis several MBD protein seem augment tumorigenesis seem function primarily dna repair protein protein seem relevant potential therapeutic target fact knockout viable strongly resistant tumorigenesis mechanism resistance least partially understand make ideal target therapeutic intervention key point modulation dna methylation pattern protein interpret pattern modify neoplastic process reduction level reduce tumorigenesis tissue exacerbate tissue deficiency show suppress intestinal neoplasia animal model apparently little protumorigenic role tissue identify promise new therapeutic target deficiency show suppress intestinal neoplasia identify promise therapeutic target deficiency multiple effect tumorigenesis primary consequence increase mutation rate fail DNA repair spontaneous deamination event implicate neoplastic process precise role MBD1 MBD3 remain establish Wolffe methylcpgbinde protein target specific gene repression Eur Biochem mechanism target base attack DNA cytosine carbon methylation biochemistry remodeling transcriptional activation cast order appearance fundamental role epigenetic event cancer domain evolve role dna methylation animal Trends Genet Jones role dna methylation mammalian epigenetic science Strathdee role methylation promoter loss expression drug resistance ovarian cancer Plumb Reversal drug resistance human tumor xenografts deoxyazacytidine induce demethylation gene promoter cancer Res genetic suppression polyp formation reduction cpgisland hypermethylation ApcMin dnmt1hypomorphic mouse cancer res intestinal neoplasia deletion Mol Cell Biol dose schedule S17S22 improve patient outcome myelodysplastic syndrome result phase III randomized study cancer targeted mutation DNA methyltransferase gene result embryonic lethality cell JacksonGrusby loss genomic methylation cause apoptosis epigenetic deregulation nature CLINICAL practice ONCOLOGY SANSOM VOL wwwnaturecomclinicalpracticeonc deficiency lead enhanced microsatellite instability mouse embryonic stem cell tumor mice genomic hypomethylation science effect dna hypomethylation intestinal liver carcinogenesis Meehan Identification mammalian protein bind specifically dna contain methylate Lewis Purification sequence cellular localization novel chromosomal protein bind methylate dna cell transcriptional repressor belong MeCP1 histone deacetylase complex cross component transcriptional repressor MeCP1 share motif dna methyltransferase HRX protein functional characterization p66p68 component MeCP1 complex complex repress transcription preferential binding remodeling deacetylate methylate nucleosome Genes Dev Bird Identification characterization family mammalian methylcpg bind protein Mol cell Biol Hendrich Genomic structure chromosomal mapping murine human Mbd1 Mbd3 gene Prokhortchouk p120 catenin partner repressor repression methylcpgbinde protein mecp2 involve histone deacetylase complex Nature Jones Methylated DNA recruit histone deacetylase repress transcription Wade complex couple dna methylation chromatin remodelling histone deacetylation Zhang Analysis subunit reveal histone deacetylase core complex connection dna methylation Genes Dev thymine glycosylase bind product deamination methylate cpg site Nature Kondo thymine dna glycosylase MBD4 repress transcription associate methylate p16INK4a gene Mol cell Biol affinity different MBD protein specific methylated locus depend intrinsic bind property mcpgbinde domain human MBD3 bind mcpg interact NuRDMi2 component HDAC1 MTA2 Biol Chem Ballestar methylcpg bind protein identify novel site epigenetic inactivation human cancer profile methylcpg bind domain protein occupancy hypermethylate promoter tumor suppressor gene human cancer cancer Res transcriptional silence euchromatin methyl cpg bind protein MBD1 isoform Mol Cell Biol Villa methylcpg bind protein require pmlrar function domain glycosylase link transcriptional repression dna repair chromatin Bader MBD1 MBD2 gene chromosome infrequently mutate human colon lung cancer lack methylcpg bind protein deficit adult neurogenesis hippocampal function Lewis Purification sequence cellular localization novel chromosomal protein bind methylate dna cell Zhang MeCP1 complex repress transcription preferential binding remodeling deacetylate methylate nucleosome Genes Dev functional characterization p66p68 component MeCP1 complex Sekimata Involvement novel zinc finger protein MIZF transcriptional repression interact methylcpgbinde protein Hendrich closely relate protein MBD3 play distinctive interact role mouse development Genes Dev Sansom Deficiency suppress intestinal tumorigenesis gene allow constitutive signal colorectal cancer association methylcpg bind protein silent p14p16 locus human neoplasia dna methyltransferase deficiency modify cancer susceptibility mouse lack dna mismatch repair Mol Cell Biol deficiency accelerate p53 mediate lymphomagenesis protein antisense inhibitor suppress tumourigenesis human cancer cell line vitro vivo carcinogenesis antitumor activity combination MBD2antisense electrotransfer gene therapy bleomycin electrochemotherapy Zhang Analysis subunit reveal histone deacetylase core complex connection dna methylation Genes Dev epigenetic analysis MBD3 colon lung cancer cancer Noh Methyl CpGbinding domain protein mediate cancerselective cytotoxicity histone deacetylase inhibitor differential transcriptional reprogramming lung cancer cell Cancer Res vol SANSOM nature CLINICAL practice mbd3l1 mbd3l2 new protein homologous methylcpgbinde protein MBD3 characterization MBD3L1 testisspecific transcriptional repressor interact MBD3 component complex oppose methylation silence prokhortchouk Kaisodeficient mouse show resistance intestinal cancer Mol Cell Biol Prokhortchouk p120 catenin partner repressor Reynolds catenin p120ctn interact novel domain zinc finger transcription factor Mol Cell Biol genomewide repressor transcription essential amphibian development Development signal modulate transcriptional repressor p120catenin Nat Cell Biol role complexe cancer cancer p120ctnbinde partner modal dnabinding protein recognize sequencespecific consensus methylate inucleotide rapsyn promoter kaiso coordinately regulate canonical Wnt gene target Dev Cell filion family human zinc finger protein bind methylate dna repress transcription Mol Cell Biol Geerdink MECP2 mutation boy severe neonatal encephalopathy clinical neuropathological molecular finding Villard affected boy syndrome family clinical molecular finding neurology transcriptional repressor abundant bind site genomic chromatin cell repression methylcpgbinde protein mecp2 involve histone deacetylase complex Nature Klose dna bind selectivity mecp2 due requirement sequence adjacent methylCpG Mol Cell require prostate cancer cell growth expression human neoplastic nonneoplastic breast tissue association oestrogen receptor status cancer Nakagawachi silencing effect cpg island hypermethylation histone modification methylguanineDNA methyltransferase gene expression human cancer Role MED1 MBD4 gene dna repair human cancer Cell Physiol repeat silent nonsense mutation p53 enhance cpg mutability tumorigenesis mbd4deficient mouse science inactivation increase transition mutation promote gastrointestinal tumor formation Fritzell role dna mismatch repair cytotoxicity ionize radiation cancer res status modulate apoptosis mutation frequency murine small intestine Meyers role hMLH1 dna mismatch repair protein fluoropyrimidinemediated cell death cell cycle response cancer res Sansom MBD4 deficiency reduce apoptotic response dna damage agent murine small intestine Cortellino base excision repair enzyme mediate dna damage response drug associate mismatch repair system integrity central molecule maintenance genome integrity response dna damage Sansom MBD4 deficiency increase mutation accelerate tumourigenesis mouse lack MMR Oncogene death domain protein interact methylcpg bind domain protein potential link genome surveillance apoptosis frameshift mutation gene sporadic colon cancer mismatch repair deficiency Wade Methyl CpGbinding protein transcriptional repression Guezennec MBD2NuRD MBD3NuRD distinct complex different biochemical functional property Mol Cell Biol compete interest author declare compete interest",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 31,
                    "epigenetic": 8,
                    "demethylation": 1
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "MBD1": 5,
                    "METHYLBINDING": 2,
                    "MBD3": 6,
                    "Mbd3": 1,
                    "ZBTB4": 1,
                    "Mbd1": 1,
                    "NuRDMi2": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "MBD1": 40,
                    "METHYLBINDING": 40,
                    "MBD3": 40,
                    "Mbd3": 40,
                    "ZBTB4": 40,
                    "Mbd1": 40,
                    "NuRDMi2": 40
                },
                "Ethnographic Terms": {
                    "methylation": 17,
                    "epigenetic": 17,
                    "demethylation": 17
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Methyl nutrients_ DNA methylation_ and cardiovascular disease.pdf",
            "cleaned_text": "Res mnfr Methyl nutrient dna methylation cardiovascular disease Glier1 Pathology Laboratory Medicine Child Vancouver Canada Department Food Nutrition Health Child Vancouver Canada Department Pediatrics Child British Columbia Vancouver Canada play important role development prevention cardiovascular disease cvd molecular mechanism fully understand dna methylation implicate underlie molecular mechanism account effect etary factor development prevention CVD dna methylation epigenetic process provide mark genome gene set transcriptionally activate silence epigenomic mark heritable also responsive environmental shift change nutritional status especially vulnerable development adenosylmethionine methyl group donor dna methylation several nutrient require production adenosylmethionine methyl nutrient include vitamin folate riboavin vitamin b12 vitamin choline amino acids methionine cysteine serine glycine imbalance metabolism nutrient potential affect dna methylation focus provide overview current derstande relationship methyl nutrient status dna methylation pattern potential role interaction cvd pathology vitamin cardiovascular disease dna methylation adenosylmethionine receive revise Accepted March Introduction Diet play role development cardiovascular disease cvd underlie molecular mechanism etary constituent contribute CVD pathology par tially understand involve epigenetic process genetic dene change gene expression occur change dna sequence pro cesse include dna methylation chromatin modication Correspondence British Columbia Child Family Research Insti tute Ave v5z 4H4 mail adenosylmethionine BMI body mass index CAD coronary artery disease cystathioninesynthase CVD disease dnmt dna methyltransferase HHcy hyperhomo cysteinemia MTHFR methylenetetrahydrofolate reductase pbmc peripheral blood mononuclear cell pemt phos phatidylethanolamine methyltransferase tetrahydrofolate histone methylation acetylation mirna pro cesse provide mark genome gene set transcriptionally activate silence itable transmit parent daughter cell tosis however epigenomic mark also responsive environmental shift change nutritional status attractive dietrelated target preven tion treatment cvd change dna methylation pattern implicate pathology CVD however knowledge regard effect dietary factor dna methylation pattern role CVD pathology infancy study require study help improve understanding role diet etiology CVD provide new target dietrelated CVD prevention treatment provide overview current state knowl edge regard dietary factor dna methylation context cvd pathology dietary factor require reaction often refer methyl nutrient require generation adenosylmethionine key methyl donor DNA rna protein phospholipid Methyl nutrient include vitamin WILEYVCH Res figure Schematic representation metabolic pathway associate generation adenosylmethionine characterize liver adenosylmethionine b12 vitamin B12 BHMT betaine homocysteine methyltrans ferase cystathionine synthase cytidine diphosphocholine choline phosphocholine choline kinase CPT choline phosphotransferase phosphocholine cytidylyltransferase lyase dihydrofolate avin adenine dinucleotide methionine synthase MTHF methyltetrahydrofolate methylenetetrahydrofolate reductase methyltransferase phosphatidylcholine phos phatidylethanolamaine pemt phosphatidylethanolamine methyl transferase pyridoxal phosphate SAHH AdoHcy hydrolase serine tetrahydrofolate zinc folate riboavin vitamin b12 vitamin pyridoxal phos phate choline amino acid methionine cysteine glycine serine summary research assess ing relationship alteration methyl nutrient status change dna methylation highlight consequence methyl nutrient imbalance folic acid fortication present follow synopsis current understanding dietrelated change dna methylation pattern affect CVD pathology Methyl nutrient metabolism Methyl nutrient metabolically require genera tion AdoMet primary methyl donor DNA rna protein lipid AdoMet generation involve interrelated biochemical pathway folate cycle methionine cycle transsulfuration pathway brief scription pathway metabolic relationship illustrate cycle folate watersoluble vitamin active form late tetrahydrofolate function pro duction purine pyrimidine remethylation homocysteine methionine use purine synthe sis follow conversion thymidy late synthesis follow conversion methyleneTHF Conversion methyleneTHF require glycine accomplished serine hydroxymethyltransferase Folate methylTHF vitamin b12 require Res methionine synthase catalyze teine methionine accomplish reductase mthfr require riboavin cofactor follow homocysteine cle back process repeat ciency vitamin b12 presence adequate folate result accumulation methylTHF crease methionine synthase activity refer methyl folate trap hypothesis conversion methyleneTHF methylTHF unidirectional trap ping methylTHF Methionine cycle methionine essential sulfurcontaining amino acid convert methionine form follow methyl donation follow reversible liberation adeno sine formation homocysteine catalyze AdoHcy hydrolase Homocysteine nonprotein form amino acid possible fate remethylation methionine conversion cysteine glutathione homocysteine thionine accomplish ubiquitous methionine synthase require vitamin B12 utilize methyl donor addi pathway homocysteine remethylation methionine catalyze zincdependent betaine homocysteine methyltransferase utilize betaine methyl donor obtain diet endogenously synthesize choline Betainehomo cysteine methyltransferase find high level liver kidney Choline come phosphatidylcholine obtain diet endogenously synthesize cytidine diphospho choline pathway additional pathway phosphatidyl choline synthesis present tissue liver involve methylation phosphatidylethanolamine phosphatidylcholine phosphatidylethanolamine methyl transferase pemt Transsulfuration pathway Homocysteine irreversibly convert cysteine twostep process involve formation follow conversion enzyme require vitamin cofactor transsulfuration pathway find liver pancrea kidney intestine tissuespecic activity cystathioninelyase teine use protein synthesis metabolize compound include taurine glutathione dna methylation dna methylation involve addition methyl group position cytosine cpg dinucleotide estimate genome methylate dna methylation also occur cytosine residue adjacent guanine residue term non methylation however study require termine role regulate gene expression lation dna accomplish dna methyltransferase dnmt novo methylation occur embryogene sis accomplish main tenance methylation occur somatic cell division accomplish immediately follow fertilization initial stage embryo development genomewide demethylation parental genome reprogramme methylation pattern mechanism involve epigenetic reprogramming complex asymmetry mechanism degree happen maternal paternal genome nomenon suggest presence heritable epigenetic mem ory pattern transmit somatic cell division lifespan furthermore genetic reprogramming occur early embryonic development maybe especially vulnerable environmental factor affect methylation several exam ple literature whereby change nutrition status development adulthood affect dna methylation pattern profound effect gene pression phenotype furthermore epigenetic regulation gene expression dna methylation prole tissue cell specic vulnerability cell tissue specic dependent developmental stage sex organism refer cpg island dene region dna great base pair high expect dinucleotide content land often associate gene promoter usually unmethylated play role govern gene expression especially pat tern cpg island also find intragenic tergenic region function remain fully elucidate Methylation DNA intergenic intragenic region often occur repeat element short inter spersed element Alu long interspersed element line line usually methylate Methyla tion dna site promoter region regulatory site often associate silence gene expression silence gene expression also occur alteration dna methylation promoter region island sequence stream often refer cpg island shore addion dna methylation also play important role chromo inactivation allelesilence imprint gene WILEYVCH Res silence gene expression dna methylation occur several mean example methylation pede bind regulatory factor require tran scriptional activation line important note methylation silence always involve land methylation cpg site contain important regulatory factor bind site ate silence gene expression Methylated dna also serve target methylbinding protein MeCP1 also interfere transcriptional tivation furthermore methylated dna inuence chromatin structure repressive state transcriptionally active Methyl nutrient imbalance dna methylation study investigate methyl nutrient imbalance dna methylation focus folate status example conduct metabolic balance study postmenopausal woman place lowfolate diet day day baseline day plasma folate decrease nmol homocysteine increase mol lymphocyte global DNA methy lation decrease similarly low global DNA methy lation leukocyte report elderly woman feed lowfolate diet accompany low serum folate concentration nmol elevate serum total homocysteine concentration mol evidence methyl nutrient imbalance fect dna methylation come study subject mozygous common Caucasian popula tion MTHFR 677C variant rs1801133 variant code thermolabile form enzyme result impaired ability synthesize methylTHF often accompany elevated plasma total homocysteine global dna hypomethylation subject MTHFR 677C variant genotype plasma folate concentration less nmol ele vated plasma total homocysteine concentration mol report low global dna methylation leukocyte compare subject genotype suggest effect variant global methyla tion dependent folate status individual classic example genenutrient interaction several study show concentration AdoHcy increase result low adometadohcy ratio vitro study demon strate elevate AdoHcy concentration reduce adometadohcy ratio inhibit dna methyltransferase action liver cultured human broblast suggest low adometadohcy ratio indicator reduce dna methylation capacity however relation ship increase intracellular AdoHcy concentration low adometadohcy ratio dna methylation unclear report literature suggest effect adometadohcy ratio dna methylation tissue specic example study subject report elevated plasma lymphocyte AdoHcy concen tration associate reduce global DNA methy lation leukocyte lymphocyte respectively study report relationship study report genespecic association HHcy dna methylation human subject subject renal failure hemodialysis global dna hypomethylation compare control subject subset severe HHcy mol biallelic expression imprint H19 gene change dna methylation leukocyte interestingly lower plasma total homocysteine concen tration methylTHF supplementation return H19 monoallelic expression study similar discrepancy report mouse model tissuespecic relationship circulate total homocysteine concentration intra cellular AdoHcy concentration global dna methylation example severe HHcy report elevate concentration Ado Hcy liver kidney brain reduce level global DNA methylation liver kidney brain addition dietinduced HHcy high low adometadohcy ratio liver accompany low maternal H19 allele methylation low mrna level loss maternal imprinting liver contrast differ ence detect AdoHcy brain ever cast dietinduced HHcy high maternal H19 methylation low H19 mrna tion brain Furthermore dietinduced HHcy report low concentration liver high AdoHcy concentration brain difference global dna methylation tissue together study indicate effect AdoHcy concentration tissue specic result genespecic hypermethylation global DNA pomethylation effect dna methylation contribute gene expression prole promote CVD risk Fig tissue specicity relationship total homocysteine concentration intracellular AdoHcy concentration DNA methylation impor tant factor interpret result human study cause dna methylation often assess peripheral blood mononuclear cell pbmc leukocyte hetero geneous cell population elaborate study specic blood cell type monocyte lymphocyte require clarify effect circulate total homocysteine concen tration intracellular change AdoHcy concentration global genespecic dna methylation WILEYVCH Weinheim wwwmnfjournalcom Res figure Schematic representation illustrate potential mechanism whereby methyl nutrient imbalance alter gene expression change dna methylation contribute cardiovascular disease hydrolysis adenosylhomocysteine AdoHcy mocysteine reversible reaction synthesis AdoHcy favor inadequate removal homocysteine result increase homocysteine AdoHcy concentration report inhibit methyltransferase inhibit DNA methy lation reaction effect methyl nutrient imbalance AdoHcy concentration dna methylation pattern tissue specic result global dna hypomethylation genespecic hypermethylation change change dna methylation capacity alter gene expression produce gene expression prole promote CVD pathology Methyl nutrient imbalance cardiovascular disease CVD Hyperhomocysteinemia HHcy much attention past focus homocysteine possible role CVD pathology observational study HHcy risk factor CVD speculate change dna methylation contribute vas cular complication associate however recent vitamin intervention trial design low circulate tal homocysteine concentration fail reduce secondary cvd event negative nding trial consequence fact circulate total homo cysteine concentration baseline subject elevate enough affect CVD pathology therefore low ere concentration subsequent effect cvd event nding several study animal model human report association HHcy vascular endothelial dysfunction dene study impair vascular endotheliumdependent vasodilatation early indicator vascular disease often precede primary cardiovascular event exam ple subject acute HHcy mol follow oral methionine load report endothelial dysfunction similarly study mouse model produce target disruption gene encode enzyme require methyl nutrient metabolism encode methionine synthase dietinduced HHcy also report endothelial dys function recently folate also implicate endothelial dysfunction effect nitric oxide metabolism study subject coronary artery disease CAD report homozy gous MTHFR 677C variant elevate vascular methylTHF concentration difference vascular total homocysteine concentration sociate endothelial dysfunction vascular oxidative stress Methyl nutrient imbalance lipid metabolism Lipid metabolism link methyl nutrient metabolism methionine cycle synthesis phos phatidylcholine hepatic synthesis synthe size way rst pemt pathway responsible synthesize second pathway responsible remain ing Liver require synthesis secretion lipoprotein liver therefore play indirect role delivery lipid long chain polyunsaturated fatty acid vascular endothelium extrahepatic tissue WILEYVCH report associate disturbance lipid metabolism include decrease plasma hdl chole terol apolipoprotein concentration hepatic lipid accumulation furthermore study group report Cbs mouse mild moderate HHcy disturbance hepatic fatty acid phospholipid metabolism involve gene encode enzyme require metabolism essential fatty acid linoleic acid linolenic acid respectively er also report regulation cholesterol metabolism dna methylation model study report methylation silence liver receptor alpha Lxra pression nuclear receptor regulate cholesterol fatty acid metabolism liver fetal mouse expose mater nal protein restriction compare fetus controlfed dam Cysteine CVD risk factor relationship total cysteine CVD risk rst describe study identie association tween circulate total cysteine concentration body mass index BMI BMI use adult obesity wellknown risk factor CVD take report independent positive association tween plasma total cysteine concentration BMI fat mass baseline follow increased weight gain also report animal model sup plemente high dietary cysteine cysteinerich protein diet take together study suggest cir culating total cysteine concentration marker adiposity important risk factor CVD direct relationship cysteine CVD dis ease well study case control study report high level plasma total cysteine tion subject cerebral infarction peripheral terial disease myocardial infarction compare healthy control crosssectional study human hyperlipidemia report higher circulating cysteine concen tration CVD furthermore Concerted Action Project casecontrol study subject CVD control subject port shape association plasma total cysteine concentration CVD great risk observe subject plasma total cysteine concentration mol mol similarly small casecontrol study assess relationship plasma total cysteine concentration atherosclerosis case dene subject occlusion vessel occlusion second vessel control group assess coronary control subject occlusion vessel population base healthy control study report case signicantly high plasma total cysteine concen tration control subject high tertile plasma total cysteine concentration odd ratio coronary atherosclerosis compare subject low tertile plasma total cysteine concentration however relationship disappear adjustment CVD risk factor include BMI present signicance relationship plasma total cysteine CVD pathol ogy unclear exist secondary association adiposity plasma total cysteine concentration Atherosclerosis DNA methylation Atherosclerosis characterize proliferation vascular smooth muscle cell lipid accumulation connective tissue development inammatory cell inltration calcica tion Changes global genespecic DNA pattern implicate pathology atheroscle rosis occur change methyl nutrient metabolism acquire tissue sample coronary vessel assess change dna methylation human study always feasible often blood sample col lecte advisable target specic blood cell type oppose quantify dna methylation change pbmc heterogeneous cell population example mono cytesmacrophage lymphocyte predom inant leukocyte atherosclerotic artery report play key role pathology atheroscle rosis assess change dna methylation pattern specic blood cell type monocyte inform pathology atherosclerosis change dna methylation pattern produce gene expres sion prole promote development progression atherosclerosis Fig many study animal human link atherosclerosis dna methylation example study report genomic dna hypomethylation advance atherosclerotic lesion human subject atherosclerotic lesion mouse decient apolipoprotein apoe aortic neointima balloon denude White rabbit assess dna methylation early stage atherosclerosis port vascular lesion global dna hypomethylation aorta PBMCs also able detect change dna methylation pattern tissue appearance vascular lesion take together nding mouse suggest role dna methylation development atherosclerosis addition human study report male subject history CVD CVD risk factor high leukocyte global dna methylation status furthermore nding report nega tive association leukocyte line methylation status circulate vascular cell adhesion molecule WILEYVCH Res Figure Schematic model lustrate altered dna methylation contribute cardiovascular disease alter dna methylation pattern gene expression specic tissue age sex ethnicity concentration male subject European descent cvd man establish CVD similarly nding Diabetes report leukocyte line methylation status negatively ate plasma ldl positively associate plasma hdl nding support concept global change dna methylation contribute early stage cvd pathology study address genespecic change atherosclerosis tissue collect patient undergo coronary artery bypass grafting report hypermethylation ESR1 encode estrogen receptor alpha aorta inter nal mammary artery saphenous vein great level observe coronary artery atherosclerotic plaque find ing report inverse rela tionship elevated plasma activate coagulation factor VIIa concentration mean hypomethy lation encode coagulation factor VII promoter pbmc man woman CAD compare subject study rabbit atherosclerosis show hypomethylation encode extracellular superoxide dismutase global hypomethy lation atherosclerotic tissue aorta addi tional study require denitely assess role change dna methylation pathology atherosclerosis Folic acid fortication mandatory fortication grain product folic acid introduce North America prevention neural tube defect recent estimate report reduc tion neural tube defect inception mandatory fortication program furthermore folate status Canadians rise recent stud ies report less population folate decient high red blood cell folate level nmol similar nding observe however little know regard ing effect high folic acid intake folate form use fortication grain supplement methyl metabolism dna methylation date study report effect folic acid supplementation day leukocyte global DNA methylation contrast study woman childbeare age port effect folic acid supplementation range day whole blood global dna methylation coagulate blood sample uncoagulated blood sample similarly study subject MTHFR 677C variant high plasma total homocysteine concentration mean mol report signicant lower plasma total homocysteine follow folic acid supplementation effect leukocyte global dna methylation additional study require determine effect high folic acid intake dna methylation pattern dna methyla tion pattern specic blood cell type monocyte rather heterogeneous whole blood leukocyte metabolism folate cobalamin also call B12 tightly link together case ciency adequate folate status folate become trapped MTHF unable participate metabolic reaction furthermore high folic acid intake mask hematological sign study WILEYVCH old adult datum collect con veyed low serum pmol elevated folate nmol concentration associate anemia great cognitive impairment addition report participant cobalamin decient pmol less folate deciency nmol high nmol folate status differential effect folatecobalamin imbalance dna methylation pattern relevance CVD warrant investigation conclusion currently knowledge diet play role ing dna methylation pattern translate disease pathology early stage obtain human animal study suggest change dna methylation pattern responsive change nutritional status highly tissue cell specic study mouse provide detailed nding tissue easily obtainable human study reason advisable target primary blood cell type involve disease example target monocyte inve tigate dna methylation CVD Detection risk serve mean prevent future cardiovascular event myocardial infarction stroke provide insight potential reversibil ity alter dna methylation pattern lead treatment CVD epigenetic grow rapidly ever investigation pertain epigenetic change dna methylation pattern need elucidate treatment biomarker CVD implement clinical setting work support funding Heart Stroke Foun dation support university graduate fellowship support investigatorship author declare conict interest silence cancer sociation promoter hypermethylation element target early nutritional effect epigenetic gene regulation Mol Cell Biol Laukkanen Mannermaa local hypomethylation atherosclerosis find rabbit sod gene Biol dna hypomethylation methyltransferase expres sion atherosclerotic lesion DNA methylation polymorphism precede histological sign atherosclerosis mouse lack apolipoprotein GoldschmidtClermont Wilhide Held man methylation estrogen receptor gene associate aging atherosclerosis cardio vascular system GoldschmidtClermont Dong Inactivation monocarboxylate transporter MCT3 DNA methylation atherosclerosis Circulation metabolism liver disease Stover Physiology folate vitamin b12 health disease Nutr Rev S12 Mato MartinezChantar Methion ine metabolism liver disease kinetic property cdna cloning mammalian betainehomocysteine Phospholipid biosynthesis mam malian cell Biochem Cell Biol Selhub Homocysteine metabolism sulfurcontaining amino acid overview Nutr 1636s1640s Law maintain modify dna methylation pattern plant animal man DNA methylomes base resolution show widespread epigenomic difference Nature Bestor DNA methyltransferase mammal exibility epigenetic gene regula tion mammalian development Nature Probst Almouzni Heterochromatin establishment context genomewide epigenetic reprogramming Trends Genet Waterland wean diet affect genomic imprint insulinlike growth factor locus permethylation Fads2 alter hepatic fatty acid phospholipid metabolism mouse hyperhomocysteine Biol Chem Sulistyoningrum Aeliunas Tissuespecic relationship WILEYVCH Res allelespecic H19Igf2 methylation imprint mouse cpg island regulation transcription Genes Dev human colon cancer methylome show similar hypo hypermethylation conserve island shore silence chromosome inactivation vance understand facultative heterochromatin forma tion Ideraabdullah imprinting mechanism mammal epigenetic programming maternal behavior methylcpgbinde protein Eur Biochem Taylor erate folate depletion increase plasma homocysteine decrease lymphocyte dna methylation postmenopausal woman Kauwell Hutson DNA methylation decrease response moderate folate depletion elderly woman candidate genetic risk factor vascular disease common mutation methylenetetrahydrofolate reductase polymorphism folatemetabolize gene serum total homocysteine concentration healthy elderly population methylenetetrahydrofolate reductase mthfr 677C 1298A mutation associate Weisenberger methylenetetrahydrofolate reductase C677 mutation induce change genomic dna methylation uracil misincorporation possible molecular basis cancer risk modication Int Cancer Mason com mon mutation methylenetetrahydrofolate reduc tase gene affect genomic dna methylation teraction folate status USA increase plasma homocysteine associate parallel increase plasma adenosylhomocysteine lymphocyte dna hypomethylation Biol Chem crease homocysteine adenosylhomocysteine centration dna hypomethylation vascular disease Endothe lial dysfunction elevation adenosylhomocysteine cystathionine betasynthasedecient mouse Circ Res Devlin Arning genotype dietinduced hyperhomocys teinemia vascular function mouse blood Devlin Bottiglieri change H19 methylation expression mouse hyperhomocysteinemia Hoffman adenosylmethionine adenosylhomocystein metabolism isolate rat liver effect methionine homocystein adenosine Piqueras adenosylhomocysteine agent Boers Smulders dna methylation status impair treat decient patient Rock Effect acute hyperhomocysteinemia methylation potential dna methylation lymphocyte healthy male volunteer Physiol Renal Physiol f786f792 treatment unbalanced methylation change allelic expression induce hyperhomocys teinaemia patient uraemia cystathionine betasynthase knock mouse elevation total plasma homocysteine crease tissue adenosylhomocysteine response adenosylmethionine dna methylation tissue spe cic Nutr Homocysteine study collaboration Homocysteine risk ischemic heart disease stroke metaanalysis JAMA Bonaa Njolstad trial investigator homocysteine lower cardiovascular event acute myocardial infarction Spence lower homocysteine patient stroke prevent recurrent stroke myocardial farction death vitamin intervention stroke pre vention randomize control trial Food dysfunction obe sity etiological role atherosclerosis diabetes Obesity Bellamy McDowell oral methionine load acutely impairs endothelial function healthy adult circulation pendence hyperhomocysteinemia vascular dysfunc tion cystathionine betasynthasedecient mouse Physiol Heart Circ Physiol h970h975 Dayal Arning bral vascular dysfunction mediate superoxide hyper homocysteinemic mouse Stroke Weiss Heydrick Postea Keller Inu ence hyperhomocysteinemia cellular redox state impact homocysteineinduce endothelial dysfunction med dayal Devlin McCaw bral vascular dysfunction methionine synthasedecient mouse Circulation polymorphism reveal functional portance methyltetrahydrofolate homocysteine regulation vascular redox state endothelial function human atherosclerosis circulation phospholipid biosyn thesis isolate rat hepatocyte effect different sub strate ular distinction phosphatidylcholine synthesis pathway phosphatidylethanolamine methylation pathway active synthesis phosphatidyl choline require low density lipoprotein secretion rat hepatocyte Biol Chem group specicity requirement phosphatidylcholine biosynthesis low density lipoprotein secretion cultured hepatocyte Enokido abnormal lipid metabolism cystathionine betasynthasedecient mice animal model hyperhomocysteinemia Biol Chem reduce apolipoprotein expression hyperhomo cysteinemic mouse male coronary artery disease total homocysteine lowdensity lipoprotein cholesterol high density lipoprotein cholesterol serum patient myocardial infarction Clin Biochem liver receptor gene promoter hyper methylate mouse model prenatal protein restric tion Physiol Refsum total cysteine risk factor vascular disease relation plasma cysteine plasma coronary atherosclerosis Atherosclerosis Elshorbagy Nurk Gjesdal tell Homocysteine cysteine body composition cysteine link amino acid lipid metabolism Okawa Morita Sugiyama Cysteine supplementa tion decrease plasma homocysteine concentration rat feed lowcasein diet rat Biochem Elshorbagy ValdiviaGarcia supplementation reverse methionine restriction effect rat adiposity Lipid dietary cystine level affect metabolic rate gly control adult mice Nutr Biochem Fukushima sulfhydrylcontaining amino acid patient cerebral infarction hypertensive subject Atheroscle rosis Redox status protein bind plasma homo cysteine aminothiol patient earlyonset peripheral vascular disease bur Gaziano Homocysteine metabolism risk myocardial infarction relation vitamin B12 folate Epidemiol teine cardiovascular risk factor hyperlipidemic tient Atherosclerosis atherosclerosis atherosclerosis Arterioscler Thromb Vasc Biol DNA biomarker cardiovascular disease risk e9692 Bollati repetitive element dna methylation circulate dothelial inammation marker normative age study Epigenetics cash McGarvey Houseman disease risk factor DNA methy lation line repeat region peripheral blood Samoan islander Res Friso Lotto Choi Girelli Promoter methylation coagulation gene inuence plasma FVII concentration relate coronary artery disease Tairou duction neuraltube defect folic acid fortication Engl Med Colapinto status population CMAJ Pfeiffer Johnson Jain Yetley trend blood folate vitamin tion Clin Nutr Boulet trend postfortication prevalence spina Teratol effect folic acid supplementation global dna methylation man woman moderately elevated homocysteine nomic dna methylation change response folic acid supplementation populationbase intervention study woman reproductive age plo e28144 acid effect adenosylmethionine adenosylhomocysteine dna methylation patient intermediate hyperhomocysteinemia vitamin B12 Proc Nutr Soc Morris Selhub Folate vitamin status relation anemia cognitive impairment old Americans age folic acid fortication MacFarlane homocysteine status folate replete population result Clin Nutr WILEYVCH wwwmnfjournalcom",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 103,
                    "epigenetic": 11,
                    "demethylation": 1
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "methyltrans": 1,
                    "Caucasian": 1,
                    "AdoHcy": 8,
                    "European": 1,
                    "Canadians": 1,
                    "Atheroscle": 1,
                    "Samoan": 1,
                    "Americans": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "methyltrans": 115,
                    "Caucasian": 115,
                    "AdoHcy": 115,
                    "European": 115,
                    "Canadians": 115,
                    "Atheroscle": 115,
                    "Samoan": 115,
                    "Americans": 115
                },
                "Ethnographic Terms": {
                    "methylation": 15,
                    "epigenetic": 15,
                    "demethylation": 15
                }
            },
            "disparity_metadata": {
                "ethnicity": "European descent",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Methyl Rotation Barriers in Proteins from 2H Relaxation Data. Implications for Protein Structure.pdf",
            "cleaned_text": "Pavlova OVal Pharmakologie FMP RobertssleStrasse receive mail nikolaipurdueedu sidechain backbone relaxation datum collect multiple temperature sample SH3 domain spectrin Combined analyse datum allow determination temperaturedependent correlation time characterize fast methyl motion molecular dynamic simulation confirm dominate methyl rotation corresponding activation energy approximate methyl rotation barrier methyl group spectrin SH3 domain average barrier height thus determine kcalmol value deem representative fluid hydrophobic protein core barrier increase other lower contact surround atom local order produce systematically high low barrier comparison simulation predict average barrier kcalmol calculate potential mean force rigid barrier appropriate averaging multiple snapshot latter result prompt investigate rigid methyl rotation barrier series nmr structure case barrier prove high expect kcalmol certain degree cause tight pack side chain NMR structure stem structure calculation procedure coordinate first anneal temperature subject energy minimization several case barrier kcalmol indicative Waals violation notable exception structure solve use force field tight methyl packing avoid structure solve mean dynamic ensemble refinement method result demonstrate methyl rotation barrier derive experiment traditionally associate study protein dynamic also use context structural work particularly interesting view recent effort incorporate dynamic datum process protein structure elucidation introduction long recognize dynamic parameter protein sidechain provide useful probe protein study solid solutionstate NMR provide wealth information methyl dynamic datum source believe generally consistent particular good agreement solid solutionstate datum note sample globular protein methylbearing side chain sequester inside sufficiently rigid scaffold solid sample generously hydrated study room temperature nmr study methyl dynamic protein involve number spin probe typically dynamic observe methyl site dominate rapid rotation methyl fold symmetry axis accordingly fast motion manifest spin relaxation mainly represent methyl rotation note fast motion correlation time vary roughly factor residue residue underscore diverse dynamic behavior methylbeare side chain experimental study choose residue SH3 domain chicken spectrin spc SH3 structure protein characterize ray crystallography8 well solution solidstate NMR collect Purdue University Pharmakologie FMP Sparks Cole Torchia Young Chem Scr Pavlova Chem Soc Sci Sykes Nicholson Arango Young Bax Torchia Biochemistry Louis Zhang Sui Yang Chem soc Musacchio Noble Pauptit Wierenga Saraste Nature publish web ja0702061 CCC chem SOC backbone sidechain methyl relaxation datum different sample spc SH3 different temperature use spectral density mapping approach identify single side chain affect intermediate timescale 1ns local dynamic methyl site prove compatible simple LipariSzabo model parametrize variable associate order parameter Saxis2 value obtain different temperature use produce plot determine activation energy distinct methyl site case make value approximate sufficient accuracy energy barrier rotate methyl group suggest average barrier height kcal mol find experimental study spc SH3 typical protein indeed mostly find protein hydrophobic core rather irregular amorphous structure longrange order core therefore reason expect systematically high low barrier sometimes occur crystal small model compound interpret experimental result turn molecular dynamic simulation trajectory spc SH3 record explicit solvent temperature use program use data methyl barrier calculate forcibly rotate methyl group otherwise rigid structure snapshot result subsequently average series snapshot produce Vrigid technically averaging apply transition rate rather directly barrier treatment become clear barrier height highly sensitive dynamic fluctuation protein structure nmr structure consist multiple conformer degree representative dynamic fluctuation take place protein start premise decide calculate number nmr ensemble bank turn several structure produce average barrier kcalmol line expectation give approximate character calculation hand group structure abnormally high barrier excess kcalmol generally attribute overly tight sidechain packing least part effect bring structure calculation procedure nate anneal temperature energyminimize structure calculate protocol acquire certain lowtemperature charactersin particular outside atom often position methyl proton thus obstruct methyl rotation category nmr structure stand group structure solve help force field treat expand sphere consequently intercalation effect avoid realistic barrier kcalmol obtain even significantly reasonable barrier find structure solve mean dynamic ensemble refinement approach approach seek accurately reproduce motional variability protein structure anticipate methyl rotation barrier incorporate method target structure refinement Background Relaxation Methyls Deuterium universally attractive probe spin evolution dominate single quadrupolar interaction furthermore turn quadrupolar tensor protein methyl site practically change residue relaxation rate measure single spin19 express spectral density 2D describe model methyl group execute random jump equivalent site case overall tumble protein isotropic model produce biexponential correlation function respective spectral density identical LipariSzabo spectral density express as23 rot Saxis2 represent order parameter methyl fold symmetry axis rot correlation time overall tumbling particular model exchange rate nearestneighbor jump occur simple model contain fitting parameter Saxis2 term model sophisticated theory develop model consider diffusion methyl group potential correlation function case feature steep drop cause rapid harmonic oscillation potential well follow region decay due transition potential well follow illustrate kind correlation function obtain molecular dynamic simulation note model experimentally threesite jump therefore ultimately reduce addition fast spin methyl group overall molecular tumbling spectral density also influence form Diehl Heinemann Biomol NMR NMR Rossum Diehl Nature Bruccoleri Olafson NMR manual Groningen Best Vendruscolo Nature Schaumburg Kay Chem Soc Torchia Wallach Chem Phys Edholm Torchia Chem Soc Saxis Saxis rot internal motion long side chain fast axial fluctuation fold rotameric jump involve torsional angle Rotameric jump methylbeare side chain first identify lineshape analysis solidstate NMR spectra later solutionstate study focus scalar dipolar coupling confirm significant fraction protein side chain conformationally disorder characteristic rate sidechain rotameric jump vary widely case rotameric jump influence relaxation rate suggest rot case jump occur low nanosecond range rot directly identify relaxation datum turn relatively small fraction side chain fall category datum analysis adapt account effect jump alternatively affected residue simply remove consideration finally residue jump occur relatively fast time scale rot Fast jump responsible low order parameter Saxis2 quite common leucine side chain jump also observe molecular dynamic simulation presence fast rotameric jump complicate data analysis long identify methyl rotation alone follow use result molecular dynamic simulation probe relationship methyl rotation correlation time methyl rotation involve relatively light particle proton deuteron tunnel possible effect subject many nmr study conduct low temperature important methyl tunneling room temperature effect significant molecular dynamic datum correct reproduce correct problem question treat Liljefors calculation employ different model show activation energy methyl rotameric jump nearly temperatureindependent range good agreement large body experimental evidence see important find nearly identical height potential barrier control methyl rotation barrier define difference maximum minimum potential energy deviation quantity amount less less kcalmol include approximately tunnel correction recent work tanowicz suggest tunneling correction disappear altogether room temperature measurement carry activation energy methyl reorientation CH3CH3 kcalmol value obtain barrier height ch3ch2ch2ch3 number study activation energy determine individual amino acid mainly solidstate NMR measurement also do protein selectively label respect certain type amino acid report value typically fall range kcalmol special situation methionine barrier associate thioether bond low solidstate measurement usually perform widetemperature range case span essentially case plot linear entire temperature range consistent view methyl rotation activate process certain crystal higherthanexpecte activation energy find increase barrier attribute crystal packing effect obstruct methyl rotation example find zwitterionic alanine crystallographic structure compound show methyl group substantially less sum later calculation worker confirm increase cause crystalline environment mainly due van der Waals term relatively modest contribution electrostatic interaction absence crystal packing effect barrier approximately kcalmol predict alanine leucines DFT calculation vacuo Experimental Results single deuterium spin allow measurement distinct relaxation rate worker recently demonstrate rate accurately measure protein lead selfconsistent result self consistency deuterium relaxation experiment establish take advantage redundancy present set rate rate express spectral density 2d principle sufficient measure rate preferably high sensitivity attain specific measurement scheme start analyze methyl r1zzdz2 rate measure sample spc SH3 domain rate transform spectral density result fit LipariSzabo model sf2 treat fitting parameter rot fix accord relaxation datum measure sample analysis demonstrate aside single side chain methyl site perfect compliance model top panel figure show typical spectral density profile supplement bestfit curve sole exception side chain Val Biochemistry Opella biochemistry Soc Mittermaier soc Chou Case Bax Chem soc good Biochemistry Tang Iwahara Clore Biomol NMR Kay Mol Biol Best Clarke Karplus Mol Biol NMR Horsewill Prog NMR Spectrosc Chatfield Wong Phys Chem Chem Phys Lett Latanowicz Phys Chem Latanowicz Concepts AdV Protein Chem Alsanoosi Tunnelling spectroscopy dynamic CH3 homologous series ketones Springer Proceedings Physics Springer Berlin Vol SpijkerAssink Griffin Biochemistry Methyl Rotation Barriers Proteins chem soc VOL methyl site bottom panel figure previously conformational disorder side chain detect use ray solidstate NMR also demonstrate present set relaxation datum explain assume methyl group affect degree rotameric jump time scale several nanosecond context study however merely observe model fail fit datum choose exclude residue consideration obtain activation energy associate repeat measurement well field mhz temperature ascertain separation internal dynamic overall rotation achieve correctly measurement duplicate use different sample spc SH3 first sample express use glucose carbon source permit detection methyl site second sample prepare pyruvate limiting observation site ultimately datum sample available methyl site datum glucosederived sample available site datum pyruvate sample hand additional site latter case glucose sample datum unusable spectral overlap difference spc SH3 concentration extent difference deuteration level sample turn systematically different respect reorientational motion protein specifically glucosederived sample produce rot value high series measurement interfere however analysis methyl dynamic rot case determine independently datum see Materials Methods datum methyl site temperature fit model note set r1zz datum measure restrict analysis estimate error saxis2 procedure implement part fitting routine result value use produce plot datum sample prove fully consistent fit collectively obtain activation energy representative fit show figure choice residue explain figure caption Methyl rotation barrier protein subject recent study base result simulation experimental component study however repre sente datum activation energy determine work provide much suitable material type analysis hence turn simulation attempt examine nature methyl rotation barrier protein bridge dynamic structural aspect problem Comparison Figure show correlation function methyl quadrupolar interaction presume axially symmetric principal axis carbonproton bond correlation function extract trajectory spc SH3 initial part function present plot methyl site select figure figure full correlation function show solid line Figure fact complex assume model generate correlation function begin steep sub Faelber Diehl Reif Chem Soc Quadrupolar order relaxation experiment suffer somewhat strong scalar coupling effect Leu side chain Unpublished work mcgrawhill Lipari Szabo Chem Soc figure spectral density profile select methyl site spc SH3 top panel represent typical quality datum fitting use model determine basis fit residual Xue CHEM SOC VOL time scale drop mainly cause harmonic axial fluctuation experience methyl follow period decay time constant dominate methyl spinning remain part correlation function fall plot region decay mainly overall molecular rotation behavior quantitatively predict model modelfree parametrization correlation function introduce worker addition full base correlation function Figure also show reduce version dash line methyl rotation retain dotted line rotameric jump symmetric well include clearly appreciable difference actual correlation function reduce version specifically concerned difference full correlation function relevant analysis relaxation datum reduce correlation function relevant characterization methyl rotation barrier continuous dotted line datum provide good opportunity quantify difference goal mind employ full correlation function simulate relaxation rate methyl site spc SH3 simulated rate quently fit model result set base value obtain mirror experimentally determined separately fit reduce correlation function dot line combination exponential thus obtain value comparison NMR Spectrosc figure arrhenius plot representative methyl group spc SH3 value glucose pyruvatederived sample red blue symbol respectively fit generate minimize residual contribution point weight inverse proportion error size error bar uncertainty evaluate help jackknife procedure use reduce data set consist point result methyl group consequently sort accord magnitude uncertainty entry middle sort list present figure leave right determined activation energy uncertainty interval kcalmol type treatment apply methyl site datum sample available show case jackknife procedure involve reduce data set consist point follow identify plot use distinct symbol value present figure derive assumption rotational diffusion spc SH3 isotropic assumption later use analysis simulation datum approximation well justify indicate relaxation datum anisotropy spc SH3 modest methyl relaxation rate dominate fast dynamic rather overall tumbling long side chain tend sample multiple conformation lead partial average anisotropic tumbling effect validate assumption analysis repeat use version model incorporate anisotropic tumbling correlation function rm deviation set value derive use isotropic anisotropic model find well level experimental uncertainty bias exceed kcalmol figure base correlation function select residue spc SH3 solid line represent datum use standard processing scheme see Materials Methods correlation function compute accord polynomial angle orientation methyl protoncarbon bond point time separate interval rotational correlation time take rot obtain interpolation experimental datum dash line represent datum manipulate prior calculation specifically torsional angle parametrize methyl rotation extract datum vector trajectory regenerate assume rotation ideal tetrahedral methyl group accord form dynamic system line represent simplification CH3 rotation reduce sequence rotameric jump specifically value range reset value reset value reset vector trajectory regenerate assume rotameric jump form motion present small displacement actual potential well canonical value find inconsequential context calculation Methyl Rotation Barriers Proteins CHEM SOC VOL illustrate Figure expect value turn systematically short average absorb effect fast fluctuation accurate measure methyl rotation corresponding activation energy provide reasonable approximation see let turn analysis full correlation function figure harmonic motion responsible initial drop parametrize term additional order parameter Suf2 correlation time uf subscript stand ultrafast uf short less motional process relaxationactive hence spectral density corresponding rewrite rot result view true spectral density somewhat different model First establish even comprehensive set relaxation allow separation base readily understand first term fall extreme narrowing limit make separation impossible also important keep mind subsume quadrupolar coupling constant consider specifically report solid solutionstate18 experiment estimate effect determined activation energy resort simulation brief use simulate relaxation rate different temperature employ experimental study result fit model use determine activation energy surprisingly activation energy reproduce correctly Suf2 assume compromise Suf2 allow vary temperature quantitate temperature dependence Suf2 record long trajectory spc SH3 temperature see Materials Methods trajectory estimate average Suf2 change unit consistent general notion temperature dependence fastmotion order parameter rather subtle basis result estimate apparent activation energy differ target activation energy result base analysis regard caution general observation make section sufficiently intuitive Relaxationbased correlation time underestimate methyl rotation correlation time reason presence ultrafast axial fluctuation particularly involve methyl group Apparent activation energy somewhat overestimate acti vation energie methyl rotation happen amplitude ultrafast motion temperaturedependent conventional method evaluate barrier potential mean force Vpmf probability distribution torsional angle control methyl rotation obtain molecular dynamic energy profile generate manner methyl group represent Figure show figure procedure evaluate barrier Vpmf describe addition calculate call rigid barrier single structure snapshot load XPLOR54 select methyl group rotate maintain rest structure fix result energy profile respect proton barrier evaluate calculation carry multiple snapshot produce series value Vrigid index enumerate snapshot result average follow appreciate average apply rate rather directly barrier accordance principle chemical kinetic follow procedure refer logaverage large set snapshot result representative equilibrium distribu tion conformational specie small set principle calculate energyweighted average however total energy associate ith snapshot weakly depend state specific methyl group environment make approach impractical study make attempt calculate adiabatic barrier definition adiabatic barrier rather Phys Mol Biol figure Comparison methyl correlation time extract trajectory multiple methyl site spc SH3 domain obtain full correlation function use simulate relaxation rate rate subsequently fit model obtain reduce correlation function describe methyl rotameric jump see caption Figure fit biexponential curve correlation coefficient datum plot point fall diagonal correspond residue affect nanosecond time scale local dynamic rot recall treatment experimental datum point exclude complementary plot figure correlate base value experimentally determined value Saxis rot arbitrary14 priori clear extent environment relax response methyl rotation fact adiabatic barrier sometimes prove inferior approxima tion ultimately favor logaveraged rigid barrier provide straightforward way deal ensemble protein structure involve adjustable param eter apart standard force field setting discuss detail logaveraged rigid barrier view structural concept adiabatic barrier gravitate realm molecular dynamic assess quality rigid barrier approximation compare Vrigid Vpmf purpose Vrigid calculate use set regularly spaced snapshot result comparison methyl group spc SH3 domain present figure turn quantity tightly correlate Vrigid average kcalmol high suggest therefore provide simple reasonably curate instrument evaluate methyl rotation barrier property rigid barrier worth note magnitude Vrigid primarily determine snapshot low barrier rigid expense snapshot high barrier rigid trivial consequence log average property illustrate figure show histogram rigid select methyl group arrow plot mark corresponding value Vrigid readily appreciate plot average skew general term state disproportionately sensitive excited state rare conformation barrier happen low view observation question arise still robust parameter calculate small set structure test prepare small set consist randomly select snapshot size choose typical protein structure solve NMR value obtain calculation present Figure expect substantial uncertainty emerge size ensemble reduce mean value however remain reasonable instance result average methyl group ensemble obtain kcalmol high modest nearly constant offset thus even small dynamic ensemble good indicator mean barrier height Comparison show comparison derive barrier experimentally determined activation energy methyl group spc SH3 structure clearly discernible correlation persite basis First note substantial experimental uncertainty make difficult establish correlation future study problem alleviate use wide temperature range particular employ thermophilic proteins55 Rance Palmer Mol Biol figure Methyl rotation barrier derive trajectory spc SH3 domain point represent specific methyl group average snapshot uniformly distribute length trajectory interval average snapshot extract trajectory random calculation repeat randomly form ensemble figure histogram rigid select methyl group base snapshot trajectory spc SH3 indicate arrow corresponding logaveraged value conduct measurement supercoole differ ence discuss also contribute sitespecific variation important however apparent inability molecular dynamic deliver accuracy require perresidue comparison experimental datum recent study little correlation observe simulated experimental methyl even experimental simulate Saxis2 fails reproduce perresidue variation figure reproduce average value reasonably well Vpmf kcalmol perturbation cause environment apparently create low high barrier balance little effect indeed protein hydrophobic core loosely pack local order potentially lead systematically low systematically high barrier example crystalline alanine follow assume kcal mol typical barrier height spc SH3 domain protein hypothesis somewhat speculative draw general notion fluid hydrophobic core implication Protein Structure previous section discuss rigid barrier calculation structural ensemble find logaverage member ensemble average methyl group protein produce reasonable predictably value somewhat high outcome rigorous analysis corresponding experimental result observation hold also small ensemble size typical nmr structure generally recognize nmr structure encode information internal protein motion certain degree view dynamic ensemble recently effort make construct structural ensemble accurately reproduce dynamic property protein perspective interesting see rigid barrier calculate nmr ensemble match expect value figure show Vrigid profile NMR structure spc SH3 1AEY sake comparison experi mental datum draw plot signifi not correlation observe parameter perresidue basis several methyl group barrier clearly overestimated note treat ensemble conformer Figure encounter barrier excess kcalmol average value also appreciably high expect basis molecular dynamic test clearly quality input coordinate affect outcome calculation explore possibility calculation repeat use ray structure figure result Vrigid kcal mol line expectation give rigid barrier calculation single conformer inevitably lead slightly exaggerated barrier note ray structure low resolution 1shg give rise Sharma Szyperski Chem Soc Prabhu Sharp Biochemistry biochemistry Biochemistry LindorffLarsen Sci Figure Methyl rotation barrier characterize experimental datum red molecular dynamic simulation turquoise value base experimental datum sample indicate open red circle average methyl group kcalmol consider estimate make previous section activation energy methyl rotameric jump slightly low chem SOC VOL kcalmol datum show observed trend suggest rigid barrier provide potential measure structure quality put observation broad context compile table Vrigidand Vrigidare determine number ray nmr structure respectively facilitate comparison choose set protein ray nmr structure determine essence nmr structure use crystal lographic structure protonate proton coordinate refine prior calculation rigid barrier result nmr structure group category accord structure calculation software use include rely force field program typically always invoke AMBER force field use force field name separate entry new dynamic ensemble refinement approach also use force field classification course tentative variety Case Debolt Biomol NMR figure rigid barrier activation energy methyl group rotation spc SH3 Vrigid NMR ensemble consist conformer green Vrigid ray structure 1U06 first chain blue experimentally determine red ray structure protonate prior calculation proton coordinate refine describe Materials Methods Methyl Rotation Barriers Proteins chem soc vol different protocol auxiliary program use calculate structure convenient begin discussion result table consider barrier calculate ray structure expect barrier overestimate demon strated early barrier depend excited dynamic state protein calculate accurately base structure sense good guidance present ultrahighresolution structure Vrigidvalues structure fall range kcalmol suggest therefore single accurate set coordinate rigid barrier calculation procedure overestimate true barrier height kcal mol time table contain number crystal lographic structure abnormally high Vrigidvalues case trace steric hindrance ultimately reflect limited resolution specific defect structure lowestresolution ray structure show unrealistic barrier excess kcalmol hand occur ray structure high resolution go ray NMR structure expect opposite trend take effect generally low quality nmr structure steric conflict lead high barrier nmr structure represent ensemble many conformational state logaverage procedure lead low barrier thing consider majority nmr structure fall range kcalmol similar crystallographic structure however substantial fraction structure high Vrigidvalues expect correlate conventional measure structure quality particular refer steric clash instance popular structure validation program determine number bump interatomic distance short sum Waals radius less turn nmr structure table low bump atom contrary structure high bump atom notable feature illustrate figure show figure example methyl group external proton red sphere tuck methyl proton configuration favorable point view Waals interaction however steric clash clearly occur methyl rotate trend illustrate Figure extent responsible systematic overestimation barrier necessarily reflect presence conformation illustrate Figure unexpected conformation rare presence little consequence reasonably low consider example figure structural ensemble form randomly choose snapshot use rigid barrier calculation typical Vrigid case much Table Vrigidand Vrigidkcalmol select ray NMR rayb DIANADYANA AMBERDISCOVER GROMOS DER bungarotoxin apolipoprotein 1AEP barnase barstar 1B2S 1BTB bpti 1PIT calmodulin cdc42 chemotaxis 1CEYd crambin cytochrome dihydrofolate reductase 1diu helicase 1B79 hipip phosphocarrier 1HDN interleukin 3il8 repressor hpc 1CJG 1LQC profilin 1FIL spectrin SH3e 1U06 1AEY syntaxin 1br0 ribonuclease ribonuclease thioredoxin ubiquitin 1ubq set protein use table mainly protein database compose rayNMR pair several addition Primary sequence protein raynmr pair identical exception point mutation case mutation several terminal residue procedure use calculation rigid barrier Vrigidand Vrigidfor ray nmr structure respectively describe Materials Methods crystallographic resolution report bracket terminal domain delete structure structure calculate refine restrain molecular dynamic energy minimization consistency previous analysis Val methyl site include calculate average barrier spc SH3 structure calculate energyminimize low entry table close experimental result clear however conventional nmr structure different true dynamic ensemble see case recall majority NMR structure anneal temperature subject energy minimization circumstance conformation show figure tend occur frequently result high Vrigidvalues obtain see Table observation underscore somewhat ambivalent nature nmr structure nmr datum collect room temperature structure calculation protocol make least respect lowtemperature structure notable exception general trend group NMR structure refine mean GROMOS fifth column Table structure show low barrier readily explain methyl group treat united atom approximation expand sphere consequently packing effect illustrate Figure occur refinement see figure explicit proton add structure rigid barrier remain low reflect healthy separation methyl surround atom interesting observation nmr structure calculate apparently provide good model dynamic methyl environment protein core lately effort underway build nmr structure provide faithful representation protein dynamic particular worker develop dynamic ensemble refinement approach dynamic NMR datum order param eter incorporate structure calculation use strategy author generate coordinate ubiquitin work provide sufficiently independent check quality ensemble turn structure gives rise perfectly reasonable rigid barrier kcal mol substantially well obtain ubiquitin structure see bottom row table figure fact barrier height find analysis collection snapshot hence structure indeed view miniature ensemble build control diverse nmr datum conclude remark several efficient method develop predict backbone dynamic basis protein structure contrast search structural determinant sidechain dynamic limit success correlation methyl structural parameter solvent exposure local packing density prove tenuous good time demonstrate subtle structural change cause point mutation alter study attempt relate activation energy associate yet structural parameter find correlation perresidue basis average rigid barrier prove meaningful measure structure quality emphasize however experimental datum different protein need make confident judgment barrier height typically encounter protein variety nmr parameter use assess quality structure traditionally static parameter use purpose chemical shift dipolar coupling work provide example structure validation use experimental parameter essentially dynamic origin namely methyl rotation barrier experimental information methyl barrier protein help generate well structural model representative protein dynamic nature Materials Methods Sample Conditions spc SH3 express grow cell d2o use pyruvate sole carbon source alternatively D2O glucose carbon source protein concentration sample respectively sample condition unbuffere d2o nmr measurement NMR spectra record mhz Varian Inova spectrometer temperature relaxation datum collect use experiment worker experiment correction associate twospin order deal main pulse sequence20 need separate experiment measurement sample point relaxation curve take record experiment deuterium spin lock field apply maximum measure relaxation rate sample temperature together result modelfree analysis deposit BMRB datum record use update version experiment relaxation period crosscorrelation suppress apply Phys Zhang Bruschweiler Chem Soc FormanKay Biomol NMR NMR Brunger clore Mol Biol clore Garrett Chem Soc Doreleijers Mading Maziuk Sojourner NMR Singer FormanKay Biochemistry Korzhnev Torchia Kay Chem Soc figure Steric hindrance methyl rotation Val methyl blue cyan red model coordinate set 1AEY spc SH3 line view bond leave panel perpendicular right panel particular pair choose illustration purpose fact example neat packing nevertheless general trend whereupon outside atom partially insert methyl proton evident many nmr structure Methyl Rotation Barriers Proteins CHEM SOC VOL pulse profile75 invert signal perturb water spectra process use nmrPipe package peak intensity quantify use nlinl datum set reduce exclude datum flexible terminus residue heteronuclear NOEs find less retain datum analyze mean program R2R1diffusion77 use protein coordinate simulation perform use program version force field modify TIP3P water potential force constant associate methyl torsional angle revise recommend reduce kcalmol position Ile default value mol empirical CMAP correction effect restrain backbone dynamic use default option start protein structure build first chain ray structure miss first residue belong flexible terminus cubic water box build protein size box determine add nonbonded interaction cutoff long dimension protein crystallographic water molecule retain box equilibrate trim truncated octahedron system set periodic boundary condition bond involve hydrogen atom constrain equi librium value use shake algorithm electrostatic interac tion particle mesh scheme use Gaussian width realspace interaction calculate cutoff transition function nonbonded list maintain update heuristically reciprocal space contribution calculate algorithm use grid point box length sixthorder spline interpolation scheme equation motion integrate use leapfrog scheme time step system energyminimize sequential run step harmonic restraint use force constant subsequently heat step heavy backbone atom harmonically constrain force constant particle mass kcalmolamu equilibration consist simula tion particle mass harmonic restraint follow simulation harmonic restraint equilibration well subsequent production run perform condition atm production run coordinate store simulation require workstation GHz dualcore Xeon processor backbone rmsd course trajectory show figure addition trajectory",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "crystallography8": 1,
                    "Vrigid": 8,
                    "Biomol": 1,
                    "Spectrosc": 2,
                    "approxima": 1,
                    "Vrigidvalues": 3,
                    "Gaussian": 1,
                    "simula": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Methyl TROSY spectroscopy_ a versatile NMR approach to study challenging biological systems.pdf",
            "cleaned_text": "Methyl TROSY spectroscopy versatile nmr approach study challenge biological system Sprangers Institute Biophysics edit history receive accept Available online xxxx isotope label large protein complex group major goal structural biology unravel molecular machine function detail end solutionstate NMR spectroscopy ideally suit able study biological assembly methyl trosy method possible record highquality datum complex far kda molecular weight discuss theoretical back ground methyl trosy spectroscopy information extract methyl TROSY spectra approach use assign methyl resonance large complex addition touch insight obtain number challenge biological system include proteasome rna exosome molecular chaperone proteincoupled receptor anticipate methyl trosy method increasingly important modern structural biology approach information regard static structure complement insight conformational change dynamic intermolecular interaction author publish Elsevier open access article license content introduction methyl trosy effect sample preparation Methyl group label coli base protein expression label Leucine methyl labeling Alanine Threonine Combinatorial label methyl group cellbased protein expression eukaryote Yeast Insect cell mammalian cell cellfree protein expression partial isotope label author publish Elsevier open access article license corresponding author mail address remcosprangers xxx Contents list available journal homepage wwwelseviercomlocatepnmrs cite article Schtz TROSY spectroscopy versatile nmr approach study challenge biological system spectroscopy posttranslational isotope label methyl group chemical shift assignment residue type Methyl assignment throughbond correlation base NOEs Assignment paramagnetic probe Methyl assignment sitedirected mutagenesis shift prediction automated methyl assignment hmqcbase experiment scan Dynamics Pico nanosecond timescale motion millisecond timescale motion structure application involve methyl trosy Barrelshaped protease proteasome complex exosome complex Chaperones Hsp90 Membrane protein gpcrs integrate structural biology conclusion outlook Acknowledgments Introduction NMR spectroscopy unique ability study biomolecular structure interaction dynamic natural setting NMR spectroscopic study assemblie molecular weight kda however challenging rare large system rapid spin relaxation rate prevent routine recording highquality nmr spectra molecular weight limit solutionstate NMR spec troscopy shift signicantly numerous report demonstrate complex far kda size amenable detailed nmr study breakthrough ascribe important technological advance hand sample preparation isotope labeling method establish sample deuteration result signicant decrease transverse relaxation rate hand exploitation transverse relaxation optimize spectroscopy trosy effect result additional signicant sensitivity gain protein nmr spectroscopy base approach reduce transverse relaxation rate nmr experiment initially introduce protein later adapt aromatic spin system methyl group opinion combination specialize methyl labeling scheme methyl trosy technique success ful approach allow solutionstate NMR spectroscopy study high molecular weight assembly provide comprehensive overview theoretical background methyl trosy spectroscopy discuss strategy nmr sample preparation approach exploit assign methyl group resonance finally introduce number method use obtain infor mation regard protein structure interaction dynamic present small selection recent highly impre sive application methyl trosy nmr spectroscopy thereby provide require background information people interested apply methyl trosy technique biological system interest methyl trosy effect sensitivity nmr experiment depend amount magnetization available start pulse sequence part magnetization transfer detectable magnetization transfer efciency rate magnetization term decay experiment relaxation regard methyl group highly favorable rst ini tial magnetization result equivalent proton contribute nal signal second possible preserve magnetization extended time base spectroscopic trosy technique trosy method rst exploit amide group spin system relaxation dominate dipoledipole chemical shift anisotropy mecha part magnetization amide group relaxation mechanism interfere destructively result extended time slowly relax magnetization component select traditional experiment remain ing magnetization actively suppress pulse sequence large protein principle result signicant gain signal noise fact initial magnetization contribute observable signal magnetic dependence amide principle function opti mally mhz proton frequency lead maximum peak height ghz similar principle exploit methyl group methyl group small interfere signicantly relaxation mechanism spinsystem methyl group describe energy level Fig methyl group xxx xxxx xxx cite article Schtz TROSY spectroscopy versatile nmr approach study challenge biological system pathway isolate methyl group part large biomolecular complex methyl group spin system contain proton spin carbon spin describe eigenfunction associate energy level carbon spin state indicate blue proton spin state indicate red thin bold line indicate slow fast relaxation rate associate carbon blue proton red transition subscript RSLOW CHand RFAST rate refer carbon relaxation rate state rslow RFAST state rslow RFAST associated monoexponential relaxation rate different transition subscript refer carbon single multiple quantum rate respectively subscript refer proton relaxation rate subscript refer effect external proton deuteron dependence gray olive protein deuteration level base crystal structure MSG 1D8C methyl group relaxation rate determine base residue value subsequently rate combine obtain average rate protein deuteration level different random proton deuterium distribution use simulate random deuteration protein obtain distribution expect rate panel isoleucine Cc1 atom assume fully deuterate atom introduce protein deuterated isoleucine precursor isoleucine Cc1 atom assume fully protonate fully protonate isoleucine precursor use methyl group valine leucine methionine alanine also protonate single methyl group I147 MSG note large distribution rate single residue experience ensemble protein make nmr sample variation residue rate due random heterogeneous distribution proton deuterium atom specic methyl group panel effect average randomly place proton likely cause strong relaxation least isoleucine methyl group protein randomly place proton less likely cause relaxation specic methyl group I147 panel result averaged rate large homogeneous panel rate individual methyl group show panel large perresidue variation relaxation rate cause external proton deuterium spin present methyl group restrict specic residue rate calculate leucine valine methyl resonance case pro pro methyl group NMRactive protonate close proximity methyl group residue result large relaxation rate leucine valine contain nmr active protonate methyl group randomly pro group methyl group residue fully deuterate result signicantly decrease rate Schtz Sprangers Progress Nuclear Magnetic Resonance Spectroscopy xxx xxxx xxx cite article Schtz TROSY spectroscopy versatile nmr approach study challenge biological system connect large macromolecule basis wavefunction choose offdiagonal element density matrix relax monoexponential manner Fig energy level separate block possible transfer magnetization mean chemical shift evolution couple radio frequency pulse basis wave function write combina tion spin state spin state total possible transition indi cat horizontal blue line Fig transition separate slowly relax coherence thin blue line slow SLOW fast relax coherence thick blue line fast fast carbon relaxation rate depend proton spin state indicate subscript single quan tum transition subscript zerodouble addition possible transition indicate red vertical line transition separate slowly relax transition thin red line slow fast relax ing coherence thick red line fast relaxation rate magnetization methyl group additionally affect presence proton deuterium spin close spatial proximity methyl group distance dependence describe term take proton spin ip rate account term result phase proton magnetization due longrange dipolar interaction known structure latter relaxation effect estimate base distance methyl group atom vicinity important note term signicantly lower environment methyl group perdeuterated nal proton cause time fast dipolar relaxation external deuterium expression SLOW FAST slow fast slow FAST derive proton carbon CSAs take account contribution relaxation rate small effect external proton deuter on neglect assume small equation reveal slow sin gle quantum relaxation rate fast single quantum relaxation rate slow fast slow 13c zerodouble quantum relaxation SLOW rate latter result imply part zerodouble quantum magnetization methyl group insensitive magnetization loss dipolar relax ation mechanism methyl group relax due interaction external proton deuteron small perdeuterated isoleucine methyllabele protein rota tional correlation time corresponding kda ubiquitin external proton deuteron result relaxation rate order assume respectively base carbon proton relaxation rate estimate SLOW fast slow fast slow fast slowly tumble protein correspond kDa proteasome rate increase factor rate scale linearly thus increase around slow fast slow fast slow fast First number indicate signicant difference fast slowly relax magnetization term highly deuterate protein factor coherence factor coherence observation show important design nmr experiment aim preserve select slowly relax magnetiza tion term Second calculate rate show relax ation rate high relaxation rate factor slowly relax term factor fast relaxing term due signicant contribution dipolar relaxation effect external proton coherence regard thus desirable avoid presence term pulse sequence Third note rate mention increase signicantly protein contain high proton density ond term contribute increase rapidly graphically show cal culate isoleucine CH3 label protein rotational correlation time kda MSG deuteration level isoleucine position fully deuterate different level background deuteration loss full background deuteration relaxation effect external proton signicantly increase specic deuteration level dominate overall methyl group relaxation rate importance high deuteration level close methyl group interest high light relaxation rate simulate MSG isoleucine position fully proto nate sample result protein preparation use fully protonate isoleucine precursor see section graph show rate proto nate isoleucine methyl group similar protein random deuterate deuterate isoleucine posi tion protein perdeuterate protonate isoleucine position highlight importance proper preparation precursor molecule use prepare protein nmr sample likewise introduction additional NMRactive protonate methyl group protein increase rate especially highly deuterate back ground compare fig information gain additional lvma methyl group provide thus partially com promise increase relaxation cause high proton density protein relaxation rate specic methyl group strongly depend spatial distri bution proton protein protein sample deuterate differently cause broad distribution relax ation rate specic methyl group remain determined spread relaxation rate methyl reso nance inuence quantitative determination nmr parame ter include proton deuterium relaxation rate focus relaxation rate expe rience methyl group isoleucine residue methyl group amino acid equally important ensure proton density observed methyl group low methyl group leucine valine residue close spa tial proximity thus represent special case protona tion methyl group cause signicant relaxation methyl group result relatively high rate leucine valine methyl resonance expect Fig high relaxation rate reduce factor use labeling scheme yield leucine valine residue randomly methyl group protonate label methyl group fully deuterate see section finally low protein deuteration level result small difference fast slowly relax term reduce maximal achievable methyl trosy effect summary TROSY spectra espe cially large assembly large benet signicantly protein deuteration level high achievable Fig base density matrix calculation show fast slowly relax magnetization term decay mixed dur ing specic nmr experiment result loss magnetization hsqc experiment red rst pulse split initial proton magnetization part relax slowly slow relax fast cite article Schtz TROSY spectroscopy versatile nmr approach study challenge biological system Spectroscopy fast rst step rst step amount slow fast relax magneti zation due relaxation long distribute subsequent proton pulse result mix slowly fast relax coherence carbon pulse ensure formation coherence carbon chemical shift evo lution part remain magnetization relax slowly slow part relax fast fast fast slowly relax component mix due proton pulse follow second step remain magnetization relax part slowly SLOW part fast fast proton chemical shift detection detectable magnetization consist different part relax differently importantly magnetization experience slow relaxation step constitute total equilibrium magnetiza tion large complex fast result spectra signicantly reduce quality rst step experiment blue magnetization relax slowly slow relax fast fast case hsqc experiment subsequent carbon pulse create coherence mix slowly fast relax magnetization term slowly decay magnetization continue decay slowly slow fast decay magnetization continue decay fast FAST carbon pulse one mix slowly fast decay coher ence second period slowly fast decaying coherence decay slow fast respectively dur ing proton chemical shift detection magnetization consist part decay slowly decay rapidly complete pulse sequence initial magnetiza tion thus experience slow relaxation complete experi ment complete separation slow fast relax pathway increase quality nmr spectra signicantly note slowly fast relax magnetization term give rise signal frequency thus need actively suppress fast relax coherence do experiment remain slowly relax magnetization thus add nal signal intensity demonstrate difference hsqc experiment describe simulate decay magnetization 13CH3labeled methyl group number highly deuterate protein widely use NMR eld Fig red blue curve correspond HSQC experiment respectively simulation focusse value correspond kda ubiquitin kda MSG kda proteasome use time carbon chemical shift evolution time proton chemical shift evolution time practice value adjust optimize spec tral quality important realize decay total magnetization transfer mono exponential sum fast slowly relax part relax monoexponentially Fig illustrate experiment blue signicantly outperform hsqc experiment red molecular weight increase due fact slowly relax magnetization term consistently preserve experiment rst proton pulse fact magnetization relax slowly magnetization carbon chemical shift evolution step note additional gain signalnoise hsqc experiment use sensitivity enhancement approach possible methyl group second coher ence transfer pathway refocusse methyl group delay set time inclusion sensitivity enhancement scheme pulse sequence advisable result loss methyl trosy effect due requirement additional proton pulse thus spectra signicantly impair quality addition sensitivity enhancement scheme increase length NMR pulse sequence result additional relaxation loss especially large protein complex demonstrate experimentally high quality spec tra methyllabele sample record domain kda proteasome double ring kda different temperature protein sample prepare highly deuterate background Fig Relaxation HSQC experiment schematic representation HSQC top red bottom blue experiment time set refer carbon proton chemical shift evolution time respectively relaxation mechanism active pulse sequence indicate Simulation decay magnetization hsqc red blue experiment datum simulate methyl group connect biomolecule tumble simulation carbon chemical shift evolution time set base relaxation rate required spectral resolution advantageous increase decrease maximum carbon acquisition time real experiment xxx xxxx xxx cite article Schtz TROSY spectroscopy versatile nmr approach study challenge biological system see next section NMRactive group isoleucine leucine valine alanine methionine residue ILVMA label Fig RecAlike domain leucine valine residue ILV label Fig halfproteasome spectra RecAlike domain spectra halfproteasome record pro cessed identically illustrate spectral quality 13c trace select resonance indicate spectra RecAlike domain Fig trace scale identi cally difference signalnoise different easily visible datum clear signalnoise decrease decrease temperature expect halfproteasome trace scale trace intensity highlight change linewidth temperature expect line width methyl resonance increase decrease temper ature importantly base NMR spectra clear high quality spectra intermediate size protein obtain low temperature kda RecAlike domain even system molecular weight kda possible record spectra decent quality low temperature halfproteasome demonstrate experimentally methyl TROSY spectra make challenging biological system amenable NMR spectro study simplicity methyl TROSY experiment number variation fourpulse pulse sequence suggest increase sensitivity time use method introduce approach methyl group selectively excited pulse even highly deuterate protein result enhance longitudinal relaxation methyl group pos sibility reduce recycle delay result signalnoise unit experimental time signicantly increase addition realize small imperfection central proton pulse experiment result presence additional resonance locate JCH cen tral carbon resonance intensity artifact order percent intensity central methyl reso nance nevertheless strong methyl resonance kda RecAlike domain ILVMA label kda halfproteasome ILV label quality methyl trosy spectra methyl trosy spectra kda ILVMAlabeled RecAlike domain protein concentration d2obase buffer record mhz proton frequency spectra record carbon acquisition time scan inter scan delay result total experimental time min spectra process identically use linear prediction carbon dimension shift square sine bell window function dimension spectra show contour level trace consistent absolute scaling decrease temperature signalnoise ratio decrease linewidth increase nevertheless even temperature low spectral quality remain extremely high SOFAST methyl trosy spectra kda ilvlabele methyl group valine leucine randomly label protein concentration d2obase buffer record mhz proton frequency spectra record carbon acquisition time scan delay result total experimental time min spectra process identically use linear prediction carbon dimension shift square sine bell window function dimension spectra show contour level trace scale maximum intensity visualize increase linewidth temperature addition signicant reduction signalnoise ratio clearly observe relatively low spectral quality still possible detect large number wellresolve resonance kda complex Schtz Sprangers Progress Nuclear Magnetic Resonance Spectroscopy xxx xxxx xxx cite article Schtz TROSY spectroscopy versatile nmr approach study challenge biological system undesired resonance interfere spectral analysis artifact suppress gradient extensive phase cycling efciently eliminate use compos 90y240x90y 90y180x90y central proton pulse summary methyl trosy experiment exploit inter ference dipolar relaxation mechanism preserve slowly relax magnetization term strength dipolar interaction eldindependent result methyl trosy experiment function optimally magnetic strength strong contrast trosy aromatic trosy experiment exploit relaxation mechanism scale magnetic latter trosy technique thus function optimally single magnetic strength Sample preparation Methyl group label prerequisite record high quality methyl trosy spectra preparation highly deuterate sample reduce contain isolated label methyl group naturally methyl group find third proteinogenic amino acids alanine threonine methionine tion describe labeling strategy suit prepara tion nmr sample contain NMRactive methyl group highly deuterate background coli base protein expression protein expression coli compatible growth medium base d2o practice possible exclude proton growth medium due presence proton salt crystal water part phos phate stock due highly hygroscopic nature d2o result absorption atmospheric water long incubation growth time addition deuterate chemical include glucose deuteration level thus also introduce proton nal protein product practice thus possible prepare protein sample deuteration level signicantly exceed past current effort try optimize protein overexpression yield high cost associate protein deuteration isotope labeling minimize ond advantage coli protein expression host meta bolic pathway utilized selectively channel methyl group specic residue target protein Fig Table end isotopelabeled amino acids amino acid precursor add growth medium cell ensure label compound end target site scramble amino acid necessary add additional metabolite genetically modify expres sion host simplicity reliability methyl labeling coli far commonly use strategy prepare Fig coli metabolic pathway involve biogenesis methylcontaining amino acid methylcontaining amino acids valine leucine isoleucine threonine methionine alanine show bottom key metabolite use precursor methyl labeling table include structural formula indicate bold color blue red fonttype italic upright methyl group consistent stereospecic location molecule full arrow indicate onestep reaction dash arrow indicate multiple reaction doubleheaded arrow indicate reversible reaction enzyme catalyze reaction indict number deletion number correspond gene coli genome exploit construct strain specic pathway block see table gure prepare base datum derive xxx xxxx xxx cite article Schtz TROSY spectroscopy versatile nmr approach study challenge biological system group isotope labeling strategy Labeling Precursor Amount methionine scramble methylthio ketobutyrate scramble Ile ketobutyrate scramble combine acetolactate hydroxyethyl ketobutyrate Addition ketoisovalerate prevent unexpected scramble leucine valine methyl group Ile hydroxyethyl ketobutyrate Addition ketoisovalerate prevent unexpected scramble leucine valine methyl group leub strainc addition leucine valine require Leu Val ketoisovalerate Scrambling Leu ketoisocaproate None ketoisovalerate Based andVal valine require ketoisovalerate Addition ketoisocaproate inhibit use ketoisovalerate leucine biogenesis base isoleucine leucine require pro acetolactate 13c scramble base require pro acetolactate 13c scramble base require Val pro acetolactate 13c addition leucine inhibit use acetolactate leucine biogenesis base isoleucine leucine require valine addition leucine requirede base ilvD leub strainc addition leucine valine requiredc Val pro acetolactate 13c addition leucine inhibit use acetolactate leucine biogenesis base isoleucine leucine require valine addition leucine requirede base ilvD leub strainc addition leucine valine requiredc Leu acetolactate base isoleucine valine require leucine 13CH3 Addition valine requirede base ilvD leub strainc addition leucine valine requiredc Leu pro acetolactate 13c base isoleucine valine require leucine 13CH3 Addition valine requirede base ilvD leub strainc addition leucine valine requiredc Ala alanine Addition glycerol succinate isoleucine ketoisovalerate Addition hydroxyethyl ketobutyrate ketoisovalerate Addition ketobutyrate ketoisovalerate scramble isoleucine Thr threonine addition ketobutyrate glycine base thrC strain Addition isoleucine ketobutyrate Ile Met methionine ketobutyrate Schtz Sprangers Progress Nuclear Magnetic Resonance Spectroscopy xxx xxxx xxx cite article Schtz TROSY spectroscopy versatile nmr approach study challenge biological system sample methyl trosy spectroscopy labeling scheme describe work growth medium base glucose carbon source example glycerol use main carbon source cellular metabolic pathway change result situation specic precursor long solely use corresponding amino acid synthe sis pathway one underrepresented amino acids protein average occurrence methyllabele methionine residue thus result limited number nmr resonance consequently low degree signal overlap coli methionine residue label NMRactive methyl group independent strategy Fig First methionine precursor methylthiooxobutanoate MOB Table add minimal growth medium Second methionine labeling conveniently achieve direct addition methionine growth medium Table efciently repress endogenous methionine synthesis latter strat also function well enrich medium require ground amount unlabele methionine growth medium remove enzyme methioninelyase methyl group methionine couple side chain carbon possible use fully methionine methylonly label methionine application use fully protonate methionine adequate methyl group distant side chain proton due connect sulfur atom large assembly special case advantageous use form methionine deuterate methyllabeled carbon methyl group frequently use methyl reporter large protein complexe result spectra often well resolve labeling isoleucine methyl group achieve addition ketobutyrate oxobutanoate Table growth medium straightforward cost efcient CH2CH3 ethyl moiety ketobutyrate end Cc1H2Cd1H3 position isoleucine residue Fig depend labeling ketobutyrate isoleucine residue thus produce specically carbon deuteriumlabeled form full 13clabele isoleucine residue require observe intraresidue correlation methyl group backbone amide resonance achieve uniformly ketobutyrate combination glu cose hand record spectra high resolution carbon dimension Cd1 coupling efciently remove use ketobutyrate methyl group suppress dipolar relaxation effect nearby proton important high molecular weight complex ketobutyrate deuterate position use fully proto nate ketobutyrate conveniently convert CD2 form incubate precursor high d2o indeed highquality nmr spectra large protein record use d2o base minimal growth medium use ketobutyrate Ile precursor incompatible labeling scheme simultaneously aim incorporate stereospecically label leucine valine residue base acetolactate see incompatibility labeling scheme overcome use isoleucine precursor hydroxyethylketobutyrate acetohydroxybutanoate close isoleucine amino acid biosynthesis pathway Fig appropriate isotope label precursor result efcient isoleucine label Incompatibilities ketobutyrate isoleucine pre cursor addition methyllabele alanine also report case label methyl group alanine result partial label isoleucine methyl group degree scramble however low often neglect experience level scramble isotopelabeled methyl group continue Labeling Precursor Amount ketoisovalerate ketoisovalerate alanine ketoisovalerate alanine methionine Thr ketobutyrate ketoisovalerate alanine methionine threonine glycine incorporation level label methyl group target protein case high nevertheless author laboratory variation absolute incorporation level observe even produce protein multiple time potentially due difference growth bacteria general variation nal level protein expression obtain full protein deuteration require add additional supplement perdeuterated form amount reduce compromise spectral quality highly challenging system abcdeuterated methionine use ilvD leub strain include deletion ilvD leub synthesis isoleucine hydroxyethylketobutyrate synthesis ketoisocaproate ketoisovalerate thereby inhibit deletion strain twophase expression protocol use growth phase supplementation deuterated amino acid synthesize strain require expression phase specically methyllabele amino acid add well require deuterated amino acid strain include deletion ilvB ilvG ilvi synthesis isoleucine valine leucine ketobutyrate pyruvate inhibit Fig strain include deletion ilve synthesis valine ketobutyrate synthesis leucine ketoisocaproate inhibit Fig Leu strain include deletion leub synthesis ketoisocaproate ketoisovalerate inhibit Fig thrc strain contain deletion thrc synthesis homoserine inhibit Fig usage form result random nonstereospecic label LeuVal methyl group suppress intraresidue methylmethyldipolar interaction enhance spectral resolution possible combine labeling valine leucine leucine valine leucine leucine amount reduce compromise labeling efciency scramble strain thrc use scramble Gly observe Schtz Sprangers Progress Nuclear Magnetic Resonance Spectroscopy xxx xxxx xxx cite article Schtz TROSY spectroscopy versatile nmr approach study challenge biological system interfere experiment small additional resonance rarely result additional spectral overlap Isoleucine isoleucine methyl groups label group use pyruvate sole carbon source growth medium base d2o case methyl group leucine valine isoleucine label methyl group alanine residue label approx imately signicant drawback approach par tial exchange methyl group result mixture isotopomeric form CH3 CH2D CHD2 cd3 methyl group complicate NMR spectra obtain result signicant sensitivity loss specic isotopomer select spectroscopically homogeneous labeling methyl group achieve addition isoleucine precursor hydroxyethyl ketobutyrate13C growth medium Fig table precursor commercially obtain signi cantly stable ethyl ester form prior addition pre cursor growth medium need esterie enzymatically base treatment alternatively precur sor synthesize store frozen usage precursor racemic mixture precursor material utilize coli enzyme unexpected scramble methyl group hydroxyethyloxobutyrate proRmethyls group valine leucine observe valine share highly overlap biosynthesis pathway last common precursor ketoisovalerate methyloxobutanoate oxoisovalerate Table simultaneously label leucine valine residue ch3ch3 isopropyl group precursor incorporate isopropyl group leucine valine resi due labeling ketoisovalerate thus directly determine labeling protein Methylonly ketoisovalerate use ensure leucine valine methyl group form isolated spin system isoleucine labeling ensure high resolution twodimensional protoncarbon correlation record suffer carboncarbon coupling reduce proton density thus relaxation rate proton ketoisovalerate replace deuterium conveniently achieve dissolve protonate precur sor D2O high elevated temperature proton methyl group isopropyl moiety apart Protons methyl group thus contribute signicantly relaxation rate methyl group effect prevent use ketoisovalerate randomly fully protonate methyl group fully deuterate Use form precursor result nonstereospecic incorporation methyl group leucine valine side chain result protein methyl group label large complex spectra superior quality label Leucine overlap leucinevaline region correla tion spectrum increase signicantly increase molecular complexity case advantageous stereospecically label isopropyl methyl group leucine valine residue label pro methyl group possible base acetolactate Hydroxymethyloxobu tanoate Table methyl group attach carbon italic end pro methyl group methyl moiety incorporate pro methyl group chemically stable ethyl ester form precursor commercially available esteried high prior usage natively show stereospecic 13CH3labeling leucine valine methyl group achieve direct addition synthesize stereospecically label amino acid minimal growth medium lat ter method offer possibility simultaneous labeling valine leucine valine leucine methyl group methyl labeling resonance methyl group leucine valine resi due part share common spectral region Fig large molecular assembly contain many unique leucine valine residue thus desirable label leucine valine residue label solely leucine residue ketoisocaproate methyl oxopentanoate oxoisocaproate use Fig Table suit large complex methyl group precursor randomly speci cally label valine residue use combination deuterate ketoisocaproate Table manner leucine biosynthe sis pathway saturate compound NMRactive precursor fully incorporate valine residue alternatively leucine pathway inhibit direct addition deuterate leucine growth medium alternative strategy valinespecic methyl labeling use coli strain lack dihydroacid dehydratase isopropylmalate dehydrogenase enzyme DleuB respectively background biosynthesis isoleu cine ketobutyrate biosynthesis leucine ketoisovalerate block Fig growth medium sup plemente ketoisovalerate perdeuterated leucine isoleucine result label valine methyl group Table likewise deletion ilvb ilvG ilvI gene inhibit acetolactate synthase pathway interfere leucine line isoleucine biosynthesis background label hydroxyethylketobutyrate add isoleucine production require produce leucine valine Table finally dele tion leub gene use specically label resi due advantage auxotrophic expression strain reduce amount label amino acid precursor require achieve full label incorporation Alanine Alanine one abundant amino acid find protein core surface short alanine side chain provide advantage motion methyl group correlate motion backbone optimal spec tral resolution achieve incorporated alanine deuterate position carbonlabele position cell alanine readily metabolize pyruvate central metabolite many biosynthesis pathway mente coli growth medium NMRactive alanine fore result signicant isotope scramble prevent minimal growth medium supplement amino acid form high cost Schtz Sprangers Progress Nuclear Magnetic Resonance Spectroscopy xxx xxxx xxx cite article Schtz TROSY spectroscopy versatile nmr approach study challenge biological system deuterate amino acid approach suitable largescale production perdeuterated protein alternative perdeuterated rich medium supplement methyl label alanine use however approach suffer low incorporation level due presence NMRinactive ala growth medium currently costefcient way prevent metabolic scramble alanine methyl group simultaneous addition ketoisovalerate succinate isoleucine deuterate form D2Obased minimal growth medium Table Threonine compare methylcontaining amino acid threonine high propensity find protein surface nucleotide bind site due capability form side chain hydrogen bond unfortunately label threonine challenge due many crosslink biosynthesis pathway threonine amino acid Fig First attempt threonine residue base use carbon source strategy suffer low labeling efciency severe isotope scramble even presence supplement alanine isoleucine methionine lysine Fig Methyl group assignment strategy ilvmalabeled methyl trosy spectrum individual amino acid type identie base sample NMRactive cyan middle magenta right methyl group note signicant overlap chemical shift range methyl resonance alanine valine residue valine leucine residue label sample scramble methyl group alanine leucine valine suppress addition NMRinactive ketoisovalerate Table label sample scramble label ketoisovalerate precursor leucine suppress addition assignment methyl resonance possible transfer methyl group magnetization protein backbone blue arrow alternatively outandback experiment red arrow use correlate methyl group resonance subset side chain resonance schematic representation approach resonance representative small part complex red assign assignment subsequently transfer full assembly black resonance note resonance shift small part full assembly indicate residue provide shift change small relative dispersion signal approach still give unambiguous result schematic representation structurebase assignment methyl resonance measured intensity experimental distance match know distance dimensional structure display strip represent datum experiment schematic representation assignment methyl group spin label attach protein base known structure experimental pre subsequently match distance know structure weak signal oxidize spectrum relative corresponding signal control reduce spectrum shorter distance methyl group spin label schematic representation assignment methyl resonance isoleucine base mutagenesis spectra black mutant green protein compare resonance isoleucine absent mutant spectrum note additional chemical shift perturbation isoleucine mutant protein due slight change local structure case change extent unambiguous",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "RFAST": 3,
                    "NMRactive": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Methyl-CpG binding domain protein 2 represses transcription from hypermethylated \u03c0-class glutathione S-transferase gene promoters in hepatocellular carcinoma__.pdf",
            "cleaned_text": "methylcpg bind Domain Protein Represses Transcription Hypermethylated Class Glutathione DNA MethylationAssociated GSTP1 repression page copyright publish Manuscript M203009200 CAUL DNA MethylationAssociated GSTP1 repression MBD2 DNA MethylationAssociated GSTP1 repression Page CAUL Summary pathogenesis human hepatocellular carcinoma hcc island encompass class glutathione transferase gene GSTP1 become hypermethylate repression transcription accompany cpg island hypermethylation propose mediate methylcpg bind domain MBD protein report inhibition transcription hypermethylate GSTP1 promoter hep3b hcc cell fail express gstp1 mrna gstp1 polypeptide appears mediate cell azadeoxycytidine aza methyltransferase inhibitor activate expression treatment histone deacetylase inhibitor little effect precisely assess contribution pattern GSTP1 cpg island methylation gstp1 mrna expression Hep3B cell treat subject limit dilution cloning bisulfite sequencing use map methylation pattern GSTP1 promoter region gstp1 express nonexpresse clone clone express GSTP1 mrna northern blot analysis quantitative pcr widespread demethylation least GSTP1 allele evident immunoprecipitation experiment reveal presence sp1 GSTP1 promoter Hep3B cell contrast Sp1 detect GSTP1 promoter GSTP1 express Hep3B test responsible inhibition transcription hypermethylate GSTP1 promoter sirnas use reduce polypeptide level Hep3B cell methylation GSTP1 promoter sequence result diminish luciferase reporter activity transfection Hep3B DNA MethylationAssociated GSTP1 repression Page CAUL cell however hypermethylate GSTP1 promoter sequence transfecte Hep3B cell treat siRNA target mrna repression luciferase reporter expression evident finding implicate repression expression associate GSTP1 cpg island hypermethylation hcc cell DNA MethylationAssociated GSTP1 repression Page CAUL dna methylation change stereotypically accompany carcinogenesis global DNA methlyation level decrease cancer cpg island sequence tend target hypermethlyation Hypermethylation cpg island appear responsible transcriptional silence critical gene include caretaker gene tumor suppressor gene select development cancer cancer progression variety human cancer normal cpg dinucelotide methylation pattern think establish embryonic development maintain dna methyltransferase target dna replication site interaction PCNA1 hepatocellular carcinoma hcc number gene know accumulate aberrant cpg island hypermethylation change include p16 Cadherin mechanism cpg island hypermethylation global hypomethylation appear HCC human cancer establish mechanism hypermethylation cpg island act suppress transcription gene area active research methylcpgbinding domain family protein identify candidate mediator process DNA MethylationAssociated GSTP1 repression Page CAUL protein contain conserve methylcpgbinde domain first identify capable bind dna contain single mcpg MeCP2 also contain transcriptional repression domain permit interaction Sin3a histone deacetylase HDAC form postulate mcpgdependent transcriptional repression complex also bind dna contain mcpg show part transcriptional repression complex contain HDACs MBD3 protein complex appear capable disrupt histone dna interaction promote chromatin remodeling cancer gene inactivate somatic cpg island hypermethylation role HDACs transcriptional silence unclear gene treatment HDAC inhibitor sufficient reverse repression associate cpg island hypermethylation gene treatment alone unable restore gene expression treatment combination DNMT inhibitor report trigger reactivation cancer gene carry somatic cpg island hypermethylation gstp1 encoding human class glutathione transferase report target somatic cpg island hypermethlyation HCCs breast cancer prostate cancer Hep3B cell human HCC line show contain densely hypermethylate GSTP1 cpg island sequence devoid GSTP1 mrna report Hep3B hcc cell repression gstp1 associate cpg island hypermethylation reverse treatment DNA MethylationAssociated GSTP1 repression Page CAUL deoxycytidine aza unaffected treatment furthermore Hep3B cell treat subject limit dilution cloning assess quantitative pcr GSTP1 mrna bisulfite genomic sequencing GSTP1 cpg island methylation hep3baza clone express GSTP1 mrna contain least unmethylated GSTP1 cpg island allele Hep3B aza clone fail reverse hypermethylation GSTP1 cpg island fail express GSTP1 mrna repression transcription hypermethylate GSTP1 cpg island allele Hep3B cell appear mediate immunoprecipitation analysis nucleoprotein complexe Hep3B cell reveal preferential association hypermethylate GSTP1 promoter sequence furthermore sirnas target mrnas introduce transfection Hep3B cell cell reduce level cell reduce level incapable repress transcription GSTP1 promoter datum collect suggest perhaps HDAC independent pathway act repress transcription hypermethylate GSTP1 promoter hcc cell experimental procedures culture Hep3B cell treatment aza Human Hep3B cell DNA MethylationAssociated GSTP1 repression Page CAUL propagate MEM growth medium supplement sodium pyruvate fetal bovine serum Invitrogen Treatment Hep3B cell accomplish add drug complete growth medium concentration aza 100ng solution aza dmso ethanol store isolate individual Hep3B clone vary degree GSTP1 cpg island methylation Hep3B cell treat aza maintain complete growth medium drug cell subject limit dilution cloning drugfree medium use well culture plate Hep3Baza clone isolate maintain complete growth medium drug assessment gstp1 expression GSTP1 cpg island hypermethylation detection GSTP1 mrna northern Blot Analysis GSTP1 Polypeptides Immunoblot Total RNA isolate Hep3B cell Hep3Baza clone use RNeasy rna isolation kit quantify use assay purify rna g electrophorese agarose gel presence formaldehyde transfer BioRad filter assess GSTP1 mrna level hybridization specific GSTP1 cdna probe ATCC prepare use dna labelling system follow hybridization QuickHybe stratagene hybridization solution contain heatdenatured salmon sperm DNA MethylationAssociated GSTP1 repression Page CAUL DNA Sigma blot wash twice SSC SSC NaCl sodium citrate SDS room temperature SDS Blot expose OMAT film Immunoblot analysis GSTP1 polypeptide total protein extract cultured hcc cell accomplish describe previously detection GSTP1 mrna use Quantitative Reverse TranscriptasePolymerase Chain Reaction PCR total rna Hep3Baza subject quantitative pcr GSTP1 mrna use multicolor real time pcr system PCR cDNA synthesize rna use Omniscript kit pcr reaction include rna sense gggcagtgccttcacatagt antisense ggagacctcaccctgtacca primer Master Mix QuantiTect SYBR Green pcr kit PCR cycle second clone GSTP1 cdna use standard quantification internal control mrna encode bind protein also detect quantitative pcr use specific sense CACGAACCACGGCACTGATT antisense TTTTCTTGCTGCCAGTCTGGAC primer pcr cycle cdna detection PCR assay run triplicate GSTP1 copy number estimate threshold amplification cycle number use software supply iCycler Thermal Cycler MBD2 DNA MethylationAssociated GSTP1 repression Page CAUL Mapping GSTP1 cpg island DNA Methylation pattern genomic dna genomic DNA isolate Hep3B cell use kit map mcpg dinucleotide GSTP1 cpg island region bisulfite genomic sequencing approach undertake purified dna treat EcoRI admix salmon sperm DNA treat sodium bisulfite previously describe bisulfitetreated DNA subject round pcr amplify GSTP1 CPG island allele use primer recognize antisense strand GSTP1 bisulfite conversion First round pcr primer second round pcr primer AACCTAAACCACAACAGTAAAACAT ttggttttatgttgggagttttga pcr reaction condition describe previously permit dna sequence individual GSTP1 cpg island allele pcr product purify electrophoresis agarose gel use Qiaquick gel extraction kit ligate pCR21pTOPO clone vector introduce TOP Shot competent bacteria Invitrogen Plasmid DNA isolate use Qiaprep kit subject dna sequence analysis use M13 sequence primer grow Hep3B cell Hep3Baza clone cell fix formaldehyde wash twice icecold contain protease inhibitor cocktail III Calbiochem recover scrape DNA MethylationAssociated GSTP1 repression Page CAUL centrifugation g cell pellet resuspend chromatin lysis buffer SDS EDTA TrisHCl incubate minute sonicate use sonicator reduce dna fragment size sonicate chromatin lysate clarify centrifugation g minute supernate add precipitation buffer SDS Triton NaCl edta TrisHCl precleare ssdnaprotein agarose incubation gentle agitation centrifugation nucleoprotein complex aliquotte fraction immunoprecipitation use specific antibody sp1 acetylate histone antibody solution add nucleoprotein complexe complex mixture incubate gentle agitation collect addition salmon sperm agarose incubation rotation centrifugation g minute Pelleted immunocomplexe wash low salt wash buffer SDS Triton NaCl EDTA TrisHCl high salt wash buffer SDS Triton NaCl EDTA TrisHCl LiCldeoxycholate buffer LiCl sodium deoxycholate buffer EDTA trisHCl complex elute final wash immunoprecipitate SDS nahco3 incubation room temperature reverse DNA MethylationAssociated GSTP1 repression Page CAUL crosslinke protein dna add eluted immunoprecipitate incubate overnight protein digest add proteinase EDTA incubate mixture DNA recover phenolchloroform extraction EtOH precipitation detect GSTP1 cpg island dna quantitative pcr undertake use multicolor real time pcr system Quantitect SYBR Green Master mix pcr cycle cycle 30seconds GSTP1 primer sense antisense ACTCACTGGTGGCGAAGACT pcr assay run trip GSTP1 copy number estimate threshold amplification cycle number use software supply iCycler Thermal Cycler amount GSTP1 dna recover immunoprecipitation specific antibody express percent total amount GSTP1 dna nucleoprotein complex immunoprecipitation siRNA sirna duplex design target N19 sequence open reading frame encode siRNA target mrna encoding lamin already available siRNA target sequence also submit blast search human genome sequence ensure target specificity rna chemically synthesize obtain anneal form follow target sequence use mrna aagaggauggauugcccggcc mecp2 mrna target lamin DNA MethylationAssociated GSTP1 repression Page CAUL AAGGACCUGGAGGCUCUGCUG siRNAs transfecte Hep3B cell use Oligofectamine additional siRNA transfection undertake later increase efficiency target protein knockdown effectiveness target protein reduction monitor immunoblot analysis total protein extract prepare lysing cell SDS electrophorese polyacrylamide gel NOVEX MES run buffer NOVEX transfer nitrocellulose membrane probe antibody acetylated histone lamin Calbiochem use horseradish peroxidaseconjugated antiIgG Amersham previously describe effect cpg Island Hypermethylation GSTP1 Promoter Activity GSTP1 promoterluciferase reporter construct contain sequence GSTP1 transcription start site treat SssI cpg methylase leave untreated transfecte Hep3B cell use LipofectAMINE Invitrogen transfecte cell lyse use Passive Lysis Buffer Promega Luciferase reporter activity assay use JET luminometer CMV promotergalactosidase reporter construct use monitor transfection efficiency result DNA MethylationAssociated GSTP1 repression Page CAUL Hep3B Cells Containing Hypermethylated GSTP1 cpg island use DNA Methyltranferase Inhibitor class glutathione transferase appear upregulated rat model hcc human class glutathione transferase express human HCCs human HCC cell line Hep3B normal human liver tissue GSTP1 cpg island unmethylate even GSTP1 usually express however Hep3B HCC cell GSTP1 promoter previously show heavily methylate subject Hep3B cell treatment aza DNMT inhibitor HDAC inhibitor GSTP1 expression evident cell treat aza Fig ascertain combination aza effective restore expression aza alone Hep3B cell treat sequentially total drug treatment Fig prior exposure Hep3B cell potentiate effect aza increase mrna level exposure aza treatment synergistic effect restore expression finding consistent role GSTP1 cpg island hypermethylation silence transcriptional Hep3B cell suggest mechanism methylationassociated inhibition transcription require HDACs Bisulfite Genomic Sequencing Analysis individual hep3b clone isolate aza treatment well characterize effect cpg island hypermethylation expression Hep3B cell treat cell isolate individual hep3baza subclone limit dilution clone hep3baza DNA MethylationAssociated GSTP1 repression Page CAUL clone recover clone express significant level GSTP1 mrna northern blot Fig quantitative pcr analysis Fig dnmt inhibitor report restore expression many gene repress cpg island hypermethylation cancer cell however reduction gene expression remethylation cpg island sequence prolong passage cell culture describe gene T24 bladder cancer cell restoration p16 mrna expression treatment aza completely reverse population doubling absence inhibitor remarkably Hep3Baza clone GSTP1 mrna expression remain stable least month continuous cell culture absence aza show apparent difference propensity island remethylation p16 T24 cell GSTP1 Hep3B cell attribute difference selection loss p16 GSTP1 expression mechanism establish genomic dna clone subject bisulfite genomic sequence capable mapping mcpg dinucleotide GSTP1 transcriptional regulatory region reduction GSTP1 cpg island hypermethylation evident Hep3Baza clone express GSTP1 mrna interest pcr primer bisulfite genomic sequence analysis flank polymorphic ATAAA repeat locate GSTP1 transcription start site permit discrimination dinucleotide methylation pattern individual GSTP1 allele Hep3B cell Hep3Baza clone find contain different repeat length consistent instability polymorphic repeat point development isolation propagation Hep3B hcc cell line Four DNA MethylationAssociated GSTP1 repression Page CAUL Hep3Baza clone appear lose GSTP1 allele aza treatment limit dilution cloning Hep3Baza clone reduction GSTP1 cpg island methylation reduction restrict GSTP1 allele furthermore Hep3Baza subclone display reversal GSTP1 cpg island hypermethylation different gstp1 allele suggest bias aza action specific GSTP1 allele hep3baza clone appear completely reverse hypermethylation GSTP1 allele Hep3Baza clone partially reverse GSTP1 cpg island hypermethylation experiment support direct correlation GSTP1 cpg island hypermethylation gstp1 repression ascertain family protein form transcriptional repression complex hypermethylate GSTP1 cpg island perform chromatin immunoprecipitation analyse Hep3B cell contain hypermethylate GSTP1 cpg island fail express GSTP1 mrna hep3baza clone cell contain unmethylated GSTP1 cpg island allele express high level GSTP1 mrna Fig Antibodies sp1 acetylated histone use detect active transcription complex antibodie use detect repressive transcription complex Hep3B cell perhaps small amount mecp2 Sp1 acetylate detect GSTP1 promoter contrast Hep3Baza clone cell Sp1 small amount acetylate histone detect GSTP1 promoter least GSTP1 allele reduce level present difference level GSTP1 MBD2 DNA MethylationAssociated GSTP1 repression Page CAUL nucleoprotein complexe Hep3B cell Hep3Baza clone cell attributable difference polypeptide level protein readily detect protein extract cell line thus presence least unmethylated GSTP1 promoter allele permit assembly gstp1protein complex contain transcriptional transactivator Sp1 histone exclusive presence hypermethylate GSTP1 promoter allele allow assembly GSTP1 protein complex contain MBD family protein sssicatalyze CpG Methylation GSTP1 Promoter Sequences Reduces GSTP1 Promoter Activity Hep3B Cells Hep3Baza Clone Cells stable high level gstp1 expression induce brief treatment Hep3Baza clone cell aza correlate reversal GSTP1 cpg island hypermethylation assembly Sp1containing complex GSTP1 promoter principle dna methylationindependent increase transactivation activity still contribute high level gstp1 expression Hep3Baza clone cell also nucleoside dnmt inhibitor report increase expression gene absence alteration dna methylation nonetheless unmethylated GSTP1 promoter sequence transfecte Hep3B Hep3Baza clone cell similar luciferase reporter expression level normalize CMV promoterdriven galactosidase reporter expression level see furthermore aza treatment appear increase activity unmethylate GSTP1 promoter however gstp1 promoter sequence treat cpg methylase sssi transfection mark DNA MethylationAssociated GSTP1 repression Page CAUL reduction luciferase reporter expression Hep3B Hep3Baza clone cell observe sirna knockdown Hep3B cell test responsible repression transcription hypermethylate GSTP1 promoter allele level family protein reduce Hep3B cell treatment specific sirnas capable degrade mrna transcript target specific manner Fig effectiveness siRNA knockdown family protein monitor immunoblot analysis remarkably GSTP1 promoter transfecte Hep3B cell treat siRNA target mrna reduction protein level appear render Hep3B cell incapable repress transcription finally combine knockdown level mecp2 level Hep3B cell well reverse alleviate repression hypermethylate GSTP1 promoter knockdown alone consider finding locate hypermethylate GSTP1 promoter Hep3B cell lack repression activity hypermethylate GSTP1 promoter Hep3B cell reduce level strongly suggest likely mediate island hypermethylationdependent repression gstp1 discussion datum collect suggest cpg island hypermethylation responsible DNA MethylationAssociated GSTP1 repression Page CAUL transcriptional silence GSTP1 Hep3B cell GSTP1 repression reverse treatment aza treatment DNMT inhibitor HDAC inhibitor certain gene silence cpg island hypermethylation treatment activate gene expression indicate participation hdac transcriptional repression gene alone incapable restore gene function chromatin immunoprecipitation experiment detect acetylate histone association active GSTP1 promoter hep3baza clone cell association inactive GSTP1 promoter parent Hep3B cell suggest histone acetylation likely accompany gstp1 transcription however absence stimulation gstp1 expression hypermethylate GSTP1 promoter Hep3B cell suggest HDACs play critical role island hypermethylationassociate GSTP1 repression mechanism aberrant methylation pattern develop cancer cell determine several cytosine methyltransferase gene identify characterize dnmt3b essential mouse development thought function maintenance methyltransferase normal cell present replication focus phase cell cycle certain circumstance also promote novo cpg dinucleotide methylation cancer cell DNMT3b contribute novo maintenance dna methylation way colorectal carcinoma cell carry disrupt allele display reduction mcpg furthermore DNMT3b seem express high level embryonic development low level normal adult tissue DNA MethylationAssociated GSTP1 repression Page CAUL increase expression dnmt3b mrna report human cancer Nonetheless prominently implicate early stage cancer development dnmt mouse develop few intestinal polyp cross Dnmt1 background Dnmt1 also appear essential fos transformation rat fibroblast force Dnmt1 overexpression recapitulate fostransformed phenotype antisense Dnmt1 cDNA inhibit transformation fos observation act facilitate cancer development catalyze novo cpg island methylation irrefutably establish report act transcriptional repressor independent dna methyltransferase activity form complex HDAC2 DMAP1 methylcpgbinde domain protein contain sequence similar amino acid motif show responsible mcpg bind bind mecp2 first protein identify act transcriptional repressor interaction Sin3A HDACs MECP2 mutation responsible syndrome neurodegenerative disorder female severe mental retardation death male target disruption lead similar phenotype mouse study find small amount MeCP2 association hypermethylate GSTP1 promoter Hep3B cell chromatin immunoprecipitation unable increase promoter activity treatment siRNA target mrna set GSTP1 promoter hypermethylation datum suggest require transcriptional repression DNA MethylationAssociated GSTP1 repression Page CAUL hypermethylate GSTP1 promoter Hep3B cell MeCP1 multicomponent transcriptional repression complex contain protein likely serve recruit MeCP1 complex protein hypermethylate transcriptional promoter MBD3 bind mcpg perhaps reason cell mouse unable prevent transcription exogenous hypermethylate promoter Mbd3 cell remain capable promoter hypermethylationassociated repression detect bind hypermethylate GSTP1 promoter Hep3B cell chromatin immunoprecipitation show reduction level prevent repression GSTP1 associate hypermethylation confirm finding preliminary datum collect use breast cancer cell suggest siRNA knockdown trigger induction gstp1 mrna expression presence hypermethylate GSTP1 promoter participation silencing hypermethylate GSTP1 promoter Hep3B cell provide partial explanation failure reactivate expression MeCP1 contain helicase hdac transfection cdna encoding dominantnegative report alleviate repression model hypermethylate transcriptional promoter GSTP1 Hep3B cell cpg island hypermethylation appear cause transcriptional silence mbd2dependent mechanism perhaps mbd2associate protein help mediate repression hypermethylate GSTP1 promoter finding support critical role silence gene target DNA MethylationAssociated GSTP1 repression Page CAUL somatic cpg island hypermethylation cancer development work support Grant correspondence address Room BuntingBlaustein Cancer Research Building Orleans Street Tel fax mail bnelsonjhmiedu abbreviation use aza azadeoxycytidine TSA PCNA proliferate cell nuclear antigen TRD transcriptional repression domain HDAC histone deacetlyase 2Lin manuscript preparation Fig Activation GSTP1 expression Hep3B cell treatment aza Hep3B cell treat aza TSA 100ng hour expression GSTP1 mrna monitor northern blot analysis use GSTP1 cdna probe upper panel bromide staining use loading control bottom panel DNA MethylationAssociated GSTP1 repression Page CAUL aza restore GSTP1 expression Hep3B cell Hep3B cell treat sequentially period 100ng drug expression monitor northern blot analysis describe Fig Fig GSTP1 expression Hep3B clone isolate hour aza exposure Hep3B cell treat maintain complete growth medium drug thereafter drugtreate cell subject limit dilution cloning individual clone isolate expression monitor northern blot analysis describe Fig Fig quantitative pcr GSTP1 mrna hep3baza clone Hep3Baza sublcone assess GSTP1 mrna level use quantitative pcr display ratio gstp1 mrnatbp mrna subclone Fig Bisulfite genomic sequencing mapping mcpg GSTP1 cpg island Hep3B cell hep3baza clone genomic DNA isolate Hep3B cell treat amplify pcr target GSTP1 cpg island subject dna sequence analysis describe experimental PROCEDURES minimum individual pcr product clone sequence cell type pcr product clone less conversion noncpg cytosine thymine DNA MethylationAssociated GSTP1 repression Page CAUL consider sequence share ATAAA repeat length collect individual GSTP1 allele allele present Hep3B cell GSTP1 ATAAA repeat allele cell type mcpg map percentage clone mcpg specific site display Fig immunoprecipitation target GSPT1 promoter Hep3B Hep3B aza clone cell complex recover Hep3Baza clone cell subject immunoprecipitation antibody Sp1 acetylate immunoprecipitate analyze quantitative pcr target GSTP1 promoter amount GSTP1 promoter dna immunoprecipitate show percentage total GSTP1 promoter dna MBD2 acetylate Hep3B Hep3Baza clone cell monitor use immunoblot analysis Fig inhibition GSTP1 promoter activity Hep3B cell cpg methylation Hep3B cell transfecte unmethylated methylated GSTP1 promoterluciferase reporter construct CMV promoter galactosidase control determine aza trigger transactivation unmethylate GSTP1 promoter Hep3B cell treat activity normalize galactosidase activity assess transfection show DNA MethylationAssociated GSTP1 repression Page CAUL Fig Alleviation repression hypermethylate GSTP1 promoter target reduction use siRNA Hep3B cell repeatedly transfecte siRNA target mrna encode lamin MeCP2 reduction level target protein monitor immunoblot analysis sirna treatment promoter activity asssesse transient transfection describe DNA MethylationAssociated GSTP1 repression Page CAUL CAUL CAUL CAUL CAUL CAUL CAUL CAUL CAUL CAUL CAUL hepatocellular carcinoma cell transferase gene promoter hypermethylate class glutathione repress transcription methylcpg bind domain protein publish online jbcM203009200 access update version article JBC Affinity Sites find article mini Reflections Classics similar topic alert correction article post article cite choose JBC mail alert Click article cite access free CAUL",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 15,
                    "demethylation": 1
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "GSTP1": 8,
                    "PCNA1": 1,
                    "Omniscript": 1,
                    "TTTTCTTGCTGCCAGTCTGGAC": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "GSTP1": 16,
                    "PCNA1": 16,
                    "Omniscript": 16,
                    "TTTTCTTGCTGCCAGTCTGGAC": 16
                },
                "Ethnographic Terms": {
                    "methylation": 11,
                    "demethylation": 11
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Methylation matters.pdf",
            "cleaned_text": "article methylation matter Christoph Plass dna methylation basic sci entist grow awareness medical correct pattern genomic methyla tion essential healthy cell organ methylation pattern properly establish maintain disor der diverse mental retardation immune deciency sporadic herited cancer follow appropriate silence growth regulate gene simultaneous destabilisation whole chromosome methylation defect help create chaotic state cancer cell evolve Methylation defect present cell onset obvious malignancy therefore explain simply consequence deregulated cancer cell researcher able detect exquisite sensitiv ity cell harbour methylation fect sometimes month year time cancer clinically detect able furthermore aberrant methylation specic gene directly link tumour response chemo therapy patient survival advance ability observe methylation tus entire cancer cell genome lead unmistakable conclusion methylation abnormality far prevalent expect methyl omic approach permit integration ever grow repertoire methylation defect genetic alteration cata logue tumour discuss current knowledge dna methylation normal cell disease state relate directly current stand mechanism tumour arise Med Genet methylation cancer methylcytosine base Methylation cytosine known endogenous modication dna mammal occur enzymatic addition methyl group carbon position cyto sine majority methylcytosine mammalian DNA present cpg dinucleotide sequence CpNpG CpT also exhibit methylation generally much low frequency mouse embryonic stem cell however non cpg methylation comprise total methylcytosine uniformly distribute human genome genome present approximately contrast cpg island com prise genome approximately base pair several length frequency approximately time great genome whole base draft version human genome estimate cpg island genome roughly consistent previous estimate island nearly always encompass gene promoter exon approximately gene contain cpg island note exception imprint gene several gene inactive chromosome female island mally unmethylated island methylate suggest pattern methylation serve compartmentalise genome transcriptionally active inactive zone dna methylation present organism bacteria human bacteria methyla tion part defence mechanism reduce amount gene transfer specie particular mutant strain bacteria lack detectable methylation nevertheless survive proliferate early study unable detect cytosine methylation fruit melanogaster recent report however show low level methylation cytosine resi due particularly early developmental stage contrast bacteria deletion dna methyltransferase gene mouse lethal suggest methylation additional indispensable function mammal establish dna methylation pattern ceed dene phase develop ment organism general germ cell female less methylated male gamete methylation pattern erase genome wide demethylation cell stage blastocyst formation implantation stage methylation pattern establish follow wave novo methylation adult amount pattern methylation tissue cell Sutter Room n261 USA Costello Division Human Cancer Genetics Department Molecular Virology Immunology 464A West 12th Avenue Columbus USA Plass Correspondence jcostelloucsfedu Plass plassmedctrosuedu groupbmjcom publish type specic evidence age related methylation change cpg island promoter gene include oestrogen receptor gene MYOD1 Methylation pat tern certain genomic region appear polymorphic people inher ite suggest persistence certain methylation stage development encryption methylation pattern mation Methylation machinery DNA methyltransferase DNMT1 DNMT3A DNMT3B identi ed mammalian cells Elimination one gene germline mouse lethal Mouse embryo homozygous deletion Dnmt1 Dnmt3B die birth deletion lead death mately birth mouse heterozygous mutant one DNA methyltransferase appear normal fertile conditional deletion Dnmt1 mouse broblast result p53 dependent apoptosis massive dysregulation gene expression initial methylation dna require novo methylase activity mostly present early embryonic development methyltransferase possess novo activity appear certain distinct sequence target methylation activity far great hemimethylated DNA thus term maintenance methylase ubiquitously express somatic tissue16 interact PCNA replication fork consistent func tion maintain methylation pattern also interact protein complex HDAC2 DMAP1 DNMT1 associ ate protein mediate transcriptional repre sion certain developmental process also involve erasure methylation pattern enzyme demethylate activity proposed30 debate alternative explanation include dna replication absence maintenance methylation result passive demethylation function methylation Cytosine methylation number func tion prove other actively debate gene regulatory element promoter hancer insulator repressor generally suppress function normal cell imprint gene gene inactive chromosome prominent example transcriptional repression methylation methylation gene decient region heterochromatin pear crucial maintain conformation integrity chromosome methyla tion also propose genome defence surreptitious mobile genetic element mechanism methylation block transcription propose First methylation inhibit bind certain transcription factor contain recognition site second mechanism involve protein protein complex respectively bind spe cically methylate indirectly inhibit bind transcription factor limit access regulatory element inhibitory mediate ability methylate cpg bind protein recruit histone deacetylase hdac example MeCP1 recruit HDAC1 HDAC2 relate protein bind Sin3HDAC corepressor com plex HDACs deacetylate lysine residue terminal tail histone facilitate interaction adjacent histone turn help form transcriptionally repressive chromatin structure protein methyl bind domain identie role mediate eVects DNA methylation remain deter mine development inactivation chromosome female cell occur process dependent methylation cpg island contain promoter majority gene inactive chromosome include housekeeping gene HPRT G6PD PGK1 methylate transcriptionally silent presumably ensure equivalent expres sion level male female cell many gene silence precede methylation50 therefore serve maintain silence rather initiate event expression XIST inactive specic transcript gene also correlate methylation status promoter express inactive methylated silent active Dnmt1 delete embryonic stem cell express normally silence gene active chromo male also critical expression imprint gene majority gene express maternal pater nal allele small number imprint gene express parent origin specic manner Imprinting involve allele specic methylation cpg island associate gene mechanism fully understand however recent study suggest involvement protein chromatin boundary function bind unmethylated allele imprinting control region upstream H19 methylated allele methyla tion pattern reproducibly establish imprint gene genomic region sequence specicity methyltransferase postulate rst indication occur describe recent report protein complex consist together HDAC1 Theo retically complex specically tar get gene contain bind site abnormal methylation disease importance dna methylation pattern human health underline recent identication mutation methylation publish related gene link human disease Mutations methyltransferase gene DNMT3B find patient syn drome mutation methylate cpg bind protein mecp2 observe patient syndrome ICF syndrome rare autosomal recessive disorder characterise presence vari able immunodeciency instability peri centromeric heterochromatin chromosome mild facial anomaly rst observation indicate defect methylation machinery show dna patient Addi tionally chromosomal abnormality observe patient also induce normal lymphocyte follow treatment mapping allow localisation syndrome candidate gene chromosome chromosomal location DNMT3B recently several group report mutation DNMT3B ICF patient consistent idea methylation defect syndrome link mental disorder characterise mental retar dation autistic behaviour occur exclusively female mutation chromosome gene mecp2 encode methylate dna bind protein occur least thirds sporadic syndrome case familial case major ity mutation occur methylate cpg bind domain transcriptional repression domain recruit sin3 HDAC corepressor complex human disease show associate imprint region defect imprint gene epigenetic regulation example include syndrome BWS human chromosome syndrome syndrome chromosome 15q11q13 characterise mild moderate mental retardation patient slow moving overweight severe hyperphagia patient show severe mental retarda tion thin hyperactive show disor der movement uncontrolled laughter rst hint possible imprint syndrome come nding delete fragment syndrome opposite parental origin deletion occur paternal copy case maternal copy delete additional evidence come nde maternal disomy chromosome patient paternal disomy chromosome datum suggest gene transcribe paternal allele gene express maternal allele several imprinted gene identie critical region include paternally express maternally express gene identie alter dna methylation pattern lead dys regulation gene imprinted gene cluster BWS characterise number growth abnormality include gigantism however phenotypic expression variable BWS patient prone Wilms tumour adrenocortical carcinoma hepatoblastoma embryonal rhabdomyosar coma wilm tumour show exhibit preferential loss maternal allele chromosome cluster least imprint gene identie include paternally express IGF2 maternally express H19 evi dence independent imprinting control centre common abnormality BWS patient IGF2 detectable chromosomal abnormality overwhelming evidence implicat ing dna methylation change BWS change include loss imprinting IGF2 silence H19 promoter methylation defect methylation underlie con tribute disorder able reversible nature methylation intriguing theory propose regard ing role epigenetic possibly aberrant methylation play complex non mendelian disorder schizophrenia aVective disorder genomic methylation imbalance cancer underlie basis cancer cumulative series genetic epigenetic alteration lead deregulated cell growth particular alteration provide selective growth advantage tumour cell con ferre resistance therapy increase posi tive growth signal activation oncogene eliminate growth limit signal inactivation tumour sup pressor gene Mutations nucle otide sequence occur frequently human contribute initiation malignant progression tumour epigenetic mutation involve cytosine meth ylation rst observe primary cancer like contro versial idea science take catch imbalance cytosine methylation prevalent human sporadic cancer methylation pattern defect include genome wide hypomethylation localise aberrant hypermethylation cpg island balance present together single tumour net eVect usually decrease total methylation level genome hypomethylation cpg island hypermethylation link common underlie mechanism result distinct abnormality cancer cell currently unknown however know pomethylation hypermethylation occur specic distinct site cancer cell methylation matter publish genome suggest diverent defect precede malignancy indicate simply consequence malignant state discover interpret methylation defect researcher adapt principle cancer genomic include theory clonal evolution tumour cell hit model tumour suppressor gene inactivation inactivate allele prove tumour suppressor gene sporadic cancer potentially act second hit devel opment hereditary cancer methylation imbalance contribute directly tumour initiation alteration occur early stage cancer premalignant cell imbalance contribute directly tumour progression methylation defect crease frequency severity coordi nately increase malignancy grade also expect cell harbour func tionally important methylation abnormality select manner consistent clonal evolution cancer cell finally mechanistic explanation link methylation change malignant behaviour available evidence premalig nant tissue primary human tumour vitro vivo model cancer support supposition Hypomethylation amount methylcytosine genomic DNA measure directly indi rectly inverse value capacity dna sample accept tritiate methyl group universal methyl donor adenosylmethionine distinct meth od show similar general trend hypomethylation tumour extent genome wide hypomethylation tumour parallel closely degree malignancy tumour type pendent breast ovarian cervical brain tumour example hypomethylation crease progressively increase malig nancy grade additionally study breast lesion show signicant correla tion extent hypomethylation disease stage tumour size degree malignancy thus hypomethylation serve biological marker prognostic value cell nonmalignant medical con dition gastritis colitis also display progressive hypomethylation less degree relative malignant cell contrast escalate hypomethylation tumour progression level hypomethyla tion benign colon polyp malignant colon adenocarcinoma quantitatively unlikely hypomethylation reect divide state premalignant cancer cell normal tissue cultured cell show correlation cell turnover self renewal rate overall level methylcytosine correlative datum alone consistent contributory reective role hypomethylation tumour initiation malignant progression evidence hypomethylation contribute directly malignancy mechanism occur several hypothesis propose include hypomethylation mediate transcrip tional activation oncogene activation latent retrotransposon chromo somal instability hypothesis receive support identica tion genome site subject hypomethyla tion cancer Pioneering study suggest loss methylation tumour involve segment genome include quence high medium low copy number subsequent report conrme nding detailed fashion provide additional rationale depth investiga tion hypothesis consider datum pertinent hypothesis activation Pugh102 propose pomethylation lead inappropriate activation gene important neoplastic growth hypomethylation provide selective advantage tumour cell cell clonally evolve appear prominent population tumour pomethylation body number gene find primary cancer include know oncogene CMYC108 oncogene overexpre sion absence gene amplication fairly common date compelling mechanistic correlative evidence local hypomethylation cause overexpression Hypomethylation human cancer caus ally relate transcriptional activation large group gene SAGE family unrelated gene family locate chromosome cellular function unknown mage gene prototype group rst discover coding tumour specic antigen recognise cyto lytic lymphocytes113 currently study potential anticancer vaccine mage type gene germline specic gene aberrantly activate melanomas many tumour type unmethyl ate spermatogenic cell methylate adult somatic tissue include allele active inactive chromosome Studies mage promoter suggest gene use methylation primary mechanism silence adult somatic tissue promoter mage type gene intermediate density constitute unique class promoter fall somewhere constitutively unmethylate island promoter conditionally methylate cpg poor pro moter mage promoter demethylation pos sibly consequence genome wide hypomethylation lead transcriptional acti vation mage gene cancer cell mage gene expression tumour cell stimulate production antimage lymphocyte therefore instead provide selective growth advantage hypomethylation publish instance increase immuno genicity cancer cell facilitate elimi nation DNA Hypomethylation cancer cell lead transcriptional activation mobile genetic element call retrotransposon suggestion relate directly theory primary function methylation defend genome deleterious eVects resident invade parasite abundant retrotransposon human genome know long intersperse nuclear element lines l1 full length L1s open reading frame encode nucleic acid bind protein second encode protein endonu clease reverse transcriptase activity allow mobilisation genome RNA intermediate thou sand L1s exist human genome inactive owe truncation rearrange ment mutation competent transposition additionally many L1s methylate transcriptionally silent unknown nonmutated L1s intact L1s silence manner loss promoter methylation transcriptional activation element report variety sporadic cancer type full length nonmutated transposable element transcribe reverse transcribe integrate disrupt important growth regulate gene mutational insertion sporadic cancer find disrupt gene CMYC gene sporadic tumour colon breast respectively suggest certain L1s active human cell disrupted gene nucleotide sequence insertion site exhibit signature retrotransposon integration mutational insertion nonautonomous rotransposons Alu element also occur germline Alu mediate mutation observe BRCA1 family hereditary predis position breast ovarian cancer123 gene family predispose colon cancer relative mutational mechanism transposon mediate mutational insertion rare well study human gene role genome hypomethylation permit transposition cancer cell resolve substantial evidence unleashing transcription large num ber retrotransposon sequence meth ylation dependent manner deleterious eVect retrotransposon cancer require transposition suggest typically strong activity ltr promoter l1s hypomethylation mediate transcriptional activation L1s also disrupt expression nearby gene promoter delete abundant retro transposon human endogenous retro viruse retain also demethylated express cancer direct evidence disrupt expression gene near transcriptionally acti vate yet report primary human cancer CHROMOSOME INSTABILITY Hypomethylation specic chromosomal domain also link chromosome instability propose hypomethylation contribute malignancy disturbance chromosomal domain abnormal gene dosage eVects lose gain chromosome fragment normal somatic cell pericentromeric heterochroma tin region chromosome heavily methylate breast adenocarcino mas ovarian epithelial tumour sporadic Wilms tumour region signicantly hypomethylated frequently unstable abnormality associate hypomethylation region include unbalanced juxtacentro meric translocation whole arm deletion similar rearrangement involve chromo some also induce mitogen stimulate normal cell treat azacytidine azadeoxycytidine cause dna hypomethylation Hypomethylation causally relate chromosome instability apparent need mitogen stimula tion cell division process suggest relationship multifactorial additional link hypomethylation chromosome instability come study syndrome rare genetic dis order human cause inherit mutation dna methyltransferase DNMT3B somatic cell patient heterochromatin chromosome abnormally hypomethylate Mitogen stimulation lym phocyte patient result high frequency abnormality involve chromo some less degree chromosome similar nature chromosomal abnormality see spo radic cancer normal cell treat demethylate agent note patient increase incidence cancer causal relationship chromosome instability also sup port directly study mouse cell homozygous deletion methyl transferase Dnmt1 mutant cell mostly signicantly crease mutation rate primarily involve genomic deletion thus datum sporadic human cancer patient mouse cell lack Dnmt1 suggest hypomethyla tion predispose chromosome possibly facilitate additional growth stimulate factor inappropriate cell division got FOLATE several line evidence suggest dna hypomethylation chromosome instability matter publish result insuycient dietary folate provide carbon unit number biochemical process include production universal donor also supply methyl group cytosine dna First liver rat feed decient diet exhibit genome hypomethylation increase dna strand break occasionally involve p53 gene rat typically develop liver cancer eVect reduce dietary folate also observe diet study human hypomethylation reversible control folate repletion relative study human show signicant relationship reduce tissue folate lev el tumour hypomethylation patient various grade cervical intraepithelial neoplasia reduce folate level observe neoplastic tissue serum relationship reduce folate cancer evident requirement folate cellular bio chemistry yet possible make causal link folate deciency induce dna hypomethylation cancer methylation level also determine genetic factor relate folate metabolism methylenetetrahydrofolate reductase MTHFR gene encode enzyme involve synthesis methyl donor SAM specic MTHFR gene polymorphism reduce enzyme activity study peo ple homozygous reduced MTHFR activity genotype show signicantly reduce level genome hypomethylation peripheral leucocyte relative subject homozygous wild type mthfr dna methylation correlate directly folate level subject reduced activity MTHFR reduce folate dna hypomethylation ate abnormal chromosomal segregation hypothesise particular MTHFR polymorphism risk factor maternal meiotic nondisjunction syndrome child young mother MTHFR polymorphism also associate increase risk neural tube defect vascular disease modify cancer risk strong epidemiological evidence suycient dietary folate important reduce risk certain cancer thus role downstream genome hypomethylation cancer risk seem important area future study present reduced methyl donor insuycient folate know cellular mechanism lead genome hypomethylation cancer role putative demethylate enzyme dysfunction methyltransferase create hypomethyl ate state suggest remain unproven cpg island hypermethylation candidate gene approach begin inception investigation abnormal island tion topple notion molecular underpinning sporadic cancer purely genetic island pro moter inactivate allele prove cancer gene act concert genetic mechanism include point mutation dele tion Methylation cancer suppressor gene typically restrict nonmutated allele demethylate agent capable restore gene activity tumour suppressor function culture tumour cell great deal excitement come possibility dormant nonmutated gene chemically reactivate restore functional tumour suppressor activity cancer patient alternative gene replacement therapy clinical trial test haemato poietic solid tumour soon way candidate gene approach test aber rant methylation establish cancer gene particularly tumour sample specic allele harbour genetic alteration gene lucrative approach uncover methylation relate gene silence account type malignant behaviour exhibit human cancer cell table Genes involve cell cycle regula tion DNA repair drug resistance cation diVerentiation apoptosis angiogenesis metastasis invasion inappropriately silence methylation similar gene silence event recapitulate chemically genetically induce mouse model human cancer combination functional study cancer gene mechanistic study link methylation gene silence considerable evidence cpg island methylation contribute directly malig methylation also inuence expression imprint gene cancer cell Methylation regulate expression number imprint gene critical embryonic figure genetic epigenetic mechanism inactivate cancer gene mechanism act alone various combination cause biallelic inactivation cancer gene deletion methylation CH3 Normal chromosome tumour chromosome cancer gene homozygous methylation mutation methylation Mutation deletion homozygous deletion mutation ch3 ch3 ch3 Costello Plass publish development environment tumour cell dysregulation imprint gene oncogenic consequence complete loss function imprint gene occur deletion single tionally active allele show cyclin dependent kinase inhibitor p57KIP2 lung cer H19 Wilms tumour NOEY2 member superfamily breast ovarian cancer silent allele also lead complete inactivation imprint gene normally inhibit cell growth conversely activation growth support gene IGF2 occur uniparental disomy active allele addition loss imprint signal subsequent loss imprint gene expres sion result biallelic expression growth promote gene show IGF2 Wilms tumour colorectal cancer biallelic methylation bind site result biallelic IGF2 expression primarily tumour also show methylation silence p16 aberrant methylation cpg island observe cell overtly malignant example cultured mammary epithelial cell extend life span widely consider normal contain densely methylate p16 promoter lack expression loss p16 expression appear gradual proceed coordinately increase promoter meth ylation aberrant cpg island methylation pre cede malignancy also observe vivo example frequent widespread cpg island methylation present nondysplastic tissue patient oesophagus associated adenocarcinoma gastric cancer patient p16 cadherin promoter methylate tumour normal gastric mucosa similarly promoter oestrogen receptor gene aberrantly methyl ate patient inammatory oesophagitis thus cpg island methylation simply consequence malignant state detect normal appear tissue onset cancer aberrant methylation useful marker early precancer detection CANCER METHYLOMICS Cancer gene inactivate variety mechanism include point mutation dele tion methylation particular gene often mechanism predominate inactivation example p16 tumour suppressor gene brain breast tumour inactivate primarily homozygous deletion p53 gene frequently aVected deletion allele point mutation allele nearly tumour type involve observation suggest exist entirely diverent set important cancer gene inactivate primarily aberrant methylation allele theory gene remain undiscovered sively genetic screening method use Table Aberrantly methylate gene cancer function Genes example Apoptosis Death associate protein kinase kinase Caspase CASP8 methylation induce silence TMS1 Angiogenesis Thrombospondin THBS1 cell cycle retinoblastoma 9p21 cyclin dependent kinase CDKN2A cyclin dependent kinase CDKN2B p73 TP73 stratin diVerentiation antigen MYOD pair box gene PAX6 Retinoic acid receptor RAR2 3p24 wilm tumour WT1 DNA repair hMLH13p23p21 methylguanineDNA methyltransferase MGMT Metastasisinvasion cadherin CDH1 tissue inhibitor metalloproteinase protease inhibitor PI5 drug resistance detoxication transferase resistance MDR1 Signal transduction adenomatous polyposis colon APC Androgen receptor Oestrogen receptor ESR1 Ras association domain family member RASSF1A Serinethreonine protein kinase STK11 Transcription transcription factor syndrome Hypermethylated cancer HIC breast cancer type BRCA1 antigen channel voltage dependent type alpha subunit CACNA1 G CALCA fragile histidine triad gene FHIT 3p14 telomerase reverse transcriptase transmembrane protein contain epidermal growth factor domain sulphate proteoglycan CSPG2 methylation matter groupbmjcom publish foundation set discovery aberrantly methylate gene number method screen genome aberrantly methylate gene develop include pcr base method array hybridisa tion restriction landmark genome scan ning genome scan ning method involve mass spectrometry nonradioactive oligo cpg island array method also emerge suitable method address hypothesis state strong bias cpg island cover large number gene note current focus island promoter overlook less cpg rich promoter also subject aberrant methylation silence restriction landmark genome scan approach uniquely suited simultaneously assess methylation status thousands island separate radiolabelle fragment dimension allow distinction single copy cpg island multicopy cpg rich sequence methylation sensitivity endonuclease activity provide basis diverential methylation analysis site occur primarily cpg island gene use identify novel imprint gene novel target dna amplication methylation169 human cancer identify deletion meth ylation gene amplication mouse model tumorigenesis additionally chromosome origin dis play prole determine massively parallel analysis critical pattern recognition tumour type estimate overall inuence cpg island methylation cancer cell genome total number aberrantly methylate cpg island sporadic human tumour estimate prole analysis cover cpg island primary human tumour total potential methylation event average methylate cpg island tumour estimate range total number methylate site variable case diverent tumour type suggest methylation subtype tumour similar ogy Aberrant methylation proportion gene correlate loss gene expres sion illuminate pat tern methylation yield clue underlie mechanism aberrant meth ylation example observation cpg island preferentially methylate suggest clonal selection diverent susceptibility island shape pattern tumour process stochastic nonrandom outcome tumour suggest mecha nisms active methylation prove cancer gene argument support clonal selection straightforward tumour suppress ability show application methylation datum show aberrant methylation usually find contiguous tissue cancer patient suggest concerted methylation change clonal expansion cell aber rant hypermethylation gene aberrantly methylate tumour type specic manner tumour figure methylation detection use procedure leave panel methylation deletion lead fragment loss rlgs prole methylation appear far common portion prole low grade glioma right panel dig end label hormozygous methylation 1st dimension 2nd dimension methylation EcoRV digest dim digest 2nd publish type even histological subtype specicity also observe study BRCA1 important cancer gene pattern result loss gene activity many case suggest methylation specic subset gene contribute development specic tumour type homozygous methylation specic gene quite frequent even low malignancy grade tumour statistical ground datum suggest methylation allele predispose methylation second allele gene allelic transfer methylation involve homologous gene pair ing observe plant result suppress expression endogenous gene transgene pair methylate unmethylated homologous chromo segment mitosis lead transient hemimethylated state nance methyltransferase predilection hemimethylated substrate certain unusual dna structure present precise time location homologous pairing lead homozygous methyla tion particular gene depend rate tumour cell specic locus specic aber rant methylation exceptionally high fre quency homozygous methylation consider circumstantial support allelic transfer methylation persistence monoallelic methylation many case indi cat transallelic spread methylation obligate event understand impact importance CpG island methylation extent methylation capable silence gene type gene methylate methylation gene contrib ute tumorigenesis expect gene express normal cell give rise tumour level extent methylation cancer cell suf cient silence decrease expression gene primary tumour expression gene measurable phenotype tumour cell methyla tion primary sole mechanism inactivation expect unmeth ylate copy promoter support transcription transfecte cell endogenous promoter methylate experimental demethylation aza deoxycytidine reactivate expression methylate gene foundation expectation assumption eat gene silence primary consequence cpg island methylation function prove many gene seem premature suggest cpg island methylation event cancer cell similar consequence even arise mechanism location location location aberrant cpg island methylation alone uniformly connote inappropriate gene silence aberrant methylation promoter gene expression case promote expression alternatively lack correlation indicate single test island representative remainder island sparse tion insuycient silence ate gene particularly promoter activity strong occasionally aberrant methylation observe gene tionally inactive normal cell type tumour originate inactivate rst epigenetic mecha nism involve methylation explanation nonrandom methylation transcriptional eVects distant gene dictate alternate promoter usage also involve alternatively sus ceptibilitie aberrant methylation con tribute formation nonrandom pattern question address part assess specicity DNA methyltransferase cancer cell ever account tumour type specicity methylation event factor addition nucleotide sequence invoke poten tial factor inuence methylation status diver tissue include local chromatin conformation gene activity exposure exogenous agent clearly location extent individual methyla tion event important determinant aberrant island methylation cancer METHYLOMICS prevalence specicity aberrant methylation raise important question regard ing relative contribution genetic epi genetic mechanism genesis human tumour comprehensive view underlie mechanism tumorigenesis methylation pattern compare gene chromosome region identie tra ditional genomic analysis tumour cpg island methylation precede genetic instability cancer cell gene important genome integrity frequently silence aberrant methylation cancer encode dna mismatch repair protein Loss function colon cancer associate fold great mutation rate genome particularly apparent short repeat sequence term microsatel lite promoter methylation gene silence signicantly correlate microsatellite instability experimental demethylation tumour cell line lead expression restoration dna mismatch repair procient phenotype additionally study pro moter indicate methylation minimal region promoter also methyl ate primary tumour suycient inhibit transcription pro moter methylation account majority sporadic colon tumour exhibit microsatel lite instability also observe sporadic endometrial cancer195 hereditary colon gastric tumour Methylation second gene indirectly involve maintain dna integrity matter publish gene find breast tumour tumour type protein induce arrest follow ing dna damage breast cancer cell line express accumulate great number chromosomal break expose irradiation thus aberrant methylation gene silencing predispose genetic instability rather reec tion random recurrent component genetic methylation abnor malitie nearly chromosomal band implicate genetic loss tumour type initial study consider tumour tumour type aberrant methylation event detect island test background alteration reect unstable genetic methylation state tumour cell term mutator phenotype192 methylator phenotype198 roughly equate former latter state respectively Studies cell line suggest undened linkage pheno type contrast direct test meth ylation capacity extent exist methyla tion distinguish mutator non mutator colon cancer cell line proportion frequently methylate cpg island locate region recurrent genetic loss tumour type suggest target independent recurrent genetic alteration line fact signicant proportion low grade astrocytoma relatively normal appearing genome methylomic indicate cpg island methylation frequent widespread sig nicant interest determine proportion silence event measurable role tumorigenesis number aberrant methylation site coincide recurrent site deletion hit mechanism combine deletion methylation yet address globally evidence suggest important support discover eVector homo logue RASSF1A locate pre cise region chromosome 3p21 subject allelic loss small cell lung cancer nonsmall cell lung cancer remain allele frequently heavily methylate promoter much low frequency gene also subject point mutation furthermore RASSF1A function tumour suppressor gene express lung cancer cell line case coincide point mutation meth ylation event restrict wild type allele several study show correlation aberrant cpg island methylation site chromosomal breakage coin cident site alteration think occur allele obviously diverent time tumorigenesis rather dif ferent allele describe deletion methylation event perhaps aberrant methylation mark region deletion unknown mechanism alternatively coinciding site alteration reect unstable chromatin susceptible meth ylation deletion example dense hyper methylation observe break point cluster region chromosome patient chromo normal myeloid precur sor syndrome dene deletion long arm chromosome breakpoint interval 11q23 q24 deletion syndrome cause expansion repeat fragile site fra11b contain island protooncogene CBL2 addition recent study describe hypermethylation major breakpoint cluster region blastomas chromosome 17p11 short arm chromosome break occur genetic event specic medulloblastoma aberrantly hypermethylate cpg island methylate medulloblastoma supratentorial PNETs tumour type exhibit loss 17p genetic methylation alteration prevalent cultured tumour cell primary tumour reect culture condition favour growth cell particular spectrum mutation meth ylation nucleotide alteration dilution admix normal cell population primary tumour grow culture natively selection many mutation reduce relaxed cultured cell finally rate mutation increase cultured cell relative primary cancer chicken EGG aberrant methylation cpg island cell cause consequence gene inactivity possibly frequently pose question arise study methylation associate chromo inactivation many gene inactive chromosome transcriptionally silence methylation lead prevailing notion methylation causal gene silence perhaps require main tenance inactive state recent study cell Dnmt1 delete mouse suggest methylation necessary proper inactivation potentially mediate methylation gene promoter nevertheless comparison chromo inactivation aberrant cpg island methylation cancer problematic feature fundamentally diver ent inactivation occur development organism aberrant cpg island methylation occur adult paediatric tumour cell inactivation program cellular process involve entire chromo aberrant cpg island occur deregulated cancer cell localise cpg island involvement island gene respect aberrant publish island methylation similar local mutation general defect involve deletion chromosome copy number change MECHANISMS aberrant island model cpg island become methylated cancer outline propose mechanism involve loss factor normally protect island methylation depend nature factor aberrant methylation cause consequence transcription inhibi tion protective factor successfully compete methyltransferase site island prevent methylation protective factor structural pro tein transcription factor example recognition site SP1 transcription bind find island mutation SP1 site transgenic mouse lead methylation transgene cpg island however mouse homozygous deletion SP1 gene island remain unmethylated certainly transcription factor ser",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 164,
                    "demethylation": 5,
                    "epigenetic": 6
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "elimi": 1,
                    "CACNA1": 1,
                    "CpG": 1,
                    "SP1": 2
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "elimi": 175,
                    "CACNA1": 175,
                    "CpG": 175,
                    "SP1": 175
                },
                "Ethnographic Terms": {
                    "methylation": 5,
                    "demethylation": 5,
                    "epigenetic": 5
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Methyl_CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.pdf",
            "cleaned_text": "Valle1 Espada Juan Cruz cigudosa1 Huang2 Spanish National Cancer Centre CNIO Melchor Spanish National Cancer Centre CNIO Ellis Fischel Cancer Center University 3corresponde author mail bind protein mediate histone deacetylasedependent transcriptional silence methylate cpg island use chromatin immuno precitation ChIP find prole exist hypermethylate promoter breast cancer cell common pattern tone modication share unique distribution also characterize chromosome comparative genomic hybridization immunopre cipitated DNA immunolocalization import antly demonstrate association methylate DNA serve identify novel target epigenetic inactivation human cancer com bin ChIP assay island microarray ChIP chip scenario reveal show many gene regulate multiple other associate single MBD target gene display methylation associate transcriptional silence breast cancer cell primary tumour candidate include homeobox gene PAX6 prolactin hormone receptor dipeptidylpeptidase other result support essential role gene silence combine genomic strategy potential catch new hypermethyl ate gene cancer ChIP methylationepigenetic DNA methylation major epigenetic modication mammalian genome play active role tional repression increase evidence emerge surround active role island hypermethylation tumour suppressor gene cancer development progression necessary step epigenetic pathway cancer involve methylcpg bind protein mediate transcriptional silence hypermethylated gene promoter mammalian family MBD protein compose member namely MeCP2 MBD1 MBD3 exception involve dna repair MBD protein associate histone deacetylase hdac couple dna methylation transcrip tional silencing modication chromatin Ballestar moreover recent research demonstrate presence MBD protein mediate transcriptionally silence state several promoter hypermethylate tumour suppressor gene cancer imprint chromosome inactivate gene normal cell essential issue concern physiological relevance existence different MBDcontaining repressor complexe straightforward explan ation complex target different subset gene understand speci role different inherent interest biochemically char acterize MBDcontaining complex thus far MBD3 bestcharacterize member family report integral component complex also contain nucleosome remodelling ATPase HDAC1 hdac2 protein Mammalian MBD3 contrast Xenopus homologue selectively bind methylate dna mammal complex target methylate DNA association form MBD2a combination synonymous MeCP1 complex rst identi display bind activity methylate dna complex also interact sequence speci dna bind protein cause transcriptional repression case MBD1 early report suggest hdacdependent repression recent datum indicate MBD1 repress transcription manner involve association novel chromatinassociated factor alternative approach understand biology MBD protein arise study target report association methylate locus reveal complex picture hand single association MBD protein methylate locus Magdinier describe however multiple recruitment MBD protein report several gene early study indicate methylcpg bind protein identify novel site epigenetic inactivation human cancer signicant difference association DNA instance MBD2MeCP1 release nucleus low salt suggest stably complexe DNA seem require densely methylate dna MBD1 also affect transcription ate hypomethylated promoter reason speci role MBD contain complex remain explore use chromatin immunoprecipitation chip antibody speci particular MBD together immunocyto logical analysis potentially provide powerful tool identify set gene control particular MBDcontaining complex therefore way stand individual role complex rst step determine target MBD protein genomewide context combine individualized study MBD ChIP assay several promoter tumour suppressor gene global genomic approach methylcytosine analysis product comparative genomic hybridization import antly also combine chip analysis cpg island microarray global pro target study show existence unique pattern site transform cell unmask new set epigenetically silence gene cancer result pro exist hypermethylate island promoter investigate involvement epigenetic repression initially adopt candidate gene approach study gene know hypermethylate breast tumour model specically breast cancer cell line MDA ChIP analyze perform use antibody raise epitope unique MBD protein mecp2 MBD3 recently validate antibody investigate recruitment MBD protein imprintedmethylated loci perform western blot analysis antibody cell line study ensure MBD protein indeed express Figure ChIP assay perform order identify particular MBD protein associate methylate dna sequence MDA cell additionally normal lymphocyte represent nontumoural noncultured cell non transform lymphoblastoid cell line also use negative control type dna sequence analyze island promoter tumour suppressor gene dna methylation expression status well characterize island imprint gene IGF2 insulinlike growth factor different repetitive sequence namely sat2 satellite NBL2 nonsatellite repeat tumour suppressor gene explore Ras association domain family gene RASSF1A glutathione transferase GSTP1 gene retinoic acid receptor gene breast cancer gene BRCA1 methylguanineDNA methyltransferase gene MLH1 summary methylation status promoter gene show figure MBD binding observe unmethylated promoter however speci pro occupancy find methylate cpg island present methylate GSTP1 promoter RASSF1A MeCP2 bind BRCA1 present Figure none select promoter association MBD1 MBD3 contrast promoter unmethylated lymphocyte lymphoblastoid cell line exhibit bind normal cell figure positive control association methylate region IGF2 imprint gene repetitive sequence Sat2 observe cell analyze MDA MCF7 normal lymphocyte lymphoblastoid cell line figure presence dna methylation MBD associ ation accompany histone deacetylation lysine histone methylation promoter figure restoration histone acetylation demethylation histone occur rapidly use demethylate agent Consistent result previous nding also find promoter unmethylated devoid enrich acetylate histone lysine demethylated Figure immunoprecipitate methylate dna candidate gene approach identify target necessary time consume therefore overcome drawback global screen target employ independent genomic approach use start material immunopre cipitated DNA rst analyze high performance capillary electrophoresis total dna content mbdimmunoprecipitated dna mcf7 cell average fold enrichment dna DNA input DNA observe figure strongly support notion MBD protein tightly associate vivo methylate dna sequence furthermore gradient dna content overall amount bind DNA observe protein bind high ratio methylate cytosine human genome MBD3 low figure result support differential distribution bind genome associate extensive chromosomal region explore distribution MBD protein particular chromosomal region use modication comparative genomic hybridization protocol label dna MDA immunoprecipitate one antibody competitively hybridize input dna cell Figure find MBDimmunopre Ballestar cipitated sequence see thick green segment karyotype unevenly distribute chromosome yield characteristic pattern broad megabaselength band figure noteworthy pattern banding differ obtain DNA competitively hybridize DNA extract normal cell see example discard artifact aneuploidy cancer cell remarkable nde result band share different also cell line study figure see inset instance common speci region chromosome band 22q recurrently enrich ChIP isolated sequence cell line figure see inset quantitative difference distribution however still apparent number region contain immunoprecipitated sequence high MBD3 segment obtain segment furthermore quantitative differ ence also observe breast cancer cell line chromosome MDA contain much high proportion sequence compare ecte high number hypermethyl Fig ChIP analysis occupancy MBD protein histone modication status several hypermethylate promoter antisera amecp2 aMBD3 test MDA nuclear extract left molecular size band prestaine standard Kaleidoscope BioRad indicate comparable result obtain MDA nuclear extract summary methylation status study promoter MDA extract occupancy analyse ChIP assay Input unbound fraction antibody control show follow bind fraction antibody ChIP assay show correspond MDA cell isolated lymphocyte result lymphoblastoid cell line undistinguishable obtain control lymphocyte group sequence show cpg island tumour suppressor gene imprint gene IGF2 repetitive sequence NBL2 Analysis acetylation status promoter commercial antiacetylH3 antiacetylh4 use cell azadC treat cell show analysis methylation status study antibody branched peptide nger dimethylate sequence use novel methylcpg bind target cancer ate cpg island present MCF7 Paz datum suggest tend cluster certain chromosomal loci observation consistent appearance nuclear domain obtain antisera immunolocalization experiment observe immunostaine antimbd antisera produce combine pattern discrete focus context diffuse nuclear stain datum show diffuse MBD pattern colocalize stain especially case MBD1 MBD focus also coincident spot datum show observ ation ect observed MBD nuclear distribution due architectural feature nucleus genome sequence pattern identify novel hypermethylate gene cancer resolution immunolocalization allow identication speci sequence associate MBD protein obtain accurate compre hensive gene target human breast cancer combine chromatin immunopre cipitation array technology ChIP chip genomic hybridization MBDimmunoprecipitated DNAs metaphase chromosome show combination comparative genome hybridization ChIP assay Ideograms show hybridization chip dna human karyotype thick vertical line side chromosome ideogram indicate recurrent enrichment green exclusion red chromosome chromo somal region green red line correspond respectively MBD1 inside analysis show correspond MDA sample inset show chromosome sample Fig Analysis global dna methylation hpce mbdimmunoprecipitated sample electropherograms correspond input fraction immunoprecipitate dna cell show graph show methylcytosine content fraction probe MDA DNA chip assay use different antisera describe dna microarray contain library island island microarray provide high throughput method identication vivo nuclear factor target demonstrate E2F independent island microarray inde pendent chromatinimmunoprecipitated sample perform MBD protein cell line purely quantitative standpoint produce high number positive clone support ing vitro datum show high nity methylate DNA follow MBD1 MBD3 MeCP2 figure array hybridization result spot cpg island show clone positive positive singly respectively Figure therefore datum indicate target sequence tend occupy single preferentially rather double triple occupancy order identify gene immunoprecipitate sequence cpg islandpositive clone common independent experiment subgroup immunoprecipitate subgroup immunoprecipitate unique MBD subgroup immunoprecipitate MBD3 last subset choose basis report regard MBD3 link MeCP1 complex summarize sequence datum blast search result list novel MBD target gene MDA breast cancer cell include excellent candidate gene malignant phenotype gene already associate cancer prolactin hormone receptor PRLR protein tyrosine phosphatase nonreceptor type dipeptidyl peptidase PIP5 essential con identi clone bind vivo result individual MDA cell antibody conrme result island microarray figure sequence immunoprecipitate antiserum result conrme use correspond commer cial antibody datum show negative control perform individual chip analysis isolated lymphoblastoid cell line find absent promoter gene association MBD protein conrme subset gene subject characteriza tion dna methylation expression bisul genomic sequencing span corresponding cpg island use demonstrate hypermethylation Representative microarray image different MBDimmunoprecipitated MDA sample cy5 label chromatin dna hybridize cpg island microarray describe text hybridization image acquire normalize signal intensity hybridize spot compare control total input show percentage total positive clone relative total input control obtain mbdimmunoprecipitated dna graph show percentage positive clone different combination MBD protein single MBD Conrmation MBD target individual chip analysis pcr primer design individual loci input antibody unbound fraction immunoprecipitate fraction bind show novel methylcpg bind target cancer correspond breast cancer cell line binding MDA figure furthermore result conrme methylationspeci PCR analysis figure dna extract isolated lymphocyte lymphoblastoid cell line also analyze methylation status gene bisul genomic sequencing methylationspeci PCR case gene unmethylate normal cell agreement absence bind previously demonstrate address functional consequence island promoter hypermethylation association bind perform expression analysis table MBD target identi ChIPCpG microarray analysis Gene Accession Location MBD present cell line mcf7 cell clone rp11403i13 al356957 also clone RP1199O17 AC018706 MeCP2 DKFZp686D16148 mecp2 also MDA AL035701 MeCP2 FLJ00132 AK074061 mecp2 shoygo ax09h10 BG941206 MBD1 also MDA bing4 NM005452 MBD1 clone RP11576P10 7p11p21 MBD1 pak2 clone RP177N19 Z98886 aj010277 1q23q24 MBD2 atp5i baa78778 also MDA cox6c p09669 MBD3 also LOC199704 XM113994 MBD3 leng6 AF211971 MBD3 also MDA clone AC012309 MBD3 stearoylCoA desaturase BAA93510 MBD3 pair box protein pax CAB05885 MBD3 also MDA mps A48045 also MDA cox6c P09669 MBD3 ptpn4 also MDA efna5 P52803 5q21 MBDs bcat2 nm001190 dppiv p27487 MBDs MDA cell clone image bg331429 pip5k BC007833 1q22q24 mecp2 FLJ32618 AK057180 mecp2 FLJ32618 AK057180 mecp2 FLJ32760 AK057322 mecp2 CS0DJ015YH07 al558734 mecp2 oatp AB031050 MBD1 clone YB67A06 af147380 ptprm NM002845 18p11 MBD1 clone RP1207F6 AL133258 NM021161 prlr NM000949 5p13 clone AL355178 clone RP13202B6 AL591625 bat5 NM021160 MBD3 dkfzp564e1878 hspc228 AL136684 MBD3 HSPC228 NM016485 6q24 MCF7 HSPC228 NM016485 6q24 mef2a NM005587 also af038461 MBDs Apolipoprotein precursor Apo P02649 also clone image bf509821 MBDs Beta crystallin crybb2 P43320 MBDs NM024709 MBDs Ballestar describe gene analyze case find gene unmethylated sequence MBD binding express hypermethylate gene transcriptionally silence latter case use azadeoxycytidine able restore gene expression figure furthermore demonstrate island hypermethylation merely feature particular breast cancer cell line present signicant proportion human primary breast carcinoma Figure gene PAX6 PRLR inhibit growth MDA cell gain insight potential role hypermethylate gene identi ChIP chip strategy genomic screening decide reintroduce gene MDA cell line carry hypermethylate tumour suppressor gene vector contain PAX6 independently use transfect MDA cell gene silence association methylation positive control growth inhibition use wildtype p53 mutant form p53 use additional negative control empty vector hour transfection cell select neomycin resistant colony develop stain expect wildtype p53 control dramatically suppress colony formation mutant p53 produce similar number colony empty vector figure interestingly find number neomycinresistant colony transfecte PAX6 reduce compare control vector independent experiment figure thus datum support hypothesis loss expression gene breast cancer cell relate cell growth Discussion estimate cpg dinucleotide mammalian genome methylate majority remain unmethylated cpg site locate cpg island find frequently promoter rst exon region proteincode gene cancer inhibition transcription hypermethylation island contribute inactivation regulatory dna repair gene propose MBD protein serve bridge histone modication enzyme hypermethylate DNA associate gene inactivation Bird Wolffe result support notion presence MBD protein essential general feature methylationmediate silence tumour suppressor dna repair gene First identi MBD protein select promoter previously characterize hypermethylated status Secondly general screen target use chromatin immuno precipitate probe cpg island microarray find positive clone study methylate Fig dna methylation expression analysis particular gene find use ChIP chip approach Bisul genomic sequence PRLR cpg island demonstrate hypermethylation MDA cell hypomethylation mcf7 cell contrary cpg island hypermethylate mcf7 cell MDA cell fragment sequence show become schematic representation site include PCR fragment show cpg site represent circle black methylate pcr conrm presence hypermethylation primary breast tumour number case show indicate summary table bisul sequence methylationspeci PCR result primary breast tumour dark light shading indicate methylation methylation respectively expression analysis monitor pcr amplication GAPDH panel top band GAPDH bottom band speci gene novel methylcpg bind target cancer interestingly candidate gene genomewide analyze distribution genome reveal complex picture instance pattern association appear gene speci sequence associate speci MBD other associate several see Figure table example mecp2 MBD identi association ENPP4 PIP5 K promoter other sequence apoe promoter NBL2 nonsatellite repeat find associated figure datum microarray hybridization suggest slight tendency single association association rather intermediate state double triple occupancy association MBD3 DNA constitute particularly interesting case mammalian MBD3 directly bind methylate dna propose mbd3containe complex recruit methylated sequence recruitment reason investigate pattern distribution chromo some cpg microarray clone similar however antisera recognize MBD2a subfraction antibody develop terminus mbd2a absent form therefore partial coincidence distribution MBD3 due fact antibody immunoprecipitate sequence global methylcytosine quantitation chromatin immunoprecipitate antibody immuno localization study strongly support notion protein truly associate vivo methylate sequence mention even MBD3 pull methylate dna probably due interaction possess high specicity methylate dna mbd3containe complex ability protein associate methylate DNA corroborate methylation analysis MBD target identi ChIP chip interestingly nding MBD protein partially colocalize methylcyto sine vivo suggest factor also participate nuclear localization MBD protein also support distribution metaphasic chromosome combine band pattern obtain sequence obtain chip chip see Table know methylate gene association demonstrate several locus however degree overlap complete instance gene BRCA1 coincide associate band identi hand conserved chromosomal band MBD protein appear associate coincide imprint centre well know methylation pattern Perk thus band pattern chromosome obtain ect distribution part due architectural feature nuclear organization Fig effect exogenous expression PAX6 PRLR colony formation MDA cell PAX6 PRLR methyl ationsilenced cell MDA transfecte PAX6 PRLR expression vector empty vector indicate material method relative number resistant colony transfection calculate percentage colony respect untransfected cell show inset effect exogenous expression wildtype mutant p53 also show chromatin immunoprecipit ate antibody different use hybridization probe island microarray ideal material identify novel gene become methylated cancer ChIP chip approach provide highthroughput method identify cpg island also worth note gene select characterization methyl ation expression status actually epigenetically silence success island microarray lead believe approach utilize systematically identify target hypermethylation cancer see also discovery novel hypermethylate gene use identify potential gene involve cancer instance rst hypermethylate gene ned candidate tumour suppressor absence mutation show recently possess function mouse knockout model cancer cell system one utilize high number sequence become methylate gene methylate tumour type instead clear specicity pattern methylate gene observe depend tumour type hypothesize genetic mutation preferential methylation certain gene confer Darwinian evolutionary advantage different cancer cell support idea show reintroduction identi gene inhibit colony formation therefore plausible many novel methylate gene identi approach good candidate provide advantage cancer cell expression lose case gene able identify approach instance prolactin receptor identi association cell previously report associate mammary gland differentiation summary integrate approach reveal existence speci pro differential occupancy hypermethylate cpg islandspromoter tumour suppressor gene transform cell singular pattern MBD bind determine rst single locus later whole genomic approach pro vide rst evidence ubiquitous presence methylate cpg island promoter demonstrate usefulness identify newly epi genetically inactivate gene cancer cell Materials method antibody cell line polyclonal rabbit antisera make linear peptide correspond ing amino acid human antiserum human human MBD3 ambd3 peptide common MBD1 isoform aMBD1 antibody test speci immunoprecipitate ability comparison target immunoprecipitate antibody commercial amecp2 also perform antibody MeCP2 also use chip assay MCF7 MDA cell cultured Dulbecco modi Eagle medium glucose glutamine supplement fetal bovine serum lympho cell line establish isolate lymphocyte whole blood gradient centrifugation cell resuspend supernatant B95 cell line produce EpsteinBarr virus RPMI medium contain fetal bovine serum phytohemagglutinin primary culture medium change day immunoprecipitation analysis ChIP assay perform previously describe timecourse experiment formaldehyde xation perform yield good combination vivo xed chromatin high dna recovery small average size chromatin fragment analysis chromatin shear average length pcr amplication perform speci primer analyse promoter promoter sensitivity pcr amplication evaluate serial dilution total dna collect sonication input fraction independent chip experiment perform cell line pcr amplication input DNA unbound wash fraction antibody control nally unbound bind fraction antibody run agarose gel Primers condition promoter available request Global methylcytosine quantication Quantication content carry high performance capillary electrophoresis previously describe brief immunoprecipitate dna sample speedback pre concentrated enzymatically hydrolyze nal volume sample directly inject high performance capillary electrophoresis apparatus content determine percentage total cytosine peak area peak area peak area competitive hybridization chip product metaphase chromosome study distribution chromosome immunopre cipitated DNA one protein design modi version strategy hybridization perform MDA cell line hybridization compare input dna fraction chip experiment immunoprecipitate DNA speci protein MBD1 MBD3 mecp2 input DNA label nicktranslation kit immunoprecipitated fraction label experiment conventional assay carry input dna cell line metaphase capture uorescent microscope BX60 camera Sensys camera analyse use image analysis system hybridization high number chromosome analyse Immunostaining confocal uorescence microscopy isolated nucleus MCF7 resuspend volume methanol xe min room temperature drop xed nucleus spot glass coverslip air dry min chromatin decondensation coverslips incubate HCl min brie wash water incubate min standard Trisborate buffer Nuclei rinse block doublestaine mouse monoclonal antibody conjunction rabbit polyclonal antibody indicate see confocal optical section obtain use TCS confocal microscope equip argon laser image process use cpg island microarray analysis immunoprecipitate fraction chip experiment label use probe microarray previously describe slide contain cpg island locus dna sample process essentially describe previously test sample include antibody control label cy5 red hybridize slide process accord method microarraysorg scan slide use GenePix 4000A Novel methylCpG bind target cancer Axon analyse image Pro4 program hybridization independent chip experiment perform MBD protein cell line Normalization apply use global average intensity hybridize locus slide positive clone do common positive clone independent hybridization experiment dna methylation analysis particular gene carry genomic DNA describe previously establish methylation status pcr analysis bisulmodi genomic dna use procedure First gene study analyse bisul genomic sequence corresponding cpg island describe elsewhere strand sequence second analysis use methylationspeci PCR gene analyse tissue sample previously describe DNA treat SssI methyltransferase use positive control methylate gene design bisul genomic sequencing methylationspeci pcr primer accord genomic sequence presume transcription start site investi gate gene Primer sequence pcr condition methylation analysis available request Semiquantitative pcr expression analysis reversetranscribed total rna treat use oligo primer Superscript reverse transcriptase carry pcrs volume contain pcr buffer MgCl2 primer use pcr amplication ampli gene multiple cycle number cycle determine appropriate condition obtain semiquantitative difference expression level pcr primer design different exon avoid amplication dna pcr perform simultaneously set primer GAPDH internal control ensure quality loading accuracy Primer sequence available request cell culture transfection MDA grow DMEM glucose supplement penicillin streptomycin amphotericin humidi CO2 incubator maintain log phase growth transfection psvgalactosidase control pcdnapax6 also contain neomycin resistance gene MDA cell perform lipofection method cell seed sixwell plate day transfection density cellswell plasmid dna transfecte reagent accord manufac turer recommendation experiment repeat time transfection bgal activity measure use bgal activity kit cell carry control vector clone express protein transfecte select complete medium supplement geneticin posttransfection stable clone maintain complete medium Total RNA individual clone extract PCR perform con clone express transfecte gene MDA cell also transfecte vector contain insert stable clone isolate selection stable g418resistant colony xe stain methylene blue methanol p53 pWZLhp53 mutant p53 use additional positive negative control ment grateful antiserum methylation provide detail specicity also thank antiserum like thank provide expression vector transfection experiment work support project fund bind domain protein repress transcription hypermethylate class glutathione transferase gene promoter hepatocellular carcinoma cell Biol Chem Ballestar Wolffe methylcpgbinde protein targeting speci gene repression repression belt brace chromatin Cell Cedar DNA methylation gene activity Cell Chatah proteincouple receptor activation induce membrane translocation activation phosphatidylinositolphosphate kinase Rac Rho dependent pathway Chen disruption hic1 predispose mice genderdependent spectrum malignant tumor nonrandom chromosomal gain loss multiple myeloma comparative genomic hybridization DNA methylation analysis mammalian cell Methods Osta release methylcpg bind protein histone deacetylase methylate human multidrug resistance gene MDR1 activation Mol Cell Biol Esteller cpg island hypermethylation tumor suppressor gene boom present bright future gene hypermethylation pro human cancer Cancer complex repress transcription preferential binding remodeling deacetylate methylate nucleosome Genes Dev Ballestar Delaval Hever histone lysine methylation mark regulatory region imprint mouse gene DNA methylation pro method application Montoya nity different MBD protein speci methylate locus depend intrinsic bind property Shimotake Ohki Chiba transcriptional regulation methyl bind protein MBD1 Mol Cell Biol Ichimura Saya transcriptional repression characterization family mammalian methylcpg bind protein Mol Cell Biol Hendrich closely relate protein MBD3 play distinctive interact role mouse development Genes Dev pcr novel pcr assay methylation status cpg island Zinger growth factor human cancer trend Endocrinol Metab Jones fundamental role epigenetic event cancer Bachelot Binart role prolactin growth hormone mammary gland development Heterogeneity modication involvement chromatin component island silence human CDH1 gene cancer cell histone lysine create bind site protein USA Magdinier association methylcpg bind protein silent p14p16 locus human neoplasia Bird active repression methylate gene chromosomal protein MBD1 Mol Cell Biol altered chromatin structure associate methylationinduced gene silence cancer cell correlation accessibility methylation mecp2 binding acetylation Nucleic Acids Res Velicescu lysine methylation associate aberrant gene silence cancer cell rapidly reverse azadeoxycytidine Cancer Res Ogata Hamaoka Effects overexpression PTP36 putative protein tyrosine phosphatase cell adhesion cell growth cytoskeleton HeLa cell Biol Chem Paz systematic pro dna methylation human cancer cell line cancer Res Paz Wei Genetic unmask epigenetically silence tumor suppressor gene colon cancer cell cient dna methyltransferase imprint mechanism regional control center peptidase inhibit cellular invasion melanoma cell Hendrich methylcpg bind protein cancer important MBDs Inhibition lung cancer cell growth induction apoptosis reexpression 3p21 candidate tumor suppressor gene SEMA3B cpg bind protein transcriptional repression complex couple dna methylation chromatin remodelling histone deacetylation Yan Oberley isolate human transcription factor target couple chromatin immunoprecipitation cpg island microarray analysis Genes Dev Xie Bartram overexpresse gene genetic alteration breast cancer cell use combination suppression subtractive hybridiz ation multiplex fish comparative genomic hybridization Int cpg island microarray identify colorectal tumor high degree concurrent methylation Methods Yoshikawa Matsubara Qian soc negative regulator pathway silence methylation human hepatocellular carcinoma show growth suppression activity ErdjumentBromage Tempst Bird subunit reveal histone deacetylase core complex connection DNA methylationgene Dev receive revise accept Novel methylcpg bind target cancer",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "epigenetic": 6,
                    "methylation": 34,
                    "demethylation": 1
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "MBD1": 6,
                    "MBDcontaining": 3,
                    "MBD3": 6,
                    "Mammalian MBD3": 1,
                    "NBL2 nonsatellite": 1,
                    "MBD1 MBD3": 2,
                    "NBL2": 1,
                    "Darwinian": 1,
                    "Semiquantitative": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "MBD1": 41,
                    "MBDcontaining": 41,
                    "MBD3": 41,
                    "Mammalian MBD3": 41,
                    "NBL2 nonsatellite": 41,
                    "MBD1 MBD3": 41,
                    "NBL2": 41,
                    "Darwinian": 41,
                    "Semiquantitative": 41
                },
                "Ethnographic Terms": {
                    "epigenetic": 22,
                    "methylation": 22,
                    "demethylation": 22
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Miscibility_ crystallinity and morphological behavior of binary blends of poly _ethylene oxide_ and poly _methyl vinyl ether_maleic acid_.pdf",
            "cleaned_text": "miscibility crystallinity morphological behavior binary blend polyethylene oxide polymethyl vinyl ethermaleic acid Federal Rio Janeiro bInstituto Estadual Campinas Campinas Sao Paulo receive receive revise form accept DSC optical microscopy use determine miscibility crystallinity blend polyethylene oxide polymethyl vinyl ethermaleic acid PMVEMAc Single observe blend indicate miscibility dependence weight cent present negative deviation linearity high content associate great blend free volume mobility exibility pure progressive decrease degree crystallinity size spherullite PMVEMAc add observe ftir provide evidence speci interaction polymer right reserve Blends Miscibility PEO Introduction Polymer solid electrolyte pse material great technological interest application solid state battery capacitor electrochromic device polymer electrolyte material charac terize interesting conductivity behavior highly dependent local structure uenced crystal lization ionic association rst studied polymer PSE PEO due fact easily dissolve alkali metal salt however possess ionic conduction appreciable 658C tempera ture peosalt electrolyte consist mixture spherullite crystalline phase separate amorphous solution salt ion conduction take place primarily amorphous region method improve conductivity base polymer matrix incorporation plasticizer make matrix liquid addition small molecule oligomer ethylene carbonate propylene carbonate plasticizer facilitate long chain segmental motion however serious disadvantage plasticizer volatile room temperature lead loss sample effort enhance ionic conductivity solid electrolyte base focus suppress crystallization incorporate compound low copolymerization macromonomers Copolymerization way low melting point modulus well crystallinity increase solubility transparency possible alternative graft crosslinke novel approach promise fact preparation require nontrivial synthetic process serious drawback practical appli cation considerable importance develop easy method prepare polymer electrolyte high ionic conductivity dimensional stability regard recent work preparation polymer electro lyte blend polymer interest Blend ing polymer economic quick alternative obtain material optimize property main advantage blendbased system simplicity preparation easy control physical property compositional change much work do binary peobased blend second component non crystalline able inhibit crystallization blend thermal mechanical adhesive property associate high transparency opti mize depend noncrystalline polymer property desire application device optimize deposition cast electrode Polymer see front matter right reserve Corresponding author Fax mail address cast method allow obtain PSE lm less thick diminish time response device important consideration choice blend component intermolecular interaction consider play key role polymer miscibility well report basic oxygen good protonaccepte polymer permit hydrogenbonde interaction blend proton donor polymer work part study development group new host pse base crystal linity reduce blend obtain nanocomposite study investigate miscibility binary blend base pmvemac second polymer selfassociate hydrogen bond pure state capable hydrogen bonding basic oxygen polymethyl vinyl ethermaleic acid pmvemac mol mol supply utilize preparation pmvemac ratio dissolve methanol solution stir Films prepare cast solution preheat glass plate dry constant weight dessicator vacuum differential scan calorimetry DSC evaluate miscibility thermal behavior blend DSC measurement perform General apparatus apparatus indium standard nitrogen atmosphere Samples rst heat 1508C heating rate run min isotherm sample cool 21008c rate run heat run III melting temperature apparent melting DHm determine DSC endothermic peak second heating run transition temperature estimate onset temperature melt enthalpy temperature derive area maxi mum endothermic peak respectively degree crystallinity calculate follow equation blend DHmblend DHo PEO DHmPEO DHo PEO DHmblend DHmPEO apparent melting enthalpy gram blend present blend respectively DHo heat melting gram crystalline morphological study sample deposit glass plate analyze optical microscopy cross polars Fourier transform infrared spectroscopy ftir ftir measure sample prepare cast directly NaCl pellet lm dry vacuum FTIR spectra obtain spectro meter room temperature twentyeight scan take resolution gain sample curve peopmvemac blend recorded heating rate Schematic plot determination result discussion DSC blend prepared describe transparent include rich Blends present elas ticity pure adhere well glass property desirable application pse DSC curve show ampli glass tran sition temperature evident Table glass transition temperature glass transition width melt tempera ture DHmblend dhmpeo crystallinity degree sample show glass transition temperature observe sample indicate miscibility limit detection DSC technique glass transition width sample rich pmvemac attain high value observe Table transition width ne difference onset endset glass transition process illustrate Fig ect number relaxation process associate glass transition system exhibit microenvironment cause dipoledipole inter action hydrogen bonding undergo relaxation process different relaxation time result e broaden glass transition value DTg range 308c expect semicrystalline homopolymer observe pmvemac value 768C ect heterogeneity molecular level chain region rich ether group region rich acid group different chain region undergo different relaxation time cause broaden observe factor explain high value observe pmvemac hydrogen bond intra interchain arrangement sample rich PMVEMAc observe attain high value associate intrinsic characteristic copolymer however presence broad affect determination glass transition temperature system utilize describe dependence composition blend Fig one empirical equation describe dependence blend composition miscible system mass percentage glass transition temperature polymer respectively see observe increase PMVEMAc composition dependence calculate blend composition exhibit positive deviation respect linearity equation describe behavior rather poorly valid ideal mixture assume homo geneous heterogeneous interaction equivalent exothermic mixture interaction differ ent polymer favor condition hold blend study see strong evidence miscibility experimental data however present negative deviation respect linearity associate great blend free volume mobility exibility pure Fig decrease 728C pure 648C Rocco Polymer Table Thermal property peopmvemac blend DTg DHmblend DHmPEO PEO Fig dependence peopmvemac blend weight cent Fox equation prediction blend see melt tempera ture obtain likely correspond equi librium melt temperature rather ect morphological aspect crystal size defect crystal line phase also thermodynamic aspect morpho logical aspect determine crystallization kinetic uence morphological analysis evident tendency lower increase pmvemac concentration blend indicate miscibility decrease great decrease 588C PMVEMAc addition consistent observe noncrystallinecrystalline polymer blend phase diagram blend show melt point line liquid phase present line crystal together PEOPMVEMAc noncrystalline phase coexist line crystalline phase coexist glass homogeneous peopmvemac phase visco elastic region phase diagram comprehend great range temperature necessary intend application system analysis optical photomicrograph show large crystal sample contain progressive reduction size crystal see pronounce high concentration pmvemac sample contain crystal see resolution magnication utilize result base DSC optical microscopy indi cate crystallinity sample reduce addition PMVEMAc inhibit crystallization obvious modication kinetics crystal formation depression melting point indi cat negative FloryHuggins interaction parameter x12 polymer component decrease melting point crystallizable compo nent miscible blend thermodynamically describe indicate negative interaction parameter x12 polymer decrease crystallinity change composition amorphous phase blend reinforce explanation negative deviation linearity experimental datum ftir DSC study conclude PMVEMAc blend miscible report ether good proton accept polymer make hydrogen bonding possible Fig Dependence dhm peopmvemac blend weight cent photomicrograph blend PEOPMVEMAc Bar represent blend protondonating polymer polymer use work present acid group proton donor play important role bility peopmvemac blend show ftir spectra pure polymer blend composition study hydroxyl region easily amenable quantitative evaluation vibrational overlap possible change absorption coefcient frequency free self interasso ciated component however pure pmvemac present carbonyl group yield stretching mode center shoulder probably due contribution free bind CyO respectively carbonyl stretching band function composition blend show blend pmvemac clear decrease shoulder intensity probably due decrease concentration bind carbonyl group time see peak maximum shift high wavenumber stretching mode center probably group PMVEMAc form hydrogen bond basic oxygen atom free CyO group previously involve intramolecular hydrogen bond result solubility dilution pmvemac spectra range pure blend show crystalline phase presence triplet peak stretching vibration maximum change intensity shape position stretch mode associate inter action pmvemac decrease position stretch maximum note Fig ftir spectra pure pure pmvemac PEOPMVE MAc blend structure hydrogen bond interaction pmvemacpmvemac peopmvemac molecule Fig ftir spectra carbonyl group region pure pmvemac peopmvemac blend Fig ftir spectra record pure frequency range increase pmvemac concentration stretch mode lie cm21 broaden band particularly high pmvemac content also observe intensity peak cm21 decrease probably due decrease crystallinity blend observe calculated degree crystallinity result indicate intermolecular hydrogen bonding ether oxygen acid group form consistent shift see previously region stretch spectrum MAc however hydroxyl region easily amenable quantitative evaluation work qualitative study vibrational mode change do motivated preliminary study CyO mode present spectra hydroxyl stretching region pmvemac peopmvemac blend large vibrational band due group stretch pure pmvemac center band attribute contribution stretch vibration free selfassociated hydrogen bonding hydroxyl group pure pmvemac weak band acid group dimer observe justi presence selfassociation interaction blend polymer add peak origin ally shift gradually low wavenumber reach cm21 PEO Peak change indicate free selfassociated group decrease bene formation interassociate hydrogen bond basic oxygen high composi tion group pmvemac probably randomly distribute increase number group statistically favor formation interassociate interaction weak interaction molecular level ftir study provide strong evidence speci interaction pmvemac molecule favor bility blend time responsible increase value conclusion study peopmvemac blend use DSC show single value intermediate pure constituent indicate miscibility study dependence weight cent present negative deviation linearity high content associate great blend free volume mobility exibility pure presence MAc blend hinder crystallization thus decrease calculated degree crystallinity size spherullite depress melting point system result present clearly show pmvemac blend miscible entire range composition study molecular level miscibility PMVEMAc mainly attribute intramolecular hydrogen bond result obtain system consider promissory matrix pse ment author like thank CNPq fellowship Appl Meneghelo Paraventi Rudge Gottesfeld Rocco Electroanal Chem editor solid state electrochemistry Press Armand editor elec trolyte Elsevier applied science solid state Ionics Harvey solid state ionic Chintapallis Grad Polymer Polymer Polym Sci Polym Lett Eur Polym fish Xia Smid Makromol Chem state ionic solid state ionic Przyluski Florjanczyk synth Met Anal Cal Fig ftir spectra hydroxyl group region pure pmvemac peopmvemac blend MJF Coleman Graf painter Speci interaction bility polymer blend Technomic Publishing Cimmino Macromolecules Eur Polym Polym Phys Polyethylene oxide spectroscopy 2nd Publishing Macromolecules",
            "term_counts": {
                "Mental Health Terms": {
                    "depression": 1
                },
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "DHmPEO": 1,
                    "noncrystallinecrystalline": 1,
                    "PEOPMVE": 1
                }
            },
            "co_occurrence_matrix": {
                "Mental Health Terms": {
                    "DHmPEO": 1,
                    "noncrystallinecrystalline": 1,
                    "PEOPMVE": 1
                },
                "Ethnographic Terms": {
                    "depression": 3
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Monitoring Biodegradation of Methyl tert-Butyl Ether _MTBE_ Using Compound-Specific Carbon Isotope Analysis.pdf",
            "cleaned_text": "monitor Biodegradation Methyl tertbutyl ether MTBE use Waterloo Waterloo Ontario Canada Methyl tertbutyl ether common gasoline oxygenate frequently detect surface water groundwater aim study evaluate potential compoundspecific isotope analysis assess situ biodegradation groundwater purpose effect relevant physical biological process carbon isotope ratio evaluate laboratory study carbon isotope fractionation organicphasegasphasepartitioningaqueous phasegasphase partitioning organic phaseaqueousphase partitioning small comparison carbon isotope fractionation measure biodegradation microcosms base aquifer sediment site experiment substrate cometabolic experiment primary substrate become enrich degradation experiment similar isotopic enrichment factor obtain Biodegradation TBA accumulate transiently cometabolic microcosms also accompany carbon isotope fractionation isotopic enrichment factor study suggest carbon isotope analysis potential tool trace situ biodegradation TBA thus well understand fate contaminant environment introduction many industrialized nation attempt minimize air pollution vehicular emission use reformulate gasoline approach addition methyl tertbutyl ether gasoline initially octane enhancer elimination tetraalkyl lead mid1990s widely use fuel oxygenate reduce emission low ground ozone level beneficial atmosphere become frequently detect environmental contaminant detect urban air surface water shallow groundwater estimate release leak underground storage tank MTBE affect quality drinking water strong taste odor possible carcinogenic effect result issue drinking water advisory much great solubility water gasoline compound concern BTEX example solubility reformulate gasoline volume solubility benzene conventional gasoline sorb weakly solids appear difficult biodegrade travel nearly unretarded groundwater long plume dissolve frequently observe several laboratory study biodegradation aerobic bacteria observe other report recalcitrant particularly anaerobic condition Biodegradation occur presence cosubstrate linear branch sole carbon energy source degradation fungus also report route initial transformation propose figure direct transformation tertbutyl alcohol TBA transformation tertbutyl formate subsequently undergo abiotic biotic hydrolysis tba abiotic hydrolysis fast process halflife day neutral temperature initial transformation carbon methoxy methyl group andthecarbonofthetertbutylgroupmaybefurtheroxidize co2 biodegradation often observe laboratory experiment less evidence biodegradation field site possibly due lack adequate tool monitor biodegradation frequently migrate long distance degradation rate low difficult assess biodegradation base concentration use mass balance approach furthermore occurrence TBA stable intermediate product reliable indicator biodegradation biodegradation occur significant TBA accumulation TBA already present gasoline well mean obtain evidence situ degradation great value investigation fate environment evaluate performance biodeg radationbase remediation technologie potential tool monitor situ biodegradation organic contaminant determination compound specific isotope ratio contaminant method fax mail FIGURE propose pathway initial transformation methyl tertbutyl ether tertbutyl formate tertbutyl alcohol TBA Environ Sci Technol environmental science technology VOL es001338w Published Web show promise gain insight origin fate chlorinate solvent aquifer method rely occurrence kinetic isotope effect inorganic organic compound whereby molecule light isotope react fast molecule compound heavy isotope result characteristic difference isotope ratio sor product occur isotope fractionation precursor becomes increasingly enrich heavy isotope degradation proceed large shift carbon isotope composition remain contaminant observe reductive dechlorination chlorinate ethene aerobic oxidation dichloromethane aerobic oxidation dichloroethane contrast small shift occur biodegradation aromatic hydrocarbon reason difference fact kinetic isotope effect mainly occur respect atom bond form break initial transformation step measurement yield average isotope ratio atom element compound therefore enrichment heavy isotope likely detectable small molecule give TBA contain carbon atom respectively reasonable expect detect able carbon isotope fractionation degradation stable isotope analysis diagnostic depend occurrence kinetic isotope effect biodegradation also nitude potential isotope fractionation associate physical process affect organic contaminant concen tration groundwater previous study isotope frac tionation volatilization sorption chlorinate solventsandaromatichydrocarbonshavesuggestedthatonly small carbon isotope fractionation occur process study method carbon isotope analysis develop occurrence magnitude carbon isotope fractionation evaluate biodegradation partition organic phase aqueous phase gas phase effect sorption isotope ratio investigate sorb weakly aquifer solid biodegrada tion study include microcosm amend microcosmswithmtbeand3methylpentaneascosubstrate cometabolic microcosm isotope ratio cumulate also determine evaluate TBA degradation accompany isotope fractionation partition experiment mixture vol use aromatic compound toluene important gasoline constituent typically add gasoline vol experiment perform organic phaseaqueous phase partition experiment organic phase dispense vial contain organicfree water magnetic stirrer displace equivalent amount water entire experiment include addition organic phase vial keep upside prevent contact organic phase Teflonlined septum needle sampling stir aqueous phase remove ratio dissolve determine use method describe organic phasegasphase partition experiment organic phase mixture dispense vial fill helium close open screw capcontainingaTeflonlinedseptumThevialwaskeptunder static condition gas phase remove ratio determine use method describe aqueous phasegasphase partitioning add bottle complete fill close open screw cap contain Teflonlined septa stir headspace introduce replace aqueous solution helium bottle place upside rotary shaker rpm headspace sample analyze ratio use method describe aerobic microcosmenrichmentsinvestigatedinthisstudywerebased original MTBEdegrading aquifer microcosms original microcosms prepare use aquifer sediment groundwater aquifer shallow sandy unconfined aquifer locate assess potential biodegradation site study degradation absence cosubstrate occur microcosm lag period day suggest metabolize microorganism relatively rare site microcosm sterile control significant change concentration occur active microcosm use study microcosms sand groundwater originally prepare use material zone slug groundwater pass use material uncontaminated zone aquifer microcosm sand groundwater sand slurry parent microcosm divide replenish site groundwater amend withmtbeand mineralmedium follow parent microcosms split generation microcosms sand groundwater twice amend mineral medium second generation microcosm pair split third generation microcosms sand groundwater use study parent microcosm split generation microcosms sand groundwater amend time mineral medium study second generation microcosm replenish groundwater total volume mineral medium second third generation microcosm contain screwcap bottle seal screw cap Mininert valve Vici Precision Sampling incubate dark room mineral medium use study contain K2HPO4 KH2PO4 nh4no3 CaCl22H2O fecl3 repeat addition undoubtedly increase population degrader relative native population lead modification indigenous condition well recognize refer sand groundwater contain microcosm use study microcosm enrichment outset experiment report microcosm enrichment amend filter sterilize stock solution concentration addition bottle initially shake rpm allow settle initial sample take thereafter microcosm enrichment incubate shake dark room temperature sample microcosm water obtain periodically use glass syringe sample preserve mercuric chloride analyze immediately vol environmental science technology concentration store later TBA concentration analysis carbon isotope analysis contrast MTBEmetabolizing microcosms alkanedegrade sys tem evidently cometabolize readily initiate aquifer sediment study series aerobic microcosm prepare aquifer material never expose methylpentane alkane choose use primary substrate microcosm condition sterile control methylpentane prepare duplicate micro cosms consist screwcap bottle equip valve closure contain aquifer sand groundwater mineral medium filtersterilize stock solution provide initial concentration methylpen tanecontaine microcosm also inject neat methylpentane initially additional time immediately follow analysis experiment use gastight glass syringe additional mineral medium add include sterile control microcosms day sterile control microcosm contain aquifer sand autoclaved groundwater poison azideandwereamendedwiththeMTBEstock solution mineral medium methylpentane microcosm incubate sample describe previous section analysis concentration aqueous sample dispense screwcap vial Teflonlined septum equilibrate headspace gas inject gas chromatograph equip capillary column flame ionization detection Concentrations TBA determine microcosm pair inject aliquot aqueous solution 5840A gas chromatograph Agilent equip flame ionization detector column pack Carbopack mesh Oakville Canada detection limit TBA relative standard deviation TBA Isotope Analysis stable isotope analysis perform use gas chromatography combustionisotope ratio mass spectrometry system system consist Agilent Agilent Palo Alto splitsplitless injector combustion interface operate Isochrom mass spec trometer determine previously describe dissolved extract solidphase microextraction use use previous study quantify dissolve low concentration vial volume choose minimize require samplesizeandsinceithasbeenshownthatwhenextracte immerse fiber aqueous phase direct extraction efficiency high small vial extraction solution remove thecompletelyfilledvial2mLtoavoidcontactofthesample fiber holder extraction perform continuously stir sample practical reason extraction time limit min even high extraction efficiency reach use long extrac tion time splitless injection commonly use method result tail split injection use small split ratio use minimize loss sensitivity regard analysis future field sample additional test perform aim decrease minimal require concentration purpose effect add NaCl common method improve extraction efficiency use headspace investigate volatile semi volatile compound high amount compound extract headspace direct give extraction time mass transfer compound fiber fast gas phase aqueous phase contrast less volatile compound mass transfer headspace becomes limit headspace provide advantage compare direct headspace vial use increase amount compound available extraction prior extraction standard solution remove sample stir min rpm magnetic stirrer promote partition compound headspace afterward fiber expose headspace sample min stir rpm test degree carbon isotope fractionation aqueous phase fiber evaluate describe detection limit determine calculate require concentration obtain peak height low end linear range 13C12Cratios report usual delta notation value define ratio sample international standard VPDB Vienna Peedee Belemnite respectively sample analyze obtain value correct isotope fractionation extraction describe ref average report TheanalyticalsystemwasverifieddailyusingMTBE dissolve uncertainty measurement Quantification Isotope Fractionation partition experiment phase present Isotope fractionation phase quantify use follow equation isotopic enrichment factor 13Cy carbon isotope ratio phase respectively initial carbon isotope ratio fraction phase test phase present aqueous phase fiber coating gas phase however amount TBA gas phase negligible direct headspace therefore isotope fractionation tween aqueous phase fiber coating also quantify use use evaluate isotope fractionation remain constant experiment quantify isotope fractionation simplified equation use apply enrichment factor initial isotope ratio substrate isotope ratio remain fraction substrate isotopic enrichment factor result Isotope analysis use extract TBA deplete compare dissolve TBA yx 13Cy 13Cy 13cs environmental science technology VOL table magnitude isotope fractionation similar condition previous study depletion observe extraction organic acid use polar fiber significant carbon isotope fractionation occur extraction chlorinate solvent use polydimethylsiloxane fiber require concentration carbon isotope analysis lowerforMTBEthanTBAAdditionofNaClstronglydecreases detection limit TBA less effect MTBE Headspace SPME lead low detection limit detection limit TBA high comparable condition direct isotopefractionationduringpartitioningprocesse partitioning process evaluate study magnitude enrichment factor depend demonstratesthat isotope equilibrium reach rapidly gas phase enrich compare organic phase similarly gas phase slightly enrich compare dissolve water effect minimal significant isotope effect occur partition organic aqueous phase Isotope Fractionation microcosm enrichment substrate degrade figure similar concentration profile observe duplicate microcosms TBA detect microcosm pair low concentration microcosm enrichment degradation begin lag period day microcosm enrichment degradation start immediately add similar con measure duplicate microcosm enrich ment isotope ratio determined micro cosm pair pair pair isotope ratio determine microcosm similar result obtain microcosm microcosmenrichmentsthe13cofmtbesteadilyincreased total shift degradation observe sterile control significant change concentration MTBE observe cometabolic microcosms complete degradation take long TBA accumulate transiently figure sum TBA concentration start decrease day TBA concentration day indicate TBA consume cosubstratefree microcosm concentration maine constant experiment confirm degradation take place presence cosubstrate become enrich similarly microcosm enrichment sig nificant change MTBE observe 13cofinitial TBA large MTBE figure day table isotopic enrichment factor Confidence Interval Extraction MTBE TBA Solid Phase Microextraction Minimal Required Concentration CMin Carbon Isotope Analysis MTBE TBA conditionsa Efw CMin pbb CMin pbb direct direct direct headspace extraction modevial volumenacl table Organic PhaseGas phase Ego aqueous PhaseGas phase Egw Organic PhaseAqueous phase Ewo Partitioning MTBE Confidence Interval hour Ego Egw Ewo Egw Ewo figure Concentration MTBE concentration TBA open marker MTBE microcosm enrichment sole carbon energy source 2ii sterile control uncertainty measurement correspond approximately size marker figure leave concentration MTBE fill diamond TBA open diamond microcosm methylpentane primary substrate sum TBA crosshair equivalent Right concentration MTBE sterile control square microcosm cosubstrate fill triangle theuncertaintyofthe13cmeasurementcorrespondsapproximately size marker vol ENVIRONMENTAL science TECHNOLOGY 13c TBA steadily increase indicate degrade evaluate enrichmentfactorsformtbedegradationremainedconstant experiment compare enrichment factor different experiment 13c value wereplottedagainstlnffigure4andtheenrichmentfactor quantify base use linear regression similar enrichment factor observe cometabolic microcosm microcosm enrichment substrate table enrichment factor value enrichment factor TBA degradation estimate base value TBA complete degradation period TBA probably control TBA degradation affect TBA production degradation enrichment factor obtain TBA degradation discussion analytical test demonstrate couple sensitive method analyze carbon isotope ratio detection limit advisory limit method less sensitive TBA reduction detection limit require field measurement TBA concentration typically low concentration detection limit low headspace direct TBA direct sensitive different behavior ofthetwocompoundscanbeexplainedbythelowervolatility dissolve TBA compare dissolve low volatility TBA slow mass transfer TBA aqueous phase headspace probably limit extrac tion efficiency headspace partition experiment demonstrate carbon isotope fractionation partition organic aqueous gas phase small large effect occur organic phasegasphase partitioning whereby molecule slightly volatile moleculeswith carbon previously report evaporation chlorinatedsolventsandaromatichydrocarbonsfrom pure nonaqueous phase origin explainedusingprinciplesofstatisticalthermodynamic furthermore small inverse isotope effect respect carbon also observe aqueous phasegas phase partition chlorinate solvent enrichment factor partitioning process relate use follow equation calculated gw agree measured go range uncertainty Table demonstrate measure enrichment factor consistent biodegradation MTBE TBA significantly increase experiment demon strate reaction rate slightly fast molecule molecule good correlation biodegradation TBA Figure Table indicate enrichment factor remain constant experiment similar observation previously make isotope fraction ation associate reductive dechlorination chlorinate ethene oxidation dichloromethane toluene dichloroethane enrichment factor degradation similar microcosm enrichment substrate cometabolic microcosm Table due similarity enzymatic mechanism use bacteria initial transformation range enrichment factor obtain aerobic anaerobic oxidation toluene small enrichment factor observe biodegradation chlori nate solvent reaction rate slightly fast bond molecule product expect deplete relative precursor previously observe biodegradation chlorinate solvent however study relationship observe initial whereby TBA enrich compare apparent contra diction arise kinetic isotope effect occur mainly respect bond form break initial transformation step isotope analysis yield average carbon atom molecule case MTBEtheinitialtransformationstepinvolvesonlythecarbon methoxy methyl group independent reaction mechanism use figure group remove transform TBA TBA expect reflect isotope effect associate transformation rather mainly reflect thetertbutylgroupinmtbeandisotopefractionationduring biodegradation TBA sum TBA concentration decrease TBA become positive time confirm degrade degradation accompany carbon isotope fraction transformation transformation TBA probably ratelimiting step min eralization accompany significant carbon isotope fractionation implication isotope analysis potentially use trace biodegrada tion organic contaminant field site isotope fractionation associate biodegradation much large thanisotopefractionationassociatedwithphysicalprocesse furthermore shift isotope ratio due biodegradation also large variation isotopic com figure Rayleigh type plot microcosm enrichment fill circle fill square fill triangle cometabolic microcosm open diamond line calculated isotope ratio use average enrichment factor experiment uncertainty measurement correspond approximately size marker table enrichment factor culture compound stdev MTBE MTBE MTBE MTBE MTBE TBA go gw environmental science technology VOL position spill compound occur gasoline enter subsurface leak storage tank prolonged period time important physical process gasoline advective dispersive trans port aquifer solid volatilization aqueous phase minor importance low organic carbonwater partitioning coefficient low TBA originate degradation advective dispersive transport probably important physical process affect concentration dispersion expect significantly affect isotope ratio dissolve com pound datum present study demonstrate dissolution organic phase companie significant carbon isotope fractionation least equilibrium condition thus physical process expect lead significant change dissolve contrast biodegradation accompany systematic shift value significant shift time uncer tainty measurement occur degradation TBA degradation base enrichment factor determine study kinetic isotope effect probably mainly occur respect carbon methoxy methyl group even small fraction detect positionspecific isotope analysis however purpose method remove recover methoxy methyl group isotope fractionation develop analytical method develop study make possible determine compoundspecific value concentration advisory level therefore well suited practical application conclusion study show compoundspecific isotope analysis TBA potential tool trace situ compound thus contribute well understand fate TBA environment acknowledgment project support grant NSERC author thank support measurement literature cite Zogorski Richards Pankow Goldman Scholl Seyfried Environ Sci Technol Squillace Zogorski Zogorski Mackay Wilson Proceedings petroleum hydrocarbon organic chemical groundwater prevention detection remediation conference reme fall Salanitro Appl Environ Microbiol Wanken Javanmardian Yang Biotechnol Zhang Microbiol Microbiol fate dissolve methanol methyltertiarybutylether monoaromatic hydrocarbon shallow sand aquifer Mormile Liu Suflita Environ Sci Technol Water Environ Res Hardison Curry Ciuffetti Hyman Appl Environ Microbiol Tratnyek Environ natural attenuation subsurface methanogenic condition Environ Sci Technol Heraty Environ Sci Technol Geochem Heraty Fuller Sturchio Org Geochem Hunkeler Aravena Appl Environ Microbiol Richnow Drever Heraty Holt Org Geochem Harrington Poulson Drever Org Geochem Butler Schirmer Barker MTBE Biodegradation Workshop EPA Office Research Development American Petroleum Institute Mariotti Letolle Tardieux Tardieux Plant Soil Physicochim Biol receive revise manuscript ceive Accepted November es001338w vol ENVIRONMENTAL SCIENCE TECHNOLOGY",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "contra": 1,
                    "Heraty": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Nonflammable methyl nonafluorobutyl ether for electrolyte used in lithium secondary batteries.pdf",
            "cleaned_text": "Nonammable Methyl Nonauorobutyl Ether Electrolyte use Lithium Secondary Batteries Juichi Arai Hitachi Limited Hitachi Research Laboratory Ibarakiken Use nonammable methyl nonauorobuyl ether study develop inherently safe electrolyte lithium secondary battery ash point NFP solution prepare mix proper amount common electrolyte solvent dimethyl carbonate ethyl methyl carbonate NFP electrolyte obtain dissolve organic lithium salt SO2C2F5 LiBETI NFP solution cell capacity NFP electrolyte mol LiBETI MFEEMC vol limit process graphite anode Electrolyte component investigate term modify solid electrolyte interface improve performance cycle life NFP electrolyte add cyclic carbonate ethylene carbonate electrolyte reduce interfacial resistance graphite cell cylindrical cell add electrolyte discharge capacity current rate capacity keep initial capacity cycle current rate room temperature effect additive chargedischarge capacity graphite cell also investigate term electrochemical spectroscopy ray photoelectron spectroscopy solidstate 7Li nuclear magnetic resonance attenuate total reection infrared spectroscopy right reserve Manuscript submit revise manuscript receive Available electronically Lithium secondary battery indispensable power source portable electronic device also develop power electric vehicle EVs lithium secondary battery quire organic solvent high oxidation durability elec trolyte operate oxidation voltage water organic electrolyte solvent safety concern lithium secondary battery due high ammability stance ethyl methyl carbonate common electrolyte solvent use battery ash point commercial lithium battery rmly base safety device positive temperature coefcient thermal switch device current intermitted device CID low critical issue safety battery crush thus inherently safe battery desire use ash point NFP nonammable electrolyte challenge development nonammable electrolyte make use reretardant additives6 nonam mable solvent Depression heat generation elevat temperature add electrolyte measure accelerate rate calorimeter ylphosphate investigate retardant nonammable solvent add TMP conventional electrolyte depress burn rate accord UL94based examination use TMP cosol vent electrolyte mixture volume reduce heat generation cell CH4 gas generation charge graphite anode due decomposition TMP critical issue application approach effectively improve safety lithium secondary battery electrolyte still thus possibility burst ame idea inherently safe battery use nonammable solvent main component electrolyte reduce mability eliminate investigate triuoropropylene carbonate carbonate clec mixed sol vent electrolyte low cosolvent eliminate electrolyte use nonammable solvent methyl non auorobuyl ether MFE main component electrolyte solvent vol mixture LiBETI linso2c2f5mfeemc vol repre sentative novel electrolyte propose use electrolyte investigate cycle life cylindrical cell cell discharge almost capacity mah cell use vol rate though discharge less mah rate well safety obtain use electrolyte demonstrate nail test cell use electrolyte show thermal runaway nail penetrate even cell overcharge discharge capacity fade signicantly cycle cycle life test rate paper focus improvement cell performance use modify electrolyte component enhance li1 transport rate solid electrolyte interface term add cyclic carbonate present performance LiBETI MFEEMC vol modied electrolyte graphite cell electrochemical impedance spectroscopy solid state 7Li nuclear magnetic resonance nmr ray photoelectron spectroscopy attenuate reection infrared spectroscopy measurement make analyze lithium intercalate state graphite anode lm electrode cell use modied electrolyte cell performance include rate capability cycle life cylindrical cell study electrolyte additive structure electrolyte solvent show Fig MFE semiuorinate ether main component NFP electrolyte physical property summarize Table datum comparison feature NFP also wide temperature range liquid phase low viscosity low surface tension desirable property electrolyte solvent high density due uori nate group mix well solvent low dipole moment dimethyl carbonate diethyl carbonate obtain NFP mixed solution linear carbonate certain mixing ratio sum marize table study choose cyclic carbonate electrolyte additive order improve cell performance cause cyclic carbonate know lm precursor miscibility limit Member mail a219a228 A219 license place see ecsdlorgsitetermsuse address Redistribution subject term use see Electrolyte preparationsthe electrolyte prepared mix volume percent dissolve lithium bispentauoroethylsulfo nyl imide Company adjust concentration additive ethylene carbonate propylene carbonate butylene carbonate purchase ylvinylene carbonate provide also use additive electrolyte preparation storage do lle glove box keep less dew point water vacuum dry prior use cell fabrication electrochemical ode prepare coating dry methyl pyr rolidone paste compose synthetic graphite poly vinylidene uoride pvdf binder copper foil cathode form aluminum foil coating dry paste contain graphite conduct supporter test cell semble cm2 electrode thick polyethylene separator cylindrical cell fabri cat connect roll electrode separator put cell electrolyte inject separately degas cell performance test cell measure battery controller measurement test cell carry use SI1260 impedancegainphase analyzer control com puter instal processor measurement software Corrware measurement make performance value cylindrical cell measure battery controller Spectroscopic measurements7LiNMR spectra graphite tercalated sample obtain spec trometer magic angle spin single pulse mode aqueous solution LiCl use external standard spinning speed khz achieve sample sis electrode surface run test cell carry Scientic ESCALAB spectrometer ultrahigh vacuum ray source use sample dry vacuum prior measurement remove residual solvent bind energy neutral peak use internal standard calibrate bind energy scale spectra elec trode surface measure Bio Rad Digilab FTS55A spec trometer singlereection prism attachment atmosphere incident angle beam reso lution set integration scan result performance analysis performance use vol study representative nonam mable electrolytes12a LiPF6EMC vol lecte electrolyte compare cell performance performance LiBETIMFEEMC graphite test cell evaluate nd limit cell capacity figure show chargedischarge voltage curve vol vol cell rst run function cell capacity cell charge constant current cm22 open circuit voltage OCV discharge current achieve min rest end charge g21 charge g21 discharge capacity result show g21 charge g21 discharge capacity LiBETIMFEEMC electrolyte charge discharge performance cell thus cell capacity electrolyte limited cathode reaction figure show chargedischarge voltage curve graphite cell rst run function cell capacity cell charge discharge achieve min rest end charge constant current mAh g21 charge g21 discharge capacity lead efciency contrast g21 charge g21 discharge capacity result Table Physical property nonauorobutyl ether methyl carbonate weight melting point boiling point Flash point NFP Viscosity s21 Surface tension m21 Density dm23 Table FPs MFE cosolvent mixture volume fraction vol NFP NFP NFP NFP NFP NFP NFP Figure Chemical structure electrolyte solvent main solvent cosolvent additive A219A228 A220 License place see ecsdlorgsitetermsuse address Redistribution subject term use see ciency voltage curve indicate large voltage drop graphite cell use charge discharge process compare cell use thus graphite anode inuence capacity depression cathode MFEEMC use measurement make graphite cell charge discharge state characterize electrochemical property consideration difference cell figure show ColeCole plot cell intercept value real part impedance MFEEMC cm2 large cm2 low ionic conductivity cm21 affect voltage prole lead voltage drop process see assume interfacial resistance Rct diameter slightly collapse semicircle compose element Rct relate resis tance ion transfer reaction Rct value measure charge state Fig similar thus ion transfer process regulate cell capacity Rct MFEEMC discharge state cm2 large charge state cm2 charge state cm2 become small discharge state characteristic frequency give peak semicircle relate Rct doublelayer capacitance general represent vary charge discharge stay constant Rct calculate list Table III express thickness layer represent permittivity vacuum relative dielectric constant material respectively layer give include solvent ion molecule absorbent system composition inuence thickness layer varied charge discharge process cell thickness cell twice thick cell charge state assume system value consider value uorinated compound small alkane cell close thickness decrease increase discharge figure voltage prole charge discharge cell use lipf6emc cm22 current density figure voltage prole charge discharge graphite cell use lipf6emc cm22 current density figure ColeCole plot graphite cell use EMC measure charge discharge A219A228 A221 license place see ecsdlorgsitetermsuse address Redistribution subject term use see process change think modication lm need decrease resistance low frequency inuence process improve cell capacity performance analysis additive improve relate ionic ductivity Rct relate structure absor bent well performance cell difcult improve ionic conductivity solvent high dipole moment thus expect real ize high solvation high dissociation solvent low dipole moment mix volume percent focus progress Rct addition high dipole moment high permittivity compound lipf6 reduce become large include product decomposition additive accord electrolyte vol prepare concentration almost maximum value uniform electrolyte lution sustain figure show rate capability test cell electrolyte MFEEMC comparison function discharge current cell charge discharge current discharge capacitie cell use signicantly improve rate addition improvement insufcient compare rate discharge discharge discharge mah dis charge improve cell capacity operate rate double bond seem affect cell capacity lot difference chemical structure bond order unclear reactivity double bond affect cell capacity residual double bond reaction product alkyl group CH3 CH3 seem inuence cell capacity effect lipf6 addition investigate add LiBETIMFEEMC Figure show rate capabil ity test cell use also use comparison lipf6 improve rate capability cell lipf6 cell able discharge even rate particular discharge capacity comparable current rate thus determine lipf6 additive work high current rate enhance discharge capacity figure show discharge capacity test cell current rate function concentration optimum concentration lipf6 improve rate capability rate capability cell use maximum discharge pacity reason rate capability drop instability electrolyte solution due aggregation add induced phase separation lution Table III estimate Rct measure charge discharge Rct cm2 cm22 Rct cm2 cm22 LiBETIMFEEMC LiPF6EMC figure rate capability cell use LiBETIMFEEMC LiBETIMFEEMC Figure rate capability test cell use also use comparison A219A228 A222 license place see ecsdlorgsitetermsuse address Redistribution subject term use see test graphite cell carry verify effect additive figure show voltage prole cell cell LiBETIMFEEMC comparison function cell capacity cell charge mah g21 discharge mAh g21 lead efciency charge capacity almost cell LiBETIMFEEMC mah g21 efciency prove compare system efciency cell charge mah g21 discharge g21 charge discharge efciency charge capacity much improve com pare electrolyte system mAh g21 com pare electrolyte system keep charge discharge efciency system thus effect efciency lipf6 play important role charge process measure cell charge discharge characterize electrochemical property lm Figure show ColeCole plot measure charge discharge cell estimation Rct list Table MFEEMC charge cm2 discharge signicantly reduce add cm2 charge cm2 discharge Adding reduce cm2 charge cm2 dis charge additive stabilize Rct charge discharge process Rct cell increase charge cm2 discharge Rct MFEEMC cell decrease charge cm2 discharge Rct MFEEMC lipf6 cell decrease charge cm2 discharge change cell use additive result obtain conventional electrolyte Fig also increase addition lipf6 see Table III suggest thickness lm reduce change ample inclusion reaction product additive lm additive strong enough prevent reaction decomposition system thus addition affect Rct lead well electrochemical property lm large charge discharge capacity spectroscopic analysis graphite anode electrolyte characterize charge intercalation state figure voltage prole charge discharge graphite cell use LiBETIMFEEMC1EC cm22 current density figure cell discharge capacity function concentration cell discharge current rate figure ColeCole plot graphite cell use measure charge discharge A219A228 A223 license place see ecsdlorgsitetermsuse address Redistribution subject term use see electrolyte masnmr measurement charge graphite electrolyte perform Fig peak ppm see spectra attribute rst stage appear ppm attribute LiC18 third high stage peak around ppm satellite band main peak graphite anode charge show peak graphite anode charge electrolyte possess peak due also small charge capacity mah g21 compare system ppm peak find carbon ber anode charge capacity mah g21 compare peak ratio spectra charge electrolyte see clearly increase anode charge thus improve charge capacity electrolyte also realize high density stage lithium intercalation characterize lm graph anode charge electrolyte measure sample charge discharge condition describe previous section figure show spectra measure charge discharge characteristic peak observe spectra measure stretching stretching CHx bend peak indicate existence carbonate compound reaction product carbonate com pound spectra change much discharge indicate lm form electrolyte stable spectra sample charge electrolyte differ compare absorbance intensity spectra think thickness lm form anode order MFEEMC mfeemc order good agreement order magnitude Rct measure discharge thus thickness vary electrolyte compo nent lipf6 inhibit growth lm system spectra lm form cell linso2cf3containe electrolyte assign follow peak stretch SO2 peak asymmetric stretch SO2 peak symmetric stretch SO2 peak stretch SvO spectra observe anode charge electrolyte find peak cm21 peak ascribe so2cf2cf3 derivative consider spectrum measure method varied reectance specimen peak appear around cm21 attribute CHx wag salt formation main component form anode electrolyte find so2cf2cf3 anion derivative anode charge electrolyte peak increase add thus additive affect form compound group spe cie small enhanced lead low ColeCole plot cell charge discharge LiPF6 compare MFEEMC Figure show XPS spectra anode charge discharge electro lyte spectrum system charge peak around attribute CF2 due binder CH2 due binder CHx due reaction product solvent respectively anode specimen main component lm clearly find CHx spectrum electrolyte system discharge peak become small new peak appear around attribute CF3 additionally peak due Table Estimated Rct measure charge discharge Rct cm2 cm22 Rct cm2 cm22 LiBETIMFEEMC LiBETIMFEEMC figure masnmr spectra graphite charge use record external standard LiCl Journal A219A228 license place see ecsdlorgsitetermsuse address Redistribution subject term use see become obvious suggest discharge become thin charge side reac tion take place discharge agree change see measurement resistance Rct become small discharge charge electrolyte see Fig spectra obtain electrolyte distinctively differ spectra give electrolyte Fig large peak due CF3 CF2 suggest lm form electrolyte clude so2cf2cf3 derivative find measurement ratio peak equal ratio belong pvdf large Rct electrolyte measurement related specie spectra elec trolyte charge Fig 12a CHx peak increase addition lipf6 thus specie group lm effect reduce Rct cell use electrolyte peak decrease spectra measure discharge electrolyte electrolyte ditive Fig chemical specie CH2 CHx act reduce Rct charge enlarge discharge thus lipf6 give highly conductive component charge figure show XPS spectra anode peak attribute PO3 respectively PF6 derivative viously include anode charge see thus conrme lm addition peak intensity ratio PO3 specimen obtain MFEEMC Fig different PO3 peak big peak even figure spectra graph anode measure charge discharge use MFEEMC LiBETIMFEEMC libetimfeemc Figure spectra graphite anode measure charge discharge use LiBETIMFEEMC1EC a219a228 A225 license place see ecsdlorgsitetermsuse address Redistribution subject term use see remain end charge discharge anode operate however PO3 peak detect begin ne charge disappear end charge discharge spectra anode run measure surface lm thus fact mean PO3 specie present bottom lm surface carbon think PF6 molecule stack reaction product lithium alkyl carbonate beginning charge react oxy gen present surface carbon draw suggest around derive reaction PF5 residual h2o electrolyte LiMn2O4 dissolution phenomenon think electro chemical reaction PO3 peak depend state PO3 specie grow layer sufcient thickness PF6 molecule react oxygen anymore specie increase lm thickness seem thick LiPF6 charge base peak intensity ratio suggest lm form small small result large Rct cell use electrolyte thickness lm cylindrical cell performance addi tive evaluate cell performance use cylindrical cell Figure show rate capability cell LiPF6EMC cell charge constant current constant voltage cutoff current limit discharge constant current select current rate dene cell lipf6 keep capacity capacity cell lose capacity rate capability cell signicantly improve add lipf6 Figure XPS spectra graphite anode measure various charge state discharge state LiBETIMFEEMC LiPF6EMC figure suggest reaction scheme generation po3 lipf6 electrochemical reaction figure rate capability cell use A219A228 license place see ecsdlorgsitetermsuse address Redistribution subject term use see rate capability cell enough compare figure show discharge voltage prole cell rate rate voltage prole cell close initial drop voltage steep voltage drop thus make Rct small sustain discharge cell voltage initial voltage drop due relate conductivity elec trolyte still try resolve point term devel opment novel salt high dissolution mixed solvent high dissociation LiBETI Figure show result cycle life test rate cell charge constant current constant voltage cutoff current limit discharge constant current cycle life cell use signicantly improve add low high current rate cell use keep initial capacity cycle cell use MFEEMC reach initial capacity cycle cycle life test cell use keep initial capacity even cycle cycle life even well cell use LiPF6EMC LiBETI know react aluminum cath ode current collector dissolve sol vent low dipole moment depress reaction rate reaction thus effect point pre vent dissolution reaction aluminum lead good cyclability po3 lm carbon anode prevent successive decomposition lipf6 inhibit aluminum corrosion conclusion improve cell performance use NFP electrolyte contain well safety lithium secondary battery investigate electrolyte component use several additive charge discharge capability cell use vol control reaction graphite anode capacity limitation find cell use electrolyte compare LiPF6EMC add cyclic carbonate precursor see rate capability cell use electrolyte substantially improve addition together cyclic carbonate improve rate capability even measurement reveal additive reduce Rct also graphite cell use electrolyte spectra indicate crease amount lithium carbonate lm form graphite anode charge LiBETIMFEEMC XPS measurement indicate derivative dominant compo nent lm form LiBETIMFEEMC electro lyte derivative clearly exist lm form improvement rate capability cycle life demonstrate cylindrical cell use cell discharge capacity capacity obtain keep initial capacity cycle cycle life test figure voltage prole charge discharge cell use current rate figure cycle life cell use current rate A219A228 license place see ecsdlorgsitetermsuse address Redistribution subject term use see believe promise electrolyte give great safety lithium secondary battery assist meet publication cost article Winter Besenhard Spahr Nova Adv mater Zhang Kong A463 Smart Batnakumar Surampudi Meeting Vol Phoenix Oct Jow 52nd Meeting International Society Electrochemistry San Francisco a1058 Shinoda Ozaki Kita Honolulu Oct Arai Appl Electrochem press Soc a217 Aurbach Gofer trochem Soc Shiraishi Kanamura Imanishi solid State Ionics Matsuta Asada Salitra a525 Acta Eriksson Andersson Bishop A69 soc Kanamura A185 ter Electrochem ter Arai A219A228 license place see ecsdlorgsitetermsuse address Redistribution subject term use see",
            "term_counts": {
                "Mental Health Terms": {
                    "depression": 1
                },
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "sentative": 1,
                    "LiBETI": 1,
                    "Salitra": 1
                }
            },
            "co_occurrence_matrix": {
                "Mental Health Terms": {
                    "sentative": 1,
                    "LiBETI": 1,
                    "Salitra": 1
                },
                "Ethnographic Terms": {
                    "depression": 3
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Nutrition and epigenetics_ an interplay of dietary methyl donors_ one-carbon metabolism and DNA methylation.pdf",
            "cleaned_text": "current epigenetic interplay dietary methyl donor onecarbon metabolism dna methylation Anderson1 Karilyn sant1 Dana Dolinoy Ann USA receive receive revise form accept DNA methylation extensively study mechanism epigenetic gene regulation increase evidence indicate dna methylation labile response nutritional environmental influence Alterations dna methylation profile lead change gene expression result diverse phenotype potential increase disease risk primary methyl donor dna methylation adenosylmethionine SAM specie generate cyclical cellular process call onecarbon metabolism Onecarbon metabolism catalyze several enzyme presence dietary micronutrient include folate choline betaine vitamin reason nutrition status particularly micronutrient intake focal point investigate epigenetic mechanism animal evidence link nutrition dna methylation fairly extensive epidemiological evidence less comprehensive serve integrate study animal vivo human epidemiological datum pertain nutritional regulation dna methylation identify area current knowledge limit right reserve metabolism dietary methyl donor dna methylation examine dna methylation context diet Epigenetics study mitotically heritable yet potentially reversible molecular modication dna chromatin alteration underlie dna sequence increasingly recognize epigenetic mark provide mechanistic link environment nutrition disease dna sequence fairly permanent epigenetic modication dynamic life course heavily inuence external factor thus external effect epigenome alter gene expression give rise phenotypic disparity include disease formation modication include chromatin remodeling histone tail modication dna methylation recently expand include noncoding RNA microRNA gene regulation dna methylation widely study form epigenetic modication occur onecarbon metabolism pathway dependent several enzyme presence dietary micronutrient cofactor include availability folate choline betaine diet Fig ATPdriven reaction methionine convert adenosylmethionine sam universal cellular methyl donor dna methyltransferase dnmt covalently attach methyl group carbon position cytosine basis generate methylcytosine thus methylate dna mammal dna methylation primarily stable repressive mark find cytosine cpg dinucleotide however regulation dynamic previously believe regulatory event occur genespecic global manner passive demethyl ation dna tissue widely accept evidence active demethylation mostly limit various stage develop ment passive demethylation typically occur DNMT activity reduce inhibit time dna replication occur simply addition methyl group newly synthesize strand DNA cell division active demethylation enzymatic conversion methylcytosine cytosine fairly controversial mechanism occur still remain elucidate Enzymatic conversion methylcytosine produce additional basis carboxylcytosine potential role epigenetic regulation yet characterize addition Lister provide evidence methylation noncpg cytosine human embryonic available online wwwsciencedirectcom Journal Nutritional Biochemistry Funding work support grant P30 Core Center P30 ES017885 P20 grant ES018171 Support KES provide Grant T32 es007062 Conict interest author conict interest declare compete nancial interest corresponding author mail address author contribute equally article consider rst author see front matter right reserve cell suggest methylation noncpg site important developmental homeostasis distribution cpg sequence mammalian genome nonrandom greatly underrepresented mammalian genome due evolutionary spontaneous deamination methylcytosine majority unmethylate cpg site occur island dene discreet region contain preponderance content normally cpg island locate gene promoter exon housekeeping gene contrast promoter regulatory region repetitive dna sequence transposable element methylate consequently inhibit parasitic transposable repetitive element replicate dna methylation pattern prone change life course especially reprogramme event associate mal development aging example epigenome particularly dynamic embryogenesis extensive dna synthesis elaborate dna methylation patterning require normal tissue development establish early development individual age gradual dna hypomethylation occur genomewide level concurrent promoter hyper methylation normally unmethylate cpg island lead example genome instability genespecic suppression respec tively additionally cancer often associate lated DNA notable hypermethylation tumor suppressor gene compare normal tissue reprogramme event life course result tissuespecic dna methylation pattern difference epigenetic pattern important cellular differentiation tissue homeostasis context nutritional biochemistry signicant onecarbon metabolism pathway cyclical regenerate dietary micronutrient Nutriepigenomics emerge discipline examine role dietary inuence gene expression mately dna methylation event dietary practice particularly micronutrient intake inuence disease phenotype study nutriepigenomic particularly timely context deve lopmental origin health disease dohad hypothesis posit increase susceptibility disease follow early life experience shape epigenetic modication dna methylation modication take interspecie approach synthesize exist nutriepigenomic literature order identify sensitive period life course diet substantially alter dna methylation vestigate vary level nutrient exposure vulnerable time point researcher grasp magnitude degree impact nutrient onecarbon metabolism subsequently dna methylation careful attention give area research need understand link dietary micronutrient dna methylation life course health disease Nutriepigenomics study utilize combination global candidate gene less extent genomewide approach examine inuence methyl donor dna methylation recently attempt elucidate effect nutritional status epigenome candidate gene drive base epigenetic technique limited genome restrict doseresponse assessment con animal model emerge advance epigenomic highthroughput quantitative epigenetic technology allow identication constellation genomic loci altered epigenetic status follow dosedependent exposure epigenetic epidemiology proache facilitate identication epigenetically gion genome human cell thus identify epigenetic biomarker enable clinician identify risk individual prior disease onset furthermore genetic mutation epigenetic mark potentially reversible therefore epigenetic approach prevention treatment nutritional supplementation pharmaceutical therapy develop counteract negative epigenomic prole study combine methyl donor supplementation novel experiment investigate maternal methyl donor supple mentation utero clearly demonstrate impact early nutrition shape epigenome axin fuse axinfu viable yellow Avy murine model contain metastable epiallele locus variably express isogenic individual due establishment stochastic epigenetic modication early development variable dna methylation intracisternal particle dietary micronutrient onecarbon metabolism substrate obtain diet highlight yellow Vitamin cofactor conversion tetrahydrofolate methylene precursor cofactor methylenetetrahydrofolate reductase mthfr conversion methylene methyl B12 precursor methionine synthase involve production methionine homocysteine betaine avin adenine dinucleotide DMG dimethyl glycine MTHFR methylenetetrahydrofolate reductase adenosylhomo cysteine tetrahydrofolate retroelement intron gene result distinct kinky tail phenotype kinky hypomethylated tail kink hypermethylate genetically identical mouse Waterland demonstrate maternal diet supplement methyl donor include folic acid vitamin B12 betaine choline result offspring display less kinky tail phenotype accordingly hypermethylation axinfu metastable epial lele similarly coat color isogenic Avy mouse correlate sto chastic methylation upstream gene promoter result phenotype range yellow hypomethylated brown hypermethylate fur methyl donorsupplemente maternal diet shift distribution coat color phenotype brown comparison unsupplemented mother shift brown phenotype concomitant hypermethylation Avy furthermore use Avy model demonstrate maternal diet supplement methyl donor negate shift hypomethylation due bisphenol exposure restore normal stochastic methylation offspring AxinFu Avy model serve informative visual epigenetic biosensor maternal nutritional status particularly methyl donor need maintenance onecarbon metabolism dna methylation additional vivo rodent study rely wild type strain rodent investigate effect maternal methyl donor supplementation alter phenotype especially exacerbation disease example modulation allergic airway disease risk explore use C57BL mouse Hypermethylation gene crucial lymphocyte regulation Runx3 arise offspring expose methyl donor utero result increase allergic airway disease development conjunction amplied symptom severity furthermore C57BL mouse expose methyl donor sup plementation utero exhibit enhanced colitis susceptibility also associate aberrant dna methylation gene associate immunologic process crucial carbon metabolism catalyze conversion homocysteine methionine generate methyltetrahydrofolate relationship role MTHFR genotype dna methylation investigate extensive study look MTHFR variant conduct healthy woman week participant randomly assign study diet consist establish concentration folate betaine choline phosphatidylcholine sphin various choline source cell cytosine extension assay use determine global percent methylation diet MTHFR covariate show signicant effect leukocyte dna methylation study reduce dietary choline folate intake woman associate decrease global methylation leukocyte dna moreover dietary resupplementation folate result DNA remethylation global scale strength association robust individual MTHFR mutation suggest folate supple mentation crucial methylation maintenance individual MTHFR polymorphism Studies individual methyl donor folate dietary folate extensively study micronutrient animal epidemiological dna methylation research Table Folate reduce dihydrofolate subsequently tetrahydrofolate serve single carbon donor form methyl consequently methyl feed onecarbon metabolism cycle donate methyl group homocysteine convert methionine cofactor vitamin provide enzymatic support necessary transformation make possible dietary folate feed onecarbon metabolism cycle replenish cellular reason folate supplementation generally associate increase dna methylation vice versa folate restriction underscore however conicte evidence emerge suggest mechanism associate micro nutrient inuence dna methylation complex previously understand notable animal study evaluate global methyl ation effect maternal folate status First murine offspring expose lowfolate diet gestation lactation exhibit crease global methylation small intestinal tissue adult measure cytosine extension technique quantify unmethy lated cytosine island contrast measurement global methylation methyl acceptance incorporation methyl follow utero folate supplementation associate cpg hypomethylation mammary tissue rat offspring age finally postweane folate sup plementation equivalent recommend intake level woman childbeare age result decrease global methylation level murine colorectal tissue measure liquid chromatog raphymass spectrometry thus vivo animal datum support role global dna hypomethylation folate restric tion folate supplementation number human epidemiological study also measure global dna methylation indirectly incorporation methyl SAM look correlation folate dna methylation colorectal cancer postmenopausal woman First study conduct patient admit colonoscopy patient test negative colonic mucosa lymphocyte dna methylation find weakly associate serum folate concentration dietary folate measure use food frequency questionnaire patient diagnose folate supplementation diagnosis correlate increase global dna methylation Table Studies provide folate impact dna methylation author study populationtissue methylation measure human pregnant woman maternal blood cord blood Primary breast tumor pregnant woman cord blood leukocyte Genespecic cancer case control leukocyte Genespecic Stidley smoker sputum cultured glioblastomas Donk Colon tumor MTHFR variant Healthy adult colonic mucosa leukocyte colonic mucosa woman leukocyte Global van Engeland Colon tumor Genespecic Rampersaud Postmenopausal woman leukocyte various adult tissue Adult small intestine various adult tissue Genespecic Rat Adult mammary tissue small intestine colonic mucosa liver adipose tissue Adult liver blood Global genespecic postmenopausal woman dietary folate restriction correspond decrease serum folate concentration associate decrease dna methylation leukocyte dosedependent manner moreover folate supplementation cell cultured human glioblastomas methylate dna globally hypomethylated glioblastoma therefore human evidence suggest folate intake global dna methylation positively correlate numerous study utilize candidate genespecic approach investigate effect folate dna methylation locus select often associate disease outcome interest cancer diabetes prospect future preventative therapeutic strategy diet target epigenome example acetyltransferase gene human homologue NAT1 associate cancer development include breast carcinogenesis overexpresse display increase methylation adult rat expose highfolate diet additionally effect folate deciency methylation p53 important tumor suppressor gene evaluate rat feed lowfolate diet exhibit hepatic hypomethylation exon region p53 suggest methylation status play role molecular underpinning carcinogenesis Folic acid supplementation rat juvenilepubertal period increase methylation promoter region insulin receptor PPAR glucocorticoid receptor gene involve metabolic homeostasis compare offspring expose utero environment exception folateadequate diet puberty rat exhibit distinct alteration dna methylation measure several locus involve weaning adult exposure folate depletion gestation lactation importantly result experiment indicate folate exposure alter dna methylation gene tissuespecic manner different life stage additionally difference methylation dependent sex genotype aforementioned vivo candidate study explore folate role methylation target tissue type use blood surrogate biomarker methylation target tissue permit thorough human epigenetic research develop ment noninvasive methylation measurement epigenetic epi demiology study mouse deprive folate utero show hypomethylation differentially methylate region imprint locus insulinlike growth factor slc389a4cgl1 blood liver kidney tissue conversely show signicant methylation difference blood kidney liver provide evidence methylation gene tissue specic grow investigation folate role methylation status select gene know alter disease susceptibility human evidence obtain food frequency questionnaire suggest folate intake signicant effect genespecic methylation white blood cell likewise low folate intake combine high alcohol consumption demonstrate nonsignicant change gene promoter methylation blood patient study examine serum folate tion smoker detect methylation gene previously hypermethylate lung cancer interestingly increase serum folate associate decrease methylation smoker gene examine alternatively positive correlation serum folate concentration promoter methylation identie RASSF1A gene increase expression implicate multiple disease breast lung cancer gene expression examine study increase promoter methylation repress RASSF1A expression subsequently decrease cancer risk together datum suggest folate associate protection cancer human study also investigate role maternal folate status offspring methylation crosssectional study pregnant woman time parturition look imprint gene IGF2 imprint gene express due allelic repression epigenetic modication dna methylation imprinted gene functionally prone deregulate event investigate methylationbased study blood maternal blood collect time delivery serum folate concentration determine specimen determine maternal cord blood folate concentration associate methylation outcome promoter IGF2 additionally hypomethylation IGF2 promoter umbilical cord blood leukocyte inversely associate maternal report folate supplementation pregnancy study look correlation diet methyl ation epigenomewide scale Illumina GoldenGate bead array use conduct epigenomewide study examine connection human folate intake breast cancer dietary folate determine food frequency questionnaire strongly associate genomewide scale hypermethylation cpg site cancerrelate gene promoter epigenomewide scale study necessary discover candidate locus variable methylation potential increase individual popu lation susceptibility disease betaine Choline indirect methyl group donor onecarbon metabolism pathway dietary choline oxidize betaine contribute methionine homeostasis donation methyl group homocysteine result homo cysteine conversion methionine Fig thus number animal vivo less extent human study investigate role dietary choline betaine impact global candidate gene dna methylation Table Choline deciency associate altered neurogenesis low decline memory function choline crucial maintenance onecarbon metabolism several study investigate choline deciency inuence global didate gene methylation fetal brain well tissue global methylation analysis Embryonic Day mouse fetal brain display signicant shift hypomethylation candidate gene also analyze dna methylation status include Cdkn3 Cdkn2b Calb2 candidate gene show hypomethylation promoter region offspring expose maternal cholinedecient diet additionally choline deciency Gestational Days decrease methylation cpg site locate promoter fetal hippocampus examination early choline exposure fetal brain gene methylation perform candidate locus display hypomethylation expose maternal choline decient diet correlate increase expression encode protein VEGF angiopoietin respectively global methylation rat brain liver tissue analyze follow exposure cholinedecient diet ed interestingly global hypomethylation occur brain global hypermethylation observe liver tissue furthermore hypermethylation liver correlate hypomethylation cpg site Dnmt1 gene encode dna methyltransferase thus datum suggest early choline deciency ability deprive DNA methylation machinery proper substrate onecarbon olism lead increase expression methyltransferase subsequently increase methylation specic locus case imprinted gene complex concept explore understand wholly mechanism involve genespecic methylation supplementation also explore role carcinogenesis adult rat expose vary level betaine diet Hypermethylation tumor suppressor gene p16 display liver tissue rat expose dose compare control group concomitantly correlate decrease mrna expression p16 chicken betaine supplementation associate modest positional effect lipoprotein lipase gene promoter measure adipocyte promoter highly hypomethylated several site find hypermethylate betaine supplementation gene expression signicantly decrease betaine supplementation inuence dna methylation change unknown Vitamins B12 watersoluble vitamin B12 important catalytic role folate onecarbon metabolism serve coenzyme key enzyme folate cycle convert methylene vitamin precursor dinucleotide cofactor mthfr enzyme responsible reduction methylene methyl b12 coenzyme methionine synthase cata lyze reaction homocysteine product SAM methionine thus dietary consumption watersoluble vitamin potential affect efciency onecarbon metabolism pathway animal human study evaluate role vitamin b12 dna methylation prole table vivo rat model show deprivation vitamin B12 addition diet supplement folate enhance placental global hypomethyla tion compare diet exclusively supplement folate sug geste interaction micronutrient alter methylation pattern profoundly excess deprivation micronutrient human epidemiological study examine role vitamin b12 regulation dna methyla tion use crosssectional study design assess vitamin b12 folate status pregnant woman time parturition blood igf2 methylation promoter inversely correlate maternal blood serum b12 additionally maternal blood methylation promoter inversely correlate maternal serum B12 second study examine relationship plasma vitamin b12 concentration dna methylation smoking status former smoker increase serum vitamin b12 concentration associate decrease methylation several multidiseaserelated gene promoter similar decrease methylation associate increase serum vitamin concentration disease link gene essential amino acid continuously regenerate homocysteine onecarbon metabolism serve precursor SAM Fig thus uctuation methionine diet potential effect dna methylation methionine immense role methyl donor limited evidence evaluate methionine dna methylation table rat feed methioninesupplemented diet change p53 promoter region methylation additionally plasma methionine concen tration inversely correlate dna methylation pro moter several multidiseaserelated gene former current smoker discussion role nutrition onecarbon metabolism DNA methyla tion extensively study animal model human however reveal epidemiologic datum become increasingly robust Herein highlight datum alter consumption folate choline betaine vitamin methionine act modify methylation globally promoter diseaserelate gene animal human thus nutriepigenetic approach provide molecular foundation understand role diet life course prospective role disease prevention therapy limited number human study micronutrient intake methylation nonetheless multiple laboratory establish solid foundation use animal vivo model future study discipline body literature indicate importance exposure timing genotype tissue gene specic dna methylation interpretation result methylation cell type dependent comprehensive epigenetic analysis remain optimal approach future study continue focus tissue specicity dna methylation investigation likely signicantly inuence vary disease state addition examine surround methyl donor exposure window susceptibility life course embryogenesis fertilization neonatal puberty aging thoroughly investigate vulnerable epigenetic state combine tissuespecic outcome shape knowledge disease etiology possibly preventive thera peutic approach disease vast array methodology use detect dna methylation nutriepigenetic study even epigenetic technology evolve traditional method use restriction enzyme focus candidate gene modern technology allow unbiased epigenomewide investigation tissue specie main goal nutriepigenetic well understand role diet disease epigenomewide investigation involve deep sequenc ing tile array technology valuable future study Table Studies provide choline betaine vitamin methionine impact dna methylation author study populationtissue methylation measure Choline betaine adipocyte fetal brain fetal brain Genespecic Rat adult liver fetal liver brain Global genespecic fetal brain Global genespecic vitamin pregnant woman maternal blood cord blood Genespecic Kulkarni Rat placenta global Vineis Lung cancer case control leukocyte Genespecic Methionine adult kidney cancer case control leukocyte Nutritional Biochemistry apply integrative approach identify key regulatory pathway interaction diet epigenetic mechanism histone modication chromatin remodeling complex also consider additionally investigate interaction micronutrient require onecarbon metabolism indirectly affect supply maintain cycle efciency implicit integrate genomewide application nutriepigenetics continue emerge enable clinical public health practice apply epigenetically drive therapeutic preventative strategy evaluate population individual certain disease state example register dietitian make nutritional recommendation base individual epigenetic prole epigenome particularly sensitive various time point life course target nutriepigenomic population intervention efcient cost effective continue animal nutriepigenomic model translate human research strengthen understanding biological pathway associate diet human health modification epigenetic reprogramming mammalian development reprogramming mammalian develop ment science pathway nucleus Selhub Homocysteine metabolism Maunakea conserve role intragenic dna methylation regulate alternative promoter Nature Zhang Active DNA demethylation many road lead Nat Rev Mol Cell Biol Ito Tet protein convert methylcytosine formylcytosine carboxylcytosine Science lister hotspot aberrant epigenomic reprogramming human induce pluripotent stem cell Nature methylation fate cpg dinucleotide vertebrate genome dna methylation mutation Mol Mech Mutagen cpg island regulation transcription Genes Dev difference arise lifetime monozygotic twin reprogramming mouse primordial germ cell Mech Dev drift age identical twin time everything environmentally induce change epigenome animal epigenetic Mugatroyd Janus face dna methylation age aging phenotypic plasticity epigenetic human disease Nature developmental origin adult disease Attig programming epigenetic epiallele mammal Trends Genet Vasicek dominant mutation mouse fuse gene result transposon insertion Waterland maternal methyl supplement increase offspre dna methylation fuse mutation obese yellow mouse Waterland element target early nutritional effect epigenetic gene regulation Mol Cell Biol Jirtle Maternal nutrient supplementation counteract bisphenol induce dna hypomethylation early development Hollingsworth utero supplementation methyl donor enhance allergic airway disease mouse Clin Invest Schaible Maternal methyldonor supplementation induce prolong murine offspring colitis susceptibility association mucosal epigenetic microbiomic change methylenetetrahydrofolate reductase enzyme metabolic significance risk impact folate requirement status reliable indicator moderate change dietary choline consumption premenopausal woman Shelnutt reductase 677C polymorphism affect dna methylation response control folate intake young woman depletion pregnancy lactation reduce genomic DNA methylation murine adult offspring effect maternal postweaning folic acid supplementation mammary tumor risk offspring cancer res sie KKY effect maternal postweaning folic acid supplementation colorectal cancer risk offspring Gut Pufulete Effect folic acid supplementation genomic DNA methyla tion patient colorectal adenoma Gut Pufulete Influence folate status genomic DNA methylation colonic mucosa subject colorectal adenoma cancer cancer rampersaud genomicdna methylation decrease response moderate folate depletion elderly woman supplementation limit aggressiveness glioma remethylation dna repeat element gene govern apoptosis proliferation Wakefield Boukouvala Sim Characterisation cpg methylation upstream control region mouse Nat2 evidence geneenvironment inter action polymorphic gene implicate folate metabolism deficiency rat induce dna strand break hypo methylation p53 tumor suppressor gene Burdge Folic acid supplementation juvenilepubertal period rat modify phenotype epigenotype induce prenatal nutrition Nutr Effect maternal post wean folate supply genespecific dna methylation small intestine weaning adult wild type mouse Front Genet McKay blood surrogate marker tissuespecific dna methylation change due folate depletion postpartum female mouse Mol Nutr Food Res folate intake combination MTHFR C677 genotype promoter methylation tumor suppressor dna repair gene sporadic colorectal adenomas cancer epidemiol biomarker Prev Effects dietary folate alcohol intake promoter methylation sporadic colorectal cancer folate green vegetable protect gene promoter methylation aerodigestive tract smoker Cancer res dna methylation change associate cancer risk factor blood level vitamin metabolite prospective study folate vitamin b12 methylation insulinlike growth factor maternal cord blood Eur Clin Nutr dolinoy disease variation IGF2 differentially methylate region maternal folic acid use pregnancy epigenetic Christensen Breast cancer dna methylation profile associate tumor size alcohol folate intake e1001043 choline metabolism gene variant development uterine cervical carcinoma dietary choline reverse effect folate deficiency neurogenesis apoptosis fetal mouse brain maternal dietary choline deficiency alter fetal mouse hippocampus dietary choline deficiency alter global genespecific DNA methylation develop hippocampus mouse fetal brain deficiency alter global histone methylation epigenetic mark Re1 site calbindin gene gestational choline deficiency cause global gene dna hypermethylation regulation expression assessment effect betaine p16 myc dna methylation mrna expression chemical induce rat liver cancer model Cancer Biochemistry Effect dietary betaine supplementation lipogenesis gene expression cpg methylation lipoprotein lipase gene broiler Mol Biol Rep Perry Effect vitamin availability serine cell Biophys Low dietary choline low dietary riboflavin pregnancy influence reproductive outcome heart development mouse Kulkarni Effects alter maternal folic acid vitamin B12 docosahexaenoic acid placental global DNA methylation pattern rat e17706 effect dietary supplementation methionine genomic stability p53 gene promoter methylation rat Environ Mutagen dolinoy variable histone modification Avy metastable epiallele epigenetic",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "epigenetic": 35,
                    "methylation": 127,
                    "demethylation": 4
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "angiopoietin": 1,
                    "Re1": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "angiopoietin": 166,
                    "Re1": 166
                },
                "Ethnographic Terms": {
                    "epigenetic": 2,
                    "methylation": 2,
                    "demethylation": 2
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Out of equilibrium dynamics of poly _vinyl methyl ether_ segments in miscible poly _styrene_-poly _vinyl methyl ether_ blends.pdf",
            "cleaned_text": "equilibrium dynamic polyvinyl methyl ether segment miscible polystyrenepolyvinyl methyl ether blend dric sica Universidad del Pa Vasco UPVEHU Unidad sica Materiales UPVEHU 2Donostia Paseo San receive revise manuscript receive publish local dynamic low component polymer blend dynamically asymmetric polystyrene polyvinyl methyl ether study glass transition dielectric relaxation spectro copy particular attention pay blend high content weight fraction high relaxation process slow localize motion induce secondary relaxation detect even blend fall equilibrium temperature regime structural recovery process efcient time scale motional process relaxation attribute rather localize weakly cooperative motion result topological constraint impose frozen chain number introduction miscible polymer blend component display strong difference glass transition temperature anomalously transition observe differential scan calorimetry DSC however molecular length scale mean motional rate com ponent deeply affect blending remain distinct feature evidence different asymmetric blend polystyrenepolyvinyl methyl ether polyisoprenepolyvinyl ethylene mean dielectric relaxation spectroscopy nuclear magnetic reso nance NMR quasielastic neutron scattering instance recently chain connectivity voke account remain difference seg mental dynamic component underlie idea chain connectivity concentration component estimate small volume note corresponding length around give seg ment type high macroscopic concentration polymer blend main feature local dynamic blend strong broaden ing relaxation time distribution component comparison pure homopolymer broaden continuously increase temperature low ere glass transition observation attribute concentration uctuation blend thermody namically drive uctuation uctuation duce chain connectivity effect thus nomenological description segmental dynamic blend component well establish complete theoretical model still miss work previously mention report measure ment perform close glass transition contrast local dynamic polymer blend far less explore however question particularly important academic also industrial point view indeed polymer blend offer good avenue combine low cost property component homopolymer reason tech nologically important processing property nished product require good knowledge dynamical property also glass transition main difculty time dependent phenomenon also consider deed even case single homopolymer due nonequilibrium nature glassy state specic volume spontaneously decrease system cool set isothermal condition course evolution call structural recovery process physical aging also induce time dependence chanical dielectric property case blend segmental mobility component different calorimetric glass transition chain segment high component consider static time scale seg mental motion low component previous different polystyrenepolyvinyl methyl ether blend consider mean tional rate segmental motion find time low one observe component course difference expect higher increase content high compo nent besides concentration uctuation blend frozen evidence small angle neutron scatter case blend instance thus reasonable physical picture low com ponent dynamic asymmetric blend consider glass transition correspond motional pro cesse mobile chain embed frozen matrix form high component mention physical aging occur corresponding author Email address wapcolejehu PHYSICAL 651X take account describe local low component behavior blend rich low component differ observe blend large content high component indeed second case time scale structural recovery process essentially govern time scale involve densication matrix form high component result aging effect expect occur time scale relevant local dynamic low component contrast blend rich low component even corre sponding homopolymer surround chain low component display time evolution time scale local dynamic idea mind explore paper dynamical behavior low component blend glass transition indeed system characterize strong dynamical asymmetry homopolymer exhibit difference value emphasize blend extensively investigate previously see instance work concern blend rich study close intend limit inuence aging process follow gument mention mainly consider blend high concentration regime motional process probe mean broadband dielectric relaxation spectroscopy experimental section Atactic polystyrene polyvinyl methyl ether PVME use prepare blend sample follow lecular characteristic weightaverage molecular weight mol21 polydispersity index w521 mol21 initially aqueous solution dry vacuum remove trace water blend various composition weight fraction range cast toluene solution polymer mis cible proportion solvent casting car rie directly electrode use dielectric relax ation measurement diameter room temperature obtain lm thickness dry vacuum oven temperature progressively raise nal temperature maintain drying process enable remove residual solvent sample avoid bubble formation glass transition temperature homopoly mer blend determine model DSC instrument scanning rate min21 DSC measurement perform sample directly cut lm investigate dielectric relaxation spectro copy DSC trace blend display different weight fraction fp case single glass transition observe imply par FIG DSC trace blend various composition heating rate symbol represent midpoint glass transition composition dependence calorimetric glass transition temperature fp denote weight fraction blend open symbol stand dielectric glass transition temperature blend deduce temperature peak maximum Fig lorthioir PHYSICAL ticular phase separation occur blend preparation dielectric measurement value determine temperature correspond heat capacity change variation report Fig complex dielectric permittivity 5e82ie9 measure range use trol high resolution dielectric analyzer Alpha analyzer temperature high second electrode ameter stack blend lm press vacuum blend rich fp separation electrode maintain mean small spac er sample cell set cryostat temperature control nitrogen gas jet heating system couple controller accuracy temperature value well probe range temperature low dielectric measurement perform SolartronSchlumberger frequencyresponse analyzer supplement module spectrometer couple helium refrigeration system equip ment sample keep electrode diameter separation noteworthy case blend dielectric signal mainly originate compo nent strong difference dielectric strength finally like recall different relaxation process observe homopolymer dielectric spectroscopy variation dielectric loss temperature report Fig frequency khz absorption peak locate curve obtain khz correspond main chain relaxation relevant glass transition additional secondary relaxation process namely peak detect respectively latter relate localize motion polar side group OCH3 precisely accord recent work respectively attribute free restricted rotation methyl group bond denote methine carbon process stand probe temperature range process occur III result figure show temperature dependence dielec tric loss measure homopolymer well blend various composition fps frequency value low enough allow clear resolution different relaxation process moreover value normalize weight fraction fpvme get relevant comparison intensity relaxation peak different system low limit investigate temperature range increase due hightemperature tail process see comparison part spectra malize value different blend clearly super posable one homopolymer feature conrme comparison process isochro nal plot perform high frequency consistent previous study localize tion involve process hardly affect blend contrast see Fig process strongly affect blend crease corresponding peak start shift high temperature display strong broaden shift peak relate expect slow segmental motion chain add broaden relaxation FIG loss component complex dielectric obtain function tempera ture homopolymer FIG obtain pure blend various composition fps535 sample value divide weight content fpvme box curve indicate breadth calorimetric glass transition dot ted line indicate midpoint value EQUILIBRIUM dynamics POLYVINYL PHYSICAL time distribution attribute concentration uc tuation observation also agreement previous study polymer blend exhibit large difference however additional pro cess seem grow content unam biguously observe blend corresponding fps550 lead high fps value double peak structure plot latter peak dominate dielectric loss high temperature close correspond process scribe previously follow focus peak dominate dielectric response perature range tempting interpret doublepeak structure observe blend fps possible bimodal relaxation time distribution underlie process indeed large even bimodal distribution emerge recent mod el take account thermodynamic uctuation describe segmental dynamic miscible blend however approach assume con sidered blend equilibrium therefore plicable describe lowtemperature peak occur glass transition temperature blend rich thus knowledge lowtemperature process never describe detail literature follow ing sake simplicity call process relaxation emphasize notation mean relaxation completely independent process temperature range relaxation process occurs locate blend see thus nonequilibrium effect consider due structural recovery process dielectric loss expect time dependent relevant question address time scale involve change equilibrium state purpose homopolymer different blend anneal xed temperature case measure anneal sample heat remove memory effect temperature dependence measure annealing report Fig pure blend rich comparison curve record fre quency annealing also plot course unannealed anneal state signicant decrease sig nal whole temperature range observe con trast blend physical aging affect inter mediate temperature range relaxation peak appear well resolve anneal ing value unchanged indi cat even relaxation process occur temperature blend fall equilib rium time scale involve time evolution process far large pure get deep understanding origin low temperature contribution observe single xed frequency proceed isothermal measurement mainly focus blend high amount spectra obtain different temperature blend plot Fig whole perature regime investigate single relax ation peak detect spectral window frequency peak maxi mum close isothermal spectrum roughly relate maximum occur plot temperature measure mainly originate relaxation process temperature peak enter consider spectral window see origin signal observe lowfrequency part dielectric loss tempera ture high assumption consistent FIG Effect physical aging temperature dependence dielectric loss measure solid open symbol represent datum obtain unannealed anneal sample circle correspond square blend arrow indicate anneal temperature detail annealing describe text dielectric loss spectra record blend different temperature solid line experimental datum accord equation lorthioir PHYSICAL slight increase level signal broad shoulder serve lowfrequency side process interested probably correspond peak indeed know particularly broad high con centration regime thus spectra also include contribution peak reason follow restrict probe temperature range value low follow intend use isothermal measure ment characterize lowtemperature dielec tric response frequency peak maximum shape dielectric strength due non equilibrium effect question timedependent charac terization whole frequency range raise purpose blend high content heat calo rimetric cool time variation dielectric loss monitor figure report function measure blend anneal clearly small decrease signal observe difference increase low frequency part however peak position highfrequency part relaxation process nearly change lowfrequency part peak anneal display close peak maximum slope slightly high anneal feature gether decrease signal sug gest observe change due shift slow process consider spectral window however relaxation process want characterize nearly change result imply timeindependent charac terization lowtemperature peak allow rea sonable time scale worth add blend let vacuum oven calorimetric display additional signicant change present thus process evolve signicantly time scale isothermal measurement measurement require min allow characterization time independent parameter dene characteristic relaxation time tmax frequency max maximum peak observe isothermal measurement tmax512pf max plot tmax blend show comparison datum obtain follow procedure homopolymer blend low content fPS535 also include latter note peak maximum relate process detect frequency range blend rich Arrheniuslike behavior observe temperature low RTD activation energy similar blend mol21 independent dataset give value report Table also worthy remark characteristic relaxation time motion relate observed process decrease raise content table Arrhenius parameter process blend weight fraction Sample mol21 PVME FIG Effect physical aging dielectric loss spectrum measure blend anneal lle circle anneal time day empty circle FIG plot characteristic relaxation time tmax pure empty square blend fps535 empty circle empty uptriangle lle downtriangle lle diamond cross function temperature dotted line experimental datum equation solid line law EQUILIBRIUM POLYVINYL PHYSICAL dielectric loss record blend describe peak maximum mean equation see solid line Fig vpd vpd angular frequency relate loss peak maximum exponent fall range ep9 constant proportional peak ampli tude equation approximate power law lowfrequency side highfrequency independent exponent enable probe breadth asymmetry considered relax ation process thus shape underlie relax ation time distribution temperature dependence shape parameter present blend report value obtain limit frequency range use tte procedure value satisfactorily describe power law close value report low high frequency tail come probe spectral window lead unprecise shape exponent value addition blend great incertitude affect shape exponent value due weakness dielectric signal clearly shape depend much nearly unaffected amount relaxation peak broad rather symmetric finally quantity interest dielectric strength relate relaxation peak estimate use equation experimental replace lytical expression deduce func tion blend fps570 dielectric loss peak center consider spectral window see thus lead precise determination fps570 fps case due weakness dielectric signal experimental datum use evaluation limit highfrequency side value process compare dielectric strength relate total num ber PVME segment blend latter estimate product dielectric strength pure depvme50 weight fraction increase corresponding relative dielectric strength also evidence inset show amount chain segment contribute relaxation peak important content raise discussion dielectric measurement evidence addi tion peak relaxation process occur blend rich corresponding FIG temperature dependence shape parameter see denition text blend rich fp lle downtriangle lle diamond cross loss spectra normalize weight fraction record blend fps570 lle downtriangle lle diamond cross Inset variation blend composition relative dielectric strength dielectric strength process dielectric strength total number segment blend lorthioir PHYSICAL electric loss broad symmetric follow Arrheniuslike temperature dependence feature indicate relaxation process display similarity characteristic secondary relaxation thus underlie motional process rather localize however clearly distinguish peak observed blend indeed latter occur activation energy mol21 time low consider relaxation process par ticular difference value pro cesse suggest motion involve relaxation extend large length scale motion relate process uctuation pendant group OCH3 addition noteworthy peak blend depen dent concentration contrast peak blend fps high chain segment average surround chain subchain composition range effective glass transition estimate model propose stand precisely expect increase varied thus probe temperature range low segmental motion give rise relaxation process occur environment consist frozen chain result cooperative motion involv ing chain portion possible mainchain motion possible conformational transition rotational uctuation imply ing monomer unit compatible topo logical constraint induce chain thus strain segmental motion chain promote local rearrangement consistent behavior lowtemperature peak previously describe similarity secondary process focus temperature dependence serve blend rich let rst come back case homopolymer glass transition temperature dependence relaxation time polymer describe VogelFulcher law exps t2t0d dependence rationalize use theory base entropy system approach reorientational time give unit relate accord entropy minimum number particle involve cooperative motion molar eleman tary activation energy reciprocal frequency tempt number con stant emphasize equation apply far entropy expect temperature independent law result accord corresponding activation energy law express AG5 frozen note segmental motion far homopolymer extremely slow situation related occur blend rich far time scale segmental motion rather low follow inter pretation temperature range motion take place matrix make frozen chain thus con gurational entropy temperature range sentially temperature independent take account activation energy process order magnitude use parameter correspond homopolymer result value mol21 indeed different value deduce temperature dependence blend find mol21 difference rationalize consider value freeze slightly different correspond blend interpretation also consistent fact apparent activation energy blend find nearly independent composition sake simplicity con sidered mean weight fraction whole blend disregard effect concentration uctuation however latter least partially responsible large breadth relaxation process depend local concentration correspond tion less constrain previously describe process also observe temperature variation measure blend see though appear far less pronounced high fps value indeed due concentration uctuation region blend perience local weight fraction much high region motion also give rise additional relaxation process explain blend rich consistent previous study blend rich PVME fps535 suggest segment mixture display motional process fast pure blend peak observe isothermal measurement far low glass transition temperature border accessible frequency range assume peak shape indepen dent temperature range frequencytemperature superposition highfrequency tail peak lead activation energy mol21 consistent value obtain blend rich EQUILIBRIUM dynamics POLYVINYL PHYSICAL interpretation molecular motion induce relaxation process also consistent result taine physical age experiment indeed blend rich evolution anneal drive structural recovery process chain experiment anneal temperature least low calo rimetric thus much low effective glass transition temperature thus time scale involve aging matrix far high consider nealing time result absence signicant effect anneal shape observed lowtemperature peak behavior contrast case homopolymer blend rich latter chain average mainly rounded chain thus environment undergo structural relaxation choose anneal ing time see case pvme Fig stage interesting compare result previous study physical age blend particular report blend analyze model model one prove component mainly responsible physical ing process monitor allow compare datum dielectric measurement mainly sensitive analysis model lead apparent activation energy enthalpy relaxation mol21 value determine temperature range correspond activation energy relaxation complete physical aging blend value compare apparent acti vation energy deduce dielectric datum blend use extrapolation tmax see thus obtain value range mol21 vary indeed consistent value report Ref addition use model author tte enthalpic relaxation measurement use function characteristic time approximate perature dependence rough find apparent activation energy equilibrium relaxation blend mol21 value close agreement acti vation energy process deduce follow equilibrium segmental dynamic low find pure glassy state mol21 mean time domain dielectric measurement basic question remain concern value relaxation time involve process indeed speed localize motion observe content increase see Fig Fig suggest connement effect take place blend indeed follow previous view chain con dimensional solidlike matrix obvious dene conning length segment rst approach consider chain sur rounded one connement length order typical interchain distance homopolymer con length analogous consider previously study system nanocom posites make polymer chain intercalate inner gallery silicate layer nanocomposite con distance also close strong dif ference case blend connement ill dene polymer chain know display structural dynamical behavior different bulk state well admit segmental motion speed slow due competition pure geometric connement effect interac tion con polymer chain con surface point mind follow anal ogy polymer con welldened matrix assume rst approach interface effect chain segmental dynamic take account indeed case blend weak Waals interaction phenyl ring methoxyl group occur evidence twodimensional NMR experiment con text expect pure connement induce speed segmental dynamic comparison con state homopolymer rationalize observe speed blend rich however analogy system con distance uniform take great care indeed even con simple liquid recent molecular dynamic simula tion evidence depend roughness con wall smooth rough speeding slow ing observe relaxation dynamic liquid dielectric spectroscopy experiment currently develop blend clarify origin speeding observe finally occurrence segmental motion late process blend rich particular interest mechanical property material turn blend appear articial way induce molecular mobility glassy state feature great interest pos sible industrial application multicomponent system conclusion investigate motional process low component homogeneous phase miscible polymer blend dynamically asymmetric glass transition blend rich high component mainly consider addition wellknown secondary relaxation relaxation process call relaxation detect blend relaxation relate motion chain segment constrain matrix form frozen chain respect molecular nature lorthioir PHYSICAL relaxation certainly relate segmental relaxation constrained geometry attribution consistent fact structural covery process essentially drive matrix much slow time scale involve motion speed motional process increase concentration blend observe system polymer chain con well order matrix discuss suggest speeding also result connement chain matrix acknowledgment author UPV00206 support Sergot Laupretre Phys jichristidi Macromolecules Nucl Phys Rev Lett Lodge Cendoya Alegr Polym molecule publish Struik Physical Aging Amorphous Polymers Materials Elsevier recent Res Dev Macromol Res Alegr GuerricaEchevarr molecule Thies Macromolecules Kumar Jonscher Dielectric Relaxation Solids Chelsea electric Press London precisely m1nam reduce case symmetric loss peak edit Berlin Adam Matsuoka relaxation Phenomena Polymers Hanser Munich Cowie Manias EQUILIBRIUM DYNAMICS POLYVINYL PHYSICAL",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "involv": 1,
                    "simula": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain _MBD_ of methyl-CpG binding protein 2 _MeCP2_.pdf",
            "cleaned_text": "oxidative damage methylcpg sequence inhibit bind methylcpg bind domain MBD methylCpG binding protein mecp2 Tsai1 Adrian bird1 Loma Loma Linda 1Institute Cell Molecular Biology University Edinburgh Edinburgh EH9 receive revise Accepted July Cytosine methylation cpg dinucleotide believe important gene regulation generally associate reduce level transcrip tion gene silence involve series interac tion begin bind methylcpg bind protein MBPs follow recruitment histonemodifying enzyme together promote chromatin condensation inactivation widely know alteration methylation pattern associated gene activity often find human tumor however mechanism methylation pattern alter currently understand paper investigate impact oxidative damage methylcpg site bind selective placement oxoguanine oxog hydroxymethylcytosine recognition sequence contain specific modification assay bind ing methylcpg bind domain MBD member family methylcpg bind pro tein MeCP2 result reveal oxidation single guanine oxoG single HmC significantly inhibit bind MBD oligonucleotide duplex reduce bind affinity least order magnitude oxidative damage dna therefore result heritable epigenetic change chromatin organization introduction Cytosine methylation pattern high eukaryote import ant gene regulation follow dna replication methyla tion occur enzymatically position cytosine residue preferentially hemimethylate cpg dinucleotide promoter region generally associate transcription repression propose mechanism cpg methylation repress gene expression bind specic protein methylcpg bind ing protein MBPs methylcpg bind protein mecp2 member family contain well conserved amino acids domain discriminate oligonucleotide odns contain methylate unmethylated cpg dinucleotide bind methylate dna MBPs recruit cytosine methyl transferase histone deacetylase protein involve chromatin remodeling initial bind MBPs methylate critical event epigenetic regulation gene activity methylation pattern frequently alter human tumor long recognize hydrolytic deamination methylcytosine residue thymine account mutation observe human tumor recently however recognize epigenetic silence tumor suppressor gene aberrant loss methylation promoter region transform gene frequently observe human tumor absence mutation mechanism form dna damage result alteration methylation pattern transcriptional activity thoroughly study precise nature high afnity mbps late cpg dinucleotide yet fully understand ever specic contact guanine functional group well hydrophobic patch interact symmetric methyl group wellconserved methylCpG bind ing domain implicate basis previous nding predict oxidation guanine disrupt interaction dna study focus effect endogenous oxidative damage product derive reactive oxygen spe cie ROS bind guanine oxidation damage product oxoguanine oxoG major form dna damage oxida oxog convert position guanine hydrogen bond acceptor hydrogen bond donor well replace proton oxygen atom figure modication potentially interfere recognition methylcpg dinucleotide MBPs know conversion hydrogen bond acceptor guanine hydrogenbond donor oxog exploit oxog repair enzyme hogg1 correspondence address fax email lsowerssomlluedu Vol right reserve online glycosylase discriminate undamaged oxidized guanine residue suggest purine posi tion generally important landmark specicity interaction human genome cytosine residue methylate minor base substantially less work do damage product derive addition reaction product deaminate readily corresponding thymine derivative fore lose background generate predominant thymine methyl group thymine susceptible oxidation slightly reactive oxidation generate hydroxymethyl cytosine formylcytosine carboxycytosine Figure detect mammalian cell specic glycosylase activity par puried mammalian tissue well recognize thymine methyl group important landmark inter action oxidation methyl group thymine generate recently show interfere transcription factor bind fore suspect oxidation hydrophobic methyl group hydrophilic hydroxymethyl group also interfere bind investigate effect guanine oxidation bind series ODN substrate prepare contain HmC oxog residue select position figure bind series ODN duplex study use gel electrophoretic mobility shift assay result reveal methylation strand ODN increase bind order magnitude symmetric methylation increase bind afnity order magnitude apparent methylationinduce increase bind afnity theoretical maximum predict contribution methyl group replacement residue replacement guanine oxoG observe effectively reverse increase bind afnity afford residue fore oxidation guanine oxog vivo inhibit initial bind mbps interfere subsequent step chromatin condensation cascade result potentially heritable epigenetic alteration material METHODS ODN synthesis odn figure contain normal basis modied base prepare standard solid phase synthesis use macia Expedite Nucleic Acid Synthesis System Applied Biosystems automate dna synthesizer NH2 CH3 NH2 CH2OH cytosine methylcytosine hydroxymethylcytosine HmC NH2 oxoguanine oxoG guanine NH2 NH2 CH3 thymine agcttatcgcagcnggcgcgaatctga TCGAATAGCGTCGGNCGCGCTTAGACT Figure Structures cytosine methylcytosine hydroxymethylcytosine thymine guanine oxog Sequence ODN duplex use position cytosine HmC strand yield duplex respectively duplex name base modification position slash denoting modification different strand central cpg modification upper strand indicate slash modification low strand indicate slash duplex contain oxog use name manner similar duplex contain position upper low strand oxog replace boldface low strand duplex contain position upper strand position low strand give name Vol New York University sequencefigure1btopstrandanditscomplementfigure1b bottom strand choose base bind experi ment conduct Free Hendrich phosphoramidite prepared accord method develop laboratory phosphor use obtain contain ODNs remove solid support deprotecte aqueous ammonia odns remove solid support deprotecte aqueous ammonia Aldrich overnight deprotecte odns puried PolyPak car tridge sequence composition odns graphy hplc analysis follow digestion odns nuclease bacterial alkaline phosphatase Sigma overnight odns contain oxoG central guanine position Figure boldface synthesize TriLink Biotechnologies San Diego Protein expression purification pafb105 construct encode mouse MeCP2 residue pET6H vector overexpresse coli BL21 DE3pLysS expression purication carry essentially accord protocol free total litre inoculate overnight culture trans formant coli BL21 DE3pLysS dilution grown a600 prior induction isopropylthiogalactoside cell vest wash HEPES NaCl resuspend bind buffer imidazole TrisHCl NaCl glycerol Triton mercaptoethanol cat cellular debris pellete min clear lysate retain mix nitriloacetic acid agarose resin bind buffer Binding conduct gentle shake mixture pack column nal resin volume column wash bind buffer contain imidazole elute bind buffer contain imidazole elution fraction load EMD SO2 column wash bind buffer step elute bind buffer contain bind buffer contain bind buffer contain NaCl majority pure protein elute fraction contain NaCl eluate pool dialyze litre NaCl glycerol Triton puried protein judge pure sdspage westernblot analysis show protein react strongly anti antibody Electrophoretic mobility shift assay 27mer ODNs Figure label polynucleotide kinase condition recom mend enzyme supplier label ODNs puried use column label complementary strand Figure upper strand incubate fold excess unlabeled strand figure low strand HEPES EDTA min allow cool room temperature slowly duplex formation duplex anneal possible combination position indicate strand figure conrm duplex formation cytosine modication anneal odns digest MspI accord con dition recommend enzyme supplier product size denature polyacrylamide gel MspI able cleave duplex cytosine modie symmetrically asymmetrically cpg able cleave unmodied duplex datum show result accordance datum present conrm presence cytosine modication duplex duplex contain oxog also label anneal describe presence oxog duplex duplex glycosylase accord condition recommend enzyme supplier reaction product visualize denature polyacrylamide gel vary concentration incubate label duplex polypoly nh42so4 KCl min room temperature reaction volume addition loading buffer glycerol bind reaction load nondenature polyacrylamide acrylamide bisacrylamide gel prerun sample electrophorese visualization quantication gel carry use software model datum analysis believe bind symmet rically methylate dna substrate monomer therefore follow bind scheme describe bind MBD substrate unbound MBD unbound ODN duplex MBDODN duplex complex scheme dissociation constant concentration MBD ODN duplex bind MBDODN duplex complex dene follow rearrangement equation yield follow equation datum radioactivity band quantie use software fraction bind plot function protein tion fraction duplex bind determine protein concentration follow fraction duplex bind total total total total concentration bind unbound substitution equation equation yield equation fraction duplex bind total total determine dissociation constant ODN duplex use study average minimum datum set obtain duplex equation nonlinear regression use sigmaplot software SPSS Science apparentfree energy change DDGap MBD bind fully methylate duplex compare duplex calculate accord follow equation kcal mol positive DDGap indicate decrease bind duplex interest compare symmetrically methylate duplex negative DDGap indicate increase bind duplex interest error propagation determination DDGap experi mentally determine value calculate use basic equation error propagation give result ODN duplex sequence represent Figure synthesize base sequence previously use examine bind property 27mer contain central cpg dinucleotide systematically modied describe duplex synthesize possible combination hemi symmetrical figure central cpg assay bind MBD mecp2 different protein concentration range figure duplex contain single oxog Figure across next fully methylate cpg dinucleo tide unmethylated cpg dinucleotide also assay bind manner figure last duplex contain position upper strand position lowerstrand figure result next base pair also assay figure Table determined duplex use nonlinear regression equation simple noncooperative monomeric binding show bind require methylate cpg dinucleotide necessary sufcient bind target duplex previously bind MBD MeCP2 single methyl pair report symmetrically methylate cpg pair obtain bind study deter mine different duplex comparable datum report figure bind duplex vary concentration assay Free Table also report reduce bind MBD dna contain hemimethylate cpg unmethylate cpg pair data conrm duplex hemi unmethylate cpg dinucleotide sequence bind MBD well symmetric methylcpg duplex however note signicant quantitative difference bind hemi unmethylated duplex observe figure hemi methylate cpg duplex fold higher fully methylate cpg pair unmethy lated duplex fold high table figure DDGap hemimethylated duplex compare fully methylate duplex kcal mol DDGap unmethylated duplex kcal mol Table datum reveal residue contribute equally bind residue lower factor compare unmethylated pair also datum indicate apparentfree energy change remove residue methyl cpg dinucleotide additive table furthermore datum consistent bind target duplex monomer recognize hmc5mc 5mCHmC 5mc5mc MBD concentration percent Binding figure nonlinear regression plot average percentage binding determine set titration duplex concentration duplex contain normal purine site site oxoG site methylated cytosine fully methylate duplex much MBD MBD1 bind curve fully methylate duplex reveal inection point Figure suggest bind residue methyl pair inection point expect binding entail MBD symmetrically methylate cpg dinuclotide datum assay duplex bind also consistent datum report indeed MBD MeCP2 homo logou MBD MBD4 also recognize mismatch methylcpg dinucleotide datum show obtain duplex nearly identical obtain duplex table figure signicant difference apparentfree energy change MBD bind duplex table bind constant duplex contain oxidation damage product also determine cing residue symmetrically methylate cpg dinucleotide regardless replace decrease bind figure increase fold Figure Table DDGap value kcal mol Table thereby indicate bind equivalent hemi methylate duplex Replacement methylcytosine reduce afnity duplex place free energy change range unmodie pair figure Table result suggest context MBD bind oxidize methyl group methyl cpg dinucleotide func tionally equivalent demethylate residue addition effect oxoG fully methylate cpg determine result show dramatic reduction bind fully methylate cpg compare fully methylate cpg oxidize guanine figure increase fold Figure Table presence oxog unmethylated cpg also adversely affect binding result fold increase compare undamaged unmethylated cpg table figure presence oxog hemimethylated CpG also reduce bind level unmethylated duplex Figure Table Dissociation constant free energy change MBD MeCP2 bind 27mer duplex contain possible combination hemi symmetrical cpg pair contain oxog hemi symmetrically methylate cpg dinucleotide contain mismatch methyl cpg sequence context coefficient kcal mol 5mC5mC hmc5mc use sigmaplot bind duplex deter mine nonlinear regression set datum obtain plot average percentage bind duplex concentration MBD fit equation see Materials Methods TherangesseenintheKdvaluesarethestandarderrorfortheregressionanalysis DDGap value compare free energy change MBD bind symmet rically methylate duplex bind duplex represent duplex top strand figure write slash unlabeled bottom strand write slash figure figure bind duplex vary concentration assay substitution guanine oxoG hemimethylated duplex reduce bind substantially oxog adjacent pair residue however effect great adjacent residue figure Table datum conrm multiple site methylate cpg dinucleotide need strong bind MBD Figure oxidative damage site dramatically interfere interaction discussion conclusion high eukaryote cytosine methylation crucial gene regulation development genomic imprinting chromosome inactivation underscore importance methylation normal development differentiation aberrant methylation pattern observe many human cancer mechanism perturbation arise important yet relatively unexplored aspect cancer development little known currently potential mechanism dna damage result epigenetic change previously examine impact oxoG capacity human DNA methyltransferase late dinucleotide observe replacement guanine oxog inhibit methylation cytosine resi due adjacent oxog residue little effect methylation dinucleotide target cytosine pair oxog residue observe hemimethylate cpg dinucleotide replacement guanine residue oxog substantially diminish bind great effect see oxog residue place adjacent residue table figure currently unknown guanine residue specic sequence prone oxidation previously Watanabe demonstrate replacement inhibit MBD bind inhibition binding result tion explain basis unfavorable steric clash methyl group loss position hydrogen bond acceptor predominant keto tautomeric form oxoG place proton position result conversion hydrogen bond accep tor donor result oxog discuss accordance methylation study provide additional evidence position guanine act hydrogen bond acceptor formation complex methyl group likely site oxida tion damage pyrimidine component methylate cpg dinucleotide result formation Figure previously predict residue oxidized human cell day normal metabolic condition even great number ing oxidative stress conversion predict mutagenic substantially perturb dna structure indeed genome even phage contain residue instead cytosine residue miscode lesion mammalian genome specic glycosylase remove worker argue primary role HmU glycosylase repair product derive oxidation methyl group thymine important interaction prox imity methyl group major groove form dna helix symmetrically methylate cpg sequence illustrate figure contribution Waals interaction solvation effect believe con tribute favorable bind afnity result presence methyl group contribution Waals interaction small kcal mol solvation effect large kcal mol thymine replace uracil HmU bind site AP1 transcription factor bind energy decrease modest kcal mol contrast contribution methyl group MBD binding estimate kcal mol represent upper limit effect methyl group specicity interaction methyl group critical discrimination mbps methylated unmethylated DNA predict conrme experimentally oxida tion HmC impede binding protein recog nize methyl group accordance similar study thymine oxidation damage product protein recognize thymine methyl group result suggest pyrimidine methyl group oxidation generally substantially interfere interaction programming eukaryotic cell rely specic placement methyl group select cpg dinucleo tide mechanism methylation pattern initially establish well understand establish symmetrically methylate cpg dinucleotide Figure molecular model sequence GCmCGGC methyl group depict green position guanine methylcpg dinucleotide depict dark blue multiple site methylate cpg dinucleotide need strong bind MBD major site contact methyl group hydrogen bond accept nitrogen major groove dna close proximity disruption MBD bind result oxidative damage one site convert hemimethylated dinucleotide result semiconservative dna replication hemimethylated par ental strand direct methylation progeny strand maintenance methylase regenerate symmetrically methylate site binding examine preferential methylation hemimethylated site base specic recognition methyl group residue parental strand maintenance methylase follow dna replication methylation MBPs includ ing mecp2 study selectively bind methylate cpg site result indicate symmetric lation increase afnity bind relative unmethylated sequence factor additional afnity afford methylation theoretical possible methyl substituent indicate import ance cytosine methylation selective bind mbps additional protein afnity MBPs accumulate covalently modify histone protein immediate vicinity lead condense less transcription ally active chromatin region sequence event methylation signal DNA use establish condense regional chromatin structure follow cell division DNA organism constantly damage substantial work report previously array lesion miscode block dna replication signicantly less work do role dna damage alter epigenetic programming exist datum suggest bind mbps methylate dna critical link cascade event maintain heritable gene silence result study report accordance previous study indicate contact point guanine residue methylate cpg dinucleotide require highafnity bind mbps interaction methyl group pro vide high level discrimination methylate unmethylated dna sequence oxidation show eliminate discrimination pair oxidative lesion break normal chain event allow propagation epigenetic signal perhaps explain part disregulation transcriptional activity observe tumor ment gratefully assistance preparation graphic study sup port part CA84487 support part training program eukaryotic DNA Science Riggsand Jones generegulationand cancer DNA methylation gene activity Biochem Bird High level novo methylation alter chromatin structure cpg island cell line Cell Jaenisch Bird Epigenetic regulation gene expression genome integrate intrinsic environmental signal chromatin organization dna methylation determine gene expression Semin Cancer Biol Bird repressionbelt brace chromatin Cell nanmeehanandbirddissectionofthemethylcpg bind domain chromosomal protein mecp2 Biol Chem Meehan Lewis Bird Characterization mecp2 vertebrate dna bind protein affinity methylate DNA Nucleic Acids Res Lewis Meehan Henzel MaurerFogy Bird Purification sequence cellular localization novel chromosomal protein bind methylate DNA Cell MagdinierandWolffeSelectiveassociationofthemethyl cpg bind protein silent p14p16 locus human neoplasia altered chromatin structure associate methylationinduced gene silence cancer cell correlation accessibility methylation mecp2 binding acetylation Nucleic Acids Res Nan Bird biological function methylcpg bind protein mecp2 implication syndrome Brain Dev S32S37 Bird DNA methylation specify chromosomal localization MeCP2 Mol Cell Biol Holliday dna methylation epigenetic inheritance Methods cpg methylationdependent repression human methylguanine dna methyltransferase gene link chromatin structure alteration Carcinogenesis protein mecp2 target molecule maintenance dna methyltransferase Dnmt1 Biol Chem Kouzarides methylcpgbinde protein mecp2 link dna methylation histone methylation Johnson Bird Transcriptional repression methylGpGbinding protein MeCP2 involve histone deacetylase complex Nature meet tail repression Cell Jones Veenstra Kass DNA recruit histone deacetylase repress transcription Nature Genet Zhang Hendrich Johnson Turner transcriptional repressor belong MeCP1 histone deacetylase complex Nature Genet Jeppesen Bird active repression methylate gene chromosomal protein MBD1 Mol Cell Biol Jones role dna methylation cancer Adv cancer Res Jones mutation cancer DNA methylation human carcinogenesis Biol Chem Santini Kantarjian Changes dna methylation neoplasia pathophysiology therapeutic implication Vol New York University Jones Mechanisms involvement dna methylation colon carcinogenesis Cancer Res Hendrich Hardeland Jiricny Bird thymine glycosylase bind product deamination methylate cpg site Nature Nan Campoy transcriptional repressor abundant bind site genomic chromatin characterization family mammalian methylCpG bind protien solution structure domain bind methylate dna Mol Biol Ohki Shimotake Fujita structure methylcpg bind domain human MBD1 complex methylate DNA Cell Kasai deoxyguanosine position ascorbic acid reduce agent hydroxyguanine moiety deoxyribonucleic acid gammairradiation aqueous solution Biochemistry oxoguanine enemy trend specific basis DNA synthesis oxidationdamaged base oxodG Nature Mori Kasai Inoue dna template contain modify base adjacent residue HiroshiNishimuraand abundant form oxidative dna damage cause substitution basis recognition repair endogenous mutagen oxoguanine DNA Nature Jang GoddardIII principle calculation tautomer pKa value oxoguanine implication mutagenicity repair GamaSosa distribution methylcytosine human DNA different type tissue cell Nucleic acid res Burdzy Noyes Valinluck stableisotope enrich methylpyrimidine use probe base reactivity DNA Nucleic Acids reaction hydroxyl radical nucleic acid basis related compound gamma irradiate aqueous solution deamination demethylation methylcytosine brain deoxyribonucleic acid base content maturation normal malnourished rat presence hydroxymethylcytosine animal deoxyribonucleic acid phylogenetic evidence role glycosylase maintenance methylcytosine DNA DNA glycosylase activity mammalian tissue Gumport effect baseanaloguesubstitutionsonthemethylationbytheEcoRImodification methylase octadeoxyribonucleotide contain modify EcoRI recognition sequence Gumport effect base analogue substitution cleavage EcoRI restriction endonuclease octadeoxyribonucleotide contain modify EcoRI recognition sequence highperformance liquid chromatography analysis dna oxidize vivo Anal Biochem Cadet Tripier oxidative base damage dna use hplc32ppostlabelling selective ion monitoring assay IARC Sci Publ dna lesion inhibit bind transcription factor contribution thymine methyl group specific recognition poly mononucleotide analysis relative free energy solvation thymine uracil situ preparation deoxyribonucleoside phosphoramidite use polymer support synthesis oligodeoxyribonucleoside phase synthesis restriction endonuclease cleavage oligodeoxy nucleotide contain hydroxymethylcytosine Targeted mutation DNA methyltransferase gene result embryonic lethality Cell Shiota DNA methylation development normal clone animal Differentiation Dausmann JacksonGrusby Germline passage require establishment ofmethylation andexpressionpatternsofimprintedbutnot nonimprinte gene Genes Dev Francke syndrome cause mutation link encoding methylcpgbinde protein Nature Genet Chromatin modification epigenetic reprogramming mammalian development Nature Rev Genet Bird DNA methylation pattern epigenetic memory DNA adduct hydroxyldeoxyguanosine hydroxyguanine affects function human dna methyltransferase Tsuruzoe dna bind domain glycosylase link transcriptional repression dna repair chromatin basis nucleic acid bacterialandanimalviruse theoccurrenceof5hydroxymethylcytosine Rogstad perturbation dna function Bestor alter methylation pattern cancer cell genome cause consequence cancer cell direct moiety carbon cytosine activity human dnacytosine methyltransferase",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 38,
                    "epigenetic": 10,
                    "demethylation": 1
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "PolyPak": 1,
                    "MBD1": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "PolyPak": 49,
                    "MBD1": 49
                },
                "Ethnographic Terms": {
                    "methylation": 2,
                    "epigenetic": 2,
                    "demethylation": 2
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Palladium _II_-catalyzed direct conversion of methyl arenes into aromatic nitriles..pdf",
            "cleaned_text": "organic chemistry frontier research article Cite receive accept 5th c4qo00218k direct conversion allyl arene alkenyl nitrile Yan Zhanga mild palladiumcatalyze ammoxidation approach lead formation triple bond allyl group develop directly convert allylarene alkenyl nitrile Introduction nitrile unique structural unit organic synthesis versatile building block natural product agricultural chemical pharmaceutical dye important application various field eort devote development ecient synthetic method type nitrile compound however method far develop base functional group transformation addition reaction good knowledge case catalyze direct conversion allyl derivative correspond unsaturated nitrile report demon strate oxidative bond transformation allyl arene alkene correspond nitrile nitrogen source dichlorodicyanobenzoqui none DDQ oxidant allyl radical generate singleelectrontransfer propose key step intermediate transformation allylic bond transformation relate recent study tran sitionmetalcatalyze direct allylic functionalization terminal alkene emerge powerful strategy organic synthesis hand recently report direct synthesis aromatic nitrile methyl arene OAc hydroxyphthalimide NHPI catalyst tertbutyl nitrite tBuONO nitrogen source radical propose key intermediate reaction Scheme continuation interest development novel cyanation method ceive similar allyl radical also generate similar catalytic system direct conversion terminal alkene alkenyl nitrile achieve Herein report catalyze direct transformation allyl arene correspond alkenyl nitrile using tertbutyl nitrite nitrogen source oxidant reaction proceed mild condition aorde moderate good yield alkenyl nitriles Scheme result discussion similar previous study investigation begin evaluation direct transformation corresponding cinnamonitrile oxidative con dition Table absence additive reaction catalyze mol OAc tertbutyl nitrite give trace amount entry reaction dioxane acetonitrile produce yield respectively entry form yield presence hydroxyphthalimide additive catalytic amount mol mol OAc entry reaction optimize use mol OAc entry also examine carbon radical pro duce catalyst trihydroxyisocyanuric acid THICA additive reaction aorde diminished Scheme oaccatalyze cyanation methyl arene allyl arene electronic supplementary information available preparation sub strate characterization datum NMR spectra see c4qo00218k aBeijing BNLMS Education College Chemistry Peking University mail wangjbpkuedu Fax Tel bState Shanghai journal View Article Online View Journal View Issue yield also examine additive however reaction give yield entry metal catalyst include PdCl2MeCN OAc CuCl OAc also examine aorde low yield trace amount product entry optimize reaction condition various allylarene investigate mol OAc mol NHPI catalyst system Scheme Electrondonating substitu ent para meta ortho posi tion arene group aect reaction aorde correspond alkenyl nitrile yield remarkably sensitive substituent functional group trimethylsilyl tolerate well transformation substrate substitute electronwithdrawe group also work well aorde desire product moderate yield noteworthy reaction also work heteroarylsubstituted propene giving yield addition polycyclic aromaticsubstituted propene also successfully convert corre ponde alkenyl nitrile good yield similar transformation methyl arene plausible mechanism propose show Scheme initially oxidant tertbutyl nitrite react generate active phthalimide oxyl radical PINO tertbutyl nitrite decompose radical methylpropanol allyl arene go singleelectrontransfer set oxidation PINO produce correspond allyl radical subsequently radical recombination radical occur form intermediate isomerization aldoxime oaccatalyze dehydration finally lead desire nitrile product substantiate mechanistic hypo Table Optimization reaction conditionsa Entry Cat mol TBN equiv additive mol Solvent OAc none OAc none OAc none Dioxane OAc none MeCN OAc OAc OAc OAc TEMPO MeCN PdCl2MeCN NHPI OAc NHPI MeCN Trace OAc reaction condition mmol catalyst additive tert butyl nitrite TBN dry solvent stir isolated yield NHPI hydroxyphthalimide THICA trihydroxyisocyanuric acid TEMPO tetramethyl piperidinyloxy Scheme Scope catalyze direct conversion allylarene alkenyl nitrile otherwise note reaction condition follow mmol tertbutyl nitrite mmol OAc mmol mmol yield isolated product give atertButyl nitrite equiv use nitrite equiv use journal View Article online thesis carry reaction dard condition absence OAc catalyst reaction give complex mixture oxime correspond cinnamaldehyde identi fie conclusion develop novel catalyze direct synthesis alkenyl nitrile corresponding allyl arene mild condition use tertbutyl nitrite nitrogen source inexpensive NHPI catalyst notably transformation bond cleave form bond reaction oer novel method synthesis biologically medicinally important alkenyl nitriles experimental section General palladiumcatalyze reaction perform nitrogen atmosphere flamedrie reaction flask sol vent distil nitrogen atmosphere prior use dry intermediate indicator dichloroethane dry chromatography mesh silica gel employ nmr spectra record mhz mhz shift report ppm use tetramethylsilane internal spectra record infrared spectrometer LRMS obtain Agilent inert mass spectrometer obtain ESI GCT reaction carry dry seal tube atmos phere nitrogen otherwise note material obtain commercial supplier use purifi cation start material prepare corresponding aryl bromide accord previously report literature prepare thiophene accord ing previously report literature General procedure catalyze reaction nitrogen atmosphere allylbenzene mmol mmol equiv mmol equiv OAc mmol equiv stir cool reaction dilute result mixture filter filtrate concentrated purification column chromatography mixture give pure light yellow oil nmr CDCl3 MHz nmr CDCl3 MHz transmethylcinnamonitrile general procedure give pure white solid yield nmr CDCl3 MHz nmr CDCl3 MHz transmethylcinnamonitrile general procedure give pure light yellow oil yield nmr CDCl3 MHz nmr CDCl3 MHz transmethylcinnamonitrile general procedure give light yellow oil yield nmr CDCl3 MHz nmr CDCl3 MHz transmethoxylcinnamonitrile general procedure give pure yellow oil yield nmr CDCl3 MHz nmr CDCl3 MHz transmethoxylcinnamonitrile general procedure give pure white solid yield nmr CDCl3 MHz nmr CDCl3 MHz transmethoxylcinnamonitrile general procedure give pure light yellow oil yield nmr CDCl3 MHz nmr CDCl3 MHz neat scheme propose mechanism Organic Chemistry Frontiers Research Article journal View article Online HRMS ESI calcd C10H10NO find transtertbutylcinnamonitrile general pro cedure give pure yellow oil yield nmr CDCl3 MHz nmr CDCl3 MHz transtrimethylsilylcinnamonitrile general pro cedure give pure yellow oil yield nmr CDCl3 MHz nmr CDCl3 MHz neat HRMS ESI calcd find transphenylcinnamonitrile general procedure give pure white solid yield nmr CDCl3 MHz nmr CDCl3 MHz neat HRMS ESI calcd find transfluorocinnamonitrile general procedure give pure yellow solid yield nmr CDCl3 MHz nmr CDCl3 MHz transchlorocinnamonitrile general procedure give pure light yellow solid yield nmr CDCl3 MHz nmr CDCl3 MHz general procedure give pure yellow solid yield nmr CDCl3 MHz nmr CDCl3 MHz transtrifluoromethylcinnamonitrile general procedure give pure white solid yield nmr CDCl3 MHz nmr CDCl3 MHz general pro cedure give pure white solid yield nmr CDCl3 MHz nmr CDCl3 MHz neat HRMS ESI calcd find transthiophenacrylonitrile general pro cedure give pure yellow oil yield nmr CDCl3 MHz nmr CDCl3 MHz transnaphthalenacrylonitrile general pro cedure give pure white solid yield nmr CDCl3 MHz nmr CDCl3 MHz transnaphthalenacrylonitrile general pro cedure give pure white solid yield nmr CDCl3 MHz nmr CDCl3 MHz transphenanthrenacrylonitrile general procedure give pure white solid yield nmr CDCl3 MHz nmr CDCl3 MHz neat HRMS ESI calcd find ment project support Program grant Notes see Fatiadi Preparation Synthetic Applications Cyano Compounds Patai New Int Yamaguchi Fujiwara Int Nakao soc Zhou Oishi Research Article Organic Chemistry Frontiers Org Chem Front journal View Article Online Yamaguchi Int select report heterogeneous approach acrylonitrile propene see Faraday bond formation see Prabagaran Sirois bond formation see Soc Int bond formation see White Chem Soc Howell White Chem Soc Wang CF3 bond formation see Wang Zhang bond formation see Int Int Hirai Sawatari recent see recent example see Synth Commun Wang Zhang Org Article journal View Article Online",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {}
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Piracetam defines a new binding site for allosteric modulators of \u03b1-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid _AMPA_ receptors.pdf",
            "cleaned_text": "pubsacsorgjmc jm901905j Piracetam define New Binding Site Allosteric modulator ampa receptor Ithaca New York receive Glutamate receptor prevalent excitatory neurotransmitter receptor vertebrate central nervous system important potential drug target cognitive enhancement treatment schizophrenia allosteric modulator ampa receptor promote dimerization bind dimer interface reduce desensitization deactivation pyrrolidine allosteric modulator piracetam first class drug discover determine structure ligand bind domain ampa receptor subtype glua3 piracetam corresponding structure glua3 drug bind GluA3 similar manner suggest little subunit specificity however bind site piracetam differ considerably bind symmetrical site center dimer interface Piracetam bind multiple site dimer interface low occupation unique bind site potential allosteric modulator new site importance design new allosteric regulator introduction Ionotropic glutamate receptor iGluRs find vertebrate central nervous system neuron responsible majority excitatory synaptic transmission addi tion important role process learning memory receptor associate disor der Parkinson Alzheimer disease chorea neurological disorder include epilepsy ischemic brain damage iglur compose subunit arrange havebeen identify characterize pharmacological property quence functionality biological role sensitive synthetic agonist methylaspartic acid NMDA GluN1 GluN3A synthetic agonist naturally occur neurotoxin kainate ligand bind domain ampa receptor canexist intwoalternativelysplicedform closing rate sensitivity allosteric modulator extracellularagonistbinde domain s1s2domain ionotropic glutamate receptor consist lobe agonistbinde pocket locate lobe structure S1S2 domain GluA3 GluA4 subtype determine presence variety agonist partial agonist antagonist provide structural insight process channel activation desensitization structural basis difference agonist antagonist selectivity recently full tetrameric structure receptor determine bind antagonist structure determine closed channel form availability structure provide new insight quaternary structure iGluRs provide useful framework understand channel activation first nootropic agent discovered26 find originally effective protective agent hypoxiainduced amnesia affect number neuronal protein evidence suggest act ampa receptor member racetam family drug considerably potent act directly ampa receptor allo steric modulator ampa receptor block slow desensitization slow deactivation enhance synaptic pla ticity characteristic lead clinical trial several drug Alzheimer disease attention deficit disorder available mild mentia Europe structure bind dimer agonistbinde domain GluA2o reported30itbind ina symmetricalsiteatthedimerinterface consistent allosteric activator bind dimer interface slow prevent dissociation dimer dimer form activation receptor correspondence address phone fax mail reo1cornelledu aAbbreviations althiazide ampa aminohydroxy methylisoxazolepropionic acid iglur ionotropic glutamate pyrrolidinooxazinobenzodioxanone GluA2i N754S mutation GluA2o mimic flip form respect bind allosteric modulator flop form GluA2 GluA3i flip form GluA3 HCTZ hydrochlorothiazide HFMZ hydroflumethiazide isopropyl thiogalactoside NMDA methylaspartic acid PEPA phenylsulfonylaminoethylthiodifluorophenoxyacetamide S1S2 extracellular ligandbinde domain glua3 tcmz trichlormethiazide Vol think represent active form protein preventing dimer dissociation block slow desensitization36 well effect deactivation bind site allosteric activator atthe dimer interface actually large surface several subsite include central subsite pair lateral subsite figure bind site allosteric activator consist subsite typically activa tor bind site include subsite bind copy dimer symmetry dimer inter face density correspond overlap molecule observe true CX614 CX546 hand benzothiadiazide activator bind copy dimer interface bind site include lateral subsite differentially occupy depend structure benzothiadiazide rather large surface nonoverlapping subsite suggest mean whichactivator affinity increase thatis generate multivalent compound interact different sub site proof principle demonstrate dimeric biarylpropylsulfonamide compound synthesize Kaae collaborator report bind S1S2 domain GluA3i piracetam bind S1S2 domain GluA3i GluA2o case glutamate agonistbinde site bind GluA3i manner similar GluA2o small change side chain rotameric state Likewise piracetam bind show obvious subtype differ ence density low glua3 important note subtle difference outlying region affect bind affinity however piracetam bind multiple position dimer interface prominent position lateral edge dimer interface represent unique subsite report viously new site value design new multivalent allosteric modulator Experimental Section Materials Glutamate obtain purchase purity judge HPLC S1S2J construct flop form denote GluA2o obtain linker region replace ion channel cassette consist residue glycine threonine n754s mutation pre pare allow bind flipspecific allosteric modulator denote construct flip form GluA3 GluA3i describe previously S1S2 protein prepare describe Gouaux23 slight modification Briefly pet22b plasmid transform coli strain Origami DE3 cell grow medium supplement antibiotic ampicillin kanamycin culture cool min isopropylthiogalactoside add final concentration culture allow grow cell pellete S1S2 protein purify use column follow size column finally ion exchangesepharose column maintain buffer purification last column protein concentrate store sodium acetate sodium azide glutamate crystallization crystallization trial protein concentrate use centrifugal filter presence glutamate final piracetam concentration crystal grow use hang drop techni que drop contain ratio protein solution reservoir solution reservoir solution poly ethylene glycol PEG sodium cacodylate zinc acetate Crystal Structure Determination Data collect Cornell High Energy Synchrotron Source beamline use area detector systems chargecouple device detector Data set index scale solve molecular replacement refine use use model building glutamatebound structure 3DP6 use search model use GluA3 result Discussion Binding Sites Piracetam GluA2 S1S2 allosteric modulator ampa receptor pirace tam bind S1S2 dimer interface Figure show position dimer context full length receptor crystal structure piracetam bind flop form GluA2o n754s mutation flop form mimic flip form determine show figure piracetam bind position symmetry dimer correspond set distinct bind site difference GluA2o limit several change rotameric state side chain structure show general density piracetam low protein suggest modulator mobility bind site portion bind site occupy later possibility consistent low affinity compound ampa receptor Binding site set bind site pyrrolidine ring piracetam partially overlap position pyrrolidine ring structure structural analogue piracetam bind S1S230 figure include central subsite subsite well portion subsite case bind largely subsite portion subsite modulator bind symmetrical orientation time piracetam substitutes amide methoxyphenyl group copy potentially bind central location orientation pyrrolidine ring rotate approximately relative carbonyl pointing cleft bind surface figure S1S2 bind water molecule bury cleft form bond network carbonyl pyrrolidine ring backbone I481 side chain hydroxyl S754 difference piracetam structure bond water make carbonyl oxygen pyrrolidine ring piracetam benzoyl carbonyl water molecule fill subsite Binding Site second set bind site site figure figure overlap partially thiazide bind site subsite contrast thiazide depend substituent position fill preferentially rather subsite amide piracetam interact side chain hydroxyl side chain carboxyl D760 proximity bind site bind site suggest bind site occupy give time Binding site third set bind site site figure correspond previously report allosteric modulator bind site represent strong density set bind site surface expose bind site inverted shape crevice form monomer make dimer crevice open pocket face membrane expose solvent figure case amide interact side chain amide pyrrolidine carbonyl interact side chain carboxyl D760 side chain hydroxyl S729 Figure Binding site glua3 S1S2 Piracetam structure GluA3i obtain presence piracetam overall density piracetam low see GluA2o density bind site describe low determine orientation piracetam density bind site strong strong orientation bind site identical GluA2o datum show figure structure GluA2 bind piracetam position ligand bind domain S1S2 dimer context fulllength tetrameric receptor show crystal structure bind antagonist ZK200775 ligand bind domain monomer colored shade blue colored shade green light color lobe dark color form bind piracetam show orientation symmetrical set bind site find dimer interface label bind site bind site partially overlap unlikely occupy simultaneously detail bind site piracetam show several water molecule bind site important interaction structure piracetam Vol S1S2 structure GluA3i S1S2 glutamate agonistbinde site bind solve show figure bind site largely similar previous structure bind GluA2o fluorowillardiine figure consistent fact sequence bind site differ little subtype minor difference however observe small change dihedral angle observe GluA2o GluA3i result side chain S497 exist distinct rotameric state figure state form bond pyrrolidinone ring show green carbon figure form watermediated bond side chain k763 case GluA2o water mediate bond K763 observe rotameric state also different GluA2o GluA3i GluA2o point bind cleft GluA3i point solvent GluA3i structure flip form position serine asparagine GluA2o additional space due small side chain result additional water molecule interface GluA3i effect substitution seem change bind site significantly small flop form report piracetam water molecule bury bind cleft bond carbonyl oxygen side chain S754 water molecule show figure orientation picture however case isthebenzoylcarbonylthat makesthe bondto water molecule instead pyrrolidine carbonyl Conclusions base structure Piracetam weak modulator ampa receptor increase response presumably due block desensitization rela tively low affinity28 variety effect clinical effect piracetam necessarily mediate ampa receptor description bind site ampa receptor provide insight possible strategy design new effective allo teric modulator bind site allosteric modulator ampa ceptor determine large number case use crystallography CX614 dimeric biaryl propylsulfonamide several derivative thiazides37 modulator bind rather large surface dimer inter face subdivide central subsite subsite figure set lateral subsite subsite occupy mainly subsite a30 interaction subsite thiazide occupy combination subsite subsite alone preferentially occupy subsite rela tively large substituent position span subsite however size subsituent decrease ring rotate occupy largely subsite seem due fact subsite less solvent expose hydrophobic contrast piracetam occu subsite rather populate superficial subsite bind site piracetam water fill subsite lack direct interaction piracetam N754 flop s754 flip suggest cyclothiazide alternatively splice version protein likely strategy propose increase affinity allosteric modulator produce hybrid compound figure Overlay position bind fluorowillardiine agonist bind site structure piracetam bind glutamate bind site molecule bind give dimer interface interface symmetrical orientation observe show carbon color yellow carbon color green water molecule structure show yellow sphere molecule piracetam show white carbon water molecule red sphere bind site piracetam consist set distinct site label bind site describe previously show circle structure rotate illustrate position subsite piracetam site color backbone indicated span several subsite flopselective allosteric modulator PEPA phenylsulfonylaminoethylthio difluorophenoxyacetamide dimeric biarylpropyl sulfonamide compound describe Kaae span sub site interact side bind surface biarylpropylsulfonamide compound occupy portion subsite sulfonamide group case PEPA subsite fully occupy phenyl ring opposite side bind site amide PEPA interact N754 confer flop specifi city unpublished datum structure S1S2 bind piracetam open new possibility drug design bind site figure hasnot beenpreviously describe interaction allosteric modulator possibility increase affinity allosteric modulator covalently link substituent take advantage interaction make piracetam bind site structural similarity compare piracetam much specific ampa receptor potent bind site similar GluA2o GluA3i structure electron density drug bind site high piracetam similarity structure suggest little ampa subtype specificity lead compound develop potent allosteric modulator ampa receptor many potent modulator bind similar manner Replacement methyoxybenzoyl group acetamide group piracetam result decrease affinity interestingly partial popu lation several bind site dimer interface report allosteric activator Figure Structure GluA3i bind aniracetam Dimer GluA3 S1S2 bind glutamate copy show shade blue shade green show orientation carbon white carbon green orientation side chain S497 show carbon white case green Water molecule show red sphere detail bind site orientation correspond contact show side chain S497 orientation one form watermediated bond side chain K763 form water mediate bonding network carbonyl aniracetam Table Structural Statistics structure parameter piracetam piracetam GluA2o piracetam GluA3i aniracetam GluA3i space group P22121 P22121 P2221 P2221 unit cell ray source wavelength resolution measure reflection unique reflection data redundancy completeness code 3LSL 3LSX 3LSW Current Model Refinement Statistics phase molecule RworkRfree free test set size protein atom heteroatom rmsd bond length rmsd bond angle deg Journal Medicinal Chemistry Vol glutamatebound glua2structure 3DP6 usedasthe search model use GluA3 Table Conclusion Pyrrolidine allosteric modulator bind GluA3 similar manner suggest little subunit specificity however piracetam differ siderably bind mode bind clearly symmetrical bind site dimer interface Piracetam hand bind multiple site low occupation unique bind site potential allosteric modulator identification new site importance design new allosteric regulator acknowledgment author thank Prof Vollum Institute GluR2 S1S2J construct discussion significant advice work support R01NS049223 work base research conduct Cornell High Energy Synchrotron Source CHESS support Award DMR use Macromolecular Diffraction CHESS MacCHESS facility support Award trayneli glutamate receptor ion channel Pharmacol Rev Asztely glutamate receptor possible role expression hippocampal synaptic plasticity Soderling Reg ulatory mechanism ampa receptor synaptic plasticity Neurosci ampa receptor synaptic plasticity neuronal death Trends Neurosci Alt Nisenbaum Bleakman Witkin role ampa receptor mood disorder ampa receptor subunit GluR2 gate injurious signal ischemic stroke Mosbacher molecular determinant submillise cond desensitization glutamate receptor Science Pei flip flop difference channel opening kinetic Biochemistry Partin ampa receptor flip flop mutant affect deactivation desensitization tion thiocyanate glutamate receptor recognition activation Mayer Olson Gouaux Mechanisms ligand bind ion channel crystal structure glutamate serine complex closed state Mechanisms activation antag onism AMPAsensitive glutamate receptor crystal structure GluR2 ligand bind core Gouaux Structure glutamatereceptor ligandbinding core complex kainate Nature Hogner Kastrup Jin Liljefors Mayer Egebjerg Gouaux structural basis ampa receptor activation ligand selectivity crystal structure agonist complex GluR2 ligandbinde core Gouaux structural basis partial agonist action ionotropic glutamate receptor Gouaux ligandbinde core complex importance moiety substituent bind mode agonist FEBS ture S1S2 glutamate bind domain protein struct funct Correlating ampa receptor activation cleft closure subunit crystal structure ligand bind domain complex full partial agonist istry structure GluR5 ligand bind core molecular mechanism underlie kainate receptor selectivity Neuron struc ture kainate receptor GluR5 ligand bind core dimer novel GluR5selective antagonist Schousboe Egebjerg agonism antagonism ionotropic glutamate receptor struc ture ligandbinde core complex domoic acid SternBach Structure kainate receptor subunit agonistbinde domain complexe Sci Furukawa Gouaux Mechanisms activation inhibition specificity crystal structure NMDA receptor NR1 ligandbinde core Gouaux Subunit arrangement function NMDA receptor Nature ray structure symmetry mechanism glutamate tor Nature Giurgea Lefevre Lescrenier protection hypoxia induce amnesia rat nootropic approach pharmacology integrative activity brain Integr Psychol Behav Scapagnini Nicoletti Nootropic drug positively modulate alphaaminohydroxymethylisoxazolepropionic acidsensitive glutamate receptor neuronal culture Neuro chem receptor potentiator appli cation depression Parkinson disease target week Gouaux Partin Mechanism positive allosteric modulator act ampa receptor Neurosci reverse learning memory deficit follow prenatal ethanol exposure modulate function synaptic ampa receptor Neuropsychopharmacology factor regulate magnitude longterm potentiation induce theta pattern stimulation potential positive ampa modulator relationship ampa receptor subunit preclinical datum kainate receptor neuro logical disease therapy horizon Neuropsychopharmacol ogy overview pharma codynamic pharmacokinetic property therapeutic potential senile cognitive disorder drug age Sun Olson Horning Gouaux Mechanism glutamate receptor desensitization Nature allosteric modulator bind site GluR2 thiazide derivative Vol Structural proof dimeric positive modulator bridge identical ampa receptorbinde site phy Carter Sweet Eds Methods Enzymology Vol Academic Press New York Part Adams GrosseKunstleve Read build new software automate crystallographic structure determina tion Biol modelbuilde tool molecular graphic Biol structural feature cyclothiazide responsible effect onpeak current amplitudeand desensitization kinetics iGluR2 Mol Biol pharmacological property clinical use CNS Drug Rev Gouliaev structurally relate nootropic Brain Res Rev Sekiguchi Fleck Takeo novel allosteric potentiator ampa receptor potentia tion quisqualate receptor nootropic drug aniracetam Shi Katchmen Lynch Modulation time course fast glutamate channel kinetics aniracetam Science",
            "term_counts": {
                "Mental Health Terms": {
                    "depression": 1
                },
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "I481": 1,
                    "D760": 2
                }
            },
            "co_occurrence_matrix": {
                "Mental Health Terms": {
                    "I481": 1,
                    "D760": 1
                },
                "Ethnographic Terms": {
                    "depression": 3
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Poly _aryl ether ketone_ s with _3_methyl_ phenyl and _3_trifluoromethyl_ phenyl side groups.pdf",
            "cleaned_text": "Polyaryl ether ketone BAIJUN LIU GUIBIN WANG WEI YUHUI JIN CHUNHAI CHEN ZHENHUA JIANG WANJIN ZHANG ZHONGWEN YEN WEI2 People Republic China 2department Chemistry Pennsylvania receive accept July publish online InterScience wwwintersciencewileycom new bisphenol monomer prepare twostep synthesis series polyaryl ether ketone derive bisphenol nucleophilic aromatic substitution polycondensation various bisuoro compound polycondensation proceed quantitatively tetramethylene sulfone presence anhydrous potassium carbon eat afford polymer inherent viscosity uorinated polymer show low glasstransition temperature high thermaldecomposition temperature corresponding nonuorinated polymer solubility poly mer improve introduction bulky pendant group polymer form transparent strong exible lm tensile strength mpa young modulus GPa elongation break polymer low dielectric constant mhz compare methylated polymer triuoromethylated polymer exhibit low water sorption attribute strong hydrophobicity uorinecontaine group Polym Sci Part uoropolymer synthesis dielectric property introduction Polyaryl ether ketone paek include poly ether ether ketone PEEK polyether ether tone ketone PEEKK polyether ether tone diphenyl ketone PEEKDK family highperformance engineering thermoplastic know excellent thermal mechanical electrical property class advanced material currently receive considerable tention potential application aerospace automobile electronic high ogy eld however difcult paek use thin lm coating low solubility almost know solvent concentrated sulfuric acid great deal research PAEKs concentrate introduction pendant group improve solubility processability desire prop ertie meet various demand thermal stability sacriced paek phenyl methyl butyl bromomethyl side group successfully prepare need become particularly acute hightemperature material use tronic device substrate print circuit board dielectric insulate layer multilayer structure coating electronic packaging therefore aromatic polymer low dielectric constant high thermal stability correspondence mail hw7527sinacom part Polymer Chemistry vol low water absorption good solubility study extensively low dielectric stant one important requirement introduction uorine substitution bulky side group formation nanofoam regard effective way reduce electric constant unique characteristic uo rine substitution include high electronegativ ity low polarity low surface free energy many uorinecontaine polymer prepare particular polymer contain hexauoroisopropyl moiety exploit application optical waveguide material microelectronic device branes general incorporation uori nate substituent polymer crease dielectric constant moisture absorp tion refractive index increase free volume solubility thermal stability interested synthesis aromatic polymer nonuorinated uori nate bulky pendant group article present successful preparation new bisphenol monomer methylphenylhydroqui none triuoro methylphenylhydroqui none nucleophilic aromatic substitution polymerization bisphenol monomer various diuorosubstitute aromatic compound afford new paek many interesting prop erties EXPERIMENTAL Materials Toluidine Shanghai Chemical Reagent triuoromethylaniline Dongyang Reagent benzoquinone Dalian Jizhou Chemical zinc powder agent hydrochloric acid agent sodium nitrite agent sodium bicarbonate toluene agent use receive Tetramethylene sulfone purchase puried distillation duce pressure uorobezoylbenzene biphenyl prepare laboratory accord standard procedure synthesis new bisphenol monomer polymer illustrate Schemes respectively measurement spectra KBr pellet lm measure Nicolet Impact Fourier transform infra red FTIR spectrometer mhz mhz mhz NMR spectra record NMR spectrome ter tetramethyl silane NMR Gel permeation chromatogram obtain instrument tetrahydrofuran eluent rate min differential scan calorimetry DSC measurement perform instru ment heating rate min nitro gen glasstransition temperature take DSC curve center step transition second heating run gravimetric analysis perform thermal analyzer system heating rate min air elemental analysis carry elemental analyzer Mass spectra Scheme Synthesis bisphenol monomer polyaryl ether ketone obtain mass spectrometer inherent viscosity measurement carry ubbelohde viscometer concentrate sulfuric acid polymer thin lm stressstrain test cast methylpyrrolidinone solution glass plate follow evaporation solvent dry vacuo completeness solvent removal conrme DSC measure ment stressstrain behavior lm evaluate room temperature strain rate min dielectric constant thin polymer lm measure impedance Monomer Synthesis Synthesis Methylbenzoquinone TBQ beaker equip drop funnel thermometer place hydrochloric acid water ice Toluidine mol add dropwise stir mixture dropping funnel concentrated water solution sodium nitrite mol add dropwise mixture stir yield clear solution result solution ltered add dropwise mixture benzoquinone mol sodium bicarbonate mol water reaction mixture stir room precipitate collect ltration wash thoroughly water dry vacuum oven product recrystallize butanol give yellow crystal yield dsc c13h10o2 mol find KBr nmr CDCl3 ppm nmr CDCl3 ppm Synthesis Trifluoromethylbenzoquinone procedure similar synthesis TBQ triuoromethylaniline use starting material yield dsc C13H7F3O2 mol Found NMR CDCl3 ppm nmr CDCl3 ppm OCF3 NMR CDCl3 ppm OCF3 KBr synthesis TPQ mol powder mol deionized water place threenecked ask equip mechanical stirrer condenser drop Scheme Synthesis polymer polymer funnel mixture heat stirring follow addition HCl dropwise rate drop second complete addition reaction mixture allow hot mixture ltered ltrate cool room temperature pour large amount deionize water white solid collect recrystallize toluene yield dsc mol find KBr nmr CDCl3 ppm nmr CDCl3 ppm Synthesis Trifluoromethyl phenylhydroquinone procedure similar synthesis replace starting material yield dsc C13H9F3O2 mol find KBr nmr CDCl3 ppm nmr CDCl3 ppm OCF3 NMR CDCl3 ppm CF3 Polymer Synthesis TPEEK TPH mmol mmol diuorobenzophenone mmol anhydrous k2co3 TMS toluene place ask equip mechanical stirrer nitro gen inlet trap condenser reaction mixture allow toluene remove distillation system heat polymerization complete viscous mixture pour water threadlike polymer pulverize powder cool ing powder wash hot methanol water several time dry white polymer powder obtain quantitative yield Gel permeation chromatography GPC THF molecular weight weightaverage molecular weightnum beraverage molecular weight NMR CDCl3 ppm nmr CDCl3 ppm synthesize polymeriza tion equiv equiv diuorobenzophenone procedure similar synthesis polymerization period prolong NMR CDCl3 ppm nmr CDCl3 ppm OCF3 NMR CDCl3 ppm CF3 TPEEKK TPEEKDK PEEKK TPEEKK prepare polymerization equiv biphenyl respectively accord procedure use PEEKK synthesize uorobenzoylbenzene POLYARYL ether bisuorobenzoylbiphenyl respectively manner result discussion monomer Synthesis bisphenol monomer synthesize step coupling methylphenyldiazonium chloride triuoromethylphenyldiazonium chloride benzoquinone presence nahco3 yield TBQ respectively follow reduc tion HCl see Scheme structure TBQ TPH spectrometry NMR spectro copy elemental analysis spectra TBQ show absorption band due symmetric stretch carbonyl group reduction character istic absorption disappear tic bands hydroxy group around appear peak ppm NMR spectra assign hydroxy pro ton absent spectrum TPQ peak ppm assign methyl aromatic proton respectively nmr spectra TPQ exhibit peak quartet peak ppm nmr spectra attribute 1jcof couple carbon uorine atom triuoromethyl group NMR spectrum single peak ppm characteristic uorine atom triuoromethyl group Polyether ketone Synthesis polymerization bisphenol monomer stoichiometric amount different bisuoro monomer carry pres ence excess potassium carbonate base show Scheme polymerization complete solid content toluene use azeotropic removal water reaction temperature late formation rst govern amount toluene reux water generate deprotonation bisphenol remove trap comple tion bisphenolate formation reaction temperature increase high molecular weight polymer readily taine existence bulky pendant group monomer signicant effect polymerization molecular weight polymer adjust vari ation feed ratio bisphenols monomer interesting note polymerization period short dramatically increase viscosity reaction system observe completion bisphenolate formation result ing polymer high inherent viscosity table ftir spectra polymer support structure polymer exhibit characteristic absorption band due aryl ether linkage correspond aryl carbonyl group nmr spectra signment peak good agreement propose structure signal ppm NMR spectra assign aromatic proton polymer backbone peak ppm NMR spectrum attribute methyl proton nmr spectrum show peak correspond distinguishable carbon signal NMR spectrum peek lap chemical shift phenyl carbon attach carbonyl group quar tet peak ppm arise 1jcof 2JCOF couple carbon uorine atom pedant group single peak also observe ppm NMR spectrum PEEK expect crystallinity PAEKs examine wideangle ray diffraction PAEKs exhibit amorphous pattern result table inherent Viscosity Thermal Properties paek Polymer DT5 DT10 TPEEKK PEEKK PEEKDK explain presence bulky pen dant group disrupt regularity molecular chain inhibit close pack polymer chain paek thermal property new PAEKs inated nonuorinated evaluate DSC PAEKs melt endotherm observe DSC trace observation conrm amorphous nature PAEKs depict Table value polymer low corresponding polymer possible explanation low value polymer substitution methyl lead ternal plasticization addition geometry freevolume factor PAEKs exhibit good thermal stability summarize Table temperature weight loss DT5 weight loss air anticipate uorinated poly mer show high thermal stability corresponding nonuorinated polymer attribute strong bond comparison COH bond Solubility paek Mechanical Properties solubility new PAEKs greatly prove incorporation methylphenyl triuoromethylphenyl group conven tional peek side group dissolve know organic solvent sharp contrast signicant solubility dimethylform amide dimethylacetamide DMAc chloroform room temperature cellent solubility attribute presence bulky pendant group lead increase free volume ever incorporation rigid carbonyl biphenyl moiety solubility polymer relatively low tpeekk TPEEKDK PEEKK find soluble chloroform DMF heating room temperature dissolve mechanical property PAEK thin lm cast hot summarize Table lm transparent strong lm tensile strength mpa young modulus GPa elon gation break dielectric constant polymer list Table measure thin lm mhz dielectric constant conventional peek pendant group electric constant polymer decrease bulky triuoromethylphenyl methyl phenyl pendant group incorporate polymer chain related factor explain observed effect bulky pendant group dielectric property polymer First bulky side group attach polymer main chain push neighboring chain apart result loosely pack polymer low dielectric stant token incorporation bulky pendant group disrupt crystallinity lead less dense amorphous structure decrease dielectric constant paek Polymer Tensile strength mpa Young Modulus gpa elongation Break PEEK PEEKK PEEKDK TPEEKK TPEEKDK Table Dielectric Constant Water sorption paek Polymer dielectric tpeek TPEEKK PEEKK PEEKDK POLYARYL ether ketone nonuorinated uorinated polymer find similar dielectric constant compete factor consider First substitution OCF3 OCH3 result increase dipole moment dielectric constant however uorine substitution reduce moisture sorption increase free volume lead low dielectric constant case polymer factor approximately offset word bulkiness pendant group methylphenyl tri uoromethylphenyl main reason decrease dielectric constant polymer water uptake polymer mea sure immersion polymer lm mm3 water follow wipe tissue paper removal water surface water take calculate difference weight procedure sult show water uptake poly mer general range table compare polymer polymer exhibit appreciably low water sorption low water sorption uorinecontaining polymer attribute increase hydrophobicity introduction triuoromethyl group conclusion series methylphenyl nylsubstitute PAEKs successfully synthesize new bisphenol monomer respectively polymer remarkably improve solubility common organic solvent DMF DMAc chloroform unsubstituted counterpart polymer form transparent strong exible lm tensile strength mpa young modulus GPa elongation break polymer amorphous exhibit low dielec tric constant range mhz compare methylphenylsubstituted polymer triuoromethylphenylsubstituted polymer show low high thermal low water sorption author gratefully nancial sup port Develop ment Program note Rose Polymer Ohno Takata Endo Polym Sci Polym Chem Zhang Polymer ecule Higashi Bennett Farris Wang Roovers Polym Sci Part ics Packaging Handbook Reinhold Singer STEPI Proceedings Tech nip McGrath Mercer Goodman Polym Sci Part Hsu High perform Polym Wang Organic Synthesis Reaction Part Science Press Tesoro Hougham Tesoro ecule",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {}
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Profound Methyl Effects in Drug Discovery and a Call for New C_ H Methylation Reactions.pdf",
            "cleaned_text": "issue WileyVCH KGaA Weinheim Organic chemistry chin Profound Methyl Effects Drug Discovery call New Methylation reaction ref SCHOENHERR CERNAK Angew Chem Int Dep Med Chem Merck Res Lab Rahway USA",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {}
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Radiation-induced degradation of methyl orange in aqueous solutions.pdf",
            "cleaned_text": "Husznk RPC appear receive Date August Revised Date cite article air orgradphyschem pdf file article undergo enhancement acceptance addition cover page metadata format readability yet definitive version record version undergo additional copyediting typesetting publish final form provide version give early visibility article note production process error discover affect content legal disclaimer apply journal pertain Preproof radphyschem Morbi scelerisque magna Integer imperdiet ligula sit vestibulum dapibus tellus sed dictum non maximus augue velit Vivamus nulla enim convallis vel leo sit est metus lorem tempor lectus cursus est rhoncus tempor nisl porttitor ipsum quis mattis quam Class aptent conubia habitant morbi tristique senectus netus egesta ipsum arcu cursus commodo egestas vulputate orci risus libero vulputate massa accumsan consequat consectetur ante sit massa orci volutpat vitae non elementum posuere diam varius est tellus auctor sed ligula condimentum Cras ultrices nisl non nisl interdum tincidunt ante tempor elit quam Mauris eget vehicula ante semper venenatis sollicitudin Etiam venenatis non libero vitae rutrum vestibulum vestibulum dignissim sed nisl sapien vitae tincidunt neque Aliquam blandit risus Preproof radphyschem Vestibulum metus tellus non ornare diam quis fermentum eros orci molestie lectus egestas enim turpis Aenean tempor malesuada odio scelerisque convallis tristique ligula commodo lectus augue interdum bibendum rhoncus felis tellus eget gravida nisl commodo mauris maximus ultricie Integer consequat molestie scelerisque Phasellus mattis metus ipsum Aliquam faucibus maximus augue vitae molestie Vivamus odio ullamcorper lectus consequat fermentum lorem lectus vehicula elit tempor Interdum malesuada fame ante ipsum faucibus libero Nunc tristique erat vitae scelerisque ultricies suscipit enim molestie convallis qui provident similique sunt officia laborum dolorum fuga quidem rerum facilis expedita distinctio libero tempore cum soluta eligendi optio cumque nihil impedit quo metus lectus non ligula ultrices felis eleifend ante Suspendisse lectus consectetur molestie velit enim venenatis tristique Mauris pulvinar libero quis faucibus consectetur Preproof radphyschem Morbi scelerisque magna Integer imperdiet ligula sit vestibulum dapibus tellus sed dictum non maximus augue velit Vivamus nulla enim convallis vel leo sit est metus lorem tempor lectus cursus est scelerisque magna Integer imperdiet ligula sit vestibulum dapibus tellus sed dictum non maximus augue velit Vivamus nulla enim convallis vel leo sit est metus lorem tempor lectus cursus est Vivamus egestas sit scelerisque justo ultricie ligula massa tempus vitae ante hendrerit libero porta libero sagittis lacus arcu molestie tempor vestibulum mattis vitae cursus consequat tellus volutpat tellus rutrum cursus malesuada ipsum Proin ornare ero ornare nec nulla sit velit tempor condimentum ipsum dolor sit adipiscing elit Phasellus tellus tempus tincidunt lorem felis mattis ipsum dolor sit adipiscing elit faucibus est dictum elementum consequat dignissim vitae arcu egestas ligula habitant morbi tristique senectus Radiation Physics Chemistry Journal Preproof faucibus maximus augue vitae molestie Vivamus odio ullamcorper lectus consequat fermentum lorem lectus vehicula elit tempor Interdum malesuada fame ante ipsum faucibus libero Nunc tristique erat vitae scelerisque ultricies suscipit enim molestie convallis venenatis non libero vitae rutrum vestibulum vestibulum dignissim sed nisl sapien vitae tincidunt neque Aliquam blandit risus mauris velit tellus eget gravida nisl commodo mauris maximus ultricie Integer consequat molestie scelerisque Phasellus mattis metus ipsum quis elementum tempus faucibus mauris sapien vitae lobortis lectus diam pharetra egesta metus vitae pretium sed urna sollicitudin facilisis ligula Cras magna ligula porttitor tellus gravida commodo est non vestibulum rutrum nulla pretium egestas tellus rutrum cursus malesuada ipsum Proin ornare ero ornare nec nulla sit velit tempor condimentum ipsum dolor sit adipiscing elit Phasellus tellus tempus Preproof non libero vitae rutrum vestibulum vestibulum aliquet euismod magna dignissim sed nisl sapien vitae tincidunt neque Aliquam blandit risus Morbi scelerisque magna Integer imperdiet ligula sit vestibulum dapibus tellus sed dictum non maximus augue velit Vivamus nulla enim convallis vel leo sit est metus lorem tempor lectus cursus est ipsum dolor sit adipiscing elit Aliquam tempor aliquet risus auctor rutrum justo quis non purus hac habitasse imperdiet est vel massa fringilla fringilla eros sollicitudin tellus Mauris tempus efficitur scelerisque arcu facilisis vitae non libero vitae rutrum vestibulum vestibulum dignissim sed nisl sapien vitae tincidunt neque Aliquam blandit risus gravida fringilla quam fermentum non sodales orci Morbi facilisis mattis sollicitudin sit amet ornare mollis sit urna faucibus ante ipsum faucibus ultrice posuere cubilia curae Donec laoreet massa sit amet dui sit Preproof dapibus tincidunt lorem felis mattis ipsum dolor sit adipiscing elit faucibus est dictum elementum consequat dignissim vitae arcu egestas ligula habitant morbi tristique senectus metus tellus non ornare diam quis fermentum eros orci molestie lectus egestas enim turpis Aenean tempor malesuada odio scelerisque convallis tristique ligula commodo lectus augue interdum bibendum rhoncus felis iste natus error sit accusantium doloremque laudantium totam rem aperiam inventore veritatis quasi architecto vitae dicta enim ipsam voluptatem sit fugit sed magni ratione nesciunt Neque porro quisquam dolorem ipsum sit amet tellus auctor sed ligula condimentum Cras ultrices nisl non nisl interdum tincidunt ante tempor elit quam Mauris eget vehicula ante semper venenatis sollicitudin ipsum dolor sit adipiscing elit Aliquam tempor aliquet risus auctor rutrum justo quis non purus hac habitasse imperdiet est vel massa fringilla fringilla eros sollicitudin tellus Mauris tempus efficitur scelerisque arcu facilisis vitae Preproof radphyschem quis tempus faucibus mauris sapien vitae lobortis lectus diam pharetra egesta metus vitae pretium sed urna sollicitudin facilisis ligula Cras magna ligula porttitor tellus gravida commodo est non vestibulum rutrum risus libero vulputate massa accumsan consequat consectetur ante sit massa orci volutpat vitae non elementum posuere diam Vestibulum metus tellus non dictum dignissim mauris ornare diam quis fermentum eros orci molestie lectus egestas enim turpis Aenean tempor malesuada odio scelerisque convallis tristique ligula commodo lectus augue interdum bibendum rhoncus felis iste natus error sit accusantium doloremque laudantium totam rem aperiam inventore veritatis quasi architecto vitae dicta enim ipsam voluptatem sit fugit sed magni ratione nesciunt Neque porro quisquam dolorem ipsum sit amet consectetur rhoncus tempor nisl porttitor ipsum quis mattis quam Class aptent conubia habitant morbi tristique senectus netus egesta ipsum arcu cursus commodo egestas vulputate Preproof risus libero vulputate massa accumsan consequat consectetur ante sit massa orci volutpat vitae non elementum posuere diam Vestibulum metus tellus non dictum dignissim mauris ornare diam quis fermentum eros orci molestie lectus egestas enim turpis Aenean tempor malesuada odio scelerisque convallis tristique ligula commodo lectus augue interdum bibendum rhoncus felis non libero vitae rutrum vestibulum vestibulum dignissim sed nisl sapien vitae tincidunt neque Aliquam blandit risus Cras metus lectus non ligula ultrices felis eleifend ante Suspendisse lectus consectetur molestie velit enim venenatis tristique Mauris pulvinar libero quis faucibus consectetur tellus eget gravida nisl commodo mauris maximus ultricie Integer consequat molestie scelerisque Phasellus mattis metus ipsum Preproof egestas sit scelerisque justo ultricie ligula massa tempus vitae ante hendrerit libero porta libero sagittis lacus arcu molestie tempor vestibulum mattis vitae cursus consequat tellus volutpat gravida fringilla quam fermentum non sodales orci Morbi facilisis mattis sollicitudin sit amet ornare mollis sit urna faucibus ante ipsum faucibus ultrice posuere cubilia curae Donec laoreet massa sit amet dui sit lectus ipsum dolor sit adipiscing elit vulputate augue eget odio hac habitasse platea ligula sit fringilla lacus maximus vitae lobortis sapien commodo nulla vitae facilisis dignissim orci elit rhoncus tempor nisl porttitor ipsum quis mattis quam Class aptent conubia habitant morbi tristique senectus netus egesta ipsum arcu cursus commodo egestas vulputate orci varius est tellus auctor sed ligula condimentum Cras ultrices nisl non nisl interdum tincidunt ante tempor elit quam Mauris eget vehicula ante semper venenatis sollicitudin lacus Preproof risus libero vulputate massa accumsan consequat consectetur ante sit massa orci volutpat vitae non elementum posuere diam pretium egestas tellus rutrum cursus malesuada ipsum Proin ornare ero ornare nec nulla sit velit tempor condimentum ipsum dolor sit adipiscing elit Phasellus tellus tempus tincidunt lorem felis mattis ipsum dolor sit adipiscing elit faucibus est dictum elementum consequat dignissim vitae arcu egestas ligula habitant morbi tristique senectus ipsum dolor sit adipiscing elit vulputate augue eget odio hac habitasse platea ligula sit fringilla lacus maximus vitae lobortis sapien commodo nulla vitae facilisis dignissim orci elit dapibus error sit accusantium doloremque laudantium totam rem aperiam inventore veritatis quasi architecto vitae dicta enim ipsam voluptatem sit fugit sed magni ratione nesciunt Neque porro quisquam dolorem ipsum sit amet consectetur Preproof gravida fringilla quam fermentum non sodales orci Morbi facilisis mattis sollicitudin sit amet ornare mollis sit urna faucibus ante ipsum faucibus ultrice posuere cubilia curae Donec laoreet massa sit amet dui sit lectus Proin eget ante Morbi tristique mattis sit justo eros Donec urna risus faucibus arcu bibendum vestibulum lorem pharetra enim ornare consequat eros Proin sollicitudin non libero vitae rutrum vestibulum vestibulum dignissim sed nisl sapien vitae tincidunt neque Aliquam blandit risus quis tempus faucibus mauris sapien vitae lobortis lectus diam pharetra egesta metus vitae pretium sed urna sollicitudin facilisis ligula Cras magna ligula porttitor tellus gravida commodo est non vestibulum rutrum qui provident similique sunt officia laborum dolorum fuga quidem rerum facilis expedita distinctio libero tempore cum soluta eligendi optio cumque nihil impedit quo quod Radiation Physics Chemistry Journal Preproof egestas sit scelerisque justo ultricie ligula massa tempus vitae ante hendrerit libero porta libero sagittis lacus arcu molestie tempor vestibulum mattis vitae cursus consequat tellus volutpat faucibus maximus augue vitae molestie Vivamus odio ullamcorper lectus consequat fermentum lorem lectus vehicula elit tempor Interdum malesuada fame ante ipsum faucibus libero Nunc tristique erat vitae scelerisque ultricies suscipit enim molestie convallis tellus rutrum cursus malesuada ipsum Proin ornare ero ornare nec nulla sit velit tempor condimentum ipsum dolor sit adipiscing elit Phasellus tellus tempus Quisque risus libero vulputate massa accumsan consequat consectetur ante sit massa orci volutpat vitae non elementum quis tempus faucibus mauris sapien vitae lobortis lectus diam pharetra egesta metus vitae pretium sed urna sollicitudin facilisis ligula Cras magna ligula porttitor tellus gravida commodo est non vestibulum rutrum Preproof radphyschem Lorem ipsum dolor sit adipiscing elit sed eiusmod tempor labore quis consequat irure dolor reprehenderit sint occaecat cupidatat non proident sunt officia deserunt laborum Cras metus lectus non ligula ultrices felis eleifend ante Suspendisse lectus consectetur molestie velit enim venenatis tristique Mauris pulvinar libero quis faucibus consectetur dignissim massa cursus arcu quis dolor cursus bibendum hendrerit orci nec urna ullamcorper gravida porta turpis ante ipsum faucibus non libero vitae rutrum vestibulum vestibulum dignissim sed nisl sapien vitae tincidunt neque Aliquam blandit risus error sit accusantium doloremque laudantium totam rem aperiam inventore veritatis quasi architecto vitae dicta enim ipsam voluptatem sit fugit sed magni ratione nesciunt Neque porro quisquam dolorem ipsum sit amet consectetur Preproof radphyschem Etiam tincidunt nisi eget faucibus porta magna dignissim tristique Morbi sodales enim quis risus nisi venenatis dolor elit dictum tincidunt semper eleifend metus tellus non dictum dignissim mauris ornare diam quis fermentum eros orci molestie lectus egestas enim turpis Aenean tempor malesuada odio scelerisque convallis tristique ligula commodo lectus augue interdum bibendum rhoncus felis ipsum dolor sit adipiscing elit Aliquam tempor aliquet risus auctor rutrum justo quis non purus hac habitasse imperdiet est vel massa fringilla fringilla eros sollicitudin tellus Mauris tempus efficitur scelerisque arcu facilisis vitae dapibus tincidunt lorem felis mattis ipsum dolor sit adipiscing elit faucibus est dictum elementum consequat dignissim vitae arcu egestas ligula habitant morbi tristique senectus tincidunt lorem felis mattis ipsum dolor sit adipiscing elit faucibus est dictum elementum consequat dignissim vitae arcu egestas ligula habitant morbi tristique senectus Radiation Physics Chemistry Journal Preproof iste natus error sit accusantium doloremque laudantium totam rem aperiam inventore veritatis quasi architecto vitae dicta enim ipsam voluptatem sit fugit sed magni ratione nesciunt Neque porro quisquam dolorem ipsum sit qui provident similique sunt officia laborum dolorum fuga quidem rerum facilis expedita distinctio libero tempore cum soluta eligendi optio cumque nihil impedit quo pretium egestas tellus rutrum cursus malesuada ipsum Proin ornare ero ornare nec nulla sit velit tempor condimentum ipsum dolor sit adipiscing elit Phasellus tellus tempus Proin eget ante Morbi tristique mattis sit justo Nunc efficitur eros Donec urna risus faucibus arcu bibendum vestibulum lorem pharetra enim ornare consequat eros Proin sollicitudin ipsum dolor sit adipiscing elit Aliquam tempor aliquet risus auctor rutrum justo quis non purus hac habitasse imperdiet est vel massa fringilla fringilla eros sollicitudin tellus Mauris tempus efficitur scelerisque arcu facilisis vitae Preproof faucibus maximus augue vitae molestie Vivamus odio ullamcorper lectus consequat fermentum lorem lectus vehicula elit tempor Interdum malesuada fame ante ipsum faucibus libero Nunc tristique erat vitae scelerisque ultricies suscipit enim molestie convallis error sit accusantium doloremque laudantium totam rem aperiam inventore veritatis quasi architecto vitae dicta enim ipsam voluptatem sit fugit sed magni ratione nesciunt Neque porro quisquam dolorem ipsum sit tellus eget gravida nisl commodo mauris maximus ultricie Integer consequat molestie scelerisque Phasellus mattis metus ipsum egestas sit scelerisque justo ultricie ligula massa tempus vitae ante hendrerit libero porta libero sagittis lacus arcu molestie tempor vestibulum mattis vitae cursus consequat tellus volutpat laoreet varius est tellus auctor sed ligula condimentum Cras ultrices nisl non nisl interdum tincidunt ante tempor elit quam Mauris eget vehicula ante semper venenatis sollicitudin lacus Preproof radphyschem Proin eget ante Morbi tristique mattis sit justo eros Donec urna risus faucibus arcu bibendum vestibulum lorem pharetra enim ornare consequat eros Proin sollicitudin scelerisque magna Integer imperdiet ligula sit vestibulum dapibus tellus sed dictum non maximus augue velit Vivamus nulla enim convallis vel leo sit est metus lorem tempor lectus cursus est Vivamus egestas sit scelerisque justo ultricie ligula massa tempus vitae ante hendrerit libero porta libero sagittis lacus arcu molestie tempor vestibulum mattis vitae cursus consequat tellus volutpat laoreet varius est tellus auctor sed ligula condimentum Cras ultrices nisl non nisl interdum tincidunt ante tempor elit quam Mauris eget vehicula ante semper venenatis sollicitudin metus tellus non quis fermentum eros orci molestie lectus egestas enim turpis Aenean tempor malesuada odio scelerisque convallis tristique ligula commodo lectus augue interdum bibendum Preproof radphyschem Cras metus lectus non ligula ultrices felis eleifend ante Suspendisse lectus consectetur molestie velit enim venenatis tristique Mauris pulvinar libero quis faucibus consectetur lorem est Etiam tincidunt nisi eget faucibus porta magna dignissim tristique Morbi sodales enim quis risus nisi venenatis dolor elit dictum tincidunt semper eleifend gravida fringilla quam fermentum non sodales orci Morbi facilisis mattis sollicitudin sit amet ornare mollis sit urna faucibus ante ipsum faucibus ultrice posuere cubilia curae Donec laoreet massa sit amet dui sit lectus massa cursus arcu quis dolor cursus bibendum hendrerit orci nec urna ullamcorper gravida porta turpis ante ipsum faucibus tellus eget gravida nisl commodo mauris maximus ultricie Integer consequat molestie scelerisque Phasellus mattis metus ipsum Preproof radphyschem Lorem ipsum dolor sit adipiscing elit vulputate augue eget odio hac habitasse platea ligula sit fringilla lacus maximus vitae lobortis sapien commodo nulla vitae facilisis dignissim orci elit dapibus tellus auctor sed ligula condimentum Cras ultrices nisl non nisl interdum tincidunt ante tempor elit quam Mauris eget vehicula ante semper venenatis sollicitudin nisi scelerisque magna Integer imperdiet ligula sit vestibulum dapibus tellus sed dictum non maximus augue velit Vivamus nulla enim convallis vel leo sit est metus lorem tempor lectus cursus est dapibus tincidunt lorem felis mattis ipsum dolor sit adipiscing elit faucibus est dictum elementum consequat dignissim vitae arcu egestas ligula habitant morbi tristique senectus ipsum dolor sit adipiscing elit Aliquam tempor aliquet risus auctor rutrum justo quis non purus hac habitasse imperdiet est vel massa fringilla fringilla eros sollicitudin tellus Mauris tempus efficitur scelerisque arcu facilisis vitae Preproof tellus eget gravida nisl commodo mauris maximus ultricie Integer consequat molestie scelerisque Phasellus mattis metus ipsum scelerisque magna Integer imperdiet ligula sit vestibulum dapibus tellus sed dictum non maximus augue ultrice velit Vivamus nulla enim convallis vel leo sit est metus lorem tempor lectus cursus est gravida fringilla quam fermentum non sodales orci Morbi facilisis mattis sollicitudin sit amet ornare mollis sit urna faucibus ante ipsum faucibus ultrice posuere cubilia curae Donec laoreet massa sit amet dui sit lectus Proin eget ante Morbi tristique mattis sit justo eros Donec urna risus faucibus arcu bibendum vestibulum lorem pharetra enim ornare consequat eros Proin sollicitudin scelerisque magna Integer imperdiet ligula sit vestibulum dapibus tellus sed dictum non maximus augue velit Vivamus nulla enim convallis vel leo sit est metus lorem tempor lectus cursus est Preproof radphyschem Curabitur varius est tellus auctor sed ligula condimentum Cras ultrices nisl non nisl interdum tincidunt ante tempor elit quam Mauris eget vehicula ante semper venenatis sollicitudin lacus Curabitur varius est tellus auctor sed ligula condimentum Cras ultrices nisl non nisl interdum tincidunt ante tempor elit quam Mauris eget vehicula ante semper venenatis sollicitudin Etiam tincidunt nisi eget faucibus porta magna dignissim tristique Morbi sodales enim quis risus nisi venenatis dolor elit dictum tincidunt semper eleifend error sit laudantium totam rem aperiam inventore veritatis quasi architecto vitae dicta enim ipsam voluptatem sit fugit sed magni ratione nesciunt Neque porro quisquam dolorem ipsum sit amet ipsum dolor sit adipiscing elit sed eiusmod tempor labore quis consequat irure dolor reprehenderit sint occaecat cupidatat non proident sunt officia deserunt Preproof radphyschem Vestibulum metus tellus non ornare diam quis fermentum eros orci molestie lectus egestas enim turpis Aenean tempor malesuada odio scelerisque convallis tristique ligula commodo lectus augue interdum bibendum risus libero vulputate massa accumsan consequat consectetur ante sit massa orci volutpat vitae non elementum posuere diam Quisque risus libero vulputate massa accumsan consequat consectetur ante sit massa orci volutpat vitae non elementum diam Cras metus lectus non ligula ultrices felis eleifend ante Suspendisse lectus consectetur molestie velit enim venenatis tristique Mauris pulvinar libero quis faucibus consectetur lorem est Etiam tincidunt nisi eget faucibus porta magna dignissim tristique Morbi sodales enim quis risus nisi venenatis dolor elit dictum tincidunt semper Preproof dapibus tincidunt lorem felis mattis ipsum dolor sit adipiscing elit faucibus est dictum elementum consequat dignissim vitae arcu egestas ligula habitant morbi tristique senectus egestas sit scelerisque justo ultricie ligula massa tempus vitae ante hendrerit libero porta libero sagittis lacus arcu molestie tempor vestibulum mattis vitae cursus consequat tellus volutpat egestas sit scelerisque justo ultricie ligula massa tempus vitae ante hendrerit libero porta libero sagittis lacus arcu molestie tempor vestibulum mattis vitae cursus consequat tellus volutpat ipsum dolor sit adipiscing elit Aliquam tempor aliquet risus auctor rutrum justo quis non purus hac habitasse imperdiet est vel massa fringilla fringilla eros sollicitudin tellus Mauris tempus efficitur scelerisque arcu facilisis vitae non libero vitae rutrum vestibulum vestibulum dignissim sed nisl sapien vitae tincidunt neque Aliquam blandit risus Preproof radphyschem Lorem ipsum dolor sit adipiscing elit vulputate augue eget odio hac habitasse platea ligula sit fringilla lacus maximus vitae lobortis sapien commodo nulla vitae facilisis dignissim orci elit dapibus tincidunt lorem felis mattis ipsum dolor sit adipiscing elit faucibus est dictum elementum consequat dignissim vitae arcu egestas ligula habitant morbi tristique senectus aliquet ligula Sed gravida fringilla quam fermentum non sodales orci Morbi facilisis mattis sollicitudin sit amet ornare mollis sit urna faucibus ante ipsum faucibus ultrice posuere cubilia curae Donec laoreet massa sit amet dui sit tincidunt lorem felis mattis ipsum dolor sit adipiscing elit faucibus est dictum elementum consequat dignissim vitae arcu egestas ligula habitant morbi tristique senectus tellus auctor sed ligula condimentum Cras ultrices nisl non nisl interdum tincidunt ante tempor elit quam Mauris eget vehicula ante semper venenatis sollicitudin lacus Preproof radphyschem Cras metus lectus non ligula ultrices felis eleifend ante Suspendisse lectus consectetur molestie velit",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "imperdiet": 14,
                    "metus": 8,
                    "interdum": 16,
                    "venenatis": 9,
                    "Vestibulum": 4,
                    "Interdum": 4,
                    "Suspendisse": 6,
                    "pharetra": 4,
                    "arcu": 12,
                    "Neque porro quisquam": 7,
                    "Proin": 7,
                    "Etiam": 4
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Rapid methylation on carbon frameworks useful for the synthesis of 11 CH 3-incorporated PET tracers_ Pd _0_-mediated rapid coupling of methyl iodide with an__.pdf",
            "cleaned_text": "communication wwwrscorgobc methylation carbon framework useful synthesis pet tracer mediate rapid coupling methyl iodide alkenyltributylstannane lead methylalkene receive 26th October accept 8th December first publish web 3rd January mediate rapid coupling methyl iodide excess alkenyltributylstannane examine aim incorporate shortlive methyl group biologically signicant organic compound methylalkene unit synthesis pet tracer Four set reaction condition use perform DMF min condition use CH3IstannanePd2dbatolylCuClK2CO3 work almost case condition use CH3IstannanePd2dbatolylCuX CsF show good result regard general applicability tin substrate afford corresponding methylated product yield base consumption methyl iodide less effective tolyl particularly unsaturated carbonyl substrate regio stereoisomerization occur reaction condition efciency protocol demonstrate synthesis methylate compound Positron emission tomography PET noninvasive vivo imaging method enable distribution analysis radiotracer living system brain heart active tissue organ pet tracer shortlive positronemitting radionuclide detectable indicator utilize monitor biochemical process localization target molecule volve important biofunction related phenomenon useful tool diagnosis disease drug development high level radioactivity strong permeability ray photon produce annihilation event shortlive radionuclide safe enough PET human dosage radiotracer extremely low femto attomolar level far critical concentration pharmacological effect arise concept refer microdose aDivision Regeneration Advanced Medical Science Gifu University Graduate School Medicine Yanagido mail sity supplementary information available general experi mental remark synthetic method characterization alkenyl corresponding methylalkene see rapid methylation carbon framework PET tracer synthesis Part Parts see ref positronemitte radionuclide currently available practical term radioactivity half life min importantly potentially replace carbon atom organic compound addition various synthetically wellestablished precursor readily available contrast advantage temporal restriction preparation PET tracer incorporate total time allow synthesis PET tracer generally set radionuclide mean complete preparation tracer accomplish min consider time reaction purication injection time allow reaction tracer synthesis thus development rapid reaction crucial meet necessity already establish rapid methyl iodide excess amount mediate reaction sp3 sp2 hybridize carbon respectively reaction center proceed efciently DMF give corresponding methylated compound high yield use precursor favorable high tolerance various chemical reaction chromatographic purication condition enable incorporation radioisotope nal step extremely low polarity enable easy separation desire product large amount unreacted stannane indeed sp3sp2aryl coupling reaction apply successfully synthesis methyl ester efcient prostaglandin probe achieve image novel prostacyclin receptor IP2 express central nervous system live monkey human brain intravenous injection notable benet PET tracer synthesis use simple 11Cmethylation carbon framework follow methyl group nonpolar least bulky group little effect biological activity parent compound halflife min short make many basic research experiment clinical trial possible day special precaution include treatment radiolabele byproduct synthesis reaction tolerance CH3 derivative metabolic process high compare CH3 ch3 derivative take advantage consideration focus expand utility rapid methylation wide range substrate investigate rapid sp3 sp2alkenyl coupling synthesis new pet tracer methylalkene structure observe frequently various biologically signicant compound exemplie retinoid Org Biomol Chem journal publish January University Regina View Article Online Journal Homepage Table content issue vitamin squalene isoprenoid succeed develop novel general protocol applicable wide variety choose nonfunctional functional alkenyl tributylstannane practical pet tracer synthesis mind use ratio9 methyl iodide tin substrate rapid methylation Table First examine condition report previously worker sp3sp2vinyl however methylation base allylpdcl2meme4nf molar ratio system presence molecular sieve min give desire product yield respectively base consumption reaction use source Pd2dba2MeMe4NF min also give desire product respectively change solvent DMF slightly improve yield extent improvement unsatisfactory respectively therefore apply condition establish previously sp3sp2aryl couple vinyl system thus mixture ch3ipd2dba tolylCuClK2CO3 DMF heat min Table entry condition give methylate product heptene single product yield likewise reaction isomer give heptene yield entry thus methylation proceed complete check reaction additional alkenyltributylstannane conrm generality condition reaction tin substrate substituent position tend low reaction yield entry use Cs2CO3 instead k2co3 condition effective improve yield substrate conjugate alkene give product yield entry however methylation tributylstannylstyrene substitute nonconjugated alkenylstannane still unsatisfactory afford product yield entry case increase quantity add tolyl equiv condition markedly improve yield reaction product presence give yield Table result use CH3IstannanePd2dbatolylCuClK2CO3 condition summarize Table condition find improve reaction entry markedly exception entry therefore nature quantity sterically congest triaryl phosphine important facilitate crosscoupling reaction reaction condition use standard sp2sp2 coupling observation indicate combine use salt CsF phosphine work efciently show Table system rst report enhance crosscouple sp2sp2 substrate combination however original condition insufcient purpose methylation use CH3IstannanePPh3CuICsF ch3istannanepdcl2cuicsf DMF min give yield respectively likewise reaction use CH3IstannanePd2dbaPPh3CuICsF ch3istannanepd2dbacuicsf DMF min also give yield respectively however course study find use bulky phosphine tolyl instead strongly promote reaction detail summarize Table condition consist equiv respect methyl iodide Table entry 5th column condition Table seem good term minimum use phosphine uoride ion afford desire product yield reaction sensitive quantity phosphine using equiv give coupling product yield limitation overcome change copper salt addition increase quantity uoride ion thus reaction use 2MeCuCl CuICsF give coupling product yield table entry 3rd 9th column modied condition Table use tolyl prove good choice promote coupling reaction efciently thus process use tolyl equiv equiv equiv afford yield table entry 6th column condition table increase quantity bulky phosphine equiv promote reaction almost perfectly table entry 3rd 6th 9th column modied condition table consider result table condition include slight modication namely Pd2dbaCuXCsF respectively apply tin compound Table Condition modication base quantity tolyl work well entry give coupling product yield condition poor entry difference presumably due high nucleophilic character trialkylphosphines compare triarylphosphine tends undergo conjugate addition unsaturated carbonyl group unfavorable side effect enhance increase quantity phosphine ligand table modication condition entry effect mark contrast reaction use tolyl favor large amount phosphine ligand table modication condition entry practical viewpoint use tolyl also convenient former crystalline journal publish January University Regina View Article Online Table Rapid trap methyl iodide alkenyltributylstannanes Yield Conditionsc Entry Alkenyltributylstannanea methylated product 88e 91i 90f 95d 93e 80f 96h 93h 72e Stereoisomerically pure judge NMR spectra product detect analysis single product comparison authentic sample yield determine analysis base consumption use nonane heptane decane internal standard average run reaction perform DMF min reaction condition molar ratio ch3istannanepd2dba tolylCuClK2CO3 CH3IstannanePd2dbatolylCuClK2CO3 CH3IstannanePd2dba Cs2CO3 use instead K2CO3 CH3IstannanePd2dbatolylCuClK2CO3 CH3IstannanePd2dba2MeCuClCsF CH3IstannanePd2dbatolylCuClCsF ch3istannanepd2dbatolylcuicsf compound stable air latter airsensitive oily material necessitate handle glovebox inert gas thus consider wide range applicable tin substrate ease use triarylphosphines condition well actual pet tracer synthesis use coordinatively unsaturated complex tolyl therefore use sterically bulky phosphine cone angle tolyl seem important enhance sp3sp2alkenyl coupling efciency condition similar case sp3sp2phenyl coupling trialkylphosphine markedly high electrondonate ability arylsubstituted phosphine pKa tolyl trialkylphosphines Org Biomol Chem journal publish January University Regina View Article Online Table Rapid trap methyl iodide tributylcyclohexenstannane give use K2CO3 Additives equiv K2CO3 CuBr K2CO3 CuI K2CO3 Entry Phosphine equiv yield determine analysis base consumption use nonane internal standard Data average run reaction condition ch3ipd2dbapr3cuxk2co3 molar ratio DMF min Table Rapid trap methyl iodide tributylcyclohexenstannane give use Additives equiv Entry Phosphine equiv 2Me tolyl 66b 38b tolyl 86b 18b yield determine analysis base consumption use nonane internal standard Data average run otherwise note reaction condition ch3ipd2dbapr3cuxcsf molar ratio DMF min Data single run property alkyl ligand phosphine atom inuence coupling efciency great extent indicate large difference rapid methylation alkynylstannane sp3 coupling rapid sp3sp2alkenyl couple study however role alkyl substituent marked discrimination remain unclear high efciency combine use consider synergic effect generation reactive organocopper specie transmetallation18 removal 3SnX formation insoluble 3SnF shift equilibrium alkenylcopper similar manner efciency combination k2co3 employ condition Table explain synergic effect transmetallation formation stable bistributylstannylcarbonate 3SnO thus synergic effect concept12 introduction bulky triarylphosphine allow realization efcient general protocol rapid sp3sp2alkenyl coupling reaction potentially useful PET tracer synthesis also investigate reaction use excess additive methyl iodide fold tolylcubrcsf give yield table modied condition entry thus reaction inuence increase additive respect methyl iodide promise combine system applicable actual pet study experience pet study heat mixture methyl iodidestannanecuxunder continuous operation prior mix iodide mix result solution stannane copper salt uoride salt expect well term high reproducibility use method reaction use CH3IPd2dbatolyl cubrcsf gave yield accordingly actual synthesis PET tracer conduct condition continuous stepwise mixing use stannane give high radiochemical yield HPLC analytical yield condition Scheme Scheme Synthesis journal publish January University Regina View Article Online summary develop efcient protocol rapid trap methyl iodide excess alkenyltributylstannane rapid sp3sp2alkenyl coupling method provide rm chemical basis synthesis short live pet tracer methylalkene unit Retinoids articial derivative involve important biological signal pathway agonist target nuclear RARRXR receptors23 prototypical proteincouple receptor rhodopsin Squalene triterpenoid contain isoprene unit major metabolite derive key intermediate production important bioactive steroid PET study use correspond tracer contribute possibility vivo biomolecular study synthesis abovementioned pet tracer use molecular imaging report due course ment work support part thank JSPS Incorporation perform pet laboratory photonic Notes orkman Suzuki Jpn orkman orkman Resul label Radiopharm Hosoya see also application group base method 11CmethylMADAM label Radiopharm therein agren therein 11cmethyl Kawashima Magata ethyl Fowler Positron Emission Tomography Autoradiography Phelps Mazziotta angstr Principles Nuclear Medicine 2nd edn sect Discovery West Jones Cancer Acta Handbook Radiopharmaceuticals Welch Stille Angew Chem Int organostannane see istry 2nd edn WileyVCH Weinheim Suzuki Kato Int Engl Takechi orkman Suzuki Scand Watanabe Matsumura Takechi Kato Morii orkman synthesis pet tracer rather different standard organic synthesis reaction involve trapping extremely small amount approximately nmol level contain 12CH3I large amount react substrate therefore set reaction use excess alkenylstannane respect methyl iodide Tang Menzel increase amount tolyl effective Cs2CO3 use instead K2CO3 conrme use Baldwin Angew Chem Int typical procedure table entry condition dry Schlenk tube Pd2dba lmol lmol place addition DMF mixture stir min room temperature follow successive addition solution stannane lmol methyl iodide DMF solution lmol stir min mixture cool rapidly ice bath addition diethyl ether mixture load short column silica gel elute diethyl ether follow addition nonane DMF solution lmol internal standard result solution analyze instrument equip ame ionization detector capillary column science lm thickness stationary phase carrier gas rate min injector temperature detector temperature column temperature initial nal temperature gradient min min yield methylcyclohexene base start retention time min nonane Goel Chem White Lett omezBengoa Rev Mukaida Jpn Kokai Tokkyo Organometallics Rev Terstiege Chem Soc Gallagher Terstiege pet tracer synthesis table entry condition iodide prepare reduction LiAlH4 follow journal publish January University Regina View Article Online treatment accord establish method iodide trap solution Pd2dba lmol tolyl lmol DMF room temperature solution transfer vial contain stannane lmol lmol lmol DMF wash result mixture heat min Salts palladium residue reaction mixture remove solidphase extraction wash DMFH2O combine eluate analyze HPLC yield retention time min science mobile phase ch3cnh2o rate min detection reaction equimolar amount lmol use catalytic amount pd2dbatolylcuclcsf DMF min afford yield thus methylation also useful introduction CD3 longlived 14CH3 organic framework synthesize molecular probe metabolic study particular synthesis enrich methylated probe attract great deal attention view drug microdose human subsequent longterm analysis metabolite accelerator mass spectrometry see ref Kagechika journal publish January University Regina View Article Online",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 10
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "CH3IstannanePPh3CuICsF": 1,
                    "trialkylphosphines": 2
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "CH3IstannanePPh3CuICsF": 10,
                    "trialkylphosphines": 10
                },
                "Ethnographic Terms": {
                    "methylation": 3
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Reading RNA methylation codes through methyl-specific binding proteins.pdf",
            "cleaned_text": "article publisher Wales Registered Number registered office W1 3jh Click update RNA Biology Publication detail include instruction author subscription information read rna methylation code bind protein Hea Department Chemistry online Apr cite article read rna methylation code bind protein RNA Biology rna link article PLEASE SCROLL ARTICLE make effort ensure accuracy information contain publication platform however agent licensor make representation warranty whatsoever accuracy completeness suitability purpose opinion view express publication opinion view author view endorse accuracy rely independently verify primary source information liable loss action claim proceeding demand cost expense damage liability howsoever cause arise directly indirectly connection relation arise use article use research teaching private study purpose substantial systematic reproduction redistribution resell loan sublicense systematic supply distribution form anyone expressly forbid Terms Conditions access use find distribute wwwlandesbiosciencecom RNA Biology RNA Biology June PointView PointView PointView methyladenosine m6A prevalent modification eukaryotic mrnas regulate yeast cell fate essential development fertility metazoan presence mrna know function m6A remain mystery spate discovery focus discovery m6A reader protein specifically recognize m6A function tune mrna stability broad significance m6adependent regulation gene expression Eukaryotic mrnas mrnas encode precise protein sequence also convey information processing transportation translation decay thereby collectively create complex layer gene regulation posttranscriptional stage know mechanism involve rna structure translation regulation contribute posttranscriptional regulation gene expression establish regulatory mode mrna involve short rna sequence untranslated region exemplify rich element stability ironresponsive element translation zipcode element localization micro RNA seeding sequence translation stability mrna cap polyadenylated tail paper discuss new mechanism regulation reversible internal rna methylation essential description m6A methyladenosine m6A major internal noncap modification eukaryotic mrna mrna average mrna m6A residue context m6A recent advance m6asequence technology also reveal enrichment long exon stop codon widespread distribution m6A site human transcript m6A content individual mrnas nonuniform m6A site non stoichiometric mrnas free m6A m6A posttranscriptionally instal m6A methyltransferase coordination mrna processing event namely polyadenylation capping splicing addition previously identify subunit METTL3 recently reveal component mammalian m6A methltransferase complex form stable heterodimer METTL3 enzymatic core interact heterodimer affect methyltransferase activity cell discovery functionally significant m6A demethylase define mrna methylation reversible process METTL3 essential proper meiotic entry bud yeast viability plant fruit fly human HeLa cell defect read rna methylation code bind protein rna methylation m6A methyladenosine reversible rna modification gene expression regulation rna stability protein YTH domain correspondence chuanheuchicagoedu submit revise Accepted publish Online January distribute RNA Biology volume Issue AlkBH5 affect body weight fertility respectively thus demonstrate physiological importance m6A consider new layer information top primary sequence methylation demethylation resemble write erase yet mechanism read methylation information exist m6A repel rnabinding protein interact recognize bind protein reader potential reader suggest early pull experiment use methylate rna probe characterize domain family protein m6A reader provide first functional role m6A reading process analogy partner though scientifically accurate advantageous order work pattern chemical modification dna mrna protein comparable study dna methylcpg bind protein MeCPs believe reader provide clue uncover mechanism cellular function associate m6A YTH Domain Family m6A Specific Binding Proteins YTH domain newly discover domain bind short degenerate singlestranded rna sequence domain family member various eukaryotic specie human domain family contain member YTHDF1 YTHDF3 selectively identify use synthetic rna bait contain m6A also discover slightly different bait sequence protein significantly high affinity methylated probe measure gel shift assay thus m6Aspecific binders Nextgeneration sequencing advance complex isolation technique greatly empower transcriptomewide study RNAbinding protein integration photoactivatable ribonucleosideenhanced crosslinking immunoprecipitation ribosome profiling mrna lifetime profiling result current conclusion indeed bind m6A cell bind site agree well m6A site direct interaction polysome major function accelerate decay target roughly determine knockdown domain terminus sufficient recognize terminal domain involve localize rna processing body rna decay occur result use reporter system show bind ythdf2 rna target take place parallel late stage deadenylation prerequisite step eukaryotic mrna decay take together result lead mechanistic model YTHDF2 transduce m6A code rna turnover signal modular structure convey bind rna decay machinery recent study homolog yeast support conserve role domain protein control mrna turnover ythdf2 homolog fission yeast Schizosaccharomyces pombe selectively degrade meiotic mrna transcript rna surveillance machinery vegetative growth bud yeast Saccharomyces cerevisiae m6A conditionally accumulate sporulation induce nutrition starvation Pho92 MRB1 correspond domain protein bud yeast also show reader protein regulate stability mrna important transcription factor phosphate signal transduction pathway bind phosphate dependent manner Mechanistically Pho92 interact Pop2Ccr4Not deadenylation complex coincide observation localize human hela cell hence study yeast shed light possible role m6A nutrition metabolism regulation mrna stability m6ADependent well understand effect m6A worth discuss m6Adependent control mrna stability compare mean gene expression regulation base transcriptomewide measurement rna level cell population temporal mrna level change response external stimulus suggest primarily determine change transcription rate however change mrna degradation rate important figure specific bind protein recognize dna rna methylation methylbinding protein recognize mammalian DNA methylation black ball figure also illustrate methylation state bind protein green orange interact various transcriptional factor purple control transcription domain family protein blue selectively recognize internal rna methylation red ball fate mrna control interplay bind protein protein factor pink interact domain family protein rnabinding protein RBPs dark blue purple recognize rna sequence structure January distribute wwwlandesbiosciencecom RNA Biology order define sharp response also observe transcript bear m6A inherently short lifetime nontarget Genes roughly classify housekeeping gene protein production always demand regulatory gene protein production conditional strictly control low abundance give mrnas encode housekeeping gene free globin histone YTHDF2 rna target enrich regulatory gene transcription factor possible m6A represent mechanism impose precise control expression regulatory gene transcriptional level transcriptional factor tfs recognize genomic sequence time dna methylation form chemical modification exist high eukaryote specific reader protein recognize order exert additional regulation gene expression Fig Nature seem use trick gain additional control gene expression mrna level various rna bind protein parallel tfs DNA exist affect transport storage splicing stability mrnas show reader protein also exist recognize internal mrna methylation provide additional complexity mean affect eventual protein production methylation add remove mrna therefore m6a code dynamic reversible dependent cell type state feature m6A extremely important dynamic cell differentiation process neuronal27 development highly possible m6A code function concert rna sequence element well RNAbinding protein analogous interplay tfs reader protein DNA future direction YTHDF1 YTHDF3 already identify m6Aspecific bind protein therefore functional characterization protein ongoing give high sequence similarity YTHDFs possible protein degenerate extent show mediate translocation m6Acontaining RNA translatable pool nonribosomal mRNAprotein particle however know m6acontaine rna target ythdf2 translation exit translation addition various RNAbinding protein coat mrnas therefore tempting envision m6A reader work concert sequencespecific rna bind protein collectively decide fate mrna valuable characterize protein interactome protein finally knockdown ythdf2 cause reduce viability HeLa cell however knockout model organism knockout mouse exact physiological function remain unknown future investigation area necessary discovery characterization m6A reader protein represent critical step order understand reversible m6adependent regulation RNA level still vast knowledge gap molecular detail biological necessity m6A require research connection potential conflict interest disclose acknowledgment work support thank edit manuscript Tuck formation internal methyladenine residue eucaryotic messenger RNA Int Biochem PMID org711X sequence methyladenosine site HeLa cell messenger ribonucleic acid biochemistry pmid Schwartz SalmonDivon Ungar JacobHirsch Topology human mouse m6A RNA methylome reveal nature PMID Mason Jaffrey Comprehensive analysis mrna methylation reveal enrichment near stop codon cell pmid cell Tabach Ruvkun Highresolution mapping reveal conserve widespread dynamic mrna methylation program yeast meiosis cell pmid orgcell Polayes Matera Rottman Purification cdna clone AdoMetbinding subunit human mrna adenosinemethyltransferase rna PMID Han METTL14 complex mediate mammalian nuclear RNA adenosine methylation Nat Chem Biol PMID orgnchembio Lindahl methyladenosine nuclear RNA major substrate obesityassociated PMID Fedorcsak Wang Song ALKBH5 mammalian RNA demethylase impact rna metabolism mouse fertility Mol Cell pmid IME4 gene mediate nutritional control meiosis Saccharomyces cerevisiae Mol cell Biol pmid rna methylation MIS complex regulate cell fate decision yeast e1002732 PMID Vespa Herzog Fray MTA Arabidopsis messenger rna adenosine methylase interact homolog sexspecific splicing factor Plant Cell PMID OrrWeaver Drosophila Inducer MEiosis IME4 require Notch signal oogenesis PMID orgpnas methyladenosine dependent regulation messenger rna stability Nature PMID dna methylation inhibit transcription indirectly methylcpg bind protein cell PMID January distribute RNA Biology volume issue Rafalska YTH domain novel rna bind domain PMID orgjbcM110 Stoilov Rafalska new domain nuclear protein Trends Biochem Sci pmid orgs0968 Burger Jungkamp Transcriptome wide identification RNAbinding protein microrna target site PARCLIP Cell PMID orgcell Newman Weissman analysis vivo translation nucleotide resolution use ribosome profiling science pmid science Decapping decay messenger rna occur cytoplasmic processing body Science pmid orgscience prerequisite body formation mrna decay mammalian cell Cell Biol pmid Hiriart RNA surveillance machinery direct RNAi complex specific meiotic gene fission yeast pmid orgemboj novel protein Pho92 conserve domain regulate phosphate metabolism decrease mrna stability cerevisiae PMID Timpte Bokar Induction sporulation Saccharomyces cerevisiae lead mrna potential mechanism activity IME4 gene pmid gkf573 Rabani Levin Fan Adiconis Raychowdhury Garber labeling rna uncover principle rna production degradation dynamic mammalian cell pmid expression regulation mediate reversible rna methylation PMID orgnrg3724 hess fat mass obesity associate gene Fto regulate activity dopaminergic midbrain circuitry PMID bird dna methylation pattern epigenetic memory PMID",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 22,
                    "demethylation": 1,
                    "epigenetic": 1
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "RNAbinding": 2,
                    "Han": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "RNAbinding": 24,
                    "Han": 24
                },
                "Ethnographic Terms": {
                    "methylation": 3,
                    "demethylation": 3,
                    "epigenetic": 3
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Reversal of maternal programming of stress responses in adult offspring through methyl supplementation_ altering epigenetic marking later in life.pdf",
            "cleaned_text": "DevelopmentPlasticityRepair Reversal Maternal Programming Stress response Adult offspring Methyl Supplementation alter Epigenetic Marking Later Life Frances Champagne H3 G pal exon glucocorticoid receptor promoter examine epigenetic programming reversible adult life centrally infuse adult offspring essential amino acid methionine precursor adenosylmethionine serve donor methyl group dna methylation report methionine infusion reverse effect maternal behavior dna methylation nerve growth factorinducible protein bind exon promoter expression adrenalandbehavioralresponsestostresssuggestingacausalrelationshipamongepigenomicstateGRexpressionandstressresponses adult offspring result demonstrate inherent stability epigenomic mark establish early life behavioral programming potentially reversible adult brain Key word maternal behavior rat hippocampus glucocorticoid receptor epigenetic methionine introduction hypothalamicpituitaryadrenal response stress inducible defense mammal activate response threat primate rodent nonmammalian specie maternal effect magnitude defensive response offspring rat effect mediate variation maternal care maternal behavior stably alter development response stress offspring tissuespecific effect gene expression magnitude response stress function neural stimulation hypothalamic corticotropinreleasing factor release activate pituitaryadrenal system modulatory influence glucocorticoidnegative feedback inhibit synthesis release thus dampen response stress Kloet adult offspring mother exhibit crease level pup lickinggrooming archedback nurse high mother life show increase hippocampal glucocorticoid receptor expression hanced glucocorticoid feedback sensitivity compare adult animal rear low mother predictably adult offspring high moth er show decrease hypothalamic expression modest response stress difference hippocampal level abolish effect early experience response stress adulthood suggest difference hippocampal pression serve mechanism effect early experience development individual difference response stress adult offspring high mother also less fearful condition stress animal rear low dam study show measure biological offspring low mother rear high dam resemble normal offspring high vice versa finding suggest variation maternal behav ior directly program rudimentary defensive response stress serve mechanism nongenomic transmission individual difference stress reactivity generation previous study suggest epigenetic mechanism involve longterm maternal programming spring response stress adulthood Weaver exon promoter sequence uniquely express brain exhibit considerable transactivational activity receive Aug revise Oct accept Oct work support grant CIHR support Senior Scientist award project support Distinguished Investigator Award Schizophrenia Affective Disorders Correspondence address follow Pharmacology H3 G mail Psychiatry Center LaSalle Boulevard Room Verdun Montre Quebec Canada H4H mail michaelmeaneymcgill Neuroscience Journal Neuroscience adult offspring low moth er express significantly low level hippocampal exon mrna transcript compare offspring high mother adult offspring low mother exon promoter hypermethylate associate hypoacety lated histone lysine reduce bind nerve growth factorinducible protein transcription factor also know zenk adult offspring high mother promoter hypomethylated associate hyperacetylated histone bind increase level NGFI Weaver central infusion histone deacetylase HDAC inhibitor enhance histone acetylation exon promoter offspring low moth er increase bind induced hypomethylation cpg dinucleotide sequence promoter eliminate maternal effect hippocampal expression sponses stress commonly think dna methylation pattern plastic devel opment fix adult postmitotic tissue datum imply demethylation machinery present adult brain gain access methylate gene pharmacologically duce alteration chromatin conformation indeed epi genetic status adult genome truly dynamic equilib rium methylation demethylation possible reverse dna methylation pattern direction induce hypermethylation dietary methionine convert methionine adenosyl transferase adenosylmethionine also term serve donor methyl group dna methylation methyl donor propose cause dna hypermethylation activate dna methylation enzyme inhibit tive demethylation importantly synthe sis SAM dependent local availability methionine Cooney reason DNA methylation pat tern exon promoter adult offspring main sensitive dna methylation DNA demethyl ation enzyme increase brain methionine level result dna hypermethylation reversal maternal programming expression response stress current finding support hypothesis suggest methylation status specific dna sequence modifiable even postmitotic cell thus otherwise stable effect ternal care phenotype potentially reversible Materials Methods Animals maternal behavior animal use study derive LongEvans hooded rat bear colony animal originally obtain animal mate male draw randomly breed stock maintain colony case offspring high low mother use study animal group draw single mother time wean day life pup house animal cage day life animal cage point time testing occur early age procedure perform accord guideline develop pro tocol approve havioral observation perform mother litter house Plexiglas cage permit clear view activity cage Food water provide libitum colony maintain lightdark schedule light maternal behavior score describe previously behavior dam observe observation period first postpartum Observations occur regular time period light phase period dark phase lightdark cycle observation period behavior mother score min observation period observation mother day tion perform individual unaware origin animal occasion disturbance animal room observation session uncomplete mother observe actly number period variation datum therefore analyze percentage observation animal engage target behavior follow behavior score mother pup mother lickinggroome pup mother nursing pup archedback posture blanket posture mother lay pup passive posture mother lie back side pup nurse note behavioral category mutually exclusive example lickinggrooming often occur mother nurse pup frequency maternal lickinggrooming archedback nursing large number mother normally bimodally distribute hence high low mother represent end continuum rather distinct population define population cur rent study observe maternal behavior cohort mother devise group mean behavior first life mother define female frequency score lickinggrooming archedback nursing mean low mother define female frequency score lickinggrooming archedback nursing mean previous report lickinggrooming behavior suggest frequency lick grooming archedback nursing highly correlate Intracerebroventricular infusion intracerebroventricular cannula placement old adult male high low offspring anesthetize area ear neck scapu lae shaven shaven skin swab iodine mount secure stereotaxic frame cut make directly midline fascia muscle separate expose skull surface clean dry sterile gauze cotton swab stainlesssteel guide cannula gauge length Plastics One aim left lateral ventricle posterior bregma lateral midline ventral brain surface Guide cannula secure dental cement jeweler screw keep patent stylet gauge animal place heat lamp regain consciousness transfer single cage recovery period animal receive single infusion consecutive day describe Animals remove cage gently hold infusion cannula gauge attach tubing polyethylene lower guide total volume saline methionine saline saline vehicle alone inject use infusion cannula min period infusion cannula leave place additional min infusion animal return home cage sodium bisulfite mapping Sodium bisulfite mapping perform use procedure sodium bisulfite solution NaBis hydroquinone add resus pended DNA incubate DNA elute qiaquick PCR purification kit Tris buffer add final concentration incubate NH4OAc add final concentration NH4OA follow addition bisulfite dna solution cool min precipitate solution centrifuge rpm min pelleted DNA lyophilize Neurosci alter Epigenetic Marking Later Life resuspend ddh2o rat exon promoter region accession number AJ271870 sodium bisulfitetreated hippocampal DNA subject pcr amplification use outside primer forward ttttttaggtttttttagaggg reverse ther mocycler protocol involve initial denaturation cycle min cycle denaturation min anneal min extension min follow final extension cycle min terminate pcr product use template subsequent pcr reaction use nest primer forward reverse CCCAAACTCCCTCC nest pcr product purify qiaquick PCR purification kit DNA elute buffer purified product separate agarose gel band correspond dna fragment cut gel DNA extract Agarose Gel Extraction Qiagen elute buffer pcr product subclone original cloning kit transform chemically make competent bacteria grow anoside treat ampicillin Invitrogen Carls bad plate different clone plate mini preppe grow broth treat ampicillin pellet resuspend STET crose Mannheim Germany dissolve buffer add sample subsequently boil finally recovered DNA resus pended Tris EDTA RNase plasmid contain ligate exon promoter DNA fragment sequence animal sequencing kit start procedure protocol manufacturer sequencing reaction resolve denature page run trisborateedta visualize autoradiography neuronalspecific nuclear protein immunohisto chemistry whole brain remove old adult male spring rapid decapitation min removal home cage coronal section correspond stereotaxic level bregma thaw mount section slide gelatinsubbed slide temporarily store cryostat sectioning complete slide vacuum dry desacator store section process parallel section fix min parafor wash ethanol min block contain immerse HCl antibody kind gift dilute serum nuclear protein NeuN conjugate monoclonal anti body dilute serum apply section incubate leave hybridize negative control section rat produce omit addition primary antibody rabbit IgG Invitrogen dilute serum apply label section section dry coverslippe NeuN labeling perform use fluorescence microscope equip high resolution color digital camera connected computer run appropriate filter combination planapochromatic oilimmersion objective use capture age positive nucleus entire area dentate gyrus hippocampal region horn image convert format import image analysis system Catharines Ontario ada quantification observer blind experimental condition perform analysis immunoprecipitation assay preparation fix tis sue old adult male high low offspring deeply anesthetize sodium pentobarbital tran scardially perfuse heparinized saline flush follow paraformaldehyde min perfusion brain remove postfixe fixation solution night transfer phosphate buffer sucrose immunoprecipitation chip assay CraneRobinson perform follow ChIP assay kit protocol state dissect rat brain chromatin immunoprecipitate use rabbit polyclonal antiacetylhistone antibody lution Waltham rabbit polyclonal antingfi antibody normal rabbit IgG nonimmune antibody lysate keep quantify amount dna present different sample immu noprecipitation input proteindna complex uncrosslinked add sample follow EDTA TrisHCl extrac tion freeDNA ethanol precipitate resuspend rat hip pocampal exon promoter region accession number AJ271870 uncrosslinked DNA subject PCR amplifica tion forward primer reverse primer GGAGGGAAACCGAGTTTC pcr reaction perform PCR system protocol use Madison thermocycler protocol volved initial denaturation cycle min cycle anneal min extension min follow final extension cycle min terminate control unequal loading acetylhistone immuno precipitate rat hippocampal actin promoter region accession number V01217 uncrosslinked DNA subject pcr amplification forward primer TCAACTCACTTCTCTC TACT reverse primer GCAAGGCTTTAACGGAAAAT pcr reaction perform PCR system protocol use thermo cycler protocol describe previously control purity immunoprecipitate rat hippocampal exon estrogen ceptor promoter region accession number uncrosslinked DNA subject pcr amplification forward primer GAAGAAACTCCCCTCAGCAT reverse primer GAAATCAAAACACCGATCCT PCR reaction form follow PCR system protocol use thermocycler protocol involve initial denaturation cycle min cycle denaturation min anneal min extension min follow final extension cycle min terminate pcr reaction DNA purify nonimmunoprecipitated sample immuno precipitate sample repeat exhaustively use vary amount template ensure result linear range PCR total amplify product separate agarose gel poststaine ethidium bromide visualize band corre sponde exon glucocorticoid receptor promoter actin promoter exon promoter DNA fragment nucleic acid transfer Southern blot positively charge nylon transfer membrane sham Biosciences oligonucleotide specific exon promoter sequence accession number AJ271870 syn thesize forward TCCCGAGCGGTTCCAAGCCT well oligonucleotide specific actin promoter sequence accession number V01217 forward oligonucleotide specific exon promoter sequence accession number forward oli gonucleotide radiolabele polynucleotide kinase Madison hybridize membrane alter Epigenetic Marking Later Life Neurosci November expose PhosphorImager screen Plate Fujifilm screen scan PhosphorImager Storm840 Sunnyvale run ne Storm840 software optical density reading determine use computerassisted densitome try program calculate final signal sample value band antibody lane divide value band input lane control equal loading sample final signal exon promoter amplify acetylhistone immunoprecipi tation divide final signal actin promoter amplify precipitate pcr analysis whole brain remove rapid decapitation min animal removal home cage hippocam pal tissue dissect snap frozen dry ice store total hippocampal rna isolate reagent method precipitate RNA dissolve quantify absorbance overall quality yield rna preparation determine denature agarose gel electrophoresis fractionation addition rna integrity confirm use cdna synthesize reaction volume contain total rna murine leukemia virus reverse transcriptase Burlington Ontario ada random primer concentration deoxynucleotide triphosphate hibitor mrna denature min random primer anneal min mrna reverse transcribe reverse transcriptase heat inac tivate min product store rat hippocampal exon region accession number AJ271870 subject pcr amplification forward primer cagttaatatttgc reverse primer ttgaactcttgggg ttctctgg control equal loading rat hippocampal actin exon region accession number also sub jecte PCR amplification forward primer GTTGCTAGCCAG gctgtgct reverse primer cggatgtccacgtcacactt exon actin amplification perform parallel use reaction mixture contain synthesize cdna product pcr buffer dNTPs Taq polymerase primer thermocycler protocol involve initial cycle min cycle denaturation annealing extension follow final extension cycle min terminate Samples remove cycle cycle determine linear range separate agarose gel visualize band correspond exon actin cDNA fragment nucleic acid transfer Southern blot positively charge nylon transfer membrane bond oligonucleotide specific exon sequence accession number AJ271870 forward TCCCAGGCCAGTTAATATTTGC synthesize well oligonucleotide specific actin sequence accession number V01217 forward GTTGCTAGCCAGGC TGTGCT oligonucleotide radiolabele hybridize membrane expose Phospho rImager screen overnight screen scan PhosphorImager Storm840 ular Dynamics run Storm840 software ROD reading determine use computerassisted densitometry program control equal load ing sample signal exon region divide signal actin region amplify sample Western blot whole brain remove old adult male high low offspring rapid decapitation min removal home cage hippocampi dissect snap frozen dry ice store hippocampal tissue whole cell extract prepare use tissue sonicate ice pulse acid buffer hippocampal tissue contain NaCl protease inhibitor benzenesulfonylfluouride leupeptin supernatant subsequently take determine level protein whole hippocampus western blot perform use equal quantity protein separate page precast gel Ontario Canada stain molecular marker Invitrogen Burlington Canada load protein electrophoretically transfer trocellulose membrane membrane block Carnation dry milk Trisbuffered saline Tween TBS wash briefly incubate antirat monoclonal primary antibody block buffer Affin ity BioReagents Golden Membranes wash min incubate horseradish peroxidase conjugate sheep IgG antibody science wash band visual ize enhanced chemiluminescence appose autoradiography film Hyperfilm Amersham Bio science develop single band observe kda verify accuracy sample loading select blot incu bate min stripping solution TrisHCl mercaptoethanol SDS block reprobe tubulin monoclonal antibody single band observe kda intensity signal similar lane reading band determine use computerassisted densitometry program sample run triplicate different blot study single blot derive sample animal response restraint stress stress response testing involve place old adult male high low offspring Plexi gla restrainer min period Prestress blood sample take rat removal cage restraint stress perform light cycle blood sampling tail vein min onset restraint corticosterone mea sured radioimmunoassay highly specific antiserum corticosterone mmol tracer antiserum crossreact slightly deoxycorticosterone aldosterone cortisol progesterone intraassay interassay coefficient vari ation respectively standard curve effective concentration detection limit assay test behavioral stress response testing perform describe previously use old adult male high low offspring Naive animal place Plexiglas cylinder high diameter fill water depth min min training session animal remove water allow dry min return home cage animal replace waterfilled cylinder total duration immobility record min test session immobile behavior score whenever animal remain passively afloat struggle slightly hunch upright position head slightly immerse rat make movement necessary keep head water observer blind experimental condition score behavior single min training exposure sufficient produce relatively constant level immobility subsequent min test highly reproducible different group Neurosci November alter Epigenetic Marking Later Life Results effect methionine methylation pattern exon promoter determine effect methionine treatment adult offspring high low mother infuse methionine saline vehicle day consecutive day difference methylation map use sodium bisulfite technique Comb particular interest consensus sequence Fig statistical analysis datum cpg site reveal significant effect group treatment region well significant group treatment region interaction group treatment interaction group gion interaction treatment region interaction result veale significant difference methylation number region exon promoter sequence sig nificant difference site site dinucleotide consensus sequence report previously cytosine site dinucleotide heavily methylate offspring low mother rarely offspring high mother contrast cytosine site dinucleotide consensus sequence almost always methylate independent maternal care Statis tical analysis datum site reveal highly significant effect group treatment region well significant group treatment interaction group region interaction treat ment region interaction analysis reveal cytosine consensus sequence significantly ate adult offspring low mother compare offspring high dam methionine treatment significantly crease cytosine methylation dinucleotide offspring high mother compare vehicle treat high mother thus thionine treatment produce remethyla tion site dinucleotide offspring high mother finding suggest thionine treatment reverse pomethylated status exon promoter adult offspring high mother Maternal care alter methylation status dinucleotide exon sequence case site meth ylation similarly reverse central methionine infusion Fig signif icance site transcription factor bind currently unknown focus ongoing study thus stable dna methylation mark maternal behavior reversible adult offspring hippocampus increase methionine Methionine alter methylation site dinucleotide consensus sequence critical effect bind exon promoter previous study use electrophilic mobility shift assay purified recombinant ngfi protein Mil brandt differentially methylate oligonucleotide quence contain consensus sequence find methylation cytosine site dinu cleotide completely eliminate bind however methylation cytosine site slightly reduce ngfi protein bind Weaver important question effect methio limited subset gene disrupt DNA methylation pattern entire nome surprisingly result microarray analysis perform hippocampal tissue separate cohort methioninetreate high low offspring show methionine treatment significantly fecte gene represent population gene chip unpublished observation finding suggest impressive level specificity certainly exclude pos sibility component modify gene rele vant effect observe appear Figure1 dinucleotide exon promoter region vehicle methioninetreate adult high low offspring clone sequence animal animal group percentage methylate cytosine residue mean SEM first cpg dinucleotide percentage methylate cytosine residue meansemforthe5site16and3site17cpgdinucleotideswithinthengfiaconsensussequence divconfocalphotomicrographsofrepresentative5positiveneuronslocatedwithintheca1hippocampalregion Ammon horn vehicle methioninetreate adult high low offspring animal group section animal large round nucleus correspond neuronal nucleus indicate arrow point upward include analysis partial small nucleus indicate arrow point downward include quantification Scale bar alter Epigenetic Marking Later Life Neurosci November result emerge function widespread alteration hippocampal gene expression examine ternal care methionine treatment effect global dna meth ylation level dorsal hippocampal coronal section methionine vehicletreated adult offspring coimmunos taine use antibody specific NeuN assess genomic methylation level tissue section analyze thoroughly entire area dentate gyrus hippocampal region horn however staining intensity different region remain regardless maternal care methionine treatment representative image staining CA1 region treatment group show figure neuronal nucleus consider positive round intensely fluorescent strong contrast surround tissue labeling intensity background consistent slide ANOVA reveal significant effect group vehicletreated high vehicletreate low treatment vehicletreate low methioninetreate low vehicletreate high methioninetreate high result show nei ther maternal care methionine treatment affect global dna methylation level finding suggest alteration cytosine methylation adult brain global proce dure surprisingly specific alone meth ylate DNA convert methyl donor SAM DNA methylation reaction increase change dna methylation pattern gene DNA machinery present gene DNA replicate expect maintenance dna methyltransferase dnmt normally present replication fork ubiquitously present become clear chromatin dna methylation enzyme target spe cific gene regulate process thus specificity effect methionine likely determine occupancy distinct promoter dnmt tempting speculate gene volve crucial regulatory function persis tently associate DNA methylation machinery thus hypersensitive global change methionine level ture experiment elucidate mechanism target DNA methylationdemethylation machinery specific gene hippocampus effect methionine bind exon promoter Differences methylation exon promoter tightly associate effect histone acetylation bind ing Weaver test hypothesis effect methionine dna methylation result decrease tone acetylation residue histone associate exon promoter decrease interaction promoter sequence change tone acetylation association promoter perform chip analysis histone acetylation protein bind exon promoter tive chromatin environment vivo Intact hippocampi treat offspring high low mother crosslinke vivo perfusion selectively immunoprecipitate pro teinDNA complex antibody acetylate histone ngfi complex uncrosslinked precipitate genomic DNA sub jected pcr amplification primer specific exon promoter sequence Fig ANOVA reveal signifi not group effect significant group treatment interaction effect histone acetyla tion however significant group treatment interaction effect analysis show vehicle methionine treat offspring high mother show significantly great association exon sequence group suggest effect methio treatment acetylation contrast vehicletreated offspring high mother show significantly great association exon sequence group Fig result indicate decrease bind protein hippocampal exon pro moter adult offspring methioninetreate high Figure Methionine eliminate maternal effect bind independently tone acetylation immunoprecipitation analysis association histone acetylation bind exon promoter sequence hippocampal tissue vehicle methioninetreate adult offspring high low abnmother input acetylate histone top ngfi middle primary antibody immunoprecipi blot amplify exon region acetylhistone immuno precipitate hippocampal tissue band dna loading control use primer specificfortheubiquitouslyexpressedactinpromoterregion171bpbandRepresen tativeSouthernblotoftheamplifiedexon17regionoftheGRfromNGFIAimmunoprecipitated hippocampal tissue band Exon promoter region contain recognition element amplify immunoprecipitate hippocampal tissue run control specificity show signal mean SEM exon sequence amplify acetylhistone immunoprecipitated hippocampal tissue vehicle methioninetreate adult high low offspring animal group Neurosci November alter Epigenetic Marking Later Life mother compare vehicletreated offspring high mother significant difference methioninetreate offspring high mother vehicle methioninetreate offspring low dam absence methionine effect offspring low mother expect animal exon promoter region show little bind summary methionine treatment decrease bind hippocampal exon promoter affect level histone acetylation dna methylation know silence gene expression different mechanism first site specific dna methylation methylation dinucleotide bind site directly block bind transcription factor cognate sequence thus inhibit transcription necessarily alter chro matin structure second mechanism indirect methylated dna bind protein methylcpg bind protein recruit region dense methylation target HDACs chromatin result histone deacetyla tion subsequent chromatin inactivation preclude involvement acetylation site histone involvement acetylation site histone histone datum consistent hypothesis methionineinduced remethylation bind site inhibit transcription direct mechanism block binding alter histone acetylation mechanism also previous datum reveal absence bind hypermethylate exon promoter region adult low offspring unpublished observation thus methyl ation case result recruitment methylate dna bind protein histone deacetylation show previously sitespecific methylation sufficient block bind exon promoter later adult hood show promoter methylate associate deacetylated histone postnatal day Weaver propose induction histone acetylation enable demethylation dinucleotide bind result transcrip tion activation thus unidirectional causal relationship state histone acetylation state methyl ation exon promoter whereby state methylation determine state histone acetylation devel histone acetylation sult demethylation methylation necessarily alter histone acetylation thus increase methylation site exon promoter methionine treatment sufficient inhibit ngfi bindingevenintheabsenceof change histone acetylation sitespecific exclusion transcription factor association effect methionine expression effect maternal care response stress ate difference hippocampal gene expression glucocorticoid feedback sensitivity gene pression hippocampus increase adult offspring high compare low mother difference mediate differential methylation dinucleotide site consensus sequence exon promoter subsequent alteration histone acetylation bind exon sequence differential epigenetic mark ulate expression exon promoter high low offspring reversal epigenetic marking accompany decrease hippocampal expression examine maternal behavior methionine treatment affect hippocampal exon mrna level pcr analysis perform use purified hippocampal mrna vehicle methioninetreate adult offspring high low mother positive control hip pocampal mrna adult offspring low mother also analyze manipulation show previously increase protein expression ANOVA reveal significant effect group treatment significant group treatment interaction analysis show offspring low mother vehicletreated offspring high dam show significantly respectively great exon mrna level group suggest methionine treatment significantly reduce hip pocampal exon mrna level offspring high dam support result show hippocampal protein expression also nificantly decrease methioninetreate offspring high mother level comparable vehicle methioninetreate offspring low mother ANOVA reveal highly significant main effect group treatment well significant group treatment interaction effect Post analysis indicate methionine treatment significantly decrease hippocampal expression offspring high mother vehicle treat high offspring methioninetreate high offspring eliminate difference hip pocampal expression offspring low high mother methioninetreate high offspring methioninetreate low offspring methionine treatment significantly reduce expres sion high adult offspring global abundance pro tein hippocampus apparently decrease indicate equal tubulin immunoreactivity Fig Effects methionine response stress adult offspring high mother show increase hippocampal expression enhance glucocorticoid feedback sensitivity modest response stress offspring low mother give methionine treatment reverse group difference hip pocampal expression examine adrenocortical sponses stress separate cohort vehicle methionine treat animal Fig statistical analysis plasma corticosterone datum reveal significant effect group treatment time well significant group treatment interaction effect Post analysis reveal plasma corticosterone response restraint stress vehicletreated adult offspring high mother significantly low methionine vehicletreated adult offspring low mother methioninetreate offspring high mother response stress offspring low mother unaffected methionine treatment alter Epigenetic Marking Later Life Neurosci November effect behavioral response stress rodent force swim restrict space escape eventually cease apparent attempt cape become immobile Porsolt learnedhelplessnessinduced immobility selectively sensitive anti depressant treatment adrenalectomize rat quire immobile response normally unable retain response subsequent testing effect verse glucocorticoid administration Funder maternal behav ior affect level circulate glucocor ticoid hippocampal expression offspring use test model assess effect methio treatment behavioral response stress adult offspring high low mother Fig statistical anal ysis length time animal spend immobile reveal significant effect group treat ment well significant group treatment interaction analysis reveal methionine treatment increase length time spring high mother spend mobile test comparable low mal thus length time vehicle treat adult offspring high mother spend immobile significantly short compare methionine vehicletreated adult spring low mother methioninetreate offspring high mother test perfor mance low offspring unaffected methionine treatment summary methionine treatment reverse endocrine behavioral response stress adult offspring high mother well epigenetic pro gramme exon promoter Discussion study reveal methionine well establish dietary modulator methylation reverse DNA methylation pattern promoter stress response thus demonstrate causal relationship program ming response stress maternal havior epigenomic status adult offspring current datum demonstrate epigenomic mark involve stable covalent modification DNA trigger maternal behavior stable life mark potentially reversible even terminally differentiate tissue hippocampus Methylation pattern alter inhibition dnmt change supply methyl donor cell division synthesis ate nascent strand however generally believe meth ylation pattern remain stable postmitotic tissue finding provide novel support model suggest dynamic Figure3 MethionineeliminatesthematernaleffectonhippocampalGRexpressionandHPAresponsestostressRepresen tative pcr illustrate absolute level hippocampal exon mrna transcript level vehicletreated Veh TSA treated100ngandmethioninetreatedmetadultoffspringofhighandlowlgabnmother group molecular weight marker correspond single major band bottom panel show pcr actin illustrate absolute hippocampal mrna transcript level molecular weight marker corre spond single major band intensity signal similar lane mean SEM exon mrna transcript level vehicle methionine treat adult offspringofhighandlowlgabnmother illustrate absolute level electrophorese hippocampal immunoreactivity vehicle methioninetreate adult offspring high low mother animal group molecular weight marker Santa CruzBiotechnologycorrespondtoasinglemajorbandat92kDaThebottompanelshowsthemembranereprobedfortubulin immunoreactivity illustrate absolute level electrophorese hippocampal protein bind transfer membrane highandlowlgabnmother 5animalspergroupMeanSEMplasmacorticosteroneresponsestoa20 mother animal group Neurosci November alter Epigenetic Marking Later Life process methylation status modifiable even post mitotic cell study together previous paper Weaver show demethylation chronic tone deacetylase blockade demonstrate enzymatic chinery necessary demethylation remethylation operative differentiated cell neuron previous study demonstrate maternal behavior alter histone conformation methyl ation status site dinucleotide consensus sequence bind cognate sequence vivo datum provide epigenetic mech anism longterm programming stress responsivity perience early life pharmacological inhibition histone deacetylation result demethylation exon promoter adult hippocampus reversal effect low maternal stress responsivity datum present show methionine sion cause remethylation exon promoter high maternal stress responsivity mech independent histone acetylation consider methionine alter dna methylation indirectly challenge accessibility activity dnmt dem ethylase finding demonstrate dna methylation demethylation machinery present adult hippocam pus suggest balance activity play pivotal role stability dna methylation pattern experiment present involved infusion methionine left lateral ventricle raise possibil ity diet affect phenotype study intracellular level methionine seem affect dietary intake polymorphism enzyme involve methi onine metabolism methylenetetrahydrofolatereductase tempting consider together datum possibility diet modify epigenetic program me brain early development also adult life Human epidemiological animal model datum indi cate susceptibility adultonset chronic disease influ enced persistent adaptation prenatal early postnatal nutrition methionine crucial mal brain development brain aging pathogenesis neurodegenerative disorder play essential role gene expression protein synthesis cell signal lipid transport tabolism neuron survival dna methyltransferase require establish maintain pattern Synthesis SAM dependent availability dietary folate vitamin b12 methionine cho line",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "epigenetic": 8,
                    "methylation": 44,
                    "demethylation": 9
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "nonmammalian": 1,
                    "Kloet": 1,
                    "LongEvans": 1,
                    "Plexiglas": 1,
                    "Southern": 2,
                    "Phospho": 1,
                    "Western": 1,
                    "Naive": 1,
                    "dem": 1,
                    "influ": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "nonmammalian": 61,
                    "Kloet": 61,
                    "LongEvans": 61,
                    "Plexiglas": 61,
                    "Southern": 61,
                    "Phospho": 61,
                    "Western": 61,
                    "Naive": 61,
                    "dem": 61,
                    "influ": 61
                },
                "Ethnographic Terms": {
                    "epigenetic": 11,
                    "methylation": 11,
                    "demethylation": 11
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Reversing DNA methylation_ mechanisms_ genomics_ and biological functions.pdf",
            "cleaned_text": "lead Edge reverse DNA methylation Mechanisms Genomics Biological Functions Hao wu1 2Program Cellular Molecular Medicine Boston Children Hospital 3department Genetics 4Harvard Stem Cell Institute Harvard Medical School WAB149 G Longwood Avenue USA Correspondence yzhanggeneticsmedharvardedu Methylation cytosine mammalian genome represent key epigenetic modication dynamically regulate development compelling evidence suggest dynamic regu lation dna methylation mainly achieve cyclic enzymatic cascade comprise cytosine methylation iterative oxidation methyl group TET dioxygenase restoration unmodied cytosines replicationdependent dilution dna glycosylaseinitiate base excision repair discuss mechanism function dna demethylation mammalian genome focus particularly developmental modulation cytosine modify pathway couple active reversal dna methylation diverse biological process Introduction long recognize cytosine genome part genetic code also carry epigenetic information chemical modication pyrimidine ring dual function associate cytosine provide mean developmental stage celltype specic epigenetic memory directly deposit DNA Bird Methylation position cyto sine methylcytosine 5mC highly conserve epigenetic modication dna find plant animal fungal model Law Jacobsen profound impact genome stability gene expression development mammal new dna methylation pattern establish novo DNA methyltransferase DNMT3B Okano Okano figure activity modulate catalytically inactive family mem ber DNMT3L Goll Bestor somatic cell primarily restrict palindromic cpg dinucleotide typically methylate symmetric manner novo methyl ation figure Methylation cytosine nonCpG context prevalent plant rare mammalian celltype recent work suggest noncpg methylation relatively abundant oocyte pluripotent embryonic stem cell esc mature neuron function mammalian noncpg methylation remain unclear roughly CpGs human genome methylate somatic cell mitosis global cpg methylation pattern faithfully maintain daughter cell action maintenance dna methyltransferase obligate partner ubiquitinlike plant homeo domain ring nger domain preferentially recognize hemimethylated maintenance methylation fig ure inheritability cpg methylation suggest role longterm epigenetic regulation require diverse biological process stable silence gene expression maintenance genome stability establishment genomic imprint dna methylation pattern somatic cell stably maintain genomewide loss dna demethylation observe specic developmental stage preimplantation embryo develop primordial germ cell PGCs dna demethylation important set pluripotent state early embryo erase parentaloriginspecic imprint develop PGCs Mounting evidence indicate rapid erasure major wave reprogramming fully explain replication dependent passive loss suggest existence enzymatic activity capable actively remove modify methyl group cytosine however unify mechanistic understanding active dna demethyla tion process mammalian cell emerge recently discuss transformative discovery translocation TET protein oxidase provide major insight mechanism active dna demethylation Cell biochemical basis TET enzyme oxidative modication 5mC recently elsewhere focus inte grated understanding mechanism genomic biological function mammalian dna demethylation process First summarize current mechanistic understanding passive active dna demethylation pathway Second examine recent advance development genomic mapping tech nologie oxidation derivative stand potential regulatory function oxidize cytosine basis mammalian genome finally discuss distinct mode dna demethylation dynamic achieve modulation cytosinemodifye enzymatic pathway satisfy need diverse biological process DNA Demethylation Mammals dna demethylation take place passively actively dna replication maintenance machinery restore symmetrical cpg methylation pattern methylate unmodied cytosine nascent DNA strand passive loss therefore achieve successive cycle dna replication absence functional dnmt1uhrf1 passive dilution figure example replication dependent passive loss global erasure maternal genome mouse preimplantation develop ment see compelling evidence indicate also rapidly erase independently DNA replication specic biological setting plant mammal Zhang change involve active dna demethylation mechanism require enzy matic reaction modify remove owe plant thaliana active erasure mediate silence ros1 family dna glycosylase base excision repair BER machinery however mammalian orthologs figure Domain Architecture diagram predict functional domain protein involve novo methyl ation maintenance methylation oxidation excision tet protein contain terminal catalytic domain include rich insert large doublestranded helix DSBH domain TET3 protein also contain terminal CXXC domain contain uracil DNA glycosylase domain number amino acid fulllength isoform indicate numbering correspond mouse protein add atrxdnmt3dnmt3l pwwp prolinetryptophantryptophanproline motif MTase dna methyltransferase domain bah bromoadjacent homology CXXC zinc nger ring associate ring really interesting new gene homeodomain ubiquitinlike domain stepwise cytosine modication pathway include cytosine methylation dnmt iterative oxidation tet protein dnmt use adenosylmethionine SAM methyl donor catalyze methylation position cytosine yield enosylhomocysteine ketoglu tarate dependent dioxygenase TET protein use baseipping mechanism ip target base duplex dna catalytic site active site bind conserve residue TETs coordinate water TET enzyme use molecular oxygen substrate catalyze oxidative decarboxylation yield co2 enzymebound succinate reactive high valent oxo intermediate enzyme bind oxo intermediate react generate net oxidative transfer single oxygen atom substrate result regeneration specie Base excision repair plant mammal complete dna demethylation plant DMEROS1 family bifunctional dna glycosylase capable catalyze release base dna cleavage glycosidic bond generate abasic apurinic DNA backbone nick lyase activity DMEROS1 enzyme sugar group cleave endonuclease result singlenucleotide gap lle unmodied DNA polymerase ligase activity mammal oxidize basis 5fC5caC excise monofunctional dna glycosylase protein require provide lyase activity remove sugar ring generate singlenucleotide gap Cell enzyme identie Mammalian cell therefore achieve active dna demethylation use different mechanism early effort focus test various know dna modify protein dna repair enzyme cytosine deaminases DNA glycosylase Box however experi mental evidence propose candidate often restrict specic biological setting many case activity substantiate follow study thus study reveal consensus mechanistic framework active dna demethylation mammal breakthrough come presence hydroxymethylcytosine 5hmC oxidize derivative unambiguously demonstrate mammalian genome TET family DNA dioxygenase identie enzyme convert Kriaucionis subsequent study reveal TET protein oxidize 5hmC mylcytosine 5fC carboxycytosine 5caC Ito Pfaffeneder series discovery establish biochemical basis stand molecular mechanism active dna demethyla tion mammal Figure Mechanisms passive active Reversal cpg dna diagram replicationdependent passive loss oxidize dyad passive dilution occur absence DNA methylation maintenance machinery DNMT1 UHRF1 contrast oxidation derivative 5hmC potentially 5fC 5caC facilitate passive demethylation hemihy droxymethylate substrate form active dna demethylation term active modication follow passive dilution DNMT3 efciently methylate cpg dyad hemimodie unclear diagram replicationindepen dent dna demethylation dyad TET mediate sequential oxidation excision result abasic site repair BER regenerate unmodied cyto sine possible intermediate product total distinct single dyad DNMTTETTDGBER enzymatic cascade depict state left half represent top strand cpg dyad right half indicate bottom strand arrow represent enzymatic reaction colorcode accord correspond ing enzyme many potential combination intermediate step active dna demethylation process highlight gray note directly excise generate abasic site clarity reaction depict Iterative Oxidation tet protein discovery enzymatic activity modi fye oxidation moti vate known pathway involve oxidative modication thymine rst involve biosynthesis base base present genome parasite brucei cause African sleep sickness biosynthesis achieve twostep process bind ing protein rst oxidize DNA glycosyltransferase complete synthesis base add glucose group 5hmU Borst protein member ketoglutarate dependent dioxygenase family Loenarz bioinformatic analysis identi ed human gene TET1 homolog JBP1 Iyer TET1 initially discover fusion partner histone methyltransferase mixedlineage leukemia MLL1 q22q23 certain acute myeloid leukemia Ono contain terminal catalytic domain consist Cysrich region doublestranded helix DSBH fold sion cultured cell result reduction genomic level recombinant TET1 protein oxidize result product determine figure similar enzymatic activity Cell Elsevier Inc Box Known Putative Mechanisms Active erasure Methylcytosines oxidationindependent active DNA Demethylation Mecha nism Enzymatic Removal straightforward way achieve dna demethylation direct removal however thermo dynamically unfavorable reaction study propose methylcpgbinde domain protein catalyze reaction lead release methanol labora tory reproduce nding active erasure paternal 5mC occur normally fertilize oocyte lack date compelling evidence support biochemical reaction take place ical condition repair short genomic region contain methylated cytosine nucleotide indirectly result erasure major dna excision repair mechanism repair single strand dna damage base excision repair nucleotide excision repair NER BER use correct damage basis mismatch base pair mismatch repair bulky dna lesion form exposure radiation chemical bulky dna lesion recognize specic enzymatic activity introduce dual incision anke damage region result singlestranded gap usually tide lle dna repair polymerase ligase Gadd45 growth arrest protein family protein report stimulate active DNA deme thylation evidence suggest Gadd45 induce active dna demethylation embryo mammalian cell conicting result also report furthermore Gadd45b null mouse grossly normal global alteration dna methylation level thus role Gadd45 dna demethylation remain uncertain dna demethylation achieve dna glycosylase efciently excise base DNA strong genetic biochemical evidence support use mechanism plant dna glycosylase include methylcpg binding domaincontaine protein also propose excision activity Zhu however excision activity enzyme signicantly fold lower activity mismatch addition null mouse viable normal dna methylation pattern development interestingly Tdg null mouse die exhibit modest increase level gene promoter robust activity 5fC 5caC likely 5fC5caC excision activity instead marginal excision activity responsible methylation defect observe Tdgdecient cell see main text Deamination Repair 5mC Base Deamination generate thymine result mismatch repair multiple dna glycosylase replace mismatched activation induce deaminase know function generate mutation dna rna biologically important antibody diversication cell rna edit biochemical analysis suggest also deaminate Morgan however efciently act singlestrand doublestrand dna exhibit substantially low activity fold relative cytosine canonical substrate addition aid apobec1knockout mouse exhibit expect cell immunological defect viable fertile Nevertheless study zebrash embryo PGCs ESChuman broblast fuse iPSCs support potential role AID APOBECmediated deamination dna demethylation study need clarify exact biochemical mechanism function protein dna methylation Moreover novo DNMTs report possess deaminase activity absence adenosylmethionine SAM tivi give relatively abundant live cell general donor many essential enzyme vivo relevance DNMTmediated deamination remain unknown complex protein ELP3 report promote paternal genome demethylation mouse zygote propose radical SAM domain ELP3 involve demethylation process direct biochemical evidence demonstrate demethylation activity ELP3 currently lack active DNA Demethylation Mechanisms ReplicationDependent passive Dilution oxidize iterative oxidation TET protein generate oxidize cytosine basis cytosine analog facilitate dna demethylation impair binding activity maintenance methylation machinery dnmt1uhrf1 dna replication compelling evidence suggest mechanism use erasure paternal genome methylation preimplantation development well complete demethylation imprint control region develop see main text dna RepairMediated Excision Modied tdgmediated excision follow TET protein oxidize 5fC 5caC efciently excise repair BER pathway multiple study biochemically validate pathway see main text compelling genetic genomic evidence suggest TET active dna demethylation take place mouse esc extensive mechanism utilize vivo celltype currently unknown deamination 5hmC follow BER similar deamination protein theo retically deaminate generate hydroxyuracil 5hmU study show deamination take place cultured cell mouse brain result 5hmU mismatch repair dna glycosylase however subsequent study show protein exhibit detectable deaminase activity 5hmC Box continue continue next page Cell also demonstrate TET protein mouse physiological relevance tetmediate oxidation 5hmC readily detect celltype particularly enrich genome adult neuron Globisch Kriaucionis second pathway provide clue enzymatic activ ity TET protein involve uracil conversion pyrimidine salvage pathway process rst convert thymine hydroxylase THase also dependent dioxygenase 5hmU formyluracil cil 5caU successive oxidation reaction isoorotate decarboxylase complete conversion decarboxylation 5caU smiley similarity chemistry conversion oxidative modication 5mC suggest possibility TET enzyme function similarly THase mediate iterative oxidation Zhang improved chro matographic separation condition tet protein show capable oxidize 5fC 5caC Ito Figure mass spectrometry analysis show cell type 5caC detectable mouse esc level least order magnitude less 5hmC neder low abundance 5fC 5caC partially due presence specic enzymatic activity capable efciently excise highly oxidize basis DNA see thus tetmediate oxidation reaction extend previously recognize binary state cyto sine modication 5mC distinct state mammalian genome raise possibility new cytosine analog play role dynamic regulation Passive Restoration Unmodied Cytosines ReplicationDependent Dilution oxidize presence oxidize basis cpg site facilitate replicationdependent passive loss conicte result regard efciently recognize hemihydroxymethylate cpg site hcg Frauer independent study establish DNMT1 signicantly less efcient fold methylating hcg hemimethylated mcg site vitro hemimodied carry also impair function unclear sum TET protein initiate twostep demethylation process proliferate cell involve initial active tion oxidation subsequent replication dependent passive dilution potentially 5fC 5caC figure mode active DNA lation distinct simple passive dilution Figure Kohli effective even presence functional methylation maintenance machinery dna demethylation presence DNMT1UHRF1 report erythro poiesis Shearstone interesting examine oxidation contribute dna demethylation system interestingly comparable methylase activity mcg hcg site suggest involve maintain level divide cell high TET activity support notion mouse esc decient DNMT3B become globally hypo methylate prolonged culturing paternal genome passively dilute presence maternal pro tein early preimplantation development alone sufcient effectively methylate hemimodied site study need elucidate interplay oxidation replicationdepen dent demethylation oxidize addition passive dilution modie cytosine several TET initiate replicationindependent active demethylation mechanism propose Box active dna demethylation process also involve initial oxidative modica tion complete demethylation replica tionindependent active restoration unmodied First removal oxidize position substituent hydroxymethylation 5hmC dnmt keviciute decarboxylation 5caC putative decarboxylase directly revert oxidize base unmodied cyto sine Second DNA glycosylasemediated excision oxidize basis include removal 5hmU deamination product Box continue biochemical assay cell overexpresse enzyme Nabel challenge biochemical plausibility propose mechanism potential explanation negligible activity AIDAPOBEC relatively bulky steric size position substituent cytosine 5mC ohch signicant negative impact deaminase activity Nabel Direct Removal Oxidized Position Substitute Dehydroxymethylation dnmt direct removal methyl group thermodynamically challenge removal oxidize methyl group feasible biochemical study suggest remove hydroxymethyl group 5hmC generate unmodied cytosine absence oxidizing condition give present relatively high level cell type physiological relevance reaction remain unclear Decarboxylation 5caC thymine salvage pathway conversion complete isoorotate decarboxylasemediated decarboxylation give chemical similarity THase TET enzyme propose decarboxylation activity exist mammalian cell directly convert 5caC unmodied cytosine study suggest 5caC decarboxylase activity exist mouse lysate responsible enzyme await identied Cell 5hmC Guo 5fC5caC result abasic site repair BER restore unmethylated propose demethyla tion pathway mechanism involve exci sion receive experimental support member uracil DNA glycosylase superfamily Figure know use baseipping mechanism remove pyrimidine base mismatch initiate BER give precedent excision repair plant figure dna glycosylase long suspect playing role active dna demethylation mammal particularly attractive candidate act scaffold protein bridge transcriptional coactivator CBPp300 numerous transcription factor support gene regulatory role early study sug geste promote dna demethylation direct excision deamination product biochemically feasible mechanism prob ably play limited role dna demethylation give marginal excision activity deaminase selectivity singlestranded DNA Box role dna demethylation revisit additional oxidized cyto sine analog discover genome efciently remove exhibit robust exci sion activity 5fC 5caC 5fC 5caC pair duplex DNA fact high activity compared mismatch cognate substrate molecular basis excision stem effect 5fC 5caC destabilize basesugar linkage glyco sidic bond basis weakened glycosidic bond efciently excise dna glycosylase biophysical analysis indicate active site possess specic structural feature mediate recognition oxidize basis Zhang support physiological relevance mechanism expression TET HEK293 cell rapidly deplete 5fC 5caC Nabel mouse esc cause fold increase level 5fC 5caC Shen Song thus methylation iterative oxidation excision repair offer complete cytosinemodifying cascade permit replicationindependent erasure dna methylation figure member family dna glycosylase dispensable embryonic development null mouse embryo exhibit wide range developmental defect die embryonic day interestingly dna glycosylase efciently excise suggest unique role 5fC5caC excision activity embryonic development indeed mutant embryo carry glycosylase activity defec tive mutation mouse phenocopy developmental defect Tdg null embryo Cortellino give robust excision repair activity mismatch mutation potentially ensure proper development reduce genetic mutation however induce embryonic lethality phenotype fully penetrant incompatible repair defect exhibit highly vari able phenotype due stochastic mutation different gene thus inactivation primarily result epigenetic rather genetic defect genome dysregulation level accumulation ectopic 5fC5caC specic gene regulatory sequence Tdgdecient mouse potentially affect transcription cause developmental defect vivo analysis need clarify exten sive dna demethylation pathway utilize vivo elucidate exact mechanism activity contribute transcription development Intermediate Steps TETTDGMediated replication Independent dna demethylation consider cytosine methylation demethylation pro cess context stepwise enzymatic cascade prompt key mechanistic question TET enzyme act dna substrate processively distributively successive oxidation reaction preferred inter mediate step TET enzymatically revert unmodied cytosine tdgmediate excision 5fC5caC preferentially generate singlestrand break doublestrand break mapping study show steadystate 5hmC almost exclusively find context even mouse esc neuron noncpg methylation prevalent Lister thus oxidative modication TET protein occur mostly context line recent structural biochemical analysis human TET2 catalytic domain dioxygenase indicate oxidase strong pref erence oxidize cpg site noncpg context alternatively iterative oxidation nonCpG site occur much fast rate site transiently generate rapidly convert remove TDGBER Baseresolution mapping Tdg mutant cell potentially capture shortlive oxidize basis site dyad cytosinemodifying pathway DNMTTETTDGBER theoretically generate distinct cytosine modication state hmC caC abasic symmetric form figure Base resolution mapping mouse esc indicate less 5hmC potentially present symmetrically modi form furthermore crystal structure TET2 complex dna contain mcg GCm suggest TET enzyme initiate oxidation reaction dna bending base ipping act single symmetrically methylate cpg site thus hemimodie dyad predominant pool intermediate generate oxidation reaction Strand asymmetry associate 5hmC 5fC 5caC imply active demethylation frequently generate single abasic site Cell methylate typically lead formation frequency symmetrically oxidize physiologically relevant abasic site single dyad abasic frequently generate increase chance introduce deleterious mutation curiously biochemical assay show high excision activity hemicarboxyl methylate site caCG fully carboxylmethylate also help reduce frequency generate technology allow simultaneous mapping 5fC 5caC baseresolu tion help determine relative frequency DSBs introduce active demethyla tion process dna demethylation maintain proper gene expression cellular identity require precise control dna methylation pattern likely default epigenetic state promoter mammalian genome thus direct regulation dna methylation machinery generally lead global change level however regulatory mechanism modulate substrate accessibility enzymatic activity expression level genomic target TET enzyme provide precise control pattern oxidize specic loci genome Regulation Substrate Accessibility TET Enzymes quantitative mass spectrometry analysis mouse esc suggest signicantly prevalent 5fC 5caC Ito Pfaffeneder suggest TET enzyme tend stall processivity oxidation regulate substrate accessibility tet enzyme vitro biochemical analysis suggest initial reaction rate TET enzyme oxidize signicantly high oxidize indicate TET protein efcient utilize compare substrate structural analysis TET2 catalytic domain show methyl group involve TET2 dna interaction thus allow active site accommodate oxidize derivative oxidation remain determined active site TET enzyme distinct afnity 5hmC ingly domaincontaine protein recently identie protein report able enhance processivity tet enzyme potentially ability ip modie cytosine dna duplex increase substrate accessibility TET protein regulation enzymatic activity Metabolites evidence indicate change metabolic state cell affect relative concentration enzymatic turn inuence activity DNA fye enzyme TET enzyme require oxygen catalyze oxidation reac tion primarily produce isocitrate tricarbox ylic acid cycle isocitrate dehydrogenase IDH2 IDH3 mitochondria Cytosolic IDH1 provide alternative source interestingly inactivate mutation cycle enzyme fumarate hydratase succi nate dehydrogenase SDH tumorassociate missense mutation result accumulation high tion fumarate succinate oncometabolite hydroxy glutarate share structural similarity competitively inhibit dependent dioxygenase include TET enzyme JmjCdomaincontaining histone demethylase Klose vitamin also know ascorbic acid micronutrient know activity human also implicate modulation tet activity recent study support role vitamin stimulate catalytic activity TET protein Blaschke Minor Yin vitamin directly interact catalytic domain tet protein act positive modulator tet activity facilitate conformational change recycle cofactor esc vitamin signif icantly increase level oxidation product larly 5fC 5caC fold Moreover mouse esc culture presence vitamin adopt methylome resemble blastocyst vivo TET enzyme addition terminal catalytic domain TET3 encode zinc nger CXXC domain termini figure CXXC domain present many chromatinassociated protein strong prefer ence unmethylated TET2 lack CXXC domain neighboring gene inhibi tion axin complex also know encode CXXC domain highly similar also know CXXC6 TET3 possible originally part ancestral TET2 gene go chromosomal inversion separate CXXC domain catalytic domain occupancy analysis suggest preferentially localize unmethylated promoter genic region mouse esc also enrich unmethylate cpg sequence directly interact TET2 biochemical structural analysis indicate TET1 CXXC domain also recognize methylated cyto sine TET3 CXXC domain target unmethylated cytosine context thus CXXC domain specically recognize unmethylated cpg site CXXC domain increase exibility sequence selectivity play role facilitate recruitment TET enzyme specic genomic target Cell TET gene exhibit different expression pattern developmentalstage manner highlevel detect mouse esc inner cell mass blastocyst develop TET3 broadly express various mouse adult tissue ingly TET3 TET enzyme present mouse oocyte onecell zygote Wossidlo Transcriptional control TET gene likely mediate transcription factor instance upstream promoter region gene contain large cluster bind site pluripotencyrelated transcription factor suggest role pluripo tencyrelate tfs maintain TET1 expression indeed highly express mouse esc level rapidly downregulate differentiation give relatively large size mrna untranslated region UTR TET1 gene TET mrnas also regu late posttranscriptionally micrornas indeed recent study report role oncogenic miR negatively regulate TET protein level context breast cancer development hematopoietic stem cell transforma tion Song Song addition target TET2 protein degradation caspase dependent mechanism similarly CXXC domain TET3 negatively regulate protein stability suggest autoinhibitory mechanism regulate TET protein level genomic distribution oxidize Methylcytosines potential Roles transcription regulation genomewide mapping oxidize basis mamma lian genome represent unbiased approach investigate potential role tetmediated demethylation pathway oxidize cytosine epigenome function tran scriptional regulation principle DNMT TET enzyme modify approximately CpGs diploid mammalian genome adopt epigenetic state Genomewide Mapping Technologies oxidize basis multiple method exploit specic biochemical biophysical property modie cytosine basis develop map distribution genome figure method categorize group enrichmentbased approach utilize antibodies selective chemical labeling modied cytosine Box second baseresolution mapping method bisulte sequence afnity base method generally straightforward perform costeffective however resolution method limit size dna fragment several base pair afnityenrichment methodology region enrich modied basis compare signal normalize sequence read count pulldown negative con trol IgG input thereby provide measurement relative foldenrichment pulldowncontrol contrast baseresolu tion map modied basis determine cytosine include exact position strand modied typically measure percentage number modi ed cytosinesnumber cytosine give cyto sine probability cytosine condently identie modie govern sequencing depth abun dance modication cytosine specic cell type give low abundance oxidize methylcytosine baseresolution method require relatively high sequencing depth detect estimate normal sequencing depth Seq baseresolution map ping 5hmC TABseq Figure Box condently detect cytosine average high level ymethylation regardless local density cytosine sub strate result baseresolution method enhance sensitivity detect individual cytosine modie level sparsely distribute cluster 5hmC indeed 5hmC peak identie afnitybased method antibody GLIB Figure contain least approximately highcondence cytosine detect mouse esc peak afnitybased method cover dence 5hmC identie afnitybased method integrate signal multiple cytosine give genomic region capable detect closely clustered cytosine low level modication otherwise miss baseresolution method increase sequencing depth baseresolution mapping experiment help identify cytosine carry lowlevel modication unclear infrequently modied cytosine biologically relevant summary afnitybase mapping method consistently identify region enrich cytosine frequently modie level result differ sparsely distribute infrequently modied cyto sine discrepancy publish genomewide mapping study due use different methodology datum analysis strategy well vary denition give genomic feature focus recent advance map ping oxidize basis include stem cell potential gene regulatory role various genomic feature oxidize Methylcytosines Gene Promoters approximately mammalian promoter associate short sequence term cpg island CGIs average kilobase long Bird cpg rich promoter also know generally unmethylated transcriptionally active methylation histone variant H2A enrich HCPs antagonize DNMT bind lack HCPs predict TET mediate oxidative modication 5mC minimal pro moter indeed current consensus view afnity enrichment baseresolution mapping study suggest Cell proximal region surround transcriptional start site active promoter mostly HCPs generally devoid wildtype Tdgdepleted mouse esc exemplie promoter rest Zfp281 figure overlap unmethylated region TET protein enrich figure Genomewide mapping Methods Cytosine Modications Summary seq afnityenrichment base genomewide mapping method DNA cytosine modication conjunction various chemical enzymatic pretreatment seq afnityenrichment antibody chemical tagging method develop map seq oxBSseq DNA immunoprecipita tion DIP 5hmC oxBSseq 5hmC CMS JBP1 GLIB hMeSeal 5fC fCABseq 5fC DIP Seal pulldown 5caC caCABseq 5caC DIP see Box notably oxBSseq fcabseq caCABseq require subtract signal conventional seq modie seq indirectly determine position abundance oxidize basis 5fC 5caC tematically map baseresolution relatively rare wildtype cell require unusually high sequencing coverage con dently determine position abundance Shown genomic distribution oxidize basis representative loci mouse esc genomic distribution control wildtype Ctrl control knockdown Tdgdepleted knockout Tdg Tdg knock mouse esc show repre sentative loci distribution measure afnitybased method 5hmC CMS hMeSeal Pastor baseresolu tion method TABSeq scale distribution 5fC 5caC deter mine antibody 5fC5caC chemical tagging Seal Song method dna methylation level estimate DIP Shen con ventional seq scale wildtype mouse esc base local methylation level genome categorize fmrs fully methylate region methylation LMRs low methylate region methylated region also show genomic datum set wild type mouse esc include major histone modication hypersensitivity site ect bind site pluripotency tfs Whyte region locate upstream zfp281 gene highlight gray induce ectopic 5caC overlap chro matin feature active enhancer bind site ripotency factor Oct4NanogSox2 active promoter fore facilitate steadystate transcription catalytic activityindependent function stabilize recruit chromatinmodi fye complex Box Afnitybased method show preferentially enrich promoter gene express mediumlow level mouse human esc Pastor enriched promoter generally associate intermediate Cell Elsevier Inc Box Genomewide Mapping Technologies achieve use modicationspecic antibody chemicaltaggingspecic oxidation derivative figure AntibodyBased Immunoprecipitation antibody available oxidize basis procedure simple Song however evidence antibodybased method pulldown certain type simple repeat poly nonspecically Matarese Subtracting IgG control signal signal partially alle viate problem AntibodyBased method base sodium bisultemediate conversion 5hmC cytosine methylene sulphonate CMS highly specic antibody generate use enrich dna fragment serum low background compare anti5hmc serum Pastor however presence bulky moiety dna introduce pcr bias JBP1 5hmC method involve initial conversion 5hmC glycosylate 5hmC g5hmc use glucosyltransferase bacteriophage natural g5hmcbinde protein use enrich g5hmccontaine genomic DNA however recent study suggest generally produce weak signal compare antibody 5hmC hMeSeal GLIB exploit naturally occur glucosylation process several method develop chemically enzymatically label 5hmC biotin tag Pastor highly selective strong interaction biotin streptavidin allow efcient pulldown 5hmCcontaining dna rst method term hMeSeal Song puried use transfer azidemodied glucose analog glucose 5hmC biotin group attach g5hmc alkynebiotin probe click chemistry Song second approach name glucosylation periodate oxidation biotinylation rst use transfer unmodied glucose 5hmC Next sodium periodate use oxidize vicinal hydroxyl group glucose aldehyde group modie add biotin tag g5hmc Pastor chemical labeling method enhance sensitivity low background compare antibodybased method Song however similar antibody method still exhibit degree densitydependency tend efciently pulldown dna fragment contain multiple modied basis Biotin Seal 5fC pull strategy direct label 5fC biotin tag use aminooxy biotin probe suggest Pfaffeneder use generate genomewide distribution map however method side reac tion cytosine abasic site result relatively high background Based hMeSeal indirect 5fC labeling method term Seal develop Song Seal rst use block endogenous genome unmodied glucose Next sodium borohydride NaBH4 use reduce 5fC 5hmC convert derive endogenous 5fC hMeSeal SingleNucleotide Resolution Methods Baseresolution map oxidation derivative involve use bisulte sequence seq thirdgeneration sequencing platform Seq standard seq 5mC resistant deamination consequently read pcr amplication Clark contrast unmodie 5fC 5caC deam inated bisulte treatment read sequence thus methylation signal standard seq represent sum complicate interpretation seq result exploit distinct chemical property treatment traditional seq adapt map oxidize figure oxBSSeq 5hmC oxidative bisulte sequencing potassium perruthenate use specically oxidize 5fC deaminate bisulte treatment DNA sample treat NaHSO3 5hmC 5fC5caC detect sequencing remain intact read therefore subtract signal map standard seq signal reveal location abundance 5hmC TABSeq TETassisted bisulte sequence rst protect oxidation gluco sylation use oxidize 5caC presence highly active recombinant TET protein fcabseq chemical modication assist seq method ethylhydroxylamine EtONH2 use prevent bisultemediate deamination Song subtract standard seq signal signal fCABseq reveal location abundance caCABSeq 5caC similar fCABseq 5caC modie ethyl dimethylaminopropylcarbodiimide hydrochloride resist deamination however method side reaction genomic dna thirdgeneration Sequencing Technology singlemolecule sequencing technology directly sequence dna molecule need pcr amplication singlemolecule realtime sequence realtime recording nucleotide incorporation generate sequence identity also DNA polymerase kinetic poly merase replication rate modied cytosine slow compare unmodied basis combine chemical labeling enzymatic modication add glucosyl group 5hmC oxidize 5caC increase kinetic difference use detect strandspecic oxidized basis baseresolution high condence sequencing monitor current signal individual DNA molecular pass nanoscale protein pore also show potential detect oxidize basis third Box continue continue next page Cell low CpGdensity intermediatecpg promoter low promoter mapping 5hmC also indicate 5hmC abundant HCPs recent study show 5fC5caC tend accumulate transcriptionally inactive poise pro moter absence mouse esc fact high level mouse esc find pro moter anking region lineagespecic transcription mostly ICPs Tbx5 Figure Shen indicate active demethylation occur loci peak surround ICPs line agespecic gene frequently overlap region LMRs previously identie standard partially methylate region well bivalent domain contain H3K4me3 active histone mark H3K27me3 polycomb repression complex PRC2 deposit repressive mark TET protein oxidize methylcytosine contribute establish ment maintenance transcriptionally several mecha nisms include maintenance partially methylation state mediate active demethylation recruitment TETinteracting corepressor complex",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 35,
                    "epigenetic": 8,
                    "demethylation": 46,
                    "5mC": 9,
                    "H3K27me3": 1
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Mammalian": 1,
                    "African": 1,
                    "Cysrich": 1,
                    "JmjCdomaincontaining": 1,
                    "lian": 1,
                    "TETinteracting": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "Mammalian": 99,
                    "African": 99,
                    "Cysrich": 99,
                    "JmjCdomaincontaining": 99,
                    "lian": 99,
                    "TETinteracting": 99
                },
                "Ethnographic Terms": {
                    "methylation": 6,
                    "epigenetic": 6,
                    "demethylation": 6,
                    "5mC": 6,
                    "H3K27me3": 6
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Scaffolds based on alginate-PEG methyl ether methacrylate-Moringa oleifera-Aloe vera for wound healing applications.pdf",
            "cleaned_text": "Accepted Manuscript title scaffold base methyl ether methacrylateMoringa vera wound healing application author S0144 appear receive date revise date cite article RubioElizalde BernaldezSarabia arez CastroCese scaffold base methyl ether methacrylateMoringa oleifera Aloe vera wound healing application PDF le unedited manuscript accept publication service customer provide early version manuscript manuscript undergo copyediting typesetting result proof publish nal form note production process error discover affect content legal disclaimer apply journal pertain base methyl ether methacrylateMoringa vera wound healing application aUniversidad TijuanaEnsenada Apdo Postal Baja Mxico bDepartamento Carretera Playitas Mxico cCONACyTCentro Parque Tecnolgico Quertaro Sanfandila Corresponding author acastrocicese Tel ext Graphical Highlights PEGMA plasticizer improve stability property alginatebased scaffold AlginatePEGMA vera oleifera scaffold wound healing promotion feature AlginatePEGMA scaffold oleifera inhibit proliferation aureus viability skin fibroblast increase scaffold vera oleifera ACCEPTED MANUSCRIPT study seek improve handling stability aqueous medium healing property alginatebase threedimensional structure apply wound scaffold thus alginate plasticize PEGmethyl ether methacrylate PEGMA blend freezedried gel vera aqueous leave extract oleifera scaffold remain structurally stable almost time long pure alginate material high porous architecture require tissue scaffolding application maintain alginate plasticization PEGMA vera increase water uptake capability scaffold oleifera provide antioxidant capacity antiinflammatory property antimicrobial activity aureus Blending vera oleifera alginatePEGMA significantly increase scaffold cell viability evaluation compare scaffold plant extract experimental result show vera oleifera biocomposite great potential wound healing application alginate plasticization scaffold wind heal Moringa oleifera Aloe vera introduction Wound healing complex process involve wellorchestrated integration biological molecular event cell migration cell proliferation extracellular matrix deposition Falanga Scaffolds threedimensional structure provide support tissue formation also cover wound physical barrier external infection alternative facilitate wound heal respect property scaffold porous biocompatible cell need adhere migrate dimensional network Scaffolds also need biodegradable allow cell produce extracellular matrix structural functional characteristic consider design scaffold wound healing application keep fabrication cost effective possible scale make time research laboratory small batch production base requirement polysaccharide promise candidate wound care tissue engineering alginate polysaccharide intrinsically biocompatible biodegradable readily available consist guluronic acid mannuronic acid residue linkage calcium ion Ca2 add eggbox structure form cation interaction ca2 guluronate block alginate make processing alginate cost effective moreover alginatebased material previously use wound healing application due hemostatic property Formisano however tissue scaffolding application pure alginate material poor structural integrity thus inadequate handling stability property overcome drawback plasticization reduce intermolecular attraction force polymer chain increase handling stability alginatebased material however alginate plasticizer ratio fine ACCEPTED MANUSCRIPT tune order improve handling stability property keep porous architecture require material tissue scaffolding application scaffold facilitate regeneration wound tissue act template tissue formation also likely incorporation natural compound wound healing effect antioxidant antiinflammatory antimicrobial property thus produce advanced dressing wound healing application flower plant Aloe vera vera Moringa oleifera oleifera contain phytochemical compound promote wound healing give antioxidant antimicrobial antiinflammatory property Shah AminiNik clear mucilaginous gel vera obtain leaf pulp report physiologically active compound accelerate wound healing promote rate wound closure study regard evaluation aqueous leave extract oleifera wound heal albino rat model show wound close fast treatment moreover organic active component gel vera increase fibroblast adhesion proliferation aqueous leave extract oleifera promote proliferation human dermal fibroblast cell characteristic particular interest alginate structure lack signal sequence cell adhesion Based hypothesize incorporation vera oleifera increase cell proliferation alginate scaffold provide wound healing property biological effect associate polyphenol content plant incorporation plasticizer polyethylene glycol methyl ether methacrylate PEGMA optimum ratio improve handling stability aqueous medium property scaffold compromise porous architecture require tissue scaffolding application development porous dressing incorporate natural wound heal agent honey well extract certain plant Allium sativum Cleome droserifolia report recently study focused enhance antimicrobial property dress material achieve suitable concentration natural heal agent wound healing support however good knowledge work conduct enhance handling stability aqueous medium property scaffold incorporate plasticizer time porous architecture require tissue scaffolding application maintain thus present study seek increase handling stability aqueous medium alginatebased scaffold plasticization cell proliferation wound healing property biological effect associate polyphenol content vera oleifera effect PEGMA chemical property scaffold analyze compare stability aqueous medium shape retention property alginatebased material wound healing application antioxidant antiinflammatory antimicrobial property obtain scaffold evaluate well effect cell viability use human skin fibroblast model material method material ACCEPTED manuscript Aloe vera aloe barbadensis Miller leave obtain greenhouse Norte Mxico January Moringa oleifera leave buy certify organic acid sodium salt molecular weight mol mannuronic acid guluronic acid ratio purchase polyethylene glycol methyl ether methacrylate gallic acid Hydroxytetramethylchromanecarboxylic acid Trolox difenilpicrilhidrazil DPPH sodium nitroprusside SNP sodium nitrite NaNO2 also purchase skin fibroblast ATCC CRL Staphylococcus aureus ATCC coli ATCC obtain aqueous extract report organic component gel vera aqueous leave extract oleifera increase adhesion proliferation fibroblast contribute overcome lack cell adhesion sequence pure alginate scaffold base vera gel aqueous extract oleifera leave obtain follow vera leave leave drain remove yellowish latex colorless liquid vera gel leave collect frozen freezedried Dry oleifera leave pulverize use aqueous extraction min filter use filter oleifera extract freeze freezedried Fig extract store use obtain extract completely watersoluble homogeneous distribution plant extract scaffold achieve procedure describe next preparation composite scaffold scaffold prepare follow PEGMA add sodium alginate solution final concentration respectively homogenize use stick blender alginate crosslinke ca2 add equal volume CaCl2 final concentration stir intensively stick blender smooth solution obtain order determine concentration oleifera evaluate solution Whatman disk agar disk diffusion method use Carbenicillin solution control concentration show antimicrobial activity aureus diameter inhibition zone increase concentration oleifera higher particular diameter inhibition zone oleifera solution similar control result shown thus choose oleifera comparable antimicrobial effect control however also decide prepare evaluate scaffold oleifera case detect decrease antimicrobial activity blending component form scaffold vera show antibacterial activity experimental condition antimicrobial preliminary assay ACCEPTED MANUSCRIPT result present however vera gel contain highly hydrophilic compound increase cell affinity composite scaffold thus concentration vera choose base maximum concentration freezedried extract allow preservation structural integrity scaffold give preliminary result interested study effect vera oleifera blend however vera composite scaffold also prepare order obtain information regard effect water uptake give high hydrophilicity component base freezedried oleifera vera extract add result alginatepegma solution final concentration vera vera oleifera vera oleifera designate respectively Fig solution pour well plate freeze follow freezedrye Fig form porous sponge designate composite scaffold solution prepare water pure alginate scaffold prepare follow method addition PEGMA evaluate interaction alginate shape retention stability behavior property antioxidant antiinflammatory antimicrobial cell viability evaluate use alginate pegma scaffold oleifera vera extract designate blank scaffold representation preparation process composite scaffold vera gel cut inner part leave concentrate freezedrye phytochemical compound oleifera leave extract water min concentrated freezedrye oleifera vera extract homogenize alginate ether methacrylate ACCEPTED MANUSCRIPT PEGMA use stick blender alginatepegmaextract pour polystyrene mold freeze freezedrie obtain porous scaffold improved wound healing stability property spectroscopic microscopic characterization structure surface cross section scaffold image use scan electron microscopy SEM ZEISS voltage variable pressure condition chemical composition scaffold analyze spectrophotometer cell range superficial diffractogram record radiation use step scan mode step step spot dimension ray tube voltage current set respectively nontargeted metabolomic analysis scaffold analyze phytochemical compound metabolite present scaffold employ liquid chromatography couple mass spectrometry use system column pore size interface tripletof mass spectrometer detail method refer supplementary method analysis scaffold place vial ethyl acetate acetone stir min sonicate min ice bath sample centrifuge min supernatant transfer previously weigh tube extract compound concentrate use concentrated extract keep analysis handling stability water uptake property handling property evaluate compare shape term scaffold diameter completely bent unplasticized plasticized scaffold place open plastic tweezer tweezer close tip lever contact tweezer open scaffold take tweezer shape compare scaffold stability evaluate term integrity shape retention function immersion time phosphatebuffere saline occasional agitation solution refreshed assay avoid scaffold crumble due sample manipulation water uptake measure base sample weight absorption distil water scaffold diameter high fully soak distilled water min absorption swollen sample remove excess moisture scaffold surface absorb delicate task wiper triplicate set ACCEPTED manuscript sample analyze composite scaffold water uptake calculate use follow formula water uptake mass scaffold time initial mass scaffold quantification scaffold soak distilled water distilled water refresh min refreshed water save total phenolic content antioxidant capacity antiinflammatory activity relate scavenging assay assay do triplicate method evaluation describe next determination total phenolic content method use determine total phenolic content follow modification sample transfer well plate mix thoroughly min Na2CO3 add incubate darkness absorbance measure water blank BioTek Epoch plate reader Gallic acid use standard result express nmol gallic acid equivalent scaffold determination antioxidant activity antioxidant capacity examine DPPH assay modification dpph radical dpph solution prepare absolute ethanol volume DPPH sample mixed well plate incubate darkness min thereafter absorbance record percentage absorbance inhibition calculate use formula absorbance value control sample min respectively standard curve obtain use standard solution trolox different concentration nmol absolute ethanol dpph inhibition scavenging effect extract contain composite scaffold compare Trolox standard result ACCEPTED MANUSCRIPT express term nmol Trolox equivalent antioxidant capacity teac scaffold Antiinflammatory activity relate scavenge sodium nitroprusside assay use determine scavenging capacity extract contain composite scaffold volume sample mixed well plate incubate darkness add well incubate darkness absorbance read min scavenging determine use next formula scavenge absorbance absorbance sample Pardau activity antimicrobial activity composite scaffold evaluate modification agar disk diffusion method composite scaffold diameter high place agar plate agar contain aureus coli evenly spread agar plate Carbenicillin solution use positive control incubate aureus coli antibacterial effect composite scaffold evaluate compare size inhibition zone diameter viability assay human skin fibroblast cell cultured confluence Iscove Modified Dulbecco Medium IMDM supplement fetal bovine serum antibioticantimycotic solution humidify atmosphere co2 Cells detach plate use trypsin incubate min solution cell centrifuge min collect cell count use chamber trypan blue SigmaAldrich Scaffolds place triplicate well plate cell seed per well supplement medium plate incubate humidified atmosphere CO2 Growth medium replace scaffold incubate thereafter unattached cell composite scaffold wash cell adhere scaffold remained attach well periphery detach trypsin transfer well plate finally add plate incubate absorbance measure BioTek Epoch plate ACCEPTED MANUSCRIPT statistical analysis datum result phenolic content antioxidant capacity scavenge antimicrobial activity statistically analyze way anova cell viability analyze way anova use posteriori test difference consider statistically significant statistical analysis perform use prism software specimen use evaluation composite scaffold result discussion alginate scaffold study interaction alginate PEGMA spectroscopy perform unplasticized plasticize alginatebased scaffold alginate spectrum peak assign stretch vibration bond peak represent asymmetric symmetric stretching vibration COO group respectively peak attribute stretching vibration bond PEGMA spectrum present characteristic band correspond stretching CH3 group peak attribute stretch carbonyl group unplasticized plasticized alginate scaffold show similar pattern alginate powder plasticize alginate scaffold peak represent asymmetric symmetric stretching vibration COO group respectively shift high frequency generally weaken bond shift low frequency plausible explanation opposite result original hydrogen bond water alginate weaken intercalation large amount water plasticizer PEGMA hydrophilic band shift high frequency suggest hydrogen bond alginate water partially replace relatively weak hydrogen bond time Avrous appearance band spectrum scaffold confirm composite formation Vicinanza intensity band correspond stretching increase plasticized scaffold result increase group provide PEGMA diffraction analysis use determine crystalline structure alginate powder unplasticized plasticized alginate scaffold PEGMA comparison purpose alginate powder show main diffraction peak correspond third relate amorphous nature sodium alginate peak become broad intensity increase plasticized scaffold compare unplasticized indicate reduction degree crystallinity due lead amorphous structure crystalline peak PEGMA detect plasticized alginate scaffold suggest recrystallize alginate matrix therefore PEGMA intercalate alginate chain disrupt original alginate structure ACCEPTED MANUSCRIPT Fig effect PEGMA alginate scaffold spectra ray diffraction pattern different alginatebased scaffold PEGMA present study prepare spongious alginatebased wound dressing diameter high incorporate reduce intermolecular attraction force alginate chain thus improve handling stability property alginatebased material alginate scaffold plasticization do certain degree allow keep porous threedimensional structure require tissue scaffolding application thus material porous flexible elastic alginateplasticized film scaffold sufficient mechanical integrity allow handling implantation also remodeling process implant improved handling property plasticized scaffold apparent completely bent show shape retention term scaffold diameter suggest plasticize scaffold handle implantation significantly affect shape ACCEPTED manuscript Fig effect PEGMA handling shape retention stability aqueous medium alginate scaffold blue arrow point bent segment scaffold red arrow point small piece disintegrated scaffold shape scaffold delineate red dotted line show scaffold shape retention term diameter white continuous line show shape change time tissue engineering application scaffold expect degrade wound healing therefore study effect PEGMA stability unplasticized plasticized alginatebased scaffold first assay alginate scaffold begin disintegrate scaffold split segment compare unplasticized scaffold show delay disintegration Fig result attribute incorporation PEGMA alginate degradation mainly control polymer chemistry physical feature scaffold analysis show intercalate alginate chain lead amorphous structure general hydrophilic amorphous polymer show increase degradability aqueous medium hydrophobic crystalline polymer alginate PEGMA hydrophilic polymer however methyl methacrylate hydrophobic group present make polymer less hydrophilic alginate thus scaffold show delay degradation compare pure alginatebased ACCEPTED MANUSCRIPT scaffold base alginate scaffold plasticize show increase stability aqueous medium structural characteristic chemical composition composite scaffold microstructure surface cross section Fig scaffold analyze Scanning Electron Microscopy SEM biocomposite intend apply threedimensional structure provide support tissue formation thus interconnect pore structure critical importance scaffold semispherical interconnected pore surface cross section fig adequate range pore size scaffold depend cell type use tissue implant human skin fibroblast cell growth pore small suitable thus scaffold comply architecture requisite SEM provide quantitative information porosity see pore distribution quite similar scaffold independently plant extract incorporate Fig indicate extract add significantly affect architecture scaffold Fig Photographs representative scaffold SEM micrograph show microstructure surface cross section scaffold blend vera vera oleifera vera oleifera composition biocomposite scaffold influence water uptake release phytochemical derive plant extract implant wound tissue metabolomic analysis mean powerful technique allow obtain snapshot ACCEPTED MANUSCRIPT dozen hundreds metabolite compound present natural product extract therefore assess phytochemical present extract potentially associate biological effect scaffold cultured cell perform nontargeted metabolomic analysis employ online database search metabolomic study often comprise generation datum contain hundreds thousands variable peak related compound proper datum analysis necessary reduce complexity omic datum detail metabolomic datum processing describe support information total ion chromatogram representative sample show Supplementary Fig tight cluster quality control sample principal component analysis indicate reliable assurance method employ Supplementary Fig Spectral datum search online database process data appropriate software describe support information indicate presence composite scaffold Table hand biocomposite addition mention metabolite positive presence quercetin Representative extract ion chromatogram eic potential metabolite identify scaffold scaffold extract signal vera composite scaffold eic signal vera oleifera composite scaffold obtain positive ionization mode number peak refer compound tentatively identify Table ACCEPTED manuscript Table differential metabolite identify vera Aloe vera Moringa oleifera composite scaffold Peak min accurate mass MS2 fragment ion putative metabolite Mass accuracy ppm composite scaffold Chlorogenic acid hydroxymethyl oxopropyltrihydroxy hydroxymethyloxan acid Roseoside hydroxymethyl methoxyphenoxyoxane triol trihydroxyoxanmethoxy oxopropanoic acid Methyl quercetin isorhamnetin Isorhamnetin glucoside Isolariciresinol monoglucoside acetylglucoside composite scaffold hydroxymethyl oxopropyltrihydroxy hydroxymethyloxan MANUSCRIPT kaempferol derivative well chlorogenic acid polyphenol previously report oleifera extract metabolite identify extract ion chromatogram eic blank alginatePEGMA scaffold Fig Table Aloin active ingredient Aloe vera gel previously demonstrate promote fast rate wound closure chlorogenic acid hydrophilic polyphenol protective effect skin induce oxidative damage possibly reduction ROS Kitagawa Yoshii Morita Teraoka Polyphenols derivative metabolite quercetin know antiulcer behavior vivo also antiinflammatory action previous study show quercetin exert antiinflammatory action trinitrobenzene sulfonic acid TNBSinduced colitis rat polyphenolic compound identify scaffold come water extract oleifera vera gel blend form composite scaffold quercetin less hydrophilic rutin chlorogenic acid hydrophilic polyphenol thus releasement availability cell expect place contact physiological medium wound tissue physicochemical property cell adhesion proliferation scaffold facilitate high water uptake hydrophilicity interconnectivity porous architecture scaffold wound healing application good water uptake indicate material absorb wound exudate help form moist heal environment base alginatePEGMA blank scaffold blend vera composite scaffold high water absorption respectively however hydration capacity scaffold reduce contain oleifera oleifera respectively Fig water uptake capability biomaterial depend mainly hydrophilicity porosity material SEM analysis show microstructure porosity scaffold quite similar independently composition fig porosity scaffold also relate crosslinking degree alginatepegmaextracts biocomposite scaffold ca2 pegma concentration thus difference water uptake profile scaffold relate hydrophilicity incorporate extract indicate quercetin relatively hydrophobic metabolite contain oleifera scaffold Fig Table thus water uptake profile influence composition scaffold porous morphology scaffold exhibit indicate SEM Fig porous morphology facilitate entrapment water scaffold matrix addition incorporation vera contribute increase water uptake water absorb property water uptake capacity scaffold similar alginate composite dressing hemostasis application swell degree scaffold make biopolymer sativa water absorption diabetic wound heal ACCEPTED MANUSCRIPT Phenolic compound extract water blend alginatepegma polymeric matrix therefore phenolic compound expect solubilize aqueous medium wound tissue thus evaluate rate solubilization extract measure increment phenolic water contact scaffold Folin Ciocalteu assay rate profile mainly depend type extract rather concentration Fig example phenolic compound vera composite release rapidly composite scaffold however vera oleifera vera oleifera blend composite composite respectively release similar rate compare water uptake extract release profile see composite scaffold absorb water time biocomposite large burst effect scaffold Incorporation oleifera slow release rate phenolic compound mainly less hydrophilic character component oleifera extract quercetin Fig Table result agreement previous report release profile bioactive compound composite Trenaxamic acid release first min case addition hyaluronan accelerate release rate give hydrophilic property cause fast water absorption consequent large burst effect moreover solubilization rate result demonstrate plant extract homogeneously distribute scaffold allow phytochemical component plant extract part alginate pegma matrix goal previously mention vera oleifera contain phytochemical compound promote fibroblast adhesion lack property pure alginate scaffold Fig water uptake scaffold rate solubilization extractsderive phenolic compound aqueous medium Blank alginatepegma scaffold alginatepegma vera scaffold AlginatePEGMA vera oleifera scaffold vera oleifera scaffold error bar show standard deviation group Phenolic content antioxidant antiinflammatory activity total phenolic content composite scaffold determine colorimetric assay express nmol gallic acid equivalent scaffold composite scaffold low phenolic content nmol scaffold ACCEPTED MANUSCRIPT incorporation oleifera alginatepegma blend increase total phenolic content nmol scaffold time high respect biocomposite double concentration oleifera increase total phenolic scaffold time high respect composite time high respect composite scaffold activity determine DPPH method express nmol Trolox equivalent antioxidant capacity scaffold effect extract dpph radical indicate presence compound ability interact free radical act electron donor hydrogen atom activity increase nmol TEAC scaffold composite material nmol TEAC scaffold biocomposite time nmol TEAC scaffold composite scaffold time respect biocomposite correspondingly thus high phenolic content great antioxidant effect prepared composite scaffold agreement previous work indicate total phenolic content major contributor antioxidant activity herb wound healing neutrophil macrophage produce reactive oxygen specie ros defense mechanism invade microbe however excessive ros production lead oxidative stress detrimental effect wound heal chronic nonhealing wound high level ROS associate impaired wound repair previous study show oleifera leave extract antioxidant activity measure EC50 significantly reduce relative amount intracellular ros HEK cell Vongsak use high concentration oleifera prepare scaffold antioxidant capacity oleifera extract EC50 result show mean needed use high extract concentration scavenge free radical DPPH base antioxidant capability composite scaffold expect enhance wound healing reduce ROS adequate level support wound heal antiinflammatory activity composite scaffold evaluate term ability scavenge nitric oxide proinflammatory mediator release high level pathological condition trigger inflammation scavenging activity biocomposite determine sodium nitroprusside assay produce react reagent produce pinkred color complex disrupt presence scavenger Pardau therefore low absorbance great scavenging thus high antiinflammatory activity relate removal capacity composite scaffold biocomposite scavenge activity Fig Blank alginatePEGMA scaffold scavenge scaffold contain extract however previously report PEG possess antiinflammatory property thus scavenge capacity scaffold extract attribute incorporation addition vera composite scaffold influence scavenging capacity biocomposite statistical difference find however incorporation oleifera increase scavenge composite ACCEPTED MANUSCRIPT material oleifera metabolite quercetin report antiinflammatory polyphenol agreement scavenge activity find composite scaffold moreover study compare anti inflammatory effect aloin metabolite identify biocomposite Fig Table Fig Phenolic content scaffold express nmol gallic acid equivalent scaffold antioxidant activity express nmol Trolox equivalent antioxidant capacity teac scaffold Antiinflammatory activity scaffold relate scavenge alginate pegma vera oleifera scaffold vera oleifera scaffold error bar show standard deviation group level significance denote genistein also identify scaffold oleifera Fig Table show low antiinflammatory effect quercetin show high effect agreement result addition study report correlation antiinflammatory activity total phenolic content medicinal plant perform correlation analysis find scaffold high antiinflammatory activity high phenolic content thus result agreement previous finding compound antiinflammatory property accelerate wound healing part reduction neutrophil infiltration inhibition production tumor necrosis factor alpha TNF inflammatory cell Arawaka Fujiwara thus antiinflammatory activity scaffold enhance wound healing contribute modulate inflammatory response accept manuscript antimicrobial activity antimicrobial effect composite scaffold evaluate representative positive strain aureus gramnegative strain Escherichia coli prevalent infectious wound Fig blank scaffold composite scaffold exhibit activity bacterial strain evaluate previous study compare antibacterial activity aqueous ethanol acetone extract vera aureus Streptococcus pyogen Pseudomonas aeruginosa coli Fig antimicrobial activity scaffold photograph show inhibition zone composite scaffold aureus incubation diameter inhibition zone scaffold aureus Biocomposites show antimicrobial activity coli incubation antibiotic disk positive control alginatepegma scaffold alginatepegma vera scaffold AlginatePEGMA vera oleifera scaffold vera oleifera scaffold error bar show standard deviation group level significance denote ethanol acetone extract show activity aureus coli aqueous extract show activity use water soluble fraction inner gel vera prepare composite scaffold therefore result agreement previous report null antimicrobial activity aqueous extract vera aureus coli however composite ACCEPTED MANUSCRIPT scaffold show activity aureus coli moreover increase concentration oleifera increase antibacterial effect composite material diameter inhibition zone large therefore antibacterial activity material attribute incorporation oleifera extract composite scaffold previous study correlate phenolic content antioxidant capacity antimicrobial activity Peixoto VzquezArmenta double concentration oleifera incorporate composite scaffold increase phenolic antioxidant activity thus high antimicrobial activity find compare attribute high phenolic content antioxidant activity composite scaffold propose explanation antibacterial property polyphenol compound compound form soluble complex protein bind bacterial adhesin polyphenol disturb signal receptor cell surface finally inhibit growth bacteria hand aureus dominant organism involve initial stage infectious process skin injury occur gramnegative coli find later stage chronic wound develop therefore antimicrobial activity oleiferacontaining scaffold complement tissue healing inhibit growth aureus organism find early stage infectious process cell viability cell viability analyze assay seed ccd1112sk human skin fibroblast scaffold increase decrease viable cell number detect measure formazan concentration reflect optical density analysis directly relate viability cell seed composite scaffold respect incubation time addition blend vera oleifera alginatePEGMA increase viability cell composite scaffold 3rd day evaluation compare scaffold contain extract contain vera incubation composite scaffold contain extract oleifera vera show high cell viability compare scaffold extract respect type scaffold fibroblast viability influence type concentration extract blend alginatePEGMA blank alginatepegma scaffold fibroblast viability increase however vera incorporate scaffold fibroblast remain viable incubation time increase behavior find composite scaffold however double concentration oleifera increase cell viability composite scaffold respect material propose amount water associate scaffold play crucial role cell attachment proliferation result water uptake behavior show scaffold absorb less water biocomposite thus plausible explanation finding reduce water uptake note oleifera extract correlate low cell proliferation find cell distribute confluent layer due meshwork bundle actincontaining microfilament permit movement penetrate ACCEPTED MANUSCRIPT cell substratum water associate scaffold directly affect growth cell layer Depan scaffold absorb less water continuous cell layer form time scaffold result show wash away thus result show fibroblast viability increase vera blend vera oleifera use prepare alginatepegma scaffold Aloin metabolite identify composite scaffold Fig Table anthraquinone compound highly stable excellent water solubility previous work demonstrate directly promote proliferation fibroblast vascular endothelial cell moreover oleifera report aqueous leaf extract promote proliferation human dermal fibroblast therefore result agreement previous finding scaffold contain oleifera vera show high cell viability pure alginatePEGMA scaffold summarize incorporation vera oleifera increase cell number alginatebase scaffold prime importance biomaterial tissue scaffolding application viability human skin fibroblast ccd1112sk cell scaffold Blank alginatepegma scaffold alginatepegma vera scaffold AlginatePEGMA vera oleifera scaffold vera oleifera scaffold error bar show standard deviation group asterisk indicate statistical difference evaluation cell viability type composite scaffold level significance denote Letters indicate statistical difference type scaffold evaluation level significance denote ggg Conclusions scaffold base alginatePEGMA oleifera vera prepare evaluate cellfree cellbased assay delay disintegration increase stability aqueous medium obtain alginate plasticize PEGMA plasticization ACCEPTED MANUSCRIPT optimize point increase handling stability aqueous medium keep porous architecture require tissue scaffolding application vera contribute increase water uptake capability scaffold due high water absorb property oleifera provide antioxidant capacity improve antiinflammatory property relate scavenging imparted antimicrobial activity aureus alginatepegmabase scaffold heal property mainly attribute polyphenolic compound contain plant antioxidant antiinflammatory antimicrobial capacity increase phenolic content scaffold high blending vera oleifera produce scaffold significantly increase evaluation number viable human skin fibroblast cell compare alginatepegma scaffold plant extract result attribute active component present vera gel oleifera leave aqueous extract characteristic make vera oleifera scaffold good choice evaluation vivo wound healing study wound healing application conflict interest author declare conflict interest ment ctedrasconacyt thank help SEM image Daniel VillaRodrguez also thank valuable technical help pertain preparation sample software analysis CeMIEGeo help enthusiastic participation Tijuana preliminary experiment work gratefully appreciate Appendix Supplementary data method datum processing analysis total ion chromatogram tic representative scaffold Principal Component Analysis PCA pcvg biomaterial sample accept manuscript Singer Lowmolecular weight polyethylene glycol improve survival experimental sepsis Critical Care Medicine phytochemical antimicrobial activity Aloe vera clinical pathogen Alginate hydrogel biomaterial musculoskeletal regeneration Concepts Springer Nature activity plant extract use externally traditional medicine Ethnopharmacology softtissue infection critical role telavancin treatment Formisano Boateng Quaglia Composite alginatehyaluronan sponge delivery tranexamic acid postextractive alveolar wound chitosanpolycaprolactonehyaluronic acid bilayer scaffold potential wound healing application Biological Macromolecules novel wound dress base composite sponge effectively kill bacteria accelerate wound healing Carbohydrate Polymers characterization tetramethylpiperidineoxyl cellulose nanocrystalalginate biodegradable composite dressing hemostasis application formulation Moringa oleifera standardize leaf extract film dress wound healing application Ethnopharmacology Misra Structurep",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "PEGmethyl": 1,
                    "TNBSinduced": 1,
                    "Vongsak": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Synthesis and antimicrobial applications of 5_ 5_-ethylenebis _5-methyl-3-_3-triethoxysilylpropyl_ hydantoin_.pdf",
            "cleaned_text": "biomaterial synthesis antimicrobial application ethylenebismethyltriethoxysilylpropylhydantoin Lianga Alabama USA cDepartment Received accept novel durable long last halamine siloxane monomer precursor prepare characterize nmr ftir purpose functionalize surface various material work precursor halamine moiety attach siloxane covalent bonding surface cotton ber simulated laundering test indicate chlorinate halamine structure survive many repeat home laundering material render biocidal exposure oxidative halogen solution dilute household bleach chlorinate material biocidal coli loss halogen longterm use consumption microbe surface simply recharge exposure dilute bleach regain biocidal activity right reserve Biocides Bioactivity halamine recently grow concern reduce eliminate infection completely especially cause antibioticresistant bacteria methicillinresistant Staphylococcus aureus MRSA vancomycinresistant Enterococci VRE show long survival time commonly use hospital fabric hospital privacy drape scrub suit lab coat survival transfer microorganism patient health care worker document medical gown uniform use currently prove provide ineffective barrier health care worker numerous study demonstrate great need antimicrobial textile polymer able protect major pathogen halamine compound provide protection show excellent biocidal function wide range microorganism fungus bacteria virus yeast addition demonstrate capability rapid total inactivation various microorganism cause microorganism develop resistance stability halamines directly relate structure evidence dissociation constant solution furthermore halamine structure capable kill microorganism directly release free chlorine system halamine compose amine amide imide halamine bond dissociation constant present Table think structure contain amide halamine bond practical use exhibit moderate rate transfer active chlorine halamine structure aqueous solution cell organism provide reasonably rapid biocidal activity equilibrium dissociation halamine see front matter right reserve biomaterial corresponding author fax mail address aqueous solution well understand h2o Bleach Inactivate Pathogens amine halamine bond stable offer slow kill rate amide halamine imide halamine offer rapid kill rate least stable structure rapidly lose active chlorine thus amide function seem reason able compromise stability biocidal efcacy mind precursor ethylenebismethyl triethoxysilylpropylhydantoin design chlorinate provide effective biocide capable surface enable textile coat withstand numerous home laundering cycle provide durable effective broadspectrum biocidal textile example surface material render biocidal halamine siloxane include cellulose synthetic ber ceramic plastic polyurethane metal case cellulose bind surface almost certainly covalent nature due condensation reaction group siloxane cellulose loss halogen longterm use consumption microbe surface surface textile simply recharge exposure dilute bleach thus regain biocidal activity limiting factor biocidal efcacy ultimately readily halamine precursor wash surface material due hydrolysis form silyl ether linkage prior work lower molecular weight monomer triethoxysilylpropyldimethylhy show excellent biocidal efcacy textile tendency hydrolyze fabric extended machine washing therefore seem reasonable increase molecular weight hydrophobicity number chemical bond surface provide effective durable antimicrobial coating various material Experimental Materials chemical purchase use receive purication otherwise note fabric use style bleach Cotton print Pittston household bleach Cloroxs brand bacteria use aureus ATCC coli o157 ATCC American Type Culture Collection Rockville soy agar employ NMR spectra obtain use spectro meter datum obtain Shimadzu Prestige FTIR Tensile strength measure model reactor use high pressure reactor carry example experiment add steal vessel mol potassium cyanide mol ammonium carbonate mixture ethanol water solvent mixture seal heat constant stirring reactor vessel allow cool room temperature reaction mixture pour beaker contain water precipitate form vacuum ltered mother liquor neutralize pHE7 drop wise addition HCl acid solution period ARTICLE PRESS Table Stability halamine structure constant example Imide structure trichlorocyanuric acid dichloro structure dichlorotetramethylimidazolidinone chlorodimethyloxazolidinone Amine structure o10 chlorotetramethylimidazolidinone min precipitate desire product dry vacuum oven overnight solid weigh yield obtain spectroscopic datum obtain nmr dmso KBr Preparation ethylenebismethyl triethoxysilylpropylhydantoin Scheme Prparation ethylenebismethyltriethoxysilylpropyl dantoin carry example experiment rst prepare sodium salt ethanediylbismethylhydantoin do mix mol methylhydantoin round bottom ask mol sodium hydroxide absolute ethanol solvent solution reuxe min constant stirring sodium salt isolate remove ethanol reduce pressure place vacuum oven overnight remove water produce byproduct sodium salt obtain anhydrous add solvent salt dissolve reaction solution heat mol chloropropyl triethoxy silane add drop wise period min chloro propyltriethoxysilane add temperature raise reaction mixture stir constantly cool ambient temperature KCl produce reaction DMF solvent remove ltration evapora tion respectively KCl dry oven weigh method determine percent yield reaction DMF residual remove hexane extraction dark gold oil leave behind desire product mass correspond yield mass KCl correspond yield spectroscopic datum ethylenebismethyl triethoxysilylpropylhydantoin nmr dmso kbr coating procedure ethylenebismethyltriethoxysilylpropylhydantoin mono mer coat surface cotton swatch soak swatch bath contain weight crude product aforementioned monomer dissolve mixture ethanol water soaking procedure coated swatch cure swatch soak detergent solution follow several water rinse remove weakly bond coating add weight coated swatch mea sure dry follow cooling 60min desiccator also FTIR spectra observe dry swatch coating process tensile strength ber measure order assess loss strength ber induce coating procedure chlorination procedure coated cotton swatch chlorinate soak aqueous solution household bleach buffer ambient temperature min swatch wash water dry remove occluded free chlorine loading bind chlorine swatch determine describe analytical titration procedure analytical titration procedure determination oxidative chlorine content standard iodometricthiosulfate titration procedure employ example coated chlorinate cotton swatch material suspend acetic acid solution addition starch indicator solution titrate sodium thiosulfate blue color disappear end point weight percent cotton swatch determine equation Cl normality eqv volume respectively consume titration weight gram cotton swatch sample test inch square cotton swatche uncoated serve control other coat ethylenebismethyltriethoxysilylpropyl dantoin monomer unchlorinated serve second type control other coat chlorinated ethylenebismethyl triethoxysilylpropylhydantoin monomer prepare dry swatch challenge aureus ATCC coli o157 ATCC use sandwich test test bacterial suspension place center swatch second identical swatch lay hold place sterile weight insure good contact swatch inoculum bacterial suspension employ test contain colony form unit actual number determine counting CH2 ch2 CH3 Acetonylacetone KCN nh42co3 EtOH 200mL CH3 CH2 ch2 ch3 850C Scheme Preparation ethanediylbismethylhydantoin H3C CH2 ch2 CH3 DMF H3C CH2 CH2 CH3 CH2 OEt OEt OEt H2C EtO EtO EtOH Reflux Chloropropyltriethoxysilane 2eq 1150C Scheme Preparation ethylenebismethyltriethoxysilylpropylhydantoin Barnes Biomaterials spread plate soy agar plate contact time min various swatch place sterile conical centrifuge tube contain sterile sodium thiosulfate quench oxidativefree chlorine present vortexe remove bacteria swatch remove serial dilution quench solution plate Trypticase soy agar plate incubate count viable bacteria durability coating laundering test perform swatch cotton coat ethylenebismethyltriethoxysilylpropylhydantoin monomer prepare detailed half swatch chlorinate follow aforementioned procedure type coat swatch subject laundry washing cycle use Test method Test procedure Samples evaluate washing cycle retention coating sample chlorinate washing chlorinate procedure describe order assess much chlorine load variable number washing cycle chlorinate washing divide group half assess chlorine loading rechlorination half rechlorinate assess chlorine loading result discussion cotton swatch treat monomer describe experimental section find signicant loss tensile strength ber typically add weight gain measure swatch ftir spectra coated swatch exhibit band characteristic vibrational mode observe uncoated cotton control provide evidence covalent bonding new monomer cellulose chlorination find average oxidative chlorine loading swatch weight treat cotton swatch challenge aureus coli o157 concentration phosphate buffer solution use modie version method find aureus colony log inactivate swatch treat chlorinate ethylenebis methyltriethoxysilylpropylhydantoin monomer contact interval min swatch treat unchlorinated monomer experience log reduction min table control sample untreated cotton swatch give log reduction well min interval also find coli log inactivate swatch treat chlorinate ethylenebismethyl triethoxysilylpropylhydantoin monomer contact interval min unchlorinated monomer untreated swatch experience log reduction contact time interval Table thus determine cotton cloth treat monomer chlorinate become capable rapid total inactivation gram positive gram negative bacteria comparison siloxane monomer describe previously find deactivate log aureus contact interval min contact interval min necessary inactivate log coli finally result wash test perform swatche cotton contain monomer coating chlorinate outline chlorination procedure ARTICLE PRESS Table efcacie coat cotton swatch aureus Sample coating log reduction contact time min Exp Cotton control chlorinated monomerc Exp Cotton control bCotton treat ethylenebismethyltriethoxysilylpro chlorinate percent add weight cCotton treat ethylenebismethyltriethoxysilylpro chlorinate loading ppm active fabric dInoculum concentration eCotton treat ethylenebismethyltriethoxysilylpro chlorinate loading ppm active fabric Table efcacie coat cotton swatch coli O157 sample coating log reduction contact time min Exp Cotton control chlorinated monomerc Exp Cotton control bCotton treat ethylenebismethyltriethoxysilylpro chlorinate percent add weight cCotton treat ethylenebismethyltriethoxysilylpro chlorinate loading ppm active fabric dInoculum concentration eCotton treat ethylenebismethyltriethoxysilylpro chlorinate loading ppm active fabric other unchlorinated comparison purpose pre sente table average oxidative chlorine loading monomercoated sample weight observation clearly evident datum Table First monomeric coating partially wash surface successive laundering cycle Second prechlorination reduce rate loss perhaps due increase hydrophobicity chlorinate surface Third evident coating condition sufcient biocidal efcacy regenerate rechlorination even launder cycle low concentration bleach add laundering cycle possibly maintain biocidal activity cotton material lifetime comparison ethylenebismethyltriethoxysilyl propyl monomer retention cotton surface launder cycle monomer retention launder cycle result novel compound discuss herein much effective durable coating textile fabric conclusion postulate propose herein increase potential covalent bonding surface use ethylenebismethyltriethoxysilylpropylhydantoin instead low molecular weight monomer validate acknowledgment author support USAF Contract FO8637 work enterococci staphylococci hospital fabric plastic slaughter Hayden comparison effect universal use glove gown glove use alone acquisition enterococci medical intensive care unit micro organism nurse patient clean air environment Ransjo Attempts control clothesborne infection burn unit clothing routine clinical use epidemiology crosscolonization organism contaminated textile Hambraeus transfer Staphylococcus aureus nurse uniform Smith Nichols Barrier efciency surgical gown really protect patient pathogen Arch Surg Quebbeman Telford Hubbard Wadsworth Hardman Goodman Risk blood contamination injury operating room personnel tion gown false sense security Infect Control false faith surgeon gown surgical drape Surg Waterman Muzik Evaluation protective value hospital gown blood strikethrough aureus pene tration Infect Control polymer Trends Polym Sci water disinfectant halaminequat siloxane copolymer use biocidal coating biomaterial new cyclic halamine biocidal polymer article press Table Durability halamine siloxane coat surface cotton number laundering cycle chlorinate chlorinate launderingb chlorinate rechargec number laundering cycle remain cotton surface treat cotton swatch chlorinate launder equivalent ppm active fabric treat cotton swatch chlorinate launder treat cotton swatch chlorinate launder rechlorinated Sun new polymeric water disinfectant Water Resour Bull halamine siloxane use biocidal coating material regenerable antibacterial nish ing fabric biocidal property Text Chem Colorist regenerable antimicrobial textile synthesis application methyloltetramethylimida zolidinone Weese polystyrene bead functionalize methylate polystyr Sci novel halamine monomer prepare biocidal polyurethane coating Coat Trans Novel halamine siloxane monomer polymer prepare biocidal coating Surf Coat Int part Coat Trans Wang Antimicrobial property novel halamine siloxane coating Coat Trans",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {}
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Synthesis and characterization of a practically better DEPMPO-type spin trap_           5-_2_2-dimethyl-1_3-propoxy cyclophosphoryl_-5-methyl-1-pyrroline N-oxide__.pdf",
            "cleaned_text": "synthesis characterization practically well spin trap dimethylpropoxy cyclophosphorylmethyl pyrroline oxide MASATO HIROAKI KAMEDA3 taiichi OKADA3 OSAMU INANAMI4 SHUNSAKU OHTA1 TOSHIHIKO OZAWA5 KEISUKE MAKINO6 YASHIGE KOTAKE7 1Kyoto Pharmaceutical University Yamashina Kawasaki 3Mikuni Toyonaka 4Graduate Hokkaido Japan 5National Institute Radiological Science Inage Chiba Uji receive revise form Dimethylpropoxy cyclophosphorylmethylpyrroline oxide new cyclic DEPMPOtype nitrone evaluate capability hydroxyl superoxide radical colorless crystalline freely soluble water solid diluted aqueous solution develop electron spin resonance ESR signal least month ambient condition spintrap superoxide hydroxyl radical chemical biological system spectra readily assignable Half life superoxide adduct produce illuminate hydrogen peroxide solution approximately min biological system hypoxanthine xanthine oxidase XOD halflife superoxide adduct approximately min illuminate hydrogen peroxide solution conversion superoxide adduct hydroxyl adduct overall capability similar high melting point low hygroscopic property long highly advantageous practical use spin trap DMPO DEPMPO superoxide Abbreviations dimethylpyrroline oxide diethoxyphosphorylmethylpyrroline oxide dimethylpropoxy cyclophosphorylmethylpyrroline oxide electron spin resonance hyperne splitting constant PMA phorbol myristate acetate Introduction inception spin trappingtechnique become indispensable toolfor research free radical chemistry biology believe oxygen radical play crucial role biological oxidative damage essential requirement spin trapping compound spin trap high ability trap stabilize oxygen radical superoxide hydroxyl radical quantication biological oxygen radical DMPO figure leave printissn online correspondence Oowada Division Dialysis Center Asao Clinic Manpukuji Asao Kawasaki fax mail s2oowadaniftycom Free Radical Research personal use frequently use however regrettable short poor availability pure compound short lifetime superoxide adduct seem discourage repel investigator wide use summarize drawback biological spin trap difcult handle melting point 358C neat aqueous solution readily develop free radical impurity ambient condition superoxide adduct unstable half life ph7 superoxide adduct decompose hydroxyl adduct presence metal ion attempt overcome drawback several DMPOanalogs syn thesize test study structural modication make introduce methyl group position replace methyl group high alkyl alkyloxy carbamoyl group replace methyl group substituted phosphoryl group spin trap achieve considerable improvement stability superoxide adduct compare become commer cially available example case Figure center drawback poor stability spin trap superoxide adduct improve thus use make possible rst vivo electron spin resonance ESR detection spin adduct mouse however neat hygroscopic oil handling require extra effort report synthesis characterization new DEPMPOtype spin trap dimethyl propoxy cyclophosphorylmethylpyrroline oxide name dimethyl oxo2l5dioxaphosphinanmethyl dihydropyrrole oxide figure structure similar melting point therefore slightly hygroscopic colorless crystalline room temperature moreover dilute aqueous solution store ambient condition free radical impurity develop stabilityof hydroxyland superoxide adduct well overall believe practically useful spin trap use expand versatility spin trapping technique biological oxygen radical research Materials method synthesis start chemical synthesize follow reaction scheme show figure starting cyclic hydrogen phosphite synthesize accord publish procedure ethanol mol mol mix stir phosphorus trichloride mol add dropwise temperature addition keep 208C reaction mixture vacuumdistille product collect 1458C identie use NMR room temperature methyl pyrroline mol add dropwise stir dichloromethane solution cyclic phosphite mol dichloromethane reaction mixture pass silicapacked glass column diameter long eluent chloroformethanol product separate solvent remove vacuum rotary evaporator yield crude crystal yield 1128C acid mcpba oxidation perform follow dichloromethane solution mmol dichloromethane mcpba mmol dichloromethane add dropwise ice reactant wash saturate sodium carbonate solution dry magnesium sulfate subsequently solvent evaporate product separate silica gel pack glass column diameter long eluent yield crystal yield puried crystallization toluene ethyl acetate chemical use synthesis free Figure Structures DMPO figure synthetic reaction scheme new DEPMPOtype spin trap personal use radical generation purchase otherwise specied oxidase XOD purchase analysis analysis preform Octanolwater distribution coefcient determine use establish spectroscopic method nmr spectra record CDCl3 use Inova mhz nmr spectrometer Positive ion mass spectra obtain 102A mass spectrometer fastatom bombardment method use glycerol matrix spectra obtain KBr disk method employ Shimadzu spectrometer Kyoto Japan Hydroxyl superoxide adduct formation spectra radical produce use indepen dent method short situ illumination typically light mediumpressure mercury arc dilute aqueous solution hydrogen peroxide presence reaction system consist phosphate buffer solution ferrous sulfate hydrogen peroxide radical spintrappe situ illuminate aqueous hydrogen peroxide solution Magnetic scan initiate immediately illumination terminate biological system superoxide produce hypoxanthine XOD system XOD DETAPAC mix phosphate buffer phorbol myristate acetate PMA opsonizedzymozan cal stimulate bovine neutrophil previously publish procedure employ isolation stimulation phil method bovine blood collect strictly follow protocol approve institutional animal care use committee Hokkaido University Spin trap kinetic pseudo rstorder decay spin adduct measure repeatedly record signal intensity decay constant superoxide adduct measure illuminate hydrogen peroxide aqueous solution illumination decay record XOD system decay record addition XOD inhibitor allopurinol follow method previously publish decay follow second order kinetic condition spin trap concentration hydronium ion present large excess treat pseudo rstorder halflife function component concentration also decay rate calculate base rst derivative ESR intensity thus differ rate calculate concentration relative spin trap rate superoxide hydroxyl radical determine use competi tivetrapping method spin trap mixed ESR signal intensity compare however due heavy overlap line CYPMPOderived spin adduct unable directly compare therefore obtain relative spin trapping rate respect ESR measurement spectra record room temperature band spectrometer operation software use disposable cell typical instrumental setting follow incidentmicrowave modulation amplitude timeconstant sweep rate min Computer ESR spectrum simulation carry use software package physical analysis slightly hygroscopic colorless crystalline melting point distribution coefcient approximately indicate soluble water time octanol DMPO develop ESRactive specie aqueous solution buffer leave ambient condition close brown bottle table list chemicalphysical property relevant practical spin trap experiment include spectroscopic parameter kinetic constant hydroxyl superoxide adduct also list property sake comparison result physicochemical spectroscopic analysis follow elemental analysis C10H18HO4P Calcd C48 Found C48 spectra cm21 personal use NMR CDCl3 dddd dddd nmr CDCl3 NMR CDCl3 Mass spectra M248 ESR spectra hydroxyl superoxide adduct Figure show spectra trap product illuminate hydrogen peroxide solution reaction system respect ively figure top middle spectra consist identical group line split large coupling phosphorus spectral pattern similar hydroxyl adduct therefore rational assign spectra hydroxyl adduct fact illuminate dilute hydrogen peroxide pure hydroxyl radical source support assignment spectra reproduce computer spectrum simulation Figure bottom hyperne splitting constant use list Table ESR spectra superoxide adduct obtain wellestablished superoxide source illuminate hydrogen peroxide solution figure XOD system figure stimulate neutrophil figure top middle spectra similar pattern superoxide adduct support assignment bottom spectrum Figure computer simulate spectrum superoxide adduct use simulation list table kinetic measurement measure method describe experimental section list Table decay curve superoxide adduct XOD system record addition allopurinol show figure logarithmic plot show left panel Figure indicate linear curve suggest decay apparent physical property spin trap DMPO DMPO Appearance ambient condition solid weighable viscous oil white powder weighable Melting point 358C 1268C Water solubility good good good octanolwater distribution coefcient Hygroscopic property unknown high Low free radical impurity neat form Rapid development Slow development Slow development stability aqueous solution spontaneous free radical formation unknown formation free radical purify crystallization recommend store temperature 2808C 2808C commercial availability adduct Diastereomer half life min min trapping rate adduct Diastereomer AgH Half life min min min mink mink trap rate ratio actual rate gather MSDS Milwaukee Chemical commercially available spin trap include available Alexis Biochemicals San Diego USA Commercialization consider spontaneous decay curve ESR signal intensity superoxide adduct produce situ illumination light hydrogen peroxide aqueous solution calculate decay curve ESR signal intensity superoxide adduct produce hypo xanthineXOD system decay record addition XOD inhibitor allopurinol figure Ref new DEPMPOtype spin trap personal use discussion paper describe synthesis characterization new DEPMPOtype spin trap trapping rate hydroxyl superoxide radical stability spin adduct similar furthermore spin adduct almost spin adduct possess asymmetric chiral car bon result presence diastereomer thus spectrum consist overlap radical specie similar note previous paper considerable confusion description spin adduct origin emphasize conformational isomer different chemical physical property include parameter essentially isolable ability trap superoxide effective chemical biological superoxide generating system PMA stimulate bovine neutrophil previous report indi cat human mouse neutrophil unable trap superoxide radical hydroxyl radical adduct detect however trap superoxide show report spectra adduct figure ESR spectrum hydroxyl adduct adduct produce illuminate hydrogen peroxide top system h2o2 ferrous sulfate middle computersimulated spectrum adduct hfsc use computersimulation list table bottom figure ESR spectrum superoxide adduct Superoxide adduct produce XOD illuminate hydrogen peroxide spectrum superoxide adduct use computersimulation list Table hydroxyl superoxide adduct produce min illumination hydrogen peroxide separate pair line center assign superoxide adduct wide pair weak intensity hydroxyl adduct narrow pair strong intensity respectively personal use bovine neutrophil similar suggest superoxide trapping ability good see decomposition superoxide adduct hydroxyl adduct datum show therefore small hydroxyl adduct signal figure artifact kinetic measurement superoxide adduct XOD system indicate pseudo rstorder decay halflife min halflife superoxide adduct suggest electronic inuence adduct stability diethoxy phosphoryl alicycloxy phosphoryl group similar excellent spin trap capability superoxide hydroxyl radical addition line adduct clearly separate readily identiable however practically speak find handle considerably less demanding commercial report contain hydroxyl amine contaminant interfere spin trap reaction contrast less hydrophilic readily puried crystallization organic solvent toluene ethyl acetate test show aqueous solution develop ESRactive specie room temperature datum show suggest stock solution storable long period case addition poor commercial availability pure freeradical impurity free spin trap prepare fresh spin trap solution immediately spin trapping experiment believe become practically useful spin trap agent ment thank enthusiastic support encouragement develop also thank elemental analysis mass spectrometer operation identication shortlive free radical electron spin resonance trap technique spin trap organolead tin mercury compound trap Radical addition reaction dimethylpyrrolineoxide spin trap cyclic nitrone trap ESR parameter spin adduct oxide biological application rate superoxide generation biological system spin trapping use rapid oxygen depletion measure decay rate spin adduct cautionary note spin trap presence iron figure ESR spectrum record stimulate bovine neutrophil balanced salt solution pmastimulated top presence SOD middle zymozan stimulate bottom figure Decay signal superoxide adduct produce XOD system addition XOD inhibitor allopurinol ESR signal intensity arbitrary unit plot function time min addition allopurinol logarithmic plot top line decay linear scale show halflife superoxide adduct calculate min see Table comparison new DEPMPOtype spin trap personal use Rauckman Production hydroxyl radical decomposition superoxide spintrappe adduct trap chemistry tetramethylpyrrolineoxide improve cyclic spin trap Kotake Chiral spin trap spin trap chemistry methylphenylpyrroline oxide MPPO biochemical application solid cyclic spin trap relatively superior trap detect superoxide anion glutathiyl radical free radic Biol Med Hadad Zweier Spin trap carbamoyl methylpyrroline oxide AMPO theoretical exper Tuccio oxide new efcient phosphorylate vivo spin trap oxygen center radical Nohl Spin trap lipid radical spin trap detection superoxide alkyl alkoxyl radical aqueous lipid phase trap superoxide presence betacyclodextrin Chem Commun Camb Timmins Kotake free radical direct vivo detection comparison diethoxyphosphorylmethylpyrrolineoxide spin trap SO4 Free Radic Biol Med derivative Janzen West Kotake DuBose Biological spin trap methodology partition compound Harbour electron spin resonance study spin adduct HO2 radical nitrones ultraviolet photolysis aqueous hydrogen peroxide solution Inanami detection intraphagosomal superoxide polymorphonuclear leukocyte use diethoxypho sphorylmethylpyrrolineoxide Kotake fate hydroxyl radical adduct phenyltertbutylnitrone aqueous medium kotake spin resonance spectra diastereomeric nitroxyls produce spin trap radical removal contaminating hydroxylamine spin trap evaluation use indicate radical cation formation reaction Kamibayashi Free Radic res personal use",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "DMPOanalogs": 1,
                    "stabilityof": 1,
                    "ESRactive": 2
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Synthesis and evaluation of anticonvulsant and antimicrobial activities of 3_hydroxy_6_methyl_2_substituted 4H_pyran_4_one derivatives.pdf",
            "cleaned_text": "antimicrobial activity antimicrobial activity Synthesis Evaluation Anticonvulsant Antimicrobial Activities droxymethylsubstitute Pyranone derivative title compound prepare reaction substituted piperazine derivative anticonvulsant activity determine vivo maximal electroshock subcutaneous toxicity test neurological deficit antimicrobial activity new compound investigate bacteria fungus use microdilution broth method CALIS OEZALP Arch Pharm Pharm Chem Fac Pharm",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {}
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Synthesis and pharmacological study of ethyl 1-methyl-5-_substituted 3_ 4-dihydro-4-oxoquinazolin-3-yl_-1H-pyrazole-4-acetates.pdf",
            "cleaned_text": "dition scientique dicale SAS right reserve PII S0223SCO short communication Synthesis pharmacological study ethyl methylsubstituted dihydrooxoquinazolinpyrazoleacetate aDipartimento degli bDipartimento viale receive accept several new ethyl methylsubstituted dihydrooxoquinazolinpyrazoleacetate substitute alternatively position quinazolinone nucleus synthesise compound screen analgesic antiinammatory activity acute toxicity ulcerogenic effect substitution benzene moiety ring show advantage analgesic activity improve case antiinammatory activity compound show appreciable antiinammatory activity time low ethyl methylsubstituted dihydrooxoquinazolinpyrazoleacetate antiinammatory activity analgesic activity ulcerogenic propriety introduction research group long interested chemistry pharmacology quinazoli nones bearing heterocyclic nucleus pyrazole isoxazole indazole compound show analgesic antiinammatory antineoplastic activity pyrazole derivative structure type bear ethoxycarbonylmethyl group position pyrazole nucleus present structural feature heteroary lalkanoic ester see gure compound show remarkable analgesic activity associate appreciable antiexudative property reduce ulcerogenic effect systemic toxicity report ester afford vivo related acid wellestablished class nonsteroidal antiinamma tory agent therapeutically useful treatment acute well chronic inammatory condition particular active principle antiinammatory antirheumatic agent calcium salt phenyl chlorophenylpyrazoleacetic acid Figure structure compound correspondence reprint mail address gdaidoneunipa show good proportion clinical efcacy gastroduodenal side effect order improve property unsubstituted quinazolinone prepare new series compound substitute nucleus group similar lipophylic character exert opposite electronic effect chemistry synthesis quinazoline derivative carry follow gure amino derivative react ethyl orthoacetates produce desire quinazoli none structure compound assign basis analytical well spectroscopic datum spectra exhibit band region due endocyclic ester carbonyl group NMR spectra indicate hinder ternal rotation bond link pyrazole nucleus fact sub stituent methyl ethyl phenyl group spectra exhibit methylene group acetate moiety double doublet region value typical geminal coupling spectrum compound show also signal methylene portion ethyl group bond position ring appear multiplet region due geminal vicinal coupling Pharmacology new quinazolinone screen order evaluate analgesic antiinammatory tivitie behavioural effect acute toxicity lastly ulcerogenic potential Indomethacin INDO phenylbutazone PBZ test assay standard result discussion datum report table behavioural effect acute toxicity mouse mouse test compound induce remark able behaviour modication accord assay dose whereas slight transient sedation effect note compound show marked sedation min administration period Death generally occur postdrug animal survive mouse appear normal remain observation period analgesic activity phenylbenzoquinoneinduce writhing test mouse compound quite active phenylbutazone compound active slightly active phenylbutazone figure synthetic pathway compound activity acetic acid peritonitis assay quinazolinone exhibit remarkable antiexudative tion case fourfold higher phenylbutazone low rat paw oedema test compound show fair activity however less active phenylbutazone activity active compound show low harmful effect stomach test dose administer twice interval fast rat PBZ indomethacin produce serious gastric ulcer animal conclusion pharmacological datum obtain compound compare previously report unsubstituted analogue type seem CH3 substitution gen erally show advantage analgesic activity allow obtain case high inhibition value paw oedema test acetic acid peritonitis test tution inuence study activity follow ferent trend finally compound select appreciable antiinammatory activ ity time low ulcerogenic index Table Pharmacological data Antiinammatory activity activity acute toxicity Compound index rat acid peritonitis Approximate LD50 oedema inhibition writhingt inhibition protection PBZ INDO oral administration test INDOindomethacin PBZphenylbutazone Student test control value percent control PBZ INDO INDO INDO INDO Physical data ethyl methylsubstituted dihydrooxoquinazolinpyrazoleacetate Formula Analyses Yields compound C17H17N4O3Cl c22h19n4o3cl c17h17n4o3cl c22h19n4o3cl c17h18n4o3 c18h20n4o3 nmr unresolved signal CH3 CH2 superimpose singlet ch3ch2 set signal C6H3 pyrazole quinazolinone CH3 CH3 methylene methylene superimpose signal ch3ch2 set signal C6H3 pyrazole CH3 CH3 multiplet CH2CH3 superimpose singlet ch3ch2 set signal C6H3 pyrazole CH3 superimpose H2O signal CH2 CH3 CH2 set signal c6h3 C6H5 pyrazole CH2 superimpose signal ch3ch2 set signal C6H3 quinazolinone pyrazole CH3 CH3 methylene methylene superimpose singlet ch3ch2 set signal C6H3 pyrazole CH3 CH3 multiplet dmso signal CH2CH3 methylene methylene superimpose signal ch3ch2 set signal C6H3pyrazole CH3 h2o signal CH2 CH3 CH2 set signal C6H5 C6H3 pyrazole CH3 CH3 CH2 CH2CH3 C6H3 quinazolinone pyrazole CH3 CH3 CH3 methylene methylene CH2CH3 C6H3 pyrazole CH3 CH3 CH2CH3 methylene methylene CH3CH2 C6H3 pyrazole Experimental protocol Chemistry melt point take chi capillary apparatus uncorrected spectra record JASCO spectrometer mull NMR spectra obtain dmso CDCl3 solution spectrom use analysis perform laboratory theoretical value oxoquinazolinpyrazoleacetates amino derivative appro priate ethyl orthoester reuxe cool room temperature crystalline white solid separate ltere lize ethanol yield datum compound report table method Swiss male mouse SpragueDawley rat use animal starve administration maintain temperature test compound domethacin phenylbutazone PBZ suspend aqueous methylcellulose solution adminis tere orally intraperitoneally control animal ceive amount vehicle behavioural effect acute toxicity mouse multidimensional screeningevaluative proce dure use group animal com Maggio European Journal Medicinal Chemistry pound administer dose orally intraperitoneally animal keep observation symptomatology check later approximate LD50 obtain mortal ity day later analgesic activity phenylbenzoquinone writhing test Analgesia assess mean phenylbenzo quinone writhing group male mouse mouse give ethanol number writhes count min beginning min injection test compound PBZ domethacin orally administer min analgesic effect express percentage protection comparison control antiinammatory activity oedema group rat use test compound PBZ give orally domethacin give later carrageenin solution inject tissue right hind paw volume measure mercury plethysmometer prior later increase volume paw adopt measure oedema swell reduction treat animal calculate percentage inhibition comparison control acetic acid peritonitis Groups rat test Peritonitis pro duce injection acetic acid solution rat kill ether peritoneal exudate collect measure test compound PBZ give orally dose min injection acetic acid Indomethacin administer way antiexudative sponse express percentage exudate volume reduction compare control activity Groups rat use compound give orally animal fast treatment repeat domethacin phenylbutazone administer twice respectively rst dose rat sacriced ether inhalation stomach remove open great curvature examine dissect micro scope presence gastric ulcer severity mucosal damage index grade mean score lesion exceptional severe lesion order take account centage rat ulcer index ulceration calculate basis follow formula mean degree ulcersnumber animal ulcer number animal statistical analysis result express mean oneway analysis comparison control unpaired student test use determine statistical signicance ment financial support gratefully AmicoRoxas Eur Daidone Plescia Leone Farmaco Farmaco Plescia Cutuli AmicoRoxas Eur Med Chem Daidone Plescia Cutuli Mangano Caruso Daidone Maggio Heterocycles vol Academic Press New York ArzneimForschDrug Immunopharmacology Spandonis Costache Med Int Kollich Fromme Klein MedWochenschr Daidone Cutuli Berkowitz Fink Ngai Pharmacol Exp Ther Winter Risley Nuss Proc Soc Exp Biol Med ArrigoniMartelli Boll Chim Farm Domenioz Ann Acad Sci",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Swiss": 1,
                    "adminis": 1,
                    "Farmaco": 2
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Synthesis of renewable diesel with hydroxyacetone and 2-methyl-furan.pdf",
            "cleaned_text": "Registered Charity Number feature see Tao Zhang Chem Commun Showcasing research Chinese Academy Sciences Dalian China Synthesis renewable diesel hydroxyacetone methylfuran jet fuel range branch alkane synthesize rst time combination hydroxyalkylationalkylation HAA methylfuran hydroxyacetone hydrodeoxygenation compare previous acetone route hydroxyacetone route exhibit high reactivity diesel yield journal Cite Synthesis renewable diesel hydroxyacetone methylfuran Shanshan Aiqin jet fuel range branch alkane synthesize first time combination hydroxyalkylationalkylation HAA methylfuran hydroxyacetone subsequent electronwithdrawing effect hydroxyl group hydroxyacetone route exhibit evident advantage high reactivity diesel yield previous acetone route ecient utilization biomass production fuel chemical solution excessive dependence society fossil energy environmental problem cause utiliza tion fossil fuel recent year use important alternative fuel due renewability low toxicity low sulphur content high biodegradability cetane value Glycerol product biodiesel production production ton biodiesel lead generation approximately ton glycerol rapid growth annual biodieselproductionfromo1milliontonsin2000toabout10million tons large quantity glycerol generate supply glycerol lead sharp decrease glycerol price point view atom economy utilization excess glycerol feedstock fuel high valueadded chemical great significance jet fuel kind demand fuel fuel mainly obtain petroleum currently themaincomponentofagricultural residue follow pioneering work Huberetal12thesynthesisofdieselandjetfuelrangealkanesfrom lignocellulose derive platform chemical attract tremendous attention dehydration product glycerol compound similar structure acetone use potential platform compound synthesis renewable diesel jet fuel combination couple reaction hydrodeoxygenation previous work find aldol condensation hydroxyacetone furfural hydroxymethyl furfural take place catalysis solid base organic base however due serious cleavage occur aldol condensation product low yield liquid alkaneso30wereobtainedtofulfilltheneedforrealapplication new route high selectivity diesel jet fuel range alkane developed recent work group find diesel jet fuel range branch alkane synthesize hydroxyalkylationalkylation HAA methylfuran lignocellulose derive carbonyl compound follow prepared selective hydrogenation furfural produce industrial scale hydrolysisdehydration hemicellulose part agricultural waste forest residue lignocellulose derive carbonyl compound aldehyde furfural hydroxymethylfurfural methylfurfural butanal ethanal ketone acetone pentanone furan compound hydroxyacetone let alone use product precursor synthesis diesel jet fuel range branch alkane work hydroxyacetone series solid acid catalyst report first time prepared product hydrodeoxygenate catalyst hydroxyacetone carry series solid acid catalyst HPLC NMR see Fig analyse identify main product small amount hydroxymethylmethylfuranheptanedione Scheme detect product compound produce hydrolysis base information reaction pathway hydroxyacetone propose Scheme absence methylfuran propanediol scheme liquid product explain much high rate alkylation step hydroxyalkylation Fig show conversion yield series solid acid catalyst mail taozhangdicp Fax Beijing China electronic supplementary information available experimental section nmr mass spectra see c3cc42296h receive accept 7th May c3cc42296h wwwrscorgchemcomm ChemComm COMMUNICATION publish Amherst View Article Online View Journal View Issue Chem Commun journal exhibit high activity hydroxy acetone advantage Nafion resin significant low catalyst loading see fig accord result show Fig ESI activity sequence dierent catalyst Amberlyst SO3H ZrP USY ZSM far TON deduce yield Fig acid amount measure chemisorption NH3 concern resin also demonstrate evidently high catalytic eciency solid acid catalyst see find intrinsic reason dierence activity various catalyst also compare activity H2SO4 acid choose represent strong acid medium acid weak acid respectively facilitate comparison molar concentration total acid amount acid solution keep mol mmol accord result show fig sequence yield catalysis dierent acid H2SO4 H3PO4 CH3COOH sequence consistent acid strength accord result sensitive acid strength catalyst strong acid active medium acid weak acid reaction analogously activity sequence Nafion resin resin sulfate active carbon also rationalize acid strength accord literature Nafion perfluorinate sulfonic acid resin often denote superacid crosslinke polystyrene resin however sulfate active carbon amorphous carbon bear cooh phenolic group function acid site resin acid strength group enhance presence fluorine make acid strength high resin sulfate active carbon consequently Nafion resin high activity efficiency hydroxyacetone stability Nafion HAA hydroxy acetone also study exclude influence reaction residue include hydroxyalkylation product unreacte hydroxyacetone catalyst wash thoroughly methanol usage dry result show fig evident change activity Nafion resin observe even repeatedly use time result show Nafion resin stable investigate condition accord high activity stability resin consider promise catalyst real application fig s10 illustrate influence catalyst loading reaction temperature reaction time yield resin optimum condition yield yield obtain resin react use precursor synthesis renewable diesel jet fuel previous work group propanediylbismethylfuran prepare acetone work reactivity hydroxyacetone acetone compare reaction condition evidently high yield product achieve resin hydroxyacetone use replace acetone carbonyl compound react s11 consider advantage Scheme Reaction pathway HAA methylfuran hydroxyacetone Fig Conversion yield dierent solid acid catalyst reaction condition mmol mmol hydroxyacetone hydroxyacetone molar ratio catalyst Fig TON TOF dierent solid acid catalyst reaction condition mmol mmol hydroxyacetone hydroxyacetone molar ratio catalyst Communication ChemComm publish May University Amherst View Article Online journal hydroxyacetone route high reactivity hydroxyacetone explain enhance electrophilicity carbonyl group electronwithdrawe eect hydroxyl group attach carbon atom final aim work HAA product hydroxyacetone main component also explore loaded active carbon catalyst result show analysis product hydroxyacetone totally convert co2 hydrocarbon final product result show enough complete compare product acetone reaction condition evidently high carbon yield diesel jet fuel range alkane alkane obtain HAA product hydroxyacetone predominant component alkane HAA product high carbon yield diesel jet fuel range alkane HAA product hydroxy acetone also explain presence hydroxyl group previous work group find cleavage HAA product preferable branched carbon atom generate cleavage decrease diesel jet fuel yield extent cleavage depend stability carbocation form process HAA product acetone hydroxyacetone tertiary carbocation generate cleavage branch carbon atom electronwithdrawing effect hydroxyl group electron donate effect methyl group branch carbon atom product hydroxyacetone weaken result carbocation intermediate produce cleavage become less stable cleavage reaction restrain work brand new route synthesis diesel jet fuel range branch alkane develop hydroxyacetone follow investigate solid acids Nafion resin exhibit high activity stability solventfree condition yield product obtain resin product catalyst carbon yield diesel jet fuel range alkane achieve compare acetone route describe previous work hydroxyacetone route many advantage high reactivity high carbon yield diesel jet fuel range alkane process explain electronwithdrawing effect hydroxyl group work support talent project Key Laboratory Catalysis R201113 Notes Rev Rev Bond Olcay Sci Corma Int Crossley Quintana Energy Environ Sci Lett Sci Wang Wang Lange Weingarten Rev yield dierent alkane hydrodeoxygenation HAA product acetone hydroxyacetone catalyst reaction condition catalyst liquid feedstock flow rate min hydrogen flow rate diesel gasoline light alkane account alkane respectively method use calculation carbon yield describe ChemComm Communication publish Amherst View Article Online",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {}
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Synthesis_ crystal growth and FTIR_ NMR_ SHG studies of 4-methoxy benzaldehyde-N-methyl-4-stilbazolium tosylate _MBST_.pdf",
            "cleaned_text": "Crystal Growth Synthesis crystal growth ftir NMR study methoxy benzaldehydemethylstilbazolium tosylate Lakshmana Santhana Raghavanb Huangb Ichimurac Chennai India bDepartment Electrical Engineering National Tsing cDepartment receive accept communicate novel organic nonlinear optical material methoxy benzaldehydemethylstilbazolium tosylate synthesize good optical quality crystal grow slow cool solution growth technique powder ray diffraction study carry lattice parameter calculate ftir spectra record identify various functional group present crystal NMR spectrum study also do powder second harmonic generation study do powder technique result compare urea Elsevier Science right reserve characterization Recrystallization Supersaturated solution ray diffraction growth solution Single crystal growth Organic compound nonlinear optic material nonlinear optical device introduction much attention give organic nonlinear optical material promising application include telecommunica tion optical computing optical datastorage application generally successful popular approach material achieve step rst imply synthesis extend conjugate system donor acceptor group ensure large known second molecular class material compare inorganic material nonlinearity associate chromophore organic material lead observable bulk nonlinearity w2 also chormophore orient noncentrosymmetric environment vital design molecule high noncentrosymmetry effort lead development organic material dimethylaminomethylstilbazolium tosylate Corresponding author mail address proframasamyhotmailcom annaunivedu see front matter Elsevier Science right reserve PII DAST crystal extend effort synthesize methoxy tosylate derivative stilbazolium tosylate new material high property find possess large electrooptic property lack reasonably large highquality crystal prevent real application optical sampling sampling device frequency conversion effect report investigate growth crystal order obtain high quality crystal way obtain reasonably large crystal investigate report article crystal grow saturate methanol solution slow cool technique slow cool solution growth technique widely use growth organic inorganic material present study synthesize crystal grow slow cool solution growth technique crystal characterize use powder ray diffraction ftir NMR powder study synthesize condensation methylmethyl pyridinium tosylate prepare picoline methyl toluene sulfonate C8H10O3S methoxy presence piperidine catalyst Scheme stepstep synthesis procedure follow toluene picoline mol methyl para toluene sulfonate mol take together bottom ask apparatus mixture heat form salt insoluble toluene heat mixture dimethyl formamide add toluene salt mixture crystal mixture salt dissolve add mixture salt Scheme synthesis MBST Lakshmana Perumal Journal Crystal Growth drop piperidine add catalyst solution turn red colour mixture reuxe stark apparatus trap remove water collection equivalent amount water reaction cool room temperature yelloworange colour crystal obtain vacuum ltration proximately equivalent substance collect study Crystal growth Recrystallized salt take dissolve methanol 451C accord solubility saturate solution prepare solution ltered use lter paper porosity beaker contain solution shield hermetically prevent evaporation solvent Growth carry constant temperature bath control accuracy 011C Transparent high optical quality seed obtain slow evaporation method hang solution help nylon thread cool rate employ initial nal stage growth process normal ambient room temperature reach crystal harvest powder ray diffraction study powder ray diffraction study carry demonstrate crystallinity use ray diffractometer employ Cuka range lattice para meter calculate FTIR NMR spectral study ftir spectra record use corporation wavelength range kbr pellet technique middle infrared spectrum material show NMR spec trum record crystal dissolve Fig ftir spectrum Perumal Journal Crystal Growth deuterate methanol use highresolu tion nmr spectrometer mhz nmr spectrum show Fig Powder SHG measurement relative efciency urea measure use powder tech nique set consist YAG switch laser wavelength beam fall focusse thin section material contain cuvette specication laser source use pulse energy peak power khz repeti tion rate pulse width crystal powdered use ball mill get uniform particle size schematic experimental set use show Fig result discussion growth rate crystal mainly depend crystal growth parameter temperature degree supersaturation solution effort take increase growth rate crystal increase supersatura tion solution crystal size experimental setup Fig nmr spectrum Perumal Journal Crystal Growth exhibit plate growth morpho logy highly polished surface grow conventional slow cool solution growth technique crystal grow slow cool solution growth technique show Fig middle spectrum record show intense envelope due stretch water envelope peak due aromatic stretch peak present low wave number portion envelope peak assign aromatic ring skeletal vibration olinic stretch respectively asymmetric symmetric stretching mode SO2 group observe respectively ch3 stretch position para disubstitute nature aromatic ring evident bend mode aromatic ring hydrogen show NMR spectrum crystal peak ppm assign pyridinium ring hydrogen para disubstitute nature aromatic ring evident peak ppm signal ppm due pyridinium methyl hydrogen methoxy methyl hydrogen Fig Photograph crystal Wavelength Negative Votage MBST Pure Urea Fig peak intensity urea ray diffraction spectrum Perumal Journal Crystal Growth observe singlet ppm methyl group toluene sulfonate molecule produce signal ppm signal due olinic proton observe ppm intense peak ppm due solvent measurement use laser beam show intense emission green light peak intensity powder observe time high urea Fig show peak intensity curve urea crystal belong triclinic system space group powder study conrm crystallinity synthesize crystal salt calculated lattice parameter volume Conclusion synthesize crystal grow slow cool solution growth technique powder ray diffraction study carry lattice parameter value calculate FTIR NMR spectra record identify various functional group present material powder measurement show peak intensity time urea growth parameter optimize growth large single crystal ment author grateful UGC award teacher fellowship FDP Organic Molecules Crystals Academic Press ACS Symposium Series Williams AngChem Int Engl Nakanishoi res Soc int Mtg Adv Mater Marder Perry Schaefer Science Marder Perry Yakymyshyn Chem Mater Subramanian Mater Chem Phys Subramanian Crystal Growth Lakshmana Perumal Journal Crystal Growth",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Recrystallized": 1,
                    "Subramanian": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Synthesis_ screening for antitubercular activity and 3D-QSAR studies of substituted N-phenyl-6-methyl-2-oxo-4-phenyl-1_ 2_ 3_ 4-tetrahydro-pyrimidine-5-carboxamides.pdf",
            "cleaned_text": "original article Synthesis screen antitubercular activity qsar study substitute tetrahydropyrimidinecarboxamide Vijay Chintan Dholakia Chemistry Saurashtra University Kalina Santacruz Maharashtra Unimark Remedies Ltd Received receive revise form accept available online Multidrug resistance commonly use antitubercular drug propel development new structural class antitubercular agent paper report synthesis evaluation qsar analysis set substitute agent react various aromatic aldehyde urea yield tetrahydropyrimidine derivative phenyl carbamoyl group position various substitution phenyl phenyl aromatic ring compound screen antitubercular activity Mycobacterium tuberculosis h37rv strain qsar model generate training set molecule molecule align use atom technique comfa CoMSIA model generate molecule align atom method show correlation coefcient crossvalidate respectively qsar model externally validate test set molecule predictive record comfa CoMSIA model respectively comfa CoMSIA contour helped design new molecule improved activity SAS right reserve activity CoMFA comsia world population infect Myco bacterium tuberculosis lead cause death develop world Approximately people die year multidrug resistance tuberculosis MDR dene resistance least isoniazid rifampicin serious threat tuberculosis control prevention block biosynthesis mycolic acid essential component mycobacterial cell wall believe oxidize cat alase peroxidase KatG active form Mutations KatG gene associate INH resistant tuberculosis isolate Resistance fampicin associate mutation core region rpob gene encode subunit rna poly merase case development resis tance tuberculosis commonly use antitubercular Corresponding author fax correspond author fax mail address anamikshahhotmailcom org see front matter SAS right reserve ejmech available online wwwsciencedirectcom 2103e2115 drug necessitate long duration therapy emergence multidrug resistance force development new structural class antitubercular agent several show promising activity tuberculosis several report literature new structural class antitubercular agent derivative imidazole value var ious drugresistant strain tuberculosis highly active vitro vivo Acyclic deoxy mono saccharide derivative carbohydrate class value strain effective derivative benzoic acid hydrazone class good lead drug design study Calanolide naturally occur coumarin derivative inhibitor HIV reverse tran scriptase also show promising vitro activity tuberculosis value rine derivative quite potent tuberculosis h37rv strain MIC effective compound pyrrole class exhibit value Mycobacterium avium tuberculosis respectively MIC value report benzoxazine derivative tuberculosis various diterpenoid derive plant describe possess tuberculosis activ ity tuberculosis new structural clas ses build important plot focused development new antitubercular drug Pyridines pyrimidine also identie antitubercular activity developed new structural class antitubercular agent carbothioamides recognize novel class compound good titubercular activity compound series also belong pyridine class compound MIC effect various substitution activity class study pyrimidine group diaminopyrimidines identi ed IC50 safety index effective derivative chloropyrimidine series successful compound anilinopyrimidine series display monophosphate tive evaluate bind thymidine phate kinase tuberculosis effective inhibitor thus structural class hold great hope development new effective antitubercu synthesize evaluate several bear lipophilic group antitubercular agent assumption compound act pro drug penetration convert carboxylate anion enzymatic hydrolysis effective analog show inhibition bacterium concentration series examine detail qsar analysis continuation work seek explore modify tetrahydropyrimidine view aza analog pyridine development new antitubercular agent subject anal ysis understand relationship structure activ ity class paper describe synthesis evaluation qsar study series result discussion Chemistry various substitute acetoacetanilide prepare react substituted amine ethyl acetoacetate tolu catalytic amount KOH Scheme reaction mixture heat different acetoacetanilide synthesize bear various electron donating electron withdraw group diCH3 diCH3 CH3 diCH3 diCH3 OCH3 diCl no2 phenyl ring Acetoacetanilides thus obtain use diketone adduct multicomponent reaction acetoacetanilide react substituted aldehyde urea methanol use conc HCl catalytic amount obtain title compound 4aeg depict scheme reaction time find vary depend substitution aldehyde diketone structure synthesize compound spectral analysis carbonyl group amide observe cyclic ketone observe spectra NMR spectra proton attach observe ppm proton attach methyl group deshielde observe ppm signal N1H N3H carbamoyl group observe ppm molecular ion peak total agreement molecular weight elemental analysis find match calculate elemental composition permissible error limit activity synthesize compound test antitubercular activity tuberculosis h37rv strain percentage inhibition datum compound report Tables Compounds dimethyl carbamoyl side chain spectively show inhibition thus methyl group position show high potency substitu tion phenyl ring also alter activity compound Compound side chain compound NO2 group meta position compound para position compound 2103e2115 lead decrease inhibition thus compound methyl substitution phenyl carbamoyl side chain eOPh eNO2 substitution meta position phenyl ring potent substitution para position replacement methyl group phenyl ring phenyl carbamoyl side chain halogen result loss potency Compounds halogen substitute differ ent position phenyl ring phenyl carbamoyl side chain show good potency meta para substitute phenyl ring thus conclude methyl group phenyl ring side chain meta substituted phenyl ring show good potency nd structural requirement well activity datum result obtain subject qsar analysis qsar study computational detail technique comfa car rie run Pen tium computer WS4 Ligand preparation dataset divide training set molecule table test set molecule table basis chemical biological diversity use similar study activity value transform follow NH2 Scheme reagent condition naohkoh toluene CHO H2N NH2 Scheme reagent condition HCl methanol reux 2103e2115 log activity logc logit molar concentration concentration molecular weight log log inhibition inhibition molecule build use Builder module Sybyl crystal structure methylmethoxyphenyl methyloxotetrahydropyrimidinecarboxylate use template build molecule dataset template structure pyrimidine ring boat conformation phenyl ring atom pyrimidine ring ration ligand geometry optimize energy minimization method use MMFF94 forceeld charge atom gradient reach maintain template structure rigid minimization molecular alignment molecule dataset align technique First atom technique use atom common crystal structure methylmethoxyphenylmethyl oxotetrahydropyrimidinecarboxylate second approach molecule align technique steric electrostatic eld active molecule series extract use alignment eld molecule Fig comfa CoMSIA study CoMFA Analy sis 36e38 study carry default setting cubic lattice grid space probe atom energy cutoff CoMSIA physicochemical property steric elec trostatic hydrophobic hydrogenbond donor accep tor explore attenuation factor set default value comfa CoMSIA descriptor use independent variable log activity dependent variable partial least square regre sion analysis derive qsar model model internally evaluate leaveoneout LOO crossvali dation optimal number component determine method subsequently use derive nal qsar model addition con ventional correlation coefcient standard error also compute robustness model gauge crossvalidation use leavegroupout LGO group bootstrapping carry run CoMFA Table Molecules use training set comfa CoMSIA study Compound inhibition log activitya OCH3 CH3 CH3 OPh CH3 CH3 OPh CH3 CH3 NO2 no2 ch3 CH3 no2 ch3 CH3 NO2 NO2 no2 CH3 CH3 no2 ch3 CH3 NO2 NO2 NO2 NO2 OCH3 NO2 no2 CH3 NO2 MIC log acitivity calculate describe text Table Molecules use test set comfa CoMSIA study Compound inhibition log activitya no2 CH3 NO2 OPh CH3 CH3 NO2 no2 ch3 CH3 NO2 MIC log acitivity calculate describe text structure build molecule training test set 2103e2115 CoMSIA model also validate predictivity external dataset molecule statistical datum report table molecule exhibit large residual duce dataset alternate conformation qsar model regenerate statistical parameter comfa CoMSIA model obtain atom alignment well corresponding value model obtain alignment Table graphical analysis comfa CoMSIA contour map generate use scalar product coefcient standard deviation stdev COEFF set favored dis favor level respectively CoMFA CoMSIA con tour depict atom alignment model respectively comfa model equal steric electrostatic contribution activity electrostatic hydrophobicity contribution see dominate CoMSIA model qsar contour relation biolog ical activity molecule describe Figs CoMFA steric eld green contour favor substitu tion bulky group meta position phenyl phenyl moiety disfavor steric eld low contour see para position phenyl group also support CoMSIA steric contour addition disfavor steric CoMSIA contour also see meta0position phenyl residue comfa electrostatic contour depict electroposi tive group blue contour favor meta sition phenyl group meta para position phenyl group however electronegative group red contour meta0position phenyl moi ety likely increase activity CoMSIA electro static contour also favor electropositive group para position phenyl ring addi tion electronegative group para position phenyl group hydrophobic contour CoMSIA indicate desire undesired hydrophobic region phenyl ring hydrophobic group white contour cause activity decrease place posi tion phenyl ring meta0 para position phenyl ring small hydrophobic group yellow eld accept meta position phenyl ring bond donor eld absent CoMSIA model disfavor eld bond acceptor see red alignment dataset table statistic comfa CoMSIA model alignment Field alignment CoMFA CoMSIA CoMFA PLS statistic LOO LGO bootstrap component contribution 2103e2115 contour Fig vicinity carboxamide ortho meta position phenyl ring favor magenta contour find encapsulate para position phenyl ring new molecule design improved activity new molecule design basis contour map see active molecule Variations Table make phenyl ring meta position Modications Table also make carbamoyl group see molecule group type pyridyl pyridyl ring suit able substituent predict high activity correspondingly substitute phenyl ring molecule pyridyl ring bear nitro dimethylaminocarbonyl car bonyl methoxy great activity molecule unsubstituted pyridyl ring newly design molecule depict Table Conclusions title compound obtain use reac tion react acetoacetanilide derivative substitute urea methanol catalytic amount conc HCl synthesize compound show range antituber cular activity extend inhibition berculosis molecule align way atom method CoMFA carry map structural feature modulate inhibitory activity molecule comfa model generate atom alignment well term statistical parameter model Analysis comfa CoMSIA con tour provide detail ne relationship link structure activity offer clue structural modication improve activity Experimental Synthesis Melting point determine open glass capillary bath uncorrected NMR spectra record NMR spectropho use spectra record FAB Fast Atom Bombardment technique ionization thin layer chromatography perform gel 60F254 plate General method preparation phenylmethyloxophenyltetrahydro pyrimidinecarboxamide aldehyde mmol acetoaceta nilide mmol take methanol round bottom ask mixture reuxe min clear solution result drop conc HCl add solution reaction mixture reuxe water bath progress reaction mon itore reaction complete ask remove water bath allow cool room separate solid collect suction wash methanol recrystallize oxomethoxyphenyltetrahydro pyrimidinecarboxamide yield nmr dmso ppm nmr ppm Fig comfa contour molecule steric contour favor green disfavored yellow electrostatic contour electropositive blue electronegative red 2103e2115 Fig CoMSIA contour molecule steric contour favor green disfavored yellow electrostatic contour electropositive blue electronegative red hydrophobic contour favor yellow disfavor white donor contour favor cyan acceptor contour favor magenta disfavor purple disfavor red C21H23N3O3 find Dimethylphenylmethyloxo phenoxyphenyltetrahydropyrimidine carboxamide yield nmr dmso ppm nmr ppm Anal Calcd find Dimethylphenylmethyloxo phenoxyphenyltetrahydropyrimidine carboxamide yield nmr dmso ppm nmr ppm Anal Calcd find Chlorophenylmethyloxo nitrophenyltetrahydropyrimidine carboxamide 196e198 yield nmr CDCl3 ppm nmr ppm Anal Calcd find Dimethylphenylmethyloxo nitrophenyltetrahydropyrimidine carboxamide yield nmr dmso ppm nmr ppm Anal Calcd C20H20N4O4 find tetrahydropyrimidinecarboxamide 157e158 yield NMR CDCl3 ppm nmr ppm Anal Calcd find carboxamide 244e245 yield NMR CDCl3 ppm nmr ppm Anal Calcd find nitrophenyltetrahydropyrimidine carboxamide yield NMR CDCl3 ppm fig gure use explain comfa 2103e2115 nmr ppm Anal Calcd C18H14Cl2N4O4 find Dimethylphenylmethyloxo hydroxyphenyltetrahydropyrimidine carboxamide yield nmr dmso ppm 69e7 Table new molecule improved predict activity predict activity comfa predict activity comsia N001 NO2 eOCONHCH3 CH3 N003 eCOCH3 CH3 CH3 N005 eNHSO2CH3 CH3 N006 ecf3 CH3 also see table comparison 2103e2115 nmr ppm Anal Calcd C20H21N3O3 find hydroxyphenyltetrahydropyrimidine carboxamide 206e208 yield NMR CDCl3 ppm nmr ppm Anal Calcd find Chloroourophenylmethyloxo chlorophenyltetrahydropyrimidine carboxamide 270e272 yield nmr CDCl3 ppm nmr ppm Anal Calcd C18H15Cl2FN3O2 find nitrophenyltetrahydropyrimidine carboxamide 254e255 yield NMR CDCl3 ppm nmr ppm Anal Calcd C18H15FN4O4 find Dimethylphenylmethyloxo nitrophenyltetrahydropyrimidine carboxamide 254e256 yield nmr dmso ppm nmr ppm Anal Calcd C20H20N4O4 find Dimethylphenylmethyloxo nitrophenyltetrahydropyrimidine carboxamide yield nmr dmso ppm nmr ppm Anal Calcd C20H20N4O4 find carboxamide 245e246 yield nmr CDCl3 ppm nmr ppm Anal Calcd find Chloroourophenylmethyloxo nitrophenyltetrahydropyrimidine carboxamide 208e209 yield NMR CDCl3 ppm nmr ppm Anal Calcd C18H14ClFN4O3 find carboxamide 210e212 yield NMR CDCl3 ppm nmr ppm find chlorophenyltetrahydropyrimidine carboxamide 270e272 yield nmr CDCl3 ppm nmr ppm Anal Calcd C18H15ClFN3O2 find nitrophenyltetrahydropyrimidine carboxamide yield NMR CDCl3 ppm nmr ppm Anal Calcd C19H18N4O5 find carboxamide 210e212 yield NMR CDCl3 ppm nmr ppm Anal Calcd find carboxamide 210e212 yield NMR dmso ppm nmr ppm Anal Calcd C19H18N4O4 find carboxamide yield NMR CDCl3 ppm nmr ppm Anal Calcd C18H15FN4O4 find carboxamide yield nmr dmso ppm nmr ppm Anal Calcd C19H18 N4O4 find Chlorophenylmethyloxo chlorophenyltetrahydropyrimidine carboxamide 208e210 yield NMR CDCl3 ppm nmr ppm Anal Calcd C18H15Cl2N3O2 find Chlorophenylmethyloxo nitrophenyltetrahydropyrimidine carboxamide yield NMR CDCl3 ppm nmr ppm Anal Calcd find phenoxyphenyltetrahydropyrimidine carboxamide yield nmr dmso ppm nmr ppm Anal Calcd find tetrahydropyrimidinecarboxamide yield nmr CDCl3 ppm nmr ppm Anal Calcd find Dimethylphenylmethyloxo nitrophenyltetrahydropyrimidine carboxamide yield nmr dmso ppm nmr ppm Anal Calcd C20H20 N4O4 find oxonitrophenyltetrahydropyrimidine carboxamide yield nmr CDCl3 ppm nmr ppm Anal Calcd C18H14ClFN4O4 find activity activity determine use system modie describe Stock solution test compound prepare dimethylsulfoxide dmso sterilize passage lter Millex Millipore Bedford Fifty microliter add radiometric broth achieve receive dmso ical include positive drug con trol solubilize diluted dmso add broth achieve minimum inhibitory concentration low concentration inhibit inoculum tuberculosis strain ATCC American type culture collection cultured rotary shaker broth supplement glycerol Tween culture turbidity achieve optical density 45e0 Bacteria pellete centrifugation wash twice resuspend onefth original volume Dulbecoo phosphate buffer line Santa Ana large bacterial clump remove passage gene aliquot freeze culture thaw appropriate dilution perform vial inoculate reach growth index Onetenth dilute inoculum use inoculate fresh broth contain test compound additional control vial include receive dilute inoculum well dmso use calcu late rifampicin respectively establish procedure culture incubate Growth hibition determine control culture acheive Assays usually complete percentage inhibition dene test sample control Minimum inhibitory concen tration compound effect reduction change less observe luted control later reach least ment author thankful antitubercular screening try provide laboratory facility computational facility support RIDNPROJRPS 677e686 Frieden Sterling Tuberculosis fact Espinal Tuberculosis Rattan Kalia Ahmad Emerg Infect Dis Bodmer Zurcher Imboden Telenti Antimicrob Chemo ther 345e348 Clin Microbiol Rev 836e871 Nayyar Jain Stover Langhorne Yuan Baker Shaopei Keeler Patent Pathak Pant Srivastava Malvezzi 557e560 Fuller Bokesch Young Cardellina Kadushin Soejarto Lett Nolsoe Lett 1207e1219 Gundersen NissenMeyer Porretta Pompei Lett Massa Waisser Gregor Kubicova Klimesova Kunes Ubiali Pagani Pregnolato Terreni Lett Waisser Drazkova Kunes Farmaco Rosowsky Forsch Queener Med Chem Agarwal Srivastava Sinha Keller Lett 1755e1757 Froeyen Dugue Herdewijn Calenbergh Varu SYBYL Hanley Louis Spellmeyer Bookshelf Hanley Louis Sturzebecher Klebe Med Chem Wold PLSdPartial Least Squares Projec tion Latent structure qsar Drug Design Theory Methods Applications ESCOM Lieden aid 587e619 Politis Franzblau Antimicrob Agents Chemother 2103e2115",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Chintan": 1,
                    "CoMSIA": 22,
                    "Calanolide": 1,
                    "American": 1,
                    "Ubiali": 1,
                    "Terreni": 1,
                    "Farmaco": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "The chemistries and consequences of DNA and RNA methylation and demethylation.pdf",
            "cleaned_text": "full term condition access use find RNA Biology ISSN Print Online Journal homepage DNA RNA Methylation Thomas Carell cite article DNA RNA Methylation Demethylation RNA Biology link article accepted author version post online submit article journal View relate article datum Point View DNA RNA Methylation Chemistry receive Jan revise apr accept Apr Corresponding author Email franziskatraubecupunimuenchen Email ThomasCarellcupunimuenchen LMU MunichButenandtstr discovery desoxyadenine uracil information carry building block form basis rna dna various modification nucleoside discover Fig particularly trna also ribosomal rna modify basis central element need fine tune translation genetic code bacterial pathogen many methylated basis present block bind small molecule work translation inhibitor result resistance antibiotic aminoglycoside recently discover also messenger rna mrna contain modify basis yet fully understand function basis reveal modification chemistry extent reversible suggest modification modification chemistry novel yet unexplored regulatory function regard methylate adenine well analyze modification recently also reversible formation dimethyl adenine m6Am discover accord current knowledge reversible chemistry modify rna basis limited methyl group introduce methyltransferase remove demethylase DNA contrast prime carrier genetic information biosphere structurally less complex modify basis know prominent methylated base methyl deoxycytosine 5mdC Ideas potential chemistry methylation demethylation focus aspect follow excellent consult Fig example methylate oxidize basis find RNA DNA 5mdC abundant modify base genomic dna eukaryote also present DNA prokaryote mammal 5mdC typically reach global level typically genomic dna methylate adenine DNA equivalent m6A RNA dna modification intensive investigation moment wellcharacterized modification bacterial DNA13 presence recently show several high eukaryotic organism Caenorhabditis elegan 5mdC detectable dynamically regulate link epigenetic marks15 early embryo Drosophila melanogaster level high decrease fast development result low level adult tissue unicellular green alga Chlamydomonas reinhardtii discover gene mainly locate transcription start site recently report mammalian DNA include human mouse also contain seem distribute genome absent gene exon mouse embryonic stem cell mesc DNA show correlate ALKBH1 depletion finding question previous paradigm DNA modification mammalian genome limited cytosine residue however group try confirm result novel ultrasensitive method able detect mESC dna dna mouse tissue Chlamydomonas DNA serve positive control deliver expect positive result observation suggest present define time point mammalian dna epigenetic mark question relevant modification mammalian DNA thus certainly intensive investigation dna base methylation addition DNA rna basis catalyze dna rna methyltransferase use adenosylmethionine active donor methyltransferase methylate rna basis extensive investigation enzyme catalyze methylation dna well characterize mammalian cell active DNAmethyltransferases dnmt DNMT1 DNMT3a exist novo DNMTs methylate canonical basis contrast maintain methylation status cell division operate hemimethylated dna replication template strand already methylate newly synthesize strand lack methylation convert methylation inheritable modification transfer reproduction dnmt thus cytosine methylation essential multicellular organism exist presence absence associate various important cellular function transcription control chromosome silencing genomic imprint global deletion DNMTs lead severe cellular aberration therefore lethal early embryogenesis postnatal differentiation methylome highly dynamic celltypecharacteristic pattern establish process 5mdC locate CpGdinucleotide context majority somatic cell noncpg methylation also present embryonic stem cell many pluripotent progenitor cell adult brain however also dominate vertebrate occur type dna sequence context include repetitive regulatory sequence gene transposable element contrast invertebrate mostly repetitive sequence methylate majority cytosine depend cell type methylate leave call cpg island CGI actively transcribe gene unmethylated pattern cpg context region high cpg frequency length least base pair compare bulk genomic dna find promoter region mammalian genome even high level human genome symmetric methylation cpg GpC island consequently hallmark silence gene enzymatic mechanism methyltransferase methylate dna rna basis show certain nucleophilicity amino group RNA base attack coenzyme directly lead immediate methylation type direct methylation certainly operate formation 6m2A m6am SAM nature methyl iodide hence reactive enough methylate even weak nucleophilic center exocyclic amino group feature sp2hybridized atom weak nucleophilic lone pair atom type direct methylation create basis possess methyl group attach heteroatom establish hetCH3 system important context active demethylation vide infra contrast formation hetCH3 connection methylation base dna position far complex center feature nucleophilicity make direct methylation impossible Nature solve problem exploit helper nucleophile Fig dnmt enzyme attack base first nucleophilic thiol addition reaction establish nucleophilic enamine substructure green Fig subsequently methylate cofactor importantly helper nucleophile subsequently eliminate thereby establish aromatic system complex enzymatic transformation allow nature methylate carbon atom create CH3 connectivity feature strong stable single bond fig mechanism methylation lead formation hetch3 CH3 connectivity RNA DNA Chemistry Demethylation order establish reversibility need switch biochemical process nature require remove attach methyl group removal group find predominantly RNA find occur help ketoglutarate dependent oxidase protein contain reactive center react strongly oxidize specie oxygen concomitant decarboxylation succinate Fig specie able atom group form react bind hydroxylradical form hetch2 hemiaminalacetal functionality however structure unstable water decompose spontaneous reaction loss formaldehyde give unmethylated compound interesting formaldehyde form byproduct reaction typically rather toxic compound need see molecule detoxify context demethylation reaction particularly well study removal methyl group m6A revert canonical RNA base far dependent oxidase find catalyze oxidation fat mass obesityassociated protein FTO protein second show knockdown lead increase amount turn overexpression result decrease m6A level Alkbh5deficient mouse similar effect FTO knockdown human cell result increase m6A level mrna demethylation activity protein comparable show direct demethylation demethylation supposed create hm6A intermediate find also 5mdC enzymatically oxidize stepwise fashion give follow 5fdC carboxydesoxycytosine 5cadC Teneleven translocation TET enzyme fe2 dependent dioxygenase discover catalyze iterative 5mdC oxidation reaction regard first oxidation step transform fe2 catalyze reaction generate stable CH2 connectivity primary alcohol stable water Fig consequently stable dna base modification suggest base indeed epigenetic function example constitute nucleotide neuron special neural cell type cerebellum nucleotide embryonic stem cell high level fully differentiate tissue find brain cytosine evidence accumulate give gene able accelerate transcription surprising mainly present promoter actively transcribe gene TET enzyme sense require orchestrate transcriptional activity gene vertebrate tet protein exist different type TET differ regard chemistry seem different spatiotemporal activity mostly express stem cell TET3 upregulate differentiation abundant TET enzyme fully differentiate cell global TET3knockout lethal embryogenesis prevent epigenetic reprogramming differentiation interesting presence mammalian DNA describe first already take confirm really present substantial amount highly depend cell Fig oxidation m6A follow decomposition hemiaminal oxidation 5mdC stable oxidize basis especially 5cadC Fig associate yet distinct cellular function 5fdC report regulatory purpose also stable epigenetic mark accordance previous finding recently report singlecell 5fdcsequence method call CLEVERseq reveal generation 5fdC promoter region precede upregulation gene expression faint evidence epigenetic function 5fdC currently mainly consider intermediate way active dna demethylation process dna demethylation crucial process cell development especially fertilization paternal part genome early embryogenesis maternal part genome development germ cell dna demethylation take place genomewide manner allow broad reprogramming fertilize oocyte cell early embryo development also fully differentiate cell occur specific site genome brain example locusspecific dna demethylation novo methylation induce neural activation argue dna demethylation important normal brain function include memory formation learn dna demethylation take place actively mean passively methylate nascent DNA strand hemimethylated dna replication passive demethylation occur absent block replication process happen example early embryogenesis ensure demethylation maternal genome interestingly demethylation Drosophila catalyze TET homologue DMAD dTet DMAD depletion result high level unchanged 5mdC pattern lethal pupa stage shortly TET possess similar catalytic active DSBH domain however activity observe yet mammalian TET enzyme oxidation 5fdC 5cadC create stable molecule due lack het atom position discuss turn unstable structure chemical manipulation chemically attractive mechanism require 5fdC 5cadC attack helper nucleophile preferentially thiol group position reaction fig Hydratization 5fdC tautomerization react 5fdC 5cadC allow formulate iminotype substructure prone deformylation decarboxylation red arrow indeed show reaction 5fdC 5cadC lead spontaneous deformylation decarboxylation show suggest chemistry feasible currently evidence type chemistry occur vivo show stem cell lysate feature decarboxylate activity interesting observation deformylation decarboxylation 5fdC 5cadC reaction thiol nucleophile lead reaction intermediate box key intermediate observe already methylation 5mdC DNMTs therefore tempting speculate dnmt enzyme involve deformylation decarboxylation maybe follow immediate methylation reaction sequence follow chemical logic need clarify near future reaction occur indeed nature however show indeed able remove formaldehyde convert directly therefore support idea potential mechanism chemically induce active demethylation potential immediate methylation context interesting note 5hmC 5fC also discover rna human cell trna position C34 oxidation corresponding RNA base 5mrC 5frC catalyze fe2 dependent enzyme ALKBH1 also responsible m1a demethylation mammalian interestingly 5hmrC detect intermediate dependent 5mrC oxidation Drosophila 5hmrC discover polyadenylate rna associate enhanced mrnatranslation efficiency back normal level 5mrC lower efficiency surprisingly oxidation reaction catalyze TET homologue also responsible demethylation oxidize 5mdC moreover evidence TET enzyme also responsible 5mrC oxidation73 moment clear TETmediated 5hmrC formation stable rather transient modification contrast chemical mechanism active demethylation discuss strong evidence exist active demethylation formation 5fdC 5cadC also link base excision repair repair also mismatch cause deamination 5hmdU Fig mechanism include excision 5dfC ore subsequent activation BER mismatch specific thymine dna glycosylase recognize mismatch even high activity excise 5mdC reactivity observe dna glycosylase evidence excise 5fdC 5cadC also vivo give fact 5fdC level time increase cell compare wildtype however demethylation unlikely demethylation mechanism rather occur define promoter region genome genomewide manner cause abasic site happen genomewide impair genomic stability crucial correct development Second TDG knockout start lethal embryonic day level low zygote paternal genome demethylated active demethylation base excision repair possibility discuss direct removal 5fdC 5cadC xdC base pair removal deaminate 5hmdU mismatch BER glycosylase recently suggest nature need oxidize 5mdC 5fdC 5cadC demethylation third pathway exist zygote drastic demethylation occur 5mdC globally erase paternal part genome maternal part shield demethylation paternal pronuclei replication level increase level drop global demethylation detect Tet3deficient zygote deamination genomic subsequent mismatch repair mechanism observation however also impair genomic stability implication misguide methylation demethylation distribution tightly regulated ensure anticipated functionality cell response dna damage hallmark cancer cell completely different methylation hydroxylmethylation pattern many cancer type global methylation level decrease promoter region important regulatory tumor suppressor gene hypermethylate therefore silence example hypermethylation promoter region transcriptional repressor SIRT1 survival protein protooncogene consequently upregulate also show certain coordinately methylate tumor cell call phenotype initially discover fusion protein MLL1 methyltransferase patient acute lymphoblastic leukemia characterize mutation MLL1 protein consider oncogene biological function TET enzyme elucidate prove TET enzyme actually tumor suppressor silence various type tumor decrease level activity TET1 therefore reduce hmdC level associate hematopoietic malignancy colon breast prostate liver lung cancer show great level proliferation breast cancer increase invasion rate direct consequence TET1 downregulation TET2 mutation consequently decrease level occur various myeloid malignancy include chronic myelomonocytic leukemia myeloid proliferative neoplasm acute myeloid leukemia mutation gene isocitrate dehydrogenase IDH lead production hydroxyglutarate 2HG metabolite inhibit TET2 activity example also malignant glioma result dramatic decrease level interestingly TET2 mutation seem mutually exclusive type tumor mutation one high oncogenic potential recent result show mutation TET gene inhibition cancer metabolite important tumorigenesis also tumor hypoxia responsible reduce TET activity evidence epigenetic metabolism closely connect cancer metabolism also normal cell intermediate tricitric acid TCA cycle part nitrogen catabolism deamination glutamate key metabolite substrate TET enzyme dioxygenase involve epigenetic regulation histone lysine demethylase link epigenetic directly metabolism level rate limit TET activity high level result high TET activity direct impact differentiation process depend cell type status promote selfrenewal induce differentiation brown adipose tissue BAT development example TET3 mediate cell commitment brown adipose tissue demethylate Prdm16 promoter activate protein kinase AMPK1 influence level positively increase TET activity therefore mediate cell commitment brown adipose tissue Glutamate glutamine metabolism increase level lead selfrenewal pluripotent mouse embryonic stem cell succinate supply lead differentiation additionally succinate also fumarate intermediate cycle show inhibitory effect TET enzyme vitro future challenge prove existence reveal distinct biological function various dna rna modification exist role modify basis mrna currently extensive investigation DNA especially function regulatory learning process brain also development cancer cell great interest ment thank PhD fellowship thank financial support program sfb support Excellence Cluster CiPSM Center Integrated Protein Science regulatory function dna modification methylcytosine Nucleic Acid Modifications Regulation Gene Expression Cell Chem Biol modification regulation gene expression focus trna Montanaro importance slightly modify role edit gene expression control connection cancer Sloan tune ribosome influence modification eukaryotic ribosome biogenesis function RNA Biol Yacoubi Bailly CrecyLagard Biosynthesis function posttranscriptional modification transfer rnas Annu Rev Genet Lioy Goussard resistance methyltransferase block endogenous methylation affect translation efficiency fitness host rna Methylcytosine Eukaryotic DNA Science Haase Gupta Benes Genomics DNA cytosine methylation Escherichia coli reveal role stationary phase transcription Ljungdahl DNA methylation thermophylic bacteria methylcytosine methylcytosine methyladenine GamaSosa distribution methylcytosine human DNA different type tissue cell Koch Tissue distribution hydroxymethylcytosine search active demethylation intermediate e15367 Costa methylate deoxyadenosine vertebrate reveal diversity dna modification abundant DNA methylation early embryogenesis zebrafish pig AristizabalCorrales DNA elegan cell modification Drosophila cell active transcription start site Chlamydomonas Cell DNA methylation adenine mammalian embryonic stem cell Nature Costa methylate deoxyadenosine vertebrate reveal diversity dna modification Rahimoff Genome Mouse Embryonic Stem Cells Tissues Angewandte Chemie International Edition DNA cytosine methyltransferase Mechanism human methyldirected dna methyltransferase fidelity cytosine methylation nucleoside tRNA trna methyltransferase Bestor Laudano Mattaliano Ingram Cloning sequence cdna encoding DNA Cells Journal Molecular Biology cloning characterization family novel mammalian DNA cytosine methyltransferase DNA dnmt3b essential Novo Methylation Mammalian Development Cell Pradhan Recombinant Human DNA Cytosine Methyltransferase Klose Bird Genomic DNA methylation mark mediator Trends Biochem Sci interaction replication machinery require maintenance dna methylation human cell Cell Biol Bestor Jaenisch Targeted mutation DNA methyltransferase gene result embryonic lethality cell Burger Scholer dnabinding factor shape mouse methylome distal regulatory region Nature Ramsahoye Biniszkiewicz NonCpG methylation prevalent embryonic stem cell mediate dna methyltransferase lister Hawkins Hon Human DNA methylomes base resolution show widespread epigenomic difference Nature analyse sequence parentorigin dependent dna methylation mouse genome cell DNA methylation landscape provocative insight epigenomic bird Macleod fraction mouse genome derive island nonmethylate DNA cell Bird CpGrich island function dna methylation nature cpg island gene human mouse mammalian promoter use dna methyltransferase reveal nucleosome position single molecule level dna methylation inhibit transcription indirectly methylcpg bind protein cell Feng DNA methylation repress transcription vivo Wong ECY Methyladenosine conformational marker regulate substrate specificity human demethylase methyladenosine nuclear RNA major substrate obesityassociated Niu Fedorcsak mammalian RNA demethylase impact rna metabolism mouse fertility Mol Cell Pastor Conversion methylcytosine hydroxymethylcytosine mammalian DNA partner TET1 Science Swenberg Tet protein convert methylcytosine formylcytosine carboxylcytosine Science nuclear dna base hydroxymethylcytosine present neuron brain science UribeLewis predominantly stable dna modification Pfaffeneder Age dependent level methyl hydroxymethyl formylcytosine human mouse brain tissue bind 5hmC enrich active gene accessible chromatin nervous system cell Laube TET3 recruit rest induction gene expression Cell Rep Costa Hore NANOGdependent function TET2 establishment pluripotency nature Rao Nardone Regulate Hydroxymethylcytosine Production Cell Lineage Specification Mouse Embryonic Stem Cells Cell Stem cell sensitive enzymatic quantification hydroxymethylcytosine genomic DNA e181 role dna dioxygenase epigenetic reprogramming oocyte nature presence hydroxymethylcytosine animal deoxyribonucleic acid Koch Tissue distribution hydroxymethylcytosine search active demethylation intermediate e15367 UribeLewis stable dna modification mammal Song Formylcytosine Landscapes Mammalian Early Embryos SingleBase Resolution Cell Stem Cell Mayer demethylation zygotic paternal genome Nature active demethylation paternal genome mouse zygote Current Biology Epigenetic Reprogramming Plant Animal Development Science epigenetic event mammalian germcell development reprogramming neuronal activity modify DNA methylation landscape adult brain Morris Monteggia role dna methylation dna methyltransferase learn memory Dialogues Clinical Neuroscience promote epigenetic dna Adult Neurogenesis science conceptual link dna methylation reprogramme early embryo primordial germ cell current Opinion Cell Biology Pfaffeneder Mller Hagemeier Truss Mechanism stemcell activity carboxycytosine decarboxylation determine isotope trace methyltransferase add aldehydes dna Nat Chem Biol NSUN3 ABH1 modify wobble position expand codon recognition mitochondrial translation alkbh1mediate trna Demethylation regulate translation cell e16 distribution function rna hydroxymethylcytosine science formation hydroxymethylcytosine existence hydroxymethylcytosine formylcytosine DNA rna mammal Thymine DNA glycosylase rapidly excise formylcytosine carboxylcytosine potential implication active demethylation cpg site Tetmediated formation carboxylcytosine excision mammalian DNA Science Arab DNA glycosylase promote substrate turnover Tdg dna demethylation Cortellino Sannai Moore Caretti Cigliano Thymine DNA glycosylase essential active dna demethylation link repair cell Embryonic lethal phenotype reveal function maintain epigenetic stability Nature Amouroux Nashun novo dna methylation drive accumulation mouse zygote Nat Cell Biol Burgess Rada Reik Dean active demethylation mouse zygote involve cytosine deamination base excision repair Impaired hydroxylation methylcytosine myeloid cancer mutant TET2 epigenomic cancer cell regulate SIRT1 Modulate p53Dependent dnadamage Responses cell Toyota cpg island methylator phenotype colorectal cancer Proceedings cpg island methylator phenotype underlie sporadic microsatellite instability tightly associate BRAF mutation colorectal cancer island methylator phenotype cancer cancer CXXC Domain fuse Acute Myeloid Leukemia development associate decrease TET gene expression methylcytosine hydroxylation Krepelova TET1 tumour suppressor inhibit colon cancer growth derepresse inhibitor pathway Suppresses Cancer Invasion activate tissue Inhibitors Metalloproteinases Cell report Decrease hydroxymethylcytosine associate progression hepatocellular carcinoma downregulation TET1 PLoS e62828 Langemeijer SMC Kuiper Aslanyan acquire mutation TET2 common myelodysplastic syndrome TET2 mutation peripheral cell lymphoma correlate TFHlike feature adverse clinical parameter blood Wang Hydroxyglutarate Competitive Inhibitor KetoglutarateDependent Dioxygenases cancer cell Roles TET2 mutation myeloid disorder role mutation epigenetic regulator myeloid malignancy cancer Anna tumour hypoxia cause dna hypermethylation reduce TET activity nature tetcatalyze methylcytosine hydroxylation dynamically regulate metabolite cell res epigenetic modifier elicit epithelialmesenchymal transition Nature Intracellular alphaketoglutarate maintain pluripotency embryonic stem cell Nature TeSlaa Chaikovsky Lipchina Escobar Hochedlinger alpha accelerate Initial Differentiation prime Human Pluripotent Stem Cells Cell Metab AMPKalphaKetoglutarate Axis Dynamically Mediates dna Demethylation Prdm16 Promoter Brown Adipogenesis Cell Metab Cao succinate Regulate Expression Hypoxiainducible Genes TET",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 40,
                    "demethylation": 36,
                    "epigenetic": 15
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "hetCH3": 3,
                    "ABH1": 1,
                    "Arab": 1,
                    "TFHlike": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "hetCH3": 91,
                    "ABH1": 91,
                    "Arab": 91,
                    "TFHlike": 91
                },
                "Ethnographic Terms": {
                    "methylation": 6,
                    "demethylation": 6,
                    "epigenetic": 6
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "The expression of spinal methyl-CpG-binding protein 2_ DNA methyltransferases and histone deacetylases is modulated in persistent pain states.pdf",
            "cleaned_text": "research Open Access expression spinal methylcpgbinde protein dna methyltransferase histone deacetylase modulate persistent pain state Background dna cpg methylation carry dna methyltransferase induce chromatin remodeling gene silence transcription repressor complex comprise methylcpgbinde protein mecp2 subset histone deacetylase recently find activity crucial role pattern gene expression see superficial dorsal horn rapidly injection rat ankle joint aim present study analyse change expression dna methyltransferase subset histone deacetylase superficial dorsal horn maintenance phase persistent pain state process cell specific expression also investigate result use immunohistochemistry find neurone oligodendrocyte astrocyte express mecp2 Microglia oligodendrocyte precursor cell cell never show positive stain MeCP2 Quantitative analysis show expression increase superficial dorsal horn day follow injection ankle joint decrease follow spare nerve injury overall expression dna methyltransferase subset histone deacetylase follow pattern expression however significant change expression target previously show regulate early time point follow injection ankle joint finally expression also regulate damage dorsal root ganglion neurone follow spare nerve injury conclusion result strongly suggest change chromatin compaction regulate bind mecp2 complex methylate dna involve modulation gene expression superficial dorsal horn dorsal root ganglia maintenance persistent pain state Spinal nerve injury inflammation chronic pain dna methyltransferase deacetylase background induction maintenance persistent pain state inflammatory neuropathic involve number change gene expression dorsal root ganglia drg spinal cord Regula tion gene expression achieve DNA cpg methylation process implement dna methyl transferase dnmts dna methylation induce chroma tin remodeling gene silence transcriptional repressor complex comprise Methyl CpGbinding protein MeCP2 subset histone deacetylase hdac recently find activity crucial role pattern gene expression see superficial dorsal horn follow injection Complete Freund adjuvant CFA rat ankle joint rapid increase expression correspondence ucgasmgucl Contributed equally Department Cell WC1E Tochiki Molecular Pain MOLECULAR PAIN licensee article distribute term permit unrestricted use distribution reproduction medium provide original work properly cite family gene transcriptional control MeCP2 occur follow injection include serum glucocorticoid regulated kinase SGK1 bind protein FKBP5 glucocorticoid recep torregulate chaperone family phenolpreferre member SULT1A1 crucially find support induction ankle joint inflammation indicate key role control epigenetic mechanism induction persistent pain state pattern dna methylation establish maintain dnmt process gen erally regard fairly stable event adult animal recent evidence suggest dynamically regulate adult nervous system crucial synaptic plasticity memory formation pain processing memory formation share number mechanism dependent synaptic plasticity likely dna methylation therefore DNMT activity regulate devel opment longterm pain state HDAC expression similarly likely change longterm pain state indeed HDACs contribute chromatin compaction remove acetyl group histone tail allow interaction DNA backbone other show subset HDACs regulate shortterm thermal hyperalgesia develop injection hindpaw focus interest specific HDAC isoform namely HDAC know part repre sor complex HDAC isoform exhibit great change spinal cord injection CFA hindpaw present study analyse expression level MeCP2 dnmt HDACs model sistent pain states ankle joint inflammation induce spare nerve injury SNI Changes mrna expression analyse initial insult time point mechanical hyperalgesia stable additionally investigate cell specificity mecp2 expression superficial dorsal horn role induction pain state far investigate neurone recent study show express subset glial cell consider key role glia development chronic pain state specifically astrocyte microglia potential role glial mecp2 need examine result cell specific expression superficial dorsal horn neuronal glial expression inve tigate superficial dorsal horn animal undergo surgery day perfusion animal receive injection ankle joint perfusion sham animal group neurone antineuronal nucleus NeuN positive cell express condi tion figure expression glial cell low level oligodendrocyte positive cell Figure astrocyte antiglial positive cell Figure express saturate signal neuronal mecp2 ever microglia calciumbinding adaptor molecule positive cell oligodendrocyte precursor cell OPCs NG2 positive cell never show mecp2 stain figure respectively expression increase superficial dorsal horn day post injection ankle joint expression superficial dorsal horn analyse use qpcr mecp2 isoform generate alternative splicing duce protein differ termini mecp2 transcript express almost ubiquitously high expression isoform brain mecp2 isoform investigate use specific primer find bilateral increase mecp2 unilateral increase MeCP2 contral ateral side post injection Figure Table investigate expression gene find control superficial dorsal horn shortly injection ankle joint find significant change SGK1 FKBP5 SULT1a1 expression Figure Table mecp2 expression decrease superficial dorsal horn day post surgery decrease ipsilaterally follow surgery significant change expression mecp2 target gene Figure Table expression level dnmt HDACs superficial dorsal horn parallel mecp2 post injection ankle joint surgery change mecp2 expression superficial dorsal horn likely indication change chro matin compaction ask expression level DNMT1 DNMT3a DNMT3b subset HDACs HDAC1 also modu late persistent pain state find expression pattern dnmt HDACs mirror overall bilateral regulation follow injection ankle joint Pain page ipsilateral downregulation follow surgery figure respectively Table mecp2 expression neurone day post surgery peripheral nerve damage show reduce mecp2 expression dorsal horn wanted know effect nerve transection mecp2 neuronal level drg hypothesis decrease injured neurone allow regulation gene expression require regeneration mecp2 expression analyse section stain marker damage follow surgery figure measure expression DRG section animal cell section animal find expression small large fiber decrease positive neurone compare negative neurone small fiber large fiber Figure finally express subset glial cell superficial dorsal horn analyse MeCP2 expres sion cell find cell S100 positive cell express figure discussion present study show mrna level MeCP2 dnmt subset HDACs modu late superficial dorsal horn persistent pain state suggest state chromatin com paction regulate maintenance phase chronic pain state also look cell specificity expression find express neurone nonneuronal cell specifically astrocyte oligodendrocyte much low level however change mecp2 expression measure qpcr therefore attributa ble specific cell type cell specific expression cell specificity mecp2 expression source controversy number study find express glial cell recent study clearly show expression astrocyte OPCs oligodendrocyte microglia Authors study suggest discrepancy previous report due use different primary antibody different immunohistochemical methodology clearly choice antibody crucial importance find antimecp2 antibody indeed lead false positive staining see method section present study stain rat spinal cord tissue commercial antibody Millipore successfully use other show expression glial cell mouse brain tissue also apply amplification method reveal expres sion protein low level condi tion find express astrocyte oligodendrocyte much low level neurone however failed confirm expression mecp2 opc microglia consider other clearly show level mecp2 microglia brain even lower level expression microglia spinal cord detectable present condition mecp2 expression level indeed report show important regional varia tion therefore also explain neun MeCP2 NeuN Figure neurone express rat superficial dorsal horn confocal image rat superficial dorsal horn section Colocalization green Millipore antibody NeuN red MeCP2 see nucleus neurone arrow however mecp2 stain clearly nonneuronal arrow heads Pictures show single focal plane scale bar Molecular Pain page find OPCs other report similar level expression cell type brain Changes mecp2 DNMT HDAC expression maintenance phase persistent pain state regardless cell type observe significant change MeCP2 phosphorylation spinal cord day follow injection ankle joint surgery datum show find significant change level expression regulate model inflammation clear downregulation neuropathic model change parallel dnmt subset HDACs pattern dna methylation establish maintain dnmt maintenance dnmt ensure methylation pattern copy faith fully cell division Figure mecp2 express oligodendrocyte astrocyte microglia oligodendrocyte precursor cell rat superficial dorsal horn confocal image rat superficial dorsal horn section Colocalization green Millipore antibody red MeCP2 see nucleus oligodendrocyte Colocalization mecp2 green Millipore antibody GFAP red DAPI nuclear marker blue see nucleus astrocytes Expression mecp2 green Millipore antibody red mecp2 stain see microglia Expression MeCP2 green Millipore antibody NG2 red DAPI nuclear marker blue mecp2 stain see OPCs Pictures show single focal plane scale bar Molecular Pain page regulate novo DNA methylation response environmental factor regulation expression together regulation mecp2 subset HDACs suggest increase chromatin compaction therefore overall downregulation gene expression indeed find previous microarray study majority regulated gene superficial dor sal horn day follow injection ankle joint remarkably also show injection ankle joint gene transcription globally upregulate expression mecp2 dnmt subset hdac decrease downregulation mecp2 dnmt HDACs day follow also indicate overall regulation gene expression maintenance phase persistent pain model number microarray study look change gene expression neuropathic pain model many focus drg investigate superficial dorsal horn classify regulated gene however show majority regulate gene follow transection support present finding remarkably change epigenetic mediator superficial dorsal horn bilateral model joint inflammation surprising many study report contralateral effect arthritis model poorly understand neurogenic mechanism believe central development main tenance contralateral effect specifically model induce joint inflammation symme try joint involvement see contralateral sensory nerve show alter function prior evident sign inflammation observation explain bilateral change epigenetic mediator see present study hdac5 hdac1 hdac2 hdac5 FKBP5 sgk1 FKBP5 sgk1 sult1a1 dnmt1 dnmt3a2 dnmt3b dnmt3a2 dnmt3b sham ipsi sham joint target gene ankle joint SNI mrna expression level normalize sham mrna expression level normalize sham mrna expression level normalize sham mrna expression level normalize sham Figure Expression mecp2 dnmt hdac increase follow injection ankle joint decrease follow surgery expression downstream target dnmt HDACs quantify qpcr axis represent mrna expression percentage control sham animal datum show mean SEM sham contra sham ipsi ipsi contra group group Pain page change mecp2 expression report indi cate likely involve regula tion gene responsible sustain increase level hypersensitivity maintenance sistent pain state however post injection postSNI significant change expression target modulate onset induce ankle inflammation result suggest even mechani cal hyperalgesia reach steady level combina tion gene express course persistent pain state highly specific pain model time point study finally study first look MeCP2 expres sion drg find level decrease positive neurone SNI MeCP2 therefore probably contribute large change gene expression see drg surgery well neuropathic pain model permit expression regeneration associate gene dnmt inhibitor HDAC inhibitor regulation inflammatory pain state result show dnmt HDAC mRNAs regulate superficial dorsal horn day follow ing CFA injection ankle joint raise possi bility dnmt HDAC inhibitor reduce longterm increase sensitivity induce pre vious study show intrathecal injection larine DNA methylation inhibitor form covalent complex DNA methyltransferase reduce pain sen sitivity administer shortly injection however alleviation hypersensitivity short live inefficient reduce pain sensitivity give HDAC inhibitor also show provide analgesia model hindpaw inflammation effect longterm unknown possibility dnmt HDAC inhibitor reduce sensitivity induce CFA injection ankle joint also remain explore Table Primers sequence qpcr result qpcr analysis mrna primer sequence CFA SNI Ispi Sham Contra ccttcttaaacttcaggggtttc gggctgtcttgtatgagatgc ggagtgtgtgaaagagaaa tagccttcctcagacaat DNMT3a actgagaatttgccatct DNMT3b ggagacagcagacatctt gtcactacagttcccattaac HDAC1 cctcaccgaatccgaatg cgaatagaacgcaagaacttg HDAC2 tcaagtttctacgatcaataagg cttctccgacattaaatctctg HDAC5 aagtacgttcaaggctaa cgactgctctcttcttaa Actin agattactgccctggctccta aggacctctcgaagtgttggatac tgtagattcaacttgccgctgtc significant group group Pain page MeCP2 glia datum show change mecp2 expression superficial dorsal horn determine cell type change occur expression level much great neurone glia expect change reflect neuronal expression level sup port previous study show change MeCP2 phosphorylation specifically neurone superficial dorsal horn injection ankle joint however change MeCP2 expres sion level also due large change astrocytic level recently report change dna methylation seem occur microglia astrocyte glial MeCP2 seem crucial normal CNS function syndrome chromosome link aut ism spectrum disorder cause mutation gene encode recently disease attribu te loss mecp2 function neuron however new study challenge assumption show deficient glia cause abnormal itie neighbouring neurone strongly suggest glia role progression syndrome expression DRGs ATF3 ATF3 small fiber large fiber mecp2 expression level normalize expression level negative cell animal mecp2 S100 cell MeCP2 S100 DAPI Figure mecp2 expression reduce damage neuron follow SNI surgery image DRG section follow surgery Colocalization green Millipore antibody red neurone Arrow indicate neurone express bar measure mecp2 expression positive neuron use confocal microscopy mecp2 expression quantify measure staining intensity normalize mecp2 expression negative cell subgroup small large fiber cell body diameter confocal image rat dorsal root ganglion section Expression mecp2 green Millipore antibody S100 red DAPI nuclear marker blue Pictures show single focal plane scale bar Pain page consider importance glia development chronic pain state role spinal astrocytic mecp2 pain state require exami nation crucial experiment find astrocytic gene regulate mecp2 con tribute persistent pain state conclusion result clearly show DNMT HDAC level modulate superficial dorsal horn maintenance phase persistent pain state therefore highly likely change dna methylation chromatin compaction contribute regulation pattern gene expression responsible nance longterm pain state finally express neurone also subset glial cell crucial investigate role chronic pain state especially astrocyte method subject procedure comply rat Col lege use experiment Ani mal keep home cage relative humidity lightdark cycle light food water provide libi tum effort make minimise animal suffering reduce number animal use Antibodies drug begin study use antibody expect specific nuclear stain observe clear label astrocytic cyto plasm rat superficial dorsal horn figure order ascertain validity stain use tis sue universal mecp2 knockout animal gift find antibody use also label astrocyticlike process dorsal horn mouse Figure suggest nonspecific stain contrast anti body direct purchase Millipore show specific nuclear stain wildtype animal figure 5B3 antibody therefore use rest study purchase M6818 terminus Millipore Cat terminus AntiNG2 obtain antineuronal nucleus antiglial antis100 Z0334 respectively anti ionized calciumbinding adaptor molecule IBa1 anti diamidinophenylindole D1306 antiactivating ogy cat complete Freund adjuvant CFA purchase joint inflammation inflammation induce injection Poole left ankle joint halothane anaesthesia induce close chamber deliver halothane combine antibody animal antibody Millipore MeCP2 animal mecp2 antibody Millipore animal figure mecp2 antibody wrongly label astrocytic process superficial dorsal horn Colocalization mecp2 green antibody astrocyte red superficial dorsal horn nave rat Images dorsal horn section knock animal gift Bird stain antimecp2 antibody horn wild type animal C57BL stain Millipore antimecp2 antibody Scale bar Molecular Pain page min maintain injection delivery face mask halothane combine min needle enter ankle joint anterior lateral position ankle keep plantaflexion open joint treatment consist anaesthetize animal spare nerve injury surgery spare nerve injury perform describe isoflurane anaesthesia bicep femoris muscle expose section expose sciatic nerve terminal branch sural common peroneal tibial nerve com mon peroneal tibial nerve tightly ligate silk section distal ligation Care take avoid touch stretch spare sural nerve sham surgery sciatic nerve expose describe contact make nerve immunohistochemistry immunohistochemistry rat deeply tize pentobarbital day injection SNI surgery relevant sham surgery perfuse transcar dially saline contain heparin fol low paraformaldehyde PFA phosphate buffer adult rat lumbar spinal cord dorsal root ganglia drg dissect postfixed solution transfer sucrose solution contain azide minimum spinal cord drg cut freezing micro tome set Sections leave incubate antimecp2 anti body Antirabbit biotinylate secondary antibody use concentration leave min sample incubate avidin biotin complex vectastain vectastain min fol low signal amplification step biotinylated tyramide solution min finally section incubate FITC avidin double labelling section leave room temperature second primary anti body antiatf3 direct secondary use concentration Alexa section double label also use nuclear marker dole DAPI third stain DAPI add final wash section coverslippe Poole protect fluorescence fade store dark box control immunohisto chemistry include omit first second primary antibody immunohistochemical experiment repeat animal minimum treatment set double stain real time reverse transcriptase polymerase chain reaction qpcr assay Tissue collection rna preparation tissue collection animal terminally tize injection sham surgery spinal cord segment correspond lumbar area rapidly remove ipsilat eral contralateral dorsal horn quadrant dis secte frozen dry ice sample store process total rna extract homogenize dorsal quadrant use acid phenol extraction method reagent rneasy minicolumn rna tion calculate A260 value give sample show satisfactory quality use qpcr qpcr rna sample treat ley Equal amount total rna reverse transcribe use random nonamer Poole oligo primer Promega Superscript III Invitrogen Carlsband total reaction volume cdnas immediately quantify realtime PCR keep experiment Realtime pcr reaction perform DNA use QuantiTect SYBR Green PCR Qiagen genespecific primer see table primer sequence cdna dilute H20 amplify threestep cycling program final reaction volume Control cdna sample obtain transcriptase always include well sample cdna template efficiency pcr calculate gene use serial dilution reaction form triplicate minimum threshold cycle value normalize Actin CFA experiment hypoxanthine guanine phosphoribosyl transferase HGPRT SNI experiment gene expression specifi city product determine melting curve analysis ratio relative expression target gene Actin HGPRT calculate use formula gene expression ipsi contralateral side express centage expression sham animal mean expression sham animal arbitrarily give value expression level single sample calculate accordingly Pain page Confocal microscopy image double stain tissue acquire confocal microscopy use laser scan microscope describe sition processing perform Adobe Illustrator Quantitative analysis mecp2 expression DRG section use confocal microscopy measure mecp2 expression positive negative neu ron gain laser strength set beginning experiment fix datum collection Representative area cell population section select scan cell body corresponding nucleus analyse mea sure staining intensity intensity stain cell nucleus record arbitrary unit area cell body nucleus note staining status cell posi tive negative datum ipsilateral section process individually animal value relative total mecp2 content neuronal nucleus calculate multiply mean inten sity mecp2 immunofluorescence nucleus area nucleus nerve cell measure classify small fibre cell body diameter large fibre neuron subdivide group depend cell stain positive negative group small large fibre expression positive fibre express percentage negative fibre mean expression negative fibre give value expression level nucleus calculate accordingly statistical data analysis statistical test perform SPSS statis tic analyse qpcr datum run first eat analysis pain model gene validate use sample analyse con firm treatment effect analysis follow univariate test analyse specific gene LSD posthoc analysis analyse mecp2 expression positive neurone datum use always analyse present figure Abbreviations apc adenomatosis complete Freund adjuvant DNMT dna methyl transferase dorsal root ganglion FKBP5 bind protein gfap HDAC histone deacetylase molecule knockout mecp2 methylcpgbinde protein oligodendrocyte precursor cell SGK1 serum glucocorticoid regulated kinase spare nerve injury SULT1A1 sulfotransferase family phenolpreferre member ment work support grant number author like thank MeCP2 knock mouse tissue author contribution conceive design perform experiment analyse datum perform experiment author contribute writing manuscript approve final manuscript Competing interest author declare compete interest receive accept publish February coupling gene chip analysis rat genetic variance identify potential target gene contribute neuropathic allodynia development differential regulation immune response macrophageneuron interaction dorsal root ganglion young adult rat follow nerve injury Mol Pain identification gene expression profile dorsal root ganglion rat peripheral axotomy model neuropathic pain Iadarola peripheral inflammation increase scya2 expression sensory ganglia cytokine endothelial relate gene expression inflame tissue role transcriptional repressor methylcpgbinde protein plasticityrelated gene serum glucocorticoidinducible kinase induction inflammatory pain state Neurosci complement induction spinal cord microglia result anaphylatoxin C5amediated pain hypersensitivity Neurosci LacroixFralish differential spinal cord gene expression rodent model radicular neuropathic pain anesthesiology transcriptional repression methylcpgbinde protein mecp2 involve histone deacetylase complex Nature day sweatt dna methylation memory formation inhibition class histone deacetylase spinal cord attenuate inflammatory hyperalgesia Mol Pain Stuart Hunt injury induce activation extracellular signalregulate kinase ERK rat rostral ventromedial medulla RVM age dependant require lamina projection pathway Mol Pain spare nerve injury animal model persistent peripheral neuropathic pain pain descend serotonergic control regulate inflammationinduced mechanical sensitivity methylcpgbinde protein phosphorylation rat superficial dorsal horn Mol Pain Mandel autonomous influence MeCP2deficient glia neuronal dendritic morphology Harvey LaSalle Jin syndrome astrocyte abnormal spread mecp2 deficiency gap junction Neurosci Tochiki Molecular Pain page syndrome microglia damage dendrite synapsis elevated release glutamate Neurosci transcriptional repressor cause syndrome express embryonic nonneuronal cell control growth Brain Res Dev Brain Res Kerr express histoneoctamer level globally alter chromatin state glial cell chronic pain neuroscientist pathological protective role glia chronic pain targeting astrocyte signal chronic pain Neurotherapeutics spinal astrocyte therapeutic target pathological pain spinal astrocyte pain processing nonneuronal cell therapeutic target Coull bdnf microglia cause shift neuronal anion gradient underlie neuropathic pain nature change face microglia science Smith activated microglia nociception pain physician Mnatzakanian previously unidentified open reading frame define new protein isoform relevant syndrome differential distribution splice variant postnatal mouse brain Cassel Carouge Gensburger Anglard Burgun Dietrich Fluoxetine cocaine induce epigenetic factor MBD1 adult rat brain Zoghbi syndrome know sure progressively express postmigratory neuron involve neuronal maturation rather cell fate decision developmental expression methyl cpg bind protein dynamically regulate rodent brain neuroscience Asano Sanosaka methylcpg bind protein involve restrict differentiation plasticity neuron insight syndrome mecp2 level display tissue cellspecific difference correlate neuronal maturation methylcpg bind protein enhance green fluorescent protein reporter mouse model provide new tool study neuronal basis syndrome change epigenetic machinery superficial dorsal horn correlate pattern gene expression follow development joint inflammation pattern pain microarray study pain pain neurogenic mechanism symmetrical arthritis Decaris Guingamp Chat evidence neurogenic transmission induce degenerative cartilage damage distant local inflammation Arthritis Rheum Donaldson Seckl McQueen discrete adjuvantinduced monoarthritis rat effect adjuvant dose Neurosci Methods sensory nerve alter function contralateral monoarthritis contribute symmetrical spread inflammation replicate highdensity rat genome oligonucleotide microarray reveal hundreds regulate gene dorsal root ganglion peripheral nerve injury role spinal novo dna methylation development inflammatory pain SFN Ref Type Drago Gereau epigenetic modulation receptor histone deacetylase inhibitor treatment inflammatory pain Mol Pharmacol neuronal activity modify DNA methylation landscape adult brain role glia progression syndrome nature Leith Fisher Berliocchi local translation primary afferent fiber regulate nociception e1961 Cite article expression spinal methylcpg bind protein dna methyltransferase histone deacetylase modulate persistent pain state Molecular Pain submit next manuscript take full advantage convenient online submission Thorough peer space constraint color gure charge immediate publication acceptance freely available redistribution submit manuscript wwwbiomedcentralcomsubmit Tochiki Molecular Pain page",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 14,
                    "FKBP5": 5,
                    "epigenetic": 6
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "contra": 1,
                    "Ani": 1,
                    "Mnatzakanian": 1,
                    "MBD1": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "contra": 25,
                    "Ani": 25,
                    "Mnatzakanian": 25,
                    "MBD1": 25
                },
                "Ethnographic Terms": {
                    "methylation": 4,
                    "FKBP5": 4,
                    "epigenetic": 4
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "The mechanism of sonophotocatalytic degradation of methyl orange and its products in aqueous solutions.pdf",
            "cleaned_text": "mechanism sonophotocatalytic degradation methyl orange product aqueous solution Muthupandian Ashokkumar VIC Australia Article history receive receive revise form Accepted March Available online acoustic cavitation Methyl orange study find hybrid technique sonophotocatalysis able degrade parent organic pollutant methyl orange product analysis product form whole degradation demonstrate selection oxidation process able control degradation pathway show product anal ysis solution alter amount product generate sonophotocatalytic degradation reveal different degradation rate methyl orange product result solution nature organic product furthermore comparison datum obtain oxidation process degradation reaction intermediate identie advantage combine system conclude sonophotocatalysis capable yield complete fast mineralization organic pollutant individual process however degradation parent compound overall mineralization low additive effect negative synergistic effect Elsevier right reserve introduction photocatalytic sonolytic degra dation organic pollutant find useful remediation environmental contaminant critical limit individual process relatively low efciency complete mineralization organic pollutant considerable effort direct enhance efcacy advanced oxi dation process AOPs form hybrid system technique number research group examine combination ultrasound photocatalysis know sonophotocatalysis SPC environmental remediation effective ness SPC highlight follow ultrasound acoustic cavitation provide extra source cavita tion acoustic cavitation remove intermediate photocatalytic active site acoustic cavitation generate num ber physical effect shear force turbulence crostreaming help regenerate active catalytic surface iii catalyst pollutant form pow der agglomerate acoustic cavitation increase unifor mity dispersion thereby increase available surface area acoustic cavitation able enhance mass transfer ward interface acoustic cavitation capa ble accelerate adsorption activity reactant photocatalyst sonolysis likely decompose hydrophobic part pollutant compound unlikely occur surface photocatalyst however combine use photocatalysis sonolysis treatment pollutant rather limited mostly due lack detailed mechanism hybrid process publication deal degradation kinetic parent organic pollutant function operation condition relatively little known reaction product pathway associate sonophotocatalytic treatment product analysis play critical role explore understand mechanism combine system establish framework application Methyl orange typical azo dye select pollutant study several recent study sonophotocatalytic treatment show promising potential application hybrid system however publication mainly focus inuence various catalyst primary degradation parent pollutant good knowledge identication degradation product sonophotocatalyt degradation methyl orange study date present work degradation bothMO derivative product systematically examine key aspect study evaluation degradation behavior subsequent product form photocatalytic sonochemical sonophotocatalytic see front matter right reserve ultsonch corresponding author fax mail address list available journal homepage wwwelseviercomlocateultsonch degradation find synergistic degra dation intermediate product form lead high min eralization efciency combine process chemical purchase commercial source use purchase degradation experiment aqueous solution contain use initial solution acid sodium hydroxide purchase use adjust solution series different concentration acid alkaline solu tion make control solution P25 tio2 specic surface area use photocatalyst loading photocatalyst experi ment ultra pure water use preparation aqueous solution source Milli system Millipore Degradation experiment Sonophotocatalytic experiment conduct cylindrical vessel quartz plate side soni cation vessel contain jacket allow solution cool cold water ultrasound transducer khz place bottom vessel power absorb solution xe experiment measure calorimetry experiment carry air atmosphere know sonication water air atmo sphere generate nitric acid however deliberately add chloric acid sodium hydroxide order maintain solution respectively hence change due nitric acid formation issue experiment xenonarc lamp use light source photocatalytic degradation experiment optical lter cutoff wavelength instal vessel lamp photocatalysis sonicator switch sonolysis experiment carry light irradiation presence photocatalyst sonophotocatalysis solution irradiate light ultrasound experiment conduct solution stir overhead stirrer min disperse photocatalyst allow adsorption equilibrium dye reach surface whole degradation experiment stirring speed keep constant rpm bench top meter use monitor solution analysis sample ltered ter remove suspended tio2 particle analytical determination progress degradation regularly monitor visible absorption use Varian spectrophotometer computer control high performance raphy HPLC system Shimadzu system comprise solvent delivery pump visible diode array detector autosampler use characterize organic pollutant product concentrationtime prole detector wave length range set qualitatively quantitatively analyze formation product fraction separate HPLC column mobile phase consist methanol ammonium acetate ow rate mobile phase min mineralized carbon measure use Shimadzu Total Organic Carbon TOC Analyzer model TOCVCSH equip autosampler experiment perform duplicate maximum standard deviation maximum coefcient variation exceed case additional measurement conduct maximum standard deviation maximum coefcient variation set acceptable criterion mass spectrometry perform lend Technologies AccurateMass TOF couple Agi lend Series HPLC system Chromatographic separation degradation product perform use Eclipse Plus C18 col umn Agilent Technologies instrument calibrate use automatic tuning procedure respective standard compound mass spectra record Auto mode gas temperature set collision energy set increase linearly offset mass prole acquire process use discussion Photocatalytic sonolytic sonophotocatalytic degradation chromatogram sonophotocatalysis change observe show similar chromatogram collect sonolytic photocatalytic experiment show clear decrease concentration increase irradiation time comparison degradation rate constant observe different AOPs different solution value show Fig order kinetic model apply compare degradation performance advanced oxidation process choose experimental condition initial concentration degradation reac tant concentration time rate constant order kinetic base assumption chromatograph observe min sonophotocatalytic degradation ultrasonic frequency khz power detection wavelength monitor concentration initial degradation reaction step attack dye molecule whole degradation process production radical remain constant react organic pol lutant however degradation product build solution compete radical order investigate inuence individual oxidation process datum rst min select use calculate rate constant list Table obvious sonophotocatalyt process fast nonhybrid degradation table list experimentally obtain rate constant base rst order treatment datum ratio sonophotocatalytic rate constant sum rate constant individual process use evaluate synergistic fect combine system show Synergistic Index rate constant hotocatalysis sonolysis photocatalysis respectively order reduce inuence adsorption sample adjust prior analysis separate adsorption experiment show minimum adsorption occur tio2 clearly see signicant inuence sonolysis generally due different ionic form acidbase organic molecule consequently different surface activity different value degradation exhibit dependent rate constant slight difference rate constant obtain different solution val ues imply large difference bubblesolution surface activity anionic zwitterionic form Table rate constant photocatalytic degrada tion almost twice obtain Accord ing generally accept mechanism photocatalysis overall degradation efciency determine competition photogenerate recombination free chargecarri er trap charge carrier surface adsorb pollutant due electrostatic attraction positively charge negative charge zwitterionic dye adsorption dye semiconductorsolution inter face facilitate fast sonophotocatalytic degradation likely due mechanism responsible lytic component process moreover solution val ues clearly see Table apparent synergistic effect combine system value sonophotocatalytic system show additive effect neous photocatalysis ultrasonic irradiation initialize degrada tion organic pollutant reaction radical therefore appear condition experiment AOPs generate equivalent quantity radical irrespec tive presence degradation kinetic sonolysis photoca talysis sonophotocatalysis aqueous solution contain load oxidation system apply ultrasonic frequency khz power detection wavelength use HPLC Table pseudo rstorder rate constant sonolysis photocatalysis sonophotoc atalysis aqueous solution Sonophoto Sono Photo Sonophoto min synergistic index Fig Changes TOC observe function irradiation time photocatalytic sonochemical sonophotocatalytic degradation aqueous solution load photocatalytic sonophotocatalytic process ultrasonic frequency khz power show TOC content aqueous solution contain sonochemical photocatalytic lytic degradation process obvious TOC system gradually decrease increase irradiation time quite obey rstorder kinetic whole time range examine photocatalytic sonochemical oxidation process effectively mineralize azo dye see combine system high mineralization efciency com pare individual process however degradation parent compound overall mineralization low additive effect individual process negative synergistic effect propose sonophotocatalytic degradation pathway chromatogram sonophotocatalysis present Fig chromatogram show clearly appearance peak corre sponde product degradation parent evident product form AOPs min degradation nearly remove photocatalysis sonolysis Fig sonophotocatalysis however accord min many intermediate specie still present solution main product observe chromatograph AOPs peak respond remain decrease follow order sonophotocatalysis photocatalysis sonolysis tion indicate photocatalytic sonophotocatalytic deg radation process efcient process decompose parent azo dye observation correspond spectra kinetic result TOC analysis addition ally product include hydrophobic well hydrophilic intermediate compound mention previously solvo phyllic nature compound favour differ process sonophotocatalytic degradation hydrophobic product tend surface active bubblesolution interface therefore readily degrade acoustic cavitation However great capability decompose hydrophilic product molecular structure product deduce analyze sample compare result literature parent molecule retention time min exhibit clear signal correspond nega tive ion worth note intermediate product exhibit long retention time retention time min indicate great hydrophobicity normally hydroxylated product show hydrophillic char acter contradiction conrme product monohydroxylate hydrophobic hydroxylated product observe photocatalysis number search group product retention time min demethylated intermediate form cleave methyl group mol ecule remain intermediate compound product form addition hydroxyl group cleavage methylene group example product retention time min derivative form addition hydroxyl group extraction methyl group molecule base structure product form degradation identied intermediate contain azo group sulfonic group structure intermediate conrme spectroscopy show list product Fig molecule form sonolytic photocatalytic sonophotocatalyt degradation originate hydroxylation demethylation show propose sonophotocatalytic degradation pathway scheme degradation pathway mainly Fig high performance liquid chromatograph observe min photo catalytic sonolytic sonophotocatalytic degradation tio2 load oxidation system sonolysis sonophotocatalysis ultrasonic frequency khz power detection wavelength range chromatographs monitor concentration focus transformation intermediate specie precede aromatic ringopene Products intermediate compound form demethylation hydroxylation respectively Fig demethylation process involve homo lytic rupture nitrogencarbon bond amine group lead ing substitution methyl group hydrogen atom consecutive demethylation likely pathway formation Products decomposition process mole undergo sonolysis photocatalysis radical attack main cause degradation Products form multiple substitution hydroxyl group evidently due simultaneous independent occurrence demethyl ation hydroxylation expect couple take place alternatively consequently product degradation determine individual demethylation hydroxylation process combination product primary intermediate product Product demethy lated product product monohydroxylated product monitor order investigate photocatalytic sonophotocatalytic degradation intermediate product show HPLC peak area intermediate function irradiation time peak area prod ucts different value rst increase subsequently crease demonstrate undergo process formation decomposition show formation trend product function irradiation time sonolysis photocatalysis sonophotoca talysis peak area photocatalysis sonophotocatal ysis show bell shape trend irradiation time amount product form process reach maximum rst however amount product exist solution gradually increase whole sonochemical deg radation process observation demonstrate position fast formation photocatalytic sonophotocatalytic degradation hybrid technique well decompose intermediate destruction inter mediate sonolysis seem slow advanced oxidation process compare amount product form considerably large show indicate spite formation main active specie environment capable change pro portion product form consequently possible choose right process condition order inhibit forma tion certain product also harmful environ ment amount product sonophotocatalytic process reach maximum min photocatalysis min hybrid system exhibit great synergistic effect degradation Product show change amount product time AOPs respectively illustration propose degradation pathway event take place sonophotocatalytic degradation hydroxylation photocatalytic sonophotocatalytic process fast sonolysis rst min hydroxylated photocatalysis rate sonophotocatalysis however min amount mono hydroxylated product sonophotocatalysis decrease photocatalysis increase min reason fast sonophotocatalytic decomposition product lie pathway Compared Product Product exhibit great hydrophobicity hplc chromatograph Fig lead high bubblesolution surface activity property allow molecule accumulate liquidbubble interface thus increase exposure primary radical generate cavitation bubble maximum amount Products high possible reason alkaline environ ment favour formation radical consequently itate hydroxylation process conclusion result report demonstrate sonophotocatalysis effective technique environmental remediation low solution environment facilitate sonophotocatalytic degra dation aqueous solution physicochemi cal propertie organic specie affect hydrophobicity therefore surface active property change con tribute change overall sonophotocatalysis rate demonstrate solution affect build rate product generate sonolysis photocatalysis sonophotocatalysis find hotocatalytic degradation parent organic pollutant derivative product much fast individual oxidation process combine particular demon strate signicantly effective degrade intermediate product therefore sonop hotocatalytic technique likely lead complete fast mineralization organic pollutant aqueous solu tion individual process observe sonolysis effective decompose hydrophobic organic compound photocatalysis well hydrophilic compound hydropho bic quality solute lead high surface activity mol ecule result enhance encounter organic molecule highly reactive primary radical liquidbubble interface Hydrophilic molecule hand readily adsorb surface tio2 pose photocatalysis result show paper also signicant understand sonophotocatalytic degradation Fig concentration change Products min sonophotocatalytic degradation tio2 load experiment sonolysis sonophotocatalysis process frequency ultrasound khz power activity provide information relate decomposition pathway organic dye molecule ment nancial support infrastructural facility provide PFPC special research centre fund greatly particular ment extend colleague help preparation manuscript thank University IPRS Reller Photoinduced reactivity titanium dioxide Prog solid State Chem Fujishima Fundamentals Applications 1st BKC Inc Rao Tryk Titanium dioxide photocatalysis Photochem application semiconductor photocatalysis environmental remediation Combinative hybrid sonophotochemical oxidation process treatment pollutant water environmental remediation heterogeneous sonophotocatalytic oxidation process treatment pollutant water assist chemical process Rev Chem Eng Ashokkumar Augugliaro Litter combination heterogeneous photocatalysis chemical physical operation tool improve photoprocess performance Photobiol advanced oxidation process synergistic degradation ibuprofen aqueous environment Hazard Mater Madhavan degradation monocrotophos use Fe3 Hazard Mater Neppolian Sonophotocatalytic degradation use bi2 TiZrO4 visible light responsive photocatalyst sonophotocatalytic reactor wastewater treatment critical Madhavan Grieser Ashokkumar Degradation orange advanced oxidation process combine sonolysis photocatalysis degradation mineralization chlorinate aromatic compound BejaranoPerez SurezHerrera sonophotocatalytic degradation congo red methyl orange presence catalyst sonophotocatalytic degradation methyl orange nanosized particle aqueous solution Sonophotocatalytic degradation methyl orange carbon nanotubetio2 aqueous solution Wantala Tipayarom Sonophotocatalytic activity methyl orange IIITiO2 react Kinet Catal Lett Zhang Sonophotoelectrocatalytic degradation azo dye tio2 nanotube electrode degradation azo dye aqueous solution new heterogeneous kinetic model take account local concentration radical azo dye Ultrason Sonochem Singla mechanism degradation benzoic acid aqueous solution Intermed Singla degradation yellow dye aqueous solution oxidation methyl orange presence titanium dioxide aqueous suspension part parametric study Desalination Baiocchi Brussino Prevot Palmisano Marci Characterization methyl orange photocatalytic degradation product hplcvis diode array atmospheric pressure ionization quadrupole ion trap mass spectrometry Int degradation azo dye organiccappe anatase nanocrystal immobilize substrate degradation methyl orange aqueous suspension mesoporous titania nanoparticle Chemosphere degradation azobenzene relate azo dye rate enhancement Phys Chem Baiocchi Pazzi Analytical control photocatalytic treatment degradation sulfonate azo dye",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "demethylation": 5
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Sonophotocatalytic": 1,
                    "Varian": 1,
                    "Sonophoto": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "Sonophotocatalytic": 5,
                    "Varian": 5,
                    "Sonophoto": 5
                },
                "Ethnographic Terms": {
                    "demethylation": 3
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "The methyl-CpG-binding protein MBD7 facilitates active DNA demethylation to limit DNA hyper-methylation and transcriptional gene silencing.pdf",
            "cleaned_text": "article methylcpgbinde Protein MBD7 Facilitates active DNA Demethylation Limit DNA Hyper Methylation Transcriptional gene silence Graphical Highlights prevent dna hypermethylation gene silence bind genomic region high density methylation prevent dna methylation spread physically associate IDM1 JianKang Zhu Correspondence show bind highly methylate dense chromatin region physically associate IDM protein enable dna demethylase prevent aberrant spread dna methylation Accession Numbers GSE58789 GSE58787 Cell article methylcpgbinde Protein MBD7 Facilitates active DNA Demethylation limit DNA HyperMethylation Zhaobo Lang Duan ChuanChih Hsu Chunlei Wang JianKang zhu1 1Shanghai Center Plant Stress Biology Shanghai Institutes Shanghai China 2department Horticulture Landscape Architecture Purdue University West Lafayette USA Section Directorate Rice Research Hyderabad India 4School Hangzhou 6department Biochemistry West Lafayette USA 7State Key Laboratory Plant Physiology Beijing 8corst author Correspondence jkzhupurdueedu SUMMARY dna methylation conserve epigenetic mark play important role plant vertebrate devel opment genome stability gene regulation canonical methylcpgbinding domain pro tein important interpreter dna methylation recognize methylated site recruit chro matin remodeler histone deacetylase histone methyltransferase repress transcription show Arabidopsis MBD7 increased DNA Methylation IDM3 antisilence factor prevent gene repression DNA hypermethy lation preferentially bind highly methyl ate dense region physically associate antisilence factor include tone acetyltransferase IDM1 domain protein previously show facilitate active DNA deme thylation methylcytosine DNA glycosylase lyase ROS1 thus tether IDM protein methylate dna enable function dna demethylase turn limit dna methylation prevent transcriptional gene silence introduction dna methylation conserve epigenetic mark plant ver tebrate play important role development genome several wellknown epigenetic phenomenon genomic imprint paramutation chromosome mammal methylcytosine 5mC occur mainly dinucleotide plant find sequence context plant dna methylation establish DNA methylation RdDM pathway CHG methylation require ortholog plant specic enzyme respectively methylation car rie DRM2 pathway require chromatin modeling protein dna methylation associate transcriptional silence methylcpgbinding domain MBD protein impor tant interpreter dna methylation Hendrich Bird generally MBD protein recognize methylated site cruit chromatin remodeler histone deacetylase histone methyltransferase repress transcription recent analysis genomewide bind site MBD protein mammalian cell conrme MBD protein typically enrich methylate genomic region methyl ationdependent MBD protein bind promoter coincide gene silence genome predict encode canonical MBD protein bind cically methylate site vitro Gra function plant MBD protein poorly stand available information consistent conserved role effector dna methylation cause tran scriptional repression Gra DNA methylation dynamically control methylation demethylation reaction vertebrate active dna demethylation initiate oxidation deamination cite article press Lang methylcpgbinde Protein MBD7 Facilitates active DNA Demethylation Limit DNA Hyper Methylation methylcytosine tet enzyme respectively follow DNA glycosylase TDG plant active dna demethylation initiate ROS1DME family dna glycosylase ROS1 neces sary prevent dna hypermethylation thousands genomic region Qian dna demethylation enzyme target specic genomic locus poorly stand subset genomic region ros1 function quire histone acetyltransferase increase DNA Methylation IDM1 Qian partner protein study employ previously describe forward genetic screen uncover antisilence factor screen identie several anti silence factor Antisilencing ASI1 Enhanced Downy Mildew EDM2 addition new allele know antisilence factor IDM1 ROS1 find limit dna methylation particularly transposable element TEs enrich highly meth ylate dense site genome enrichment coincide function prevent dna methylation spread hypermethylation protein interaction analysis reveal associate IDM3 idm2like protein vivo also associate IDM1 result suggest model recognize methylate dna recruit regulator active dna demethylation prevent dna methylation spread transcriptional silence result ASI2 AntiSilencing Factor prevent spread DNA previously develop screen antisilence mutant employ wildtype plant express virus sucrose trans porter transgene exhibit shortroot pheno type grow medium contain sucrose figure plant express neomycin phosphotransferase hygromycin phosphotransferase transgene thus resistant kanamycin hygromycin identie recessive mutant asi2 population plant muta genize ethylmethane sulfonate asi2 mutant plant develop long root sucrosecontaine medium due reduce suc2 expression figure S1A sensitive hygromycin kanamycin due reduced expres sion nptii figure form chromatin immunoprecipitation ChIP observe reduce occupancy rna polymerase Pol enrichment repressive chromatin mark promoter asi2 mutant plant suggest reduce rna level cause decrease Pol transcription promoter ure S1C S1D next analyze dna methylation asi2 plant genomic sequencing find part promoter region hypermethylate plant permethylation extend neighboring region region asi2 mutant plant figure thus spread dna methylation promoter silence transgene asi2 mutant plant support hypothesis treatment DNA methylation inhibitor azadeoxycytidine aza suppress kanamycin sensitivity asi2 mutant plant figure restore expression SUC2 Figure S1E plant TEs repeat silence dna methyl ation repressive histone modication Law find expression gene repetitive gene cluster reduce asi2 Figure expression At1TE04710 also decrease asi2 figure expression repeat ONSEN TSI induce prolonged heat treatment observe reduce heatinduced expression ONSEN TSI asi2 compare plant figure addition At1TE04710 TSI ONSEN display increase dna methylation asi2 figure S1F thus recessive asi2 mutation cause dna hypermethylation silence transgenic endogenous locus thereby indicate antisilence role ASI2 Methyl CpGBinding Protein MBD7 encode ASI2 mapbased cloning find asi2 point mutation AT5g59800 create premature stop codon figure longroot phenotype asi2 complement native fuse tag gfp tag figure pcr assay indicate myctagged MBD7 able rescue suppress expression 35S::HPTII trans gene asi2 figure s2a find myctagged protein enrich transgene promoter ChIPqPCR figure result conrm transgene silence asi2 cause mutation thus refer asi2 mutant mbd7 hereafter also intro duce transgene dna insertion allele SAIL697E08mbd7 cross DNA mutant plant expect mbd7 mutant plant taine transgene also show phenotype figure S2B result demonstrate dysfunction cause transgene silence phenotype plant mbd7 Mutation induce DNA Hypermethylation Endogenous Genomic Regions Wholegenome bisulte sequence identie differen tially methylate region mbd7 hypermethylate hypomethylate hypermethylate cytosine HMCs select validation ChopPCR assay genomic dna digest methylationsensitive restriction endonuclease test template pcr primer anke restriction site observe amplication genomic digest mbd7 DNA figure consistent cite article press Lang methylcpgbinde Protein MBD7 Facilitates active DNA Demethylation Limit DNA Hyper Methylation hypermethylation candidate site great number hypermethylate hypomethylated region suggest mainly antagonize dna methylation find hypermethylate DMRs mbd7 locate tes obvious specic type Figure dna methylation level increase sequence context increase independent length figure s2d mutant plant hypermethylate concentrate centromeric region figure test preferentially regulate TEs locate region compare number hypermethylate dmrassociated tes total number consecutive window density distribu Col sucrose glucose asi2 idm3 region promoter SUC2 region rep rep signal dna methylation asi2 relative transcript level SUC2 nptii ROS1 asi2 relative transcript level TSI ONSEN relative transcript level TSI ONSEN HSP70 asi2 asi2 glucose Col asi2 glucose kanamycin glucose kanamycinaza Figure ASI2 antagonize Transcriptional Silencing Prevents DNA Hypermethy lation isolation asi2 mutant transgenic overexpression sucrose transporter gene SUC2 Arabidopsis ecotype Col result hypersensitivity exogenous sucrose indi cat short root phenotype trans genic plant wildtype Dysfunction ASI2 rescue sucroseinhibite root growth phenotype qpcr quantication transgene transcript level asi2 comparison plant Rela tive ros1 transcript level include change control ASI2 dysfunction cause loss kanamycin resistance transgenic plant treatment DNA methylation inhibitor aza restore kanamycin resistance asi2 mutant dna methylation status enrichment transgene asi2 idm3 mutant show screenshot IGB display sequencing result vertical bar track indicate dna methylation level enrichment chro matin replicate datum transgenic plant control plant display qpcr analysis at1te04710 at1g26380 asi2 plant ASI1 dysfunction compromise heatinduced expression ONSEN TSI HSP70 qpcr measurement transcript level asi2 mutant relative corresponding value error bar indicate signicant twotaile test see also figure tion hypermethylate te chromosome show obvious centromeric pericen tromeric TEs rather concen tration hypermethylate te region correspond high total number figure S2E mcgdense Regions previously identie methyl CpGbinding protein Gra however genomic target know identify endogenous target perform ChIP use plant express native follow highthroughput sequence identied peak enrichment chromatin region inter genic region correspond gene gene contain annotated repeat pattern chromosomal distribution bind peak similar mbd7 hyperdmrs figure approximately mbd7 hyperDMRs overlap bind peak cite article press Lang methylcpgbinde Protein MBD7 Facilitates active DNA Demethylation Limit DNA Hyper Methylation examine correlation binding dna methylation context First genome divide region enrichment calculate region top MBD7enriched region select analysis evaluate inuence dna methylation level enrichment rank region methylation level generate heat map enrichment however pattern enrichment evident rank datum show suggest methylation level individual CHG CHH motifs determine bind density value reecte methylation level methyl cytosine density region equal sum methylation percentage individual cytosine gion normalize region length consider methylation level also methyl cytosine density region calculate methylation density genomic region region rank mCG mCHG mchh density heat map pattern indi cat enrichment associate methylation density rather methylation density figure consistent previous nde bind mcg site mCHG site tight relationship enrichment methylation density genome wide instead top support analysis use previously describe method genomic region rank leave right methylation density enrichment methylation density value indicate red blue line respectively Fig method use correlation observe enrichment methylation den sity CHG CHH context datum show MBD7GFP sucrose glucose mbd7 antibody promoter relative value input idm3 HMC5 HMC9 HMC13 digestion control mbd7 idm3 ATG TAA figure mcpgbinde asi2 idm3 Methylome Analysis diagram gene show mutation site dna insertion position mbd7 allele Boxes line denote exon intron respectively long root phenotype asi2 cause mutation expression drive native promoter restore short root phenotype mbd7 examination MBD7 enrichment transgene promoter use ChIP assay Promoter ACTIN7 use control error bar indicate signicant twotaile test choppcr validation idm3 result biological replicate show Methylationsensitive restriction enzyme primer list table distribution idm3 see also figure Molecular Cell cite article press Lang methylcpgbinde Protein MBD7 Facilitates active DNA Demethylation Limit DNA Hyper Methylation majority bind site region analyze methylation density associate window window geneassociated window gene window find window generally high methylation density gene window figure expect test preferred bind due high due specic feature select window gene window comparable methylation density compare enrichment figure find great enrichment TEs gene even comparable mcg density figure pattern consistent range mCG density test figure S3C result suggest bind region high mcg density instead recognize bind locate tes MBD7 Binding Coincides role prevent DNA Hypermethylation investigate correlation bind inuence dna methylation calculate enrichment number hyper differentially methylate cytosine dmcs mutant genomic region interestingly number hyper dmc mutant positively correlate enrichment bin genomic region enrichment high number hyper dmc bin compare numerous bin genomic region enrichment figure result indicate bind chromatin coincide function prevent dna hypermethylation understand inuence dna methyl ation bind site compare methylation level tween mbd7 MBD7binding region group control region randomly select methylation level also calculate mbd7 mCHG mCG level elevate mbd7binding region control region figure S3C Boxplot analysis indicate increase average methylation level mbd7binde region due increase majority region rather extremely large increase small number region figure datum also show enrichment protein promoter region Figure consis tent result figure addition datum reveal enrichment At1TE04710 ONSEN TSI region Figure S1F increase dna methylation mbd7 result suggest physical bind locus attenuate silence locus figure prevent dna hypermethylation high CHG CHH Methylation density low low high enrichment Number Hyper DMC relative MBD7 enrichment enrichment enrichment mcg density enrichment mCG density figure high mCG sity Binding Coincides role prevent dna Hypermethylation Chromosomal distribution bind peak correlation MBD7 enrichment dna methylation density top MBD7enriched region select analysis region enrichment represent color light yellow low red high density examine context Comparison methylation density gene tes genome Comparison MBD7 chromatin enrichment right panel subset locus show similar mcg density range leave panel Correlation MBD7 enrichment DNA hypermethylation mbd7 mutant plant genomic region relative enrichment number hyper dmcs calculate number dis play genomic region enrichment hyper dmc indicate see also figure Molecular Cell cite article press Lang methylcpgbinde Protein MBD7 Facilitates active DNA Demethylation Limit DNA Hyper Methylation idm3 mutant phenocopy mutant screen isolate increase DNA Methylation idm3 idm3 show long root phenotype sucrosecontaine medium reduce SUC2 transcript level figure Map base cloning idm3 idm3 identie missense muta tion at1g20870 figure conrm mutation at1g20870 responsible antisilence defect idm3 mutant transform native at1g20870 gene fuse idm3 mutant find root growth SUC2 transgene expression phenotype rescue fig ure predict encode domain ACD protein localize nucleus Figure S4A similar figure s4b belong family small heat shock protein expression heat induc ible Figure S4C sequence idm3 mutant plant veale dna methylation spread neighboring sequence transgene promoter figure Consistent notion increase dna methylation responsible silence transgene expression trans gene restore idm3 mutant treatment cytosine methylation inhibitor aza reveal qpcr figure aza treatment also increase expression transgene figure result suggest transgene already subject DNA methylationdependent silence plant consistent high level dna methylation observe region promoter Figure mbd7 many hyperdmrs hypodmrs idm3 approximately hyperdmrs also hypermethylate mbd7 ChopPCR analysis conrme several endogenous genomic site hypermethylate idm3 mutant plant mbd7 figure suspect idm3 idm3 point mutation represent weak allele also nd dna insertion allele idm3 use crisprcas system generate new allele idm3 idm3 idm3 frag ment delete gene idm3 frameshift mutation region create premature stop Col IDM34xMYC idm3 idm3 idm3 idm32ros113idm1 sucrose glucose TAA idm3 idm3 ATT insertion idm3 deletion asi2 asi2 ros1 DMSO aza suc2 transcript idm3 idm3 relative transcript level hsp20 hsp20 ros1 SUC2 nondigestion control Col idm3 idm3 ros1 idm1 idm2 figure IDM3 Functions prevent transcriptional silence idm3 mutant isolate base long root phenotype grow exogenous sucrose transgenic expression gene rescue idm3 root growth phenotype ros1 idm1 use control dysfunction suppresse SUC2 transgene expression qpcr result mean biological replicate fold change normalize transcript level compare signicant compare compare idm3 twotaile test diagram gene show mutation site idm3 mutant box line denote exon intron respectively transcriptional silence idm3 mutant release chemical inhibition dna methylation plant treat DNA methylation inhibitor aza solvent dmso control Gene expression level normalize plant qpcr result mean biological replicate fold change normalize transcript level result mean bio logical replicate twotaile test Analysis dna methylation level DT76 locus idm3 idm3 mutant see also figure Molecular Cell cite article press Lang methylcpgbinde Protein MBD7 Facilitates active DNA Demethylation Limit DNA Hyper Methylation codon figure examine dna methylation choppcr locus Qian idm3 idm3 amplication genomic digest mutant DNA indicate locus hypermethylate idm3 idm3 mutant ros1 idm1 idm2 figure thus IDM3 require pre vent transgene silencing dna hypermethylation order understand function identie mbd7interacte protein perform immunoprecipitation follow liquid chromatographytandem mass mutant plant complement native plant express serve control protein precipi tat antibody mbd74xmyc transgenic plant control plant uncover transgenebase screen antisilence factor IDM1 Qian IDM3 figure similar experiment carry use idm3 mutant plant complement native promoterdriven immuno precipitate identie also IDM1 Figure addition idm1 mutant plant complement native IDM1GFP find IDM1 figure result show associate IDM1 vivo Yeast twohybrid y2h assay use determine interact directly IDM1 IDM2 IDM3 yeast cell express bind domain activa tion domain able grow lack leucine tryptophan histidine minusfour medium medium lack leucine tryptophan histidine adenine figure suggest strong interaction tween transfecte yeast cell grow media Figure indicate relatively weak interaction tween interact IDM1 y2h assay datum show interaction split luciferase complemen tation assay protoplast figure split luciferase complementation assay also indicate interaction interaction much weak indicate relative luciferase activity figure interaction also conrme use split luciferase complementation assay tobacco leave figure interestingly also interact assay observe interaction IDM1 assay consistent previous result also interact IDM1 split luciferase complementation assay figure y2h split luciferase complementation result show interact interact IDM1 result consistent datum figure show association IDM1 vivo contain domain terminal domain know StkC domain Figure perform y2h assay different deletion mutant find bind stkc domain MBD domain figure test stkc protein interaction domain important antisilence function separately transform native coding sequence prombd7 native contain MBD domain fulllength protein domain rescue root phenotype mbd7 Fig ure s5a indicate StkC domain require antisilence function least transgene loci result indicate association IDM1 vivo Figure show previously IDM1 histone acetyltransferase catalyze H3K18 H3K23 acetylation Qian reduce silence promoter idm1 mutant plant assay reveal h3k23ac level reduce mbd7 mutant plant promoter idm1 tants Figures S5B S5C result consistent notion IDM1 protein complex vivo suggest important IDM1 function plant Affects Subset Genomic Regions target active DNA Demethylation IDM1 show require prevent hypermethylation hundreds genomic region sub set target active demethylation ROS1 DML2 previously determine idm1 idm2 rdd ros1 dml2 dml3 triple mutant mutant find methylome compare idm3 tant genetic background mutant control contain transgene twice subject transformation con tain several transgene see Experimental Procedures even control methylome different Col control datum show therefore determine DNA methylome mbd7 idm3 dard Col background idm1 idm2 rdd find increase dna methylation respectively mately overlap hyperDMRs rdd overlap hyper ros1 overlap hyperDMRs idm1 overlap hyperDMRs idm2 overlap hyperdmrs idm3 several example share hyperDMRs mbd7 idm1 idm2 idm3 ros1 mutant show figure s6a s6d also display result show enrich ment level region furthermore examine IDM1 occupancy locus use chip tag IDM1 ChIP assay indicate IDM1 protein enrich chromatin test loci plant cite article press Lang methylcpgbinde Protein MBD7 Facilitates active DNA Demethylation Limit DNA Hyper Methylation MBD MBD MBD STKC Full MBD7 306aa MBD MBD MBD 3mbd 232aa STKC STKC 306aa MBD7 Purification Protein Score coverage Unique Peptides IDM3 IDM1 IDM2 Protein Score coverage Unique Peptides IDM3 IDM1 IDM3 Purification nluccluc nlucidm3cluc ros1nluccluc ros1nlucidm2cluc ros1nlucidm3cluc IDM1nLUCMBD7cLUC idm2nlucmbd7cluc idm3nlucmbd7cluc idm1nlucidm3cluc IDM2nLUCcLUC IDM3nLUCcLUC STKCIDM3 stkc 3mbd LeuTrpHis fullIDM3 full stkcidm2 IDM2 STKC 3mbd full LeuTrpHis LeuTrp HisAde Protein Score coverage Unique Peptides IDM1 MBD7 IDM1 Purification Relative LUC activity figure physically interact protein associate detect follow myctagged MBD7 MYCtagged IDM1 biological replicate protein purications representative result show Tests IDM3MBD7 interaction yeast twohybrid assay protein full truncated form 3MBD fuse GAL4 bind domain fuse GAL4 activation domain legend continue next page cite article press Lang methylcpgbinde Protein MBD7 Facilitates active DNA Demethylation Limit DNA Hyper Methylation enrichment substantially reduce mutant plant figure s6e result suggest IDM1 bind target loci dependent result suggest affect specic subset genomic region require IDM1 IDM2 DNA demethyla tion understand achieve specicity analyze methylation density different group hyperDMRs idm1 idm2 idm3 mutant hyper overlap high methylation density nonoverlapping hyperdmrs sim ulation randomly select region show signi not difference figure S6F result suggest function together IDM1 preferentially genomic region high methylation density consistent requirement high mCG density bind indeed analyse datum show highly enrich dense hyper nonoverlapping hyperDMRs figure s6 g signicant difference find use control datum plant figure s6 g discussion find cellular anti silence factor inhibit dna hypermethylation genomic region prevent transcriptional gene silence dna methylation conserve epigenetic mark silence TEs invasive element many plant animal genome gene island sea spread silence adjacent transcriptionally active gene active dna demethylation mechanism prevent dna methylation spread protect nearly gene example EPF2 gene control size stomatal stem cell population leaf epidermis close methylate active dna demethylation require pre vent methylation spread transcriptional silence EPF2 Yamamuro DNA demethylase ros1 mutant EPF2 silence dna methylation spread proximal result overproduction stomatal lineage cell many imprint gene plant require DNA demethylase DME dna methylation expression endosperm gene evolve te regulatory sequence nding reveal associate methylate dna recruit antisilence factor create permissible chromatin environment bind dna demethylase ROS1 thus result suggest IDM protein limit spread dna methylation promote active dna demethylation active dna demethylation also necessary prune DNA methylation landscape many thus important prevent oversilence addition know long time dna methylation cause transcriptional silence transgene plant important understand transcriptional silence transgene avoid prevent order keep transgenic trait stable agricultural biotechnology industry key enzyme active dna demethylation identie vertebrate active dna demethyla tion initiate deamination oxidation aid APOBECs tet enzyme respectively follow DNA glycosylase TDG plant active dna demethylation initiate ROS1DME family dna glycosylase Zhu dna demethylation enzyme target specic genomic locus poorly understand plant histone acetyltransferase IDM1 require target ROS1 subset genomic region demethylation know H3K18 H3K23 acetylation mark create IDM1 affect ROS1 target regulation consider acetylation switch analo gous model propose target chromatin modeling complex SWR1 yeast IDM1 IDM2 regulate demethylation similar subset genomic locus target ROS1 family demethylase IDM2ROS5 nuclear ACD protein interact IDM1and affect H3K18 acetylation activity interestingly identie protein closely relate also require prevent dna hypermethylation gene silence MBD protein contain domain terminal Stkc domain Consistent ability bind methylate assay reveal genomewide bind correlate density methylate methylate CHG CHH site result suggest bind region high mcg density instead preferen tially recognize bind locate possible addition high mCG density feature hetero chromatic histone mark also contribute binding show binding coincident role prevent dna hypermethylation therefore instead Tests IDM2MBD7 interaction yeast twohybrid assay protein full truncated form 3MBD fuse fuse Analyses IDM2MBD7 IDM3MBD7 protein interaction split luciferase complementation assay protoplast transfecte gene use standardize protoplast transfection efciency express test protein protein unrelated gene silence include ABAhypersensitive germination protein serve negative control examination protein interaction ROS1 IDM1 split luciferase complementation assay tobacco benthamiana leave Luciferase activity detect post inltration white circle indicate leaf region inltrate agrobacterium strain contain indicate construct see also figure Molecular Cell cite article press Lang methylcpgbinde Protein MBD7 Facilitates active DNA Demethylation Limit DNA Hyper Methylation hyperdmrs mbd7 Effect mbd7 IDM1 Binding Chromatin Levels dna methylation chromatin enrichment several share hyperDMRs dash box mbd7 idm3 idm2 idm1 ros1 mutant total dna methylation level box region mutant quantie wholegenome bisulte sequence datum show bottom panel IDM1 protein enrichment share hyperDMRs ChIP perform Promoter ACTIN7 use control region error bar indicate signicant twotaile test see also figure Molecular Cell cite article press Lang methylcpgbinde Protein MBD7 Facilitates active DNA Demethylation Limit DNA Hyper Methylation read DNA methylation signal cause silence interpret DNA methylation signal avoid dna methylation spread hypermethylation prevent silence interact directly IDM3 also interact IDM1 addition interact result show associate IDM1 well vivo result indicate amount IDM1 immunoprecipitate low compare amount figure sult suggest exist tight complex IDM1 loosely transiently ate complex addition motif also contain domain conserve plant orthologs find protein result show domain necessary function antisilence plant consistent domain responsible mediate interaction result suggest model bind methyl ate tes repeat MBD motif use domain bind thus bring IDM1 methylate DNA figure H3K18ac h3k23ac mark create IDM1 allow ros1 related DNA deme thylase recruit restrict methylation spread pre vent hypermethylation active demethylation figure consistent model IDM1 recruitment target genomic region dependent Figures S6E reduce mbd7 mutant plant idm1 plant promoter figure s5b s5c interesting IDM1 also contain domain bind methylate seem single MBD domain IDM1 sufcient bring IDM1 target genomic region tar geting require contain multiple MBD domain nevertheless single domain help anchor IDM1 genomic site recruit result suggest IDM protein form previously unknown antisilence complex promote dna demethylation protein complex promote dna methylation transcriptional gene silence well study contrast nothing know system protein complex func tion regulate dna demethylation result suggest bind highly methylate genomic region MBD motif use domain bind thus bring IDM1 methylate DNA figure H3K18ac h3k23ac mark create IDM1 allow ros1 related DNA demethylase recruited restrict methylation spread prevent hypermethylation active demethylation figure also recruit histone modi cation enzyme IDM1 help target DNA deme thylase IDM1 affects subset genomic region demethylate ROS1 related dna glycosylase possible genomic region affect dna methylation prevent establishment mainte nance dna methylation rather facilitate active dna demethylation hand genomic region subject active dna demethylation affect indicate presence mechanism target DNA demethylase experimental PROCEDURES Plant Materials Mutant Screening Cloning inthis study refer transgenic plant express phosphatestarvation responsive promoter drive luciferase reporter gene later transform construct contain CaMV promoterdriven sucrose transporter 35S::HPTII transgene pool plant generate screen mutant longroot pheno type seedling grow vertically plate sucrose agar plant exhibit severely suppress root growth medium screen mutant longroot phenotype dayold seedling mapping gene cloning form describe previously plant material gene cloning provide choppcr rna analysis choppcr assay carry accord detailed procedure describe information include Table WholeGenome Bisulte Sequencing Data Analysis Fourteendayold seedling use extraction genomic DNA Bisul te conversion library construction deep sequencing perform tie accord modication detailed Supplemental Experimental Procedures ChIP Assay ChIP assay perform describe bead cat 10003D use precleare antibody bind ing antibody antiH3K9me2 antiH3K18ac cat antipol IDM1 IDM3 MBD7 ROS1 Facilitate ROS1 function create permissible chromatin environment prevent dna hypermethylation gene silence Methyl cytosine Genomic DNA IDM1 Histone acetyltransferase domain protein ros1 dna glycosylaselyase Figure Working Model Functions bind highly methylate genomic region MBD motif use domain bind thus bring IDM1 methylate DNA H3K18ac h3k23ac mark create IDM1 allow ros1 related DNA demethylase recruit curb methylation spread prevent hypermethylation active demethylation cite article press Lang methylcpgbinde Protein MBD7 Facilitates active DNA Demethylation Limit DNA Hyper Methylation Data Analysis proMBD7::gMBD74xMYC transgenic plant use plant control ChIP perform accord previously publish protocol sample send library construction sequence bind call SICER compare replicate MBD7Myc ChIP sample repli cat control protein enrichment calculate accord ing follow enrichment log28 ChIP log28 nInput NChIP Input represent number map chip input tag correspond bin NChIP sum map tag figure relative enrichment value calculate enrichment value log2 enrichment value detailed method describe Supplemental Experi mental procedure yeast TwoHybrid Assay Coding sequence truncate 3MBD STKC stop codon clone pdest22 pdest32 yeast hybrid assay perform describe Bai Analysis oral tissue epitopetagge transgenic line use conjugate MYC antibody Milli pore cat use describe Law protein sample subject analysis detail Supplemental Experimental Procedures Split Luciferase Complementation Assays Split luciferase complementation assay perform tobacco leave protoplast detail provide number highthroughput sequence datum generate study submit NCBI Gene Expression Omnibus GSE58789 GSE58787 gse59712 additional data set use study SUPPLEMENTAL INFORMATION Supplemental Information include gure table Supplemental Experimental Procedures find article online orgmolcel author contribution design study interpret datum write manuscript perform much experimental work contribute exper iment discussion result bioinformatics analysis perform mass spectrometry experiment contribute discussion interpretation result acknowledgment work support Health Grants r01gm070795 receive Revised Accepted publish soybean receptor type protein phosphatase dependent independent genomic targeting principle MBD protein family Cell Bennetzen contribution transposable ele ment structure function evolution plant genome Biol extensive demethylation repetitive element seed development underlie gene imprint Pikaard Multisubunit RNA polymerase purveyor noncode rna plant gene silence Biol function dna methylation plant animal characterization family mammalian methylcpg bind protein Mol cell Biol siRNA pathway prevent transgenerational retrotransposition plant subject stress Nature Karthikeyan Varadarajan expression Arabidopsis phos phate transporter Plant Physiol Kohli TET enzyme dynamic dna demethylation Nature Law Jacobsen Establishing maintain modify dna methylation pattern plant animal Vashisht protein complex require polymerase transcript rna direct dna methylation arabidopsis Curr Biol Zhang genomic evidence sucrose global regulator plant response phosphate starvation Arabidopsis Plant Physiol Lei Wang promote IBM1 distal lation regulate genome dna methylation pattern USA crisprcas system efcient genome engineering plant DNA methylation epigenetic pathway increase complexity Trnovsky methylation inactivation marker gene sequentially transform plant bromage Tempst Reinberg tran scriptional repressor belong MeCP1 histone deacetylase complex histone acetyltransferase regulate active DNA lation Qian active dna demethylation crystal domain protein cite article press Lang methylcpgbinde Protein MBD7 Facilitates active DNA Demethylation Limit DNA Hyper Methylation dna demethylation zebrash involve coupling deaminase glycosylase gadd45 Cell Wei Wang dominate histone acetylation target SWR1 promoter replacement DNA histone methylation plant trend Genet Wang protein regu late plant dna methylation control mrna process int",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 92,
                    "epigenetic": 5,
                    "5mC": 1,
                    "demethylation": 26
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Antisilencing": 1,
                    "SUC2": 2,
                    "Methylationsensitive": 1,
                    "idm2": 5,
                    "MBD74xMYC": 1,
                    "H3K18": 3,
                    "SWR1": 2,
                    "ABAhypersensitive": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "Antisilencing": 124,
                    "SUC2": 124,
                    "Methylationsensitive": 124,
                    "idm2": 124,
                    "MBD74xMYC": 124,
                    "H3K18": 124,
                    "SWR1": 124,
                    "ABAhypersensitive": 124
                },
                "Ethnographic Terms": {
                    "methylation": 16,
                    "epigenetic": 16,
                    "5mC": 16,
                    "demethylation": 16
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "The mGluR5 antagonist 6-methyl-2-_phenylethynyl_ pyridine decreases ethanol consumption via a protein kinase C\u03f5-dependent mechanism.pdf",
            "cleaned_text": "mGluR5 decrease ethanol Consumption Protein Kinase Dependent Mechanism Andrew Mcgeehan Chapel Hill receive accept Glutamatergic neurotransmission play critical role addic tive behavior recent evidence indicate genetic pharmacological inactivation type metabotropic gluta mate receptor mGluR5 reduce selfadministration caine nicotine alcohol mglur5 couple activation protein kinase pkc target deletion epsilon isoform pkc mouse reduce ethanol investigate functional link mGluR5 PKC show acute admin istration mglur5 agonist nylglycine mice increase phosphorylation pkc activation loop terminal region S729 increase dependent mglur5 stimulation also phosphatidylinositol kinase PI3 K addition selective mGluR5 antagonist reduce basal level phosphoryla tion PKC S729 also show dose reduce ethanol consumption wildtype mouse suggest PKC important signal target modulation ethanol consumption mglur5 tagonist Radioligand bind experiment use reveal genotypic difference response result alter mglur5 level bind pkc null mouse datum indicate mGluR5 couple pkc pi3kdependent pathway PKC require ability mGluR5 antagonist reduce ethanol neurotransmission play important role behavioral neurochemical effect drug abuse drug selfadministration study examine role ionotropic glutamate receptor sub type increase evidence metabotropic glutamate receptor mglur also play important role drugrelate example mouse lack type mglur mglur5 show dramatically reduce level cocaine selfadministration cocaine induce hyperactivity addition study use selective mglur5 antagonist confirm role mGluR5 cocainerelated behavior place hyper locomotion selfadministration Chiamulera Kenny nicotine Kenny ethanol also reduce work support Grants AA13276 Bowles Center Alcohol Studies fund provide medical research alcohol substance abuse publication date citation information find mol ABBREVIATIONS mglur5 type metabotropic glutamate receptor diacylglycerol pkc protein kinase CHPG chloro hydroxyphenylglycine methylphenylethynylpyridine ANOVA analysis variance PI3 K phosphatidylinositol kinase hydrochloride 895X MOLECULAR PHARMACOLOGY Vol Copyright Printed ASPET Journals April molpharmaspetjournalsorg mglur5 antagonist finally blockade mGluR5 crease threshold current level intracranial selfstimu lation suggest receptor centrally involve primary reward mechanism Activation group mglur include mglur1 mGluR5 stimulate activity phospholipase thereby generate diacylglycerol turn activate PKC Hermans Challiss different pkc gene identify encode isozyme activate currently know PKC isozyme activate mGluR5 candidate pkc mglur5 enrich region brain volved drug selfadministration addiction include frontal cortex striatum nucleus accumbens hip pocampus moreover considerable anatomical overlap expression mGluR5 pkc brain Romano pkc downstream signal target mglur5 interesting note research show similar pharmacological blockade mglur5 genetic deletion pkc reduce ethanol consumption mouse seek establish biochemical link mGluR5 PKC determine PKC nec essary ability mGluR5 antagonist reduce consumption Materials Methods Animals male mouse age month use experi ment house temperature humiditycontrolled Plexiglas cage BioZone Fort Mill lightdark cycle light food water available libitum note male wildtype C57BL littermate generation use study ethanol consumption experiment see procedure conduct accordance procedure dissolve suspend dimethyl sulfoxide dilution artificial cerebrospinal fluid administration MPEP dissolve physiological saline intraperitoneal administration chemical agent obtain Santa Intracerebroventricular Cannula Implantation Drug treatment experiment involve administration CHPG mouse anesthetize ketamine xylazine place stereotaxic frame equip mouse adapter plastic guide cannula gauge outer diameter plastic aim lateral ventricle unilaterally implant use follow ordinate bregma skull surface point posterior lateral ventral cannula secure skull screw dental cement mouse postsurgical recovery experiment gauge outside diameter microinjection needle Plastics One extend ventral tip guide cannula use drug administration needle con nected gastight syrinx FEP tubing dialysis drive syringe pump flow rate min total infusion fluid microinjection needle leave place additional min infusion allow diffusion drug ventricle separate experimental group mouse treat follow saline mpep min administration CHPG correspond vehicle dilute LY294002 corresponding vehicle dilute methyl sulfoxide min administration CHPG saline final drug treatment mouse euthanize brain move place icecold phosphatebuffere saline dissection striatal tissue Striatal Homogenate Preparation Immunoblot Analy sis striatal tissue place volume homogenization buffer consist EDTA sucrose phenylmethylsulfonyl fluoride dilution protease inhibitor cocktail serine threonine phosphatase inhibitor cocktail homogenize stroke motorize homogenizer rpm centrifuge g min supernatant store western analysis western analysis sample split equal aliquot protein subject gel electro phoresis use separate BisTris gel transfer nitrocellulose membrane preblocke phosphatebuffere saline contain bovine serum albumin phosphoPKC nonfat dry milk powder total pkc incubation primary antibody use follow rabbit polyclonal anti body t566 dilution antiphosphopkce S729 dilution t638pkc Beverly dilution dilution dilution membrane wash incubate horseradish peroxidaseconjugated donkey antirabbit IgG anti sera dilution min immunoreactive band detect enhanced chemiluminescence Piscataway Protein band correspond molecular mass approximately visualize ager resolution use software optical density band divide corresponding total PKC band yield pkc ratio cortex striatum tissue naive wildtype mouse homogenize volume icecold assay buffer consist TrisHCl NaCl homogenate centrifuge g min pellet resuspend assay buffer immediately use Receptor bind crude membrane fraction determine use mmol Louis concentration range nonspecific binding determine use Binding study perform use protein reaction volume incubation room temperature tissue rapidly filter Whatman filter radioactivity remain filter detect liquid scintillation count bind experiment animal perform repli cate experiment genotype brain region ethanol Consumption study c57bl SvJae PKC heterozygous null mouse generation backcross C57BL background April molpharmaspetjournalsorg generation mouse heterozygous mutation subsequently mate female SvJae PKC heterozygous mouse generate hybrid wildtype mouse study mouse house individually cage equip bottle grom met end allow simultaneous access bottle contain ethanol contain tap water beginning bottle remove cage amount fluid consume record Animals access fluid twobottle choice session conduct week animal allow access solution least week baseline consumption establish administration logical agent mouse administer saline volume immediately access session animal receive saline dose balanced randomized order maximum injection week ethanol consumption define gram kilogram ethanol define milliliters ethanol consume total milliliter consume water consumption define milliliter Statistical Analyses Data immunoblot radioligand bind experiment analyze oneway analysis variance ANOVA follow multiple compari son test oneway ANOVA rank appropriate ethanol consumption study analyze twoway anova onefactor repetition treatment follow multiple comparison test consider statistically significant test result PhosphoPKC experiment use phosphospecific antibody detect phosphorylation PKC T566 phosphorylation kinase site consider reflect increase activatable pool PKC Parekh Akita Cenni activation loop PKC phosphorylate phospholipiddependent kinase PDK1 turn activate lipid product phosphatidylinositol kinase PI3 K PKC phosphorylate T566 phosphor ylate terminal autophosphory lation heterologous kinase see Discussion Administration mglur5 agonist wildtype mouse Fig increase abundance striatal phospho PKC S729 immunoreactivity relative total PKC immu noreactivity block systemic pretreatment surprising also increase phosphorylation PKC T566 also block systemic pretreatment Fig increase also inhibit pretreatment PI3 K inhibitor LY294002 Fig contrast CHPG modify ratio phosphoPKC T638 total PKC immunoreac tivity Fig additional experi ment reveal single peripheral administration saline reduce basal level phosphoPKC relative total pkc immunoreactiv ity Fig Ethanol Consumption report previously baseline ethanol consumption significantly high wildtype mouse compare mouse likewise baseline ethanol significantly high wildtype compare mouse Administration dose dependently reduce ethanol consumption wildtype mouse analysis ethanol consumption genotype reveal significant main effect genotype treatment genotype treatment interaction likewise regard ethanol main effect treatment genotype treatment interaction trend significant main effect genotype ethanol effect genotype treatment water intake observe genotype treatment inter action control possibility differential effect ethanol consumption wild type PKCnull mouse result genotypic differ ence mGluR5 density affinity perform radioli gand bind study use crude cortical striatal membrane preparation wildtype pkc null mouse saturation bind curve show genotypic difference ligand bind density observe cortex wildtype null striatum wildtype null likewise geno typic difference ligand affinity observe cortex wildtype pkc null striatum wildtype pkc null discussion finding identify first time novel mGluR5 pkc signal pathway brain regulate ethanol consumption use PKCnull mouse find abil ity mGluR5 antagonist reduce ethanol con sumption dependent presence pkc alteration ethanol consumption result tere mglur5 number bind mutant mouse difference radiolabele bind cortex striatum wildtype PKCnull mouse observe furthermore use phosphospecific anti body phosphorylate T566 PKC LY294002 inhibitor PI3 K find activation mglur5 increase activatable pool pkc PI3 K PDK1 regulated phosphorylation PKC T566 demonstrate 3T3 cell stimulate plateletderived growth factor human embryonic kidney cell stimulate serum serum starvation Parekh result provide first vivo evidence regulate PDK1 medi ate phosphorylation PKC proteincoupled neurotransmitter receptor mGluR5 moreover result also indicate mGluR5 couple PI3 K striatum finding provide vivo functional significance recent demonstration mGluR5 associate mGluR5 Coupling pkc Mediates ethanol Consumption ASPET Journals April molpharmaspetjournalsorg PI3 K PI3 K enhancerhomer protein complex however examine effect LY294002 basal level PKC phosphorylation ously show inhibition PDK1 function use kinase inactive mutant PDK1 rather pharmacological inhibition PI3 K ly294002 alter basal phosphorylation PKC thus predict administration ly294002 alone alter basal level PKC phosphorylation give recent evidence PI3 K contribute ioral plasticity associate repeat exposure cocaine role lipid kinase drug ethanol selfadministration clearly merit measurement pkc activity perform present study rather quantify level phos phorylation PKC use specific antisera phorylation site enzyme phosphorylation PKC isozyme strongly correlate increase activ ity kinase seem essential expression maximal kinase activity PKC isoform contain phos phorylation site activation loop terminal hydrophobic region think sequential phorylation site lead activation enzyme example demonstrate transphosphorylation pkc activation loop T500 PDK1 render competent autophosphory late residue T641 autophosphorylate pkc remain cata lytically competent inactive translocate membrane bind lipid activator PKC contain similar phosphorylation site activation loop terminus S710 likely pkc isoform undergo similar sequential activation sequence activation loop pkc know phosphorylate PDK1 fig mGluR5 receptor posi tively couple pkc pathway dependent mglur5 agonist signifi cantly increase level active PKC measure ratio phospho PKC S729 phosphoPKC T566 immunoreactivitie total PKC immunoreactivity saline follow vehicle effect significantly attenuate animal pre treat saline follow CHPG PI3 K kinase inhibitor LY294002 sig nificantly attenuate ability CHPG increase level phospho PKC T566 relative total pkc vehicle CHPG effect CHPG treatment observe level phosphoPKC T638 relative total PKC systemic administration saline result reduction level phospho PKC S729 immunoreactivity relative total pkc immunoreactivity saline Data show repre send mean animal condition immuno blot analyse April molpharmaspetjournalsorg turn activate lipid product PI3 K pdk1mediate phosphorylation activation loop constitutive event maturation conventional pkc isozyme PKC isozyme regulate activity PI3 K Newton pdk1mediate phosphorylation PKC T566 trigger sequential phosphorylation S710 however phosphorylation reflect auto phosphorylation subject debate inve tigator demonstrate complete abolition phosphor ylation PKC S729 presence pkc inhibitor other find partial duction phosphorylation site latter finding suggest certain condition kinase participate phosphorylation PKC S729 however author also show evidence autophosphorylation process pkc activation kinase inactive mutant PKC fail show phosphory lation PKC S729 regardless mechanism PKC phosphorylation use several study marker change pkc activation present study show activation mGluR5 CHPG stimulate phosphorylation PKC indicate stimulation mglur5 increase available pool pkc become active find ing alone reduce phosphorylation PKC S729 striatum indicate role mglur5 set basal level activatable pkc brain region consistent result report mGluR5 exhibit constitutive activity recep tor undergo endocytosis absence agonist cul ture hippocampal neuron mGluR5 PKC highly coexpresse numer ous region adult rodent brain cerebral cortex olfactory bulb striatum nucleus accumbens hip pocampu current study choose examine dorsal striatum region contain high level protein adjacent lateral ventricle make easily accessible admin istere drug play important role persistent drugrelate habit however striatum also contain significant level PKC thus possibility exist mglur5 region also couple pkc isozyme find modify ratio phosphoPKC T638 Fig PKC require ability mGluR5 antagonist reduce ethanol consumption Saline MPEP administer immediately twobottle access session lack effect administration water intake salinetreated mouse genotype wild type correspond treatment value represent mean animal dose Fig Saturation curve bind membrane cerebral cortex striatum wildtype mouse value represent mean replicate experiment group miceexperiment mGluR5 April molpharmaspetjournalsorg total PKC immunoreactivity indicate effect mglur5 stimulation pkc phosphorylation striatum specific Consistent nonselective group mglur ligand report induce translocation pkc PKC cortical synaptosomes suggest mglur5 coupling pkc specific forebrain region current study underline importance PKC downstream signal target mglur5 ability mGluR5 antagonist reduce ethanol selfadministra tion study need determine dys regulation signal pathway contribute disorder excessive ethanol consumption alcohol abuse alcoholism demonstrate mGluR5 also play important role reinforce behavioral effect drug abuse cocaine nicotine study date examine role PKC activity modulation cocaine nicotine selfadministration well behav ioral neural plasticity induce drug study provide detailed understanding cellular substrate underlie drug addiction interest ing show rewarding effect morphine alter coadministration dose mouse high dose require rodent spe cie preliminary evidence suggest morphine reward enhance mouse lack PKC Newton thus research need aim identify proteincouple receptor mGluR5 couple pkc brain region know crit ically involve rewarding effect morphine ventral tegmental area addition drug abuse mGluR5PKC signal cascade relevance central vous system pathology antagonism mglur5 deletion pkc produce parallel reduc tion anxiety hyperalgesia Hodge Acknowledgments thank London generous donation antisera phospho Protein kinase PKC unique structure function Bio chem antagonist reduce ethanolseeking relapse behavior harmacology Patel protein kinase isoenzyme expression autophosphorylation progression pressure overloadinduced leave ventricular hypertrophy Mol Cell Biochem Sonnenburg Maraldi Newton Toker Regulation novel protein kinase epsilon phosphorylation Tacconi locomotor stimulant effect cocaine absent mglur5 null mutant mouse rescue protein kinase regulate ethanol hypnotic sensitivity adult mouse Neurosci role therapeutic potential metabotropic gluta mate receptor Dutil Keranen DePaoliRoach vivo regulation protein kinase transphosphorylation follow autophosphorylation OlivoMarin metabotropic glutamate receptor mGluR5 endocytose clathrin independent pathway Lovinger habit form drug abuse striatal synaptic plasticity Trends Neurosci potentiation brain stimulation reward reverse eticlopride rat psychopharmacology Hermans Challiss Structural signal regulatory property group metabotropic glutamate receptor prototypic family protein couple receptor McMahon allosteric GABAA receptor modulator alcohol mouse lack PKC Nat Neurosci Messing decrease anxietylike behavior reduce stress hormone neurosteroid supersensitivity mouse lack protein kinase Investig plasticity addiction PI3 kinase cocaine behavioral sensitization Kalivas Glutamate system cocaine addiction metabotropic alpha aminohydroxymethylisoxazole propionate glutamate ceptor regulate deficit brain reward function associate nicotine withdrawal rat Pharmacol Exp ther up down addiction role metabotropic glutamate receptor Trends Pharmacol Sci glutamate receptor tagonist decrease nicotine cocaine selfadministration nicotine cocaineinduced facilitation brain reward function rat Newton Protein kinase regulate vivo functionally distinct phosphorylation Wang novel nociceptor signal pathway demonstrate protein kinase mutant mouse Spooren Gentsch vivo characterization allosteric modulator metabotropic glutamate receptor subtype article Amino acid brain reinforcement mechanism intracranial selfadministration intracranial placeconditione study Effect mGluR5 antagonist acute locomotor stimulant property cocaine amphetamine dopamine reuptake inhibitor GBR12909 mice Psychopharmacology Mcgeehan Olive mGluR5 antagonist reduce condition rewarding effect cocaine drug abuse Synapse Kondo Localization mrnas novel atypical well conventional protein kinase PKC isoform brain develop mature rat phosphorylation protein kinase potential measure activation Newton Regulation protein kinase Newton Protein kinase structural spatial regulation phosphor ylation cofactor macromolecular interaction Rev Messing enhanced sensitivity morphine reward analgesia mouse lack PKC Soc Neurosci Abstr receptor neuroanatomy pharmacology role drug addiction Rev press reduce operant ethanol selfadministration vivo mesolimbic dopamine response ethanol pkc deficient mouse Eur Neurosci control kinase pathway act npkc npkc pathway control protein kinase phosphorylation EMBO Eur Mol Biol Organ Pastorino AlbaniTorregrossa PellegriniGiampietro induce translocation cortical synaptosome couple mglur Eur Neurosci antag onist decrease nicotine selfadministration rat mouse Psychophar macology condition reward inhibit mGluR5 antagonist Neuropharmacology McDonald Malley April molpharmaspetjournalsorg distribution metabotropic glutamate receptor mglur5 immunoreactivity rat brain PI3 kinase enhancerhomer complex couple mGluRI PI3 kinase prevent neuronal apoptosis Fujisawa Ogita intracellular localization epsilonsubspecies protein nase rat brain presynaptic localization epsilonsubspecies Brain Res epsilon isoform protein kinase mammalian nerve terminal Sharko Iller metabotropic glutamate receptor subtype mglu5 alcohol selfadministration Alcohol Clin Exp Res Suppl:112A Shigemoto Immunohistochemical localization metabotropic glutamate receptor mGluR5 rat brain function group group metabotropic glutamate receptor behavioural characterization implication treatment CNS disorder Behav Pharmacol allosteric antagonist shed light receptor CNS disorder Trends Pharmacol Sci subspecie protein kinase mammalian central nervous system onism metabotropic glutamate receptor inhibit nicotine cocainetaking behaviour prevent nicotinetriggered relapse nicotineseeke Eur Pharmacol mechanism addiction behavior transmitter release gene expression addictive plasticity striatum role metabotropic glutamate receptor pharmacol synaptic plasticity drug reward circuitry Wise opiate reward site substrate Rev phosphorylation isozyme protein kinase adult rat dorsal root ganglia inflammation nerve injury address correspondence San Horton Suite mail foliveitsaucsfedu mGluR5 Coupling PKC Mediates ethanol Consumption ASPET Journals April molpharmaspetjournalsorg",
            "term_counts": {
                "Mental Health Terms": {
                    "anxiety": 1
                },
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Plexiglas": 1,
                    "PDK1": 1,
                    "mGluR5PKC": 1,
                    "Hermans": 1
                }
            },
            "co_occurrence_matrix": {
                "Mental Health Terms": {
                    "Plexiglas": 1,
                    "PDK1": 1,
                    "mGluR5PKC": 1,
                    "Hermans": 1
                },
                "Ethnographic Terms": {
                    "anxiety": 4
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "The role and impact of rubber in poly _methyl methacrylate__lithium triflate electrolyte.pdf",
            "cleaned_text": "short communication role impact rubber polymethyl methacrylate lithium triate electrolyte Faculty Applied Science Universiti Selangor Universiti Skudai Johor receive receive revise form accept Available online research new thin freestande lm polymethyl methacrylate epoxidise natural rubber dope lithium triate LiCF3SO3 salt prepare solvent casting method incorporation find increase conductivity pmmalicf3so3 order magnitude room temperature high conductivity achieve room temperature LiCF3SO3 salt introduce blend contain formation excessive hydrogen bond interchain crosslinking limit performance blend high concentration ionic conduction mechanism LiCF3SO3 electrolyte obey rule ion transport material thermally assist Elsevier right reserve polymer electrolyte transparent polymeric material posse many desirable property light weight high light transmittance chemical resistance uncoloure resistance weathering corrosion good insulate property amorphous morphology polar functional group polymer chain exhibit high afnity lithium ion plasticiz ing organic solvent therefore display essen tial characteristic potential polymer electrolyte mate rial oxygen atom carbonyl group expect form coordinate bond lithium ion dope salt use polymer host material development polymer base electrolyte find gel form give high ionic conductivity subambient temperature good solvent retention ability corresponding author fax mail address latifhotmailcom date gel electrolyte receive much attention test electrochemical device system exhibit high ionic conductivity room temperature well interfacial property lithium electrode compare base gel follow study several system base apply application electrochromic device good optical property become good candidate nonlinear optical application communication technology serious drawback plasticize gelbased system poor mechanical property date remain unsolved mechanical property improve modify polymersolvent ratio however adversely affect conductivity material ous problem face system presence easily corrode lithium metal anode electro chemical cell high ionic conductivity reach blend polymer polymer circumvent problem associate poor mechanical property blend approach form freestande see front matter right reserve Sources Fig structure PMMA Fig Structure ENR base electrolyte therefore provide good mechan ical property Rhoo verie blend concept PVCPMMA electrolyte system also demonstrate use PVCPMMA blend lithium ion polymer battery mechanical strength increase content PVC increase however conductivity system decrease due poor adhesion lead increase interfacial resistance work main polymer host polymethyl methacry late PMMA blend epoxidised natural rubber ENR Fig modication lower glass transition temperature PMMA also give rubberlike characteristic new material good elasticity adhesion therefore provide excellent contact electrode electrolyte battery work solid electrolyte form thin free standing lm fabricate alone form brittle epoxidised natural rubber add reprove brittle property lm hence pro ducethesoftelastomericgoodelasticityandadhesionpropertie freestande characteristic predict give excellent contact electrolytic layer electrode battery Experimental Materials PMMA ALDRICH tetrahydrofuran merck LiCF3SO3 ALDRICH use fur ther obtain Siliau Negeri Sembilan Malaysia Preparation blend stock solution prepare separately dissolve polymer continuous stirring magnetic stirrer polymer solution mixed beaker together LiCF3SO3 salt concentration xe sample preparation concentration add weight amount LiCF3SO3 salt add solution contain weight stir preparation step do glove box electrolyte solution cast glass Petri dish leave dry solvent evaporation room temperature lm obtain dry oven solvent free lm keep desiccator use measurement analysis analysis carry use SHIMADZU Fourier transform infra red spectrophotometer use perform analysis blend complex frequency range impedance spectroscopy measure impedance lm sample cut round shape size electrode sample sandwich stainless steel block electrode diameter Hioki LCR use perform impedance mea surement electrolyte lm frequency range mhz ColeCole plot obtain bulk resistance sample determined hence con ductivityofthesampleswerethencalculatedusing RbA sample thickness effective contact area electrode electrolyte cm2 bulk resistance result discussion blend produce thin transparent exible freestande lm dope licf3so3 salt however phase separation observe surface lm show blend homogeneous study show spectrum pure blend doped lm concentrate CH3 ch3 band PMMA epoxide group spectrum blend lm group expect coordinating site lithium ion band PMMA affect presence blend ever band shift low frequency however ch3 ch3 band respectively find shift blend hand band respectively find absent blend therefore assume opening Sources Fig spectrum pure pure blend blend dope LiCF3SO3 salt double bond due formation interchain cross link system broad band observe spectrum support presence hydrogen bond polymer chain therefore also conclude blend partially compatible hydrogen bond analysis conrme interaction occur blend interaction occur hydrogen bonding chain explain observe spectra blend licf3so3 salt add system vibrational band assign nondegenerate vibrational mode so3 free anion respectively observe shoulder CF3 become weak so3 slightly broaden shift amount salt increase indicate formation ion pair ion aggregate number ion increase furthermore carbonyl band blend observe broaden due interaction occur carbonyl group CH3 CH3 band also shift blend observation conrme formation polymersalt complexe electrolyte lm occur coordinate bond ionic conductivity overall conductivity blend high individual pure form dope amount LiCF3SO3 salt play role plasticizer reduce viscosity chain hence increase chain mobility hand act mechanical stiffener previously act plasticizer PVC blend find reduce stiffness PVC note blend present high con ductivity value compare blend composition increase amount blend increase number reactive epoxide group potential form hydrogen bond formation exce sive number hydrogen bond also reduce segmental motion polymer responsible transport lithium ion furthermore increase number molecule induce interchain crosslinking hence develop highly viscous phase blend matrix reduce chain segment mobility occurrence highly viscous phase retard migration lithium ion blend matrix increase concentration blend also increase number oxygen atom contribute epoxide group accord also cause excessive coordination site lithium ion hinder migration ion polymer chain high conductivity achieve room temperature LiCF3SO3 salt introduce blend contain observe high conduct sample room temper ature also exhibit high electrical conductivity temperature high conductivity also achieve sample plot Fig blend various amount LiCF3SO3 salt exhibit straight line indicate plot ver sus LiCF3SO3 electrolyte obey rule ionic conduction mate rial thermally assist Fig ColeCole plot high conducting sample average conductivity LiCF3SO3 various composition temperature Conductivity PE1T1 PE1T2 PE1T3 PE2T1 PE2T2 PE2T3 Fig Arrhenius plot different amount licf3so3 PMMAENR LiCF3SO3 electrolyte Fig activation energy salt PMMAENR blend calculate gradient plot observe exhibit trend increase amount salt increase decrease note activation energy combination energy defect formation energy defect migration fore suggest rise due energy require provide conductive condition migration ion however PE2T3 offer well environment hence require less energy ion transport find blend exhibit high composition due presence highly crosslinkedviscousphasein20enr50thathamperstheionic motion site table summarize aver age conductivity respective value LiCF3SO3 various composition blend lm exhibit conductivity order magnitude high individual form dope LiCF3SO3 salt high achieve room temperature add PMMA contain formation excessive hydrogen bond interchain crosslinking limit performance blend high concentration ment financial support grant highly acknowl edge thank Guthrie Polymer Sdn Bhd Siliau provide free sample Appl Polym Sci Acta Liu solid State Ionics Electrochim Acta Mani Mani Solid State Ionics Dereggi Macromolecules Acta Rajendran Acta Ratnam Polym Testing Glasse Linford Schlindwein Solid State Ionics",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Hioki": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "The role of DNA methylation in mammalian epigenetics.pdf",
            "cleaned_text": "science Science Role DNA Methylation Mammalian Epigenetics copy personal noncommercial use click colleague client customer order highquality copy wish distribute article other follow guideline obtain republish repurpose article portion article information current follow resource relate article available online version article include highresolution figure find online update information service access free cite article article article cite article article host HighWire Press see cite article subject collection article appear follow register trademark right reserve title Copyright American Association Advancement Science New York Avenue print online publish December Science constitute small proportion total mammalian genome precise control expression presence whelming background noncode dna present substantial problem regulation dna contain intron repetitive ele ment potentially active transposable element require effective mechanism longterm silence Mammals appear take advantage possibility afford cytosine methylation provide heritable mechanism alter interaction assist silence Genes transcribe methylationfree promoter even adjacent transcribe nontranscribed region exten sively methylate promoter use regulate keep noncode dna include transposable element suppress also use longterm epigenetic silence link imprint gene increase decrease level transcrip tion depend methylation inactivate positive negative regulatory element dna methylation essential develop ment mammal work researcher still know exactly recent advance lead cloning preliminary characterization know active DNA cytosine methyltransferase great understanding methylation signal interpret mammalian cell postsyn thetic addition methyl group posi tion cytosiness alter appearance major groove dna dna bind ing protein bind epigenetic marker dna copy dna synthesis result heritable change chromatin structure promoter use mammal prevent transcriptional initiation ensure silence gene inactive chromosome imprint gene parasitic dna potential role methylation tissuespecific gene expres sion regulation promoter less well establish also tantalize evidence normal chromosome structure affected methylation human disease include cancer cause pacte abnormal methylation cpg dinucleotide site almost methylation mammal sente DNA Clusters CpGs call cpg island often find association gene often promoter first exon also region end exact definition cpg island evolve original suggestion gion great base pair high content observedexpected ratio occurrence cpg probably modify slightly high term length content thus exclude substantial number small onic region repetitive parasitic dna salient property island unmethylate germline indeed somatic tissue thus ensure continue existence face strong mutagenic pressure deamination cpg island often func tion strong promoter also propose function replication origin even generally meth ylate investigation role dna methylation mammal focus cpg island rather region majority methylation find Methylation Patterns Prokaryotes methylase show tion potential methylation site mammal question address detail invention bisulfite sequencing pattern methyl modification read ease notnecessarilyconflicting model account vary pattern exclusion access methylation site protein bind specific dna region methylationtargete mechanism steer sequencespecific bind protein dence first model come study show removal sp1 bind site flank island lead novo meth ylation development suggest DNA methylase gain access relevant island flank Sp1 site occupy sp1 transcription factor also modulation dna bind protein affinity directly affect methylation state site pro tein bind experiment suggest exclusion DNMTs play role formation pattern occur early development however unequivocal evidence yet dominant mechanism vivo physical barrier methyl ation cpg island also mechanism override specific developmental cue example novo methylation promoter link gene occur inactive active chromosome time implan tation exclusion model suggest pattern see germ somatic cell analogous footprinting process everything get methylate region mostly island access site exclude local chromatin structure Sp1 site evidence targeting model come recent work show association enzyme protein include histone transcriptional pressor RP58 other ever show interaction lead novo methylation ing also suggest lack methyl ation satellite dna mouse human cell deficient DNMT3b activity indicat ing repetitive heterochromatic dna target DNMTs function transcriptional suppressor collaboration protein hdac absence dna methylation thus necessary evaluate early experiment claim show enzymatic activity methyltransferase rather protein responsible observe repression gene expression Importance Spreading concept silence spread come study field matinization Comprehensive Cancer Center Depart ment Biochemistry Molecular Biology Keck School Medicine University Southern California Eastlake Avenue 8302L Los geles USA correspondence address mail VOL science wwwsciencemagorg vation early experiment methylation field show novo methylation integrate retroviral sequence spread host sequence flank integration site also propose repetitive element short long intersperse nuclear element lines serve focus novo methylation methylation spread attrac tor modification mechanism spread remain unknown related fact partially methylate dna well substrate unmethylated DNA vitro recent study show methylate DNA allosterically activate catalytic center perhaps methylation attract methylation thus ensure selfper petuate methylate state phenomenon spread explain propensity cpg island become methylated novo spread surround methyl ate sequence aging cancer overall level genomic methylation decrease mechanism underlie profound alternation distribution methyl group remain unknown Methylation mammalian transcription often say methylation block gene expression statement oversimplification change interaction protein dna lead alteration chromatin struc ture decrease increase rate transcription position methylation change relative transcrip tion start site critical outcome Fig Methylation promoter cpg island lead bind methylate cpg bind protein transcription repressor include hdac block tion initiation precise role global suppressors methyl ate promoter yet fully fine knockout mouse methylcpg bind ing protein Mecp2 yet show increase expression endogenous gene parasitic dna however protein well act redundant fashion deficiency member family compensated other Reso lution issue likely stimulate much research clear fully understand methyl ation signal interpret cell define role prevent transcriptional initiation methylation stop tran script elongation mammal property methylation essential allow mammalian cell prevent spurious tion transcription potentially active pro moter intragenomic parasite embed gene interfere regulation host gene figure also show methylation silencer insulator element block bind cognate bind protein potentially abolish repressive activity gene expression therefore mammalian cell take full advantage alter appear ance major groove dna result alternative effect transcrip tion modulation interaction dna bind protein Methylation regulate tissue Specic Gene Expression dna modification pattern tissue specific incontrovertible lead hypothesis variable methylation pattern responsible tissuespecific gene expression however many experi ment examine relation methyl ation gene expression compro mise precise location methylation change relative transcrip tion start regulatory region precisely define also point large number site investigate experiment locate transposable element make relevance observe change gene expression obscure detailed study show change promoter link rectly transcriptional repression thus even clear evidence bind transcription factor myc cognate site block meth ylation detailed experiment tential role kind change define regulatory region develop ment perform likewise exception cpg island mal gene promoter become methyl ate differentiate cell example island muscle determination gene MyoD1 methylate nonexpresse tissue brain potential role dna methylation control tissuespecific gene expression therefore main question specialized gene variably methylate cell link expression remain largely unanswered methylation major contributor generation diseasecausing germ line mutation somatic mutation cause cancer recent work show abnormal methylation promoter regulatory gene cause silence substantial pathway cancer development much excite ment generate finding rare disease immunodeficiency meric instability facial anomaly syn drome common kind mental retardation young girl syn drome potentially cause Fig dna methylation inu ence bind protein dna thus alter expression hypothetical mam malian gene unmethyl ate open lollipop active island pro moter Pro transcription factor tfs transcrip tion initiation site initiate proceed downstream element even methylate close lollipop presumably coat methyl bind domain protein histone deacetylase hdac note precise role yet denedother protein play important role process enhancer functional silencer insulator methylate thus occupy respective cognate protein Methylation permissive expression transcript initiate potentially active line element methylated note autosomal gene cpg island promoter unmethylate independently level expression methylation promoter involve ne control Bottom permanently silence gene imprint gene gene inactive chromosome promoter methylate lead bind HDACs transcriptional suppressor chromatin compaction transcription factor normally regulate gene expression able access promoter illustration also show lack methylation silencer insulator lead bind cognate protein gcf2 binding factor CTCF bind factor respectively thus prevent enhancer function transposable element exem ply line element sometimes unmethylated therefore potentially initiate transcription transposition wwwsciencemagorg science VOL change methylation machinery patient mutation dnmt3b gene lead undermethylation satellite dna specific chromosomal decondensation syndrome patient mutation MBDs MeCP2 therefore able interpret methylation signal correctly disease suggest meth ylation need complete development also require development birth price requirement methylation essen tial mammal seem substantial increase cancer risk study dna methylation mam mal stimulate identification key enzyme methylate dna interaction dna dna bind ing protein link methylation chromatin structure perhaps major function methylase mammal longterm silence noncode dna genome contain substantial portion repetitive element lack methylation promoter essential gene allow potentially active regulate process hand still know specific pattern see gene differ entiated cell type involve transcrip tional control simply reflect alter chromatin state DNA methylation field currently state high activity link stable epigenetic state chromatin structure heterochromatinization begin become clear disruption link lead substantial disease state include chromo somal integrity mental retardation cer understand epigenetic state establish maintain develop strategy modify therapeutically therefore likely area intense future research Okano Bell Haber Cell Bestor Laudano Mattaliano Ingram Mol Biol Nature Genet Larsen Prydz Genomics GardinerGarden Frommer Mol Biol unpublished datum Antequera embo Bioessays Bird Genes Dev Brandeis Nature Biol Han Biol Reik Dean Genet Rountree Bachman Baylin Nature ide Jaenisch Nature Mol Cell Biol Turker Semin Cancer Biol Marasco Sufrin Sci Carotti Funiciello Palitti istry Genet Jones Nature Nature Holmes Martin Bird Nature Akbarian Tudor Nature Wilson Bird Genes Trends Genet Gonzalgo cancer Res Rountree Selker Genes Dev Moore Nature Genet Eden EMBO Hark Nature DNA methylation Molecular Biology Biological Signicance Eds vol trend Genet Prendergast Ziff Science Sci Cooper Science cancer Res Jones Nature support grant R01 CA82422 NCI DNA Methylation Epigenetic Inheritance plant filamentous Fungi lamentous fungi share mammal enzyme responsible dna methylation organism dna methylation associate gene silencing transposon control however plant fungus differ mammal genomic distribution sequence specicity heritability methylation consider role transposon play establish methylation pattern epigenetic consequence perturbation change call epimuta tion occur nucleotide sequence form genetic information cell chromosomal protein dna methylation also inherit portant phenotypic consequence plant filamentous fungi genomic meth ylation restrict mostly transposon repeat mammal contrast code sequence methylate well cept call cpg island often encompass first exon gene difference likely reflect colonization mammalian intron transposon possibility methylation spread flanking exon course human genome contain far less exonic dna transposon thus contribute level cytosine meth ylation overall lose methylation become activat gene gain extra methylation become silence first epimutation serve note transposon underwent cycle inactivity maize change phase ate change dna methylation distinct change state usually sequence rearrangement defective intact transposon also modify epigenetically preset ter exposure active transposon Cold Spring Harbor Laboratory Cold Spring Harbor USA correspondence address mail permanent address nomique tale INRACNRS AUGUST VOL SCIENCE",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "methylation": 53,
                    "epigenetic": 5
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Han": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "Han": 58
                },
                "Ethnographic Terms": {
                    "methylation": 1,
                    "epigenetic": 1
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "The toxicological assessment of cyclopentyl methyl ether _CPME_ as a green solvent.pdf",
            "cleaned_text": "molecule molecules18033183 molecule Toxicological Assessment Cyclopentyl Methyl Ether CPME Green Solvent Kiyoshi Watanabe Specialty Chemicals Division ZEON corporation Marunouchi Chiyoda receive revised form Accepted publish Cyclopentyl methyl ether CPME use chemical synthesis alternative hazardous solvent accord early investigation other CPME low acute subchronic toxicity moderate irritation negative mutagenicity negative skin sensitization local Lymph Node Assay Calculated Permitted Daily Exposure PDE value CPME obtain day oral toxicity test day CPME thus assume class equivalent solvent Tripartite Guideline wide synthetic utility detailed toxicity study suggest CPME green sustainable solvent choice modern chemical transformation CPME ethereal solvent process chemistry toxicity study green solvent Introduction Ethereal solvent widely use chemical synthesis wellknown drawback large scale operation circumstance cyclopentyl methyl ether CPME develop low toxic alternative solvent wide synthetic applicability complement previous report other report notable utility CPME organic synthesis especially process chemistry research furthermore also disclose important toxicological evaluation include acute toxicity mammalian subchronic toxicity study mutagenicity already emphasize previous CPME notable physical property summarize follow low peroxide formation high hydrophobicity relative stability acidic basic condition high boiling point low melting point open ACCESS Molecules low heat vaporization narrow explosion area low solubility salt thus many synthetic application CPME notable practical example catalytic reaction use CPME solvent summarize Schemes Scheme Palladium carboncatalyze aromatic secondary amination crosscoupling reaction aryl magnesium bromide alkyl halide Scheme asymmetric catalytic cycloetherification hydroxy unsaturated ketones Scheme replacement reaction medium toluene CPME allow reaction completion afford desire product yield sole product furthermore amount base reduce Scheme diethyl ether give good result yield formation biphenyl CPME yield also suitable solvent yield product decrease notably tetrahydrofuran yield yield however diethyl ether hard use large quantity low boiling flash point easy peroxide formation scheme solvent optimization process identify CPME suitable solvent enantioselectivity moreover catalytic loading even lower mol ambient temperature still give excellent yield enantioselectivity mention CPME prove suitable solvent various catalytic reaction CPME already use production pharmaceutical aroma chemical electronic material process solvent already register list corresponding legislation new chemical substance commercially available country other purpose article provide mammalian toxicity information CPME toxicity hardly know help recognize green process solvent arn OMe CPME Molecules Results Discussion Toxicity Evaluation quite important grasp toxicity CPME prove suitable process solvent describe many mammalian toxicity study acute toxicity subcronic toxicity mutagenicity perform toxicity study conduct guideline testing chemical number parenthesis indicate corresponding guideline Acute Toxicity Studies first acute toxicity study carry purpose evaluate toxicity expose CPME large quantity time rat rabbit select experimental animal study include oral dermal inhalation dermal irritationcorrosion Eye irritationcorrosion skin sensitization local Lymph Node Assay test respectively Irritation show reversible response corrosion show irreversible result acute toxicity study CPME summarize Table Table acute toxicity study CPME toxicity test guideline result acute oral toxicity LD50rats Acute dermal toxicity LD50rats Acute inhalation toxicity LD50rats acute dermal irritationcorrosion Rabbit elicit welldefine moderate severe dermal irritation Acute eye irritationcorrosion Rabbit elicit considerable conjunctival irritation animal ocular response resolve instillation Skin sensitizationLLNA Negative Acute Oral Toxicity OECD Acute oral toxicity study carry purpose evaluate toxicity CPME swallow female rat die single dose maximum dose death male rat female rat occur single dose study range LD50 single oral dose estimate great low judge classify harmful swallow H302 accordance OECD Acute dermal toxicity study carry purpose evaluate toxicity skin CPME apply single dose maximum dose study Molecules LD50 CPME dermal contact estimate great death systemic response observe Acute Inhalation Toxicity OECD Acute inhalation toxicity study carry purpose evaluate toxicity CPME breathe vapor exposure level maximum concentration study LC50 CPME inhalation estimate great significant effect observe Acute Dermal IrritationCorrosion OECD acute dermal irritationcorrosion study carry purpose evaluate toxicity skin CPME apply study single semiocclusive application CPME intact rabbit skin give welldefine moderate severe dermal irritation dermal reaction gradually ameliorate resolve completely however slight dermal irritation still evident remain animal study termination day addition thicken skin desquamation note animal area ulceration edge dose site animal crack skin animal primary calculate judge accord classify skin irritation accordance Acute eye irritationcorrosion study carry purpose evaluate toxicity eye cpme eye study instillation single ocular dose cpme eye rabbit give considerable conjunctival irritation animal corneal damage iridial inflammation observe diffuse beefy red colouration conjunctiva swell partial eversion lid see animal diffuse crimson colouration conjunctiva normal swelling observe remain animal ocular response first note instillation reaction gradually ameliorate resolve instillation judge Globally Harmonized System Classification Labeling Chemicals GHS CPME classify eye irritation accordance Skin Sensitization Local Lymph Node Assay LLNA OECD skin sensitization study carry purpose induce allergic reaction cpme test substance regard sensitizer least concentration chemical result great increase incorporation compare control value assay testcontrol ratio obtain supply respectively indicate CPME show potential induce skin sensitization Molecules Subchronic toxicity Studies first subchronic toxicity study repeat dose oral toxicity study usually use select highly advanced examination evaluate systemic toxicity CPME swallow chronically day subchronic inhalation toxicity study choose base result observed effect level NOAEL observe adverse effect level CPME obtain result repeat toxicity study CPME summarize Table Table repeat toxicity study CPME toxicity test guideline result repeat dose day oral toxicity day male day female inhalation toxicity day study male mg female Repeated Dose Day oral toxicity Study OECD repeat dose oral toxicity study carry purpose evaluate systemic toxicity CPME swallow select dosage day oral toxicity rat dose dosage level day corn oil Treatment day tolerate death see male treatment tolerate day therefore dose regimen day propose study intermediate day low day dose level select basis key dosage relative labeling requirement unscheduled death observe male rat receive day occur treatment due poor clinical condition clinical sign note male rat receive day consist salivation note isolated occasion active behavior piloerection abnormal gait body tremor convulsion hunch posture fast respiration thin appearance Salivation wet coat note frequently female rat receive day Salivation also note isolated occasion male rat receive day day treatmentrelated clinical sign note female rat receive day rat receive day reveal high mean activity female rat receive day activity recovery female rat previously treat day comparable control gain recovery group male female rat previously treat day comparable control hematology blood chemistry urinalysis change associate treatment observe rat receive day low control urinary protein chloride level male regard organ weight macroscopic pathology little change nothing attributable CPME note terminal recover rat microscopic pathology female rat receive day male female rat receive day reveal change consider attributable treatment addition treatment relate finding observe tissue examine recovery group animal previously treat day change associate treatment observe molecule rat receive day low control urinary protein chloride level male however change slight similar lower urinary parameter note treat female group microscopic change observe kidney treat animal thus change day consider adverse nature toxicological importance conclude dosage level day male day female represent CPME dosage level day male consider represent NOAEL CPME study Subchronic Inhalation Toxicity Day study OECD Subchronic inhalation day toxicity study carry purpose evaluate systemic toxicity cpme inhale dose find study day repeat dose toxicity study inhalation exposure rat conduct prior present study testing facility use male female expose target concentration result dose find study reveal CPME lethal effect concentration result salivation body weight change high value white blood cell count concentration consequently maximum target exposure concentration study set obvious toxic effect expect target exposure concentration study set common ratio approximately moreover target concentration set control group expose air contain test substance also prepare igs rat expose gaseous cpme normal condition day inhalation exposure reversibility observe effect also examine recovery period concentration set CPME Acute accurate concentration male rat female rat respectively male rat female rat exposure group indicate salivation nasal discharge low body weight male rat female rat exposure group low body weight gain male rat exposure group compare control group recovery period low body weight also see male rat female rat exposure group however body weight gain animal recover level control group female rat exposure group indicate low food consumption compare control group recover recovery period blood chemistry high value alanine aminotransferase potassium male exposure group compare control group difference observe recovery period pathological examination male rat exposure group indicate high absolute body weightrelative kidney weight compare control group hyaline droplet proximal tubular epithelium kidney moreover simple hyperplasias mucosal epithelium urinary bladder male rat female rat exposure group conclude change kidney urinary bladder attributable CPME exposure influence present animal subject Molecules necropsy end recovery period adverse effect hematology parameter ophthalmoscopy attributable test substance therefore toxicological effect observe male rat female rat exposure group significant change never observe male female rat expose CPME consequently low observe adverse effect level CPME conclude observed effect level CPME conclude male rat female rat condition study reversibility adverse effect recovery period accurately CPME conclude male rat female rat condition study similarly CPME male rat female rat respectively Mutagenicity Studies finally mutagenicity study perform screen test predict carcinogenicity CPME compose bacterial reverse mutation test test vitro mammalian chromosome aberration test vivo mammalian erythrocyte micronucleus test previously report CPME also show negative mutagenicity study conduct result mutagenicity study CPME summarize Table Table Mutagenicity study CPME toxicity test guideline result bacterial reverse mutation study test Negative vitro mammalian chromosome aberration test Negative vivo mammalian erythrocyte micronucleus test Negative Bacterial Reverse mutation Test Ames Test OECD bacterial reverse mutation test test carry purpose evaluate mutagenicity bacteria CPME study CPME show evidence mutagenic activity bacterial system Mammalian Chromosome aberration Test OECD vitro mammalian chromosome aberration test carry purpose evaluate mutagenicity mammalian cell CPME study CPME consider ability induce chromosomal aberration Vivo Mammalian Erythrocyte Micronucleus Test OECD vivo mammalian erythrocyte micronucleus test carry purpose evaluate vivo mutagenicity mammal CPME study CPME show evidence cause chromosome damage bear marrow cell toxicity administer orally gavage clinical sign observe include underactivity overactivity flatten posture abnormal gait fast irregular respiration reduce righting reflexe clinical sign molecule underactivity abnormal gait fast respiration observe dose animal survive schedule termination Experimental General CPME prepare zeon corporation reagent material obtain commercial product rat use obtain rabbit strain typhimurium National Collection Type Cultures London strain coli Marine Bacteria Aberdeen Chinese Hamster Lung CHL Cells strain mix liver preparation induce rat toxicity study conduct OECD Guidelines Testing Chemicals Section Good Laboratory Practice Animal Management room use rat rabbit mouse maintain relative humidity light lighting light respectively standard laboratory rodent diet tap water provide libitum cage make stainless steel stainless steel grid floor Acute oral toxicity single oral gavage CPME formulate aqueous methylcellulose give fast rat Acute dermal toxicity single dose level maximum dose CPME apply group rat male female dermal application Acute Inhalation Toxicity Noseonly inhalation vapor level maximum concentration nominal CPME apply rat male female chamber Acute Dermal IrritationCorrosion single ocular dose volume CPME apply intact rabbit skin Molecules Acute Eye IrritationCorrosion single ocular dose volume CPME drop eye rabbit Skin Sensitization Local Lymph Node Assay llna proliferative response lymph node cell drain auricular lymph node assess follow initial application measurement incorporation thymidine scintillation count suspension response express radioactive disintegration minute lymph node dpmnode ratio incorporation test node relative record control nodestestcontrol ratio Repeated Dose Day Oral toxicity Study CPME administer oral gavage group male female rat dosage level day completion administration regime experimental animal kill evaluate cpme toxicity symptom mortality clinical sign neurobehavioral screen bodyweight food consumption food conversion efficiency water consumption hematology blood chemistry urinalysis organ weight macroscopic pathology microscopic pathology Subchronic Inhalation toxicity Day study toxic effect CPME examine igs rat expose gas consecutive inhalation exposure reversibility observe effect also examine recovery period target concentration study set CPME completion administration experimental animal kill evaluate systemic toxicity symptom cpme mortality clinical sign neurobehavioral screen bodyweight food consumption food conversion efficiency water consumption haematology blood chemistry urinalysis organ weight macroscopic pathology microscopic pathology result CPME determine respectively Bacterial Reverse mutation Test Ames Test Suspensions bacterial cell Salmonella typhimurium strain TA1535 TA1537 TA98 TA100 coli strain expose CPME presence absence exogenous metabolic activation system mix incubation substantial increase revertant colony count obtain strain follow exposure CPME plate presence absence mix apparent toxicity bacteria Mammalian Chromosome aberration Test test Chinese Hamster Lung CHL cell use concentration set mmol CPME cell growth inhibition test Molecules conduct concentration CPME shortterm treatment assay absence presence mix continuous treatment assay cell growth inhibition test CPME inhibit cell growth treatment condition result chromosomal aberration test conduct treatment condition incidence cell chromosomal aberration less test substance treatment group treatment condition Vivo Mammalian Erythrocyte Micronucleus Test mouse expose CPME single oral administration dose level sacrifice appropriate time treatment bone marrow extract preparation make stain analyze presence micronucleus statistically significant increase frequency micronucleated immature erythrocyte substantial decrease proportion immature erythrocyte observe mouse treat CPME kill later compare vehicle control value case conclusion mention CPME preferable characteristic make useful solvent organic synthesis process chemistry toxicity study CPME relatively low acute toxicity negative skin sensitization llna negative mutagenicity show moderate severe irritation skin eye calculate PDE value CPME obtain day oral toxicity test day CPME presume class equivalent solvent q3c guideline judge toxicity cpme globally Harmonized System Classification Labeling Chemicals GHS CPME classify harmful swallow H302 cause skin irritation eye irritation accordance handle CPME especially important swallow expose skin eye acknowledgment greatly thank precise instruction manuscript preparation kind advice help Notes Constable Sherwood Binks solvent selection guideembedde sustainability solvent selection start medicinal chemistry Torisawa Improved Pinner Reaction CPME Solvent Synth Commun Torisawa Cyclopentyl Methyl Ether New Alternative Process Solvent Org Process Res Dev Molecules Watanabe contribution Cyclopentyl Methyl Ether CPME Green Chemistry Process Innovation Proceedings 2nd International Symposium Process Chemistry Ferry Johnson Mathe Scott Toxicological Assessment Methyltetrahydrofuran Sajiki Evaluation Aromatic Amination Catalyzed Palladium Carbon Adv synth Catal Yamaguchi Ando Nagaya application ironcatalyze CrossCoupling Reaction Aryl magnesium bromide Alkyl Halides Chem Lett Asano Matsubara Asymmetric Catalytic Cycloetherification mediate Bifunctional Organocatalysts operation Development OECD OECD Guidelines Testing Chemicals Section available online guidelinesforthetestingchemicalssectionhealtheffects20745788jsessionid1jtmh2rly59bu oecdlive access oral Arch Toxicol OECD OECD Guidelines Testing Chemicals section test Acute Dermal toxicity available online access OECD OECD Guidelines Testing Chemicals section test Acute Inhalation Toxicity Available online access OECD OECD Guidelines Testing Chemicals section test acute dermal irritationcorrosion available online expiresaccnameguestchecksum483e0ffb37860e681faeed0f77b44e19 access Neun Effects Alkalinity Eye Irritation Potential Solutions Prepared Single Toxicol cut ocular Toxicol Kimber Basketter Murine Local Lymph Node Assay Collaborative Studies New Directions Commentary Food Chem Toxicol OECD OECD Guidelines Testing Chemicals section test Repeated Dose day Oral toxicity Study Rodents available online docserver9740701epdfexpiresaccnameguestchecksum access OECD OECD Guidelines Testing Chemicals section test Subchronic Inhalation Toxicity day study available online docserver9741301epdfexpiresaccnameguestchecksum access Molecules Ames McCann Yamasaki Methods detect Carcinogens Mutagenicity test Mutat res Sofuni Comparison Chromosome Aberration Induction Compounds test Chinese Hamster Cell CHL Culture Mutat Res Heddle Rapid Vivo Test Harmonized Tripartite Guideline Impurities guideline residual solvent class solvent available online publicwebsiteichproductsguidelinesqualityq3cstep4q3cr5step4pdf access document show solvent limited PDE Permitted Daily Exposure maximum acceptable intake day residual solvent pharmaceutical product PDE day weight adjustment PDE value calculate use modify factor conversion rat human variability individual toxicity study rat weight adjustment Sample availability CPME available author reagent company World author licensee article open access article distribute term condition Creative Commons Attribution license",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "molecules18033183": 1,
                    "semiocclusive": 1,
                    "Chinese": 2
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Tropospheric oxidation mechanism of dimethyl ether and methyl formate.pdf",
            "cleaned_text": "Tropospheric Oxidation Mechanism Dimethyl Ether Methyl Formate West Final Form NoVember oxidation mechanism dimethyl ether investigate use initio method structure energetics reactant product transition structure determine pathway involve oxidation mechanism detailed pathway lead experimentally observe product dimethyl ether oxidation present energetic specie transition structure involve oxidation process calculate MP2 energie principal pathway follow initial attack dimethyl ether ch3och3 radical formation step lead formation methyl formate consistent experimentally observe product oxidation pathway methyl formate also consider mobile source emission impact urban tropospheric ozone formation spur research development alternative fuel engine maker automotive company look way decrease emis sion NOx Fuel composition affect tendency fuel form soot particle nox increase carbon hydrogen ratio number carboncarbon bond increase tendency fuel form soot oxygenate hydrocarbon ether add fuel maintain performance lower tailpipe emission ether DME fuel antiknock agent propose diesel fuel substitute use methanol ignition improver diesel engine report reduce hydrocarbon emission attractive feature include low selfignition temperature low octane number high cetane number reduce combustion noise particle emission NOx emission engine nonsoote economically produce onestep synthesis Engine test show diesel engine emission level surpass ULEV regulation medium duty vehicle many investigator study fate dimethyl ether combus tion application Studies determine thermal decomposition dimethyl ether follow later propose bond fission initiate chain thermal degradation reaction barrier reaction estimate kcal mol Product study find concentration CH4 formation CH4 explain follow mechanism net result conversion dimethyl ether CH4 CH2O bond cleavage evidence present suggest bond cleavage compete bond cleavage mercury photosen sitize decomposition experiment reaction identify elimination elimination CH4 competitive channel use initio methodology thus formation CH4 CH2O explain reaction bond cleavage reaction proceed fourcentered transition structure reaction possible explanation detection hydrogen previous experimental investigation reaction yield CH2OCH3 radical product reaction describe fate thorough investigation possible thermal degradation channel CH2OCH3 yet undertake atmospheric oxidation study seheste first step involve ion hydrogen atom dimethyl ether tropospheric hydroxyl radical CH3OCH2 radical participate channel propose seheste Reaction aforementioned bond cleavage reaction CH2OCH3 CH3OCH3 CH3OCH CH3OCH3 CH4 CH2O CH2OCH3 ch2och3 ch3 CH2O CH2OCH3 CH2OCH3 product CH2OCH3 O2CH2OCH3 CH2OCH3 O2CH2OCH3 CH3 ch3o CH3 CH3 C2H6 CH3 CH3OCH3 CH4 CH2OCH3 ch2och3 CH3 CH2O Phys Chem jp9919718 publish web reaction reaction addition reaction reaction result formation groundstate O2CH2OCH3 collisional quenching third body reaction result formation excitedstate O2CH2OCH3 reaction radical reaction subsequent fate methoxymethylperoxy radical O2CH2OCH3 subject numerous study examine dimethyl ether degradation pathway absence scenario methoxymeth ylperoxy radical O2CH2OCH3 combine yield methoxymethoxy radical och2och3 reaction meth oxymethoxy radical react yield methyl formate HO2 reaction investigation find rate reaction varied pressure also depend ratio cl2 result imply existence secondary chemical reaction O2CH2OCH3 always display eliminate pos sibility unimolecular bond cleavage reaction rela tive amount increase rate constant increase thus intermediate react ultimately lead fur ther removal O2CH2OCH3 relative amount cl2 increase rate constant decrease thus intermediate react Cl2 ultimately lead regeneration O2CH2OCH3 possible explanation observation atom ejection radical reaction thus high concentration hydrogen atom form reaction react excess oxygen yield HO2 radical HO2 radical react methoxymethylperoxy radical reaction explain increase rate O2CH2OCH3 loss high concentration high concentration Cl2 hydrogen atom emit reaction react excess chlorine form hydrochloric acid additional chlorine radical excess chlorine radical react dimethyl ether ultimately produce additional O2CH2OCH3 explain decrease rate O2CH2OCH3 loss question intend address possibility thermal degradation pathway bond cleavage OCH2OCH3 bond cleavage rearrangement compete low total pressure significant concentration formal detect use FTIR spectroscopy possible explanation find isomerization O2CH2OCH3 form ch2och2ooh sixmembered transition structure Formaldehyde form decomposition ch2och2ooh form radical reaction seheste investigate isomeriza tion reaction methoxymethylperoxy radical methoxymethylperoxy radical form reaction O2CH2OCH3 reaction path followeds collisional quenching form groundstate O2CH2OCH3 intermolecular rearrangement form ch2och2ooh reaction decompose form formaldehyde molecule hydroxyl radical total pressure collisional quenching formation methoxym ethylperoxy radical find dominate concentration third body low significant collisional quench rearrangement forma tion formaldehyde find dominate previous investigation study degradation dimethyl ether absence use radical initiate hydrogen ion simulate reaction DME tropospheric radical presence reaction product determine use ftir spectroscopy production methyl formate accompany loss methyl ether quantitatively yield methyl formate relative loss find initial hydrogen ion dimethyl ether hydroxyl radical reac tion suggest responsible formation methyl formate ion hydrogen atom OCH2OCH3 reaction occur bond radical center possibility attack carbon form och2och2 ultimately however evidence participation degradation channel find investigation include formation methyl formate atmospheric fate methyl formate largely undetermined addition relative thermodynamic much dimethyl ether degradation mechanism unknown present detailed initio investigation oxidation dimethyl ether Computational Method calculation perform package program geometry optimization specie carry structure well bond length angle geometry fully optimize geometry frequency calculation perform use secondorder MllerPlesset UMP2 level restricted wave function unrestricted orbital active use g basis set addition G2MP2 energy calculate use methodology total energy correct add zeropoint energy predict total energy obtain energy thermal energy specie add total energy instead zeropoint energy reaction enthalpy obtain use correct energy follow equation reaction number product reactant change improve accuracy method isodesmic reaction use Isodesmic isogiric reaction reactant product contain type bond OCH2OCH3 OCH2OCH3 OCH2OCH3 HO2 ch3oc OCH2OCH3 CH3OC HO2 O2CH2OCH3 OCH2OCH3 HO2 O2CH2OCH3 CH3OCH2OOH HO2 O2CH2OCH3 ch3ocoh O2CH2OCH3 HO2CH2OCH2 Vol good number bond spin multiplicity electronic similarity reactant product error calculated energy cancel specie degree spin contamination monitor doublet system value exceed however class reaction condition meet hydrogen ion reaction initiate molecular oxygen value excess lead deteriorate estimate barrier height III Results discussion complete map possible degradation pathway show figure Structures closed involve oxidation Dimethyl Ether show figure dimethyl ether exist c2v symmetry equivalent bond length distinct hydrogen environment plane hydrogen bond length outplane bond length table list calculated structure experimental value calculated value reasonable agreement experimental finding methoxymethyl radical Figure display symmetry differ bond length bond length decrease relative parent ether bond increase length group hydrogen atom remain plane dihedral angle bond length bond remain outplane dihedral angle slightly long bond length molecule attach vacant outplane site CH2OCH3 form O2CH2OCH3 Figure Methyl formate adopt symmetry illustrate Figure Electron diffraction microwave study show planar cis form stable trans form figure atmospheric degradation pathway dimethyl ether methyl formate Methyl Formate Phys Chem Vol Phys Chem Vol good energy difference range low high kcal mol experimental investigation list difference kcal mol gauche form methyl formate represent barrier height rotation report kcal mol table list calculated structure methyl formate well literature value show table value agree experimental finding ether linkage bond increase opposing bond decrease substantially carbonyl bond also decrease typical double bond length oxygen atom orient downward form COCO dihedral angle Hydrogen ion methyl formate yield CH3 OCO radical illustrate Figure molecule remain symmetry dihedral angle COC close transition structure involve oxidation dimethyl ether methyl formate table structure coordinate MP231 G exptb plane outplane plane outplane hcoc plane hcoc outplane Bond length angstrom bond angle degree table structure Methyl Formatea coordinate G exptb plane plane outplane OCOC hcoc plane length angstrom bond angle degree oxidation Dimethyl Ether Methyl Formate Phys Chem Vol OCO subsequent reaction result formation respectively Hydrogen ion methyl formate also result formation CH2OCOH Figure dimethyl ether outplane hydrogen remove leave hydrogen plane position bond length dihedral angle plane hydrogen bond length dihedral angle molecular oxygen addition CH2OCOH yield O2CH2OCOH figure form peroxide bond bond length bond lengthen alkyl radical reduce och2ocoh show figure structure formic acid anhydride show figure structure formic acid study denote plane outplane formyl group respectively con former find stable isomer follow kcal mol conformer finally kcal mol isomer conformer oxygen atom COC plane orient anti respect trans side molecule carbonyl bond distance ether linkage dis tance distance pose cis side contain long carbonyl bond distance short bond distance slightly long bond distance COC angle connect side table report structure formic acid anhydride compare literature value structure reasonable agreement experimental determination structure transformic acid show figure bond length carbonyl bond bond length make angle respect bond single bond long make angle respect bond bond length orient trans bond Closed involve oxidation Dimethyl Ether overall reaction mechanism illustrate figure heat formation reactant product well document literature however many key intermediate thermodynamic datum yet exist thus second part investigation focus determine heat formation specie involve oxidation mechanism series isodesmic scheme use end isodesmic nature reaction allow highaccuracy determination reaction enthalpie heat formation specie interest determine use literature value remain specie reaction table list thermodynamic property specie use isodesmic reaction table list heat formation degradation intermediate isodesmic reaction use generate many literature value Table take work use group additivity method estimate heat formation various specie involve combustion dimethyl ether heat formation dimethyl ether radical report previous study use present ogy Dimethyl ether find heat formation kcal mol radical find heat formation kcal mol value dimethyl ether agreement literature value radical find disagree substantially radical find heat formation kcal mol literature value kcal mol deviate value show Table reaction dependent heat formation CH3O radical heat formation methoxy radical relatively large error associate kcal mol third reaction reaction set also use controversial value heat formation CH3OCH2 radical show third reaction agreement first reaction lending support kcal mol value use heat formation ch3och2 methoxymethylperoxy O2CH2OCH3 radical heat formation kcal mol literature value kcal mol deviate relatively large first reaction involve methoxy radical relatively high uncertainty heat formation hf298 CH3O2 radical determine kcal mol measure Kondo table structure Formic Acid Anhydridea coordinate COC COC Bond length angstrom bond angle degree table known thermodynamic constant Species involve Isodesmic Reactionsa specie k ref CH23B1 CH4 ch3 CH2O HCO CH2OCH3 HOO H2O2 CH3O CH3O2 co2 ch3ooh HCO2 CH3OCOH value kcal mol Raghavachari Redfern Pople Chem Phys Lay Bozzelli Phys Chem Good Francisco Chem Phys Chem Phys Lett janaf table Langford Batten Vol good heat formation later remeasure mol revise mol finally initio investigation find mol level theory value Hf298 kcal mol use study fourth reaction scheme incorporate previously determine heat formation meth oxymethoxy radical hydroxyl radical fourth reaction agreement first lending credibility calculate heat formation radical methoxymethylperoxy radical CH2OCH2OOH find heat formation kcal mol literature value mol deviate present value isodesmic scheme use calculate heat formation list Table first reaction use establish enthalpy value methane methyl radical table Isodesmic Reaction Schemes closed involve species isodesmic reaction Hf298 light OCH2OCH3 OCH2OCH3 CH4 CH3O CH3OCH3 OCH2OCH3 CH2O CH3O ch3ocoh OCH2OCH3 CH3 ch3o CH2OCH3 O2CH2OCH3 O2CH2OCH3 CH4 CH3O CH3OCH3 HO2 O2CH2OCH3 CH3O CH3O2 CH3OCH2O O2CH2OCH3 CH4 CH3O2 CH3OCH3 O2CH2OCH3 OCH2OCH3 HO2 CH2OCH2OOH ch2och2ooh ch3 CH3OOH ch3och3 CH2OCH2OOH CH4 H2O2 ch3 CH3OCH2O CH2OCH2OOH CH4 HO2 h2o2 ch3 CH3OCH2O2 ch3ocoh ch3ocoh CH2O ch3och3 co2 ch3ocoh CH4 ch3och3 ch2o ch3ocoh CH3 ch3och3 CHO ch4 ch3ocoh ch3 CH4 CH3OCH3 CHO ch3ocoh CHO CH2OCOH CH2OCOH CH4 CH3OCH3 CHO CH2OCOH CH4 ch3ocoh CH3 ch2ocoh ch2o ch3ocoh CHO CH3OC CH3OC CH4 CH3O2 ch3ocoh CH3O2 CH2O ch3oc HO2 ch3oc ch3oc h2o2 CH3OC o2ch2ocoh O2CH2OCOH CH4 CH3O2 ch3ocoh o2ch2ocoh CH3O2 CH3OCH3 CH2O O2CH2OCOH HO2 OCH2OCOH o2ch2ocoh och2ocoh ch3oc ch3oc CH4 ch3ocoh ch3o ch3oc CH4 CH3OCH3 och2ocoh OCH2OCOH CH4 ch3ocoh ch3o och2ocoh CH4 ch3ocoh hococoh HOCOCOH ch3och3 HOCOCOH HOCOCOH CH2O CH3OCOH co2 ch3 CH3OH HCO CH4 CH3OH CH2O use value calculate level theory kcal mol oxidation Dimethyl Ether Methyl Formate Phys Chem vol methyl hydroperoxide dimethyl ether second third reaction incorporate datum methoxymethylperoxy radical consistency reaction suggest reasonable value methoxymethylperoxy radical CH2OCH2OOH lie proximately kcal mol high energy CH3OCH2O2 G level theory calculate kcal mol value equilibrium constant conversion CH3OCH2O2 CH2OCH2OOH estimate order seheste observe evidence formation CH2O conversion reaction low total pressure rate constant reaction k6c compare reaction high limit Sehested find respectively limit rate constant consecutive reaction k6c compare k6ck16 determine addition pressure independent estimate calculate cm3 molecule value result following rate datum cm6 molecule k6c cm3 molecule thus atmospheric condition significant concentration third body exist formation groundstate methoxy methoxy radical expect dominate revisit work use pulse radiolysis technique investigation follow rate datum obtain cm6 molecule k6c13lowpressure cm3 molecule Independently Maricq determine nearly identical value rate investigation find cm6 molecule k6c13lowpressure cm3 molecule value study reasonable agreement previous investigation low pressure excited state CH3OCH2O2 collisionally quench ground state high energy CH3OCH2O2 radical rearrange ch2och2ooh however atmospheric combustion condi tion concentration third body relatively high CH3OCH2O2 radical likely quench ground state case calculation work seheste suggest conversion CH2OCH2OOH improbable Methyl formate calculate heat formation kcal mol wellestablished heat formation kcal mol deviate less indicate low enthalpy formation methyl formate stable specie compare precursor Methyl formate undergo hydrogen ion reaction form CH2OCOH Heats formation specie find literature find slightly stable CH2OCOH kcal mol CH3OCO mol CH2OCOH mol isodesmic reaction set use specie CH4 CH3 CH2O respective reaction set addition CH2OCOH yield o2ch2ocoh respectively heat formation kcal mol respectively specie first reaction set involve conversion methane CH3O2 radical latter reaction set incorporate formation HO2 radical radical water addition latter reaction use heat formation och2ocoh respectively discuss precede paragraph show Table reaction set consistent lending credibility calculate value och2ocoh possible degradation inter mediate previous comparison much large difference heat formation specie heat formation kcal mol och2ocoh heat formation kcal mol literature value kcal mol deviate Formic acid anhydride stable specie propose reaction scheme heat formation kcal mol literature value heat formation specie find Formic acid find heat formation kcal mol value agreement wellestablished literature value kcal mol deviation less exist oxidation first step oxidation dimethyl ether reaction radical reaction illustrate figure long outplane bond prefer ion hydroxyl radical approach transition structure bond increase length ultimately remove dimethyl ether hydroxyl radical approach form bond find length transition structure enthalpy reaction barrier height also list figure reaction predict kcal mol use level theory kcal mol MP2 level theory Good determine heat formation mol use literature value heat formation dimethyl ether kcal mol water kcal mol hydroxyl radical kcal mol heat reaction kcal mol derive Good predict reaction mol use calculated bond dissociation enthalpy dimethyl ether determina tion reasonable agreement barrier height hydrogen ion predict kcal mol MP2 level theory respectively determination find barrier height kcal mol rate reaction study average activation energy kcal mol report average rate constant reaction approximately cm3 molecule use experimental rate datum chemical transport model Good determine atmospheric lifetime day dimethyl ether reaction hydroxyl radical atmospheric degradation dimethyl ether predict occur solely troposphere set molecule calculate heat formation use theory find average absolute deviation kcal mol experiment MP2 value find deviate experiment kcal mol activation energy calculate dimethyl etherhydroxyl radical reaction experimental error give estimate MP2 error CH3OCH2 CH3OCH2Cl Phys Chem Vol good CH2OCH3 form CH2OCH3 participate follow reaction channel reaction bond cleavage reaction form CH2 ch3o radical use heat formation Tables enthalpy reaction kcal mol calculate using MP2 level theory heat formation kcal mol determine high energy barrier find reaction several point calculate reaction coordinate indicate gradual progression product also bond cleavage reaction form formaldehyde CH2O methyl radical ch3 reaction slightly endothermic reaction enthalpy kcal mol reaction barrier kcal mol find work estimate reaction barrier kcal mol energetic reaction illustrate figure transition structure figure bond adjacent CH3 functional group increase CH2OCH3 transition structure CH2 functional group CH2OCH3 orient parallel COC plane CH2O functional group pull away however functional group reorient perpendicular COC plane reaction produce formaldehyde methyl radical reaction reaction however proceed fourcentered transition structure show figure thermodynamic reaction identical reaction barrier height much large barrier height compare kcal mol barrier height reaction transition structure structure C2V symmetry illustrate figure bond long shared hydrogen atom bond length reaction involve hydrogen transfer carbon oxygen threere transition structure heat reaction reaction kcal mol unfavorable thermo dynamic suggest channel probably unimportant even combustion condition Reaction addition reaction involve oxygen reaction outplane hydrogen form radical reaction add vacant outplane site illustrate Figure energetic reaction quite favorable heat reaction kcal mol determine use calculated heat formation reaction enthalpy determined MP2 level theory respectively bimo addition radical barrier associate Table summarize result possible ch2och3 reaction channel figure Energetics degradation pathway dimethyl ether CH2OCH3 CH2 ch3o CH2OCH3 CH2O CH3 CH2OCH3 CH2O CH3 CH2OCH3 CH2OCH3 O2CH2OCH3 Oxidation Dimethyl Ether Methyl Formate Phys Chem Vol O2CH2OCH3 O2CH2OCH3 radical form point participate major reaction channel discuss undergo molecular rearrangement form CH2OCH2OOH reaction 13a intermediate decompose form formaldehyde molecule hydroxyl radical reaction formation ch2och2ooh endothermic kcal mol follow dissociation formaldehyde exothermic kcal mol net reaction convert meth oxymethylperoxy radical formaldehyde hydroxyl radical exothermic kcal mol atmospheric condition reaction methoxy radical form radical NO2 expect principal reaction channel reaction Langer study kinetic reaction use pulse radiolysis absorption technique moni tore increase absorption attribute formation NO2 radical rate reaction determine rate reaction cm3 molecule rate time fast methoxymethylperoxy selfreaction reaction study molecule atmospheric condition concentration much high methoxymethylperoxy radical therefore meth oxymethylperoxy reaction dominate self reaction support mechanism put forth step exothermic kcal mol first step rearrangement reaction OCH2OCH3 radical form reaction participate follow reaction channel Reaction unimolecular bond fission reaction produce formaldehyde methoxy radical Figure show rupture bond OCH2OCH3 gradually lengthen reactant proceed transition structure thermodynamic kinetic reaction illustrate figure reaction endothermic kcal mol activation barrier kcal mol Reaction rearrangement reaction hydrogen atom attach carbonyl carbon atom shift central oxygen atom form methanol radical figure transition structure hydrogen partially bond carbon oxygen reaction exothermic kcal mol activation barrier kcal mol Figure depict reaction hydrogen atom ejection reaction discuss fracture bond increase transition structure reaction slightly endothermic reaction enthalpy kcal mol barrier height modest kcal mol Reaction ion reaction hydrogen atom radical form methyl formate hydroperoxy radical HO2 figure thermodynamic kinetic depict figure reaction exothermic reaction enthalpy kcal mol activation energy modest kcal mol value find slightly expect value typical singlet system reaction list reaction favor conclusion support investigation methyl formate find form almost exclusively possible reaction OCH2OCH3 summarize Table Oxidation Hydrolysis Methyl Formate main reaction channel atmospheric interest methyl formate participate first reaction hydrogen ion reaction involve tropospheric hydroxyl radical third reaction hydrolysis reaction form methanol formic acid Reaction illustrate Figure transition structure approach hydroxyl radical approach carbonyl hydrogen bond lengthen length form bond decrease eventually depart water molecule Reaction illustrate figure transition structure hydroxyl radical approach outplane hydrogen bond lengthen form bond decrease eventually depart water molecule hydrogen ion reaction find similar thermodynamic kinetic property Reaction activation energy kcal mol reaction enthalpy kcal mol Figure Reaction barrier height kcal mol reaction enthalpy kcal mol Figure Reaction slightly favor barrier reaction reaction however hydroxyl radical time likely collide methyl group hydrogen carbonyl hydrogen Calve measure activation energy roughly kcal mol reaction methyl formate hydroxyl table reaction pathway reaction enthalpyb activation barrier reaction MP2 heat formation MP2 CH2OCH3 CH2 ch3o CH2OCH3 ch2och3 CH2O CH3 CH2OCH3 CH2O CH3 CH2OCH3 O2CH2OCH3 barrier barrier value kcal mol Reaction enthalpy compute O2CH2OCH3 OCH2OCH3 NO2 CH2O CH3O OCH2OCH3 ch3oh CHO och2och3 ch3ocoh ch3ocoh HO2 ch3ocoh CH3OCO ch3ocoh CH2OCOH ch3ocoh Vol good radical determination reasonable agreement value consider estimate error associate methodology mention previously reaction hydrolysis reaction form methanol formic acid reaction illustrate Figure transition structure oxygen atom water molecule approach carbonyl carbon neously carbonyl carbon pull away ch3o group distance atom water molecule begin dissociate associate oxygen atom ch3o group dissociate bond water molecule form bond methanol activation energy kcal mol reaction enthalpy slightly endothermic kcal mol level theory kcal mol use individual heat formation addition endothermic tropy change hydrolysis reaction calculate mol thus equilib rium constant order temperature require shift equilibrium product der combustion condition scenario possible action compete hydrogen ion action energetically favor fast however water major product combustion reaction order magnitude concentrated molecule hydroxyl radical molecule ambient atmo sphere Table summarize energetic reaction participate follow reaction mechanism reaction simple bond cleavage reaction form carbon dioxide methyl radical reaction illustrate figure reaction exothermic kcal mol activation barrier kcal mol Figure reaction also simple cleavage reaction form CH3O carbon monoxide transition structure show figure illustrate cleave bond increase COCO dihedral angle change substantially carbonyl bond decrease triple bond carbon monoxide form reaction illustrate Figure endothermic kcal mol activation barrier kcal mol Reaction bimolecular addition reaction form CH3 reaction illustrate Figure proceed barrier exothermic kcal mol structure show figure describe previously reaction favor possible degradation pathway available radical highpressure condition addition reaction typically rate constants49 order cm3 molecule troposphere concentration order molecule thus lifetime respect addition expect order micro second contrast reaction estimate activation energy kcal mol estimate factor cm3 molecule thus lifetime respect unimolecular dissociation expect order millisecond estimate lifetime suggest addition dominant fate radical CH2OCOH CH2OCOH participate follow reaction mechanism reaction unimolecular cleavage reaction form formaldehyde formyl radical transition structure figure 2bb cleave bond increase oppose ether linkage bond decrease reaction illustrate Figure endothermic kcal mol reaction barrier kcal mol reaction cleavage reaction form CH2 HCO2 radical reaction endothermic kcal mol expect play major role degradation mechanism even consider potential formation co2 hydrogen ejection HCO2 reaction enthalpy kcal mol still exist contrast reaction reaction molecular oxygen addition reaction proceed barrier reaction enthalpy predict kcal mol addition reaction expect dominate possible reaction pathway o2ch2ocoh expect follow following reaction reaction lead formation OCOH cleavage reaction reaction form carbon dioxide methoxy radical reaction find kcal mol barrier height find kcal mol Reaction hydrogen ion reaction initiate Figure 2aa incoming atom remove outplane hydrogen atom CO2 fragment reaction pathway OCH2OCH3a reaction enthalpyb activation barrier reaction MP2 heat formation MP2 OCH2OCH3 CH2O CH3O OCH2OCH3 ch3oh CHO och2och3 ch3ocoh ch3ocoh HO2 value kcal mol Reaction enthalpy compute ch3 co2 ch3o CH3OCO ch3oc ch2ocoh CH2O HCO CH2OCOH CH2 CH2OCOH O2CH2OCOH RO2 RO2 ro2 NO2 ch3oc ch3o co2 CH3OC HO2 CH2O co2 oxidation Dimethyl Ether Methyl Formate Phys Chem Vol neously eject dissociate bond length show Table figure reaction favorable reaction enthalpy kcal mol activation energy kcal mol reaction value expect value figure Energetics degradation pathway methyl formate pathway follow extraction carbonyl hydrogen pathway follow extraction methyl hydrogen note refer fourcenter squarelike transition state represent Vol good Francisco OCH2OCOH och2ocoh participate follow pathway reaction hydrogen ejection reaction form formic acid anhydride transition structure figure 2dd cleave bond length reaction endothermic kcal mol overcome reaction barrier kcal mol reaction hydrogen ion reaction initiate molecular oxygen figure 2ee show form bond cleave bond lengthen carbonyl bond decrease och2ocoh transition structure ultimately formic acid anhydride energetic illustrate Figure favorable reaction enthalpy kcal mol reaction barrier kcal mol hydrogen ion reaction initiate molecular oxygen value slightly high expect value doublet system Reaction illustrate figure 2cc result formation CH2O HCO2 transition structure dissociate bond lengthen opposing single bond decrease reaction find endothermic kcal mol reaction barrier kcal mol recent work suggest alkoxy radical general structure OCHOR isomerize membered ring transition structure give RCO alkoxy radical OCH2O thus expect yield reaction transition structure illustrate Figure 2ff reaction exothermic kcal mol overcome modest barrier kcal mol reaction compete reaction energetically favor reaction result formation formic acid HOCOCOH decomposition formic acid anhydride find produce acid carbon monoxide transition structure propose involve simultaneous cleavage ether bond hydrogen shift cleave fragment carbonyl oxygen fragment Straight bond cleavage produce think highly improbable time constant formation formic acid carbon monoxide determine room temperature transition structure formation formic acid illustrate Figure 2gg reaction find exothermic kcal mol several pathway formic acid remove unimolecular decom position reaction radical process unimolecular decomposition reaction refer dehydration decarboxylation reaction table reaction pathway Methyl Formatea reaction enthalpyb activation barrier reaction MP2 heat formation mp2 ch3ocoh ch3ocoh CH2OCOH ch3ocoh value kcal mol Reaction enthalpy compute table Comparison Decomposition Pathways CH2OCOHa reaction enthalpyb activation barrier reaction MP2 heat formation mp2 CH3OCO ch3 co2 ch3o barrier barrier CH2OCOH CH2O HCO CH2OCOH CH2 HCO2 CH2OCOH o2ch2ocoh barrier barrier value kcal mol Reaction enthalpy compute table Comparison Decomposition Pathways OCH2OCOHa reaction enthalpyb activation barrier reaction MP2 heat formation MP2 ch3oc ch3o co2 CH3OC HO2 CH2O co2 och2ocoh CH2O HCO2 och2ocoh HOCOCOH OCH2OCOH HO2 HOCOCOH och2ocoh HCO value kcal mol Reaction enthalpy compute OCH2OCOH HOCOCOH OCH2OCOH HO2 HOCOCOH och2ocoh CH2O och2ocoh HCO co2 co2 oxidation Dimethyl Ether Methyl Formate Phys Chem Vol Reaction decarboxylation reaction slightly exothermic reaction enthalpy kcal mol Reaction dehydration reaction endothermic reaction mol Blake report thermal decomposition formic acid decarboxylation reaction first order rate expression 47e dehydration reaction rate report temperature rate find second order rate constant cm3 mol temperature rate find fractional order 39e Samsonov report activation energie range kcal mol dehydration reaction suggest dissociation formic acid free radical product illustrate process however shock tube study conclude reaction unimportant report threshold energy dehydration decarboxylation reaction kcal mol respectively use shock tube methodology determine secondorder reaction rate dehydration experiment cm3 mol 32e Saito initio calculation level use split valence basis set show energy dehydration process kcal mol decarboxylation kcal mol investigate concerted molecular bond fission unimolecular dissociation channel find decarboxylation dehydration channel energetically favor rear rangement radical reaction activation energy dehydration decarboxylation reaction consistent work kcal mol respectively study photodissociation dynamic formic acid include hydrogen bond cleave reaction produce radical Formic acid vibronically excited wavelength follow excitation atom detect use TOF mass spectrometry weak atom signal report wavelength long due part weak parent absorption wavelength thermal photodissociation pathway unlikely compete hydroxyl radical initiate hydrogen ion reaction reaction show reactivity essentially however find react much slow show reaction proceed hydrogen ion acidic hydrogen atom dissociation HCO2 also find Jolly conclusion major feature atmospheric oxidation mechanism dimethyl ether predict theoretically Atmo spheric model study dimethyl ether show lifetime dimethyl ether expect time dimethyl ether degrade low region troposphere Hydrogen ion dimethyl ether initiate hydroxyl radical follow addition form methoxymethylperoxy radical O2CH2OCH3 ultimately radical OCH2OCH3 fate radical predict dominate conversion methyl formate hydrogen ion mechanism initiate molecular oxygen prediction methyl formate byproduct oxidation dimethyl ether consistent experimental observation find oxidation methyl formate occur pathway pathway initiate ion carbonyl hydrogen hydroxyl radical form radical fate radical conversion CH2O CO2 HO2 radical second pathway result removal methyl hydrogen methyl formate form CH2OCOH radical fate conversion formic acid anhydride HOCOCOH oxygen addition hydrogen ion step also mediate molecular oxygen Formic acid anhydride ultimately rearrange formic acid carbon monoxide unimolecular rearrangement mech anism Formic acid react hydroxyl radical form co2 atom rate reaction molecule use simplistic expression atmo spheric lifetime molecule formic acid estimate atmospheric lifetime approximately month alternatively suggest formic acid hydrogen bond atmospheric water vapor thus slow reactivity hydroxyl radical condition heterogeneous process wet dry deposition formic acid compete industry consider derivative dimethyl ether possible fuel alternative expect oxidation mechanism derivative model basis property energetic find dimethyl ether system Askey Hinshelwood Proc Soc London a115 Leifer Urey Chem Soc Benson Chem Phys Pottie Harrison losse Chem Nash Francisco Phys Chem Japar Wallington Hayman Nielsen Ellerman Phys Chem Phys seheste seheste seheste seheste Kinet Frisch Trucks Head Pople revision Raghavachari Curtiss Raghavachari Pople Chem Phys Hehre Kasai Meyers Chem Phys Curl Chem Phys Soc Jones Lister Wennerstrom Vol good theochem Subrahmanyam Miyazawa Bull Chem Soc Chem Phys Lett Vaccani Roos Bauder nthard Chem Phys Raaska Cathonnet Int Chem Kinet Good Francisco Chem Phys Raghavachari Redfern Pople Chem Phys Kondo Bensen Phys Chem Slagle Gutman Chem Soc Knyazev Slagle Phys Chem Jungkamp Seinfeld Chem Phys Lett Lay Bozzelli Phys Chem Maricq szente Hybl Phys Chem Chem Good Francisco Phys Chem Dagaut Kurylo Int Chem Kinet Wallington Ansino Skews Int Chem Kinet Trully Droege Int Chem Kinet Perry Atkinson Pitts Chem Phys Good Francisco Jain DeMore Sander Golden Petrv react Kinet Catal Lett Evans McAlpine Phys Hsu Shaub Nineteenth International Symposium Combustion Combustion Institute Pittsburgh Phys Langford Batten Kono Ashford Chem Soc Faraday Trans Singleton Soc wine Jolly oxidation Dimethyl Ether Methyl Formate Phys Chem Vol",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "carboncarbon": 1,
                    "followeds": 1,
                    "CH2OCOH": 1,
                    "HCO2 CH2OCOH": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Uncovering the role of 5-hydroxymethylcytosine in the epigenome.pdf",
            "cleaned_text": "epigenetic mark genome central establishment tissuespecific gene expression programme therefore cell differentiation development recently know epigenetic mark DNA methylcytosine establish DNA methyltrans ferase dnmt preferentially cpg dinucleotide generally associate gene repression long regard stable highly heritable mark nonetheless DNA methylation pattern undergo genomewide reprogramming establishment primordial germ cell Importantly molecular mechanism involve reprogramming begin address enzyme enzyme TET family find oxidize hydroxymethylcytosine base first detect mammalian DNA recent experimentally robust detection 5hmC mouse cerebellum7 embryonic stem cell esc lead hypothesis 5hmC intermediate removal indeed moderately low level genome cytosine consistent hypothesis shortlive entity alternatively complementarily 5hmC epigenetic modification right attract unique panel chromatin transcriptional modifier thus add layer complexity intricate network epigenetic regulator astonishingly numer ous finding relate TET enzyme 5hmC build short time TET enzyme appear involve demethylation dna totipotent zygote pluri potent esc remarkably pathway demethylation involve oxida tion 5hmC formylcytosine 5fC carboxylcytosine 5caC also detect genome well interaction demethylation path way method mark develop show thus far 5hmC distinct distribution genome ate promoter gene expression well Polycombmediated silence TETs new epigenetic modifier TET protein recently identify new oxoglutarate ygenases similarity member enzyme superfamily8 Genes TET subfamily present Metazoa arise common ancestor undergo triplication form jawed mouse TETs show oxidize vitro vivo10 presence 5hmC depend pre exist vivo12 suggest route synthesis genomic 5hmC Protein structure tet protein contain predict domain bind iron oxoglutarate also contain unique domain cysteinerich region think involve dna additionally TET3 contain CXXC zinc finger domain know dnabinding domain common protein dna cytosinemethyltransferase protein maintain cpg methylation replication however CXXC domain differ eral CXXCcontaining protein propose difference prevent DNA er suggest domain still bind dna distinct nature allow bind unmethylated methylate hydroxymethylated dna CXXC domain bind almost exclusively unmethylated dna importantly wildtype bind genome similarly CXXC domain protein version contain mutation CXXC domain show CXXC domain important genomewide pattern binding15 discuss TET expression level trying understand role several technique develop allow quantification different tissue BOX existence mammalian tet uncover role hydroxymethylcytosine epigenome find catalyse oxidation methylcytosine wellknown epigenetic mark hydroxymethylcytosine mammalian dna exciting prospect novel epigenetic modification dynamically regulate dna methylation lead rapid accumulation publication wide array field biochemistry stem cell biology start scratch surface interesting clue role hydroxymethylcytosine quickly emerge TETs important role epigenetic reprogramming regulation tissue specific gene expression progress nature volume JANUARY right reserve enzyme raise possibility distinct panel genomic target tissuespecific expression lead specific physiological effect indeed esc primary TET enzyme repression follow differentiation body correlate reduction levels5 moreover high level tet1 expression also detect PGCs17 suggest associate pluripotent state Expression far high oocyte zygote 5hmC level rise dramatically fertilization male adult tissue level fairly constant cytosine level vary high tissue central nervous system21 amount genome dependent level TET activity steadystate level 5hmC also depend activity modify 5hmc23 possibly rate dna replication 5hmC maintain replication demethylation intermediate several mechanism removal proposed26 mam mal widely accept pathway passive demethylation replication nonetheless 5mC largely lose paternal genome fertilization replication initiated2 demethyla tion observe nonreplicating cell example suggest active demethylation pathway plant dna glycosylase remove leav ing abasic site repair base excision repair BER machinery contrast know mammalian glycosylase example thymine dna glycosylase methylcpgbinde domain protein show weak activity vitro27 however enzyme strong activity mismatch create deamination cytidine deaminase activationinduced cytidine deaminase mrna edit enzyme catalytic polypeptide family27 suggest mammal active dna demethylation occur twostep process involve deamination follow mismatch repair indeed contribute dna demethylation PGCs28 however activity also involve interestingly highly express PGCs17 discovery oxidation TET enzyme open new avenue explore potential active demethylation mechanism first discuss evidence part demethylation process vivo look biochemical pathway involve detail demethylation vivo initial support role TETs removal come tion overexpression cultured cell lead decrease level small increase level unmodified Conversely tet1 depletion lead accumulation globally15 specific genomic region retrotransposon tran scription factor bind mouse brain appear important Box Quantifying map hydroxymethylcytosine several technique adapt newly develop quantify profile genome describe key challenge future develop technique provide singlenucleotide resolution mapping sequencing classically use methylcytosine singlenucleotide mapping treatment convert unmodified cytosine uracil however sequencing distinguish 5hmC52 distinguish unmodified cytosine carboxylcytosine 5caC next generation genomewide sequencer promise deliver method mapping method involve direct sequence unamplified dna explore difference physical property allow different basis distinguish include 5hmC53 thin layer chromatography use global quantification Cytosines end restriction site example mspi restriction site isotopically label transfer phosphate group hydrolyse resolve thin layer chromatography tlc allow detection 5hmC particular dinucleotide context example analysis similar tlcbase method also allow global quantification 5hmC specific sequence technique useful owe sequence specificity accurate quantification difficult liquid chromatography mass spectrometry use global quantification Hydrolysed nucleotide resolve liquid chromatography detect mass spectrometry exact quantification achieve inclusion isotopically label standards21 constitute gold standard global quantification require extensive experience method Glucosylation use global local quantification 5hmC glucosylate glucosyltransferase Quantification genomic 5hmC level perform use isotopically label uridine diphosphate substrate compare know standards12 seemingly accurate perhaps widely accessible Glucosylation also alter activity certain restriction enzyme example MspI cut CmCGG ChmCGG site cgluccgg local level measure methylationsensitive restriction follow quantitative local absolute quantification useful restrict site enzymatic cleavage antibody detection use global quantification map several antibody raise 5hmC allow global quantification dotblot enzymelinked immunosorbent assay ELISA Mapping also do dna pulldown follow genomewide sequence hMeDIPseq antibody product treatment 5hmC cytosine methylenesulphonate also use prevent apparent bias anti5hmc antibody display regions10 global quantification use approach less accurate achieve easy mapping relative nature use antibody carry risk unspecific bind labelling use global quantification mapping also use transfer glucose 5hmC allow use click chemistry specifically tag 5hmC example biotin 5hmC quantify use avidin conjugate horseradish peroxidase map pull sequence biotincontaine DNA alternative chemical strategy tag 5hmC biotin involve oxidation glucosylate 5hmC follow reaction aldehydereactive probe39 global quantification use chemicallabelle method less accurate pulldown efficient highly specific map relative progress JANUARY volume wwwnaturecomgenetic right reserve NH2 NH2 NH2 NH2 NH2 4grnkecvkqp 4GRNKECVKQP FGECTDQZNCVKQP JO7 1ZKFCVKQPRCVJYC figure potential pathway dna demethylation genomic methylcytosine remove passively replication several pathway active demethylation also propose include hydroxymethylcytosine intermediate activationinduced cytidine deaminase AIDapolipo protein mrna edit enzyme catalytic polypeptide family produce mismatch recognize dna glycosylase produce abasic site repair base excision repair BER alternatively 5hmC oxidize formylcytosine 5fC carboxylcytosine 5caC TET enzymes24 remain possible deformylation 5fC decarboxylation 5caC convert intermediate directly back cytosine enzymatic activity describe date instead thymine DNA glyco sylase show cleave 5fC 5caC24 implicate BER pathway dna demethylation 5hmU dnmt dna methyltransferase bind domain protein strandselective monofunctional uracildna glycosylase demethylation brainderived neuro trophic factor fibroblast growth factor Fgf1 gene promoter part physiological response electroconvulsive stimulation23 seemingly inconsistent example myeloid tumour carry TET2 mutation decrease activity decrease global 5hmC level actually associate cpg hypomethylation possible methylation machinery also impair tumours10 finally loss paternal genome fertilize egg correlate increase male pronucleus time female pronucleus remain methylate contain low level strike asym metry highly suggestive involvement demethylation paternal genome indeed tet3deplete zygote fail demethylate particular certain promoter region example also know pou5f1 compelling evidence TET3 involve dna demethyla tion potentially oxidation nonetheless direct link catalytic activity enzyme still miss possible noncatalytic function tet3 demethylation recently show immunostaine paternal 5hmC lose passively replication preimplantation develop ment29 suggest convert remove replication immunostaine quantitative remain possible portion convert remain remove distinct pathway indeed demethylation trans posable element apparent sequencing replication initiated30 potential mechanism Conversion 5hmC promote passive demethyla tion time replication prevent activity hydroxymethylate active hemihydroxymethylate cpgs31 chaperone also know NP95 crucial func tion bind similar affinities32 potentially promote activity hydroxymethylate vivo evidence pre implantation embryo suggest 5hmC passively remove study require clarify point term potential active demethylation pathway remove deamination pathway similar discuss deaminase act FIG indeed expression deaminase neural cell promote removal 5hmC aid overexpression lead global accumulation hydroxymeth yluracil 5hmU deamination product 5hmC23 furthermore singlestrand selective monofunctional uracildna glycosylase strong activity mismatch appear involve pathway23 potential redundan cie multiple deaminase glycosylase activity operate vivo likely complicate future study mechanism active pathway propose involve oxidation step modify first 5fC 5caC FIG indeed TETs recently show catalyse addi tional oxidation step 5fC 5caC detect esc low levels22 reduce TETs substrate comparison fast removal 5fC 5caC explain low abundance interestingly remove 5caC24 raise suggestion BER machinery operate pathway however possible activity deformylate 5fC decarboxylate 5caC generating also exist likely multiple pathway removal genome TET enzyme involve several interesting different tissue use dif ferent demethylation pathway depend demethylation genomewide local target genome example PROGRESS nature volume JANUARY right reserve 0CVWTG4GXKGYUGPGVKEU PCEVKXGIGPGU ogvjncvkqpogfkcvgf EVKXGIGPGU KXCNGPVIGPGU figure Mechanisms gene expression control hydroxymethylcytosine TETs DNA methylation promoter region normally associate silence gene bind methylcpg bind domain MBDcontaining protein methylcytosine 5mC mediate chromatin remodelling gene repression oxidation hydroxymethyl cytosine 5hmC teneleven translocation TET protein therefore relieve repressive effect indeed bind 5hmC43 additionally tet binding prevent access dna methyltransferase dnmt contribute maintenance unmethylated promoter however 5hmC TET enzyme also associate repressed gene namely interaction repressor complex38 removal also promote recruit ment repressive complex PRC2 therefore methylation histone lysine bivalent gene silent transcriptionally poise activation function 5hmC TETs Roles pluripotent cell Oocytes capacity reprogram somatic nucleus clone somatic cell nuclear transfer demethylation activity oocyte part important process similarly pluripotent cell esc embryonic germ cell egc ability reprogram somatic cell nucleus fuse include demethyla tion specific gene Oct4 Nanog therefore interest esc level transcript rela tively high substantially reduce fol low differentiation embryoid bodies5 also downregulated35 number recent study thus look role TET1 esc add vast amount exist epigenomic datum cell type13 Immunofluorescent label mouse human chromosome show 5mC enrich matin exclusively 5hmC appear mainly euchromatic suggest associate gene activity13 high resolution mapping achieve development profiling strategy make use genomewide sequencing technologies BOX mouse esc 5hmC find enrich gene body specifically exon also transcription start site promoters13 surprisingly bind cgis15 esc 5hmC preferentially locate region intermediate density enrich promoter CGIs intra genic CGIs Nonetheless gain follow TET1 depletion37 suggest maintain cgi hypo methylation block access DNA methylation machinery rapidly demethylate FIG additional evidence regulatory role 5hmC esc suggest enrichment bind site pluripotencyassociated transcription factor bind factor bind pro tein dna impair DNA methyla tion 5hmC relieve repressive effect many finding human esc consistent mouse esc enrichment tss gene body additionally enrichment enhancer also describe human ESCs40 effect distribution 5hmC gene expression esc gene body presence 5hmC appear consistently correlate gene expression13 however evidence correlation promoter 5hmC transcription inconsistent study issue important address future work analysis confound fact 5hmC 5mC often exist genome13 promoter repressive effect transcription potential involvement demethylation presence 5hmC relieve silenc ing effect prevent bind methylbinding proteins43 FIG addi tion possible protein involve gene regulation exist specifically bind line potential activating role several gene downregulate TET1 knockdown esc surprisingly large number gene interestingly many derepresse gene repre sive complex PRC2 targets36 esc gene often bivalently mark active mark trimethylation histone lysine H3K4me3 repressive mark H3K27me3 enrich developmental gene transcription ally poise rapidly acti vate silence depend specific differentiation pathway take 5hmC enrich bivalent gene tet1 depletion impair PRC2 bind targets13 suggest maintenance hypomethyla tion TET1 allow PRC2 binding36 5hmC perhaps involve promoter pause rna polymerase II40 increase methylation dynamic PRC2 target gene line concept bivalency noncatalytic role silencing also suggest interaction repressor progress JANUARY volume wwwnaturecomgenetic right reserve complex involve histone dea cetylation38 FIG Altogether finding indicate 5hmC multiple regulatory role esc depend density chromatin environment increase evidence esc induce pluripotent stem cell suggest TET protein involve regulate pluripotency differentiation potential reversal see differentiation reprogramme differentiate cell ipsc associate activation accumulation link 5hmC pluripotency highlight existence cluster bind site pluripotency relate transcription factor upstream appear control level directly Importantly depletion esc lead downregulation several pluripotencyassociated genes13 gene silence embry oid body formation lose gain promoters13 furthermore several extraembryonic lineage marker example caudal type homeobox Cdx2 eomesodermin bind protein Gata6 expression marker detect formation wildtype body specific depletion TET1 increase transdifferentiation potential esc extraembryonic tis accordingly tet1depleted cell skew differentiation potential teratomas trophoblastlike cells35 wildtype cell able contribute trophectoderm lineage embryos11 interestingly finding depletion TET2 increase transdifferentiation potential esc simultaneous knockdown TET2 appear less efficient increa ing transdifferentiation potential compare TET1 knockdown alone35 result suggest balance expression different TET protein hydroxymethylation specific target contribute establishment inner cell mass trophectoderm compartment morula blastocyst transition however Tet2knockout45 mouse viable tet1 mice display various degree growth restriction44 suggest TET1 activity crucial embryonic development target preimplantation devel opment longterm effect development notably reduction level esc therefore generation triple mouse necessary elucidate 5hmC require embryogenesis TET2 haematopoiesis role TET enzyme differentiation also study context haema TET2 mutation frequently involve human myeloid malignancy often affect catalytic activity TET2 Accordingly 5hmC level bone marrow patient carry TET2 mutation general low wildtype counterpart independ ent zygosity wide range malignancy TET2 muta tion find suggest deficiency involve early stage tumorigenesis possibly stem cell compartment indeed study use mouse tet2knockout model support hypothesis45 tet2null mouse viable appear develop normally age start die haematopoi etic malignancy involve differentia tion importantly tet2null mice display increase haematopoietic stem cell number well myeloid progenitor cells45 fact stem cell high selfrenewal ability culture wildtype cell suggest expression promote haematopoietic differentiation find ing consistent high level expression seen differentiate haematopoietic lineage compare progenitor cells10 therefore 5hmC Glossary Blastocyst preimplantation embryo contain fluidfilled cavity blastocoel focal cluster cell embryo develop inner cell mass epithelial layer cell surface primitive endoderm peripheral trophectoderm cell form extraembryonic part placenta CCCTC bind factor zinc finger transcriptional repressor recognize bind many site genome insulator activity well important chromatin organization Click chemistry general term chemical reaction high chemical yield large thermodynamic drive force reaction type wide scope stereospecific simple perform create product stable physiological condition product easily removable dna sequence considerably high content expect genome average deplete dna methylation genome find promoter region gene mammal body structure form differentiate embryonic stem cell culture resemble early embryo embryonic stem cell esc pluripotent cell establish culture inner cell mas blastocyst cell selfrenew indefinitely culture differentiate derivative embryonic cell lineage vitro vivo inner cell mass cluster undifferentiated cell blastocyst give rise entire fetus extraembryonic placental tissue stage preimplantation development embryo ball contain cell pellucida precede formation blastocyst outer cell tendency become trophectoderm inner cell tendency become inner cell mass epiblast subsequently fetal tissue form primordial germ cell PGCs cell arise early embryo give rise mature gamete oocyte sperm set early development migrate gonad eventually undergo meiosis develop mature gamete pronuclei form maternal paternal genome respectively shortly fertilization mammalian embryo follow dna replication pronucleus dissolve zygote undergo first mitotic division contain differentiated cell germ layer ectoderm mesoderm endoderm arise germ cell pluripotent cell outer layer blastocyststage embryo give rise trophoblast implantation provide bulk extraembryonic lineage placenta Trophoblast cell lineage first emerge outer trophectoderm layer blastocyst implantation become predominant cell type extraembryonic tissue placenta progress nature volume JANUARY right reserve appear promote differentiation haema topoietic cell contrast role esc demonstrate 5hmC distinct function different cell type likely different function depend expression specific TET enzyme crosstalk level gene regulation TETs brain high level tissue find adult brain particularly hypothala mus cerebral cortex also high particular interest neuronal cell adult brain cease divide hence erasure dna methylation appear require active demethylation pre liminary evidence23 possibility raise neuronal tissue pathway demethylation involve oxidation methyl group TET1 follow deamination 5hmU aid APOBEC1 5hmU excise glycosylase TDG23 5hmC profiling also perform mouse cerebellum reveal 5hmC enrich gene body upstream deplete TSS50 similar pattern describe human cortex42 profile resemble locate gene body find associate high level transcription esc possible gene body general epigenetic feature presence promoter particularly feature pluripotent cell type Conclusion perspective clear 5hmC TETs important role epigenetic reprogram ming regulation tissuespecific gene expression role bona fide epigenetic mark remain pos sible specific protein describe date contrast potential demethylation intermediate support several study suggest perhaps constitute main cellular role particularly interesting connection emerge oxidation deami nation pathway resolution reaction product dna repair replication FIG hand TET enzyme appear epigenetic function catalytic role interesting investigate mecha nisms determine evolve catalytic role attractive aspect oxidation TETs potential sensitivity environmental condition namely dependence oxo glutarate oxygen raise possibility TETs sense metabolic oxidative cell state role cellular adaptation alter study undoubtedly involve additional model evaluate even wide span potential role include role reprogram ming ipsc generation reprogramming fusion esc EGCs well imprint retrotransposon regulation give importance dna methylation context author part CB22 3at mail online reprogramming mouse primordial germ cell Mech erase genomic imprinting memory mouse clone embryo produce day primordial germ cell Development zygotic paternal genome Nature Oswald Active demethylation paternal genome mouse Conversion methylcytosine hydroxymethylcytosine mammalian DNA partner TET1 Science presence hydroxymethylcytosine animal deoxyribonucleic acid Biochem nuclear dna base hydroxymethylcytosine present neuron brain Science Iyer Anantharaman Comparative genomic transcription factor chromatin protein parasitic protist eukaryote Int Parasitol iyer Rao Prediction novel family enzyme involve oxidative complex modification basis nucleic acid cell cycle impaired hydroxylation methylcytosine myeloid cancer mutant TET2 Role Tet protein conversion cell selfrenewal inner cell mass specification Nature Szwagierczak Bultmann Schmidt Spada sensitive enzymatic quantification hydroxymethylcytosine genomic DNA e181 regulation hydroxymethylcytosine mouse cell differentiation Nature Frauer Different bind property function CXXC zinc finger domain Dnmt1 e16627 regulation gene expression hydroxylase mouse embryonic stem cell protein modulate dna methylation gene transcription hydroxylation methylcytosine reprogramme mouse germ line entail base excision repair pathway hydroxymethylcytosine mammalian zygote link epigenetic reprogramming Nature Commun paternal genome fertilization involve genomewide oxidation methylcytosine role dna dioxygenase epigenetic reprogramming oocyte Nature Globisch Tissue distribution hydroxymethylcytosine search active demethylation intermediate e15367 Pfaffeneder discovery formylcytosine embryonic stem cell dna methylcytosine promote active dna demethylation adult brain Cell Tetmediated formation carboxylcytosine excision mammalian DNA Science Ito Tet protein convert methylcytosine formylcytosine carboxylcytosine active dna demethylation many road lead Nature Rev Mol Cell Biol Zhu active dna demethylation mediate dna glycosylase Annu Rev erasure dna methylation mouse primordial germ cell affect aid deficiency Nature loss hydroxymethylcytosine mouse preimplantation embryo Science Wossidlo dynamic link dna demethylation dna strand break repair mouse zygote cytosine damage product alter site selectivity human dna maintenance methyltransferase DNMT1 Cancer Res Frauer Recognition Uhrf1 domain e21306 Cortellino Thymine DNA glycosylase essential active dna demethylation link repair Cell Maiti DNA glycosylase rapidly excise formylcytosine carboxylcytosine potential implication active demethylation cpg site regulate hydroxymethylcytosine production cell lineage specification mouse embryonic stem cell Cell Stem Cell Dual function transcriptional regulation mouse embryonic stem cell analysis hydroxymethylcytosine distribution reveal dual function transcriptional regulation mouse embryonic stem cell hydroxymethylcytosine transcription dna methylation fidelity Nature Pastor mapping hydroxymethylcytosine embryonic stem cell Nature Szulwach Integrating hydroxymethylcytosine epigenomic landscape human embryonic stem cell e1002154 Stroud Feng Morey Kinney hydroxymethylcytosine associate enhancer gene body human embryonic stem cell Genome Biol R54 PROGRESS JANUARY volume wwwnaturecomgenetic right reserve mapping human brain damage methylcpg sequence inhibit bind methylcpg bind domain MBD methylCpG binding protein mecp2 Nucleic Acids Res Dawlaty tet1 dispensable maintain pluripotency loss compatible embryonic postnatal development Cell Stem Cell Teneleventranslocation TET2 negatively regulate homeostasis differentiation hematopoietic stem cell mouse mouse lead dysregulate hematopoietic stem cell subsequent development myeloid malignancy Blood TET2 inactivation result pleiotropic hematopoietic abnormality mouse recurrent event human lymphomagenesis Cancer Cell MoranCrusio tet2 loss lead increase hematopoietic stem cell selfrenewal myeloid transformation cancer cell sixth DNA base hydroxymethylcytosine brain Int Edn Engl Song selective chemical labeling reveal genomewide distribution hydroxymethylcytosine Hypothesis environmental regulation hydroxymethylcytosine oxidative stress behaviour hydroxymethylcytosine bisulfite sequence e8888 detection dna methylation singlemolecule realtime sequence Nature Methods Wanunu Discrimination methylcytosine hydroxymethylcytosine dna molecule Tissuespecific distribution dynamic change hydroxymethylcytosine mammalian genome hydroxymethylcytosine different human tissue Nucleic Acids ment like thank member laboratory stimulate discussion work support NoE EpiGeneSys BLUEPRINT competing interest statement author declare compete financial interest information homepage links active online pdf progress nature volume JANUARY right reserve",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {
                    "epigenetic": 14,
                    "methylation": 16,
                    "demethylation": 34,
                    "5mC": 4,
                    "H3K27me3": 1
                },
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "methyltrans": 1,
                    "levels5": 1,
                    "0CVWTG4GXKGYUGPGVKEU": 1,
                    "MBDcontaining": 1
                }
            },
            "co_occurrence_matrix": {
                "Epigenetic Terms": {
                    "methyltrans": 69,
                    "levels5": 69,
                    "0CVWTG4GXKGYUGPGVKEU": 69,
                    "MBDcontaining": 69
                },
                "Ethnographic Terms": {
                    "epigenetic": 4,
                    "methylation": 4,
                    "demethylation": 4,
                    "5mC": 4,
                    "H3K27me3": 4
                }
            },
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "Uptake_ metabolism_ and toxicity of methyl tert-butyl ether _MTBE_ in weeping willows.pdf",
            "cleaned_text": "metabolism toxicity methyl tertbutyl ether weep willow receive receive revise form accept available online Methyl tertbutyl ether high volume production chemical commonly use gasoline oxygenate Uptake metabolism toxicity tree investigate study weeping willow expose hydroponic solution spike incubate normalize relative transpiration NRT rate weeping willow use determine toxicity possible intermediate tertbutyl alcohol TBA solution tissue aerial part plant air analyze result toxicity test show severe sign toxicity reduction find treatment group high dose chlorosis leave large reduction observe exposure weep willow almost apply remove hydroponic solution plant treatment group small amount MTBE detect plant tissue large fraction apply find air plant transpiration Mass balance study show assimilate plant hydroponic solution metabolize transport plant Phytovolatilization relevant removal process stream concentration factor tscf important parameter design engineer phytoremediation system estimate conclusion compound persistent attack plant enzyme atmospheric much susceptible photooxidation decomposition Phytoremediation MTBE pollute soil groundwater alternative presently available remediation technology Elsevier right reserve Metabolism Methyl tertbutyl ether MTBE Phytoremediation toxicity Willows introduction large volume commercial use methyl tertbutyl ether fuel oxygenate replace alkyl lead addi tive trace back deal air pollution additive gasoline intend boost rating fuel reduce air pollution accept worldwide production increase make second list organic chemical manufacture approximately gasoline contain oxy genate cause leak environment mainly attribute gasoline spill leak correspond author fax mail address jdguhkucchku pipeline underground abovegroundstorage tank transport accident high solubility water low sorption tendency soil rapidly penetrate soil layer enter groundwater shortly spill become problematic pollutant urban soil groundwater worldwide draft lifetime health advisory limit issue toxicity MTBE animal human well doc umented establish carcinogenic animal Inhalation MTBE vapor cause headache nausea high concentration ppm people neurological cardiac allergic symptom associate chronic low level exposure also report classie possible human car algae invertebrate sh intensively study work however response vascular see front matter right reserve B137 plant organic chemical group category unique feature common feature growth parameter acute phytotoxicity assay undertake laboratory assess toxicity MTBE weeping willow use plant transpiration rate end point determination quite persistent abiotic decomposition natural attenuation aquifer slow case undetectable halflife least year number aerobic microorganism find able degrade however still feasible application detailed degradation pathway microorganism understand poorly conclu sive result tertbutyl alcohol TBA rst stable intermediate degradation process initially attack cytochrome CYP monooxygenase probable formation intermediate tertbutoxy methanol release formaldehyde TBA product Human liver also capable actively metabolize TBA similarly cytochrome p450 enzyme play critical role metabolism Plant uptake transpiration organic compound largely dependent octanolwater partition coefcient log measurement chemical afnity water lipid fat process effective log optimum range log range readily transpire plant phytoremediation feasible remedial technique remove contaminate site plant possess various enzyme detoxify degrade toxic chemical cyp450 widely distribute plant kingdom play crucial role plant metabolism hydroxylation fatty acid phenylpropanoid biosynthesis lignin precursor syn thesis terpenoid secondary metabolite also metabolism xenobiotic Phytoremediation MTBE study different continent climatic zone however information available concern phytoremediation terrestrial plant objectiveofthisstudywastoprovidequantitativedatathatcanbe use design engineer phytoremediation method tree exposure regime weep willow take grow campus China Tree cutting long remove mature specimen use study obtain single tree place bucket tap water room natural sunlight new root leave appear period growth preroote cutting transfer individual ask lle approximately modie nutrient solution Table ask seal cork stopper cut center silicon sealant prevent escape Table Composition modied nutrient solution hydroponic grow tree study nmol NaNO3 MgCl26H2O cocl26h2o kh2po4 cucl22h2o nahco3 namoo42h2o water chemical wrap aluminum foil prevent algal growth treatment concentration replicate prepare ask house climate control maintain constant temperature continuous articial light plant condition rst allow adaptation new environmental condition weight plantask system measure indi vidually ask include tree cutting weigh way transpiration rate determine Trees similar transpiration rate select test nutrient solution tree replace spiked solution control use analyt ical grade different treatment concentration apply weight ask include tree cutting measure incubation presence aqueous solution root stem leave measure end experiment mass balance carry assess loss hydroponic solution recovery different part plant material pos sibly metabolism transport plant concentration solution analyze duration estimate TSCF value normalize relative transpiration specially design acute toxicity test chemical water soil willow cutting weight loss water subject exposure compare initial loss prior exposure use assess toxicity compare toxic effect cutting differ ent initial transpiration toxicant add weight loss express relative transpiration transpiration normalize respect initial transpiration rate eliminate necessity cutting equal similar initial transpiration respect transpiration noncontaminated control cutting include effect normal growth cutting test mean malize relative transpiration calculate NRT 1Ti concentration time period abso lute transpiration replicate control always show inhibition tree transpiration usually con nectedwithothereffectsreducedgrowthnecrosisofleavesand severe case death inhibition NRT typically accompany complete inhibition growth analysis major degradation product use purge trap gas chromatographymass selec tive detector system equip capillary column thickness siliconecoated fusedsilica capillary column equivalent use maintain purge chamber improve purge efciencie purge equally HewlettPackard Series temperatureprogrammable equip pressure pro gramme splitsplitless injection use temperature program min rate min hold min carrier gas use helium injection port temperature sample inject use split mode mass range amu scan electron ionization mass spectroscopy study electron energy solution sample water sample directly inject depend concentration hydro ponic solution additional pretreatment procedure carry prior analysis plant material Willow root stem leave separately end incubation blotdried dip liquid nitrogen pulverize place bottle analysis component biomass sample store isolate light concentration determine biomass analyze use technique aqueous solution ple sample analyze transpire plant remove transpiration measure use mod ied test chamber illustrate Fig treat plant schematic diagram test chamber system measure transpiration air Fig normalize relative transpiration NRT weep willow grow hydroponic solution spike value mean replicate prepare describe place glass chamber airow system tub ing outow vessel connect carbon tube serve trap airborne gas trap tube wrap aluminum foil place vessel change gas tube analyze MTBE MTBE air analyze base describe repli cate conduct treatment group duration test result discussion Phytotoxicity MTBE weeping willow hydroponic solution show normalize relative transpiration weep ing willow grow hydroponic solution spike various level study logarithm datum use correlation dosage high slightly high nontreate plant negligible reductionofnrtwasobservedfortheweepingwillowsexpose however reduction find treatment group expose expose high dose weeping willow show severe toxic symptom short time period show signicant reduction NRT Chlorosis leave observe treatment group whole duration test note Fig Toxic effect MTBE weeping willow linear regression square value add treatment group show slightly increase initial exposure indicate fact large frac tion apply hydroponic solution remove plant physiological function plant gradually restore afterward concentration lower effect concentration EC10 dene concen tration chemical produce maximum possible response specic chemical study response inhibition maximum observe slope linear regression exposure tion log10 use calculate ec10value ec10value weep willow respectively wide range LC50 invertebrate vertebrate use mortality sen sitive end point microalgae measure report report LC50 value respectively magna common zooplankton specie show similar sensitivity survival signicantly reduce animal expose observedeffectconcentration lowestobservedeffectconcentration loec growth Toxicity find slightly high rainbow trout mykiss study combine LC50 EC50values lettuce Lactuca sativa wild oats sativa wheat aestivum sweet corn Zea may range dry respectively growth shoot root use sensitive end point result current study indicate weep willow seem less sensitive specie test uptake hydroponic solution weep willow control plant slight change con detect solution entire period exposure datum show probably due experimental error handling headspace removal disap pearance aqueous solution attribute uptake willow result also show apply remove hydroponic solution presence willow treatment group period exposure water root stem leave also analyze end experiment small amount MTBE detect plant biomass high concentration plant material find root follow stem low concentration biomass leave Figs concentration detect study low report tissue concentration literature possibly different specie physiological stage plant use mass balance assessment MTBE Fig measure MTBE root plant expose differ ent concentration value mean replicate vertical bar represent standard deviation stem plant expose dif ferent concentration MTBE value mean replicate vertical bar represent standard deviation recover plant biomass consider initial use indicate recover plant time analysis exposure slightly low value obtain study however find approximately dose incorporate hybrid poplar eucalyptus tree tissue plant expose solution day period study approximately apply find gas trap due plant transpiration breakdown product detect solution plant material treatment group mass balance overall experiment show apply lose due headspace removal percentage headspace obtain study low latter apply detect headspace removal result study indicate quite recalcitrant attack plant enzyme however susceptible photo measure MTBE leave plant expose dif ferent concentration MTBE value mean replicate vertical bar represent standard deviation B137 Table Mass balance MTBE study expose concentration solution tissue transpire headspace removal mean replicate sample transpire replicate parenthesis standard deviation denote concentration limit detection headspace removal Mass tissue masstranspired oxidation vapor phase reaction photochemically produce hydroxyl radical estimate halflife day atmosphere Table Additional ndings Zhang use sixchannel system alfalfa plant find pronounce rhizosphere effect bacterial strain capable degrade add channel vegetated channel bacteria show low amount surface soil low vege tation bacteria alone find phytovolatilization dominant disappearance process vessel poplar tree Populus deltoide nigra initial mass detect plant biomass metabolite find HPLC analy sis use radiolabele technique also find mass water remove small poplar sapling populus deltoids nigra period high ppb low ppb con centration detect biomass ppb level conrme passage plant mass bal ance indicate largely untransforme transport small poplar sapling air study leaf cell Danish plant specie family find unable degrade MEBE trace amount metabolite TBA detect solu tion root poplar Populus robusta willow hybrid Salix viminalis schwerinii unlikely conclude small amount degradation observe really originate plant cell rootcolonize bacteria determination transpiration stream concentration factor tscf organic contaminant solution phase reach root surface mass transfer penetrate root enter xylem transport transpiration stream tran spiration stream chemical react partition plant tissue metabolize detoxied plant enzyme escape gaseous diffusion stomata leave spiration stream concentration factor concentration xylem sap respect external solution concentration use characterize estimate ability plant extract pollutant contaminate medium translo cate shoot use simple mathematical description estimate tscf woody plant experiment carry poplar TSCF exp log approach valid assumption diffu sion occurrence plant root degradation plant personal communication correlation predict TSCF value high TSCF also calculate equation experiment do grass barley TSCF exp log study relationship percentage mass remove aqueous solution volume water tran spired tree use determine TSCF value TSCF dvtransp slope line plot percent reduction mass water volume water tran spire initial volume water treat system factor incorporate value plot graph observed TSCF value compute graphical method yield estimate similar value TSCF also report however low tscf value experimen tally determine approximately calculate TSCF study indicate readily take root plant stay long quickly translocate xylem leave evaporate metabolize B137 Fig percent mass reduction volume water transpire Conclusions MTBE pollution soil groundwater occur world toxicity test hydroponic solution use malize relative transpiration sensitive end point show shortterm acute toxicity MTBE weeping willow relate dosage exposure period severe sign toxicity observe treatment group expose high dose MTBE weeping willow find able extract hydroponic solution due plant transpiration small amount apply detect tissue plant mass balance study show take plant hydroponic solution metabolize transport phytovolatilization relevant removal process quite persistent acttack plant enzyme susceptible photooxidation atmosphere infor mation collectively suggest phytoremediation pollute soil groundwater alternative present available remediation technology ment work support studentship Phytoremediation MTBE groundwater plume extent past release contaminate community water supplier 210A Sewell Water quality marina relate methyl tertbutyl ether Pollut air use scientic information regulate reformulate fuel Squillace Zogorski Price Preliminary assess ment occurrence possible source groundwater Environ Sci Technol ether gasoline additivecause testicular lymphomaematopietic cancer rat Burgess Dottridge Symington Methyl tertiary butyl ether groundwater contaminant grow concern Mather Banks Dumpleton Fermor Eds groundwater contaminant risk assessment groundwater contaminate Methyl tertbutyl ether acute aquatic toxicity substance carry ship Naro Acute toxicity methyltertiarybutyl ether aquatic organism 15th Annual SETAC Meeting toxicity methyl tertbutyl ether freshwater organism Steen Toxi city methyl tertbutyl ether marine organism ambient water quality criterion calculation publish literature pertain uptakeaccumulation translocation adhesion biotransformation organic chemical vascular plant Vandecasteele Monot Microbial degradation fate environment methyl tertbutyl ether related fuel oxygenate Isolation bacterial culture degrade methyl tertbutyl ether Microbiol tertbutyl ether pure bacterial culture Microbiol dation gasoline oxygenate methyl tertbutyl ether ethyl tertbutyl ether tertamyl methyl ether propaneoxidizing bacteria iron Chapelle widespread potential microbial degradation surfacewater sediment Anaerobic biodegradation know poten tial gasoline oxygenate terrestrial subsurface Metabolism methyl tertbutyl ether gasoline ether human liver microsome heterologously express human cytochrome P450 identication major catalyst BriggsBromilowEvansRelationshipbetweenlipopholic ity root uptake translocation nonionize chemical barely predictive relationship uptake organic contaminant hybrid poplar tree Burken Uptake metabolism organic compound PhytoremediationTransformation process organic chemical plant ContaminationModeling cesse Lewis Boca Raton cytochrome Phytochem istry potential phytoremediation metabolism Danish vegetation Burken Phytoremediation MTBE hybrid poplar tree b137 phytotoxicity test use transpiration willow Arch Environ Contam Toxicol Hockett Shortterm Subchronic toxicity Staticrenewal Test Conditions Study Number ENSR Fort Collins Kampbell McGill toxicity methyl tertbutyl ether plant sativa Zea may sativa Newman Osgood Strand Phytoremediation MTBE naval site Soil Groundwater Cleanup FebruaryMarch experimental study phytoreme diation ground water proceeding",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Danish": 2
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "__-___-7-chloro-8-hydroxy-3-methyl-1-phenyl-2_ 3_ 4_ 5-tetrahydro-1H-3-benzazepine hydrochloride _SCH23390_ directly inhibits G protein-coupled inwardly rectifying__.pdf",
            "cleaned_text": "Classic Dopamine Receptor Antagonist Chloro benzazepine hydrochloride SCH23390 Directly inhibit ProteinCoupled inwardly rectify potassium Channels ELDO KUZHIKANDATHIL1 Chapel Hill receive accept article available online drobenzazepine hydrochloride SCH23390 widely use highly selective antagonist dopamine receptor investigate crosstalk dopamine receptor signal pathway discover addition receptor antagonist SCH23390 related com pound inhibit proteincouple inwardly rectify potassium GIRK channel present evidence SCH23390 block endogenous GIRK current induce somatostatin dopamine receptor AtT cell IC50 inhibition receptorindependent constitutive GIRK current Chinese hamster ovary cell express GIRK channel also block sch23390 inhibition girk channel somewhat selective member closely relate family inwardly rectify potassium channel well various endogenous cationic current present AtT cell affect addition current clamp recording SCH23390 depolarize membrane potential induce AtT cell fire action potential indi cat potential physiological significance GIRK channel inhibition identify chemical feature contribute GIRK channel block test several structurally relate compound skf38393 chlorohydroxyphenyl tetrahydrobenzazepine hydrochloride methylSCH23390 hydrochloride iodo SCH23390 result indicate halide atom critical block GIRK channel take together result suggest SCH23390 related compound provide basis design novel GIRK channelselective blocker perhaps importantly study exclusively use SCH23390 probe receptor function diag nostic receptor involvement need reevaluate light result previously show dopamine receptor couple activate proteincouple inwardly rectify ing potassium GIRK channel kandathil inhibit type calcium chan nel give coexpression dopamine receptor central nervous system neuron particularly subset nucleus accumben neuron interested explore functional consequence coupling address issue use ligand highly lective receptor long serve diagnostic probe receptor function ligand chlorohydroxymethylphenyltetrahydro benzazepine hydrochloride SCH23390 highly antagonist dopamine receptor least fold high affinity receptor recep tor SCH23390 member phenyltetrahydrobenzazepine structural class also include partial agonist hydro chloride SKF38393 SCH23390 widely use vivo characterize receptor function work support grant NS18788 grant current address Physiology ABBREVIATIONS GIRK proteincouple inwardly rectify potassium channel SCH23390 tetrahydrobenzazepine hydrochloride SKF38393 hydrochloride hydrochloride iodoSCH23390 tetrahydroiodomethylphenylbenzazepin hydrochloride ventral tegmental area quinpirole Chinese hamster ovary cell potassium 895X MOLECULAR PHARMACOLOGY Vol Copyright Printed ASPET Journals February molpharmaspetjournalsorg distinguish receptor receptor SCH23390 inhibit receptormediated activation adenylyl cyclase IC50 publish study use sch23390 concentration antagonize receptor function report tion SCH23390 also directly inhibit current GIRK channel GIRK channel subfamily inwardly rectify potassium channel consist major isoform Kir3 Kir3 Func tional GIRK channel tetramer compose identical heteromeric sub unit known girk form heteromultimer vivo recent evidence suggest GIRK4 form functional timer channel activate subunit protein release heterotrimeric complex proteincoupled recep tor bind ligand cloning GIRK channel family numerous report indicate coupling variety proteincouple receptor extensive functional biochemical charac terization selective GIRK channel blocker yet report many toxin block voltagedependent channel peptide bee venom known distinctive blocker inwardly rectify potassium channel nately peptide discriminate GIRK channel renal outer medullary rom chan nels lack selective GIRK channel blocker limit characterization role neurotransmission recently use alternative dominantnegative strategy establish role chan nel maintain rest membrane potential well modulate neurosecretory activity report selective direct inhibition GIRK2 channel dopamine receptor antagonist SCH23390 result suggest concen tration routinely use study receptor function SCH23390 effectively block GIRK channel depolarize membrane potential induce action potential activity cell test several different phenyltetrahydrobenzaz epine compound also demonstrate halide atom compound critical blockade Materials Methods Cell Culture CHO cell grow Ham F12 medium fetal calf serum penicillinstreptomycin AtT mouse pituitary cell grow Ham F10 medium fetal calf serum heatinactivate horse serum gentamicin AtT cell stably express human dopamine receptor maintain transient transfection subsequent electrophysiological characterization cell plate glass coverslip coat polylysine AtT Cells AtT cell stably express human D2S receptor generate clonal selection transfection expression plasmid pcdna3 mediate reagent code sequence receptor subclone cell transiently transfecte use LipofectAMINE Invitrogen pcdna3 vector encode various potassium channel gift enhanced green fluorescent protein efficiency assess enhanced green fluorescent protein marker current achieve routinely electrophysiology Agonistactivated current measure cell wholecell patch clamp technique use pipette construct polished homemade microforge magnification cell hold current elicit ramp voltage command hyperpolarizing step indicate protocol current response normalize cell capacitance picoamperespicofarad count variation cell size standard external solution use NaCl KCl CaCl2 MgCl2 HEPES glucose pipette solution contain potassiumaspartate NaCl HEPES glucose Fig sch23390 block inward current induce quinpirole somatostatin SST AtT cell stably express human dopamine receptor representative trace show obtain wholecell recording mode cell hold duration drug application indicate code bar trace concentrationdependent inhibition endogenous GIRK current induce AtT cell express human receptor smooth curve represent fit datum set equation yield IC50 coefficient datum point represent percentage induce current current current mean AtT cell hold February molpharmaspetjournalsorg enhance inwardly rectify current control drug exposure carry solution elevated extracellular potassium sub stitution Analysis Wholecell macroscopic cur rent response ramp step command sample Digidata interface use pClamp software file import sigmaplot SPSS display analysis student test perform relevant datum use sigmaplot test datum consider statistically different drug Quinpirole somatostatin make stock solution distil water use final concentration otherwise indicate Stock solution SCH23390 SigmaRBI TOCRIS chlorohydroxyphenyltetrahydro benzazepine hydrochloride normethylSCH23390 SigmaRBI tetrahydroiodomethylphenylbenzaz epin hydrochloride iodoSCH23390 SigmaRBI SKF38393 SigmaRBI make concentration distil water electrophysiological experiment drug solution deliver indicate concentration cell reled micropipette array result SCH23390 Blocks AgonistActivated GIRK Currents AtT cell experiment investigate crosstalk dopamine receptor signal pathway discover SCH23390 block GIRK current show previously cell express GIRK2 isoform transfecte dopamine receptor native somatostatin receptor activate endog enous GIRK current cell Figure show GIRK current activate dopamine tor somatostatin receptor completely inhibit sch23390 inhibition sch23390 rapid reversible furthermore representative recording demonstrate kinetic inhibition recovery quite different latter much slow GIRK current induce quinpirole receptor agonist AtT cell inhibit sch23390 dosedependent manner EC50 SCH23390 also inhibit somatostatininduced GIRK cur rent similar efficacy potency representative example show sch23390 different manufacturer SigmaRBI TOCRIS use study yield identical result suggest inhibition artifact SCH23390 inhibition GIRK Currents Receptor Independent ability sch23390 inhibit GIRK current induce different proteincoupled receptor dopamine somatostatin receptor sug gest inhibition reflect ligand interaction receptor receptorindependent assess possibility examine ability SCH23390 directly block current cell express human GIRK channel coexpression proteincou plead receptor other demonstrate previously robust constitutive inwardly rectify current serve elevated extracellular potassium cell overex press GIRK channel receptor receptor agonist application feature permit direct test receptorindependent block GIRK channel SCH23390 Figure show representative current sponses voltage step cell coexpresse human GIRK2 isoform Inward current enhance change mal external potassium concentration upper record external potassium middle record application sch23390 cell dramatically suppress constitutive GIRK current low record figure currentvoltage plot derive raw current trace indicate block appreciably voltage dependent interestingly also show SCH23390 block small physiologically relevant outward GIRK current CHO cell CHO cell transfecte receptor express current associate GIRK channel correspondingly unaffected sch23390 datum show take together result strongly suggest SCH23390 directly inhibit GIRK channel inhibition receptorindependent representative current trace cell transiently transfecte human girk2expressing plasmid trace represent current response voltage step obtain wholecell recording mode hold poten tial set cur rent response cell expose standard external solu tion external solution solution SCH23390 broken line indicate current level current voltage plot generate cur rent response show demon strate block constitutive GIRK current sch23390 CHO cell express human GIRK2 smooth curve repre send fit equa tion datum sch23390 Selectively block GIRK Channels ASPET Journals February molpharmaspetjournalsorg examine dosedependence SCH23390 inhibition constitutive GIRK current cell express human GIRK1GIRK2 heteromultimer human GIRK2 homomultimer figure show SCH23390 seem inhibit girk1girk2 heteromultimeric channel sig nificantly high potency EC50 inhibit channel EC50 parent affinity low observe inhibition native GIRK channel mouse AtT cell Fig difference reflect speciesspecific sequence difference mouse human GIRK channel alternately give differential ability SCH23390 block GIRK heteromultimer homomultimer possible unknown reason transient coexpression human GIRK2 channel cell result high proportion GIRK2 homomultimer compare tive GIRK channel AtT cell show ously cell express endogenous GIRK2 isoform finally addition inhibit girk1girk2 channel serve SCH23390 also inhibit GIRK1GIRK4 channel express cell datum show cantly inhibited SCH23390 next interested explore inhibition girk Kir3 channel SCH23390 unique class inward rectifier approach question test ability SCH23390 block member relate family inwardly rectify potassium channel CHO cell transfecte dividually plasmid express human kir2 kir2 kir2 figure show representative recording current response voltage ramp transfecte cell high concentration SCH23390 test inward current CHO cell express ing kir2 kir2 kir2 inhibit inhibition constitutive inward cur rent cell express human girk1girk2 channel cell human GIRK2 channel alone cell datum point represent percentage mean inward current observe solution individual datum set fit equation yield IC50 value human human alone Representative inward cur rent response individual cell transiently express man isoform kir2 kir2 kir2 volt age ramp whole cell recording perform transfection cell hold response elicit standard external solution external solution external solution SCH23390 February molpharmaspetjournalsorg respectively inhibit high concentration sch23390 inhibition much less GIRK channel see exhibit slow kinetic furthermore SCH23390 effect channel block channel respectively also test ability sch23390 inhibit current generate voltage ramp command native channel AtT cell other show previously cell hibit voltagegated sodium calcium outwardly rectify ing potassium current Figure show representative current response voltage ramp command AtT cell express dopamine receptor inwardly rectify GIRK current duce quinpirole completely inhibit SCH23390 current elicit unaffected latter current represent sodium cal cium delayedrectifier potassium channel sistant SCH23390 concentration comparison relative sensitivity quinpirole activate GIRK current voltagegated potassium current fig sch23390 document resistance result support suggestion channel specific many channel examine Chlorine Atom SCH23390 critically volved GIRK Channel Block several compound closely relate structurally SCH23390 available skf38393 particularly interesting sch23390 dopamine receptor antagonist skf38393 partial agonist receptor widely use activate receptor vivo chem ical structure compound exhibit key dif ference first skf38393 lack methyl group substi tut chlorine atom SCH23390 hydroxyl group Fig furthermore intermediate compound methylSCH23390 lack methyl group present SCH23390 test structural analog block human girk1girk2 channel express cell Fig ure show representative experiment consti tutive GIRK current completely inhibit SCH23390 normethylSCH23390 marginally reduce skf38393 cell examine SCH23390 normethylSCH23390 block constitutive GIRK current approximately skf38393 block approximately current furthermore small block skf38393 exhibit much slow kinetic compare sch23390 normethylSCH23390 also test compound use native GIRK cur rent induce receptor activation mouse AtT cell agreement result constitutive current agonistinduced GIRK current AtT cell signifi cantly inhibited SCH23390 normethylSCH23390 compare SKF38393 iodoSCH23390 Fig iodoSCH23390 less effective sch23390 normethylSCH23390 significantly effective SKF38393 block quinpiroleinduced current result suggest halide atom position SCH23390 critically involve mediate GIRK nel blockade SCH23390 AtT cell evaluate potential physiological significance SCH23390 block test effect com pound membrane potential AtT cell demonstrate previously GIRK channel play important role maintain rest membrane potential furthermore activation endogenous GIRK channel heterologously express dopamine receptor AtT cell hyperpolarize membrane potential inhibit neurosecretory activity hypothesize SCH23390 inhibit GIRK channel prevent even reverse receptor duce hyperpolarization AtT cell test hypoth esis record membrane potential response selective agonist quinpirole current clamp AtT cell stably express human receptor expect application quinpirole hyperpolarize membrane potential inhibit spontaneous action poten fig whole cell current obtain voltage ramp single AtT cell express human receptor cell treat external solution contain SCH23390 Quinpirole SCH23390 apply solution note current elicit affect SCH23390 bar graph compare percentage inhibition mean sensitive current voltagegated current SCH23390 SCH23390 Selectively block GIRK Channels ASPET Journals February molpharmaspetjournalsorg tial cell SCH23390 methylSCH23390 reverse response quinpirole depo larize membrane potential induce resumption spontaneous action potential contrast skf38393 signifi cantly alter GIRK current alter quinpirole induce hyperpolarization Fig result agreement experiment show support premise sch23390mediate block GIRK channel directly affect electrical activity cell impor tantly also indicate SCH23390 inhibit small physiologically relevant outward current GIRK channel Fig Discussion article present evidence classic dopamine receptor antagonist SCH23390 widely use definitive probe receptor involvement brain function also effectively completely inhibit GIRK channel SCH23390 inhibit native GIRK channel AtT cell human GIRK channel heterologously express cell dosedependent manner inhibition rapid kinetic IC50 approximately AtT cell feature tion suggest dramatic reduction current reflect direct interaction sch23390 GIRK channel First inhibition quite rapid consistent direct block channel Second inhibition observe constitutively active GIRK channel absence ago coexpresse proteincoupled receptor nature constitutive GIRK current cell overexpresse subunit entirely clear complexity signal component link proteincoupled receptor effector expression system examine likely reflect spontaneous isomerization receptor cause constitutive current insensitive sulpiride specific receptor antagonist cell express receptor Kir3 channel unpublished observation constitutive current also unlikely reflect spontaneous dissociation protein heterotrimer contain subunit pretreatment pertussis toxin block agonistinduced GIRK current constitutive current datum consistent channel block definitively rule possibility SCH23390 allosterically interfere gate induce free dimer phosphatidylinositolbisphosphate Herlitze regard latter mecha recently suggest blockade GIRK channel express oocyte membranepermeable local anesthetic bupivacaine destabilization phosphatidylinositolbisphos phate bind channel survey study use SCH23390 probe receptor function reveal compound often use concentration range result fig chemical structure different phenyltetrahydrobenzazepine compound use study representative current recording cell transiently express human GIRK2 cell hold treat solution SCH23390 SCH normethylSCH23390 SCH SKF38393 SKF black bar bottom trace indicate duration drug application drug apply external solution contain bar graph show SCH23390 normethylSCH23390 block human GIRK2 channel express cell equal efficacy SKF38393 much less effective student test compound use concentration bar graph compare ability various phenyltetrahydrobenzazepine compound inhibit induce current AtT cell express receptor compound test concentration iodoSCH23390 skf38393 significantly less effective iodoSCH23390 significantly well skf38393 block induced current number bar represent number cell test February molpharmaspetjournalsorg suggest concentration range SCH23390 also effectively block GIRK channel present potential problem particularly study exclusively use SCH23390 differentiate receptor physiological function cribed receptor coupling GIRK channel include modulation neuronal secretory activity addition receptor antagonist SCH23390 also block GIRK channel useful ness distinguish receptor function receptor function become problematic instance receptor coexpresse exam ple datum demonstrate SCH23390 inhibit functional response dopamine receptor activation depolarize cell induce action potential evidence present article result native neuron normally erroneously interpret suggest receptor normally inhibit excitation thus light result present useful reevaluate previous study use SCH23390 exclusively determine receptor function direct evidence indicate volvement GIRK channel block particular previous study type example study com plication exist instructive use SCH23390 investigate role receptor ventral tegmental area cocaine selfadminis tration rat injection sch23390 approximate final concentration sum fold dilution increase cocaine selfadminis tration suggest dendritically release dopamine mally moderate reward behavior receptor activation consider neuron contain receptor couple GIRK channel plausible sch23390 action reflect inhibition GIRK current subsequent excitation neuron identification girk channel atypical target SCH23390 similar finding recent report receptor ligand inhibit GIRK channel current examine activation girk1girk2 heteromultimeric channel several opioid receptor ligand laevis oocyte also express opioid receptor addition expect activation nanomolar tion selective agonist observe reduction GIRK current micromolar concentration reduction observe oocyte express Kir3 opioid receptor furthermore observe sch23390 IRK1 channel insensitive opioid agonist channel propoxyphene methadone exhibit EC50 value respectively report indicate several antipsychotic drug haloperidol thio ridazine pimozide also block GIRK channel express laevis oocyte author report haloperidol thioridazine pimozide clozapine block GIRK channel IC50 value respectively potency SCH23390 block girk1girk2 channel serve IC50 great compound take together previous study current observation reiterate need reevaluate previous study use selective ligand determine function receptor vivo concentration moderately exceed EC50 value association respective proteincoupled receptor sch23390mediate block GIRK channel exhibit several interesting property SCH23390 selec tively block GIRK channel ability block heteromul timeric girk1girk2 channel significantly different ability block channel addition speciesspecific difference GIRK channel sequence differential potency partly explain significantly different IC50 value tive mouse GIRK channel AtT cell transiently express human GIRK channel cell Fig possible native GIRK channel AtT cell compose predominantly GIRK1GIRK2 heteromultimer cell transiently transfecte GIRK2 plasmid express high percentage GIRK2 homomultimer heterologously press GIRK1GIRK2 construct quire explore speculation practical consequence observation intriguing possibility SCH23390 current clamp recording representative AtT cell express receptor demonstrate SCH23390 normethylSCH23390 skf38393 block hyperpolarization induce quinpirole compound use concentration black bar trace indicate duration drug application note quinpirole inhibit spontaneous action potential SCH23390 SCH23390 depolarize membrane potential induce cell fire action potential sch23390 Selectively block GIRK Channels ASPET Journals February molpharmaspetjournalsorg derivative useful pharmacological tool probe subunit composition GIRK channel vivo result show Fig combine ability SCH23390 depolarize membrane potential indicate compound block inward potassium current also small physiologically relevant ward current GIRK channel property par ticularly important compound structurally relate sch23390 use pharmacotherapeutic strategy block GIRK channel vivo result also suggest zepines potential candidate design novel blocker GIRK channel end demonstrate halide atom present compound essential mediate GIRK channel block iodoSCH23390 also block GIRK channel less effectively fig indicate chlorine position suggest size atom position phenyltetrahydrobenzazepine important determinant GIRK channel block exam ine hypothesis interesting test effect remove chlorine atom position substitute fluorine bromine atom addition important evaluate contribution phenyl group position phenyltetrahydrobenzazepine compound acknowledgment thank Chapel Hill provide advice iodoSCH23390 compound thank also Research Triangle Park provide expression plasmid encode various potassium channel critical reading manuscript also thank alert related finding opioid ligand receptor activation excite rat striatal large aspiny neuron vitro Neurosci agonist property dopaminergic antagonist D1A dopamine receptor uncouple D1A dopamine receptor protein Paron Logothetis recombinant inwardly rectify potassium channel couple bind protein Gen Physiol Identification native atrial protein regulate inwardly rectify GIRK4 channel homomultimer Ehrengruber heteromeric proteingate inward rectifier channel overexpresse adenovirus gene transfer inhibit excitability hippocampal neuron Jan Jan evidence direct bind protein gate inwardly rectify channel important channel activation Takai Characterization protein gate channel compose subunit dopaminergic neuron substantia nigra Neurosci sch23390 potential antipsychotic unique interaction dopaminergic system Pharmacol Exp ther novel highaffinity inhibitor inward rectifier channel biochemistry Akita potently selectively block muscarinic channel rabbit cardiac myocyte Pharmacol Exp ther Inhibition various antipsychotic drug protein activate inwardly rectify GIRK channel press Xenopus oocyte Pharmacol neuronal protein gate inwardly rectify channel activate gbg subunit function heteromultimer human dopamine inhibit type calcium channel secretory activity AtT cell Neurosci mutant identify role GIRK channel dopamine receptormediated regulation secretion activity Gen Physiol Human dopamine D2L receptor couple inward rectifier potassium channel mammalian cell line Mol Cell Neurosci Tinker protein subunit key role determine specificity coupling activation protein gate inwardly rectify channel Tinker role member pertussis toxinsensitive family protein coupling receptor activation proteingate inwardly rectify potassium channel dopamine receptor pepti dergic neuron nucleus accumben comparison dopa mine receptor provide evidence family inward rectifier protein couple channel brain FEBS Lett Jan protein gate inwardly rectify channel protein GIRK2 alter expression weaver brain Neurosci putative dopamine receptor agonist lack mesolimbic selectivity Eur Pharmacol current pituitary cell line AtT differential role stimulussecretion coupling endocrinology Logothetis Kurachi gamma subunit protein activate muscarinic channel heart Nature Lond Herlitze protein gate inward rectifier channel Eur Biochem mechanism underlie dopamine receptormediated inhibition dopaminergic neuron ventral teg mental area pharmacol Neve biology dopamine receptor Dopamine Receptors Neve Press dopamine receptor ventral tegmental area decrease cocaine reward possible role dendritically release dopamine Neurosci Tytgat dual modulation channel opioid receptor ligand Eur Pharmacol dopamine receptor couple proteinregulate potassium channel Xenopus oocytes Mol Pharmacol protein regulation potassium channel Pharmacol Rev dopamine receptor mechanism ischemiainduce impairment CA1 presynap tic fiber spike rat hippocampal slice Brain Res Slesinger Mechanism underlie inhibition proteingate inwardly rectify channel address correspondence Oxford Department Cell Molecular Physiology MSRB University North Carolina Chapel Hill mail February molpharmaspetjournalsorg",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Chinese": 2,
                    "benzazepine": 1,
                    "Kir2 IRK1": 1,
                    "ridazine": 1,
                    "heteromul timeric": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "__interaction with calf thymus DNA as well as electrochemical studies of adducts formed by azomethine _2-__3_ 5-dimethylphenylimino_ methyl_ phenol_ and organotin _IV__.pdf",
            "cleaned_text": "synthesis characterization biological screening interaction calf thymus dna well electrochemical study adduct form organotin chloride Chemistry QuaidAzam University Islamabad Pakistan Department Biochemistry QuaidAzam University Islamabad Pakistan Article history receive Accepted March Available online Azomethine Organotin adduct transfer biological activity Cyclic voltammetry Novel azomethine adduct synthesize reaction CH3 c4h9 C6H5 C6H11 dimethylphenyliminomethylphenol product character ize elemental analysis 119Sn nmr spectroscopy Triphenyltin chloride dimethylphenyliminomethylphenol also characterize single crystal analysis spectroscopic crystal datum suggest complex ligand act monodentate neutral molecule coordinate oxygen tin atom form pentacoordinated tin specie phenolic hydrogen ligand transfer imine nitrogen atom due coordination oxygen tin complex formation ligand complex screen biological activity includ ing dna interaction enzymatic antibacterial antifungal cytotoxicity study electro chemical behavior synthesize compound also study result obtained evidence irreversible oxidation right reserve complex massive impact medicine attractive candidate design new anticancer agent Cis platin carboplatin oxaloplatin rst clinically use antitumor drug platinum base treatment efcient several type solid tumor effectiveness limit serious nephrotoxicity myelotoxicity peripheral neuropathy tumor resistance overcome clinical problem large number new nonplatinumbased anticancer complex screen complex contain take lead connection good antitumor activity remark ably low toxicity diorganotin complex find even well activity cisplatin make suitable candidate possible clinical use chemistry organotin compound gain paramount attention account interesting structural feature schizonticidal antimalarial fungicidal activity tential agricultural biocide compound range application include use boat paint additive prevent attack microorganism insecticide fungus cide C4H93Sn watersoluble tributyl mesylimide widely use wood preservative several organotin com pound use commercially hydrochloric acid scavenger polyvinyl chloride preparation wellestablished highly effective universal stabilizer rigid exible PVCs Organotin specie provide excellent protection pvc high thermal stress confer crystal clarity nishe article relatively report rsnsch2cooc8h17 compound inhibit dehydrochlorina tion reaction exchange anionic moiety atom polymer caution nowadays compound ban environmental concern Azomethine ligand consider privileged ligand ease preparation use uorogenic agent herbicidal block agent Coordination azometh ines organotin compound receive considerable attention respect structural variation potential application medicinal chemistry biotechnology Azomethines neutral deprotonated form react organotin halide complex form port exhibit different mode coordination cause wide application see front matter right reserve corresponding author fax mail address drsa54yahoocom list available journal homepage wwwelseviercomlocatepoly interaction organometallic compound dna interest therapeutic treatment molecule recognize specic dna sequence alter local dna structure inhibit access activator repressor protein ultimately affect geneexpression process chemotherapeu tic drug dnatargete bind ability organotin com pound DNA depend coordination number nature group bond central tin atom small mole bind dna covalent noncovalent interaction binding take place nitrogenous basis negatively charge oxygen phosphate backbone DNA current article report synthesis azomethine ligand dimethylphenyliminomethylphenol complex organotin compound synthesize ligand complex characterize various technique includ ing nmr elemental analysis single crystal analysis activity include interaction DNA enzy matic study antibacterial antifungal cytotoxicity synthesize ligand organotin complex study drugDNA bind parameter synthesize compound calculate electrochemical behavior synthesize compound also study method reagent C4H93SnCl C6H53SnCl C6H11 SnCl c4h9sncl3 taine use tion solvent purchase dry use accord literature procedure melting point determine capillary tube use electrothermal melting point apparatus spectra range obtain do use CHNS apparatus nmr record NMR spectrometer use CDCl3 internal refer ence CDCl3 shift couple constant value give multiplicity signal NMR spectra give chemical shift singlet doublet triplet quartet quint quintet multiplet 119Sn NMR spectra record sample redissolved dmso instrument measurement record work fre quency MHz chemical shift external standard absorption spectra mea sure Shimadzu Vis spectrophotometer Viscosity measure ubbelohde viscometer room temperature electrical conductance measure WTW Series Inolab Cond ray diffraction datum collect equip detector set crystal crystal cool use KRYOFLEX low temperature device intensity measurement perform use graphite monochromate radiation seal ceramic diffraction tube setting structure solve method extension model accomplish direct method use program SIR2004 Final renement carry fullmatrix least square tech nique use modied version program PLUTO preparation illustration platon package experiment carry use lAutolab run GPES software Netherlands Measurements carry use glassy carbon work electrode GCE geometric area cm2 wire counter electrode saturated calomel electrode onecompartment electrochemical cell clean polishing alumina paste rinse water experiment stock solution prepare ethanol Compound use representative example organo tin complex experiment carry room temperature synthesis Synthesis ligand dimethylphenyliminomethyl phenol amount dimethylamine add freshly dry toluene mixture reuxe water form remove use apparatus solvent move use rotavapor product obtain form oily yellow viscous liquid chemical reaction show scheme yield molecular formula physical state liquid broad nmr CDCl3 ppm h10 H40 H10 H11 H12 nmr CDCl3 ppm C20 C40 Solubil ity Chloroform ethanol dmso acetone General procedure synthesis organotin complex prepared dissolve mmol freshly dry toluene follow addition mmol CH3 c4h9 C6H5 C6H11 c4h9sncl3 reaction mixture stir reuxe content ask cool ltered ltrate rotary evaporated get desire product recrystallize mixed solvent chloroform hexane general chemical reaction show scheme trial experiment presence triethylamine also perform comparison product one prepare triethylamine ligand take freshly dry stoichiometric amount triethylamine add mixture stir reuxe stoichiometric amount organotin compound add mixture stir reuxe content ask allow settle tere rotary evaporated get desire product NMR spectrum extra peak triethylamine observe compare product triethylamine conclude triethylamine role adduct formation Trimethyltinchloride dimethylphenyliminomethyl phenol yield molecular formula C18H24 ClNOSn Mol Anal Calc C18H24ClNOSn find broad hydrogen bond NMR CDCl3 ppm h10 H40 H10 H11 H12 SnMe nmr CDCl3 ppm C10 C20 C40 C10 C11 C12 SnCH3 119sn nmr dmso ppm solubility chloroform ethanol DMSO acetone dimethylphenyliminomethyl phenol yield molecular formula C27H42 ClNOSn Mol physical state liquid broad hydrogen bond NMR CDCl3 ppm h10 H40 H10 H11 H12 quint SnCH2CH2CH2CH3 NMR CDCl3 ppm C20 C40 C12 13Ca 119Sn13Ca 119Sn13Ca SnCH2CH2CH2 CH3 119Sn nmr dmso ppm Molar Conductance cm2 mol solubility chloroform ethanol dmso acetone Triphenyltinchloride dimethylphenyliminomethyl phenol yield molecular formula c33h30clnosn Anal Calc C33H30ClNOSn Found broad hydrogen bond NMR CDCl3 ppm h10 H40 H10 H11 H12 SnPh nmr CDCl3 ppm C20 C40 C12 119Sn13Cb 119Sn13Cc SnPh nmr dmso ppm ductance solubility chloroform ethanol dmso acetone dimethylphenylimino molecular formula c33h48 ClNOSn Mol Anal Calc C33H48ClNOSn Found broad hydrogen bond NMR CDCl3 ppm h10 H40 H10 H11 H12 Hb0 quint Hc0 NMR CDCl3 ppm C20 C40 C12 119Sn13Cb 119Sn13Cc SnCy 119sn nmr dmso ppm solubility chloroform ethanol dmso acetone Butyltintrichloride dimethylphenylimino methyl phenol yield molecular formula Anal Calc c19h24cl3nosn Found broad hydrogen bond NMR CDCl3 ppm h10 H40 H10 H11 H12 quint SnCH2CH2CH2CH3 NMR CDCl3 ppm C20 C40 C10 C11 C12 119Sn13Cb NH2 toluene Reflux H3C H3C Scheme structural representation formation azomethine ligand Reflux H3C H3C Scheme General structural representation organotin complex SnCH2CH2 CH2CH3 119sn nmr dmso ppm solubility chloroform ethanol dmso acetone dna interaction study Vis spectroscopy DNA dissolve double deionized water keep nucleotide protein ratio obtain ratio absorbance a260a280 indicate DNA free protein dna concentration deter mine absorption spectroscopy use molar absorption coefcient cm DNA find stock solution working solution prepare dilution method compound dissolve ethanol con centration absorption titration form keep concentration compound xed vary DNA concentration equivalent solution DNA add complex solution elimi nate absorbance DNA compounddna solution allow incubate min room temperature measurement make absorption spectra record use cuvette path length room temperature Enzymatic activity assay alkaline phosphatase inhibition inhibition alkaline phosphatase assay monitor rate hydro lysis nitrophenyl phosphate pNPP Na2CO3 NaHCO3 sodium carbonatebicarbonate buffer enzyme catalyze hydrolysis phosphate monoester result formation inorganic phosphate alcohol identity alcohol vary depend specic phos phatase assay alkaline phosphatase activity take advantage fact enzyme utilize nonbio logical substrate nitrophenyl phosphate colourless give yellow coloured nitrophenol hydrolysis help monitor reaction show Scheme Stock solution inhibitor compound dmso prepare room temperature buffer substrate mixed ratio make reagent solution agent solution take cell enzyme vary concentration inhibitor add activity alkaline phosphatase presence sence inhibitor measure spectrophotometrically release yellow coloured nitrophenol chromophore monitor wavelength enzyme activity press nitrophenol release min min concentration inhibitor average take inhibition enzyme inhibitor calculate follow formula unit enzyme A405 min test A405 min blank total enzyme inhibitor VmL enzyme take dilution factor Millimolar extinction coefcient nitrophenol addition inhibitor activity enzyme decrease high concentration almost completely inhibit case show Fig Antibacterial assay synthesize ligand organotin complex test bacterial strain coli ATCC15224 Enterobactor aerogene bronchiseptica pneumoniae agar welldiffusion method use determination antibacterial activity Broth culture contain colony form unit test strain add nutrient agar medium mix well pour sterile petri plate medium allow solidify well dig sterile metallic borer dmso solution test sample add respective well DMSO serve negative control standard antibacterial drug use positive control plate bacterial strain prepare incubate aerobically activity determine measure diameter zone show complete inhibition Antifungal assay Antifungal activity fungal strain Aspergillus niger Fusarium solani Mucor specie determine use tube dilution method Screw cap test tube contain Sabouraud dex trose agar SDA medium autoclaved min tube allow cool nonsolidied SDA load compound stock solution dmso make nal concentration tube allow solidify slant position room temperature tube inoculate diameter piece inoculum fungal culture medium supplement dmso Turbinane use negative positive control respectively tube incubate growth determine mea sure linear growth growth inhibition calcu late growth control show equation growth inhibition linear growth test samplemm Linear growth controlmm Cytotoxicity Cytotoxicity study brineshrimp lethality assay method Brineshrimp Artemia salina egg hatch articial sea water sea salt room temperature shrimp transfer vial contain articial sea water shrimp vial nal concentration compound ken stock solution dmso o2n h2o alkaline phosphatase O2N nitrophenyl phosphate colorless nitrophennol yellow colored Scheme hydrolysis nitrophenyl phosphate catalyze alkaline phosphatase number survive shrimp count analyze biostat computer program Probit analysis deter mine LD50 value result discussion synthesize condensation dimethyl amine salicylaldehyde structural formula tauto meric equilibrium show scheme new complex prepare reaction CH3 c4h9 C6H5 C6H11 toluene composition new compound conrme analytical datum sug gested structure recognize spectroscopic investigation factor selection azomethine ability exist ketoenol form establish amineimine equilibrium presence hydrogen bond membere chelate ring common solvent azomethine exist appreciable amount ketoenamine ketamine form spectra infrared spectrum free ligand band serve region attributable stretch ing vibration free group indicate intramolecular hydrogen bonding ligand instead band shift low frequency overlap range behavior observe spectra adduct point fact ring form intramolecular hydrogen bond ligand retain adduct weak broad band appear range free ligand assign overlap band find shift slightly high frequency due change hydrogen bonding coordination phenolic oxygen atom tin shift strong band occur attributable free ligand low frequency indicate adduct formation proton transfer phenolic oxygen atom imine nitrogen atom comparison spectrum free ligand reveal band observe due shift low frequency provide evidence participation oxygen bonding tin weaken bond appearance new band observe region indicate complex formation band assign bond nmr spectra NMR spectrum ligand show signal droxyl proton ppm pronounce shift clearly due strong intramolecular hydrogen bonding chemical shift proton sensitive notable feature NMR spectra complex broaden phenolic proton peak due weaken bond strengthen hydrogen bond interaction proton signal electric change signal attributable imine proton spectra ligand complex indicate atom coordinate tin coupling observe group atom due complex nature proton NMR spec trum show singlet ppm CH3 value range pentacoordinated tri compound 119Sn het eronuclear coupling value use calculate angle use equation tion 119Sn couple constant equation give value angle Me3SnClHL characteristic resonance peak nmr spectra complex record CDCl3 nmr spectrum ligand peak ppm belong methine carbon atom respectively signif icant change chemical shift carbon nmr spectra complex compare ligand show duct formation chemical shift SnPh3 moiety ppm CDCl3 solution indi cat vecoordinated triphenyltin centre Coordination tin atom organotin compound relate coupling constant coupling con stant synthesize compound give Table case butyl derivative compound small space couple easily atom 119Sn chemical shift value give information envi ronment tin atom spectra record dmso coordinate solvent 119Sn shift depend electronreleasing power alkyl aryl group also nature rnsnx4 electronreleasing power alkyl group increase electronegativity decrease tin atom become progressively shielded 119Sn value move high important prop erty 119Sn chemical shift increase coordina tion number tin usually produce large upeld shift 119sn Holecek other suggest value coordinate vecoordinated ppm coordinate tin atom relative Refs 119Sn nmr spectra complex show sharp singlet indicate formation single specie however value strongly dependent nature orientation organic group bond tin shift observe complex explain quantitatively term increase electron den sity tin atom coordination number increase 119Sn chemical shift value measure coordinate solvent synthesize compound show pentacoordination CH3 CH3 CH3 CH3 scheme possible tautomeric form tin trigonal bipyrimidal geometry infer result geometry tin solid solution state conclude complex seem act monodentate neutral ligand coordinate tin oxygen atom intramolecular hydrogen bond still exist Scheme Crystal structure molecular structure triphenyltinchloride dimethylphenyliminomethylphenol crystallographic numbering scheme show crystal datum select bond distance angle give table respectively complex exist monomer coordination tin centre complex dene phenyl group oxy gen atom phenolic group chlorine atom geom etry atom determine value large basal angle around next large basal angle value perfect square pyramid unity perfect trigonal pyramidal geometry value cl1sn1 equal indicate distort trigonal bipyramidal geometry tin atom phenyl group locate basal plane occupy equatorial position electronegative atom occupy axial position trigonal bipyramid phenolic oxygentin bond distance corre spond much weak interaction similar value report triphenyltin compound droxyl atom involve intramolecular interaction imine atom select bond length bond angle give Table detail hydrogen bond give Table case free ligand phenolic atom attach nolic atom enol imine form form hydrogen bonding imine atom case complex pheno lic atom transfer imine atom keto amine form form hydrogen bond phenolic atom show crystal structure free ligand bond length show double bond character complex bond length increase show single bond character also C48 bond length free ligand complex bond length decrease c19 show double bond charac ter keto form thus information show case free ligand imine form dominant case adduct amine form dominant molecular packing structure show spectroscopy interaction azomethine organotin com plexe DNA examine Vis spectroscopy order get information mode interaction bind ing strength effect vary concentration dna electronic absorption spectra Table angle base NMR parameter select organotin derivative compound 119sn Angle H3C H3C Scheme Structure suggest coordination Fig platon diagram Ph3SnClHL Table Crystal datum structure renement parameter Ph3SnClHL Formula C33H30ClN2O2Sn Formula weight Crystal system monoclinic group Crystal habitsize yellow prism Total reection Total unique datum observe datum 0342p wr2 maximum average shifterror Minimum maximum residual density goodness organotin complex show increase concentration dna absorption band com plexe affect result tendency hypochromism strong absorption compound near region attribute longliving triplet excited state aromatic system binding dna cause hypochromism slight shift observe increase concentration dna spectral characteristic indicative bind dna hypochromic effect spectral feature dna concern doublehelix structure spec tral change process reect change conformation structure dna complex bind Hypochro mism result contraction helix dna well conformational change dna result damage doublehelical structure DNA intercalation bind dna orbital bind gand couple orbital base pair dna coupling orbital partially lle electron thus decrease transition probability hence result icity result suggest organotin complex interact DNA intercalation mode interac tion hypochromic effect observe signicant change shift spectral prole indication weak interaction dna stability bind property complex study DNA examine take spectra result obtain base variation absorbance associationbinde constant complex DNA determine accord ing equation KDNA associationbinding constant absor bance drug complex DNA respectively absorption coefcient drug drug dna complex respectively association constant taine interceptslope ratio dna plot value bind constant calculate peak spectra Table selected bond length bond angle Ph3SnClHL Bond length C26 c34 sn1 C19C20 sn1c13 C19C24 c19 C48 C24C25 C25 C42 Bond angle cl1sn1 cl1sn1c13 sn1c13 cl1sn1 C26C31 Sn1C19 Table Hydrogenbond geometry Ph3SnClHL Symmetry code Fig molecular packing Ph3SnClHL view axis dotted line show intramolecular bonding bind constant value respectively gibb0 free energy determine general gas constant temperature gibb0 free energy value mol respectively negative value show interaction compound DNA spontaneous process Viscometric study viscometric technique effective tool clarify mode interaction small molecule dna viscosity dna sensitive dna length change therefore measurement Fig absorption spectra absence presence dna arrow direction indicate increase concentration dna inside graph plot dna determination bind constant free energy DNA adduct Fig absorption spectra ch33snclhl absence presence dna arrow direction indicate increase concentration dna inside graph plot dna determination bind constant free energy ch33snclhldna adduct addition compound often consider least ambigu ous critical method clarify interaction mode compound DNA provide reliable evidence bind mode relative viscosity measurement prove reliable method assignment mode bind compound dna case classic intercalation dna base pair separate order host bind compound result lengthen DNA helix subsequently increase dna viscosity hand bind compound exclu sively DNA groove mean partial condition cause bend kink DNA helix reduce effective length Fig absorption spectra absence presence dna arrow direction indicate increase concentration dna inside graph plot dna determination bind constant free energy C4H93SnClHLDNA adduct Fig absorption spectra C6H53SnClHL absence presence dna arrow direction indicate increase concentration dna inside graph plot dna determination bind constant free energy c6h53snclhldna adduct result DNA viscosity decrease remain unchanged groove binder electrostatic interaction lengthen DNA molecule series solution make constant concentration dna vary concentration com pound sample allow equili brate min ow time measurement value relative viscosity calculate ratio sample represent time DNA solution compound respectively plot compounddna ratio Fig show viscosity increase addition increase amount compound therefore intercalation mode select interaction DNA Enzymatic study effect various concentration organotin complexe activity enzyme study hydrolysis pnpp tase catalyze transfer phosphate group water hydroly sis alcohol transphosphorylation use wide variety phosphomonoester characterize high optima broad substrate specicity study serve presence organotin complex sult deactivation enzyme activity enzyme markedly decrease increase concentration organotin complex almost completely lose high concentration remarkable activity ligand due group play important role enzy matic activity study azomethine organo tin complex high activity exhibit Ph3Sn derivative low activity organotin complex probably due formation stable bond complexation tin oxygen atom different behavior triphenyl tin complex due weak interaction ligand tin bulky phenyl group thereby regulate mation R3Sn moiety play key role inhibition alkaline phosphatase enzyme inhibition show Fig antimicrobial activity cytotoxicity vitro biological screening test synthesize ligand organotin complex carry antibacterial activity experiment perform triplicate use agar welldiffusion method use positive control criterion activity base zone inhibition inhibition zone show signicant activity zone inhibition activity good low nonsignicant activity antibacterial study demonstrate compound ligand compound activity test bacteria show signicant activity path ogenic strain aureus luteus bronchiseptica show signicant activity strain aureus luteus coli bronchiseptica activity exhibit coli well use positive control show low good activity pathogenic strain show nonsignicant good activity test strain result show Table synthesize ligand organotin also sub jected antifungal activity test fungal strain naria species specie fumigatus use tube dilution method result show Table Terbinane use standard drug assay criterion activity base percent growth inhibition growth inhibition consider signicant activity inhibition activity good inhibition activity moderate inhibition activity graphical representation inhibition organotin complex Fig effect increase amount compound relative viscosity dna DNA consider nonsignicant result show synthe sized organotin complex general activity ligand case Complex show growth inhibition test fungal strain drug similarly complex show signicant inhib iting activity strain less compound Com plexe show good activity test strain antimicrobial activity azomethine express considerable enhancement coordination metal ion increase activity due fact struc ture mainly possess additional bond report early azomethines nitrogen oxygen donor system inhibit enzyme activity enzyme require group activity appear especially susceptible deactivation metal ion coordination exact biochemical mechanism completely understand mode action antimicrobial involve var ious target microorganism target include follow high activity metal complex due different property metal ion chelation polarity metal ion reduce due overlap ligand orbital partial share posi tive charge metal ion donor group thus chela tion increase penetration complex lipid membrane blockage metal bind site enzyme microorganism Tweedy0s chelation theory predict chelation reduce polarity metal atom mainly partial share positive charge donor group possible electron delocalization entire ring conse quently increase lipophilic character chelate favor permeation lipid layer bacterial membrane Interference synthesis cellular wall cause damage lead alter cell permeability character istic disorganize lipoprotein arrangement ultimately result cell death Deactivation various cellular enzyme play vital role metabolic pathway microorganism Denaturation cellular protein cause normal cellular process impair Formation hydrogen bond azomethine group active center various cellular ent result interference normal cellular process vii inhibition replication dna interact enzyme prosthetic group nonprotein group cytotoxicity study brineshrimp lethality method result summarize Table LD50 datum show test compound even ligand toxic LD50 value range comparison drug Tricaine LD50 value toxic compare test compound drug study conductance synthesize ligand complex ethanol fall range Scm2mol sug geste nonelectrolytic nature show stabile hence undergo ionization electrochemical characterization redox behaviour study cyclic voltammetry mVs scan rate saturate solu tion ethanol initially start record potential limit 1st voltammogram start positive direction oxidation peak observe show compound oxidiz able condition correspond peak observe reverse scan indicate oxidation product compound reducible response also show absence peak cathodic part vol tammogram indicate stability oxidation state case therefore oxidation complex always record positive going direction rst scan show single irreversible oxidation peak anodic peak complex attribute oxida tion group attribution strengthen appearance irreversible anodic peak region guanine due oxidation group report early electrochemist high oxidation potential Table Antimicrobial Activity organotin compound Compound Antibacterial Antifungal Average zone inhibition inhibition mean value percent growth inhibition aureus pneumonia luteus aerogene coli brochiseptica Flavus solani niger fumigatus Terbinanec Show activity drug antibacterial activity drug antifungal activity activity Standard deviation inhibition fungal growth linear growth test linear growth vehicle control indicate difcult oxidize compare ion electron imine group make cult involvement lone pair electron hydro gen bonding hydrogen phenolic group result also support crystallography nmr spectroscopy high peak current link great mobility molecular mass low record suc cessive scan solution clean electrode surface decrease peak current complex observe 2nd scan show Fig decrease peak current explain adsorption oxidation product surface low er available electrode surface area cv also obtain different scan rate saturate solution increase scan rate slight shift peak potential positive value observe difference peak potential potential peak half height diffusioncontrolled irreversible system aan anodic charge transfer coefcient number electron ratedetermining step calculate peak current ampere irreversible system give number electron transfer oxidation number scan electrode area cm2 diffusion coefcient concentration mol plot assume value obtain similarly value diffusion coefcient calculate respectively low value correspond slow mobility great molecular mass cyclic voltammetric behavior absence presence DNA bare GCE show Fig voltammogram presence DNA register crease peak current rationale diminution peak current probable decrease concentration free formation macromolecular dna complex interac tion DNA expect cause alteration dna copying machinery stop proliferation cancerous cell similar behavior observe weak current signal noise allow quantitative measurement conclusion ligand dimethylphenyliminomethylphenol organotin complex successfully synthesize ligand treat different organotin chlo ride form correspond complex conclude ligand coordinate oxygen atom lead formation coordinate tin specie synthesize compound show moderate antimicrobial cytotoxic activity Table Cytotoxicity organotin compound compound shrimp kill dilutiona LD50 datum base mean value replicate compare standard drug Tricaine methanesulfonate LD50 value scan ethanol 1st scan ethanol 1st scan 2nd scan ethanol cv absence presence dna conductance ligand complex record ethanol room temperature fall range Scm2 mol suggest nonelectrolytic nature result cyclic voltammetry reveal intercalative mode interaction compound dna dominant mode negative value free energy change indicate spontaneity interaction Elec trochemical characterization reveal compound irreversibly oxidize glassy carbon electrode vary sequence acknowledgment author gratefully Associate Professor QuaidAzam University Islamabad Pakistan fruitful discussion Professor help 119Sn nmr measurement perform PhD student nancial support also greatly Appendix Supplementary material datum structure report paper deposit CCDC complex copy information obtain free charge CB2 Fax mail depos ccdccam MetalBased drug Organomet Chem Special issue recent Advances Organotin Chemistry Editorial Eur Med Chem Pellerito Nagy Coord Chem Rev Met Chem Saxena Tandon Crowe Polyhedron Varsheny Appl Polyhedron Zarracino quinone Hop Organomet Chem Kawakami MiyaUchi Tanaka Inorg Nucl Chem Pettiniari Pettiniari Troyanov Inorg Chim Acta Dey Saha Das Polyhedron Organomet Chem Powell Appl Carraher Eds Macromolecules Containing Metal York Chap Lin Kokot Anal Biochem Armarego Chai Eds 5th Zhang Wang Nucleic Acids Ahlers Biochem Chinese Chem Lett New York Harwood Academic Publishers Sedaghat Jalilian Kumar Tiekink Dalton Trans Yearwood Popovic MatkovicCalogovic Yeap Declercq Polyhedron Lockhart Manders Lockhart Nadvornik Handlir Holecek Handlir Lycka Pejchal Holecek Nadvornik Lycka Collect Pruchnik Ciunik Rao Dalton Trans Shujha Chem Zhang Yuan Zhao GonzalezRuiz Olives Biomedical Engineering Trends Research isbn Biochem Merz MetzlerNolte Acta Chaudhary Elem Prasad Kumar Thangadurai Natarajan Trans Met Chem Kurup Wiley principle method application Press",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "Azomethine": 2,
                    "Organotin": 2,
                    "Azomethines": 1,
                    "Enzymatic": 2,
                    "azomethine": 2,
                    "Tricaine": 1,
                    "Chinese": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        },
        {
            "paper_name": "__using imidazole _catalytic_ in aqueous medium_ and the vibrational spectroscopic studies on 6-amino-4-_4_-methoxyphenyl_-5-cyano-3-methyl-1-phenyl-1_ 4__.pdf",
            "cleaned_text": "list available Acta Part Molecular Biomolecular Spectroscopy ourna page efcient simple approach synthesis pyranopyrazole use imidazole catalytic aqueous medium vibrational spectroscopic study use density functional theory Chemistry Bangalore Article history receive receive revise form hydrate acetoacetate vibrational spectroscopic analysis describe onepot component synthesis pyranopyrole aryl aldehyde ethyl acetoacetate malononitrile hydrazine hydrate presence catalytic amount organocatalyst imidazole water medium plausible mechanism formation catalyze pyranopyrazole envisage method rapid simple provide product good yield ecofriendly addition base optimize geometry frequency intensity vibrational band obtain density functional theory calculation use g basis set vibrational frequency calculate scale value com pare experimental Raman spectra observe calculated frequency find good agreement Elsevier right reserve introduction Pyranopyrazoles fuse heterocyclic compound possess many biological property fungicidal bacterici dal vasodilatory activity act anticancer agent also nd application pharmaceutical ent biodegradable agrochemical apart pyranopyrazole show act potential insecticidal molluscicidal agent result considerable attention focus development new methodology synthesis heterocy cle Multicomponent reaction MCRs reaction reactant react together give product single step suitable reaction condition mcr offer advantage simplicity synthetic efciency tional chemical reaction mcr additional advantage selectivity synthetic convergency atomeconomy use water solvent active area research Corresponding author mail address mafpashagmailcom pashaymailcom green chemistry number classic reaction car rie strictly anhydrous condition hazardous toxic organic solvent also carry water proper use catalyst reaction condition mcr carry water medium offer well environ mental protection hence consider clean green reaction Pyranopyrazole rst synthesize reaction methylphenylpyrazolinone later report onepot component reac tion pyrazolone aromatic aldehyde malononitrile presence triethyl amine catalyst ethanol get pyranopyrazole method report condensation methylpiperidone pyrazolineone malononitrile absolute ethanol report method use mixture methyldihydropyrazol malononitrile different aromatic aldehyde presence ammonium acetate ethanol compo nent reaction aldehydes ethyl acetoacetate malononitrile hydrazine hydrate water catalytic cyclodextrin report reac tion carry Shestopalov use catalytic amount triethyl amine ethanol however report see front matter right reserve saa Acta Part Scheme method associate disadvantage use expensive environmentally hazardous reagent low yield product drastic reaction condition tedious work proce dure continuation work synthesis biologically active heterocyclic organic compound 14a herein report simple efcient synthesis pyranopyrazole component reaction aromatic aldehyde ethyl acetoacetate malononitrile hydrazine hydrate presence organocatalyst imidazole water Scheme method environmentally friendly car rie water involve use inexpensive ecofriendly organocatalyst give high yield product min result discussion detailed exploration reaction ethyl acetoacetate malononitrile hydrazine hydrate presence imidazole consider optimiza tion amount catalyst use study effect solvent rate reaction initially reac tion carry absence catalyst product find even min Addition mmol imidazole afford product low yield increase amount imidazole mmol give yield increase amount catalyst increase product yield next order investigate effect solvent reaction carry conventional organic solvent ethanol water Water solvent provide good yield compare ethanol order establish generality catalyst successfully apply reaction various araldehyde hydrazine hydrate result study present Table clear table excellent product yield obtain aryl heteroaryl aldehyde furthermore reaction compatible presence various functional group OCH3 NO2 NH2 CH3 Fig Structure C15H14N4O2 table Synthesis pyranopyrazole various aromatic aldehyde malononitrile ethyl acetoacetate hydrazine hydrate Entry aromatic aldehyde Producta Time min yield MeO OMe O2N OMe MeO OMe MeO NO2 product know identie comparison spectra melting point authentic sample prepare know method isolate yield compound characterize NMR spectral analysis Acta Part Scheme plausible mechanism formation pyranopyrazole Fig numbering system adopt optimize structure aminomethoxyphenylcyanomethylphenyldihydropyranopyrazole Acta Part Table optimize bond length bond angle H30 H30 H31 h31 H30 O11 H34 C34 H32 H34 H33 c19 H33 C10 H32H34 C18 H34 N20 O11H34 O29 O11C12 O11C12 H33 c12h13 c19 C12H15 H33 N16N17 C10 N16H23 C18 N17C18 c19 C18C24 o20 C19N28 C19N28 C24 C18N17 C34H35 N20O29 N20H21 N20H22 O29C10 Experimental chemical commercial use reaction monitor use Silica gel tlc plate synthesize compound character ize NMR spectral analysis compare product TLC comparison melt point product prepare know method NMR spectra record spectrophotometer spectra record spectrophotometer attenu ate total reectance ATR module Raman record solid phase MultiRAM Raman spec trophotometer use YAG laser operate excitation source resolution vibrational spec troscopic study aminomethoxyphenylcyano methylphenyldihydropyranopyrazole do record Raman spectra region respectively typical procedure preparation pyranopyrazole aromatic aldehyde mmol malononitrile mmol ethyl acetoacetate mmol hydrazine hydrate mmol imidazole mmol take water heated preheat hot plate min various aromatic aldehyde use table optimize dihedral angle aminomethoxyphenylcyanomethyl angle H30 C18 H31 H33C10 H30H31 O11 N20 C34 O29 H30C34 C19O29 C18C10N16 H31 C18C10O29 h32 C18N17 c34 c10c18c24 N20H21 H33 O29N20H21 O29C10 H33 N20O29C10 c34 C10N16N17 C34H35 C10N16H23 H32C34 O29C10N16N17 H32C34H35 o29c10n16h23 O11C12 C10O29 C34O11C12 n16c10o29 c34 O11C12H13 C34H35 O11C12H14 o11c34 o11c12c15 O11C34H35 C10N16N17C18 H23N16N17C18 c19 n16n17c18 N16N17C18C24 c19 C18C24H25 H33 c18c24h26 h33c19 c18c24h27 C10 C18 N17C18C24H26 yield product time take completion reaction summarize Table Mechanism plausible mechanism formation imidazole catalyze pyranopyrazole envisage formation pyranopyrazole catalyze imidazole involve protonation ethyl acetoacetate imidazole follow intermolecular attack hydrazine hydrate subsequent loss water intramolecular nucleophillic attack group carbonyl carbon give similarly protonation aldehyde imidazole reaction iminoacrylonitrile afford benzylidenemalononitrile III Addition III presence imidazole follow rearrangement give expect pyranopyrazole show Scheme vibrational spectroscopic study aminomethoxyphenylcyanomethyl organic molecule provide insight important molecular prop erties Knowledge electronic structure spectral property help understand biological activity density functional theory quantum mechanical theory use Acta Part Table Comparison calculated experimental vibrational frequency character intensity raman intensity freq Raman freq n28c19c7c6 O11C1C34C5 torsion nitrile group C1C5C34 C12O11C5 N28C19C7C6 Phenyl ring def C4C34C5 C2C1C5 plane bend phenyl ring N28C19C7 C19C7C9 bend nitrile group n17n16c10c8 H26C24C18C8 C18N17N16C10 Pyrazole ring torsion C4C34C5C1 C2C1C5C34 C3C2C1C5 Phenyl ring torsion c1c5 stretch ether O11C5 linkage c3c2c1 stretch N17C18 H25C24H27 N25C24C18C8 Methyl ring wag attach pyrazole ring h22n20c9 stretch pyran ring O11C12 stretch ether attach phenyl ring N17N16 stretch pyrazole ring H14C12H13 plane bend torsion methyl group attach ether linkage h13c12o11c5 h14c12o11c5 C3C2 H33C6C3 stretch phenyl ring HCC asym bending Phenyl ring bend 1328vw 1363vw h26c24h25 h25c24h27 plane bend methyl group attach pyrazole N17C18 H23N16N17 stretch bend pyrazole ring def H27C24H26 HCC sym bend methyl group attach pyrazole ring h26c24h25 h26c24c18c8 H25C24H27 h26c24h25 HCC asym bend CH3 group attach pyrazole ring group bend methoxy group N16C10 O29C10 H23N16N17 n16c10c8 stretch HNN bend pyrazole ring stretch pyran ring C10C8 H21N20H22 stretch pyran ring plane NH2 bend C34 Phenyl ring breathe C2C1 C3C2 C10C8 Ring breathing pyran ring NH2 bend n20c9 H21N20H22 Siddekha Spectrochimica Acta Part Table continued Mode Calculated Experimental PED approximate character intensity raman intensity freq Raman freq 2191vs 2191vs n28c19 c19 nitrile group c6h33 stretch stretch methyl group attach ether linkage C24 H25 C24 H26 C24 H27 sym stretch methyl group attach pyrazole ring C12H14 asym stretch methyl group attach ether linkage C4H32 asym stretch phenyl ring sym stretch phenyl ring N20H21 stretch group attach pyran ring stretch pyrazole ring N20H21 asym stretch NH2 group attach pyran ring bend torsion stretch asym asymmetric symmetric def deformation investigate electronic structure ground state manybody system particular atom molecule Raman spectroscopy recently prove valuable tool investigation complex molecule biological interest recently vibrational spectral study theoretical computa tion relate natural coumarin derivative violet perchlorate molecule dichloro nitrophenol appear literature Atalay report theoretical study molecular struc ture vibrational spectra aminophenylthiadiazole aminobenzoylphenylpyrimidin successfully use density functional method study spec tral property molecule phenylthienylmethylene hydrazine thiophenmethylthiophen benzimidazole paper report interpretation vibra tional spectra computation relate structure dihydropyranopyrazole Fig use density functional theory computational detail density functional theory calculation carry use Gaussian package Equilibrium structure vibrational frequency optimize use functional g basis set Frequency calculation carry optimize structure use program available Gaussian software Equilibrium symmetry predict energy Hartrees potential energy distribution carry use program spectrum aminomethoxyphenylcyanomethylphenyldihydropyranopyrazole Part Transmittance Wavenumber Fig spectrum aminomethoxyphenylcyanomethylphenyldihydropyranopyrazole spectrum aminomethoxyphenylcyanomethylphenyldihydropyranopyrazole Intensity Wavenumber Fig Raman spectrum mized geometry molecule numbering system give optimize bond length bond angle present Table optimize dihedral angle give Table vibrational analysis dihydropyranopyrazole atom hence mode fundamental vibration predict equilibrium metry molecule energy hartrees detail vibrational analysis carry assign ment observed fundamental band propose basis peak position relative intensity contribution observed frequency give reliability precision spectral analysis calculated harmonicvibrational frequency observed transmittance spectrum aminomethoxyphenylcyanomethylphenyldihydropyranopyrazole transmittance wavenumber spectrum aminomethoxyphenylcyanomethylphenyldihydropyranopyrazole Raman frequency various mode vibration present table comparison calculate frequency experimental value indicate overestimation calculated vibrational mode due neglect anharmonicity real system hence computed frequency multiply scale factor offset systematic error cause neglecting give good agreement observe frequency calculation provide valuable insight vibrational spectrum molecular parameter pyrazole ring methyl substituent pyran ring nitrile amino group phenyl ring methoxy substituent pyran C10O29 pyrazoleC10C18N16N17 fuse together lie plane phenyl ring C34 lie perpen dicular plane fuse ring hence vibrational spectral analysis perform base characteristic vibration methyl group amino group nitrile group methoxy group phenyl ring Raman spectra show group vibration molecule consideration methyl group attach pyrazole ring side chain phenyl ring methoxy substituent asymmetric stretch mode methyl group expect around symmetric stretch molecule symmet ric stretch methyl group vibration record Raman consistent predict value asymmetric stretch vibration compute match Raman spectrum symmetric asymmetric bend vibration methyl group normally expect region respectively asymmetric bend methyl group observe Raman good agreement theoretically calculate value symmetric bending calculate observe medium band plane bend torsion methyl group attach ether linkage calculate experi mentally see group vibration NH2 wag compute observe stretch group attach pyran ring calculate good agreement experimental value respectively asym stretch NH2 group attach pyran ring calculate appear observe Raman stretch pyrazole ring calculate also see nitrile group stretch vibration generally occur region difcult assign band get mixed several band study pyrazole ring contain bond show stretch vibration Raman consistent calculate frequency bend vibration characteristic band nitrile group attach pyran ring observe Raman spec tra good agreement computed value torsion nitrile group calculate agree observed value pyrazole ring calculate consistent experimental value raman spectrum vibration generally stretch plane bending plane bend vibration appear range plane bend methyl group attach pyrazole ring calculate experimentally observe Raman weak band stretch hydrogen attach pyran ring observe raman spectrum match predicted frequency group vibration ether linkage form cyclic ether pyran ring methoxy group attach phenyl ring stretch calculate CH3 cyclic ether find consistent record value Raman calculated Stretch pyran ring NH2 coincide well observed value Raman spectra Phenyl ring vibration asymmetric stretch phenyl ring calculate experimental value respectively symmetric stretch phenyl ring calculate good agreement value Raman spectrum Phenyl ring breathing observe agree computed value Phenyl ring deformation com puted agree record value Raman plane bend phenyl ring calculate observe phenyl ring torsion agreement observed value convenient efcient protocol develop synthesis pyranopyrazole high yield use catalytic amount imidazole organocatalyst water demonstrate synthesis milder fast require tedious work procedure effort make present study optimize structure C15H14N4O2 geometric parameter vibrational frequen cie calculate use method g basis set theoretical result experimental value tiplied gain multiplication factor find good agreement experimental value Raman result conrm validity potential energy distribution observe frequency organic molecule possess similar functional group synthesize structure study use calculation vibrational spectral analysis find vibrational frequency value report corresponding functional group consistent val ue observe functional group present acknowledgment gratefully New Delhi short term Bangalore help Raman spectral analysis dur ing Summer Research Fellowship programme author also like record NMR spectra Science Bangalore edit manuscript Wunder PCT Indian Chem 36b Der Junek aigner Synthesis Sharanina Marshtupa Puzanova Org Kandhasamy Serb Metz Metwally Zhu Bienayme Eds Multicomponent reaction Total Synthesis Natural Products WileyVCH Yakovenko Magedov Kornienko Org Chem Bienayme Shestopalov Emeliyanova Shestopalov Niazimbetova Pasha Jayashankara Pharmacol Toxicol heterocycle Pasha Jayashankara Synth Commun Jayashankara vol Wiley Chichester Proceedings Trendalova Int Quant Chem Georgieva Trendalova Zhu Jiang THEOCHEM Vogel Gbureck Kiefer Mol struct Spectrosc Part Spectrochim Acta Yakuphanoglu Atalay Sekerci Spectrochim Acta Sekerci Atalay Yakuphanoglu Avci Basoglu Spectrochim Acta Barone Nakatsuji Toyota Honda Montgomery Brothers mand Burant Iyengar Millam Salvador Foresman Wallingford Phys Rev Jamroz Vibrational Energy Distribution Analysis Warsaw PROGRAM Assignments Vibrational Spectra Benzene derivative Raman Ramalingam Sethuraman tian Acta",
            "term_counts": {
                "Mental Health Terms": {},
                "Epigenetic Terms": {},
                "Socioeconomic Terms": {},
                "Ethnographic Terms": {
                    "H21N20H22": 1,
                    "Gaussian": 2,
                    "pyrazoleC10C18N16N17": 1,
                    "C15H14N4O2": 1,
                    "tian": 1
                }
            },
            "co_occurrence_matrix": {},
            "disparity_metadata": {
                "ethnicity": "Unknown",
                "socioeconomic_status": "Unknown"
            }
        }
    ],
    "global_summary": {
        "total_term_counts": {
            "Mental Health Terms": {
                "bipolar": 2,
                "depression": 5,
                "anxiety": 1
            },
            "Epigenetic Terms": {
                "epigenetic": 448,
                "demethylation": 791,
                "methylation": 3046,
                "5mC": 30,
                "H3K27me3": 17,
                "FKBP5": 5
            },
            "Socioeconomic Terms": {},
            "Ethnographic Terms": {
                "methyltrans": 16,
                "daugh": 2,
                "methylenetetra": 2,
                "MeCpGdinucleotide": 4,
                "Tat": 8,
                "SN2": 8,
                "Clusterin": 2,
                "Hotchkiss": 2,
                "zincfinger": 4,
                "MBD1": 36,
                "MBD3": 18,
                "ZBTB4": 5,
                "Dnmts": 2,
                "Methylbinding": 4,
                "Tet": 4,
                "Han": 8,
                "Shellnut": 2,
                "Methylsensitive": 2,
                "Southern": 4,
                "SINEs": 4,
                "statis": 3,
                "Pufulete": 2,
                "Western": 13,
                "MethylampGlobal": 2,
                "angiopoietin": 2,
                "Re1": 2,
                "isoxazole": 1,
                "CXXCcysteine": 1,
                "Vavouri": 1,
                "Szulwach": 2,
                "TSSs": 1,
                "HIST1H1D": 1,
                "H1foo": 1,
                "posttrans": 1,
                "Szenker": 1,
                "HIST1H4C": 1,
                "Islam": 1,
                "Dunican": 2,
                "analy": 1,
                "Hakka": 3,
                "chemis": 1,
                "involv": 2,
                "Sirjean": 1,
                "MPTPinduced": 1,
                "antiAMPK": 1,
                "AMPKamyc": 1,
                "Capil": 1,
                "Glycans": 1,
                "Proteoglycans": 1,
                "sialoglycans": 1,
                "Sphingoglycolipids": 1,
                "Rigaku": 1,
                "Gaussian": 4,
                "Zhang": 2,
                "azomethine": 3,
                "Thionyl": 1,
                "Sritrairat": 6,
                "intrasubject": 1,
                "gentian": 1,
                "Africa Gentian": 1,
                "Thai": 2,
                "secoirids": 1,
                "Gentian": 1,
                "Zairian": 1,
                "dimethylpyrrolineoxide": 1,
                "Mutat": 2,
                "Heme": 1,
                "Mammalian": 4,
                "Indole": 1,
                "CpG": 2,
                "SwissProt": 1,
                "S32S37": 1,
                "NuRDMi2": 3,
                "British": 1,
                "Italian": 1,
                "Mbd1": 2,
                "CreloxP": 1,
                "kd1": 3,
                "Pyrazol pyrimidinamines Jak2": 1,
                "hetero": 1,
                "Dichlorocyclopropylpyrazolpyrimidin": 1,
                "trichloropyrimidine": 1,
                "Dichlorofluoromethoxypyrazolpyrimidin": 1,
                "Conservative": 1,
                "isocyanate7": 1,
                "hydroxyethylpiperazine9": 1,
                "cistrans": 3,
                "concentrat": 4,
                "Chiracel": 1,
                "European": 6,
                "French": 1,
                "coe": 1,
                "chromatinDNAmodifying": 1,
                "Somatic": 1,
                "promoterproximal": 1,
                "Azacytidine": 1,
                "Meiotic": 1,
                "Boezeman": 1,
                "H3K18": 4,
                "methy": 3,
                "Tc1Tc2": 1,
                "Hornstra": 1,
                "DNMT1s": 2,
                "contri": 1,
                "DNAbinding": 1,
                "Czech": 1,
                "Herbicidal": 1,
                "HgCI2": 1,
                "influ": 3,
                "ischemichypoxic": 3,
                "Inuit": 5,
                "Canadian": 2,
                "Cana dian": 1,
                "AhRagonists": 1,
                "cisNonachlor": 1,
                "inacti": 1,
                "Omniscript": 2,
                "Pyr": 1,
                "Greenlandic Inuit": 1,
                "Cocarcino": 1,
                "Perspect": 3,
                "Neurotoxicol": 1,
                "dra": 1,
                "Australian": 1,
                "Barnerjee": 1,
                "deox": 1,
                "CTCCTTAATGTCACGCACGATTTC": 1,
                "SP1": 4,
                "MGMTsilenced": 2,
                "TSAsensitive": 1,
                "HpaII EcoRI": 2,
                "Mexican": 1,
                "African American": 1,
                "Caucasian": 3,
                "FLAGPol": 25,
                "Pol": 3,
                "LC3": 1,
                "NeoFLAGPol": 1,
                "MPGoverexpressing": 1,
                "Alkylating": 1,
                "pIRESNeotrans": 1,
                "VADFMK": 1,
                "Hui": 2,
                "Chinese": 8,
                "Ibeanu": 1,
                "AgCl": 1,
                "DGEBAPEEKMOH6": 2,
                "PEEKMOH6": 1,
                "TgKTg0": 1,
                "Swiss": 4,
                "Twentytwo": 1,
                "Leishmaniaendemic": 1,
                "PseKNC": 1,
                "Korean": 1,
                "Nazari": 1,
                "Identication": 1,
                "Articial": 1,
                "deconvolve": 1,
                "German": 1,
                "Contam": 3,
                "METHYLBINDING": 2,
                "Mbd3": 1,
                "AdoHcy": 8,
                "Canadians": 1,
                "Atheroscle": 1,
                "Samoan": 1,
                "Americans": 1,
                "crystallography8": 1,
                "Vrigid": 8,
                "Biomol": 1,
                "Spectrosc": 2,
                "approxima": 1,
                "Vrigidvalues": 3,
                "simula": 2,
                "RFAST": 3,
                "NMRactive": 1,
                "GSTP1": 8,
                "PCNA1": 1,
                "TTTTCTTGCTGCCAGTCTGGAC": 1,
                "elimi": 1,
                "CACNA1": 1,
                "MBDcontaining": 4,
                "Mammalian MBD3": 1,
                "NBL2 nonsatellite": 1,
                "MBD1 MBD3": 2,
                "NBL2": 1,
                "Darwinian": 1,
                "Semiquantitative": 1,
                "DHmPEO": 1,
                "noncrystallinecrystalline": 1,
                "PEOPMVE": 1,
                "contra": 2,
                "Heraty": 1,
                "sentative": 1,
                "LiBETI": 1,
                "Salitra": 1,
                "PolyPak": 1,
                "I481": 1,
                "D760": 2,
                "imperdiet": 14,
                "metus": 8,
                "interdum": 16,
                "venenatis": 9,
                "Vestibulum": 4,
                "Interdum": 4,
                "Suspendisse": 6,
                "pharetra": 4,
                "arcu": 12,
                "Neque porro quisquam": 7,
                "Proin": 7,
                "Etiam": 4,
                "CH3IstannanePPh3CuICsF": 1,
                "trialkylphosphines": 2,
                "RNAbinding": 2,
                "nonmammalian": 1,
                "Kloet": 1,
                "LongEvans": 1,
                "Plexiglas": 2,
                "Phospho": 1,
                "Naive": 1,
                "dem": 1,
                "African": 1,
                "Cysrich": 1,
                "JmjCdomaincontaining": 1,
                "lian": 1,
                "TETinteracting": 1,
                "PEGmethyl": 1,
                "TNBSinduced": 1,
                "Vongsak": 1,
                "DMPOanalogs": 1,
                "stabilityof": 1,
                "ESRactive": 2,
                "adminis": 1,
                "Farmaco": 3,
                "Recrystallized": 1,
                "Subramanian": 1,
                "Chintan": 1,
                "CoMSIA": 22,
                "Calanolide": 1,
                "American": 1,
                "Ubiali": 1,
                "Terreni": 1,
                "hetCH3": 3,
                "ABH1": 1,
                "Arab": 1,
                "TFHlike": 1,
                "Ani": 1,
                "Mnatzakanian": 1,
                "Sonophotocatalytic": 1,
                "Varian": 1,
                "Sonophoto": 1,
                "Antisilencing": 1,
                "SUC2": 2,
                "Methylationsensitive": 1,
                "idm2": 5,
                "MBD74xMYC": 1,
                "SWR1": 2,
                "ABAhypersensitive": 1,
                "PDK1": 1,
                "mGluR5PKC": 1,
                "Hermans": 1,
                "Hioki": 1,
                "molecules18033183": 1,
                "semiocclusive": 1,
                "carboncarbon": 1,
                "followeds": 1,
                "CH2OCOH": 1,
                "HCO2 CH2OCOH": 1,
                "levels5": 1,
                "0CVWTG4GXKGYUGPGVKEU": 1,
                "Danish": 2,
                "benzazepine": 1,
                "Kir2 IRK1": 1,
                "ridazine": 1,
                "heteromul timeric": 1,
                "Azomethine": 2,
                "Organotin": 2,
                "Azomethines": 1,
                "Enzymatic": 2,
                "Tricaine": 1,
                "H21N20H22": 1,
                "pyrazoleC10C18N16N17": 1,
                "C15H14N4O2": 1,
                "tian": 1
            }
        },
        "top_relationships": {
            "('Mental Health Terms', 'Epigenetic Terms')": {
                "terms": {},
                "co_occurrence_count": 0,
                "jaccard_similarity": 0.0
            },
            "('Mental Health Terms', 'Socioeconomic Terms')": {
                "terms": {},
                "co_occurrence_count": 0,
                "jaccard_similarity": 0.0
            },
            "('Mental Health Terms', 'Ethnographic Terms')": {
                "terms": {},
                "co_occurrence_count": 0,
                "jaccard_similarity": 0.0
            },
            "('Epigenetic Terms', 'Mental Health Terms')": {
                "terms": {},
                "co_occurrence_count": 0,
                "jaccard_similarity": 0.0
            },
            "('Epigenetic Terms', 'Socioeconomic Terms')": {
                "terms": {},
                "co_occurrence_count": 0,
                "jaccard_similarity": 0.0
            },
            "('Epigenetic Terms', 'Ethnographic Terms')": {
                "terms": {},
                "co_occurrence_count": 0,
                "jaccard_similarity": 0.0
            },
            "('Socioeconomic Terms', 'Mental Health Terms')": {
                "terms": {},
                "co_occurrence_count": 0,
                "jaccard_similarity": 0.0
            },
            "('Socioeconomic Terms', 'Epigenetic Terms')": {
                "terms": {},
                "co_occurrence_count": 0,
                "jaccard_similarity": 0.0
            },
            "('Socioeconomic Terms', 'Ethnographic Terms')": {
                "terms": {},
                "co_occurrence_count": 0,
                "jaccard_similarity": 0.0
            },
            "('Ethnographic Terms', 'Mental Health Terms')": {
                "terms": {},
                "co_occurrence_count": 0,
                "jaccard_similarity": 0.0
            },
            "('Ethnographic Terms', 'Epigenetic Terms')": {
                "terms": {},
                "co_occurrence_count": 0,
                "jaccard_similarity": 0.0
            },
            "('Ethnographic Terms', 'Socioeconomic Terms')": {
                "terms": {},
                "co_occurrence_count": 0,
                "jaccard_similarity": 0.0
            }
        }
    }
}